*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 86 HIS A 98 HIS^? -3.60 C ACT A 203s A 250 ALA A 135 ALA~? 6.35 OXT ACT A 203 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -52.93 68.60 64.38 -53.51 68.88 63.01 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 86 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 250 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP C 74 ASP^? 14.86 O ACT C 201 A 86 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 250 ALA C 135 ALA~? 15.67 O2 EDO A 301 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -49.12 46.81 68.31 -48.42 46.56 69.64 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 86 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 250 ALA D 135 ALA~? 18.41 CH3 ACT A 203 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -39.82 78.98 44.65 -40.33 80.39 44.94 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o00 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER A 101 SER.? 7.80 O2 EDO A 301 A 123 HIS A 98 HIS^? -3.60 C ACT A 203s A 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 45.74 29.80 42.79 47.58 31.06 41.64 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 44.17 25.61 37.60 45.21 25.56 35.81 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 39.85 24.35 34.94 41.12 25.58 33.83 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 A 98 SER B 101 SER.? 19.25 O ACT C 201 A 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 45.74 29.80 42.79 47.58 31.06 41.64 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 44.17 25.61 37.60 45.21 25.56 35.81 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 39.85 24.35 34.94 41.12 25.58 33.83 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 A 98 SER C 101 SER.? 7.85 O1 EDO A 301 A 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 45.74 29.80 42.79 47.58 31.06 41.64 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 44.17 25.61 37.60 45.21 25.56 35.81 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 39.85 24.35 34.94 41.12 25.58 33.83 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 A 98 SER D 101 SER.? 9.16 OXT ACT A 203 A 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 45.74 29.80 42.79 47.58 31.06 41.64 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 44.17 25.61 37.60 45.21 25.56 35.81 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 39.85 24.35 34.94 41.12 25.58 33.83 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o00 naa= 3 ULMN 5 1qfn_c00 GLUTAREDOXIN 1 user 1 5 # 1 A 8 ARG A 24 ARG~? 13.97 CH3 ACT A 201 A 10 GLY A 29 GLY~? 9.49 CH3 ACT A 201 A 13 TYR A 75 TYR^? -4.52 O ACT A 201s A 18 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 72 TYR A 95 TYR^? -3.85 O ACT A 201s coo 14.12 0.56 10.07 14.47 -1.43 12.53 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 11.68 8.58 8.27 11.25 8.03 8.62 -30.30 78.71 63.24 -31.02 78.43 63.55 coo 1.58 4.12 7.79 -0.96 4.19 9.09 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 9.96 -3.05 6.91 12.39 -3.56 11.39 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 1.66 -1.95 5.69 -0.06 -2.26 7.90 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 5 1qfn_c00 GLUTAREDOXIN 1 user 2 5 # 2 A 8 ARG B 24 ARG~? 14.02 CH3 ACT B 201 A 10 GLY B 29 GLY~? 9.46 CH3 ACT B 201 A 13 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 18 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 72 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 14.12 0.56 10.07 14.47 -1.43 12.53 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 11.68 8.58 8.27 11.25 8.03 8.62 -29.24 51.82 91.44 -28.87 51.66 90.72 coo 1.58 4.12 7.79 -0.96 4.19 9.09 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 9.96 -3.05 6.91 12.39 -3.56 11.39 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 1.66 -1.95 5.69 -0.06 -2.26 7.90 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 5 1qfn_c00 GLUTAREDOXIN 1 user 3 5 # 3 A 8 ARG C 24 ARG~? 14.09 CH3 ACT C 201 A 10 GLY C 29 GLY~? 9.51 CH3 ACT C 201 A 13 TYR C 75 TYR^? -4.54 O ACT C 201s A 18 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 72 TYR C 95 TYR^? -3.84 O ACT C 201s coo 14.12 0.56 10.07 14.47 -1.43 12.53 -40.53 35.15 48.39 -41.31 34.14 51.19 coo 11.68 8.58 8.27 11.25 8.03 8.62 -32.89 40.21 50.79 -33.62 40.36 51.16 coo 1.58 4.12 7.79 -0.96 4.19 9.09 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 9.96 -3.05 6.91 12.39 -3.56 11.39 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 1.66 -1.95 5.69 -0.06 -2.26 7.90 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 5 1qfn_c00 GLUTAREDOXIN 1 user 4 5 # 4 A 8 ARG D 24 ARG~? 13.98 CH3 ACT D 201 A 10 GLY D 29 GLY~? 9.48 CH3 ACT D 201 A 13 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 18 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 72 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 14.12 0.56 10.07 14.47 -1.43 12.53 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 11.68 8.58 8.27 11.25 8.03 8.62 -57.91 65.08 34.12 -57.15 65.32 34.32 coo 1.58 4.12 7.79 -0.96 4.19 9.09 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 9.96 -3.05 6.91 12.39 -3.56 11.39 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 1.66 -1.95 5.69 -0.06 -2.26 7.90 -48.26 66.56 42.41 -49.21 65.61 44.87 1qfn_c00 source 1qfn GLUTAREDOXIN 1 : 4 hits 1qfn_c00 naa= 5 ULMN 4 13pk_c00 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 A 39 ARG A 33 ARG.? 12.39 O ACT A 201 A 219 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 376 GLY A 145 GLY.? 13.13 O ACT A 201 A 399 GLY A 29 GLY~? 9.49 CH3 ACT A 201 coo -12.38 76.96 90.60 -12.31 75.41 87.97 -37.81 74.92 58.71 -38.09 77.66 57.35 coo -15.03 67.62 79.35 -16.01 71.68 83.38 -34.66 75.11 72.84 -31.25 72.89 69.03 coo -9.88 73.08 89.49 -9.40 72.65 89.00 -38.43 80.69 60.76 -38.91 80.43 61.42 coo -11.12 75.93 79.79 -10.82 76.54 80.30 -30.30 78.71 63.24 -31.02 78.43 63.55 ULMN 4 13pk_c00 3-PHOSPHOGLYCERATE KINASE user 2 4 # 2 A 39 ARG C 33 ARG.? 12.41 O ACT C 201 A 219 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 376 GLY C 145 GLY.? 13.18 O ACT C 201 A 399 GLY C 29 GLY~? 9.51 CH3 ACT C 201 coo -12.38 76.96 90.60 -12.31 75.41 87.97 -34.58 43.27 59.73 -33.36 40.62 60.70 coo -15.03 67.62 79.35 -16.01 71.68 83.38 -43.47 42.54 48.33 -38.69 45.48 48.28 coo -9.88 73.08 89.49 -9.40 72.65 89.00 -35.71 37.24 58.49 -36.57 37.39 58.47 coo -11.12 75.93 79.79 -10.82 76.54 80.30 -32.89 40.21 50.79 -33.62 40.36 51.16 ULMN 4 13pk_c00 3-PHOSPHOGLYCERATE KINASE user 3 4 # 3 A 39 ARG D 33 ARG.? 12.34 OXT ACT D 201 A 219 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 376 GLY D 145 GLY.? 13.27 OXT ACT D 201 A 399 GLY D 29 GLY~? 9.48 CH3 ACT D 201 coo -12.38 76.96 90.60 -12.31 75.41 87.97 -55.21 72.58 39.53 -56.74 74.11 37.37 coo -15.03 67.62 79.35 -16.01 71.68 83.38 -47.37 61.41 34.65 -51.85 60.71 37.83 coo -9.88 73.08 89.49 -9.40 72.65 89.00 -54.58 73.10 33.20 -53.72 72.98 33.25 coo -11.12 75.93 79.79 -10.82 76.54 80.30 -57.91 65.08 34.12 -57.15 65.32 34.32 13pk_c00 source 13pk 3-PHOSPHOGLYCERATE KINASE : 3 hits 13pk_c00 naa= 4 ULMN 4 13pk_c02 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 C 39 ARG A 33 ARG.? 12.39 O ACT A 201 C 219 LYS A 79 LYS^? -3.45 CH3 ACT A 201s C 376 GLY A 145 GLY.? 13.13 O ACT A 201 C 399 GLY A 29 GLY~? 9.49 CH3 ACT A 201 coo -3.47 26.80 67.67 -1.24 26.00 69.62 -37.81 74.92 58.71 -38.09 77.66 57.35 coo 5.22 26.79 80.32 0.48 26.84 77.06 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 1.35 28.76 68.50 2.09 28.66 68.61 -38.43 80.69 60.76 -38.91 80.43 61.42 coo 2.85 20.10 73.72 2.25 20.01 73.15 -30.30 78.71 63.24 -31.02 78.43 63.55 ULMN 4 13pk_c02 3-PHOSPHOGLYCERATE KINASE user 2 4 # 2 C 39 ARG C 33 ARG.? 12.41 O ACT C 201 C 219 LYS C 79 LYS^? -3.44 CH3 ACT C 201s C 376 GLY C 145 GLY.? 13.18 O ACT C 201 C 399 GLY C 29 GLY~? 9.51 CH3 ACT C 201 coo -3.47 26.80 67.67 -1.24 26.00 69.62 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 5.22 26.79 80.32 0.48 26.84 77.06 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 1.35 28.76 68.50 2.09 28.66 68.61 -35.71 37.24 58.49 -36.57 37.39 58.47 coo 2.85 20.10 73.72 2.25 20.01 73.15 -32.89 40.21 50.79 -33.62 40.36 51.16 ULMN 4 13pk_c02 3-PHOSPHOGLYCERATE KINASE user 3 4 # 3 C 39 ARG D 33 ARG.? 12.34 OXT ACT D 201 C 219 LYS D 79 LYS^? -3.52 CH3 ACT D 201s C 376 GLY D 145 GLY.? 13.27 OXT ACT D 201 C 399 GLY D 29 GLY~? 9.48 CH3 ACT D 201 coo -3.47 26.80 67.67 -1.24 26.00 69.62 -55.21 72.58 39.53 -56.74 74.11 37.37 coo 5.22 26.79 80.32 0.48 26.84 77.06 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 1.35 28.76 68.50 2.09 28.66 68.61 -54.58 73.10 33.20 -53.72 72.98 33.25 coo 2.85 20.10 73.72 2.25 20.01 73.15 -57.91 65.08 34.12 -57.15 65.32 34.32 13pk_c02 source 13pk 3-PHOSPHOGLYCERATE KINASE : 3 hits 13pk_c02 naa= 4 ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 D 39 ARG A 33 ARG.? 12.39 O ACT A 201 D 219 LYS A 79 LYS^? -3.45 CH3 ACT A 201s D 376 GLY A 145 GLY.? 13.13 O ACT A 201 D 399 GLY A 29 GLY~? 9.49 CH3 ACT A 201 coo 0.59 75.69 110.95 1.51 77.84 112.93 -37.81 74.92 58.71 -38.09 77.66 57.35 coo 1.28 85.37 123.16 0.84 80.41 120.28 -34.66 75.11 72.84 -31.25 72.89 69.03 coo -1.06 80.88 111.45 -0.91 81.65 111.55 -38.43 80.69 60.76 -38.91 80.43 61.42 coo 7.52 81.86 116.81 7.49 81.18 116.34 -30.30 78.71 63.24 -31.02 78.43 63.55 ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 2 4 # 2 D 39 ARG C 33 ARG.? 12.41 O ACT C 201 D 219 LYS C 79 LYS^? -3.44 CH3 ACT C 201s D 376 GLY C 145 GLY.? 13.18 O ACT C 201 D 399 GLY C 29 GLY~? 9.51 CH3 ACT C 201 coo 0.59 75.69 110.95 1.51 77.84 112.93 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 1.28 85.37 123.16 0.84 80.41 120.28 -43.47 42.54 48.33 -38.69 45.48 48.28 coo -1.06 80.88 111.45 -0.91 81.65 111.55 -35.71 37.24 58.49 -36.57 37.39 58.47 coo 7.52 81.86 116.81 7.49 81.18 116.34 -32.89 40.21 50.79 -33.62 40.36 51.16 ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 3 4 # 3 D 39 ARG D 33 ARG.? 12.34 OXT ACT D 201 D 219 LYS D 79 LYS^? -3.52 CH3 ACT D 201s D 376 GLY D 145 GLY.? 13.27 OXT ACT D 201 D 399 GLY D 29 GLY~? 9.48 CH3 ACT D 201 coo 0.59 75.69 110.95 1.51 77.84 112.93 -55.21 72.58 39.53 -56.74 74.11 37.37 coo 1.28 85.37 123.16 0.84 80.41 120.28 -47.37 61.41 34.65 -51.85 60.71 37.83 coo -1.06 80.88 111.45 -0.91 81.65 111.55 -54.58 73.10 33.20 -53.72 72.98 33.25 coo 7.52 81.86 116.81 7.49 81.18 116.34 -57.91 65.08 34.12 -57.15 65.32 34.32 13pk_c03 source 13pk 3-PHOSPHOGLYCERATE KINASE : 3 hits 13pk_c03 naa= 4 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 C 88 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 89 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 92 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 115 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 35.82 109.51 58.11 36.79 111.39 58.16 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 34.50 112.32 53.52 36.24 113.36 54.10 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 44.76 111.03 53.07 46.05 111.62 51.50 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 43.88 105.59 49.49 44.98 111.77 48.53 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 C 88 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 89 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 92 ASP D 99 ASP.? 7.94 CH3 ACT A 203 C 115 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 35.82 109.51 58.11 36.79 111.39 58.16 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 34.50 112.32 53.52 36.24 113.36 54.10 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 44.76 111.03 53.07 46.05 111.62 51.50 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 43.88 105.59 49.49 44.98 111.77 48.53 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 3 4 # 3 C 88 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 89 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 92 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 115 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 35.82 109.51 58.11 36.79 111.39 58.16 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 34.50 112.32 53.52 36.24 113.36 54.10 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 44.76 111.03 53.07 46.05 111.62 51.50 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 43.88 105.59 49.49 44.98 111.77 48.53 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 4 4 # 4 C 88 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 89 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 92 ASP B 99 ASP.? 16.09 OXT ACT B 201 C 115 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 35.82 109.51 58.11 36.79 111.39 58.16 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 34.50 112.32 53.52 36.24 113.36 54.10 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 44.76 111.03 53.07 46.05 111.62 51.50 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 43.88 105.59 49.49 44.98 111.77 48.53 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 5 4 # 5 C 88 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 89 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 92 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 115 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 35.82 109.51 58.11 36.79 111.39 58.16 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 34.50 112.32 53.52 36.24 113.36 54.10 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 44.76 111.03 53.07 46.05 111.62 51.50 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 43.88 105.59 49.49 44.98 111.77 48.53 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 6 4 # 6 C 88 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 89 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 92 ASP B 99 ASP.? 16.09 OXT ACT B 201 C 115 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 35.82 109.51 58.11 36.79 111.39 58.16 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 34.50 112.32 53.52 36.24 113.36 54.10 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 44.76 111.03 53.07 46.05 111.62 51.50 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 43.88 105.59 49.49 44.98 111.77 48.53 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 7 4 # 7 C 88 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 89 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 92 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 115 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 35.82 109.51 58.11 36.79 111.39 58.16 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 34.50 112.32 53.52 36.24 113.36 54.10 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 44.76 111.03 53.07 46.05 111.62 51.50 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 43.88 105.59 49.49 44.98 111.77 48.53 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 8 4 # 8 C 88 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 89 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 92 ASP D 99 ASP.? 7.94 CH3 ACT A 203 C 115 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 35.82 109.51 58.11 36.79 111.39 58.16 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 34.50 112.32 53.52 36.24 113.36 54.10 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 44.76 111.03 53.07 46.05 111.62 51.50 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 43.88 105.59 49.49 44.98 111.77 48.53 -54.54 71.95 50.35 -50.70 67.51 52.69 1a95_c00 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 8 hits 1a95_c00 naa= 4 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 A 88 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 89 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 92 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 115 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 28.94 110.40 17.72 27.05 109.42 17.78 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 27.21 110.68 22.97 26.09 108.99 22.41 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 28.82 100.59 20.87 28.57 98.90 22.12 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 34.37 100.82 23.64 28.36 99.87 25.42 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 A 88 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 89 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 92 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 115 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 28.94 110.40 17.72 27.05 109.42 17.78 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 27.21 110.68 22.97 26.09 108.99 22.41 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 28.82 100.59 20.87 28.57 98.90 22.12 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 34.37 100.82 23.64 28.36 99.87 25.42 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 3 4 # 3 A 88 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 89 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 92 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 115 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 28.94 110.40 17.72 27.05 109.42 17.78 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 27.21 110.68 22.97 26.09 108.99 22.41 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 28.82 100.59 20.87 28.57 98.90 22.12 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 34.37 100.82 23.64 28.36 99.87 25.42 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 4 4 # 4 A 88 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 89 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 92 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 115 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 28.94 110.40 17.72 27.05 109.42 17.78 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 27.21 110.68 22.97 26.09 108.99 22.41 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 28.82 100.59 20.87 28.57 98.90 22.12 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 34.37 100.82 23.64 28.36 99.87 25.42 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 5 4 # 5 A 88 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 89 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 92 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 115 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 28.94 110.40 17.72 27.05 109.42 17.78 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 27.21 110.68 22.97 26.09 108.99 22.41 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 28.82 100.59 20.87 28.57 98.90 22.12 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 34.37 100.82 23.64 28.36 99.87 25.42 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 6 4 # 6 A 88 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 89 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 92 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 115 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 28.94 110.40 17.72 27.05 109.42 17.78 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 27.21 110.68 22.97 26.09 108.99 22.41 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 28.82 100.59 20.87 28.57 98.90 22.12 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 34.37 100.82 23.64 28.36 99.87 25.42 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 7 4 # 7 A 88 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 89 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 92 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 115 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 28.94 110.40 17.72 27.05 109.42 17.78 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 27.21 110.68 22.97 26.09 108.99 22.41 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 28.82 100.59 20.87 28.57 98.90 22.12 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 34.37 100.82 23.64 28.36 99.87 25.42 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 8 4 # 8 A 88 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 89 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 92 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 115 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 28.94 110.40 17.72 27.05 109.42 17.78 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 27.21 110.68 22.97 26.09 108.99 22.41 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 28.82 100.59 20.87 28.57 98.90 22.12 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 34.37 100.82 23.64 28.36 99.87 25.42 -54.54 71.95 50.35 -50.70 67.51 52.69 1a95_c01 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 8 hits 1a95_c01 naa= 4 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 B 88 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 89 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 92 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 115 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 15.87 130.02 20.98 17.78 130.94 20.91 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 18.52 128.66 25.62 19.66 130.36 25.09 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 17.38 138.95 26.03 17.97 140.13 27.68 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 11.86 138.01 29.49 18.01 139.06 30.49 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 B 88 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 89 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 92 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 115 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 15.87 130.02 20.98 17.78 130.94 20.91 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 18.52 128.66 25.62 19.66 130.36 25.09 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 17.38 138.95 26.03 17.97 140.13 27.68 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 11.86 138.01 29.49 18.01 139.06 30.49 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 3 4 # 3 B 88 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 89 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 92 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 115 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 15.87 130.02 20.98 17.78 130.94 20.91 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 18.52 128.66 25.62 19.66 130.36 25.09 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 17.38 138.95 26.03 17.97 140.13 27.68 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 11.86 138.01 29.49 18.01 139.06 30.49 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 4 4 # 4 B 88 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 89 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 92 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 115 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 15.87 130.02 20.98 17.78 130.94 20.91 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 18.52 128.66 25.62 19.66 130.36 25.09 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 17.38 138.95 26.03 17.97 140.13 27.68 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 11.86 138.01 29.49 18.01 139.06 30.49 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 5 4 # 5 B 88 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 89 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 92 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 115 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 15.87 130.02 20.98 17.78 130.94 20.91 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 18.52 128.66 25.62 19.66 130.36 25.09 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 17.38 138.95 26.03 17.97 140.13 27.68 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 11.86 138.01 29.49 18.01 139.06 30.49 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 6 4 # 6 B 88 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 89 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 92 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 115 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 15.87 130.02 20.98 17.78 130.94 20.91 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 18.52 128.66 25.62 19.66 130.36 25.09 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 17.38 138.95 26.03 17.97 140.13 27.68 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 11.86 138.01 29.49 18.01 139.06 30.49 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 7 4 # 7 B 88 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 89 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 92 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 115 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 15.87 130.02 20.98 17.78 130.94 20.91 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 18.52 128.66 25.62 19.66 130.36 25.09 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 17.38 138.95 26.03 17.97 140.13 27.68 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 11.86 138.01 29.49 18.01 139.06 30.49 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 8 4 # 8 B 88 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 89 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 92 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 115 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 15.87 130.02 20.98 17.78 130.94 20.91 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 18.52 128.66 25.62 19.66 130.36 25.09 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 17.38 138.95 26.03 17.97 140.13 27.68 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 11.86 138.01 29.49 18.01 139.06 30.49 -54.54 71.95 50.35 -50.70 67.51 52.69 1a95_c02 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 8 hits 1a95_c02 naa= 4 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 D 88 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 89 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 92 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 115 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 16.10 122.43 61.36 15.17 120.52 61.32 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 16.52 120.83 56.08 14.84 119.68 56.64 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 6.41 122.44 58.21 4.75 122.21 56.90 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 6.66 128.09 55.52 5.74 122.11 53.55 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 D 88 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 89 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 92 ASP D 99 ASP.? 7.94 CH3 ACT A 203 D 115 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 16.10 122.43 61.36 15.17 120.52 61.32 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 16.52 120.83 56.08 14.84 119.68 56.64 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 6.41 122.44 58.21 4.75 122.21 56.90 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 6.66 128.09 55.52 5.74 122.11 53.55 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 3 4 # 3 D 88 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 89 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 92 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 115 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 16.10 122.43 61.36 15.17 120.52 61.32 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 16.52 120.83 56.08 14.84 119.68 56.64 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 6.41 122.44 58.21 4.75 122.21 56.90 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 6.66 128.09 55.52 5.74 122.11 53.55 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 4 4 # 4 D 88 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 89 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 92 ASP B 99 ASP.? 16.09 OXT ACT B 201 D 115 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 16.10 122.43 61.36 15.17 120.52 61.32 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 16.52 120.83 56.08 14.84 119.68 56.64 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 6.41 122.44 58.21 4.75 122.21 56.90 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 6.66 128.09 55.52 5.74 122.11 53.55 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 5 4 # 5 D 88 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 89 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 92 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 115 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 16.10 122.43 61.36 15.17 120.52 61.32 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 16.52 120.83 56.08 14.84 119.68 56.64 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 6.41 122.44 58.21 4.75 122.21 56.90 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 6.66 128.09 55.52 5.74 122.11 53.55 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 6 4 # 6 D 88 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 89 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 92 ASP B 99 ASP.? 16.09 OXT ACT B 201 D 115 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 16.10 122.43 61.36 15.17 120.52 61.32 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 16.52 120.83 56.08 14.84 119.68 56.64 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 6.41 122.44 58.21 4.75 122.21 56.90 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 6.66 128.09 55.52 5.74 122.11 53.55 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 7 4 # 7 D 88 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 89 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 92 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 115 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 16.10 122.43 61.36 15.17 120.52 61.32 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 16.52 120.83 56.08 14.84 119.68 56.64 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 6.41 122.44 58.21 4.75 122.21 56.90 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 6.66 128.09 55.52 5.74 122.11 53.55 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 8 4 # 8 D 88 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 89 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 92 ASP D 99 ASP.? 7.94 CH3 ACT A 203 D 115 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 16.10 122.43 61.36 15.17 120.52 61.32 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 16.52 120.83 56.08 14.84 119.68 56.64 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 6.41 122.44 58.21 4.75 122.21 56.90 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 6.66 128.09 55.52 5.74 122.11 53.55 -54.54 71.95 50.35 -50.70 67.51 52.69 1a95_c03 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 8 hits 1a95_c03 naa= 4 ULMN 4 1amy_c03 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 4 # 1 179 ASP A 99 ASP.? 5.71 O2 EDO A 301 204 GLU A 72 GLU~? 5.31 O ACT A 201 206 TRP A 69 TRP~? 6.39 O ACT A 201 289 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 4.34 62.44 32.05 4.22 64.48 32.53 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 9.53 62.76 36.39 10.06 65.94 34.23 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 4 1amy_c03 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 4 # 2 179 ASP B 99 ASP.? 16.09 OXT ACT B 201 204 GLU B 72 GLU~? 5.30 OXT ACT B 201 206 TRP B 69 TRP~? 6.43 OXT ACT B 201 289 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 4.34 62.44 32.05 4.22 64.48 32.53 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 9.53 62.76 36.39 10.06 65.94 34.23 -34.09 46.73 83.20 -34.39 49.33 86.13 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 4 1amy_c03 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 4 # 3 179 ASP C 99 ASP.? 5.79 O1 EDO A 301 204 GLU C 72 GLU~? 5.32 O ACT C 201 206 TRP C 69 TRP~? 6.41 O ACT C 201 289 ASP C 74 ASP^? 14.86 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 4.34 62.44 32.05 4.22 64.48 32.53 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 9.53 62.76 36.39 10.06 65.94 34.23 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 4 1amy_c03 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 4 # 4 179 ASP D 99 ASP.? 7.94 CH3 ACT A 203 204 GLU D 72 GLU~? 5.29 OXT ACT D 201 206 TRP D 69 TRP~? 6.43 OXT ACT D 201 289 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 4.34 62.44 32.05 4.22 64.48 32.53 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 9.53 62.76 36.39 10.06 65.94 34.23 -55.42 69.82 43.51 -57.48 67.10 41.55 coo 9.42 68.07 30.27 7.35 68.27 30.10 -50.30 76.97 42.14 -51.14 78.91 42.11 1amy_c03 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 4 hits 1amy_c03 naa= 4 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 A 232 GLU A 21 GLU~? 19.20 CH3 ACT A 201 A 280 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 283 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 288 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 5.76 85.47 37.35 6.76 85.56 39.24 -26.74 85.39 73.13 -25.47 87.07 73.30 coo 4.25 95.66 42.75 4.18 93.57 42.69 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 9.66 95.18 46.95 8.19 90.97 44.00 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 13.49 92.75 43.16 12.39 91.15 42.33 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 2 4 # 2 A 232 GLU B 21 GLU~? 20.11 CH3 ACT B 201 A 280 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 283 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 288 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo 5.76 85.47 37.35 6.76 85.56 39.24 -19.23 61.49 94.88 -18.90 62.15 96.87 coo 4.25 95.66 42.75 4.18 93.57 42.69 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 9.66 95.18 46.95 8.19 90.97 44.00 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 13.49 92.75 43.16 12.39 91.15 42.33 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 3 4 # 3 A 232 GLU D 21 GLU~? 20.13 CH3 ACT D 201 A 280 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 283 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 288 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo 5.76 85.47 37.35 6.76 85.56 39.24 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 4.25 95.66 42.75 4.18 93.57 42.69 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 9.66 95.18 46.95 8.19 90.97 44.00 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 13.49 92.75 43.16 12.39 91.15 42.33 -50.66 64.65 33.24 -49.08 64.98 31.89 1aq0_c00 source 1aq0 1,3-1,4-BETA-GLUCANASE : 3 hits 1aq0_c00 naa= 4 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 B 232 GLU A 21 GLU~? 19.20 CH3 ACT A 201 B 280 GLU A 80 GLU^? 14.51 CH3 ACT A 201 B 283 LYS A 79 LYS^? -3.45 CH3 ACT A 201s B 288 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -26.74 85.39 73.13 -25.47 87.07 73.30 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 -35.46 76.50 78.57 -37.32 76.28 79.54 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 -34.66 75.11 72.84 -31.25 72.89 69.03 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 2 4 # 2 B 232 GLU B 21 GLU~? 20.11 CH3 ACT B 201 B 280 GLU B 80 GLU^? 7.87 CH3 ACT A 202 B 283 LYS B 79 LYS^? -3.44 CH3 ACT B 201s B 288 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -19.23 61.49 94.88 -18.90 62.15 96.87 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 -19.12 60.55 81.96 -17.78 60.17 80.39 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 -23.75 57.07 83.29 -29.11 56.74 84.70 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 3 4 # 3 B 232 GLU C 21 GLU~? 19.29 CH3 ACT C 201 B 280 GLU C 80 GLU^? 14.47 CH3 ACT C 201 B 283 LYS C 79 LYS^? -3.44 CH3 ACT C 201s B 288 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -37.51 33.35 41.29 -36.60 32.00 39.94 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 -48.24 40.72 45.31 -50.16 40.73 46.15 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 -43.47 42.54 48.33 -38.69 45.48 48.28 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 4 4 # 4 B 232 GLU D 21 GLU~? 20.13 CH3 ACT D 201 B 280 GLU D 80 GLU^? 14.49 CH3 ACT D 201 B 283 LYS D 79 LYS^? -3.52 CH3 ACT D 201s B 288 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -52.88 57.10 23.42 -54.02 56.21 21.88 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 -42.96 58.73 31.72 -40.96 59.40 31.80 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 -47.37 61.41 34.65 -51.85 60.71 37.83 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -50.66 64.65 33.24 -49.08 64.98 31.89 1aq0_c01 source 1aq0 1,3-1,4-BETA-GLUCANASE : 4 hits 1aq0_c01 naa= 4 ULMN 4 1avf_c06 GASTRICSIN user 1 4 # 1 J 32 ASP A 99 ASP.? 5.71 O2 EDO A 301 J 35 SER A 101 SER.? 7.80 O2 EDO A 301 J 75 TYR C 108 TYR^? 12.28 O ACT C 201 J 217 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -48.36 60.96 55.15 -47.04 58.94 54.93 coo -41.81 -30.90 17.10 -43.71 -28.85 16.83 -49.57 50.97 53.11 -51.32 50.02 55.06 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 4 1avf_c06 GASTRICSIN user 2 4 # 2 J 32 ASP C 99 ASP.? 5.79 O1 EDO A 301 J 35 SER C 101 SER.? 7.85 O1 EDO A 301 J 75 TYR A 108 TYR^? 12.28 O ACT A 201 J 217 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -40.26 55.74 71.04 -39.54 57.94 70.33 coo -41.81 -30.90 17.10 -43.71 -28.85 16.83 -40.87 65.49 73.93 -43.61 66.01 74.07 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -33.09 51.46 70.73 -34.18 51.80 72.52 1avf_c06 source 1avf GASTRICSIN : 2 hits 1avf_c06 naa= 4 ULMN 4 1bf2_c01 ISOAMYLASE user 1 4 # 1 375 ASP A 99 ASP.? 5.71 O2 EDO A 301 435 GLU A 72 GLU~? 5.31 O ACT A 201 437 TRP A 97 TRP^? -5.71 O1 EDO A 301s 510 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 88.62 69.90 41.16 89.05 70.67 43.04 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 89.52 76.11 40.17 89.01 75.16 41.97 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 92.40 77.76 42.22 89.96 80.25 40.39 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 84.89 77.60 46.67 85.63 75.79 46.03 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 4 1bf2_c01 ISOAMYLASE user 2 4 # 2 375 ASP A 99 ASP.? 5.71 O2 EDO A 301 435 GLU A 72 GLU~? 5.31 O ACT A 201 437 TRP A 97 TRP^? -5.71 O1 EDO A 301s 510 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 88.62 69.90 41.16 89.05 70.67 43.04 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 89.52 76.11 40.17 89.01 75.16 41.97 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 92.40 77.76 42.22 89.96 80.25 40.39 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 84.89 77.60 46.67 85.63 75.79 46.03 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 4 1bf2_c01 ISOAMYLASE user 3 4 # 3 375 ASP B 99 ASP.? 16.09 OXT ACT B 201 435 GLU B 72 GLU~? 5.30 OXT ACT B 201 437 TRP B 97 TRP^? 8.79 OXT ACT B 201 510 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 88.62 69.90 41.16 89.05 70.67 43.04 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 89.52 76.11 40.17 89.01 75.16 41.97 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 92.40 77.76 42.22 89.96 80.25 40.39 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 84.89 77.60 46.67 85.63 75.79 46.03 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 4 1bf2_c01 ISOAMYLASE user 4 4 # 4 375 ASP C 99 ASP.? 5.79 O1 EDO A 301 435 GLU C 72 GLU~? 5.32 O ACT C 201 437 TRP C 97 TRP^? -5.77 O2 EDO A 301s 510 ASP C 74 ASP^? 14.86 O ACT C 201 coo 88.62 69.90 41.16 89.05 70.67 43.04 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 89.52 76.11 40.17 89.01 75.16 41.97 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 92.40 77.76 42.22 89.96 80.25 40.39 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 84.89 77.60 46.67 85.63 75.79 46.03 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 4 1bf2_c01 ISOAMYLASE user 5 4 # 5 375 ASP C 99 ASP.? 5.79 O1 EDO A 301 435 GLU C 72 GLU~? 5.32 O ACT C 201 437 TRP C 97 TRP^? -5.77 O2 EDO A 301s 510 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 88.62 69.90 41.16 89.05 70.67 43.04 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 89.52 76.11 40.17 89.01 75.16 41.97 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 92.40 77.76 42.22 89.96 80.25 40.39 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 84.89 77.60 46.67 85.63 75.79 46.03 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 4 1bf2_c01 ISOAMYLASE user 6 4 # 6 375 ASP D 99 ASP.? 7.94 CH3 ACT A 203 435 GLU D 72 GLU~? 5.29 OXT ACT D 201 437 TRP D 97 TRP^? 8.35 CH3 ACT A 203 510 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 88.62 69.90 41.16 89.05 70.67 43.04 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 89.52 76.11 40.17 89.01 75.16 41.97 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 92.40 77.76 42.22 89.96 80.25 40.39 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 84.89 77.60 46.67 85.63 75.79 46.03 -50.30 76.97 42.14 -51.14 78.91 42.11 1bf2_c01 source 1bf2 ISOAMYLASE : 6 hits 1bf2_c01 naa= 4 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 1 4 # 1 A 325 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 354 GLU A 72 GLU~? 5.31 O ACT A 201 A 356 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 421 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 31.05 49.37 64.51 31.97 51.11 63.85 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 29.07 50.42 58.36 29.02 52.18 59.49 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 32.40 51.51 54.93 28.61 52.36 55.13 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 30.82 59.76 58.47 31.12 59.02 60.40 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 2 4 # 2 A 325 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 354 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 356 TRP B 69 TRP~? 6.43 OXT ACT B 201 A 421 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 29.07 50.42 58.36 29.02 52.18 59.49 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 32.40 51.51 54.93 28.61 52.36 55.13 -34.09 46.73 83.20 -34.39 49.33 86.13 coo 30.82 59.76 58.47 31.12 59.02 60.40 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 3 4 # 3 A 325 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 354 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 356 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 421 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 29.07 50.42 58.36 29.02 52.18 59.49 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 32.40 51.51 54.93 28.61 52.36 55.13 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 30.82 59.76 58.47 31.12 59.02 60.40 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 4 4 # 4 A 325 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 354 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 356 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 421 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 31.05 49.37 64.51 31.97 51.11 63.85 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 29.07 50.42 58.36 29.02 52.18 59.49 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 32.40 51.51 54.93 28.61 52.36 55.13 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 30.82 59.76 58.47 31.12 59.02 60.40 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 5 4 # 5 A 325 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 354 GLU C 72 GLU~? 5.32 O ACT C 201 A 356 TRP C 69 TRP~? 6.41 O ACT C 201 A 421 ASP C 74 ASP^? 14.86 O ACT C 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 29.07 50.42 58.36 29.02 52.18 59.49 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 32.40 51.51 54.93 28.61 52.36 55.13 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 30.82 59.76 58.47 31.12 59.02 60.40 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 6 4 # 6 A 325 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 354 GLU C 72 GLU~? 5.32 O ACT C 201 A 356 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 421 ASP C 74 ASP^? 14.86 O ACT C 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 29.07 50.42 58.36 29.02 52.18 59.49 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 32.40 51.51 54.93 28.61 52.36 55.13 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 30.82 59.76 58.47 31.12 59.02 60.40 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 7 4 # 7 A 325 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 354 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 356 TRP D 69 TRP~? 6.43 OXT ACT D 201 A 421 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 29.07 50.42 58.36 29.02 52.18 59.49 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 32.40 51.51 54.93 28.61 52.36 55.13 -55.42 69.82 43.51 -57.48 67.10 41.55 coo 30.82 59.76 58.47 31.12 59.02 60.40 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 8 4 # 8 A 325 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 354 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 356 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 421 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 31.05 49.37 64.51 31.97 51.11 63.85 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 29.07 50.42 58.36 29.02 52.18 59.49 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 32.40 51.51 54.93 28.61 52.36 55.13 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 30.82 59.76 58.47 31.12 59.02 60.40 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 9 4 # 9 A 325 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 354 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 356 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 421 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 29.07 50.42 58.36 29.02 52.18 59.49 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 32.40 51.51 54.93 28.61 52.36 55.13 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 30.82 59.76 58.47 31.12 59.02 60.40 -50.30 76.97 42.14 -51.14 78.91 42.11 1bvz_c02 source 1bvz ALPHA-AMYLASE II : 9 hits 1bvz_c02 naa= 4 ULMN 4 1bvz_c03 ALPHA-AMYLASE II user 1 4 # 1 B 325 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 354 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 356 TRP B 97 TRP^? 8.79 OXT ACT B 201 B 421 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 27.87 10.66 47.95 27.82 8.60 48.27 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 24.60 10.88 44.33 28.44 10.20 44.29 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 26.02 1.87 43.38 25.90 1.97 45.49 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 4 1bvz_c03 ALPHA-AMYLASE II user 2 4 # 2 B 325 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 354 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 356 TRP D 97 TRP^? 8.35 CH3 ACT A 203 B 421 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 27.87 10.66 47.95 27.82 8.60 48.27 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 24.60 10.88 44.33 28.44 10.20 44.29 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 26.02 1.87 43.38 25.90 1.97 45.49 -44.77 63.42 52.85 -43.43 61.81 52.77 1bvz_c03 source 1bvz ALPHA-AMYLASE II : 2 hits 1bvz_c03 naa= 4 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP A 74 ASP^? 5.73 OXT ACT A 203 M 206 SER B 107 SER^? 7.39 OXT ACT B 201 M 210 ARG B 51 ARG.? 7.67 O ACT B 201 M 214 ASN B 50 ASN^? 4.93 O ACT B 201 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -39.13 57.82 80.42 -37.65 56.39 79.89 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 2 4 # 2 A 61 ASP A 100 ASP.? 9.07 O2 EDO A 301 M 206 SER B 107 SER^? 7.39 OXT ACT B 201 M 210 ARG B 51 ARG.? 7.67 O ACT B 201 M 214 ASN B 50 ASN^? 4.93 O ACT B 201 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -39.13 57.82 80.42 -37.65 56.39 79.89 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 3 4 # 3 A 61 ASP B 74 ASP^? 14.88 OXT ACT B 201 M 206 SER A 107 SER^? 6.74 O1 EDO A 301 M 210 ARG A 51 ARG.? 6.25 O1 EDO A 301 M 214 ASN A 50 ASN^? 5.02 OXT ACT A 201 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -28.17 63.14 65.41 -30.17 63.83 65.25 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 4 4 # 4 A 61 ASP B 100 ASP.? 15.93 OXT ACT B 201 M 206 SER A 107 SER^? 6.74 O1 EDO A 301 M 210 ARG A 51 ARG.? 6.25 O1 EDO A 301 M 214 ASN A 50 ASN^? 5.02 OXT ACT A 201 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -28.17 63.14 65.41 -30.17 63.83 65.25 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 5 4 # 5 A 61 ASP C 74 ASP^? 14.86 O ACT C 201 M 206 SER D 107 SER^? 7.30 OXT ACT D 201 M 210 ARG D 51 ARG.? 7.60 O ACT D 201 M 214 ASN D 50 ASN^? 4.92 O ACT D 201 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -54.56 58.39 48.20 -53.45 60.06 47.53 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 6 4 # 6 A 61 ASP C 100 ASP.? 9.05 C1 EDO A 301 M 206 SER D 107 SER^? 7.30 OXT ACT D 201 M 210 ARG D 51 ARG.? 7.60 O ACT D 201 M 214 ASN D 50 ASN^? 4.92 O ACT D 201 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -54.56 58.39 48.20 -53.45 60.06 47.53 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 7 4 # 7 A 61 ASP D 74 ASP^? 14.85 OXT ACT D 201 M 206 SER C 107 SER^? 6.74 O2 EDO A 301 M 210 ARG C 51 ARG.? 6.22 O2 EDO A 301 M 214 ASN C 50 ASN^? 4.97 OXT ACT C 201 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -35.45 55.77 48.86 -36.44 54.81 50.47 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 8 4 # 8 A 61 ASP D 100 ASP.? 7.94 OXT ACT A 203 M 206 SER C 107 SER^? 6.74 O2 EDO A 301 M 210 ARG C 51 ARG.? 6.22 O2 EDO A 301 M 214 ASN C 50 ASN^? 4.97 OXT ACT C 201 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -35.45 55.77 48.86 -36.44 54.81 50.47 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 8 hits 1c17_c11 naa= 4 ULMN 4 1d8h_c00 MRNA TRIPHOSPHATASE CET1 user 1 4 # 1 A 393 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 433 GLU A 72 GLU~? 5.31 O ACT A 201 A 456 LYS C 68 LYS~? -2.77 O ACT C 201s A 458 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 8.61 51.76 73.74 9.78 51.49 70.80 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 14.59 54.44 69.55 14.31 53.05 67.99 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 1.72 46.30 68.29 5.79 48.68 67.64 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 6.20 47.59 62.97 6.73 49.77 65.20 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 4 1d8h_c00 MRNA TRIPHOSPHATASE CET1 user 2 4 # 2 A 393 ARG A 147 ARG.? 13.06 CH3 ACT A 201 A 433 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 456 LYS A 139 LYS.? 17.81 O ACT A 201 A 458 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 8.61 51.76 73.74 9.78 51.49 70.80 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 14.59 54.44 69.55 14.31 53.05 67.99 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 1.72 46.30 68.29 5.79 48.68 67.64 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 6.20 47.59 62.97 6.73 49.77 65.20 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 4 1d8h_c00 MRNA TRIPHOSPHATASE CET1 user 3 4 # 3 A 393 ARG B 147 ARG.? 12.52 CH3 ACT A 202 A 433 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 456 LYS B 139 LYS.? 6.99 C1 EDO A 302 A 458 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 8.61 51.76 73.74 9.78 51.49 70.80 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 14.59 54.44 69.55 14.31 53.05 67.99 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 1.72 46.30 68.29 5.79 48.68 67.64 -18.83 46.84 75.05 -16.49 49.79 71.17 coo 6.20 47.59 62.97 6.73 49.77 65.20 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 4 1d8h_c00 MRNA TRIPHOSPHATASE CET1 user 4 4 # 4 A 393 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 433 GLU C 72 GLU~? 5.32 O ACT C 201 A 456 LYS A 68 LYS~? -2.78 O ACT A 201s A 458 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 8.61 51.76 73.74 9.78 51.49 70.80 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 14.59 54.44 69.55 14.31 53.05 67.99 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 1.72 46.30 68.29 5.79 48.68 67.64 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 6.20 47.59 62.97 6.73 49.77 65.20 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 4 1d8h_c00 MRNA TRIPHOSPHATASE CET1 user 5 4 # 5 A 393 ARG C 147 ARG.? 13.23 CH3 ACT C 201 A 433 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 456 LYS C 139 LYS.? 18.79 O ACT C 201 A 458 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 8.61 51.76 73.74 9.78 51.49 70.80 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 14.59 54.44 69.55 14.31 53.05 67.99 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 1.72 46.30 68.29 5.79 48.68 67.64 -50.26 41.49 60.64 -55.14 42.95 58.84 coo 6.20 47.59 62.97 6.73 49.77 65.20 -49.78 47.48 57.01 -51.73 47.13 59.31 1d8h_c00 source 1d8h MRNA TRIPHOSPHATASE CET1 : 5 hits 1d8h_c00 naa= 4 ULMN 4 1d8h_c01 MRNA TRIPHOSPHATASE CET1 user 1 4 # 1 B 393 ARG A 51 ARG.? 6.25 O1 EDO A 301 B 433 GLU A 72 GLU~? 5.31 O ACT A 201 B 456 LYS C 68 LYS~? -2.77 O ACT C 201s B 458 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo -1.83 99.06 29.59 -0.10 96.84 28.90 -33.46 60.54 65.68 -36.32 61.50 66.33 coo -1.96 91.25 27.47 0.16 91.64 27.05 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 7.52 102.36 32.33 4.96 99.05 30.60 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 9.47 95.54 30.17 6.44 95.66 31.22 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 4 1d8h_c01 MRNA TRIPHOSPHATASE CET1 user 2 4 # 2 B 393 ARG B 147 ARG.? 12.52 CH3 ACT A 202 B 433 GLU B 80 GLU^? 7.87 CH3 ACT A 202 B 456 LYS B 139 LYS.? 6.99 C1 EDO A 302 B 458 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo -1.83 99.06 29.59 -0.10 96.84 28.90 -19.28 50.88 84.48 -18.42 53.72 85.30 coo -1.96 91.25 27.47 0.16 91.64 27.05 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 7.52 102.36 32.33 4.96 99.05 30.60 -18.83 46.84 75.05 -16.49 49.79 71.17 coo 9.47 95.54 30.17 6.44 95.66 31.22 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 4 1d8h_c01 MRNA TRIPHOSPHATASE CET1 user 3 4 # 3 B 393 ARG C 51 ARG.? 6.22 O2 EDO A 301 B 433 GLU C 72 GLU~? 5.32 O ACT C 201 B 456 LYS A 68 LYS~? -2.78 O ACT A 201s B 458 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo -1.83 99.06 29.59 -0.10 96.84 28.90 -39.28 57.54 52.97 -41.40 56.18 54.75 coo -1.96 91.25 27.47 0.16 91.64 27.05 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 7.52 102.36 32.33 4.96 99.05 30.60 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 9.47 95.54 30.17 6.44 95.66 31.22 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 4 1d8h_c01 MRNA TRIPHOSPHATASE CET1 user 4 4 # 4 B 393 ARG C 147 ARG.? 13.23 CH3 ACT C 201 B 433 GLU C 80 GLU^? 14.47 CH3 ACT C 201 B 456 LYS C 139 LYS.? 18.79 O ACT C 201 B 458 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo -1.83 99.06 29.59 -0.10 96.84 28.90 -44.23 36.97 53.78 -44.90 36.38 50.84 coo -1.96 91.25 27.47 0.16 91.64 27.05 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 7.52 102.36 32.33 4.96 99.05 30.60 -50.26 41.49 60.64 -55.14 42.95 58.84 coo 9.47 95.54 30.17 6.44 95.66 31.22 -49.78 47.48 57.01 -51.73 47.13 59.31 1d8h_c01 source 1d8h MRNA TRIPHOSPHATASE CET1 : 4 hits 1d8h_c01 naa= 4 ULMN 4 1d8h_c02 MRNA TRIPHOSPHATASE CET1 user 1 4 # 1 C 393 ARG A 51 ARG.? 6.25 O1 EDO A 301 C 433 GLU A 72 GLU~? 5.31 O ACT A 201 C 456 LYS C 68 LYS~? -2.77 O ACT C 201s C 458 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 5.89 19.72 74.11 3.89 22.05 73.98 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 2.64 24.82 79.60 2.66 26.04 77.84 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 2.79 21.47 64.30 3.04 22.87 68.57 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -0.70 27.77 67.44 -0.05 25.34 69.46 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 4 1d8h_c02 MRNA TRIPHOSPHATASE CET1 user 2 4 # 2 C 393 ARG A 124 ARG.? -3.54 OXT ACT A 201s C 433 GLU A 111 GLU^? 4.34 CH3 ACT A 201 C 456 LYS A 68 LYS~? -2.78 O ACT A 201s C 458 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 5.89 19.72 74.11 3.89 22.05 73.98 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 2.64 24.82 79.60 2.66 26.04 77.84 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 2.79 21.47 64.30 3.04 22.87 68.57 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -0.70 27.77 67.44 -0.05 25.34 69.46 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 4 1d8h_c02 MRNA TRIPHOSPHATASE CET1 user 3 4 # 3 C 393 ARG A 147 ARG.? 13.06 CH3 ACT A 201 C 433 GLU A 80 GLU^? 14.51 CH3 ACT A 201 C 456 LYS A 139 LYS.? 17.81 O ACT A 201 C 458 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 5.89 19.72 74.11 3.89 22.05 73.98 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 2.64 24.82 79.60 2.66 26.04 77.84 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 2.79 21.47 64.30 3.04 22.87 68.57 -48.50 74.28 70.24 -48.23 71.73 76.05 coo -0.70 27.77 67.44 -0.05 25.34 69.46 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 4 1d8h_c02 MRNA TRIPHOSPHATASE CET1 user 4 4 # 4 C 393 ARG B 147 ARG.? 12.52 CH3 ACT A 202 C 433 GLU B 80 GLU^? 7.87 CH3 ACT A 202 C 456 LYS B 139 LYS.? 6.99 C1 EDO A 302 C 458 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 5.89 19.72 74.11 3.89 22.05 73.98 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 2.64 24.82 79.60 2.66 26.04 77.84 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 2.79 21.47 64.30 3.04 22.87 68.57 -18.83 46.84 75.05 -16.49 49.79 71.17 coo -0.70 27.77 67.44 -0.05 25.34 69.46 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 4 1d8h_c02 MRNA TRIPHOSPHATASE CET1 user 5 4 # 5 C 393 ARG C 51 ARG.? 6.22 O2 EDO A 301 C 433 GLU C 72 GLU~? 5.32 O ACT C 201 C 456 LYS A 68 LYS~? -2.78 O ACT A 201s C 458 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 5.89 19.72 74.11 3.89 22.05 73.98 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 2.64 24.82 79.60 2.66 26.04 77.84 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 2.79 21.47 64.30 3.04 22.87 68.57 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -0.70 27.77 67.44 -0.05 25.34 69.46 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 4 1d8h_c02 MRNA TRIPHOSPHATASE CET1 user 6 4 # 6 C 393 ARG C 124 ARG.? -3.50 OXT ACT C 201s C 433 GLU C 111 GLU^? 4.32 CH3 ACT C 201 C 456 LYS C 68 LYS~? -2.77 O ACT C 201s C 458 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 5.89 19.72 74.11 3.89 22.05 73.98 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 2.64 24.82 79.60 2.66 26.04 77.84 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 2.79 21.47 64.30 3.04 22.87 68.57 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -0.70 27.77 67.44 -0.05 25.34 69.46 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 4 1d8h_c02 MRNA TRIPHOSPHATASE CET1 user 7 4 # 7 C 393 ARG C 147 ARG.? 13.23 CH3 ACT C 201 C 433 GLU C 80 GLU^? 14.47 CH3 ACT C 201 C 456 LYS C 139 LYS.? 18.79 O ACT C 201 C 458 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 5.89 19.72 74.11 3.89 22.05 73.98 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 2.64 24.82 79.60 2.66 26.04 77.84 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 2.79 21.47 64.30 3.04 22.87 68.57 -50.26 41.49 60.64 -55.14 42.95 58.84 coo -0.70 27.77 67.44 -0.05 25.34 69.46 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 4 1d8h_c02 MRNA TRIPHOSPHATASE CET1 user 8 4 # 8 C 393 ARG D 124 ARG.? -3.55 O ACT D 201s C 433 GLU D 111 GLU^? 4.46 CH3 ACT D 201 C 456 LYS D 68 LYS~? -2.80 OXT ACT D 201s C 458 ARG D 51 ARG.? 7.60 O ACT D 201 coo 5.89 19.72 74.11 3.89 22.05 73.98 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 2.64 24.82 79.60 2.66 26.04 77.84 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 2.79 21.47 64.30 3.04 22.87 68.57 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -0.70 27.77 67.44 -0.05 25.34 69.46 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 4 1d8h_c02 MRNA TRIPHOSPHATASE CET1 user 9 4 # 9 C 393 ARG D 147 ARG.? 13.02 CH3 ACT D 201 C 433 GLU D 80 GLU^? 14.49 CH3 ACT D 201 C 456 LYS D 139 LYS.? 18.54 OXT ACT D 201 C 458 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 5.89 19.72 74.11 3.89 22.05 73.98 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 2.64 24.82 79.60 2.66 26.04 77.84 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 2.79 21.47 64.30 3.04 22.87 68.57 -39.84 73.21 37.09 -35.07 70.74 37.87 coo -0.70 27.77 67.44 -0.05 25.34 69.46 -40.22 67.90 41.60 -38.15 70.12 41.98 1d8h_c02 source 1d8h MRNA TRIPHOSPHATASE CET1 : 9 hits 1d8h_c02 naa= 4 ULMN 4 1di1_c00 ARISTOLOCHENE SYNTHASE user 1 4 # 1 A 92 TYR A 42 TYR^? 9.79 CH3 ACT A 201 A 112 PHE A 64 PHE~? 7.17 OXT ACT A 201 A 178 PHE A 54 PHE^? -3.83 O1 EDO A 302s A 333 TRP A 30 TRP~? -4.28 CH3 ACT A 201s coo 36.26 31.30 22.39 35.67 33.02 24.49 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 45.52 35.08 26.96 42.72 35.07 26.70 -28.19 64.67 60.35 -30.23 64.79 62.27 coo 43.67 42.67 22.02 43.98 41.21 24.38 -22.35 57.66 65.34 -22.90 56.19 67.67 coo 37.80 27.73 29.78 38.27 31.62 30.15 -29.79 74.32 65.17 -29.61 70.47 64.42 ULMN 4 1di1_c00 ARISTOLOCHENE SYNTHASE user 2 4 # 2 A 92 TYR B 42 TYR^? 9.74 CH3 ACT B 201 A 112 PHE B 64 PHE~? 7.22 O ACT B 201 A 178 PHE B 54 PHE^? 14.58 O ACT B 201 A 333 TRP B 30 TRP~? -4.15 CH3 ACT B 201s coo 36.26 31.30 22.39 35.67 33.02 24.49 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 45.52 35.08 26.96 42.72 35.07 26.70 -41.04 53.74 82.96 -38.84 53.80 81.23 coo 43.67 42.67 22.02 43.98 41.21 24.38 -45.35 62.65 79.93 -44.68 64.28 77.75 coo 37.80 27.73 29.78 38.27 31.62 30.15 -31.05 54.49 87.84 -34.09 54.74 85.35 ULMN 4 1di1_c00 ARISTOLOCHENE SYNTHASE user 3 4 # 3 A 92 TYR C 42 TYR^? 9.67 CH3 ACT C 201 A 112 PHE C 64 PHE~? 7.20 OXT ACT C 201 A 178 PHE C 54 PHE^? 14.66 OXT ACT C 201 A 333 TRP C 30 TRP~? -4.24 CH3 ACT C 201s coo 36.26 31.30 22.39 35.67 33.02 24.49 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 45.52 35.08 26.96 42.72 35.07 26.70 -31.32 54.61 52.00 -34.04 54.10 52.45 coo 43.67 42.67 22.02 43.98 41.21 24.38 -32.62 62.02 44.82 -34.97 63.26 43.94 coo 37.80 27.73 29.78 38.27 31.62 30.15 -34.65 44.47 49.46 -34.53 48.36 50.06 ULMN 4 1di1_c00 ARISTOLOCHENE SYNTHASE user 4 4 # 4 A 92 TYR D 42 TYR^? 9.84 CH3 ACT D 201 A 112 PHE D 64 PHE~? 7.18 O ACT D 201 A 178 PHE D 54 PHE^? 14.64 O ACT D 201 A 333 TRP D 30 TRP~? -4.23 CH3 ACT D 201s coo 36.26 31.30 22.39 35.67 33.02 24.49 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 45.52 35.08 26.96 42.72 35.07 26.70 -58.34 61.83 48.37 -55.63 62.31 47.87 coo 43.67 42.67 22.02 43.98 41.21 24.38 -57.35 52.85 53.07 -55.03 51.53 53.92 coo 37.80 27.73 29.78 38.27 31.62 30.15 -55.89 62.34 37.62 -55.77 61.79 41.52 1di1_c00 source 1di1 ARISTOLOCHENE SYNTHASE : 4 hits 1di1_c00 naa= 4 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 1 4 # 1 B 92 TYR A 42 TYR^? 9.79 CH3 ACT A 201 B 112 PHE A 64 PHE~? 7.17 OXT ACT A 201 B 178 PHE A 54 PHE^? -3.83 O1 EDO A 302s B 333 TRP A 30 TRP~? -4.28 CH3 ACT A 201s coo 99.56 54.98 23.15 101.17 54.32 25.32 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 95.53 46.26 28.54 97.54 48.18 28.09 -28.19 64.67 60.35 -30.23 64.79 62.27 coo 102.10 41.65 23.98 100.86 42.71 26.26 -22.35 57.66 65.34 -22.90 56.19 67.67 coo 96.01 57.16 30.39 98.35 54.06 31.01 -29.79 74.32 65.17 -29.61 70.47 64.42 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 2 4 # 2 B 92 TYR B 42 TYR^? 9.74 CH3 ACT B 201 B 112 PHE B 64 PHE~? 7.22 O ACT B 201 B 178 PHE B 54 PHE^? 14.58 O ACT B 201 B 333 TRP B 30 TRP~? -4.15 CH3 ACT B 201s coo 99.56 54.98 23.15 101.17 54.32 25.32 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 95.53 46.26 28.54 97.54 48.18 28.09 -41.04 53.74 82.96 -38.84 53.80 81.23 coo 102.10 41.65 23.98 100.86 42.71 26.26 -45.35 62.65 79.93 -44.68 64.28 77.75 coo 96.01 57.16 30.39 98.35 54.06 31.01 -31.05 54.49 87.84 -34.09 54.74 85.35 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 3 4 # 3 B 92 TYR C 42 TYR^? 9.67 CH3 ACT C 201 B 112 PHE C 64 PHE~? 7.20 OXT ACT C 201 B 178 PHE C 54 PHE^? 14.66 OXT ACT C 201 B 333 TRP C 30 TRP~? -4.24 CH3 ACT C 201s coo 99.56 54.98 23.15 101.17 54.32 25.32 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 95.53 46.26 28.54 97.54 48.18 28.09 -31.32 54.61 52.00 -34.04 54.10 52.45 coo 102.10 41.65 23.98 100.86 42.71 26.26 -32.62 62.02 44.82 -34.97 63.26 43.94 coo 96.01 57.16 30.39 98.35 54.06 31.01 -34.65 44.47 49.46 -34.53 48.36 50.06 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 4 4 # 4 B 92 TYR D 42 TYR^? 9.84 CH3 ACT D 201 B 112 PHE D 64 PHE~? 7.18 O ACT D 201 B 178 PHE D 54 PHE^? 14.64 O ACT D 201 B 333 TRP D 30 TRP~? -4.23 CH3 ACT D 201s coo 99.56 54.98 23.15 101.17 54.32 25.32 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 95.53 46.26 28.54 97.54 48.18 28.09 -58.34 61.83 48.37 -55.63 62.31 47.87 coo 102.10 41.65 23.98 100.86 42.71 26.26 -57.35 52.85 53.07 -55.03 51.53 53.92 coo 96.01 57.16 30.39 98.35 54.06 31.01 -55.89 62.34 37.62 -55.77 61.79 41.52 1di1_c01 source 1di1 ARISTOLOCHENE SYNTHASE : 4 hits 1di1_c01 naa= 4 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 1 4 # 1 A 132 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 136 ARG A 67 ARG~? 13.20 O2 EDO A 302 A 275 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 435 GLU C 72 GLU~? 5.32 O ACT C 201 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 -26.96 59.20 61.32 -28.18 60.32 59.98 coo -4.99 57.22 1.82 -7.93 56.43 2.21 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 2 4 # 2 A 132 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 136 ARG C 67 ARG~? 12.50 O2 EDO A 302 A 275 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 435 GLU A 72 GLU~? 5.31 O ACT A 201 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 -32.08 60.14 50.84 -31.64 58.95 52.54 coo -4.99 57.22 1.82 -7.93 56.43 2.21 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 3 4 # 3 A 132 GLU D 53 GLU^? 10.32 O ACT A 203 A 136 ARG D 67 ARG~? 13.15 O ACT A 203 A 275 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 435 GLU D 72 GLU~? 5.29 OXT ACT D 201 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 -56.60 59.52 53.75 -57.18 61.28 52.77 coo -4.99 57.22 1.82 -7.93 56.43 2.21 -60.60 65.68 53.30 -61.45 62.86 52.44 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 -51.77 69.18 47.61 -51.44 67.29 46.71 1dl2_c00 source 1dl2 CLASS I ALPHA-1,2-MANNOSIDASE : 3 hits 1dl2_c00 naa= 4 ULMN 4 1ec9_c08 GLUCARATE DEHYDRATASE user 1 4 # 1 A 207 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 313 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 339 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 373 GLU B 137 GLU~? 6.31 C2 EDO A 302 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -13.77 -18.44 -12.02 -15.08 -19.60 -13.14 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -15.84 -18.80 -8.52 -17.83 -18.60 -9.07 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -18.40 -37.63 -11.89 -18.73 -39.61 -11.35 -20.73 44.81 67.02 -21.84 45.98 65.65 1ec9_c08 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c08 naa= 4 ULMN 4 1ec9_c09 GLUCARATE DEHYDRATASE user 1 4 # 1 B 207 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 313 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 339 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 373 GLU B 137 GLU~? 6.31 C2 EDO A 302 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -12.58 20.23 10.32 -13.80 21.58 11.35 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -14.24 20.83 6.67 -16.32 20.73 7.02 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -14.73 39.78 9.65 -14.76 41.74 9.00 -20.73 44.81 67.02 -21.84 45.98 65.65 1ec9_c09 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c09 naa= 4 ULMN 4 1ec9_c10 GLUCARATE DEHYDRATASE user 1 4 # 1 C 207 LYS B 71 LYS~? 10.83 OXT ACT B 201 C 313 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 339 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 373 GLU B 137 GLU~? 6.31 C2 EDO A 302 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 14.38 -3.57 -21.43 15.64 -4.13 -22.99 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 16.32 -0.08 -20.39 18.30 -0.81 -20.35 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.17 4.23 -38.89 19.57 5.42 -40.57 -20.73 44.81 67.02 -21.84 45.98 65.65 1ec9_c10 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c10 naa= 4 ULMN 4 1ec9_c11 GLUCARATE DEHYDRATASE user 1 4 # 1 D 207 LYS B 71 LYS~? 10.83 OXT ACT B 201 D 313 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 339 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 373 GLU B 137 GLU~? 6.31 C2 EDO A 302 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 12.06 1.87 22.99 13.29 2.38 24.60 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 13.74 -1.84 22.10 15.79 -1.45 22.35 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 13.94 -5.98 40.88 13.74 -7.36 42.48 -20.73 44.81 67.02 -21.84 45.98 65.65 ULMN 4 1ec9_c11 GLUCARATE DEHYDRATASE user 2 4 # 2 D 207 LYS D 71 LYS~? -3.20 CH3 ACT A 203s D 313 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 339 HIS A 98 HIS^? -3.60 C ACT A 203s D 373 GLU D 137 GLU~? 19.20 CH3 ACT A 203 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 12.06 1.87 22.99 13.29 2.38 24.60 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 13.74 -1.84 22.10 15.79 -1.45 22.35 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 13.94 -5.98 40.88 13.74 -7.36 42.48 -34.89 75.05 43.86 -34.35 73.81 45.48 1ec9_c11 source 1ec9 GLUCARATE DEHYDRATASE : 2 hits 1ec9_c11 naa= 4 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 1 4 # 1 A 33 ARG B 124 ARG.? -3.52 O ACT B 201s A 42 ARG B 51 ARG.? 7.67 O ACT B 201 A 197 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 203 ARG B 123 ARG.? 17.76 O ACT B 201 coo 23.24 19.51 21.94 24.57 16.76 21.61 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 16.08 17.48 28.78 19.09 16.85 28.49 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 28.26 9.63 19.68 28.71 10.56 22.55 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 33.62 12.31 23.18 30.84 12.90 24.36 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 2 4 # 2 A 33 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 42 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 197 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 203 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 23.24 19.51 21.94 24.57 16.76 21.61 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 16.08 17.48 28.78 19.09 16.85 28.49 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 28.26 9.63 19.68 28.71 10.56 22.55 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 33.62 12.31 23.18 30.84 12.90 24.36 -33.35 53.49 35.15 -35.34 55.60 34.14 1f75_c00 source 1f75 UNDECAPRENYL PYROPHOSPHATE SYNTHETASE : 2 hits 1f75_c00 naa= 4 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 1 4 # 1 B 33 ARG A 37 ARG~? 13.73 CH3 ACT A 201 B 42 ARG A 58 ARG~? 18.13 CH3 ACT A 201 B 197 ARG A 146 ARG.? 16.48 CH3 ACT A 201 B 203 ARG A 24 ARG~? 13.97 CH3 ACT A 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -28.83 80.54 58.97 -30.62 82.33 60.70 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 40.75 3.79 10.50 41.03 0.76 9.97 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -33.88 82.79 71.01 -36.66 83.48 69.87 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 2 4 # 2 B 33 ARG A 124 ARG.? -3.54 OXT ACT A 201s B 42 ARG A 49 ARG^? -3.92 O ACT A 202s B 197 ARG A 58 ARG~? 18.13 CH3 ACT A 201 B 203 ARG A 8 ARG.? 15.23 CH3 ACT A 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 40.75 3.79 10.50 41.03 0.76 9.97 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -20.16 79.98 64.14 -22.57 80.76 62.41 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 3 4 # 3 B 33 ARG A 124 ARG.? -3.54 OXT ACT A 201s B 42 ARG A 51 ARG.? 6.25 O1 EDO A 301 B 197 ARG A 58 ARG~? 18.13 CH3 ACT A 201 B 203 ARG A 8 ARG.? 15.23 CH3 ACT A 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 40.75 3.79 10.50 41.03 0.76 9.97 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -20.16 79.98 64.14 -22.57 80.76 62.41 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 4 4 # 4 B 33 ARG A 124 ARG.? -3.54 OXT ACT A 201s B 42 ARG A 58 ARG~? 18.13 CH3 ACT A 201 B 197 ARG A 49 ARG^? -3.92 O ACT A 202s B 203 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 42.69 1.07 -0.40 42.64 1.65 2.61 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 40.75 3.79 10.50 41.03 0.76 9.97 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 5 4 # 5 B 33 ARG A 124 ARG.? -3.54 OXT ACT A 201s B 42 ARG A 58 ARG~? 18.13 CH3 ACT A 201 B 197 ARG B 92 ARG^? -3.69 CH3 ACT A 202s B 203 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 40.75 3.79 10.50 41.03 0.76 9.97 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 6 4 # 6 B 33 ARG A 124 ARG.? -3.54 OXT ACT A 201s B 42 ARG B 92 ARG^? -3.69 CH3 ACT A 202s B 197 ARG A 8 ARG.? 15.23 CH3 ACT A 201 B 203 ARG A 58 ARG~? 18.13 CH3 ACT A 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 40.75 3.79 10.50 41.03 0.76 9.97 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -18.95 73.08 58.27 -17.11 75.32 59.26 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 7 4 # 7 B 33 ARG A 124 ARG.? -3.54 OXT ACT A 201s B 42 ARG B 92 ARG^? -3.69 CH3 ACT A 202s B 197 ARG A 58 ARG~? 18.13 CH3 ACT A 201 B 203 ARG A 8 ARG.? 15.23 CH3 ACT A 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 40.75 3.79 10.50 41.03 0.76 9.97 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -20.16 79.98 64.14 -22.57 80.76 62.41 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 8 4 # 8 B 33 ARG B 8 ARG.? 14.49 CH3 ACT B 201 B 42 ARG B 58 ARG~? 17.86 CH3 ACT B 201 B 197 ARG B 24 ARG~? 14.02 CH3 ACT B 201 B 203 ARG B 146 ARG.? 16.58 CH3 ACT B 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 40.75 3.79 10.50 41.03 0.76 9.97 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -21.21 49.21 92.90 -18.50 50.59 92.50 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 9 4 # 9 B 33 ARG B 33 ARG.? 12.67 OXT ACT B 201 B 42 ARG B 138 ARG~? 16.35 OXT ACT B 201 B 197 ARG B 146 ARG.? 16.58 CH3 ACT B 201 B 203 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 40.75 3.79 10.50 41.03 0.76 9.97 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -20.35 54.64 90.03 -19.09 51.96 89.19 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 10 4 # 10 B 33 ARG B 37 ARG~? 13.57 CH3 ACT B 201 B 42 ARG B 58 ARG~? 17.86 CH3 ACT B 201 B 197 ARG B 146 ARG.? 16.58 CH3 ACT B 201 B 203 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -31.32 49.06 94.80 -28.26 48.93 94.55 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 40.75 3.79 10.50 41.03 0.76 9.97 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -20.35 54.64 90.03 -19.09 51.96 89.19 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 11 4 # 11 B 33 ARG B 124 ARG.? -3.52 O ACT B 201s B 42 ARG B 51 ARG.? 7.67 O ACT B 201 B 197 ARG B 123 ARG.? 17.76 O ACT B 201 B 203 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 40.75 3.79 10.50 41.03 0.76 9.97 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 12 4 # 12 B 33 ARG B 124 ARG.? -3.52 O ACT B 201s B 42 ARG B 58 ARG~? 17.86 CH3 ACT B 201 B 197 ARG A 92 ARG^? 14.09 CH3 ACT A 201 B 203 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 40.75 3.79 10.50 41.03 0.76 9.97 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 13 4 # 13 B 33 ARG B 124 ARG.? -3.52 O ACT B 201s B 42 ARG B 58 ARG~? 17.86 CH3 ACT B 201 B 197 ARG B 49 ARG^? 10.37 O ACT B 201 B 203 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 40.75 3.79 10.50 41.03 0.76 9.97 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 14 4 # 14 B 33 ARG C 37 ARG~? 13.73 CH3 ACT C 201 B 42 ARG C 58 ARG~? 18.03 CH3 ACT C 201 B 197 ARG C 146 ARG.? 16.63 CH3 ACT C 201 B 203 ARG C 24 ARG~? 14.09 CH3 ACT C 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -28.52 38.86 52.29 -30.70 36.70 52.27 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 40.75 3.79 10.50 41.03 0.76 9.97 -36.58 32.85 52.68 -38.87 31.31 51.32 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -40.53 35.15 48.39 -41.31 34.14 51.19 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 15 4 # 15 B 33 ARG C 124 ARG.? -3.50 OXT ACT C 201s B 42 ARG C 51 ARG.? 6.22 O2 EDO A 301 B 197 ARG C 123 ARG.? 17.68 OXT ACT C 201 B 203 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 40.75 3.79 10.50 41.03 0.76 9.97 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 16 4 # 16 B 33 ARG C 124 ARG.? -3.50 OXT ACT C 201s B 42 ARG C 58 ARG~? 18.03 CH3 ACT C 201 B 197 ARG C 49 ARG^? 10.47 OXT ACT C 201 B 203 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 40.75 3.79 10.50 41.03 0.76 9.97 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 17 4 # 17 B 33 ARG C 124 ARG.? -3.50 OXT ACT C 201s B 42 ARG C 58 ARG~? 18.03 CH3 ACT C 201 B 197 ARG D 92 ARG^? 13.56 CH3 ACT D 201 B 203 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 40.75 3.79 10.50 41.03 0.76 9.97 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 18 4 # 18 B 33 ARG D 37 ARG~? 13.59 CH3 ACT D 201 B 42 ARG D 58 ARG~? 18.01 CH3 ACT D 201 B 197 ARG D 146 ARG.? 16.60 CH3 ACT D 201 B 203 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -62.21 67.18 33.74 -60.13 67.79 31.56 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 40.75 3.79 10.50 41.03 0.76 9.97 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -50.90 63.83 27.93 -49.90 66.74 27.73 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 19 4 # 19 B 33 ARG D 124 ARG.? -3.55 O ACT D 201s B 42 ARG C 92 ARG^? 13.71 CH3 ACT C 201 B 197 ARG D 8 ARG.? 14.56 CH3 ACT D 201 B 203 ARG D 58 ARG~? 18.01 CH3 ACT D 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 40.75 3.79 10.50 41.03 0.76 9.97 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -67.82 58.42 40.52 -68.76 57.03 37.97 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 20 4 # 20 B 33 ARG D 124 ARG.? -3.55 O ACT D 201s B 42 ARG C 92 ARG^? 13.71 CH3 ACT C 201 B 197 ARG D 58 ARG~? 18.01 CH3 ACT D 201 B 203 ARG D 8 ARG.? 14.56 CH3 ACT D 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 40.75 3.79 10.50 41.03 0.76 9.97 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -64.40 57.42 32.12 -63.44 60.33 32.35 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 21 4 # 21 B 33 ARG D 124 ARG.? -3.55 O ACT D 201s B 42 ARG D 49 ARG^? 10.44 O ACT D 201 B 197 ARG D 58 ARG~? 18.01 CH3 ACT D 201 B 203 ARG D 8 ARG.? 14.56 CH3 ACT D 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 40.75 3.79 10.50 41.03 0.76 9.97 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -64.40 57.42 32.12 -63.44 60.33 32.35 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 22 4 # 22 B 33 ARG D 124 ARG.? -3.55 O ACT D 201s B 42 ARG D 51 ARG.? 7.60 O ACT D 201 B 197 ARG D 58 ARG~? 18.01 CH3 ACT D 201 B 203 ARG D 8 ARG.? 14.56 CH3 ACT D 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 40.75 3.79 10.50 41.03 0.76 9.97 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -64.40 57.42 32.12 -63.44 60.33 32.35 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 23 4 # 23 B 33 ARG D 124 ARG.? -3.55 O ACT D 201s B 42 ARG D 58 ARG~? 18.01 CH3 ACT D 201 B 197 ARG C 92 ARG^? 13.71 CH3 ACT C 201 B 203 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 40.75 3.79 10.50 41.03 0.76 9.97 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -52.23 44.53 37.75 -52.43 42.56 40.08 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 24 4 # 24 B 33 ARG D 124 ARG.? -3.55 O ACT D 201s B 42 ARG D 58 ARG~? 18.01 CH3 ACT D 201 B 197 ARG D 49 ARG^? 10.44 O ACT D 201 B 203 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 40.75 3.79 10.50 41.03 0.76 9.97 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 25 4 # 25 B 33 ARG D 124 ARG.? -3.55 O ACT D 201s B 42 ARG D 58 ARG~? 18.01 CH3 ACT D 201 B 197 ARG D 88 ARG^? 18.35 CH3 ACT C 201 B 203 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 40.75 3.79 10.50 41.03 0.76 9.97 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -49.94 47.28 44.16 -51.45 46.27 46.66 1f75_c01 source 1f75 UNDECAPRENYL PYROPHOSPHATE SYNTHETASE : 25 hits 1f75_c01 naa= 4 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 A 231 GLU A 21 GLU~? 19.20 CH3 ACT A 201 A 279 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 282 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 288 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -26.74 85.39 73.13 -25.47 87.07 73.30 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 4 # 2 A 231 GLU B 21 GLU~? 20.11 CH3 ACT B 201 A 279 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 282 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 288 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -19.23 61.49 94.88 -18.90 62.15 96.87 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 3 4 # 3 A 231 GLU B 21 GLU~? 20.11 CH3 ACT B 201 A 279 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 282 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 288 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -19.23 61.49 94.88 -18.90 62.15 96.87 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 4 4 # 4 A 231 GLU C 21 GLU~? 19.29 CH3 ACT C 201 A 279 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 282 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 288 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 5 4 # 5 A 231 GLU D 21 GLU~? 20.13 CH3 ACT D 201 A 279 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 282 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 288 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -42.96 58.73 31.72 -40.96 59.40 31.80 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 6 4 # 6 A 231 GLU D 21 GLU~? 20.13 CH3 ACT D 201 A 279 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 282 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 288 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -50.66 64.65 33.24 -49.08 64.98 31.89 1ghs_c00 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 6 hits 1ghs_c00 naa= 4 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 B 231 GLU A 21 GLU~? 19.20 CH3 ACT A 201 B 279 GLU A 27 GLU~? 9.74 CH3 ACT A 201 B 282 LYS A 79 LYS^? -3.45 CH3 ACT A 201s B 288 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -26.74 85.39 73.13 -25.47 87.07 73.30 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 4 # 2 B 231 GLU A 21 GLU~? 19.20 CH3 ACT A 201 B 279 GLU A 80 GLU^? 14.51 CH3 ACT A 201 B 282 LYS A 79 LYS^? -3.45 CH3 ACT A 201s B 288 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -26.74 85.39 73.13 -25.47 87.07 73.30 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 3 4 # 3 B 231 GLU B 21 GLU~? 20.11 CH3 ACT B 201 B 279 GLU B 27 GLU~? 9.83 CH3 ACT B 201 B 282 LYS B 79 LYS^? -3.44 CH3 ACT B 201s B 288 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -19.23 61.49 94.88 -18.90 62.15 96.87 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 4 4 # 4 B 231 GLU B 21 GLU~? 20.11 CH3 ACT B 201 B 279 GLU B 80 GLU^? 7.87 CH3 ACT A 202 B 282 LYS B 79 LYS^? -3.44 CH3 ACT B 201s B 288 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -19.23 61.49 94.88 -18.90 62.15 96.87 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 5 4 # 5 B 231 GLU C 21 GLU~? 19.29 CH3 ACT C 201 B 279 GLU C 27 GLU~? 9.88 CH3 ACT C 201 B 282 LYS C 79 LYS^? -3.44 CH3 ACT C 201s B 288 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 6 4 # 6 B 231 GLU C 21 GLU~? 19.29 CH3 ACT C 201 B 279 GLU C 80 GLU^? 14.47 CH3 ACT C 201 B 282 LYS C 79 LYS^? -3.44 CH3 ACT C 201s B 288 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 7 4 # 7 B 231 GLU D 21 GLU~? 20.13 CH3 ACT D 201 B 279 GLU D 27 GLU~? 9.75 CH3 ACT D 201 B 282 LYS D 79 LYS^? -3.52 CH3 ACT D 201s B 288 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -42.96 58.73 31.72 -40.96 59.40 31.80 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 8 4 # 8 B 231 GLU D 21 GLU~? 20.13 CH3 ACT D 201 B 279 GLU D 80 GLU^? 14.49 CH3 ACT D 201 B 282 LYS D 79 LYS^? -3.52 CH3 ACT D 201s B 288 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -50.66 64.65 33.24 -49.08 64.98 31.89 1ghs_c01 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 8 hits 1ghs_c01 naa= 4 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 A 170 ARG A 49 ARG^? -3.92 O ACT A 202s A 278 ARG A 67 ARG~? 13.20 O2 EDO A 302 A 298 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 348 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -25.12 58.31 69.83 -26.93 60.25 71.40 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -32.08 60.14 50.84 -31.64 58.95 52.54 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 A 170 ARG A 58 ARG~? 18.13 CH3 ACT A 201 A 278 ARG A 67 ARG~? 13.20 O2 EDO A 302 A 298 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 348 ASP A 34 ASP~? 14.63 O ACT A 201 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -18.95 73.08 58.27 -17.11 75.32 59.26 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -32.08 60.14 50.84 -31.64 58.95 52.54 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 3 4 # 3 A 170 ARG B 67 ARG~? 13.55 O ACT B 201 A 278 ARG C 138 ARG~? 16.31 O ACT C 201 A 298 GLU C 96 GLU^? 13.00 O ACT C 201 A 348 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -45.57 49.20 81.23 -45.93 51.82 82.79 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -46.75 44.46 65.88 -44.64 42.30 66.40 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -46.59 45.81 59.59 -47.94 44.44 60.43 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 4 4 # 4 A 170 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 278 ARG C 67 ARG~? 12.50 O2 EDO A 302 A 298 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 348 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -37.64 60.68 44.02 -39.72 58.44 44.33 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -26.96 59.20 61.32 -28.18 60.32 59.98 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 5 4 # 5 A 170 ARG C 58 ARG~? 18.03 CH3 ACT C 201 A 278 ARG C 67 ARG~? 12.50 O2 EDO A 302 A 298 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 348 ASP C 34 ASP~? 14.66 O ACT C 201 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -22.97 47.67 45.60 -22.11 45.78 43.37 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -26.96 59.20 61.32 -28.18 60.32 59.98 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 6 4 # 6 A 170 ARG D 67 ARG~? 13.15 O ACT A 203 A 278 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 298 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 348 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -60.60 65.68 53.30 -61.45 62.86 52.44 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -50.06 71.52 64.11 -49.59 74.03 62.40 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -44.74 70.71 67.91 -46.53 71.68 68.48 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -44.77 63.42 52.85 -43.43 61.81 52.77 1i8t_c02 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 6 hits 1i8t_c02 naa= 4 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 B 170 ARG A 67 ARG~? 13.20 O2 EDO A 302 B 278 ARG D 106 ARG^? 14.88 OXT ACT D 201 B 298 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 348 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -8.10 23.98 3.08 -8.58 21.04 2.27 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -19.09 15.00 16.26 -16.38 15.21 14.84 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -19.42 16.58 21.15 -18.01 16.20 19.59 -43.29 70.99 40.99 -41.92 72.19 39.92 coo -3.61 14.95 13.27 -5.31 15.62 12.23 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 B 170 ARG D 92 ARG^? 13.56 CH3 ACT D 201 B 278 ARG C 16 ARG~? 20.89 CH3 ACT C 201 B 298 GLU C 17 GLU~? 23.53 CH3 ACT C 201 B 348 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo -8.10 23.98 3.08 -8.58 21.04 2.27 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -19.09 15.00 16.26 -16.38 15.21 14.84 -48.56 36.19 35.88 -49.41 34.92 38.55 coo -19.42 16.58 21.15 -18.01 16.20 19.59 -44.57 31.78 35.88 -45.60 32.67 34.25 coo -3.61 14.95 13.27 -5.31 15.62 12.23 -38.79 45.04 28.56 -40.00 45.30 26.84 1i8t_c03 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 2 hits 1i8t_c03 naa= 4 ULMN 4 1j00_c00 THIOESTERASE I user 1 4 # 1 A 44 GLY A 145 GLY.? 13.13 O ACT A 201 A 73 ASN A 31 ASN~? 8.53 CH3 ACT A 201 A 154 ASP A 150 ASP.? 22.07 CH3 ACT A 201 A 157 HIS A 151 HIS.? 15.97 CH3 ACT A 201 coo 5.31 35.31 46.19 5.56 34.58 46.17 -38.43 80.69 60.76 -38.91 80.43 61.42 coo 1.82 33.37 49.33 3.83 34.09 49.37 -36.15 78.19 63.69 -37.32 77.26 65.21 coo 8.45 43.15 56.37 9.67 41.50 55.89 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 9.95 38.09 54.06 8.12 38.46 53.08 -43.83 81.49 70.61 -45.02 79.78 70.42 ULMN 4 1j00_c00 THIOESTERASE I user 2 4 # 2 A 44 GLY C 145 GLY.? 13.18 O ACT C 201 A 73 ASN C 31 ASN~? 8.68 CH3 ACT C 201 A 154 ASP C 150 ASP.? 20.99 CH3 ACT C 201 A 157 HIS C 151 HIS.? 16.03 CH3 ACT C 201 coo 5.31 35.31 46.19 5.56 34.58 46.17 -35.71 37.24 58.49 -36.57 37.39 58.47 coo 1.82 33.37 49.33 3.83 34.09 49.37 -36.93 39.85 55.08 -38.97 40.48 55.12 coo 8.45 43.15 56.37 9.67 41.50 55.89 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 9.95 38.09 54.06 8.12 38.46 53.08 -46.81 35.18 56.40 -47.74 36.88 57.21 ULMN 4 1j00_c00 THIOESTERASE I user 3 4 # 3 A 44 GLY D 145 GLY.? 13.27 OXT ACT D 201 A 73 ASN D 31 ASN~? 8.51 CH3 ACT D 201 A 154 ASP D 150 ASP.? 21.68 CH3 ACT D 201 A 157 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo 5.31 35.31 46.19 5.56 34.58 46.17 -54.58 73.10 33.20 -53.72 72.98 33.25 coo 1.82 33.37 49.33 3.83 34.09 49.37 -53.58 68.96 34.68 -51.50 68.66 35.10 coo 8.45 43.15 56.37 9.67 41.50 55.89 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 9.95 38.09 54.06 8.12 38.46 53.08 -44.04 70.63 29.61 -43.01 70.81 31.43 1j00_c00 source 1j00 THIOESTERASE I : 3 hits 1j00_c00 naa= 4 ULMN 4 1j00_c01 THIOESTERASE I user 1 4 # 1 A 44 GLY A 145 GLY.? 13.13 O ACT A 201 A 73 ASN A 31 ASN~? 8.53 CH3 ACT A 201 A 154 ASP A 150 ASP.? 22.07 CH3 ACT A 201 A 157 HIS A 151 HIS.? 15.97 CH3 ACT A 201 coo 5.31 35.31 46.19 5.56 34.58 46.17 -38.43 80.69 60.76 -38.91 80.43 61.42 coo 1.82 33.37 49.33 3.83 34.09 49.37 -36.15 78.19 63.69 -37.32 77.26 65.21 coo 8.45 43.15 56.37 9.67 41.50 55.89 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 9.95 38.09 54.06 8.12 38.46 53.08 -43.83 81.49 70.61 -45.02 79.78 70.42 ULMN 4 1j00_c01 THIOESTERASE I user 2 4 # 2 A 44 GLY C 145 GLY.? 13.18 O ACT C 201 A 73 ASN C 31 ASN~? 8.68 CH3 ACT C 201 A 154 ASP C 150 ASP.? 20.99 CH3 ACT C 201 A 157 HIS C 151 HIS.? 16.03 CH3 ACT C 201 coo 5.31 35.31 46.19 5.56 34.58 46.17 -35.71 37.24 58.49 -36.57 37.39 58.47 coo 1.82 33.37 49.33 3.83 34.09 49.37 -36.93 39.85 55.08 -38.97 40.48 55.12 coo 8.45 43.15 56.37 9.67 41.50 55.89 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 9.95 38.09 54.06 8.12 38.46 53.08 -46.81 35.18 56.40 -47.74 36.88 57.21 ULMN 4 1j00_c01 THIOESTERASE I user 3 4 # 3 A 44 GLY D 145 GLY.? 13.27 OXT ACT D 201 A 73 ASN D 31 ASN~? 8.51 CH3 ACT D 201 A 154 ASP D 150 ASP.? 21.68 CH3 ACT D 201 A 157 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo 5.31 35.31 46.19 5.56 34.58 46.17 -54.58 73.10 33.20 -53.72 72.98 33.25 coo 1.82 33.37 49.33 3.83 34.09 49.37 -53.58 68.96 34.68 -51.50 68.66 35.10 coo 8.45 43.15 56.37 9.67 41.50 55.89 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 9.95 38.09 54.06 8.12 38.46 53.08 -44.04 70.63 29.61 -43.01 70.81 31.43 1j00_c01 source 1j00 THIOESTERASE I : 3 hits 1j00_c01 naa= 4 ULMN 4 1jof_c00 CARBOXY-CIS,CIS-MUCONATE CYCLASE user 1 4 # 1 A 148 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 196 ARG D 147 ARG.? 13.02 CH3 ACT D 201 A 212 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 274 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo 44.36 8.80 -7.84 45.65 7.19 -7.47 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 42.36 7.67 -4.04 44.13 5.42 -5.12 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 43.03 9.86 -0.36 44.78 10.10 -1.50 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 44.71 3.03 0.31 45.16 5.56 -1.49 -50.90 63.83 27.93 -49.90 66.74 27.73 1jof_c00 source 1jof CARBOXY-CIS,CIS-MUCONATE CYCLASE : 1 hits 1jof_c00 naa= 4 ULMN 4 1jof_c01 CARBOXY-CIS,CIS-MUCONATE CYCLASE user 1 4 # 1 B 148 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 196 ARG A 147 ARG.? 13.06 CH3 ACT A 201 B 212 GLU A 27 GLU~? 9.74 CH3 ACT A 201 B 274 ARG A 24 ARG~? 13.97 CH3 ACT A 201 coo 30.18 -22.84 28.44 32.24 -22.49 28.19 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 29.85 -20.79 24.46 32.56 -20.33 25.84 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 29.21 -23.07 20.75 30.25 -24.35 22.10 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 35.12 -19.11 20.58 33.60 -21.26 22.27 -33.88 82.79 71.01 -36.66 83.48 69.87 ULMN 4 1jof_c01 CARBOXY-CIS,CIS-MUCONATE CYCLASE user 2 4 # 2 B 148 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 196 ARG A 147 ARG.? 13.06 CH3 ACT A 201 B 212 GLU A 27 GLU~? 9.74 CH3 ACT A 201 B 274 ARG A 146 ARG.? 16.48 CH3 ACT A 201 coo 30.18 -22.84 28.44 32.24 -22.49 28.19 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 29.85 -20.79 24.46 32.56 -20.33 25.84 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 29.21 -23.07 20.75 30.25 -24.35 22.10 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 35.12 -19.11 20.58 33.60 -21.26 22.27 -35.10 85.34 65.39 -35.74 86.54 68.15 ULMN 4 1jof_c01 CARBOXY-CIS,CIS-MUCONATE CYCLASE user 3 4 # 3 B 148 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 196 ARG D 147 ARG.? 13.02 CH3 ACT D 201 B 212 GLU D 27 GLU~? 9.75 CH3 ACT D 201 B 274 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo 30.18 -22.84 28.44 32.24 -22.49 28.19 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 29.85 -20.79 24.46 32.56 -20.33 25.84 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 29.21 -23.07 20.75 30.25 -24.35 22.10 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 35.12 -19.11 20.58 33.60 -21.26 22.27 -50.90 63.83 27.93 -49.90 66.74 27.73 1jof_c01 source 1jof CARBOXY-CIS,CIS-MUCONATE CYCLASE : 3 hits 1jof_c01 naa= 4 ULMN 4 1jof_c02 CARBOXY-CIS,CIS-MUCONATE CYCLASE user 1 4 # 1 C 148 HIS D 151 HIS.? 15.66 CH3 ACT D 201 C 196 ARG D 147 ARG.? 13.02 CH3 ACT D 201 C 212 GLU D 27 GLU~? 9.75 CH3 ACT D 201 C 274 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo -17.42 -6.79 23.45 -18.90 -5.75 22.40 -44.04 70.63 29.61 -43.01 70.81 31.43 coo -14.73 -3.50 22.15 -17.30 -3.74 20.46 -46.62 68.18 31.08 -46.22 65.54 29.55 coo -13.53 -0.27 24.79 -15.48 -0.88 25.45 -50.66 64.65 33.24 -49.08 64.98 31.89 coo -16.74 2.06 18.88 -17.01 0.04 21.22 -50.90 63.83 27.93 -49.90 66.74 27.73 1jof_c02 source 1jof CARBOXY-CIS,CIS-MUCONATE CYCLASE : 1 hits 1jof_c02 naa= 4 ULMN 4 1jof_c03 CARBOXY-CIS,CIS-MUCONATE CYCLASE user 1 4 # 1 D 148 HIS D 151 HIS.? 15.66 CH3 ACT D 201 D 196 ARG D 147 ARG.? 13.02 CH3 ACT D 201 D 212 GLU D 27 GLU~? 9.75 CH3 ACT D 201 D 274 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo -1.80 29.55 -7.20 -3.67 29.81 -6.27 -44.04 70.63 29.61 -43.01 70.81 31.43 coo -2.18 25.39 -5.85 -4.12 27.26 -4.32 -46.62 68.18 31.08 -46.22 65.54 29.55 coo -3.35 22.14 -8.56 -4.26 23.90 -9.32 -50.66 64.65 33.24 -49.08 64.98 31.89 coo -7.73 22.70 -3.02 -6.32 24.34 -5.23 -50.90 63.83 27.93 -49.90 66.74 27.73 1jof_c03 source 1jof CARBOXY-CIS,CIS-MUCONATE CYCLASE : 1 hits 1jof_c03 naa= 4 ULMN 4 1jof_c04 CARBOXY-CIS,CIS-MUCONATE CYCLASE user 1 4 # 1 E 148 HIS D 151 HIS.? 15.66 CH3 ACT D 201 E 196 ARG D 147 ARG.? 13.02 CH3 ACT D 201 E 212 GLU D 27 GLU~? 9.75 CH3 ACT D 201 E 274 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo 3.58 -8.78 -33.03 3.89 -10.82 -33.40 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 5.70 -8.14 -36.90 6.23 -10.93 -35.72 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 3.50 -7.21 -40.60 2.24 -8.41 -39.37 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 7.55 -13.06 -41.11 5.43 -11.71 -39.33 -50.90 63.83 27.93 -49.90 66.74 27.73 1jof_c04 source 1jof CARBOXY-CIS,CIS-MUCONATE CYCLASE : 1 hits 1jof_c04 naa= 4 ULMN 4 1jof_c05 CARBOXY-CIS,CIS-MUCONATE CYCLASE user 1 4 # 1 F 148 HIS D 151 HIS.? 15.66 CH3 ACT D 201 F 196 ARG D 147 ARG.? 13.02 CH3 ACT D 201 F 212 GLU D 27 GLU~? 9.75 CH3 ACT D 201 F 274 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo 35.85 -19.76 -69.89 34.29 -21.12 -69.58 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 34.71 -18.16 -65.90 32.44 -19.82 -67.19 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 36.95 -19.08 -62.31 37.14 -20.71 -63.65 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 30.15 -20.94 -61.79 32.67 -21.26 -63.59 -50.90 63.83 27.93 -49.90 66.74 27.73 1jof_c05 source 1jof CARBOXY-CIS,CIS-MUCONATE CYCLASE : 1 hits 1jof_c05 naa= 4 ULMN 4 1jof_c06 CARBOXY-CIS,CIS-MUCONATE CYCLASE user 1 4 # 1 G 148 HIS D 151 HIS.? 15.66 CH3 ACT D 201 G 196 ARG D 147 ARG.? 13.02 CH3 ACT D 201 G 212 GLU D 27 GLU~? 9.75 CH3 ACT D 201 G 274 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo 55.66 26.48 -66.68 55.93 28.27 -65.63 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 51.47 26.65 -65.07 53.39 28.45 -63.49 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 48.10 27.98 -67.52 49.85 28.97 -68.28 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 48.87 31.88 -61.63 50.45 30.76 -64.08 -50.90 63.83 27.93 -49.90 66.74 27.73 1jof_c06 source 1jof CARBOXY-CIS,CIS-MUCONATE CYCLASE : 1 hits 1jof_c06 naa= 4 ULMN 4 1kim_c01 THYMIDINE KINASE user 1 4 # 1 B 59 GLY A 109 GLY^? 6.82 OXT ACT A 201 B 83 GLU A 160 GLU.? 13.50 O ACT A 201 B 163 ARG A 106 ARG^? 14.48 O1 EDO A 301 B 222 ARG B 49 ARG^? 10.37 O ACT B 201 coo 12.62 99.24 38.96 12.68 98.60 38.52 -34.97 66.16 72.79 -35.28 66.58 73.38 coo 14.40 90.04 44.78 14.76 92.05 44.57 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 17.43 90.38 41.69 17.76 92.72 39.75 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 13.56 96.78 47.94 12.87 95.13 45.44 -40.89 64.28 77.45 -37.86 63.79 77.23 1kim_c01 source 1kim THYMIDINE KINASE : 1 hits 1kim_c01 naa= 4 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 1 4 # 1 A 15 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 35 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 126 ARG D 51 ARG.? 7.60 O ACT D 201 A 165 ASP D 149 ASP.? 20.02 CH3 ACT D 201 coo 25.71 11.82 52.50 25.05 7.88 50.17 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 23.50 1.36 54.56 23.86 1.61 52.50 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 33.89 4.42 51.79 30.99 5.09 51.05 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 42.34 11.15 22.32 43.58 12.11 23.75 -48.61 69.27 22.33 -50.68 68.95 22.00 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 2 4 # 2 A 15 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 35 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 126 ARG D 51 ARG.? 7.60 O ACT D 201 A 165 ASP D 150 ASP.? 21.68 CH3 ACT D 201 coo 25.71 11.82 52.50 25.05 7.88 50.17 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 23.50 1.36 54.56 23.86 1.61 52.50 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 33.89 4.42 51.79 30.99 5.09 51.05 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 42.34 11.15 22.32 43.58 12.11 23.75 -44.02 71.14 22.58 -44.47 73.01 23.46 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 3 4 # 3 A 15 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 35 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 126 ARG B 51 ARG.? 7.67 O ACT B 201 A 165 ASP B 149 ASP.? 20.03 CH3 ACT B 201 coo 25.71 11.82 52.50 25.05 7.88 50.17 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 23.50 1.36 54.56 23.86 1.61 52.50 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 33.89 4.42 51.79 30.99 5.09 51.05 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 42.34 11.15 22.32 43.58 12.11 23.75 -13.67 50.22 91.33 -14.75 50.15 93.16 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 4 4 # 4 A 15 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 35 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 126 ARG B 51 ARG.? 7.67 O ACT B 201 A 165 ASP B 150 ASP.? 20.21 CH3 ACT A 202 coo 25.71 11.82 52.50 25.05 7.88 50.17 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 23.50 1.36 54.56 23.86 1.61 52.50 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 33.89 4.42 51.79 30.99 5.09 51.05 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 42.34 11.15 22.32 43.58 12.11 23.75 -10.73 49.15 87.46 -11.06 47.07 87.30 1ltq_c00 source 1ltq POLYNUCLEOTIDE KINASE : 4 hits 1ltq_c00 naa= 4 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 1 4 # 1 A 147 SER A 18 SER~? 19.91 CH3 ACT A 201 A 159 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 184 ARG A 24 ARG~? 13.97 CH3 ACT A 201 A 189 GLU A 21 GLU~? 19.20 CH3 ACT A 201 coo 53.09 24.63 27.00 51.51 25.19 25.28 -24.38 83.84 77.64 -22.19 83.01 78.40 coo 52.64 14.17 18.05 51.99 14.09 16.04 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 45.78 18.05 21.49 44.51 17.88 18.72 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 49.07 22.26 28.01 48.95 23.27 26.11 -26.74 85.39 73.13 -25.47 87.07 73.30 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 2 4 # 2 A 147 SER B 18 SER~? 19.96 CH3 ACT B 201 A 159 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 184 ARG B 24 ARG~? 14.02 CH3 ACT B 201 A 189 GLU B 21 GLU~? 20.11 CH3 ACT B 201 coo 53.09 24.63 27.00 51.51 25.19 25.28 -20.65 65.45 94.60 -21.88 67.54 95.01 coo 52.64 14.17 18.05 51.99 14.09 16.04 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 45.78 18.05 21.49 44.51 17.88 18.72 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 49.07 22.26 28.01 48.95 23.27 26.11 -19.23 61.49 94.88 -18.90 62.15 96.87 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 3 4 # 3 A 147 SER C 18 SER~? 19.83 CH3 ACT C 201 A 159 GLU C 80 GLU^? 14.47 CH3 ACT C 201 A 184 ARG C 24 ARG~? 14.09 CH3 ACT C 201 A 189 GLU C 21 GLU~? 19.29 CH3 ACT C 201 coo 53.09 24.63 27.00 51.51 25.19 25.28 -39.67 35.11 36.68 -39.03 36.29 34.63 coo 52.64 14.17 18.05 51.99 14.09 16.04 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 45.78 18.05 21.49 44.51 17.88 18.72 -40.53 35.15 48.39 -41.31 34.14 51.19 coo 49.07 22.26 28.01 48.95 23.27 26.11 -37.51 33.35 41.29 -36.60 32.00 39.94 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 4 4 # 4 A 147 SER D 18 SER~? 20.00 CH3 ACT D 201 A 159 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 184 ARG D 24 ARG~? 13.98 CH3 ACT D 201 A 189 GLU D 21 GLU~? 20.13 CH3 ACT D 201 coo 53.09 24.63 27.00 51.51 25.19 25.28 -52.79 52.80 24.41 -53.57 50.53 24.92 coo 52.64 14.17 18.05 51.99 14.09 16.04 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 45.78 18.05 21.49 44.51 17.88 18.72 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 49.07 22.26 28.01 48.95 23.27 26.11 -52.88 57.10 23.42 -54.02 56.21 21.88 1og1_c00 source 1og1 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2 : 4 hits 1og1_c00 naa= 4 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 1 4 # 1 A 36 LYS A 62 LYS~? 17.60 O ACT A 201 A 108 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 211 ARG A 58 ARG~? 18.13 CH3 ACT A 201 A 319 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 26.40 -0.07 5.65 25.70 1.89 10.82 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 13.95 1.15 16.48 15.65 1.17 15.18 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 30.30 5.19 11.85 28.49 2.83 12.64 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 2 4 # 2 A 36 LYS B 62 LYS~? 17.44 OXT ACT B 201 A 108 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 211 ARG B 58 ARG~? 17.86 CH3 ACT B 201 A 319 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo 26.40 -0.07 5.65 25.70 1.89 10.82 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 13.95 1.15 16.48 15.65 1.17 15.18 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 30.30 5.19 11.85 28.49 2.83 12.64 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 3 4 # 3 A 36 LYS C 62 LYS~? 12.50 O2 EDO A 302 A 108 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 211 ARG C 58 ARG~? 18.03 CH3 ACT C 201 A 319 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 26.40 -0.07 5.65 25.70 1.89 10.82 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 13.95 1.15 16.48 15.65 1.17 15.18 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 30.30 5.19 11.85 28.49 2.83 12.64 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 4 4 # 4 A 36 LYS D 62 LYS~? 17.47 OXT ACT D 201 A 108 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 211 ARG D 58 ARG~? 18.01 CH3 ACT D 201 A 319 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo 26.40 -0.07 5.65 25.70 1.89 10.82 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 13.95 1.15 16.48 15.65 1.17 15.18 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 30.30 5.19 11.85 28.49 2.83 12.64 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 -50.66 64.65 33.24 -49.08 64.98 31.89 1p4n_c00 source 1p4n UDP-MURNAC-PENTAPEPTIDE : 4 hits 1p4n_c00 naa= 4 ULMN 4 1p4r_c00 BIFUNCTIONAL PURINE BIOSYNTHESIS PROuser 1 4 # 1 A 266 LYS C 139 LYS.? 18.79 O ACT C 201 A 267 HIS C 141 HIS.? 17.85 O ACT C 201 A 431 ASN C 103 ASN.? 7.35 O1 EDO A 301 A 592 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 0.26 22.09 34.68 -3.45 19.36 33.12 -50.26 41.49 60.64 -55.14 42.95 58.84 coo 2.87 18.25 32.93 2.17 16.30 33.22 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 11.44 27.50 23.30 13.30 27.55 22.28 -44.48 55.23 67.22 -44.54 56.80 68.65 coo 15.28 24.00 30.62 14.74 24.27 28.61 -40.81 49.03 67.16 -39.15 48.14 68.10 1p4r_c00 source 1p4r BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH : 1 hits 1p4r_c00 naa= 4 ULMN 4 1p4r_c01 BIFUNCTIONAL PURINE BIOSYNTHESIS PROuser 1 4 # 1 B 266 LYS C 139 LYS.? 18.79 O ACT C 201 B 267 HIS C 141 HIS.? 17.85 O ACT C 201 B 431 ASN C 103 ASN.? 7.35 O1 EDO A 301 B 592 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 16.46 21.36 21.89 16.46 24.95 18.59 -50.26 41.49 60.64 -55.14 42.95 58.84 coo 15.13 24.90 25.09 15.98 26.81 24.92 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 2.00 16.40 28.58 0.63 16.55 30.19 -44.48 55.23 67.22 -44.54 56.80 68.65 coo 8.34 17.88 34.80 6.52 18.00 33.76 -40.81 49.03 67.16 -39.15 48.14 68.10 1p4r_c01 source 1p4r BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH : 1 hits 1p4r_c01 naa= 4 ULMN 4 1ptd_c01 PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHuser 1 4 # 1 32 HIS A 151 HIS.? 15.97 CH3 ACT A 201 69 ARG A 76 ARG^? 8.97 OXT ACT A 203 82 HIS A 141 HIS.? 11.20 OXT ACT A 203 274 ASP A 150 ASP.? 22.07 CH3 ACT A 201 coo 17.95 33.65 102.53 17.45 31.62 102.61 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 21.40 29.87 95.89 20.75 29.43 98.86 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 13.78 26.89 97.17 14.10 26.88 99.25 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 13.65 36.01 104.94 14.62 34.25 104.47 -43.95 88.27 71.85 -43.22 89.50 70.29 1ptd_c01 source 1ptd PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C : 1 hits 1ptd_c01 naa= 4 ULMN 4 1qh9_c01 2-HALOACID DEHALOGENASE user 1 4 # 1 A 10 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 41 ARG B 51 ARG.? 7.67 O ACT B 201 A 118 SER A 107 SER^? 6.74 O1 EDO A 301 A 180 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 20.70 13.03 9.13 22.27 11.81 9.81 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 23.00 19.17 17.85 22.49 17.70 15.19 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 17.70 9.25 13.10 16.68 11.30 13.99 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 26.47 11.43 10.70 25.16 9.82 11.06 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 4 1qh9_c01 2-HALOACID DEHALOGENASE user 2 4 # 2 A 10 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 41 ARG D 51 ARG.? 7.60 O ACT D 201 A 118 SER C 107 SER^? 6.74 O2 EDO A 301 A 180 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 20.70 13.03 9.13 22.27 11.81 9.81 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 23.00 19.17 17.85 22.49 17.70 15.19 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 17.70 9.25 13.10 16.68 11.30 13.99 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 26.47 11.43 10.70 25.16 9.82 11.06 -44.15 62.19 57.97 -45.93 61.14 58.45 1qh9_c01 source 1qh9 2-HALOACID DEHALOGENASE : 2 hits 1qh9_c01 naa= 4 ULMN 4 1qrg_c00 CARBONIC ANHYDRASE user 1 4 # 1 A 62 GLU B 21 GLU~? 20.11 CH3 ACT B 201 A 75 GLN B 47 GLN^? 17.37 O ACT B 201 A 84 GLU B 17 GLU~? 23.60 CH3 ACT B 201 A 202 ASN B 57 ASN~? 18.11 O ACT B 201 coo 31.58 50.21 48.39 31.33 50.18 50.48 -19.23 61.49 94.88 -18.90 62.15 96.87 coo 15.01 67.80 50.45 13.17 67.90 51.59 -43.79 66.33 88.09 -45.65 65.30 88.17 coo 31.72 45.69 48.66 33.65 44.89 48.92 -16.26 64.60 95.04 -14.82 64.68 96.59 coo 11.82 69.95 45.33 12.39 70.17 47.37 -46.90 59.98 91.63 -48.14 58.47 90.79 ULMN 4 1qrg_c00 CARBONIC ANHYDRASE user 2 4 # 2 A 62 GLU D 21 GLU~? 20.13 CH3 ACT D 201 A 75 GLN D 47 GLN^? 17.53 O ACT D 201 A 84 GLU D 17 GLU~? 23.59 CH3 ACT D 201 A 202 ASN D 57 ASN~? 18.22 O ACT D 201 coo 31.58 50.21 48.39 31.33 50.18 50.48 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 15.01 67.80 50.45 13.17 67.90 51.59 -62.04 48.65 46.19 -63.34 49.20 47.78 coo 31.72 45.69 48.66 33.65 44.89 48.92 -50.49 54.35 20.83 -50.89 54.35 18.75 coo 11.82 69.95 45.33 12.39 70.17 47.37 -67.77 54.18 46.88 -68.13 55.47 48.54 1qrg_c00 source 1qrg CARBONIC ANHYDRASE : 2 hits 1qrg_c00 naa= 4 ULMN 4 1x9h_c00 GLUCOSE-6-PHOSPHATE ISOMERASE user 1 4 # 1 A 135 ARG B 24 ARG~? 14.02 CH3 ACT B 201 A 203 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 219 HIS A 161 HIS.? 19.24 O ACT B 201 A 298 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 46.78 3.24 25.36 49.46 4.02 24.06 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 45.62 7.41 24.38 46.18 6.66 26.27 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 17.74 16.81 28.99 16.41 15.60 30.09 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 54.03 15.54 30.62 51.73 9.72 31.19 -18.83 46.84 75.05 -16.49 49.79 71.17 1x9h_c00 source 1x9h GLUCOSE-6-PHOSPHATE ISOMERASE : 1 hits 1x9h_c00 naa= 4 ULMN 4 1x9h_c01 GLUCOSE-6-PHOSPHATE ISOMERASE user 1 4 # 1 B 135 ARG B 24 ARG~? 14.02 CH3 ACT B 201 B 203 GLU B 27 GLU~? 9.83 CH3 ACT B 201 B 219 HIS A 161 HIS.? 19.24 O ACT B 201 B 298 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 18.36 26.71 24.52 15.92 26.01 22.78 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 19.67 22.60 23.25 18.70 23.07 25.03 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 46.63 12.38 30.98 47.80 13.39 32.39 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 10.17 13.56 26.79 12.26 19.06 29.15 -18.83 46.84 75.05 -16.49 49.79 71.17 1x9h_c01 source 1x9h GLUCOSE-6-PHOSPHATE ISOMERASE : 1 hits 1x9h_c01 naa= 4 ULMN 4 2plc_c01 PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHuser 1 4 # 1 45 HIS A 151 HIS.? 15.97 CH3 ACT A 201 84 ARG A 76 ARG^? 8.97 OXT ACT A 203 93 HIS A 141 HIS.? 11.20 OXT ACT A 203 278 ASP A 150 ASP.? 22.07 CH3 ACT A 201 coo 31.87 31.30 28.72 31.86 29.46 29.73 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 24.84 27.81 28.65 27.85 27.30 28.97 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 27.02 27.68 36.08 29.06 27.20 35.96 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 35.36 34.87 31.53 34.51 32.98 31.23 -43.95 88.27 71.85 -43.22 89.50 70.29 ULMN 4 2plc_c01 PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHuser 2 4 # 2 45 HIS C 151 HIS.? 16.03 CH3 ACT C 201 84 ARG C 76 ARG^? 14.32 O ACT C 201 93 HIS C 141 HIS.? 17.85 O ACT C 201 278 ASP C 150 ASP.? 20.99 CH3 ACT C 201 coo 31.87 31.30 28.72 31.86 29.46 29.73 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 24.84 27.81 28.65 27.85 27.30 28.97 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 27.02 27.68 36.08 29.06 27.20 35.96 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 35.36 34.87 31.53 34.51 32.98 31.23 -46.61 28.46 55.57 -45.54 29.27 57.21 ULMN 4 2plc_c01 PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHuser 3 4 # 3 45 HIS D 151 HIS.? 15.66 CH3 ACT D 201 84 ARG D 76 ARG^? 14.20 OXT ACT D 201 93 HIS D 141 HIS.? 18.95 OXT ACT D 201 278 ASP D 150 ASP.? 21.68 CH3 ACT D 201 coo 31.87 31.30 28.72 31.86 29.46 29.73 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 24.84 27.81 28.65 27.85 27.30 28.97 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 27.02 27.68 36.08 29.06 27.20 35.96 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 35.36 34.87 31.53 34.51 32.98 31.23 -44.02 71.14 22.58 -44.47 73.01 23.46 2plc_c01 source 2plc PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C : 3 hits 2plc_c01 naa= 4 ULMN 4 3csm_c00 CHORISMATE MUTASE user 1 4 # 1 A 16 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 157 ARG A 49 ARG^? -3.92 O ACT A 202s A 168 LYS A 68 LYS~? -2.78 O ACT A 201s A 246 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo 37.85 22.13 39.07 35.08 21.72 40.26 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 42.53 17.43 30.59 39.80 18.74 31.20 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 36.10 13.35 45.30 34.36 14.97 39.48 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 36.95 11.32 36.89 36.00 13.20 36.97 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 4 3csm_c00 CHORISMATE MUTASE user 2 4 # 2 A 16 ARG B 124 ARG.? -3.52 O ACT B 201s A 157 ARG B 49 ARG^? 10.37 O ACT B 201 A 168 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 246 GLU B 53 GLU^? 11.09 O ACT B 201 coo 37.85 22.13 39.07 35.08 21.72 40.26 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 42.53 17.43 30.59 39.80 18.74 31.20 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 36.10 13.35 45.30 34.36 14.97 39.48 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 36.95 11.32 36.89 36.00 13.20 36.97 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 4 3csm_c00 CHORISMATE MUTASE user 3 4 # 3 A 16 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 157 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 168 LYS C 68 LYS~? -2.77 O ACT C 201s A 246 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo 37.85 22.13 39.07 35.08 21.72 40.26 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 42.53 17.43 30.59 39.80 18.74 31.20 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 36.10 13.35 45.30 34.36 14.97 39.48 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 36.95 11.32 36.89 36.00 13.20 36.97 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 4 3csm_c00 CHORISMATE MUTASE user 4 4 # 4 A 16 ARG D 124 ARG.? -3.55 O ACT D 201s A 157 ARG D 49 ARG^? 10.44 O ACT D 201 A 168 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 246 GLU D 53 GLU^? 10.32 O ACT A 203 coo 37.85 22.13 39.07 35.08 21.72 40.26 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 42.53 17.43 30.59 39.80 18.74 31.20 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 36.10 13.35 45.30 34.36 14.97 39.48 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 36.95 11.32 36.89 36.00 13.20 36.97 -56.60 59.52 53.75 -57.18 61.28 52.77 3csm_c00 source 3csm CHORISMATE MUTASE : 4 hits 3csm_c00 naa= 4 ULMN 4 3csm_c01 CHORISMATE MUTASE user 1 4 # 1 B 16 ARG A 124 ARG.? -3.54 OXT ACT A 201s B 157 ARG A 49 ARG^? -3.92 O ACT A 202s B 168 LYS A 68 LYS~? -2.78 O ACT A 201s B 246 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo 36.39 28.16 -15.11 39.30 27.67 -15.87 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 30.58 24.11 -7.00 33.37 25.38 -7.33 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 38.96 18.92 -20.31 39.88 21.02 -14.46 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 36.95 17.56 -11.96 37.91 19.44 -12.06 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 4 3csm_c01 CHORISMATE MUTASE user 2 4 # 2 B 16 ARG B 124 ARG.? -3.52 O ACT B 201s B 157 ARG B 49 ARG^? 10.37 O ACT B 201 B 168 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 246 GLU B 53 GLU^? 11.09 O ACT B 201 coo 36.39 28.16 -15.11 39.30 27.67 -15.87 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 30.58 24.11 -7.00 33.37 25.38 -7.33 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 38.96 18.92 -20.31 39.88 21.02 -14.46 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 36.95 17.56 -11.96 37.91 19.44 -12.06 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 4 3csm_c01 CHORISMATE MUTASE user 3 4 # 3 B 16 ARG C 124 ARG.? -3.50 OXT ACT C 201s B 157 ARG C 49 ARG^? 10.47 OXT ACT C 201 B 168 LYS C 68 LYS~? -2.77 O ACT C 201s B 246 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo 36.39 28.16 -15.11 39.30 27.67 -15.87 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 30.58 24.11 -7.00 33.37 25.38 -7.33 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 38.96 18.92 -20.31 39.88 21.02 -14.46 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 36.95 17.56 -11.96 37.91 19.44 -12.06 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 4 3csm_c01 CHORISMATE MUTASE user 4 4 # 4 B 16 ARG D 124 ARG.? -3.55 O ACT D 201s B 157 ARG D 49 ARG^? 10.44 O ACT D 201 B 168 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 246 GLU D 53 GLU^? 10.32 O ACT A 203 coo 36.39 28.16 -15.11 39.30 27.67 -15.87 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 30.58 24.11 -7.00 33.37 25.38 -7.33 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 38.96 18.92 -20.31 39.88 21.02 -14.46 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 36.95 17.56 -11.96 37.91 19.44 -12.06 -56.60 59.52 53.75 -57.18 61.28 52.77 3csm_c01 source 3csm CHORISMATE MUTASE : 4 hits 3csm_c01 naa= 4 ULMN 4 3pva_c00 PENICILLIN V ACYLASE user 1 4 # 1 A 1 CYH A 127 CYH.? 6.15 O ACT A 202 A 82 TYR B 108 TYR^? -4.79 O ACT A 202s A 175 ASN B 129 ASN.? 9.80 OXT ACT A 201 A 228 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 33.45 48.14 65.69 31.97 46.93 63.48 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 28.89 50.18 59.86 26.24 49.97 59.06 -26.20 55.78 72.02 -24.40 54.06 70.73 coo 33.57 53.38 62.58 33.15 51.44 63.28 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 34.39 52.40 70.14 33.86 52.54 67.13 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 4 3pva_c00 PENICILLIN V ACYLASE user 2 4 # 2 A 1 CYH C 127 CYH.? 10.01 O ACT D 201 A 82 TYR D 108 TYR^? 12.28 OXT ACT D 201 A 175 ASN D 129 ASN.? 9.72 OXT ACT C 201 A 228 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 33.45 48.14 65.69 31.97 46.93 63.48 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 28.89 50.18 59.86 26.24 49.97 59.06 -40.41 63.05 43.73 -38.60 65.12 43.23 coo 33.57 53.38 62.58 33.15 51.44 63.28 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 34.39 52.40 70.14 33.86 52.54 67.13 -39.28 57.54 52.97 -41.40 56.18 54.75 3pva_c00 source 3pva PENICILLIN V ACYLASE : 2 hits 3pva_c00 naa= 4 ULMN 4 3pva_c01 PENICILLIN V ACYLASE user 1 4 # 1 B 1 CYH A 127 CYH.? 6.15 O ACT A 202 B 82 TYR B 108 TYR^? -4.79 O ACT A 202s B 175 ASN B 129 ASN.? 9.80 OXT ACT A 201 B 228 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 32.27 85.21 87.17 30.27 86.64 88.60 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 25.64 84.12 90.91 22.95 84.76 90.68 -26.20 55.78 72.02 -24.40 54.06 70.73 coo 30.48 80.09 90.00 30.60 82.04 89.29 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 34.07 80.63 83.30 32.52 80.76 85.96 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 4 3pva_c01 PENICILLIN V ACYLASE user 2 4 # 2 B 1 CYH C 127 CYH.? 10.01 O ACT D 201 B 82 TYR D 108 TYR^? 12.28 OXT ACT D 201 B 175 ASN D 129 ASN.? 9.72 OXT ACT C 201 B 228 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 32.27 85.21 87.17 30.27 86.64 88.60 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 25.64 84.12 90.91 22.95 84.76 90.68 -40.41 63.05 43.73 -38.60 65.12 43.23 coo 30.48 80.09 90.00 30.60 82.04 89.29 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 34.07 80.63 83.30 32.52 80.76 85.96 -39.28 57.54 52.97 -41.40 56.18 54.75 3pva_c01 source 3pva PENICILLIN V ACYLASE : 2 hits 3pva_c01 naa= 4 ULMN 4 3pva_c02 PENICILLIN V ACYLASE user 1 4 # 1 C 1 CYH A 127 CYH.? 6.15 O ACT A 202 C 82 TYR B 108 TYR^? -4.79 O ACT A 202s C 175 ASN B 129 ASN.? 9.80 OXT ACT A 201 C 228 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 48.27 81.91 65.05 50.50 82.61 63.32 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 54.53 78.96 61.73 57.29 79.13 61.93 -26.20 55.78 72.02 -24.40 54.06 70.73 coo 49.08 76.16 63.13 49.29 78.23 63.54 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 45.65 78.46 69.63 47.18 77.81 67.07 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 4 3pva_c02 PENICILLIN V ACYLASE user 2 4 # 2 C 1 CYH C 127 CYH.? 10.01 O ACT D 201 C 82 TYR D 108 TYR^? 12.28 OXT ACT D 201 C 175 ASN D 129 ASN.? 9.72 OXT ACT C 201 C 228 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 48.27 81.91 65.05 50.50 82.61 63.32 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 54.53 78.96 61.73 57.29 79.13 61.93 -40.41 63.05 43.73 -38.60 65.12 43.23 coo 49.08 76.16 63.13 49.29 78.23 63.54 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 45.65 78.46 69.63 47.18 77.81 67.07 -39.28 57.54 52.97 -41.40 56.18 54.75 3pva_c02 source 3pva PENICILLIN V ACYLASE : 2 hits 3pva_c02 naa= 4 ULMN 4 3pva_c03 PENICILLIN V ACYLASE user 1 4 # 1 D 1 CYH A 127 CYH.? 6.15 O ACT A 202 D 82 TYR B 108 TYR^? -4.79 O ACT A 202s D 175 ASN B 129 ASN.? 9.80 OXT ACT A 201 D 228 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 40.47 49.69 92.26 41.71 48.52 94.65 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 45.39 51.66 97.76 47.96 51.06 98.62 -26.20 55.78 72.02 -24.40 54.06 70.73 coo 41.33 55.21 94.53 41.38 53.11 94.15 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 40.26 53.28 87.19 40.85 53.78 90.13 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 4 3pva_c03 PENICILLIN V ACYLASE user 2 4 # 2 D 1 CYH C 127 CYH.? 10.01 O ACT D 201 D 82 TYR D 108 TYR^? 12.28 OXT ACT D 201 D 175 ASN D 129 ASN.? 9.72 OXT ACT C 201 D 228 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 40.47 49.69 92.26 41.71 48.52 94.65 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 45.39 51.66 97.76 47.96 51.06 98.62 -40.41 63.05 43.73 -38.60 65.12 43.23 coo 41.33 55.21 94.53 41.38 53.11 94.15 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 40.26 53.28 87.19 40.85 53.78 90.13 -39.28 57.54 52.97 -41.40 56.18 54.75 3pva_c03 source 3pva PENICILLIN V ACYLASE : 2 hits 3pva_c03 naa= 4 ULMN 4 3pva_c04 PENICILLIN V ACYLASE user 1 4 # 1 E 1 CYH A 127 CYH.? 6.15 O ACT A 202 E 82 TYR B 108 TYR^? -4.79 O ACT A 202s E 175 ASN B 129 ASN.? 9.80 OXT ACT A 201 E 228 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 24.70 146.52 -9.39 26.95 147.59 -10.87 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 31.02 144.22 -13.07 33.78 144.37 -12.84 -26.20 55.78 72.02 -24.40 54.06 70.73 coo 25.59 141.14 -12.25 25.75 143.10 -11.50 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 22.05 142.40 -5.46 23.64 142.17 -8.04 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 4 3pva_c04 PENICILLIN V ACYLASE user 2 4 # 2 E 1 CYH C 127 CYH.? 10.01 O ACT D 201 E 82 TYR D 108 TYR^? 12.28 OXT ACT D 201 E 175 ASN D 129 ASN.? 9.72 OXT ACT C 201 E 228 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 24.70 146.52 -9.39 26.95 147.59 -10.87 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 31.02 144.22 -13.07 33.78 144.37 -12.84 -40.41 63.05 43.73 -38.60 65.12 43.23 coo 25.59 141.14 -12.25 25.75 143.10 -11.50 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 22.05 142.40 -5.46 23.64 142.17 -8.04 -39.28 57.54 52.97 -41.40 56.18 54.75 3pva_c04 source 3pva PENICILLIN V ACYLASE : 2 hits 3pva_c04 naa= 4 ULMN 4 3pva_c05 PENICILLIN V ACYLASE user 1 4 # 1 F 1 CYH A 127 CYH.? 6.15 O ACT A 202 F 82 TYR B 108 TYR^? -4.79 O ACT A 202s F 175 ASN B 129 ASN.? 9.80 OXT ACT A 201 F 228 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 16.99 110.19 12.19 18.04 108.69 14.50 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 21.88 111.41 17.99 24.45 110.68 18.75 -26.20 55.78 72.02 -24.40 54.06 70.73 coo 17.75 115.44 15.25 17.83 113.44 14.66 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 16.79 114.65 7.75 17.33 114.69 10.74 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 4 3pva_c05 PENICILLIN V ACYLASE user 2 4 # 2 F 1 CYH C 127 CYH.? 10.01 O ACT D 201 F 82 TYR D 108 TYR^? 12.28 OXT ACT D 201 F 175 ASN D 129 ASN.? 9.72 OXT ACT C 201 F 228 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 16.99 110.19 12.19 18.04 108.69 14.50 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 21.88 111.41 17.99 24.45 110.68 18.75 -40.41 63.05 43.73 -38.60 65.12 43.23 coo 17.75 115.44 15.25 17.83 113.44 14.66 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 16.79 114.65 7.75 17.33 114.69 10.74 -39.28 57.54 52.97 -41.40 56.18 54.75 3pva_c05 source 3pva PENICILLIN V ACYLASE : 2 hits 3pva_c05 naa= 4 ULMN 4 3pva_c06 PENICILLIN V ACYLASE user 1 4 # 1 G 1 CYH A 127 CYH.? 6.15 O ACT A 202 G 82 TYR B 108 TYR^? -4.79 O ACT A 202s G 175 ASN B 129 ASN.? 9.80 OXT ACT A 201 G 228 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 10.18 112.97 -14.39 8.70 112.17 -16.80 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 5.66 115.90 -19.84 3.01 115.79 -20.68 -26.20 55.78 72.02 -24.40 54.06 70.73 coo 10.30 118.64 -16.67 9.88 116.63 -16.23 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 11.01 116.60 -9.21 10.51 117.08 -12.21 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 4 3pva_c06 PENICILLIN V ACYLASE user 2 4 # 2 G 1 CYH C 127 CYH.? 10.01 O ACT D 201 G 82 TYR D 108 TYR^? 12.28 OXT ACT D 201 G 175 ASN D 129 ASN.? 9.72 OXT ACT C 201 G 228 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 10.18 112.97 -14.39 8.70 112.17 -16.80 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 5.66 115.90 -19.84 3.01 115.79 -20.68 -40.41 63.05 43.73 -38.60 65.12 43.23 coo 10.30 118.64 -16.67 9.88 116.63 -16.23 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 11.01 116.60 -9.21 10.51 117.08 -12.21 -39.28 57.54 52.97 -41.40 56.18 54.75 3pva_c06 source 3pva PENICILLIN V ACYLASE : 2 hits 3pva_c06 naa= 4 ULMN 4 3pva_c07 PENICILLIN V ACYLASE user 1 4 # 1 H 1 CYH A 127 CYH.? 6.15 O ACT A 202 H 82 TYR B 108 TYR^? -4.79 O ACT A 202s H 175 ASN B 129 ASN.? 9.80 OXT ACT A 201 H 228 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 8.50 146.16 12.74 6.65 147.77 14.25 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 1.87 144.34 16.24 -0.84 144.99 16.04 -26.20 55.78 72.02 -24.40 54.06 70.73 coo 6.77 140.57 14.76 6.77 142.71 14.39 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 10.44 142.28 8.30 8.78 141.82 10.81 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 4 3pva_c07 PENICILLIN V ACYLASE user 2 4 # 2 H 1 CYH C 127 CYH.? 10.01 O ACT D 201 H 82 TYR D 108 TYR^? 12.28 OXT ACT D 201 H 175 ASN D 129 ASN.? 9.72 OXT ACT C 201 H 228 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 8.50 146.16 12.74 6.65 147.77 14.25 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 1.87 144.34 16.24 -0.84 144.99 16.04 -40.41 63.05 43.73 -38.60 65.12 43.23 coo 6.77 140.57 14.76 6.77 142.71 14.39 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 10.44 142.28 8.30 8.78 141.82 10.81 -39.28 57.54 52.97 -41.40 56.18 54.75 3pva_c07 source 3pva PENICILLIN V ACYLASE : 2 hits 3pva_c07 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 100 ARG C 123 ARG.? 17.68 OXT ACT C 201 A 116 GLN C 47 GLN^? 17.31 OXT ACT C 201 coo 32.24 20.09 5.34 30.38 19.04 5.27 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 26.40 25.34 6.28 26.15 22.33 7.25 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 26.74 21.94 13.78 27.57 20.97 12.08 -28.71 56.50 38.57 -27.41 57.79 39.66 12as_c00 source 12as ASPARAGINE SYNTHETASE : 1 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP C 116 ASP.? 19.40 CH3 ACT C 201 B 100 ARG C 123 ARG.? 17.68 OXT ACT C 201 B 116 GLN C 47 GLN^? 17.31 OXT ACT C 201 coo 32.18 48.37 12.48 33.96 49.46 12.97 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 39.04 43.25 11.37 38.30 45.35 13.56 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 37.43 42.63 19.41 36.76 44.08 17.97 -28.71 56.50 38.57 -27.41 57.79 39.66 12as_c01 source 12as ASPARAGINE SYNTHETASE : 1 hits 12as_c01 naa= 3 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 75 TYR^? -4.52 O ACT A 201s B 190 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 222 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 7.17 16.59 41.26 8.01 19.20 40.73 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 13.38 20.00 35.06 11.43 22.49 39.53 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 9.76 26.58 38.10 11.63 25.78 38.76 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR B 75 TYR^? -4.59 OXT ACT B 201s B 190 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 222 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 7.17 16.59 41.26 8.01 19.20 40.73 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 13.38 20.00 35.06 11.43 22.49 39.53 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 9.76 26.58 38.10 11.63 25.78 38.76 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR B 95 TYR^? -3.87 OXT ACT B 201s B 190 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 222 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 7.17 16.59 41.26 8.01 19.20 40.73 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 13.38 20.00 35.06 11.43 22.49 39.53 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 9.76 26.58 38.10 11.63 25.78 38.76 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 140 TYR C 75 TYR^? -4.54 O ACT C 201s B 190 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 222 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 7.17 16.59 41.26 8.01 19.20 40.73 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 13.38 20.00 35.06 11.43 22.49 39.53 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 9.76 26.58 38.10 11.63 25.78 38.76 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 140 TYR D 75 TYR^? -4.49 OXT ACT D 201s B 190 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 222 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 7.17 16.59 41.26 8.01 19.20 40.73 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 13.38 20.00 35.06 11.43 22.49 39.53 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 9.76 26.58 38.10 11.63 25.78 38.76 -49.03 74.78 51.99 -47.35 75.78 52.80 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 5 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 222 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 140 TYR A 75 TYR^? -4.52 O ACT A 201s coo -4.61 20.12 30.34 -2.74 22.65 25.95 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 1.51 16.60 24.17 0.82 19.23 24.79 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 222 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 140 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo -4.61 20.12 30.34 -2.74 22.65 25.95 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 1.51 16.60 24.17 0.82 19.23 24.79 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 222 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 140 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo -4.61 20.12 30.34 -2.74 22.65 25.95 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 1.51 16.60 24.17 0.82 19.23 24.79 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 190 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 222 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 140 TYR C 75 TYR^? -4.54 O ACT C 201s coo -4.61 20.12 30.34 -2.74 22.65 25.95 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 1.51 16.60 24.17 0.82 19.23 24.79 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 190 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 222 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 140 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo -4.61 20.12 30.34 -2.74 22.65 25.95 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 1.51 16.60 24.17 0.82 19.23 24.79 -52.06 69.71 41.47 -52.08 66.98 40.85 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 5 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 102 ASP A 150 ASP.? 22.07 CH3 ACT A 201 A 193 GLY A 145 GLY.? 13.13 O ACT A 201 coo 25.57 41.22 61.68 24.18 39.98 62.50 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 22.33 45.48 59.73 23.35 43.67 60.06 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 22.57 32.23 64.13 21.98 32.82 64.22 -38.43 80.69 60.76 -38.91 80.43 61.42 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 102 ASP B 150 ASP.? 20.21 CH3 ACT A 202 A 193 GLY B 145 GLY.? 13.34 OXT ACT B 201 coo 25.57 41.22 61.68 24.18 39.98 62.50 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 22.33 45.48 59.73 23.35 43.67 60.06 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 22.57 32.23 64.13 21.98 32.82 64.22 -25.17 44.53 88.88 -24.74 44.79 88.19 ULMN 3 1a0j_c12 TRYPSIN user 3 3 # 3 A 57 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 102 ASP C 150 ASP.? 20.99 CH3 ACT C 201 A 193 GLY C 145 GLY.? 13.18 O ACT C 201 coo 25.57 41.22 61.68 24.18 39.98 62.50 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 22.33 45.48 59.73 23.35 43.67 60.06 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 22.57 32.23 64.13 21.98 32.82 64.22 -35.71 37.24 58.49 -36.57 37.39 58.47 ULMN 3 1a0j_c12 TRYPSIN user 4 3 # 4 A 57 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 102 ASP D 150 ASP.? 21.68 CH3 ACT D 201 A 193 GLY D 145 GLY.? 13.27 OXT ACT D 201 coo 25.57 41.22 61.68 24.18 39.98 62.50 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 22.33 45.48 59.73 23.35 43.67 60.06 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 22.57 32.23 64.13 21.98 32.82 64.22 -54.58 73.10 33.20 -53.72 72.98 33.25 1a0j_c12 source 1a0j TRYPSIN : 4 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 102 ASP A 150 ASP.? 22.07 CH3 ACT A 201 B 193 GLY A 145 GLY.? 13.13 O ACT A 201 coo 44.08 45.58 52.81 45.86 46.55 52.85 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 43.04 44.75 47.18 43.31 45.51 49.13 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 50.46 51.91 56.90 50.65 51.62 56.14 -38.43 80.69 60.76 -38.91 80.43 61.42 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 102 ASP B 150 ASP.? 20.21 CH3 ACT A 202 B 193 GLY B 145 GLY.? 13.34 OXT ACT B 201 coo 44.08 45.58 52.81 45.86 46.55 52.85 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 43.04 44.75 47.18 43.31 45.51 49.13 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 50.46 51.91 56.90 50.65 51.62 56.14 -25.17 44.53 88.88 -24.74 44.79 88.19 ULMN 3 1a0j_c13 TRYPSIN user 3 3 # 3 B 57 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 102 ASP C 150 ASP.? 20.99 CH3 ACT C 201 B 193 GLY C 145 GLY.? 13.18 O ACT C 201 coo 44.08 45.58 52.81 45.86 46.55 52.85 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 43.04 44.75 47.18 43.31 45.51 49.13 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 50.46 51.91 56.90 50.65 51.62 56.14 -35.71 37.24 58.49 -36.57 37.39 58.47 ULMN 3 1a0j_c13 TRYPSIN user 4 3 # 4 B 57 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 102 ASP D 150 ASP.? 21.68 CH3 ACT D 201 B 193 GLY D 145 GLY.? 13.27 OXT ACT D 201 coo 44.08 45.58 52.81 45.86 46.55 52.85 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 43.04 44.75 47.18 43.31 45.51 49.13 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 50.46 51.91 56.90 50.65 51.62 56.14 -54.58 73.10 33.20 -53.72 72.98 33.25 1a0j_c13 source 1a0j TRYPSIN : 4 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 151 HIS.? 15.97 CH3 ACT A 201 C 102 ASP A 150 ASP.? 22.07 CH3 ACT A 201 C 193 GLY A 145 GLY.? 13.13 O ACT A 201 coo 34.37 41.18 73.21 34.04 43.09 73.87 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 34.89 38.34 78.12 35.11 39.59 76.42 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 35.43 51.03 72.12 35.20 50.72 72.87 -38.43 80.69 60.76 -38.91 80.43 61.42 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS B 151 HIS.? 13.45 CH3 ACT A 202 C 102 ASP B 150 ASP.? 20.21 CH3 ACT A 202 C 193 GLY B 145 GLY.? 13.34 OXT ACT B 201 coo 34.37 41.18 73.21 34.04 43.09 73.87 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 34.89 38.34 78.12 35.11 39.59 76.42 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 35.43 51.03 72.12 35.20 50.72 72.87 -25.17 44.53 88.88 -24.74 44.79 88.19 ULMN 3 1a0j_c14 TRYPSIN user 3 3 # 3 C 57 HIS C 151 HIS.? 16.03 CH3 ACT C 201 C 102 ASP C 150 ASP.? 20.99 CH3 ACT C 201 C 193 GLY C 145 GLY.? 13.18 O ACT C 201 coo 34.37 41.18 73.21 34.04 43.09 73.87 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 35.43 51.03 72.12 35.20 50.72 72.87 -35.71 37.24 58.49 -36.57 37.39 58.47 ULMN 3 1a0j_c14 TRYPSIN user 4 3 # 4 C 57 HIS D 151 HIS.? 15.66 CH3 ACT D 201 C 102 ASP D 150 ASP.? 21.68 CH3 ACT D 201 C 193 GLY D 145 GLY.? 13.27 OXT ACT D 201 coo 34.37 41.18 73.21 34.04 43.09 73.87 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 34.89 38.34 78.12 35.11 39.59 76.42 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 35.43 51.03 72.12 35.20 50.72 72.87 -54.58 73.10 33.20 -53.72 72.98 33.25 1a0j_c14 source 1a0j TRYPSIN : 4 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 151 HIS.? 15.97 CH3 ACT A 201 D 102 ASP A 150 ASP.? 22.07 CH3 ACT A 201 D 193 GLY A 145 GLY.? 13.13 O ACT A 201 coo 8.19 15.01 95.72 7.78 16.53 97.01 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 13.53 16.28 93.98 11.45 16.21 94.40 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 1.80 21.25 100.04 2.61 21.42 100.18 -38.43 80.69 60.76 -38.91 80.43 61.42 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS B 151 HIS.? 13.45 CH3 ACT A 202 D 102 ASP B 150 ASP.? 20.21 CH3 ACT A 202 D 193 GLY B 145 GLY.? 13.34 OXT ACT B 201 coo 8.19 15.01 95.72 7.78 16.53 97.01 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 13.53 16.28 93.98 11.45 16.21 94.40 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 1.80 21.25 100.04 2.61 21.42 100.18 -25.17 44.53 88.88 -24.74 44.79 88.19 ULMN 3 1a0j_c15 TRYPSIN user 3 3 # 3 D 57 HIS C 151 HIS.? 16.03 CH3 ACT C 201 D 102 ASP C 150 ASP.? 20.99 CH3 ACT C 201 D 193 GLY C 145 GLY.? 13.18 O ACT C 201 coo 8.19 15.01 95.72 7.78 16.53 97.01 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 13.53 16.28 93.98 11.45 16.21 94.40 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 1.80 21.25 100.04 2.61 21.42 100.18 -35.71 37.24 58.49 -36.57 37.39 58.47 ULMN 3 1a0j_c15 TRYPSIN user 4 3 # 4 D 57 HIS D 151 HIS.? 15.66 CH3 ACT D 201 D 102 ASP D 150 ASP.? 21.68 CH3 ACT D 201 D 193 GLY D 145 GLY.? 13.27 OXT ACT D 201 coo 8.19 15.01 95.72 7.78 16.53 97.01 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 13.53 16.28 93.98 11.45 16.21 94.40 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 1.80 21.25 100.04 2.61 21.42 100.18 -54.58 73.10 33.20 -53.72 72.98 33.25 1a0j_c15 source 1a0j TRYPSIN : 4 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 33 ARG.? 12.39 O ACT A 201 265 HIS A 98 HIS^? -3.60 C ACT A 203s 274 TYR A 108 TYR^? 12.28 O ACT A 201 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -37.81 74.92 58.71 -38.09 77.66 57.35 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 0.94 52.26 9.16 1.95 54.78 9.91 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG A 76 ARG^? 8.97 OXT ACT A 203 265 HIS A 98 HIS^? -3.60 C ACT A 203s 274 TYR A 108 TYR^? 12.28 O ACT A 201 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 0.94 52.26 9.16 1.95 54.78 9.91 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG A 76 ARG^? 8.97 OXT ACT A 203 265 HIS A 151 HIS.? 15.97 CH3 ACT A 201 274 TYR A 108 TYR^? 12.28 O ACT A 201 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 0.94 52.26 9.16 1.95 54.78 9.91 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 1a41_c01 TOPOISOMERASE I user 4 3 # 4 223 ARG A 147 ARG.? 13.06 CH3 ACT A 201 265 HIS A 141 HIS.? 11.20 OXT ACT A 203 274 TYR A 108 TYR^? 12.28 O ACT A 201 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -40.14 80.19 70.35 -38.27 80.75 72.73 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 0.94 52.26 9.16 1.95 54.78 9.91 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 1a41_c01 TOPOISOMERASE I user 5 3 # 5 223 ARG B 33 ARG.? 12.67 OXT ACT B 201 265 HIS B 98 HIS^? 14.98 OXT ACT B 201 274 TYR B 108 TYR^? -4.79 O ACT A 202s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -30.14 45.04 86.20 -29.28 42.52 87.71 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 0.94 52.26 9.16 1.95 54.78 9.91 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 1a41_c01 TOPOISOMERASE I user 6 3 # 6 223 ARG B 76 ARG^? 14.33 OXT ACT B 201 265 HIS B 98 HIS^? 14.98 OXT ACT B 201 274 TYR B 108 TYR^? -4.79 O ACT A 202s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 0.94 52.26 9.16 1.95 54.78 9.91 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 1a41_c01 TOPOISOMERASE I user 7 3 # 7 223 ARG B 76 ARG^? 14.33 OXT ACT B 201 265 HIS B 151 HIS.? 13.45 CH3 ACT A 202 274 TYR B 108 TYR^? -4.79 O ACT A 202s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 0.94 52.26 9.16 1.95 54.78 9.91 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 1a41_c01 TOPOISOMERASE I user 8 3 # 8 223 ARG B 138 ARG~? 16.35 OXT ACT B 201 265 HIS B 141 HIS.? 15.94 CH3 ACT A 202 274 TYR B 93 TYR^? -4.16 CH3 ACT B 201s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -23.44 41.55 74.26 -23.57 39.98 76.87 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 0.94 52.26 9.16 1.95 54.78 9.91 -27.85 57.31 80.17 -30.64 57.51 79.89 ULMN 3 1a41_c01 TOPOISOMERASE I user 9 3 # 9 223 ARG B 138 ARG~? 16.35 OXT ACT B 201 265 HIS B 141 HIS.? 15.94 CH3 ACT A 202 274 TYR B 108 TYR^? -4.79 O ACT A 202s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -23.44 41.55 74.26 -23.57 39.98 76.87 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 0.94 52.26 9.16 1.95 54.78 9.91 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 1a41_c01 TOPOISOMERASE I user 10 3 # 10 223 ARG B 147 ARG.? 12.52 CH3 ACT A 202 265 HIS B 141 HIS.? 15.94 CH3 ACT A 202 274 TYR B 108 TYR^? -4.79 O ACT A 202s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -19.28 50.88 84.48 -18.42 53.72 85.30 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 0.94 52.26 9.16 1.95 54.78 9.91 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 1a41_c01 TOPOISOMERASE I user 11 3 # 11 223 ARG C 33 ARG.? 12.41 O ACT C 201 265 HIS C 98 HIS^? 11.61 O2 EDO A 301 274 TYR C 108 TYR^? 12.28 O ACT C 201 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -34.58 43.27 59.73 -33.36 40.62 60.70 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 0.94 52.26 9.16 1.95 54.78 9.91 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 1a41_c01 TOPOISOMERASE I user 12 3 # 12 223 ARG C 76 ARG^? 14.32 O ACT C 201 265 HIS C 98 HIS^? 11.61 O2 EDO A 301 274 TYR C 108 TYR^? 12.28 O ACT C 201 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -42.25 40.39 61.14 -41.06 40.24 63.98 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 0.94 52.26 9.16 1.95 54.78 9.91 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 1a41_c01 TOPOISOMERASE I user 13 3 # 13 223 ARG C 76 ARG^? 14.32 O ACT C 201 265 HIS C 151 HIS.? 16.03 CH3 ACT C 201 274 TYR C 108 TYR^? 12.28 O ACT C 201 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -42.25 40.39 61.14 -41.06 40.24 63.98 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 0.94 52.26 9.16 1.95 54.78 9.91 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 1a41_c01 TOPOISOMERASE I user 14 3 # 14 223 ARG C 147 ARG.? 13.23 CH3 ACT C 201 265 HIS C 141 HIS.? 17.85 O ACT C 201 274 TYR C 108 TYR^? 12.28 O ACT C 201 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -44.23 36.97 53.78 -44.90 36.38 50.84 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 0.94 52.26 9.16 1.95 54.78 9.91 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 1a41_c01 TOPOISOMERASE I user 15 3 # 15 223 ARG D 33 ARG.? 12.34 OXT ACT D 201 265 HIS D 98 HIS^? 13.13 CH3 ACT A 203 274 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -55.21 72.58 39.53 -56.74 74.11 37.37 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 0.94 52.26 9.16 1.95 54.78 9.91 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 1a41_c01 TOPOISOMERASE I user 16 3 # 16 223 ARG D 76 ARG^? 14.20 OXT ACT D 201 265 HIS D 98 HIS^? 13.13 CH3 ACT A 203 274 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -47.81 74.29 36.53 -48.87 77.02 37.43 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 0.94 52.26 9.16 1.95 54.78 9.91 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 1a41_c01 TOPOISOMERASE I user 17 3 # 17 223 ARG D 76 ARG^? 14.20 OXT ACT D 201 265 HIS D 151 HIS.? 15.66 CH3 ACT D 201 274 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -47.81 74.29 36.53 -48.87 77.02 37.43 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 0.94 52.26 9.16 1.95 54.78 9.91 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 1a41_c01 TOPOISOMERASE I user 18 3 # 18 223 ARG D 138 ARG~? 16.38 OXT ACT D 201 265 HIS D 141 HIS.? 18.95 OXT ACT D 201 274 TYR D 93 TYR^? -4.14 CH3 ACT D 201s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -42.61 77.59 41.75 -44.95 78.80 40.20 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 0.94 52.26 9.16 1.95 54.78 9.91 -47.46 60.74 39.76 -48.96 60.10 42.05 ULMN 3 1a41_c01 TOPOISOMERASE I user 19 3 # 19 223 ARG D 138 ARG~? 16.38 OXT ACT D 201 265 HIS D 141 HIS.? 18.95 OXT ACT D 201 274 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -42.61 77.59 41.75 -44.95 78.80 40.20 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 0.94 52.26 9.16 1.95 54.78 9.91 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 1a41_c01 TOPOISOMERASE I user 20 3 # 20 223 ARG D 147 ARG.? 13.02 CH3 ACT D 201 265 HIS D 141 HIS.? 18.95 OXT ACT D 201 274 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -46.62 68.18 31.08 -46.22 65.54 29.55 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 0.94 52.26 9.16 1.95 54.78 9.91 -40.41 63.05 43.73 -38.60 65.12 43.23 1a41_c01 source 1a41 TOPOISOMERASE I : 20 hits 1a41_c01 naa= 3 ULMN 3 1a4s_c00 BETAINE ALDEHYDE DEHYDROGENASE user 1 3 # 1 A 166 ASN A 129 ASN.? 9.65 O ACT B 201 A 263 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 297 CYH A 127 CYH.? 6.15 O ACT A 202 coo -29.12 -17.91 -4.01 -27.90 -16.18 -4.17 -38.33 60.18 72.42 -36.71 58.96 73.06 coo -22.63 -7.00 -2.71 -20.98 -7.55 -3.90 -29.42 69.91 72.34 -30.01 70.85 70.54 coo -26.23 -13.20 -9.20 -24.31 -12.88 -7.19 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 1a4s_c00 BETAINE ALDEHYDE DEHYDROGENASE user 2 3 # 2 A 166 ASN A 129 ASN.? 9.65 O ACT B 201 A 263 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 297 CYH A 127 CYH.? 6.15 O ACT A 202 coo -29.12 -17.91 -4.01 -27.90 -16.18 -4.17 -38.33 60.18 72.42 -36.71 58.96 73.06 coo -22.63 -7.00 -2.71 -20.98 -7.55 -3.90 -29.98 61.01 82.70 -30.12 59.10 83.58 coo -26.23 -13.20 -9.20 -24.31 -12.88 -7.19 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 1a4s_c00 BETAINE ALDEHYDE DEHYDROGENASE user 3 3 # 3 A 166 ASN B 129 ASN.? 9.80 OXT ACT A 201 A 263 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 297 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -29.12 -17.91 -4.01 -27.90 -16.18 -4.17 -31.81 57.09 70.18 -32.97 58.85 69.97 coo -22.63 -7.00 -2.71 -20.98 -7.55 -3.90 -29.42 69.91 72.34 -30.01 70.85 70.54 coo -26.23 -13.20 -9.20 -24.31 -12.88 -7.19 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 1a4s_c00 BETAINE ALDEHYDE DEHYDROGENASE user 4 3 # 4 A 166 ASN B 129 ASN.? 9.80 OXT ACT A 201 A 263 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 297 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -29.12 -17.91 -4.01 -27.90 -16.18 -4.17 -31.81 57.09 70.18 -32.97 58.85 69.97 coo -22.63 -7.00 -2.71 -20.98 -7.55 -3.90 -29.98 61.01 82.70 -30.12 59.10 83.58 coo -26.23 -13.20 -9.20 -24.31 -12.88 -7.19 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 1a4s_c00 BETAINE ALDEHYDE DEHYDROGENASE user 5 3 # 5 A 166 ASN C 129 ASN.? 9.72 O ACT D 201 A 263 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 297 CYH C 127 CYH.? 10.01 O ACT D 201 coo -29.12 -17.91 -4.01 -27.90 -16.18 -4.17 -47.56 56.76 52.53 -47.22 58.18 50.99 coo -22.63 -7.00 -2.71 -20.98 -7.55 -3.90 -40.57 48.44 44.93 -39.46 47.54 46.50 coo -26.23 -13.20 -9.20 -24.31 -12.88 -7.19 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 1a4s_c00 BETAINE ALDEHYDE DEHYDROGENASE user 6 3 # 6 A 166 ASN C 129 ASN.? 9.72 O ACT D 201 A 263 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 297 CYH C 127 CYH.? 10.01 O ACT D 201 coo -29.12 -17.91 -4.01 -27.90 -16.18 -4.17 -47.56 56.76 52.53 -47.22 58.18 50.99 coo -22.63 -7.00 -2.71 -20.98 -7.55 -3.90 -50.16 56.56 39.52 -51.23 58.35 39.21 coo -26.23 -13.20 -9.20 -24.31 -12.88 -7.19 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 1a4s_c00 BETAINE ALDEHYDE DEHYDROGENASE user 7 3 # 7 A 166 ASN D 129 ASN.? 9.72 OXT ACT C 201 A 263 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 297 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -29.12 -17.91 -4.01 -27.90 -16.18 -4.17 -42.23 60.94 49.15 -42.50 59.01 49.99 coo -22.63 -7.00 -2.71 -20.98 -7.55 -3.90 -40.57 48.44 44.93 -39.46 47.54 46.50 coo -26.23 -13.20 -9.20 -24.31 -12.88 -7.19 -47.67 56.31 47.24 -47.42 53.67 48.08 ULMN 3 1a4s_c00 BETAINE ALDEHYDE DEHYDROGENASE user 8 3 # 8 A 166 ASN D 129 ASN.? 9.72 OXT ACT C 201 A 263 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 297 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -29.12 -17.91 -4.01 -27.90 -16.18 -4.17 -42.23 60.94 49.15 -42.50 59.01 49.99 coo -22.63 -7.00 -2.71 -20.98 -7.55 -3.90 -50.16 56.56 39.52 -51.23 58.35 39.21 coo -26.23 -13.20 -9.20 -24.31 -12.88 -7.19 -47.67 56.31 47.24 -47.42 53.67 48.08 1a4s_c00 source 1a4s BETAINE ALDEHYDE DEHYDROGENASE : 8 hits 1a4s_c00 naa= 3 ULMN 3 1a4s_c01 BETAINE ALDEHYDE DEHYDROGENASE user 1 3 # 1 B 166 ASN A 129 ASN.? 9.65 O ACT B 201 B 263 GLU A 111 GLU^? 4.34 CH3 ACT A 201 B 297 CYH A 127 CYH.? 6.15 O ACT A 202 coo -17.71 28.81 3.98 -17.49 26.70 4.16 -38.33 60.18 72.42 -36.71 58.96 73.06 coo -16.93 16.15 2.64 -15.22 15.89 3.84 -29.42 69.91 72.34 -30.01 70.85 70.54 coo -17.36 23.25 9.07 -15.77 22.09 7.09 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 1a4s_c01 BETAINE ALDEHYDE DEHYDROGENASE user 2 3 # 2 B 166 ASN A 129 ASN.? 9.65 O ACT B 201 B 263 GLU B 111 GLU^? 4.46 CH3 ACT B 201 B 297 CYH A 127 CYH.? 6.15 O ACT A 202 coo -17.71 28.81 3.98 -17.49 26.70 4.16 -38.33 60.18 72.42 -36.71 58.96 73.06 coo -16.93 16.15 2.64 -15.22 15.89 3.84 -29.98 61.01 82.70 -30.12 59.10 83.58 coo -17.36 23.25 9.07 -15.77 22.09 7.09 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 1a4s_c01 BETAINE ALDEHYDE DEHYDROGENASE user 3 3 # 3 B 166 ASN B 129 ASN.? 9.80 OXT ACT A 201 B 263 GLU A 111 GLU^? 4.34 CH3 ACT A 201 B 297 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -17.71 28.81 3.98 -17.49 26.70 4.16 -31.81 57.09 70.18 -32.97 58.85 69.97 coo -16.93 16.15 2.64 -15.22 15.89 3.84 -29.42 69.91 72.34 -30.01 70.85 70.54 coo -17.36 23.25 9.07 -15.77 22.09 7.09 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 1a4s_c01 BETAINE ALDEHYDE DEHYDROGENASE user 4 3 # 4 B 166 ASN B 129 ASN.? 9.80 OXT ACT A 201 B 263 GLU B 111 GLU^? 4.46 CH3 ACT B 201 B 297 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -17.71 28.81 3.98 -17.49 26.70 4.16 -31.81 57.09 70.18 -32.97 58.85 69.97 coo -16.93 16.15 2.64 -15.22 15.89 3.84 -29.98 61.01 82.70 -30.12 59.10 83.58 coo -17.36 23.25 9.07 -15.77 22.09 7.09 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 1a4s_c01 BETAINE ALDEHYDE DEHYDROGENASE user 5 3 # 5 B 166 ASN C 129 ASN.? 9.72 O ACT D 201 B 263 GLU C 111 GLU^? 4.32 CH3 ACT C 201 B 297 CYH C 127 CYH.? 10.01 O ACT D 201 coo -17.71 28.81 3.98 -17.49 26.70 4.16 -47.56 56.76 52.53 -47.22 58.18 50.99 coo -16.93 16.15 2.64 -15.22 15.89 3.84 -40.57 48.44 44.93 -39.46 47.54 46.50 coo -17.36 23.25 9.07 -15.77 22.09 7.09 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 1a4s_c01 BETAINE ALDEHYDE DEHYDROGENASE user 6 3 # 6 B 166 ASN C 129 ASN.? 9.72 O ACT D 201 B 263 GLU D 111 GLU^? 4.46 CH3 ACT D 201 B 297 CYH C 127 CYH.? 10.01 O ACT D 201 coo -17.71 28.81 3.98 -17.49 26.70 4.16 -47.56 56.76 52.53 -47.22 58.18 50.99 coo -16.93 16.15 2.64 -15.22 15.89 3.84 -50.16 56.56 39.52 -51.23 58.35 39.21 coo -17.36 23.25 9.07 -15.77 22.09 7.09 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 1a4s_c01 BETAINE ALDEHYDE DEHYDROGENASE user 7 3 # 7 B 166 ASN D 129 ASN.? 9.72 OXT ACT C 201 B 263 GLU C 111 GLU^? 4.32 CH3 ACT C 201 B 297 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -17.71 28.81 3.98 -17.49 26.70 4.16 -42.23 60.94 49.15 -42.50 59.01 49.99 coo -16.93 16.15 2.64 -15.22 15.89 3.84 -40.57 48.44 44.93 -39.46 47.54 46.50 coo -17.36 23.25 9.07 -15.77 22.09 7.09 -47.67 56.31 47.24 -47.42 53.67 48.08 ULMN 3 1a4s_c01 BETAINE ALDEHYDE DEHYDROGENASE user 8 3 # 8 B 166 ASN D 129 ASN.? 9.72 OXT ACT C 201 B 263 GLU D 111 GLU^? 4.46 CH3 ACT D 201 B 297 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -17.71 28.81 3.98 -17.49 26.70 4.16 -42.23 60.94 49.15 -42.50 59.01 49.99 coo -16.93 16.15 2.64 -15.22 15.89 3.84 -50.16 56.56 39.52 -51.23 58.35 39.21 coo -17.36 23.25 9.07 -15.77 22.09 7.09 -47.67 56.31 47.24 -47.42 53.67 48.08 1a4s_c01 source 1a4s BETAINE ALDEHYDE DEHYDROGENASE : 8 hits 1a4s_c01 naa= 3 ULMN 3 1a4s_c02 BETAINE ALDEHYDE DEHYDROGENASE user 1 3 # 1 C 166 ASN A 129 ASN.? 9.65 O ACT B 201 C 263 GLU A 111 GLU^? 4.34 CH3 ACT A 201 C 297 CYH A 127 CYH.? 6.15 O ACT A 202 coo 21.46 -14.18 22.47 21.02 -12.84 20.88 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 18.98 -8.30 11.46 17.52 -6.95 12.17 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 21.48 -6.84 20.62 19.38 -7.54 18.90 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 1a4s_c02 BETAINE ALDEHYDE DEHYDROGENASE user 2 3 # 2 C 166 ASN A 129 ASN.? 9.65 O ACT B 201 C 263 GLU B 111 GLU^? 4.46 CH3 ACT B 201 C 297 CYH A 127 CYH.? 6.15 O ACT A 202 coo 21.46 -14.18 22.47 21.02 -12.84 20.88 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 18.98 -8.30 11.46 17.52 -6.95 12.17 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 21.48 -6.84 20.62 19.38 -7.54 18.90 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 1a4s_c02 BETAINE ALDEHYDE DEHYDROGENASE user 3 3 # 3 C 166 ASN B 129 ASN.? 9.80 OXT ACT A 201 C 263 GLU A 111 GLU^? 4.34 CH3 ACT A 201 C 297 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo 21.46 -14.18 22.47 21.02 -12.84 20.88 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 18.98 -8.30 11.46 17.52 -6.95 12.17 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 21.48 -6.84 20.62 19.38 -7.54 18.90 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 1a4s_c02 BETAINE ALDEHYDE DEHYDROGENASE user 4 3 # 4 C 166 ASN B 129 ASN.? 9.80 OXT ACT A 201 C 263 GLU B 111 GLU^? 4.46 CH3 ACT B 201 C 297 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo 21.46 -14.18 22.47 21.02 -12.84 20.88 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 18.98 -8.30 11.46 17.52 -6.95 12.17 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 21.48 -6.84 20.62 19.38 -7.54 18.90 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 1a4s_c02 BETAINE ALDEHYDE DEHYDROGENASE user 5 3 # 5 C 166 ASN C 129 ASN.? 9.72 O ACT D 201 C 263 GLU C 111 GLU^? 4.32 CH3 ACT C 201 C 297 CYH C 127 CYH.? 10.01 O ACT D 201 coo 21.46 -14.18 22.47 21.02 -12.84 20.88 -47.56 56.76 52.53 -47.22 58.18 50.99 coo 18.98 -8.30 11.46 17.52 -6.95 12.17 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 21.48 -6.84 20.62 19.38 -7.54 18.90 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 1a4s_c02 BETAINE ALDEHYDE DEHYDROGENASE user 6 3 # 6 C 166 ASN C 129 ASN.? 9.72 O ACT D 201 C 263 GLU D 111 GLU^? 4.46 CH3 ACT D 201 C 297 CYH C 127 CYH.? 10.01 O ACT D 201 coo 21.46 -14.18 22.47 21.02 -12.84 20.88 -47.56 56.76 52.53 -47.22 58.18 50.99 coo 18.98 -8.30 11.46 17.52 -6.95 12.17 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 21.48 -6.84 20.62 19.38 -7.54 18.90 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 1a4s_c02 BETAINE ALDEHYDE DEHYDROGENASE user 7 3 # 7 C 166 ASN D 129 ASN.? 9.72 OXT ACT C 201 C 263 GLU C 111 GLU^? 4.32 CH3 ACT C 201 C 297 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo 21.46 -14.18 22.47 21.02 -12.84 20.88 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 18.98 -8.30 11.46 17.52 -6.95 12.17 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 21.48 -6.84 20.62 19.38 -7.54 18.90 -47.67 56.31 47.24 -47.42 53.67 48.08 ULMN 3 1a4s_c02 BETAINE ALDEHYDE DEHYDROGENASE user 8 3 # 8 C 166 ASN D 129 ASN.? 9.72 OXT ACT C 201 C 263 GLU D 111 GLU^? 4.46 CH3 ACT D 201 C 297 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo 21.46 -14.18 22.47 21.02 -12.84 20.88 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 18.98 -8.30 11.46 17.52 -6.95 12.17 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 21.48 -6.84 20.62 19.38 -7.54 18.90 -47.67 56.31 47.24 -47.42 53.67 48.08 1a4s_c02 source 1a4s BETAINE ALDEHYDE DEHYDROGENASE : 8 hits 1a4s_c02 naa= 3 ULMN 3 1a4s_c03 BETAINE ALDEHYDE DEHYDROGENASE user 1 3 # 1 D 166 ASN A 129 ASN.? 9.65 O ACT B 201 D 263 GLU A 111 GLU^? 4.34 CH3 ACT A 201 D 297 CYH A 127 CYH.? 6.15 O ACT A 202 coo 25.54 3.42 -22.59 24.52 2.45 -20.95 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 20.72 -0.76 -11.60 18.80 -1.24 -12.34 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 22.24 -3.13 -20.79 20.78 -1.47 -19.04 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 1a4s_c03 BETAINE ALDEHYDE DEHYDROGENASE user 2 3 # 2 D 166 ASN A 129 ASN.? 9.65 O ACT B 201 D 263 GLU B 111 GLU^? 4.46 CH3 ACT B 201 D 297 CYH A 127 CYH.? 6.15 O ACT A 202 coo 25.54 3.42 -22.59 24.52 2.45 -20.95 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 20.72 -0.76 -11.60 18.80 -1.24 -12.34 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 22.24 -3.13 -20.79 20.78 -1.47 -19.04 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 1a4s_c03 BETAINE ALDEHYDE DEHYDROGENASE user 3 3 # 3 D 166 ASN B 129 ASN.? 9.80 OXT ACT A 201 D 263 GLU A 111 GLU^? 4.34 CH3 ACT A 201 D 297 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo 25.54 3.42 -22.59 24.52 2.45 -20.95 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 20.72 -0.76 -11.60 18.80 -1.24 -12.34 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 22.24 -3.13 -20.79 20.78 -1.47 -19.04 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 1a4s_c03 BETAINE ALDEHYDE DEHYDROGENASE user 4 3 # 4 D 166 ASN B 129 ASN.? 9.80 OXT ACT A 201 D 263 GLU B 111 GLU^? 4.46 CH3 ACT B 201 D 297 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo 25.54 3.42 -22.59 24.52 2.45 -20.95 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 20.72 -0.76 -11.60 18.80 -1.24 -12.34 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 22.24 -3.13 -20.79 20.78 -1.47 -19.04 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 1a4s_c03 BETAINE ALDEHYDE DEHYDROGENASE user 5 3 # 5 D 166 ASN C 129 ASN.? 9.72 O ACT D 201 D 263 GLU C 111 GLU^? 4.32 CH3 ACT C 201 D 297 CYH C 127 CYH.? 10.01 O ACT D 201 coo 25.54 3.42 -22.59 24.52 2.45 -20.95 -47.56 56.76 52.53 -47.22 58.18 50.99 coo 20.72 -0.76 -11.60 18.80 -1.24 -12.34 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 22.24 -3.13 -20.79 20.78 -1.47 -19.04 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 1a4s_c03 BETAINE ALDEHYDE DEHYDROGENASE user 6 3 # 6 D 166 ASN C 129 ASN.? 9.72 O ACT D 201 D 263 GLU D 111 GLU^? 4.46 CH3 ACT D 201 D 297 CYH C 127 CYH.? 10.01 O ACT D 201 coo 25.54 3.42 -22.59 24.52 2.45 -20.95 -47.56 56.76 52.53 -47.22 58.18 50.99 coo 20.72 -0.76 -11.60 18.80 -1.24 -12.34 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 22.24 -3.13 -20.79 20.78 -1.47 -19.04 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 1a4s_c03 BETAINE ALDEHYDE DEHYDROGENASE user 7 3 # 7 D 166 ASN D 129 ASN.? 9.72 OXT ACT C 201 D 263 GLU C 111 GLU^? 4.32 CH3 ACT C 201 D 297 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo 25.54 3.42 -22.59 24.52 2.45 -20.95 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 20.72 -0.76 -11.60 18.80 -1.24 -12.34 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 22.24 -3.13 -20.79 20.78 -1.47 -19.04 -47.67 56.31 47.24 -47.42 53.67 48.08 ULMN 3 1a4s_c03 BETAINE ALDEHYDE DEHYDROGENASE user 8 3 # 8 D 166 ASN D 129 ASN.? 9.72 OXT ACT C 201 D 263 GLU D 111 GLU^? 4.46 CH3 ACT D 201 D 297 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo 25.54 3.42 -22.59 24.52 2.45 -20.95 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 20.72 -0.76 -11.60 18.80 -1.24 -12.34 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 22.24 -3.13 -20.79 20.78 -1.47 -19.04 -47.67 56.31 47.24 -47.42 53.67 48.08 1a4s_c03 source 1a4s BETAINE ALDEHYDE DEHYDROGENASE : 8 hits 1a4s_c03 naa= 3 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 1 3 # 1 B 13 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 40 LYS D 79 LYS^? -3.52 CH3 ACT D 201s B 114 HIS D 141 HIS.? 18.95 OXT ACT D 201 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -47.37 61.41 34.65 -51.85 60.71 37.83 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -42.77 77.11 33.23 -41.72 76.77 31.45 1a4y_c00 source 1a4y RIBONUCLEASE INHIBITOR : 1 hits 1a4y_c00 naa= 3 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 1 3 # 1 E 13 HIS D 151 HIS.? 15.66 CH3 ACT D 201 E 40 LYS D 79 LYS^? -3.52 CH3 ACT D 201s E 114 HIS D 141 HIS.? 18.95 OXT ACT D 201 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -42.77 77.11 33.23 -41.72 76.77 31.45 1a4y_c01 source 1a4y RIBONUCLEASE INHIBITOR : 1 hits 1a4y_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 72 GLU~? 5.31 O ACT A 201 A 60 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 175 TYR A 75 TYR^? -4.52 O ACT A 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 56.42 28.06 12.93 55.01 27.92 14.50 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 45.02 22.04 15.38 46.16 24.00 13.76 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 72 GLU~? 5.31 O ACT A 201 A 60 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 175 TYR A 95 TYR^? -3.85 O ACT A 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 56.42 28.06 12.93 55.01 27.92 14.50 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 45.02 22.04 15.38 46.16 24.00 13.76 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU A 72 GLU~? 5.31 O ACT A 201 A 60 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 175 TYR A 75 TYR^? -4.52 O ACT A 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 56.42 28.06 12.93 55.01 27.92 14.50 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 45.02 22.04 15.38 46.16 24.00 13.76 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 60 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 175 TYR A 75 TYR^? -4.52 O ACT A 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 56.42 28.06 12.93 55.01 27.92 14.50 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 45.02 22.04 15.38 46.16 24.00 13.76 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 60 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 175 TYR A 95 TYR^? -3.85 O ACT A 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 56.42 28.06 12.93 55.01 27.92 14.50 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 45.02 22.04 15.38 46.16 24.00 13.76 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 6 3 # 6 A 49 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 60 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 175 TYR A 75 TYR^? -4.52 O ACT A 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 56.42 28.06 12.93 55.01 27.92 14.50 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 45.02 22.04 15.38 46.16 24.00 13.76 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 7 3 # 7 A 49 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 60 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 175 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 56.42 28.06 12.93 55.01 27.92 14.50 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 45.02 22.04 15.38 46.16 24.00 13.76 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 8 3 # 8 A 49 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 60 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 175 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 56.42 28.06 12.93 55.01 27.92 14.50 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 45.02 22.04 15.38 46.16 24.00 13.76 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 9 3 # 9 A 49 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 60 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 175 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 56.42 28.06 12.93 55.01 27.92 14.50 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 45.02 22.04 15.38 46.16 24.00 13.76 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 10 3 # 10 A 49 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 60 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 175 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 56.42 28.06 12.93 55.01 27.92 14.50 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 45.02 22.04 15.38 46.16 24.00 13.76 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 11 3 # 11 A 49 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 60 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 175 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 56.42 28.06 12.93 55.01 27.92 14.50 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 45.02 22.04 15.38 46.16 24.00 13.76 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 12 3 # 12 A 49 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 60 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 175 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 56.42 28.06 12.93 55.01 27.92 14.50 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 45.02 22.04 15.38 46.16 24.00 13.76 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 13 3 # 13 A 49 GLU C 72 GLU~? 5.32 O ACT C 201 A 60 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 175 TYR C 95 TYR^? -3.84 O ACT C 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 56.42 28.06 12.93 55.01 27.92 14.50 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 45.02 22.04 15.38 46.16 24.00 13.76 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 14 3 # 14 A 49 GLU C 72 GLU~? 5.32 O ACT C 201 A 60 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 175 TYR C 75 TYR^? -4.54 O ACT C 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 56.42 28.06 12.93 55.01 27.92 14.50 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 45.02 22.04 15.38 46.16 24.00 13.76 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 15 3 # 15 A 49 GLU C 72 GLU~? 5.32 O ACT C 201 A 60 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 175 TYR C 75 TYR^? -4.54 O ACT C 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 56.42 28.06 12.93 55.01 27.92 14.50 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 45.02 22.04 15.38 46.16 24.00 13.76 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 16 3 # 16 A 49 GLU C 96 GLU^? 13.00 O ACT C 201 A 60 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 175 TYR C 75 TYR^? -4.54 O ACT C 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 56.42 28.06 12.93 55.01 27.92 14.50 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 45.02 22.04 15.38 46.16 24.00 13.76 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 17 3 # 17 A 49 GLU C 96 GLU^? 13.00 O ACT C 201 A 60 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 175 TYR C 95 TYR^? -3.84 O ACT C 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 56.42 28.06 12.93 55.01 27.92 14.50 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 45.02 22.04 15.38 46.16 24.00 13.76 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 18 3 # 18 A 49 GLU C 96 GLU^? 13.00 O ACT C 201 A 60 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 175 TYR C 75 TYR^? -4.54 O ACT C 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 56.42 28.06 12.93 55.01 27.92 14.50 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 45.02 22.04 15.38 46.16 24.00 13.76 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 19 3 # 19 A 49 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 60 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 175 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 56.42 28.06 12.93 55.01 27.92 14.50 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 45.02 22.04 15.38 46.16 24.00 13.76 -52.06 69.71 41.47 -52.08 66.98 40.85 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 20 3 # 20 A 49 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 60 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 175 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 56.42 28.06 12.93 55.01 27.92 14.50 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 45.02 22.04 15.38 46.16 24.00 13.76 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 21 3 # 21 A 49 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 60 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 175 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 56.42 28.06 12.93 55.01 27.92 14.50 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 45.02 22.04 15.38 46.16 24.00 13.76 -52.06 69.71 41.47 -52.08 66.98 40.85 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 22 3 # 22 A 49 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 60 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 175 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 56.42 28.06 12.93 55.01 27.92 14.50 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 45.02 22.04 15.38 46.16 24.00 13.76 -52.06 69.71 41.47 -52.08 66.98 40.85 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 23 3 # 23 A 49 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 60 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 175 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 56.42 28.06 12.93 55.01 27.92 14.50 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 45.02 22.04 15.38 46.16 24.00 13.76 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 24 3 # 24 A 49 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 60 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 175 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 46.10 28.27 19.27 45.48 26.99 20.84 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 56.42 28.06 12.93 55.01 27.92 14.50 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 45.02 22.04 15.38 46.16 24.00 13.76 -52.06 69.71 41.47 -52.08 66.98 40.85 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 24 hits 1a50_c03 naa= 3 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 1 3 # 1 44 LYS A 68 LYS~? -2.78 O ACT A 201s 141 HIS A 151 HIS.? 15.97 CH3 ACT A 201 333 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 69.56 26.03 31.04 72.53 30.39 31.84 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 85.95 39.62 33.57 84.70 40.34 35.09 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 87.31 36.08 32.89 89.57 36.58 34.95 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 2 3 # 2 44 LYS A 71 LYS~? 4.32 C2 EDO A 301 141 HIS A 151 HIS.? 15.97 CH3 ACT A 201 333 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 69.56 26.03 31.04 72.53 30.39 31.84 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 85.95 39.62 33.57 84.70 40.34 35.09 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 87.31 36.08 32.89 89.57 36.58 34.95 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 3 3 # 3 44 LYS B 68 LYS~? -2.79 OXT ACT B 201s 141 HIS B 151 HIS.? 13.45 CH3 ACT A 202 333 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo 69.56 26.03 31.04 72.53 30.39 31.84 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 85.95 39.62 33.57 84.70 40.34 35.09 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 87.31 36.08 32.89 89.57 36.58 34.95 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 4 3 # 4 44 LYS B 71 LYS~? 10.83 OXT ACT B 201 141 HIS B 151 HIS.? 13.45 CH3 ACT A 202 333 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo 69.56 26.03 31.04 72.53 30.39 31.84 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 85.95 39.62 33.57 84.70 40.34 35.09 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 87.31 36.08 32.89 89.57 36.58 34.95 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 5 3 # 5 44 LYS C 68 LYS~? -2.77 O ACT C 201s 141 HIS C 151 HIS.? 16.03 CH3 ACT C 201 333 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo 69.56 26.03 31.04 72.53 30.39 31.84 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 85.95 39.62 33.57 84.70 40.34 35.09 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 87.31 36.08 32.89 89.57 36.58 34.95 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 6 3 # 6 44 LYS C 71 LYS~? 4.19 C1 EDO A 301 141 HIS C 151 HIS.? 16.03 CH3 ACT C 201 333 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo 69.56 26.03 31.04 72.53 30.39 31.84 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 85.95 39.62 33.57 84.70 40.34 35.09 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 87.31 36.08 32.89 89.57 36.58 34.95 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 7 3 # 7 44 LYS D 68 LYS~? -2.80 OXT ACT D 201s 141 HIS D 151 HIS.? 15.66 CH3 ACT D 201 333 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 69.56 26.03 31.04 72.53 30.39 31.84 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 85.95 39.62 33.57 84.70 40.34 35.09 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 87.31 36.08 32.89 89.57 36.58 34.95 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 8 3 # 8 44 LYS D 71 LYS~? -3.20 CH3 ACT A 203s 141 HIS D 151 HIS.? 15.66 CH3 ACT D 201 333 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 69.56 26.03 31.04 72.53 30.39 31.84 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 85.95 39.62 33.57 84.70 40.34 35.09 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 87.31 36.08 32.89 89.57 36.58 34.95 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 9 3 # 9 44 LYS D 134 LYS~? 17.34 O ACT A 201 141 HIS D 151 HIS.? 15.66 CH3 ACT D 201 333 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 69.56 26.03 31.04 72.53 30.39 31.84 -37.62 76.93 46.97 -33.08 76.47 49.79 coo 85.95 39.62 33.57 84.70 40.34 35.09 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 87.31 36.08 32.89 89.57 36.58 34.95 -46.62 68.18 31.08 -46.22 65.54 29.55 1aa6_c01 source 1aa6 FORMATE DEHYDROGENASE H : 9 hits 1aa6_c01 naa= 3 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 30 TRP~? -4.28 CH3 ACT A 201s 223 ASP A 34 ASP~? 14.63 O ACT A 201 258 LYS A 68 LYS~? -2.78 O ACT A 201s coo 127.19 33.46 26.14 126.78 36.79 28.15 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 126.95 41.66 23.38 128.48 40.72 24.51 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 138.83 37.95 25.17 133.50 36.37 26.52 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP A 69 TRP~? 6.39 O ACT A 201 223 ASP A 34 ASP~? 14.63 O ACT A 201 258 LYS D 134 LYS~? 17.34 O ACT A 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 126.95 41.66 23.38 128.48 40.72 24.51 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 138.83 37.95 25.17 133.50 36.37 26.52 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 3 3 # 3 142 TRP A 69 TRP~? 6.39 O ACT A 201 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 258 LYS D 134 LYS~? 17.34 O ACT A 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 126.95 41.66 23.38 128.48 40.72 24.51 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 138.83 37.95 25.17 133.50 36.37 26.52 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 4 3 # 4 142 TRP A 82 TRP^? 14.68 O ACT B 201 223 ASP B 86 ASP.? 24.07 CH3 ACT B 201 258 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -30.38 69.86 83.05 -34.07 70.22 84.37 coo 126.95 41.66 23.38 128.48 40.72 24.51 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 138.83 37.95 25.17 133.50 36.37 26.52 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 5 3 # 5 142 TRP A 97 TRP^? -5.71 O1 EDO A 301s 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 258 LYS A 134 LYS~? 11.98 O ACT A 203 coo 127.19 33.46 26.14 126.78 36.79 28.15 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 126.95 41.66 23.38 128.48 40.72 24.51 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 138.83 37.95 25.17 133.50 36.37 26.52 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 6 3 # 6 142 TRP A 97 TRP^? -5.71 O1 EDO A 301s 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 258 LYS A 139 LYS.? 17.81 O ACT A 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 126.95 41.66 23.38 128.48 40.72 24.51 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 138.83 37.95 25.17 133.50 36.37 26.52 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 7 3 # 7 142 TRP A 97 TRP^? -5.71 O1 EDO A 301s 223 ASP A 99 ASP.? 5.71 O2 EDO A 301 258 LYS A 134 LYS~? 11.98 O ACT A 203 coo 127.19 33.46 26.14 126.78 36.79 28.15 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 126.95 41.66 23.38 128.48 40.72 24.51 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 138.83 37.95 25.17 133.50 36.37 26.52 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 8 3 # 8 142 TRP A 97 TRP^? -5.71 O1 EDO A 301s 223 ASP A 130 ASP.? 4.80 O1 EDO A 301 258 LYS A 134 LYS~? 11.98 O ACT A 203 coo 127.19 33.46 26.14 126.78 36.79 28.15 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 126.95 41.66 23.38 128.48 40.72 24.51 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 138.83 37.95 25.17 133.50 36.37 26.52 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 9 3 # 9 142 TRP A 104 TRP^? -4.29 OXT ACT A 203s 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 258 LYS A 139 LYS.? 17.81 O ACT A 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 126.95 41.66 23.38 128.48 40.72 24.51 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 138.83 37.95 25.17 133.50 36.37 26.52 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 10 3 # 10 142 TRP A 104 TRP^? -4.29 OXT ACT A 203s 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 258 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 127.19 33.46 26.14 126.78 36.79 28.15 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 126.95 41.66 23.38 128.48 40.72 24.51 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 138.83 37.95 25.17 133.50 36.37 26.52 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 11 3 # 11 142 TRP A 142 TRP.? 12.79 O ACT A 201 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 258 LYS A 139 LYS.? 17.81 O ACT A 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -42.03 80.57 64.19 -41.88 78.10 67.25 coo 126.95 41.66 23.38 128.48 40.72 24.51 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 138.83 37.95 25.17 133.50 36.37 26.52 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 12 3 # 12 142 TRP B 30 TRP~? -4.15 CH3 ACT B 201s 223 ASP B 34 ASP~? 14.61 OXT ACT B 201 258 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 127.19 33.46 26.14 126.78 36.79 28.15 -31.05 54.49 87.84 -34.09 54.74 85.35 coo 126.95 41.66 23.38 128.48 40.72 24.51 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 138.83 37.95 25.17 133.50 36.37 26.52 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 13 3 # 13 142 TRP B 82 TRP^? 9.86 O ACT A 202 223 ASP A 86 ASP.? 20.24 CH3 ACT A 202 258 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -23.37 68.40 78.71 -20.56 66.90 76.39 coo 126.95 41.66 23.38 128.48 40.72 24.51 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 138.83 37.95 25.17 133.50 36.37 26.52 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 14 3 # 14 142 TRP B 97 TRP^? 8.79 OXT ACT B 201 223 ASP B 74 ASP^? 14.88 OXT ACT B 201 258 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 126.95 41.66 23.38 128.48 40.72 24.51 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 138.83 37.95 25.17 133.50 36.37 26.52 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 15 3 # 15 142 TRP B 97 TRP^? 8.79 OXT ACT B 201 223 ASP B 74 ASP^? 14.88 OXT ACT B 201 258 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 126.95 41.66 23.38 128.48 40.72 24.51 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 138.83 37.95 25.17 133.50 36.37 26.52 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 16 3 # 16 142 TRP B 97 TRP^? 8.79 OXT ACT B 201 223 ASP B 99 ASP.? 16.09 OXT ACT B 201 258 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 126.95 41.66 23.38 128.48 40.72 24.51 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 138.83 37.95 25.17 133.50 36.37 26.52 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 17 3 # 17 142 TRP B 104 TRP^? 15.21 C2 EDO A 302 223 ASP B 74 ASP^? 14.88 OXT ACT B 201 258 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 126.95 41.66 23.38 128.48 40.72 24.51 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 138.83 37.95 25.17 133.50 36.37 26.52 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 18 3 # 18 142 TRP B 142 TRP.? 12.90 OXT ACT B 201 223 ASP B 74 ASP^? 14.88 OXT ACT B 201 258 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 -21.52 44.96 85.54 -21.40 47.93 82.96 coo 126.95 41.66 23.38 128.48 40.72 24.51 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 138.83 37.95 25.17 133.50 36.37 26.52 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 19 3 # 19 142 TRP C 30 TRP~? -4.24 CH3 ACT C 201s 223 ASP C 34 ASP~? 14.66 O ACT C 201 258 LYS C 68 LYS~? -2.77 O ACT C 201s coo 127.19 33.46 26.14 126.78 36.79 28.15 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 126.95 41.66 23.38 128.48 40.72 24.51 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 138.83 37.95 25.17 133.50 36.37 26.52 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 20 3 # 20 142 TRP C 69 TRP~? 6.41 O ACT C 201 223 ASP C 34 ASP~? 14.66 O ACT C 201 258 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 126.95 41.66 23.38 128.48 40.72 24.51 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 138.83 37.95 25.17 133.50 36.37 26.52 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 21 3 # 21 142 TRP C 82 TRP^? 14.73 O ACT D 201 223 ASP D 86 ASP.? 24.19 CH3 ACT D 201 258 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -49.41 47.73 38.89 -52.68 46.73 40.85 coo 126.95 41.66 23.38 128.48 40.72 24.51 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 138.83 37.95 25.17 133.50 36.37 26.52 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 22 3 # 22 142 TRP C 97 TRP^? -5.77 O2 EDO A 301s 223 ASP C 74 ASP^? 14.86 O ACT C 201 258 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 127.19 33.46 26.14 126.78 36.79 28.15 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 126.95 41.66 23.38 128.48 40.72 24.51 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 138.83 37.95 25.17 133.50 36.37 26.52 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 23 3 # 23 142 TRP C 97 TRP^? -5.77 O2 EDO A 301s 223 ASP C 74 ASP^? 14.86 O ACT C 201 258 LYS C 139 LYS.? 18.79 O ACT C 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 126.95 41.66 23.38 128.48 40.72 24.51 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 138.83 37.95 25.17 133.50 36.37 26.52 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 24 3 # 24 142 TRP C 97 TRP^? -5.77 O2 EDO A 301s 223 ASP C 99 ASP.? 5.79 O1 EDO A 301 258 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 127.19 33.46 26.14 126.78 36.79 28.15 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 126.95 41.66 23.38 128.48 40.72 24.51 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 138.83 37.95 25.17 133.50 36.37 26.52 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 25 3 # 25 142 TRP C 97 TRP^? -5.77 O2 EDO A 301s 223 ASP C 130 ASP.? 4.74 O2 EDO A 301 258 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 127.19 33.46 26.14 126.78 36.79 28.15 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 126.95 41.66 23.38 128.48 40.72 24.51 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 138.83 37.95 25.17 133.50 36.37 26.52 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 26 3 # 26 142 TRP C 104 TRP^? 12.40 O2 EDO A 301 223 ASP C 74 ASP^? 14.86 O ACT C 201 258 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 126.95 41.66 23.38 128.48 40.72 24.51 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 138.83 37.95 25.17 133.50 36.37 26.52 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 27 3 # 27 142 TRP C 104 TRP^? 12.40 O2 EDO A 301 223 ASP C 74 ASP^? 14.86 O ACT C 201 258 LYS C 139 LYS.? 18.79 O ACT C 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 126.95 41.66 23.38 128.48 40.72 24.51 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 138.83 37.95 25.17 133.50 36.37 26.52 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 28 3 # 28 142 TRP C 142 TRP.? 12.80 O ACT C 201 223 ASP C 74 ASP^? 14.86 O ACT C 201 258 LYS C 139 LYS.? 18.79 O ACT C 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -40.60 36.63 58.98 -43.29 38.84 57.12 coo 126.95 41.66 23.38 128.48 40.72 24.51 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 138.83 37.95 25.17 133.50 36.37 26.52 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 29 3 # 29 142 TRP D 30 TRP~? -4.23 CH3 ACT D 201s 223 ASP D 34 ASP~? 14.62 OXT ACT D 201 258 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 127.19 33.46 26.14 126.78 36.79 28.15 -55.89 62.34 37.62 -55.77 61.79 41.52 coo 126.95 41.66 23.38 128.48 40.72 24.51 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 138.83 37.95 25.17 133.50 36.37 26.52 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 30 3 # 30 142 TRP D 82 TRP^? 14.82 OXT ACT C 201 223 ASP C 86 ASP.? 24.03 CH3 ACT C 201 258 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -41.91 50.50 36.33 -38.54 52.46 35.78 coo 126.95 41.66 23.38 128.48 40.72 24.51 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 138.83 37.95 25.17 133.50 36.37 26.52 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 31 3 # 31 142 TRP D 97 TRP^? 8.35 CH3 ACT A 203 223 ASP D 74 ASP^? 14.85 OXT ACT D 201 258 LYS D 134 LYS~? 17.34 O ACT A 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 126.95 41.66 23.38 128.48 40.72 24.51 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 138.83 37.95 25.17 133.50 36.37 26.52 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 32 3 # 32 142 TRP D 97 TRP^? 8.35 CH3 ACT A 203 223 ASP D 74 ASP^? 14.85 OXT ACT D 201 258 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 126.95 41.66 23.38 128.48 40.72 24.51 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 138.83 37.95 25.17 133.50 36.37 26.52 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 33 3 # 33 142 TRP D 97 TRP^? 8.35 CH3 ACT A 203 223 ASP D 99 ASP.? 7.94 CH3 ACT A 203 258 LYS D 134 LYS~? 17.34 O ACT A 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 126.95 41.66 23.38 128.48 40.72 24.51 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 138.83 37.95 25.17 133.50 36.37 26.52 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 34 3 # 34 142 TRP D 104 TRP^? 14.89 CH3 ACT A 203 223 ASP D 74 ASP^? 14.85 OXT ACT D 201 258 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 126.95 41.66 23.38 128.48 40.72 24.51 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 138.83 37.95 25.17 133.50 36.37 26.52 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 35 3 # 35 142 TRP D 142 TRP.? 12.80 OXT ACT D 201 223 ASP D 74 ASP^? 14.85 OXT ACT D 201 258 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 127.19 33.46 26.14 126.78 36.79 28.15 -49.78 73.48 32.42 -47.22 70.87 33.88 coo 126.95 41.66 23.38 128.48 40.72 24.51 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 138.83 37.95 25.17 133.50 36.37 26.52 -39.84 73.21 37.09 -35.07 70.74 37.87 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 35 hits 1aam_c01 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG A 138 ARG~? 6.49 OXT ACT A 203 78 HIS A 98 HIS^? -3.60 C ACT A 203s 122 TYR C 75 TYR^? -4.54 O ACT C 201s coo 48.32 72.26 30.89 48.69 69.28 31.53 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 53.63 68.24 34.99 53.08 69.10 33.16 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 75.01 61.87 32.93 75.34 59.26 31.96 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ab4_c00 GYRASE A user 2 3 # 2 32 ARG A 138 ARG~? 6.49 OXT ACT A 203 78 HIS A 98 HIS^? -3.60 C ACT A 203s 122 TYR C 93 TYR^? -4.09 CH3 ACT C 201s coo 48.32 72.26 30.89 48.69 69.28 31.53 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 53.63 68.24 34.99 53.08 69.10 33.16 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 75.01 61.87 32.93 75.34 59.26 31.96 -43.00 47.58 49.22 -41.38 49.87 49.22 ULMN 3 1ab4_c00 GYRASE A user 3 3 # 3 32 ARG B 138 ARG~? 16.35 OXT ACT B 201 78 HIS B 98 HIS^? 14.98 OXT ACT B 201 122 TYR C 95 TYR^? -3.84 O ACT C 201s coo 48.32 72.26 30.89 48.69 69.28 31.53 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 53.63 68.24 34.99 53.08 69.10 33.16 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 75.01 61.87 32.93 75.34 59.26 31.96 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1ab4_c00 GYRASE A user 4 3 # 4 32 ARG C 138 ARG~? 16.31 O ACT C 201 78 HIS C 98 HIS^? 11.61 O2 EDO A 301 122 TYR A 75 TYR^? -4.52 O ACT A 201s coo 48.32 72.26 30.89 48.69 69.28 31.53 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 53.63 68.24 34.99 53.08 69.10 33.16 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 75.01 61.87 32.93 75.34 59.26 31.96 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ab4_c00 GYRASE A user 5 3 # 5 32 ARG C 138 ARG~? 16.31 O ACT C 201 78 HIS C 98 HIS^? 11.61 O2 EDO A 301 122 TYR A 93 TYR^? -4.07 CH3 ACT A 201s coo 48.32 72.26 30.89 48.69 69.28 31.53 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 53.63 68.24 34.99 53.08 69.10 33.16 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 75.01 61.87 32.93 75.34 59.26 31.96 -34.34 70.13 71.57 -32.99 68.09 70.18 1ab4_c00 source 1ab4 GYRASE A : 5 hits 1ab4_c00 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 31 ASN~? 8.53 CH3 ACT A 201 63 ARG A 24 ARG~? 13.97 CH3 ACT A 201 255 ARG A 37 ARG~? 13.73 CH3 ACT A 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -36.15 78.19 63.69 -37.32 77.26 65.21 coo 44.36 11.24 3.39 41.81 12.78 4.00 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 38.40 3.83 10.26 40.02 6.30 9.25 -28.83 80.54 58.97 -30.62 82.33 60.70 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN A 31 ASN~? 8.53 CH3 ACT A 201 63 ARG A 37 ARG~? 13.73 CH3 ACT A 201 255 ARG A 24 ARG~? 13.97 CH3 ACT A 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -36.15 78.19 63.69 -37.32 77.26 65.21 coo 44.36 11.24 3.39 41.81 12.78 4.00 -28.83 80.54 58.97 -30.62 82.33 60.70 coo 38.40 3.83 10.26 40.02 6.30 9.25 -33.88 82.79 71.01 -36.66 83.48 69.87 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 3 3 # 3 22 ASN A 31 ASN~? 8.53 CH3 ACT A 201 63 ARG A 146 ARG.? 16.48 CH3 ACT A 201 255 ARG A 37 ARG~? 13.73 CH3 ACT A 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -36.15 78.19 63.69 -37.32 77.26 65.21 coo 44.36 11.24 3.39 41.81 12.78 4.00 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 38.40 3.83 10.26 40.02 6.30 9.25 -28.83 80.54 58.97 -30.62 82.33 60.70 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 4 3 # 4 22 ASN A 31 ASN~? 8.53 CH3 ACT A 201 63 ARG A 146 ARG.? 16.48 CH3 ACT A 201 255 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 42.10 13.02 11.14 41.85 11.12 10.23 -36.15 78.19 63.69 -37.32 77.26 65.21 coo 44.36 11.24 3.39 41.81 12.78 4.00 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 38.40 3.83 10.26 40.02 6.30 9.25 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 5 3 # 5 22 ASN A 50 ASN^? 5.02 OXT ACT A 201 63 ARG A 49 ARG^? -3.92 O ACT A 202s 255 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 -28.17 63.14 65.41 -30.17 63.83 65.25 coo 44.36 11.24 3.39 41.81 12.78 4.00 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 38.40 3.83 10.26 40.02 6.30 9.25 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 6 3 # 6 22 ASN A 110 ASN^? 10.87 O ACT B 201 63 ARG A 92 ARG^? 14.09 CH3 ACT A 201 255 ARG B 124 ARG.? -3.52 O ACT B 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 44.36 11.24 3.39 41.81 12.78 4.00 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 38.40 3.83 10.26 40.02 6.30 9.25 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 7 3 # 7 22 ASN A 110 ASN^? 10.87 O ACT B 201 63 ARG B 49 ARG^? 10.37 O ACT B 201 255 ARG B 124 ARG.? -3.52 O ACT B 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 44.36 11.24 3.39 41.81 12.78 4.00 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 38.40 3.83 10.26 40.02 6.30 9.25 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 8 3 # 8 22 ASN A 110 ASN^? 10.87 O ACT B 201 63 ARG B 92 ARG^? -3.69 CH3 ACT A 202s 255 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 44.36 11.24 3.39 41.81 12.78 4.00 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 38.40 3.83 10.26 40.02 6.30 9.25 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 9 3 # 9 22 ASN A 112 ASN^? 9.36 O ACT A 202 63 ARG A 88 ARG^? 11.13 CH3 ACT A 202 255 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -24.96 67.02 76.01 -26.38 66.67 77.57 coo 44.36 11.24 3.39 41.81 12.78 4.00 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 38.40 3.83 10.26 40.02 6.30 9.25 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 10 3 # 10 22 ASN A 112 ASN^? 9.36 O ACT A 202 63 ARG A 123 ARG.? 8.27 CH3 ACT A 202 255 ARG A 49 ARG^? -3.92 O ACT A 202s coo 42.10 13.02 11.14 41.85 11.12 10.23 -24.96 67.02 76.01 -26.38 66.67 77.57 coo 44.36 11.24 3.39 41.81 12.78 4.00 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 38.40 3.83 10.26 40.02 6.30 9.25 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 11 3 # 11 22 ASN A 112 ASN^? 9.36 O ACT A 202 63 ARG A 123 ARG.? 8.27 CH3 ACT A 202 255 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -24.96 67.02 76.01 -26.38 66.67 77.57 coo 44.36 11.24 3.39 41.81 12.78 4.00 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 38.40 3.83 10.26 40.02 6.30 9.25 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 12 3 # 12 22 ASN A 112 ASN^? 9.36 O ACT A 202 63 ARG A 124 ARG.? -3.54 OXT ACT A 201s 255 ARG A 49 ARG^? -3.92 O ACT A 202s coo 42.10 13.02 11.14 41.85 11.12 10.23 -24.96 67.02 76.01 -26.38 66.67 77.57 coo 44.36 11.24 3.39 41.81 12.78 4.00 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 38.40 3.83 10.26 40.02 6.30 9.25 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 13 3 # 13 22 ASN A 112 ASN^? 9.36 O ACT A 202 63 ARG A 124 ARG.? -3.54 OXT ACT A 201s 255 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 42.10 13.02 11.14 41.85 11.12 10.23 -24.96 67.02 76.01 -26.38 66.67 77.57 coo 44.36 11.24 3.39 41.81 12.78 4.00 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 38.40 3.83 10.26 40.02 6.30 9.25 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 14 3 # 14 22 ASN B 31 ASN~? 8.56 CH3 ACT B 201 63 ARG B 24 ARG~? 14.02 CH3 ACT B 201 255 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -26.33 48.60 87.43 -25.42 49.22 85.60 coo 44.36 11.24 3.39 41.81 12.78 4.00 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 38.40 3.83 10.26 40.02 6.30 9.25 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 15 3 # 15 22 ASN B 31 ASN~? 8.56 CH3 ACT B 201 63 ARG B 37 ARG~? 13.57 CH3 ACT B 201 255 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -26.33 48.60 87.43 -25.42 49.22 85.60 coo 44.36 11.24 3.39 41.81 12.78 4.00 -31.32 49.06 94.80 -28.26 48.93 94.55 coo 38.40 3.83 10.26 40.02 6.30 9.25 -20.35 54.64 90.03 -19.09 51.96 89.19 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 16 3 # 16 22 ASN B 31 ASN~? 8.56 CH3 ACT B 201 63 ARG B 146 ARG.? 16.58 CH3 ACT B 201 255 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -26.33 48.60 87.43 -25.42 49.22 85.60 coo 44.36 11.24 3.39 41.81 12.78 4.00 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 38.40 3.83 10.26 40.02 6.30 9.25 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 17 3 # 17 22 ASN B 31 ASN~? 8.56 CH3 ACT B 201 63 ARG B 146 ARG.? 16.58 CH3 ACT B 201 255 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -26.33 48.60 87.43 -25.42 49.22 85.60 coo 44.36 11.24 3.39 41.81 12.78 4.00 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 38.40 3.83 10.26 40.02 6.30 9.25 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 18 3 # 18 22 ASN B 110 ASN^? 6.46 O ACT A 202 63 ARG A 49 ARG^? -3.92 O ACT A 202s 255 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 44.36 11.24 3.39 41.81 12.78 4.00 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 38.40 3.83 10.26 40.02 6.30 9.25 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 19 3 # 19 22 ASN B 110 ASN^? 6.46 O ACT A 202 63 ARG A 92 ARG^? 14.09 CH3 ACT A 201 255 ARG B 124 ARG.? -3.52 O ACT B 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 44.36 11.24 3.39 41.81 12.78 4.00 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 38.40 3.83 10.26 40.02 6.30 9.25 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 20 3 # 20 22 ASN B 110 ASN^? 6.46 O ACT A 202 63 ARG B 92 ARG^? -3.69 CH3 ACT A 202s 255 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 44.36 11.24 3.39 41.81 12.78 4.00 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 38.40 3.83 10.26 40.02 6.30 9.25 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 21 3 # 21 22 ASN B 112 ASN^? 12.13 O ACT B 201 63 ARG B 88 ARG^? 18.43 CH3 ACT A 201 255 ARG B 124 ARG.? -3.52 O ACT B 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -32.04 67.09 81.98 -30.67 67.45 80.39 coo 44.36 11.24 3.39 41.81 12.78 4.00 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 38.40 3.83 10.26 40.02 6.30 9.25 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 22 3 # 22 22 ASN B 112 ASN^? 12.13 O ACT B 201 63 ARG B 123 ARG.? 17.76 O ACT B 201 255 ARG B 49 ARG^? 10.37 O ACT B 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -32.04 67.09 81.98 -30.67 67.45 80.39 coo 44.36 11.24 3.39 41.81 12.78 4.00 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 38.40 3.83 10.26 40.02 6.30 9.25 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 23 3 # 23 22 ASN B 112 ASN^? 12.13 O ACT B 201 63 ARG B 123 ARG.? 17.76 O ACT B 201 255 ARG B 124 ARG.? -3.52 O ACT B 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -32.04 67.09 81.98 -30.67 67.45 80.39 coo 44.36 11.24 3.39 41.81 12.78 4.00 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 38.40 3.83 10.26 40.02 6.30 9.25 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 24 3 # 24 22 ASN B 112 ASN^? 12.13 O ACT B 201 63 ARG B 124 ARG.? -3.52 O ACT B 201s 255 ARG B 49 ARG^? 10.37 O ACT B 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -32.04 67.09 81.98 -30.67 67.45 80.39 coo 44.36 11.24 3.39 41.81 12.78 4.00 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 38.40 3.83 10.26 40.02 6.30 9.25 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 25 3 # 25 22 ASN B 112 ASN^? 12.13 O ACT B 201 63 ARG B 124 ARG.? -3.52 O ACT B 201s 255 ARG B 123 ARG.? 17.76 O ACT B 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -32.04 67.09 81.98 -30.67 67.45 80.39 coo 44.36 11.24 3.39 41.81 12.78 4.00 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 38.40 3.83 10.26 40.02 6.30 9.25 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 26 3 # 26 22 ASN C 31 ASN~? 8.68 CH3 ACT C 201 63 ARG C 24 ARG~? 14.09 CH3 ACT C 201 255 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -36.93 39.85 55.08 -38.97 40.48 55.12 coo 44.36 11.24 3.39 41.81 12.78 4.00 -40.53 35.15 48.39 -41.31 34.14 51.19 coo 38.40 3.83 10.26 40.02 6.30 9.25 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 27 3 # 27 22 ASN C 31 ASN~? 8.68 CH3 ACT C 201 63 ARG C 37 ARG~? 13.73 CH3 ACT C 201 255 ARG C 24 ARG~? 14.09 CH3 ACT C 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -36.93 39.85 55.08 -38.97 40.48 55.12 coo 44.36 11.24 3.39 41.81 12.78 4.00 -28.52 38.86 52.29 -30.70 36.70 52.27 coo 38.40 3.83 10.26 40.02 6.30 9.25 -40.53 35.15 48.39 -41.31 34.14 51.19 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 28 3 # 28 22 ASN C 31 ASN~? 8.68 CH3 ACT C 201 63 ARG C 146 ARG.? 16.63 CH3 ACT C 201 255 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -36.93 39.85 55.08 -38.97 40.48 55.12 coo 44.36 11.24 3.39 41.81 12.78 4.00 -36.58 32.85 52.68 -38.87 31.31 51.32 coo 38.40 3.83 10.26 40.02 6.30 9.25 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 29 3 # 29 22 ASN C 31 ASN~? 8.68 CH3 ACT C 201 63 ARG C 146 ARG.? 16.63 CH3 ACT C 201 255 ARG C 76 ARG^? 14.32 O ACT C 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -36.93 39.85 55.08 -38.97 40.48 55.12 coo 44.36 11.24 3.39 41.81 12.78 4.00 -36.58 32.85 52.68 -38.87 31.31 51.32 coo 38.40 3.83 10.26 40.02 6.30 9.25 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 30 3 # 30 22 ASN C 50 ASN^? 4.97 OXT ACT C 201 63 ARG C 49 ARG^? 10.47 OXT ACT C 201 255 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 -35.45 55.77 48.86 -36.44 54.81 50.47 coo 44.36 11.24 3.39 41.81 12.78 4.00 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 38.40 3.83 10.26 40.02 6.30 9.25 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 31 3 # 31 22 ASN C 110 ASN^? 10.92 O ACT D 201 63 ARG C 92 ARG^? 13.71 CH3 ACT C 201 255 ARG D 124 ARG.? -3.55 O ACT D 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 44.36 11.24 3.39 41.81 12.78 4.00 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 38.40 3.83 10.26 40.02 6.30 9.25 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 32 3 # 32 22 ASN C 110 ASN^? 10.92 O ACT D 201 63 ARG D 49 ARG^? 10.44 O ACT D 201 255 ARG D 124 ARG.? -3.55 O ACT D 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 44.36 11.24 3.39 41.81 12.78 4.00 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 38.40 3.83 10.26 40.02 6.30 9.25 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 33 3 # 33 22 ASN C 110 ASN^? 10.92 O ACT D 201 63 ARG D 92 ARG^? 13.56 CH3 ACT D 201 255 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 44.36 11.24 3.39 41.81 12.78 4.00 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 38.40 3.83 10.26 40.02 6.30 9.25 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 34 3 # 34 22 ASN C 112 ASN^? 12.25 OXT ACT C 201 63 ARG C 88 ARG^? 18.42 CH3 ACT D 201 255 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 44.36 11.24 3.39 41.81 12.78 4.00 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 38.40 3.83 10.26 40.02 6.30 9.25 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 35 3 # 35 22 ASN C 112 ASN^? 12.25 OXT ACT C 201 63 ARG C 123 ARG.? 17.68 OXT ACT C 201 255 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 44.36 11.24 3.39 41.81 12.78 4.00 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 38.40 3.83 10.26 40.02 6.30 9.25 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 36 3 # 36 22 ASN C 112 ASN^? 12.25 OXT ACT C 201 63 ARG C 123 ARG.? 17.68 OXT ACT C 201 255 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 44.36 11.24 3.39 41.81 12.78 4.00 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 38.40 3.83 10.26 40.02 6.30 9.25 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 37 3 # 37 22 ASN C 112 ASN^? 12.25 OXT ACT C 201 63 ARG C 124 ARG.? -3.50 OXT ACT C 201s 255 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 44.36 11.24 3.39 41.81 12.78 4.00 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 38.40 3.83 10.26 40.02 6.30 9.25 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 38 3 # 38 22 ASN C 112 ASN^? 12.25 OXT ACT C 201 63 ARG C 124 ARG.? -3.50 OXT ACT C 201s 255 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 44.36 11.24 3.39 41.81 12.78 4.00 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 38.40 3.83 10.26 40.02 6.30 9.25 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 39 3 # 39 22 ASN D 31 ASN~? 8.51 CH3 ACT D 201 63 ARG D 24 ARG~? 13.98 CH3 ACT D 201 255 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -53.58 68.96 34.68 -51.50 68.66 35.10 coo 44.36 11.24 3.39 41.81 12.78 4.00 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 38.40 3.83 10.26 40.02 6.30 9.25 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 40 3 # 40 22 ASN D 31 ASN~? 8.51 CH3 ACT D 201 63 ARG D 37 ARG~? 13.59 CH3 ACT D 201 255 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -53.58 68.96 34.68 -51.50 68.66 35.10 coo 44.36 11.24 3.39 41.81 12.78 4.00 -62.21 67.18 33.74 -60.13 67.79 31.56 coo 38.40 3.83 10.26 40.02 6.30 9.25 -50.90 63.83 27.93 -49.90 66.74 27.73 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 41 3 # 41 22 ASN D 31 ASN~? 8.51 CH3 ACT D 201 63 ARG D 146 ARG.? 16.60 CH3 ACT D 201 255 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -53.58 68.96 34.68 -51.50 68.66 35.10 coo 44.36 11.24 3.39 41.81 12.78 4.00 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 38.40 3.83 10.26 40.02 6.30 9.25 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 42 3 # 42 22 ASN D 31 ASN~? 8.51 CH3 ACT D 201 63 ARG D 146 ARG.? 16.60 CH3 ACT D 201 255 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -53.58 68.96 34.68 -51.50 68.66 35.10 coo 44.36 11.24 3.39 41.81 12.78 4.00 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 38.40 3.83 10.26 40.02 6.30 9.25 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 43 3 # 43 22 ASN D 110 ASN^? 10.92 OXT ACT C 201 63 ARG C 49 ARG^? 10.47 OXT ACT C 201 255 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 44.36 11.24 3.39 41.81 12.78 4.00 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 38.40 3.83 10.26 40.02 6.30 9.25 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 44 3 # 44 22 ASN D 110 ASN^? 10.92 OXT ACT C 201 63 ARG C 92 ARG^? 13.71 CH3 ACT C 201 255 ARG D 124 ARG.? -3.55 O ACT D 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 44.36 11.24 3.39 41.81 12.78 4.00 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 38.40 3.83 10.26 40.02 6.30 9.25 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 45 3 # 45 22 ASN D 110 ASN^? 10.92 OXT ACT C 201 63 ARG D 92 ARG^? 13.56 CH3 ACT D 201 255 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 44.36 11.24 3.39 41.81 12.78 4.00 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 38.40 3.83 10.26 40.02 6.30 9.25 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 46 3 # 46 22 ASN D 112 ASN^? 12.21 O ACT D 201 63 ARG D 88 ARG^? 18.35 CH3 ACT C 201 255 ARG D 124 ARG.? -3.55 O ACT D 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 44.36 11.24 3.39 41.81 12.78 4.00 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 38.40 3.83 10.26 40.02 6.30 9.25 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 47 3 # 47 22 ASN D 112 ASN^? 12.21 O ACT D 201 63 ARG D 123 ARG.? 17.60 O ACT D 201 255 ARG D 49 ARG^? 10.44 O ACT D 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 44.36 11.24 3.39 41.81 12.78 4.00 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 38.40 3.83 10.26 40.02 6.30 9.25 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 48 3 # 48 22 ASN D 112 ASN^? 12.21 O ACT D 201 63 ARG D 123 ARG.? 17.60 O ACT D 201 255 ARG D 124 ARG.? -3.55 O ACT D 201s coo 42.10 13.02 11.14 41.85 11.12 10.23 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 44.36 11.24 3.39 41.81 12.78 4.00 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 38.40 3.83 10.26 40.02 6.30 9.25 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 49 3 # 49 22 ASN D 112 ASN^? 12.21 O ACT D 201 63 ARG D 124 ARG.? -3.55 O ACT D 201s 255 ARG D 49 ARG^? 10.44 O ACT D 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 44.36 11.24 3.39 41.81 12.78 4.00 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 38.40 3.83 10.26 40.02 6.30 9.25 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 50 3 # 50 22 ASN D 112 ASN^? 12.21 O ACT D 201 63 ARG D 124 ARG.? -3.55 O ACT D 201s 255 ARG D 123 ARG.? 17.60 O ACT D 201 coo 42.10 13.02 11.14 41.85 11.12 10.23 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 44.36 11.24 3.39 41.81 12.78 4.00 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 38.40 3.83 10.26 40.02 6.30 9.25 -58.14 46.42 43.58 -55.81 44.43 43.54 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 50 hits 1aj0_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 34 ASP~? 14.63 O ACT A 201 187 GLU D 137 GLU~? 19.20 CH3 ACT A 203 229 LYS D 134 LYS~? 17.34 O ACT A 201 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -30.67 77.29 56.10 -29.14 77.80 54.72 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -34.89 75.05 43.86 -34.35 73.81 45.48 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 45 ASP^? 16.09 OXT ACT A 202 187 GLU A 59 GLU~? 18.41 O2 EDO A 302 229 LYS A 62 LYS~? 17.60 O ACT A 201 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -19.57 66.85 53.38 -18.14 66.20 51.96 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP A 74 ASP^? 5.73 OXT ACT A 203 187 GLU A 72 GLU~? 5.31 O ACT A 201 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -38.02 65.72 60.64 -36.78 66.00 62.33 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP A 74 ASP^? 5.73 OXT ACT A 203 187 GLU A 96 GLU^? 11.70 OXT ACT A 203 229 LYS A 139 LYS.? 17.81 O ACT A 201 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -44.74 70.71 67.91 -46.53 71.68 68.48 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 5 3 # 5 33 ASP A 99 ASP.? 5.71 O2 EDO A 301 187 GLU C 72 GLU~? 5.32 O ACT C 201 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -37.42 52.13 59.26 -38.02 51.91 57.25 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 6 3 # 6 33 ASP A 99 ASP.? 5.71 O2 EDO A 301 187 GLU C 72 GLU~? 5.32 O ACT C 201 229 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -37.42 52.13 59.26 -38.02 51.91 57.25 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 7 3 # 7 33 ASP A 100 ASP.? 9.07 O2 EDO A 301 187 GLU A 72 GLU~? 5.31 O ACT A 201 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -38.02 65.72 60.64 -36.78 66.00 62.33 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 8 3 # 8 33 ASP A 100 ASP.? 9.07 O2 EDO A 301 187 GLU D 72 GLU~? 5.29 OXT ACT D 201 229 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -51.77 69.18 47.61 -51.44 67.29 46.71 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 9 3 # 9 33 ASP A 100 ASP.? 9.07 O2 EDO A 301 187 GLU D 72 GLU~? 5.29 OXT ACT D 201 229 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -51.77 69.18 47.61 -51.44 67.29 46.71 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 10 3 # 10 33 ASP A 149 ASP.? 18.85 CH3 ACT A 201 187 GLU A 21 GLU~? 19.20 CH3 ACT A 201 229 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -38.64 88.42 71.14 -36.90 88.52 69.95 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -26.74 85.39 73.13 -25.47 87.07 73.30 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 11 3 # 11 33 ASP A 149 ASP.? 18.85 CH3 ACT A 201 187 GLU A 27 GLU~? 9.74 CH3 ACT A 201 229 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -38.64 88.42 71.14 -36.90 88.52 69.95 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -34.88 77.89 68.90 -36.12 78.93 70.26 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 12 3 # 12 33 ASP B 45 ASP^? 20.35 O ACT B 201 187 GLU B 59 GLU~? 20.69 O ACT B 201 229 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -47.90 53.57 92.50 -49.95 53.72 93.03 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 13 3 # 13 33 ASP B 74 ASP^? 14.88 OXT ACT B 201 187 GLU B 72 GLU~? 5.30 OXT ACT B 201 229 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -35.13 47.70 77.85 -34.58 49.69 78.28 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 14 3 # 14 33 ASP B 74 ASP^? 14.88 OXT ACT B 201 187 GLU B 96 GLU^? 10.60 C1 EDO A 302 229 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -24.44 47.78 75.39 -22.51 46.98 75.05 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 15 3 # 15 33 ASP B 100 ASP.? 15.93 OXT ACT B 201 187 GLU B 72 GLU~? 5.30 OXT ACT B 201 229 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -35.13 47.70 77.85 -34.58 49.69 78.28 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 16 3 # 16 33 ASP B 130 ASP.? 9.25 OXT ACT B 201 187 GLU C 72 GLU~? 5.32 O ACT C 201 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -37.42 52.13 59.26 -38.02 51.91 57.25 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 17 3 # 17 33 ASP B 149 ASP.? 20.03 CH3 ACT B 201 187 GLU B 27 GLU~? 9.83 CH3 ACT B 201 229 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -13.67 50.22 91.33 -14.75 50.15 93.16 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -24.11 53.46 86.45 -22.04 53.54 86.08 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 18 3 # 18 33 ASP C 45 ASP^? 20.17 OXT ACT C 201 187 GLU C 59 GLU~? 13.48 O2 EDO A 302 229 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -20.25 53.72 49.66 -20.40 52.10 51.04 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 19 3 # 19 33 ASP C 74 ASP^? 14.86 O ACT C 201 187 GLU C 72 GLU~? 5.32 O ACT C 201 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -37.42 52.13 59.26 -38.02 51.91 57.25 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 20 3 # 20 33 ASP C 74 ASP^? 14.86 O ACT C 201 187 GLU C 96 GLU^? 13.00 O ACT C 201 229 LYS C 139 LYS.? 18.79 O ACT C 201 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -46.59 45.81 59.59 -47.94 44.44 60.43 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 21 3 # 21 33 ASP C 99 ASP.? 5.79 O1 EDO A 301 187 GLU A 72 GLU~? 5.31 O ACT A 201 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -38.02 65.72 60.64 -36.78 66.00 62.33 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 22 3 # 22 33 ASP C 99 ASP.? 5.79 O1 EDO A 301 187 GLU A 72 GLU~? 5.31 O ACT A 201 229 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -38.02 65.72 60.64 -36.78 66.00 62.33 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 23 3 # 23 33 ASP C 100 ASP.? 9.05 C1 EDO A 301 187 GLU B 72 GLU~? 5.30 OXT ACT B 201 229 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -35.13 47.70 77.85 -34.58 49.69 78.28 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 24 3 # 24 33 ASP C 100 ASP.? 9.05 C1 EDO A 301 187 GLU B 72 GLU~? 5.30 OXT ACT B 201 229 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -35.13 47.70 77.85 -34.58 49.69 78.28 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 25 3 # 25 33 ASP C 100 ASP.? 9.05 C1 EDO A 301 187 GLU C 72 GLU~? 5.32 O ACT C 201 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -37.42 52.13 59.26 -38.02 51.91 57.25 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 26 3 # 26 33 ASP C 149 ASP.? 18.79 CH3 ACT C 201 187 GLU C 21 GLU~? 19.29 CH3 ACT C 201 229 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -42.93 29.00 51.56 -40.94 29.30 50.94 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -37.51 33.35 41.29 -36.60 32.00 39.94 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 27 3 # 27 33 ASP C 149 ASP.? 18.79 CH3 ACT C 201 187 GLU C 27 GLU~? 9.88 CH3 ACT C 201 229 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -42.93 29.00 51.56 -40.94 29.30 50.94 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -40.23 39.97 50.79 -41.89 38.66 50.83 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 28 3 # 28 33 ASP D 45 ASP^? 20.33 O ACT D 201 187 GLU D 59 GLU~? 18.52 O ACT D 201 229 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -69.73 60.64 47.66 -70.08 62.16 46.23 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 29 3 # 29 33 ASP D 74 ASP^? 14.85 OXT ACT D 201 187 GLU D 72 GLU~? 5.29 OXT ACT D 201 229 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -51.77 69.18 47.61 -51.44 67.29 46.71 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 30 3 # 30 33 ASP D 74 ASP^? 14.85 OXT ACT D 201 187 GLU D 96 GLU^? 13.00 OXT ACT D 201 229 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -43.29 70.99 40.99 -41.92 72.19 39.92 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 31 3 # 31 33 ASP D 100 ASP.? 7.94 OXT ACT A 203 187 GLU D 72 GLU~? 5.29 OXT ACT D 201 229 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -51.77 69.18 47.61 -51.44 67.29 46.71 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 32 3 # 32 33 ASP D 130 ASP.? 7.40 CH3 ACT A 203 187 GLU A 72 GLU~? 5.31 O ACT A 201 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -38.02 65.72 60.64 -36.78 66.00 62.33 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 33 3 # 33 33 ASP D 149 ASP.? 20.02 CH3 ACT D 201 187 GLU D 27 GLU~? 9.75 CH3 ACT D 201 229 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -48.61 69.27 22.33 -50.68 68.95 22.00 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -50.66 64.65 33.24 -49.08 64.98 31.89 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -47.37 61.41 34.65 -51.85 60.71 37.83 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 33 hits 1ald_c00 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 99 ASP.? 5.71 O2 EDO A 301 35 SER A 101 SER.? 7.80 O2 EDO A 301 215 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -48.36 60.96 55.15 -47.04 58.94 54.93 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP B 99 ASP.? 16.09 OXT ACT B 201 35 SER B 101 SER.? 19.25 O ACT C 201 215 ASP C 74 ASP^? 14.86 O ACT C 201 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -36.32 37.86 70.76 -37.96 39.10 69.46 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1am5_c04 PEPSIN user 3 3 # 3 32 ASP C 99 ASP.? 5.79 O1 EDO A 301 35 SER C 101 SER.? 7.85 O1 EDO A 301 215 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -40.26 55.74 71.04 -39.54 57.94 70.33 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1am5_c04 PEPSIN user 4 3 # 4 32 ASP D 99 ASP.? 7.94 CH3 ACT A 203 35 SER D 101 SER.? 9.16 OXT ACT A 203 215 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -48.40 79.65 53.68 -48.43 78.54 55.84 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -44.71 72.29 58.72 -45.62 72.95 56.93 1am5_c04 source 1am5 PEPSIN : 4 hits 1am5_c04 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 45 ASP^? 16.09 OXT ACT A 202 214 ASP B 86 ASP.? 24.07 CH3 ACT B 201 289 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 26.86 59.76 46.36 25.42 58.23 45.92 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 74 ASP^? 5.73 OXT ACT A 203 214 ASP B 99 ASP.? 16.09 OXT ACT B 201 289 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 26.86 59.76 46.36 25.42 58.23 45.92 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 74 ASP^? 5.73 OXT ACT A 203 214 ASP D 28 ASP~? 12.70 CH3 ACT D 201 289 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 26.86 59.76 46.36 25.42 58.23 45.92 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 74 ASP^? 5.73 OXT ACT A 203 214 ASP D 28 ASP~? 12.70 CH3 ACT D 201 289 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 26.86 59.76 46.36 25.42 58.23 45.92 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 74 ASP^? 5.73 OXT ACT A 203 214 ASP D 28 ASP~? 12.70 CH3 ACT D 201 289 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 26.86 59.76 46.36 25.42 58.23 45.92 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 99 ASP.? 5.71 O2 EDO A 301 214 ASP B 74 ASP^? 14.88 OXT ACT B 201 289 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 26.86 59.76 46.36 25.42 58.23 45.92 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP A 100 ASP.? 9.07 O2 EDO A 301 214 ASP A 149 ASP.? 18.85 CH3 ACT A 201 289 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP A 100 ASP.? 9.07 O2 EDO A 301 214 ASP A 150 ASP.? 22.07 CH3 ACT A 201 289 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 26.86 59.76 46.36 25.42 58.23 45.92 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP A 100 ASP.? 9.07 O2 EDO A 301 214 ASP B 100 ASP.? 15.93 OXT ACT B 201 289 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP A 116 ASP.? 19.55 CH3 ACT A 201 214 ASP B 28 ASP~? 12.70 CH3 ACT B 201 289 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP A 116 ASP.? 19.55 CH3 ACT A 201 214 ASP B 149 ASP.? 20.03 CH3 ACT B 201 289 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 26.86 59.76 46.36 25.42 58.23 45.92 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 9.42 68.07 30.27 7.35 68.27 30.10 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP A 116 ASP.? 19.55 CH3 ACT A 201 214 ASP B 150 ASP.? 20.21 CH3 ACT A 202 289 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 26.86 59.76 46.36 25.42 58.23 45.92 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 9.42 68.07 30.27 7.35 68.27 30.10 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP A 130 ASP.? 4.80 O1 EDO A 301 214 ASP B 28 ASP~? 12.70 CH3 ACT B 201 289 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP A 130 ASP.? 4.80 O1 EDO A 301 214 ASP D 74 ASP^? 14.85 OXT ACT D 201 289 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 26.86 59.76 46.36 25.42 58.23 45.92 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 9.42 68.07 30.27 7.35 68.27 30.10 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP A 149 ASP.? 18.85 CH3 ACT A 201 214 ASP A 45 ASP^? 16.09 OXT ACT A 202 289 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 26.86 59.76 46.36 25.42 58.23 45.92 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 9.42 68.07 30.27 7.35 68.27 30.10 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP A 149 ASP.? 18.85 CH3 ACT A 201 214 ASP A 100 ASP.? 9.07 O2 EDO A 301 289 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 26.86 59.76 46.36 25.42 58.23 45.92 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 9.42 68.07 30.27 7.35 68.27 30.10 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP A 149 ASP.? 18.85 CH3 ACT A 201 214 ASP D 130 ASP.? 7.40 CH3 ACT A 203 289 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 26.86 59.76 46.36 25.42 58.23 45.92 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 9.42 68.07 30.27 7.35 68.27 30.10 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP B 45 ASP^? 20.35 O ACT B 201 214 ASP A 86 ASP.? 20.24 CH3 ACT A 202 289 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 26.86 59.76 46.36 25.42 58.23 45.92 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 9.42 68.07 30.27 7.35 68.27 30.10 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP B 74 ASP^? 14.88 OXT ACT B 201 214 ASP A 99 ASP.? 5.71 O2 EDO A 301 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 26.86 59.76 46.36 25.42 58.23 45.92 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP B 74 ASP^? 14.88 OXT ACT B 201 214 ASP C 130 ASP.? 4.74 O2 EDO A 301 289 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 26.86 59.76 46.36 25.42 58.23 45.92 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 21 3 # 21 179 ASP B 74 ASP^? 14.88 OXT ACT B 201 214 ASP C 149 ASP.? 18.79 CH3 ACT C 201 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 26.86 59.76 46.36 25.42 58.23 45.92 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 22 3 # 22 179 ASP B 74 ASP^? 14.88 OXT ACT B 201 214 ASP C 149 ASP.? 18.79 CH3 ACT C 201 289 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 26.86 59.76 46.36 25.42 58.23 45.92 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 23 3 # 23 179 ASP B 74 ASP^? 14.88 OXT ACT B 201 214 ASP C 150 ASP.? 20.99 CH3 ACT C 201 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 26.86 59.76 46.36 25.42 58.23 45.92 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 24 3 # 24 179 ASP B 99 ASP.? 16.09 OXT ACT B 201 214 ASP A 74 ASP^? 5.73 OXT ACT A 203 289 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 26.86 59.76 46.36 25.42 58.23 45.92 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 25 3 # 25 179 ASP B 99 ASP.? 16.09 OXT ACT B 201 214 ASP D 130 ASP.? 7.40 CH3 ACT A 203 289 ASP C 74 ASP^? 14.86 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 26.86 59.76 46.36 25.42 58.23 45.92 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 26 3 # 26 179 ASP B 99 ASP.? 16.09 OXT ACT B 201 214 ASP D 130 ASP.? 7.40 CH3 ACT A 203 289 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 26.86 59.76 46.36 25.42 58.23 45.92 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 27 3 # 27 179 ASP B 116 ASP.? 19.49 CH3 ACT B 201 214 ASP A 28 ASP~? 12.70 CH3 ACT A 201 289 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 26.86 59.76 46.36 25.42 58.23 45.92 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 28 3 # 28 179 ASP B 116 ASP.? 19.49 CH3 ACT B 201 214 ASP A 149 ASP.? 18.85 CH3 ACT A 201 289 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 29 3 # 29 179 ASP B 130 ASP.? 9.25 OXT ACT B 201 214 ASP C 149 ASP.? 18.79 CH3 ACT C 201 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 26.86 59.76 46.36 25.42 58.23 45.92 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 30 3 # 30 179 ASP B 130 ASP.? 9.25 OXT ACT B 201 214 ASP C 150 ASP.? 20.99 CH3 ACT C 201 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 26.86 59.76 46.36 25.42 58.23 45.92 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 31 3 # 31 179 ASP B 130 ASP.? 9.25 OXT ACT B 201 214 ASP D 99 ASP.? 7.94 CH3 ACT A 203 289 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 26.86 59.76 46.36 25.42 58.23 45.92 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 32 3 # 32 179 ASP B 149 ASP.? 20.03 CH3 ACT B 201 214 ASP B 100 ASP.? 15.93 OXT ACT B 201 289 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 33 3 # 33 179 ASP B 149 ASP.? 20.03 CH3 ACT B 201 214 ASP C 100 ASP.? 9.05 C1 EDO A 301 289 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 26.86 59.76 46.36 25.42 58.23 45.92 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 34 3 # 34 179 ASP C 45 ASP^? 20.17 OXT ACT C 201 214 ASP D 86 ASP.? 24.19 CH3 ACT D 201 289 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 26.86 59.76 46.36 25.42 58.23 45.92 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 35 3 # 35 179 ASP C 74 ASP^? 14.86 O ACT C 201 214 ASP B 28 ASP~? 12.70 CH3 ACT B 201 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 36 3 # 36 179 ASP C 74 ASP^? 14.86 O ACT C 201 214 ASP B 28 ASP~? 12.70 CH3 ACT B 201 289 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 37 3 # 37 179 ASP C 74 ASP^? 14.86 O ACT C 201 214 ASP B 28 ASP~? 12.70 CH3 ACT B 201 289 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 38 3 # 38 179 ASP C 74 ASP^? 14.86 O ACT C 201 214 ASP D 99 ASP.? 7.94 CH3 ACT A 203 289 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 26.86 59.76 46.36 25.42 58.23 45.92 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 39 3 # 39 179 ASP C 99 ASP.? 5.79 O1 EDO A 301 214 ASP D 74 ASP^? 14.85 OXT ACT D 201 289 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 26.86 59.76 46.36 25.42 58.23 45.92 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 9.42 68.07 30.27 7.35 68.27 30.10 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 40 3 # 40 179 ASP C 100 ASP.? 9.05 C1 EDO A 301 214 ASP C 149 ASP.? 18.79 CH3 ACT C 201 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 26.86 59.76 46.36 25.42 58.23 45.92 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 41 3 # 41 179 ASP C 100 ASP.? 9.05 C1 EDO A 301 214 ASP C 150 ASP.? 20.99 CH3 ACT C 201 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 26.86 59.76 46.36 25.42 58.23 45.92 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 42 3 # 42 179 ASP C 100 ASP.? 9.05 C1 EDO A 301 214 ASP D 100 ASP.? 7.94 OXT ACT A 203 289 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 26.86 59.76 46.36 25.42 58.23 45.92 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 43 3 # 43 179 ASP C 116 ASP.? 19.40 CH3 ACT C 201 214 ASP D 28 ASP~? 12.70 CH3 ACT D 201 289 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 26.86 59.76 46.36 25.42 58.23 45.92 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 44 3 # 44 179 ASP C 116 ASP.? 19.40 CH3 ACT C 201 214 ASP D 149 ASP.? 20.02 CH3 ACT D 201 289 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 26.86 59.76 46.36 25.42 58.23 45.92 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 45 3 # 45 179 ASP C 130 ASP.? 4.74 O2 EDO A 301 214 ASP B 74 ASP^? 14.88 OXT ACT B 201 289 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 26.86 59.76 46.36 25.42 58.23 45.92 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 46 3 # 46 179 ASP C 130 ASP.? 4.74 O2 EDO A 301 214 ASP D 28 ASP~? 12.70 CH3 ACT D 201 289 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 26.86 59.76 46.36 25.42 58.23 45.92 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 47 3 # 47 179 ASP C 149 ASP.? 18.79 CH3 ACT C 201 214 ASP B 130 ASP.? 9.25 OXT ACT B 201 289 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 26.86 59.76 46.36 25.42 58.23 45.92 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 48 3 # 48 179 ASP C 149 ASP.? 18.79 CH3 ACT C 201 214 ASP C 45 ASP^? 20.17 OXT ACT C 201 289 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 26.86 59.76 46.36 25.42 58.23 45.92 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 49 3 # 49 179 ASP C 149 ASP.? 18.79 CH3 ACT C 201 214 ASP C 100 ASP.? 9.05 C1 EDO A 301 289 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 26.86 59.76 46.36 25.42 58.23 45.92 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 50 3 # 50 179 ASP D 45 ASP^? 20.33 O ACT D 201 214 ASP C 86 ASP.? 24.03 CH3 ACT C 201 289 ASP D 116 ASP.? 19.52 CH3 ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 9.42 68.07 30.27 7.35 68.27 30.10 -63.55 47.24 34.96 -64.48 49.07 34.39 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 51 3 # 51 179 ASP D 74 ASP^? 14.85 OXT ACT D 201 214 ASP A 130 ASP.? 4.80 O1 EDO A 301 289 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 26.86 59.76 46.36 25.42 58.23 45.92 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 52 3 # 52 179 ASP D 74 ASP^? 14.85 OXT ACT D 201 214 ASP A 149 ASP.? 18.85 CH3 ACT A 201 289 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 53 3 # 53 179 ASP D 74 ASP^? 14.85 OXT ACT D 201 214 ASP A 149 ASP.? 18.85 CH3 ACT A 201 289 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 54 3 # 54 179 ASP D 74 ASP^? 14.85 OXT ACT D 201 214 ASP A 150 ASP.? 22.07 CH3 ACT A 201 289 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 26.86 59.76 46.36 25.42 58.23 45.92 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 55 3 # 55 179 ASP D 74 ASP^? 14.85 OXT ACT D 201 214 ASP A 150 ASP.? 22.07 CH3 ACT A 201 289 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 26.86 59.76 46.36 25.42 58.23 45.92 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 56 3 # 56 179 ASP D 74 ASP^? 14.85 OXT ACT D 201 214 ASP C 99 ASP.? 5.79 O1 EDO A 301 289 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 26.86 59.76 46.36 25.42 58.23 45.92 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 9.42 68.07 30.27 7.35 68.27 30.10 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 57 3 # 57 179 ASP D 99 ASP.? 7.94 CH3 ACT A 203 214 ASP B 130 ASP.? 9.25 OXT ACT B 201 289 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 26.86 59.76 46.36 25.42 58.23 45.92 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 58 3 # 58 179 ASP D 99 ASP.? 7.94 CH3 ACT A 203 214 ASP B 130 ASP.? 9.25 OXT ACT B 201 289 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 26.86 59.76 46.36 25.42 58.23 45.92 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 59 3 # 59 179 ASP D 99 ASP.? 7.94 CH3 ACT A 203 214 ASP C 74 ASP^? 14.86 O ACT C 201 289 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 26.86 59.76 46.36 25.42 58.23 45.92 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 60 3 # 60 179 ASP D 116 ASP.? 19.52 CH3 ACT D 201 214 ASP C 28 ASP~? 12.80 CH3 ACT C 201 289 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 26.86 59.76 46.36 25.42 58.23 45.92 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 9.42 68.07 30.27 7.35 68.27 30.10 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 61 3 # 61 179 ASP D 116 ASP.? 19.52 CH3 ACT D 201 214 ASP C 149 ASP.? 18.79 CH3 ACT C 201 289 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 26.86 59.76 46.36 25.42 58.23 45.92 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 62 3 # 62 179 ASP D 130 ASP.? 7.40 CH3 ACT A 203 214 ASP A 149 ASP.? 18.85 CH3 ACT A 201 289 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 63 3 # 63 179 ASP D 130 ASP.? 7.40 CH3 ACT A 203 214 ASP A 150 ASP.? 22.07 CH3 ACT A 201 289 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 26.86 59.76 46.36 25.42 58.23 45.92 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 64 3 # 64 179 ASP D 130 ASP.? 7.40 CH3 ACT A 203 214 ASP B 99 ASP.? 16.09 OXT ACT B 201 289 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 26.86 59.76 46.36 25.42 58.23 45.92 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 65 3 # 65 179 ASP D 149 ASP.? 20.02 CH3 ACT D 201 214 ASP A 100 ASP.? 9.07 O2 EDO A 301 289 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 26.86 59.76 46.36 25.42 58.23 45.92 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 9.42 68.07 30.27 7.35 68.27 30.10 -55.65 65.73 30.36 -54.18 65.67 28.83 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 66 3 # 66 179 ASP D 149 ASP.? 20.02 CH3 ACT D 201 214 ASP D 100 ASP.? 7.94 OXT ACT A 203 289 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 26.86 59.76 46.36 25.42 58.23 45.92 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 9.42 68.07 30.27 7.35 68.27 30.10 -55.65 65.73 30.36 -54.18 65.67 28.83 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 66 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 99 ASP.? 5.71 O2 EDO A 301 204 GLU A 72 GLU~? 5.31 O ACT A 201 289 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 4.34 62.44 32.05 4.22 64.48 32.53 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 99 ASP.? 5.71 O2 EDO A 301 204 GLU A 72 GLU~? 5.31 O ACT A 201 289 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 4.34 62.44 32.05 4.22 64.48 32.53 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 116 ASP.? 19.55 CH3 ACT A 201 204 GLU A 114 GLU^? 11.87 CH3 ACT A 202 289 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 4.34 62.44 32.05 4.22 64.48 32.53 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 9.42 68.07 30.27 7.35 68.27 30.10 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 86 ASP.? 24.07 CH3 ACT B 201 204 GLU B 114 GLU^? 18.04 O ACT B 201 289 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 4.34 62.44 32.05 4.22 64.48 32.53 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 9.42 68.07 30.27 7.35 68.27 30.10 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 99 ASP.? 16.09 OXT ACT B 201 204 GLU B 72 GLU~? 5.30 OXT ACT B 201 289 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 4.34 62.44 32.05 4.22 64.48 32.53 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 99 ASP.? 16.09 OXT ACT B 201 204 GLU B 72 GLU~? 5.30 OXT ACT B 201 289 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 4.34 62.44 32.05 4.22 64.48 32.53 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP B 116 ASP.? 19.49 CH3 ACT B 201 204 GLU B 114 GLU^? 18.04 O ACT B 201 289 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 4.34 62.44 32.05 4.22 64.48 32.53 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP B 130 ASP.? 9.25 OXT ACT B 201 204 GLU B 72 GLU~? 5.30 OXT ACT B 201 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 4.34 62.44 32.05 4.22 64.48 32.53 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP C 86 ASP.? 24.03 CH3 ACT C 201 204 GLU C 114 GLU^? 18.18 OXT ACT C 201 289 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 4.34 62.44 32.05 4.22 64.48 32.53 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP C 99 ASP.? 5.79 O1 EDO A 301 204 GLU C 72 GLU~? 5.32 O ACT C 201 289 ASP C 74 ASP^? 14.86 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 4.34 62.44 32.05 4.22 64.48 32.53 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP C 99 ASP.? 5.79 O1 EDO A 301 204 GLU C 72 GLU~? 5.32 O ACT C 201 289 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 4.34 62.44 32.05 4.22 64.48 32.53 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 9.42 68.07 30.27 7.35 68.27 30.10 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP C 116 ASP.? 19.40 CH3 ACT C 201 204 GLU C 114 GLU^? 18.18 OXT ACT C 201 289 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 4.34 62.44 32.05 4.22 64.48 32.53 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP D 99 ASP.? 7.94 CH3 ACT A 203 204 GLU D 72 GLU~? 5.29 OXT ACT D 201 289 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 4.34 62.44 32.05 4.22 64.48 32.53 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 9.42 68.07 30.27 7.35 68.27 30.10 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP D 99 ASP.? 7.94 CH3 ACT A 203 204 GLU D 72 GLU~? 5.29 OXT ACT D 201 289 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 4.34 62.44 32.05 4.22 64.48 32.53 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP D 116 ASP.? 19.52 CH3 ACT D 201 204 GLU D 114 GLU^? 18.05 O ACT D 201 289 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 4.34 62.44 32.05 4.22 64.48 32.53 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 9.42 68.07 30.27 7.35 68.27 30.10 -53.41 42.17 31.38 -52.32 40.44 30.82 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 15 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 28 ASP~? 12.70 CH3 ACT A 201 227 GLU A 96 GLU^? 11.70 OXT ACT A 203 289 ASP A 149 ASP.? 18.85 CH3 ACT A 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.64 88.42 71.14 -36.90 88.52 69.95 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 28 ASP~? 12.70 CH3 ACT A 201 227 GLU A 111 GLU^? 4.34 CH3 ACT A 201 289 ASP A 34 ASP~? 14.63 O ACT A 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 3.96 55.76 41.24 4.83 57.69 41.17 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 34 ASP~? 14.63 O ACT A 201 227 GLU A 72 GLU~? 5.31 O ACT A 201 289 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 3.96 55.76 41.24 4.83 57.69 41.17 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 9.42 68.07 30.27 7.35 68.27 30.10 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 74 ASP^? 5.73 OXT ACT A 203 227 GLU A 137 GLU~? 14.03 O ACT A 203 289 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 3.96 55.76 41.24 4.83 57.69 41.17 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 74 ASP^? 5.73 OXT ACT A 203 227 GLU D 96 GLU^? 13.00 OXT ACT D 201 289 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 3.96 55.76 41.24 4.83 57.69 41.17 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 74 ASP^? 5.73 OXT ACT A 203 227 GLU D 96 GLU^? 13.00 OXT ACT D 201 289 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 3.96 55.76 41.24 4.83 57.69 41.17 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 9.42 68.07 30.27 7.35 68.27 30.10 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP A 86 ASP.? 20.24 CH3 ACT A 202 227 GLU A 21 GLU~? 19.20 CH3 ACT A 201 289 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 3.96 55.76 41.24 4.83 57.69 41.17 -26.74 85.39 73.13 -25.47 87.07 73.30 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP A 86 ASP.? 20.24 CH3 ACT A 202 227 GLU A 111 GLU^? 4.34 CH3 ACT A 201 289 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 3.96 55.76 41.24 4.83 57.69 41.17 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP A 99 ASP.? 5.71 O2 EDO A 301 227 GLU A 53 GLU^? 10.41 O2 EDO A 302 289 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 3.96 55.76 41.24 4.83 57.69 41.17 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP A 99 ASP.? 5.71 O2 EDO A 301 227 GLU A 137 GLU~? 14.03 O ACT A 203 289 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 3.96 55.76 41.24 4.83 57.69 41.17 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP A 99 ASP.? 5.71 O2 EDO A 301 227 GLU C 53 GLU^? 11.18 OXT ACT C 201 289 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 3.96 55.76 41.24 4.83 57.69 41.17 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP A 99 ASP.? 5.71 O2 EDO A 301 227 GLU C 53 GLU^? 11.18 OXT ACT C 201 289 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 3.96 55.76 41.24 4.83 57.69 41.17 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP A 99 ASP.? 5.71 O2 EDO A 301 227 GLU C 53 GLU^? 11.18 OXT ACT C 201 289 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 3.96 55.76 41.24 4.83 57.69 41.17 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP A 99 ASP.? 5.71 O2 EDO A 301 227 GLU C 96 GLU^? 13.00 O ACT C 201 289 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 3.96 55.76 41.24 4.83 57.69 41.17 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP A 100 ASP.? 9.07 O2 EDO A 301 227 GLU A 96 GLU^? 11.70 OXT ACT A 203 289 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP A 100 ASP.? 9.07 O2 EDO A 301 227 GLU A 96 GLU^? 11.70 OXT ACT A 203 289 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP A 100 ASP.? 9.07 O2 EDO A 301 227 GLU C 111 GLU^? 4.32 CH3 ACT C 201 289 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP A 100 ASP.? 9.07 O2 EDO A 301 227 GLU D 96 GLU^? 13.00 OXT ACT D 201 289 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 3.96 55.76 41.24 4.83 57.69 41.17 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP A 100 ASP.? 9.07 O2 EDO A 301 227 GLU D 111 GLU^? 4.46 CH3 ACT D 201 289 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 3.96 55.76 41.24 4.83 57.69 41.17 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP A 100 ASP.? 9.07 O2 EDO A 301 227 GLU D 137 GLU~? 19.20 CH3 ACT A 203 289 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 21 3 # 21 179 ASP A 100 ASP.? 9.07 O2 EDO A 301 227 GLU D 137 GLU~? 19.20 CH3 ACT A 203 289 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 22 3 # 22 179 ASP A 116 ASP.? 19.55 CH3 ACT A 201 227 GLU A 21 GLU~? 19.20 CH3 ACT A 201 289 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 3.96 55.76 41.24 4.83 57.69 41.17 -26.74 85.39 73.13 -25.47 87.07 73.30 coo 9.42 68.07 30.27 7.35 68.27 30.10 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 23 3 # 23 179 ASP A 116 ASP.? 19.55 CH3 ACT A 201 227 GLU A 111 GLU^? 4.34 CH3 ACT A 201 289 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 3.96 55.76 41.24 4.83 57.69 41.17 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 24 3 # 24 179 ASP A 116 ASP.? 19.55 CH3 ACT A 201 227 GLU B 160 GLU.? 4.71 OXT ACT A 202 289 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 3.96 55.76 41.24 4.83 57.69 41.17 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 9.42 68.07 30.27 7.35 68.27 30.10 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 25 3 # 25 179 ASP A 130 ASP.? 4.80 O1 EDO A 301 227 GLU A 53 GLU^? 10.41 O2 EDO A 302 289 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 3.96 55.76 41.24 4.83 57.69 41.17 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 26 3 # 26 179 ASP A 130 ASP.? 4.80 O1 EDO A 301 227 GLU A 53 GLU^? 10.41 O2 EDO A 302 289 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 3.96 55.76 41.24 4.83 57.69 41.17 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 9.42 68.07 30.27 7.35 68.27 30.10 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 27 3 # 27 179 ASP A 130 ASP.? 4.80 O1 EDO A 301 227 GLU A 111 GLU^? 4.34 CH3 ACT A 201 289 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 3.96 55.76 41.24 4.83 57.69 41.17 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 28 3 # 28 179 ASP A 130 ASP.? 4.80 O1 EDO A 301 227 GLU A 137 GLU~? 14.03 O ACT A 203 289 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 3.96 55.76 41.24 4.83 57.69 41.17 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 29 3 # 29 179 ASP A 130 ASP.? 4.80 O1 EDO A 301 227 GLU A 137 GLU~? 14.03 O ACT A 203 289 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 3.96 55.76 41.24 4.83 57.69 41.17 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 9.42 68.07 30.27 7.35 68.27 30.10 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 30 3 # 30 179 ASP A 130 ASP.? 4.80 O1 EDO A 301 227 GLU C 96 GLU^? 13.00 O ACT C 201 289 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 3.96 55.76 41.24 4.83 57.69 41.17 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 31 3 # 31 179 ASP A 130 ASP.? 4.80 O1 EDO A 301 227 GLU C 96 GLU^? 13.00 O ACT C 201 289 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 3.96 55.76 41.24 4.83 57.69 41.17 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 32 3 # 32 179 ASP A 149 ASP.? 18.85 CH3 ACT A 201 227 GLU A 17 GLU~? 23.86 CH3 ACT A 201 289 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 3.96 55.76 41.24 4.83 57.69 41.17 -26.80 87.18 79.85 -26.18 89.13 80.39 coo 9.42 68.07 30.27 7.35 68.27 30.10 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 33 3 # 33 179 ASP B 28 ASP~? 12.70 CH3 ACT B 201 227 GLU B 96 GLU^? 10.60 C1 EDO A 302 289 ASP B 149 ASP.? 20.03 CH3 ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 3.96 55.76 41.24 4.83 57.69 41.17 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.67 50.22 91.33 -14.75 50.15 93.16 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 34 3 # 34 179 ASP B 28 ASP~? 12.70 CH3 ACT B 201 227 GLU B 111 GLU^? 4.46 CH3 ACT B 201 289 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 3.96 55.76 41.24 4.83 57.69 41.17 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 35 3 # 35 179 ASP B 34 ASP~? 14.61 OXT ACT B 201 227 GLU B 72 GLU~? 5.30 OXT ACT B 201 289 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 3.96 55.76 41.24 4.83 57.69 41.17 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 36 3 # 36 179 ASP B 74 ASP^? 14.88 OXT ACT B 201 227 GLU B 137 GLU~? 6.31 C2 EDO A 302 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 3.96 55.76 41.24 4.83 57.69 41.17 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 37 3 # 37 179 ASP B 86 ASP.? 24.07 CH3 ACT B 201 227 GLU B 21 GLU~? 20.11 CH3 ACT B 201 289 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 3.96 55.76 41.24 4.83 57.69 41.17 -19.23 61.49 94.88 -18.90 62.15 96.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 38 3 # 38 179 ASP B 86 ASP.? 24.07 CH3 ACT B 201 227 GLU B 111 GLU^? 4.46 CH3 ACT B 201 289 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 3.96 55.76 41.24 4.83 57.69 41.17 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 39 3 # 39 179 ASP B 99 ASP.? 16.09 OXT ACT B 201 227 GLU B 53 GLU^? 11.09 O ACT B 201 289 ASP C 74 ASP^? 14.86 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 40 3 # 40 179 ASP B 99 ASP.? 16.09 OXT ACT B 201 227 GLU B 137 GLU~? 6.31 C2 EDO A 302 289 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 3.96 55.76 41.24 4.83 57.69 41.17 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 41 3 # 41 179 ASP B 99 ASP.? 16.09 OXT ACT B 201 227 GLU B 137 GLU~? 6.31 C2 EDO A 302 289 ASP C 74 ASP^? 14.86 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 3.96 55.76 41.24 4.83 57.69 41.17 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 42 3 # 42 179 ASP B 99 ASP.? 16.09 OXT ACT B 201 227 GLU B 137 GLU~? 6.31 C2 EDO A 302 289 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 3.96 55.76 41.24 4.83 57.69 41.17 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 43 3 # 43 179 ASP B 99 ASP.? 16.09 OXT ACT B 201 227 GLU C 96 GLU^? 13.00 O ACT C 201 289 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 3.96 55.76 41.24 4.83 57.69 41.17 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 44 3 # 44 179 ASP B 99 ASP.? 16.09 OXT ACT B 201 227 GLU C 96 GLU^? 13.00 O ACT C 201 289 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 3.96 55.76 41.24 4.83 57.69 41.17 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 45 3 # 45 179 ASP B 100 ASP.? 15.93 OXT ACT B 201 227 GLU B 96 GLU^? 10.60 C1 EDO A 302 289 ASP C 74 ASP^? 14.86 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 3.96 55.76 41.24 4.83 57.69 41.17 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 46 3 # 46 179 ASP B 116 ASP.? 19.49 CH3 ACT B 201 227 GLU B 111 GLU^? 4.46 CH3 ACT B 201 289 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 3.96 55.76 41.24 4.83 57.69 41.17 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 47 3 # 47 179 ASP B 130 ASP.? 9.25 OXT ACT B 201 227 GLU B 53 GLU^? 11.09 O ACT B 201 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 48 3 # 48 179 ASP B 130 ASP.? 9.25 OXT ACT B 201 227 GLU B 53 GLU^? 11.09 O ACT B 201 289 ASP C 74 ASP^? 14.86 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 49 3 # 49 179 ASP B 130 ASP.? 9.25 OXT ACT B 201 227 GLU B 137 GLU~? 6.31 C2 EDO A 302 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 3.96 55.76 41.24 4.83 57.69 41.17 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 50 3 # 50 179 ASP B 130 ASP.? 9.25 OXT ACT B 201 227 GLU B 137 GLU~? 6.31 C2 EDO A 302 289 ASP C 74 ASP^? 14.86 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 3.96 55.76 41.24 4.83 57.69 41.17 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 51 3 # 51 179 ASP B 149 ASP.? 20.03 CH3 ACT B 201 227 GLU B 17 GLU~? 23.60 CH3 ACT B 201 289 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 3.96 55.76 41.24 4.83 57.69 41.17 -16.26 64.60 95.04 -14.82 64.68 96.59 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 52 3 # 52 179 ASP C 28 ASP~? 12.80 CH3 ACT C 201 227 GLU C 96 GLU^? 13.00 O ACT C 201 289 ASP C 149 ASP.? 18.79 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 3.96 55.76 41.24 4.83 57.69 41.17 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -42.93 29.00 51.56 -40.94 29.30 50.94 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 53 3 # 53 179 ASP C 28 ASP~? 12.80 CH3 ACT C 201 227 GLU C 111 GLU^? 4.32 CH3 ACT C 201 289 ASP C 34 ASP~? 14.66 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 54 3 # 54 179 ASP C 34 ASP~? 14.66 O ACT C 201 227 GLU C 72 GLU~? 5.32 O ACT C 201 289 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 55 3 # 55 179 ASP C 74 ASP^? 14.86 O ACT C 201 227 GLU C 137 GLU~? 15.84 O2 EDO A 301 289 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 3.96 55.76 41.24 4.83 57.69 41.17 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 56 3 # 56 179 ASP C 86 ASP.? 24.03 CH3 ACT C 201 227 GLU C 21 GLU~? 19.29 CH3 ACT C 201 289 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 3.96 55.76 41.24 4.83 57.69 41.17 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 57 3 # 57 179 ASP C 86 ASP.? 24.03 CH3 ACT C 201 227 GLU C 111 GLU^? 4.32 CH3 ACT C 201 289 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 58 3 # 58 179 ASP C 99 ASP.? 5.79 O1 EDO A 301 227 GLU A 53 GLU^? 10.41 O2 EDO A 302 289 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 59 3 # 59 179 ASP C 99 ASP.? 5.79 O1 EDO A 301 227 GLU A 53 GLU^? 10.41 O2 EDO A 302 289 ASP C 74 ASP^? 14.86 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 60 3 # 60 179 ASP C 99 ASP.? 5.79 O1 EDO A 301 227 GLU A 53 GLU^? 10.41 O2 EDO A 302 289 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 9.42 68.07 30.27 7.35 68.27 30.10 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 61 3 # 61 179 ASP C 99 ASP.? 5.79 O1 EDO A 301 227 GLU A 96 GLU^? 11.70 OXT ACT A 203 289 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 62 3 # 62 179 ASP C 99 ASP.? 5.79 O1 EDO A 301 227 GLU B 53 GLU^? 11.09 O ACT B 201 289 ASP C 74 ASP^? 14.86 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 63 3 # 63 179 ASP C 99 ASP.? 5.79 O1 EDO A 301 227 GLU C 53 GLU^? 11.18 OXT ACT C 201 289 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 64 3 # 64 179 ASP C 99 ASP.? 5.79 O1 EDO A 301 227 GLU C 137 GLU~? 15.84 O2 EDO A 301 289 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 65 3 # 65 179 ASP C 99 ASP.? 5.79 O1 EDO A 301 227 GLU C 137 GLU~? 15.84 O2 EDO A 301 289 ASP C 74 ASP^? 14.86 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 66 3 # 66 179 ASP C 100 ASP.? 9.05 C1 EDO A 301 227 GLU A 111 GLU^? 4.34 CH3 ACT A 201 289 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 3.96 55.76 41.24 4.83 57.69 41.17 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 67 3 # 67 179 ASP C 100 ASP.? 9.05 C1 EDO A 301 227 GLU B 96 GLU^? 10.60 C1 EDO A 302 289 ASP C 74 ASP^? 14.86 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 3.96 55.76 41.24 4.83 57.69 41.17 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 68 3 # 68 179 ASP C 100 ASP.? 9.05 C1 EDO A 301 227 GLU B 111 GLU^? 4.46 CH3 ACT B 201 289 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 3.96 55.76 41.24 4.83 57.69 41.17 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 69 3 # 69 179 ASP C 100 ASP.? 9.05 C1 EDO A 301 227 GLU B 137 GLU~? 6.31 C2 EDO A 302 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 3.96 55.76 41.24 4.83 57.69 41.17 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 70 3 # 70 179 ASP C 100 ASP.? 9.05 C1 EDO A 301 227 GLU B 137 GLU~? 6.31 C2 EDO A 302 289 ASP C 74 ASP^? 14.86 O ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 3.96 55.76 41.24 4.83 57.69 41.17 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 71 3 # 71 179 ASP C 100 ASP.? 9.05 C1 EDO A 301 227 GLU C 96 GLU^? 13.00 O ACT C 201 289 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 3.96 55.76 41.24 4.83 57.69 41.17 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 72 3 # 72 179 ASP C 100 ASP.? 9.05 C1 EDO A 301 227 GLU C 96 GLU^? 13.00 O ACT C 201 289 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 3.96 55.76 41.24 4.83 57.69 41.17 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 73 3 # 73 179 ASP C 116 ASP.? 19.40 CH3 ACT C 201 227 GLU C 21 GLU~? 19.29 CH3 ACT C 201 289 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 3.96 55.76 41.24 4.83 57.69 41.17 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 74 3 # 74 179 ASP C 116 ASP.? 19.40 CH3 ACT C 201 227 GLU C 111 GLU^? 4.32 CH3 ACT C 201 289 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 75 3 # 75 179 ASP C 116 ASP.? 19.40 CH3 ACT C 201 227 GLU C 111 GLU^? 4.32 CH3 ACT C 201 289 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 76 3 # 76 179 ASP C 130 ASP.? 4.74 O2 EDO A 301 227 GLU A 96 GLU^? 11.70 OXT ACT A 203 289 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 77 3 # 77 179 ASP C 130 ASP.? 4.74 O2 EDO A 301 227 GLU A 96 GLU^? 11.70 OXT ACT A 203 289 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 78 3 # 78 179 ASP C 130 ASP.? 4.74 O2 EDO A 301 227 GLU C 53 GLU^? 11.18 OXT ACT C 201 289 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 79 3 # 79 179 ASP C 130 ASP.? 4.74 O2 EDO A 301 227 GLU C 53 GLU^? 11.18 OXT ACT C 201 289 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 80 3 # 80 179 ASP C 130 ASP.? 4.74 O2 EDO A 301 227 GLU C 111 GLU^? 4.32 CH3 ACT C 201 289 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 81 3 # 81 179 ASP C 130 ASP.? 4.74 O2 EDO A 301 227 GLU C 137 GLU~? 15.84 O2 EDO A 301 289 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 82 3 # 82 179 ASP C 130 ASP.? 4.74 O2 EDO A 301 227 GLU C 137 GLU~? 15.84 O2 EDO A 301 289 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 83 3 # 83 179 ASP C 149 ASP.? 18.79 CH3 ACT C 201 227 GLU C 17 GLU~? 23.53 CH3 ACT C 201 289 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.57 31.78 35.88 -45.60 32.67 34.25 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 84 3 # 84 179 ASP D 28 ASP~? 12.70 CH3 ACT D 201 227 GLU D 111 GLU^? 4.46 CH3 ACT D 201 289 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 3.96 55.76 41.24 4.83 57.69 41.17 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 85 3 # 85 179 ASP D 34 ASP~? 14.62 OXT ACT D 201 227 GLU D 72 GLU~? 5.29 OXT ACT D 201 289 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 3.96 55.76 41.24 4.83 57.69 41.17 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 9.42 68.07 30.27 7.35 68.27 30.10 -55.65 65.73 30.36 -54.18 65.67 28.83 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 86 3 # 86 179 ASP D 74 ASP^? 14.85 OXT ACT D 201 227 GLU D 137 GLU~? 19.20 CH3 ACT A 203 289 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 87 3 # 87 179 ASP D 86 ASP.? 24.19 CH3 ACT D 201 227 GLU D 21 GLU~? 20.13 CH3 ACT D 201 289 ASP D 116 ASP.? 19.52 CH3 ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 3.96 55.76 41.24 4.83 57.69 41.17 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 9.42 68.07 30.27 7.35 68.27 30.10 -63.55 47.24 34.96 -64.48 49.07 34.39 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 88 3 # 88 179 ASP D 86 ASP.? 24.19 CH3 ACT D 201 227 GLU D 111 GLU^? 4.46 CH3 ACT D 201 289 ASP D 116 ASP.? 19.52 CH3 ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 3.96 55.76 41.24 4.83 57.69 41.17 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -63.55 47.24 34.96 -64.48 49.07 34.39 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 89 3 # 89 179 ASP D 99 ASP.? 7.94 CH3 ACT A 203 227 GLU A 96 GLU^? 11.70 OXT ACT A 203 289 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 90 3 # 90 179 ASP D 99 ASP.? 7.94 CH3 ACT A 203 227 GLU A 96 GLU^? 11.70 OXT ACT A 203 289 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 91 3 # 91 179 ASP D 99 ASP.? 7.94 CH3 ACT A 203 227 GLU D 53 GLU^? 10.32 O ACT A 203 289 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 3.96 55.76 41.24 4.83 57.69 41.17 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 92 3 # 92 179 ASP D 99 ASP.? 7.94 CH3 ACT A 203 227 GLU D 137 GLU~? 19.20 CH3 ACT A 203 289 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 93 3 # 93 179 ASP D 99 ASP.? 7.94 CH3 ACT A 203 227 GLU D 137 GLU~? 19.20 CH3 ACT A 203 289 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 94 3 # 94 179 ASP D 99 ASP.? 7.94 CH3 ACT A 203 227 GLU D 137 GLU~? 19.20 CH3 ACT A 203 289 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 95 3 # 95 179 ASP D 100 ASP.? 7.94 OXT ACT A 203 227 GLU D 96 GLU^? 13.00 OXT ACT D 201 289 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 3.96 55.76 41.24 4.83 57.69 41.17 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 96 3 # 96 179 ASP D 116 ASP.? 19.52 CH3 ACT D 201 227 GLU D 111 GLU^? 4.46 CH3 ACT D 201 289 ASP D 45 ASP^? 20.33 O ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 3.96 55.76 41.24 4.83 57.69 41.17 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -67.68 49.50 43.87 -67.26 48.38 42.12 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 97 3 # 97 179 ASP D 116 ASP.? 19.52 CH3 ACT D 201 227 GLU D 111 GLU^? 4.46 CH3 ACT D 201 289 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 3.96 55.76 41.24 4.83 57.69 41.17 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 98 3 # 98 179 ASP D 130 ASP.? 7.40 CH3 ACT A 203 227 GLU D 53 GLU^? 10.32 O ACT A 203 289 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 3.96 55.76 41.24 4.83 57.69 41.17 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 99 3 # 99 179 ASP D 130 ASP.? 7.40 CH3 ACT A 203 227 GLU D 53 GLU^? 10.32 O ACT A 203 289 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 3.96 55.76 41.24 4.83 57.69 41.17 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 9.42 68.07 30.27 7.35 68.27 30.10 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 100 3 # 100 179 ASP D 130 ASP.? 7.40 CH3 ACT A 203 227 GLU D 137 GLU~? 19.20 CH3 ACT A 203 289 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 101 3 # 101 179 ASP D 130 ASP.? 7.40 CH3 ACT A 203 227 GLU D 137 GLU~? 19.20 CH3 ACT A 203 289 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 102 3 # 102 179 ASP D 149 ASP.? 20.02 CH3 ACT D 201 227 GLU D 17 GLU~? 23.59 CH3 ACT D 201 289 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo -0.62 65.95 29.97 0.31 67.47 31.05 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 3.96 55.76 41.24 4.83 57.69 41.17 -50.49 54.35 20.83 -50.89 54.35 18.75 coo 9.42 68.07 30.27 7.35 68.27 30.10 -55.65 65.73 30.36 -54.18 65.67 28.83 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 102 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 99 ASP.? 5.71 O2 EDO A 301 E 36 SER A 101 SER.? 7.80 O2 EDO A 301 E 213 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 26.30 12.96 16.78 25.46 12.99 18.72 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 28.33 15.15 21.27 28.70 13.12 19.97 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 20.15 16.04 19.79 21.65 14.49 19.86 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 3 # 2 E 33 ASP B 99 ASP.? 16.09 OXT ACT B 201 E 36 SER B 101 SER.? 19.25 O ACT C 201 E 213 ASP C 74 ASP^? 14.86 O ACT C 201 coo 26.30 12.96 16.78 25.46 12.99 18.72 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 28.33 15.15 21.27 28.70 13.12 19.97 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 20.15 16.04 19.79 21.65 14.49 19.86 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 3 3 # 3 E 33 ASP C 99 ASP.? 5.79 O1 EDO A 301 E 36 SER C 101 SER.? 7.85 O1 EDO A 301 E 213 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 26.30 12.96 16.78 25.46 12.99 18.72 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 28.33 15.15 21.27 28.70 13.12 19.97 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 20.15 16.04 19.79 21.65 14.49 19.86 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 4 3 # 4 E 33 ASP D 99 ASP.? 7.94 CH3 ACT A 203 E 36 SER D 101 SER.? 9.16 OXT ACT A 203 E 213 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 26.30 12.96 16.78 25.46 12.99 18.72 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 28.33 15.15 21.27 28.70 13.12 19.97 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 20.15 16.04 19.79 21.65 14.49 19.86 -44.71 72.29 58.72 -45.62 72.95 56.93 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 4 hits 1apt_c04 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS A 98 HIS^? -3.60 C ACT A 203s 254 LYS A 71 LYS~? 4.32 C2 EDO A 301 333 ARG A 33 ARG.? 12.39 O ACT A 201 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 26.09 4.87 14.60 27.89 3.33 10.26 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 37.35 7.47 11.84 34.90 6.11 10.60 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 2 3 # 2 232 HIS A 98 HIS^? -3.60 C ACT A 203s 254 LYS A 134 LYS~? 11.98 O ACT A 203 333 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 26.09 4.87 14.60 27.89 3.33 10.26 -53.24 65.33 66.31 -57.37 62.85 65.73 coo 37.35 7.47 11.84 34.90 6.11 10.60 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 3 3 # 3 232 HIS B 98 HIS^? 14.98 OXT ACT B 201 254 LYS B 71 LYS~? 10.83 OXT ACT B 201 333 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 26.09 4.87 14.60 27.89 3.33 10.26 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 37.35 7.47 11.84 34.90 6.11 10.60 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 4 3 # 4 232 HIS C 98 HIS^? 11.61 O2 EDO A 301 254 LYS C 71 LYS~? 4.19 C1 EDO A 301 333 ARG C 33 ARG.? 12.41 O ACT C 201 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 26.09 4.87 14.60 27.89 3.33 10.26 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 37.35 7.47 11.84 34.90 6.11 10.60 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 5 3 # 5 232 HIS C 98 HIS^? 11.61 O2 EDO A 301 254 LYS C 134 LYS~? 17.33 O2 EDO A 301 333 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 26.09 4.87 14.60 27.89 3.33 10.26 -51.34 49.79 67.51 -53.85 50.99 71.42 coo 37.35 7.47 11.84 34.90 6.11 10.60 -49.78 47.48 57.01 -51.73 47.13 59.31 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 5 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 107 SER^? 6.74 O1 EDO A 301 A 292 ASP C 74 ASP^? 14.86 O ACT C 201 A 322 HIS A 141 HIS.? 11.20 OXT ACT A 203 coo 36.34 32.23 39.60 36.43 34.62 39.93 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 19.73 19.18 41.39 21.50 18.65 40.34 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 41.69 45.14 46.60 41.78 47.19 46.18 -49.96 77.41 66.16 -51.01 75.70 66.78 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER C 107 SER^? 6.74 O2 EDO A 301 A 292 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 322 HIS C 141 HIS.? 17.85 O ACT C 201 coo 36.34 32.23 39.60 36.43 34.62 39.93 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 19.73 19.18 41.39 21.50 18.65 40.34 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 41.69 45.14 46.60 41.78 47.19 46.18 -47.33 38.55 64.23 -48.23 40.22 65.13 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 2 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 32 SER.? 11.27 CH3 ACT A 201 B 292 ASP A 116 ASP.? 19.55 CH3 ACT A 201 B 322 HIS A 98 HIS^? -3.60 C ACT A 203s coo 35.42 71.28 22.94 36.24 69.06 22.37 -34.08 78.47 59.42 -31.66 78.25 59.14 coo 24.74 78.07 5.59 24.32 79.03 7.46 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 48.81 64.16 26.34 49.30 62.16 26.73 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 107 SER^? 6.74 O1 EDO A 301 B 292 ASP C 74 ASP^? 14.86 O ACT C 201 B 322 HIS A 141 HIS.? 11.20 OXT ACT A 203 coo 35.42 71.28 22.94 36.24 69.06 22.37 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 24.74 78.07 5.59 24.32 79.03 7.46 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 48.81 64.16 26.34 49.30 62.16 26.73 -49.96 77.41 66.16 -51.01 75.70 66.78 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 107 SER^? 7.39 OXT ACT B 201 B 292 ASP B 150 ASP.? 20.21 CH3 ACT A 202 B 322 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 24.74 78.07 5.59 24.32 79.03 7.46 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 48.81 64.16 26.34 49.30 62.16 26.73 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER C 32 SER.? 11.23 CH3 ACT C 201 B 292 ASP C 116 ASP.? 19.40 CH3 ACT C 201 B 322 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 -32.31 40.22 56.18 -30.64 40.82 54.50 coo 24.74 78.07 5.59 24.32 79.03 7.46 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 48.81 64.16 26.34 49.30 62.16 26.73 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER C 107 SER^? 6.74 O2 EDO A 301 B 292 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 322 HIS C 141 HIS.? 17.85 O ACT C 201 coo 35.42 71.28 22.94 36.24 69.06 22.37 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 24.74 78.07 5.59 24.32 79.03 7.46 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 48.81 64.16 26.34 49.30 62.16 26.73 -47.33 38.55 64.23 -48.23 40.22 65.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER C 107 SER^? 6.74 O2 EDO A 301 B 292 ASP B 100 ASP.? 15.93 OXT ACT B 201 B 322 HIS A 98 HIS^? -3.60 C ACT A 203s coo 35.42 71.28 22.94 36.24 69.06 22.37 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 24.74 78.07 5.59 24.32 79.03 7.46 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 48.81 64.16 26.34 49.30 62.16 26.73 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER D 107 SER^? 7.30 OXT ACT D 201 B 292 ASP D 150 ASP.? 21.68 CH3 ACT D 201 B 322 HIS A 98 HIS^? -3.60 C ACT A 203s coo 35.42 71.28 22.94 36.24 69.06 22.37 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 24.74 78.07 5.59 24.32 79.03 7.46 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 48.81 64.16 26.34 49.30 62.16 26.73 -46.65 67.75 58.52 -46.50 68.86 56.74 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 7 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 8 ARG.? 15.23 CH3 ACT A 201 B 342 ASP A 28 ASP~? 12.70 CH3 ACT A 201 B 531 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 8 ARG.? 15.23 CH3 ACT A 201 B 342 ASP A 34 ASP~? 14.63 O ACT A 201 B 531 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG A 8 ARG.? 15.23 CH3 ACT A 201 B 342 ASP A 116 ASP.? 19.55 CH3 ACT A 201 B 531 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG A 49 ARG^? -3.92 O ACT A 202s B 342 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 531 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG A 49 ARG^? -3.92 O ACT A 202s B 342 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 531 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 B 325 ARG A 51 ARG.? 6.25 O1 EDO A 301 B 342 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 531 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 B 325 ARG A 51 ARG.? 6.25 O1 EDO A 301 B 342 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 531 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 B 325 ARG A 51 ARG.? 6.25 O1 EDO A 301 B 342 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 531 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 B 325 ARG A 58 ARG~? 18.13 CH3 ACT A 201 B 342 ASP A 34 ASP~? 14.63 O ACT A 201 B 531 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 B 325 ARG A 58 ARG~? 18.13 CH3 ACT A 201 B 342 ASP A 116 ASP.? 19.55 CH3 ACT A 201 B 531 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 B 325 ARG A 106 ARG^? 14.48 O1 EDO A 301 B 342 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 531 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 12 3 # 12 B 325 ARG A 123 ARG.? 8.27 CH3 ACT A 202 B 342 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 531 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 13 3 # 13 B 325 ARG A 123 ARG.? 8.27 CH3 ACT A 202 B 342 ASP A 116 ASP.? 19.55 CH3 ACT A 201 B 531 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 14 3 # 14 B 325 ARG A 138 ARG~? 6.49 OXT ACT A 203 B 342 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 531 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 15 3 # 15 B 325 ARG A 146 ARG.? 16.48 CH3 ACT A 201 B 342 ASP A 34 ASP~? 14.63 O ACT A 201 B 531 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 16 3 # 16 B 325 ARG A 146 ARG.? 16.48 CH3 ACT A 201 B 342 ASP A 150 ASP.? 22.07 CH3 ACT A 201 B 531 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 17 3 # 17 B 325 ARG B 8 ARG.? 14.49 CH3 ACT B 201 B 342 ASP B 28 ASP~? 12.70 CH3 ACT B 201 B 531 ARG B 124 ARG.? -3.52 O ACT B 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 18 3 # 18 B 325 ARG B 8 ARG.? 14.49 CH3 ACT B 201 B 342 ASP B 34 ASP~? 14.61 OXT ACT B 201 B 531 ARG B 124 ARG.? -3.52 O ACT B 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 19 3 # 19 B 325 ARG B 8 ARG.? 14.49 CH3 ACT B 201 B 342 ASP B 116 ASP.? 19.49 CH3 ACT B 201 B 531 ARG B 58 ARG~? 17.86 CH3 ACT B 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -41.40 56.24 95.43 -40.17 57.59 97.88 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 20 3 # 20 B 325 ARG B 8 ARG.? 14.49 CH3 ACT B 201 B 342 ASP B 116 ASP.? 19.49 CH3 ACT B 201 B 531 ARG B 124 ARG.? -3.52 O ACT B 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 21 3 # 21 B 325 ARG B 51 ARG.? 7.67 O ACT B 201 B 342 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 531 ARG B 67 ARG~? 13.55 O ACT B 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -45.57 49.20 81.23 -45.93 51.82 82.79 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 22 3 # 22 B 325 ARG B 58 ARG~? 17.86 CH3 ACT B 201 B 342 ASP B 34 ASP~? 14.61 OXT ACT B 201 B 531 ARG B 8 ARG.? 14.49 CH3 ACT B 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -31.04 58.38 97.06 -32.26 55.57 97.13 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 23 3 # 23 B 325 ARG B 58 ARG~? 17.86 CH3 ACT B 201 B 342 ASP B 34 ASP~? 14.61 OXT ACT B 201 B 531 ARG B 124 ARG.? -3.52 O ACT B 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 24 3 # 24 B 325 ARG B 58 ARG~? 17.86 CH3 ACT B 201 B 342 ASP B 116 ASP.? 19.49 CH3 ACT B 201 B 531 ARG B 124 ARG.? -3.52 O ACT B 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 25 3 # 25 B 325 ARG B 106 ARG^? 5.91 C1 EDO A 302 B 342 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 531 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 26 3 # 26 B 325 ARG B 123 ARG.? 17.76 O ACT B 201 B 342 ASP B 45 ASP^? 20.35 O ACT B 201 B 531 ARG B 124 ARG.? -3.52 O ACT B 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 27 3 # 27 B 325 ARG B 138 ARG~? 16.35 OXT ACT B 201 B 342 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 531 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 28 3 # 28 B 325 ARG B 146 ARG.? 16.58 CH3 ACT B 201 B 342 ASP B 34 ASP~? 14.61 OXT ACT B 201 B 531 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 29 3 # 29 B 325 ARG B 146 ARG.? 16.58 CH3 ACT B 201 B 342 ASP B 150 ASP.? 20.21 CH3 ACT A 202 B 531 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 30 3 # 30 B 325 ARG C 8 ARG.? 14.74 CH3 ACT C 201 B 342 ASP C 116 ASP.? 19.40 CH3 ACT C 201 B 531 ARG C 58 ARG~? 18.03 CH3 ACT C 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -22.97 47.67 45.60 -22.11 45.78 43.37 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 31 3 # 31 B 325 ARG C 49 ARG^? 10.47 OXT ACT C 201 B 342 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 531 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 32 3 # 32 B 325 ARG C 49 ARG^? 10.47 OXT ACT C 201 B 342 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 531 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 33 3 # 33 B 325 ARG C 51 ARG.? 6.22 O2 EDO A 301 B 342 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 531 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 34 3 # 34 B 325 ARG C 51 ARG.? 6.22 O2 EDO A 301 B 342 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 531 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 35 3 # 35 B 325 ARG C 51 ARG.? 6.22 O2 EDO A 301 B 342 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 531 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 36 3 # 36 B 325 ARG C 58 ARG~? 18.03 CH3 ACT C 201 B 342 ASP C 34 ASP~? 14.66 O ACT C 201 B 531 ARG C 8 ARG.? 14.74 CH3 ACT C 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -27.18 40.10 42.21 -27.55 39.63 45.22 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 37 3 # 37 B 325 ARG C 58 ARG~? 18.03 CH3 ACT C 201 B 342 ASP C 34 ASP~? 14.66 O ACT C 201 B 531 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 38 3 # 38 B 325 ARG C 58 ARG~? 18.03 CH3 ACT C 201 B 342 ASP C 116 ASP.? 19.40 CH3 ACT C 201 B 531 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 39 3 # 39 B 325 ARG C 106 ARG^? 14.47 O2 EDO A 301 B 342 ASP C 74 ASP^? 14.86 O ACT C 201 B 531 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 40 3 # 40 B 325 ARG C 123 ARG.? 17.68 OXT ACT C 201 B 342 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 531 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 41 3 # 41 B 325 ARG C 138 ARG~? 16.31 O ACT C 201 B 342 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 531 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 42 3 # 42 B 325 ARG C 146 ARG.? 16.63 CH3 ACT C 201 B 342 ASP C 34 ASP~? 14.66 O ACT C 201 B 531 ARG C 76 ARG^? 14.32 O ACT C 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -36.58 32.85 52.68 -38.87 31.31 51.32 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 43 3 # 43 B 325 ARG C 146 ARG.? 16.63 CH3 ACT C 201 B 342 ASP C 150 ASP.? 20.99 CH3 ACT C 201 B 531 ARG C 76 ARG^? 14.32 O ACT C 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -36.58 32.85 52.68 -38.87 31.31 51.32 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 44 3 # 44 B 325 ARG D 51 ARG.? 7.60 O ACT D 201 B 342 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 531 ARG D 67 ARG~? 13.15 O ACT A 203 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -60.60 65.68 53.30 -61.45 62.86 52.44 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 45 3 # 45 B 325 ARG D 58 ARG~? 18.01 CH3 ACT D 201 B 342 ASP D 34 ASP~? 14.62 OXT ACT D 201 B 531 ARG D 124 ARG.? -3.55 O ACT D 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 46 3 # 46 B 325 ARG D 58 ARG~? 18.01 CH3 ACT D 201 B 342 ASP D 116 ASP.? 19.52 CH3 ACT D 201 B 531 ARG D 124 ARG.? -3.55 O ACT D 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 47 3 # 47 B 325 ARG D 106 ARG^? 14.88 OXT ACT D 201 B 342 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 531 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 48 3 # 48 B 325 ARG D 123 ARG.? 17.60 O ACT D 201 B 342 ASP D 45 ASP^? 20.33 O ACT D 201 B 531 ARG D 124 ARG.? -3.55 O ACT D 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 49 3 # 49 B 325 ARG D 123 ARG.? 17.60 O ACT D 201 B 342 ASP D 116 ASP.? 19.52 CH3 ACT D 201 B 531 ARG D 124 ARG.? -3.55 O ACT D 201s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 50 3 # 50 B 325 ARG D 138 ARG~? 16.38 OXT ACT D 201 B 342 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 531 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -40.22 67.90 41.60 -38.15 70.12 41.98 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 51 3 # 51 B 325 ARG D 146 ARG.? 16.60 CH3 ACT D 201 B 342 ASP D 34 ASP~? 14.62 OXT ACT D 201 B 531 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 52 3 # 52 B 325 ARG D 146 ARG.? 16.60 CH3 ACT D 201 B 342 ASP D 150 ASP.? 21.68 CH3 ACT D 201 B 531 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -47.81 74.29 36.53 -48.87 77.02 37.43 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 52 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 8 ARG.? 15.23 CH3 ACT A 201 A 342 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 531 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG A 8 ARG.? 15.23 CH3 ACT A 201 A 342 ASP A 34 ASP~? 14.63 O ACT A 201 A 531 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG A 8 ARG.? 15.23 CH3 ACT A 201 A 342 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 531 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG A 49 ARG^? -3.92 O ACT A 202s A 342 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 531 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 A 325 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 342 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 531 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 A 325 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 342 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 531 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 A 325 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 342 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 531 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 A 325 ARG A 58 ARG~? 18.13 CH3 ACT A 201 A 342 ASP A 34 ASP~? 14.63 O ACT A 201 A 531 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 A 325 ARG A 58 ARG~? 18.13 CH3 ACT A 201 A 342 ASP A 116 ASP.? 19.55 CH3 ACT A 201 A 531 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 A 325 ARG A 67 ARG~? 13.20 O2 EDO A 302 A 342 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 531 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 A 325 ARG A 67 ARG~? 13.20 O2 EDO A 302 A 342 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 531 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 12 3 # 12 A 325 ARG A 88 ARG^? 11.13 CH3 ACT A 202 A 342 ASP A 116 ASP.? 19.55 CH3 ACT A 201 A 531 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 13 3 # 13 A 325 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 342 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 531 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 14 3 # 14 A 325 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 342 ASP A 34 ASP~? 14.63 O ACT A 201 A 531 ARG A 8 ARG.? 15.23 CH3 ACT A 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -20.16 79.98 64.14 -22.57 80.76 62.41 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 15 3 # 15 A 325 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 342 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 531 ARG A 8 ARG.? 15.23 CH3 ACT A 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -20.16 79.98 64.14 -22.57 80.76 62.41 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 16 3 # 16 A 325 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 342 ASP A 116 ASP.? 19.55 CH3 ACT A 201 A 531 ARG A 58 ARG~? 18.13 CH3 ACT A 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -18.95 73.08 58.27 -17.11 75.32 59.26 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 17 3 # 17 A 325 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 342 ASP A 116 ASP.? 19.55 CH3 ACT A 201 A 531 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 18 3 # 18 A 325 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 342 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 531 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 19 3 # 19 A 325 ARG A 146 ARG.? 16.48 CH3 ACT A 201 A 342 ASP A 34 ASP~? 14.63 O ACT A 201 A 531 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 20 3 # 20 A 325 ARG A 146 ARG.? 16.48 CH3 ACT A 201 A 342 ASP A 150 ASP.? 22.07 CH3 ACT A 201 A 531 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 21 3 # 21 A 325 ARG A 147 ARG.? 13.06 CH3 ACT A 201 A 342 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 531 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 22 3 # 22 A 325 ARG B 8 ARG.? 14.49 CH3 ACT B 201 A 342 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 531 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -20.35 54.64 90.03 -19.09 51.96 89.19 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 23 3 # 23 A 325 ARG B 8 ARG.? 14.49 CH3 ACT B 201 A 342 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 531 ARG B 124 ARG.? -3.52 O ACT B 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 24 3 # 24 A 325 ARG B 8 ARG.? 14.49 CH3 ACT B 201 A 342 ASP B 116 ASP.? 19.49 CH3 ACT B 201 A 531 ARG B 58 ARG~? 17.86 CH3 ACT B 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -41.40 56.24 95.43 -40.17 57.59 97.88 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 25 3 # 25 A 325 ARG B 8 ARG.? 14.49 CH3 ACT B 201 A 342 ASP B 116 ASP.? 19.49 CH3 ACT B 201 A 531 ARG B 124 ARG.? -3.52 O ACT B 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 26 3 # 26 A 325 ARG B 16 ARG~? 17.22 CH3 ACT A 202 A 342 ASP B 86 ASP.? 24.07 CH3 ACT B 201 A 531 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -15.28 68.46 88.00 -14.07 65.73 87.25 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 27 3 # 27 A 325 ARG B 51 ARG.? 7.67 O ACT B 201 A 342 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 531 ARG B 67 ARG~? 13.55 O ACT B 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -45.57 49.20 81.23 -45.93 51.82 82.79 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 28 3 # 28 A 325 ARG B 51 ARG.? 7.67 O ACT B 201 A 342 ASP C 74 ASP^? 14.86 O ACT C 201 A 531 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 29 3 # 29 A 325 ARG B 58 ARG~? 17.86 CH3 ACT B 201 A 342 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 531 ARG B 8 ARG.? 14.49 CH3 ACT B 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -31.04 58.38 97.06 -32.26 55.57 97.13 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 30 3 # 30 A 325 ARG B 58 ARG~? 17.86 CH3 ACT B 201 A 342 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 531 ARG B 124 ARG.? -3.52 O ACT B 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 31 3 # 31 A 325 ARG B 58 ARG~? 17.86 CH3 ACT B 201 A 342 ASP B 116 ASP.? 19.49 CH3 ACT B 201 A 531 ARG B 124 ARG.? -3.52 O ACT B 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 32 3 # 32 A 325 ARG B 67 ARG~? 13.55 O ACT B 201 A 342 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 531 ARG B 51 ARG.? 7.67 O ACT B 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -45.57 49.20 81.23 -45.93 51.82 82.79 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 33 3 # 33 A 325 ARG B 67 ARG~? 13.55 O ACT B 201 A 342 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 531 ARG B 51 ARG.? 7.67 O ACT B 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -45.57 49.20 81.23 -45.93 51.82 82.79 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 34 3 # 34 A 325 ARG B 88 ARG^? 18.43 CH3 ACT A 201 A 342 ASP B 116 ASP.? 19.49 CH3 ACT B 201 A 531 ARG B 124 ARG.? -3.52 O ACT B 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 35 3 # 35 A 325 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 342 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 531 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 36 3 # 36 A 325 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 342 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 531 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 37 3 # 37 A 325 ARG B 124 ARG.? -3.52 O ACT B 201s A 342 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 531 ARG B 8 ARG.? 14.49 CH3 ACT B 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -31.04 58.38 97.06 -32.26 55.57 97.13 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 38 3 # 38 A 325 ARG B 124 ARG.? -3.52 O ACT B 201s A 342 ASP B 45 ASP^? 20.35 O ACT B 201 A 531 ARG B 8 ARG.? 14.49 CH3 ACT B 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -31.04 58.38 97.06 -32.26 55.57 97.13 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 39 3 # 39 A 325 ARG B 124 ARG.? -3.52 O ACT B 201s A 342 ASP B 116 ASP.? 19.49 CH3 ACT B 201 A 531 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 40 3 # 40 A 325 ARG B 124 ARG.? -3.52 O ACT B 201s A 342 ASP B 116 ASP.? 19.49 CH3 ACT B 201 A 531 ARG B 58 ARG~? 17.86 CH3 ACT B 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -41.40 56.24 95.43 -40.17 57.59 97.88 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 41 3 # 41 A 325 ARG B 138 ARG~? 16.35 OXT ACT B 201 A 342 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 531 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 42 3 # 42 A 325 ARG B 146 ARG.? 16.58 CH3 ACT B 201 A 342 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 531 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 43 3 # 43 A 325 ARG B 146 ARG.? 16.58 CH3 ACT B 201 A 342 ASP B 150 ASP.? 20.21 CH3 ACT A 202 A 531 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 44 3 # 44 A 325 ARG B 147 ARG.? 12.52 CH3 ACT A 202 A 342 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 531 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 45 3 # 45 A 325 ARG C 8 ARG.? 14.74 CH3 ACT C 201 A 342 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 531 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 46 3 # 46 A 325 ARG C 8 ARG.? 14.74 CH3 ACT C 201 A 342 ASP C 34 ASP~? 14.66 O ACT C 201 A 531 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 47 3 # 47 A 325 ARG C 8 ARG.? 14.74 CH3 ACT C 201 A 342 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 531 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 48 3 # 48 A 325 ARG C 33 ARG.? 12.41 O ACT C 201 A 342 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 531 ARG C 138 ARG~? 16.31 O ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 49 3 # 49 A 325 ARG C 33 ARG.? 12.41 O ACT C 201 A 342 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 531 ARG C 138 ARG~? 16.31 O ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 50 3 # 50 A 325 ARG C 33 ARG.? 12.41 O ACT C 201 A 342 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 531 ARG C 138 ARG~? 16.31 O ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 51 3 # 51 A 325 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 342 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 531 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 52 3 # 52 A 325 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 342 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 531 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 53 3 # 53 A 325 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 342 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 531 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 54 3 # 54 A 325 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 342 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 531 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 55 3 # 55 A 325 ARG C 58 ARG~? 18.03 CH3 ACT C 201 A 342 ASP C 34 ASP~? 14.66 O ACT C 201 A 531 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 56 3 # 56 A 325 ARG C 58 ARG~? 18.03 CH3 ACT C 201 A 342 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 531 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 57 3 # 57 A 325 ARG C 67 ARG~? 12.50 O2 EDO A 302 A 342 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 531 ARG A 49 ARG^? -3.92 O ACT A 202s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 58 3 # 58 A 325 ARG C 67 ARG~? 12.50 O2 EDO A 302 A 342 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 531 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 59 3 # 59 A 325 ARG C 88 ARG^? 18.42 CH3 ACT D 201 A 342 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 531 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 60 3 # 60 A 325 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 342 ASP C 74 ASP^? 14.86 O ACT C 201 A 531 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 61 3 # 61 A 325 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 342 ASP C 34 ASP~? 14.66 O ACT C 201 A 531 ARG C 8 ARG.? 14.74 CH3 ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -27.18 40.10 42.21 -27.55 39.63 45.22 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 62 3 # 62 A 325 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 342 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 531 ARG C 8 ARG.? 14.74 CH3 ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -27.18 40.10 42.21 -27.55 39.63 45.22 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 63 3 # 63 A 325 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 342 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 531 ARG C 58 ARG~? 18.03 CH3 ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -22.97 47.67 45.60 -22.11 45.78 43.37 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 64 3 # 64 A 325 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 342 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 531 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 65 3 # 65 A 325 ARG C 138 ARG~? 16.31 O ACT C 201 A 342 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 531 ARG C 33 ARG.? 12.41 O ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 66 3 # 66 A 325 ARG C 138 ARG~? 16.31 O ACT C 201 A 342 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 531 ARG C 33 ARG.? 12.41 O ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 67 3 # 67 A 325 ARG C 138 ARG~? 16.31 O ACT C 201 A 342 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 531 ARG C 33 ARG.? 12.41 O ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 68 3 # 68 A 325 ARG C 138 ARG~? 16.31 O ACT C 201 A 342 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 531 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 69 3 # 69 A 325 ARG C 138 ARG~? 16.31 O ACT C 201 A 342 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 531 ARG C 33 ARG.? 12.41 O ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 70 3 # 70 A 325 ARG C 146 ARG.? 16.63 CH3 ACT C 201 A 342 ASP C 34 ASP~? 14.66 O ACT C 201 A 531 ARG C 76 ARG^? 14.32 O ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -36.58 32.85 52.68 -38.87 31.31 51.32 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 71 3 # 71 A 325 ARG C 146 ARG.? 16.63 CH3 ACT C 201 A 342 ASP C 150 ASP.? 20.99 CH3 ACT C 201 A 531 ARG C 76 ARG^? 14.32 O ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -36.58 32.85 52.68 -38.87 31.31 51.32 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 72 3 # 72 A 325 ARG C 147 ARG.? 13.23 CH3 ACT C 201 A 342 ASP C 74 ASP^? 14.86 O ACT C 201 A 531 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 73 3 # 73 A 325 ARG D 8 ARG.? 14.56 CH3 ACT D 201 A 342 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 531 ARG D 124 ARG.? -3.55 O ACT D 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 74 3 # 74 A 325 ARG D 8 ARG.? 14.56 CH3 ACT D 201 A 342 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 531 ARG D 124 ARG.? -3.55 O ACT D 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 75 3 # 75 A 325 ARG D 8 ARG.? 14.56 CH3 ACT D 201 A 342 ASP D 45 ASP^? 20.33 O ACT D 201 A 531 ARG D 124 ARG.? -3.55 O ACT D 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 76 3 # 76 A 325 ARG D 51 ARG.? 7.60 O ACT D 201 A 342 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 531 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 77 3 # 77 A 325 ARG D 51 ARG.? 7.60 O ACT D 201 A 342 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 531 ARG D 67 ARG~? 13.15 O ACT A 203 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -60.60 65.68 53.30 -61.45 62.86 52.44 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 78 3 # 78 A 325 ARG D 58 ARG~? 18.01 CH3 ACT D 201 A 342 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 531 ARG D 124 ARG.? -3.55 O ACT D 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 79 3 # 79 A 325 ARG D 58 ARG~? 18.01 CH3 ACT D 201 A 342 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 531 ARG D 124 ARG.? -3.55 O ACT D 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 80 3 # 80 A 325 ARG D 67 ARG~? 13.15 O ACT A 203 A 342 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 531 ARG D 51 ARG.? 7.60 O ACT D 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -60.60 65.68 53.30 -61.45 62.86 52.44 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 81 3 # 81 A 325 ARG D 88 ARG^? 18.35 CH3 ACT C 201 A 342 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 531 ARG D 124 ARG.? -3.55 O ACT D 201s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 82 3 # 82 A 325 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 342 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 531 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 83 3 # 83 A 325 ARG D 124 ARG.? -3.55 O ACT D 201s A 342 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 531 ARG D 8 ARG.? 14.56 CH3 ACT D 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -64.40 57.42 32.12 -63.44 60.33 32.35 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 84 3 # 84 A 325 ARG D 124 ARG.? -3.55 O ACT D 201s A 342 ASP D 45 ASP^? 20.33 O ACT D 201 A 531 ARG D 8 ARG.? 14.56 CH3 ACT D 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -64.40 57.42 32.12 -63.44 60.33 32.35 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 85 3 # 85 A 325 ARG D 124 ARG.? -3.55 O ACT D 201s A 342 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 531 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 86 3 # 86 A 325 ARG D 124 ARG.? -3.55 O ACT D 201s A 342 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 531 ARG D 58 ARG~? 18.01 CH3 ACT D 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -67.82 58.42 40.52 -68.76 57.03 37.97 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 87 3 # 87 A 325 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 342 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 531 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -40.22 67.90 41.60 -38.15 70.12 41.98 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 88 3 # 88 A 325 ARG D 146 ARG.? 16.60 CH3 ACT D 201 A 342 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 531 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 89 3 # 89 A 325 ARG D 146 ARG.? 16.60 CH3 ACT D 201 A 342 ASP D 150 ASP.? 21.68 CH3 ACT D 201 A 531 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 90 3 # 90 A 325 ARG D 147 ARG.? 13.02 CH3 ACT D 201 A 342 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 531 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -40.22 67.90 41.60 -38.15 70.12 41.98 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 90 hits 1asy_c01 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 35 SER A 101 SER.? 7.80 O2 EDO A 301 A 217 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -48.36 60.96 55.15 -47.04 58.94 54.93 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 35 SER B 101 SER.? 19.25 O ACT C 201 A 217 ASP C 74 ASP^? 14.86 O ACT C 201 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -36.32 37.86 70.76 -37.96 39.10 69.46 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1avf_c04 GASTRICSIN user 3 3 # 3 A 32 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 35 SER C 101 SER.? 7.85 O1 EDO A 301 A 217 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -40.26 55.74 71.04 -39.54 57.94 70.33 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1avf_c04 GASTRICSIN user 4 3 # 4 A 32 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 35 SER D 101 SER.? 9.16 OXT ACT A 203 A 217 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -48.40 79.65 53.68 -48.43 78.54 55.84 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -44.71 72.29 58.72 -45.62 72.95 56.93 1avf_c04 source 1avf GASTRICSIN : 4 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 99 ASP.? 5.71 O2 EDO A 301 J 35 SER A 101 SER.? 7.80 O2 EDO A 301 J 217 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -48.36 60.96 55.15 -47.04 58.94 54.93 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP B 99 ASP.? 16.09 OXT ACT B 201 J 35 SER B 101 SER.? 19.25 O ACT C 201 J 217 ASP C 74 ASP^? 14.86 O ACT C 201 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -36.32 37.86 70.76 -37.96 39.10 69.46 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1avf_c05 GASTRICSIN user 3 3 # 3 J 32 ASP C 99 ASP.? 5.79 O1 EDO A 301 J 35 SER C 101 SER.? 7.85 O1 EDO A 301 J 217 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -40.26 55.74 71.04 -39.54 57.94 70.33 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1avf_c05 GASTRICSIN user 4 3 # 4 J 32 ASP D 99 ASP.? 7.94 CH3 ACT A 203 J 35 SER D 101 SER.? 9.16 OXT ACT A 203 J 217 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -48.40 79.65 53.68 -48.43 78.54 55.84 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -44.71 72.29 58.72 -45.62 72.95 56.93 1avf_c05 source 1avf GASTRICSIN : 4 hits 1avf_c05 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 84 PHE^? 19.84 CH3 ACT A 201 A 223 ASP B 86 ASP.? 24.07 CH3 ACT B 201 A 265 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 39.74 52.86 65.74 41.15 55.14 66.52 -24.05 77.11 82.23 -23.91 79.14 84.16 coo 30.70 47.50 67.53 29.83 49.47 67.39 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 19.99 54.53 64.11 20.55 58.78 68.33 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 265 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 39.74 52.86 65.74 41.15 55.14 66.52 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 19.99 54.53 64.11 20.55 58.78 68.33 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 223 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 265 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 39.74 52.86 65.74 41.15 55.14 66.52 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 19.99 54.53 64.11 20.55 58.78 68.33 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 223 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 265 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 39.74 52.86 65.74 41.15 55.14 66.52 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 19.99 54.53 64.11 20.55 58.78 68.33 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE A 140 PHE.? 11.31 O ACT A 201 A 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 265 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 39.74 52.86 65.74 41.15 55.14 66.52 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 19.99 54.53 64.11 20.55 58.78 68.33 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE B 84 PHE^? 19.62 CH3 ACT A 202 A 223 ASP A 86 ASP.? 20.24 CH3 ACT A 202 A 265 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 39.74 52.86 65.74 41.15 55.14 66.52 -22.29 70.30 88.22 -19.89 71.38 89.16 coo 30.70 47.50 67.53 29.83 49.47 67.39 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 19.99 54.53 64.11 20.55 58.78 68.33 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 223 ASP C 74 ASP^? 14.86 O ACT C 201 A 265 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 30.70 47.50 67.53 29.83 49.47 67.39 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 19.99 54.53 64.11 20.55 58.78 68.33 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 223 ASP C 74 ASP^? 14.86 O ACT C 201 A 265 LYS C 139 LYS.? 18.79 O ACT C 201 coo 39.74 52.86 65.74 41.15 55.14 66.52 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 30.70 47.50 67.53 29.83 49.47 67.39 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 19.99 54.53 64.11 20.55 58.78 68.33 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 223 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 265 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 30.70 47.50 67.53 29.83 49.47 67.39 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 19.99 54.53 64.11 20.55 58.78 68.33 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ax4_c04 TRYPTOPHANASE user 10 3 # 10 A 130 PHE C 84 PHE^? 19.83 CH3 ACT C 201 A 223 ASP D 86 ASP.? 24.19 CH3 ACT D 201 A 265 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 39.74 52.86 65.74 41.15 55.14 66.52 -43.84 41.52 34.02 -45.03 39.44 32.58 coo 30.70 47.50 67.53 29.83 49.47 67.39 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 19.99 54.53 64.11 20.55 58.78 68.33 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1ax4_c04 TRYPTOPHANASE user 11 3 # 11 A 130 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 223 ASP C 74 ASP^? 14.86 O ACT C 201 A 265 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 39.74 52.86 65.74 41.15 55.14 66.52 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 30.70 47.50 67.53 29.83 49.47 67.39 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 19.99 54.53 64.11 20.55 58.78 68.33 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ax4_c04 TRYPTOPHANASE user 12 3 # 12 A 130 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 223 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 265 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 39.74 52.86 65.74 41.15 55.14 66.52 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 30.70 47.50 67.53 29.83 49.47 67.39 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 19.99 54.53 64.11 20.55 58.78 68.33 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ax4_c04 TRYPTOPHANASE user 13 3 # 13 A 130 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 223 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 265 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 39.74 52.86 65.74 41.15 55.14 66.52 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 30.70 47.50 67.53 29.83 49.47 67.39 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 19.99 54.53 64.11 20.55 58.78 68.33 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ax4_c04 TRYPTOPHANASE user 14 3 # 14 A 130 PHE C 140 PHE.? 11.33 O ACT C 201 A 223 ASP C 74 ASP^? 14.86 O ACT C 201 A 265 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 39.74 52.86 65.74 41.15 55.14 66.52 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 30.70 47.50 67.53 29.83 49.47 67.39 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 19.99 54.53 64.11 20.55 58.78 68.33 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ax4_c04 TRYPTOPHANASE user 15 3 # 15 A 130 PHE D 84 PHE^? 19.80 CH3 ACT D 201 A 223 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 265 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 39.74 52.86 65.74 41.15 55.14 66.52 -48.20 48.22 29.39 -47.23 47.53 26.85 coo 30.70 47.50 67.53 29.83 49.47 67.39 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 19.99 54.53 64.11 20.55 58.78 68.33 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1ax4_c04 TRYPTOPHANASE user 16 3 # 16 A 130 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 265 LYS A 134 LYS~? 11.98 O ACT A 203 coo 39.74 52.86 65.74 41.15 55.14 66.52 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 19.99 54.53 64.11 20.55 58.78 68.33 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1ax4_c04 TRYPTOPHANASE user 17 3 # 17 A 130 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 265 LYS A 139 LYS.? 17.81 O ACT A 201 coo 39.74 52.86 65.74 41.15 55.14 66.52 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 19.99 54.53 64.11 20.55 58.78 68.33 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1ax4_c04 TRYPTOPHANASE user 18 3 # 18 A 130 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 223 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 265 LYS A 134 LYS~? 11.98 O ACT A 203 coo 39.74 52.86 65.74 41.15 55.14 66.52 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 19.99 54.53 64.11 20.55 58.78 68.33 -53.24 65.33 66.31 -57.37 62.85 65.73 1ax4_c04 source 1ax4 TRYPTOPHANASE : 18 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 84 PHE^? 19.84 CH3 ACT A 201 B 223 ASP B 86 ASP.? 24.07 CH3 ACT B 201 B 265 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 7.48 54.94 99.62 7.67 52.27 100.42 -24.05 77.11 82.23 -23.91 79.14 84.16 coo 10.43 61.66 91.81 9.80 60.04 90.61 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 5.43 58.06 80.08 8.57 53.00 79.37 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 265 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 7.48 54.94 99.62 7.67 52.27 100.42 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 5.43 58.06 80.08 8.57 53.00 79.37 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 223 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 265 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 7.48 54.94 99.62 7.67 52.27 100.42 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 5.43 58.06 80.08 8.57 53.00 79.37 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 223 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 265 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 7.48 54.94 99.62 7.67 52.27 100.42 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 5.43 58.06 80.08 8.57 53.00 79.37 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE A 140 PHE.? 11.31 O ACT A 201 B 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 265 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 7.48 54.94 99.62 7.67 52.27 100.42 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 5.43 58.06 80.08 8.57 53.00 79.37 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE B 84 PHE^? 19.62 CH3 ACT A 202 B 223 ASP A 86 ASP.? 20.24 CH3 ACT A 202 B 265 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 7.48 54.94 99.62 7.67 52.27 100.42 -22.29 70.30 88.22 -19.89 71.38 89.16 coo 10.43 61.66 91.81 9.80 60.04 90.61 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 5.43 58.06 80.08 8.57 53.00 79.37 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 223 ASP C 74 ASP^? 14.86 O ACT C 201 B 265 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 10.43 61.66 91.81 9.80 60.04 90.61 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 5.43 58.06 80.08 8.57 53.00 79.37 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 223 ASP C 74 ASP^? 14.86 O ACT C 201 B 265 LYS C 139 LYS.? 18.79 O ACT C 201 coo 7.48 54.94 99.62 7.67 52.27 100.42 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 10.43 61.66 91.81 9.80 60.04 90.61 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 5.43 58.06 80.08 8.57 53.00 79.37 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 223 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 265 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 10.43 61.66 91.81 9.80 60.04 90.61 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 5.43 58.06 80.08 8.57 53.00 79.37 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ax4_c05 TRYPTOPHANASE user 10 3 # 10 B 130 PHE C 84 PHE^? 19.83 CH3 ACT C 201 B 223 ASP D 86 ASP.? 24.19 CH3 ACT D 201 B 265 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 7.48 54.94 99.62 7.67 52.27 100.42 -43.84 41.52 34.02 -45.03 39.44 32.58 coo 10.43 61.66 91.81 9.80 60.04 90.61 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 5.43 58.06 80.08 8.57 53.00 79.37 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1ax4_c05 TRYPTOPHANASE user 11 3 # 11 B 130 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 223 ASP C 74 ASP^? 14.86 O ACT C 201 B 265 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 7.48 54.94 99.62 7.67 52.27 100.42 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 10.43 61.66 91.81 9.80 60.04 90.61 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 5.43 58.06 80.08 8.57 53.00 79.37 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ax4_c05 TRYPTOPHANASE user 12 3 # 12 B 130 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 223 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 265 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 7.48 54.94 99.62 7.67 52.27 100.42 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 10.43 61.66 91.81 9.80 60.04 90.61 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 5.43 58.06 80.08 8.57 53.00 79.37 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ax4_c05 TRYPTOPHANASE user 13 3 # 13 B 130 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 223 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 265 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 7.48 54.94 99.62 7.67 52.27 100.42 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 10.43 61.66 91.81 9.80 60.04 90.61 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 5.43 58.06 80.08 8.57 53.00 79.37 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ax4_c05 TRYPTOPHANASE user 14 3 # 14 B 130 PHE C 140 PHE.? 11.33 O ACT C 201 B 223 ASP C 74 ASP^? 14.86 O ACT C 201 B 265 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 7.48 54.94 99.62 7.67 52.27 100.42 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 10.43 61.66 91.81 9.80 60.04 90.61 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 5.43 58.06 80.08 8.57 53.00 79.37 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ax4_c05 TRYPTOPHANASE user 15 3 # 15 B 130 PHE D 84 PHE^? 19.80 CH3 ACT D 201 B 223 ASP C 86 ASP.? 24.03 CH3 ACT C 201 B 265 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 7.48 54.94 99.62 7.67 52.27 100.42 -48.20 48.22 29.39 -47.23 47.53 26.85 coo 10.43 61.66 91.81 9.80 60.04 90.61 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 5.43 58.06 80.08 8.57 53.00 79.37 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1ax4_c05 TRYPTOPHANASE user 16 3 # 16 B 130 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 265 LYS A 134 LYS~? 11.98 O ACT A 203 coo 7.48 54.94 99.62 7.67 52.27 100.42 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 5.43 58.06 80.08 8.57 53.00 79.37 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1ax4_c05 TRYPTOPHANASE user 17 3 # 17 B 130 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 265 LYS A 139 LYS.? 17.81 O ACT A 201 coo 7.48 54.94 99.62 7.67 52.27 100.42 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 5.43 58.06 80.08 8.57 53.00 79.37 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1ax4_c05 TRYPTOPHANASE user 18 3 # 18 B 130 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 223 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 265 LYS A 134 LYS~? 11.98 O ACT A 203 coo 7.48 54.94 99.62 7.67 52.27 100.42 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 5.43 58.06 80.08 8.57 53.00 79.37 -53.24 65.33 66.31 -57.37 62.85 65.73 1ax4_c05 source 1ax4 TRYPTOPHANASE : 18 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 84 PHE^? 19.84 CH3 ACT A 201 C 223 ASP B 86 ASP.? 24.07 CH3 ACT B 201 C 265 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -24.05 77.11 82.23 -23.91 79.14 84.16 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -28.16 75.31 91.23 -27.42 77.23 90.74 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 105 PHE^? 4.28 O1 EDO A 301 C 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 265 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -6.55 73.45 23.60 -6.77 71.48 21.66 -44.46 62.63 64.59 -44.88 60.33 63.05 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 105 PHE^? 4.28 O1 EDO A 301 C 223 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 265 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -6.55 73.45 23.60 -6.77 71.48 21.66 -44.46 62.63 64.59 -44.88 60.33 63.05 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE A 105 PHE^? 4.28 O1 EDO A 301 C 223 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 265 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -6.55 73.45 23.60 -6.77 71.48 21.66 -44.46 62.63 64.59 -44.88 60.33 63.05 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE A 140 PHE.? 11.31 O ACT A 201 C 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 265 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -6.55 73.45 23.60 -6.77 71.48 21.66 -44.06 74.70 68.64 -42.76 73.46 70.80 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE B 84 PHE^? 19.62 CH3 ACT A 202 C 223 ASP A 86 ASP.? 20.24 CH3 ACT A 202 C 265 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -22.29 70.30 88.22 -19.89 71.38 89.16 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -16.25 74.73 81.62 -15.60 74.59 83.62 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE B 105 PHE^? 13.39 C2 EDO A 302 C 223 ASP C 74 ASP^? 14.86 O ACT C 201 C 265 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -31.64 46.86 70.65 -33.68 45.82 69.04 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE B 105 PHE^? 13.39 C2 EDO A 302 C 223 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 265 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -31.64 46.86 70.65 -33.68 45.82 69.04 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ax4_c06 TRYPTOPHANASE user 9 3 # 9 C 130 PHE C 84 PHE^? 19.83 CH3 ACT C 201 C 223 ASP D 86 ASP.? 24.19 CH3 ACT D 201 C 265 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -43.84 41.52 34.02 -45.03 39.44 32.58 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -53.41 42.17 31.38 -52.32 40.44 30.82 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1ax4_c06 TRYPTOPHANASE user 10 3 # 10 C 130 PHE C 105 PHE^? 4.31 O2 EDO A 301 C 223 ASP C 74 ASP^? 14.86 O ACT C 201 C 265 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -44.99 53.92 62.00 -44.50 56.25 63.46 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ax4_c06 TRYPTOPHANASE user 11 3 # 11 C 130 PHE C 105 PHE^? 4.31 O2 EDO A 301 C 223 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 265 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -6.55 73.45 23.60 -6.77 71.48 21.66 -44.99 53.92 62.00 -44.50 56.25 63.46 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ax4_c06 TRYPTOPHANASE user 12 3 # 12 C 130 PHE C 105 PHE^? 4.31 O2 EDO A 301 C 223 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 265 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -44.99 53.92 62.00 -44.50 56.25 63.46 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ax4_c06 TRYPTOPHANASE user 13 3 # 13 C 130 PHE C 140 PHE.? 11.33 O ACT C 201 C 223 ASP C 74 ASP^? 14.86 O ACT C 201 C 265 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -46.25 41.88 58.15 -47.27 43.20 55.89 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ax4_c06 TRYPTOPHANASE user 14 3 # 14 C 130 PHE D 84 PHE^? 19.80 CH3 ACT D 201 C 223 ASP C 86 ASP.? 24.03 CH3 ACT C 201 C 265 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -48.20 48.22 29.39 -47.23 47.53 26.85 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -38.79 45.04 28.56 -40.00 45.30 26.84 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1ax4_c06 TRYPTOPHANASE user 15 3 # 15 C 130 PHE D 105 PHE^? 7.74 CH3 ACT A 203 C 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 265 LYS A 134 LYS~? 11.98 O ACT A 203 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -44.21 71.05 49.68 -44.30 71.93 52.33 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1ax4_c06 TRYPTOPHANASE user 16 3 # 16 C 130 PHE D 105 PHE^? 7.74 CH3 ACT A 203 C 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 265 LYS A 139 LYS.? 17.81 O ACT A 201 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -44.21 71.05 49.68 -44.30 71.93 52.33 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1ax4_c06 TRYPTOPHANASE user 17 3 # 17 C 130 PHE D 105 PHE^? 7.74 CH3 ACT A 203 C 223 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 265 LYS A 134 LYS~? 11.98 O ACT A 203 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -44.21 71.05 49.68 -44.30 71.93 52.33 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -53.24 65.33 66.31 -57.37 62.85 65.73 1ax4_c06 source 1ax4 TRYPTOPHANASE : 17 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 84 PHE^? 19.84 CH3 ACT A 201 D 223 ASP B 86 ASP.? 24.07 CH3 ACT B 201 D 265 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -24.05 77.11 82.23 -23.91 79.14 84.16 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -28.16 75.31 91.23 -27.42 77.23 90.74 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 105 PHE^? 4.28 O1 EDO A 301 D 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 265 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -38.60 55.38 52.70 -40.06 57.72 53.04 -44.46 62.63 64.59 -44.88 60.33 63.05 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 105 PHE^? 4.28 O1 EDO A 301 D 223 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 265 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -38.60 55.38 52.70 -40.06 57.72 53.04 -44.46 62.63 64.59 -44.88 60.33 63.05 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE A 105 PHE^? 4.28 O1 EDO A 301 D 223 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 265 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -38.60 55.38 52.70 -40.06 57.72 53.04 -44.46 62.63 64.59 -44.88 60.33 63.05 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE A 140 PHE.? 11.31 O ACT A 201 D 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 265 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -38.60 55.38 52.70 -40.06 57.72 53.04 -44.06 74.70 68.64 -42.76 73.46 70.80 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE B 84 PHE^? 19.62 CH3 ACT A 202 D 223 ASP A 86 ASP.? 20.24 CH3 ACT A 202 D 265 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -22.29 70.30 88.22 -19.89 71.38 89.16 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -16.25 74.73 81.62 -15.60 74.59 83.62 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE B 105 PHE^? 13.39 C2 EDO A 302 D 223 ASP C 74 ASP^? 14.86 O ACT C 201 D 265 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -31.64 46.86 70.65 -33.68 45.82 69.04 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE B 105 PHE^? 13.39 C2 EDO A 302 D 223 ASP C 74 ASP^? 14.86 O ACT C 201 D 265 LYS C 139 LYS.? 18.79 O ACT C 201 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -31.64 46.86 70.65 -33.68 45.82 69.04 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1ax4_c07 TRYPTOPHANASE user 9 3 # 9 D 130 PHE B 105 PHE^? 13.39 C2 EDO A 302 D 223 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 265 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -31.64 46.86 70.65 -33.68 45.82 69.04 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ax4_c07 TRYPTOPHANASE user 10 3 # 10 D 130 PHE C 84 PHE^? 19.83 CH3 ACT C 201 D 223 ASP D 86 ASP.? 24.19 CH3 ACT D 201 D 265 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -43.84 41.52 34.02 -45.03 39.44 32.58 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -53.41 42.17 31.38 -52.32 40.44 30.82 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1ax4_c07 TRYPTOPHANASE user 11 3 # 11 D 130 PHE C 105 PHE^? 4.31 O2 EDO A 301 D 223 ASP C 74 ASP^? 14.86 O ACT C 201 D 265 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -44.99 53.92 62.00 -44.50 56.25 63.46 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ax4_c07 TRYPTOPHANASE user 12 3 # 12 D 130 PHE C 105 PHE^? 4.31 O2 EDO A 301 D 223 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 265 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -38.60 55.38 52.70 -40.06 57.72 53.04 -44.99 53.92 62.00 -44.50 56.25 63.46 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ax4_c07 TRYPTOPHANASE user 13 3 # 13 D 130 PHE C 105 PHE^? 4.31 O2 EDO A 301 D 223 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 265 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -44.99 53.92 62.00 -44.50 56.25 63.46 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ax4_c07 TRYPTOPHANASE user 14 3 # 14 D 130 PHE C 140 PHE.? 11.33 O ACT C 201 D 223 ASP C 74 ASP^? 14.86 O ACT C 201 D 265 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -46.25 41.88 58.15 -47.27 43.20 55.89 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ax4_c07 TRYPTOPHANASE user 15 3 # 15 D 130 PHE D 84 PHE^? 19.80 CH3 ACT D 201 D 223 ASP C 86 ASP.? 24.03 CH3 ACT C 201 D 265 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -48.20 48.22 29.39 -47.23 47.53 26.85 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -38.79 45.04 28.56 -40.00 45.30 26.84 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1ax4_c07 TRYPTOPHANASE user 16 3 # 16 D 130 PHE D 105 PHE^? 7.74 CH3 ACT A 203 D 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 265 LYS A 134 LYS~? 11.98 O ACT A 203 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -44.21 71.05 49.68 -44.30 71.93 52.33 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1ax4_c07 TRYPTOPHANASE user 17 3 # 17 D 130 PHE D 105 PHE^? 7.74 CH3 ACT A 203 D 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 265 LYS A 139 LYS.? 17.81 O ACT A 201 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -44.21 71.05 49.68 -44.30 71.93 52.33 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1ax4_c07 TRYPTOPHANASE user 18 3 # 18 D 130 PHE D 105 PHE^? 7.74 CH3 ACT A 203 D 223 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 265 LYS A 134 LYS~? 11.98 O ACT A 203 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -44.21 71.05 49.68 -44.30 71.93 52.33 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -53.24 65.33 66.31 -57.37 62.85 65.73 1ax4_c07 source 1ax4 TRYPTOPHANASE : 18 hits 1ax4_c07 naa= 3 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 A 140 TRP A 30 TRP~? -4.28 CH3 ACT A 201s A 222 ASP A 34 ASP~? 14.63 O ACT A 201 A 258 LYS A 68 LYS~? -2.78 O ACT A 201s coo 89.83 15.40 0.01 90.61 18.86 1.71 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 82.92 20.43 2.47 84.82 20.45 1.55 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 A 140 TRP A 69 TRP~? 6.39 O ACT A 201 A 222 ASP A 34 ASP~? 14.63 O ACT A 201 A 258 LYS D 134 LYS~? 17.34 O ACT A 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 82.92 20.43 2.47 84.82 20.45 1.55 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 A 140 TRP A 69 TRP~? 6.39 O ACT A 201 A 222 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 258 LYS D 134 LYS~? 17.34 O ACT A 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 82.92 20.43 2.47 84.82 20.45 1.55 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 A 140 TRP A 82 TRP^? 14.68 O ACT B 201 A 222 ASP B 86 ASP.? 24.07 CH3 ACT B 201 A 258 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -30.38 69.86 83.05 -34.07 70.22 84.37 coo 82.92 20.43 2.47 84.82 20.45 1.55 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 A 140 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 222 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 258 LYS A 134 LYS~? 11.98 O ACT A 203 coo 89.83 15.40 0.01 90.61 18.86 1.71 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 82.92 20.43 2.47 84.82 20.45 1.55 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 3 # 6 A 140 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 222 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 258 LYS A 139 LYS.? 17.81 O ACT A 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 82.92 20.43 2.47 84.82 20.45 1.55 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 3 # 7 A 140 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 222 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 258 LYS A 134 LYS~? 11.98 O ACT A 203 coo 89.83 15.40 0.01 90.61 18.86 1.71 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 82.92 20.43 2.47 84.82 20.45 1.55 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 8 3 # 8 A 140 TRP A 104 TRP^? -4.29 OXT ACT A 203s A 222 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 258 LYS A 139 LYS.? 17.81 O ACT A 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 82.92 20.43 2.47 84.82 20.45 1.55 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 9 3 # 9 A 140 TRP A 104 TRP^? -4.29 OXT ACT A 203s A 222 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 258 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 89.83 15.40 0.01 90.61 18.86 1.71 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 82.92 20.43 2.47 84.82 20.45 1.55 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 10 3 # 10 A 140 TRP A 142 TRP.? 12.79 O ACT A 201 A 222 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 258 LYS A 139 LYS.? 17.81 O ACT A 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -42.03 80.57 64.19 -41.88 78.10 67.25 coo 82.92 20.43 2.47 84.82 20.45 1.55 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 11 3 # 11 A 140 TRP B 30 TRP~? -4.15 CH3 ACT B 201s A 222 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 258 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 89.83 15.40 0.01 90.61 18.86 1.71 -31.05 54.49 87.84 -34.09 54.74 85.35 coo 82.92 20.43 2.47 84.82 20.45 1.55 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 12 3 # 12 A 140 TRP B 82 TRP^? 9.86 O ACT A 202 A 222 ASP A 86 ASP.? 20.24 CH3 ACT A 202 A 258 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -23.37 68.40 78.71 -20.56 66.90 76.39 coo 82.92 20.43 2.47 84.82 20.45 1.55 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 13 3 # 13 A 140 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 222 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 258 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 89.83 15.40 0.01 90.61 18.86 1.71 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 82.92 20.43 2.47 84.82 20.45 1.55 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 14 3 # 14 A 140 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 222 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 258 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 89.83 15.40 0.01 90.61 18.86 1.71 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 82.92 20.43 2.47 84.82 20.45 1.55 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 15 3 # 15 A 140 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 222 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 258 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 89.83 15.40 0.01 90.61 18.86 1.71 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 82.92 20.43 2.47 84.82 20.45 1.55 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 16 3 # 16 A 140 TRP B 104 TRP^? 15.21 C2 EDO A 302 A 222 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 258 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 89.83 15.40 0.01 90.61 18.86 1.71 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 82.92 20.43 2.47 84.82 20.45 1.55 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 17 3 # 17 A 140 TRP B 142 TRP.? 12.90 OXT ACT B 201 A 222 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 258 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 89.83 15.40 0.01 90.61 18.86 1.71 -21.52 44.96 85.54 -21.40 47.93 82.96 coo 82.92 20.43 2.47 84.82 20.45 1.55 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 18 3 # 18 A 140 TRP C 30 TRP~? -4.24 CH3 ACT C 201s A 222 ASP C 34 ASP~? 14.66 O ACT C 201 A 258 LYS C 68 LYS~? -2.77 O ACT C 201s coo 89.83 15.40 0.01 90.61 18.86 1.71 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 82.92 20.43 2.47 84.82 20.45 1.55 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 19 3 # 19 A 140 TRP C 69 TRP~? 6.41 O ACT C 201 A 222 ASP C 34 ASP~? 14.66 O ACT C 201 A 258 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 89.83 15.40 0.01 90.61 18.86 1.71 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 82.92 20.43 2.47 84.82 20.45 1.55 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 20 3 # 20 A 140 TRP C 69 TRP~? 6.41 O ACT C 201 A 222 ASP C 74 ASP^? 14.86 O ACT C 201 A 258 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 89.83 15.40 0.01 90.61 18.86 1.71 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 82.92 20.43 2.47 84.82 20.45 1.55 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 21 3 # 21 A 140 TRP C 82 TRP^? 14.73 O ACT D 201 A 222 ASP D 86 ASP.? 24.19 CH3 ACT D 201 A 258 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -49.41 47.73 38.89 -52.68 46.73 40.85 coo 82.92 20.43 2.47 84.82 20.45 1.55 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 22 3 # 22 A 140 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 222 ASP C 74 ASP^? 14.86 O ACT C 201 A 258 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 89.83 15.40 0.01 90.61 18.86 1.71 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 82.92 20.43 2.47 84.82 20.45 1.55 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 23 3 # 23 A 140 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 222 ASP C 74 ASP^? 14.86 O ACT C 201 A 258 LYS C 139 LYS.? 18.79 O ACT C 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 82.92 20.43 2.47 84.82 20.45 1.55 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 24 3 # 24 A 140 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 222 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 258 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 89.83 15.40 0.01 90.61 18.86 1.71 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 82.92 20.43 2.47 84.82 20.45 1.55 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 25 3 # 25 A 140 TRP C 104 TRP^? 12.40 O2 EDO A 301 A 222 ASP C 74 ASP^? 14.86 O ACT C 201 A 258 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 82.92 20.43 2.47 84.82 20.45 1.55 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 26 3 # 26 A 140 TRP C 104 TRP^? 12.40 O2 EDO A 301 A 222 ASP C 74 ASP^? 14.86 O ACT C 201 A 258 LYS C 139 LYS.? 18.79 O ACT C 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 82.92 20.43 2.47 84.82 20.45 1.55 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 27 3 # 27 A 140 TRP C 142 TRP.? 12.80 O ACT C 201 A 222 ASP C 74 ASP^? 14.86 O ACT C 201 A 258 LYS C 139 LYS.? 18.79 O ACT C 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -40.60 36.63 58.98 -43.29 38.84 57.12 coo 82.92 20.43 2.47 84.82 20.45 1.55 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 28 3 # 28 A 140 TRP C 142 TRP.? 12.80 O ACT C 201 A 222 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 258 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 89.83 15.40 0.01 90.61 18.86 1.71 -40.60 36.63 58.98 -43.29 38.84 57.12 coo 82.92 20.43 2.47 84.82 20.45 1.55 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 29 3 # 29 A 140 TRP C 142 TRP.? 12.80 O ACT C 201 A 222 ASP C 150 ASP.? 20.99 CH3 ACT C 201 A 258 LYS C 139 LYS.? 18.79 O ACT C 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -40.60 36.63 58.98 -43.29 38.84 57.12 coo 82.92 20.43 2.47 84.82 20.45 1.55 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 30 3 # 30 A 140 TRP D 30 TRP~? -4.23 CH3 ACT D 201s A 222 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 258 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 89.83 15.40 0.01 90.61 18.86 1.71 -55.89 62.34 37.62 -55.77 61.79 41.52 coo 82.92 20.43 2.47 84.82 20.45 1.55 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 31 3 # 31 A 140 TRP D 82 TRP^? 14.82 OXT ACT C 201 A 222 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 258 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -41.91 50.50 36.33 -38.54 52.46 35.78 coo 82.92 20.43 2.47 84.82 20.45 1.55 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 32 3 # 32 A 140 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 222 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 258 LYS D 134 LYS~? 17.34 O ACT A 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 82.92 20.43 2.47 84.82 20.45 1.55 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 33 3 # 33 A 140 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 222 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 258 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 82.92 20.43 2.47 84.82 20.45 1.55 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 34 3 # 34 A 140 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 222 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 258 LYS D 134 LYS~? 17.34 O ACT A 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 82.92 20.43 2.47 84.82 20.45 1.55 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 35 3 # 35 A 140 TRP D 104 TRP^? 14.89 CH3 ACT A 203 A 222 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 258 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 82.92 20.43 2.47 84.82 20.45 1.55 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 36 3 # 36 A 140 TRP D 142 TRP.? 12.80 OXT ACT D 201 A 222 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 258 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 89.83 15.40 0.01 90.61 18.86 1.71 -49.78 73.48 32.42 -47.22 70.87 33.88 coo 82.92 20.43 2.47 84.82 20.45 1.55 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -39.84 73.21 37.09 -35.07 70.74 37.87 1ay4_c02 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 36 hits 1ay4_c02 naa= 3 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 B 140 TRP A 30 TRP~? -4.28 CH3 ACT A 201s B 222 ASP A 34 ASP~? 14.63 O ACT A 201 B 258 LYS A 68 LYS~? -2.78 O ACT A 201s coo 103.45 44.39 16.20 102.66 41.02 14.32 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 110.10 38.66 15.58 108.40 39.41 14.53 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 107.51 45.54 4.76 105.41 44.51 10.25 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 B 140 TRP A 69 TRP~? 6.39 O ACT A 201 B 222 ASP A 34 ASP~? 14.63 O ACT A 201 B 258 LYS D 134 LYS~? 17.34 O ACT A 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 110.10 38.66 15.58 108.40 39.41 14.53 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 107.51 45.54 4.76 105.41 44.51 10.25 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 B 140 TRP A 69 TRP~? 6.39 O ACT A 201 B 222 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 258 LYS D 134 LYS~? 17.34 O ACT A 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 110.10 38.66 15.58 108.40 39.41 14.53 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 107.51 45.54 4.76 105.41 44.51 10.25 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 B 140 TRP A 82 TRP^? 14.68 O ACT B 201 B 222 ASP B 86 ASP.? 24.07 CH3 ACT B 201 B 258 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -30.38 69.86 83.05 -34.07 70.22 84.37 coo 110.10 38.66 15.58 108.40 39.41 14.53 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 107.51 45.54 4.76 105.41 44.51 10.25 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 B 140 TRP A 97 TRP^? -5.71 O1 EDO A 301s B 222 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 258 LYS A 134 LYS~? 11.98 O ACT A 203 coo 103.45 44.39 16.20 102.66 41.02 14.32 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 110.10 38.66 15.58 108.40 39.41 14.53 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 107.51 45.54 4.76 105.41 44.51 10.25 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 3 # 6 B 140 TRP A 97 TRP^? -5.71 O1 EDO A 301s B 222 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 258 LYS A 139 LYS.? 17.81 O ACT A 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 110.10 38.66 15.58 108.40 39.41 14.53 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 107.51 45.54 4.76 105.41 44.51 10.25 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 3 # 7 B 140 TRP A 97 TRP^? -5.71 O1 EDO A 301s B 222 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 258 LYS A 134 LYS~? 11.98 O ACT A 203 coo 103.45 44.39 16.20 102.66 41.02 14.32 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 110.10 38.66 15.58 108.40 39.41 14.53 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 107.51 45.54 4.76 105.41 44.51 10.25 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 8 3 # 8 B 140 TRP A 97 TRP^? -5.71 O1 EDO A 301s B 222 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 258 LYS A 134 LYS~? 11.98 O ACT A 203 coo 103.45 44.39 16.20 102.66 41.02 14.32 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 110.10 38.66 15.58 108.40 39.41 14.53 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 107.51 45.54 4.76 105.41 44.51 10.25 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 9 3 # 9 B 140 TRP A 104 TRP^? -4.29 OXT ACT A 203s B 222 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 258 LYS A 139 LYS.? 17.81 O ACT A 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 110.10 38.66 15.58 108.40 39.41 14.53 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 107.51 45.54 4.76 105.41 44.51 10.25 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 10 3 # 10 B 140 TRP A 104 TRP^? -4.29 OXT ACT A 203s B 222 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 258 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 103.45 44.39 16.20 102.66 41.02 14.32 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 110.10 38.66 15.58 108.40 39.41 14.53 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 107.51 45.54 4.76 105.41 44.51 10.25 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 11 3 # 11 B 140 TRP A 142 TRP.? 12.79 O ACT A 201 B 222 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 258 LYS A 139 LYS.? 17.81 O ACT A 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -42.03 80.57 64.19 -41.88 78.10 67.25 coo 110.10 38.66 15.58 108.40 39.41 14.53 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 107.51 45.54 4.76 105.41 44.51 10.25 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 12 3 # 12 B 140 TRP B 30 TRP~? -4.15 CH3 ACT B 201s B 222 ASP B 34 ASP~? 14.61 OXT ACT B 201 B 258 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 103.45 44.39 16.20 102.66 41.02 14.32 -31.05 54.49 87.84 -34.09 54.74 85.35 coo 110.10 38.66 15.58 108.40 39.41 14.53 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 107.51 45.54 4.76 105.41 44.51 10.25 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 13 3 # 13 B 140 TRP B 82 TRP^? 9.86 O ACT A 202 B 222 ASP A 86 ASP.? 20.24 CH3 ACT A 202 B 258 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -23.37 68.40 78.71 -20.56 66.90 76.39 coo 110.10 38.66 15.58 108.40 39.41 14.53 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 107.51 45.54 4.76 105.41 44.51 10.25 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 14 3 # 14 B 140 TRP B 97 TRP^? 8.79 OXT ACT B 201 B 222 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 258 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 110.10 38.66 15.58 108.40 39.41 14.53 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 107.51 45.54 4.76 105.41 44.51 10.25 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 15 3 # 15 B 140 TRP B 97 TRP^? 8.79 OXT ACT B 201 B 222 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 258 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 110.10 38.66 15.58 108.40 39.41 14.53 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 107.51 45.54 4.76 105.41 44.51 10.25 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 16 3 # 16 B 140 TRP B 97 TRP^? 8.79 OXT ACT B 201 B 222 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 258 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 110.10 38.66 15.58 108.40 39.41 14.53 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 107.51 45.54 4.76 105.41 44.51 10.25 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 17 3 # 17 B 140 TRP B 104 TRP^? 15.21 C2 EDO A 302 B 222 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 258 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 110.10 38.66 15.58 108.40 39.41 14.53 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 107.51 45.54 4.76 105.41 44.51 10.25 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 18 3 # 18 B 140 TRP B 142 TRP.? 12.90 OXT ACT B 201 B 222 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 258 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 -21.52 44.96 85.54 -21.40 47.93 82.96 coo 110.10 38.66 15.58 108.40 39.41 14.53 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 107.51 45.54 4.76 105.41 44.51 10.25 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 19 3 # 19 B 140 TRP C 30 TRP~? -4.24 CH3 ACT C 201s B 222 ASP C 34 ASP~? 14.66 O ACT C 201 B 258 LYS C 68 LYS~? -2.77 O ACT C 201s coo 103.45 44.39 16.20 102.66 41.02 14.32 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 110.10 38.66 15.58 108.40 39.41 14.53 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 107.51 45.54 4.76 105.41 44.51 10.25 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 20 3 # 20 B 140 TRP C 69 TRP~? 6.41 O ACT C 201 B 222 ASP C 34 ASP~? 14.66 O ACT C 201 B 258 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 110.10 38.66 15.58 108.40 39.41 14.53 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 107.51 45.54 4.76 105.41 44.51 10.25 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 21 3 # 21 B 140 TRP C 69 TRP~? 6.41 O ACT C 201 B 222 ASP C 74 ASP^? 14.86 O ACT C 201 B 258 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 110.10 38.66 15.58 108.40 39.41 14.53 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 107.51 45.54 4.76 105.41 44.51 10.25 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 22 3 # 22 B 140 TRP C 82 TRP^? 14.73 O ACT D 201 B 222 ASP D 86 ASP.? 24.19 CH3 ACT D 201 B 258 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -49.41 47.73 38.89 -52.68 46.73 40.85 coo 110.10 38.66 15.58 108.40 39.41 14.53 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 107.51 45.54 4.76 105.41 44.51 10.25 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 23 3 # 23 B 140 TRP C 97 TRP^? -5.77 O2 EDO A 301s B 222 ASP C 74 ASP^? 14.86 O ACT C 201 B 258 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 103.45 44.39 16.20 102.66 41.02 14.32 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 110.10 38.66 15.58 108.40 39.41 14.53 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 107.51 45.54 4.76 105.41 44.51 10.25 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 24 3 # 24 B 140 TRP C 97 TRP^? -5.77 O2 EDO A 301s B 222 ASP C 74 ASP^? 14.86 O ACT C 201 B 258 LYS C 139 LYS.? 18.79 O ACT C 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 110.10 38.66 15.58 108.40 39.41 14.53 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 107.51 45.54 4.76 105.41 44.51 10.25 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 25 3 # 25 B 140 TRP C 97 TRP^? -5.77 O2 EDO A 301s B 222 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 258 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 103.45 44.39 16.20 102.66 41.02 14.32 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 110.10 38.66 15.58 108.40 39.41 14.53 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 107.51 45.54 4.76 105.41 44.51 10.25 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 26 3 # 26 B 140 TRP C 97 TRP^? -5.77 O2 EDO A 301s B 222 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 258 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 103.45 44.39 16.20 102.66 41.02 14.32 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 110.10 38.66 15.58 108.40 39.41 14.53 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 107.51 45.54 4.76 105.41 44.51 10.25 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 27 3 # 27 B 140 TRP C 104 TRP^? 12.40 O2 EDO A 301 B 222 ASP C 74 ASP^? 14.86 O ACT C 201 B 258 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 110.10 38.66 15.58 108.40 39.41 14.53 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 107.51 45.54 4.76 105.41 44.51 10.25 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 28 3 # 28 B 140 TRP C 104 TRP^? 12.40 O2 EDO A 301 B 222 ASP C 74 ASP^? 14.86 O ACT C 201 B 258 LYS C 139 LYS.? 18.79 O ACT C 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 110.10 38.66 15.58 108.40 39.41 14.53 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 107.51 45.54 4.76 105.41 44.51 10.25 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 29 3 # 29 B 140 TRP C 142 TRP.? 12.80 O ACT C 201 B 222 ASP C 74 ASP^? 14.86 O ACT C 201 B 258 LYS C 139 LYS.? 18.79 O ACT C 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -40.60 36.63 58.98 -43.29 38.84 57.12 coo 110.10 38.66 15.58 108.40 39.41 14.53 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 107.51 45.54 4.76 105.41 44.51 10.25 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 30 3 # 30 B 140 TRP C 142 TRP.? 12.80 O ACT C 201 B 222 ASP C 150 ASP.? 20.99 CH3 ACT C 201 B 258 LYS C 139 LYS.? 18.79 O ACT C 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -40.60 36.63 58.98 -43.29 38.84 57.12 coo 110.10 38.66 15.58 108.40 39.41 14.53 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 107.51 45.54 4.76 105.41 44.51 10.25 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 31 3 # 31 B 140 TRP D 30 TRP~? -4.23 CH3 ACT D 201s B 222 ASP D 34 ASP~? 14.62 OXT ACT D 201 B 258 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 103.45 44.39 16.20 102.66 41.02 14.32 -55.89 62.34 37.62 -55.77 61.79 41.52 coo 110.10 38.66 15.58 108.40 39.41 14.53 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 107.51 45.54 4.76 105.41 44.51 10.25 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 32 3 # 32 B 140 TRP D 82 TRP^? 14.82 OXT ACT C 201 B 222 ASP C 86 ASP.? 24.03 CH3 ACT C 201 B 258 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -41.91 50.50 36.33 -38.54 52.46 35.78 coo 110.10 38.66 15.58 108.40 39.41 14.53 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 107.51 45.54 4.76 105.41 44.51 10.25 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 33 3 # 33 B 140 TRP D 97 TRP^? 8.35 CH3 ACT A 203 B 222 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 258 LYS D 134 LYS~? 17.34 O ACT A 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 110.10 38.66 15.58 108.40 39.41 14.53 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 107.51 45.54 4.76 105.41 44.51 10.25 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 34 3 # 34 B 140 TRP D 97 TRP^? 8.35 CH3 ACT A 203 B 222 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 258 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 110.10 38.66 15.58 108.40 39.41 14.53 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 107.51 45.54 4.76 105.41 44.51 10.25 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 35 3 # 35 B 140 TRP D 97 TRP^? 8.35 CH3 ACT A 203 B 222 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 258 LYS D 134 LYS~? 17.34 O ACT A 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 110.10 38.66 15.58 108.40 39.41 14.53 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 107.51 45.54 4.76 105.41 44.51 10.25 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 36 3 # 36 B 140 TRP D 104 TRP^? 14.89 CH3 ACT A 203 B 222 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 258 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 110.10 38.66 15.58 108.40 39.41 14.53 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 107.51 45.54 4.76 105.41 44.51 10.25 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 37 3 # 37 B 140 TRP D 142 TRP.? 12.80 OXT ACT D 201 B 222 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 258 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 103.45 44.39 16.20 102.66 41.02 14.32 -49.78 73.48 32.42 -47.22 70.87 33.88 coo 110.10 38.66 15.58 108.40 39.41 14.53 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 107.51 45.54 4.76 105.41 44.51 10.25 -39.84 73.21 37.09 -35.07 70.74 37.87 1ay4_c03 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 37 hits 1ay4_c03 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS A 98 HIS^? -3.60 C ACT A 203s A 171 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 190 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 22.59 2.26 43.22 21.17 3.47 42.27 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 13.63 3.81 28.83 14.49 2.91 31.59 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 24.97 7.47 37.69 21.24 10.69 35.89 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 2 3 # 2 A 85 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 171 ARG B 49 ARG^? 10.37 O ACT B 201 A 190 LYS A 139 LYS.? 17.81 O ACT A 201 coo 22.59 2.26 43.22 21.17 3.47 42.27 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 13.63 3.81 28.83 14.49 2.91 31.59 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 24.97 7.47 37.69 21.24 10.69 35.89 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 3 3 # 3 A 85 HIS A 162 HIS.? 14.54 O1 EDO A 301 A 171 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 190 LYS A 134 LYS~? 11.98 O ACT A 203 coo 22.59 2.26 43.22 21.17 3.47 42.27 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 13.63 3.81 28.83 14.49 2.91 31.59 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 24.97 7.47 37.69 21.24 10.69 35.89 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 4 3 # 4 A 85 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 171 ARG C 138 ARG~? 16.31 O ACT C 201 A 190 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 22.59 2.26 43.22 21.17 3.47 42.27 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 13.63 3.81 28.83 14.49 2.91 31.59 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 24.97 7.47 37.69 21.24 10.69 35.89 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 5 3 # 5 A 85 HIS B 141 HIS.? 15.94 CH3 ACT A 202 A 171 ARG B 33 ARG.? 12.67 OXT ACT B 201 A 190 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 22.59 2.26 43.22 21.17 3.47 42.27 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 13.63 3.81 28.83 14.49 2.91 31.59 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 24.97 7.47 37.69 21.24 10.69 35.89 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 6 3 # 6 A 85 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 171 ARG A 49 ARG^? -3.92 O ACT A 202s A 190 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 22.59 2.26 43.22 21.17 3.47 42.27 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 13.63 3.81 28.83 14.49 2.91 31.59 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 24.97 7.47 37.69 21.24 10.69 35.89 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 7 3 # 7 A 85 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 171 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 190 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 22.59 2.26 43.22 21.17 3.47 42.27 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 13.63 3.81 28.83 14.49 2.91 31.59 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 24.97 7.47 37.69 21.24 10.69 35.89 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 8 3 # 8 A 85 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 171 ARG C 33 ARG.? 12.41 O ACT C 201 A 190 LYS C 139 LYS.? 18.79 O ACT C 201 coo 22.59 2.26 43.22 21.17 3.47 42.27 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 13.63 3.81 28.83 14.49 2.91 31.59 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 24.97 7.47 37.69 21.24 10.69 35.89 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 9 3 # 9 A 85 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 171 ARG D 49 ARG^? 10.44 O ACT D 201 A 190 LYS C 139 LYS.? 18.79 O ACT C 201 coo 22.59 2.26 43.22 21.17 3.47 42.27 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 13.63 3.81 28.83 14.49 2.91 31.59 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 24.97 7.47 37.69 21.24 10.69 35.89 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 10 3 # 10 A 85 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 171 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 190 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 22.59 2.26 43.22 21.17 3.47 42.27 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 13.63 3.81 28.83 14.49 2.91 31.59 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 24.97 7.47 37.69 21.24 10.69 35.89 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 11 3 # 11 A 85 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 171 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 190 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 22.59 2.26 43.22 21.17 3.47 42.27 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 13.63 3.81 28.83 14.49 2.91 31.59 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 24.97 7.47 37.69 21.24 10.69 35.89 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 12 3 # 12 A 85 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 171 ARG D 33 ARG.? 12.34 OXT ACT D 201 A 190 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 22.59 2.26 43.22 21.17 3.47 42.27 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 13.63 3.81 28.83 14.49 2.91 31.59 -55.21 72.58 39.53 -56.74 74.11 37.37 coo 24.97 7.47 37.69 21.24 10.69 35.89 -39.84 73.21 37.09 -35.07 70.74 37.87 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 12 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS A 98 HIS^? -3.60 C ACT A 203s B 171 ARG D 106 ARG^? 14.88 OXT ACT D 201 B 190 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 2.83 4.83 10.84 1.96 4.32 7.97 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 2 3 # 2 B 85 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 171 ARG B 49 ARG^? 10.37 O ACT B 201 B 190 LYS A 139 LYS.? 17.81 O ACT A 201 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 2.83 4.83 10.84 1.96 4.32 7.97 -40.89 64.28 77.45 -37.86 63.79 77.23 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 3 3 # 3 B 85 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 171 ARG A 76 ARG^? 8.97 OXT ACT A 203 B 190 LYS A 134 LYS~? 11.98 O ACT A 203 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 2.83 4.83 10.84 1.96 4.32 7.97 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 4 3 # 4 B 85 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 171 ARG C 138 ARG~? 16.31 O ACT C 201 B 190 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 2.83 4.83 10.84 1.96 4.32 7.97 -46.75 44.46 65.88 -44.64 42.30 66.40 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 5 3 # 5 B 85 HIS B 141 HIS.? 15.94 CH3 ACT A 202 B 171 ARG B 33 ARG.? 12.67 OXT ACT B 201 B 190 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 2.83 4.83 10.84 1.96 4.32 7.97 -30.14 45.04 86.20 -29.28 42.52 87.71 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 6 3 # 6 B 85 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 171 ARG A 49 ARG^? -3.92 O ACT A 202s B 190 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 2.83 4.83 10.84 1.96 4.32 7.97 -25.12 58.31 69.83 -26.93 60.25 71.40 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 7 3 # 7 B 85 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 171 ARG B 106 ARG^? 5.91 C1 EDO A 302 B 190 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 2.83 4.83 10.84 1.96 4.32 7.97 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 8 3 # 8 B 85 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 171 ARG C 33 ARG.? 12.41 O ACT C 201 B 190 LYS C 139 LYS.? 18.79 O ACT C 201 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 2.83 4.83 10.84 1.96 4.32 7.97 -34.58 43.27 59.73 -33.36 40.62 60.70 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 9 3 # 9 B 85 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 171 ARG D 49 ARG^? 10.44 O ACT D 201 B 190 LYS C 139 LYS.? 18.79 O ACT C 201 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 2.83 4.83 10.84 1.96 4.32 7.97 -52.37 52.11 51.12 -50.46 52.95 48.87 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 10 3 # 10 B 85 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 171 ARG A 138 ARG~? 6.49 OXT ACT A 203 B 190 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 2.83 4.83 10.84 1.96 4.32 7.97 -50.06 71.52 64.11 -49.59 74.03 62.40 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 11 3 # 11 B 85 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 171 ARG C 49 ARG^? 10.47 OXT ACT C 201 B 190 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 2.83 4.83 10.84 1.96 4.32 7.97 -37.64 60.68 44.02 -39.72 58.44 44.33 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 12 3 # 12 B 85 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 171 ARG D 33 ARG.? 12.34 OXT ACT D 201 B 190 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 2.83 4.83 10.84 1.96 4.32 7.97 -55.21 72.58 39.53 -56.74 74.11 37.37 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -39.84 73.21 37.09 -35.07 70.74 37.87 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 12 hits 1azy_c01 naa= 3 ULMN 3 1b02_c02 THYMIDYLATE SYNTHASE user 1 3 # 1 A 71 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 161 CYH B 127 CYH.? 10.07 OXT ACT A 201 A 192 ASN B 112 ASN^? 12.13 O ACT B 201 coo 1.71 48.67 0.56 0.18 47.85 1.75 -29.42 69.91 72.34 -30.01 70.85 70.54 coo -2.78 50.68 10.78 -4.68 50.49 8.71 -34.42 60.97 75.89 -35.29 63.54 75.29 coo -0.10 43.44 8.03 -1.33 45.05 7.36 -32.04 67.09 81.98 -30.67 67.45 80.39 ULMN 3 1b02_c02 THYMIDYLATE SYNTHASE user 2 3 # 2 A 71 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 161 CYH A 127 CYH.? 6.15 O ACT A 202 A 192 ASN A 112 ASN^? 9.36 O ACT A 202 coo 1.71 48.67 0.56 0.18 47.85 1.75 -29.98 61.01 82.70 -30.12 59.10 83.58 coo -2.78 50.68 10.78 -4.68 50.49 8.71 -31.19 62.06 71.95 -29.40 60.66 73.55 coo -0.10 43.44 8.03 -1.33 45.05 7.36 -24.96 67.02 76.01 -26.38 66.67 77.57 ULMN 3 1b02_c02 THYMIDYLATE SYNTHASE user 3 3 # 3 A 71 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 161 CYH D 127 CYH.? 10.01 OXT ACT C 201 A 192 ASN D 112 ASN^? 12.21 O ACT D 201 coo 1.71 48.67 0.56 0.18 47.85 1.75 -40.57 48.44 44.93 -39.46 47.54 46.50 coo -2.78 50.68 10.78 -4.68 50.49 8.71 -47.67 56.31 47.24 -47.42 53.67 48.08 coo -0.10 43.44 8.03 -1.33 45.05 7.36 -49.94 50.30 41.07 -47.80 50.26 40.97 ULMN 3 1b02_c02 THYMIDYLATE SYNTHASE user 4 3 # 4 A 71 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 161 CYH C 127 CYH.? 10.01 O ACT D 201 A 192 ASN C 112 ASN^? 12.25 OXT ACT C 201 coo 1.71 48.67 0.56 0.18 47.85 1.75 -50.16 56.56 39.52 -51.23 58.35 39.21 coo -2.78 50.68 10.78 -4.68 50.49 8.71 -42.49 55.99 47.19 -42.84 57.56 44.90 coo -0.10 43.44 8.03 -1.33 45.05 7.36 -41.01 51.77 39.43 -43.15 51.81 39.53 1b02_c02 source 1b02 THYMIDYLATE SYNTHASE : 4 hits 1b02_c02 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 182 GLU A 72 GLU~? 5.31 O ACT A 201 A 286 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 26.03 44.66 108.90 25.67 42.61 108.82 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 18.06 44.02 105.38 18.08 45.37 107.03 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 25.47 38.28 112.06 27.26 39.30 111.54 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 182 GLU A 72 GLU~? 5.31 O ACT A 201 A 286 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 26.03 44.66 108.90 25.67 42.61 108.82 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 18.06 44.02 105.38 18.08 45.37 107.03 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 25.47 38.28 112.06 27.26 39.30 111.54 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 182 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 286 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 26.03 44.66 108.90 25.67 42.61 108.82 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 18.06 44.02 105.38 18.08 45.37 107.03 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 25.47 38.28 112.06 27.26 39.30 111.54 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 A 109 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 182 GLU A 72 GLU~? 5.31 O ACT A 201 A 286 ASN A 129 ASN.? 9.65 O ACT B 201 coo 26.03 44.66 108.90 25.67 42.61 108.82 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 18.06 44.02 105.38 18.08 45.37 107.03 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 25.47 38.28 112.06 27.26 39.30 111.54 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 A 109 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 182 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 286 ASN A 129 ASN.? 9.65 O ACT B 201 coo 26.03 44.66 108.90 25.67 42.61 108.82 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 18.06 44.02 105.38 18.08 45.37 107.03 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 25.47 38.28 112.06 27.26 39.30 111.54 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 A 109 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 182 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 286 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 26.03 44.66 108.90 25.67 42.61 108.82 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 18.06 44.02 105.38 18.08 45.37 107.03 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 25.47 38.28 112.06 27.26 39.30 111.54 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 7 3 # 7 A 109 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 182 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 286 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 26.03 44.66 108.90 25.67 42.61 108.82 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 18.06 44.02 105.38 18.08 45.37 107.03 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 25.47 38.28 112.06 27.26 39.30 111.54 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 8 3 # 8 A 109 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 182 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 286 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 26.03 44.66 108.90 25.67 42.61 108.82 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 18.06 44.02 105.38 18.08 45.37 107.03 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 25.47 38.28 112.06 27.26 39.30 111.54 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 9 3 # 9 A 109 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 182 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 286 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 26.03 44.66 108.90 25.67 42.61 108.82 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 18.06 44.02 105.38 18.08 45.37 107.03 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 25.47 38.28 112.06 27.26 39.30 111.54 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 10 3 # 10 A 109 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 182 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 286 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 26.03 44.66 108.90 25.67 42.61 108.82 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 18.06 44.02 105.38 18.08 45.37 107.03 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 25.47 38.28 112.06 27.26 39.30 111.54 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 11 3 # 11 A 109 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 182 GLU C 72 GLU~? 5.32 O ACT C 201 A 286 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 26.03 44.66 108.90 25.67 42.61 108.82 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 18.06 44.02 105.38 18.08 45.37 107.03 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 25.47 38.28 112.06 27.26 39.30 111.54 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 12 3 # 12 A 109 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 182 GLU C 72 GLU~? 5.32 O ACT C 201 A 286 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 26.03 44.66 108.90 25.67 42.61 108.82 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 18.06 44.02 105.38 18.08 45.37 107.03 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 25.47 38.28 112.06 27.26 39.30 111.54 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 13 3 # 13 A 109 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 182 GLU C 72 GLU~? 5.32 O ACT C 201 A 286 ASN C 129 ASN.? 9.72 O ACT D 201 coo 26.03 44.66 108.90 25.67 42.61 108.82 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 18.06 44.02 105.38 18.08 45.37 107.03 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 25.47 38.28 112.06 27.26 39.30 111.54 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 14 3 # 14 A 109 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 182 GLU C 96 GLU^? 13.00 O ACT C 201 A 286 ASN C 129 ASN.? 9.72 O ACT D 201 coo 26.03 44.66 108.90 25.67 42.61 108.82 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 18.06 44.02 105.38 18.08 45.37 107.03 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 25.47 38.28 112.06 27.26 39.30 111.54 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 15 3 # 15 A 109 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 182 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 286 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 26.03 44.66 108.90 25.67 42.61 108.82 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 18.06 44.02 105.38 18.08 45.37 107.03 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 25.47 38.28 112.06 27.26 39.30 111.54 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 16 3 # 16 A 109 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 182 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 286 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 26.03 44.66 108.90 25.67 42.61 108.82 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 18.06 44.02 105.38 18.08 45.37 107.03 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 25.47 38.28 112.06 27.26 39.30 111.54 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 17 3 # 17 A 109 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 182 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 286 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 26.03 44.66 108.90 25.67 42.61 108.82 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 18.06 44.02 105.38 18.08 45.37 107.03 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 25.47 38.28 112.06 27.26 39.30 111.54 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 18 3 # 18 A 109 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 182 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 286 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 26.03 44.66 108.90 25.67 42.61 108.82 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 18.06 44.02 105.38 18.08 45.37 107.03 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 25.47 38.28 112.06 27.26 39.30 111.54 -42.23 60.94 49.15 -42.50 59.01 49.99 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 18 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 182 GLU B 160 GLU.? 4.71 OXT ACT A 202 B 286 ASN A 57 ASN~? 14.18 O1 EDO A 302 coo 13.82 69.26 132.27 11.87 70.14 132.51 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 8.74 63.05 136.42 9.87 62.19 134.79 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 8.26 72.60 129.22 10.14 73.45 129.80 -16.25 65.99 58.99 -17.06 64.89 57.36 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 182 GLU A 72 GLU~? 5.31 O ACT A 201 B 286 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 13.82 69.26 132.27 11.87 70.14 132.51 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 8.74 63.05 136.42 9.87 62.19 134.79 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 8.26 72.60 129.22 10.14 73.45 129.80 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 182 GLU A 72 GLU~? 5.31 O ACT A 201 B 286 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 13.82 69.26 132.27 11.87 70.14 132.51 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 8.74 63.05 136.42 9.87 62.19 134.79 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 8.26 72.60 129.22 10.14 73.45 129.80 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 B 109 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 182 GLU A 72 GLU~? 5.31 O ACT A 201 B 286 ASN A 129 ASN.? 9.65 O ACT B 201 coo 13.82 69.26 132.27 11.87 70.14 132.51 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 8.74 63.05 136.42 9.87 62.19 134.79 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 8.26 72.60 129.22 10.14 73.45 129.80 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 B 109 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 182 GLU A 72 GLU~? 5.31 O ACT A 201 B 286 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 13.82 69.26 132.27 11.87 70.14 132.51 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 8.74 63.05 136.42 9.87 62.19 134.79 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 8.26 72.60 129.22 10.14 73.45 129.80 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 B 109 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 182 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 286 ASN A 129 ASN.? 9.65 O ACT B 201 coo 13.82 69.26 132.27 11.87 70.14 132.51 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 8.74 63.05 136.42 9.87 62.19 134.79 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 8.26 72.60 129.22 10.14 73.45 129.80 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 7 3 # 7 B 109 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 182 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 286 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 13.82 69.26 132.27 11.87 70.14 132.51 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 8.74 63.05 136.42 9.87 62.19 134.79 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 8.26 72.60 129.22 10.14 73.45 129.80 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 8 3 # 8 B 109 ASP B 100 ASP.? 15.93 OXT ACT B 201 B 182 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 286 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 13.82 69.26 132.27 11.87 70.14 132.51 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 8.74 63.05 136.42 9.87 62.19 134.79 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 8.26 72.60 129.22 10.14 73.45 129.80 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 9 3 # 9 B 109 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 182 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 286 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 13.82 69.26 132.27 11.87 70.14 132.51 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 8.74 63.05 136.42 9.87 62.19 134.79 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 8.26 72.60 129.22 10.14 73.45 129.80 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 10 3 # 10 B 109 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 182 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 286 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 13.82 69.26 132.27 11.87 70.14 132.51 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 8.74 63.05 136.42 9.87 62.19 134.79 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 8.26 72.60 129.22 10.14 73.45 129.80 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 11 3 # 11 B 109 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 182 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 286 ASN A 129 ASN.? 9.65 O ACT B 201 coo 13.82 69.26 132.27 11.87 70.14 132.51 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 8.74 63.05 136.42 9.87 62.19 134.79 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 8.26 72.60 129.22 10.14 73.45 129.80 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 12 3 # 12 B 109 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 182 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 286 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 13.82 69.26 132.27 11.87 70.14 132.51 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 8.74 63.05 136.42 9.87 62.19 134.79 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 8.26 72.60 129.22 10.14 73.45 129.80 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 13 3 # 13 B 109 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 182 GLU C 72 GLU~? 5.32 O ACT C 201 B 286 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 13.82 69.26 132.27 11.87 70.14 132.51 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 8.74 63.05 136.42 9.87 62.19 134.79 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 8.26 72.60 129.22 10.14 73.45 129.80 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 14 3 # 14 B 109 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 182 GLU C 72 GLU~? 5.32 O ACT C 201 B 286 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 13.82 69.26 132.27 11.87 70.14 132.51 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 8.74 63.05 136.42 9.87 62.19 134.79 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 8.26 72.60 129.22 10.14 73.45 129.80 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 15 3 # 15 B 109 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 182 GLU C 72 GLU~? 5.32 O ACT C 201 B 286 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 13.82 69.26 132.27 11.87 70.14 132.51 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 8.74 63.05 136.42 9.87 62.19 134.79 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 8.26 72.60 129.22 10.14 73.45 129.80 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 16 3 # 16 B 109 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 182 GLU C 72 GLU~? 5.32 O ACT C 201 B 286 ASN C 129 ASN.? 9.72 O ACT D 201 coo 13.82 69.26 132.27 11.87 70.14 132.51 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 8.74 63.05 136.42 9.87 62.19 134.79 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 8.26 72.60 129.22 10.14 73.45 129.80 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 17 3 # 17 B 109 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 182 GLU C 96 GLU^? 13.00 O ACT C 201 B 286 ASN C 129 ASN.? 9.72 O ACT D 201 coo 13.82 69.26 132.27 11.87 70.14 132.51 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 8.74 63.05 136.42 9.87 62.19 134.79 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 8.26 72.60 129.22 10.14 73.45 129.80 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 18 3 # 18 B 109 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 182 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 286 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 13.82 69.26 132.27 11.87 70.14 132.51 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 8.74 63.05 136.42 9.87 62.19 134.79 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 8.26 72.60 129.22 10.14 73.45 129.80 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 19 3 # 19 B 109 ASP D 100 ASP.? 7.94 OXT ACT A 203 B 182 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 286 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 13.82 69.26 132.27 11.87 70.14 132.51 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 8.74 63.05 136.42 9.87 62.19 134.79 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 8.26 72.60 129.22 10.14 73.45 129.80 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 20 3 # 20 B 109 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 182 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 286 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 13.82 69.26 132.27 11.87 70.14 132.51 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 8.74 63.05 136.42 9.87 62.19 134.79 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 8.26 72.60 129.22 10.14 73.45 129.80 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 21 3 # 21 B 109 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 182 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 286 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 13.82 69.26 132.27 11.87 70.14 132.51 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 8.74 63.05 136.42 9.87 62.19 134.79 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 8.26 72.60 129.22 10.14 73.45 129.80 -42.23 60.94 49.15 -42.50 59.01 49.99 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 21 hits 1b57_c01 naa= 3 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 60 GLU A 72 GLU~? 5.31 O ACT A 201 A 148 CYH A 127 CYH.? 6.15 O ACT A 202 A 179 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 20.47 15.77 27.32 19.04 14.27 26.94 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 21.87 3.71 21.27 20.32 3.55 23.64 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 17.09 11.24 20.19 17.85 10.05 21.76 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 A 60 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 148 CYH B 127 CYH.? 10.07 OXT ACT A 201 A 179 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 20.47 15.77 27.32 19.04 14.27 26.94 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 21.87 3.71 21.27 20.32 3.55 23.64 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 17.09 11.24 20.19 17.85 10.05 21.76 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 3 3 # 3 A 60 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 148 CYH B 127 CYH.? 10.07 OXT ACT A 201 A 179 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 20.47 15.77 27.32 19.04 14.27 26.94 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 21.87 3.71 21.27 20.32 3.55 23.64 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 17.09 11.24 20.19 17.85 10.05 21.76 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 4 3 # 4 A 60 GLU C 72 GLU~? 5.32 O ACT C 201 A 148 CYH C 127 CYH.? 10.01 O ACT D 201 A 179 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 20.47 15.77 27.32 19.04 14.27 26.94 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 21.87 3.71 21.27 20.32 3.55 23.64 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 17.09 11.24 20.19 17.85 10.05 21.76 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 5 3 # 5 A 60 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 148 CYH D 127 CYH.? 10.01 OXT ACT C 201 A 179 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 20.47 15.77 27.32 19.04 14.27 26.94 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 21.87 3.71 21.27 20.32 3.55 23.64 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 17.09 11.24 20.19 17.85 10.05 21.76 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 6 3 # 6 A 60 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 148 CYH D 127 CYH.? 10.01 OXT ACT C 201 A 179 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 20.47 15.77 27.32 19.04 14.27 26.94 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 21.87 3.71 21.27 20.32 3.55 23.64 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 17.09 11.24 20.19 17.85 10.05 21.76 -44.22 66.27 50.20 -46.22 65.66 49.92 1b5d_c04 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 6 hits 1b5d_c04 naa= 3 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 60 GLU A 72 GLU~? 5.31 O ACT A 201 B 148 CYH A 127 CYH.? 6.15 O ACT A 202 B 179 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 30.30 0.93 3.58 31.01 1.18 0.88 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 B 60 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 148 CYH B 127 CYH.? 10.07 OXT ACT A 201 B 179 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 30.30 0.93 3.58 31.01 1.18 0.88 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 3 3 # 3 B 60 GLU C 72 GLU~? 5.32 O ACT C 201 B 148 CYH C 127 CYH.? 10.01 O ACT D 201 B 179 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 30.30 0.93 3.58 31.01 1.18 0.88 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 4 3 # 4 B 60 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 148 CYH D 127 CYH.? 10.01 OXT ACT C 201 B 179 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 30.30 0.93 3.58 31.01 1.18 0.88 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -44.77 63.42 52.85 -43.43 61.81 52.77 1b5d_c05 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 4 hits 1b5d_c05 naa= 3 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 1 3 # 1 124 ASP A 74 ASP^? 5.73 OXT ACT A 203 260 ASP A 99 ASP.? 5.71 O2 EDO A 301 289 HIS A 98 HIS^? -3.60 C ACT A 203s coo 30.43 27.27 28.31 29.04 28.69 29.00 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 34.79 33.03 22.11 33.47 32.83 23.76 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 30.83 30.57 23.91 30.62 30.06 25.92 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 2 3 # 2 124 ASP A 99 ASP.? 5.71 O2 EDO A 301 260 ASP A 74 ASP^? 5.73 OXT ACT A 203 289 HIS A 98 HIS^? -3.60 C ACT A 203s coo 30.43 27.27 28.31 29.04 28.69 29.00 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 34.79 33.03 22.11 33.47 32.83 23.76 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 30.83 30.57 23.91 30.62 30.06 25.92 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 3 3 # 3 124 ASP A 100 ASP.? 9.07 O2 EDO A 301 260 ASP A 74 ASP^? 5.73 OXT ACT A 203 289 HIS A 98 HIS^? -3.60 C ACT A 203s coo 30.43 27.27 28.31 29.04 28.69 29.00 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 34.79 33.03 22.11 33.47 32.83 23.76 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 30.83 30.57 23.91 30.62 30.06 25.92 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 4 3 # 4 124 ASP B 74 ASP^? 14.88 OXT ACT B 201 260 ASP B 99 ASP.? 16.09 OXT ACT B 201 289 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo 30.43 27.27 28.31 29.04 28.69 29.00 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 34.79 33.03 22.11 33.47 32.83 23.76 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 30.83 30.57 23.91 30.62 30.06 25.92 -30.93 39.91 75.36 -31.53 38.49 76.78 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 5 3 # 5 124 ASP B 99 ASP.? 16.09 OXT ACT B 201 260 ASP B 74 ASP^? 14.88 OXT ACT B 201 289 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo 30.43 27.27 28.31 29.04 28.69 29.00 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 34.79 33.03 22.11 33.47 32.83 23.76 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 30.83 30.57 23.91 30.62 30.06 25.92 -30.93 39.91 75.36 -31.53 38.49 76.78 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 6 3 # 6 124 ASP C 74 ASP^? 14.86 O ACT C 201 260 ASP C 99 ASP.? 5.79 O1 EDO A 301 289 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 30.43 27.27 28.31 29.04 28.69 29.00 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 34.79 33.03 22.11 33.47 32.83 23.76 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 30.83 30.57 23.91 30.62 30.06 25.92 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 7 3 # 7 124 ASP C 99 ASP.? 5.79 O1 EDO A 301 260 ASP C 74 ASP^? 14.86 O ACT C 201 289 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 30.43 27.27 28.31 29.04 28.69 29.00 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 34.79 33.03 22.11 33.47 32.83 23.76 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.83 30.57 23.91 30.62 30.06 25.92 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 8 3 # 8 124 ASP C 100 ASP.? 9.05 C1 EDO A 301 260 ASP C 74 ASP^? 14.86 O ACT C 201 289 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 30.43 27.27 28.31 29.04 28.69 29.00 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 34.79 33.03 22.11 33.47 32.83 23.76 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.83 30.57 23.91 30.62 30.06 25.92 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 9 3 # 9 124 ASP D 74 ASP^? 14.85 OXT ACT D 201 260 ASP D 99 ASP.? 7.94 CH3 ACT A 203 289 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo 30.43 27.27 28.31 29.04 28.69 29.00 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 34.79 33.03 22.11 33.47 32.83 23.76 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 30.83 30.57 23.91 30.62 30.06 25.92 -48.48 77.63 46.64 -50.12 78.90 46.30 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 10 3 # 10 124 ASP D 99 ASP.? 7.94 CH3 ACT A 203 260 ASP D 74 ASP^? 14.85 OXT ACT D 201 289 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo 30.43 27.27 28.31 29.04 28.69 29.00 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 34.79 33.03 22.11 33.47 32.83 23.76 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 30.83 30.57 23.91 30.62 30.06 25.92 -48.48 77.63 46.64 -50.12 78.90 46.30 1b6g_c00 source 1b6g HALOALKANE DEHALOGENASE : 10 hits 1b6g_c00 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 75 TYR^? -4.52 O ACT A 201s A 230 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 273 LYS A 139 LYS.? 17.81 O ACT A 201 coo 9.23 21.44 106.88 10.18 19.34 105.31 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 1.45 22.80 104.16 2.58 21.02 104.01 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 2.97 11.64 107.87 6.59 15.13 107.03 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR A 95 TYR^? -3.85 O ACT A 201s A 230 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 273 LYS A 68 LYS~? -2.78 O ACT A 201s coo 9.23 21.44 106.88 10.18 19.34 105.31 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 1.45 22.80 104.16 2.58 21.02 104.01 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 2.97 11.64 107.87 6.59 15.13 107.03 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 A 145 TYR A 95 TYR^? -3.85 O ACT A 201s A 230 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 273 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 9.23 21.44 106.88 10.18 19.34 105.31 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 1.45 22.80 104.16 2.58 21.02 104.01 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 2.97 11.64 107.87 6.59 15.13 107.03 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 A 145 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 230 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 273 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 9.23 21.44 106.88 10.18 19.34 105.31 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 1.45 22.80 104.16 2.58 21.02 104.01 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 2.97 11.64 107.87 6.59 15.13 107.03 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 A 145 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 230 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 273 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 9.23 21.44 106.88 10.18 19.34 105.31 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 1.45 22.80 104.16 2.58 21.02 104.01 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 2.97 11.64 107.87 6.59 15.13 107.03 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 A 145 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 230 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 273 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 9.23 21.44 106.88 10.18 19.34 105.31 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 1.45 22.80 104.16 2.58 21.02 104.01 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 2.97 11.64 107.87 6.59 15.13 107.03 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 A 145 TYR C 75 TYR^? -4.54 O ACT C 201s A 230 ASP C 74 ASP^? 14.86 O ACT C 201 A 273 LYS C 139 LYS.? 18.79 O ACT C 201 coo 9.23 21.44 106.88 10.18 19.34 105.31 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 1.45 22.80 104.16 2.58 21.02 104.01 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 2.97 11.64 107.87 6.59 15.13 107.03 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 A 145 TYR C 95 TYR^? -3.84 O ACT C 201s A 230 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 273 LYS C 68 LYS~? -2.77 O ACT C 201s coo 9.23 21.44 106.88 10.18 19.34 105.31 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 1.45 22.80 104.16 2.58 21.02 104.01 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 2.97 11.64 107.87 6.59 15.13 107.03 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 A 145 TYR C 95 TYR^? -3.84 O ACT C 201s A 230 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 273 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 9.23 21.44 106.88 10.18 19.34 105.31 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 1.45 22.80 104.16 2.58 21.02 104.01 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 2.97 11.64 107.87 6.59 15.13 107.03 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 A 145 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 230 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 273 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 9.23 21.44 106.88 10.18 19.34 105.31 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 1.45 22.80 104.16 2.58 21.02 104.01 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 2.97 11.64 107.87 6.59 15.13 107.03 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 11 3 # 11 A 145 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 230 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 273 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 9.23 21.44 106.88 10.18 19.34 105.31 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 1.45 22.80 104.16 2.58 21.02 104.01 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 2.97 11.64 107.87 6.59 15.13 107.03 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 12 3 # 12 A 145 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 230 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 273 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 9.23 21.44 106.88 10.18 19.34 105.31 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 1.45 22.80 104.16 2.58 21.02 104.01 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 2.97 11.64 107.87 6.59 15.13 107.03 -54.54 71.95 50.35 -50.70 67.51 52.69 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 12 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 75 TYR^? -4.52 O ACT A 201s B 230 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 273 LYS A 139 LYS.? 17.81 O ACT A 201 coo 11.81 13.41 73.03 10.00 13.03 75.12 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 19.17 11.01 76.14 17.26 10.42 76.77 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 11.10 2.31 76.60 10.24 7.24 75.62 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR A 95 TYR^? -3.85 O ACT A 201s B 230 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 273 LYS A 68 LYS~? -2.78 O ACT A 201s coo 11.81 13.41 73.03 10.00 13.03 75.12 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 19.17 11.01 76.14 17.26 10.42 76.77 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 11.10 2.31 76.60 10.24 7.24 75.62 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 B 145 TYR A 95 TYR^? -3.85 O ACT A 201s B 230 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 273 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 11.81 13.41 73.03 10.00 13.03 75.12 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 19.17 11.01 76.14 17.26 10.42 76.77 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 11.10 2.31 76.60 10.24 7.24 75.62 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 B 145 TYR B 75 TYR^? -4.59 OXT ACT B 201s B 230 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 273 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 11.81 13.41 73.03 10.00 13.03 75.12 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 19.17 11.01 76.14 17.26 10.42 76.77 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 11.10 2.31 76.60 10.24 7.24 75.62 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 B 145 TYR B 95 TYR^? -3.87 OXT ACT B 201s B 230 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 273 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 11.81 13.41 73.03 10.00 13.03 75.12 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 19.17 11.01 76.14 17.26 10.42 76.77 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 11.10 2.31 76.60 10.24 7.24 75.62 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 B 145 TYR B 95 TYR^? -3.87 OXT ACT B 201s B 230 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 273 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 11.81 13.41 73.03 10.00 13.03 75.12 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 19.17 11.01 76.14 17.26 10.42 76.77 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 11.10 2.31 76.60 10.24 7.24 75.62 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 B 145 TYR C 75 TYR^? -4.54 O ACT C 201s B 230 ASP C 74 ASP^? 14.86 O ACT C 201 B 273 LYS C 139 LYS.? 18.79 O ACT C 201 coo 11.81 13.41 73.03 10.00 13.03 75.12 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 19.17 11.01 76.14 17.26 10.42 76.77 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 11.10 2.31 76.60 10.24 7.24 75.62 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 B 145 TYR C 95 TYR^? -3.84 O ACT C 201s B 230 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 273 LYS C 68 LYS~? -2.77 O ACT C 201s coo 11.81 13.41 73.03 10.00 13.03 75.12 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 19.17 11.01 76.14 17.26 10.42 76.77 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 11.10 2.31 76.60 10.24 7.24 75.62 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 B 145 TYR C 95 TYR^? -3.84 O ACT C 201s B 230 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 273 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 11.81 13.41 73.03 10.00 13.03 75.12 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 19.17 11.01 76.14 17.26 10.42 76.77 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 11.10 2.31 76.60 10.24 7.24 75.62 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 B 145 TYR D 75 TYR^? -4.49 OXT ACT D 201s B 230 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 273 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 11.81 13.41 73.03 10.00 13.03 75.12 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 19.17 11.01 76.14 17.26 10.42 76.77 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 11.10 2.31 76.60 10.24 7.24 75.62 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 11 3 # 11 B 145 TYR D 95 TYR^? -3.79 OXT ACT D 201s B 230 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 273 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 11.81 13.41 73.03 10.00 13.03 75.12 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 19.17 11.01 76.14 17.26 10.42 76.77 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 11.10 2.31 76.60 10.24 7.24 75.62 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 12 3 # 12 B 145 TYR D 95 TYR^? -3.79 OXT ACT D 201s B 230 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 273 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 11.81 13.41 73.03 10.00 13.03 75.12 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 19.17 11.01 76.14 17.26 10.42 76.77 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 11.10 2.31 76.60 10.24 7.24 75.62 -54.54 71.95 50.35 -50.70 67.51 52.69 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 12 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 84 PHE^? 19.84 CH3 ACT A 201 A 159 ASP A 86 ASP.? 20.24 CH3 ACT A 202 A 188 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 13.91 34.58 14.67 12.95 36.00 12.47 -24.05 77.11 82.23 -23.91 79.14 84.16 coo 20.97 28.40 16.26 20.19 30.15 15.34 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 22.55 41.65 15.60 18.92 37.20 14.63 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 159 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 188 LYS A 68 LYS~? -2.78 O ACT A 201s coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 20.97 28.40 16.26 20.19 30.15 15.34 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 22.55 41.65 15.60 18.92 37.20 14.63 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 159 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 188 LYS A 134 LYS~? 11.98 O ACT A 203 coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 20.97 28.40 16.26 20.19 30.15 15.34 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 22.55 41.65 15.60 18.92 37.20 14.63 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 159 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 188 LYS A 68 LYS~? -2.78 O ACT A 201s coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 20.97 28.40 16.26 20.19 30.15 15.34 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 22.55 41.65 15.60 18.92 37.20 14.63 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 159 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 188 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 20.97 28.40 16.26 20.19 30.15 15.34 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 22.55 41.65 15.60 18.92 37.20 14.63 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 159 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 188 LYS A 68 LYS~? -2.78 O ACT A 201s coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 20.97 28.40 16.26 20.19 30.15 15.34 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 22.55 41.65 15.60 18.92 37.20 14.63 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 159 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 188 LYS A 134 LYS~? 11.98 O ACT A 203 coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 20.97 28.40 16.26 20.19 30.15 15.34 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 22.55 41.65 15.60 18.92 37.20 14.63 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 8 3 # 8 A 88 PHE B 84 PHE^? 19.62 CH3 ACT A 202 A 159 ASP B 86 ASP.? 24.07 CH3 ACT B 201 A 188 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 13.91 34.58 14.67 12.95 36.00 12.47 -22.29 70.30 88.22 -19.89 71.38 89.16 coo 20.97 28.40 16.26 20.19 30.15 15.34 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 22.55 41.65 15.60 18.92 37.20 14.63 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 9 3 # 9 A 88 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 159 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 188 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 13.91 34.58 14.67 12.95 36.00 12.47 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 20.97 28.40 16.26 20.19 30.15 15.34 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 22.55 41.65 15.60 18.92 37.20 14.63 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 10 3 # 10 A 88 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 159 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 188 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 20.97 28.40 16.26 20.19 30.15 15.34 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 22.55 41.65 15.60 18.92 37.20 14.63 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 11 3 # 11 A 88 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 159 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 188 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 13.91 34.58 14.67 12.95 36.00 12.47 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 20.97 28.40 16.26 20.19 30.15 15.34 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 22.55 41.65 15.60 18.92 37.20 14.63 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 12 3 # 12 A 88 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 159 ASP C 74 ASP^? 14.86 O ACT C 201 A 188 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 13.91 34.58 14.67 12.95 36.00 12.47 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 20.97 28.40 16.26 20.19 30.15 15.34 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 22.55 41.65 15.60 18.92 37.20 14.63 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 13 3 # 13 A 88 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 159 ASP C 74 ASP^? 14.86 O ACT C 201 A 188 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 20.97 28.40 16.26 20.19 30.15 15.34 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 22.55 41.65 15.60 18.92 37.20 14.63 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 14 3 # 14 A 88 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 159 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 188 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 13.91 34.58 14.67 12.95 36.00 12.47 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 20.97 28.40 16.26 20.19 30.15 15.34 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 22.55 41.65 15.60 18.92 37.20 14.63 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 15 3 # 15 A 88 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 159 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 188 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 13.91 34.58 14.67 12.95 36.00 12.47 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 20.97 28.40 16.26 20.19 30.15 15.34 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 22.55 41.65 15.60 18.92 37.20 14.63 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 16 3 # 16 A 88 PHE C 84 PHE^? 19.83 CH3 ACT C 201 A 159 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 188 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 13.91 34.58 14.67 12.95 36.00 12.47 -43.84 41.52 34.02 -45.03 39.44 32.58 coo 20.97 28.40 16.26 20.19 30.15 15.34 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 22.55 41.65 15.60 18.92 37.20 14.63 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 17 3 # 17 A 88 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 159 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 188 LYS C 68 LYS~? -2.77 O ACT C 201s coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 20.97 28.40 16.26 20.19 30.15 15.34 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 22.55 41.65 15.60 18.92 37.20 14.63 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 18 3 # 18 A 88 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 159 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 188 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 20.97 28.40 16.26 20.19 30.15 15.34 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 22.55 41.65 15.60 18.92 37.20 14.63 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 19 3 # 19 A 88 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 159 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 188 LYS C 68 LYS~? -2.77 O ACT C 201s coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 20.97 28.40 16.26 20.19 30.15 15.34 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 22.55 41.65 15.60 18.92 37.20 14.63 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 20 3 # 20 A 88 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 159 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 188 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 20.97 28.40 16.26 20.19 30.15 15.34 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 22.55 41.65 15.60 18.92 37.20 14.63 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 21 3 # 21 A 88 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 159 ASP C 74 ASP^? 14.86 O ACT C 201 A 188 LYS C 68 LYS~? -2.77 O ACT C 201s coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 20.97 28.40 16.26 20.19 30.15 15.34 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 22.55 41.65 15.60 18.92 37.20 14.63 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 22 3 # 22 A 88 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 159 ASP C 74 ASP^? 14.86 O ACT C 201 A 188 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 20.97 28.40 16.26 20.19 30.15 15.34 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 22.55 41.65 15.60 18.92 37.20 14.63 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 23 3 # 23 A 88 PHE D 84 PHE^? 19.80 CH3 ACT D 201 A 159 ASP D 86 ASP.? 24.19 CH3 ACT D 201 A 188 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 13.91 34.58 14.67 12.95 36.00 12.47 -48.20 48.22 29.39 -47.23 47.53 26.85 coo 20.97 28.40 16.26 20.19 30.15 15.34 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 22.55 41.65 15.60 18.92 37.20 14.63 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 24 3 # 24 A 88 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 159 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 188 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 20.97 28.40 16.26 20.19 30.15 15.34 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 22.55 41.65 15.60 18.92 37.20 14.63 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 25 3 # 25 A 88 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 159 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 188 LYS D 134 LYS~? 17.34 O ACT A 201 coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 20.97 28.40 16.26 20.19 30.15 15.34 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 22.55 41.65 15.60 18.92 37.20 14.63 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 26 3 # 26 A 88 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 159 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 188 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 20.97 28.40 16.26 20.19 30.15 15.34 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 22.55 41.65 15.60 18.92 37.20 14.63 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 27 3 # 27 A 88 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 159 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 188 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 20.97 28.40 16.26 20.19 30.15 15.34 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 22.55 41.65 15.60 18.92 37.20 14.63 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 28 3 # 28 A 88 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 159 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 188 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 20.97 28.40 16.26 20.19 30.15 15.34 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 22.55 41.65 15.60 18.92 37.20 14.63 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 29 3 # 29 A 88 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 159 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 188 LYS D 134 LYS~? 17.34 O ACT A 201 coo 13.91 34.58 14.67 12.95 36.00 12.47 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 20.97 28.40 16.26 20.19 30.15 15.34 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 22.55 41.65 15.60 18.92 37.20 14.63 -37.62 76.93 46.97 -33.08 76.47 49.79 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 29 hits 1b9h_c02 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP A 99 ASP.? 5.71 O2 EDO A 301 35 SER A 101 SER.? 7.80 O2 EDO A 301 215 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 61.19 45.85 78.73 62.86 45.48 77.48 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 66.00 46.17 80.29 64.31 47.92 79.91 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 63.61 40.10 74.06 64.05 42.07 74.70 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1bbs_c06 RENIN user 2 3 # 2 32 ASP B 99 ASP.? 16.09 OXT ACT B 201 35 SER B 101 SER.? 19.25 O ACT C 201 215 ASP C 74 ASP^? 14.86 O ACT C 201 coo 61.19 45.85 78.73 62.86 45.48 77.48 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 66.00 46.17 80.29 64.31 47.92 79.91 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 63.61 40.10 74.06 64.05 42.07 74.70 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1bbs_c06 RENIN user 3 3 # 3 32 ASP C 99 ASP.? 5.79 O1 EDO A 301 35 SER C 101 SER.? 7.85 O1 EDO A 301 215 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 61.19 45.85 78.73 62.86 45.48 77.48 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 66.00 46.17 80.29 64.31 47.92 79.91 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 63.61 40.10 74.06 64.05 42.07 74.70 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1bbs_c06 RENIN user 4 3 # 4 32 ASP D 99 ASP.? 7.94 CH3 ACT A 203 35 SER D 101 SER.? 9.16 OXT ACT A 203 215 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 61.19 45.85 78.73 62.86 45.48 77.48 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 66.00 46.17 80.29 64.31 47.92 79.91 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 63.61 40.10 74.06 64.05 42.07 74.70 -44.71 72.29 58.72 -45.62 72.95 56.93 1bbs_c06 source 1bbs RENIN : 4 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP A 99 ASP.? 5.71 O2 EDO A 301 35 SER A 101 SER.? 7.80 O2 EDO A 301 215 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 61.19 45.85 78.73 62.86 45.48 77.48 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 66.00 46.17 80.29 64.31 47.92 79.91 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 63.61 40.10 74.06 64.05 42.07 74.70 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1bbs_c07 RENIN user 2 3 # 2 32 ASP B 99 ASP.? 16.09 OXT ACT B 201 35 SER B 101 SER.? 19.25 O ACT C 201 215 ASP C 74 ASP^? 14.86 O ACT C 201 coo 61.19 45.85 78.73 62.86 45.48 77.48 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 66.00 46.17 80.29 64.31 47.92 79.91 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 63.61 40.10 74.06 64.05 42.07 74.70 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1bbs_c07 RENIN user 3 3 # 3 32 ASP C 99 ASP.? 5.79 O1 EDO A 301 35 SER C 101 SER.? 7.85 O1 EDO A 301 215 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 61.19 45.85 78.73 62.86 45.48 77.48 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 66.00 46.17 80.29 64.31 47.92 79.91 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 63.61 40.10 74.06 64.05 42.07 74.70 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1bbs_c07 RENIN user 4 3 # 4 32 ASP D 99 ASP.? 7.94 CH3 ACT A 203 35 SER D 101 SER.? 9.16 OXT ACT A 203 215 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 61.19 45.85 78.73 62.86 45.48 77.48 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 66.00 46.17 80.29 64.31 47.92 79.91 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 63.61 40.10 74.06 64.05 42.07 74.70 -44.71 72.29 58.72 -45.62 72.95 56.93 1bbs_c07 source 1bbs RENIN : 4 hits 1bbs_c07 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 8 ARG.? 15.23 CH3 ACT A 201 A 141 THR A 43 THR^? 16.05 OXT ACT A 202 A 235 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 6.21 93.81 36.58 4.58 96.33 37.17 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 6.80 92.87 28.33 4.91 92.74 27.40 -16.17 72.65 63.81 -15.51 71.79 65.68 coo 12.98 90.36 47.57 11.26 89.62 46.62 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 141 THR A 46 THR^? 13.12 OXT ACT A 202 A 235 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 6.21 93.81 36.58 4.58 96.33 37.17 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 6.80 92.87 28.33 4.91 92.74 27.40 -17.27 68.11 64.46 -19.35 68.72 64.20 coo 12.98 90.36 47.57 11.26 89.62 46.62 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 141 THR A 46 THR^? 13.12 OXT ACT A 202 A 235 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 6.21 93.81 36.58 4.58 96.33 37.17 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 6.80 92.87 28.33 4.91 92.74 27.40 -17.27 68.11 64.46 -19.35 68.72 64.20 coo 12.98 90.36 47.57 11.26 89.62 46.62 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG B 124 ARG.? -3.52 O ACT B 201s A 141 THR B 46 THR^? 13.06 O ACT B 201 A 235 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 6.21 93.81 36.58 4.58 96.33 37.17 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 6.80 92.87 28.33 4.91 92.74 27.40 -41.83 63.03 90.93 -40.53 61.43 90.23 coo 12.98 90.36 47.57 11.26 89.62 46.62 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG C 8 ARG.? 14.74 CH3 ACT C 201 A 141 THR C 43 THR^? 17.19 CH3 ACT C 201 A 235 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 6.21 93.81 36.58 4.58 96.33 37.17 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 6.80 92.87 28.33 4.91 92.74 27.40 -25.42 48.08 40.00 -26.53 48.88 38.33 coo 12.98 90.36 47.57 11.26 89.62 46.62 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 141 THR C 46 THR^? 13.10 OXT ACT C 201 A 235 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 6.21 93.81 36.58 4.58 96.33 37.17 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 6.80 92.87 28.33 4.91 92.74 27.40 -27.30 52.39 40.74 -28.28 51.51 42.48 coo 12.98 90.36 47.57 11.26 89.62 46.62 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 A 137 ARG D 8 ARG.? 14.56 CH3 ACT D 201 A 141 THR D 43 THR^? 17.14 O ACT D 201 A 235 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 6.21 93.81 36.58 4.58 96.33 37.17 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 6.80 92.87 28.33 4.91 92.74 27.40 -65.70 52.73 39.05 -64.63 50.86 39.25 coo 12.98 90.36 47.57 11.26 89.62 46.62 -55.65 65.73 30.36 -54.18 65.67 28.83 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 A 137 ARG D 123 ARG.? 17.60 O ACT D 201 A 141 THR D 46 THR^? 13.15 O ACT D 201 A 235 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 6.21 93.81 36.58 4.58 96.33 37.17 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 6.80 92.87 28.33 4.91 92.74 27.40 -63.51 52.01 43.24 -62.49 53.88 42.85 coo 12.98 90.36 47.57 11.26 89.62 46.62 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 A 137 ARG D 124 ARG.? -3.55 O ACT D 201s A 141 THR D 46 THR^? 13.15 O ACT D 201 A 235 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 6.21 93.81 36.58 4.58 96.33 37.17 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 6.80 92.87 28.33 4.91 92.74 27.40 -63.51 52.01 43.24 -62.49 53.88 42.85 coo 12.98 90.36 47.57 11.26 89.62 46.62 -55.65 65.73 30.36 -54.18 65.67 28.83 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 9 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 67 ARG~? 13.20 O2 EDO A 302 D 141 THR C 66 THR~? 7.92 O2 EDO A 302 D 235 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -27.55 51.38 57.17 -25.41 51.36 57.47 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 67 ARG~? 13.20 O2 EDO A 302 D 141 THR C 66 THR~? 7.92 O2 EDO A 302 D 235 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -27.55 51.38 57.17 -25.41 51.36 57.47 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 124 ARG.? -3.54 OXT ACT A 201s D 141 THR A 46 THR^? 13.12 OXT ACT A 202 D 235 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -17.27 68.11 64.46 -19.35 68.72 64.20 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG B 124 ARG.? -3.52 O ACT B 201s D 141 THR B 46 THR^? 13.06 O ACT B 201 D 235 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -41.83 63.03 90.93 -40.53 61.43 90.23 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG C 67 ARG~? 12.50 O2 EDO A 302 D 141 THR A 66 THR~? 13.87 O ACT A 201 D 235 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -30.35 68.05 54.38 -29.23 68.39 52.56 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG C 67 ARG~? 12.50 O2 EDO A 302 D 141 THR A 66 THR~? 13.87 O ACT A 201 D 235 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -30.35 68.05 54.38 -29.23 68.39 52.56 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 D 137 ARG C 124 ARG.? -3.50 OXT ACT C 201s D 141 THR C 46 THR^? 13.10 OXT ACT C 201 D 235 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -34.72 50.67 45.47 -36.40 51.18 47.99 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -27.30 52.39 40.74 -28.28 51.51 42.48 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 D 137 ARG D 124 ARG.? -3.55 O ACT D 201s D 141 THR D 46 THR^? 13.15 O ACT D 201 D 235 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -63.51 52.01 43.24 -62.49 53.88 42.85 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -55.65 65.73 30.36 -54.18 65.67 28.83 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 8 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 8 ARG.? 15.23 CH3 ACT A 201 C 141 THR A 43 THR^? 16.05 OXT ACT A 202 C 235 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -20.16 79.98 64.14 -22.57 80.76 62.41 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -16.17 72.65 63.81 -15.51 71.79 65.68 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 67 ARG~? 13.20 O2 EDO A 302 C 141 THR C 66 THR~? 7.92 O2 EDO A 302 C 235 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -27.55 51.38 57.17 -25.41 51.36 57.47 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG A 67 ARG~? 13.20 O2 EDO A 302 C 141 THR C 66 THR~? 7.92 O2 EDO A 302 C 235 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -27.55 51.38 57.17 -25.41 51.36 57.47 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG A 123 ARG.? 8.27 CH3 ACT A 202 C 141 THR A 46 THR^? 13.12 OXT ACT A 202 C 235 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -16.75 65.40 71.93 -16.81 64.50 74.86 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -17.27 68.11 64.46 -19.35 68.72 64.20 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG A 124 ARG.? -3.54 OXT ACT A 201s C 141 THR A 46 THR^? 13.12 OXT ACT A 202 C 235 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -17.27 68.11 64.46 -19.35 68.72 64.20 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG B 124 ARG.? -3.52 O ACT B 201s C 141 THR B 46 THR^? 13.06 O ACT B 201 C 235 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -41.83 63.03 90.93 -40.53 61.43 90.23 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 C 137 ARG C 8 ARG.? 14.74 CH3 ACT C 201 C 141 THR C 43 THR^? 17.19 CH3 ACT C 201 C 235 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -27.18 40.10 42.21 -27.55 39.63 45.22 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -25.42 48.08 40.00 -26.53 48.88 38.33 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 C 137 ARG C 67 ARG~? 12.50 O2 EDO A 302 C 141 THR A 66 THR~? 13.87 O ACT A 201 C 235 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -30.35 68.05 54.38 -29.23 68.39 52.56 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 C 137 ARG C 67 ARG~? 12.50 O2 EDO A 302 C 141 THR A 66 THR~? 13.87 O ACT A 201 C 235 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -30.35 68.05 54.38 -29.23 68.39 52.56 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 C 137 ARG C 124 ARG.? -3.50 OXT ACT C 201s C 141 THR C 46 THR^? 13.10 OXT ACT C 201 C 235 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -34.72 50.67 45.47 -36.40 51.18 47.99 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -27.30 52.39 40.74 -28.28 51.51 42.48 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 C 137 ARG D 8 ARG.? 14.56 CH3 ACT D 201 C 141 THR D 43 THR^? 17.14 O ACT D 201 C 235 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -64.40 57.42 32.12 -63.44 60.33 32.35 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -65.70 52.73 39.05 -64.63 50.86 39.25 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -55.65 65.73 30.36 -54.18 65.67 28.83 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 C 137 ARG D 123 ARG.? 17.60 O ACT D 201 C 141 THR D 46 THR^? 13.15 O ACT D 201 C 235 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -58.14 46.42 43.58 -55.81 44.43 43.54 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -63.51 52.01 43.24 -62.49 53.88 42.85 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 C 137 ARG D 124 ARG.? -3.55 O ACT D 201s C 141 THR D 46 THR^? 13.15 O ACT D 201 C 235 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -63.51 52.01 43.24 -62.49 53.88 42.85 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -55.65 65.73 30.36 -54.18 65.67 28.83 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 13 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 124 ARG.? -3.54 OXT ACT A 201s B 141 THR A 46 THR^? 13.12 OXT ACT A 202 B 235 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 8.13 67.41 100.27 7.18 68.35 97.45 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 8.28 67.78 108.81 6.22 67.65 109.43 -17.27 68.11 64.46 -19.35 68.72 64.20 coo 14.55 73.52 89.47 12.81 73.95 90.56 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG B 124 ARG.? -3.52 O ACT B 201s B 141 THR B 46 THR^? 13.06 O ACT B 201 B 235 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 8.13 67.41 100.27 7.18 68.35 97.45 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 8.28 67.78 108.81 6.22 67.65 109.43 -41.83 63.03 90.93 -40.53 61.43 90.23 coo 14.55 73.52 89.47 12.81 73.95 90.56 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG C 124 ARG.? -3.50 OXT ACT C 201s B 141 THR C 46 THR^? 13.10 OXT ACT C 201 B 235 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 8.13 67.41 100.27 7.18 68.35 97.45 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 8.28 67.78 108.81 6.22 67.65 109.43 -27.30 52.39 40.74 -28.28 51.51 42.48 coo 14.55 73.52 89.47 12.81 73.95 90.56 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG D 124 ARG.? -3.55 O ACT D 201s B 141 THR D 46 THR^? 13.15 O ACT D 201 B 235 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 8.13 67.41 100.27 7.18 68.35 97.45 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 8.28 67.78 108.81 6.22 67.65 109.43 -63.51 52.01 43.24 -62.49 53.88 42.85 coo 14.55 73.52 89.47 12.81 73.95 90.56 -55.65 65.73 30.36 -54.18 65.67 28.83 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 4 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 74 ASP^? 5.73 OXT ACT A 203 16 HIS A 98 HIS^? -3.60 C ACT A 203s 67 GLY C 102 GLY.? 10.66 O1 EDO A 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -42.58 52.75 70.90 -42.60 53.28 70.31 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 74 ASP^? 5.73 OXT ACT A 203 16 HIS A 98 HIS^? -3.60 C ACT A 203s 67 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP A 99 ASP.? 5.71 O2 EDO A 301 16 HIS A 98 HIS^? -3.60 C ACT A 203s 67 GLY A 29 GLY~? 9.49 CH3 ACT A 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -30.30 78.71 63.24 -31.02 78.43 63.55 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP A 100 ASP.? 9.07 O2 EDO A 301 16 HIS A 98 HIS^? -3.60 C ACT A 203s 67 GLY A 29 GLY~? 9.49 CH3 ACT A 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -30.30 78.71 63.24 -31.02 78.43 63.55 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP A 100 ASP.? 9.07 O2 EDO A 301 16 HIS A 98 HIS^? -3.60 C ACT A 203s 67 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 6 3 # 6 14 ASP A 100 ASP.? 9.07 O2 EDO A 301 16 HIS A 98 HIS^? -3.60 C ACT A 203s 67 GLY C 102 GLY.? 10.66 O1 EDO A 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -42.58 52.75 70.90 -42.60 53.28 70.31 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 7 3 # 7 14 ASP A 150 ASP.? 22.07 CH3 ACT A 201 16 HIS A 151 HIS.? 15.97 CH3 ACT A 201 67 GLY D 102 GLY.? 12.85 CH3 ACT A 203 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -43.95 88.27 71.85 -43.22 89.50 70.29 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -46.87 80.08 50.24 -46.64 79.47 50.70 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 8 3 # 8 14 ASP B 45 ASP^? 20.35 O ACT B 201 16 HIS B 56 HIS.? 17.31 O ACT B 201 67 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 9 3 # 9 14 ASP B 45 ASP^? 20.35 O ACT B 201 16 HIS B 56 HIS.? 17.31 O ACT B 201 67 GLY A 153 GLY~? 14.45 CH3 ACT A 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -40.49 79.09 75.61 -41.22 78.96 76.01 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 10 3 # 10 14 ASP B 99 ASP.? 16.09 OXT ACT B 201 16 HIS B 98 HIS^? 14.98 OXT ACT B 201 67 GLY B 29 GLY~? 9.46 CH3 ACT B 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -29.24 51.82 91.44 -28.87 51.66 90.72 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 11 3 # 11 14 ASP B 100 ASP.? 15.93 OXT ACT B 201 16 HIS B 98 HIS^? 14.98 OXT ACT B 201 67 GLY B 29 GLY~? 9.46 CH3 ACT B 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -29.24 51.82 91.44 -28.87 51.66 90.72 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 12 3 # 12 14 ASP B 100 ASP.? 15.93 OXT ACT B 201 16 HIS B 98 HIS^? 14.98 OXT ACT B 201 67 GLY B 109 GLY^? 6.82 O ACT B 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 13 3 # 13 14 ASP C 74 ASP^? 14.86 O ACT C 201 16 HIS C 98 HIS^? 11.61 O2 EDO A 301 67 GLY A 102 GLY.? -3.56 O ACT A 203s coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -50.08 63.60 57.27 -49.56 63.13 57.61 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 14 3 # 14 14 ASP C 74 ASP^? 14.86 O ACT C 201 16 HIS C 98 HIS^? 11.61 O2 EDO A 301 67 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 15 3 # 15 14 ASP C 99 ASP.? 5.79 O1 EDO A 301 16 HIS C 98 HIS^? 11.61 O2 EDO A 301 67 GLY C 29 GLY~? 9.51 CH3 ACT C 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -32.89 40.21 50.79 -33.62 40.36 51.16 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 16 3 # 16 14 ASP C 100 ASP.? 9.05 C1 EDO A 301 16 HIS C 98 HIS^? 11.61 O2 EDO A 301 67 GLY A 102 GLY.? -3.56 O ACT A 203s coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -50.08 63.60 57.27 -49.56 63.13 57.61 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 17 3 # 17 14 ASP C 100 ASP.? 9.05 C1 EDO A 301 16 HIS C 98 HIS^? 11.61 O2 EDO A 301 67 GLY C 29 GLY~? 9.51 CH3 ACT C 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -32.89 40.21 50.79 -33.62 40.36 51.16 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 18 3 # 18 14 ASP C 100 ASP.? 9.05 C1 EDO A 301 16 HIS C 98 HIS^? 11.61 O2 EDO A 301 67 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 19 3 # 19 14 ASP C 150 ASP.? 20.99 CH3 ACT C 201 16 HIS C 151 HIS.? 16.03 CH3 ACT C 201 67 GLY B 102 GLY.? 18.26 OXT ACT B 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -46.61 28.46 55.57 -45.54 29.27 57.21 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -32.65 37.69 71.75 -32.89 38.32 71.31 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 20 3 # 20 14 ASP D 99 ASP.? 7.94 CH3 ACT A 203 16 HIS D 98 HIS^? 13.13 CH3 ACT A 203 67 GLY D 29 GLY~? 9.48 CH3 ACT D 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -57.91 65.08 34.12 -57.15 65.32 34.32 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 21 3 # 21 14 ASP D 100 ASP.? 7.94 OXT ACT A 203 16 HIS D 98 HIS^? 13.13 CH3 ACT A 203 67 GLY D 29 GLY~? 9.48 CH3 ACT D 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -57.91 65.08 34.12 -57.15 65.32 34.32 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 22 3 # 22 14 ASP D 100 ASP.? 7.94 OXT ACT A 203 16 HIS D 98 HIS^? 13.13 CH3 ACT A 203 67 GLY D 109 GLY^? 6.89 O ACT D 201 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -45.26 59.49 43.22 -44.76 59.46 42.64 1be1_c02 source 1be1 GLUTAMATE MUTASE : 22 hits 1be1_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 99 ASP.? 5.71 O2 EDO A 301 435 GLU A 72 GLU~? 5.31 O ACT A 201 510 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 88.62 69.90 41.16 89.05 70.67 43.04 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 89.52 76.11 40.17 89.01 75.16 41.97 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 84.89 77.60 46.67 85.63 75.79 46.03 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP A 99 ASP.? 5.71 O2 EDO A 301 435 GLU A 72 GLU~? 5.31 O ACT A 201 510 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 88.62 69.90 41.16 89.05 70.67 43.04 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 89.52 76.11 40.17 89.01 75.16 41.97 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 84.89 77.60 46.67 85.63 75.79 46.03 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1bf2_c00 ISOAMYLASE user 3 3 # 3 375 ASP A 116 ASP.? 19.55 CH3 ACT A 201 435 GLU A 114 GLU^? 11.87 CH3 ACT A 202 510 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 88.62 69.90 41.16 89.05 70.67 43.04 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 89.52 76.11 40.17 89.01 75.16 41.97 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 84.89 77.60 46.67 85.63 75.79 46.03 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1bf2_c00 ISOAMYLASE user 4 3 # 4 375 ASP B 86 ASP.? 24.07 CH3 ACT B 201 435 GLU B 114 GLU^? 18.04 O ACT B 201 510 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo 88.62 69.90 41.16 89.05 70.67 43.04 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 89.52 76.11 40.17 89.01 75.16 41.97 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 84.89 77.60 46.67 85.63 75.79 46.03 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1bf2_c00 ISOAMYLASE user 5 3 # 5 375 ASP B 99 ASP.? 16.09 OXT ACT B 201 435 GLU B 72 GLU~? 5.30 OXT ACT B 201 510 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 88.62 69.90 41.16 89.05 70.67 43.04 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 89.52 76.11 40.17 89.01 75.16 41.97 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 84.89 77.60 46.67 85.63 75.79 46.03 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1bf2_c00 ISOAMYLASE user 6 3 # 6 375 ASP B 99 ASP.? 16.09 OXT ACT B 201 435 GLU B 72 GLU~? 5.30 OXT ACT B 201 510 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 88.62 69.90 41.16 89.05 70.67 43.04 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 89.52 76.11 40.17 89.01 75.16 41.97 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 84.89 77.60 46.67 85.63 75.79 46.03 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1bf2_c00 ISOAMYLASE user 7 3 # 7 375 ASP B 116 ASP.? 19.49 CH3 ACT B 201 435 GLU B 114 GLU^? 18.04 O ACT B 201 510 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 88.62 69.90 41.16 89.05 70.67 43.04 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 89.52 76.11 40.17 89.01 75.16 41.97 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 84.89 77.60 46.67 85.63 75.79 46.03 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1bf2_c00 ISOAMYLASE user 8 3 # 8 375 ASP B 130 ASP.? 9.25 OXT ACT B 201 435 GLU B 72 GLU~? 5.30 OXT ACT B 201 510 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 88.62 69.90 41.16 89.05 70.67 43.04 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 89.52 76.11 40.17 89.01 75.16 41.97 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 84.89 77.60 46.67 85.63 75.79 46.03 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1bf2_c00 ISOAMYLASE user 9 3 # 9 375 ASP C 86 ASP.? 24.03 CH3 ACT C 201 435 GLU C 114 GLU^? 18.18 OXT ACT C 201 510 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 88.62 69.90 41.16 89.05 70.67 43.04 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 89.52 76.11 40.17 89.01 75.16 41.97 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 84.89 77.60 46.67 85.63 75.79 46.03 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1bf2_c00 ISOAMYLASE user 10 3 # 10 375 ASP C 99 ASP.? 5.79 O1 EDO A 301 435 GLU C 72 GLU~? 5.32 O ACT C 201 510 ASP C 74 ASP^? 14.86 O ACT C 201 coo 88.62 69.90 41.16 89.05 70.67 43.04 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 89.52 76.11 40.17 89.01 75.16 41.97 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 84.89 77.60 46.67 85.63 75.79 46.03 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1bf2_c00 ISOAMYLASE user 11 3 # 11 375 ASP C 99 ASP.? 5.79 O1 EDO A 301 435 GLU C 72 GLU~? 5.32 O ACT C 201 510 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 88.62 69.90 41.16 89.05 70.67 43.04 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 89.52 76.11 40.17 89.01 75.16 41.97 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 84.89 77.60 46.67 85.63 75.79 46.03 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1bf2_c00 ISOAMYLASE user 12 3 # 12 375 ASP C 116 ASP.? 19.40 CH3 ACT C 201 435 GLU C 114 GLU^? 18.18 OXT ACT C 201 510 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 88.62 69.90 41.16 89.05 70.67 43.04 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 89.52 76.11 40.17 89.01 75.16 41.97 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 84.89 77.60 46.67 85.63 75.79 46.03 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1bf2_c00 ISOAMYLASE user 13 3 # 13 375 ASP D 99 ASP.? 7.94 CH3 ACT A 203 435 GLU D 72 GLU~? 5.29 OXT ACT D 201 510 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 88.62 69.90 41.16 89.05 70.67 43.04 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 89.52 76.11 40.17 89.01 75.16 41.97 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 84.89 77.60 46.67 85.63 75.79 46.03 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1bf2_c00 ISOAMYLASE user 14 3 # 14 375 ASP D 99 ASP.? 7.94 CH3 ACT A 203 435 GLU D 72 GLU~? 5.29 OXT ACT D 201 510 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 88.62 69.90 41.16 89.05 70.67 43.04 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 89.52 76.11 40.17 89.01 75.16 41.97 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 84.89 77.60 46.67 85.63 75.79 46.03 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1bf2_c00 ISOAMYLASE user 15 3 # 15 375 ASP D 116 ASP.? 19.52 CH3 ACT D 201 435 GLU D 114 GLU^? 18.05 O ACT D 201 510 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 88.62 69.90 41.16 89.05 70.67 43.04 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 89.52 76.11 40.17 89.01 75.16 41.97 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 84.89 77.60 46.67 85.63 75.79 46.03 -53.41 42.17 31.38 -52.32 40.44 30.82 1bf2_c00 source 1bf2 ISOAMYLASE : 15 hits 1bf2_c00 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU A 60 GLU~? 10.63 O2 EDO A 302 70 HIS A 56 HIS.? 6.76 O1 EDO A 302 281 HIS A 161 HIS.? 19.24 O ACT B 201 coo 66.09 46.17 155.81 66.77 48.19 155.70 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 69.05 50.55 157.03 68.00 52.29 156.51 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 100.93 36.73 156.02 100.47 38.42 157.18 -48.72 65.75 79.30 -49.45 66.41 81.15 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 2 3 # 2 28 GLU A 60 GLU~? 10.63 O2 EDO A 302 70 HIS A 56 HIS.? 6.76 O1 EDO A 302 281 HIS A 162 HIS.? 14.54 O1 EDO A 301 coo 66.09 46.17 155.81 66.77 48.19 155.70 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 69.05 50.55 157.03 68.00 52.29 156.51 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 100.93 36.73 156.02 100.47 38.42 157.18 -51.28 62.77 74.01 -50.27 62.16 72.28 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 3 3 # 3 28 GLU A 137 GLU~? 14.03 O ACT A 203 70 HIS A 162 HIS.? 14.54 O1 EDO A 301 281 HIS A 56 HIS.? 6.76 O1 EDO A 302 coo 66.09 46.17 155.81 66.77 48.19 155.70 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 69.05 50.55 157.03 68.00 52.29 156.51 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 100.93 36.73 156.02 100.47 38.42 157.18 -17.38 60.38 62.27 -18.29 58.66 63.03 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 4 3 # 4 28 GLU A 137 GLU~? 14.03 O ACT A 203 70 HIS A 162 HIS.? 14.54 O1 EDO A 301 281 HIS C 151 HIS.? 16.03 CH3 ACT C 201 coo 66.09 46.17 155.81 66.77 48.19 155.70 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 69.05 50.55 157.03 68.00 52.29 156.51 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 100.93 36.73 156.02 100.47 38.42 157.18 -46.81 35.18 56.40 -47.74 36.88 57.21 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 5 3 # 5 28 GLU A 160 GLU.? 13.50 O ACT A 201 70 HIS A 161 HIS.? 19.24 O ACT B 201 281 HIS D 56 HIS.? 17.26 O ACT D 201 coo 66.09 46.17 155.81 66.77 48.19 155.70 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 69.05 50.55 157.03 68.00 52.29 156.51 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 100.93 36.73 156.02 100.47 38.42 157.18 -63.50 51.60 51.23 -61.99 51.43 52.67 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 6 3 # 6 28 GLU D 60 GLU~? 17.31 O ACT D 201 70 HIS D 56 HIS.? 17.26 O ACT D 201 281 HIS A 161 HIS.? 19.24 O ACT B 201 coo 66.09 46.17 155.81 66.77 48.19 155.70 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 69.05 50.55 157.03 68.00 52.29 156.51 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 100.93 36.73 156.02 100.47 38.42 157.18 -48.72 65.75 79.30 -49.45 66.41 81.15 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 6 hits 1bfd_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 503 TYR A 108 TYR^? 12.28 O ACT A 201 A 537 GLU A 160 GLU.? 13.50 O ACT A 201 coo 24.06 146.21 11.09 22.89 146.18 9.36 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 15.91 140.69 8.32 15.71 143.39 9.13 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 16.65 144.44 13.24 18.34 145.22 12.33 -45.30 71.21 75.74 -44.17 71.89 74.09 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU A 160 GLU.? 13.50 O ACT A 201 A 503 TYR A 95 TYR^? -3.85 O ACT A 201s A 537 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 24.06 146.21 11.09 22.89 146.18 9.36 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 15.91 140.69 8.32 15.71 143.39 9.13 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 16.65 144.44 13.24 18.34 145.22 12.33 -44.74 70.71 67.91 -46.53 71.68 68.48 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 2 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 504 TYR A 108 TYR^? 12.28 O ACT A 201 A 540 GLU A 160 GLU.? 13.50 O ACT A 201 coo 81.34 87.29 87.22 82.36 86.09 88.61 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 80.85 81.34 94.77 81.70 80.16 92.41 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 79.94 80.46 88.84 81.11 81.36 87.27 -45.30 71.21 75.74 -44.17 71.89 74.09 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 504 TYR A 108 TYR^? 12.28 O ACT A 201 B 540 GLU A 160 GLU.? 13.50 O ACT A 201 coo 86.52 35.28 112.74 87.08 36.38 110.99 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 84.93 40.21 105.31 85.72 41.45 107.72 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 83.38 41.19 112.55 85.47 40.59 112.72 -45.30 71.21 75.74 -44.17 71.89 74.09 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU A 160 GLU.? 13.50 O ACT A 201 B 504 TYR A 108 TYR^? 12.28 O ACT A 201 B 540 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 86.52 35.28 112.74 87.08 36.38 110.99 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 84.93 40.21 105.31 85.72 41.45 107.72 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 83.38 41.19 112.55 85.47 40.59 112.72 -44.74 70.71 67.91 -46.53 71.68 68.48 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c03 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 58 ARG~? 18.13 CH3 ACT A 201 A 451 GLU A 60 GLU~? 10.63 O2 EDO A 302 A 540 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo 79.04 80.20 80.81 79.58 81.40 83.63 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 81.34 87.29 87.22 82.36 86.09 88.61 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 79.94 80.46 88.84 81.11 81.36 87.27 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG A 67 ARG~? 13.20 O2 EDO A 302 A 451 GLU A 60 GLU~? 10.63 O2 EDO A 302 A 540 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo 79.04 80.20 80.81 79.58 81.40 83.63 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 81.34 87.29 87.22 82.36 86.09 88.61 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 79.94 80.46 88.84 81.11 81.36 87.27 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG A 147 ARG.? 13.06 CH3 ACT A 201 A 451 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 540 GLU A 156 GLU~? 20.10 CH3 ACT A 201 coo 79.04 80.20 80.81 79.58 81.40 83.63 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 81.34 87.29 87.22 82.36 86.09 88.61 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 79.94 80.46 88.84 81.11 81.36 87.27 -42.77 81.40 79.58 -42.85 83.31 78.67 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG B 58 ARG~? 17.86 CH3 ACT B 201 A 451 GLU B 60 GLU~? 17.33 O ACT B 201 A 540 GLU B 59 GLU~? 20.69 O ACT B 201 coo 79.04 80.20 80.81 79.58 81.40 83.63 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 81.34 87.29 87.22 82.36 86.09 88.61 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 79.94 80.46 88.84 81.11 81.36 87.27 -47.90 53.57 92.50 -49.95 53.72 93.03 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 5 3 # 5 A 382 ARG B 147 ARG.? 12.52 CH3 ACT A 202 A 451 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 540 GLU B 156 GLU~? 12.19 CH3 ACT A 202 coo 79.04 80.20 80.81 79.58 81.40 83.63 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 81.34 87.29 87.22 82.36 86.09 88.61 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 79.94 80.46 88.84 81.11 81.36 87.27 -12.52 56.39 79.83 -10.80 57.54 79.39 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 6 3 # 6 A 382 ARG B 147 ARG.? 12.52 CH3 ACT A 202 A 451 GLU B 156 GLU~? 12.19 CH3 ACT A 202 A 540 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 79.04 80.20 80.81 79.58 81.40 83.63 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 81.34 87.29 87.22 82.36 86.09 88.61 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 79.94 80.46 88.84 81.11 81.36 87.27 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 7 3 # 7 A 382 ARG C 58 ARG~? 18.03 CH3 ACT C 201 A 451 GLU C 60 GLU~? 17.22 OXT ACT C 201 A 540 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo 79.04 80.20 80.81 79.58 81.40 83.63 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 81.34 87.29 87.22 82.36 86.09 88.61 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 79.94 80.46 88.84 81.11 81.36 87.27 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 8 3 # 8 A 382 ARG C 147 ARG.? 13.23 CH3 ACT C 201 A 451 GLU C 156 GLU~? 19.44 CH3 ACT C 201 A 540 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 79.04 80.20 80.81 79.58 81.40 83.63 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 81.34 87.29 87.22 82.36 86.09 88.61 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 79.94 80.46 88.84 81.11 81.36 87.27 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 9 3 # 9 A 382 ARG D 58 ARG~? 18.01 CH3 ACT D 201 A 451 GLU D 60 GLU~? 17.31 O ACT D 201 A 540 GLU D 59 GLU~? 18.52 O ACT D 201 coo 79.04 80.20 80.81 79.58 81.40 83.63 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 81.34 87.29 87.22 82.36 86.09 88.61 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 79.94 80.46 88.84 81.11 81.36 87.27 -69.73 60.64 47.66 -70.08 62.16 46.23 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 9 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 58 ARG~? 18.13 CH3 ACT A 201 B 451 GLU A 60 GLU~? 10.63 O2 EDO A 302 B 540 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo 82.21 41.07 119.14 83.95 40.66 116.59 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 86.52 35.28 112.74 87.08 36.38 110.99 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 83.38 41.19 112.55 85.47 40.59 112.72 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG B 58 ARG~? 17.86 CH3 ACT B 201 B 451 GLU B 60 GLU~? 17.33 O ACT B 201 B 540 GLU B 59 GLU~? 20.69 O ACT B 201 coo 82.21 41.07 119.14 83.95 40.66 116.59 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 86.52 35.28 112.74 87.08 36.38 110.99 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 83.38 41.19 112.55 85.47 40.59 112.72 -47.90 53.57 92.50 -49.95 53.72 93.03 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG C 58 ARG~? 18.03 CH3 ACT C 201 B 451 GLU C 60 GLU~? 17.22 OXT ACT C 201 B 540 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo 82.21 41.07 119.14 83.95 40.66 116.59 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 86.52 35.28 112.74 87.08 36.38 110.99 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 83.38 41.19 112.55 85.47 40.59 112.72 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG D 58 ARG~? 18.01 CH3 ACT D 201 B 451 GLU D 60 GLU~? 17.31 O ACT D 201 B 540 GLU D 59 GLU~? 18.52 O ACT D 201 coo 82.21 41.07 119.14 83.95 40.66 116.59 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 86.52 35.28 112.74 87.08 36.38 110.99 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 83.38 41.19 112.55 85.47 40.59 112.72 -69.73 60.64 47.66 -70.08 62.16 46.23 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 8 ARG.? 15.23 CH3 ACT A 201 183 LYS A 22 LYS~? 15.35 CH3 ACT A 201 317 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 76.57 109.19 73.41 73.86 110.26 72.16 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 82.09 117.51 66.37 80.60 114.32 71.44 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 65.21 120.62 58.76 63.62 123.14 59.66 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG A 8 ARG.? 15.23 CH3 ACT A 201 183 LYS A 62 LYS~? 17.60 O ACT A 201 317 ARG A 49 ARG^? -3.92 O ACT A 202s coo 76.57 109.19 73.41 73.86 110.26 72.16 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 82.09 117.51 66.37 80.60 114.32 71.44 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 65.21 120.62 58.76 63.62 123.14 59.66 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG A 16 ARG~? 19.68 CH3 ACT A 201 183 LYS A 22 LYS~? 15.35 CH3 ACT A 201 317 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 76.57 109.19 73.41 73.86 110.26 72.16 -29.16 81.79 84.92 -31.07 79.42 84.55 coo 82.09 117.51 66.37 80.60 114.32 71.44 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 65.21 120.62 58.76 63.62 123.14 59.66 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG A 33 ARG.? 12.39 O ACT A 201 183 LYS A 71 LYS~? 4.32 C2 EDO A 301 317 ARG A 49 ARG^? -3.92 O ACT A 202s coo 76.57 109.19 73.41 73.86 110.26 72.16 -37.81 74.92 58.71 -38.09 77.66 57.35 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG A 33 ARG.? 12.39 O ACT A 201 183 LYS D 134 LYS~? 17.34 O ACT A 201 317 ARG D 51 ARG.? 7.60 O ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -37.81 74.92 58.71 -38.09 77.66 57.35 coo 82.09 117.51 66.37 80.60 114.32 71.44 -37.62 76.93 46.97 -33.08 76.47 49.79 coo 65.21 120.62 58.76 63.62 123.14 59.66 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 6 3 # 6 118 ARG A 37 ARG~? 13.73 CH3 ACT A 201 183 LYS A 22 LYS~? 15.35 CH3 ACT A 201 317 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 76.57 109.19 73.41 73.86 110.26 72.16 -28.83 80.54 58.97 -30.62 82.33 60.70 coo 82.09 117.51 66.37 80.60 114.32 71.44 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 65.21 120.62 58.76 63.62 123.14 59.66 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 7 3 # 7 118 ARG A 37 ARG~? 13.73 CH3 ACT A 201 183 LYS A 62 LYS~? 17.60 O ACT A 201 317 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 76.57 109.19 73.41 73.86 110.26 72.16 -28.83 80.54 58.97 -30.62 82.33 60.70 coo 82.09 117.51 66.37 80.60 114.32 71.44 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 65.21 120.62 58.76 63.62 123.14 59.66 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 8 3 # 8 118 ARG A 49 ARG^? -3.92 O ACT A 202s 183 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 317 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 82.09 117.51 66.37 80.60 114.32 71.44 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 65.21 120.62 58.76 63.62 123.14 59.66 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 9 3 # 9 118 ARG A 49 ARG^? -3.92 O ACT A 202s 183 LYS B 139 LYS.? 6.99 C1 EDO A 302 317 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 82.09 117.51 66.37 80.60 114.32 71.44 -18.83 46.84 75.05 -16.49 49.79 71.17 coo 65.21 120.62 58.76 63.62 123.14 59.66 -20.35 54.64 90.03 -19.09 51.96 89.19 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 10 3 # 10 118 ARG A 49 ARG^? -3.92 O ACT A 202s 183 LYS C 71 LYS~? 4.19 C1 EDO A 301 317 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 11 3 # 11 118 ARG A 51 ARG.? 6.25 O1 EDO A 301 183 LYS A 71 LYS~? 4.32 C2 EDO A 301 317 ARG A 37 ARG~? 13.73 CH3 ACT A 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 -28.83 80.54 58.97 -30.62 82.33 60.70 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 12 3 # 12 118 ARG A 51 ARG.? 6.25 O1 EDO A 301 183 LYS A 71 LYS~? 4.32 C2 EDO A 301 317 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 13 3 # 13 118 ARG A 51 ARG.? 6.25 O1 EDO A 301 183 LYS A 71 LYS~? 4.32 C2 EDO A 301 317 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 76.57 109.19 73.41 73.86 110.26 72.16 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 14 3 # 14 118 ARG A 51 ARG.? 6.25 O1 EDO A 301 183 LYS C 68 LYS~? -2.77 O ACT C 201s 317 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 82.09 117.51 66.37 80.60 114.32 71.44 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 15 3 # 15 118 ARG A 51 ARG.? 6.25 O1 EDO A 301 183 LYS C 68 LYS~? -2.77 O ACT C 201s 317 ARG C 138 ARG~? 16.31 O ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 82.09 117.51 66.37 80.60 114.32 71.44 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 16 3 # 16 118 ARG A 51 ARG.? 6.25 O1 EDO A 301 183 LYS C 68 LYS~? -2.77 O ACT C 201s 317 ARG D 51 ARG.? 7.60 O ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 82.09 117.51 66.37 80.60 114.32 71.44 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 17 3 # 17 118 ARG A 67 ARG~? 13.20 O2 EDO A 302 183 LYS C 62 LYS~? 12.50 O2 EDO A 302 317 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 82.09 117.51 66.37 80.60 114.32 71.44 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 65.21 120.62 58.76 63.62 123.14 59.66 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 18 3 # 18 118 ARG A 67 ARG~? 13.20 O2 EDO A 302 183 LYS C 71 LYS~? 4.19 C1 EDO A 301 317 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 19 3 # 19 118 ARG A 67 ARG~? 13.20 O2 EDO A 302 183 LYS C 71 LYS~? 4.19 C1 EDO A 301 317 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 76.57 109.19 73.41 73.86 110.26 72.16 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 20 3 # 20 118 ARG A 67 ARG~? 13.20 O2 EDO A 302 183 LYS C 71 LYS~? 4.19 C1 EDO A 301 317 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 21 3 # 21 118 ARG A 88 ARG^? 11.13 CH3 ACT A 202 183 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 317 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 82.09 117.51 66.37 80.60 114.32 71.44 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 65.21 120.62 58.76 63.62 123.14 59.66 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 22 3 # 22 118 ARG A 88 ARG^? 11.13 CH3 ACT A 202 183 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 317 ARG B 49 ARG^? 10.37 O ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 82.09 117.51 66.37 80.60 114.32 71.44 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 65.21 120.62 58.76 63.62 123.14 59.66 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 23 3 # 23 118 ARG A 88 ARG^? 11.13 CH3 ACT A 202 183 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 317 ARG B 123 ARG.? 17.76 O ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 82.09 117.51 66.37 80.60 114.32 71.44 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 65.21 120.62 58.76 63.62 123.14 59.66 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 24 3 # 24 118 ARG A 106 ARG^? 14.48 O1 EDO A 301 183 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 317 ARG A 49 ARG^? -3.92 O ACT A 202s coo 76.57 109.19 73.41 73.86 110.26 72.16 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 65.21 120.62 58.76 63.62 123.14 59.66 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 25 3 # 25 118 ARG A 106 ARG^? 14.48 O1 EDO A 301 183 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 317 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 76.57 109.19 73.41 73.86 110.26 72.16 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 65.21 120.62 58.76 63.62 123.14 59.66 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 26 3 # 26 118 ARG A 124 ARG.? -3.54 OXT ACT A 201s 183 LYS A 22 LYS~? 15.35 CH3 ACT A 201 317 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 76.57 109.19 73.41 73.86 110.26 72.16 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 82.09 117.51 66.37 80.60 114.32 71.44 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 65.21 120.62 58.76 63.62 123.14 59.66 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 27 3 # 27 118 ARG A 124 ARG.? -3.54 OXT ACT A 201s 183 LYS A 62 LYS~? 17.60 O ACT A 201 317 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 82.09 117.51 66.37 80.60 114.32 71.44 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 65.21 120.62 58.76 63.62 123.14 59.66 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 28 3 # 28 118 ARG A 124 ARG.? -3.54 OXT ACT A 201s 183 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 317 ARG B 124 ARG.? -3.52 O ACT B 201s coo 76.57 109.19 73.41 73.86 110.26 72.16 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 65.21 120.62 58.76 63.62 123.14 59.66 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 29 3 # 29 118 ARG A 146 ARG.? 16.48 CH3 ACT A 201 183 LYS A 22 LYS~? 15.35 CH3 ACT A 201 317 ARG A 58 ARG~? 18.13 CH3 ACT A 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 82.09 117.51 66.37 80.60 114.32 71.44 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 65.21 120.62 58.76 63.62 123.14 59.66 -18.95 73.08 58.27 -17.11 75.32 59.26 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 30 3 # 30 118 ARG A 146 ARG.? 16.48 CH3 ACT A 201 183 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 317 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 76.57 109.19 73.41 73.86 110.26 72.16 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 65.21 120.62 58.76 63.62 123.14 59.66 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 31 3 # 31 118 ARG A 147 ARG.? 13.06 CH3 ACT A 201 183 LYS A 139 LYS.? 17.81 O ACT A 201 317 ARG B 123 ARG.? 17.76 O ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 82.09 117.51 66.37 80.60 114.32 71.44 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 65.21 120.62 58.76 63.62 123.14 59.66 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 32 3 # 32 118 ARG B 16 ARG~? 17.22 CH3 ACT A 202 183 LYS B 22 LYS~? 15.43 CH3 ACT B 201 317 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -15.28 68.46 88.00 -14.07 65.73 87.25 coo 82.09 117.51 66.37 80.60 114.32 71.44 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 33 3 # 33 118 ARG B 16 ARG~? 17.22 CH3 ACT A 202 183 LYS B 22 LYS~? 15.43 CH3 ACT B 201 317 ARG B 123 ARG.? 17.76 O ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -15.28 68.46 88.00 -14.07 65.73 87.25 coo 82.09 117.51 66.37 80.60 114.32 71.44 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 34 3 # 34 118 ARG B 33 ARG.? 12.67 OXT ACT B 201 183 LYS B 68 LYS~? -2.79 OXT ACT B 201s 317 ARG A 49 ARG^? -3.92 O ACT A 202s coo 76.57 109.19 73.41 73.86 110.26 72.16 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 65.21 120.62 58.76 63.62 123.14 59.66 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 35 3 # 35 118 ARG B 33 ARG.? 12.67 OXT ACT B 201 183 LYS B 71 LYS~? 10.83 OXT ACT B 201 317 ARG B 49 ARG^? 10.37 O ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 36 3 # 36 118 ARG B 33 ARG.? 12.67 OXT ACT B 201 183 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 317 ARG B 49 ARG^? 10.37 O ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 82.09 117.51 66.37 80.60 114.32 71.44 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 65.21 120.62 58.76 63.62 123.14 59.66 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 37 3 # 37 118 ARG B 37 ARG~? 13.57 CH3 ACT B 201 183 LYS B 62 LYS~? 17.44 OXT ACT B 201 317 ARG B 123 ARG.? 17.76 O ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -31.32 49.06 94.80 -28.26 48.93 94.55 coo 82.09 117.51 66.37 80.60 114.32 71.44 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 65.21 120.62 58.76 63.62 123.14 59.66 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 38 3 # 38 118 ARG B 49 ARG^? 10.37 O ACT B 201 183 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 317 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo 76.57 109.19 73.41 73.86 110.26 72.16 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 65.21 120.62 58.76 63.62 123.14 59.66 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 39 3 # 39 118 ARG B 51 ARG.? 7.67 O ACT B 201 183 LYS B 71 LYS~? 10.83 OXT ACT B 201 317 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 40 3 # 40 118 ARG B 51 ARG.? 7.67 O ACT B 201 183 LYS B 71 LYS~? 10.83 OXT ACT B 201 317 ARG C 76 ARG^? 14.32 O ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 41 3 # 41 118 ARG B 51 ARG.? 7.67 O ACT B 201 183 LYS C 71 LYS~? 4.19 C1 EDO A 301 317 ARG B 138 ARG~? 16.35 OXT ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 -23.44 41.55 74.26 -23.57 39.98 76.87 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 42 3 # 42 118 ARG B 51 ARG.? 7.67 O ACT B 201 183 LYS C 71 LYS~? 4.19 C1 EDO A 301 317 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 43 3 # 43 118 ARG B 88 ARG^? 18.43 CH3 ACT A 201 183 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 317 ARG A 49 ARG^? -3.92 O ACT A 202s coo 76.57 109.19 73.41 73.86 110.26 72.16 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 65.21 120.62 58.76 63.62 123.14 59.66 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 44 3 # 44 118 ARG B 88 ARG^? 18.43 CH3 ACT A 201 183 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 317 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 76.57 109.19 73.41 73.86 110.26 72.16 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 65.21 120.62 58.76 63.62 123.14 59.66 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 45 3 # 45 118 ARG B 88 ARG^? 18.43 CH3 ACT A 201 183 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 317 ARG B 51 ARG.? 7.67 O ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 65.21 120.62 58.76 63.62 123.14 59.66 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 46 3 # 46 118 ARG B 106 ARG^? 5.91 C1 EDO A 302 183 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 317 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 82.09 117.51 66.37 80.60 114.32 71.44 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 65.21 120.62 58.76 63.62 123.14 59.66 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 47 3 # 47 118 ARG B 106 ARG^? 5.91 C1 EDO A 302 183 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 317 ARG B 49 ARG^? 10.37 O ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 82.09 117.51 66.37 80.60 114.32 71.44 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 65.21 120.62 58.76 63.62 123.14 59.66 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 48 3 # 48 118 ARG B 124 ARG.? -3.52 O ACT B 201s 183 LYS B 22 LYS~? 15.43 CH3 ACT B 201 317 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 82.09 117.51 66.37 80.60 114.32 71.44 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 49 3 # 49 118 ARG B 124 ARG.? -3.52 O ACT B 201s 183 LYS B 68 LYS~? -2.79 OXT ACT B 201s 317 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 65.21 120.62 58.76 63.62 123.14 59.66 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 50 3 # 50 118 ARG B 124 ARG.? -3.52 O ACT B 201s 183 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 317 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 82.09 117.51 66.37 80.60 114.32 71.44 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 65.21 120.62 58.76 63.62 123.14 59.66 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 51 3 # 51 118 ARG B 124 ARG.? -3.52 O ACT B 201s 183 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 317 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 76.57 109.19 73.41 73.86 110.26 72.16 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 82.09 117.51 66.37 80.60 114.32 71.44 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 65.21 120.62 58.76 63.62 123.14 59.66 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 52 3 # 52 118 ARG B 146 ARG.? 16.58 CH3 ACT B 201 183 LYS B 22 LYS~? 15.43 CH3 ACT B 201 317 ARG B 58 ARG~? 17.86 CH3 ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 82.09 117.51 66.37 80.60 114.32 71.44 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -41.40 56.24 95.43 -40.17 57.59 97.88 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 53 3 # 53 118 ARG B 146 ARG.? 16.58 CH3 ACT B 201 183 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 317 ARG B 138 ARG~? 16.35 OXT ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 82.09 117.51 66.37 80.60 114.32 71.44 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 65.21 120.62 58.76 63.62 123.14 59.66 -23.44 41.55 74.26 -23.57 39.98 76.87 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 54 3 # 54 118 ARG B 147 ARG.? 12.52 CH3 ACT A 202 183 LYS B 139 LYS.? 6.99 C1 EDO A 302 317 ARG B 51 ARG.? 7.67 O ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 82.09 117.51 66.37 80.60 114.32 71.44 -18.83 46.84 75.05 -16.49 49.79 71.17 coo 65.21 120.62 58.76 63.62 123.14 59.66 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 55 3 # 55 118 ARG C 8 ARG.? 14.74 CH3 ACT C 201 183 LYS C 22 LYS~? 15.34 CH3 ACT C 201 317 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 82.09 117.51 66.37 80.60 114.32 71.44 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 65.21 120.62 58.76 63.62 123.14 59.66 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 56 3 # 56 118 ARG C 16 ARG~? 20.89 CH3 ACT C 201 183 LYS C 22 LYS~? 15.34 CH3 ACT C 201 317 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -48.56 36.19 35.88 -49.41 34.92 38.55 coo 82.09 117.51 66.37 80.60 114.32 71.44 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 65.21 120.62 58.76 63.62 123.14 59.66 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 57 3 # 57 118 ARG C 16 ARG~? 20.89 CH3 ACT C 201 183 LYS C 22 LYS~? 15.34 CH3 ACT C 201 317 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -48.56 36.19 35.88 -49.41 34.92 38.55 coo 82.09 117.51 66.37 80.60 114.32 71.44 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 65.21 120.62 58.76 63.62 123.14 59.66 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 58 3 # 58 118 ARG C 33 ARG.? 12.41 O ACT C 201 183 LYS C 71 LYS~? 4.19 C1 EDO A 301 317 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 59 3 # 59 118 ARG C 37 ARG~? 13.73 CH3 ACT C 201 183 LYS C 22 LYS~? 15.34 CH3 ACT C 201 317 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -28.52 38.86 52.29 -30.70 36.70 52.27 coo 82.09 117.51 66.37 80.60 114.32 71.44 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 65.21 120.62 58.76 63.62 123.14 59.66 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 60 3 # 60 118 ARG C 37 ARG~? 13.73 CH3 ACT C 201 183 LYS C 62 LYS~? 12.50 O2 EDO A 302 317 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -28.52 38.86 52.29 -30.70 36.70 52.27 coo 82.09 117.51 66.37 80.60 114.32 71.44 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 65.21 120.62 58.76 63.62 123.14 59.66 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 61 3 # 61 118 ARG C 49 ARG^? 10.47 OXT ACT C 201 183 LYS A 71 LYS~? 4.32 C2 EDO A 301 317 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 62 3 # 62 118 ARG C 49 ARG^? 10.47 OXT ACT C 201 183 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 317 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 82.09 117.51 66.37 80.60 114.32 71.44 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -52.23 44.53 37.75 -52.43 42.56 40.08 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 63 3 # 63 118 ARG C 51 ARG.? 6.22 O2 EDO A 301 183 LYS A 68 LYS~? -2.78 O ACT A 201s 317 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 82.09 117.51 66.37 80.60 114.32 71.44 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 65.21 120.62 58.76 63.62 123.14 59.66 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 64 3 # 64 118 ARG C 51 ARG.? 6.22 O2 EDO A 301 183 LYS A 68 LYS~? -2.78 O ACT A 201s 317 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 76.57 109.19 73.41 73.86 110.26 72.16 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 82.09 117.51 66.37 80.60 114.32 71.44 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 65.21 120.62 58.76 63.62 123.14 59.66 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 65 3 # 65 118 ARG C 51 ARG.? 6.22 O2 EDO A 301 183 LYS A 68 LYS~? -2.78 O ACT A 201s 317 ARG B 51 ARG.? 7.67 O ACT B 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 82.09 117.51 66.37 80.60 114.32 71.44 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 65.21 120.62 58.76 63.62 123.14 59.66 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 66 3 # 66 118 ARG C 51 ARG.? 6.22 O2 EDO A 301 183 LYS C 71 LYS~? 4.19 C1 EDO A 301 317 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 67 3 # 67 118 ARG C 51 ARG.? 6.22 O2 EDO A 301 183 LYS C 71 LYS~? 4.19 C1 EDO A 301 317 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 76.57 109.19 73.41 73.86 110.26 72.16 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 68 3 # 68 118 ARG C 51 ARG.? 6.22 O2 EDO A 301 183 LYS C 71 LYS~? 4.19 C1 EDO A 301 317 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 69 3 # 69 118 ARG C 67 ARG~? 12.50 O2 EDO A 302 183 LYS A 62 LYS~? 17.60 O ACT A 201 317 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 76.57 109.19 73.41 73.86 110.26 72.16 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 82.09 117.51 66.37 80.60 114.32 71.44 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 65.21 120.62 58.76 63.62 123.14 59.66 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 70 3 # 70 118 ARG C 67 ARG~? 12.50 O2 EDO A 302 183 LYS A 71 LYS~? 4.32 C2 EDO A 301 317 ARG A 37 ARG~? 13.73 CH3 ACT A 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 -28.83 80.54 58.97 -30.62 82.33 60.70 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 71 3 # 71 118 ARG C 67 ARG~? 12.50 O2 EDO A 302 183 LYS A 71 LYS~? 4.32 C2 EDO A 301 317 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 72 3 # 72 118 ARG C 67 ARG~? 12.50 O2 EDO A 302 183 LYS A 71 LYS~? 4.32 C2 EDO A 301 317 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 73 3 # 73 118 ARG C 88 ARG^? 18.42 CH3 ACT D 201 183 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 317 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 82.09 117.51 66.37 80.60 114.32 71.44 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 74 3 # 74 118 ARG C 88 ARG^? 18.42 CH3 ACT D 201 183 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 317 ARG D 49 ARG^? 10.44 O ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 82.09 117.51 66.37 80.60 114.32 71.44 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 75 3 # 75 118 ARG C 88 ARG^? 18.42 CH3 ACT D 201 183 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 317 ARG D 123 ARG.? 17.60 O ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 82.09 117.51 66.37 80.60 114.32 71.44 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 76 3 # 76 118 ARG C 106 ARG^? 14.47 O2 EDO A 301 183 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 317 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 82.09 117.51 66.37 80.60 114.32 71.44 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 65.21 120.62 58.76 63.62 123.14 59.66 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 77 3 # 77 118 ARG C 106 ARG^? 14.47 O2 EDO A 301 183 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 317 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 82.09 117.51 66.37 80.60 114.32 71.44 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 65.21 120.62 58.76 63.62 123.14 59.66 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 78 3 # 78 118 ARG C 124 ARG.? -3.50 OXT ACT C 201s 183 LYS C 22 LYS~? 15.34 CH3 ACT C 201 317 ARG C 76 ARG^? 14.32 O ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 82.09 117.51 66.37 80.60 114.32 71.44 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 65.21 120.62 58.76 63.62 123.14 59.66 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 79 3 # 79 118 ARG C 124 ARG.? -3.50 OXT ACT C 201s 183 LYS C 62 LYS~? 12.50 O2 EDO A 302 317 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 82.09 117.51 66.37 80.60 114.32 71.44 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 65.21 120.62 58.76 63.62 123.14 59.66 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 80 3 # 80 118 ARG C 124 ARG.? -3.50 OXT ACT C 201s 183 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 317 ARG D 124 ARG.? -3.55 O ACT D 201s coo 76.57 109.19 73.41 73.86 110.26 72.16 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 82.09 117.51 66.37 80.60 114.32 71.44 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 65.21 120.62 58.76 63.62 123.14 59.66 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 81 3 # 81 118 ARG C 146 ARG.? 16.63 CH3 ACT C 201 183 LYS C 22 LYS~? 15.34 CH3 ACT C 201 317 ARG C 58 ARG~? 18.03 CH3 ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -36.58 32.85 52.68 -38.87 31.31 51.32 coo 82.09 117.51 66.37 80.60 114.32 71.44 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 65.21 120.62 58.76 63.62 123.14 59.66 -22.97 47.67 45.60 -22.11 45.78 43.37 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 82 3 # 82 118 ARG C 146 ARG.? 16.63 CH3 ACT C 201 183 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 317 ARG C 138 ARG~? 16.31 O ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -36.58 32.85 52.68 -38.87 31.31 51.32 coo 82.09 117.51 66.37 80.60 114.32 71.44 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 65.21 120.62 58.76 63.62 123.14 59.66 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 83 3 # 83 118 ARG D 8 ARG.? 14.56 CH3 ACT D 201 183 LYS D 22 LYS~? 15.49 CH3 ACT D 201 317 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 82.09 117.51 66.37 80.60 114.32 71.44 -54.47 56.23 29.06 -59.33 54.04 30.24 coo 65.21 120.62 58.76 63.62 123.14 59.66 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 84 3 # 84 118 ARG D 8 ARG.? 14.56 CH3 ACT D 201 183 LYS D 62 LYS~? 17.47 OXT ACT D 201 317 ARG D 49 ARG^? 10.44 O ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 82.09 117.51 66.37 80.60 114.32 71.44 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 85 3 # 85 118 ARG D 16 ARG~? 19.88 CH3 ACT D 201 183 LYS D 22 LYS~? 15.49 CH3 ACT D 201 317 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -43.87 51.07 24.49 -42.60 51.26 27.28 coo 82.09 117.51 66.37 80.60 114.32 71.44 -54.47 56.23 29.06 -59.33 54.04 30.24 coo 65.21 120.62 58.76 63.62 123.14 59.66 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 86 3 # 86 118 ARG D 33 ARG.? 12.34 OXT ACT D 201 183 LYS D 71 LYS~? -3.20 CH3 ACT A 203s 317 ARG D 49 ARG^? 10.44 O ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -55.21 72.58 39.53 -56.74 74.11 37.37 coo 82.09 117.51 66.37 80.60 114.32 71.44 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 65.21 120.62 58.76 63.62 123.14 59.66 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 87 3 # 87 118 ARG D 37 ARG~? 13.59 CH3 ACT D 201 183 LYS D 62 LYS~? 17.47 OXT ACT D 201 317 ARG D 123 ARG.? 17.60 O ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -62.21 67.18 33.74 -60.13 67.79 31.56 coo 82.09 117.51 66.37 80.60 114.32 71.44 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 88 3 # 88 118 ARG D 49 ARG^? 10.44 O ACT D 201 183 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 317 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 82.09 117.51 66.37 80.60 114.32 71.44 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 65.21 120.62 58.76 63.62 123.14 59.66 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 89 3 # 89 118 ARG D 51 ARG.? 7.60 O ACT D 201 183 LYS A 71 LYS~? 4.32 C2 EDO A 301 317 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 90 3 # 90 118 ARG D 51 ARG.? 7.60 O ACT D 201 183 LYS A 71 LYS~? 4.32 C2 EDO A 301 317 ARG D 138 ARG~? 16.38 OXT ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 82.09 117.51 66.37 80.60 114.32 71.44 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 -42.61 77.59 41.75 -44.95 78.80 40.20 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 91 3 # 91 118 ARG D 51 ARG.? 7.60 O ACT D 201 183 LYS D 71 LYS~? -3.20 CH3 ACT A 203s 317 ARG A 33 ARG.? 12.39 O ACT A 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 82.09 117.51 66.37 80.60 114.32 71.44 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 65.21 120.62 58.76 63.62 123.14 59.66 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 92 3 # 92 118 ARG D 51 ARG.? 7.60 O ACT D 201 183 LYS D 71 LYS~? -3.20 CH3 ACT A 203s 317 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 76.57 109.19 73.41 73.86 110.26 72.16 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 82.09 117.51 66.37 80.60 114.32 71.44 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 65.21 120.62 58.76 63.62 123.14 59.66 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 93 3 # 93 118 ARG D 51 ARG.? 7.60 O ACT D 201 183 LYS D 71 LYS~? -3.20 CH3 ACT A 203s 317 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 82.09 117.51 66.37 80.60 114.32 71.44 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 65.21 120.62 58.76 63.62 123.14 59.66 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 94 3 # 94 118 ARG D 88 ARG^? 18.35 CH3 ACT C 201 183 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 317 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 82.09 117.51 66.37 80.60 114.32 71.44 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 65.21 120.62 58.76 63.62 123.14 59.66 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 95 3 # 95 118 ARG D 88 ARG^? 18.35 CH3 ACT C 201 183 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 317 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 82.09 117.51 66.37 80.60 114.32 71.44 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 65.21 120.62 58.76 63.62 123.14 59.66 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 96 3 # 96 118 ARG D 88 ARG^? 18.35 CH3 ACT C 201 183 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 317 ARG D 51 ARG.? 7.60 O ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 82.09 117.51 66.37 80.60 114.32 71.44 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 65.21 120.62 58.76 63.62 123.14 59.66 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 97 3 # 97 118 ARG D 106 ARG^? 14.88 OXT ACT D 201 183 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 317 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 82.09 117.51 66.37 80.60 114.32 71.44 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 98 3 # 98 118 ARG D 106 ARG^? 14.88 OXT ACT D 201 183 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 317 ARG D 49 ARG^? 10.44 O ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 82.09 117.51 66.37 80.60 114.32 71.44 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 99 3 # 99 118 ARG D 124 ARG.? -3.55 O ACT D 201s 183 LYS D 22 LYS~? 15.49 CH3 ACT D 201 317 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 82.09 117.51 66.37 80.60 114.32 71.44 -54.47 56.23 29.06 -59.33 54.04 30.24 coo 65.21 120.62 58.76 63.62 123.14 59.66 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 100 3 # 100 118 ARG D 124 ARG.? -3.55 O ACT D 201s 183 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 317 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 76.57 109.19 73.41 73.86 110.26 72.16 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 82.09 117.51 66.37 80.60 114.32 71.44 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 101 3 # 101 118 ARG D 146 ARG.? 16.60 CH3 ACT D 201 183 LYS D 22 LYS~? 15.49 CH3 ACT D 201 317 ARG D 58 ARG~? 18.01 CH3 ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 82.09 117.51 66.37 80.60 114.32 71.44 -54.47 56.23 29.06 -59.33 54.04 30.24 coo 65.21 120.62 58.76 63.62 123.14 59.66 -67.82 58.42 40.52 -68.76 57.03 37.97 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 102 3 # 102 118 ARG D 146 ARG.? 16.60 CH3 ACT D 201 183 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 317 ARG D 138 ARG~? 16.38 OXT ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 82.09 117.51 66.37 80.60 114.32 71.44 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 -42.61 77.59 41.75 -44.95 78.80 40.20 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 103 3 # 103 118 ARG D 147 ARG.? 13.02 CH3 ACT D 201 183 LYS D 139 LYS.? 18.54 OXT ACT D 201 317 ARG D 51 ARG.? 7.60 O ACT D 201 coo 76.57 109.19 73.41 73.86 110.26 72.16 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 82.09 117.51 66.37 80.60 114.32 71.44 -39.84 73.21 37.09 -35.07 70.74 37.87 coo 65.21 120.62 58.76 63.62 123.14 59.66 -49.81 61.30 50.74 -48.26 63.65 49.51 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 103 hits 1bib_c00 naa= 3 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 1 3 # 1 A 102 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 174 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 198 LYS A 68 LYS~? -2.78 O ACT A 201s coo 21.59 67.76 35.19 19.10 64.95 36.34 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 27.94 65.10 43.55 24.20 64.94 40.01 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 2 3 # 2 A 102 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 174 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 198 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 21.59 67.76 35.19 19.10 64.95 36.34 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 27.94 65.10 43.55 24.20 64.94 40.01 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 3 3 # 3 A 102 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 174 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 198 LYS A 134 LYS~? 11.98 O ACT A 203 coo 21.59 67.76 35.19 19.10 64.95 36.34 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 27.94 65.10 43.55 24.20 64.94 40.01 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 4 3 # 4 A 102 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 174 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 198 LYS A 139 LYS.? 17.81 O ACT A 201 coo 21.59 67.76 35.19 19.10 64.95 36.34 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 27.94 65.10 43.55 24.20 64.94 40.01 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 5 3 # 5 A 102 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 174 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 198 LYS A 68 LYS~? -2.78 O ACT A 201s coo 21.59 67.76 35.19 19.10 64.95 36.34 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 27.94 65.10 43.55 24.20 64.94 40.01 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 6 3 # 6 A 102 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 174 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 198 LYS A 134 LYS~? 11.98 O ACT A 203 coo 21.59 67.76 35.19 19.10 64.95 36.34 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 27.94 65.10 43.55 24.20 64.94 40.01 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 7 3 # 7 A 102 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 174 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 198 LYS A 68 LYS~? -2.78 O ACT A 201s coo 21.59 67.76 35.19 19.10 64.95 36.34 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 27.94 65.10 43.55 24.20 64.94 40.01 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 8 3 # 8 A 102 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 174 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 198 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 21.59 67.76 35.19 19.10 64.95 36.34 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 27.94 65.10 43.55 24.20 64.94 40.01 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 9 3 # 9 A 102 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 174 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 198 LYS A 134 LYS~? 11.98 O ACT A 203 coo 21.59 67.76 35.19 19.10 64.95 36.34 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 27.94 65.10 43.55 24.20 64.94 40.01 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 10 3 # 10 A 102 TRP A 104 TRP^? -4.29 OXT ACT A 203s A 174 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 198 LYS A 139 LYS.? 17.81 O ACT A 201 coo 21.59 67.76 35.19 19.10 64.95 36.34 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 19.39 73.14 39.98 19.70 71.07 40.14 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 27.94 65.10 43.55 24.20 64.94 40.01 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 11 3 # 11 A 102 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 174 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 198 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 21.59 67.76 35.19 19.10 64.95 36.34 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 27.94 65.10 43.55 24.20 64.94 40.01 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 12 3 # 12 A 102 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 174 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 198 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 21.59 67.76 35.19 19.10 64.95 36.34 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 27.94 65.10 43.55 24.20 64.94 40.01 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 13 3 # 13 A 102 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 174 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 198 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 21.59 67.76 35.19 19.10 64.95 36.34 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 27.94 65.10 43.55 24.20 64.94 40.01 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 14 3 # 14 A 102 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 174 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 198 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 21.59 67.76 35.19 19.10 64.95 36.34 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 27.94 65.10 43.55 24.20 64.94 40.01 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 15 3 # 15 A 102 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 174 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 198 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 21.59 67.76 35.19 19.10 64.95 36.34 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 27.94 65.10 43.55 24.20 64.94 40.01 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 16 3 # 16 A 102 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 174 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 198 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 21.59 67.76 35.19 19.10 64.95 36.34 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 27.94 65.10 43.55 24.20 64.94 40.01 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 17 3 # 17 A 102 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 174 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 198 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 21.59 67.76 35.19 19.10 64.95 36.34 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 19.39 73.14 39.98 19.70 71.07 40.14 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 27.94 65.10 43.55 24.20 64.94 40.01 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 18 3 # 18 A 102 TRP B 104 TRP^? 15.21 C2 EDO A 302 A 174 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 198 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 21.59 67.76 35.19 19.10 64.95 36.34 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 19.39 73.14 39.98 19.70 71.07 40.14 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 27.94 65.10 43.55 24.20 64.94 40.01 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 19 3 # 19 A 102 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 174 ASP C 74 ASP^? 14.86 O ACT C 201 A 198 LYS C 68 LYS~? -2.77 O ACT C 201s coo 21.59 67.76 35.19 19.10 64.95 36.34 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 19.39 73.14 39.98 19.70 71.07 40.14 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 27.94 65.10 43.55 24.20 64.94 40.01 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 20 3 # 20 A 102 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 174 ASP C 74 ASP^? 14.86 O ACT C 201 A 198 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 21.59 67.76 35.19 19.10 64.95 36.34 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 19.39 73.14 39.98 19.70 71.07 40.14 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 27.94 65.10 43.55 24.20 64.94 40.01 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 21 3 # 21 A 102 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 174 ASP C 74 ASP^? 14.86 O ACT C 201 A 198 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 21.59 67.76 35.19 19.10 64.95 36.34 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 19.39 73.14 39.98 19.70 71.07 40.14 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 27.94 65.10 43.55 24.20 64.94 40.01 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 22 3 # 22 A 102 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 174 ASP C 74 ASP^? 14.86 O ACT C 201 A 198 LYS C 139 LYS.? 18.79 O ACT C 201 coo 21.59 67.76 35.19 19.10 64.95 36.34 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 19.39 73.14 39.98 19.70 71.07 40.14 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 27.94 65.10 43.55 24.20 64.94 40.01 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 23 3 # 23 A 102 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 174 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 198 LYS C 68 LYS~? -2.77 O ACT C 201s coo 21.59 67.76 35.19 19.10 64.95 36.34 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 19.39 73.14 39.98 19.70 71.07 40.14 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 27.94 65.10 43.55 24.20 64.94 40.01 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 24 3 # 24 A 102 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 174 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 198 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 21.59 67.76 35.19 19.10 64.95 36.34 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 19.39 73.14 39.98 19.70 71.07 40.14 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 27.94 65.10 43.55 24.20 64.94 40.01 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 25 3 # 25 A 102 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 174 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 198 LYS C 68 LYS~? -2.77 O ACT C 201s coo 21.59 67.76 35.19 19.10 64.95 36.34 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 19.39 73.14 39.98 19.70 71.07 40.14 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 27.94 65.10 43.55 24.20 64.94 40.01 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 26 3 # 26 A 102 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 174 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 198 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 21.59 67.76 35.19 19.10 64.95 36.34 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 19.39 73.14 39.98 19.70 71.07 40.14 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 27.94 65.10 43.55 24.20 64.94 40.01 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 27 3 # 27 A 102 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 174 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 198 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 21.59 67.76 35.19 19.10 64.95 36.34 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 19.39 73.14 39.98 19.70 71.07 40.14 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 27.94 65.10 43.55 24.20 64.94 40.01 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 28 3 # 28 A 102 TRP C 104 TRP^? 12.40 O2 EDO A 301 A 174 ASP C 74 ASP^? 14.86 O ACT C 201 A 198 LYS C 139 LYS.? 18.79 O ACT C 201 coo 21.59 67.76 35.19 19.10 64.95 36.34 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 19.39 73.14 39.98 19.70 71.07 40.14 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 27.94 65.10 43.55 24.20 64.94 40.01 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 29 3 # 29 A 102 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 174 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 198 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 21.59 67.76 35.19 19.10 64.95 36.34 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 19.39 73.14 39.98 19.70 71.07 40.14 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 27.94 65.10 43.55 24.20 64.94 40.01 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 30 3 # 30 A 102 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 174 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 198 LYS D 134 LYS~? 17.34 O ACT A 201 coo 21.59 67.76 35.19 19.10 64.95 36.34 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 19.39 73.14 39.98 19.70 71.07 40.14 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 27.94 65.10 43.55 24.20 64.94 40.01 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 31 3 # 31 A 102 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 174 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 198 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 21.59 67.76 35.19 19.10 64.95 36.34 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 19.39 73.14 39.98 19.70 71.07 40.14 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 27.94 65.10 43.55 24.20 64.94 40.01 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 32 3 # 32 A 102 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 174 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 198 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 21.59 67.76 35.19 19.10 64.95 36.34 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 19.39 73.14 39.98 19.70 71.07 40.14 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 27.94 65.10 43.55 24.20 64.94 40.01 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 33 3 # 33 A 102 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 174 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 198 LYS D 134 LYS~? 17.34 O ACT A 201 coo 21.59 67.76 35.19 19.10 64.95 36.34 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 19.39 73.14 39.98 19.70 71.07 40.14 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 27.94 65.10 43.55 24.20 64.94 40.01 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 34 3 # 34 A 102 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 174 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 198 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 21.59 67.76 35.19 19.10 64.95 36.34 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 19.39 73.14 39.98 19.70 71.07 40.14 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 27.94 65.10 43.55 24.20 64.94 40.01 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 35 3 # 35 A 102 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 174 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 198 LYS D 134 LYS~? 17.34 O ACT A 201 coo 21.59 67.76 35.19 19.10 64.95 36.34 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 19.39 73.14 39.98 19.70 71.07 40.14 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 27.94 65.10 43.55 24.20 64.94 40.01 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 36 3 # 36 A 102 TRP D 104 TRP^? 14.89 CH3 ACT A 203 A 174 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 198 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 21.59 67.76 35.19 19.10 64.95 36.34 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 19.39 73.14 39.98 19.70 71.07 40.14 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 27.94 65.10 43.55 24.20 64.94 40.01 -39.84 73.21 37.09 -35.07 70.74 37.87 1bjo_c00 source 1bjo PHOSPHOSERINE AMINOTRANSFERASE : 36 hits 1bjo_c00 naa= 3 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 A 757 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 759 HIS A 98 HIS^? -3.60 C ACT A 203s A 810 SER A 101 SER.? 7.80 O2 EDO A 301 coo 30.11 61.02 29.12 29.36 59.77 27.63 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 30.94 56.62 25.28 29.94 54.94 26.14 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 25.05 62.74 29.97 26.88 61.45 29.19 -48.36 60.96 55.15 -47.04 58.94 54.93 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 A 757 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 759 HIS A 98 HIS^? -3.60 C ACT A 203s A 810 SER A 101 SER.? 7.80 O2 EDO A 301 coo 30.11 61.02 29.12 29.36 59.77 27.63 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 30.94 56.62 25.28 29.94 54.94 26.14 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 25.05 62.74 29.97 26.88 61.45 29.19 -48.36 60.96 55.15 -47.04 58.94 54.93 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 3 3 # 3 A 757 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 759 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 810 SER C 101 SER.? 7.85 O1 EDO A 301 coo 30.11 61.02 29.12 29.36 59.77 27.63 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 30.94 56.62 25.28 29.94 54.94 26.14 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 25.05 62.74 29.97 26.88 61.45 29.19 -40.26 55.74 71.04 -39.54 57.94 70.33 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 4 3 # 4 A 757 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 759 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 810 SER C 101 SER.? 7.85 O1 EDO A 301 coo 30.11 61.02 29.12 29.36 59.77 27.63 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 30.94 56.62 25.28 29.94 54.94 26.14 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 25.05 62.74 29.97 26.88 61.45 29.19 -40.26 55.74 71.04 -39.54 57.94 70.33 1bmt_c04 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 4 hits 1bmt_c04 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 145 GLY.? 13.13 O ACT A 201 48 HIS A 151 HIS.? 15.97 CH3 ACT A 201 99 ASP A 150 ASP.? 22.07 CH3 ACT A 201 coo 12.38 5.55 24.25 13.27 5.59 24.39 -38.43 80.69 60.76 -38.91 80.43 61.42 coo 18.80 12.68 24.53 17.69 13.54 26.08 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 17.07 18.51 26.62 16.67 17.07 28.09 -43.95 88.27 71.85 -43.22 89.50 70.29 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY B 145 GLY.? 13.34 OXT ACT B 201 48 HIS B 151 HIS.? 13.45 CH3 ACT A 202 99 ASP B 150 ASP.? 20.21 CH3 ACT A 202 coo 12.38 5.55 24.25 13.27 5.59 24.39 -25.17 44.53 88.88 -24.74 44.79 88.19 coo 18.80 12.68 24.53 17.69 13.54 26.08 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 17.07 18.51 26.62 16.67 17.07 28.09 -10.73 49.15 87.46 -11.06 47.07 87.30 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 3 3 # 3 30 GLY C 145 GLY.? 13.18 O ACT C 201 48 HIS C 151 HIS.? 16.03 CH3 ACT C 201 99 ASP C 150 ASP.? 20.99 CH3 ACT C 201 coo 12.38 5.55 24.25 13.27 5.59 24.39 -35.71 37.24 58.49 -36.57 37.39 58.47 coo 18.80 12.68 24.53 17.69 13.54 26.08 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 17.07 18.51 26.62 16.67 17.07 28.09 -46.61 28.46 55.57 -45.54 29.27 57.21 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 4 3 # 4 30 GLY D 145 GLY.? 13.27 OXT ACT D 201 48 HIS D 151 HIS.? 15.66 CH3 ACT D 201 99 ASP D 150 ASP.? 21.68 CH3 ACT D 201 coo 12.38 5.55 24.25 13.27 5.59 24.39 -54.58 73.10 33.20 -53.72 72.98 33.25 coo 18.80 12.68 24.53 17.69 13.54 26.08 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 17.07 18.51 26.62 16.67 17.07 28.09 -44.02 71.14 22.58 -44.47 73.01 23.46 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 4 hits 1bp2_c00 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS A 98 HIS^? -3.60 C ACT A 203s A 168 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 187 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 62.47 12.00 59.65 61.76 10.14 60.31 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 55.10 8.37 73.00 55.48 9.59 70.20 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 66.76 10.09 66.23 61.80 8.06 65.82 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 A 82 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 168 ARG B 51 ARG.? 7.67 O ACT B 201 A 187 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 62.47 12.00 59.65 61.76 10.14 60.31 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 55.10 8.37 73.00 55.48 9.59 70.20 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 66.76 10.09 66.23 61.80 8.06 65.82 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 3 # 3 A 82 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 168 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 187 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 62.47 12.00 59.65 61.76 10.14 60.31 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 55.10 8.37 73.00 55.48 9.59 70.20 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 66.76 10.09 66.23 61.80 8.06 65.82 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 4 3 # 4 A 82 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 168 ARG D 51 ARG.? 7.60 O ACT D 201 A 187 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 62.47 12.00 59.65 61.76 10.14 60.31 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 55.10 8.37 73.00 55.48 9.59 70.20 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 66.76 10.09 66.23 61.80 8.06 65.82 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 5 3 # 5 A 82 HIS D 141 HIS.? 18.95 OXT ACT D 201 A 168 ARG D 33 ARG.? 12.34 OXT ACT D 201 A 187 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 62.47 12.00 59.65 61.76 10.14 60.31 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 55.10 8.37 73.00 55.48 9.59 70.20 -55.21 72.58 39.53 -56.74 74.11 37.37 coo 66.76 10.09 66.23 61.80 8.06 65.82 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 6 3 # 6 A 82 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 168 ARG D 33 ARG.? 12.34 OXT ACT D 201 A 187 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 62.47 12.00 59.65 61.76 10.14 60.31 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 55.10 8.37 73.00 55.48 9.59 70.20 -55.21 72.58 39.53 -56.74 74.11 37.37 coo 66.76 10.09 66.23 61.80 8.06 65.82 -39.84 73.21 37.09 -35.07 70.74 37.87 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 6 hits 1brw_c00 naa= 3 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 B1082 HIS B 98 HIS^? 14.98 OXT ACT B 201 B1168 ARG B 33 ARG.? 12.67 OXT ACT B 201 B1187 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 35.03 5.72 103.61 36.82 5.00 102.79 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 41.91 5.48 91.85 40.59 6.81 94.28 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -38.47 44.35 77.96 -37.73 47.88 73.83 1brw_c01 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 1 hits 1brw_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 14 PHE.? 17.18 CH3 ACT A 201 A 205 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 236 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -21.05 79.17 77.53 -20.41 78.32 74.94 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 54 PHE^? -3.83 O1 EDO A 302s A 205 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 236 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 -22.35 57.66 65.34 -22.90 56.19 67.67 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 54 PHE^? -3.83 O1 EDO A 302s A 205 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 236 LYS C 68 LYS~? -2.77 O ACT C 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -22.35 57.66 65.34 -22.90 56.19 67.67 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE A 64 PHE~? 7.17 OXT ACT A 201 A 205 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 236 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 4.14 2.10 36.34 6.69 3.08 36.92 -28.19 64.67 60.35 -30.23 64.79 62.27 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE A 64 PHE~? 7.17 OXT ACT A 201 A 205 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 236 LYS C 68 LYS~? -2.77 O ACT C 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -28.19 64.67 60.35 -30.23 64.79 62.27 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE A 64 PHE~? 7.17 OXT ACT A 201 A 205 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 236 LYS C 68 LYS~? -2.77 O ACT C 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -28.19 64.67 60.35 -30.23 64.79 62.27 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE A 115 PHE^? 13.56 CH3 ACT A 201 A 205 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 236 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -19.74 75.51 72.32 -22.50 75.42 71.86 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 8 3 # 8 A 109 PHE A 140 PHE.? 11.31 O ACT A 201 A 205 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 236 LYS A 134 LYS~? 11.98 O ACT A 203 coo 4.14 2.10 36.34 6.69 3.08 36.92 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 9 3 # 9 A 109 PHE A 140 PHE.? 11.31 O ACT A 201 A 205 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 236 LYS A 134 LYS~? 11.98 O ACT A 203 coo 4.14 2.10 36.34 6.69 3.08 36.92 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 10 3 # 10 A 109 PHE B 14 PHE.? 17.24 CH3 ACT B 201 A 205 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 236 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -25.38 68.39 92.97 -27.74 66.99 93.52 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 11 3 # 11 A 109 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 205 ASP C 34 ASP~? 14.66 O ACT C 201 A 236 LYS C 68 LYS~? -2.77 O ACT C 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 12 3 # 12 A 109 PHE B 115 PHE^? 13.53 CH3 ACT B 201 A 205 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 236 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -31.33 65.89 92.58 -30.23 63.92 90.93 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 13 3 # 13 A 109 PHE B 140 PHE.? 8.97 CH3 ACT A 202 A 205 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 236 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 14 3 # 14 A 109 PHE B 140 PHE.? 8.97 CH3 ACT A 202 A 205 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 236 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 15 3 # 15 A 109 PHE C 14 PHE.? 17.12 CH3 ACT C 201 A 205 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 236 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -38.16 40.21 34.58 -35.88 41.24 35.84 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 16 3 # 16 A 109 PHE C 54 PHE^? 14.66 OXT ACT C 201 A 205 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 236 LYS A 68 LYS~? -2.78 O ACT A 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -32.62 62.02 44.82 -34.97 63.26 43.94 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 17 3 # 17 A 109 PHE C 54 PHE^? 14.66 OXT ACT C 201 A 205 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 236 LYS D 134 LYS~? 17.34 O ACT A 201 coo 4.14 2.10 36.34 6.69 3.08 36.92 -32.62 62.02 44.82 -34.97 63.26 43.94 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 18 3 # 18 A 109 PHE C 64 PHE~? 7.20 OXT ACT C 201 A 205 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 236 LYS A 68 LYS~? -2.78 O ACT A 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -31.32 54.61 52.00 -34.04 54.10 52.45 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 19 3 # 19 A 109 PHE C 64 PHE~? 7.20 OXT ACT C 201 A 205 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 236 LYS A 68 LYS~? -2.78 O ACT A 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -31.32 54.61 52.00 -34.04 54.10 52.45 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 20 3 # 20 A 109 PHE C 64 PHE~? 7.20 OXT ACT C 201 A 205 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 236 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 4.14 2.10 36.34 6.69 3.08 36.92 -31.32 54.61 52.00 -34.04 54.10 52.45 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 21 3 # 21 A 109 PHE C 115 PHE^? 13.47 CH3 ACT C 201 A 205 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 236 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -33.76 44.24 37.19 -35.14 43.97 39.60 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 22 3 # 22 A 109 PHE C 140 PHE.? 11.33 O ACT C 201 A 205 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 236 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 4.14 2.10 36.34 6.69 3.08 36.92 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 23 3 # 23 A 109 PHE C 140 PHE.? 11.33 O ACT C 201 A 205 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 236 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 4.14 2.10 36.34 6.69 3.08 36.92 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 24 3 # 24 A 109 PHE D 14 PHE.? 17.30 CH3 ACT D 201 A 205 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 236 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -54.04 49.25 28.81 -56.13 50.24 30.39 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -47.37 61.41 34.65 -51.85 60.71 37.83 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 25 3 # 25 A 109 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 205 ASP A 34 ASP~? 14.63 O ACT A 201 A 236 LYS A 68 LYS~? -2.78 O ACT A 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 26 3 # 26 A 109 PHE D 115 PHE^? 13.59 CH3 ACT D 201 A 205 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 236 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 4.14 2.10 36.34 6.69 3.08 36.92 -57.80 50.74 33.88 -56.32 53.08 34.25 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -47.37 61.41 34.65 -51.85 60.71 37.83 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 27 3 # 27 A 109 PHE D 140 PHE.? 11.31 OXT ACT D 201 A 205 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 236 LYS D 134 LYS~? 17.34 O ACT A 201 coo 4.14 2.10 36.34 6.69 3.08 36.92 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 28 3 # 28 A 109 PHE D 140 PHE.? 11.31 OXT ACT D 201 A 205 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 236 LYS D 134 LYS~? 17.34 O ACT A 201 coo 4.14 2.10 36.34 6.69 3.08 36.92 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -37.62 76.93 46.97 -33.08 76.47 49.79 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 28 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 118 GLN.? 24.03 CH3 ACT A 201 A 91 LEU A 11 LEU.? 21.74 CH3 ACT A 201 A 133 GLU A 117 GLU.? 20.82 OXT ACT A 202 coo 43.58 43.67 66.73 42.32 42.78 68.15 -11.85 80.36 67.51 -10.49 79.45 68.87 coo 38.58 45.09 70.44 38.28 45.21 72.59 -16.28 82.97 73.25 -15.67 83.67 71.29 coo 44.05 36.87 70.65 43.15 38.64 69.97 -10.16 77.53 73.12 -10.08 75.57 72.28 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 118 GLN.? 24.03 CH3 ACT A 201 A 91 LEU A 120 LEU.? 17.31 CH3 ACT A 201 A 133 GLU A 117 GLU.? 20.82 OXT ACT A 202 coo 43.58 43.67 66.73 42.32 42.78 68.15 -11.85 80.36 67.51 -10.49 79.45 68.87 coo 38.58 45.09 70.44 38.28 45.21 72.59 -16.79 76.18 66.21 -16.58 77.34 64.41 coo 44.05 36.87 70.65 43.15 38.64 69.97 -10.16 77.53 73.12 -10.08 75.57 72.28 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 118 GLN.? 23.59 CH3 ACT B 201 A 91 LEU B 120 LEU.? 17.11 CH3 ACT B 201 A 133 GLU B 117 GLU.? 26.48 CH3 ACT B 201 coo 43.58 43.67 66.73 42.32 42.78 68.15 -35.76 66.30 101.92 -36.28 68.30 101.40 coo 38.58 45.09 70.44 38.28 45.21 72.59 -35.92 62.93 96.67 -36.17 61.35 98.13 coo 44.05 36.87 70.65 43.15 38.64 69.97 -33.80 72.26 99.63 -34.50 73.71 100.99 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN C 118 GLN.? 23.62 CH3 ACT C 201 A 91 LEU C 120 LEU.? 17.09 CH3 ACT C 201 A 133 GLU C 117 GLU.? 26.34 CH3 ACT C 201 coo 43.58 43.67 66.73 42.32 42.78 68.15 -24.41 41.14 33.87 -24.68 42.52 32.27 coo 38.58 45.09 70.44 38.28 45.21 72.59 -27.17 44.35 38.78 -25.60 43.27 39.79 coo 44.05 36.87 70.65 43.15 38.64 69.97 -28.65 43.01 29.05 -27.69 42.85 27.18 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN D 118 GLN.? 23.80 CH3 ACT D 201 A 91 LEU D 120 LEU.? 17.36 CH3 ACT D 201 A 133 GLU D 117 GLU.? 26.53 CH3 ACT D 201 coo 43.58 43.67 66.73 42.32 42.78 68.15 -67.61 48.89 30.94 -67.34 46.91 31.68 coo 38.58 45.09 70.44 38.28 45.21 72.59 -64.24 52.49 35.03 -65.88 53.68 34.30 coo 44.05 36.87 70.65 43.15 38.64 69.97 -63.64 43.50 30.85 -64.87 41.85 30.41 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 5 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 118 GLN.? 24.03 CH3 ACT A 201 B 591 LEU A 11 LEU.? 21.74 CH3 ACT A 201 B 633 GLU A 117 GLU.? 20.82 OXT ACT A 202 coo 88.06 44.34 57.19 89.06 45.53 55.74 -11.85 80.36 67.51 -10.49 79.45 68.87 coo 86.70 48.66 52.61 87.15 48.69 50.51 -16.28 82.97 73.25 -15.67 83.67 71.29 coo 95.42 44.52 54.43 93.46 45.31 54.70 -10.16 77.53 73.12 -10.08 75.57 72.28 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 118 GLN.? 24.03 CH3 ACT A 201 B 591 LEU A 120 LEU.? 17.31 CH3 ACT A 201 B 633 GLU A 117 GLU.? 20.82 OXT ACT A 202 coo 88.06 44.34 57.19 89.06 45.53 55.74 -11.85 80.36 67.51 -10.49 79.45 68.87 coo 86.70 48.66 52.61 87.15 48.69 50.51 -16.79 76.18 66.21 -16.58 77.34 64.41 coo 95.42 44.52 54.43 93.46 45.31 54.70 -10.16 77.53 73.12 -10.08 75.57 72.28 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN B 118 GLN.? 23.59 CH3 ACT B 201 B 591 LEU B 120 LEU.? 17.11 CH3 ACT B 201 B 633 GLU B 117 GLU.? 26.48 CH3 ACT B 201 coo 88.06 44.34 57.19 89.06 45.53 55.74 -35.76 66.30 101.92 -36.28 68.30 101.40 coo 86.70 48.66 52.61 87.15 48.69 50.51 -35.92 62.93 96.67 -36.17 61.35 98.13 coo 95.42 44.52 54.43 93.46 45.31 54.70 -33.80 72.26 99.63 -34.50 73.71 100.99 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN C 118 GLN.? 23.62 CH3 ACT C 201 B 591 LEU C 120 LEU.? 17.09 CH3 ACT C 201 B 633 GLU C 117 GLU.? 26.34 CH3 ACT C 201 coo 88.06 44.34 57.19 89.06 45.53 55.74 -24.41 41.14 33.87 -24.68 42.52 32.27 coo 86.70 48.66 52.61 87.15 48.69 50.51 -27.17 44.35 38.78 -25.60 43.27 39.79 coo 95.42 44.52 54.43 93.46 45.31 54.70 -28.65 43.01 29.05 -27.69 42.85 27.18 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN D 118 GLN.? 23.80 CH3 ACT D 201 B 591 LEU D 120 LEU.? 17.36 CH3 ACT D 201 B 633 GLU D 117 GLU.? 26.53 CH3 ACT D 201 coo 88.06 44.34 57.19 89.06 45.53 55.74 -67.61 48.89 30.94 -67.34 46.91 31.68 coo 86.70 48.66 52.61 87.15 48.69 50.51 -64.24 52.49 35.03 -65.88 53.68 34.30 coo 95.42 44.52 54.43 93.46 45.31 54.70 -63.64 43.50 30.85 -64.87 41.85 30.41 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 5 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 118 GLN.? 24.03 CH3 ACT A 201 C1091 LEU A 11 LEU.? 21.74 CH3 ACT A 201 C1133 GLU A 117 GLU.? 20.82 OXT ACT A 202 coo 68.29 34.44 43.03 66.67 34.74 44.37 -11.85 80.36 67.51 -10.49 79.45 68.87 coo 65.83 38.95 47.05 65.46 38.90 49.20 -16.28 82.97 73.25 -15.67 83.67 71.29 coo 63.14 29.39 46.25 63.84 31.31 45.74 -10.16 77.53 73.12 -10.08 75.57 72.28 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 118 GLN.? 24.03 CH3 ACT A 201 C1091 LEU A 120 LEU.? 17.31 CH3 ACT A 201 C1133 GLU A 117 GLU.? 20.82 OXT ACT A 202 coo 68.29 34.44 43.03 66.67 34.74 44.37 -11.85 80.36 67.51 -10.49 79.45 68.87 coo 65.83 38.95 47.05 65.46 38.90 49.20 -16.79 76.18 66.21 -16.58 77.34 64.41 coo 63.14 29.39 46.25 63.84 31.31 45.74 -10.16 77.53 73.12 -10.08 75.57 72.28 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN B 118 GLN.? 23.59 CH3 ACT B 201 C1091 LEU B 120 LEU.? 17.11 CH3 ACT B 201 C1133 GLU B 117 GLU.? 26.48 CH3 ACT B 201 coo 68.29 34.44 43.03 66.67 34.74 44.37 -35.76 66.30 101.92 -36.28 68.30 101.40 coo 65.83 38.95 47.05 65.46 38.90 49.20 -35.92 62.93 96.67 -36.17 61.35 98.13 coo 63.14 29.39 46.25 63.84 31.31 45.74 -33.80 72.26 99.63 -34.50 73.71 100.99 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN C 118 GLN.? 23.62 CH3 ACT C 201 C1091 LEU C 120 LEU.? 17.09 CH3 ACT C 201 C1133 GLU C 117 GLU.? 26.34 CH3 ACT C 201 coo 68.29 34.44 43.03 66.67 34.74 44.37 -24.41 41.14 33.87 -24.68 42.52 32.27 coo 65.83 38.95 47.05 65.46 38.90 49.20 -27.17 44.35 38.78 -25.60 43.27 39.79 coo 63.14 29.39 46.25 63.84 31.31 45.74 -28.65 43.01 29.05 -27.69 42.85 27.18 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN D 118 GLN.? 23.80 CH3 ACT D 201 C1091 LEU D 120 LEU.? 17.36 CH3 ACT D 201 C1133 GLU D 117 GLU.? 26.53 CH3 ACT D 201 coo 68.29 34.44 43.03 66.67 34.74 44.37 -67.61 48.89 30.94 -67.34 46.91 31.68 coo 65.83 38.95 47.05 65.46 38.90 49.20 -64.24 52.49 35.03 -65.88 53.68 34.30 coo 63.14 29.39 46.25 63.84 31.31 45.74 -63.64 43.50 30.85 -64.87 41.85 30.41 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 5 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 118 GLN.? 24.03 CH3 ACT A 201 A 91 LEU A 120 LEU.? 17.31 CH3 ACT A 201 A 133 GLU A 117 GLU.? 20.82 OXT ACT A 202 coo 38.23 53.34 67.59 38.84 53.87 69.56 -11.85 80.36 67.51 -10.49 79.45 68.87 coo 35.40 53.22 73.30 35.37 54.87 74.74 -16.79 76.18 66.21 -16.58 77.34 64.41 coo 45.08 56.04 70.60 43.15 55.19 70.77 -10.16 77.53 73.12 -10.08 75.57 72.28 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 118 GLN.? 23.59 CH3 ACT B 201 A 91 LEU B 120 LEU.? 17.11 CH3 ACT B 201 A 133 GLU B 117 GLU.? 26.48 CH3 ACT B 201 coo 38.23 53.34 67.59 38.84 53.87 69.56 -35.76 66.30 101.92 -36.28 68.30 101.40 coo 35.40 53.22 73.30 35.37 54.87 74.74 -35.92 62.93 96.67 -36.17 61.35 98.13 coo 45.08 56.04 70.60 43.15 55.19 70.77 -33.80 72.26 99.63 -34.50 73.71 100.99 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN C 118 GLN.? 23.62 CH3 ACT C 201 A 91 LEU C 120 LEU.? 17.09 CH3 ACT C 201 A 133 GLU C 117 GLU.? 26.34 CH3 ACT C 201 coo 38.23 53.34 67.59 38.84 53.87 69.56 -24.41 41.14 33.87 -24.68 42.52 32.27 coo 35.40 53.22 73.30 35.37 54.87 74.74 -27.17 44.35 38.78 -25.60 43.27 39.79 coo 45.08 56.04 70.60 43.15 55.19 70.77 -28.65 43.01 29.05 -27.69 42.85 27.18 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN D 118 GLN.? 23.80 CH3 ACT D 201 A 91 LEU D 120 LEU.? 17.36 CH3 ACT D 201 A 133 GLU D 117 GLU.? 26.53 CH3 ACT D 201 coo 38.23 53.34 67.59 38.84 53.87 69.56 -67.61 48.89 30.94 -67.34 46.91 31.68 coo 35.40 53.22 73.30 35.37 54.87 74.74 -64.24 52.49 35.03 -65.88 53.68 34.30 coo 45.08 56.04 70.60 43.15 55.19 70.77 -63.64 43.50 30.85 -64.87 41.85 30.41 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 4 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 354 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 421 ASP A 149 ASP.? 18.85 CH3 ACT A 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 29.07 50.42 58.36 29.02 52.18 59.49 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 30.82 59.76 58.47 31.12 59.02 60.40 -38.64 88.42 71.14 -36.90 88.52 69.95 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP A 86 ASP.? 20.24 CH3 ACT A 202 A 354 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 421 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 29.07 50.42 58.36 29.02 52.18 59.49 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 30.82 59.76 58.47 31.12 59.02 60.40 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 354 GLU A 72 GLU~? 5.31 O ACT A 201 A 421 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 31.05 49.37 64.51 31.97 51.11 63.85 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 29.07 50.42 58.36 29.02 52.18 59.49 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 30.82 59.76 58.47 31.12 59.02 60.40 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 354 GLU A 72 GLU~? 5.31 O ACT A 201 A 421 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 31.05 49.37 64.51 31.97 51.11 63.85 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 29.07 50.42 58.36 29.02 52.18 59.49 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 30.82 59.76 58.47 31.12 59.02 60.40 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 5 3 # 5 A 325 ASP A 116 ASP.? 19.55 CH3 ACT A 201 A 354 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 421 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 31.05 49.37 64.51 31.97 51.11 63.85 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 29.07 50.42 58.36 29.02 52.18 59.49 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 30.82 59.76 58.47 31.12 59.02 60.40 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 6 3 # 6 A 325 ASP A 116 ASP.? 19.55 CH3 ACT A 201 A 354 GLU A 117 GLU.? 20.82 OXT ACT A 202 A 421 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 31.05 49.37 64.51 31.97 51.11 63.85 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 29.07 50.42 58.36 29.02 52.18 59.49 -10.16 77.53 73.12 -10.08 75.57 72.28 coo 30.82 59.76 58.47 31.12 59.02 60.40 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 7 3 # 7 A 325 ASP B 86 ASP.? 24.07 CH3 ACT B 201 A 354 GLU B 114 GLU^? 18.04 O ACT B 201 A 421 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 29.07 50.42 58.36 29.02 52.18 59.49 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 30.82 59.76 58.47 31.12 59.02 60.40 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 8 3 # 8 A 325 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 354 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 421 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 29.07 50.42 58.36 29.02 52.18 59.49 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 30.82 59.76 58.47 31.12 59.02 60.40 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 9 3 # 9 A 325 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 354 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 421 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 31.05 49.37 64.51 31.97 51.11 63.85 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 29.07 50.42 58.36 29.02 52.18 59.49 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 30.82 59.76 58.47 31.12 59.02 60.40 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 10 3 # 10 A 325 ASP B 116 ASP.? 19.49 CH3 ACT B 201 A 354 GLU B 114 GLU^? 18.04 O ACT B 201 A 421 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 29.07 50.42 58.36 29.02 52.18 59.49 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 30.82 59.76 58.47 31.12 59.02 60.40 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 11 3 # 11 A 325 ASP B 116 ASP.? 19.49 CH3 ACT B 201 A 354 GLU B 117 GLU.? 26.48 CH3 ACT B 201 A 421 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 29.07 50.42 58.36 29.02 52.18 59.49 -33.80 72.26 99.63 -34.50 73.71 100.99 coo 30.82 59.76 58.47 31.12 59.02 60.40 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 12 3 # 12 A 325 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 354 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 421 ASP C 149 ASP.? 18.79 CH3 ACT C 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 29.07 50.42 58.36 29.02 52.18 59.49 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 30.82 59.76 58.47 31.12 59.02 60.40 -42.93 29.00 51.56 -40.94 29.30 50.94 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 13 3 # 13 A 325 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 354 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 421 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 29.07 50.42 58.36 29.02 52.18 59.49 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 30.82 59.76 58.47 31.12 59.02 60.40 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 14 3 # 14 A 325 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 354 GLU C 72 GLU~? 5.32 O ACT C 201 A 421 ASP C 74 ASP^? 14.86 O ACT C 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 29.07 50.42 58.36 29.02 52.18 59.49 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 30.82 59.76 58.47 31.12 59.02 60.40 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 15 3 # 15 A 325 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 354 GLU C 72 GLU~? 5.32 O ACT C 201 A 421 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 31.05 49.37 64.51 31.97 51.11 63.85 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 29.07 50.42 58.36 29.02 52.18 59.49 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 30.82 59.76 58.47 31.12 59.02 60.40 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 16 3 # 16 A 325 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 354 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 421 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 29.07 50.42 58.36 29.02 52.18 59.49 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 30.82 59.76 58.47 31.12 59.02 60.40 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 17 3 # 17 A 325 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 354 GLU C 117 GLU.? 26.34 CH3 ACT C 201 A 421 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 29.07 50.42 58.36 29.02 52.18 59.49 -28.65 43.01 29.05 -27.69 42.85 27.18 coo 30.82 59.76 58.47 31.12 59.02 60.40 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 18 3 # 18 A 325 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 354 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 421 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 31.05 49.37 64.51 31.97 51.11 63.85 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 29.07 50.42 58.36 29.02 52.18 59.49 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 30.82 59.76 58.47 31.12 59.02 60.40 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 19 3 # 19 A 325 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 354 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 421 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 29.07 50.42 58.36 29.02 52.18 59.49 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 30.82 59.76 58.47 31.12 59.02 60.40 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 20 3 # 20 A 325 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 354 GLU D 114 GLU^? 18.05 O ACT D 201 A 421 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 29.07 50.42 58.36 29.02 52.18 59.49 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 30.82 59.76 58.47 31.12 59.02 60.40 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 21 3 # 21 A 325 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 354 GLU D 117 GLU.? 26.53 CH3 ACT D 201 A 421 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 31.05 49.37 64.51 31.97 51.11 63.85 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 29.07 50.42 58.36 29.02 52.18 59.49 -63.64 43.50 30.85 -64.87 41.85 30.41 coo 30.82 59.76 58.47 31.12 59.02 60.40 -53.41 42.17 31.38 -52.32 40.44 30.82 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 21 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 28 ASP~? 12.70 CH3 ACT A 201 B 354 GLU A 27 GLU~? 9.74 CH3 ACT A 201 B 421 ASP A 149 ASP.? 18.85 CH3 ACT A 201 coo 25.90 8.19 53.87 25.36 6.97 52.29 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 27.87 10.66 47.95 27.82 8.60 48.27 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 26.02 1.87 43.38 25.90 1.97 45.49 -38.64 88.42 71.14 -36.90 88.52 69.95 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 116 ASP.? 19.55 CH3 ACT A 201 B 354 GLU A 114 GLU^? 11.87 CH3 ACT A 202 B 421 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 25.90 8.19 53.87 25.36 6.97 52.29 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 27.87 10.66 47.95 27.82 8.60 48.27 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 26.02 1.87 43.38 25.90 1.97 45.49 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP A 116 ASP.? 19.55 CH3 ACT A 201 B 354 GLU A 117 GLU.? 20.82 OXT ACT A 202 B 421 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 25.90 8.19 53.87 25.36 6.97 52.29 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 27.87 10.66 47.95 27.82 8.60 48.27 -10.16 77.53 73.12 -10.08 75.57 72.28 coo 26.02 1.87 43.38 25.90 1.97 45.49 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP B 28 ASP~? 12.70 CH3 ACT B 201 B 354 GLU B 27 GLU~? 9.83 CH3 ACT B 201 B 421 ASP B 149 ASP.? 20.03 CH3 ACT B 201 coo 25.90 8.19 53.87 25.36 6.97 52.29 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 27.87 10.66 47.95 27.82 8.60 48.27 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 26.02 1.87 43.38 25.90 1.97 45.49 -13.67 50.22 91.33 -14.75 50.15 93.16 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 5 3 # 5 B 325 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 354 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 421 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 27.87 10.66 47.95 27.82 8.60 48.27 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 26.02 1.87 43.38 25.90 1.97 45.49 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 6 3 # 6 B 325 ASP B 116 ASP.? 19.49 CH3 ACT B 201 B 354 GLU B 114 GLU^? 18.04 O ACT B 201 B 421 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 25.90 8.19 53.87 25.36 6.97 52.29 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 27.87 10.66 47.95 27.82 8.60 48.27 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 26.02 1.87 43.38 25.90 1.97 45.49 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 7 3 # 7 B 325 ASP B 116 ASP.? 19.49 CH3 ACT B 201 B 354 GLU B 117 GLU.? 26.48 CH3 ACT B 201 B 421 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 25.90 8.19 53.87 25.36 6.97 52.29 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 27.87 10.66 47.95 27.82 8.60 48.27 -33.80 72.26 99.63 -34.50 73.71 100.99 coo 26.02 1.87 43.38 25.90 1.97 45.49 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 8 3 # 8 B 325 ASP C 28 ASP~? 12.80 CH3 ACT C 201 B 354 GLU C 27 GLU~? 9.88 CH3 ACT C 201 B 421 ASP C 149 ASP.? 18.79 CH3 ACT C 201 coo 25.90 8.19 53.87 25.36 6.97 52.29 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 27.87 10.66 47.95 27.82 8.60 48.27 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 26.02 1.87 43.38 25.90 1.97 45.49 -42.93 29.00 51.56 -40.94 29.30 50.94 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 9 3 # 9 B 325 ASP C 116 ASP.? 19.40 CH3 ACT C 201 B 354 GLU C 114 GLU^? 18.18 OXT ACT C 201 B 421 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 25.90 8.19 53.87 25.36 6.97 52.29 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 27.87 10.66 47.95 27.82 8.60 48.27 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 26.02 1.87 43.38 25.90 1.97 45.49 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 10 3 # 10 B 325 ASP C 116 ASP.? 19.40 CH3 ACT C 201 B 354 GLU C 117 GLU.? 26.34 CH3 ACT C 201 B 421 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 25.90 8.19 53.87 25.36 6.97 52.29 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 27.87 10.66 47.95 27.82 8.60 48.27 -28.65 43.01 29.05 -27.69 42.85 27.18 coo 26.02 1.87 43.38 25.90 1.97 45.49 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 11 3 # 11 B 325 ASP D 28 ASP~? 12.70 CH3 ACT D 201 B 354 GLU D 27 GLU~? 9.75 CH3 ACT D 201 B 421 ASP D 149 ASP.? 20.02 CH3 ACT D 201 coo 25.90 8.19 53.87 25.36 6.97 52.29 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 27.87 10.66 47.95 27.82 8.60 48.27 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 26.02 1.87 43.38 25.90 1.97 45.49 -48.61 69.27 22.33 -50.68 68.95 22.00 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 12 3 # 12 B 325 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 354 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 421 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 27.87 10.66 47.95 27.82 8.60 48.27 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 26.02 1.87 43.38 25.90 1.97 45.49 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 13 3 # 13 B 325 ASP D 116 ASP.? 19.52 CH3 ACT D 201 B 354 GLU D 114 GLU^? 18.05 O ACT D 201 B 421 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 25.90 8.19 53.87 25.36 6.97 52.29 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 27.87 10.66 47.95 27.82 8.60 48.27 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 26.02 1.87 43.38 25.90 1.97 45.49 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 14 3 # 14 B 325 ASP D 116 ASP.? 19.52 CH3 ACT D 201 B 354 GLU D 117 GLU.? 26.53 CH3 ACT D 201 B 421 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 25.90 8.19 53.87 25.36 6.97 52.29 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 27.87 10.66 47.95 27.82 8.60 48.27 -63.64 43.50 30.85 -64.87 41.85 30.41 coo 26.02 1.87 43.38 25.90 1.97 45.49 -53.41 42.17 31.38 -52.32 40.44 30.82 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 14 hits 1bvz_c09 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN A 31 ASN~? 8.53 CH3 ACT A 201 192 ASP A 150 ASP.? 22.07 CH3 ACT A 201 195 HIS A 151 HIS.? 15.97 CH3 ACT A 201 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -36.15 78.19 63.69 -37.32 77.26 65.21 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -43.83 81.49 70.61 -45.02 79.78 70.42 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 2 3 # 2 104 ASN B 31 ASN~? 8.56 CH3 ACT B 201 192 ASP B 150 ASP.? 20.21 CH3 ACT A 202 195 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -26.33 48.60 87.43 -25.42 49.22 85.60 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 3 3 # 3 104 ASN B 103 ASN.? 17.21 C2 EDO A 302 192 ASP C 99 ASP.? 5.79 O1 EDO A 301 195 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -32.39 41.19 68.51 -33.08 39.66 67.21 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 4 3 # 4 104 ASN B 103 ASN.? 17.21 C2 EDO A 302 192 ASP C 100 ASP.? 9.05 C1 EDO A 301 195 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -32.39 41.19 68.51 -33.08 39.66 67.21 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 5 3 # 5 104 ASN C 31 ASN~? 8.68 CH3 ACT C 201 192 ASP C 150 ASP.? 20.99 CH3 ACT C 201 195 HIS C 151 HIS.? 16.03 CH3 ACT C 201 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -36.93 39.85 55.08 -38.97 40.48 55.12 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -46.81 35.18 56.40 -47.74 36.88 57.21 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 6 3 # 6 104 ASN D 31 ASN~? 8.51 CH3 ACT D 201 192 ASP D 150 ASP.? 21.68 CH3 ACT D 201 195 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -53.58 68.96 34.68 -51.50 68.66 35.10 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -44.04 70.63 29.61 -43.01 70.81 31.43 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 7 3 # 7 104 ASN D 103 ASN.? 11.64 CH3 ACT A 203 192 ASP A 99 ASP.? 5.71 O2 EDO A 301 195 HIS A 98 HIS^? -3.60 C ACT A 203s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -43.97 76.72 52.03 -43.49 78.26 53.43 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 8 3 # 8 104 ASN D 103 ASN.? 11.64 CH3 ACT A 203 192 ASP A 100 ASP.? 9.07 O2 EDO A 301 195 HIS A 98 HIS^? -3.60 C ACT A 203s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -43.97 76.72 52.03 -43.49 78.26 53.43 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 9 3 # 9 104 ASN D 129 ASN.? 9.72 OXT ACT C 201 192 ASP A 74 ASP^? 5.73 OXT ACT A 203 195 HIS A 98 HIS^? -3.60 C ACT A 203s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -46.65 67.75 58.52 -46.50 68.86 56.74 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 9 hits 1bwp_c01 naa= 3 ULMN 3 1bzc_c00 PROTEIN-TYROSINE-PHOSPHATASE user 1 3 # 1 A 181 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 215 CYH D 127 CYH.? 10.01 OXT ACT C 201 A 221 ARG D 51 ARG.? 7.60 O ACT D 201 coo -20.67 62.35 15.68 -20.16 63.09 17.59 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -17.06 60.65 8.77 -19.43 59.04 8.89 -47.67 56.31 47.24 -47.42 53.67 48.08 coo -21.54 63.29 10.68 -19.32 62.77 12.69 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 1bzc_c00 PROTEIN-TYROSINE-PHOSPHATASE user 2 3 # 2 A 181 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 215 CYH B 127 CYH.? 10.07 OXT ACT A 201 A 221 ARG B 51 ARG.? 7.67 O ACT B 201 coo -20.67 62.35 15.68 -20.16 63.09 17.59 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -17.06 60.65 8.77 -19.43 59.04 8.89 -34.42 60.97 75.89 -35.29 63.54 75.29 coo -21.54 63.29 10.68 -19.32 62.77 12.69 -37.69 55.58 74.87 -35.47 53.51 74.34 1bzc_c00 source 1bzc PROTEIN-TYROSINE-PHOSPHATASE : 2 hits 1bzc_c00 naa= 3 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN D 103 ASN.? 11.64 CH3 ACT A 203 A 108 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 144 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 16.88 2.43 18.09 16.20 3.65 19.72 -43.97 76.72 52.03 -43.49 78.26 53.43 coo 16.00 9.54 19.61 16.53 10.80 21.20 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 20.15 8.89 19.42 18.82 8.12 20.82 -49.03 74.78 51.99 -47.35 75.78 52.80 1c2t_c02 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 1 hits 1c2t_c02 naa= 3 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN D 103 ASN.? 11.64 CH3 ACT A 203 B 108 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 144 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -43.97 76.72 52.03 -43.49 78.26 53.43 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 35.12 16.22 2.69 37.05 17.04 2.40 -49.03 74.78 51.99 -47.35 75.78 52.80 1c2t_c03 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 1 hits 1c2t_c03 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 65 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 85 HIS A 151 HIS.? 15.97 CH3 ACT A 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -34.88 77.89 68.90 -36.12 78.93 70.26 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -43.83 81.49 70.61 -45.02 79.78 70.42 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 65 ARG A 146 ARG.? 16.48 CH3 ACT A 201 A 85 HIS A 151 HIS.? 15.97 CH3 ACT A 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -34.88 77.89 68.90 -36.12 78.93 70.26 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -35.10 85.34 65.39 -35.74 86.54 68.15 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -43.83 81.49 70.61 -45.02 79.78 70.42 ULMN 3 1c54_c00 RIBONUCLEASE SA user 3 3 # 3 A 54 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 65 ARG A 49 ARG^? -3.92 O ACT A 202s A 85 HIS A 56 HIS.? 6.76 O1 EDO A 302 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -26.96 59.20 61.32 -28.18 60.32 59.98 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -25.12 58.31 69.83 -26.93 60.25 71.40 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -17.38 60.38 62.27 -18.29 58.66 63.03 ULMN 3 1c54_c00 RIBONUCLEASE SA user 4 3 # 4 A 54 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 65 ARG A 24 ARG~? 13.97 CH3 ACT A 201 A 85 HIS A 151 HIS.? 15.97 CH3 ACT A 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -35.46 76.50 78.57 -37.32 76.28 79.54 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -33.88 82.79 71.01 -36.66 83.48 69.87 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -43.83 81.49 70.61 -45.02 79.78 70.42 ULMN 3 1c54_c00 RIBONUCLEASE SA user 5 3 # 5 A 54 GLU A 137 GLU~? 14.03 O ACT A 203 A 65 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 85 HIS A 161 HIS.? 19.24 O ACT B 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -53.30 67.06 70.37 -52.56 65.17 70.96 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -44.60 68.65 71.93 -47.65 68.54 71.92 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -48.72 65.75 79.30 -49.45 66.41 81.15 ULMN 3 1c54_c00 RIBONUCLEASE SA user 6 3 # 6 A 54 GLU A 160 GLU.? 13.50 O ACT A 201 A 65 ARG A 147 ARG.? 13.06 CH3 ACT A 201 A 85 HIS A 141 HIS.? 11.20 OXT ACT A 203 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -45.30 71.21 75.74 -44.17 71.89 74.09 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -40.14 80.19 70.35 -38.27 80.75 72.73 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -49.96 77.41 66.16 -51.01 75.70 66.78 ULMN 3 1c54_c00 RIBONUCLEASE SA user 7 3 # 7 A 54 GLU A 160 GLU.? 13.50 O ACT A 201 A 65 ARG B 49 ARG^? 10.37 O ACT B 201 A 85 HIS A 162 HIS.? 14.54 O1 EDO A 301 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -45.30 71.21 75.74 -44.17 71.89 74.09 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -40.89 64.28 77.45 -37.86 63.79 77.23 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -51.28 62.77 74.01 -50.27 62.16 72.28 ULMN 3 1c54_c00 RIBONUCLEASE SA user 8 3 # 8 A 54 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 65 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 85 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -24.11 53.46 86.45 -22.04 53.54 86.08 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1c54_c00 RIBONUCLEASE SA user 9 3 # 9 A 54 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 65 ARG B 146 ARG.? 16.58 CH3 ACT B 201 A 85 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -24.11 53.46 86.45 -22.04 53.54 86.08 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -21.21 49.21 92.90 -18.50 50.59 92.50 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1c54_c00 RIBONUCLEASE SA user 10 3 # 10 A 54 GLU B 53 GLU^? 11.09 O ACT B 201 A 65 ARG B 49 ARG^? 10.37 O ACT B 201 A 85 HIS A 161 HIS.? 19.24 O ACT B 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -44.66 56.42 79.28 -43.94 54.52 79.83 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -40.89 64.28 77.45 -37.86 63.79 77.23 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -48.72 65.75 79.30 -49.45 66.41 81.15 ULMN 3 1c54_c00 RIBONUCLEASE SA user 11 3 # 11 A 54 GLU B 53 GLU^? 11.09 O ACT B 201 A 65 ARG B 49 ARG^? 10.37 O ACT B 201 A 85 HIS A 162 HIS.? 14.54 O1 EDO A 301 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -44.66 56.42 79.28 -43.94 54.52 79.83 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -40.89 64.28 77.45 -37.86 63.79 77.23 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -51.28 62.77 74.01 -50.27 62.16 72.28 ULMN 3 1c54_c00 RIBONUCLEASE SA user 12 3 # 12 A 54 GLU B 53 GLU^? 11.09 O ACT B 201 A 65 ARG B 49 ARG^? 10.37 O ACT B 201 A 85 HIS B 56 HIS.? 17.31 O ACT B 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -44.66 56.42 79.28 -43.94 54.52 79.83 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -40.89 64.28 77.45 -37.86 63.79 77.23 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -48.13 62.85 85.87 -48.38 63.10 83.80 ULMN 3 1c54_c00 RIBONUCLEASE SA user 13 3 # 13 A 54 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 65 ARG B 51 ARG.? 7.67 O ACT B 201 A 85 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -35.13 47.70 77.85 -34.58 49.69 78.28 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -37.69 55.58 74.87 -35.47 53.51 74.34 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1c54_c00 RIBONUCLEASE SA user 14 3 # 14 A 54 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 65 ARG B 24 ARG~? 14.02 CH3 ACT B 201 A 85 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -19.12 60.55 81.96 -17.78 60.17 80.39 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -20.35 54.64 90.03 -19.09 51.96 89.19 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1c54_c00 RIBONUCLEASE SA user 15 3 # 15 A 54 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 65 ARG B 147 ARG.? 12.52 CH3 ACT A 202 A 85 HIS B 141 HIS.? 15.94 CH3 ACT A 202 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -24.44 47.78 75.39 -22.51 46.98 75.05 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -19.28 50.88 84.48 -18.42 53.72 85.30 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -16.42 43.62 79.59 -14.76 44.89 79.44 ULMN 3 1c54_c00 RIBONUCLEASE SA user 16 3 # 16 A 54 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 65 ARG C 76 ARG^? 14.32 O ACT C 201 A 85 HIS C 151 HIS.? 16.03 CH3 ACT C 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -40.23 39.97 50.79 -41.89 38.66 50.83 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -42.25 40.39 61.14 -41.06 40.24 63.98 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -46.81 35.18 56.40 -47.74 36.88 57.21 ULMN 3 1c54_c00 RIBONUCLEASE SA user 17 3 # 17 A 54 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 65 ARG C 146 ARG.? 16.63 CH3 ACT C 201 A 85 HIS C 151 HIS.? 16.03 CH3 ACT C 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -40.23 39.97 50.79 -41.89 38.66 50.83 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -36.58 32.85 52.68 -38.87 31.31 51.32 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -46.81 35.18 56.40 -47.74 36.88 57.21 ULMN 3 1c54_c00 RIBONUCLEASE SA user 18 3 # 18 A 54 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 65 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 85 HIS C 56 HIS.? 17.26 OXT ACT C 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -32.08 60.14 50.84 -31.64 58.95 52.54 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -37.64 60.68 44.02 -39.72 58.44 44.33 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -26.71 60.26 42.75 -28.06 61.81 43.18 ULMN 3 1c54_c00 RIBONUCLEASE SA user 19 3 # 19 A 54 GLU C 80 GLU^? 14.47 CH3 ACT C 201 A 65 ARG C 24 ARG~? 14.09 CH3 ACT C 201 A 85 HIS C 151 HIS.? 16.03 CH3 ACT C 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -48.24 40.72 45.31 -50.16 40.73 46.15 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -40.53 35.15 48.39 -41.31 34.14 51.19 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -46.81 35.18 56.40 -47.74 36.88 57.21 ULMN 3 1c54_c00 RIBONUCLEASE SA user 20 3 # 20 A 54 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 65 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 85 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -50.66 64.65 33.24 -49.08 64.98 31.89 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -47.81 74.29 36.53 -48.87 77.02 37.43 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -44.04 70.63 29.61 -43.01 70.81 31.43 ULMN 3 1c54_c00 RIBONUCLEASE SA user 21 3 # 21 A 54 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 65 ARG D 146 ARG.? 16.60 CH3 ACT D 201 A 85 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -50.66 64.65 33.24 -49.08 64.98 31.89 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -54.51 68.83 27.22 -52.30 68.02 25.26 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -44.04 70.63 29.61 -43.01 70.81 31.43 ULMN 3 1c54_c00 RIBONUCLEASE SA user 22 3 # 22 A 54 GLU D 53 GLU^? 10.32 O ACT A 203 A 65 ARG D 49 ARG^? 10.44 O ACT D 201 A 85 HIS D 56 HIS.? 17.26 O ACT D 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -56.60 59.52 53.75 -57.18 61.28 52.77 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -52.37 52.11 51.12 -50.46 52.95 48.87 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -63.50 51.60 51.23 -61.99 51.43 52.67 ULMN 3 1c54_c00 RIBONUCLEASE SA user 23 3 # 23 A 54 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 65 ARG D 33 ARG.? 12.34 OXT ACT D 201 A 85 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -51.77 69.18 47.61 -51.44 67.29 46.71 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -55.21 72.58 39.53 -56.74 74.11 37.37 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -48.48 77.63 46.64 -50.12 78.90 46.30 ULMN 3 1c54_c00 RIBONUCLEASE SA user 24 3 # 24 A 54 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 65 ARG D 51 ARG.? 7.60 O ACT D 201 A 85 HIS A 98 HIS^? -3.60 C ACT A 203s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -51.77 69.18 47.61 -51.44 67.29 46.71 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -49.81 61.30 50.74 -48.26 63.65 49.51 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1c54_c00 RIBONUCLEASE SA user 25 3 # 25 A 54 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 65 ARG D 24 ARG~? 13.98 CH3 ACT D 201 A 85 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -42.96 58.73 31.72 -40.96 59.40 31.80 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -50.90 63.83 27.93 -49.90 66.74 27.73 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -44.04 70.63 29.61 -43.01 70.81 31.43 ULMN 3 1c54_c00 RIBONUCLEASE SA user 26 3 # 26 A 54 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 65 ARG D 147 ARG.? 13.02 CH3 ACT D 201 A 85 HIS D 141 HIS.? 18.95 OXT ACT D 201 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -43.29 70.99 40.99 -41.92 72.19 39.92 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -46.62 68.18 31.08 -46.22 65.54 29.55 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -42.77 77.11 33.23 -41.72 76.77 31.45 1c54_c00 source 1c54 RIBONUCLEASE SA : 26 hits 1c54_c00 naa= 3 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 1 3 # 1 183 GLU A 59 GLU~? 18.41 O2 EDO A 302 324 ASN A 57 ASN~? 14.18 O1 EDO A 302 397 GLU A 60 GLU~? 10.63 O2 EDO A 302 coo 39.31 34.78 85.95 38.51 34.50 84.04 -19.57 66.85 53.38 -18.14 66.20 51.96 coo 43.16 34.25 82.88 42.98 32.71 84.39 -16.25 65.99 58.99 -17.06 64.89 57.36 coo 42.23 29.47 82.87 40.46 30.21 83.67 -19.73 62.99 57.19 -19.03 61.21 58.09 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 2 3 # 2 183 GLU A 60 GLU~? 10.63 O2 EDO A 302 324 ASN A 57 ASN~? 14.18 O1 EDO A 302 397 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo 39.31 34.78 85.95 38.51 34.50 84.04 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 43.16 34.25 82.88 42.98 32.71 84.39 -16.25 65.99 58.99 -17.06 64.89 57.36 coo 42.23 29.47 82.87 40.46 30.21 83.67 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 3 3 # 3 183 GLU B 59 GLU~? 20.69 O ACT B 201 324 ASN B 57 ASN~? 18.11 O ACT B 201 397 GLU B 60 GLU~? 17.33 O ACT B 201 coo 39.31 34.78 85.95 38.51 34.50 84.04 -47.90 53.57 92.50 -49.95 53.72 93.03 coo 43.16 34.25 82.88 42.98 32.71 84.39 -46.90 59.98 91.63 -48.14 58.47 90.79 coo 42.23 29.47 82.87 40.46 30.21 83.67 -48.17 57.12 87.93 -49.17 58.57 86.76 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 4 3 # 4 183 GLU B 60 GLU~? 17.33 O ACT B 201 324 ASN B 57 ASN~? 18.11 O ACT B 201 397 GLU B 59 GLU~? 20.69 O ACT B 201 coo 39.31 34.78 85.95 38.51 34.50 84.04 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 43.16 34.25 82.88 42.98 32.71 84.39 -46.90 59.98 91.63 -48.14 58.47 90.79 coo 42.23 29.47 82.87 40.46 30.21 83.67 -47.90 53.57 92.50 -49.95 53.72 93.03 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 5 3 # 5 183 GLU C 59 GLU~? 13.48 O2 EDO A 302 324 ASN C 57 ASN~? 18.23 OXT ACT C 201 397 GLU C 60 GLU~? 17.22 OXT ACT C 201 coo 39.31 34.78 85.95 38.51 34.50 84.04 -20.25 53.72 49.66 -20.40 52.10 51.04 coo 43.16 34.25 82.88 42.98 32.71 84.39 -22.76 55.02 43.39 -22.13 56.21 45.03 coo 42.23 29.47 82.87 40.46 30.21 83.67 -23.89 57.63 47.43 -24.47 59.50 46.62 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 6 3 # 6 183 GLU C 60 GLU~? 17.22 OXT ACT C 201 324 ASN C 57 ASN~? 18.23 OXT ACT C 201 397 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo 39.31 34.78 85.95 38.51 34.50 84.04 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 43.16 34.25 82.88 42.98 32.71 84.39 -22.76 55.02 43.39 -22.13 56.21 45.03 coo 42.23 29.47 82.87 40.46 30.21 83.67 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 7 3 # 7 183 GLU D 59 GLU~? 18.52 O ACT D 201 324 ASN D 57 ASN~? 18.22 O ACT D 201 397 GLU D 60 GLU~? 17.31 O ACT D 201 coo 39.31 34.78 85.95 38.51 34.50 84.04 -69.73 60.64 47.66 -70.08 62.16 46.23 coo 43.16 34.25 82.88 42.98 32.71 84.39 -67.77 54.18 46.88 -68.13 55.47 48.54 coo 42.23 29.47 82.87 40.46 30.21 83.67 -66.09 57.03 50.37 -65.56 55.61 51.84 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 8 3 # 8 183 GLU D 60 GLU~? 17.31 O ACT D 201 324 ASN D 57 ASN~? 18.22 O ACT D 201 397 GLU D 59 GLU~? 18.52 O ACT D 201 coo 39.31 34.78 85.95 38.51 34.50 84.04 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 43.16 34.25 82.88 42.98 32.71 84.39 -67.77 54.18 46.88 -68.13 55.47 48.54 coo 42.23 29.47 82.87 40.46 30.21 83.67 -69.73 60.64 47.66 -70.08 62.16 46.23 1cbg_c00 source 1cbg CYANOGENIC BETA-GLUCOSIDASE : 8 hits 1cbg_c00 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 67 ARG~? 13.20 O2 EDO A 302 127 ARG C 67 ARG~? 12.50 O2 EDO A 302 270 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo -0.83 25.63 1.57 0.97 28.05 0.90 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 67 ARG~? 13.20 O2 EDO A 302 127 ARG C 67 ARG~? 12.50 O2 EDO A 302 270 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo -0.83 25.63 1.57 0.97 28.05 0.90 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG A 67 ARG~? 13.20 O2 EDO A 302 127 ARG C 67 ARG~? 12.50 O2 EDO A 302 270 GLU C 72 GLU~? 5.32 O ACT C 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG A 88 ARG^? 11.13 CH3 ACT A 202 127 ARG B 92 ARG^? -3.69 CH3 ACT A 202s 270 GLU B 156 GLU~? 12.19 CH3 ACT A 202 coo -0.83 25.63 1.57 0.97 28.05 0.90 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -12.52 56.39 79.83 -10.80 57.54 79.39 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 5 3 # 5 71 ARG B 76 ARG^? 14.33 OXT ACT B 201 127 ARG B 138 ARG~? 16.35 OXT ACT B 201 270 GLU B 72 GLU~? 5.30 OXT ACT B 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -23.44 41.55 74.26 -23.57 39.98 76.87 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -35.13 47.70 77.85 -34.58 49.69 78.28 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 6 3 # 6 71 ARG B 88 ARG^? 18.43 CH3 ACT A 201 127 ARG A 92 ARG^? 14.09 CH3 ACT A 201 270 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 7 3 # 7 71 ARG B 92 ARG^? -3.69 CH3 ACT A 202s 127 ARG A 88 ARG^? 11.13 CH3 ACT A 202 270 GLU B 156 GLU~? 12.19 CH3 ACT A 202 coo -0.83 25.63 1.57 0.97 28.05 0.90 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -18.98 69.22 79.04 -17.48 66.59 79.46 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -12.52 56.39 79.83 -10.80 57.54 79.39 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 8 3 # 8 71 ARG B 138 ARG~? 16.35 OXT ACT B 201 127 ARG B 76 ARG^? 14.33 OXT ACT B 201 270 GLU B 72 GLU~? 5.30 OXT ACT B 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -35.13 47.70 77.85 -34.58 49.69 78.28 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 9 3 # 9 71 ARG B 147 ARG.? 12.52 CH3 ACT A 202 127 ARG B 24 ARG~? 14.02 CH3 ACT B 201 270 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -20.35 54.64 90.03 -19.09 51.96 89.19 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 10 3 # 10 71 ARG C 67 ARG~? 12.50 O2 EDO A 302 127 ARG A 67 ARG~? 13.20 O2 EDO A 302 270 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo -0.83 25.63 1.57 0.97 28.05 0.90 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 11 3 # 11 71 ARG C 67 ARG~? 12.50 O2 EDO A 302 127 ARG A 67 ARG~? 13.20 O2 EDO A 302 270 GLU A 72 GLU~? 5.31 O ACT A 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 12 3 # 12 71 ARG C 67 ARG~? 12.50 O2 EDO A 302 127 ARG A 67 ARG~? 13.20 O2 EDO A 302 270 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo -0.83 25.63 1.57 0.97 28.05 0.90 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 13 3 # 13 71 ARG C 88 ARG^? 18.42 CH3 ACT D 201 127 ARG C 123 ARG.? 17.68 OXT ACT C 201 270 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -33.35 53.49 35.15 -35.34 55.60 34.14 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 14 3 # 14 71 ARG C 88 ARG^? 18.42 CH3 ACT D 201 127 ARG C 123 ARG.? 17.68 OXT ACT C 201 270 GLU C 117 GLU.? 26.34 CH3 ACT C 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -33.35 53.49 35.15 -35.34 55.60 34.14 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -28.65 43.01 29.05 -27.69 42.85 27.18 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 15 3 # 15 71 ARG C 92 ARG^? 13.71 CH3 ACT C 201 127 ARG D 88 ARG^? 18.35 CH3 ACT C 201 270 GLU C 156 GLU~? 19.44 CH3 ACT C 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -52.23 44.53 37.75 -52.43 42.56 40.08 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -53.30 36.17 49.35 -52.27 34.34 49.18 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 16 3 # 16 71 ARG C 123 ARG.? 17.68 OXT ACT C 201 127 ARG C 88 ARG^? 18.42 CH3 ACT D 201 270 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -39.31 50.22 32.74 -39.14 52.99 31.45 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 17 3 # 17 71 ARG C 123 ARG.? 17.68 OXT ACT C 201 127 ARG C 88 ARG^? 18.42 CH3 ACT D 201 270 GLU C 117 GLU.? 26.34 CH3 ACT C 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -39.31 50.22 32.74 -39.14 52.99 31.45 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -28.65 43.01 29.05 -27.69 42.85 27.18 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 18 3 # 18 71 ARG D 88 ARG^? 18.35 CH3 ACT C 201 127 ARG C 92 ARG^? 13.71 CH3 ACT C 201 270 GLU C 156 GLU~? 19.44 CH3 ACT C 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -53.30 36.17 49.35 -52.27 34.34 49.18 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 19 3 # 19 71 ARG D 147 ARG.? 13.02 CH3 ACT D 201 127 ARG D 24 ARG~? 13.98 CH3 ACT D 201 270 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo -0.83 25.63 1.57 0.97 28.05 0.90 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -50.90 63.83 27.93 -49.90 66.74 27.73 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -50.16 56.56 39.52 -51.23 58.35 39.21 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 19 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 28 ASP~? 12.70 CH3 ACT A 201 264 GLU A 72 GLU~? 5.31 O ACT A 201 328 ASP A 34 ASP~? 14.63 O ACT A 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 59.69 92.71 39.85 58.53 92.03 41.47 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 45.39 90.72 40.63 45.07 89.14 41.90 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 34 ASP~? 14.63 O ACT A 201 264 GLU A 111 GLU^? 4.34 CH3 ACT A 201 328 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 59.69 92.71 39.85 58.53 92.03 41.47 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 74 ASP^? 5.73 OXT ACT A 203 264 GLU C 53 GLU^? 11.18 OXT ACT C 201 328 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 59.69 92.71 39.85 58.53 92.03 41.47 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 74 ASP^? 5.73 OXT ACT A 203 264 GLU C 53 GLU^? 11.18 OXT ACT C 201 328 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 59.69 92.71 39.85 58.53 92.03 41.47 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP A 74 ASP^? 5.73 OXT ACT A 203 264 GLU C 53 GLU^? 11.18 OXT ACT C 201 328 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 59.69 92.71 39.85 58.53 92.03 41.47 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP A 74 ASP^? 5.73 OXT ACT A 203 264 GLU D 53 GLU^? 10.32 O ACT A 203 328 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 59.69 92.71 39.85 58.53 92.03 41.47 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP A 74 ASP^? 5.73 OXT ACT A 203 264 GLU D 53 GLU^? 10.32 O ACT A 203 328 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 59.69 92.71 39.85 58.53 92.03 41.47 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP A 74 ASP^? 5.73 OXT ACT A 203 264 GLU D 96 GLU^? 13.00 OXT ACT D 201 328 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 59.69 92.71 39.85 58.53 92.03 41.47 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 9 3 # 9 229 ASP A 74 ASP^? 5.73 OXT ACT A 203 264 GLU D 137 GLU~? 19.20 CH3 ACT A 203 328 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 59.69 92.71 39.85 58.53 92.03 41.47 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 10 3 # 10 229 ASP A 86 ASP.? 20.24 CH3 ACT A 202 264 GLU B 160 GLU.? 4.71 OXT ACT A 202 328 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 59.69 92.71 39.85 58.53 92.03 41.47 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 45.39 90.72 40.63 45.07 89.14 41.90 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 11 3 # 11 229 ASP A 99 ASP.? 5.71 O2 EDO A 301 264 GLU A 53 GLU^? 10.41 O2 EDO A 302 328 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 59.69 92.71 39.85 58.53 92.03 41.47 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 45.39 90.72 40.63 45.07 89.14 41.90 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 12 3 # 12 229 ASP A 99 ASP.? 5.71 O2 EDO A 301 264 GLU A 53 GLU^? 10.41 O2 EDO A 302 328 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 59.69 92.71 39.85 58.53 92.03 41.47 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 13 3 # 13 229 ASP A 99 ASP.? 5.71 O2 EDO A 301 264 GLU A 160 GLU.? 13.50 O ACT A 201 328 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 59.69 92.71 39.85 58.53 92.03 41.47 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 45.39 90.72 40.63 45.07 89.14 41.90 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 14 3 # 14 229 ASP A 99 ASP.? 5.71 O2 EDO A 301 264 GLU D 111 GLU^? 4.46 CH3 ACT D 201 328 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 59.69 92.71 39.85 58.53 92.03 41.47 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 15 3 # 15 229 ASP A 100 ASP.? 9.07 O2 EDO A 301 264 GLU A 137 GLU~? 14.03 O ACT A 203 328 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 59.69 92.71 39.85 58.53 92.03 41.47 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 16 3 # 16 229 ASP A 100 ASP.? 9.07 O2 EDO A 301 264 GLU C 111 GLU^? 4.32 CH3 ACT C 201 328 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 59.69 92.71 39.85 58.53 92.03 41.47 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 45.39 90.72 40.63 45.07 89.14 41.90 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 17 3 # 17 229 ASP A 100 ASP.? 9.07 O2 EDO A 301 264 GLU D 137 GLU~? 19.20 CH3 ACT A 203 328 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 59.69 92.71 39.85 58.53 92.03 41.47 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 45.39 90.72 40.63 45.07 89.14 41.90 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 18 3 # 18 229 ASP A 116 ASP.? 19.55 CH3 ACT A 201 264 GLU A 17 GLU~? 23.86 CH3 ACT A 201 328 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 45.62 80.42 43.69 45.65 82.01 45.07 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 59.69 92.71 39.85 58.53 92.03 41.47 -26.80 87.18 79.85 -26.18 89.13 80.39 coo 45.39 90.72 40.63 45.07 89.14 41.90 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 19 3 # 19 229 ASP A 116 ASP.? 19.55 CH3 ACT A 201 264 GLU B 80 GLU^? 7.87 CH3 ACT A 202 328 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 45.62 80.42 43.69 45.65 82.01 45.07 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 59.69 92.71 39.85 58.53 92.03 41.47 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 45.39 90.72 40.63 45.07 89.14 41.90 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 20 3 # 20 229 ASP A 130 ASP.? 4.80 O1 EDO A 301 264 GLU B 111 GLU^? 4.46 CH3 ACT B 201 328 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 59.69 92.71 39.85 58.53 92.03 41.47 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 45.39 90.72 40.63 45.07 89.14 41.90 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 21 3 # 21 229 ASP A 130 ASP.? 4.80 O1 EDO A 301 264 GLU B 111 GLU^? 4.46 CH3 ACT B 201 328 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 59.69 92.71 39.85 58.53 92.03 41.47 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 45.39 90.72 40.63 45.07 89.14 41.90 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 22 3 # 22 229 ASP A 130 ASP.? 4.80 O1 EDO A 301 264 GLU C 53 GLU^? 11.18 OXT ACT C 201 328 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 59.69 92.71 39.85 58.53 92.03 41.47 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 23 3 # 23 229 ASP A 130 ASP.? 4.80 O1 EDO A 301 264 GLU C 53 GLU^? 11.18 OXT ACT C 201 328 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 59.69 92.71 39.85 58.53 92.03 41.47 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 24 3 # 24 229 ASP A 130 ASP.? 4.80 O1 EDO A 301 264 GLU C 137 GLU~? 15.84 O2 EDO A 301 328 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 59.69 92.71 39.85 58.53 92.03 41.47 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 45.39 90.72 40.63 45.07 89.14 41.90 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 25 3 # 25 229 ASP A 130 ASP.? 4.80 O1 EDO A 301 264 GLU D 53 GLU^? 10.32 O ACT A 203 328 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 59.69 92.71 39.85 58.53 92.03 41.47 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 26 3 # 26 229 ASP A 149 ASP.? 18.85 CH3 ACT A 201 264 GLU A 111 GLU^? 4.34 CH3 ACT A 201 328 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 59.69 92.71 39.85 58.53 92.03 41.47 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 27 3 # 27 229 ASP B 28 ASP~? 12.70 CH3 ACT B 201 264 GLU B 72 GLU~? 5.30 OXT ACT B 201 328 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 59.69 92.71 39.85 58.53 92.03 41.47 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 45.39 90.72 40.63 45.07 89.14 41.90 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 28 3 # 28 229 ASP B 28 ASP~? 12.70 CH3 ACT B 201 264 GLU B 156 GLU~? 12.19 CH3 ACT A 202 328 ASP B 149 ASP.? 20.03 CH3 ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 59.69 92.71 39.85 58.53 92.03 41.47 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 45.39 90.72 40.63 45.07 89.14 41.90 -13.67 50.22 91.33 -14.75 50.15 93.16 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 29 3 # 29 229 ASP B 34 ASP~? 14.61 OXT ACT B 201 264 GLU B 111 GLU^? 4.46 CH3 ACT B 201 328 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 59.69 92.71 39.85 58.53 92.03 41.47 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 45.39 90.72 40.63 45.07 89.14 41.90 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 30 3 # 30 229 ASP B 99 ASP.? 16.09 OXT ACT B 201 264 GLU B 53 GLU^? 11.09 O ACT B 201 328 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 59.69 92.71 39.85 58.53 92.03 41.47 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 31 3 # 31 229 ASP B 99 ASP.? 16.09 OXT ACT B 201 264 GLU B 53 GLU^? 11.09 O ACT B 201 328 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 59.69 92.71 39.85 58.53 92.03 41.47 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 32 3 # 32 229 ASP B 100 ASP.? 15.93 OXT ACT B 201 264 GLU B 137 GLU~? 6.31 C2 EDO A 302 328 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 59.69 92.71 39.85 58.53 92.03 41.47 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 45.39 90.72 40.63 45.07 89.14 41.90 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 33 3 # 33 229 ASP B 100 ASP.? 15.93 OXT ACT B 201 264 GLU C 137 GLU~? 15.84 O2 EDO A 301 328 ASP C 74 ASP^? 14.86 O ACT C 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 59.69 92.71 39.85 58.53 92.03 41.47 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 34 3 # 34 229 ASP B 116 ASP.? 19.49 CH3 ACT B 201 264 GLU A 80 GLU^? 14.51 CH3 ACT A 201 328 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 59.69 92.71 39.85 58.53 92.03 41.47 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 35 3 # 35 229 ASP B 116 ASP.? 19.49 CH3 ACT B 201 264 GLU B 17 GLU~? 23.60 CH3 ACT B 201 328 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 59.69 92.71 39.85 58.53 92.03 41.47 -16.26 64.60 95.04 -14.82 64.68 96.59 coo 45.39 90.72 40.63 45.07 89.14 41.90 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 36 3 # 36 229 ASP B 130 ASP.? 9.25 OXT ACT B 201 264 GLU A 111 GLU^? 4.34 CH3 ACT A 201 328 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 59.69 92.71 39.85 58.53 92.03 41.47 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 37 3 # 37 229 ASP B 130 ASP.? 9.25 OXT ACT B 201 264 GLU C 96 GLU^? 13.00 O ACT C 201 328 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 59.69 92.71 39.85 58.53 92.03 41.47 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 38 3 # 38 229 ASP C 28 ASP~? 12.80 CH3 ACT C 201 264 GLU C 17 GLU~? 23.53 CH3 ACT C 201 328 ASP C 149 ASP.? 18.79 CH3 ACT C 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 59.69 92.71 39.85 58.53 92.03 41.47 -44.57 31.78 35.88 -45.60 32.67 34.25 coo 45.39 90.72 40.63 45.07 89.14 41.90 -42.93 29.00 51.56 -40.94 29.30 50.94 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 39 3 # 39 229 ASP C 28 ASP~? 12.80 CH3 ACT C 201 264 GLU C 72 GLU~? 5.32 O ACT C 201 328 ASP C 34 ASP~? 14.66 O ACT C 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 59.69 92.71 39.85 58.53 92.03 41.47 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 45.39 90.72 40.63 45.07 89.14 41.90 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 40 3 # 40 229 ASP C 28 ASP~? 12.80 CH3 ACT C 201 264 GLU C 156 GLU~? 19.44 CH3 ACT C 201 328 ASP C 149 ASP.? 18.79 CH3 ACT C 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 59.69 92.71 39.85 58.53 92.03 41.47 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 45.39 90.72 40.63 45.07 89.14 41.90 -42.93 29.00 51.56 -40.94 29.30 50.94 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 41 3 # 41 229 ASP C 34 ASP~? 14.66 O ACT C 201 264 GLU C 111 GLU^? 4.32 CH3 ACT C 201 328 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 59.69 92.71 39.85 58.53 92.03 41.47 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 45.39 90.72 40.63 45.07 89.14 41.90 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 42 3 # 42 229 ASP C 74 ASP^? 14.86 O ACT C 201 264 GLU A 53 GLU^? 10.41 O2 EDO A 302 328 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 59.69 92.71 39.85 58.53 92.03 41.47 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 45.39 90.72 40.63 45.07 89.14 41.90 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 43 3 # 43 229 ASP C 74 ASP^? 14.86 O ACT C 201 264 GLU A 53 GLU^? 10.41 O2 EDO A 302 328 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 59.69 92.71 39.85 58.53 92.03 41.47 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 44 3 # 44 229 ASP C 74 ASP^? 14.86 O ACT C 201 264 GLU A 53 GLU^? 10.41 O2 EDO A 302 328 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 59.69 92.71 39.85 58.53 92.03 41.47 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 45.39 90.72 40.63 45.07 89.14 41.90 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 45 3 # 45 229 ASP C 74 ASP^? 14.86 O ACT C 201 264 GLU B 53 GLU^? 11.09 O ACT B 201 328 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 59.69 92.71 39.85 58.53 92.03 41.47 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 46 3 # 46 229 ASP C 74 ASP^? 14.86 O ACT C 201 264 GLU B 53 GLU^? 11.09 O ACT B 201 328 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 59.69 92.71 39.85 58.53 92.03 41.47 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 47 3 # 47 229 ASP C 74 ASP^? 14.86 O ACT C 201 264 GLU B 53 GLU^? 11.09 O ACT B 201 328 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 59.69 92.71 39.85 58.53 92.03 41.47 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 48 3 # 48 229 ASP C 74 ASP^? 14.86 O ACT C 201 264 GLU B 96 GLU^? 10.60 C1 EDO A 302 328 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 59.69 92.71 39.85 58.53 92.03 41.47 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 45.39 90.72 40.63 45.07 89.14 41.90 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 49 3 # 49 229 ASP C 74 ASP^? 14.86 O ACT C 201 264 GLU B 137 GLU~? 6.31 C2 EDO A 302 328 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 59.69 92.71 39.85 58.53 92.03 41.47 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 45.39 90.72 40.63 45.07 89.14 41.90 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 50 3 # 50 229 ASP C 99 ASP.? 5.79 O1 EDO A 301 264 GLU A 137 GLU~? 14.03 O ACT A 203 328 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 59.69 92.71 39.85 58.53 92.03 41.47 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 51 3 # 51 229 ASP C 99 ASP.? 5.79 O1 EDO A 301 264 GLU B 111 GLU^? 4.46 CH3 ACT B 201 328 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 59.69 92.71 39.85 58.53 92.03 41.47 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 45.39 90.72 40.63 45.07 89.14 41.90 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 52 3 # 52 229 ASP C 99 ASP.? 5.79 O1 EDO A 301 264 GLU C 53 GLU^? 11.18 OXT ACT C 201 328 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 59.69 92.71 39.85 58.53 92.03 41.47 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 53 3 # 53 229 ASP C 99 ASP.? 5.79 O1 EDO A 301 264 GLU C 53 GLU^? 11.18 OXT ACT C 201 328 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 59.69 92.71 39.85 58.53 92.03 41.47 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 54 3 # 54 229 ASP C 100 ASP.? 9.05 C1 EDO A 301 264 GLU A 111 GLU^? 4.34 CH3 ACT A 201 328 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 59.69 92.71 39.85 58.53 92.03 41.47 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 55 3 # 55 229 ASP C 100 ASP.? 9.05 C1 EDO A 301 264 GLU A 160 GLU.? 13.50 O ACT A 201 328 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 59.69 92.71 39.85 58.53 92.03 41.47 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 45.39 90.72 40.63 45.07 89.14 41.90 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 56 3 # 56 229 ASP C 100 ASP.? 9.05 C1 EDO A 301 264 GLU B 137 GLU~? 6.31 C2 EDO A 302 328 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 59.69 92.71 39.85 58.53 92.03 41.47 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 45.39 90.72 40.63 45.07 89.14 41.90 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 57 3 # 57 229 ASP C 100 ASP.? 9.05 C1 EDO A 301 264 GLU C 137 GLU~? 15.84 O2 EDO A 301 328 ASP C 74 ASP^? 14.86 O ACT C 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 59.69 92.71 39.85 58.53 92.03 41.47 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 58 3 # 58 229 ASP C 116 ASP.? 19.40 CH3 ACT C 201 264 GLU D 80 GLU^? 14.49 CH3 ACT D 201 328 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 59.69 92.71 39.85 58.53 92.03 41.47 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 45.39 90.72 40.63 45.07 89.14 41.90 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 59 3 # 59 229 ASP C 130 ASP.? 4.74 O2 EDO A 301 264 GLU A 53 GLU^? 10.41 O2 EDO A 302 328 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 59.69 92.71 39.85 58.53 92.03 41.47 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 45.39 90.72 40.63 45.07 89.14 41.90 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 60 3 # 60 229 ASP C 130 ASP.? 4.74 O2 EDO A 301 264 GLU A 53 GLU^? 10.41 O2 EDO A 302 328 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 59.69 92.71 39.85 58.53 92.03 41.47 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 61 3 # 61 229 ASP C 130 ASP.? 4.74 O2 EDO A 301 264 GLU A 137 GLU~? 14.03 O ACT A 203 328 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 59.69 92.71 39.85 58.53 92.03 41.47 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 45.39 90.72 40.63 45.07 89.14 41.90 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 62 3 # 62 229 ASP C 130 ASP.? 4.74 O2 EDO A 301 264 GLU D 111 GLU^? 4.46 CH3 ACT D 201 328 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 59.69 92.71 39.85 58.53 92.03 41.47 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 63 3 # 63 229 ASP C 149 ASP.? 18.79 CH3 ACT C 201 264 GLU C 111 GLU^? 4.32 CH3 ACT C 201 328 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 59.69 92.71 39.85 58.53 92.03 41.47 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 45.39 90.72 40.63 45.07 89.14 41.90 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 64 3 # 64 229 ASP D 28 ASP~? 12.70 CH3 ACT D 201 264 GLU D 72 GLU~? 5.29 OXT ACT D 201 328 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 59.69 92.71 39.85 58.53 92.03 41.47 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 45.39 90.72 40.63 45.07 89.14 41.90 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 65 3 # 65 229 ASP D 28 ASP~? 12.70 CH3 ACT D 201 264 GLU D 156 GLU.? 18.36 CH3 ACT D 201 328 ASP D 149 ASP.? 20.02 CH3 ACT D 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 59.69 92.71 39.85 58.53 92.03 41.47 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 45.39 90.72 40.63 45.07 89.14 41.90 -48.61 69.27 22.33 -50.68 68.95 22.00 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 66 3 # 66 229 ASP D 34 ASP~? 14.62 OXT ACT D 201 264 GLU D 111 GLU^? 4.46 CH3 ACT D 201 328 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 59.69 92.71 39.85 58.53 92.03 41.47 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 45.39 90.72 40.63 45.07 89.14 41.90 -55.65 65.73 30.36 -54.18 65.67 28.83 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 67 3 # 67 229 ASP D 99 ASP.? 7.94 CH3 ACT A 203 264 GLU D 53 GLU^? 10.32 O ACT A 203 328 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 45.62 80.42 43.69 45.65 82.01 45.07 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 59.69 92.71 39.85 58.53 92.03 41.47 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 68 3 # 68 229 ASP D 100 ASP.? 7.94 OXT ACT A 203 264 GLU A 137 GLU~? 14.03 O ACT A 203 328 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 45.62 80.42 43.69 45.65 82.01 45.07 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 59.69 92.71 39.85 58.53 92.03 41.47 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 69 3 # 69 229 ASP D 100 ASP.? 7.94 OXT ACT A 203 264 GLU D 137 GLU~? 19.20 CH3 ACT A 203 328 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 59.69 92.71 39.85 58.53 92.03 41.47 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 45.39 90.72 40.63 45.07 89.14 41.90 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 70 3 # 70 229 ASP D 116 ASP.? 19.52 CH3 ACT D 201 264 GLU C 80 GLU^? 14.47 CH3 ACT C 201 328 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 59.69 92.71 39.85 58.53 92.03 41.47 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 45.39 90.72 40.63 45.07 89.14 41.90 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 71 3 # 71 229 ASP D 116 ASP.? 19.52 CH3 ACT D 201 264 GLU D 17 GLU~? 23.59 CH3 ACT D 201 328 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 59.69 92.71 39.85 58.53 92.03 41.47 -50.49 54.35 20.83 -50.89 54.35 18.75 coo 45.39 90.72 40.63 45.07 89.14 41.90 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 72 3 # 72 229 ASP D 130 ASP.? 7.40 CH3 ACT A 203 264 GLU A 96 GLU^? 11.70 OXT ACT A 203 328 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 59.69 92.71 39.85 58.53 92.03 41.47 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.15 62.19 57.97 -45.93 61.14 58.45 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 72 hits 1cdg_c00 naa= 3 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 86 ASP.? 20.24 CH3 ACT A 202 257 GLU A 114 GLU^? 11.87 CH3 ACT A 202 328 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 48.97 85.16 40.39 47.18 86.25 40.47 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 45.39 90.72 40.63 45.07 89.14 41.90 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 116 ASP.? 19.55 CH3 ACT A 201 257 GLU A 114 GLU^? 11.87 CH3 ACT A 202 328 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 45.62 80.42 43.69 45.65 82.01 45.07 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 48.97 85.16 40.39 47.18 86.25 40.47 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 45.39 90.72 40.63 45.07 89.14 41.90 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP B 86 ASP.? 24.07 CH3 ACT B 201 257 GLU B 114 GLU^? 18.04 O ACT B 201 328 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 48.97 85.16 40.39 47.18 86.25 40.47 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 45.39 90.72 40.63 45.07 89.14 41.90 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 99 ASP.? 16.09 OXT ACT B 201 257 GLU B 72 GLU~? 5.30 OXT ACT B 201 328 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 48.97 85.16 40.39 47.18 86.25 40.47 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 45.39 90.72 40.63 45.07 89.14 41.90 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 116 ASP.? 19.49 CH3 ACT B 201 257 GLU B 114 GLU^? 18.04 O ACT B 201 328 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 48.97 85.16 40.39 47.18 86.25 40.47 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 45.39 90.72 40.63 45.07 89.14 41.90 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 130 ASP.? 9.25 OXT ACT B 201 257 GLU B 72 GLU~? 5.30 OXT ACT B 201 328 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 48.97 85.16 40.39 47.18 86.25 40.47 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 45.39 90.72 40.63 45.07 89.14 41.90 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP C 86 ASP.? 24.03 CH3 ACT C 201 257 GLU C 114 GLU^? 18.18 OXT ACT C 201 328 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 48.97 85.16 40.39 47.18 86.25 40.47 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 45.39 90.72 40.63 45.07 89.14 41.90 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP C 116 ASP.? 19.40 CH3 ACT C 201 257 GLU C 114 GLU^? 18.18 OXT ACT C 201 328 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 48.97 85.16 40.39 47.18 86.25 40.47 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 45.39 90.72 40.63 45.07 89.14 41.90 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 9 3 # 9 229 ASP D 86 ASP.? 24.19 CH3 ACT D 201 257 GLU D 114 GLU^? 18.05 O ACT D 201 328 ASP D 116 ASP.? 19.52 CH3 ACT D 201 coo 45.62 80.42 43.69 45.65 82.01 45.07 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 48.97 85.16 40.39 47.18 86.25 40.47 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 45.39 90.72 40.63 45.07 89.14 41.90 -63.55 47.24 34.96 -64.48 49.07 34.39 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 10 3 # 10 229 ASP D 99 ASP.? 7.94 CH3 ACT A 203 257 GLU D 72 GLU~? 5.29 OXT ACT D 201 328 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 45.62 80.42 43.69 45.65 82.01 45.07 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 48.97 85.16 40.39 47.18 86.25 40.47 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 11 3 # 11 229 ASP D 130 ASP.? 7.40 CH3 ACT A 203 257 GLU D 72 GLU~? 5.29 OXT ACT D 201 328 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 48.97 85.16 40.39 47.18 86.25 40.47 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 45.39 90.72 40.63 45.07 89.14 41.90 -49.03 74.78 51.99 -47.35 75.78 52.80 1cdg_c04 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 11 hits 1cdg_c04 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS A 141 HIS.? 11.20 OXT ACT A 203 A 262 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 358 GLU A 160 GLU.? 13.50 O ACT A 201 coo 26.19 60.87 43.98 27.48 59.27 43.30 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 27.13 54.07 50.45 26.96 54.19 48.35 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 27.06 50.43 44.36 27.99 52.27 44.74 -45.30 71.21 75.74 -44.17 71.89 74.09 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 A 232 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 262 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 358 GLU A 160 GLU.? 13.50 O ACT A 201 coo 26.19 60.87 43.98 27.48 59.27 43.30 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 27.13 54.07 50.45 26.96 54.19 48.35 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 27.06 50.43 44.36 27.99 52.27 44.74 -45.30 71.21 75.74 -44.17 71.89 74.09 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 A 232 HIS A 162 HIS.? 14.54 O1 EDO A 301 A 262 GLU A 160 GLU.? 13.50 O ACT A 201 A 358 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 26.19 60.87 43.98 27.48 59.27 43.30 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 27.13 54.07 50.45 26.96 54.19 48.35 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 27.06 50.43 44.36 27.99 52.27 44.74 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 A 232 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 262 GLU B 156 GLU~? 12.19 CH3 ACT A 202 A 358 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 26.19 60.87 43.98 27.48 59.27 43.30 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 27.13 54.07 50.45 26.96 54.19 48.35 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 27.06 50.43 44.36 27.99 52.27 44.74 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 A 232 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 262 GLU C 156 GLU~? 19.44 CH3 ACT C 201 A 358 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 26.19 60.87 43.98 27.48 59.27 43.30 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 27.13 54.07 50.45 26.96 54.19 48.35 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 27.06 50.43 44.36 27.99 52.27 44.74 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 6 3 # 6 A 232 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 262 GLU D 156 GLU.? 18.36 CH3 ACT D 201 A 358 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo 26.19 60.87 43.98 27.48 59.27 43.30 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 27.13 54.07 50.45 26.96 54.19 48.35 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 27.06 50.43 44.36 27.99 52.27 44.74 -42.96 58.73 31.72 -40.96 59.40 31.80 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 6 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS A 141 HIS.? 11.20 OXT ACT A 203 B 262 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 358 GLU A 160 GLU.? 13.50 O ACT A 201 coo 44.98 77.01 48.39 44.42 78.67 47.18 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 41.60 83.57 54.16 42.46 83.24 52.25 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 44.05 87.61 48.73 43.15 85.67 48.52 -45.30 71.21 75.74 -44.17 71.89 74.09 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 262 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 358 GLU A 160 GLU.? 13.50 O ACT A 201 coo 44.98 77.01 48.39 44.42 78.67 47.18 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 41.60 83.57 54.16 42.46 83.24 52.25 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 44.05 87.61 48.73 43.15 85.67 48.52 -45.30 71.21 75.74 -44.17 71.89 74.09 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 B 232 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 262 GLU A 156 GLU~? 20.10 CH3 ACT A 201 B 358 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo 44.98 77.01 48.39 44.42 78.67 47.18 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 41.60 83.57 54.16 42.46 83.24 52.25 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 44.05 87.61 48.73 43.15 85.67 48.52 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 B 232 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 262 GLU A 160 GLU.? 13.50 O ACT A 201 B 358 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 44.98 77.01 48.39 44.42 78.67 47.18 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 41.60 83.57 54.16 42.46 83.24 52.25 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 44.05 87.61 48.73 43.15 85.67 48.52 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 B 232 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 262 GLU B 156 GLU~? 12.19 CH3 ACT A 202 B 358 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 44.98 77.01 48.39 44.42 78.67 47.18 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 41.60 83.57 54.16 42.46 83.24 52.25 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 44.05 87.61 48.73 43.15 85.67 48.52 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 6 3 # 6 B 232 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 262 GLU C 156 GLU~? 19.44 CH3 ACT C 201 B 358 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 44.98 77.01 48.39 44.42 78.67 47.18 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 41.60 83.57 54.16 42.46 83.24 52.25 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 44.05 87.61 48.73 43.15 85.67 48.52 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 7 3 # 7 B 232 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 262 GLU D 156 GLU.? 18.36 CH3 ACT D 201 B 358 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo 44.98 77.01 48.39 44.42 78.67 47.18 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 41.60 83.57 54.16 42.46 83.24 52.25 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 44.05 87.61 48.73 43.15 85.67 48.52 -42.96 58.73 31.72 -40.96 59.40 31.80 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 7 hits 1chm_c01 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 109 GLY^? 6.82 OXT ACT A 201 A 228 SER A 107 SER^? 6.74 O1 EDO A 301 A 549 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -34.97 66.16 72.79 -35.28 66.58 73.38 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 145 GLY.? 13.13 O ACT A 201 A 228 SER A 32 SER.? 11.27 CH3 ACT A 201 A 549 ASP A 34 ASP~? 14.63 O ACT A 201 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -38.43 80.69 60.76 -38.91 80.43 61.42 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -34.08 78.47 59.42 -31.66 78.25 59.14 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY B 109 GLY^? 6.82 O ACT B 201 A 228 SER B 107 SER^? 7.39 OXT ACT B 201 A 549 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -29.36 58.56 76.35 -28.60 58.71 76.34 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 145 GLY.? 13.34 OXT ACT B 201 A 228 SER B 32 SER.? 11.07 CH3 ACT B 201 A 549 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -25.17 44.53 88.88 -24.74 44.79 88.19 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -29.79 46.60 90.02 -31.32 47.94 91.35 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY C 109 GLY^? 6.86 OXT ACT C 201 A 228 SER C 107 SER^? 6.74 O2 EDO A 301 A 549 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -44.99 51.38 49.22 -45.52 50.84 49.05 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 A 198 GLY C 145 GLY.? 13.18 O ACT C 201 A 228 SER C 32 SER.? 11.23 CH3 ACT C 201 A 549 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -35.71 37.24 58.49 -36.57 37.39 58.47 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -32.31 40.22 56.18 -30.64 40.82 54.50 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 A 198 GLY C 145 GLY.? 13.18 O ACT C 201 A 228 SER C 32 SER.? 11.23 CH3 ACT C 201 A 549 ASP C 34 ASP~? 14.66 O ACT C 201 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -35.71 37.24 58.49 -36.57 37.39 58.47 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -32.31 40.22 56.18 -30.64 40.82 54.50 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 A 198 GLY D 109 GLY^? 6.89 O ACT D 201 A 228 SER D 107 SER^? 7.30 OXT ACT D 201 A 549 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -45.26 59.49 43.22 -44.76 59.46 42.64 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 9 3 # 9 A 198 GLY D 145 GLY.? 13.27 OXT ACT D 201 A 228 SER D 32 SER.? 11.12 CH3 ACT D 201 A 549 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -54.58 73.10 33.20 -53.72 72.98 33.25 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -58.03 70.18 35.81 -59.79 68.52 36.06 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -62.38 69.46 37.89 -64.50 69.55 37.91 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 9 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 109 GLY^? 6.82 OXT ACT A 201 B1228 SER A 107 SER^? 6.74 O1 EDO A 301 B1549 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 -34.97 66.16 72.79 -35.28 66.58 73.38 coo 131.65 74.68 129.41 130.31 72.73 128.82 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 134.72 69.43 130.42 133.03 70.65 130.08 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 145 GLY.? 13.13 O ACT A 201 B1228 SER A 32 SER.? 11.27 CH3 ACT A 201 B1549 ASP A 34 ASP~? 14.63 O ACT A 201 coo 126.34 72.75 125.66 125.95 73.27 126.11 -38.43 80.69 60.76 -38.91 80.43 61.42 coo 131.65 74.68 129.41 130.31 72.73 128.82 -34.08 78.47 59.42 -31.66 78.25 59.14 coo 134.72 69.43 130.42 133.03 70.65 130.08 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY B 109 GLY^? 6.82 O ACT B 201 B1228 SER B 107 SER^? 7.39 OXT ACT B 201 B1549 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 126.34 72.75 125.66 125.95 73.27 126.11 -29.36 58.56 76.35 -28.60 58.71 76.34 coo 131.65 74.68 129.41 130.31 72.73 128.82 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 134.72 69.43 130.42 133.03 70.65 130.08 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 109 GLY^? 6.82 O ACT B 201 B1228 SER B 107 SER^? 7.39 OXT ACT B 201 B1549 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 -29.36 58.56 76.35 -28.60 58.71 76.34 coo 131.65 74.68 129.41 130.31 72.73 128.82 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 134.72 69.43 130.42 133.03 70.65 130.08 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY B 145 GLY.? 13.34 OXT ACT B 201 B1228 SER B 32 SER.? 11.07 CH3 ACT B 201 B1549 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 126.34 72.75 125.66 125.95 73.27 126.11 -25.17 44.53 88.88 -24.74 44.79 88.19 coo 131.65 74.68 129.41 130.31 72.73 128.82 -29.79 46.60 90.02 -31.32 47.94 91.35 coo 134.72 69.43 130.42 133.03 70.65 130.08 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 B1198 GLY C 109 GLY^? 6.86 OXT ACT C 201 B1228 SER C 107 SER^? 6.74 O2 EDO A 301 B1549 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 -44.99 51.38 49.22 -45.52 50.84 49.05 coo 131.65 74.68 129.41 130.31 72.73 128.82 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 134.72 69.43 130.42 133.03 70.65 130.08 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 B1198 GLY C 145 GLY.? 13.18 O ACT C 201 B1228 SER C 32 SER.? 11.23 CH3 ACT C 201 B1549 ASP C 34 ASP~? 14.66 O ACT C 201 coo 126.34 72.75 125.66 125.95 73.27 126.11 -35.71 37.24 58.49 -36.57 37.39 58.47 coo 131.65 74.68 129.41 130.31 72.73 128.82 -32.31 40.22 56.18 -30.64 40.82 54.50 coo 134.72 69.43 130.42 133.03 70.65 130.08 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 B1198 GLY D 109 GLY^? 6.89 O ACT D 201 B1228 SER D 107 SER^? 7.30 OXT ACT D 201 B1549 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 -45.26 59.49 43.22 -44.76 59.46 42.64 coo 131.65 74.68 129.41 130.31 72.73 128.82 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 134.72 69.43 130.42 133.03 70.65 130.08 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 9 3 # 9 B1198 GLY D 109 GLY^? 6.89 O ACT D 201 B1228 SER D 107 SER^? 7.30 OXT ACT D 201 B1549 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 126.34 72.75 125.66 125.95 73.27 126.11 -45.26 59.49 43.22 -44.76 59.46 42.64 coo 131.65 74.68 129.41 130.31 72.73 128.82 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 134.72 69.43 130.42 133.03 70.65 130.08 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 10 3 # 10 B1198 GLY D 145 GLY.? 13.27 OXT ACT D 201 B1228 SER D 32 SER.? 11.12 CH3 ACT D 201 B1549 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 126.34 72.75 125.66 125.95 73.27 126.11 -54.58 73.10 33.20 -53.72 72.98 33.25 coo 131.65 74.68 129.41 130.31 72.73 128.82 -58.03 70.18 35.81 -59.79 68.52 36.06 coo 134.72 69.43 130.42 133.03 70.65 130.08 -62.38 69.46 37.89 -64.50 69.55 37.91 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 10 hits 1cjy_c01 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP A 99 ASP.? 5.71 O2 EDO A 301 37 SER A 101 SER.? 7.80 O2 EDO A 301 216 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 16.90 26.20 29.49 16.22 24.50 28.41 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 12.23 24.31 30.40 14.55 23.96 31.03 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 13.93 25.52 22.10 14.75 24.44 23.75 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 3 # 2 34 ASP B 99 ASP.? 16.09 OXT ACT B 201 37 SER B 101 SER.? 19.25 O ACT C 201 216 ASP C 74 ASP^? 14.86 O ACT C 201 coo 16.90 26.20 29.49 16.22 24.50 28.41 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 12.23 24.31 30.40 14.55 23.96 31.03 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 13.93 25.52 22.10 14.75 24.44 23.75 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 3 3 # 3 34 ASP C 99 ASP.? 5.79 O1 EDO A 301 37 SER C 101 SER.? 7.85 O1 EDO A 301 216 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 16.90 26.20 29.49 16.22 24.50 28.41 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 12.23 24.31 30.40 14.55 23.96 31.03 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 13.93 25.52 22.10 14.75 24.44 23.75 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 4 3 # 4 34 ASP D 99 ASP.? 7.94 CH3 ACT A 203 37 SER D 101 SER.? 9.16 OXT ACT A 203 216 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 16.90 26.20 29.49 16.22 24.50 28.41 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 12.23 24.31 30.40 14.55 23.96 31.03 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 13.93 25.52 22.10 14.75 24.44 23.75 -44.71 72.29 58.72 -45.62 72.95 56.93 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 4 hits 1cms_c04 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 59 GLU~? 18.41 O2 EDO A 302 A 89 GLU A 36 GLU~? 17.83 CH3 ACT A 201 A 120 SER A 39 SER~? 14.37 CH3 ACT A 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -19.57 66.85 53.38 -18.14 66.20 51.96 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -24.24 76.94 53.59 -22.34 76.00 53.73 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -23.46 73.59 59.60 -22.83 73.90 57.26 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 72 GLU~? 5.31 O ACT A 201 A 89 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 120 SER A 107 SER^? 6.74 O1 EDO A 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -38.02 65.72 60.64 -36.78 66.00 62.33 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -44.74 70.71 67.91 -46.53 71.68 68.48 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -40.35 65.45 69.21 -39.92 64.63 66.96 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 89 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 120 SER B 155 SER~? 6.88 CH3 ACT A 202 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -17.01 70.06 74.63 -16.05 68.26 75.13 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -17.96 60.58 68.89 -19.86 60.60 67.97 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -15.94 58.44 77.26 -16.71 60.70 77.77 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU B 59 GLU~? 20.69 O ACT B 201 A 89 GLU B 36 GLU~? 17.47 CH3 ACT B 201 A 120 SER B 39 SER~? 14.17 CH3 ACT B 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -47.90 53.57 92.50 -49.95 53.72 93.03 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -39.08 48.65 96.43 -40.52 50.19 96.69 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -38.00 54.38 92.68 -39.49 53.00 94.02 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 89 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 120 SER B 107 SER^? 7.39 OXT ACT B 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -35.13 47.70 77.85 -34.58 49.69 78.28 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -24.44 47.78 75.39 -22.51 46.98 75.05 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -29.25 52.59 73.85 -31.29 51.35 74.31 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU C 59 GLU~? 13.48 O2 EDO A 302 A 89 GLU C 36 GLU~? 15.95 O2 EDO A 302 A 120 SER C 39 SER~? 14.22 CH3 ACT C 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -20.25 53.72 49.66 -20.40 52.10 51.04 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -22.00 43.42 52.41 -21.02 44.62 50.95 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -26.65 46.46 48.19 -24.39 46.43 49.12 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU C 72 GLU~? 5.32 O ACT C 201 A 89 GLU C 96 GLU^? 13.00 O ACT C 201 A 120 SER C 107 SER^? 6.74 O2 EDO A 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -37.42 52.13 59.26 -38.02 51.91 57.25 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -46.59 45.81 59.59 -47.94 44.44 60.43 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -45.59 51.52 55.69 -43.69 52.48 56.86 ULMN 3 1cns_c00 CHITINASE user 8 3 # 8 A 67 GLU D 59 GLU~? 18.52 O ACT D 201 A 89 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 120 SER D 39 SER~? 14.16 CH3 ACT D 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -69.73 60.64 47.66 -70.08 62.16 46.23 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -68.34 66.20 38.63 -69.40 64.56 39.44 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -63.83 60.97 39.81 -65.97 62.00 40.33 ULMN 3 1cns_c00 CHITINASE user 9 3 # 9 A 67 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 89 GLU D 53 GLU^? 10.32 O ACT A 203 A 120 SER A 101 SER.? 7.80 O2 EDO A 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -51.77 69.18 47.61 -51.44 67.29 46.71 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -56.60 59.52 53.75 -57.18 61.28 52.77 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -48.36 60.96 55.15 -47.04 58.94 54.93 ULMN 3 1cns_c00 CHITINASE user 10 3 # 10 A 67 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 89 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 120 SER D 107 SER^? 7.30 OXT ACT D 201 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -51.77 69.18 47.61 -51.44 67.29 46.71 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -43.29 70.99 40.99 -41.92 72.19 39.92 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -44.25 65.54 45.21 -46.11 66.36 46.55 1cns_c00 source 1cns CHITINASE : 10 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 59 GLU~? 18.41 O2 EDO A 302 B 89 GLU A 36 GLU~? 17.83 CH3 ACT A 201 B 120 SER A 39 SER~? 14.37 CH3 ACT A 201 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -19.57 66.85 53.38 -18.14 66.20 51.96 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -23.46 73.59 59.60 -22.83 73.90 57.26 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 114 GLU^? 11.87 CH3 ACT A 202 B 89 GLU B 160 GLU.? 4.71 OXT ACT A 202 B 120 SER B 155 SER~? 6.88 CH3 ACT A 202 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -15.94 58.44 77.26 -16.71 60.70 77.77 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 59 GLU~? 20.69 O ACT B 201 B 89 GLU B 36 GLU~? 17.47 CH3 ACT B 201 B 120 SER B 39 SER~? 14.17 CH3 ACT B 201 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -47.90 53.57 92.50 -49.95 53.72 93.03 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -38.00 54.38 92.68 -39.49 53.00 94.02 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 89 GLU B 53 GLU^? 11.09 O ACT B 201 B 120 SER C 101 SER.? 7.85 O1 EDO A 301 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -40.26 55.74 71.04 -39.54 57.94 70.33 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU C 59 GLU~? 13.48 O2 EDO A 302 B 89 GLU C 36 GLU~? 15.95 O2 EDO A 302 B 120 SER C 39 SER~? 14.22 CH3 ACT C 201 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -20.25 53.72 49.66 -20.40 52.10 51.04 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -26.65 46.46 48.19 -24.39 46.43 49.12 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU D 59 GLU~? 18.52 O ACT D 201 B 89 GLU D 36 GLU~? 17.76 CH3 ACT D 201 B 120 SER D 39 SER~? 14.16 CH3 ACT D 201 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -69.73 60.64 47.66 -70.08 62.16 46.23 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -63.83 60.97 39.81 -65.97 62.00 40.33 ULMN 3 1cns_c01 CHITINASE user 7 3 # 7 B 67 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 89 GLU D 53 GLU^? 10.32 O ACT A 203 B 120 SER A 101 SER.? 7.80 O2 EDO A 301 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -48.36 60.96 55.15 -47.04 58.94 54.93 1cns_c01 source 1cns CHITINASE : 7 hits 1cns_c01 naa= 3 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 1 3 # 1 361 GLU A 59 GLU~? 18.41 O2 EDO A 302 447 HIS A 56 HIS.? 6.76 O1 EDO A 302 485 ASN A 57 ASN~? 14.18 O1 EDO A 302 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -19.57 66.85 53.38 -18.14 66.20 51.96 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -16.25 65.99 58.99 -17.06 64.89 57.36 1coy_c00 source 1coy CHOLESTEROL OXIDASE (E.C.1.1.3.6) COMPLEX WITH: 1 hits 1coy_c00 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 95 TYR^? -3.85 O ACT A 201s A 173 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 48 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 24.35 4.55 25.11 25.94 3.23 25.53 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 173 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 48 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 24.35 4.55 25.11 25.94 3.23 25.53 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 173 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 48 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 24.35 4.55 25.11 25.94 3.23 25.53 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -47.81 74.29 36.53 -48.87 77.02 37.43 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG B 76 ARG^? 14.33 OXT ACT B 201 C 101 TYR B 95 TYR^? -3.87 OXT ACT B 201s C 173 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 32.27 5.62 48.15 31.93 6.48 51.06 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 29.64 3.64 57.39 31.22 5.14 55.65 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -33.09 51.46 70.73 -34.18 51.80 72.52 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR B 95 TYR^? -3.87 OXT ACT B 201s B 173 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 48 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR D 75 TYR^? -4.49 OXT ACT D 201s B 173 ASP D 74 ASP^? 14.85 OXT ACT D 201 D 48 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -46.62 68.18 31.08 -46.22 65.54 29.55 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 126 ALA.? 5.06 OXT ACT A 201 A 74 ASN A 110 ASN^? 10.87 O ACT B 201 A 75 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -28.54 64.52 70.82 -28.98 65.37 69.63 coo 1.20 66.40 122.20 2.03 64.53 121.46 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 4.68 65.84 125.52 4.11 65.60 126.05 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA A 126 ALA.? 5.06 OXT ACT A 201 A 74 ASN B 110 ASN^? 6.46 O ACT A 202 A 75 GLY B 109 GLY^? 6.82 O ACT B 201 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -28.54 64.52 70.82 -28.98 65.37 69.63 coo 1.20 66.40 122.20 2.03 64.53 121.46 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 4.68 65.84 125.52 4.11 65.60 126.05 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 3 3 # 3 A 1 ALA B 126 ALA.? 5.01 O ACT B 201 A 74 ASN A 110 ASN^? 10.87 O ACT B 201 A 75 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -34.85 61.51 79.63 -34.73 60.21 80.42 coo 1.20 66.40 122.20 2.03 64.53 121.46 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 4.68 65.84 125.52 4.11 65.60 126.05 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 4 3 # 4 A 1 ALA B 126 ALA.? 5.01 O ACT B 201 A 74 ASN B 110 ASN^? 6.46 O ACT A 202 A 75 GLY B 109 GLY^? 6.82 O ACT B 201 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -34.85 61.51 79.63 -34.73 60.21 80.42 coo 1.20 66.40 122.20 2.03 64.53 121.46 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 4.68 65.84 125.52 4.11 65.60 126.05 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 5 3 # 5 A 1 ALA C 126 ALA.? 5.02 OXT ACT C 201 A 74 ASN C 110 ASN^? 10.92 O ACT D 201 A 75 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -39.67 53.99 45.62 -38.91 53.15 46.65 coo 1.20 66.40 122.20 2.03 64.53 121.46 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 4.68 65.84 125.52 4.11 65.60 126.05 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 6 3 # 6 A 1 ALA C 126 ALA.? 5.02 OXT ACT C 201 A 74 ASN D 110 ASN^? 10.92 OXT ACT C 201 A 75 GLY D 109 GLY^? 6.89 O ACT D 201 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -39.67 53.99 45.62 -38.91 53.15 46.65 coo 1.20 66.40 122.20 2.03 64.53 121.46 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 4.68 65.84 125.52 4.11 65.60 126.05 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 7 3 # 7 A 1 ALA D 126 ALA.? 5.05 O ACT D 201 A 74 ASN C 110 ASN^? 10.92 O ACT D 201 A 75 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -50.75 55.53 45.15 -51.51 56.79 44.72 coo 1.20 66.40 122.20 2.03 64.53 121.46 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 4.68 65.84 125.52 4.11 65.60 126.05 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 8 3 # 8 A 1 ALA D 126 ALA.? 5.05 O ACT D 201 A 74 ASN D 110 ASN^? 10.92 OXT ACT C 201 A 75 GLY D 109 GLY^? 6.89 O ACT D 201 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -50.75 55.53 45.15 -51.51 56.79 44.72 coo 1.20 66.40 122.20 2.03 64.53 121.46 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 4.68 65.84 125.52 4.11 65.60 126.05 -45.26 59.49 43.22 -44.76 59.46 42.64 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 8 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 126 ALA.? 5.06 OXT ACT A 201 B 74 ASN A 110 ASN^? 10.87 O ACT B 201 B 75 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 39.21 14.97 27.55 40.19 16.01 27.08 -28.54 64.52 70.82 -28.98 65.37 69.63 coo 43.06 12.94 25.74 42.26 11.81 27.44 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 46.38 13.54 29.18 46.14 14.29 29.26 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA A 126 ALA.? 5.06 OXT ACT A 201 B 74 ASN B 110 ASN^? 6.46 O ACT A 202 B 75 GLY B 109 GLY^? 6.82 O ACT B 201 coo 39.21 14.97 27.55 40.19 16.01 27.08 -28.54 64.52 70.82 -28.98 65.37 69.63 coo 43.06 12.94 25.74 42.26 11.81 27.44 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 46.38 13.54 29.18 46.14 14.29 29.26 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 3 3 # 3 B 1 ALA B 126 ALA.? 5.01 O ACT B 201 B 74 ASN A 110 ASN^? 10.87 O ACT B 201 B 75 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 39.21 14.97 27.55 40.19 16.01 27.08 -34.85 61.51 79.63 -34.73 60.21 80.42 coo 43.06 12.94 25.74 42.26 11.81 27.44 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 46.38 13.54 29.18 46.14 14.29 29.26 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 4 3 # 4 B 1 ALA B 126 ALA.? 5.01 O ACT B 201 B 74 ASN B 110 ASN^? 6.46 O ACT A 202 B 75 GLY B 109 GLY^? 6.82 O ACT B 201 coo 39.21 14.97 27.55 40.19 16.01 27.08 -34.85 61.51 79.63 -34.73 60.21 80.42 coo 43.06 12.94 25.74 42.26 11.81 27.44 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 46.38 13.54 29.18 46.14 14.29 29.26 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 5 3 # 5 B 1 ALA C 126 ALA.? 5.02 OXT ACT C 201 B 74 ASN C 110 ASN^? 10.92 O ACT D 201 B 75 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 39.21 14.97 27.55 40.19 16.01 27.08 -39.67 53.99 45.62 -38.91 53.15 46.65 coo 43.06 12.94 25.74 42.26 11.81 27.44 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 46.38 13.54 29.18 46.14 14.29 29.26 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 6 3 # 6 B 1 ALA C 126 ALA.? 5.02 OXT ACT C 201 B 74 ASN D 110 ASN^? 10.92 OXT ACT C 201 B 75 GLY D 109 GLY^? 6.89 O ACT D 201 coo 39.21 14.97 27.55 40.19 16.01 27.08 -39.67 53.99 45.62 -38.91 53.15 46.65 coo 43.06 12.94 25.74 42.26 11.81 27.44 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 46.38 13.54 29.18 46.14 14.29 29.26 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 7 3 # 7 B 1 ALA D 126 ALA.? 5.05 O ACT D 201 B 74 ASN C 110 ASN^? 10.92 O ACT D 201 B 75 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 39.21 14.97 27.55 40.19 16.01 27.08 -50.75 55.53 45.15 -51.51 56.79 44.72 coo 43.06 12.94 25.74 42.26 11.81 27.44 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 46.38 13.54 29.18 46.14 14.29 29.26 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 8 3 # 8 B 1 ALA D 126 ALA.? 5.05 O ACT D 201 B 74 ASN D 110 ASN^? 10.92 OXT ACT C 201 B 75 GLY D 109 GLY^? 6.89 O ACT D 201 coo 39.21 14.97 27.55 40.19 16.01 27.08 -50.75 55.53 45.15 -51.51 56.79 44.72 coo 43.06 12.94 25.74 42.26 11.81 27.44 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 46.38 13.54 29.18 46.14 14.29 29.26 -45.26 59.49 43.22 -44.76 59.46 42.64 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 8 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 126 ALA.? 5.06 OXT ACT A 201 C 74 ASN A 110 ASN^? 10.87 O ACT B 201 C 75 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 16.14 15.08 36.63 15.28 14.65 37.81 -28.54 64.52 70.82 -28.98 65.37 69.63 coo 11.60 16.13 36.70 12.80 17.74 35.96 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 10.99 19.23 40.32 11.50 18.77 40.74 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA A 126 ALA.? 5.06 OXT ACT A 201 C 74 ASN B 110 ASN^? 6.46 O ACT A 202 C 75 GLY B 109 GLY^? 6.82 O ACT B 201 coo 16.14 15.08 36.63 15.28 14.65 37.81 -28.54 64.52 70.82 -28.98 65.37 69.63 coo 11.60 16.13 36.70 12.80 17.74 35.96 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 10.99 19.23 40.32 11.50 18.77 40.74 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 3 3 # 3 C 1 ALA B 126 ALA.? 5.01 O ACT B 201 C 74 ASN A 110 ASN^? 10.87 O ACT B 201 C 75 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 16.14 15.08 36.63 15.28 14.65 37.81 -34.85 61.51 79.63 -34.73 60.21 80.42 coo 11.60 16.13 36.70 12.80 17.74 35.96 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 10.99 19.23 40.32 11.50 18.77 40.74 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 4 3 # 4 C 1 ALA B 126 ALA.? 5.01 O ACT B 201 C 74 ASN B 110 ASN^? 6.46 O ACT A 202 C 75 GLY B 109 GLY^? 6.82 O ACT B 201 coo 16.14 15.08 36.63 15.28 14.65 37.81 -34.85 61.51 79.63 -34.73 60.21 80.42 coo 11.60 16.13 36.70 12.80 17.74 35.96 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 10.99 19.23 40.32 11.50 18.77 40.74 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 5 3 # 5 C 1 ALA C 126 ALA.? 5.02 OXT ACT C 201 C 74 ASN C 110 ASN^? 10.92 O ACT D 201 C 75 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 16.14 15.08 36.63 15.28 14.65 37.81 -39.67 53.99 45.62 -38.91 53.15 46.65 coo 11.60 16.13 36.70 12.80 17.74 35.96 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 10.99 19.23 40.32 11.50 18.77 40.74 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 6 3 # 6 C 1 ALA C 126 ALA.? 5.02 OXT ACT C 201 C 74 ASN D 110 ASN^? 10.92 OXT ACT C 201 C 75 GLY D 109 GLY^? 6.89 O ACT D 201 coo 16.14 15.08 36.63 15.28 14.65 37.81 -39.67 53.99 45.62 -38.91 53.15 46.65 coo 11.60 16.13 36.70 12.80 17.74 35.96 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 10.99 19.23 40.32 11.50 18.77 40.74 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 7 3 # 7 C 1 ALA D 126 ALA.? 5.05 O ACT D 201 C 74 ASN C 110 ASN^? 10.92 O ACT D 201 C 75 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 16.14 15.08 36.63 15.28 14.65 37.81 -50.75 55.53 45.15 -51.51 56.79 44.72 coo 11.60 16.13 36.70 12.80 17.74 35.96 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 10.99 19.23 40.32 11.50 18.77 40.74 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 8 3 # 8 C 1 ALA D 126 ALA.? 5.05 O ACT D 201 C 74 ASN D 110 ASN^? 10.92 OXT ACT C 201 C 75 GLY D 109 GLY^? 6.89 O ACT D 201 coo 16.14 15.08 36.63 15.28 14.65 37.81 -50.75 55.53 45.15 -51.51 56.79 44.72 coo 11.60 16.13 36.70 12.80 17.74 35.96 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 10.99 19.23 40.32 11.50 18.77 40.74 -45.26 59.49 43.22 -44.76 59.46 42.64 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 8 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 126 ALA.? 5.06 OXT ACT A 201 D 74 ASN A 110 ASN^? 10.87 O ACT B 201 D 75 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -28.54 64.52 70.82 -28.98 65.37 69.63 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -31.91 65.50 76.29 -33.35 65.88 77.83 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA A 126 ALA.? 5.06 OXT ACT A 201 D 74 ASN B 110 ASN^? 6.46 O ACT A 202 D 75 GLY B 109 GLY^? 6.82 O ACT B 201 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -28.54 64.52 70.82 -28.98 65.37 69.63 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -29.30 63.23 76.74 -27.50 63.37 75.59 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 3 3 # 3 D 1 ALA B 126 ALA.? 5.01 O ACT B 201 D 74 ASN A 110 ASN^? 10.87 O ACT B 201 D 75 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -34.85 61.51 79.63 -34.73 60.21 80.42 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -31.91 65.50 76.29 -33.35 65.88 77.83 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 4 3 # 4 D 1 ALA B 126 ALA.? 5.01 O ACT B 201 D 74 ASN B 110 ASN^? 6.46 O ACT A 202 D 75 GLY B 109 GLY^? 6.82 O ACT B 201 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -34.85 61.51 79.63 -34.73 60.21 80.42 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -29.30 63.23 76.74 -27.50 63.37 75.59 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 5 3 # 5 D 1 ALA C 126 ALA.? 5.02 OXT ACT C 201 D 74 ASN C 110 ASN^? 10.92 O ACT D 201 D 75 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -39.67 53.99 45.62 -38.91 53.15 46.65 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -45.77 52.18 44.66 -47.80 51.56 44.77 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 6 3 # 6 D 1 ALA C 126 ALA.? 5.02 OXT ACT C 201 D 74 ASN D 110 ASN^? 10.92 OXT ACT C 201 D 75 GLY D 109 GLY^? 6.89 O ACT D 201 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -39.67 53.99 45.62 -38.91 53.15 46.65 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -44.80 54.88 42.61 -42.77 55.08 41.96 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 7 3 # 7 D 1 ALA D 126 ALA.? 5.05 O ACT D 201 D 74 ASN C 110 ASN^? 10.92 O ACT D 201 D 75 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -50.75 55.53 45.15 -51.51 56.79 44.72 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -45.77 52.18 44.66 -47.80 51.56 44.77 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -44.99 51.38 49.22 -45.52 50.84 49.05 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 7 hits 1ct9_c07 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 28 ASP~? 12.70 CH3 ACT A 201 315 GLU A 27 GLU~? 9.74 CH3 ACT A 201 390 TYR A 75 TYR^? -4.52 O ACT A 201s coo 32.46 99.13 19.34 30.94 100.38 20.07 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 32.04 94.22 18.23 30.57 94.75 16.88 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 21.10 94.74 18.36 23.09 96.71 18.59 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP A 34 ASP~? 14.63 O ACT A 201 315 GLU A 36 GLU~? 17.83 CH3 ACT A 201 390 TYR A 42 TYR^? 9.79 CH3 ACT A 201 coo 32.46 99.13 19.34 30.94 100.38 20.07 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 32.04 94.22 18.23 30.57 94.75 16.88 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 21.10 94.74 18.36 23.09 96.71 18.59 -22.07 72.08 64.22 -24.60 72.36 65.39 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP B 28 ASP~? 12.70 CH3 ACT B 201 315 GLU B 27 GLU~? 9.83 CH3 ACT B 201 390 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 32.46 99.13 19.34 30.94 100.38 20.07 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 32.04 94.22 18.23 30.57 94.75 16.88 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 21.10 94.74 18.36 23.09 96.71 18.59 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 3 # 4 313 ASP B 28 ASP~? 12.70 CH3 ACT B 201 315 GLU B 27 GLU~? 9.83 CH3 ACT B 201 390 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 32.46 99.13 19.34 30.94 100.38 20.07 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 32.04 94.22 18.23 30.57 94.75 16.88 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 21.10 94.74 18.36 23.09 96.71 18.59 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 5 3 # 5 313 ASP B 34 ASP~? 14.61 OXT ACT B 201 315 GLU B 36 GLU~? 17.47 CH3 ACT B 201 390 TYR B 42 TYR^? 9.74 CH3 ACT B 201 coo 32.46 99.13 19.34 30.94 100.38 20.07 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 32.04 94.22 18.23 30.57 94.75 16.88 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 21.10 94.74 18.36 23.09 96.71 18.59 -37.05 59.03 91.10 -34.97 58.34 89.38 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 6 3 # 6 313 ASP C 28 ASP~? 12.80 CH3 ACT C 201 315 GLU C 27 GLU~? 9.88 CH3 ACT C 201 390 TYR C 75 TYR^? -4.54 O ACT C 201s coo 32.46 99.13 19.34 30.94 100.38 20.07 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 32.04 94.22 18.23 30.57 94.75 16.88 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 21.10 94.74 18.36 23.09 96.71 18.59 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 7 3 # 7 313 ASP C 34 ASP~? 14.66 O ACT C 201 315 GLU C 36 GLU~? 15.95 O2 EDO A 302 390 TYR C 42 TYR^? 9.67 CH3 ACT C 201 coo 32.46 99.13 19.34 30.94 100.38 20.07 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 32.04 94.22 18.23 30.57 94.75 16.88 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 21.10 94.74 18.36 23.09 96.71 18.59 -29.49 47.84 44.30 -31.93 47.16 45.50 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 8 3 # 8 313 ASP D 28 ASP~? 12.70 CH3 ACT D 201 315 GLU D 27 GLU~? 9.75 CH3 ACT D 201 390 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 32.46 99.13 19.34 30.94 100.38 20.07 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 32.04 94.22 18.23 30.57 94.75 16.88 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 21.10 94.74 18.36 23.09 96.71 18.59 -52.06 69.71 41.47 -52.08 66.98 40.85 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 9 3 # 9 313 ASP D 28 ASP~? 12.70 CH3 ACT D 201 315 GLU D 27 GLU~? 9.75 CH3 ACT D 201 390 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 32.46 99.13 19.34 30.94 100.38 20.07 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 32.04 94.22 18.23 30.57 94.75 16.88 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 21.10 94.74 18.36 23.09 96.71 18.59 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 10 3 # 10 313 ASP D 34 ASP~? 14.62 OXT ACT D 201 315 GLU D 36 GLU~? 17.76 CH3 ACT D 201 390 TYR D 42 TYR^? 9.84 CH3 ACT D 201 coo 32.46 99.13 19.34 30.94 100.38 20.07 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 32.04 94.22 18.23 30.57 94.75 16.88 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 21.10 94.74 18.36 23.09 96.71 18.59 -61.35 56.68 39.82 -58.87 57.88 39.36 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 10 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 340 GLU C 117 GLU.? 26.34 CH3 ACT C 201 A 395 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -28.04 45.85 33.79 -27.08 44.69 35.29 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -28.65 43.01 29.05 -27.69 42.85 27.18 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 340 GLU D 117 GLU.? 26.53 CH3 ACT D 201 A 395 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -63.55 47.24 34.96 -64.48 49.07 34.39 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -63.64 43.50 30.85 -64.87 41.85 30.41 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -53.41 42.17 31.38 -52.32 40.44 30.82 1cwy_c00 source 1cwy AMYLOMALTASE : 2 hits 1cwy_c00 naa= 3 ULMN 3 1d5r_c00 PHOSPHOINOSITIDE PHOSPHOTASE PTEN user 1 3 # 1 A 92 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 124 CYH D 127 CYH.? 10.01 OXT ACT C 201 A 130 ARG D 51 ARG.? 7.60 O ACT D 201 coo 38.50 84.15 22.11 36.72 85.12 21.46 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 39.50 92.46 25.29 36.94 91.57 26.24 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 39.28 86.97 26.61 39.95 87.60 23.68 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 1d5r_c00 PHOSPHOINOSITIDE PHOSPHOTASE PTEN user 2 3 # 2 A 92 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 124 CYH B 127 CYH.? 10.07 OXT ACT A 201 A 130 ARG B 51 ARG.? 7.67 O ACT B 201 coo 38.50 84.15 22.11 36.72 85.12 21.46 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 39.50 92.46 25.29 36.94 91.57 26.24 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 39.28 86.97 26.61 39.95 87.60 23.68 -37.69 55.58 74.87 -35.47 53.51 74.34 1d5r_c00 source 1d5r PHOSPHOINOSITIDE PHOSPHOTASE PTEN : 2 hits 1d5r_c00 naa= 3 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 138 TRP A 30 TRP~? -4.28 CH3 ACT A 201s A 243 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 272 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 16.93 55.67 9.65 17.16 54.23 11.19 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 14.13 45.79 13.40 14.25 49.41 18.30 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 138 TRP A 30 TRP~? -4.28 CH3 ACT A 201s A 243 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 272 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 16.93 55.67 9.65 17.16 54.23 11.19 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 14.13 45.79 13.40 14.25 49.41 18.30 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 138 TRP A 30 TRP~? -4.28 CH3 ACT A 201s A 243 ASP A 34 ASP~? 14.63 O ACT A 201 A 272 LYS A 62 LYS~? 17.60 O ACT A 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 16.93 55.67 9.65 17.16 54.23 11.19 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 14.13 45.79 13.40 14.25 49.41 18.30 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 138 TRP A 30 TRP~? -4.28 CH3 ACT A 201s A 243 ASP A 34 ASP~? 14.63 O ACT A 201 A 272 LYS A 68 LYS~? -2.78 O ACT A 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 16.93 55.67 9.65 17.16 54.23 11.19 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 14.13 45.79 13.40 14.25 49.41 18.30 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 138 TRP A 69 TRP~? 6.39 O ACT A 201 A 243 ASP A 34 ASP~? 14.63 O ACT A 201 A 272 LYS A 62 LYS~? 17.60 O ACT A 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 16.93 55.67 9.65 17.16 54.23 11.19 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 14.13 45.79 13.40 14.25 49.41 18.30 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 138 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 243 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 272 LYS A 68 LYS~? -2.78 O ACT A 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 14.13 45.79 13.40 14.25 49.41 18.30 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 138 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 243 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 272 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 18.21 54.75 18.05 19.91 55.17 21.59 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 14.13 45.79 13.40 14.25 49.41 18.30 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 138 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 243 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 272 LYS A 139 LYS.? 17.81 O ACT A 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 14.13 45.79 13.40 14.25 49.41 18.30 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 138 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 243 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 272 LYS A 68 LYS~? -2.78 O ACT A 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 14.13 45.79 13.40 14.25 49.41 18.30 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 138 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 243 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 272 LYS A 134 LYS~? 11.98 O ACT A 203 coo 18.21 54.75 18.05 19.91 55.17 21.59 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 14.13 45.79 13.40 14.25 49.41 18.30 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 138 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 243 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 272 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 18.21 54.75 18.05 19.91 55.17 21.59 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 14.13 45.79 13.40 14.25 49.41 18.30 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 138 TRP A 104 TRP^? -4.29 OXT ACT A 203s A 243 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 272 LYS A 139 LYS.? 17.81 O ACT A 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 14.13 45.79 13.40 14.25 49.41 18.30 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 13 3 # 13 A 138 TRP A 142 TRP.? 12.79 O ACT A 201 A 243 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 272 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -42.03 80.57 64.19 -41.88 78.10 67.25 coo 16.93 55.67 9.65 17.16 54.23 11.19 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 14.13 45.79 13.40 14.25 49.41 18.30 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 14 3 # 14 A 138 TRP A 142 TRP.? 12.79 O ACT A 201 A 243 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 272 LYS A 139 LYS.? 17.81 O ACT A 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -42.03 80.57 64.19 -41.88 78.10 67.25 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 14.13 45.79 13.40 14.25 49.41 18.30 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 15 3 # 15 A 138 TRP B 30 TRP~? -4.15 CH3 ACT B 201s A 243 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 272 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -31.05 54.49 87.84 -34.09 54.74 85.35 coo 16.93 55.67 9.65 17.16 54.23 11.19 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 14.13 45.79 13.40 14.25 49.41 18.30 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 16 3 # 16 A 138 TRP B 30 TRP~? -4.15 CH3 ACT B 201s A 243 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 272 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -31.05 54.49 87.84 -34.09 54.74 85.35 coo 16.93 55.67 9.65 17.16 54.23 11.19 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 14.13 45.79 13.40 14.25 49.41 18.30 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 17 3 # 17 A 138 TRP B 30 TRP~? -4.15 CH3 ACT B 201s A 243 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 272 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -31.05 54.49 87.84 -34.09 54.74 85.35 coo 16.93 55.67 9.65 17.16 54.23 11.19 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 14.13 45.79 13.40 14.25 49.41 18.30 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 18 3 # 18 A 138 TRP B 30 TRP~? -4.15 CH3 ACT B 201s A 243 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 272 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -31.05 54.49 87.84 -34.09 54.74 85.35 coo 16.93 55.67 9.65 17.16 54.23 11.19 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 14.13 45.79 13.40 14.25 49.41 18.30 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 19 3 # 19 A 138 TRP B 69 TRP~? 6.43 OXT ACT B 201 A 243 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 272 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -34.09 46.73 83.20 -34.39 49.33 86.13 coo 16.93 55.67 9.65 17.16 54.23 11.19 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 14.13 45.79 13.40 14.25 49.41 18.30 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 20 3 # 20 A 138 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 243 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 272 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 14.13 45.79 13.40 14.25 49.41 18.30 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 21 3 # 21 A 138 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 243 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 272 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 14.13 45.79 13.40 14.25 49.41 18.30 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 22 3 # 22 A 138 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 243 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 272 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 14.13 45.79 13.40 14.25 49.41 18.30 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 23 3 # 23 A 138 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 243 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 272 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 14.13 45.79 13.40 14.25 49.41 18.30 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 24 3 # 24 A 138 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 243 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 272 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 14.13 45.79 13.40 14.25 49.41 18.30 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 25 3 # 25 A 138 TRP B 104 TRP^? 15.21 C2 EDO A 302 A 243 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 272 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 16.93 55.67 9.65 17.16 54.23 11.19 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 14.13 45.79 13.40 14.25 49.41 18.30 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 26 3 # 26 A 138 TRP B 142 TRP.? 12.90 OXT ACT B 201 A 243 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 272 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -21.52 44.96 85.54 -21.40 47.93 82.96 coo 16.93 55.67 9.65 17.16 54.23 11.19 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 14.13 45.79 13.40 14.25 49.41 18.30 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 27 3 # 27 A 138 TRP B 142 TRP.? 12.90 OXT ACT B 201 A 243 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 272 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 -21.52 44.96 85.54 -21.40 47.93 82.96 coo 16.93 55.67 9.65 17.16 54.23 11.19 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 14.13 45.79 13.40 14.25 49.41 18.30 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 28 3 # 28 A 138 TRP C 30 TRP~? -4.24 CH3 ACT C 201s A 243 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 272 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 16.93 55.67 9.65 17.16 54.23 11.19 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 14.13 45.79 13.40 14.25 49.41 18.30 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 29 3 # 29 A 138 TRP C 30 TRP~? -4.24 CH3 ACT C 201s A 243 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 272 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 16.93 55.67 9.65 17.16 54.23 11.19 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 14.13 45.79 13.40 14.25 49.41 18.30 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 30 3 # 30 A 138 TRP C 30 TRP~? -4.24 CH3 ACT C 201s A 243 ASP C 34 ASP~? 14.66 O ACT C 201 A 272 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 16.93 55.67 9.65 17.16 54.23 11.19 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 14.13 45.79 13.40 14.25 49.41 18.30 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 31 3 # 31 A 138 TRP C 30 TRP~? -4.24 CH3 ACT C 201s A 243 ASP C 34 ASP~? 14.66 O ACT C 201 A 272 LYS C 68 LYS~? -2.77 O ACT C 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 16.93 55.67 9.65 17.16 54.23 11.19 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 14.13 45.79 13.40 14.25 49.41 18.30 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 32 3 # 32 A 138 TRP C 69 TRP~? 6.41 O ACT C 201 A 243 ASP C 34 ASP~? 14.66 O ACT C 201 A 272 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 16.93 55.67 9.65 17.16 54.23 11.19 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 14.13 45.79 13.40 14.25 49.41 18.30 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 33 3 # 33 A 138 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 243 ASP C 74 ASP^? 14.86 O ACT C 201 A 272 LYS C 68 LYS~? -2.77 O ACT C 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 16.93 55.67 9.65 17.16 54.23 11.19 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 14.13 45.79 13.40 14.25 49.41 18.30 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 34 3 # 34 A 138 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 243 ASP C 74 ASP^? 14.86 O ACT C 201 A 272 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 18.21 54.75 18.05 19.91 55.17 21.59 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 16.93 55.67 9.65 17.16 54.23 11.19 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 14.13 45.79 13.40 14.25 49.41 18.30 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 35 3 # 35 A 138 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 243 ASP C 74 ASP^? 14.86 O ACT C 201 A 272 LYS C 139 LYS.? 18.79 O ACT C 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 16.93 55.67 9.65 17.16 54.23 11.19 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 14.13 45.79 13.40 14.25 49.41 18.30 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 36 3 # 36 A 138 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 243 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 272 LYS C 68 LYS~? -2.77 O ACT C 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 16.93 55.67 9.65 17.16 54.23 11.19 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 14.13 45.79 13.40 14.25 49.41 18.30 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 37 3 # 37 A 138 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 243 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 272 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 18.21 54.75 18.05 19.91 55.17 21.59 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 16.93 55.67 9.65 17.16 54.23 11.19 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 14.13 45.79 13.40 14.25 49.41 18.30 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 38 3 # 38 A 138 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 243 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 272 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 18.21 54.75 18.05 19.91 55.17 21.59 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 16.93 55.67 9.65 17.16 54.23 11.19 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 14.13 45.79 13.40 14.25 49.41 18.30 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 39 3 # 39 A 138 TRP C 104 TRP^? 12.40 O2 EDO A 301 A 243 ASP C 74 ASP^? 14.86 O ACT C 201 A 272 LYS C 139 LYS.? 18.79 O ACT C 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 16.93 55.67 9.65 17.16 54.23 11.19 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 14.13 45.79 13.40 14.25 49.41 18.30 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 40 3 # 40 A 138 TRP C 142 TRP.? 12.80 O ACT C 201 A 243 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 272 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -40.60 36.63 58.98 -43.29 38.84 57.12 coo 16.93 55.67 9.65 17.16 54.23 11.19 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 14.13 45.79 13.40 14.25 49.41 18.30 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 41 3 # 41 A 138 TRP C 142 TRP.? 12.80 O ACT C 201 A 243 ASP C 74 ASP^? 14.86 O ACT C 201 A 272 LYS C 139 LYS.? 18.79 O ACT C 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -40.60 36.63 58.98 -43.29 38.84 57.12 coo 16.93 55.67 9.65 17.16 54.23 11.19 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 14.13 45.79 13.40 14.25 49.41 18.30 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 42 3 # 42 A 138 TRP D 30 TRP~? -4.23 CH3 ACT D 201s A 243 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 272 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -55.89 62.34 37.62 -55.77 61.79 41.52 coo 16.93 55.67 9.65 17.16 54.23 11.19 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 14.13 45.79 13.40 14.25 49.41 18.30 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 43 3 # 43 A 138 TRP D 30 TRP~? -4.23 CH3 ACT D 201s A 243 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 272 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -55.89 62.34 37.62 -55.77 61.79 41.52 coo 16.93 55.67 9.65 17.16 54.23 11.19 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 14.13 45.79 13.40 14.25 49.41 18.30 -47.37 61.41 34.65 -51.85 60.71 37.83 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 44 3 # 44 A 138 TRP D 30 TRP~? -4.23 CH3 ACT D 201s A 243 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 272 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -55.89 62.34 37.62 -55.77 61.79 41.52 coo 16.93 55.67 9.65 17.16 54.23 11.19 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 14.13 45.79 13.40 14.25 49.41 18.30 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 45 3 # 45 A 138 TRP D 30 TRP~? -4.23 CH3 ACT D 201s A 243 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 272 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -55.89 62.34 37.62 -55.77 61.79 41.52 coo 16.93 55.67 9.65 17.16 54.23 11.19 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 14.13 45.79 13.40 14.25 49.41 18.30 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 46 3 # 46 A 138 TRP D 69 TRP~? 6.43 OXT ACT D 201 A 243 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 272 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -55.42 69.82 43.51 -57.48 67.10 41.55 coo 16.93 55.67 9.65 17.16 54.23 11.19 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 14.13 45.79 13.40 14.25 49.41 18.30 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 47 3 # 47 A 138 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 243 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 272 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 16.93 55.67 9.65 17.16 54.23 11.19 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 14.13 45.79 13.40 14.25 49.41 18.30 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 48 3 # 48 A 138 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 243 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 272 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 16.93 55.67 9.65 17.16 54.23 11.19 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 14.13 45.79 13.40 14.25 49.41 18.30 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 49 3 # 49 A 138 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 243 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 272 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 16.93 55.67 9.65 17.16 54.23 11.19 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 14.13 45.79 13.40 14.25 49.41 18.30 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 50 3 # 50 A 138 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 243 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 272 LYS D 134 LYS~? 17.34 O ACT A 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 16.93 55.67 9.65 17.16 54.23 11.19 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 14.13 45.79 13.40 14.25 49.41 18.30 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 51 3 # 51 A 138 TRP D 97 TRP^? 8.35 CH3 ACT A 203 A 243 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 272 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 14.13 45.79 13.40 14.25 49.41 18.30 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 52 3 # 52 A 138 TRP D 104 TRP^? 14.89 CH3 ACT A 203 A 243 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 272 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 16.93 55.67 9.65 17.16 54.23 11.19 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 14.13 45.79 13.40 14.25 49.41 18.30 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 53 3 # 53 A 138 TRP D 142 TRP.? 12.80 OXT ACT D 201 A 243 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 272 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 18.21 54.75 18.05 19.91 55.17 21.59 -49.78 73.48 32.42 -47.22 70.87 33.88 coo 16.93 55.67 9.65 17.16 54.23 11.19 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 14.13 45.79 13.40 14.25 49.41 18.30 -47.37 61.41 34.65 -51.85 60.71 37.83 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 54 3 # 54 A 138 TRP D 142 TRP.? 12.80 OXT ACT D 201 A 243 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 272 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 18.21 54.75 18.05 19.91 55.17 21.59 -49.78 73.48 32.42 -47.22 70.87 33.88 coo 16.93 55.67 9.65 17.16 54.23 11.19 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 14.13 45.79 13.40 14.25 49.41 18.30 -39.84 73.21 37.09 -35.07 70.74 37.87 1d7r_c01 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 54 hits 1d7r_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 42 TYR^? 9.79 CH3 ACT A 201 A 243 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 272 LYS A 139 LYS.? 17.81 O ACT A 201 coo 2.03 68.31 21.46 0.66 68.36 23.90 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 14.13 45.79 13.40 14.25 49.41 18.30 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 75 TYR^? -4.52 O ACT A 201s A 243 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 272 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 2.03 68.31 21.46 0.66 68.36 23.90 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 16.93 55.67 9.65 17.16 54.23 11.19 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 14.13 45.79 13.40 14.25 49.41 18.30 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 95 TYR^? -3.85 O ACT A 201s A 243 ASP C 74 ASP^? 14.86 O ACT C 201 A 272 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 2.03 68.31 21.46 0.66 68.36 23.90 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 16.93 55.67 9.65 17.16 54.23 11.19 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 14.13 45.79 13.40 14.25 49.41 18.30 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR A 95 TYR^? -3.85 O ACT A 201s A 243 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 272 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 2.03 68.31 21.46 0.66 68.36 23.90 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 16.93 55.67 9.65 17.16 54.23 11.19 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 14.13 45.79 13.40 14.25 49.41 18.30 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR A 108 TYR^? 12.28 O ACT A 201 A 243 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 272 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 2.03 68.31 21.46 0.66 68.36 23.90 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 14.13 45.79 13.40 14.25 49.41 18.30 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR B 42 TYR^? 9.74 CH3 ACT B 201 A 243 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 272 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 16.93 55.67 9.65 17.16 54.23 11.19 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 14.13 45.79 13.40 14.25 49.41 18.30 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 243 ASP C 34 ASP~? 14.66 O ACT C 201 A 272 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 16.93 55.67 9.65 17.16 54.23 11.19 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 14.13 45.79 13.40 14.25 49.41 18.30 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR C 42 TYR^? 9.67 CH3 ACT C 201 A 243 ASP C 74 ASP^? 14.86 O ACT C 201 A 272 LYS C 139 LYS.? 18.79 O ACT C 201 coo 2.03 68.31 21.46 0.66 68.36 23.90 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 16.93 55.67 9.65 17.16 54.23 11.19 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 14.13 45.79 13.40 14.25 49.41 18.30 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR C 75 TYR^? -4.54 O ACT C 201s A 243 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 272 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 16.93 55.67 9.65 17.16 54.23 11.19 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 14.13 45.79 13.40 14.25 49.41 18.30 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR C 95 TYR^? -3.84 O ACT C 201s A 243 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 272 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 2.03 68.31 21.46 0.66 68.36 23.90 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 16.93 55.67 9.65 17.16 54.23 11.19 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 14.13 45.79 13.40 14.25 49.41 18.30 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR C 108 TYR^? 12.28 O ACT C 201 A 243 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 272 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 2.03 68.31 21.46 0.66 68.36 23.90 -49.57 50.97 53.11 -51.32 50.02 55.06 coo 16.93 55.67 9.65 17.16 54.23 11.19 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 14.13 45.79 13.40 14.25 49.41 18.30 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 173 TYR D 42 TYR^? 9.84 CH3 ACT D 201 A 243 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 272 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 2.03 68.31 21.46 0.66 68.36 23.90 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 16.93 55.67 9.65 17.16 54.23 11.19 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 14.13 45.79 13.40 14.25 49.41 18.30 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 13 3 # 13 A 173 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 243 ASP A 34 ASP~? 14.63 O ACT A 201 A 272 LYS A 62 LYS~? 17.60 O ACT A 201 coo 2.03 68.31 21.46 0.66 68.36 23.90 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 16.93 55.67 9.65 17.16 54.23 11.19 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 14.13 45.79 13.40 14.25 49.41 18.30 -24.69 69.09 56.72 -23.65 73.04 51.86 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 13 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 177 GLU A 156 GLU~? 20.10 CH3 ACT A 201 A 201 LEU A 154 LEU~? 11.68 CH3 ACT A 201 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -39.19 74.64 76.97 -38.88 72.97 75.63 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 177 GLU A 160 GLU.? 13.50 O ACT A 201 A 201 LEU A 154 LEU~? 11.68 CH3 ACT A 201 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -39.19 74.64 76.97 -38.88 72.97 75.63 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 177 GLU B 156 GLU~? 12.19 CH3 ACT A 202 A 201 LEU B 154 LEU~? 4.88 CH3 ACT A 202 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -19.73 57.21 79.21 -21.60 57.21 78.13 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS B 139 LYS.? 6.99 C1 EDO A 302 A 177 GLU B 156 GLU~? 12.19 CH3 ACT A 202 A 201 LEU B 157 LEU~? 8.47 CH3 ACT A 202 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -18.83 46.84 75.05 -16.49 49.79 71.17 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -16.33 52.49 75.80 -16.48 51.26 77.56 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 177 GLU C 156 GLU~? 19.44 CH3 ACT C 201 A 201 LEU C 154 LEU~? 11.42 CH3 ACT C 201 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -48.99 42.06 49.32 -48.47 44.12 49.71 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS C 139 LYS.? 18.79 O ACT C 201 A 177 GLU C 156 GLU~? 19.44 CH3 ACT C 201 A 201 LEU C 157 LEU~? 16.14 CH3 ACT C 201 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -50.26 41.49 60.64 -55.14 42.95 58.84 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -52.51 40.47 54.60 -50.95 39.18 55.35 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 177 GLU D 156 GLU.? 18.36 CH3 ACT D 201 A 201 LEU D 154 LEU.? 11.37 CH3 ACT D 201 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -41.78 62.16 34.13 -42.22 62.04 36.24 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 7 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 79 LYS^? -3.45 CH3 ACT A 201s B 177 GLU A 160 GLU.? 13.50 O ACT A 201 B 201 LEU A 154 LEU~? 11.68 CH3 ACT A 201 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 27.00 6.35 51.01 26.30 4.53 50.18 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -39.19 74.64 76.97 -38.88 72.97 75.63 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS B 79 LYS^? -3.44 CH3 ACT B 201s B 177 GLU B 156 GLU~? 12.19 CH3 ACT A 202 B 201 LEU B 154 LEU~? 4.88 CH3 ACT A 202 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 27.00 6.35 51.01 26.30 4.53 50.18 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -19.73 57.21 79.21 -21.60 57.21 78.13 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS B 139 LYS.? 6.99 C1 EDO A 302 B 177 GLU B 156 GLU~? 12.19 CH3 ACT A 202 B 201 LEU B 157 LEU~? 8.47 CH3 ACT A 202 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -18.83 46.84 75.05 -16.49 49.79 71.17 coo 27.00 6.35 51.01 26.30 4.53 50.18 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -16.33 52.49 75.80 -16.48 51.26 77.56 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS C 79 LYS^? -3.44 CH3 ACT C 201s B 177 GLU C 156 GLU~? 19.44 CH3 ACT C 201 B 201 LEU C 154 LEU~? 11.42 CH3 ACT C 201 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 27.00 6.35 51.01 26.30 4.53 50.18 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -48.99 42.06 49.32 -48.47 44.12 49.71 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS D 79 LYS^? -3.52 CH3 ACT D 201s B 177 GLU D 156 GLU.? 18.36 CH3 ACT D 201 B 201 LEU D 154 LEU.? 11.37 CH3 ACT D 201 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 27.00 6.35 51.01 26.30 4.53 50.18 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -41.78 62.16 34.13 -42.22 62.04 36.24 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 5 hits 1daa_c01 naa= 3 ULMN 3 1dco_c00 DCOH user 1 3 # 1 A 62 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 63 HIS B 141 HIS.? 15.94 CH3 ACT A 202 A 89 ASP B 150 ASP.? 20.21 CH3 ACT A 202 coo 49.66 36.74 42.37 48.88 35.30 43.64 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 49.93 35.76 35.94 51.58 36.96 35.47 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 46.15 35.33 47.12 47.46 33.99 46.29 -10.73 49.15 87.46 -11.06 47.07 87.30 ULMN 3 1dco_c00 DCOH user 2 3 # 2 A 62 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 63 HIS D 141 HIS.? 18.95 OXT ACT D 201 A 89 ASP D 150 ASP.? 21.68 CH3 ACT D 201 coo 49.66 36.74 42.37 48.88 35.30 43.64 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 49.93 35.76 35.94 51.58 36.96 35.47 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 46.15 35.33 47.12 47.46 33.99 46.29 -44.02 71.14 22.58 -44.47 73.01 23.46 1dco_c00 source 1dco DCOH : 2 hits 1dco_c00 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 646 ASP A 150 ASP.? 22.07 CH3 ACT A 201 A 739 GLY A 145 GLY.? 13.13 O ACT A 201 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 11.37 50.89 2.29 11.05 51.63 2.25 -38.43 80.69 60.76 -38.91 80.43 61.42 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 646 ASP B 150 ASP.? 20.21 CH3 ACT A 202 A 739 GLY B 145 GLY.? 13.34 OXT ACT B 201 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 11.37 50.89 2.29 11.05 51.63 2.25 -25.17 44.53 88.88 -24.74 44.79 88.19 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 646 ASP C 150 ASP.? 20.99 CH3 ACT C 201 A 739 GLY C 145 GLY.? 13.18 O ACT C 201 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 11.37 50.89 2.29 11.05 51.63 2.25 -35.71 37.24 58.49 -36.57 37.39 58.47 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 646 ASP D 150 ASP.? 21.68 CH3 ACT D 201 A 739 GLY D 145 GLY.? 13.27 OXT ACT D 201 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 11.37 50.89 2.29 11.05 51.63 2.25 -54.58 73.10 33.20 -53.72 72.98 33.25 1ddj_c12 source 1ddj PLASMINOGEN : 4 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 646 ASP A 150 ASP.? 22.07 CH3 ACT A 201 B 739 GLY A 145 GLY.? 13.13 O ACT A 201 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -43.83 81.49 70.61 -45.02 79.78 70.42 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -43.95 88.27 71.85 -43.22 89.50 70.29 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -38.43 80.69 60.76 -38.91 80.43 61.42 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 646 ASP B 150 ASP.? 20.21 CH3 ACT A 202 B 739 GLY B 145 GLY.? 13.34 OXT ACT B 201 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -16.30 48.49 82.95 -17.03 48.20 81.01 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -10.73 49.15 87.46 -11.06 47.07 87.30 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -25.17 44.53 88.88 -24.74 44.79 88.19 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 646 ASP C 150 ASP.? 20.99 CH3 ACT C 201 B 739 GLY C 145 GLY.? 13.18 O ACT C 201 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -46.81 35.18 56.40 -47.74 36.88 57.21 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -46.61 28.46 55.57 -45.54 29.27 57.21 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -35.71 37.24 58.49 -36.57 37.39 58.47 ULMN 3 1ddj_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 646 ASP D 150 ASP.? 21.68 CH3 ACT D 201 B 739 GLY D 145 GLY.? 13.27 OXT ACT D 201 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -44.04 70.63 29.61 -43.01 70.81 31.43 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -44.02 71.14 22.58 -44.47 73.01 23.46 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -54.58 73.10 33.20 -53.72 72.98 33.25 1ddj_c13 source 1ddj PLASMINOGEN : 4 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS C 151 HIS.? 16.03 CH3 ACT C 201 C 646 ASP C 150 ASP.? 20.99 CH3 ACT C 201 C 739 GLY C 145 GLY.? 13.18 O ACT C 201 coo 15.33 59.81 59.60 13.98 60.99 60.69 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 16.06 55.72 54.73 15.97 56.49 56.70 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 9.38 49.29 65.28 9.01 50.03 65.31 -35.71 37.24 58.49 -36.57 37.39 58.47 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS D 151 HIS.? 15.66 CH3 ACT D 201 C 646 ASP D 150 ASP.? 21.68 CH3 ACT D 201 C 739 GLY D 145 GLY.? 13.27 OXT ACT D 201 coo 15.33 59.81 59.60 13.98 60.99 60.69 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 16.06 55.72 54.73 15.97 56.49 56.70 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 9.38 49.29 65.28 9.01 50.03 65.31 -54.58 73.10 33.20 -53.72 72.98 33.25 1ddj_c14 source 1ddj PLASMINOGEN : 2 hits 1ddj_c14 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 226 THR C 66 THR~? 7.92 O2 EDO A 302 A 229 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 7.24 97.46 49.60 8.11 95.69 48.80 -27.55 51.38 57.17 -25.41 51.36 57.47 coo 10.53 97.56 43.71 9.33 93.71 47.17 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 226 THR A 66 THR~? 13.87 O ACT A 201 A 229 LYS A 62 LYS~? 17.60 O ACT A 201 coo 9.66 102.78 70.07 9.79 101.18 71.42 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 7.24 97.46 49.60 8.11 95.69 48.80 -30.35 68.05 54.38 -29.23 68.39 52.56 coo 10.53 97.56 43.71 9.33 93.71 47.17 -24.69 69.09 56.72 -23.65 73.04 51.86 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 226 THR C 66 THR~? 7.92 O2 EDO A 302 B 229 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 20.74 95.78 68.68 19.29 96.84 69.83 -27.55 51.38 57.17 -25.41 51.36 57.47 coo 22.32 101.61 71.64 17.89 98.63 71.55 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 226 THR A 66 THR~? 13.87 O ACT A 201 B 229 LYS A 62 LYS~? 17.60 O ACT A 201 coo 15.90 87.61 49.61 13.92 86.96 49.36 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 20.74 95.78 68.68 19.29 96.84 69.83 -30.35 68.05 54.38 -29.23 68.39 52.56 coo 22.32 101.61 71.64 17.89 98.63 71.55 -24.69 69.09 56.72 -23.65 73.04 51.86 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU B 72 GLU~? 5.30 OXT ACT B 201 C 226 THR C 66 THR~? 7.92 O2 EDO A 302 C 229 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 22.16 45.88 73.63 23.23 47.70 73.25 -27.55 51.38 57.17 -25.41 51.36 57.47 coo 28.90 45.91 73.55 25.22 49.72 72.97 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU D 72 GLU~? 5.29 OXT ACT D 201 C 226 THR A 66 THR~? 13.87 O ACT A 201 C 229 LYS A 62 LYS~? 17.60 O ACT A 201 coo 5.43 40.40 61.63 4.27 41.99 60.90 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 22.16 45.88 73.63 23.23 47.70 73.25 -30.35 68.05 54.38 -29.23 68.39 52.56 coo 28.90 45.91 73.55 25.22 49.72 72.97 -24.69 69.09 56.72 -23.65 73.04 51.86 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU B 72 GLU~? 5.30 OXT ACT B 201 D 226 THR C 66 THR~? 7.92 O2 EDO A 302 D 229 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 11.79 47.62 52.67 10.10 46.51 53.39 -27.55 51.38 57.17 -25.41 51.36 57.47 coo 10.05 41.79 49.80 7.94 44.71 53.76 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU D 72 GLU~? 5.29 OXT ACT D 201 D 226 THR A 66 THR~? 13.87 O ACT A 201 D 229 LYS A 62 LYS~? 17.60 O ACT A 201 coo 26.07 55.89 66.14 25.33 56.50 68.01 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 11.79 47.62 52.67 10.10 46.51 53.39 -30.35 68.05 54.38 -29.23 68.39 52.56 coo 10.05 41.79 49.80 7.94 44.71 53.76 -24.69 69.09 56.72 -23.65 73.04 51.86 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 98 HIS^? -3.60 C ACT A 203s A 200 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo 1.13 77.49 40.64 0.62 75.57 39.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 0.84 91.24 49.01 2.91 91.61 49.23 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 10.53 97.56 43.71 9.33 93.71 47.17 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS A 98 HIS^? -3.60 C ACT A 203s A 200 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 229 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 1.13 77.49 40.64 0.62 75.57 39.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 0.84 91.24 49.01 2.91 91.61 49.23 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 10.53 97.56 43.71 9.33 93.71 47.17 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 123 HIS A 141 HIS.? 11.20 OXT ACT A 203 A 200 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 229 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 1.13 77.49 40.64 0.62 75.57 39.98 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 0.84 91.24 49.01 2.91 91.61 49.23 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 10.53 97.56 43.71 9.33 93.71 47.17 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 123 HIS A 141 HIS.? 11.20 OXT ACT A 203 A 200 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 229 LYS D 134 LYS~? 17.34 O ACT A 201 coo 1.13 77.49 40.64 0.62 75.57 39.98 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 0.84 91.24 49.01 2.91 91.61 49.23 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 10.53 97.56 43.71 9.33 93.71 47.17 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 123 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 200 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo 1.13 77.49 40.64 0.62 75.57 39.98 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 0.84 91.24 49.01 2.91 91.61 49.23 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 10.53 97.56 43.71 9.33 93.71 47.17 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 123 HIS A 162 HIS.? 14.54 O1 EDO A 301 A 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo 1.13 77.49 40.64 0.62 75.57 39.98 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 0.84 91.24 49.01 2.91 91.61 49.23 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 10.53 97.56 43.71 9.33 93.71 47.17 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 123 HIS A 162 HIS.? 14.54 O1 EDO A 301 A 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 229 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 1.13 77.49 40.64 0.62 75.57 39.98 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 0.84 91.24 49.01 2.91 91.61 49.23 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 10.53 97.56 43.71 9.33 93.71 47.17 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 123 HIS A 162 HIS.? 14.54 O1 EDO A 301 A 200 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 229 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 1.13 77.49 40.64 0.62 75.57 39.98 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 0.84 91.24 49.01 2.91 91.61 49.23 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 10.53 97.56 43.71 9.33 93.71 47.17 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 200 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo 1.13 77.49 40.64 0.62 75.57 39.98 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 0.84 91.24 49.01 2.91 91.61 49.23 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 10.53 97.56 43.71 9.33 93.71 47.17 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 123 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 200 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 229 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 1.13 77.49 40.64 0.62 75.57 39.98 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 0.84 91.24 49.01 2.91 91.61 49.23 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 10.53 97.56 43.71 9.33 93.71 47.17 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo 1.13 77.49 40.64 0.62 75.57 39.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 0.84 91.24 49.01 2.91 91.61 49.23 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 10.53 97.56 43.71 9.33 93.71 47.17 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 229 LYS A 134 LYS~? 11.98 O ACT A 203 coo 1.13 77.49 40.64 0.62 75.57 39.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 0.84 91.24 49.01 2.91 91.61 49.23 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 10.53 97.56 43.71 9.33 93.71 47.17 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 A 123 HIS C 141 HIS.? 17.85 O ACT C 201 A 200 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 229 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 1.13 77.49 40.64 0.62 75.57 39.98 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 0.84 91.24 49.01 2.91 91.61 49.23 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 10.53 97.56 43.71 9.33 93.71 47.17 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 A 123 HIS C 141 HIS.? 17.85 O ACT C 201 A 200 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 229 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 0.84 91.24 49.01 2.91 91.61 49.23 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 10.53 97.56 43.71 9.33 93.71 47.17 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 A 123 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 200 ASP C 74 ASP^? 14.86 O ACT C 201 A 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo 1.13 77.49 40.64 0.62 75.57 39.98 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 0.84 91.24 49.01 2.91 91.61 49.23 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 10.53 97.56 43.71 9.33 93.71 47.17 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 A 123 HIS D 56 HIS.? 17.26 O ACT D 201 A 200 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 229 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 1.13 77.49 40.64 0.62 75.57 39.98 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 0.84 91.24 49.01 2.91 91.61 49.23 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 A 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 200 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo 1.13 77.49 40.64 0.62 75.57 39.98 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 0.84 91.24 49.01 2.91 91.61 49.23 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 10.53 97.56 43.71 9.33 93.71 47.17 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 A 123 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 200 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 229 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 1.13 77.49 40.64 0.62 75.57 39.98 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 0.84 91.24 49.01 2.91 91.61 49.23 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 10.53 97.56 43.71 9.33 93.71 47.17 -56.56 67.44 48.13 -52.71 65.23 44.87 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 18 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 98 HIS^? -3.60 C ACT A 203s B 200 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo 9.24 94.26 88.22 8.02 94.07 89.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 17.54 90.31 75.01 17.17 92.01 73.80 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 22.32 101.61 71.64 17.89 98.63 71.55 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS A 98 HIS^? -3.60 C ACT A 203s B 200 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 229 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 9.24 94.26 88.22 8.02 94.07 89.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 17.54 90.31 75.01 17.17 92.01 73.80 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 22.32 101.61 71.64 17.89 98.63 71.55 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 123 HIS A 141 HIS.? 11.20 OXT ACT A 203 B 200 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 229 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 9.24 94.26 88.22 8.02 94.07 89.92 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 17.54 90.31 75.01 17.17 92.01 73.80 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 22.32 101.61 71.64 17.89 98.63 71.55 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 123 HIS A 141 HIS.? 11.20 OXT ACT A 203 B 200 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 229 LYS D 134 LYS~? 17.34 O ACT A 201 coo 9.24 94.26 88.22 8.02 94.07 89.92 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 17.54 90.31 75.01 17.17 92.01 73.80 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 22.32 101.61 71.64 17.89 98.63 71.55 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 123 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 200 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo 9.24 94.26 88.22 8.02 94.07 89.92 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 17.54 90.31 75.01 17.17 92.01 73.80 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 22.32 101.61 71.64 17.89 98.63 71.55 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 123 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo 9.24 94.26 88.22 8.02 94.07 89.92 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 17.54 90.31 75.01 17.17 92.01 73.80 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 22.32 101.61 71.64 17.89 98.63 71.55 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 123 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 229 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 9.24 94.26 88.22 8.02 94.07 89.92 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 17.54 90.31 75.01 17.17 92.01 73.80 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 22.32 101.61 71.64 17.89 98.63 71.55 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 123 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 200 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 229 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 9.24 94.26 88.22 8.02 94.07 89.92 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 17.54 90.31 75.01 17.17 92.01 73.80 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 22.32 101.61 71.64 17.89 98.63 71.55 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 200 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo 9.24 94.26 88.22 8.02 94.07 89.92 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 17.54 90.31 75.01 17.17 92.01 73.80 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 22.32 101.61 71.64 17.89 98.63 71.55 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 123 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 200 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 229 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 9.24 94.26 88.22 8.02 94.07 89.92 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 17.54 90.31 75.01 17.17 92.01 73.80 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 22.32 101.61 71.64 17.89 98.63 71.55 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo 9.24 94.26 88.22 8.02 94.07 89.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 17.54 90.31 75.01 17.17 92.01 73.80 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 22.32 101.61 71.64 17.89 98.63 71.55 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 B 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 229 LYS A 134 LYS~? 11.98 O ACT A 203 coo 9.24 94.26 88.22 8.02 94.07 89.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 17.54 90.31 75.01 17.17 92.01 73.80 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 22.32 101.61 71.64 17.89 98.63 71.55 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 B 123 HIS C 141 HIS.? 17.85 O ACT C 201 B 200 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 229 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 9.24 94.26 88.22 8.02 94.07 89.92 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 17.54 90.31 75.01 17.17 92.01 73.80 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 22.32 101.61 71.64 17.89 98.63 71.55 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 B 123 HIS C 141 HIS.? 17.85 O ACT C 201 B 200 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 229 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 17.54 90.31 75.01 17.17 92.01 73.80 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 22.32 101.61 71.64 17.89 98.63 71.55 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 B 123 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 200 ASP C 74 ASP^? 14.86 O ACT C 201 B 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo 9.24 94.26 88.22 8.02 94.07 89.92 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 17.54 90.31 75.01 17.17 92.01 73.80 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 22.32 101.61 71.64 17.89 98.63 71.55 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 B 123 HIS D 56 HIS.? 17.26 O ACT D 201 B 200 ASP D 116 ASP.? 19.52 CH3 ACT D 201 B 229 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 9.24 94.26 88.22 8.02 94.07 89.92 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 17.54 90.31 75.01 17.17 92.01 73.80 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 B 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 200 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo 9.24 94.26 88.22 8.02 94.07 89.92 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 17.54 90.31 75.01 17.17 92.01 73.80 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 22.32 101.61 71.64 17.89 98.63 71.55 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 B 123 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 200 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 229 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 9.24 94.26 88.22 8.02 94.07 89.92 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 17.54 90.31 75.01 17.17 92.01 73.80 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 22.32 101.61 71.64 17.89 98.63 71.55 -56.56 67.44 48.13 -52.71 65.23 44.87 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 18 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 98 HIS^? -3.60 C ACT A 203s C 200 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo 26.77 65.84 83.49 27.06 67.76 84.27 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.52 52.01 79.59 20.28 51.65 77.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 28.90 45.91 73.55 25.22 49.72 72.97 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS A 98 HIS^? -3.60 C ACT A 203s C 200 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 229 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 26.77 65.84 83.49 27.06 67.76 84.27 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.52 52.01 79.59 20.28 51.65 77.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 28.90 45.91 73.55 25.22 49.72 72.97 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 123 HIS A 141 HIS.? 11.20 OXT ACT A 203 C 200 ASP D 99 ASP.? 7.94 CH3 ACT A 203 C 229 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 26.77 65.84 83.49 27.06 67.76 84.27 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 19.52 52.01 79.59 20.28 51.65 77.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 28.90 45.91 73.55 25.22 49.72 72.97 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 123 HIS A 141 HIS.? 11.20 OXT ACT A 203 C 200 ASP D 99 ASP.? 7.94 CH3 ACT A 203 C 229 LYS D 134 LYS~? 17.34 O ACT A 201 coo 26.77 65.84 83.49 27.06 67.76 84.27 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 19.52 52.01 79.59 20.28 51.65 77.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 28.90 45.91 73.55 25.22 49.72 72.97 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 123 HIS A 151 HIS.? 15.97 CH3 ACT A 201 C 200 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo 26.77 65.84 83.49 27.06 67.76 84.27 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 19.52 52.01 79.59 20.28 51.65 77.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 28.90 45.91 73.55 25.22 49.72 72.97 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 123 HIS A 162 HIS.? 14.54 O1 EDO A 301 C 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo 26.77 65.84 83.49 27.06 67.76 84.27 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 19.52 52.01 79.59 20.28 51.65 77.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 28.90 45.91 73.55 25.22 49.72 72.97 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 123 HIS A 162 HIS.? 14.54 O1 EDO A 301 C 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 229 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 26.77 65.84 83.49 27.06 67.76 84.27 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 19.52 52.01 79.59 20.28 51.65 77.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 28.90 45.91 73.55 25.22 49.72 72.97 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 123 HIS A 162 HIS.? 14.54 O1 EDO A 301 C 200 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 229 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 26.77 65.84 83.49 27.06 67.76 84.27 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 19.52 52.01 79.59 20.28 51.65 77.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 28.90 45.91 73.55 25.22 49.72 72.97 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 C 200 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo 26.77 65.84 83.49 27.06 67.76 84.27 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 19.52 52.01 79.59 20.28 51.65 77.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 28.90 45.91 73.55 25.22 49.72 72.97 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 123 HIS B 151 HIS.? 13.45 CH3 ACT A 202 C 200 ASP B 74 ASP^? 14.88 OXT ACT B 201 C 229 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 26.77 65.84 83.49 27.06 67.76 84.27 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 19.52 52.01 79.59 20.28 51.65 77.65 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 28.90 45.91 73.55 25.22 49.72 72.97 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo 26.77 65.84 83.49 27.06 67.76 84.27 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.52 52.01 79.59 20.28 51.65 77.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 28.90 45.91 73.55 25.22 49.72 72.97 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 C 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 229 LYS A 134 LYS~? 11.98 O ACT A 203 coo 26.77 65.84 83.49 27.06 67.76 84.27 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.52 52.01 79.59 20.28 51.65 77.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 28.90 45.91 73.55 25.22 49.72 72.97 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 C 123 HIS C 141 HIS.? 17.85 O ACT C 201 C 200 ASP B 99 ASP.? 16.09 OXT ACT B 201 C 229 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 26.77 65.84 83.49 27.06 67.76 84.27 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 19.52 52.01 79.59 20.28 51.65 77.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 28.90 45.91 73.55 25.22 49.72 72.97 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 C 123 HIS C 141 HIS.? 17.85 O ACT C 201 C 200 ASP B 99 ASP.? 16.09 OXT ACT B 201 C 229 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 19.52 52.01 79.59 20.28 51.65 77.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 28.90 45.91 73.55 25.22 49.72 72.97 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 C 123 HIS C 151 HIS.? 16.03 CH3 ACT C 201 C 200 ASP C 74 ASP^? 14.86 O ACT C 201 C 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo 26.77 65.84 83.49 27.06 67.76 84.27 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 19.52 52.01 79.59 20.28 51.65 77.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 28.90 45.91 73.55 25.22 49.72 72.97 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 C 123 HIS D 56 HIS.? 17.26 O ACT D 201 C 200 ASP D 116 ASP.? 19.52 CH3 ACT D 201 C 229 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 26.77 65.84 83.49 27.06 67.76 84.27 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 19.52 52.01 79.59 20.28 51.65 77.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 C 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 C 200 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo 26.77 65.84 83.49 27.06 67.76 84.27 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 19.52 52.01 79.59 20.28 51.65 77.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 28.90 45.91 73.55 25.22 49.72 72.97 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 C 123 HIS D 151 HIS.? 15.66 CH3 ACT D 201 C 200 ASP D 74 ASP^? 14.85 OXT ACT D 201 C 229 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 26.77 65.84 83.49 27.06 67.76 84.27 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 19.52 52.01 79.59 20.28 51.65 77.65 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 28.90 45.91 73.55 25.22 49.72 72.97 -56.56 67.44 48.13 -52.71 65.23 44.87 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 18 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 98 HIS^? -3.60 C ACT A 203s D 200 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo -10.90 48.74 53.41 -12.98 48.90 53.67 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 4.60 52.95 52.50 5.57 51.29 53.40 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 10.05 41.79 49.80 7.94 44.71 53.76 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS A 98 HIS^? -3.60 C ACT A 203s D 200 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 229 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 4.60 52.95 52.50 5.57 51.29 53.40 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 10.05 41.79 49.80 7.94 44.71 53.76 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 123 HIS A 141 HIS.? 11.20 OXT ACT A 203 D 200 ASP D 99 ASP.? 7.94 CH3 ACT A 203 D 229 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -10.90 48.74 53.41 -12.98 48.90 53.67 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 4.60 52.95 52.50 5.57 51.29 53.40 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 10.05 41.79 49.80 7.94 44.71 53.76 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 123 HIS A 141 HIS.? 11.20 OXT ACT A 203 D 200 ASP D 99 ASP.? 7.94 CH3 ACT A 203 D 229 LYS D 134 LYS~? 17.34 O ACT A 201 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 4.60 52.95 52.50 5.57 51.29 53.40 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 10.05 41.79 49.80 7.94 44.71 53.76 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 123 HIS A 151 HIS.? 15.97 CH3 ACT A 201 D 200 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo -10.90 48.74 53.41 -12.98 48.90 53.67 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 4.60 52.95 52.50 5.57 51.29 53.40 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 10.05 41.79 49.80 7.94 44.71 53.76 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 123 HIS A 162 HIS.? 14.54 O1 EDO A 301 D 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo -10.90 48.74 53.41 -12.98 48.90 53.67 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 4.60 52.95 52.50 5.57 51.29 53.40 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 10.05 41.79 49.80 7.94 44.71 53.76 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 123 HIS A 162 HIS.? 14.54 O1 EDO A 301 D 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 229 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 4.60 52.95 52.50 5.57 51.29 53.40 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 10.05 41.79 49.80 7.94 44.71 53.76 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 123 HIS A 162 HIS.? 14.54 O1 EDO A 301 D 200 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 229 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 4.60 52.95 52.50 5.57 51.29 53.40 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 10.05 41.79 49.80 7.94 44.71 53.76 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 D 200 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo -10.90 48.74 53.41 -12.98 48.90 53.67 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 4.60 52.95 52.50 5.57 51.29 53.40 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 10.05 41.79 49.80 7.94 44.71 53.76 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 123 HIS B 151 HIS.? 13.45 CH3 ACT A 202 D 200 ASP B 74 ASP^? 14.88 OXT ACT B 201 D 229 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -10.90 48.74 53.41 -12.98 48.90 53.67 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 4.60 52.95 52.50 5.57 51.29 53.40 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 10.05 41.79 49.80 7.94 44.71 53.76 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo -10.90 48.74 53.41 -12.98 48.90 53.67 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 4.60 52.95 52.50 5.57 51.29 53.40 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 10.05 41.79 49.80 7.94 44.71 53.76 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 D 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 229 LYS A 134 LYS~? 11.98 O ACT A 203 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 4.60 52.95 52.50 5.57 51.29 53.40 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 10.05 41.79 49.80 7.94 44.71 53.76 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 D 123 HIS C 141 HIS.? 17.85 O ACT C 201 D 200 ASP B 99 ASP.? 16.09 OXT ACT B 201 D 229 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -10.90 48.74 53.41 -12.98 48.90 53.67 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 4.60 52.95 52.50 5.57 51.29 53.40 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 10.05 41.79 49.80 7.94 44.71 53.76 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 D 123 HIS C 141 HIS.? 17.85 O ACT C 201 D 200 ASP B 99 ASP.? 16.09 OXT ACT B 201 D 229 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 4.60 52.95 52.50 5.57 51.29 53.40 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 10.05 41.79 49.80 7.94 44.71 53.76 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 D 123 HIS C 151 HIS.? 16.03 CH3 ACT C 201 D 200 ASP C 74 ASP^? 14.86 O ACT C 201 D 229 LYS C 68 LYS~? -2.77 O ACT C 201s coo -10.90 48.74 53.41 -12.98 48.90 53.67 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 4.60 52.95 52.50 5.57 51.29 53.40 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 10.05 41.79 49.80 7.94 44.71 53.76 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 D 123 HIS D 56 HIS.? 17.26 O ACT D 201 D 200 ASP D 116 ASP.? 19.52 CH3 ACT D 201 D 229 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 4.60 52.95 52.50 5.57 51.29 53.40 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 D 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 D 200 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 229 LYS A 68 LYS~? -2.78 O ACT A 201s coo -10.90 48.74 53.41 -12.98 48.90 53.67 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 4.60 52.95 52.50 5.57 51.29 53.40 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 10.05 41.79 49.80 7.94 44.71 53.76 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 D 123 HIS D 151 HIS.? 15.66 CH3 ACT D 201 D 200 ASP D 74 ASP^? 14.85 OXT ACT D 201 D 229 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -10.90 48.74 53.41 -12.98 48.90 53.67 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 4.60 52.95 52.50 5.57 51.29 53.40 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 10.05 41.79 49.80 7.94 44.71 53.76 -56.56 67.44 48.13 -52.71 65.23 44.87 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 18 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 138 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 161 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 29.03 88.95 86.80 28.09 90.57 84.75 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 23.31 93.18 82.88 23.00 93.71 79.86 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 33.83 91.15 88.62 31.07 91.06 83.02 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 133 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 138 ARG B 124 ARG.? -3.52 O ACT B 201s A 161 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 29.03 88.95 86.80 28.09 90.57 84.75 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 23.31 93.18 82.88 23.00 93.71 79.86 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 33.83 91.15 88.62 31.07 91.06 83.02 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 133 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 138 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 161 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 29.03 88.95 86.80 28.09 90.57 84.75 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 23.31 93.18 82.88 23.00 93.71 79.86 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 33.83 91.15 88.62 31.07 91.06 83.02 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 133 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 138 ARG D 124 ARG.? -3.55 O ACT D 201s A 161 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 29.03 88.95 86.80 28.09 90.57 84.75 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 23.31 93.18 82.88 23.00 93.71 79.86 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 33.83 91.15 88.62 31.07 91.06 83.02 -47.37 61.41 34.65 -51.85 60.71 37.83 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 4 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 93 TYR^? -4.07 CH3 ACT A 201s B 138 ARG A 124 ARG.? -3.54 OXT ACT A 201s B 161 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 4.62 122.69 99.88 5.46 122.82 97.24 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 10.44 122.27 94.08 11.02 123.87 91.53 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -0.17 119.75 99.65 2.51 123.83 95.70 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 133 TYR B 93 TYR^? -4.16 CH3 ACT B 201s B 138 ARG B 124 ARG.? -3.52 O ACT B 201s B 161 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 4.62 122.69 99.88 5.46 122.82 97.24 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 10.44 122.27 94.08 11.02 123.87 91.53 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -0.17 119.75 99.65 2.51 123.83 95.70 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 133 TYR C 93 TYR^? -4.09 CH3 ACT C 201s B 138 ARG C 124 ARG.? -3.50 OXT ACT C 201s B 161 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 4.62 122.69 99.88 5.46 122.82 97.24 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 10.44 122.27 94.08 11.02 123.87 91.53 -34.72 50.67 45.47 -36.40 51.18 47.99 coo -0.17 119.75 99.65 2.51 123.83 95.70 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 133 TYR D 93 TYR^? -4.14 CH3 ACT D 201s B 138 ARG D 124 ARG.? -3.55 O ACT D 201s B 161 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 4.62 122.69 99.88 5.46 122.82 97.24 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 10.44 122.27 94.08 11.02 123.87 91.53 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -0.17 119.75 99.65 2.51 123.83 95.70 -47.37 61.41 34.65 -51.85 60.71 37.83 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 4 hits 1dhp_c01 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 42 TYR^? 9.79 CH3 ACT A 201 150 LYS A 62 LYS~? 17.60 O ACT A 201 186 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 32.88 50.55 24.33 31.89 51.78 26.65 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 27.04 52.42 22.30 26.88 49.99 27.00 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 36.98 50.30 37.29 35.85 50.29 35.50 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 42 TYR^? 9.79 CH3 ACT A 201 150 LYS A 62 LYS~? 17.60 O ACT A 201 186 ASN A 112 ASN^? 9.36 O ACT A 202 coo 32.88 50.55 24.33 31.89 51.78 26.65 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 27.04 52.42 22.30 26.88 49.99 27.00 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 36.98 50.30 37.29 35.85 50.29 35.50 -24.96 67.02 76.01 -26.38 66.67 77.57 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR A 75 TYR^? -4.52 O ACT A 201s 150 LYS A 68 LYS~? -2.78 O ACT A 201s 186 ASN A 129 ASN.? 9.65 O ACT B 201 coo 32.88 50.55 24.33 31.89 51.78 26.65 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 27.04 52.42 22.30 26.88 49.99 27.00 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 36.98 50.30 37.29 35.85 50.29 35.50 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR A 93 TYR^? -4.07 CH3 ACT A 201s 150 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 186 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 32.88 50.55 24.33 31.89 51.78 26.65 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 27.04 52.42 22.30 26.88 49.99 27.00 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 36.98 50.30 37.29 35.85 50.29 35.50 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR B 93 TYR^? -4.16 CH3 ACT B 201s 150 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 186 ASN A 129 ASN.? 9.65 O ACT B 201 coo 32.88 50.55 24.33 31.89 51.78 26.65 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 27.04 52.42 22.30 26.88 49.99 27.00 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 36.98 50.30 37.29 35.85 50.29 35.50 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 6 3 # 6 146 TYR C 75 TYR^? -4.54 O ACT C 201s 150 LYS C 68 LYS~? -2.77 O ACT C 201s 186 ASN C 129 ASN.? 9.72 O ACT D 201 coo 32.88 50.55 24.33 31.89 51.78 26.65 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 27.04 52.42 22.30 26.88 49.99 27.00 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 36.98 50.30 37.29 35.85 50.29 35.50 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 7 3 # 7 146 TYR C 93 TYR^? -4.09 CH3 ACT C 201s 150 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 186 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 32.88 50.55 24.33 31.89 51.78 26.65 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 27.04 52.42 22.30 26.88 49.99 27.00 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 36.98 50.30 37.29 35.85 50.29 35.50 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 8 3 # 8 146 TYR D 42 TYR^? 9.84 CH3 ACT D 201 150 LYS D 62 LYS~? 17.47 OXT ACT D 201 186 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 32.88 50.55 24.33 31.89 51.78 26.65 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 27.04 52.42 22.30 26.88 49.99 27.00 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 36.98 50.30 37.29 35.85 50.29 35.50 -53.58 68.96 34.68 -51.50 68.66 35.10 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 9 3 # 9 146 TYR D 42 TYR^? 9.84 CH3 ACT D 201 150 LYS D 62 LYS~? 17.47 OXT ACT D 201 186 ASN D 112 ASN^? 12.21 O ACT D 201 coo 32.88 50.55 24.33 31.89 51.78 26.65 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 27.04 52.42 22.30 26.88 49.99 27.00 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 36.98 50.30 37.29 35.85 50.29 35.50 -49.94 50.30 41.07 -47.80 50.26 40.97 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 10 3 # 10 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s 150 LYS D 68 LYS~? -2.80 OXT ACT D 201s 186 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 32.88 50.55 24.33 31.89 51.78 26.65 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 27.04 52.42 22.30 26.88 49.99 27.00 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 36.98 50.30 37.29 35.85 50.29 35.50 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 11 3 # 11 146 TYR D 93 TYR^? -4.14 CH3 ACT D 201s 150 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 186 ASN C 129 ASN.? 9.72 O ACT D 201 coo 32.88 50.55 24.33 31.89 51.78 26.65 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 27.04 52.42 22.30 26.88 49.99 27.00 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 36.98 50.30 37.29 35.85 50.29 35.50 -47.56 56.76 52.53 -47.22 58.18 50.99 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 11 hits 1dhr_c00 naa= 3 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 1 3 # 1 A 222 TYR A 108 TYR^? 12.28 O ACT A 201 A 238 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 272 TRP A 97 TRP^? -5.71 O1 EDO A 301s coo -17.92 42.46 111.37 -18.35 40.11 109.91 -40.87 65.49 73.93 -43.61 66.01 74.07 coo -25.50 44.84 112.68 -25.52 43.37 111.17 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -27.19 39.29 113.01 -23.27 39.61 112.78 -41.41 66.78 64.19 -41.25 63.55 61.93 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 2 3 # 2 A 222 TYR B 108 TYR^? -4.79 O ACT A 202s A 238 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 272 TRP B 97 TRP^? 8.79 OXT ACT B 201 coo -17.92 42.46 111.37 -18.35 40.11 109.91 -26.20 55.78 72.02 -24.40 54.06 70.73 coo -25.50 44.84 112.68 -25.52 43.37 111.17 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -27.19 39.29 113.01 -23.27 39.61 112.78 -30.79 47.88 75.76 -34.11 46.82 73.93 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 3 3 # 3 A 222 TYR C 108 TYR^? 12.28 O ACT C 201 A 238 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 272 TRP C 97 TRP^? -5.77 O2 EDO A 301s coo -17.92 42.46 111.37 -18.35 40.11 109.91 -49.57 50.97 53.11 -51.32 50.02 55.06 coo -25.50 44.84 112.68 -25.52 43.37 111.17 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -27.19 39.29 113.01 -23.27 39.61 112.78 -42.17 50.30 59.58 -40.82 53.66 61.13 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 4 3 # 4 A 222 TYR D 108 TYR^? 12.28 OXT ACT D 201 A 238 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 272 TRP D 97 TRP^? 8.35 CH3 ACT A 203 coo -17.92 42.46 111.37 -18.35 40.11 109.91 -40.41 63.05 43.73 -38.60 65.12 43.23 coo -25.50 44.84 112.68 -25.52 43.37 111.17 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -27.19 39.29 113.01 -23.27 39.61 112.78 -47.45 69.73 45.65 -48.25 70.38 49.44 1diz_c00 source 1diz 3-METHYLADENINE DNA GLYCOSYLASE II : 4 hits 1diz_c00 naa= 3 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 1 3 # 1 B 222 TYR A 108 TYR^? 12.28 O ACT A 201 B 238 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 272 TRP A 97 TRP^? -5.71 O1 EDO A 301s coo 17.91 42.42 121.64 18.26 40.06 123.11 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 25.38 44.99 120.20 25.38 43.50 121.71 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 27.19 39.35 120.02 23.28 39.60 120.23 -41.41 66.78 64.19 -41.25 63.55 61.93 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 2 3 # 2 B 222 TYR B 108 TYR^? -4.79 O ACT A 202s B 238 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 272 TRP B 97 TRP^? 8.79 OXT ACT B 201 coo 17.91 42.42 121.64 18.26 40.06 123.11 -26.20 55.78 72.02 -24.40 54.06 70.73 coo 25.38 44.99 120.20 25.38 43.50 121.71 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 27.19 39.35 120.02 23.28 39.60 120.23 -30.79 47.88 75.76 -34.11 46.82 73.93 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 3 3 # 3 B 222 TYR C 108 TYR^? 12.28 O ACT C 201 B 238 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 272 TRP C 97 TRP^? -5.77 O2 EDO A 301s coo 17.91 42.42 121.64 18.26 40.06 123.11 -49.57 50.97 53.11 -51.32 50.02 55.06 coo 25.38 44.99 120.20 25.38 43.50 121.71 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 27.19 39.35 120.02 23.28 39.60 120.23 -42.17 50.30 59.58 -40.82 53.66 61.13 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 4 3 # 4 B 222 TYR D 108 TYR^? 12.28 OXT ACT D 201 B 238 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 272 TRP D 97 TRP^? 8.35 CH3 ACT A 203 coo 17.91 42.42 121.64 18.26 40.06 123.11 -40.41 63.05 43.73 -38.60 65.12 43.23 coo 25.38 44.99 120.20 25.38 43.50 121.71 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 27.19 39.35 120.02 23.28 39.60 120.23 -47.45 69.73 45.65 -48.25 70.38 49.44 1diz_c01 source 1diz 3-METHYLADENINE DNA GLYCOSYLASE II : 4 hits 1diz_c01 naa= 3 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 1 3 # 1 A 48 ALA A 55 ALA^? 10.63 O1 EDO A 302 A 52 HIS A 56 HIS.? 6.76 O1 EDO A 302 A 191 TRP A 113 TRP^? 8.12 CH3 ACT A 201 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -21.44 62.27 61.83 -22.27 63.55 61.72 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -25.55 70.89 71.82 -27.34 74.39 71.87 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 2 3 # 2 A 48 ALA B 55 ALA^? 12.04 O ACT B 201 A 52 HIS B 56 HIS.? 17.31 O ACT B 201 A 191 TRP B 113 TRP^? 8.18 CH3 ACT B 201 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -44.97 59.71 84.97 -43.80 58.86 85.49 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -31.63 62.84 85.81 -28.45 61.10 87.36 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 3 3 # 3 A 48 ALA C 55 ALA^? 12.11 OXT ACT C 201 A 52 HIS C 56 HIS.? 17.26 OXT ACT C 201 A 191 TRP C 113 TRP^? 8.13 CH3 ACT C 201 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -28.67 57.83 45.93 -28.88 56.47 46.57 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -26.71 60.26 42.75 -28.06 61.81 43.18 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -37.66 48.04 42.18 -38.30 44.33 43.32 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 4 3 # 4 A 48 ALA D 55 ALA^? 12.06 O ACT D 201 A 52 HIS D 56 HIS.? 17.26 O ACT D 201 A 191 TRP D 113 TRP^? 8.24 CH3 ACT D 201 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -61.44 55.28 49.65 -61.24 56.24 48.48 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -53.30 54.21 38.64 -52.86 56.34 35.35 1dj1_c00 source 1dj1 CYTOCHROME C PEROXIDASE : 4 hits 1dj1_c00 naa= 3 ULMN 3 1dnp_c00 DNA PHOTOLYASE user 1 3 # 1 A 306 TRP A 82 TRP^? 14.68 O ACT B 201 A 359 TRP B 113 TRP^? 8.18 CH3 ACT B 201 A 382 TRP B 48 TRP^? 8.84 O ACT B 201 coo 31.27 39.47 20.74 28.54 37.06 22.19 -30.38 69.86 83.05 -34.07 70.22 84.37 coo 30.66 36.51 25.88 33.61 35.64 28.35 -31.63 62.84 85.81 -28.45 61.10 87.36 coo 29.03 37.53 34.46 26.37 39.52 32.35 -39.73 60.89 87.11 -38.13 57.34 86.55 ULMN 3 1dnp_c00 DNA PHOTOLYASE user 2 3 # 2 A 306 TRP A 113 TRP^? 8.12 CH3 ACT A 201 A 359 TRP B 82 TRP^? 9.86 O ACT A 202 A 382 TRP A 82 TRP^? 14.68 O ACT B 201 coo 31.27 39.47 20.74 28.54 37.06 22.19 -25.55 70.89 71.82 -27.34 74.39 71.87 coo 30.66 36.51 25.88 33.61 35.64 28.35 -23.37 68.40 78.71 -20.56 66.90 76.39 coo 29.03 37.53 34.46 26.37 39.52 32.35 -30.38 69.86 83.05 -34.07 70.22 84.37 ULMN 3 1dnp_c00 DNA PHOTOLYASE user 3 3 # 3 A 306 TRP B 82 TRP^? 9.86 O ACT A 202 A 359 TRP A 113 TRP^? 8.12 CH3 ACT A 201 A 382 TRP A 48 TRP^? 8.95 OXT ACT A 201 coo 31.27 39.47 20.74 28.54 37.06 22.19 -23.37 68.40 78.71 -20.56 66.90 76.39 coo 30.66 36.51 25.88 33.61 35.64 28.35 -25.55 70.89 71.82 -27.34 74.39 71.87 coo 29.03 37.53 34.46 26.37 39.52 32.35 -21.95 67.01 65.30 -25.27 68.30 63.60 ULMN 3 1dnp_c00 DNA PHOTOLYASE user 4 3 # 4 A 306 TRP B 113 TRP^? 8.18 CH3 ACT B 201 A 359 TRP A 82 TRP^? 14.68 O ACT B 201 A 382 TRP B 82 TRP^? 9.86 O ACT A 202 coo 31.27 39.47 20.74 28.54 37.06 22.19 -31.63 62.84 85.81 -28.45 61.10 87.36 coo 30.66 36.51 25.88 33.61 35.64 28.35 -30.38 69.86 83.05 -34.07 70.22 84.37 coo 29.03 37.53 34.46 26.37 39.52 32.35 -23.37 68.40 78.71 -20.56 66.90 76.39 ULMN 3 1dnp_c00 DNA PHOTOLYASE user 5 3 # 5 A 306 TRP C 82 TRP^? 14.73 O ACT D 201 A 359 TRP D 113 TRP^? 8.24 CH3 ACT D 201 A 382 TRP D 48 TRP^? 8.90 O ACT D 201 coo 31.27 39.47 20.74 28.54 37.06 22.19 -49.41 47.73 38.89 -52.68 46.73 40.85 coo 30.66 36.51 25.88 33.61 35.64 28.35 -53.30 54.21 38.64 -52.86 56.34 35.35 coo 29.03 37.53 34.46 26.37 39.52 32.35 -59.58 54.71 44.23 -58.78 58.51 43.62 ULMN 3 1dnp_c00 DNA PHOTOLYASE user 6 3 # 6 A 306 TRP C 113 TRP^? 8.13 CH3 ACT C 201 A 359 TRP D 82 TRP^? 14.82 OXT ACT C 201 A 382 TRP C 82 TRP^? 14.73 O ACT D 201 coo 31.27 39.47 20.74 28.54 37.06 22.19 -37.66 48.04 42.18 -38.30 44.33 43.32 coo 30.66 36.51 25.88 33.61 35.64 28.35 -41.91 50.50 36.33 -38.54 52.46 35.78 coo 29.03 37.53 34.46 26.37 39.52 32.35 -49.41 47.73 38.89 -52.68 46.73 40.85 ULMN 3 1dnp_c00 DNA PHOTOLYASE user 7 3 # 7 A 306 TRP D 82 TRP^? 14.82 OXT ACT C 201 A 359 TRP C 113 TRP^? 8.13 CH3 ACT C 201 A 382 TRP C 48 TRP^? 8.95 OXT ACT C 201 coo 31.27 39.47 20.74 28.54 37.06 22.19 -41.91 50.50 36.33 -38.54 52.46 35.78 coo 30.66 36.51 25.88 33.61 35.64 28.35 -37.66 48.04 42.18 -38.30 44.33 43.32 coo 29.03 37.53 34.46 26.37 39.52 32.35 -30.92 52.82 43.89 -31.53 51.16 47.40 ULMN 3 1dnp_c00 DNA PHOTOLYASE user 8 3 # 8 A 306 TRP D 113 TRP^? 8.24 CH3 ACT D 201 A 359 TRP C 82 TRP^? 14.73 O ACT D 201 A 382 TRP D 82 TRP^? 14.82 OXT ACT C 201 coo 31.27 39.47 20.74 28.54 37.06 22.19 -53.30 54.21 38.64 -52.86 56.34 35.35 coo 30.66 36.51 25.88 33.61 35.64 28.35 -49.41 47.73 38.89 -52.68 46.73 40.85 coo 29.03 37.53 34.46 26.37 39.52 32.35 -41.91 50.50 36.33 -38.54 52.46 35.78 1dnp_c00 source 1dnp DNA PHOTOLYASE : 8 hits 1dnp_c00 naa= 3 ULMN 3 1dnp_c01 DNA PHOTOLYASE user 1 3 # 1 B 306 TRP A 82 TRP^? 14.68 O ACT B 201 B 359 TRP B 113 TRP^? 8.18 CH3 ACT B 201 B 382 TRP B 48 TRP^? 8.84 O ACT B 201 coo 46.11 60.68 29.45 45.44 64.17 31.12 -30.38 69.86 83.05 -34.07 70.22 84.37 coo 42.23 65.07 28.50 40.25 65.66 25.15 -31.63 62.84 85.81 -28.45 61.10 87.36 coo 33.75 67.27 29.24 35.04 65.70 32.64 -39.73 60.89 87.11 -38.13 57.34 86.55 ULMN 3 1dnp_c01 DNA PHOTOLYASE user 2 3 # 2 B 306 TRP A 113 TRP^? 8.12 CH3 ACT A 201 B 359 TRP B 82 TRP^? 9.86 O ACT A 202 B 382 TRP A 82 TRP^? 14.68 O ACT B 201 coo 46.11 60.68 29.45 45.44 64.17 31.12 -25.55 70.89 71.82 -27.34 74.39 71.87 coo 42.23 65.07 28.50 40.25 65.66 25.15 -23.37 68.40 78.71 -20.56 66.90 76.39 coo 33.75 67.27 29.24 35.04 65.70 32.64 -30.38 69.86 83.05 -34.07 70.22 84.37 ULMN 3 1dnp_c01 DNA PHOTOLYASE user 3 3 # 3 B 306 TRP B 82 TRP^? 9.86 O ACT A 202 B 359 TRP A 113 TRP^? 8.12 CH3 ACT A 201 B 382 TRP A 48 TRP^? 8.95 OXT ACT A 201 coo 46.11 60.68 29.45 45.44 64.17 31.12 -23.37 68.40 78.71 -20.56 66.90 76.39 coo 42.23 65.07 28.50 40.25 65.66 25.15 -25.55 70.89 71.82 -27.34 74.39 71.87 coo 33.75 67.27 29.24 35.04 65.70 32.64 -21.95 67.01 65.30 -25.27 68.30 63.60 ULMN 3 1dnp_c01 DNA PHOTOLYASE user 4 3 # 4 B 306 TRP B 113 TRP^? 8.18 CH3 ACT B 201 B 359 TRP A 82 TRP^? 14.68 O ACT B 201 B 382 TRP B 82 TRP^? 9.86 O ACT A 202 coo 46.11 60.68 29.45 45.44 64.17 31.12 -31.63 62.84 85.81 -28.45 61.10 87.36 coo 42.23 65.07 28.50 40.25 65.66 25.15 -30.38 69.86 83.05 -34.07 70.22 84.37 coo 33.75 67.27 29.24 35.04 65.70 32.64 -23.37 68.40 78.71 -20.56 66.90 76.39 ULMN 3 1dnp_c01 DNA PHOTOLYASE user 5 3 # 5 B 306 TRP C 82 TRP^? 14.73 O ACT D 201 B 359 TRP D 113 TRP^? 8.24 CH3 ACT D 201 B 382 TRP D 48 TRP^? 8.90 O ACT D 201 coo 46.11 60.68 29.45 45.44 64.17 31.12 -49.41 47.73 38.89 -52.68 46.73 40.85 coo 42.23 65.07 28.50 40.25 65.66 25.15 -53.30 54.21 38.64 -52.86 56.34 35.35 coo 33.75 67.27 29.24 35.04 65.70 32.64 -59.58 54.71 44.23 -58.78 58.51 43.62 ULMN 3 1dnp_c01 DNA PHOTOLYASE user 6 3 # 6 B 306 TRP C 113 TRP^? 8.13 CH3 ACT C 201 B 359 TRP D 82 TRP^? 14.82 OXT ACT C 201 B 382 TRP C 82 TRP^? 14.73 O ACT D 201 coo 46.11 60.68 29.45 45.44 64.17 31.12 -37.66 48.04 42.18 -38.30 44.33 43.32 coo 42.23 65.07 28.50 40.25 65.66 25.15 -41.91 50.50 36.33 -38.54 52.46 35.78 coo 33.75 67.27 29.24 35.04 65.70 32.64 -49.41 47.73 38.89 -52.68 46.73 40.85 ULMN 3 1dnp_c01 DNA PHOTOLYASE user 7 3 # 7 B 306 TRP D 82 TRP^? 14.82 OXT ACT C 201 B 359 TRP C 113 TRP^? 8.13 CH3 ACT C 201 B 382 TRP C 48 TRP^? 8.95 OXT ACT C 201 coo 46.11 60.68 29.45 45.44 64.17 31.12 -41.91 50.50 36.33 -38.54 52.46 35.78 coo 42.23 65.07 28.50 40.25 65.66 25.15 -37.66 48.04 42.18 -38.30 44.33 43.32 coo 33.75 67.27 29.24 35.04 65.70 32.64 -30.92 52.82 43.89 -31.53 51.16 47.40 ULMN 3 1dnp_c01 DNA PHOTOLYASE user 8 3 # 8 B 306 TRP D 113 TRP^? 8.24 CH3 ACT D 201 B 359 TRP C 82 TRP^? 14.73 O ACT D 201 B 382 TRP D 82 TRP^? 14.82 OXT ACT C 201 coo 46.11 60.68 29.45 45.44 64.17 31.12 -53.30 54.21 38.64 -52.86 56.34 35.35 coo 42.23 65.07 28.50 40.25 65.66 25.15 -49.41 47.73 38.89 -52.68 46.73 40.85 coo 33.75 67.27 29.24 35.04 65.70 32.64 -41.91 50.50 36.33 -38.54 52.46 35.78 1dnp_c01 source 1dnp DNA PHOTOLYASE : 8 hits 1dnp_c01 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 42 TYR^? 9.79 CH3 ACT A 201 A 183 LYS A 62 LYS~? 17.60 O ACT A 201 A 278 ASP A 34 ASP~? 14.63 O ACT A 201 coo 19.43 18.53 42.32 17.66 18.80 40.15 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 21.92 15.80 36.19 17.64 19.44 36.35 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 15.46 19.03 31.40 15.01 18.25 33.31 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR B 42 TYR^? 9.74 CH3 ACT B 201 A 183 LYS B 62 LYS~? 17.44 OXT ACT B 201 A 278 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 19.43 18.53 42.32 17.66 18.80 40.15 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 21.92 15.80 36.19 17.64 19.44 36.35 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 15.46 19.03 31.40 15.01 18.25 33.31 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR C 42 TYR^? 9.67 CH3 ACT C 201 A 183 LYS C 62 LYS~? 12.50 O2 EDO A 302 A 278 ASP C 34 ASP~? 14.66 O ACT C 201 coo 19.43 18.53 42.32 17.66 18.80 40.15 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 21.92 15.80 36.19 17.64 19.44 36.35 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 15.46 19.03 31.40 15.01 18.25 33.31 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1do8_c00 MALIC ENZYME user 4 3 # 4 A 112 TYR D 42 TYR^? 9.84 CH3 ACT D 201 A 183 LYS D 62 LYS~? 17.47 OXT ACT D 201 A 278 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 19.43 18.53 42.32 17.66 18.80 40.15 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 21.92 15.80 36.19 17.64 19.44 36.35 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 15.46 19.03 31.40 15.01 18.25 33.31 -62.38 69.46 37.89 -64.50 69.55 37.91 1do8_c00 source 1do8 MALIC ENZYME : 4 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 42 TYR^? 9.79 CH3 ACT A 201 B 183 LYS A 62 LYS~? 17.60 O ACT A 201 B 278 ASP A 34 ASP~? 14.63 O ACT A 201 coo 58.62 15.99 58.34 60.98 14.60 58.93 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 60.11 10.60 53.63 62.59 10.74 58.67 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 66.50 7.32 58.45 66.26 9.42 58.23 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR B 42 TYR^? 9.74 CH3 ACT B 201 B 183 LYS B 62 LYS~? 17.44 OXT ACT B 201 B 278 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 58.62 15.99 58.34 60.98 14.60 58.93 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 60.11 10.60 53.63 62.59 10.74 58.67 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 66.50 7.32 58.45 66.26 9.42 58.23 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR C 42 TYR^? 9.67 CH3 ACT C 201 B 183 LYS C 62 LYS~? 12.50 O2 EDO A 302 B 278 ASP C 34 ASP~? 14.66 O ACT C 201 coo 58.62 15.99 58.34 60.98 14.60 58.93 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 60.11 10.60 53.63 62.59 10.74 58.67 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 66.50 7.32 58.45 66.26 9.42 58.23 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR D 42 TYR^? 9.84 CH3 ACT D 201 B 183 LYS D 62 LYS~? 17.47 OXT ACT D 201 B 278 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 58.62 15.99 58.34 60.98 14.60 58.93 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 60.11 10.60 53.63 62.59 10.74 58.67 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 66.50 7.32 58.45 66.26 9.42 58.23 -62.38 69.46 37.89 -64.50 69.55 37.91 1do8_c01 source 1do8 MALIC ENZYME : 4 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 42 TYR^? 9.79 CH3 ACT A 201 C 183 LYS A 62 LYS~? 17.60 O ACT A 201 C 278 ASP A 34 ASP~? 14.63 O ACT A 201 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR B 42 TYR^? 9.74 CH3 ACT B 201 C 183 LYS B 62 LYS~? 17.44 OXT ACT B 201 C 278 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR C 42 TYR^? 9.67 CH3 ACT C 201 C 183 LYS C 62 LYS~? 12.50 O2 EDO A 302 C 278 ASP C 34 ASP~? 14.66 O ACT C 201 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1do8_c02 MALIC ENZYME user 4 3 # 4 C 112 TYR D 42 TYR^? 9.84 CH3 ACT D 201 C 183 LYS D 62 LYS~? 17.47 OXT ACT D 201 C 278 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -62.38 69.46 37.89 -64.50 69.55 37.91 1do8_c02 source 1do8 MALIC ENZYME : 4 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 42 TYR^? 9.79 CH3 ACT A 201 D 183 LYS A 62 LYS~? 17.60 O ACT A 201 D 278 ASP A 34 ASP~? 14.63 O ACT A 201 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR B 42 TYR^? 9.74 CH3 ACT B 201 D 183 LYS B 62 LYS~? 17.44 OXT ACT B 201 D 278 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR C 42 TYR^? 9.67 CH3 ACT C 201 D 183 LYS C 62 LYS~? 12.50 O2 EDO A 302 D 278 ASP C 34 ASP~? 14.66 O ACT C 201 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1do8_c03 MALIC ENZYME user 4 3 # 4 D 112 TYR D 42 TYR^? 9.84 CH3 ACT D 201 D 183 LYS D 62 LYS~? 17.47 OXT ACT D 201 D 278 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -62.38 69.46 37.89 -64.50 69.55 37.91 1do8_c03 source 1do8 MALIC ENZYME : 4 hits 1do8_c03 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 151 HIS.? 15.97 CH3 ACT A 201 E 102 ASP A 150 ASP.? 22.07 CH3 ACT A 201 E 193 GLY A 145 GLY.? 13.13 O ACT A 201 coo 11.39 26.86 25.95 9.85 26.64 27.36 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 10.90 32.83 25.96 10.83 30.68 25.98 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 4.57 20.60 30.29 4.74 21.36 30.66 -38.43 80.69 60.76 -38.91 80.43 61.42 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS B 151 HIS.? 13.45 CH3 ACT A 202 E 102 ASP B 150 ASP.? 20.21 CH3 ACT A 202 E 193 GLY B 145 GLY.? 13.34 OXT ACT B 201 coo 11.39 26.86 25.95 9.85 26.64 27.36 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 10.90 32.83 25.96 10.83 30.68 25.98 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 4.57 20.60 30.29 4.74 21.36 30.66 -25.17 44.53 88.88 -24.74 44.79 88.19 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS C 151 HIS.? 16.03 CH3 ACT C 201 E 102 ASP C 150 ASP.? 20.99 CH3 ACT C 201 E 193 GLY C 145 GLY.? 13.18 O ACT C 201 coo 11.39 26.86 25.95 9.85 26.64 27.36 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 10.90 32.83 25.96 10.83 30.68 25.98 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 4.57 20.60 30.29 4.74 21.36 30.66 -35.71 37.24 58.49 -36.57 37.39 58.47 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 4 3 # 4 E 57 HIS D 151 HIS.? 15.66 CH3 ACT D 201 E 102 ASP D 150 ASP.? 21.68 CH3 ACT D 201 E 193 GLY D 145 GLY.? 13.27 OXT ACT D 201 coo 11.39 26.86 25.95 9.85 26.64 27.36 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 10.90 32.83 25.96 10.83 30.68 25.98 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 4.57 20.60 30.29 4.74 21.36 30.66 -54.58 73.10 33.20 -53.72 72.98 33.25 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 4 hits 1ds2_c02 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 153 GLY~? 14.45 CH3 ACT A 201 B 144 GLU A 80 GLU^? 14.51 CH3 ACT A 201 B 164 GLU A 156 GLU~? 20.10 CH3 ACT A 201 coo 88.87 114.43 152.30 88.45 115.15 152.32 -40.49 79.09 75.61 -41.22 78.96 76.01 coo 85.20 111.99 152.05 86.60 110.89 150.91 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 88.14 113.46 145.73 86.79 113.92 147.30 -42.77 81.40 79.58 -42.85 83.31 78.67 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY A 153 GLY~? 14.45 CH3 ACT A 201 B 144 GLU A 156 GLU~? 20.10 CH3 ACT A 201 B 164 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo 88.87 114.43 152.30 88.45 115.15 152.32 -40.49 79.09 75.61 -41.22 78.96 76.01 coo 85.20 111.99 152.05 86.60 110.89 150.91 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 88.14 113.46 145.73 86.79 113.92 147.30 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 3 3 # 3 B 141 GLY B 153 GLY~? 9.95 CH3 ACT A 202 B 144 GLU B 156 GLU~? 12.19 CH3 ACT A 202 B 164 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 88.87 114.43 152.30 88.45 115.15 152.32 -16.29 55.07 81.81 -15.94 54.76 81.13 coo 85.20 111.99 152.05 86.60 110.89 150.91 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 88.14 113.46 145.73 86.79 113.92 147.30 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 4 3 # 4 B 141 GLY C 153 GLY~? 14.97 CH3 ACT C 201 B 144 GLU C 156 GLU~? 19.44 CH3 ACT C 201 B 164 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 88.87 114.43 152.30 88.45 115.15 152.32 -49.04 37.35 50.46 -49.67 37.47 50.95 coo 85.20 111.99 152.05 86.60 110.89 150.91 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 88.14 113.46 145.73 86.79 113.92 147.30 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 5 3 # 5 B 141 GLY D 153 GLY.? 14.87 CH3 ACT D 201 B 144 GLU D 80 GLU^? 14.49 CH3 ACT D 201 B 164 GLU D 156 GLU.? 18.36 CH3 ACT D 201 coo 88.87 114.43 152.30 88.45 115.15 152.32 -42.01 64.47 29.92 -41.35 64.91 30.11 coo 85.20 111.99 152.05 86.60 110.89 150.91 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 88.14 113.46 145.73 86.79 113.92 147.30 -37.15 64.72 28.61 -38.97 63.94 27.88 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 6 3 # 6 B 141 GLY D 153 GLY.? 14.87 CH3 ACT D 201 B 144 GLU D 156 GLU.? 18.36 CH3 ACT D 201 B 164 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo 88.87 114.43 152.30 88.45 115.15 152.32 -42.01 64.47 29.92 -41.35 64.91 30.11 coo 85.20 111.99 152.05 86.60 110.89 150.91 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 88.14 113.46 145.73 86.79 113.92 147.30 -42.96 58.73 31.72 -40.96 59.40 31.80 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 6 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 153 GLY~? 14.45 CH3 ACT A 201 C 144 GLU A 156 GLU~? 20.10 CH3 ACT A 201 C 164 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo 56.28 104.55 135.84 56.09 105.34 136.05 -40.49 79.09 75.61 -41.22 78.96 76.01 coo 58.46 103.90 139.48 57.57 102.00 139.16 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 51.71 102.03 140.09 53.02 103.62 140.54 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY B 153 GLY~? 9.95 CH3 ACT A 202 C 144 GLU B 156 GLU~? 12.19 CH3 ACT A 202 C 164 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 56.28 104.55 135.84 56.09 105.34 136.05 -16.29 55.07 81.81 -15.94 54.76 81.13 coo 58.46 103.90 139.48 57.57 102.00 139.16 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 51.71 102.03 140.09 53.02 103.62 140.54 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 3 3 # 3 C 141 GLY C 153 GLY~? 14.97 CH3 ACT C 201 C 144 GLU C 156 GLU~? 19.44 CH3 ACT C 201 C 164 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 56.28 104.55 135.84 56.09 105.34 136.05 -49.04 37.35 50.46 -49.67 37.47 50.95 coo 58.46 103.90 139.48 57.57 102.00 139.16 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 51.71 102.03 140.09 53.02 103.62 140.54 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 4 3 # 4 C 141 GLY D 153 GLY.? 14.87 CH3 ACT D 201 C 144 GLU D 80 GLU^? 14.49 CH3 ACT D 201 C 164 GLU D 156 GLU.? 18.36 CH3 ACT D 201 coo 56.28 104.55 135.84 56.09 105.34 136.05 -42.01 64.47 29.92 -41.35 64.91 30.11 coo 58.46 103.90 139.48 57.57 102.00 139.16 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 51.71 102.03 140.09 53.02 103.62 140.54 -37.15 64.72 28.61 -38.97 63.94 27.88 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 5 3 # 5 C 141 GLY D 153 GLY.? 14.87 CH3 ACT D 201 C 144 GLU D 156 GLU.? 18.36 CH3 ACT D 201 C 164 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo 56.28 104.55 135.84 56.09 105.34 136.05 -42.01 64.47 29.92 -41.35 64.91 30.11 coo 58.46 103.90 139.48 57.57 102.00 139.16 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 51.71 102.03 140.09 53.02 103.62 140.54 -42.96 58.73 31.72 -40.96 59.40 31.80 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 5 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 153 GLY~? 14.45 CH3 ACT A 201 D 144 GLU A 80 GLU^? 14.51 CH3 ACT A 201 D 164 GLU A 156 GLU~? 20.10 CH3 ACT A 201 coo 86.19 80.64 132.77 86.38 79.85 132.93 -40.49 79.09 75.61 -41.22 78.96 76.01 coo 84.75 81.24 136.88 85.62 83.14 136.43 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 91.47 83.05 136.24 90.35 81.38 136.84 -42.77 81.40 79.58 -42.85 83.31 78.67 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY A 153 GLY~? 14.45 CH3 ACT A 201 D 144 GLU A 156 GLU~? 20.10 CH3 ACT A 201 D 164 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo 86.19 80.64 132.77 86.38 79.85 132.93 -40.49 79.09 75.61 -41.22 78.96 76.01 coo 84.75 81.24 136.88 85.62 83.14 136.43 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 91.47 83.05 136.24 90.35 81.38 136.84 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 3 3 # 3 D 141 GLY B 153 GLY~? 9.95 CH3 ACT A 202 D 144 GLU B 156 GLU~? 12.19 CH3 ACT A 202 D 164 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 86.19 80.64 132.77 86.38 79.85 132.93 -16.29 55.07 81.81 -15.94 54.76 81.13 coo 84.75 81.24 136.88 85.62 83.14 136.43 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 91.47 83.05 136.24 90.35 81.38 136.84 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 4 3 # 4 D 141 GLY C 153 GLY~? 14.97 CH3 ACT C 201 D 144 GLU C 156 GLU~? 19.44 CH3 ACT C 201 D 164 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 86.19 80.64 132.77 86.38 79.85 132.93 -49.04 37.35 50.46 -49.67 37.47 50.95 coo 84.75 81.24 136.88 85.62 83.14 136.43 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 91.47 83.05 136.24 90.35 81.38 136.84 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 5 3 # 5 D 141 GLY D 153 GLY.? 14.87 CH3 ACT D 201 D 144 GLU D 80 GLU^? 14.49 CH3 ACT D 201 D 164 GLU D 156 GLU.? 18.36 CH3 ACT D 201 coo 86.19 80.64 132.77 86.38 79.85 132.93 -42.01 64.47 29.92 -41.35 64.91 30.11 coo 84.75 81.24 136.88 85.62 83.14 136.43 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 91.47 83.05 136.24 90.35 81.38 136.84 -37.15 64.72 28.61 -38.97 63.94 27.88 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 6 3 # 6 D 141 GLY D 153 GLY.? 14.87 CH3 ACT D 201 D 144 GLU D 156 GLU.? 18.36 CH3 ACT D 201 D 164 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo 86.19 80.64 132.77 86.38 79.85 132.93 -42.01 64.47 29.92 -41.35 64.91 30.11 coo 84.75 81.24 136.88 85.62 83.14 136.43 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 91.47 83.05 136.24 90.35 81.38 136.84 -42.96 58.73 31.72 -40.96 59.40 31.80 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 6 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 153 GLY~? 14.45 CH3 ACT A 201 E 144 GLU A 156 GLU~? 20.10 CH3 ACT A 201 E 164 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo 90.07 81.07 170.50 90.23 80.26 170.38 -40.49 79.09 75.61 -41.22 78.96 76.01 coo 87.05 81.30 167.53 86.38 82.74 168.94 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 84.40 80.02 173.80 85.08 79.06 172.03 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY B 153 GLY~? 9.95 CH3 ACT A 202 E 144 GLU B 156 GLU~? 12.19 CH3 ACT A 202 E 164 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 90.07 81.07 170.50 90.23 80.26 170.38 -16.29 55.07 81.81 -15.94 54.76 81.13 coo 87.05 81.30 167.53 86.38 82.74 168.94 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 84.40 80.02 173.80 85.08 79.06 172.03 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 3 3 # 3 E 141 GLY C 153 GLY~? 14.97 CH3 ACT C 201 E 144 GLU C 156 GLU~? 19.44 CH3 ACT C 201 E 164 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 90.07 81.07 170.50 90.23 80.26 170.38 -49.04 37.35 50.46 -49.67 37.47 50.95 coo 87.05 81.30 167.53 86.38 82.74 168.94 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 84.40 80.02 173.80 85.08 79.06 172.03 -48.24 40.72 45.31 -50.16 40.73 46.15 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 153 GLY~? 14.45 CH3 ACT A 201 F 144 GLU A 80 GLU^? 14.51 CH3 ACT A 201 F 164 GLU A 156 GLU~? 20.10 CH3 ACT A 201 coo 57.12 70.68 155.10 57.52 69.95 155.02 -40.49 79.09 75.61 -41.22 78.96 76.01 coo 60.62 73.13 154.21 59.05 74.26 153.35 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 56.75 71.71 148.46 58.44 71.01 149.54 -42.77 81.40 79.58 -42.85 83.31 78.67 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY A 153 GLY~? 14.45 CH3 ACT A 201 F 144 GLU A 156 GLU~? 20.10 CH3 ACT A 201 F 164 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo 57.12 70.68 155.10 57.52 69.95 155.02 -40.49 79.09 75.61 -41.22 78.96 76.01 coo 60.62 73.13 154.21 59.05 74.26 153.35 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 56.75 71.71 148.46 58.44 71.01 149.54 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 3 3 # 3 F 141 GLY B 153 GLY~? 9.95 CH3 ACT A 202 F 144 GLU B 156 GLU~? 12.19 CH3 ACT A 202 F 164 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 57.12 70.68 155.10 57.52 69.95 155.02 -16.29 55.07 81.81 -15.94 54.76 81.13 coo 60.62 73.13 154.21 59.05 74.26 153.35 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 56.75 71.71 148.46 58.44 71.01 149.54 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 4 3 # 4 F 141 GLY C 153 GLY~? 14.97 CH3 ACT C 201 F 144 GLU C 156 GLU~? 19.44 CH3 ACT C 201 F 164 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 57.12 70.68 155.10 57.52 69.95 155.02 -49.04 37.35 50.46 -49.67 37.47 50.95 coo 60.62 73.13 154.21 59.05 74.26 153.35 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 56.75 71.71 148.46 58.44 71.01 149.54 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 5 3 # 5 F 141 GLY D 153 GLY.? 14.87 CH3 ACT D 201 F 144 GLU D 80 GLU^? 14.49 CH3 ACT D 201 F 164 GLU D 156 GLU.? 18.36 CH3 ACT D 201 coo 57.12 70.68 155.10 57.52 69.95 155.02 -42.01 64.47 29.92 -41.35 64.91 30.11 coo 60.62 73.13 154.21 59.05 74.26 153.35 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 56.75 71.71 148.46 58.44 71.01 149.54 -37.15 64.72 28.61 -38.97 63.94 27.88 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 6 3 # 6 F 141 GLY D 153 GLY.? 14.87 CH3 ACT D 201 F 144 GLU D 156 GLU.? 18.36 CH3 ACT D 201 F 164 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo 57.12 70.68 155.10 57.52 69.95 155.02 -42.01 64.47 29.92 -41.35 64.91 30.11 coo 60.62 73.13 154.21 59.05 74.26 153.35 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 56.75 71.71 148.46 58.44 71.01 149.54 -42.96 58.73 31.72 -40.96 59.40 31.80 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 6 hits 1dub_c17 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 68 LYS~? -2.78 O ACT A 201s A 215 LYS C 68 LYS~? -2.77 O ACT C 201s A 277 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 0.50 24.09 51.68 1.51 29.34 52.35 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 13.06 30.79 51.73 11.40 35.76 53.48 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 13.04 31.88 60.72 10.57 35.34 57.49 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 215 LYS C 68 LYS~? -2.77 O ACT C 201s A 277 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 0.50 24.09 51.68 1.51 29.34 52.35 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 13.06 30.79 51.73 11.40 35.76 53.48 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 13.04 31.88 60.72 10.57 35.34 57.49 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS C 68 LYS~? -2.77 O ACT C 201s A 215 LYS A 68 LYS~? -2.78 O ACT A 201s A 277 LYS A 62 LYS~? 17.60 O ACT A 201 coo 0.50 24.09 51.68 1.51 29.34 52.35 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 13.06 30.79 51.73 11.40 35.76 53.48 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 13.04 31.88 60.72 10.57 35.34 57.49 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 215 LYS A 68 LYS~? -2.78 O ACT A 201s A 277 LYS A 62 LYS~? 17.60 O ACT A 201 coo 0.50 24.09 51.68 1.51 29.34 52.35 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 13.06 30.79 51.73 11.40 35.76 53.48 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 13.04 31.88 60.72 10.57 35.34 57.49 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS D 134 LYS~? 17.34 O ACT A 201 A 215 LYS A 68 LYS~? -2.78 O ACT A 201s A 277 LYS A 62 LYS~? 17.60 O ACT A 201 coo 0.50 24.09 51.68 1.51 29.34 52.35 -37.62 76.93 46.97 -33.08 76.47 49.79 coo 13.06 30.79 51.73 11.40 35.76 53.48 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 13.04 31.88 60.72 10.57 35.34 57.49 -24.69 69.09 56.72 -23.65 73.04 51.86 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 5 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 68 LYS~? -2.78 O ACT A 201s B 215 LYS C 68 LYS~? -2.77 O ACT C 201s B 277 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 6.78 45.91 16.15 7.82 40.81 15.84 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 17.88 38.77 19.81 16.38 34.23 17.24 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 20.33 37.78 11.20 16.77 34.53 13.47 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS C 68 LYS~? -2.77 O ACT C 201s B 215 LYS A 68 LYS~? -2.78 O ACT A 201s B 277 LYS A 62 LYS~? 17.60 O ACT A 201 coo 6.78 45.91 16.15 7.82 40.81 15.84 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 17.88 38.77 19.81 16.38 34.23 17.24 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 20.33 37.78 11.20 16.77 34.53 13.47 -24.69 69.09 56.72 -23.65 73.04 51.86 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 2 hits 1e19_c01 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 75 TYR^? -4.52 O ACT A 201s A 40 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 103 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 95 TYR^? -3.85 O ACT A 201s A 40 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 103 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 40 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 103 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 40 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 103 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR C 75 TYR^? -4.54 O ACT C 201s A 40 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 103 ASP C 74 ASP^? 14.86 O ACT C 201 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR C 95 TYR^? -3.84 O ACT C 201s A 40 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 103 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 40 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 103 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 40 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 103 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -44.22 66.27 50.20 -46.22 65.66 49.92 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 8 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 75 TYR^? -4.52 O ACT A 201s B 40 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 103 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 95 TYR^? -3.85 O ACT A 201s B 40 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 103 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 108 TYR^? 12.28 O ACT A 201 B 40 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 103 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 75 TYR^? -4.59 OXT ACT B 201s B 40 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 103 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR B 95 TYR^? -3.87 OXT ACT B 201s B 40 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 103 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR C 75 TYR^? -4.54 O ACT C 201s B 40 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 103 ASP C 74 ASP^? 14.86 O ACT C 201 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR C 95 TYR^? -3.84 O ACT C 201s B 40 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 103 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR C 108 TYR^? 12.28 O ACT C 201 B 40 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 103 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -49.57 50.97 53.11 -51.32 50.02 55.06 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR D 75 TYR^? -4.49 OXT ACT D 201s B 40 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 103 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR D 95 TYR^? -3.79 OXT ACT D 201s B 40 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 103 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -44.22 66.27 50.20 -46.22 65.66 49.92 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 10 hits 1e3v_c03 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS A 161 HIS.? 19.24 O ACT B 201 B 43 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 65 GLU B 53 GLU^? 11.09 O ACT B 201 coo 20.15 22.08 34.36 20.84 20.10 34.21 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 19.55 18.91 30.27 18.21 18.65 31.84 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 10.90 21.31 28.81 12.14 22.15 30.31 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 43 HIS A 161 HIS.? 19.24 O ACT B 201 B 65 GLU A 160 GLU.? 13.50 O ACT A 201 coo 20.15 22.08 34.36 20.84 20.10 34.21 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 19.55 18.91 30.27 18.21 18.65 31.84 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 10.90 21.31 28.81 12.14 22.15 30.31 -45.30 71.21 75.74 -44.17 71.89 74.09 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 3 3 # 3 B 41 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 43 HIS A 161 HIS.? 19.24 O ACT B 201 B 65 GLU B 53 GLU^? 11.09 O ACT B 201 coo 20.15 22.08 34.36 20.84 20.10 34.21 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 19.55 18.91 30.27 18.21 18.65 31.84 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 10.90 21.31 28.81 12.14 22.15 30.31 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 4 3 # 4 B 41 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 43 HIS B 141 HIS.? 15.94 CH3 ACT A 202 B 65 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 20.15 22.08 34.36 20.84 20.10 34.21 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 19.55 18.91 30.27 18.21 18.65 31.84 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 10.90 21.31 28.81 12.14 22.15 30.31 -24.44 47.78 75.39 -22.51 46.98 75.05 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 4 hits 1e7l_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 35 SER A 101 SER.? 7.80 O2 EDO A 301 A 218 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 47.22 22.34 8.57 45.16 22.02 9.13 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 43.58 20.85 5.15 44.62 23.01 5.76 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 44.05 16.99 12.67 44.05 18.89 11.74 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 35 SER B 101 SER.? 19.25 O ACT C 201 A 218 ASP C 74 ASP^? 14.86 O ACT C 201 coo 47.22 22.34 8.57 45.16 22.02 9.13 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 43.58 20.85 5.15 44.62 23.01 5.76 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 44.05 16.99 12.67 44.05 18.89 11.74 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 3 3 # 3 A 32 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 35 SER C 101 SER.? 7.85 O1 EDO A 301 A 218 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 47.22 22.34 8.57 45.16 22.02 9.13 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 43.58 20.85 5.15 44.62 23.01 5.76 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 44.05 16.99 12.67 44.05 18.89 11.74 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 4 3 # 4 A 32 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 35 SER D 101 SER.? 9.16 OXT ACT A 203 A 218 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 47.22 22.34 8.57 45.16 22.02 9.13 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 43.58 20.85 5.15 44.62 23.01 5.76 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 44.05 16.99 12.67 44.05 18.89 11.74 -44.71 72.29 58.72 -45.62 72.95 56.93 1eag_c04 source 1eag PEPTIDE INHIBITOR : 4 hits 1eag_c04 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 207 LYS A 68 LYS~? -2.78 O ACT A 201s A 366 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 207 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 366 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 3 3 # 3 A 205 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 207 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 366 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 4 3 # 4 A 205 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 207 LYS C 68 LYS~? -2.77 O ACT C 201s A 366 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 5 3 # 5 A 205 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 207 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 366 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 6 3 # 6 A 205 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 207 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 366 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -52.87 78.07 53.10 -52.52 76.84 54.77 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 6 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 207 LYS A 68 LYS~? -2.78 O ACT A 201s B 366 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 207 LYS A 68 LYS~? -2.78 O ACT A 201s B 366 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 3 3 # 3 B 205 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 207 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 366 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 4 3 # 4 B 205 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 207 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 366 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 5 3 # 5 B 205 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 207 LYS C 68 LYS~? -2.77 O ACT C 201s B 366 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 6 3 # 6 B 205 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 207 LYS C 68 LYS~? -2.77 O ACT C 201s B 366 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 7 3 # 7 B 205 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 207 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 366 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 8 3 # 8 B 205 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 207 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 366 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -52.87 78.07 53.10 -52.52 76.84 54.77 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 8 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS A 71 LYS~? 4.32 C2 EDO A 301 C 207 LYS A 68 LYS~? -2.78 O ACT A 201s C 366 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 2 3 # 2 C 205 LYS B 71 LYS~? 10.83 OXT ACT B 201 C 207 LYS B 68 LYS~? -2.79 OXT ACT B 201s C 366 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 3 3 # 3 C 205 LYS B 71 LYS~? 10.83 OXT ACT B 201 C 207 LYS B 68 LYS~? -2.79 OXT ACT B 201s C 366 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 4 3 # 4 C 205 LYS C 71 LYS~? 4.19 C1 EDO A 301 C 207 LYS C 68 LYS~? -2.77 O ACT C 201s C 366 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 5 3 # 5 C 205 LYS D 71 LYS~? -3.20 CH3 ACT A 203s C 207 LYS D 68 LYS~? -2.80 OXT ACT D 201s C 366 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 6 3 # 6 C 205 LYS D 71 LYS~? -3.20 CH3 ACT A 203s C 207 LYS D 68 LYS~? -2.80 OXT ACT D 201s C 366 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -52.87 78.07 53.10 -52.52 76.84 54.77 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 6 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS A 71 LYS~? 4.32 C2 EDO A 301 D 207 LYS A 68 LYS~? -2.78 O ACT A 201s D 366 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 2 3 # 2 D 205 LYS B 71 LYS~? 10.83 OXT ACT B 201 D 207 LYS B 68 LYS~? -2.79 OXT ACT B 201s D 366 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 3 3 # 3 D 205 LYS B 71 LYS~? 10.83 OXT ACT B 201 D 207 LYS B 68 LYS~? -2.79 OXT ACT B 201s D 366 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 4 3 # 4 D 205 LYS C 71 LYS~? 4.19 C1 EDO A 301 D 207 LYS C 68 LYS~? -2.77 O ACT C 201s D 366 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 5 3 # 5 D 205 LYS D 71 LYS~? -3.20 CH3 ACT A 203s D 207 LYS D 68 LYS~? -2.80 OXT ACT D 201s D 366 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 6 3 # 6 D 205 LYS D 71 LYS~? -3.20 CH3 ACT A 203s D 207 LYS D 68 LYS~? -2.80 OXT ACT D 201s D 366 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -52.87 78.07 53.10 -52.52 76.84 54.77 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 6 hits 1ec9_c07 naa= 3 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 1 3 # 1 A 1 CYH A 127 CYH.? 6.15 O ACT A 202 A 101 ASN B 110 ASN^? 6.46 O ACT A 202 A 102 GLY B 109 GLY^? 6.82 O ACT B 201 coo 71.16 56.96 42.22 68.62 58.09 42.46 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 72.93 61.40 42.14 73.34 60.57 44.12 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 70.24 64.11 45.02 69.59 63.75 44.65 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 2 3 # 2 A 1 CYH A 127 CYH.? 6.15 O ACT A 202 A 101 ASN B 129 ASN.? 9.80 OXT ACT A 201 A 102 GLY B 109 GLY^? 6.82 O ACT B 201 coo 71.16 56.96 42.22 68.62 58.09 42.46 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 72.93 61.40 42.14 73.34 60.57 44.12 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 70.24 64.11 45.02 69.59 63.75 44.65 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 3 3 # 3 A 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 A 101 ASN A 110 ASN^? 10.87 O ACT B 201 A 102 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 71.16 56.96 42.22 68.62 58.09 42.46 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 72.93 61.40 42.14 73.34 60.57 44.12 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 70.24 64.11 45.02 69.59 63.75 44.65 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 4 3 # 4 A 1 CYH C 127 CYH.? 10.01 O ACT D 201 A 101 ASN D 110 ASN^? 10.92 OXT ACT C 201 A 102 GLY D 109 GLY^? 6.89 O ACT D 201 coo 71.16 56.96 42.22 68.62 58.09 42.46 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 72.93 61.40 42.14 73.34 60.57 44.12 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 70.24 64.11 45.02 69.59 63.75 44.65 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 5 3 # 5 A 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 A 101 ASN C 110 ASN^? 10.92 O ACT D 201 A 102 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 71.16 56.96 42.22 68.62 58.09 42.46 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 72.93 61.40 42.14 73.34 60.57 44.12 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 70.24 64.11 45.02 69.59 63.75 44.65 -44.99 51.38 49.22 -45.52 50.84 49.05 1ecf_c00 source 1ecf GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRA: 5 hits 1ecf_c00 naa= 3 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 1 3 # 1 B 1 CYH A 127 CYH.? 6.15 O ACT A 202 B 101 ASN B 110 ASN^? 6.46 O ACT A 202 B 102 GLY B 109 GLY^? 6.82 O ACT B 201 coo 75.18 21.70 37.98 75.10 20.53 35.34 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 75.17 17.26 39.63 77.17 18.02 39.88 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 77.89 14.61 36.82 77.45 14.93 36.19 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 2 3 # 2 B 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 B 101 ASN A 110 ASN^? 10.87 O ACT B 201 B 102 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 75.18 21.70 37.98 75.10 20.53 35.34 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 75.17 17.26 39.63 77.17 18.02 39.88 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 77.89 14.61 36.82 77.45 14.93 36.19 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 3 3 # 3 B 1 CYH C 127 CYH.? 10.01 O ACT D 201 B 101 ASN D 110 ASN^? 10.92 OXT ACT C 201 B 102 GLY D 109 GLY^? 6.89 O ACT D 201 coo 75.18 21.70 37.98 75.10 20.53 35.34 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 75.17 17.26 39.63 77.17 18.02 39.88 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 77.89 14.61 36.82 77.45 14.93 36.19 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 4 3 # 4 B 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 B 101 ASN C 110 ASN^? 10.92 O ACT D 201 B 102 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 75.18 21.70 37.98 75.10 20.53 35.34 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 75.17 17.26 39.63 77.17 18.02 39.88 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 77.89 14.61 36.82 77.45 14.93 36.19 -44.99 51.38 49.22 -45.52 50.84 49.05 1ecf_c01 source 1ecf GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRA: 4 hits 1ecf_c01 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 56 HIS.? 6.76 O1 EDO A 302 A 177 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 203 LYS A 62 LYS~? 17.60 O ACT A 201 coo 8.74 45.76 47.19 9.33 46.93 45.56 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 11.68 42.31 52.96 12.05 43.92 51.65 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 18.07 52.81 49.62 14.17 49.99 48.07 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS A 98 HIS^? -3.60 C ACT A 203s A 177 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 203 LYS A 68 LYS~? -2.78 O ACT A 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 11.68 42.31 52.96 12.05 43.92 51.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 18.07 52.81 49.62 14.17 49.99 48.07 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS A 98 HIS^? -3.60 C ACT A 203s A 177 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 203 LYS A 134 LYS~? 11.98 O ACT A 203 coo 8.74 45.76 47.19 9.33 46.93 45.56 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 11.68 42.31 52.96 12.05 43.92 51.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 18.07 52.81 49.62 14.17 49.99 48.07 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 4 3 # 4 A 99 HIS A 98 HIS^? -3.60 C ACT A 203s A 177 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 203 LYS A 68 LYS~? -2.78 O ACT A 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 11.68 42.31 52.96 12.05 43.92 51.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 18.07 52.81 49.62 14.17 49.99 48.07 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 5 3 # 5 A 99 HIS A 98 HIS^? -3.60 C ACT A 203s A 177 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 203 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 8.74 45.76 47.19 9.33 46.93 45.56 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 11.68 42.31 52.96 12.05 43.92 51.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 18.07 52.81 49.62 14.17 49.99 48.07 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 6 3 # 6 A 99 HIS A 98 HIS^? -3.60 C ACT A 203s A 177 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 203 LYS A 68 LYS~? -2.78 O ACT A 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 11.68 42.31 52.96 12.05 43.92 51.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 18.07 52.81 49.62 14.17 49.99 48.07 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 7 3 # 7 A 99 HIS A 98 HIS^? -3.60 C ACT A 203s A 177 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 203 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 8.74 45.76 47.19 9.33 46.93 45.56 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 11.68 42.31 52.96 12.05 43.92 51.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 18.07 52.81 49.62 14.17 49.99 48.07 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 8 3 # 8 A 99 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 177 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 203 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 11.68 42.31 52.96 12.05 43.92 51.65 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 18.07 52.81 49.62 14.17 49.99 48.07 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 9 3 # 9 A 99 HIS B 56 HIS.? 17.31 O ACT B 201 A 177 ASP B 45 ASP^? 20.35 O ACT B 201 A 203 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo 8.74 45.76 47.19 9.33 46.93 45.56 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 11.68 42.31 52.96 12.05 43.92 51.65 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 18.07 52.81 49.62 14.17 49.99 48.07 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 10 3 # 10 A 99 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 177 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 203 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 11.68 42.31 52.96 12.05 43.92 51.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 18.07 52.81 49.62 14.17 49.99 48.07 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 11 3 # 11 A 99 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 177 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 203 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 8.74 45.76 47.19 9.33 46.93 45.56 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 11.68 42.31 52.96 12.05 43.92 51.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 18.07 52.81 49.62 14.17 49.99 48.07 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 12 3 # 12 A 99 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 177 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 203 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 11.68 42.31 52.96 12.05 43.92 51.65 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 18.07 52.81 49.62 14.17 49.99 48.07 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 13 3 # 13 A 99 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 177 ASP B 149 ASP.? 20.03 CH3 ACT B 201 A 203 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 11.68 42.31 52.96 12.05 43.92 51.65 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 18.07 52.81 49.62 14.17 49.99 48.07 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 14 3 # 14 A 99 HIS C 56 HIS.? 17.26 OXT ACT C 201 A 177 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 203 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 8.74 45.76 47.19 9.33 46.93 45.56 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 11.68 42.31 52.96 12.05 43.92 51.65 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 18.07 52.81 49.62 14.17 49.99 48.07 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 15 3 # 15 A 99 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 177 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 203 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 8.74 45.76 47.19 9.33 46.93 45.56 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 11.68 42.31 52.96 12.05 43.92 51.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 18.07 52.81 49.62 14.17 49.99 48.07 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 16 3 # 16 A 99 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 177 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 203 LYS C 68 LYS~? -2.77 O ACT C 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 11.68 42.31 52.96 12.05 43.92 51.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 18.07 52.81 49.62 14.17 49.99 48.07 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 17 3 # 17 A 99 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 177 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 203 LYS C 68 LYS~? -2.77 O ACT C 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 11.68 42.31 52.96 12.05 43.92 51.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 18.07 52.81 49.62 14.17 49.99 48.07 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 18 3 # 18 A 99 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 177 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 203 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 8.74 45.76 47.19 9.33 46.93 45.56 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 11.68 42.31 52.96 12.05 43.92 51.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 18.07 52.81 49.62 14.17 49.99 48.07 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 19 3 # 19 A 99 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 177 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 203 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 8.74 45.76 47.19 9.33 46.93 45.56 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 11.68 42.31 52.96 12.05 43.92 51.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 18.07 52.81 49.62 14.17 49.99 48.07 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 20 3 # 20 A 99 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 177 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 203 LYS C 68 LYS~? -2.77 O ACT C 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 11.68 42.31 52.96 12.05 43.92 51.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 18.07 52.81 49.62 14.17 49.99 48.07 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 21 3 # 21 A 99 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 177 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 203 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 11.68 42.31 52.96 12.05 43.92 51.65 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 18.07 52.81 49.62 14.17 49.99 48.07 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 22 3 # 22 A 99 HIS D 56 HIS.? 17.26 O ACT D 201 A 177 ASP D 45 ASP^? 20.33 O ACT D 201 A 203 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo 8.74 45.76 47.19 9.33 46.93 45.56 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 11.68 42.31 52.96 12.05 43.92 51.65 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 18.07 52.81 49.62 14.17 49.99 48.07 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 23 3 # 23 A 99 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 177 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 203 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 11.68 42.31 52.96 12.05 43.92 51.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 18.07 52.81 49.62 14.17 49.99 48.07 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 24 3 # 24 A 99 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 177 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 203 LYS D 134 LYS~? 17.34 O ACT A 201 coo 8.74 45.76 47.19 9.33 46.93 45.56 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 11.68 42.31 52.96 12.05 43.92 51.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 18.07 52.81 49.62 14.17 49.99 48.07 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 25 3 # 25 A 99 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 177 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 203 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 11.68 42.31 52.96 12.05 43.92 51.65 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 18.07 52.81 49.62 14.17 49.99 48.07 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 26 3 # 26 A 99 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 177 ASP D 149 ASP.? 20.02 CH3 ACT D 201 A 203 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 8.74 45.76 47.19 9.33 46.93 45.56 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 11.68 42.31 52.96 12.05 43.92 51.65 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 18.07 52.81 49.62 14.17 49.99 48.07 -47.37 61.41 34.65 -51.85 60.71 37.83 1ecx_c02 source 1ecx AMINOTRANSFERASE : 26 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 56 HIS.? 6.76 O1 EDO A 302 B 177 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 203 LYS A 62 LYS~? 17.60 O ACT A 201 coo 14.87 88.04 21.51 13.64 87.90 19.81 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 15.87 92.46 27.37 14.46 91.76 25.94 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 3.60 91.42 23.52 8.20 89.55 22.63 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS A 98 HIS^? -3.60 C ACT A 203s B 177 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 203 LYS A 68 LYS~? -2.78 O ACT A 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 15.87 92.46 27.37 14.46 91.76 25.94 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 3.60 91.42 23.52 8.20 89.55 22.63 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS A 98 HIS^? -3.60 C ACT A 203s B 177 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 203 LYS A 134 LYS~? 11.98 O ACT A 203 coo 14.87 88.04 21.51 13.64 87.90 19.81 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 15.87 92.46 27.37 14.46 91.76 25.94 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 3.60 91.42 23.52 8.20 89.55 22.63 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 4 3 # 4 B 99 HIS A 98 HIS^? -3.60 C ACT A 203s B 177 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 203 LYS A 68 LYS~? -2.78 O ACT A 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 15.87 92.46 27.37 14.46 91.76 25.94 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 3.60 91.42 23.52 8.20 89.55 22.63 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 5 3 # 5 B 99 HIS A 98 HIS^? -3.60 C ACT A 203s B 177 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 203 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 14.87 88.04 21.51 13.64 87.90 19.81 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 15.87 92.46 27.37 14.46 91.76 25.94 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 3.60 91.42 23.52 8.20 89.55 22.63 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 6 3 # 6 B 99 HIS A 98 HIS^? -3.60 C ACT A 203s B 177 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 203 LYS A 68 LYS~? -2.78 O ACT A 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 15.87 92.46 27.37 14.46 91.76 25.94 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 3.60 91.42 23.52 8.20 89.55 22.63 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 7 3 # 7 B 99 HIS A 98 HIS^? -3.60 C ACT A 203s B 177 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 203 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 14.87 88.04 21.51 13.64 87.90 19.81 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 15.87 92.46 27.37 14.46 91.76 25.94 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 3.60 91.42 23.52 8.20 89.55 22.63 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 8 3 # 8 B 99 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 177 ASP A 149 ASP.? 18.85 CH3 ACT A 201 B 203 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 15.87 92.46 27.37 14.46 91.76 25.94 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 3.60 91.42 23.52 8.20 89.55 22.63 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 9 3 # 9 B 99 HIS B 56 HIS.? 17.31 O ACT B 201 B 177 ASP B 45 ASP^? 20.35 O ACT B 201 B 203 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo 14.87 88.04 21.51 13.64 87.90 19.81 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 15.87 92.46 27.37 14.46 91.76 25.94 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 3.60 91.42 23.52 8.20 89.55 22.63 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 10 3 # 10 B 99 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 177 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 203 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 15.87 92.46 27.37 14.46 91.76 25.94 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 3.60 91.42 23.52 8.20 89.55 22.63 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 11 3 # 11 B 99 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 177 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 203 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 14.87 88.04 21.51 13.64 87.90 19.81 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 15.87 92.46 27.37 14.46 91.76 25.94 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 3.60 91.42 23.52 8.20 89.55 22.63 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 12 3 # 12 B 99 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 177 ASP B 100 ASP.? 15.93 OXT ACT B 201 B 203 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 15.87 92.46 27.37 14.46 91.76 25.94 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 3.60 91.42 23.52 8.20 89.55 22.63 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 13 3 # 13 B 99 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 177 ASP B 149 ASP.? 20.03 CH3 ACT B 201 B 203 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 15.87 92.46 27.37 14.46 91.76 25.94 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 3.60 91.42 23.52 8.20 89.55 22.63 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 14 3 # 14 B 99 HIS C 56 HIS.? 17.26 OXT ACT C 201 B 177 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 203 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 14.87 88.04 21.51 13.64 87.90 19.81 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 15.87 92.46 27.37 14.46 91.76 25.94 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 3.60 91.42 23.52 8.20 89.55 22.63 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 15 3 # 15 B 99 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 177 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 203 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 14.87 88.04 21.51 13.64 87.90 19.81 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 15.87 92.46 27.37 14.46 91.76 25.94 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 3.60 91.42 23.52 8.20 89.55 22.63 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 16 3 # 16 B 99 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 177 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 203 LYS C 68 LYS~? -2.77 O ACT C 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 15.87 92.46 27.37 14.46 91.76 25.94 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 3.60 91.42 23.52 8.20 89.55 22.63 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 17 3 # 17 B 99 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 177 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 203 LYS C 68 LYS~? -2.77 O ACT C 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 15.87 92.46 27.37 14.46 91.76 25.94 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 3.60 91.42 23.52 8.20 89.55 22.63 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 18 3 # 18 B 99 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 177 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 203 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 14.87 88.04 21.51 13.64 87.90 19.81 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 15.87 92.46 27.37 14.46 91.76 25.94 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 3.60 91.42 23.52 8.20 89.55 22.63 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 19 3 # 19 B 99 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 177 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 203 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 14.87 88.04 21.51 13.64 87.90 19.81 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 15.87 92.46 27.37 14.46 91.76 25.94 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 3.60 91.42 23.52 8.20 89.55 22.63 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 20 3 # 20 B 99 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 177 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 203 LYS C 68 LYS~? -2.77 O ACT C 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 15.87 92.46 27.37 14.46 91.76 25.94 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 3.60 91.42 23.52 8.20 89.55 22.63 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 21 3 # 21 B 99 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 177 ASP C 149 ASP.? 18.79 CH3 ACT C 201 B 203 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 15.87 92.46 27.37 14.46 91.76 25.94 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 3.60 91.42 23.52 8.20 89.55 22.63 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 22 3 # 22 B 99 HIS D 56 HIS.? 17.26 O ACT D 201 B 177 ASP D 45 ASP^? 20.33 O ACT D 201 B 203 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo 14.87 88.04 21.51 13.64 87.90 19.81 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 15.87 92.46 27.37 14.46 91.76 25.94 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 3.60 91.42 23.52 8.20 89.55 22.63 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 23 3 # 23 B 99 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 177 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 203 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 15.87 92.46 27.37 14.46 91.76 25.94 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 3.60 91.42 23.52 8.20 89.55 22.63 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 24 3 # 24 B 99 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 177 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 203 LYS D 134 LYS~? 17.34 O ACT A 201 coo 14.87 88.04 21.51 13.64 87.90 19.81 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 15.87 92.46 27.37 14.46 91.76 25.94 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 3.60 91.42 23.52 8.20 89.55 22.63 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 25 3 # 25 B 99 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 177 ASP D 100 ASP.? 7.94 OXT ACT A 203 B 203 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 15.87 92.46 27.37 14.46 91.76 25.94 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 3.60 91.42 23.52 8.20 89.55 22.63 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 26 3 # 26 B 99 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 177 ASP D 149 ASP.? 20.02 CH3 ACT D 201 B 203 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 14.87 88.04 21.51 13.64 87.90 19.81 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 15.87 92.46 27.37 14.46 91.76 25.94 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 3.60 91.42 23.52 8.20 89.55 22.63 -47.37 61.41 34.65 -51.85 60.71 37.83 1ecx_c03 source 1ecx AMINOTRANSFERASE : 26 hits 1ecx_c03 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP A 99 ASP.? 5.71 O2 EDO A 301 P 35 SER A 101 SER.? 7.80 O2 EDO A 301 P 215 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 10.15 33.41 11.98 7.98 33.66 12.07 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 7.57 37.60 10.00 8.86 37.02 12.03 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 4.04 29.97 8.82 4.78 31.15 10.46 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 3 # 2 P 32 ASP B 99 ASP.? 16.09 OXT ACT B 201 P 35 SER B 101 SER.? 19.25 O ACT C 201 P 215 ASP C 74 ASP^? 14.86 O ACT C 201 coo 10.15 33.41 11.98 7.98 33.66 12.07 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 7.57 37.60 10.00 8.86 37.02 12.03 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 4.04 29.97 8.82 4.78 31.15 10.46 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 3 3 # 3 P 32 ASP C 99 ASP.? 5.79 O1 EDO A 301 P 35 SER C 101 SER.? 7.85 O1 EDO A 301 P 215 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 10.15 33.41 11.98 7.98 33.66 12.07 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 7.57 37.60 10.00 8.86 37.02 12.03 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 4.04 29.97 8.82 4.78 31.15 10.46 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 4 3 # 4 P 32 ASP D 99 ASP.? 7.94 CH3 ACT A 203 P 35 SER D 101 SER.? 9.16 OXT ACT A 203 P 215 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 10.15 33.41 11.98 7.98 33.66 12.07 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 7.57 37.60 10.00 8.86 37.02 12.03 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 4.04 29.97 8.82 4.78 31.15 10.46 -44.71 72.29 58.72 -45.62 72.95 56.93 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 4 hits 1eed_c04 naa= 3 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 A 107 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 246 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 275 HIS A 98 HIS^? -3.60 C ACT A 203s coo 28.44 37.56 46.79 26.87 37.11 48.10 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 22.84 50.35 52.24 23.24 48.32 52.90 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 26.67 42.94 48.26 27.49 41.07 48.73 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 A 107 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 246 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 275 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 22.84 50.35 52.24 23.24 48.32 52.90 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 26.67 42.94 48.26 27.49 41.07 48.73 -40.81 49.03 67.16 -39.15 48.14 68.10 1ehy_c00 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 2 hits 1ehy_c00 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 246 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 275 HIS A 98 HIS^? -3.60 C ACT A 203s coo 34.84 56.77 81.62 34.95 54.74 82.03 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 43.18 49.30 68.39 44.75 49.87 69.78 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 38.73 55.10 77.62 36.80 55.01 78.46 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 246 ASP D 100 ASP.? 7.94 OXT ACT A 203 B 275 HIS A 98 HIS^? -3.60 C ACT A 203s coo 34.84 56.77 81.62 34.95 54.74 82.03 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 43.18 49.30 68.39 44.75 49.87 69.78 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 38.73 55.10 77.62 36.80 55.01 78.46 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 B 107 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 246 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 275 HIS A 98 HIS^? -3.60 C ACT A 203s coo 34.84 56.77 81.62 34.95 54.74 82.03 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 43.18 49.30 68.39 44.75 49.87 69.78 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 38.73 55.10 77.62 36.80 55.01 78.46 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 B 107 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 246 ASP D 100 ASP.? 7.94 OXT ACT A 203 B 275 HIS A 98 HIS^? -3.60 C ACT A 203s coo 34.84 56.77 81.62 34.95 54.74 82.03 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 43.18 49.30 68.39 44.75 49.87 69.78 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 38.73 55.10 77.62 36.80 55.01 78.46 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 B 107 ASP C 74 ASP^? 14.86 O ACT C 201 B 246 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 275 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 34.84 56.77 81.62 34.95 54.74 82.03 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 43.18 49.30 68.39 44.75 49.87 69.78 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 38.73 55.10 77.62 36.80 55.01 78.46 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 B 107 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 246 ASP B 100 ASP.? 15.93 OXT ACT B 201 B 275 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 34.84 56.77 81.62 34.95 54.74 82.03 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 43.18 49.30 68.39 44.75 49.87 69.78 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 38.73 55.10 77.62 36.80 55.01 78.46 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 B 107 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 246 ASP B 100 ASP.? 15.93 OXT ACT B 201 B 275 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 34.84 56.77 81.62 34.95 54.74 82.03 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 43.18 49.30 68.39 44.75 49.87 69.78 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 38.73 55.10 77.62 36.80 55.01 78.46 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 B 107 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 246 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 275 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 34.84 56.77 81.62 34.95 54.74 82.03 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 43.18 49.30 68.39 44.75 49.87 69.78 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 38.73 55.10 77.62 36.80 55.01 78.46 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 B 107 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 246 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 275 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo 34.84 56.77 81.62 34.95 54.74 82.03 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 43.18 49.30 68.39 44.75 49.87 69.78 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 38.73 55.10 77.62 36.80 55.01 78.46 -48.48 77.63 46.64 -50.12 78.90 46.30 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 9 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 246 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 275 HIS A 98 HIS^? -3.60 C ACT A 203s coo 1.90 35.26 72.76 3.20 35.74 71.18 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 12.03 20.33 71.56 10.48 19.25 70.56 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 3.92 29.96 71.75 4.22 31.96 72.31 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 246 ASP D 100 ASP.? 7.94 OXT ACT A 203 C 275 HIS A 98 HIS^? -3.60 C ACT A 203s coo 1.90 35.26 72.76 3.20 35.74 71.18 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 12.03 20.33 71.56 10.48 19.25 70.56 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 3.92 29.96 71.75 4.22 31.96 72.31 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 C 107 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 246 ASP D 100 ASP.? 7.94 OXT ACT A 203 C 275 HIS A 98 HIS^? -3.60 C ACT A 203s coo 1.90 35.26 72.76 3.20 35.74 71.18 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 12.03 20.33 71.56 10.48 19.25 70.56 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 3.92 29.96 71.75 4.22 31.96 72.31 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 C 107 ASP B 74 ASP^? 14.88 OXT ACT B 201 C 246 ASP C 74 ASP^? 14.86 O ACT C 201 C 275 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo 1.90 35.26 72.76 3.20 35.74 71.18 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 12.03 20.33 71.56 10.48 19.25 70.56 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 3.92 29.96 71.75 4.22 31.96 72.31 -30.93 39.91 75.36 -31.53 38.49 76.78 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 C 107 ASP C 74 ASP^? 14.86 O ACT C 201 C 246 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 275 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 1.90 35.26 72.76 3.20 35.74 71.18 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 12.03 20.33 71.56 10.48 19.25 70.56 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 3.92 29.96 71.75 4.22 31.96 72.31 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 C 107 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 246 ASP B 100 ASP.? 15.93 OXT ACT B 201 C 275 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 1.90 35.26 72.76 3.20 35.74 71.18 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 12.03 20.33 71.56 10.48 19.25 70.56 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 3.92 29.96 71.75 4.22 31.96 72.31 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 C 107 ASP D 74 ASP^? 14.85 OXT ACT D 201 C 246 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 275 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo 1.90 35.26 72.76 3.20 35.74 71.18 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 12.03 20.33 71.56 10.48 19.25 70.56 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 3.92 29.96 71.75 4.22 31.96 72.31 -48.48 77.63 46.64 -50.12 78.90 46.30 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 7 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 246 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 275 HIS A 98 HIS^? -3.60 C ACT A 203s coo 37.41 19.89 81.58 37.64 21.98 81.53 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 23.50 26.43 88.52 24.76 26.47 90.29 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 33.16 21.44 85.29 34.07 21.53 83.40 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 D 107 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 246 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 275 HIS A 98 HIS^? -3.60 C ACT A 203s coo 37.41 19.89 81.58 37.64 21.98 81.53 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 23.50 26.43 88.52 24.76 26.47 90.29 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 33.16 21.44 85.29 34.07 21.53 83.40 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 D 107 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 246 ASP D 100 ASP.? 7.94 OXT ACT A 203 D 275 HIS A 98 HIS^? -3.60 C ACT A 203s coo 37.41 19.89 81.58 37.64 21.98 81.53 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 23.50 26.43 88.52 24.76 26.47 90.29 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 33.16 21.44 85.29 34.07 21.53 83.40 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 D 107 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 246 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 275 HIS A 98 HIS^? -3.60 C ACT A 203s coo 37.41 19.89 81.58 37.64 21.98 81.53 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 23.50 26.43 88.52 24.76 26.47 90.29 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 33.16 21.44 85.29 34.07 21.53 83.40 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 D 107 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 246 ASP D 100 ASP.? 7.94 OXT ACT A 203 D 275 HIS A 98 HIS^? -3.60 C ACT A 203s coo 37.41 19.89 81.58 37.64 21.98 81.53 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 23.50 26.43 88.52 24.76 26.47 90.29 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 33.16 21.44 85.29 34.07 21.53 83.40 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 D 107 ASP B 150 ASP.? 20.21 CH3 ACT A 202 D 246 ASP B 28 ASP~? 12.70 CH3 ACT B 201 D 275 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo 37.41 19.89 81.58 37.64 21.98 81.53 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 23.50 26.43 88.52 24.76 26.47 90.29 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 33.16 21.44 85.29 34.07 21.53 83.40 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 D 107 ASP C 74 ASP^? 14.86 O ACT C 201 D 246 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 275 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 37.41 19.89 81.58 37.64 21.98 81.53 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 23.50 26.43 88.52 24.76 26.47 90.29 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 33.16 21.44 85.29 34.07 21.53 83.40 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 D 107 ASP C 74 ASP^? 14.86 O ACT C 201 D 246 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 275 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 37.41 19.89 81.58 37.64 21.98 81.53 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 23.50 26.43 88.52 24.76 26.47 90.29 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 33.16 21.44 85.29 34.07 21.53 83.40 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 D 107 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 246 ASP B 100 ASP.? 15.93 OXT ACT B 201 D 275 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 37.41 19.89 81.58 37.64 21.98 81.53 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 23.50 26.43 88.52 24.76 26.47 90.29 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 33.16 21.44 85.29 34.07 21.53 83.40 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 10 3 # 10 D 107 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 246 ASP B 100 ASP.? 15.93 OXT ACT B 201 D 275 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 37.41 19.89 81.58 37.64 21.98 81.53 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 23.50 26.43 88.52 24.76 26.47 90.29 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 33.16 21.44 85.29 34.07 21.53 83.40 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 11 3 # 11 D 107 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 246 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 275 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 37.41 19.89 81.58 37.64 21.98 81.53 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 23.50 26.43 88.52 24.76 26.47 90.29 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 33.16 21.44 85.29 34.07 21.53 83.40 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 12 3 # 12 D 107 ASP D 150 ASP.? 21.68 CH3 ACT D 201 D 246 ASP D 28 ASP~? 12.70 CH3 ACT D 201 D 275 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo 37.41 19.89 81.58 37.64 21.98 81.53 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 23.50 26.43 88.52 24.76 26.47 90.29 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 33.16 21.44 85.29 34.07 21.53 83.40 -44.04 70.63 29.61 -43.01 70.81 31.43 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 12 hits 1ehy_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 56 HIS.? 6.76 O1 EDO A 302 A 197 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 223 LYS A 62 LYS~? 17.60 O ACT A 201 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS A 98 HIS^? -3.60 C ACT A 203s A 197 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 223 LYS A 68 LYS~? -2.78 O ACT A 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS A 98 HIS^? -3.60 C ACT A 203s A 197 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 223 LYS A 68 LYS~? -2.78 O ACT A 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS A 98 HIS^? -3.60 C ACT A 203s A 197 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 223 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 A 114 HIS A 98 HIS^? -3.60 C ACT A 203s A 197 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 223 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 A 114 HIS A 98 HIS^? -3.60 C ACT A 203s A 197 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 223 LYS A 68 LYS~? -2.78 O ACT A 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 A 114 HIS A 98 HIS^? -3.60 C ACT A 203s A 197 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 223 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 A 114 HIS A 98 HIS^? -3.60 C ACT A 203s A 197 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 223 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 A 114 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 197 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 223 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -43.83 81.49 70.61 -45.02 79.78 70.42 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -38.64 88.42 71.14 -36.90 88.52 69.95 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 A 114 HIS B 56 HIS.? 17.31 O ACT B 201 A 197 ASP B 45 ASP^? 20.35 O ACT B 201 A 223 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 A 114 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 197 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 223 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 A 114 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 197 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 223 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 13 3 # 13 A 114 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 197 ASP B 149 ASP.? 20.03 CH3 ACT B 201 A 223 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -16.30 48.49 82.95 -17.03 48.20 81.01 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -13.67 50.22 91.33 -14.75 50.15 93.16 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 14 3 # 14 A 114 HIS C 56 HIS.? 17.26 OXT ACT C 201 A 197 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 223 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -26.71 60.26 42.75 -28.06 61.81 43.18 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 15 3 # 15 A 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 197 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 223 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 16 3 # 16 A 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 197 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 223 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 17 3 # 17 A 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 197 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 223 LYS C 68 LYS~? -2.77 O ACT C 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 18 3 # 18 A 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 197 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 223 LYS C 68 LYS~? -2.77 O ACT C 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 19 3 # 19 A 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 197 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 223 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 20 3 # 20 A 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 197 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 223 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 21 3 # 21 A 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 197 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 223 LYS C 68 LYS~? -2.77 O ACT C 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 22 3 # 22 A 114 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 197 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 223 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -46.81 35.18 56.40 -47.74 36.88 57.21 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -42.93 29.00 51.56 -40.94 29.30 50.94 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 23 3 # 23 A 114 HIS D 56 HIS.? 17.26 O ACT D 201 A 197 ASP D 45 ASP^? 20.33 O ACT D 201 A 223 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 24 3 # 24 A 114 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 197 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 223 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 25 3 # 25 A 114 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 197 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 223 LYS D 134 LYS~? 17.34 O ACT A 201 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 26 3 # 26 A 114 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 197 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 223 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 27 3 # 27 A 114 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 197 ASP D 149 ASP.? 20.02 CH3 ACT D 201 A 223 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -44.04 70.63 29.61 -43.01 70.81 31.43 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -48.61 69.27 22.33 -50.68 68.95 22.00 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -47.37 61.41 34.65 -51.85 60.71 37.83 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 27 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 56 HIS.? 6.76 O1 EDO A 302 B 197 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 223 LYS A 62 LYS~? 17.60 O ACT A 201 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS A 98 HIS^? -3.60 C ACT A 203s B 197 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 223 LYS A 68 LYS~? -2.78 O ACT A 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS A 98 HIS^? -3.60 C ACT A 203s B 197 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 223 LYS A 68 LYS~? -2.78 O ACT A 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 B 114 HIS A 98 HIS^? -3.60 C ACT A 203s B 197 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 223 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 B 114 HIS A 98 HIS^? -3.60 C ACT A 203s B 197 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 223 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 B 114 HIS A 98 HIS^? -3.60 C ACT A 203s B 197 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 223 LYS A 68 LYS~? -2.78 O ACT A 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 B 114 HIS A 98 HIS^? -3.60 C ACT A 203s B 197 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 223 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 B 114 HIS A 98 HIS^? -3.60 C ACT A 203s B 197 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 223 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 B 114 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 197 ASP A 149 ASP.? 18.85 CH3 ACT A 201 B 223 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -43.83 81.49 70.61 -45.02 79.78 70.42 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -38.64 88.42 71.14 -36.90 88.52 69.95 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 B 114 HIS B 56 HIS.? 17.31 O ACT B 201 B 197 ASP B 45 ASP^? 20.35 O ACT B 201 B 223 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 B 114 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 197 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 223 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 B 114 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 197 ASP B 100 ASP.? 15.93 OXT ACT B 201 B 223 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 13 3 # 13 B 114 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 197 ASP B 149 ASP.? 20.03 CH3 ACT B 201 B 223 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -16.30 48.49 82.95 -17.03 48.20 81.01 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -13.67 50.22 91.33 -14.75 50.15 93.16 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 14 3 # 14 B 114 HIS C 56 HIS.? 17.26 OXT ACT C 201 B 197 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 223 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -26.71 60.26 42.75 -28.06 61.81 43.18 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 15 3 # 15 B 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 197 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 223 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 16 3 # 16 B 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 197 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 223 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 17 3 # 17 B 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 197 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 223 LYS C 68 LYS~? -2.77 O ACT C 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 18 3 # 18 B 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 197 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 223 LYS C 68 LYS~? -2.77 O ACT C 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 19 3 # 19 B 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 197 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 223 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 20 3 # 20 B 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 197 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 223 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 21 3 # 21 B 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 197 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 223 LYS C 68 LYS~? -2.77 O ACT C 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 22 3 # 22 B 114 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 197 ASP C 149 ASP.? 18.79 CH3 ACT C 201 B 223 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -46.81 35.18 56.40 -47.74 36.88 57.21 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -42.93 29.00 51.56 -40.94 29.30 50.94 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 23 3 # 23 B 114 HIS D 56 HIS.? 17.26 O ACT D 201 B 197 ASP D 45 ASP^? 20.33 O ACT D 201 B 223 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 24 3 # 24 B 114 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 197 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 223 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 25 3 # 25 B 114 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 197 ASP D 100 ASP.? 7.94 OXT ACT A 203 B 223 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 26 3 # 26 B 114 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 197 ASP D 149 ASP.? 20.02 CH3 ACT D 201 B 223 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -44.04 70.63 29.61 -43.01 70.81 31.43 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -48.61 69.27 22.33 -50.68 68.95 22.00 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -47.37 61.41 34.65 -51.85 60.71 37.83 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 26 hits 1elq_c03 naa= 3 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 3 # 1 150 ASP A 74 ASP^? 5.73 OXT ACT A 203 153 ARG A 76 ARG^? 8.97 OXT ACT A 203 177 HIS A 98 HIS^? -3.60 C ACT A 203s coo 6.83 2.75 19.17 7.40 0.75 19.11 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 3 # 2 150 ASP A 74 ASP^? 5.73 OXT ACT A 203 153 ARG A 138 ARG~? 6.49 OXT ACT A 203 177 HIS A 98 HIS^? -3.60 C ACT A 203s coo 6.83 2.75 19.17 7.40 0.75 19.11 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 3 3 # 3 150 ASP A 100 ASP.? 9.07 O2 EDO A 301 153 ARG D 51 ARG.? 7.60 O ACT D 201 177 HIS A 98 HIS^? -3.60 C ACT A 203s coo 6.83 2.75 19.17 7.40 0.75 19.11 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 4 3 # 4 150 ASP B 74 ASP^? 14.88 OXT ACT B 201 153 ARG B 76 ARG^? 14.33 OXT ACT B 201 177 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo 6.83 2.75 19.17 7.40 0.75 19.11 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -30.93 39.91 75.36 -31.53 38.49 76.78 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 5 3 # 5 150 ASP B 74 ASP^? 14.88 OXT ACT B 201 153 ARG B 138 ARG~? 16.35 OXT ACT B 201 177 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo 6.83 2.75 19.17 7.40 0.75 19.11 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -30.93 39.91 75.36 -31.53 38.49 76.78 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 6 3 # 6 150 ASP C 74 ASP^? 14.86 O ACT C 201 153 ARG C 138 ARG~? 16.31 O ACT C 201 177 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 6.83 2.75 19.17 7.40 0.75 19.11 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 7 3 # 7 150 ASP C 100 ASP.? 9.05 C1 EDO A 301 153 ARG B 51 ARG.? 7.67 O ACT B 201 177 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 6.83 2.75 19.17 7.40 0.75 19.11 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 8 3 # 8 150 ASP D 74 ASP^? 14.85 OXT ACT D 201 153 ARG D 138 ARG~? 16.38 OXT ACT D 201 177 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo 6.83 2.75 19.17 7.40 0.75 19.11 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -48.48 77.63 46.64 -50.12 78.90 46.30 1emd_c01 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 8 hits 1emd_c01 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 52 ALA.? 7.92 O2 EDO A 302 A 257 ALA C 70 ALA~? 7.91 O2 EDO A 302 A 328 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 -28.67 56.33 66.41 -29.48 55.05 66.20 coo 43.22 26.73 5.37 41.81 27.09 5.79 -30.85 51.65 62.62 -29.67 52.60 62.50 coo 38.17 34.10 6.67 37.72 32.06 6.84 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 61 ALA~? 11.27 OXT ACT A 201 A 257 ALA A 55 ALA^? 10.63 O1 EDO A 302 A 328 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo 39.84 24.12 8.44 38.50 24.23 9.11 -23.47 66.96 59.63 -22.85 67.97 60.60 coo 43.22 26.73 5.37 41.81 27.09 5.79 -21.44 62.27 61.83 -22.27 63.55 61.72 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 70 ALA~? 12.37 C2 EDO A 301 A 257 ALA C 52 ALA.? 12.19 C2 EDO A 301 A 328 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 -36.52 66.89 53.48 -35.54 66.12 52.61 coo 43.22 26.73 5.37 41.81 27.09 5.79 -37.45 62.38 49.17 -37.97 63.55 50.01 coo 38.17 34.10 6.67 37.72 32.06 6.84 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 70 ALA~? 12.37 C2 EDO A 301 A 257 ALA C 52 ALA.? 12.19 C2 EDO A 301 A 328 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 39.84 24.12 8.44 38.50 24.23 9.11 -36.52 66.89 53.48 -35.54 66.12 52.61 coo 43.22 26.73 5.37 41.81 27.09 5.79 -37.45 62.38 49.17 -37.97 63.55 50.01 coo 38.17 34.10 6.67 37.72 32.06 6.84 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 83 ALA^? 17.38 O ACT A 202 A 257 ALA B 83 ALA^? 14.78 O ACT A 202 A 328 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 39.84 24.12 8.44 38.50 24.23 9.11 -27.44 73.39 82.90 -27.14 72.16 83.76 coo 43.22 26.73 5.37 41.81 27.09 5.79 -22.66 69.42 83.24 -23.04 70.52 82.25 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA A 90 ALA^? 13.57 O ACT A 202 A 257 ALA B 83 ALA^? 14.78 O ACT A 202 A 328 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 39.84 24.12 8.44 38.50 24.23 9.11 -27.00 70.90 78.40 -27.10 70.23 79.75 coo 43.22 26.73 5.37 41.81 27.09 5.79 -22.66 69.42 83.24 -23.04 70.52 82.25 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA B 5 ALA.? 18.71 CH3 ACT B 201 A 257 ALA B 41 ALA.? 11.62 CH3 ACT B 201 A 328 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -37.78 58.32 101.20 -36.54 58.26 100.29 coo 43.22 26.73 5.37 41.81 27.09 5.79 -34.48 57.97 94.75 -33.37 57.61 93.78 coo 38.17 34.10 6.67 37.72 32.06 6.84 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA B 61 ALA~? 11.33 O ACT B 201 A 257 ALA B 55 ALA^? 12.04 O ACT B 201 A 328 ASP B 45 ASP^? 20.35 O ACT B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -42.38 55.75 87.87 -41.49 56.65 88.72 coo 43.22 26.73 5.37 41.81 27.09 5.79 -44.97 59.71 84.97 -43.80 58.86 85.49 coo 38.17 34.10 6.67 37.72 32.06 6.84 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA B 83 ALA^? 14.78 O ACT A 202 A 257 ALA A 83 ALA^? 17.38 O ACT A 202 A 328 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -22.66 69.42 83.24 -23.04 70.52 82.25 coo 43.22 26.73 5.37 41.81 27.09 5.79 -27.44 73.39 82.90 -27.14 72.16 83.76 coo 38.17 34.10 6.67 37.72 32.06 6.84 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA B 90 ALA^? 13.05 O ACT A 202 A 257 ALA A 83 ALA^? 17.38 O ACT A 202 A 328 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -27.07 66.85 82.98 -26.70 67.91 81.96 coo 43.22 26.73 5.37 41.81 27.09 5.79 -27.44 73.39 82.90 -27.14 72.16 83.76 coo 38.17 34.10 6.67 37.72 32.06 6.84 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA C 52 ALA.? 12.19 C2 EDO A 301 A 257 ALA A 70 ALA~? 12.37 C2 EDO A 301 A 328 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 -37.45 62.38 49.17 -37.97 63.55 50.01 coo 43.22 26.73 5.37 41.81 27.09 5.79 -36.52 66.89 53.48 -35.54 66.12 52.61 coo 38.17 34.10 6.67 37.72 32.06 6.84 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA C 61 ALA~? 11.19 OXT ACT C 201 A 257 ALA C 55 ALA^? 12.11 OXT ACT C 201 A 328 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -27.55 53.08 48.63 -27.85 52.13 47.47 coo 43.22 26.73 5.37 41.81 27.09 5.79 -28.67 57.83 45.93 -28.88 56.47 46.57 coo 38.17 34.10 6.67 37.72 32.06 6.84 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA C 70 ALA~? 7.91 O2 EDO A 302 A 257 ALA A 52 ALA.? 7.92 O2 EDO A 302 A 328 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -30.85 51.65 62.62 -29.67 52.60 62.50 coo 43.22 26.73 5.37 41.81 27.09 5.79 -28.67 56.33 66.41 -29.48 55.05 66.20 coo 38.17 34.10 6.67 37.72 32.06 6.84 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA C 70 ALA~? 7.91 O2 EDO A 302 A 257 ALA A 52 ALA.? 7.92 O2 EDO A 302 A 328 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 -30.85 51.65 62.62 -29.67 52.60 62.50 coo 43.22 26.73 5.37 41.81 27.09 5.79 -28.67 56.33 66.41 -29.48 55.05 66.20 coo 38.17 34.10 6.67 37.72 32.06 6.84 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA C 83 ALA^? 17.61 CH3 ACT C 201 A 257 ALA D 83 ALA^? 17.67 CH3 ACT D 201 A 328 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -46.94 44.62 36.49 -47.62 45.79 35.79 coo 43.22 26.73 5.37 41.81 27.09 5.79 -44.75 49.33 32.86 -44.08 48.27 33.71 coo 38.17 34.10 6.67 37.72 32.06 6.84 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 16 3 # 16 A 229 ALA C 90 ALA^? 13.74 CH3 ACT C 201 A 257 ALA D 83 ALA^? 17.67 CH3 ACT D 201 A 328 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -43.56 47.44 39.16 -44.76 48.04 38.47 coo 43.22 26.73 5.37 41.81 27.09 5.79 -44.75 49.33 32.86 -44.08 48.27 33.71 coo 38.17 34.10 6.67 37.72 32.06 6.84 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 17 3 # 17 A 229 ALA D 61 ALA~? 11.20 O ACT D 201 A 257 ALA D 55 ALA^? 12.06 O ACT D 201 A 328 ASP D 45 ASP^? 20.33 O ACT D 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -62.57 59.32 46.16 -62.47 58.52 44.86 coo 43.22 26.73 5.37 41.81 27.09 5.79 -61.44 55.28 49.65 -61.24 56.24 48.48 coo 38.17 34.10 6.67 37.72 32.06 6.84 -67.68 49.50 43.87 -67.26 48.38 42.12 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 18 3 # 18 A 229 ALA D 83 ALA^? 17.67 CH3 ACT D 201 A 257 ALA C 83 ALA^? 17.61 CH3 ACT C 201 A 328 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -44.75 49.33 32.86 -44.08 48.27 33.71 coo 43.22 26.73 5.37 41.81 27.09 5.79 -46.94 44.62 36.49 -47.62 45.79 35.79 coo 38.17 34.10 6.67 37.72 32.06 6.84 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 19 3 # 19 A 229 ALA D 90 ALA^? 13.83 CH3 ACT D 201 A 257 ALA C 83 ALA^? 17.61 CH3 ACT C 201 A 328 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 39.84 24.12 8.44 38.50 24.23 9.11 -47.67 51.24 36.64 -46.49 50.32 36.92 coo 43.22 26.73 5.37 41.81 27.09 5.79 -46.94 44.62 36.49 -47.62 45.79 35.79 coo 38.17 34.10 6.67 37.72 32.06 6.84 -53.41 42.17 31.38 -52.32 40.44 30.82 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 19 hits 1eo7_c00 naa= 3 ULMN 3 1esc_c00 ESTERASE user 1 3 # 1 14 SER B 101 SER.? 19.25 O ACT C 201 280 TRP B 97 TRP^? 8.79 OXT ACT B 201 283 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -30.93 39.91 75.36 -31.53 38.49 76.78 ULMN 3 1esc_c00 ESTERASE user 2 3 # 2 14 SER D 101 SER.? 9.16 OXT ACT A 203 280 TRP D 97 TRP^? 8.35 CH3 ACT A 203 283 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -48.48 77.63 46.64 -50.12 78.90 46.30 1esc_c00 source 1esc ESTERASE : 2 hits 1esc_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 15 THR~? 22.99 CH3 ACT A 201 A 159 LYS A 22 LYS~? 15.35 CH3 ACT A 201 A 193 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -22.30 82.34 82.17 -21.83 84.42 81.76 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -25.90 80.72 72.77 -21.11 80.01 70.15 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 15 THR~? 22.99 CH3 ACT A 201 A 159 LYS A 22 LYS~? 15.35 CH3 ACT A 201 A 193 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -22.30 82.34 82.17 -21.83 84.42 81.76 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -25.90 80.72 72.77 -21.11 80.01 70.15 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR A 43 THR^? 16.05 OXT ACT A 202 A 159 LYS A 62 LYS~? 17.60 O ACT A 201 A 193 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -16.17 72.65 63.81 -15.51 71.79 65.68 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -24.69 69.09 56.72 -23.65 73.04 51.86 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR B 15 THR~? 23.10 CH3 ACT B 201 A 159 LYS B 22 LYS~? 15.43 CH3 ACT B 201 A 193 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -19.99 70.45 93.36 -19.15 70.03 95.31 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -24.70 61.49 92.69 -28.99 62.66 95.83 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR B 15 THR~? 23.10 CH3 ACT B 201 A 159 LYS B 22 LYS~? 15.43 CH3 ACT B 201 A 193 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -19.99 70.45 93.36 -19.15 70.03 95.31 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -24.70 61.49 92.69 -28.99 62.66 95.83 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR B 43 THR^? 17.03 O ACT B 201 A 159 LYS B 62 LYS~? 17.44 OXT ACT B 201 A 193 GLU B 53 GLU^? 11.09 O ACT B 201 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -39.88 62.28 95.16 -39.68 64.27 94.34 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -42.04 52.32 89.45 -42.77 48.33 94.37 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 38 THR C 15 THR~? 22.98 CH3 ACT C 201 A 159 LYS C 22 LYS~? 15.34 CH3 ACT C 201 A 193 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -42.08 36.63 32.38 -41.24 34.66 32.12 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -37.27 38.20 41.22 -32.34 39.66 39.29 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 38 THR C 15 THR~? 22.98 CH3 ACT C 201 A 159 LYS C 22 LYS~? 15.34 CH3 ACT C 201 A 193 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -42.08 36.63 32.38 -41.24 34.66 32.12 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -37.27 38.20 41.22 -32.34 39.66 39.29 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 38 THR C 43 THR^? 17.19 CH3 ACT C 201 A 159 LYS C 62 LYS~? 12.50 O2 EDO A 302 A 193 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -25.42 48.08 40.00 -26.53 48.88 38.33 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -25.76 50.99 51.27 -20.80 47.54 53.29 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 38 THR D 15 THR~? 23.13 CH3 ACT D 201 A 159 LYS D 22 LYS~? 15.49 CH3 ACT D 201 A 193 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -50.62 48.08 24.29 -51.63 48.51 22.43 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -54.47 56.23 29.06 -59.33 54.04 30.24 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -42.96 58.73 31.72 -40.96 59.40 31.80 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 11 3 # 11 A 38 THR D 15 THR~? 23.13 CH3 ACT D 201 A 159 LYS D 22 LYS~? 15.49 CH3 ACT D 201 A 193 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -50.62 48.08 24.29 -51.63 48.51 22.43 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -54.47 56.23 29.06 -59.33 54.04 30.24 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 12 3 # 12 A 38 THR D 46 THR^? 13.15 O ACT D 201 A 159 LYS D 62 LYS~? 17.47 OXT ACT D 201 A 193 GLU D 53 GLU^? 10.32 O ACT A 203 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -63.51 52.01 43.24 -62.49 53.88 42.85 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -64.21 62.59 45.12 -69.12 65.87 42.83 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -56.60 59.52 53.75 -57.18 61.28 52.77 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 12 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 74 ASP^? 5.73 OXT ACT A 203 260 GLU A 72 GLU~? 5.31 O ACT A 201 370 TYR A 95 TYR^? -3.85 O ACT A 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP A 74 ASP^? 5.73 OXT ACT A 203 260 GLU A 96 GLU^? 11.70 OXT ACT A 203 370 TYR A 95 TYR^? -3.85 O ACT A 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP A 100 ASP.? 9.07 O2 EDO A 301 260 GLU D 72 GLU~? 5.29 OXT ACT D 201 370 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP A 130 ASP.? 4.80 O1 EDO A 301 260 GLU A 72 GLU~? 5.31 O ACT A 201 370 TYR A 75 TYR^? -4.52 O ACT A 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1euu_c00 SIALIDASE user 5 3 # 5 92 ASP A 130 ASP.? 4.80 O1 EDO A 301 260 GLU A 96 GLU^? 11.70 OXT ACT A 203 370 TYR A 75 TYR^? -4.52 O ACT A 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1euu_c00 SIALIDASE user 6 3 # 6 92 ASP B 74 ASP^? 14.88 OXT ACT B 201 260 GLU B 72 GLU~? 5.30 OXT ACT B 201 370 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1euu_c00 SIALIDASE user 7 3 # 7 92 ASP B 74 ASP^? 14.88 OXT ACT B 201 260 GLU B 96 GLU^? 10.60 C1 EDO A 302 370 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1euu_c00 SIALIDASE user 8 3 # 8 92 ASP B 99 ASP.? 16.09 OXT ACT B 201 260 GLU B 96 GLU^? 10.60 C1 EDO A 302 370 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1euu_c00 SIALIDASE user 9 3 # 9 92 ASP B 99 ASP.? 16.09 OXT ACT B 201 260 GLU B 96 GLU^? 10.60 C1 EDO A 302 370 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1euu_c00 SIALIDASE user 10 3 # 10 92 ASP B 130 ASP.? 9.25 OXT ACT B 201 260 GLU B 96 GLU^? 10.60 C1 EDO A 302 370 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1euu_c00 SIALIDASE user 11 3 # 11 92 ASP C 74 ASP^? 14.86 O ACT C 201 260 GLU C 72 GLU~? 5.32 O ACT C 201 370 TYR C 95 TYR^? -3.84 O ACT C 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1euu_c00 SIALIDASE user 12 3 # 12 92 ASP C 74 ASP^? 14.86 O ACT C 201 260 GLU C 96 GLU^? 13.00 O ACT C 201 370 TYR C 95 TYR^? -3.84 O ACT C 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1euu_c00 SIALIDASE user 13 3 # 13 92 ASP C 100 ASP.? 9.05 C1 EDO A 301 260 GLU B 72 GLU~? 5.30 OXT ACT B 201 370 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1euu_c00 SIALIDASE user 14 3 # 14 92 ASP C 130 ASP.? 4.74 O2 EDO A 301 260 GLU C 72 GLU~? 5.32 O ACT C 201 370 TYR C 75 TYR^? -4.54 O ACT C 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1euu_c00 SIALIDASE user 15 3 # 15 92 ASP C 130 ASP.? 4.74 O2 EDO A 301 260 GLU C 96 GLU^? 13.00 O ACT C 201 370 TYR C 75 TYR^? -4.54 O ACT C 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1euu_c00 SIALIDASE user 16 3 # 16 92 ASP D 74 ASP^? 14.85 OXT ACT D 201 260 GLU D 72 GLU~? 5.29 OXT ACT D 201 370 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1euu_c00 SIALIDASE user 17 3 # 17 92 ASP D 74 ASP^? 14.85 OXT ACT D 201 260 GLU D 96 GLU^? 13.00 OXT ACT D 201 370 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1euu_c00 SIALIDASE user 18 3 # 18 92 ASP D 130 ASP.? 7.40 CH3 ACT A 203 260 GLU D 96 GLU^? 13.00 OXT ACT D 201 370 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -52.06 69.71 41.47 -52.08 66.98 40.85 1euu_c00 source 1euu SIALIDASE : 18 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 17 GLU~? 23.86 CH3 ACT A 201 A 260 ARG A 146 ARG.? 16.48 CH3 ACT A 201 A 270 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -26.80 87.18 79.85 -26.18 89.13 80.39 coo 39.80 27.50 22.98 42.20 26.56 21.34 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 48.83 21.70 19.50 47.44 24.99 15.25 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 260 ARG A 8 ARG.? 15.23 CH3 ACT A 201 A 270 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 39.80 27.50 22.98 42.20 26.56 21.34 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 48.83 21.70 19.50 47.44 24.99 15.25 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU A 36 GLU~? 17.83 CH3 ACT A 201 A 260 ARG A 67 ARG~? 13.20 O2 EDO A 302 A 270 LYS A 62 LYS~? 17.60 O ACT A 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 39.80 27.50 22.98 42.20 26.56 21.34 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 48.83 21.70 19.50 47.44 24.99 15.25 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU A 36 GLU~? 17.83 CH3 ACT A 201 A 260 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 270 LYS A 62 LYS~? 17.60 O ACT A 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 39.80 27.50 22.98 42.20 26.56 21.34 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 48.83 21.70 19.50 47.44 24.99 15.25 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 260 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 270 LYS A 68 LYS~? -2.78 O ACT A 201s coo 50.99 29.43 12.86 52.11 29.45 14.65 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 39.80 27.50 22.98 42.20 26.56 21.34 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 48.83 21.70 19.50 47.44 24.99 15.25 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 260 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 270 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 50.99 29.43 12.86 52.11 29.45 14.65 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 39.80 27.50 22.98 42.20 26.56 21.34 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 48.83 21.70 19.50 47.44 24.99 15.25 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 7 3 # 7 A 34 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 260 ARG A 146 ARG.? 16.48 CH3 ACT A 201 A 270 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 39.80 27.50 22.98 42.20 26.56 21.34 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 48.83 21.70 19.50 47.44 24.99 15.25 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 8 3 # 8 A 34 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 260 ARG A 8 ARG.? 15.23 CH3 ACT A 201 A 270 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 39.80 27.50 22.98 42.20 26.56 21.34 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 48.83 21.70 19.50 47.44 24.99 15.25 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 9 3 # 9 A 34 GLU A 156 GLU~? 20.10 CH3 ACT A 201 A 260 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 270 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 50.99 29.43 12.86 52.11 29.45 14.65 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 39.80 27.50 22.98 42.20 26.56 21.34 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 48.83 21.70 19.50 47.44 24.99 15.25 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 10 3 # 10 A 34 GLU A 156 GLU~? 20.10 CH3 ACT A 201 A 260 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 270 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 50.99 29.43 12.86 52.11 29.45 14.65 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 39.80 27.50 22.98 42.20 26.56 21.34 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 48.83 21.70 19.50 47.44 24.99 15.25 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 11 3 # 11 A 34 GLU A 156 GLU~? 20.10 CH3 ACT A 201 A 260 ARG A 146 ARG.? 16.48 CH3 ACT A 201 A 270 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 50.99 29.43 12.86 52.11 29.45 14.65 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 39.80 27.50 22.98 42.20 26.56 21.34 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 48.83 21.70 19.50 47.44 24.99 15.25 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 12 3 # 12 A 34 GLU B 17 GLU~? 23.60 CH3 ACT B 201 A 260 ARG B 146 ARG.? 16.58 CH3 ACT B 201 A 270 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -16.26 64.60 95.04 -14.82 64.68 96.59 coo 39.80 27.50 22.98 42.20 26.56 21.34 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 48.83 21.70 19.50 47.44 24.99 15.25 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 13 3 # 13 A 34 GLU B 36 GLU~? 17.47 CH3 ACT B 201 A 260 ARG B 67 ARG~? 13.55 O ACT B 201 A 270 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 39.80 27.50 22.98 42.20 26.56 21.34 -45.57 49.20 81.23 -45.93 51.82 82.79 coo 48.83 21.70 19.50 47.44 24.99 15.25 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 14 3 # 14 A 34 GLU B 36 GLU~? 17.47 CH3 ACT B 201 A 260 ARG B 124 ARG.? -3.52 O ACT B 201s A 270 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 39.80 27.50 22.98 42.20 26.56 21.34 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 48.83 21.70 19.50 47.44 24.99 15.25 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 15 3 # 15 A 34 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 260 ARG B 124 ARG.? -3.52 O ACT B 201s A 270 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 39.80 27.50 22.98 42.20 26.56 21.34 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 48.83 21.70 19.50 47.44 24.99 15.25 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 16 3 # 16 A 34 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 260 ARG B 146 ARG.? 16.58 CH3 ACT B 201 A 270 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 39.80 27.50 22.98 42.20 26.56 21.34 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 48.83 21.70 19.50 47.44 24.99 15.25 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 17 3 # 17 A 34 GLU B 156 GLU~? 12.19 CH3 ACT A 202 A 260 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 270 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 50.99 29.43 12.86 52.11 29.45 14.65 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 39.80 27.50 22.98 42.20 26.56 21.34 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 48.83 21.70 19.50 47.44 24.99 15.25 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 18 3 # 18 A 34 GLU B 156 GLU~? 12.19 CH3 ACT A 202 A 260 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 270 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 50.99 29.43 12.86 52.11 29.45 14.65 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 39.80 27.50 22.98 42.20 26.56 21.34 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 48.83 21.70 19.50 47.44 24.99 15.25 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 19 3 # 19 A 34 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 260 ARG C 8 ARG.? 14.74 CH3 ACT C 201 A 270 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 39.80 27.50 22.98 42.20 26.56 21.34 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 48.83 21.70 19.50 47.44 24.99 15.25 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 20 3 # 20 A 34 GLU C 36 GLU~? 15.95 O2 EDO A 302 A 260 ARG C 67 ARG~? 12.50 O2 EDO A 302 A 270 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 50.99 29.43 12.86 52.11 29.45 14.65 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 39.80 27.50 22.98 42.20 26.56 21.34 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 48.83 21.70 19.50 47.44 24.99 15.25 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 21 3 # 21 A 34 GLU C 36 GLU~? 15.95 O2 EDO A 302 A 260 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 270 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 50.99 29.43 12.86 52.11 29.45 14.65 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 39.80 27.50 22.98 42.20 26.56 21.34 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 48.83 21.70 19.50 47.44 24.99 15.25 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 22 3 # 22 A 34 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 260 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 270 LYS A 68 LYS~? -2.78 O ACT A 201s coo 50.99 29.43 12.86 52.11 29.45 14.65 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 39.80 27.50 22.98 42.20 26.56 21.34 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 48.83 21.70 19.50 47.44 24.99 15.25 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 23 3 # 23 A 34 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 260 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 270 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 50.99 29.43 12.86 52.11 29.45 14.65 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 39.80 27.50 22.98 42.20 26.56 21.34 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 48.83 21.70 19.50 47.44 24.99 15.25 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 24 3 # 24 A 34 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 260 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 270 LYS C 68 LYS~? -2.77 O ACT C 201s coo 50.99 29.43 12.86 52.11 29.45 14.65 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 39.80 27.50 22.98 42.20 26.56 21.34 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 48.83 21.70 19.50 47.44 24.99 15.25 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 25 3 # 25 A 34 GLU C 80 GLU^? 14.47 CH3 ACT C 201 A 260 ARG C 146 ARG.? 16.63 CH3 ACT C 201 A 270 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 39.80 27.50 22.98 42.20 26.56 21.34 -36.58 32.85 52.68 -38.87 31.31 51.32 coo 48.83 21.70 19.50 47.44 24.99 15.25 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 26 3 # 26 A 34 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 260 ARG C 8 ARG.? 14.74 CH3 ACT C 201 A 270 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 39.80 27.50 22.98 42.20 26.56 21.34 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 48.83 21.70 19.50 47.44 24.99 15.25 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 27 3 # 27 A 34 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 260 ARG C 16 ARG~? 20.89 CH3 ACT C 201 A 270 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 39.80 27.50 22.98 42.20 26.56 21.34 -48.56 36.19 35.88 -49.41 34.92 38.55 coo 48.83 21.70 19.50 47.44 24.99 15.25 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 28 3 # 28 A 34 GLU C 156 GLU~? 19.44 CH3 ACT C 201 A 260 ARG C 76 ARG^? 14.32 O ACT C 201 A 270 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 50.99 29.43 12.86 52.11 29.45 14.65 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 39.80 27.50 22.98 42.20 26.56 21.34 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 48.83 21.70 19.50 47.44 24.99 15.25 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 29 3 # 29 A 34 GLU C 156 GLU~? 19.44 CH3 ACT C 201 A 260 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 270 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 50.99 29.43 12.86 52.11 29.45 14.65 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 39.80 27.50 22.98 42.20 26.56 21.34 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 48.83 21.70 19.50 47.44 24.99 15.25 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 30 3 # 30 A 34 GLU D 17 GLU~? 23.59 CH3 ACT D 201 A 260 ARG D 146 ARG.? 16.60 CH3 ACT D 201 A 270 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -50.49 54.35 20.83 -50.89 54.35 18.75 coo 39.80 27.50 22.98 42.20 26.56 21.34 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 48.83 21.70 19.50 47.44 24.99 15.25 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 31 3 # 31 A 34 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 260 ARG D 8 ARG.? 14.56 CH3 ACT D 201 A 270 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 39.80 27.50 22.98 42.20 26.56 21.34 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 48.83 21.70 19.50 47.44 24.99 15.25 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 32 3 # 32 A 34 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 260 ARG D 67 ARG~? 13.15 O ACT A 203 A 270 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 39.80 27.50 22.98 42.20 26.56 21.34 -60.60 65.68 53.30 -61.45 62.86 52.44 coo 48.83 21.70 19.50 47.44 24.99 15.25 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 33 3 # 33 A 34 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 260 ARG D 124 ARG.? -3.55 O ACT D 201s A 270 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 39.80 27.50 22.98 42.20 26.56 21.34 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 48.83 21.70 19.50 47.44 24.99 15.25 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 34 3 # 34 A 34 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 260 ARG D 124 ARG.? -3.55 O ACT D 201s A 270 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 39.80 27.50 22.98 42.20 26.56 21.34 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 48.83 21.70 19.50 47.44 24.99 15.25 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 35 3 # 35 A 34 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 260 ARG D 146 ARG.? 16.60 CH3 ACT D 201 A 270 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 39.80 27.50 22.98 42.20 26.56 21.34 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 48.83 21.70 19.50 47.44 24.99 15.25 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 36 3 # 36 A 34 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 260 ARG D 8 ARG.? 14.56 CH3 ACT D 201 A 270 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 39.80 27.50 22.98 42.20 26.56 21.34 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 48.83 21.70 19.50 47.44 24.99 15.25 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 37 3 # 37 A 34 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 260 ARG D 16 ARG~? 19.88 CH3 ACT D 201 A 270 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 50.99 29.43 12.86 52.11 29.45 14.65 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 39.80 27.50 22.98 42.20 26.56 21.34 -43.87 51.07 24.49 -42.60 51.26 27.28 coo 48.83 21.70 19.50 47.44 24.99 15.25 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 38 3 # 38 A 34 GLU D 156 GLU.? 18.36 CH3 ACT D 201 A 260 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 270 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 50.99 29.43 12.86 52.11 29.45 14.65 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 39.80 27.50 22.98 42.20 26.56 21.34 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 48.83 21.70 19.50 47.44 24.99 15.25 -47.37 61.41 34.65 -51.85 60.71 37.83 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 39 3 # 39 A 34 GLU D 156 GLU.? 18.36 CH3 ACT D 201 A 260 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 270 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 50.99 29.43 12.86 52.11 29.45 14.65 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 39.80 27.50 22.98 42.20 26.56 21.34 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 48.83 21.70 19.50 47.44 24.99 15.25 -47.37 61.41 34.65 -51.85 60.71 37.83 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 39 hits 1euy_c00 naa= 3 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 1 3 # 1 A 233 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 254 HIS A 98 HIS^? -3.60 C ACT A 203s A 301 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 2 3 # 2 A 233 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 254 HIS A 98 HIS^? -3.60 C ACT A 203s A 301 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 3 3 # 3 A 233 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 254 HIS A 98 HIS^? -3.60 C ACT A 203s A 301 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 4 3 # 4 A 233 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 254 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 301 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 5 3 # 5 A 233 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 254 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 301 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 6 3 # 6 A 233 ASP C 74 ASP^? 14.86 O ACT C 201 A 254 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 301 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 7 3 # 7 A 233 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 254 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 301 ASP C 74 ASP^? 14.86 O ACT C 201 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 8 3 # 8 A 233 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 254 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 301 ASP C 74 ASP^? 14.86 O ACT C 201 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 9 3 # 9 A 233 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 254 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 301 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 10 3 # 10 A 233 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 254 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 301 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -50.30 76.97 42.14 -51.14 78.91 42.11 1ez2_c00 source 1ez2 PHOSPHOTRIESTERASE : 10 hits 1ez2_c00 naa= 3 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 1 3 # 1 B 233 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 254 HIS A 98 HIS^? -3.60 C ACT A 203s B 301 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 2 3 # 2 B 233 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 254 HIS A 98 HIS^? -3.60 C ACT A 203s B 301 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 3 3 # 3 B 233 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 254 HIS A 98 HIS^? -3.60 C ACT A 203s B 301 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 4 3 # 4 B 233 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 254 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 301 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 5 3 # 5 B 233 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 254 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 301 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 6 3 # 6 B 233 ASP C 74 ASP^? 14.86 O ACT C 201 B 254 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 301 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 7 3 # 7 B 233 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 254 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 301 ASP C 74 ASP^? 14.86 O ACT C 201 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 8 3 # 8 B 233 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 254 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 301 ASP C 74 ASP^? 14.86 O ACT C 201 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 9 3 # 9 B 233 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 254 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 301 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 10 3 # 10 B 233 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 254 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 301 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -50.30 76.97 42.14 -51.14 78.91 42.11 1ez2_c01 source 1ez2 PHOSPHOTRIESTERASE : 10 hits 1ez2_c01 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 28 ASP~? 12.70 CH3 ACT A 201 C 117 GLU A 21 GLU~? 19.20 CH3 ACT A 201 C 131 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 68.01 56.37 72.57 68.42 56.10 70.51 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 66.59 62.50 67.44 67.57 60.64 67.12 -26.74 85.39 73.13 -25.47 87.07 73.30 coo 69.24 52.27 71.96 69.91 50.26 71.89 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 3 # 2 C 95 ASP A 116 ASP.? 19.55 CH3 ACT A 201 C 117 GLU A 114 GLU^? 11.87 CH3 ACT A 202 C 131 GLU A 117 GLU.? 20.82 OXT ACT A 202 coo 68.01 56.37 72.57 68.42 56.10 70.51 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 66.59 62.50 67.44 67.57 60.64 67.12 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 69.24 52.27 71.96 69.91 50.26 71.89 -10.16 77.53 73.12 -10.08 75.57 72.28 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 3 3 # 3 C 95 ASP B 116 ASP.? 19.49 CH3 ACT B 201 C 117 GLU B 114 GLU^? 18.04 O ACT B 201 C 131 GLU B 117 GLU.? 26.48 CH3 ACT B 201 coo 68.01 56.37 72.57 68.42 56.10 70.51 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 66.59 62.50 67.44 67.57 60.64 67.12 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 69.24 52.27 71.96 69.91 50.26 71.89 -33.80 72.26 99.63 -34.50 73.71 100.99 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 4 3 # 4 C 95 ASP C 28 ASP~? 12.80 CH3 ACT C 201 C 117 GLU C 21 GLU~? 19.29 CH3 ACT C 201 C 131 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 68.01 56.37 72.57 68.42 56.10 70.51 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 66.59 62.50 67.44 67.57 60.64 67.12 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 69.24 52.27 71.96 69.91 50.26 71.89 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 5 3 # 5 C 95 ASP C 116 ASP.? 19.40 CH3 ACT C 201 C 117 GLU C 114 GLU^? 18.18 OXT ACT C 201 C 131 GLU C 117 GLU.? 26.34 CH3 ACT C 201 coo 68.01 56.37 72.57 68.42 56.10 70.51 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 66.59 62.50 67.44 67.57 60.64 67.12 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 69.24 52.27 71.96 69.91 50.26 71.89 -28.65 43.01 29.05 -27.69 42.85 27.18 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 6 3 # 6 C 95 ASP D 116 ASP.? 19.52 CH3 ACT D 201 C 117 GLU D 114 GLU^? 18.05 O ACT D 201 C 131 GLU D 117 GLU.? 26.53 CH3 ACT D 201 coo 68.01 56.37 72.57 68.42 56.10 70.51 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 66.59 62.50 67.44 67.57 60.64 67.12 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 69.24 52.27 71.96 69.91 50.26 71.89 -63.64 43.50 30.85 -64.87 41.85 30.41 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 6 hits 1f6d_c02 naa= 3 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 1 3 # 1 A 156 LYS B 139 LYS.? 6.99 C1 EDO A 302 A 159 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 162 HIS B 141 HIS.? 15.94 CH3 ACT A 202 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -18.83 46.84 75.05 -16.49 49.79 71.17 coo 29.80 39.37 7.24 28.18 38.06 7.48 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 30.26 35.04 5.34 28.61 35.92 4.39 -16.42 43.62 79.59 -14.76 44.89 79.44 1f7u_c00 source 1f7u ARGINYL-TRNA SYNTHETASE : 1 hits 1f7u_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 56 HIS.? 6.76 O1 EDO A 302 C 62 LYS A 62 LYS~? 17.60 O ACT A 201 F 35 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo 15.40 22.79 16.66 13.93 24.10 15.98 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 19.95 18.98 4.81 18.82 20.94 10.49 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 16.32 15.30 17.19 17.71 14.73 18.69 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS A 98 HIS^? -3.60 C ACT A 203s C 62 LYS A 68 LYS~? -2.78 O ACT A 201s F 35 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 15.40 22.79 16.66 13.93 24.10 15.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.95 18.98 4.81 18.82 20.94 10.49 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 16.32 15.30 17.19 17.71 14.73 18.69 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS A 98 HIS^? -3.60 C ACT A 203s C 62 LYS A 68 LYS~? -2.78 O ACT A 201s F 35 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 15.40 22.79 16.66 13.93 24.10 15.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.95 18.98 4.81 18.82 20.94 10.49 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 16.32 15.30 17.19 17.71 14.73 18.69 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 4 3 # 4 A 105 HIS A 98 HIS^? -3.60 C ACT A 203s C 62 LYS D 68 LYS~? -2.80 OXT ACT D 201s F 35 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 15.40 22.79 16.66 13.93 24.10 15.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.95 18.98 4.81 18.82 20.94 10.49 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 16.32 15.30 17.19 17.71 14.73 18.69 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 5 3 # 5 A 105 HIS A 98 HIS^? -3.60 C ACT A 203s C 62 LYS D 68 LYS~? -2.80 OXT ACT D 201s F 35 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 15.40 22.79 16.66 13.93 24.10 15.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.95 18.98 4.81 18.82 20.94 10.49 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 16.32 15.30 17.19 17.71 14.73 18.69 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 6 3 # 6 A 105 HIS A 98 HIS^? -3.60 C ACT A 203s C 62 LYS D 71 LYS~? -3.20 CH3 ACT A 203s F 35 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 15.40 22.79 16.66 13.93 24.10 15.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.95 18.98 4.81 18.82 20.94 10.49 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 16.32 15.30 17.19 17.71 14.73 18.69 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 7 3 # 7 A 105 HIS A 98 HIS^? -3.60 C ACT A 203s C 62 LYS D 71 LYS~? -3.20 CH3 ACT A 203s F 35 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 15.40 22.79 16.66 13.93 24.10 15.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.95 18.98 4.81 18.82 20.94 10.49 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 16.32 15.30 17.19 17.71 14.73 18.69 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 8 3 # 8 A 105 HIS A 151 HIS.? 15.97 CH3 ACT A 201 C 62 LYS A 79 LYS^? -3.45 CH3 ACT A 201s F 35 ASP A 149 ASP.? 18.85 CH3 ACT A 201 coo 15.40 22.79 16.66 13.93 24.10 15.98 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 19.95 18.98 4.81 18.82 20.94 10.49 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 16.32 15.30 17.19 17.71 14.73 18.69 -38.64 88.42 71.14 -36.90 88.52 69.95 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 9 3 # 9 A 105 HIS B 56 HIS.? 17.31 O ACT B 201 C 62 LYS B 62 LYS~? 17.44 OXT ACT B 201 F 35 ASP B 45 ASP^? 20.35 O ACT B 201 coo 15.40 22.79 16.66 13.93 24.10 15.98 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 19.95 18.98 4.81 18.82 20.94 10.49 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 16.32 15.30 17.19 17.71 14.73 18.69 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 10 3 # 10 A 105 HIS B 98 HIS^? 14.98 OXT ACT B 201 C 62 LYS B 68 LYS~? -2.79 OXT ACT B 201s F 35 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 15.40 22.79 16.66 13.93 24.10 15.98 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 19.95 18.98 4.81 18.82 20.94 10.49 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 16.32 15.30 17.19 17.71 14.73 18.69 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 11 3 # 11 A 105 HIS B 151 HIS.? 13.45 CH3 ACT A 202 C 62 LYS B 79 LYS^? -3.44 CH3 ACT B 201s F 35 ASP B 149 ASP.? 20.03 CH3 ACT B 201 coo 15.40 22.79 16.66 13.93 24.10 15.98 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 19.95 18.98 4.81 18.82 20.94 10.49 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 16.32 15.30 17.19 17.71 14.73 18.69 -13.67 50.22 91.33 -14.75 50.15 93.16 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 12 3 # 12 A 105 HIS C 56 HIS.? 17.26 OXT ACT C 201 C 62 LYS C 62 LYS~? 12.50 O2 EDO A 302 F 35 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo 15.40 22.79 16.66 13.93 24.10 15.98 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 19.95 18.98 4.81 18.82 20.94 10.49 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 16.32 15.30 17.19 17.71 14.73 18.69 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 13 3 # 13 A 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 62 LYS B 68 LYS~? -2.79 OXT ACT B 201s F 35 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 15.40 22.79 16.66 13.93 24.10 15.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.95 18.98 4.81 18.82 20.94 10.49 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 16.32 15.30 17.19 17.71 14.73 18.69 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 14 3 # 14 A 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 62 LYS B 68 LYS~? -2.79 OXT ACT B 201s F 35 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 15.40 22.79 16.66 13.93 24.10 15.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.95 18.98 4.81 18.82 20.94 10.49 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 16.32 15.30 17.19 17.71 14.73 18.69 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 15 3 # 15 A 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 62 LYS B 71 LYS~? 10.83 OXT ACT B 201 F 35 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 15.40 22.79 16.66 13.93 24.10 15.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.95 18.98 4.81 18.82 20.94 10.49 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 16.32 15.30 17.19 17.71 14.73 18.69 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 16 3 # 16 A 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 62 LYS B 71 LYS~? 10.83 OXT ACT B 201 F 35 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 15.40 22.79 16.66 13.93 24.10 15.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.95 18.98 4.81 18.82 20.94 10.49 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 16.32 15.30 17.19 17.71 14.73 18.69 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 17 3 # 17 A 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 62 LYS C 68 LYS~? -2.77 O ACT C 201s F 35 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 15.40 22.79 16.66 13.93 24.10 15.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.95 18.98 4.81 18.82 20.94 10.49 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 16.32 15.30 17.19 17.71 14.73 18.69 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 18 3 # 18 A 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 62 LYS C 68 LYS~? -2.77 O ACT C 201s F 35 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 15.40 22.79 16.66 13.93 24.10 15.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.95 18.98 4.81 18.82 20.94 10.49 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 16.32 15.30 17.19 17.71 14.73 18.69 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 19 3 # 19 A 105 HIS C 151 HIS.? 16.03 CH3 ACT C 201 C 62 LYS C 79 LYS^? -3.44 CH3 ACT C 201s F 35 ASP C 149 ASP.? 18.79 CH3 ACT C 201 coo 15.40 22.79 16.66 13.93 24.10 15.98 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 19.95 18.98 4.81 18.82 20.94 10.49 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 16.32 15.30 17.19 17.71 14.73 18.69 -42.93 29.00 51.56 -40.94 29.30 50.94 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 20 3 # 20 A 105 HIS D 56 HIS.? 17.26 O ACT D 201 C 62 LYS D 62 LYS~? 17.47 OXT ACT D 201 F 35 ASP D 45 ASP^? 20.33 O ACT D 201 coo 15.40 22.79 16.66 13.93 24.10 15.98 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 19.95 18.98 4.81 18.82 20.94 10.49 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 16.32 15.30 17.19 17.71 14.73 18.69 -67.68 49.50 43.87 -67.26 48.38 42.12 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 21 3 # 21 A 105 HIS D 98 HIS^? 13.13 CH3 ACT A 203 C 62 LYS D 68 LYS~? -2.80 OXT ACT D 201s F 35 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 15.40 22.79 16.66 13.93 24.10 15.98 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 19.95 18.98 4.81 18.82 20.94 10.49 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 16.32 15.30 17.19 17.71 14.73 18.69 -52.87 78.07 53.10 -52.52 76.84 54.77 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 21 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 62 LYS~? 17.60 O ACT A 201 C 105 HIS A 56 HIS.? 6.76 O1 EDO A 302 D 35 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo 38.76 28.25 7.87 36.33 26.41 13.58 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 34.93 19.72 17.37 34.72 18.17 15.98 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 41.01 23.02 20.83 40.65 24.26 22.55 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS A 68 LYS~? -2.78 O ACT A 201s C 105 HIS A 98 HIS^? -3.60 C ACT A 203s D 35 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 38.76 28.25 7.87 36.33 26.41 13.58 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 34.93 19.72 17.37 34.72 18.17 15.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 41.01 23.02 20.83 40.65 24.26 22.55 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS A 68 LYS~? -2.78 O ACT A 201s C 105 HIS A 98 HIS^? -3.60 C ACT A 203s D 35 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 38.76 28.25 7.87 36.33 26.41 13.58 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 34.93 19.72 17.37 34.72 18.17 15.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 41.01 23.02 20.83 40.65 24.26 22.55 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 4 3 # 4 B 62 LYS A 79 LYS^? -3.45 CH3 ACT A 201s C 105 HIS A 151 HIS.? 15.97 CH3 ACT A 201 D 35 ASP A 149 ASP.? 18.85 CH3 ACT A 201 coo 38.76 28.25 7.87 36.33 26.41 13.58 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 34.93 19.72 17.37 34.72 18.17 15.98 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 41.01 23.02 20.83 40.65 24.26 22.55 -38.64 88.42 71.14 -36.90 88.52 69.95 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 5 3 # 5 B 62 LYS A 79 LYS^? -3.45 CH3 ACT A 201s C 105 HIS A 151 HIS.? 15.97 CH3 ACT A 201 D 35 ASP A 150 ASP.? 22.07 CH3 ACT A 201 coo 38.76 28.25 7.87 36.33 26.41 13.58 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 34.93 19.72 17.37 34.72 18.17 15.98 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 41.01 23.02 20.83 40.65 24.26 22.55 -43.95 88.27 71.85 -43.22 89.50 70.29 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 6 3 # 6 B 62 LYS B 62 LYS~? 17.44 OXT ACT B 201 C 105 HIS B 56 HIS.? 17.31 O ACT B 201 D 35 ASP B 45 ASP^? 20.35 O ACT B 201 coo 38.76 28.25 7.87 36.33 26.41 13.58 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 34.93 19.72 17.37 34.72 18.17 15.98 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 41.01 23.02 20.83 40.65 24.26 22.55 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 7 3 # 7 B 62 LYS B 68 LYS~? -2.79 OXT ACT B 201s C 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 35 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 38.76 28.25 7.87 36.33 26.41 13.58 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 34.93 19.72 17.37 34.72 18.17 15.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 41.01 23.02 20.83 40.65 24.26 22.55 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 8 3 # 8 B 62 LYS B 68 LYS~? -2.79 OXT ACT B 201s C 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 35 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 38.76 28.25 7.87 36.33 26.41 13.58 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 34.93 19.72 17.37 34.72 18.17 15.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 41.01 23.02 20.83 40.65 24.26 22.55 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 9 3 # 9 B 62 LYS B 71 LYS~? 10.83 OXT ACT B 201 C 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 35 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 38.76 28.25 7.87 36.33 26.41 13.58 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 34.93 19.72 17.37 34.72 18.17 15.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 41.01 23.02 20.83 40.65 24.26 22.55 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 10 3 # 10 B 62 LYS B 71 LYS~? 10.83 OXT ACT B 201 C 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 35 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 38.76 28.25 7.87 36.33 26.41 13.58 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 34.93 19.72 17.37 34.72 18.17 15.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 41.01 23.02 20.83 40.65 24.26 22.55 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 11 3 # 11 B 62 LYS B 79 LYS^? -3.44 CH3 ACT B 201s C 105 HIS B 151 HIS.? 13.45 CH3 ACT A 202 D 35 ASP B 149 ASP.? 20.03 CH3 ACT B 201 coo 38.76 28.25 7.87 36.33 26.41 13.58 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 34.93 19.72 17.37 34.72 18.17 15.98 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 41.01 23.02 20.83 40.65 24.26 22.55 -13.67 50.22 91.33 -14.75 50.15 93.16 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 12 3 # 12 B 62 LYS B 79 LYS^? -3.44 CH3 ACT B 201s C 105 HIS B 151 HIS.? 13.45 CH3 ACT A 202 D 35 ASP B 150 ASP.? 20.21 CH3 ACT A 202 coo 38.76 28.25 7.87 36.33 26.41 13.58 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 34.93 19.72 17.37 34.72 18.17 15.98 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 41.01 23.02 20.83 40.65 24.26 22.55 -10.73 49.15 87.46 -11.06 47.07 87.30 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 13 3 # 13 B 62 LYS C 62 LYS~? 12.50 O2 EDO A 302 C 105 HIS C 56 HIS.? 17.26 OXT ACT C 201 D 35 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo 38.76 28.25 7.87 36.33 26.41 13.58 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 34.93 19.72 17.37 34.72 18.17 15.98 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 41.01 23.02 20.83 40.65 24.26 22.55 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 14 3 # 14 B 62 LYS C 68 LYS~? -2.77 O ACT C 201s C 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 35 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 38.76 28.25 7.87 36.33 26.41 13.58 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 34.93 19.72 17.37 34.72 18.17 15.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 41.01 23.02 20.83 40.65 24.26 22.55 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 15 3 # 15 B 62 LYS C 68 LYS~? -2.77 O ACT C 201s C 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 35 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 38.76 28.25 7.87 36.33 26.41 13.58 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 34.93 19.72 17.37 34.72 18.17 15.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 41.01 23.02 20.83 40.65 24.26 22.55 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 16 3 # 16 B 62 LYS C 79 LYS^? -3.44 CH3 ACT C 201s C 105 HIS C 151 HIS.? 16.03 CH3 ACT C 201 D 35 ASP C 149 ASP.? 18.79 CH3 ACT C 201 coo 38.76 28.25 7.87 36.33 26.41 13.58 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 34.93 19.72 17.37 34.72 18.17 15.98 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 41.01 23.02 20.83 40.65 24.26 22.55 -42.93 29.00 51.56 -40.94 29.30 50.94 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 17 3 # 17 B 62 LYS C 79 LYS^? -3.44 CH3 ACT C 201s C 105 HIS C 151 HIS.? 16.03 CH3 ACT C 201 D 35 ASP C 150 ASP.? 20.99 CH3 ACT C 201 coo 38.76 28.25 7.87 36.33 26.41 13.58 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 34.93 19.72 17.37 34.72 18.17 15.98 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 41.01 23.02 20.83 40.65 24.26 22.55 -46.61 28.46 55.57 -45.54 29.27 57.21 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 18 3 # 18 B 62 LYS D 62 LYS~? 17.47 OXT ACT D 201 C 105 HIS D 56 HIS.? 17.26 O ACT D 201 D 35 ASP D 45 ASP^? 20.33 O ACT D 201 coo 38.76 28.25 7.87 36.33 26.41 13.58 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 34.93 19.72 17.37 34.72 18.17 15.98 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 41.01 23.02 20.83 40.65 24.26 22.55 -67.68 49.50 43.87 -67.26 48.38 42.12 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 19 3 # 19 B 62 LYS D 68 LYS~? -2.80 OXT ACT D 201s C 105 HIS A 98 HIS^? -3.60 C ACT A 203s D 35 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 38.76 28.25 7.87 36.33 26.41 13.58 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 34.93 19.72 17.37 34.72 18.17 15.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 41.01 23.02 20.83 40.65 24.26 22.55 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 20 3 # 20 B 62 LYS D 68 LYS~? -2.80 OXT ACT D 201s C 105 HIS A 98 HIS^? -3.60 C ACT A 203s D 35 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 38.76 28.25 7.87 36.33 26.41 13.58 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 34.93 19.72 17.37 34.72 18.17 15.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 41.01 23.02 20.83 40.65 24.26 22.55 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 21 3 # 21 B 62 LYS D 68 LYS~? -2.80 OXT ACT D 201s C 105 HIS D 98 HIS^? 13.13 CH3 ACT A 203 D 35 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 38.76 28.25 7.87 36.33 26.41 13.58 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 34.93 19.72 17.37 34.72 18.17 15.98 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 41.01 23.02 20.83 40.65 24.26 22.55 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 22 3 # 22 B 62 LYS D 71 LYS~? -3.20 CH3 ACT A 203s C 105 HIS A 98 HIS^? -3.60 C ACT A 203s D 35 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 38.76 28.25 7.87 36.33 26.41 13.58 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 34.93 19.72 17.37 34.72 18.17 15.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 41.01 23.02 20.83 40.65 24.26 22.55 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 23 3 # 23 B 62 LYS D 71 LYS~? -3.20 CH3 ACT A 203s C 105 HIS A 98 HIS^? -3.60 C ACT A 203s D 35 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 38.76 28.25 7.87 36.33 26.41 13.58 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 34.93 19.72 17.37 34.72 18.17 15.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 41.01 23.02 20.83 40.65 24.26 22.55 -44.77 63.42 52.85 -43.43 61.81 52.77 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 23 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 62 LYS~? 17.60 O ACT A 201 B 105 HIS A 56 HIS.? 6.76 O1 EDO A 302 E 35 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo 20.51 39.76 8.83 21.23 37.38 14.18 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 27.18 37.56 20.68 29.07 38.28 20.13 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 19.97 40.39 22.03 18.53 39.30 23.18 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS A 68 LYS~? -2.78 O ACT A 201s B 105 HIS A 98 HIS^? -3.60 C ACT A 203s E 35 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 20.51 39.76 8.83 21.23 37.38 14.18 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 27.18 37.56 20.68 29.07 38.28 20.13 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.97 40.39 22.03 18.53 39.30 23.18 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS A 68 LYS~? -2.78 O ACT A 201s B 105 HIS A 98 HIS^? -3.60 C ACT A 203s E 35 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 20.51 39.76 8.83 21.23 37.38 14.18 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 27.18 37.56 20.68 29.07 38.28 20.13 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.97 40.39 22.03 18.53 39.30 23.18 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 4 3 # 4 A 62 LYS B 62 LYS~? 17.44 OXT ACT B 201 B 105 HIS B 56 HIS.? 17.31 O ACT B 201 E 35 ASP B 45 ASP^? 20.35 O ACT B 201 coo 20.51 39.76 8.83 21.23 37.38 14.18 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 27.18 37.56 20.68 29.07 38.28 20.13 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 19.97 40.39 22.03 18.53 39.30 23.18 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 5 3 # 5 A 62 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 105 HIS B 98 HIS^? 14.98 OXT ACT B 201 E 35 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 20.51 39.76 8.83 21.23 37.38 14.18 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 27.18 37.56 20.68 29.07 38.28 20.13 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 19.97 40.39 22.03 18.53 39.30 23.18 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 6 3 # 6 A 62 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 35 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 20.51 39.76 8.83 21.23 37.38 14.18 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 27.18 37.56 20.68 29.07 38.28 20.13 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.97 40.39 22.03 18.53 39.30 23.18 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 7 3 # 7 A 62 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 35 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 20.51 39.76 8.83 21.23 37.38 14.18 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 27.18 37.56 20.68 29.07 38.28 20.13 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.97 40.39 22.03 18.53 39.30 23.18 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 8 3 # 8 A 62 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 35 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 20.51 39.76 8.83 21.23 37.38 14.18 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 27.18 37.56 20.68 29.07 38.28 20.13 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.97 40.39 22.03 18.53 39.30 23.18 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 9 3 # 9 A 62 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 35 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 20.51 39.76 8.83 21.23 37.38 14.18 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 27.18 37.56 20.68 29.07 38.28 20.13 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.97 40.39 22.03 18.53 39.30 23.18 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 10 3 # 10 A 62 LYS C 62 LYS~? 12.50 O2 EDO A 302 B 105 HIS C 56 HIS.? 17.26 OXT ACT C 201 E 35 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo 20.51 39.76 8.83 21.23 37.38 14.18 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 27.18 37.56 20.68 29.07 38.28 20.13 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 19.97 40.39 22.03 18.53 39.30 23.18 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 11 3 # 11 A 62 LYS C 68 LYS~? -2.77 O ACT C 201s B 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 35 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 20.51 39.76 8.83 21.23 37.38 14.18 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 27.18 37.56 20.68 29.07 38.28 20.13 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.97 40.39 22.03 18.53 39.30 23.18 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 12 3 # 12 A 62 LYS C 68 LYS~? -2.77 O ACT C 201s B 105 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 35 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 20.51 39.76 8.83 21.23 37.38 14.18 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 27.18 37.56 20.68 29.07 38.28 20.13 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 19.97 40.39 22.03 18.53 39.30 23.18 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 13 3 # 13 A 62 LYS D 62 LYS~? 17.47 OXT ACT D 201 B 105 HIS D 56 HIS.? 17.26 O ACT D 201 E 35 ASP D 45 ASP^? 20.33 O ACT D 201 coo 20.51 39.76 8.83 21.23 37.38 14.18 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 27.18 37.56 20.68 29.07 38.28 20.13 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 19.97 40.39 22.03 18.53 39.30 23.18 -67.68 49.50 43.87 -67.26 48.38 42.12 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 14 3 # 14 A 62 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 105 HIS A 98 HIS^? -3.60 C ACT A 203s E 35 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 20.51 39.76 8.83 21.23 37.38 14.18 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 27.18 37.56 20.68 29.07 38.28 20.13 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.97 40.39 22.03 18.53 39.30 23.18 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 15 3 # 15 A 62 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 105 HIS A 98 HIS^? -3.60 C ACT A 203s E 35 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 20.51 39.76 8.83 21.23 37.38 14.18 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 27.18 37.56 20.68 29.07 38.28 20.13 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.97 40.39 22.03 18.53 39.30 23.18 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 16 3 # 16 A 62 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 105 HIS A 98 HIS^? -3.60 C ACT A 203s E 35 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 20.51 39.76 8.83 21.23 37.38 14.18 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 27.18 37.56 20.68 29.07 38.28 20.13 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.97 40.39 22.03 18.53 39.30 23.18 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 17 3 # 17 A 62 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 105 HIS D 98 HIS^? 13.13 CH3 ACT A 203 E 35 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 20.51 39.76 8.83 21.23 37.38 14.18 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 27.18 37.56 20.68 29.07 38.28 20.13 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 19.97 40.39 22.03 18.53 39.30 23.18 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 18 3 # 18 A 62 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 105 HIS D 98 HIS^? 13.13 CH3 ACT A 203 E 35 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 20.51 39.76 8.83 21.23 37.38 14.18 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 27.18 37.56 20.68 29.07 38.28 20.13 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 19.97 40.39 22.03 18.53 39.30 23.18 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 19 3 # 19 A 62 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 105 HIS A 98 HIS^? -3.60 C ACT A 203s E 35 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 20.51 39.76 8.83 21.23 37.38 14.18 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 27.18 37.56 20.68 29.07 38.28 20.13 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.97 40.39 22.03 18.53 39.30 23.18 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 20 3 # 20 A 62 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 105 HIS A 98 HIS^? -3.60 C ACT A 203s E 35 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 20.51 39.76 8.83 21.23 37.38 14.18 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 27.18 37.56 20.68 29.07 38.28 20.13 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 19.97 40.39 22.03 18.53 39.30 23.18 -44.22 66.27 50.20 -46.22 65.66 49.92 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 20 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 244 LYS A 139 LYS.? 17.81 O ACT A 201 coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 210 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 210 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 244 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 10.51 37.86 19.71 9.07 39.38 20.04 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -1.20 42.34 17.67 3.19 45.13 19.06 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 210 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 244 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 10.51 37.86 19.71 9.07 39.38 20.04 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -1.20 42.34 17.67 3.19 45.13 19.06 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 210 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 244 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 10.51 37.86 19.71 9.07 39.38 20.04 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -1.20 42.34 17.67 3.19 45.13 19.06 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE A 140 PHE.? 11.31 O ACT A 201 A 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 244 LYS A 134 LYS~? 11.98 O ACT A 203 coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 210 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 244 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 10.51 37.86 19.71 9.07 39.38 20.04 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 210 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 244 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 10.51 37.86 19.71 9.07 39.38 20.04 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 210 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 244 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 10.51 37.86 19.71 9.07 39.38 20.04 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 210 ASP C 74 ASP^? 14.86 O ACT C 201 A 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 10.51 37.86 19.71 9.07 39.38 20.04 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -1.20 42.34 17.67 3.19 45.13 19.06 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 210 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 10.51 37.86 19.71 9.07 39.38 20.04 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -1.20 42.34 17.67 3.19 45.13 19.06 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 112 PHE B 140 PHE.? 8.97 CH3 ACT A 202 A 210 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 244 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 10.51 37.86 19.71 9.07 39.38 20.04 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 112 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 210 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 244 LYS A 134 LYS~? 11.98 O ACT A 203 coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -1.20 42.34 17.67 3.19 45.13 19.06 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 A 112 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 210 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 244 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 10.51 37.86 19.71 9.07 39.38 20.04 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 A 112 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 210 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 244 LYS A 134 LYS~? 11.98 O ACT A 203 coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 10.51 37.86 19.71 9.07 39.38 20.04 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -1.20 42.34 17.67 3.19 45.13 19.06 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 A 112 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 210 ASP C 74 ASP^? 14.86 O ACT C 201 A 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 10.51 37.86 19.71 9.07 39.38 20.04 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -1.20 42.34 17.67 3.19 45.13 19.06 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 A 112 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 210 ASP C 74 ASP^? 14.86 O ACT C 201 A 244 LYS C 139 LYS.? 18.79 O ACT C 201 coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 10.51 37.86 19.71 9.07 39.38 20.04 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -1.20 42.34 17.67 3.19 45.13 19.06 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 A 112 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 210 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 10.51 37.86 19.71 9.07 39.38 20.04 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -1.20 42.34 17.67 3.19 45.13 19.06 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 A 112 PHE C 140 PHE.? 11.33 O ACT C 201 A 210 ASP C 74 ASP^? 14.86 O ACT C 201 A 244 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 10.51 37.86 19.71 9.07 39.38 20.04 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -1.20 42.34 17.67 3.19 45.13 19.06 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 A 112 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 A 112 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 210 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 A 112 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 210 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 244 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 10.51 37.86 19.71 9.07 39.38 20.04 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -1.20 42.34 17.67 3.19 45.13 19.06 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 A 112 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 210 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 244 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 10.51 37.86 19.71 9.07 39.38 20.04 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -1.20 42.34 17.67 3.19 45.13 19.06 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 A 112 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 210 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 244 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 9.23 46.77 25.11 11.48 48.39 24.76 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 10.51 37.86 19.71 9.07 39.38 20.04 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 26 3 # 26 A 112 PHE D 140 PHE.? 11.31 OXT ACT D 201 A 210 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 244 LYS D 134 LYS~? 17.34 O ACT A 201 coo 9.23 46.77 25.11 11.48 48.39 24.76 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 10.51 37.86 19.71 9.07 39.38 20.04 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -1.20 42.34 17.67 3.19 45.13 19.06 -37.62 76.93 46.97 -33.08 76.47 49.79 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 26 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 244 LYS A 139 LYS.? 17.81 O ACT A 201 coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 210 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 210 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 244 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 9.06 56.85 40.30 7.71 55.27 39.90 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -2.38 51.82 41.62 2.07 49.19 40.42 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 210 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 244 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 9.06 56.85 40.30 7.71 55.27 39.90 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -2.38 51.82 41.62 2.07 49.19 40.42 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 210 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 244 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 9.06 56.85 40.30 7.71 55.27 39.90 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -2.38 51.82 41.62 2.07 49.19 40.42 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE A 140 PHE.? 11.31 O ACT A 201 B 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 244 LYS A 134 LYS~? 11.98 O ACT A 203 coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 210 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 244 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 9.06 56.85 40.30 7.71 55.27 39.90 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 210 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 244 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 9.06 56.85 40.30 7.71 55.27 39.90 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -2.38 51.82 41.62 2.07 49.19 40.42 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 210 ASP B 100 ASP.? 15.93 OXT ACT B 201 B 244 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 9.06 56.85 40.30 7.71 55.27 39.90 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 210 ASP C 74 ASP^? 14.86 O ACT C 201 B 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 9.06 56.85 40.30 7.71 55.27 39.90 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -2.38 51.82 41.62 2.07 49.19 40.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 112 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 210 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 9.06 56.85 40.30 7.71 55.27 39.90 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -2.38 51.82 41.62 2.07 49.19 40.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 112 PHE B 140 PHE.? 8.97 CH3 ACT A 202 B 210 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 244 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 9.06 56.85 40.30 7.71 55.27 39.90 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -2.38 51.82 41.62 2.07 49.19 40.42 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 112 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 210 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 244 LYS A 134 LYS~? 11.98 O ACT A 203 coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -2.38 51.82 41.62 2.07 49.19 40.42 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 B 112 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 210 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 244 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 9.06 56.85 40.30 7.71 55.27 39.90 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 B 112 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 210 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 244 LYS A 134 LYS~? 11.98 O ACT A 203 coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 9.06 56.85 40.30 7.71 55.27 39.90 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -2.38 51.82 41.62 2.07 49.19 40.42 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 B 112 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 210 ASP C 74 ASP^? 14.86 O ACT C 201 B 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 9.06 56.85 40.30 7.71 55.27 39.90 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -2.38 51.82 41.62 2.07 49.19 40.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 B 112 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 210 ASP C 74 ASP^? 14.86 O ACT C 201 B 244 LYS C 139 LYS.? 18.79 O ACT C 201 coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 9.06 56.85 40.30 7.71 55.27 39.90 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -2.38 51.82 41.62 2.07 49.19 40.42 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 B 112 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 210 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 9.06 56.85 40.30 7.71 55.27 39.90 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 B 112 PHE C 140 PHE.? 11.33 O ACT C 201 B 210 ASP C 74 ASP^? 14.86 O ACT C 201 B 244 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 9.06 56.85 40.30 7.71 55.27 39.90 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -2.38 51.82 41.62 2.07 49.19 40.42 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 B 112 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 B 112 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 210 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 B 112 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 210 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 244 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 9.06 56.85 40.30 7.71 55.27 39.90 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -2.38 51.82 41.62 2.07 49.19 40.42 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 B 112 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 210 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 244 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 9.06 56.85 40.30 7.71 55.27 39.90 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -2.38 51.82 41.62 2.07 49.19 40.42 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 B 112 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 210 ASP D 100 ASP.? 7.94 OXT ACT A 203 B 244 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 8.76 47.85 34.91 11.08 46.36 35.41 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 9.06 56.85 40.30 7.71 55.27 39.90 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -2.38 51.82 41.62 2.07 49.19 40.42 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 26 3 # 26 B 112 PHE D 140 PHE.? 11.31 OXT ACT D 201 B 210 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 244 LYS D 134 LYS~? 17.34 O ACT A 201 coo 8.76 47.85 34.91 11.08 46.36 35.41 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 9.06 56.85 40.30 7.71 55.27 39.90 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -2.38 51.82 41.62 2.07 49.19 40.42 -37.62 76.93 46.97 -33.08 76.47 49.79 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 26 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 56 HIS.? 6.76 O1 EDO A 302 A 210 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 244 LYS A 62 LYS~? 17.60 O ACT A 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 10.51 37.86 19.71 9.07 39.38 20.04 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -1.20 42.34 17.67 3.19 45.13 19.06 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS A 98 HIS^? -3.60 C ACT A 203s A 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS A 98 HIS^? -3.60 C ACT A 203s A 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 244 LYS A 139 LYS.? 17.81 O ACT A 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 136 HIS A 98 HIS^? -3.60 C ACT A 203s A 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 244 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 136 HIS A 98 HIS^? -3.60 C ACT A 203s A 210 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 136 HIS A 98 HIS^? -3.60 C ACT A 203s A 210 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 136 HIS A 98 HIS^? -3.60 C ACT A 203s A 210 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 244 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 136 HIS A 98 HIS^? -3.60 C ACT A 203s A 210 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 244 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 136 HIS A 98 HIS^? -3.60 C ACT A 203s A 210 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 136 HIS A 98 HIS^? -3.60 C ACT A 203s A 210 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 244 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -1.20 42.34 17.67 3.19 45.13 19.06 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 136 HIS A 98 HIS^? -3.60 C ACT A 203s A 210 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 244 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -1.20 42.34 17.67 3.19 45.13 19.06 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 136 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 210 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 244 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 10.51 37.86 19.71 9.07 39.38 20.04 -38.64 88.42 71.14 -36.90 88.52 69.95 coo -1.20 42.34 17.67 3.19 45.13 19.06 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 136 HIS B 56 HIS.? 17.31 O ACT B 201 A 210 ASP B 45 ASP^? 20.35 O ACT B 201 A 244 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 10.51 37.86 19.71 9.07 39.38 20.04 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -1.20 42.34 17.67 3.19 45.13 19.06 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 136 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 210 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 244 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 10.51 37.86 19.71 9.07 39.38 20.04 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 A 136 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 210 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 244 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 11.28 44.53 18.60 9.91 46.00 19.20 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 10.51 37.86 19.71 9.07 39.38 20.04 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 A 136 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 210 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 244 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 11.28 44.53 18.60 9.91 46.00 19.20 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 10.51 37.86 19.71 9.07 39.38 20.04 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 A 136 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 210 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 244 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 10.51 37.86 19.71 9.07 39.38 20.04 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 A 136 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 210 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 244 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 11.28 44.53 18.60 9.91 46.00 19.20 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 10.51 37.86 19.71 9.07 39.38 20.04 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -1.20 42.34 17.67 3.19 45.13 19.06 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 A 136 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 210 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 244 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 10.51 37.86 19.71 9.07 39.38 20.04 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 A 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 210 ASP C 74 ASP^? 14.86 O ACT C 201 A 244 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 10.51 37.86 19.71 9.07 39.38 20.04 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 A 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 210 ASP C 74 ASP^? 14.86 O ACT C 201 A 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 10.51 37.86 19.71 9.07 39.38 20.04 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -1.20 42.34 17.67 3.19 45.13 19.06 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 A 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 210 ASP C 74 ASP^? 14.86 O ACT C 201 A 244 LYS C 139 LYS.? 18.79 O ACT C 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 10.51 37.86 19.71 9.07 39.38 20.04 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -1.20 42.34 17.67 3.19 45.13 19.06 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 A 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 210 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 10.51 37.86 19.71 9.07 39.38 20.04 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -1.20 42.34 17.67 3.19 45.13 19.06 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 A 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 210 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 244 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 10.51 37.86 19.71 9.07 39.38 20.04 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 A 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 210 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 244 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 10.51 37.86 19.71 9.07 39.38 20.04 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 26 3 # 26 A 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 210 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 10.51 37.86 19.71 9.07 39.38 20.04 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -1.20 42.34 17.67 3.19 45.13 19.06 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 27 3 # 27 A 136 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 210 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 244 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 10.51 37.86 19.71 9.07 39.38 20.04 -42.93 29.00 51.56 -40.94 29.30 50.94 coo -1.20 42.34 17.67 3.19 45.13 19.06 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 28 3 # 28 A 136 HIS D 56 HIS.? 17.26 O ACT D 201 A 210 ASP D 45 ASP^? 20.33 O ACT D 201 A 244 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 10.51 37.86 19.71 9.07 39.38 20.04 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -1.20 42.34 17.67 3.19 45.13 19.06 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 29 3 # 29 A 136 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 210 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 244 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 10.51 37.86 19.71 9.07 39.38 20.04 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -1.20 42.34 17.67 3.19 45.13 19.06 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 30 3 # 30 A 136 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 210 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 244 LYS D 134 LYS~? 17.34 O ACT A 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 10.51 37.86 19.71 9.07 39.38 20.04 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -1.20 42.34 17.67 3.19 45.13 19.06 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 31 3 # 31 A 136 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 210 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 244 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 10.51 37.86 19.71 9.07 39.38 20.04 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -1.20 42.34 17.67 3.19 45.13 19.06 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 32 3 # 32 A 136 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 210 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 244 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 10.51 37.86 19.71 9.07 39.38 20.04 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -1.20 42.34 17.67 3.19 45.13 19.06 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 33 3 # 33 A 136 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 210 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 244 LYS D 134 LYS~? 17.34 O ACT A 201 coo 11.28 44.53 18.60 9.91 46.00 19.20 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 10.51 37.86 19.71 9.07 39.38 20.04 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -1.20 42.34 17.67 3.19 45.13 19.06 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 34 3 # 34 A 136 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 210 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 244 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 10.51 37.86 19.71 9.07 39.38 20.04 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 35 3 # 35 A 136 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 210 ASP D 149 ASP.? 20.02 CH3 ACT D 201 A 244 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 11.28 44.53 18.60 9.91 46.00 19.20 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 10.51 37.86 19.71 9.07 39.38 20.04 -48.61 69.27 22.33 -50.68 68.95 22.00 coo -1.20 42.34 17.67 3.19 45.13 19.06 -47.37 61.41 34.65 -51.85 60.71 37.83 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 35 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 56 HIS.? 6.76 O1 EDO A 302 B 210 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 244 LYS A 62 LYS~? 17.60 O ACT A 201 coo 10.08 50.18 41.78 8.91 48.61 41.04 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 9.06 56.85 40.30 7.71 55.27 39.90 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -2.38 51.82 41.62 2.07 49.19 40.42 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS A 98 HIS^? -3.60 C ACT A 203s B 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS A 98 HIS^? -3.60 C ACT A 203s B 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 244 LYS A 139 LYS.? 17.81 O ACT A 201 coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 136 HIS A 98 HIS^? -3.60 C ACT A 203s B 210 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 244 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 136 HIS A 98 HIS^? -3.60 C ACT A 203s B 210 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 136 HIS A 98 HIS^? -3.60 C ACT A 203s B 210 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 136 HIS A 98 HIS^? -3.60 C ACT A 203s B 210 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 244 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -2.38 51.82 41.62 2.07 49.19 40.42 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 136 HIS A 98 HIS^? -3.60 C ACT A 203s B 210 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 244 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -2.38 51.82 41.62 2.07 49.19 40.42 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 136 HIS A 98 HIS^? -3.60 C ACT A 203s B 210 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 244 LYS A 68 LYS~? -2.78 O ACT A 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 136 HIS A 98 HIS^? -3.60 C ACT A 203s B 210 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 244 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -2.38 51.82 41.62 2.07 49.19 40.42 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 136 HIS A 98 HIS^? -3.60 C ACT A 203s B 210 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 244 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -2.38 51.82 41.62 2.07 49.19 40.42 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 136 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 210 ASP A 149 ASP.? 18.85 CH3 ACT A 201 B 244 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 9.06 56.85 40.30 7.71 55.27 39.90 -38.64 88.42 71.14 -36.90 88.52 69.95 coo -2.38 51.82 41.62 2.07 49.19 40.42 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 136 HIS B 56 HIS.? 17.31 O ACT B 201 B 210 ASP B 45 ASP^? 20.35 O ACT B 201 B 244 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo 10.08 50.18 41.78 8.91 48.61 41.04 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 9.06 56.85 40.30 7.71 55.27 39.90 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -2.38 51.82 41.62 2.07 49.19 40.42 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 136 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 210 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 244 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 9.06 56.85 40.30 7.71 55.27 39.90 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 B 136 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 210 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 244 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 10.08 50.18 41.78 8.91 48.61 41.04 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 9.06 56.85 40.30 7.71 55.27 39.90 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -2.38 51.82 41.62 2.07 49.19 40.42 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 B 136 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 210 ASP B 100 ASP.? 15.93 OXT ACT B 201 B 244 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 9.06 56.85 40.30 7.71 55.27 39.90 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 B 136 HIS C 56 HIS.? 17.26 OXT ACT C 201 B 210 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 244 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 10.08 50.18 41.78 8.91 48.61 41.04 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 9.06 56.85 40.30 7.71 55.27 39.90 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -2.38 51.82 41.62 2.07 49.19 40.42 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 B 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 210 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 244 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 B 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 210 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 244 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 10.08 50.18 41.78 8.91 48.61 41.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 B 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 210 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -2.38 51.82 41.62 2.07 49.19 40.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 B 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 210 ASP C 74 ASP^? 14.86 O ACT C 201 B 244 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 10.08 50.18 41.78 8.91 48.61 41.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.06 56.85 40.30 7.71 55.27 39.90 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 B 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 210 ASP C 74 ASP^? 14.86 O ACT C 201 B 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.06 56.85 40.30 7.71 55.27 39.90 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -2.38 51.82 41.62 2.07 49.19 40.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 B 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 210 ASP C 74 ASP^? 14.86 O ACT C 201 B 244 LYS C 139 LYS.? 18.79 O ACT C 201 coo 10.08 50.18 41.78 8.91 48.61 41.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.06 56.85 40.30 7.71 55.27 39.90 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -2.38 51.82 41.62 2.07 49.19 40.42 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 B 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 210 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.06 56.85 40.30 7.71 55.27 39.90 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -2.38 51.82 41.62 2.07 49.19 40.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 B 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 210 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 244 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.06 56.85 40.30 7.71 55.27 39.90 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 26 3 # 26 B 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 210 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 244 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 10.08 50.18 41.78 8.91 48.61 41.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.06 56.85 40.30 7.71 55.27 39.90 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 27 3 # 27 B 136 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 210 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 244 LYS C 68 LYS~? -2.77 O ACT C 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.06 56.85 40.30 7.71 55.27 39.90 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 28 3 # 28 B 136 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 210 ASP C 149 ASP.? 18.79 CH3 ACT C 201 B 244 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 9.06 56.85 40.30 7.71 55.27 39.90 -42.93 29.00 51.56 -40.94 29.30 50.94 coo -2.38 51.82 41.62 2.07 49.19 40.42 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 29 3 # 29 B 136 HIS D 56 HIS.? 17.26 O ACT D 201 B 210 ASP D 45 ASP^? 20.33 O ACT D 201 B 244 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo 10.08 50.18 41.78 8.91 48.61 41.04 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 9.06 56.85 40.30 7.71 55.27 39.90 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -2.38 51.82 41.62 2.07 49.19 40.42 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 30 3 # 30 B 136 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 210 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 244 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 9.06 56.85 40.30 7.71 55.27 39.90 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -2.38 51.82 41.62 2.07 49.19 40.42 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 31 3 # 31 B 136 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 210 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 244 LYS D 134 LYS~? 17.34 O ACT A 201 coo 10.08 50.18 41.78 8.91 48.61 41.04 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 9.06 56.85 40.30 7.71 55.27 39.90 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -2.38 51.82 41.62 2.07 49.19 40.42 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 32 3 # 32 B 136 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 210 ASP D 100 ASP.? 7.94 OXT ACT A 203 B 244 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 10.08 50.18 41.78 8.91 48.61 41.04 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 9.06 56.85 40.30 7.71 55.27 39.90 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -2.38 51.82 41.62 2.07 49.19 40.42 -56.56 67.44 48.13 -52.71 65.23 44.87 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 32 hits 1fc4_c05 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 281 ARG D 51 ARG.? 7.60 O ACT D 201 A 289 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 54.86 40.00 47.23 55.57 38.60 48.67 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 52.08 40.18 50.14 50.83 38.93 47.73 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 57.82 31.70 50.73 57.94 34.00 49.17 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 2 3 # 2 A 54 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 281 ARG D 51 ARG.? 7.60 O ACT D 201 A 289 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 54.86 40.00 47.23 55.57 38.60 48.67 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 52.08 40.18 50.14 50.83 38.93 47.73 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 57.82 31.70 50.73 57.94 34.00 49.17 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 3 3 # 3 A 54 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 281 ARG B 51 ARG.? 7.67 O ACT B 201 A 289 TYR B 108 TYR^? -4.79 O ACT A 202s coo 54.86 40.00 47.23 55.57 38.60 48.67 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 52.08 40.18 50.14 50.83 38.93 47.73 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 57.82 31.70 50.73 57.94 34.00 49.17 -26.20 55.78 72.02 -24.40 54.06 70.73 1foh_c00 source 1foh PHENOL HYDROXYLASE : 3 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 281 ARG D 51 ARG.? 7.60 O ACT D 201 B 289 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 90.56 80.24 98.04 90.36 81.53 96.34 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 86.62 80.67 97.51 87.37 82.00 100.10 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 91.83 88.28 92.88 92.60 85.93 94.14 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 2 3 # 2 B 54 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 281 ARG D 51 ARG.? 7.60 O ACT D 201 B 289 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 90.56 80.24 98.04 90.36 81.53 96.34 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 86.62 80.67 97.51 87.37 82.00 100.10 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 91.83 88.28 92.88 92.60 85.93 94.14 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 3 3 # 3 B 54 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 281 ARG B 51 ARG.? 7.67 O ACT B 201 B 289 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 90.56 80.24 98.04 90.36 81.53 96.34 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 86.62 80.67 97.51 87.37 82.00 100.10 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 91.83 88.28 92.88 92.60 85.93 94.14 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 4 3 # 4 B 54 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 281 ARG B 51 ARG.? 7.67 O ACT B 201 B 289 TYR B 108 TYR^? -4.79 O ACT A 202s coo 90.56 80.24 98.04 90.36 81.53 96.34 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 86.62 80.67 97.51 87.37 82.00 100.10 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 91.83 88.28 92.88 92.60 85.93 94.14 -26.20 55.78 72.02 -24.40 54.06 70.73 1foh_c01 source 1foh PHENOL HYDROXYLASE : 4 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 281 ARG D 51 ARG.? 7.60 O ACT D 201 C 289 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 42.34 76.83 49.10 43.06 78.59 50.01 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 46.12 77.15 48.13 44.44 77.61 45.70 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 42.69 86.18 51.69 41.59 83.63 51.54 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 2 3 # 2 C 54 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 281 ARG D 51 ARG.? 7.60 O ACT D 201 C 289 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 42.34 76.83 49.10 43.06 78.59 50.01 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 46.12 77.15 48.13 44.44 77.61 45.70 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 42.69 86.18 51.69 41.59 83.63 51.54 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 3 3 # 3 C 54 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 281 ARG B 51 ARG.? 7.67 O ACT B 201 C 289 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 42.34 76.83 49.10 43.06 78.59 50.01 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 46.12 77.15 48.13 44.44 77.61 45.70 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 42.69 86.18 51.69 41.59 83.63 51.54 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 4 3 # 4 C 54 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 281 ARG B 51 ARG.? 7.67 O ACT B 201 C 289 TYR B 108 TYR^? -4.79 O ACT A 202s coo 42.34 76.83 49.10 43.06 78.59 50.01 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 46.12 77.15 48.13 44.44 77.61 45.70 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 42.69 86.18 51.69 41.59 83.63 51.54 -26.20 55.78 72.02 -24.40 54.06 70.73 1foh_c02 source 1foh PHENOL HYDROXYLASE : 4 hits 1foh_c02 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 72 GLU~? 5.31 O ACT A 201 A 319 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 359 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 14.41 12.40 16.42 12.92 13.74 15.71 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 12.25 13.04 23.85 11.56 15.02 23.93 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 10.89 14.95 28.28 12.39 12.53 29.31 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 319 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 359 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 14.41 12.40 16.42 12.92 13.74 15.71 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 12.25 13.04 23.85 11.56 15.02 23.93 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 10.89 14.95 28.28 12.39 12.53 29.31 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 A 317 GLU C 72 GLU~? 5.32 O ACT C 201 A 319 ASP C 74 ASP^? 14.86 O ACT C 201 A 359 ARG C 76 ARG^? 14.32 O ACT C 201 coo 14.41 12.40 16.42 12.92 13.74 15.71 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 12.25 13.04 23.85 11.56 15.02 23.93 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 10.89 14.95 28.28 12.39 12.53 29.31 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 A 317 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 319 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 359 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 14.41 12.40 16.42 12.92 13.74 15.71 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 12.25 13.04 23.85 11.56 15.02 23.93 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 10.89 14.95 28.28 12.39 12.53 29.31 -47.81 74.29 36.53 -48.87 77.02 37.43 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 4 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 27 GLU~? 9.74 CH3 ACT A 201 B 319 ASP A 28 ASP~? 12.70 CH3 ACT A 201 B 359 ARG A 37 ARG~? 13.73 CH3 ACT A 201 coo 10.77 13.13 40.94 11.03 14.73 39.51 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 3.77 12.64 38.21 3.35 14.53 37.39 -32.24 81.95 65.60 -33.17 83.07 67.14 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -28.83 80.54 58.97 -30.62 82.33 60.70 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU A 36 GLU~? 17.83 CH3 ACT A 201 B 319 ASP A 34 ASP~? 14.63 O ACT A 201 B 359 ARG A 33 ARG.? 12.39 O ACT A 201 coo 10.77 13.13 40.94 11.03 14.73 39.51 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 3.77 12.64 38.21 3.35 14.53 37.39 -30.67 77.29 56.10 -29.14 77.80 54.72 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 319 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 359 ARG A 33 ARG.? 12.39 O ACT A 201 coo 10.77 13.13 40.94 11.03 14.73 39.51 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 3.77 12.64 38.21 3.35 14.53 37.39 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU B 27 GLU~? 9.83 CH3 ACT B 201 B 319 ASP B 28 ASP~? 12.70 CH3 ACT B 201 B 359 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 10.77 13.13 40.94 11.03 14.73 39.51 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 3.77 12.64 38.21 3.35 14.53 37.39 -24.83 51.75 92.00 -22.77 52.17 91.83 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 B 317 GLU B 36 GLU~? 17.47 CH3 ACT B 201 B 319 ASP B 34 ASP~? 14.61 OXT ACT B 201 B 359 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 10.77 13.13 40.94 11.03 14.73 39.51 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 3.77 12.64 38.21 3.35 14.53 37.39 -34.29 46.44 92.12 -35.67 46.00 93.67 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 B 317 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 319 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 359 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 10.77 13.13 40.94 11.03 14.73 39.51 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 3.77 12.64 38.21 3.35 14.53 37.39 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 7 3 # 7 B 317 GLU C 27 GLU~? 9.88 CH3 ACT C 201 B 319 ASP C 28 ASP~? 12.80 CH3 ACT C 201 B 359 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo 10.77 13.13 40.94 11.03 14.73 39.51 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 3.77 12.64 38.21 3.35 14.53 37.39 -35.43 36.60 50.52 -37.00 35.22 50.19 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 8 3 # 8 B 317 GLU C 36 GLU~? 15.95 O2 EDO A 302 B 319 ASP C 34 ASP~? 14.66 O ACT C 201 B 359 ARG C 33 ARG.? 12.41 O ACT C 201 coo 10.77 13.13 40.94 11.03 14.73 39.51 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 3.77 12.64 38.21 3.35 14.53 37.39 -27.83 42.08 55.68 -25.73 41.87 55.54 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 9 3 # 9 B 317 GLU C 96 GLU^? 13.00 O ACT C 201 B 319 ASP C 74 ASP^? 14.86 O ACT C 201 B 359 ARG C 33 ARG.? 12.41 O ACT C 201 coo 10.77 13.13 40.94 11.03 14.73 39.51 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 3.77 12.64 38.21 3.35 14.53 37.39 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 10 3 # 10 B 317 GLU D 27 GLU~? 9.75 CH3 ACT D 201 B 319 ASP D 28 ASP~? 12.70 CH3 ACT D 201 B 359 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 10.77 13.13 40.94 11.03 14.73 39.51 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 3.77 12.64 38.21 3.35 14.53 37.39 -55.65 65.73 30.36 -54.18 65.67 28.83 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 11 3 # 11 B 317 GLU D 36 GLU~? 17.76 CH3 ACT D 201 B 319 ASP D 34 ASP~? 14.62 OXT ACT D 201 B 359 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo 10.77 13.13 40.94 11.03 14.73 39.51 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 3.77 12.64 38.21 3.35 14.53 37.39 -62.38 69.46 37.89 -64.50 69.55 37.91 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -55.21 72.58 39.53 -56.74 74.11 37.37 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 12 3 # 12 B 317 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 319 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 359 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo 10.77 13.13 40.94 11.03 14.73 39.51 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 3.77 12.64 38.21 3.35 14.53 37.39 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -55.21 72.58 39.53 -56.74 74.11 37.37 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 12 hits 1fr8_c01 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG B 24 ARG~? 14.02 CH3 ACT B 201 A 201 HIS B 141 HIS.? 15.94 CH3 ACT A 202 A 204 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -20.35 54.64 90.03 -19.09 51.96 89.19 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -16.42 43.62 79.59 -14.76 44.89 79.44 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 201 HIS B 141 HIS.? 15.94 CH3 ACT A 202 A 204 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -16.42 43.62 79.59 -14.76 44.89 79.44 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 3 3 # 3 A 197 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 201 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 204 HIS B 141 HIS.? 15.94 CH3 ACT A 202 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -16.30 48.49 82.95 -17.03 48.20 81.01 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -16.42 43.62 79.59 -14.76 44.89 79.44 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 4 3 # 4 A 197 ARG B 123 ARG.? 17.76 O ACT B 201 A 201 HIS A 161 HIS.? 19.24 O ACT B 201 A 204 HIS B 56 HIS.? 17.31 O ACT B 201 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -38.78 69.90 87.63 -38.44 71.99 85.40 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -48.72 65.75 79.30 -49.45 66.41 81.15 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -48.13 62.85 85.87 -48.38 63.10 83.80 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 5 3 # 5 A 197 ARG B 124 ARG.? -3.52 O ACT B 201s A 201 HIS A 161 HIS.? 19.24 O ACT B 201 A 204 HIS B 56 HIS.? 17.31 O ACT B 201 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -48.72 65.75 79.30 -49.45 66.41 81.15 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -48.13 62.85 85.87 -48.38 63.10 83.80 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 6 3 # 6 A 197 ARG B 146 ARG.? 16.58 CH3 ACT B 201 A 201 HIS B 141 HIS.? 15.94 CH3 ACT A 202 A 204 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -21.21 49.21 92.90 -18.50 50.59 92.50 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -16.42 43.62 79.59 -14.76 44.89 79.44 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 7 3 # 7 A 197 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 201 HIS D 141 HIS.? 18.95 OXT ACT D 201 A 204 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -42.77 77.11 33.23 -41.72 76.77 31.45 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -44.04 70.63 29.61 -43.01 70.81 31.43 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 8 3 # 8 A 197 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 201 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 204 HIS D 141 HIS.? 18.95 OXT ACT D 201 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -44.04 70.63 29.61 -43.01 70.81 31.43 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -42.77 77.11 33.23 -41.72 76.77 31.45 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 9 3 # 9 A 197 ARG D 146 ARG.? 16.60 CH3 ACT D 201 A 201 HIS D 141 HIS.? 18.95 OXT ACT D 201 A 204 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -54.51 68.83 27.22 -52.30 68.02 25.26 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -42.77 77.11 33.23 -41.72 76.77 31.45 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -44.04 70.63 29.61 -43.01 70.81 31.43 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 9 hits 1g8f_c00 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 30 TRP~? -4.28 CH3 ACT A 201s A 317 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 365 ARG A 8 ARG.? 15.23 CH3 ACT A 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 85.55 26.30 41.25 85.59 24.97 39.65 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 83.47 25.30 27.10 83.44 27.82 25.29 -20.16 79.98 64.14 -22.57 80.76 62.41 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP A 69 TRP~? 6.39 O ACT A 201 A 317 GLU A 72 GLU~? 5.31 O ACT A 201 A 365 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 79.91 26.87 38.77 78.95 23.18 37.81 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 85.55 26.30 41.25 85.59 24.97 39.65 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 83.47 25.30 27.10 83.44 27.82 25.29 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 3 3 # 3 A 314 TRP A 69 TRP~? 6.39 O ACT A 201 A 317 GLU A 72 GLU~? 5.31 O ACT A 201 A 365 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 79.91 26.87 38.77 78.95 23.18 37.81 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 85.55 26.30 41.25 85.59 24.97 39.65 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 83.47 25.30 27.10 83.44 27.82 25.29 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 4 3 # 4 A 314 TRP A 82 TRP^? 14.68 O ACT B 201 A 317 GLU B 114 GLU^? 18.04 O ACT B 201 A 365 ARG A 16 ARG~? 19.68 CH3 ACT A 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -30.38 69.86 83.05 -34.07 70.22 84.37 coo 85.55 26.30 41.25 85.59 24.97 39.65 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 83.47 25.30 27.10 83.44 27.82 25.29 -29.16 81.79 84.92 -31.07 79.42 84.55 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 5 3 # 5 A 314 TRP A 82 TRP^? 14.68 O ACT B 201 A 317 GLU B 114 GLU^? 18.04 O ACT B 201 A 365 ARG B 49 ARG^? 10.37 O ACT B 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -30.38 69.86 83.05 -34.07 70.22 84.37 coo 85.55 26.30 41.25 85.59 24.97 39.65 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 83.47 25.30 27.10 83.44 27.82 25.29 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 6 3 # 6 A 314 TRP B 69 TRP~? 6.43 OXT ACT B 201 A 317 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 365 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -34.09 46.73 83.20 -34.39 49.33 86.13 coo 85.55 26.30 41.25 85.59 24.97 39.65 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 83.47 25.30 27.10 83.44 27.82 25.29 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 7 3 # 7 A 314 TRP B 69 TRP~? 6.43 OXT ACT B 201 A 317 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 365 ARG B 124 ARG.? -3.52 O ACT B 201s coo 79.91 26.87 38.77 78.95 23.18 37.81 -34.09 46.73 83.20 -34.39 49.33 86.13 coo 85.55 26.30 41.25 85.59 24.97 39.65 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 83.47 25.30 27.10 83.44 27.82 25.29 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 8 3 # 8 A 314 TRP B 82 TRP^? 9.86 O ACT A 202 A 317 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 365 ARG A 49 ARG^? -3.92 O ACT A 202s coo 79.91 26.87 38.77 78.95 23.18 37.81 -23.37 68.40 78.71 -20.56 66.90 76.39 coo 85.55 26.30 41.25 85.59 24.97 39.65 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 83.47 25.30 27.10 83.44 27.82 25.29 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 9 3 # 9 A 314 TRP B 82 TRP^? 9.86 O ACT A 202 A 317 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 365 ARG B 16 ARG~? 17.22 CH3 ACT A 202 coo 79.91 26.87 38.77 78.95 23.18 37.81 -23.37 68.40 78.71 -20.56 66.90 76.39 coo 85.55 26.30 41.25 85.59 24.97 39.65 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 83.47 25.30 27.10 83.44 27.82 25.29 -15.28 68.46 88.00 -14.07 65.73 87.25 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 10 3 # 10 A 314 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 317 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 365 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 85.55 26.30 41.25 85.59 24.97 39.65 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 83.47 25.30 27.10 83.44 27.82 25.29 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 11 3 # 11 A 314 TRP B 97 TRP^? 8.79 OXT ACT B 201 A 317 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 365 ARG B 51 ARG.? 7.67 O ACT B 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 85.55 26.30 41.25 85.59 24.97 39.65 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 83.47 25.30 27.10 83.44 27.82 25.29 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 12 3 # 12 A 314 TRP C 30 TRP~? -4.24 CH3 ACT C 201s A 317 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 365 ARG C 8 ARG.? 14.74 CH3 ACT C 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 85.55 26.30 41.25 85.59 24.97 39.65 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 83.47 25.30 27.10 83.44 27.82 25.29 -27.18 40.10 42.21 -27.55 39.63 45.22 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 13 3 # 13 A 314 TRP C 69 TRP~? 6.41 O ACT C 201 A 317 GLU C 72 GLU~? 5.32 O ACT C 201 A 365 ARG C 76 ARG^? 14.32 O ACT C 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 85.55 26.30 41.25 85.59 24.97 39.65 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 83.47 25.30 27.10 83.44 27.82 25.29 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 14 3 # 14 A 314 TRP C 69 TRP~? 6.41 O ACT C 201 A 317 GLU C 72 GLU~? 5.32 O ACT C 201 A 365 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 79.91 26.87 38.77 78.95 23.18 37.81 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 85.55 26.30 41.25 85.59 24.97 39.65 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 83.47 25.30 27.10 83.44 27.82 25.29 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 15 3 # 15 A 314 TRP C 82 TRP^? 14.73 O ACT D 201 A 317 GLU D 114 GLU^? 18.05 O ACT D 201 A 365 ARG C 16 ARG~? 20.89 CH3 ACT C 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -49.41 47.73 38.89 -52.68 46.73 40.85 coo 85.55 26.30 41.25 85.59 24.97 39.65 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 83.47 25.30 27.10 83.44 27.82 25.29 -48.56 36.19 35.88 -49.41 34.92 38.55 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 16 3 # 16 A 314 TRP C 82 TRP^? 14.73 O ACT D 201 A 317 GLU D 114 GLU^? 18.05 O ACT D 201 A 365 ARG D 49 ARG^? 10.44 O ACT D 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -49.41 47.73 38.89 -52.68 46.73 40.85 coo 85.55 26.30 41.25 85.59 24.97 39.65 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 83.47 25.30 27.10 83.44 27.82 25.29 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 17 3 # 17 A 314 TRP D 30 TRP~? -4.23 CH3 ACT D 201s A 317 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 365 ARG D 8 ARG.? 14.56 CH3 ACT D 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -55.89 62.34 37.62 -55.77 61.79 41.52 coo 85.55 26.30 41.25 85.59 24.97 39.65 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 83.47 25.30 27.10 83.44 27.82 25.29 -64.40 57.42 32.12 -63.44 60.33 32.35 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 18 3 # 18 A 314 TRP D 69 TRP~? 6.43 OXT ACT D 201 A 317 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 365 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -55.42 69.82 43.51 -57.48 67.10 41.55 coo 85.55 26.30 41.25 85.59 24.97 39.65 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 83.47 25.30 27.10 83.44 27.82 25.29 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 19 3 # 19 A 314 TRP D 69 TRP~? 6.43 OXT ACT D 201 A 317 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 365 ARG D 124 ARG.? -3.55 O ACT D 201s coo 79.91 26.87 38.77 78.95 23.18 37.81 -55.42 69.82 43.51 -57.48 67.10 41.55 coo 85.55 26.30 41.25 85.59 24.97 39.65 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 83.47 25.30 27.10 83.44 27.82 25.29 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 20 3 # 20 A 314 TRP D 82 TRP^? 14.82 OXT ACT C 201 A 317 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 365 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -41.91 50.50 36.33 -38.54 52.46 35.78 coo 85.55 26.30 41.25 85.59 24.97 39.65 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 83.47 25.30 27.10 83.44 27.82 25.29 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 21 3 # 21 A 314 TRP D 82 TRP^? 14.82 OXT ACT C 201 A 317 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 365 ARG D 16 ARG~? 19.88 CH3 ACT D 201 coo 79.91 26.87 38.77 78.95 23.18 37.81 -41.91 50.50 36.33 -38.54 52.46 35.78 coo 85.55 26.30 41.25 85.59 24.97 39.65 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 83.47 25.30 27.10 83.44 27.82 25.29 -43.87 51.07 24.49 -42.60 51.26 27.28 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 21 hits 1g8o_c01 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU A 96 GLU^? 11.70 OXT ACT A 203 516 HIS A 151 HIS.? 15.97 CH3 ACT A 201 559 HIS A 141 HIS.? 11.20 OXT ACT A 203 coo 49.01 14.50 52.53 46.99 14.61 52.78 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 41.59 7.83 54.15 41.16 9.87 53.87 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 42.22 14.55 52.50 43.91 14.87 53.60 -49.96 77.41 66.16 -51.01 75.70 66.78 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 2 3 # 2 412 GLU A 137 GLU~? 14.03 O ACT A 203 516 HIS A 161 HIS.? 19.24 O ACT B 201 559 HIS A 162 HIS.? 14.54 O1 EDO A 301 coo 49.01 14.50 52.53 46.99 14.61 52.78 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 41.59 7.83 54.15 41.16 9.87 53.87 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 42.22 14.55 52.50 43.91 14.87 53.60 -51.28 62.77 74.01 -50.27 62.16 72.28 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 3 3 # 3 412 GLU A 160 GLU.? 13.50 O ACT A 201 516 HIS A 162 HIS.? 14.54 O1 EDO A 301 559 HIS A 161 HIS.? 19.24 O ACT B 201 coo 49.01 14.50 52.53 46.99 14.61 52.78 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 41.59 7.83 54.15 41.16 9.87 53.87 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 42.22 14.55 52.50 43.91 14.87 53.60 -48.72 65.75 79.30 -49.45 66.41 81.15 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 4 3 # 4 412 GLU C 96 GLU^? 13.00 O ACT C 201 516 HIS C 151 HIS.? 16.03 CH3 ACT C 201 559 HIS C 141 HIS.? 17.85 O ACT C 201 coo 49.01 14.50 52.53 46.99 14.61 52.78 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 41.59 7.83 54.15 41.16 9.87 53.87 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 42.22 14.55 52.50 43.91 14.87 53.60 -47.33 38.55 64.23 -48.23 40.22 65.13 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 4 hits 1gal_c00 naa= 3 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 B 1 CYH A 127 CYH.? 6.15 O ACT A 202 B 98 ASN A 110 ASN^? 10.87 O ACT B 201 B 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 60.40 53.51 86.58 58.33 55.30 85.83 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 61.33 49.28 88.22 61.64 50.04 86.28 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 60.75 49.64 92.68 61.49 50.04 92.62 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 B 1 CYH A 127 CYH.? 6.15 O ACT A 202 B 98 ASN B 110 ASN^? 6.46 O ACT A 202 B 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo 60.40 53.51 86.58 58.33 55.30 85.83 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 61.33 49.28 88.22 61.64 50.04 86.28 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 60.75 49.64 92.68 61.49 50.04 92.62 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 3 # 3 B 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 B 98 ASN A 110 ASN^? 10.87 O ACT B 201 B 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 60.40 53.51 86.58 58.33 55.30 85.83 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 61.33 49.28 88.22 61.64 50.04 86.28 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 60.75 49.64 92.68 61.49 50.04 92.62 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 3 # 4 B 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 B 98 ASN B 110 ASN^? 6.46 O ACT A 202 B 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo 60.40 53.51 86.58 58.33 55.30 85.83 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 61.33 49.28 88.22 61.64 50.04 86.28 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 60.75 49.64 92.68 61.49 50.04 92.62 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 3 # 5 B 1 CYH C 127 CYH.? 10.01 O ACT D 201 B 98 ASN C 110 ASN^? 10.92 O ACT D 201 B 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 60.40 53.51 86.58 58.33 55.30 85.83 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 61.33 49.28 88.22 61.64 50.04 86.28 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 60.75 49.64 92.68 61.49 50.04 92.62 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 3 # 6 B 1 CYH C 127 CYH.? 10.01 O ACT D 201 B 98 ASN D 110 ASN^? 10.92 OXT ACT C 201 B 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo 60.40 53.51 86.58 58.33 55.30 85.83 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 61.33 49.28 88.22 61.64 50.04 86.28 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 60.75 49.64 92.68 61.49 50.04 92.62 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 7 3 # 7 B 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 B 98 ASN C 110 ASN^? 10.92 O ACT D 201 B 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 60.40 53.51 86.58 58.33 55.30 85.83 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 61.33 49.28 88.22 61.64 50.04 86.28 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 60.75 49.64 92.68 61.49 50.04 92.62 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 8 3 # 8 B 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 B 98 ASN D 110 ASN^? 10.92 OXT ACT C 201 B 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo 60.40 53.51 86.58 58.33 55.30 85.83 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 61.33 49.28 88.22 61.64 50.04 86.28 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 60.75 49.64 92.68 61.49 50.04 92.62 -45.26 59.49 43.22 -44.76 59.46 42.64 1gdo_c00 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 8 hits 1gdo_c00 naa= 3 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 D 1 CYH A 127 CYH.? 6.15 O ACT A 202 D 98 ASN A 110 ASN^? 10.87 O ACT B 201 D 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 45.17 35.76 43.57 47.17 33.90 42.78 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 44.24 40.01 45.19 43.94 39.25 43.24 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 44.81 39.60 49.65 44.07 39.23 49.57 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 D 1 CYH A 127 CYH.? 6.15 O ACT A 202 D 98 ASN B 110 ASN^? 6.46 O ACT A 202 D 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo 45.17 35.76 43.57 47.17 33.90 42.78 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 44.24 40.01 45.19 43.94 39.25 43.24 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 44.81 39.60 49.65 44.07 39.23 49.57 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 3 # 3 D 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 D 98 ASN A 110 ASN^? 10.87 O ACT B 201 D 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 45.17 35.76 43.57 47.17 33.90 42.78 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 44.24 40.01 45.19 43.94 39.25 43.24 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 44.81 39.60 49.65 44.07 39.23 49.57 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 3 # 4 D 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 D 98 ASN B 110 ASN^? 6.46 O ACT A 202 D 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo 45.17 35.76 43.57 47.17 33.90 42.78 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 44.24 40.01 45.19 43.94 39.25 43.24 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 44.81 39.60 49.65 44.07 39.23 49.57 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 3 # 5 D 1 CYH C 127 CYH.? 10.01 O ACT D 201 D 98 ASN C 110 ASN^? 10.92 O ACT D 201 D 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 45.17 35.76 43.57 47.17 33.90 42.78 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 44.24 40.01 45.19 43.94 39.25 43.24 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 44.81 39.60 49.65 44.07 39.23 49.57 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 3 # 6 D 1 CYH C 127 CYH.? 10.01 O ACT D 201 D 98 ASN D 110 ASN^? 10.92 OXT ACT C 201 D 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo 45.17 35.76 43.57 47.17 33.90 42.78 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 44.24 40.01 45.19 43.94 39.25 43.24 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 44.81 39.60 49.65 44.07 39.23 49.57 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 7 3 # 7 D 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 D 98 ASN C 110 ASN^? 10.92 O ACT D 201 D 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 45.17 35.76 43.57 47.17 33.90 42.78 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 44.24 40.01 45.19 43.94 39.25 43.24 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 44.81 39.60 49.65 44.07 39.23 49.57 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 8 3 # 8 D 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 D 98 ASN D 110 ASN^? 10.92 OXT ACT C 201 D 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo 45.17 35.76 43.57 47.17 33.90 42.78 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 44.24 40.01 45.19 43.94 39.25 43.24 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 44.81 39.60 49.65 44.07 39.23 49.57 -45.26 59.49 43.22 -44.76 59.46 42.64 1gdo_c01 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 8 hits 1gdo_c01 naa= 3 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 A 1 CYH A 127 CYH.? 6.15 O ACT A 202 A 98 ASN A 110 ASN^? 10.87 O ACT B 201 A 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 A 1 CYH A 127 CYH.? 6.15 O ACT A 202 A 98 ASN B 110 ASN^? 6.46 O ACT A 202 A 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 3 # 3 A 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 A 98 ASN A 110 ASN^? 10.87 O ACT B 201 A 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 3 # 4 A 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 A 98 ASN B 110 ASN^? 6.46 O ACT A 202 A 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 3 # 5 A 1 CYH C 127 CYH.? 10.01 O ACT D 201 A 98 ASN C 110 ASN^? 10.92 O ACT D 201 A 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 3 # 6 A 1 CYH C 127 CYH.? 10.01 O ACT D 201 A 98 ASN D 110 ASN^? 10.92 OXT ACT C 201 A 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 7 3 # 7 A 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 A 98 ASN C 110 ASN^? 10.92 O ACT D 201 A 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 8 3 # 8 A 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 A 98 ASN D 110 ASN^? 10.92 OXT ACT C 201 A 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -45.26 59.49 43.22 -44.76 59.46 42.64 1gdo_c02 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 8 hits 1gdo_c02 naa= 3 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 C 1 CYH A 127 CYH.? 6.15 O ACT A 202 C 98 ASN A 110 ASN^? 10.87 O ACT B 201 C 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 25.27 14.39 86.45 23.28 16.25 85.80 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 25.97 10.04 88.17 26.35 10.81 86.26 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 25.32 10.47 92.61 26.06 10.86 92.54 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 C 1 CYH A 127 CYH.? 6.15 O ACT A 202 C 98 ASN B 110 ASN^? 6.46 O ACT A 202 C 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo 25.27 14.39 86.45 23.28 16.25 85.80 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 25.97 10.04 88.17 26.35 10.81 86.26 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 25.32 10.47 92.61 26.06 10.86 92.54 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 3 # 3 C 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 C 98 ASN A 110 ASN^? 10.87 O ACT B 201 C 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 25.27 14.39 86.45 23.28 16.25 85.80 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 25.97 10.04 88.17 26.35 10.81 86.26 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 25.32 10.47 92.61 26.06 10.86 92.54 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 3 # 4 C 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 C 98 ASN B 110 ASN^? 6.46 O ACT A 202 C 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo 25.27 14.39 86.45 23.28 16.25 85.80 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 25.97 10.04 88.17 26.35 10.81 86.26 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 25.32 10.47 92.61 26.06 10.86 92.54 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 3 # 5 C 1 CYH C 127 CYH.? 10.01 O ACT D 201 C 98 ASN C 110 ASN^? 10.92 O ACT D 201 C 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 25.27 14.39 86.45 23.28 16.25 85.80 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 25.97 10.04 88.17 26.35 10.81 86.26 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 25.32 10.47 92.61 26.06 10.86 92.54 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 3 # 6 C 1 CYH C 127 CYH.? 10.01 O ACT D 201 C 98 ASN D 110 ASN^? 10.92 OXT ACT C 201 C 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo 25.27 14.39 86.45 23.28 16.25 85.80 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 25.97 10.04 88.17 26.35 10.81 86.26 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 25.32 10.47 92.61 26.06 10.86 92.54 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 7 3 # 7 C 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 C 98 ASN C 110 ASN^? 10.92 O ACT D 201 C 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 25.27 14.39 86.45 23.28 16.25 85.80 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 25.97 10.04 88.17 26.35 10.81 86.26 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 25.32 10.47 92.61 26.06 10.86 92.54 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 8 3 # 8 C 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 C 98 ASN D 110 ASN^? 10.92 OXT ACT C 201 C 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo 25.27 14.39 86.45 23.28 16.25 85.80 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 25.97 10.04 88.17 26.35 10.81 86.26 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 25.32 10.47 92.61 26.06 10.86 92.54 -45.26 59.49 43.22 -44.76 59.46 42.64 1gdo_c03 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 8 hits 1gdo_c03 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 72 GLU~? 5.31 O ACT A 201 A 47 ASP A 34 ASP~? 14.63 O ACT A 201 A 161 TYR A 75 TYR^? -4.52 O ACT A 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 29.81 8.06 73.13 30.21 10.11 72.95 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 37.29 15.56 67.90 37.37 13.79 70.08 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 47 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 161 TYR A 95 TYR^? -3.85 O ACT A 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 29.81 8.06 73.13 30.21 10.11 72.95 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 37.29 15.56 67.90 37.37 13.79 70.08 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 47 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 161 TYR A 93 TYR^? -4.07 CH3 ACT A 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 29.81 8.06 73.13 30.21 10.11 72.95 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 37.29 15.56 67.90 37.37 13.79 70.08 -34.34 70.13 71.57 -32.99 68.09 70.18 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 A 36 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 47 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 161 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 29.81 8.06 73.13 30.21 10.11 72.95 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 37.29 15.56 67.90 37.37 13.79 70.08 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 A 36 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 47 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 161 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 29.81 8.06 73.13 30.21 10.11 72.95 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 37.29 15.56 67.90 37.37 13.79 70.08 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 A 36 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 47 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 161 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 29.81 8.06 73.13 30.21 10.11 72.95 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 37.29 15.56 67.90 37.37 13.79 70.08 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 A 36 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 47 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 161 TYR B 93 TYR^? -4.16 CH3 ACT B 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 29.81 8.06 73.13 30.21 10.11 72.95 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 37.29 15.56 67.90 37.37 13.79 70.08 -27.85 57.31 80.17 -30.64 57.51 79.89 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 8 3 # 8 A 36 GLU C 72 GLU~? 5.32 O ACT C 201 A 47 ASP C 34 ASP~? 14.66 O ACT C 201 A 161 TYR C 75 TYR^? -4.54 O ACT C 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 29.81 8.06 73.13 30.21 10.11 72.95 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 37.29 15.56 67.90 37.37 13.79 70.08 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 9 3 # 9 A 36 GLU C 96 GLU^? 13.00 O ACT C 201 A 47 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 161 TYR C 95 TYR^? -3.84 O ACT C 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 29.81 8.06 73.13 30.21 10.11 72.95 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 37.29 15.56 67.90 37.37 13.79 70.08 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 10 3 # 10 A 36 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 47 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 161 TYR C 93 TYR^? -4.09 CH3 ACT C 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 29.81 8.06 73.13 30.21 10.11 72.95 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 37.29 15.56 67.90 37.37 13.79 70.08 -43.00 47.58 49.22 -41.38 49.87 49.22 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 11 3 # 11 A 36 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 47 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 161 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 29.81 8.06 73.13 30.21 10.11 72.95 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 37.29 15.56 67.90 37.37 13.79 70.08 -52.06 69.71 41.47 -52.08 66.98 40.85 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 12 3 # 12 A 36 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 47 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 161 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 29.81 8.06 73.13 30.21 10.11 72.95 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 37.29 15.56 67.90 37.37 13.79 70.08 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 13 3 # 13 A 36 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 47 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 161 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 29.81 8.06 73.13 30.21 10.11 72.95 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 37.29 15.56 67.90 37.37 13.79 70.08 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 14 3 # 14 A 36 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 47 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 161 TYR D 93 TYR^? -4.14 CH3 ACT D 201s coo 37.12 18.35 73.76 37.09 16.69 72.44 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 29.81 8.06 73.13 30.21 10.11 72.95 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 37.29 15.56 67.90 37.37 13.79 70.08 -47.46 60.74 39.76 -48.96 60.10 42.05 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 14 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 72 GLU~? 5.31 O ACT A 201 B 47 ASP A 34 ASP~? 14.63 O ACT A 201 B 161 TYR A 75 TYR^? -4.52 O ACT A 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 63.47 43.65 53.95 61.45 43.07 54.06 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 56.38 35.81 59.19 58.25 35.77 57.10 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 47 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 161 TYR A 95 TYR^? -3.85 O ACT A 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 63.47 43.65 53.95 61.45 43.07 54.06 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 56.38 35.81 59.19 58.25 35.77 57.10 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU A 111 GLU^? 4.34 CH3 ACT A 201 B 47 ASP A 28 ASP~? 12.70 CH3 ACT A 201 B 161 TYR A 93 TYR^? -4.07 CH3 ACT A 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 63.47 43.65 53.95 61.45 43.07 54.06 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 56.38 35.81 59.19 58.25 35.77 57.10 -34.34 70.13 71.57 -32.99 68.09 70.18 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 B 36 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 47 ASP B 34 ASP~? 14.61 OXT ACT B 201 B 161 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 63.47 43.65 53.95 61.45 43.07 54.06 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 56.38 35.81 59.19 58.25 35.77 57.10 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 B 36 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 47 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 161 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 63.47 43.65 53.95 61.45 43.07 54.06 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 56.38 35.81 59.19 58.25 35.77 57.10 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 B 36 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 47 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 161 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 63.47 43.65 53.95 61.45 43.07 54.06 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 56.38 35.81 59.19 58.25 35.77 57.10 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 B 36 GLU B 111 GLU^? 4.46 CH3 ACT B 201 B 47 ASP B 28 ASP~? 12.70 CH3 ACT B 201 B 161 TYR B 93 TYR^? -4.16 CH3 ACT B 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 63.47 43.65 53.95 61.45 43.07 54.06 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 56.38 35.81 59.19 58.25 35.77 57.10 -27.85 57.31 80.17 -30.64 57.51 79.89 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 8 3 # 8 B 36 GLU C 72 GLU~? 5.32 O ACT C 201 B 47 ASP C 34 ASP~? 14.66 O ACT C 201 B 161 TYR C 75 TYR^? -4.54 O ACT C 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 63.47 43.65 53.95 61.45 43.07 54.06 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 56.38 35.81 59.19 58.25 35.77 57.10 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 9 3 # 9 B 36 GLU C 96 GLU^? 13.00 O ACT C 201 B 47 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 161 TYR C 95 TYR^? -3.84 O ACT C 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 63.47 43.65 53.95 61.45 43.07 54.06 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 56.38 35.81 59.19 58.25 35.77 57.10 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 10 3 # 10 B 36 GLU C 111 GLU^? 4.32 CH3 ACT C 201 B 47 ASP C 28 ASP~? 12.80 CH3 ACT C 201 B 161 TYR C 93 TYR^? -4.09 CH3 ACT C 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 63.47 43.65 53.95 61.45 43.07 54.06 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 56.38 35.81 59.19 58.25 35.77 57.10 -43.00 47.58 49.22 -41.38 49.87 49.22 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 11 3 # 11 B 36 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 47 ASP D 34 ASP~? 14.62 OXT ACT D 201 B 161 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 63.47 43.65 53.95 61.45 43.07 54.06 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 56.38 35.81 59.19 58.25 35.77 57.10 -52.06 69.71 41.47 -52.08 66.98 40.85 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 12 3 # 12 B 36 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 47 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 161 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 63.47 43.65 53.95 61.45 43.07 54.06 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 56.38 35.81 59.19 58.25 35.77 57.10 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 13 3 # 13 B 36 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 47 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 161 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 63.47 43.65 53.95 61.45 43.07 54.06 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 56.38 35.81 59.19 58.25 35.77 57.10 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 14 3 # 14 B 36 GLU D 111 GLU^? 4.46 CH3 ACT D 201 B 47 ASP D 28 ASP~? 12.70 CH3 ACT D 201 B 161 TYR D 93 TYR^? -4.14 CH3 ACT D 201s coo 53.87 35.49 53.22 55.44 35.72 54.61 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 63.47 43.65 53.95 61.45 43.07 54.06 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 56.38 35.81 59.19 58.25 35.77 57.10 -47.46 60.74 39.76 -48.96 60.10 42.05 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 14 hits 1geq_c03 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 64 HIS A 98 HIS^? -3.60 C ACT A 203s A 155 ASN C 129 ASN.? 9.72 O ACT D 201 coo 3.12 38.70 24.20 3.24 38.59 26.33 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 1.90 38.00 29.77 3.91 38.35 29.95 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.89 36.55 37.38 9.27 37.99 36.08 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 64 HIS A 98 HIS^? -3.60 C ACT A 203s A 155 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 3.12 38.70 24.20 3.24 38.59 26.33 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 1.90 38.00 29.77 3.91 38.35 29.95 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.89 36.55 37.38 9.27 37.99 36.08 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 1gns_c00 SUBTILISIN BPN' user 3 3 # 3 A 32 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 64 HIS A 98 HIS^? -3.60 C ACT A 203s A 155 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 3.12 38.70 24.20 3.24 38.59 26.33 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 1.90 38.00 29.77 3.91 38.35 29.95 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.89 36.55 37.38 9.27 37.99 36.08 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 1gns_c00 SUBTILISIN BPN' user 4 3 # 4 A 32 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 64 HIS A 98 HIS^? -3.60 C ACT A 203s A 155 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 3.12 38.70 24.20 3.24 38.59 26.33 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 1.90 38.00 29.77 3.91 38.35 29.95 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.89 36.55 37.38 9.27 37.99 36.08 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 1gns_c00 SUBTILISIN BPN' user 5 3 # 5 A 32 ASP A 150 ASP.? 22.07 CH3 ACT A 201 A 64 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 155 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 3.12 38.70 24.20 3.24 38.59 26.33 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 1.90 38.00 29.77 3.91 38.35 29.95 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 9.89 36.55 37.38 9.27 37.99 36.08 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 1gns_c00 SUBTILISIN BPN' user 6 3 # 6 A 32 ASP B 150 ASP.? 20.21 CH3 ACT A 202 A 64 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 155 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo 3.12 38.70 24.20 3.24 38.59 26.33 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 1.90 38.00 29.77 3.91 38.35 29.95 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 9.89 36.55 37.38 9.27 37.99 36.08 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 3 1gns_c00 SUBTILISIN BPN' user 7 3 # 7 A 32 ASP C 74 ASP^? 14.86 O ACT C 201 A 64 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 155 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 3.12 38.70 24.20 3.24 38.59 26.33 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 1.90 38.00 29.77 3.91 38.35 29.95 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.89 36.55 37.38 9.27 37.99 36.08 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1gns_c00 SUBTILISIN BPN' user 8 3 # 8 A 32 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 64 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 155 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 3.12 38.70 24.20 3.24 38.59 26.33 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 1.90 38.00 29.77 3.91 38.35 29.95 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.89 36.55 37.38 9.27 37.99 36.08 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 1gns_c00 SUBTILISIN BPN' user 9 3 # 9 A 32 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 64 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 155 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 3.12 38.70 24.20 3.24 38.59 26.33 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 1.90 38.00 29.77 3.91 38.35 29.95 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.89 36.55 37.38 9.27 37.99 36.08 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 1gns_c00 SUBTILISIN BPN' user 10 3 # 10 A 32 ASP C 150 ASP.? 20.99 CH3 ACT C 201 A 64 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 155 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo 3.12 38.70 24.20 3.24 38.59 26.33 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 1.90 38.00 29.77 3.91 38.35 29.95 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 9.89 36.55 37.38 9.27 37.99 36.08 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 3 1gns_c00 SUBTILISIN BPN' user 11 3 # 11 A 32 ASP D 150 ASP.? 21.68 CH3 ACT D 201 A 64 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 155 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 3.12 38.70 24.20 3.24 38.59 26.33 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 1.90 38.00 29.77 3.91 38.35 29.95 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 9.89 36.55 37.38 9.27 37.99 36.08 -53.58 68.96 34.68 -51.50 68.66 35.10 1gns_c00 source 1gns SUBTILISIN BPN' : 11 hits 1gns_c00 naa= 3 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 57 ASN~? 14.18 O1 EDO A 302 A 108 HIS A 56 HIS.? 6.76 O1 EDO A 302 A 144 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo 51.28 61.14 17.85 51.16 61.61 19.96 -16.25 65.99 58.99 -17.06 64.89 57.36 coo 52.62 57.63 23.12 50.77 57.51 22.26 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 46.65 56.95 20.09 48.42 58.17 20.01 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN A 103 ASN.? 7.23 O2 EDO A 301 A 108 HIS A 98 HIS^? -3.60 C ACT A 203s A 144 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 51.28 61.14 17.85 51.16 61.61 19.96 -48.04 61.08 60.88 -48.95 59.43 59.91 coo 52.62 57.63 23.12 50.77 57.51 22.26 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 46.65 56.95 20.09 48.42 58.17 20.01 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 A 106 ASN B 57 ASN~? 18.11 O ACT B 201 A 108 HIS B 56 HIS.? 17.31 O ACT B 201 A 144 ASP B 45 ASP^? 20.35 O ACT B 201 coo 51.28 61.14 17.85 51.16 61.61 19.96 -46.90 59.98 91.63 -48.14 58.47 90.79 coo 52.62 57.63 23.12 50.77 57.51 22.26 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 46.65 56.95 20.09 48.42 58.17 20.01 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 A 106 ASN B 103 ASN.? 17.21 C2 EDO A 302 A 108 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 144 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 51.28 61.14 17.85 51.16 61.61 19.96 -32.39 41.19 68.51 -33.08 39.66 67.21 coo 52.62 57.63 23.12 50.77 57.51 22.26 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 46.65 56.95 20.09 48.42 58.17 20.01 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 3 # 5 A 106 ASN C 103 ASN.? 7.35 O1 EDO A 301 A 108 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 144 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 51.28 61.14 17.85 51.16 61.61 19.96 -44.48 55.23 67.22 -44.54 56.80 68.65 coo 52.62 57.63 23.12 50.77 57.51 22.26 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 46.65 56.95 20.09 48.42 58.17 20.01 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 3 # 6 A 106 ASN D 103 ASN.? 11.64 CH3 ACT A 203 A 108 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 144 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 51.28 61.14 17.85 51.16 61.61 19.96 -43.97 76.72 52.03 -43.49 78.26 53.43 coo 52.62 57.63 23.12 50.77 57.51 22.26 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 46.65 56.95 20.09 48.42 58.17 20.01 -49.03 74.78 51.99 -47.35 75.78 52.80 1grc_c02 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 6 hits 1grc_c02 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 22 LYS~? 15.35 CH3 ACT A 201 210 ARG A 123 ARG.? 8.27 CH3 ACT A 202 225 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 17.51 28.50 73.42 17.24 23.02 75.86 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 24.74 11.56 73.05 25.29 14.32 71.80 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 27.81 15.44 77.10 25.66 16.50 75.19 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 22 LYS~? 15.35 CH3 ACT A 201 210 ARG B 88 ARG^? 18.43 CH3 ACT A 201 225 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 24.74 11.56 73.05 25.29 14.32 71.80 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 27.81 15.44 77.10 25.66 16.50 75.19 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS A 22 LYS~? 15.35 CH3 ACT A 201 210 ARG B 92 ARG^? -3.69 CH3 ACT A 202s 225 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 17.51 28.50 73.42 17.24 23.02 75.86 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 24.74 11.56 73.05 25.29 14.32 71.80 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 27.81 15.44 77.10 25.66 16.50 75.19 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS A 68 LYS~? -2.78 O ACT A 201s 210 ARG A 138 ARG~? 6.49 OXT ACT A 203 225 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 17.51 28.50 73.42 17.24 23.02 75.86 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 24.74 11.56 73.05 25.29 14.32 71.80 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 27.81 15.44 77.10 25.66 16.50 75.19 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 5 3 # 5 160 LYS A 68 LYS~? -2.78 O ACT A 201s 210 ARG D 106 ARG^? 14.88 OXT ACT D 201 225 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 24.74 11.56 73.05 25.29 14.32 71.80 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 27.81 15.44 77.10 25.66 16.50 75.19 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 6 3 # 6 160 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 210 ARG A 88 ARG^? 11.13 CH3 ACT A 202 225 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 17.51 28.50 73.42 17.24 23.02 75.86 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 24.74 11.56 73.05 25.29 14.32 71.80 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 27.81 15.44 77.10 25.66 16.50 75.19 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 7 3 # 7 160 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 210 ARG A 123 ARG.? 8.27 CH3 ACT A 202 225 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo 17.51 28.50 73.42 17.24 23.02 75.86 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 24.74 11.56 73.05 25.29 14.32 71.80 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 27.81 15.44 77.10 25.66 16.50 75.19 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 8 3 # 8 160 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 210 ARG A 123 ARG.? 8.27 CH3 ACT A 202 225 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 17.51 28.50 73.42 17.24 23.02 75.86 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 24.74 11.56 73.05 25.29 14.32 71.80 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 27.81 15.44 77.10 25.66 16.50 75.19 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 9 3 # 9 160 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 210 ARG B 92 ARG^? -3.69 CH3 ACT A 202s 225 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo 17.51 28.50 73.42 17.24 23.02 75.86 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 24.74 11.56 73.05 25.29 14.32 71.80 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 27.81 15.44 77.10 25.66 16.50 75.19 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 10 3 # 10 160 LYS A 139 LYS.? 17.81 O ACT A 201 210 ARG A 24 ARG~? 13.97 CH3 ACT A 201 225 ARG A 146 ARG.? 16.48 CH3 ACT A 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 24.74 11.56 73.05 25.29 14.32 71.80 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 27.81 15.44 77.10 25.66 16.50 75.19 -35.10 85.34 65.39 -35.74 86.54 68.15 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 11 3 # 11 160 LYS A 139 LYS.? 17.81 O ACT A 201 210 ARG A 146 ARG.? 16.48 CH3 ACT A 201 225 ARG A 24 ARG~? 13.97 CH3 ACT A 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 24.74 11.56 73.05 25.29 14.32 71.80 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 27.81 15.44 77.10 25.66 16.50 75.19 -33.88 82.79 71.01 -36.66 83.48 69.87 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 12 3 # 12 160 LYS A 139 LYS.? 17.81 O ACT A 201 210 ARG B 123 ARG.? 17.76 O ACT B 201 225 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 24.74 11.56 73.05 25.29 14.32 71.80 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 27.81 15.44 77.10 25.66 16.50 75.19 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 13 3 # 13 160 LYS B 22 LYS~? 15.43 CH3 ACT B 201 210 ARG A 88 ARG^? 11.13 CH3 ACT A 202 225 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 17.51 28.50 73.42 17.24 23.02 75.86 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 24.74 11.56 73.05 25.29 14.32 71.80 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 27.81 15.44 77.10 25.66 16.50 75.19 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 14 3 # 14 160 LYS B 22 LYS~? 15.43 CH3 ACT B 201 210 ARG A 92 ARG^? 14.09 CH3 ACT A 201 225 ARG B 123 ARG.? 17.76 O ACT B 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 24.74 11.56 73.05 25.29 14.32 71.80 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 27.81 15.44 77.10 25.66 16.50 75.19 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 15 3 # 15 160 LYS B 22 LYS~? 15.43 CH3 ACT B 201 210 ARG B 123 ARG.? 17.76 O ACT B 201 225 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 24.74 11.56 73.05 25.29 14.32 71.80 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 27.81 15.44 77.10 25.66 16.50 75.19 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 16 3 # 16 160 LYS B 68 LYS~? -2.79 OXT ACT B 201s 210 ARG A 49 ARG^? -3.92 O ACT A 202s 225 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 24.74 11.56 73.05 25.29 14.32 71.80 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 27.81 15.44 77.10 25.66 16.50 75.19 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 17 3 # 17 160 LYS B 68 LYS~? -2.79 OXT ACT B 201s 210 ARG B 138 ARG~? 16.35 OXT ACT B 201 225 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 24.74 11.56 73.05 25.29 14.32 71.80 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 27.81 15.44 77.10 25.66 16.50 75.19 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 18 3 # 18 160 LYS B 71 LYS~? 10.83 OXT ACT B 201 210 ARG C 33 ARG.? 12.41 O ACT C 201 225 ARG C 76 ARG^? 14.32 O ACT C 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 24.74 11.56 73.05 25.29 14.32 71.80 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 27.81 15.44 77.10 25.66 16.50 75.19 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 19 3 # 19 160 LYS B 71 LYS~? 10.83 OXT ACT B 201 210 ARG C 76 ARG^? 14.32 O ACT C 201 225 ARG C 33 ARG.? 12.41 O ACT C 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 24.74 11.56 73.05 25.29 14.32 71.80 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 27.81 15.44 77.10 25.66 16.50 75.19 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 20 3 # 20 160 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 210 ARG A 92 ARG^? 14.09 CH3 ACT A 201 225 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 24.74 11.56 73.05 25.29 14.32 71.80 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 27.81 15.44 77.10 25.66 16.50 75.19 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 21 3 # 21 160 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 210 ARG B 88 ARG^? 18.43 CH3 ACT A 201 225 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 24.74 11.56 73.05 25.29 14.32 71.80 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 27.81 15.44 77.10 25.66 16.50 75.19 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 22 3 # 22 160 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 210 ARG B 123 ARG.? 17.76 O ACT B 201 225 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 24.74 11.56 73.05 25.29 14.32 71.80 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 27.81 15.44 77.10 25.66 16.50 75.19 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 23 3 # 23 160 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 210 ARG B 123 ARG.? 17.76 O ACT B 201 225 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 24.74 11.56 73.05 25.29 14.32 71.80 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 27.81 15.44 77.10 25.66 16.50 75.19 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 24 3 # 24 160 LYS B 139 LYS.? 6.99 C1 EDO A 302 210 ARG A 123 ARG.? 8.27 CH3 ACT A 202 225 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 17.51 28.50 73.42 17.24 23.02 75.86 -18.83 46.84 75.05 -16.49 49.79 71.17 coo 24.74 11.56 73.05 25.29 14.32 71.80 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 27.81 15.44 77.10 25.66 16.50 75.19 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 25 3 # 25 160 LYS B 139 LYS.? 6.99 C1 EDO A 302 210 ARG B 24 ARG~? 14.02 CH3 ACT B 201 225 ARG B 146 ARG.? 16.58 CH3 ACT B 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -18.83 46.84 75.05 -16.49 49.79 71.17 coo 24.74 11.56 73.05 25.29 14.32 71.80 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 27.81 15.44 77.10 25.66 16.50 75.19 -21.21 49.21 92.90 -18.50 50.59 92.50 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 26 3 # 26 160 LYS B 139 LYS.? 6.99 C1 EDO A 302 210 ARG B 92 ARG^? -3.69 CH3 ACT A 202s 225 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 17.51 28.50 73.42 17.24 23.02 75.86 -18.83 46.84 75.05 -16.49 49.79 71.17 coo 24.74 11.56 73.05 25.29 14.32 71.80 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 27.81 15.44 77.10 25.66 16.50 75.19 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 27 3 # 27 160 LYS B 139 LYS.? 6.99 C1 EDO A 302 210 ARG B 146 ARG.? 16.58 CH3 ACT B 201 225 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -18.83 46.84 75.05 -16.49 49.79 71.17 coo 24.74 11.56 73.05 25.29 14.32 71.80 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 27.81 15.44 77.10 25.66 16.50 75.19 -20.35 54.64 90.03 -19.09 51.96 89.19 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 28 3 # 28 160 LYS C 22 LYS~? 15.34 CH3 ACT C 201 210 ARG C 123 ARG.? 17.68 OXT ACT C 201 225 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 24.74 11.56 73.05 25.29 14.32 71.80 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 27.81 15.44 77.10 25.66 16.50 75.19 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 29 3 # 29 160 LYS C 22 LYS~? 15.34 CH3 ACT C 201 210 ARG D 88 ARG^? 18.35 CH3 ACT C 201 225 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 24.74 11.56 73.05 25.29 14.32 71.80 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 27.81 15.44 77.10 25.66 16.50 75.19 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 30 3 # 30 160 LYS C 22 LYS~? 15.34 CH3 ACT C 201 210 ARG D 92 ARG^? 13.56 CH3 ACT D 201 225 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 24.74 11.56 73.05 25.29 14.32 71.80 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 27.81 15.44 77.10 25.66 16.50 75.19 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 31 3 # 31 160 LYS C 68 LYS~? -2.77 O ACT C 201s 210 ARG B 106 ARG^? 5.91 C1 EDO A 302 225 ARG A 49 ARG^? -3.92 O ACT A 202s coo 17.51 28.50 73.42 17.24 23.02 75.86 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 24.74 11.56 73.05 25.29 14.32 71.80 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 27.81 15.44 77.10 25.66 16.50 75.19 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 32 3 # 32 160 LYS C 68 LYS~? -2.77 O ACT C 201s 210 ARG C 138 ARG~? 16.31 O ACT C 201 225 ARG C 76 ARG^? 14.32 O ACT C 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 24.74 11.56 73.05 25.29 14.32 71.80 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 27.81 15.44 77.10 25.66 16.50 75.19 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 33 3 # 33 160 LYS C 68 LYS~? -2.77 O ACT C 201s 210 ARG C 147 ARG.? 13.23 CH3 ACT C 201 225 ARG C 76 ARG^? 14.32 O ACT C 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 24.74 11.56 73.05 25.29 14.32 71.80 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 27.81 15.44 77.10 25.66 16.50 75.19 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 34 3 # 34 160 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 210 ARG C 88 ARG^? 18.42 CH3 ACT D 201 225 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 24.74 11.56 73.05 25.29 14.32 71.80 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 27.81 15.44 77.10 25.66 16.50 75.19 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 35 3 # 35 160 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 210 ARG C 123 ARG.? 17.68 OXT ACT C 201 225 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 24.74 11.56 73.05 25.29 14.32 71.80 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 27.81 15.44 77.10 25.66 16.50 75.19 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 36 3 # 36 160 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 210 ARG C 123 ARG.? 17.68 OXT ACT C 201 225 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 24.74 11.56 73.05 25.29 14.32 71.80 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 27.81 15.44 77.10 25.66 16.50 75.19 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 37 3 # 37 160 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 210 ARG D 92 ARG^? 13.56 CH3 ACT D 201 225 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 24.74 11.56 73.05 25.29 14.32 71.80 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 27.81 15.44 77.10 25.66 16.50 75.19 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 38 3 # 38 160 LYS C 139 LYS.? 18.79 O ACT C 201 210 ARG C 24 ARG~? 14.09 CH3 ACT C 201 225 ARG C 146 ARG.? 16.63 CH3 ACT C 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -50.26 41.49 60.64 -55.14 42.95 58.84 coo 24.74 11.56 73.05 25.29 14.32 71.80 -40.53 35.15 48.39 -41.31 34.14 51.19 coo 27.81 15.44 77.10 25.66 16.50 75.19 -36.58 32.85 52.68 -38.87 31.31 51.32 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 39 3 # 39 160 LYS C 139 LYS.? 18.79 O ACT C 201 210 ARG C 146 ARG.? 16.63 CH3 ACT C 201 225 ARG C 24 ARG~? 14.09 CH3 ACT C 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -50.26 41.49 60.64 -55.14 42.95 58.84 coo 24.74 11.56 73.05 25.29 14.32 71.80 -36.58 32.85 52.68 -38.87 31.31 51.32 coo 27.81 15.44 77.10 25.66 16.50 75.19 -40.53 35.15 48.39 -41.31 34.14 51.19 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 40 3 # 40 160 LYS C 139 LYS.? 18.79 O ACT C 201 210 ARG D 123 ARG.? 17.60 O ACT D 201 225 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -50.26 41.49 60.64 -55.14 42.95 58.84 coo 24.74 11.56 73.05 25.29 14.32 71.80 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 27.81 15.44 77.10 25.66 16.50 75.19 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 41 3 # 41 160 LYS D 22 LYS~? 15.49 CH3 ACT D 201 210 ARG C 88 ARG^? 18.42 CH3 ACT D 201 225 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -54.47 56.23 29.06 -59.33 54.04 30.24 coo 24.74 11.56 73.05 25.29 14.32 71.80 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 27.81 15.44 77.10 25.66 16.50 75.19 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 42 3 # 42 160 LYS D 22 LYS~? 15.49 CH3 ACT D 201 210 ARG C 92 ARG^? 13.71 CH3 ACT C 201 225 ARG D 123 ARG.? 17.60 O ACT D 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -54.47 56.23 29.06 -59.33 54.04 30.24 coo 24.74 11.56 73.05 25.29 14.32 71.80 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 27.81 15.44 77.10 25.66 16.50 75.19 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 43 3 # 43 160 LYS D 22 LYS~? 15.49 CH3 ACT D 201 210 ARG D 123 ARG.? 17.60 O ACT D 201 225 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -54.47 56.23 29.06 -59.33 54.04 30.24 coo 24.74 11.56 73.05 25.29 14.32 71.80 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 27.81 15.44 77.10 25.66 16.50 75.19 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 44 3 # 44 160 LYS D 68 LYS~? -2.80 OXT ACT D 201s 210 ARG D 138 ARG~? 16.38 OXT ACT D 201 225 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 24.74 11.56 73.05 25.29 14.32 71.80 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 27.81 15.44 77.10 25.66 16.50 75.19 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 45 3 # 45 160 LYS D 68 LYS~? -2.80 OXT ACT D 201s 210 ARG D 147 ARG.? 13.02 CH3 ACT D 201 225 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 24.74 11.56 73.05 25.29 14.32 71.80 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 27.81 15.44 77.10 25.66 16.50 75.19 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 46 3 # 46 160 LYS D 71 LYS~? -3.20 CH3 ACT A 203s 210 ARG A 33 ARG.? 12.39 O ACT A 201 225 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 17.51 28.50 73.42 17.24 23.02 75.86 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 24.74 11.56 73.05 25.29 14.32 71.80 -37.81 74.92 58.71 -38.09 77.66 57.35 coo 27.81 15.44 77.10 25.66 16.50 75.19 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 47 3 # 47 160 LYS D 71 LYS~? -3.20 CH3 ACT A 203s 210 ARG A 76 ARG^? 8.97 OXT ACT A 203 225 ARG A 33 ARG.? 12.39 O ACT A 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 24.74 11.56 73.05 25.29 14.32 71.80 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 27.81 15.44 77.10 25.66 16.50 75.19 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 48 3 # 48 160 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 210 ARG C 92 ARG^? 13.71 CH3 ACT C 201 225 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 24.74 11.56 73.05 25.29 14.32 71.80 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 27.81 15.44 77.10 25.66 16.50 75.19 -52.23 44.53 37.75 -52.43 42.56 40.08 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 49 3 # 49 160 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 210 ARG D 88 ARG^? 18.35 CH3 ACT C 201 225 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 24.74 11.56 73.05 25.29 14.32 71.80 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 27.81 15.44 77.10 25.66 16.50 75.19 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 50 3 # 50 160 LYS D 139 LYS.? 18.54 OXT ACT D 201 210 ARG D 24 ARG~? 13.98 CH3 ACT D 201 225 ARG D 146 ARG.? 16.60 CH3 ACT D 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -39.84 73.21 37.09 -35.07 70.74 37.87 coo 24.74 11.56 73.05 25.29 14.32 71.80 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 27.81 15.44 77.10 25.66 16.50 75.19 -54.51 68.83 27.22 -52.30 68.02 25.26 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 51 3 # 51 160 LYS D 139 LYS.? 18.54 OXT ACT D 201 210 ARG D 146 ARG.? 16.60 CH3 ACT D 201 225 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo 17.51 28.50 73.42 17.24 23.02 75.86 -39.84 73.21 37.09 -35.07 70.74 37.87 coo 24.74 11.56 73.05 25.29 14.32 71.80 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 27.81 15.44 77.10 25.66 16.50 75.19 -50.90 63.83 27.93 -49.90 66.74 27.73 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 51 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 298 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 2.59 0.29 25.55 4.65 0.18 25.07 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 12.42 6.10 23.27 9.95 1.57 20.16 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 298 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 2.59 0.29 25.55 4.65 0.18 25.07 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 12.42 6.10 23.27 9.95 1.57 20.16 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE A 140 PHE.? 11.31 O ACT A 201 A 298 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 2.59 0.29 25.55 4.65 0.18 25.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 12.42 6.10 23.27 9.95 1.57 20.16 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 298 ASP C 74 ASP^? 14.86 O ACT C 201 A 329 LYS C 68 LYS~? -2.77 O ACT C 201s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 2.59 0.29 25.55 4.65 0.18 25.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 12.42 6.10 23.27 9.95 1.57 20.16 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 298 ASP C 74 ASP^? 14.86 O ACT C 201 A 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 2.59 0.29 25.55 4.65 0.18 25.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 12.42 6.10 23.27 9.95 1.57 20.16 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 298 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 329 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 2.59 0.29 25.55 4.65 0.18 25.07 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 12.42 6.10 23.27 9.95 1.57 20.16 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 298 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 329 LYS C 68 LYS~? -2.77 O ACT C 201s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 2.59 0.29 25.55 4.65 0.18 25.07 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 12.42 6.10 23.27 9.95 1.57 20.16 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE B 140 PHE.? 8.97 CH3 ACT A 202 A 298 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 329 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 2.59 0.29 25.55 4.65 0.18 25.07 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 12.42 6.10 23.27 9.95 1.57 20.16 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 A 189 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 298 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 2.59 0.29 25.55 4.65 0.18 25.07 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 12.42 6.10 23.27 9.95 1.57 20.16 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 A 189 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 298 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 2.59 0.29 25.55 4.65 0.18 25.07 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 12.42 6.10 23.27 9.95 1.57 20.16 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 A 189 PHE C 140 PHE.? 11.33 O ACT C 201 A 298 ASP C 74 ASP^? 14.86 O ACT C 201 A 329 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 2.59 0.29 25.55 4.65 0.18 25.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 12.42 6.10 23.27 9.95 1.57 20.16 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 A 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 298 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 329 LYS A 68 LYS~? -2.78 O ACT A 201s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 2.59 0.29 25.55 4.65 0.18 25.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 12.42 6.10 23.27 9.95 1.57 20.16 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 A 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 298 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 2.59 0.29 25.55 4.65 0.18 25.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 12.42 6.10 23.27 9.95 1.57 20.16 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 A 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 298 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 329 LYS A 68 LYS~? -2.78 O ACT A 201s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 2.59 0.29 25.55 4.65 0.18 25.07 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 12.42 6.10 23.27 9.95 1.57 20.16 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 A 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 298 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 329 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 2.59 0.29 25.55 4.65 0.18 25.07 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 12.42 6.10 23.27 9.95 1.57 20.16 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 A 189 PHE D 140 PHE.? 11.31 OXT ACT D 201 A 298 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 329 LYS D 134 LYS~? 17.34 O ACT A 201 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 2.59 0.29 25.55 4.65 0.18 25.07 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 12.42 6.10 23.27 9.95 1.57 20.16 -37.62 76.93 46.97 -33.08 76.47 49.79 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 298 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 298 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE A 140 PHE.? 11.31 O ACT A 201 B 298 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 298 ASP C 74 ASP^? 14.86 O ACT C 201 B 329 LYS C 68 LYS~? -2.77 O ACT C 201s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 298 ASP C 74 ASP^? 14.86 O ACT C 201 B 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 298 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 329 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 298 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 329 LYS C 68 LYS~? -2.77 O ACT C 201s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE B 140 PHE.? 8.97 CH3 ACT A 202 B 298 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 329 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 B 189 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 298 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 B 189 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 298 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 B 189 PHE C 140 PHE.? 11.33 O ACT C 201 B 298 ASP C 74 ASP^? 14.86 O ACT C 201 B 329 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 B 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 298 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 329 LYS A 68 LYS~? -2.78 O ACT A 201s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 B 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 298 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 B 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 298 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 329 LYS A 68 LYS~? -2.78 O ACT A 201s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 B 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 298 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 329 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 B 189 PHE D 140 PHE.? 11.31 OXT ACT D 201 B 298 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 329 LYS D 134 LYS~? 17.34 O ACT A 201 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -37.62 76.93 46.97 -33.08 76.47 49.79 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 105 PHE^? 4.28 O1 EDO A 301 C 298 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 24.10 66.43 63.33 24.18 64.30 63.40 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 27.64 56.61 58.17 22.18 57.92 60.36 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 105 PHE^? 4.28 O1 EDO A 301 C 298 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 24.10 66.43 63.33 24.18 64.30 63.40 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 27.64 56.61 58.17 22.18 57.92 60.36 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE A 140 PHE.? 11.31 O ACT A 201 C 298 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 17.41 60.57 64.39 18.40 58.12 65.34 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 24.10 66.43 63.33 24.18 64.30 63.40 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 27.64 56.61 58.17 22.18 57.92 60.36 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 C 298 ASP C 74 ASP^? 14.86 O ACT C 201 C 329 LYS C 68 LYS~? -2.77 O ACT C 201s coo 17.41 60.57 64.39 18.40 58.12 65.34 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 24.10 66.43 63.33 24.18 64.30 63.40 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 27.64 56.61 58.17 22.18 57.92 60.36 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 C 298 ASP C 74 ASP^? 14.86 O ACT C 201 C 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 24.10 66.43 63.33 24.18 64.30 63.40 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 27.64 56.61 58.17 22.18 57.92 60.36 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 C 298 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 329 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 17.41 60.57 64.39 18.40 58.12 65.34 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 24.10 66.43 63.33 24.18 64.30 63.40 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 27.64 56.61 58.17 22.18 57.92 60.36 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 C 298 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 329 LYS C 68 LYS~? -2.77 O ACT C 201s coo 17.41 60.57 64.39 18.40 58.12 65.34 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 24.10 66.43 63.33 24.18 64.30 63.40 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 27.64 56.61 58.17 22.18 57.92 60.36 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE B 140 PHE.? 8.97 CH3 ACT A 202 C 298 ASP B 74 ASP^? 14.88 OXT ACT B 201 C 329 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 24.10 66.43 63.33 24.18 64.30 63.40 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 27.64 56.61 58.17 22.18 57.92 60.36 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 C 189 PHE C 105 PHE^? 4.31 O2 EDO A 301 C 298 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 24.10 66.43 63.33 24.18 64.30 63.40 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 27.64 56.61 58.17 22.18 57.92 60.36 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 C 189 PHE C 105 PHE^? 4.31 O2 EDO A 301 C 298 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 24.10 66.43 63.33 24.18 64.30 63.40 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 27.64 56.61 58.17 22.18 57.92 60.36 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 C 189 PHE C 140 PHE.? 11.33 O ACT C 201 C 298 ASP C 74 ASP^? 14.86 O ACT C 201 C 329 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 24.10 66.43 63.33 24.18 64.30 63.40 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 27.64 56.61 58.17 22.18 57.92 60.36 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 C 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 C 298 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 329 LYS A 68 LYS~? -2.78 O ACT A 201s coo 17.41 60.57 64.39 18.40 58.12 65.34 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 24.10 66.43 63.33 24.18 64.30 63.40 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 27.64 56.61 58.17 22.18 57.92 60.36 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 C 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 C 298 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 24.10 66.43 63.33 24.18 64.30 63.40 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 27.64 56.61 58.17 22.18 57.92 60.36 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 C 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 C 298 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 329 LYS A 68 LYS~? -2.78 O ACT A 201s coo 17.41 60.57 64.39 18.40 58.12 65.34 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 24.10 66.43 63.33 24.18 64.30 63.40 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 27.64 56.61 58.17 22.18 57.92 60.36 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 C 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 C 298 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 329 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 17.41 60.57 64.39 18.40 58.12 65.34 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 24.10 66.43 63.33 24.18 64.30 63.40 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 27.64 56.61 58.17 22.18 57.92 60.36 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 C 189 PHE D 140 PHE.? 11.31 OXT ACT D 201 C 298 ASP D 74 ASP^? 14.85 OXT ACT D 201 C 329 LYS D 134 LYS~? 17.34 O ACT A 201 coo 17.41 60.57 64.39 18.40 58.12 65.34 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 24.10 66.43 63.33 24.18 64.30 63.40 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 27.64 56.61 58.17 22.18 57.92 60.36 -37.62 76.93 46.97 -33.08 76.47 49.79 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 105 PHE^? 4.28 O1 EDO A 301 D 298 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 29.72 46.46 83.60 30.79 47.36 81.99 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 36.89 44.91 74.55 37.33 48.94 79.01 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 105 PHE^? 4.28 O1 EDO A 301 D 298 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 29.72 46.46 83.60 30.79 47.36 81.99 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 36.89 44.91 74.55 37.33 48.94 79.01 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE A 140 PHE.? 11.31 O ACT A 201 D 298 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 35.44 53.35 83.81 35.65 54.53 81.28 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 29.72 46.46 83.60 30.79 47.36 81.99 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 36.89 44.91 74.55 37.33 48.94 79.01 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 D 298 ASP C 74 ASP^? 14.86 O ACT C 201 D 329 LYS C 68 LYS~? -2.77 O ACT C 201s coo 35.44 53.35 83.81 35.65 54.53 81.28 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 29.72 46.46 83.60 30.79 47.36 81.99 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 36.89 44.91 74.55 37.33 48.94 79.01 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 D 298 ASP C 74 ASP^? 14.86 O ACT C 201 D 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 29.72 46.46 83.60 30.79 47.36 81.99 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 36.89 44.91 74.55 37.33 48.94 79.01 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 D 298 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 329 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 35.44 53.35 83.81 35.65 54.53 81.28 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 29.72 46.46 83.60 30.79 47.36 81.99 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 36.89 44.91 74.55 37.33 48.94 79.01 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE B 105 PHE^? 13.39 C2 EDO A 302 D 298 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 329 LYS C 68 LYS~? -2.77 O ACT C 201s coo 35.44 53.35 83.81 35.65 54.53 81.28 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 29.72 46.46 83.60 30.79 47.36 81.99 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 36.89 44.91 74.55 37.33 48.94 79.01 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE B 140 PHE.? 8.97 CH3 ACT A 202 D 298 ASP B 74 ASP^? 14.88 OXT ACT B 201 D 329 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 29.72 46.46 83.60 30.79 47.36 81.99 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 36.89 44.91 74.55 37.33 48.94 79.01 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 D 189 PHE C 105 PHE^? 4.31 O2 EDO A 301 D 298 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 29.72 46.46 83.60 30.79 47.36 81.99 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 36.89 44.91 74.55 37.33 48.94 79.01 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 D 189 PHE C 105 PHE^? 4.31 O2 EDO A 301 D 298 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 29.72 46.46 83.60 30.79 47.36 81.99 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 36.89 44.91 74.55 37.33 48.94 79.01 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 D 189 PHE C 140 PHE.? 11.33 O ACT C 201 D 298 ASP C 74 ASP^? 14.86 O ACT C 201 D 329 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 29.72 46.46 83.60 30.79 47.36 81.99 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 36.89 44.91 74.55 37.33 48.94 79.01 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 D 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 D 298 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 329 LYS A 68 LYS~? -2.78 O ACT A 201s coo 35.44 53.35 83.81 35.65 54.53 81.28 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 29.72 46.46 83.60 30.79 47.36 81.99 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 36.89 44.91 74.55 37.33 48.94 79.01 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 D 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 D 298 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 29.72 46.46 83.60 30.79 47.36 81.99 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 36.89 44.91 74.55 37.33 48.94 79.01 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 D 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 D 298 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 329 LYS A 68 LYS~? -2.78 O ACT A 201s coo 35.44 53.35 83.81 35.65 54.53 81.28 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 29.72 46.46 83.60 30.79 47.36 81.99 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 36.89 44.91 74.55 37.33 48.94 79.01 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 D 189 PHE D 105 PHE^? 7.74 CH3 ACT A 203 D 298 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 329 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 35.44 53.35 83.81 35.65 54.53 81.28 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 29.72 46.46 83.60 30.79 47.36 81.99 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 36.89 44.91 74.55 37.33 48.94 79.01 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 D 189 PHE D 140 PHE.? 11.31 OXT ACT D 201 D 298 ASP D 74 ASP^? 14.85 OXT ACT D 201 D 329 LYS D 134 LYS~? 17.34 O ACT A 201 coo 35.44 53.35 83.81 35.65 54.53 81.28 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 29.72 46.46 83.60 30.79 47.36 81.99 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 36.89 44.91 74.55 37.33 48.94 79.01 -37.62 76.93 46.97 -33.08 76.47 49.79 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 47 GLN^? 9.90 O1 EDO A 302 A 296 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 383 TYR A 42 TYR^? 9.79 CH3 ACT A 201 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -15.92 64.14 66.68 -15.70 62.99 64.91 coo 40.93 4.45 2.36 38.91 3.75 2.26 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 30.54 7.22 6.23 31.38 5.79 3.97 -22.07 72.08 64.22 -24.60 72.36 65.39 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 1 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 327 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 339 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 75.11 41.01 160.30 76.65 40.06 161.41 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 34 ASP~? 14.63 O ACT A 201 A 327 GLU B 36 GLU~? 17.47 CH3 ACT B 201 A 339 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 75.11 41.01 160.30 76.65 40.06 161.41 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 34 ASP~? 14.63 O ACT A 201 A 327 GLU B 36 GLU~? 17.47 CH3 ACT B 201 A 339 ARG B 58 ARG~? 17.86 CH3 ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 75.11 41.01 160.30 76.65 40.06 161.41 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 -41.40 56.24 95.43 -40.17 57.59 97.88 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP A 34 ASP~? 14.63 O ACT A 201 A 327 GLU B 59 GLU~? 20.69 O ACT B 201 A 339 ARG B 58 ARG~? 17.86 CH3 ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 75.11 41.01 160.30 76.65 40.06 161.41 -47.90 53.57 92.50 -49.95 53.72 93.03 coo 82.23 40.35 159.87 85.09 40.67 161.01 -41.40 56.24 95.43 -40.17 57.59 97.88 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 327 GLU C 80 GLU^? 14.47 CH3 ACT C 201 A 339 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 75.11 41.01 160.30 76.65 40.06 161.41 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 82.23 40.35 159.87 85.09 40.67 161.01 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 327 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 339 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 75.11 41.01 160.30 76.65 40.06 161.41 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 82.23 40.35 159.87 85.09 40.67 161.01 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP A 86 ASP.? 20.24 CH3 ACT A 202 A 327 GLU C 96 GLU^? 13.00 O ACT C 201 A 339 ARG C 76 ARG^? 14.32 O ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 82.23 40.35 159.87 85.09 40.67 161.01 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP A 86 ASP.? 20.24 CH3 ACT A 202 A 327 GLU C 96 GLU^? 13.00 O ACT C 201 A 339 ARG C 138 ARG~? 16.31 O ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 82.23 40.35 159.87 85.09 40.67 161.01 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP A 86 ASP.? 20.24 CH3 ACT A 202 A 327 GLU C 137 GLU~? 15.84 O2 EDO A 301 A 339 ARG C 138 ARG~? 16.31 O ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 82.23 40.35 159.87 85.09 40.67 161.01 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP A 86 ASP.? 20.24 CH3 ACT A 202 A 327 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 339 ARG D 51 ARG.? 7.60 O ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 82.23 40.35 159.87 85.09 40.67 161.01 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP A 86 ASP.? 20.24 CH3 ACT A 202 A 327 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 339 ARG D 138 ARG~? 16.38 OXT ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 82.23 40.35 159.87 85.09 40.67 161.01 -42.61 77.59 41.75 -44.95 78.80 40.20 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP A 116 ASP.? 19.55 CH3 ACT A 201 A 327 GLU D 53 GLU^? 10.32 O ACT A 203 A 339 ARG D 49 ARG^? 10.44 O ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 75.11 41.01 160.30 76.65 40.06 161.41 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 82.23 40.35 159.87 85.09 40.67 161.01 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 13 3 # 13 A 50 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 327 GLU B 36 GLU~? 17.47 CH3 ACT B 201 A 339 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 75.11 41.01 160.30 76.65 40.06 161.41 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 14 3 # 14 A 50 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 327 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 339 ARG B 138 ARG~? 16.35 OXT ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 75.11 41.01 160.30 76.65 40.06 161.41 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 82.23 40.35 159.87 85.09 40.67 161.01 -23.44 41.55 74.26 -23.57 39.98 76.87 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 15 3 # 15 A 50 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 327 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 339 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 85.81 57.99 116.01 86.03 55.86 115.89 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 75.11 41.01 160.30 76.65 40.06 161.41 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 16 3 # 16 A 50 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 327 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 339 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 75.11 41.01 160.30 76.65 40.06 161.41 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 17 3 # 17 A 50 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 327 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 339 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 75.11 41.01 160.30 76.65 40.06 161.41 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 82.23 40.35 159.87 85.09 40.67 161.01 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 18 3 # 18 A 50 ASP A 150 ASP.? 22.07 CH3 ACT A 201 A 327 GLU B 36 GLU~? 17.47 CH3 ACT B 201 A 339 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 19 3 # 19 A 50 ASP A 150 ASP.? 22.07 CH3 ACT A 201 A 327 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 339 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 85.81 57.99 116.01 86.03 55.86 115.89 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 20 3 # 20 A 50 ASP A 150 ASP.? 22.07 CH3 ACT A 201 A 327 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 339 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 21 3 # 21 A 50 ASP A 150 ASP.? 22.07 CH3 ACT A 201 A 327 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 339 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 82.23 40.35 159.87 85.09 40.67 161.01 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 22 3 # 22 A 50 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 327 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 339 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 85.81 57.99 116.01 86.03 55.86 115.89 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 75.11 41.01 160.30 76.65 40.06 161.41 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 23 3 # 23 A 50 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 327 GLU D 53 GLU^? 10.32 O ACT A 203 A 339 ARG D 49 ARG^? 10.44 O ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 75.11 41.01 160.30 76.65 40.06 161.41 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 82.23 40.35 159.87 85.09 40.67 161.01 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 24 3 # 24 A 50 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 327 GLU D 53 GLU^? 10.32 O ACT A 203 A 339 ARG D 51 ARG.? 7.60 O ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 75.11 41.01 160.30 76.65 40.06 161.41 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 82.23 40.35 159.87 85.09 40.67 161.01 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 25 3 # 25 A 50 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 327 GLU A 36 GLU~? 17.83 CH3 ACT A 201 A 339 ARG A 37 ARG~? 13.73 CH3 ACT A 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 75.11 41.01 160.30 76.65 40.06 161.41 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 82.23 40.35 159.87 85.09 40.67 161.01 -28.83 80.54 58.97 -30.62 82.33 60.70 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 26 3 # 26 A 50 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 327 GLU A 36 GLU~? 17.83 CH3 ACT A 201 A 339 ARG A 58 ARG~? 18.13 CH3 ACT A 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 75.11 41.01 160.30 76.65 40.06 161.41 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 82.23 40.35 159.87 85.09 40.67 161.01 -18.95 73.08 58.27 -17.11 75.32 59.26 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 27 3 # 27 A 50 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 327 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 339 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 85.81 57.99 116.01 86.03 55.86 115.89 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 75.11 41.01 160.30 76.65 40.06 161.41 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 28 3 # 28 A 50 ASP B 45 ASP^? 20.35 O ACT B 201 A 327 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 339 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 75.11 41.01 160.30 76.65 40.06 161.41 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 82.23 40.35 159.87 85.09 40.67 161.01 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 29 3 # 29 A 50 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 327 GLU C 17 GLU~? 23.53 CH3 ACT C 201 A 339 ARG C 16 ARG~? 20.89 CH3 ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 75.11 41.01 160.30 76.65 40.06 161.41 -44.57 31.78 35.88 -45.60 32.67 34.25 coo 82.23 40.35 159.87 85.09 40.67 161.01 -48.56 36.19 35.88 -49.41 34.92 38.55 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 30 3 # 30 A 50 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 327 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 339 ARG D 124 ARG.? -3.55 O ACT D 201s coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 75.11 41.01 160.30 76.65 40.06 161.41 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 82.23 40.35 159.87 85.09 40.67 161.01 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 31 3 # 31 A 50 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 327 GLU D 114 GLU^? 18.05 O ACT D 201 A 339 ARG D 123 ARG.? 17.60 O ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 75.11 41.01 160.30 76.65 40.06 161.41 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 82.23 40.35 159.87 85.09 40.67 161.01 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 32 3 # 32 A 50 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 327 GLU D 137 GLU~? 19.20 CH3 ACT A 203 A 339 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 75.11 41.01 160.30 76.65 40.06 161.41 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 82.23 40.35 159.87 85.09 40.67 161.01 -40.22 67.90 41.60 -38.15 70.12 41.98 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 33 3 # 33 A 50 ASP B 86 ASP.? 24.07 CH3 ACT B 201 A 327 GLU C 96 GLU^? 13.00 O ACT C 201 A 339 ARG C 76 ARG^? 14.32 O ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 75.11 41.01 160.30 76.65 40.06 161.41 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 82.23 40.35 159.87 85.09 40.67 161.01 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 34 3 # 34 A 50 ASP B 86 ASP.? 24.07 CH3 ACT B 201 A 327 GLU D 53 GLU^? 10.32 O ACT A 203 A 339 ARG D 51 ARG.? 7.60 O ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 75.11 41.01 160.30 76.65 40.06 161.41 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 82.23 40.35 159.87 85.09 40.67 161.01 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 35 3 # 35 A 50 ASP B 86 ASP.? 24.07 CH3 ACT B 201 A 327 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 339 ARG D 51 ARG.? 7.60 O ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 75.11 41.01 160.30 76.65 40.06 161.41 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 82.23 40.35 159.87 85.09 40.67 161.01 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 36 3 # 36 A 50 ASP B 116 ASP.? 19.49 CH3 ACT B 201 A 327 GLU D 53 GLU^? 10.32 O ACT A 203 A 339 ARG D 51 ARG.? 7.60 O ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 75.11 41.01 160.30 76.65 40.06 161.41 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 82.23 40.35 159.87 85.09 40.67 161.01 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 37 3 # 37 A 50 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 327 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 339 ARG D 58 ARG~? 18.01 CH3 ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 75.11 41.01 160.30 76.65 40.06 161.41 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 -67.82 58.42 40.52 -68.76 57.03 37.97 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 38 3 # 38 A 50 ASP B 149 ASP.? 20.03 CH3 ACT B 201 A 327 GLU A 36 GLU~? 17.83 CH3 ACT A 201 A 339 ARG A 37 ARG~? 13.73 CH3 ACT A 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 82.23 40.35 159.87 85.09 40.67 161.01 -28.83 80.54 58.97 -30.62 82.33 60.70 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 39 3 # 39 A 50 ASP B 149 ASP.? 20.03 CH3 ACT B 201 A 327 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 339 ARG C 146 ARG.? 16.63 CH3 ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 82.23 40.35 159.87 85.09 40.67 161.01 -36.58 32.85 52.68 -38.87 31.31 51.32 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 40 3 # 40 A 50 ASP B 150 ASP.? 20.21 CH3 ACT A 202 A 327 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 339 ARG C 146 ARG.? 16.63 CH3 ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 75.11 41.01 160.30 76.65 40.06 161.41 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 82.23 40.35 159.87 85.09 40.67 161.01 -36.58 32.85 52.68 -38.87 31.31 51.32 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 41 3 # 41 A 50 ASP B 150 ASP.? 20.21 CH3 ACT A 202 A 327 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 339 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 75.11 41.01 160.30 76.65 40.06 161.41 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 82.23 40.35 159.87 85.09 40.67 161.01 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 42 3 # 42 A 50 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 327 GLU B 36 GLU~? 17.47 CH3 ACT B 201 A 339 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 43 3 # 43 A 50 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 327 GLU B 36 GLU~? 17.47 CH3 ACT B 201 A 339 ARG B 58 ARG~? 17.86 CH3 ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 -41.40 56.24 95.43 -40.17 57.59 97.88 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 44 3 # 44 A 50 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 327 GLU B 59 GLU~? 20.69 O ACT B 201 A 339 ARG B 58 ARG~? 17.86 CH3 ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 -47.90 53.57 92.50 -49.95 53.72 93.03 coo 82.23 40.35 159.87 85.09 40.67 161.01 -41.40 56.24 95.43 -40.17 57.59 97.88 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 45 3 # 45 A 50 ASP C 34 ASP~? 14.66 O ACT C 201 A 327 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 339 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 46 3 # 46 A 50 ASP C 34 ASP~? 14.66 O ACT C 201 A 327 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 339 ARG D 58 ARG~? 18.01 CH3 ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 -67.82 58.42 40.52 -68.76 57.03 37.97 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 47 3 # 47 A 50 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 327 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 339 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 75.11 41.01 160.30 76.65 40.06 161.41 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 82.23 40.35 159.87 85.09 40.67 161.01 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 48 3 # 48 A 50 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 327 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 339 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo 85.81 57.99 116.01 86.03 55.86 115.89 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 75.11 41.01 160.30 76.65 40.06 161.41 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 82.23 40.35 159.87 85.09 40.67 161.01 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 49 3 # 49 A 50 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 327 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 339 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 85.81 57.99 116.01 86.03 55.86 115.89 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 75.11 41.01 160.30 76.65 40.06 161.41 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 82.23 40.35 159.87 85.09 40.67 161.01 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 50 3 # 50 A 50 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 327 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 339 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 85.81 57.99 116.01 86.03 55.86 115.89 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 75.11 41.01 160.30 76.65 40.06 161.41 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 82.23 40.35 159.87 85.09 40.67 161.01 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 51 3 # 51 A 50 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 327 GLU A 137 GLU~? 14.03 O ACT A 203 A 339 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 85.81 57.99 116.01 86.03 55.86 115.89 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 75.11 41.01 160.30 76.65 40.06 161.41 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 82.23 40.35 159.87 85.09 40.67 161.01 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 52 3 # 52 A 50 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 327 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 339 ARG B 51 ARG.? 7.67 O ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 75.11 41.01 160.30 76.65 40.06 161.41 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 82.23 40.35 159.87 85.09 40.67 161.01 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 53 3 # 53 A 50 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 327 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 339 ARG B 138 ARG~? 16.35 OXT ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 75.11 41.01 160.30 76.65 40.06 161.41 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 82.23 40.35 159.87 85.09 40.67 161.01 -23.44 41.55 74.26 -23.57 39.98 76.87 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 54 3 # 54 A 50 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 327 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 339 ARG A 49 ARG^? -3.92 O ACT A 202s coo 85.81 57.99 116.01 86.03 55.86 115.89 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 75.11 41.01 160.30 76.65 40.06 161.41 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 82.23 40.35 159.87 85.09 40.67 161.01 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 55 3 # 55 A 50 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 327 GLU A 137 GLU~? 14.03 O ACT A 203 A 339 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 82.23 40.35 159.87 85.09 40.67 161.01 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 56 3 # 56 A 50 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 327 GLU A 137 GLU~? 14.03 O ACT A 203 A 339 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 82.23 40.35 159.87 85.09 40.67 161.01 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 57 3 # 57 A 50 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 327 GLU B 53 GLU^? 11.09 O ACT B 201 A 339 ARG B 49 ARG^? 10.37 O ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 82.23 40.35 159.87 85.09 40.67 161.01 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 58 3 # 58 A 50 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 327 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 339 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 85.81 57.99 116.01 86.03 55.86 115.89 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 75.11 41.01 160.30 76.65 40.06 161.41 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 82.23 40.35 159.87 85.09 40.67 161.01 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 59 3 # 59 A 50 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 327 GLU B 36 GLU~? 17.47 CH3 ACT B 201 A 339 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 75.11 41.01 160.30 76.65 40.06 161.41 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 60 3 # 60 A 50 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 327 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 339 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 85.81 57.99 116.01 86.03 55.86 115.89 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 75.11 41.01 160.30 76.65 40.06 161.41 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 82.23 40.35 159.87 85.09 40.67 161.01 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 61 3 # 61 A 50 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 327 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 339 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 75.11 41.01 160.30 76.65 40.06 161.41 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 62 3 # 62 A 50 ASP C 150 ASP.? 20.99 CH3 ACT C 201 A 327 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 339 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 85.81 57.99 116.01 86.03 55.86 115.89 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 75.11 41.01 160.30 76.65 40.06 161.41 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 82.23 40.35 159.87 85.09 40.67 161.01 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 63 3 # 63 A 50 ASP C 150 ASP.? 20.99 CH3 ACT C 201 A 327 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 339 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 85.81 57.99 116.01 86.03 55.86 115.89 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 75.11 41.01 160.30 76.65 40.06 161.41 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 82.23 40.35 159.87 85.09 40.67 161.01 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 64 3 # 64 A 50 ASP C 150 ASP.? 20.99 CH3 ACT C 201 A 327 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 339 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 75.11 41.01 160.30 76.65 40.06 161.41 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 65 3 # 65 A 50 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 327 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 339 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 85.81 57.99 116.01 86.03 55.86 115.89 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 75.11 41.01 160.30 76.65 40.06 161.41 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 82.23 40.35 159.87 85.09 40.67 161.01 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 66 3 # 66 A 50 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 327 GLU A 160 GLU.? 13.50 O ACT A 201 A 339 ARG B 49 ARG^? 10.37 O ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 75.11 41.01 160.30 76.65 40.06 161.41 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 82.23 40.35 159.87 85.09 40.67 161.01 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 67 3 # 67 A 50 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 327 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 339 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 85.81 57.99 116.01 86.03 55.86 115.89 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 75.11 41.01 160.30 76.65 40.06 161.41 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 82.23 40.35 159.87 85.09 40.67 161.01 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 68 3 # 68 A 50 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 327 GLU B 53 GLU^? 11.09 O ACT B 201 A 339 ARG B 51 ARG.? 7.67 O ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 75.11 41.01 160.30 76.65 40.06 161.41 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 82.23 40.35 159.87 85.09 40.67 161.01 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 69 3 # 69 A 50 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 327 GLU C 36 GLU~? 15.95 O2 EDO A 302 A 339 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 75.11 41.01 160.30 76.65 40.06 161.41 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 70 3 # 70 A 50 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 327 GLU C 36 GLU~? 15.95 O2 EDO A 302 A 339 ARG C 58 ARG~? 18.03 CH3 ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 75.11 41.01 160.30 76.65 40.06 161.41 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 -22.97 47.67 45.60 -22.11 45.78 43.37 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 71 3 # 71 A 50 ASP D 45 ASP^? 20.33 O ACT D 201 A 327 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 339 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 75.11 41.01 160.30 76.65 40.06 161.41 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 82.23 40.35 159.87 85.09 40.67 161.01 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 72 3 # 72 A 50 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 327 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 339 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 85.81 57.99 116.01 86.03 55.86 115.89 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 75.11 41.01 160.30 76.65 40.06 161.41 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 82.23 40.35 159.87 85.09 40.67 161.01 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 73 3 # 73 A 50 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 327 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 339 ARG B 124 ARG.? -3.52 O ACT B 201s coo 85.81 57.99 116.01 86.03 55.86 115.89 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 75.11 41.01 160.30 76.65 40.06 161.41 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 82.23 40.35 159.87 85.09 40.67 161.01 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 74 3 # 74 A 50 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 327 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 339 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 75.11 41.01 160.30 76.65 40.06 161.41 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 82.23 40.35 159.87 85.09 40.67 161.01 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 75 3 # 75 A 50 ASP D 86 ASP.? 24.19 CH3 ACT D 201 A 327 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 339 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 85.81 57.99 116.01 86.03 55.86 115.89 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 82.23 40.35 159.87 85.09 40.67 161.01 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 76 3 # 76 A 50 ASP D 86 ASP.? 24.19 CH3 ACT D 201 A 327 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 339 ARG B 51 ARG.? 7.67 O ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 82.23 40.35 159.87 85.09 40.67 161.01 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 77 3 # 77 A 50 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 327 GLU B 59 GLU~? 20.69 O ACT B 201 A 339 ARG B 58 ARG~? 17.86 CH3 ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 -47.90 53.57 92.50 -49.95 53.72 93.03 coo 82.23 40.35 159.87 85.09 40.67 161.01 -41.40 56.24 95.43 -40.17 57.59 97.88 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 78 3 # 78 A 50 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 327 GLU C 17 GLU~? 23.53 CH3 ACT C 201 A 339 ARG C 16 ARG~? 20.89 CH3 ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 -44.57 31.78 35.88 -45.60 32.67 34.25 coo 82.23 40.35 159.87 85.09 40.67 161.01 -48.56 36.19 35.88 -49.41 34.92 38.55 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 79 3 # 79 A 50 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 327 GLU B 53 GLU^? 11.09 O ACT B 201 A 339 ARG B 51 ARG.? 7.67 O ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 75.11 41.01 160.30 76.65 40.06 161.41 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 82.23 40.35 159.87 85.09 40.67 161.01 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 80 3 # 80 A 50 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 327 GLU B 36 GLU~? 17.47 CH3 ACT B 201 A 339 ARG B 58 ARG~? 17.86 CH3 ACT B 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 75.11 41.01 160.30 76.65 40.06 161.41 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 -41.40 56.24 95.43 -40.17 57.59 97.88 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 81 3 # 81 A 50 ASP D 149 ASP.? 20.02 CH3 ACT D 201 A 327 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 339 ARG A 146 ARG.? 16.48 CH3 ACT A 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 75.11 41.01 160.30 76.65 40.06 161.41 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 82.23 40.35 159.87 85.09 40.67 161.01 -35.10 85.34 65.39 -35.74 86.54 68.15 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 82 3 # 82 A 50 ASP D 149 ASP.? 20.02 CH3 ACT D 201 A 327 GLU C 36 GLU~? 15.95 O2 EDO A 302 A 339 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 75.11 41.01 160.30 76.65 40.06 161.41 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 83 3 # 83 A 50 ASP D 150 ASP.? 21.68 CH3 ACT D 201 A 327 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 339 ARG A 146 ARG.? 16.48 CH3 ACT A 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 75.11 41.01 160.30 76.65 40.06 161.41 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 82.23 40.35 159.87 85.09 40.67 161.01 -35.10 85.34 65.39 -35.74 86.54 68.15 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 84 3 # 84 A 50 ASP D 150 ASP.? 21.68 CH3 ACT D 201 A 327 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 339 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 85.81 57.99 116.01 86.03 55.86 115.89 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 75.11 41.01 160.30 76.65 40.06 161.41 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 82.23 40.35 159.87 85.09 40.67 161.01 -40.14 80.19 70.35 -38.27 80.75 72.73 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 84 hits 1hto_c00 naa= 3 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 1 3 # 1 A 267 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 369 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 372 TYR A 93 TYR^? -4.07 CH3 ACT A 201s coo 16.47 7.99 31.03 17.36 6.90 32.63 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 16.01 4.58 27.39 13.82 5.38 28.94 -34.34 70.13 71.57 -32.99 68.09 70.18 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 2 3 # 2 A 267 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 369 ARG B 33 ARG.? 12.67 OXT ACT B 201 A 372 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 16.47 7.99 31.03 17.36 6.90 32.63 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 16.01 4.58 27.39 13.82 5.38 28.94 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 3 3 # 3 A 267 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 369 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 372 TYR B 93 TYR^? -4.16 CH3 ACT B 201s coo 16.47 7.99 31.03 17.36 6.90 32.63 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 16.01 4.58 27.39 13.82 5.38 28.94 -27.85 57.31 80.17 -30.64 57.51 79.89 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 4 3 # 4 A 267 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 372 TYR C 93 TYR^? -4.09 CH3 ACT C 201s coo 16.47 7.99 31.03 17.36 6.90 32.63 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 16.01 4.58 27.39 13.82 5.38 28.94 -43.00 47.58 49.22 -41.38 49.87 49.22 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 5 3 # 5 A 267 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 369 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 372 TYR D 93 TYR^? -4.14 CH3 ACT D 201s coo 16.47 7.99 31.03 17.36 6.90 32.63 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 16.01 4.58 27.39 13.82 5.38 28.94 -47.46 60.74 39.76 -48.96 60.10 42.05 1i1e_c00 source 1i1e BOTULINUM NEUROTOXIN TYPE B : 5 hits 1i1e_c00 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 56 HIS.? 6.76 O1 EDO A 302 A 200 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 226 LYS A 62 LYS~? 17.60 O ACT A 201 coo 23.24 46.58 4.39 24.43 46.59 2.66 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 24.51 43.28 11.18 25.17 44.50 9.58 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 34.47 51.09 7.19 28.58 51.18 7.53 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS A 98 HIS^? -3.60 C ACT A 203s A 200 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 226 LYS A 134 LYS~? 11.98 O ACT A 203 coo 23.24 46.58 4.39 24.43 46.59 2.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 24.51 43.28 11.18 25.17 44.50 9.58 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 34.47 51.09 7.19 28.58 51.18 7.53 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1i29_c01 CSDB user 3 3 # 3 A 123 HIS A 98 HIS^? -3.60 C ACT A 203s A 200 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 226 LYS A 68 LYS~? -2.78 O ACT A 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 24.51 43.28 11.18 25.17 44.50 9.58 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 34.47 51.09 7.19 28.58 51.18 7.53 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1i29_c01 CSDB user 4 3 # 4 A 123 HIS A 98 HIS^? -3.60 C ACT A 203s A 200 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 226 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 24.51 43.28 11.18 25.17 44.50 9.58 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 34.47 51.09 7.19 28.58 51.18 7.53 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1i29_c01 CSDB user 5 3 # 5 A 123 HIS A 98 HIS^? -3.60 C ACT A 203s A 200 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 226 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 23.24 46.58 4.39 24.43 46.59 2.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 24.51 43.28 11.18 25.17 44.50 9.58 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 34.47 51.09 7.19 28.58 51.18 7.53 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1i29_c01 CSDB user 6 3 # 6 A 123 HIS A 98 HIS^? -3.60 C ACT A 203s A 200 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 226 LYS A 68 LYS~? -2.78 O ACT A 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 24.51 43.28 11.18 25.17 44.50 9.58 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 34.47 51.09 7.19 28.58 51.18 7.53 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1i29_c01 CSDB user 7 3 # 7 A 123 HIS A 98 HIS^? -3.60 C ACT A 203s A 200 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 226 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 24.51 43.28 11.18 25.17 44.50 9.58 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 34.47 51.09 7.19 28.58 51.18 7.53 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1i29_c01 CSDB user 8 3 # 8 A 123 HIS A 98 HIS^? -3.60 C ACT A 203s A 200 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 226 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 23.24 46.58 4.39 24.43 46.59 2.66 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 24.51 43.28 11.18 25.17 44.50 9.58 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 34.47 51.09 7.19 28.58 51.18 7.53 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1i29_c01 CSDB user 9 3 # 9 A 123 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 200 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 226 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 24.51 43.28 11.18 25.17 44.50 9.58 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 34.47 51.09 7.19 28.58 51.18 7.53 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1i29_c01 CSDB user 10 3 # 10 A 123 HIS B 56 HIS.? 17.31 O ACT B 201 A 200 ASP B 45 ASP^? 20.35 O ACT B 201 A 226 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo 23.24 46.58 4.39 24.43 46.59 2.66 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 24.51 43.28 11.18 25.17 44.50 9.58 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 34.47 51.09 7.19 28.58 51.18 7.53 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1i29_c01 CSDB user 11 3 # 11 A 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 200 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 226 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 23.24 46.58 4.39 24.43 46.59 2.66 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 24.51 43.28 11.18 25.17 44.50 9.58 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 34.47 51.09 7.19 28.58 51.18 7.53 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1i29_c01 CSDB user 12 3 # 12 A 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 200 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 226 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 24.51 43.28 11.18 25.17 44.50 9.58 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 34.47 51.09 7.19 28.58 51.18 7.53 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1i29_c01 CSDB user 13 3 # 13 A 123 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 200 ASP B 149 ASP.? 20.03 CH3 ACT B 201 A 226 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 34.47 51.09 7.19 28.58 51.18 7.53 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1i29_c01 CSDB user 14 3 # 14 A 123 HIS C 56 HIS.? 17.26 OXT ACT C 201 A 200 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 226 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 23.24 46.58 4.39 24.43 46.59 2.66 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 24.51 43.28 11.18 25.17 44.50 9.58 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 34.47 51.09 7.19 28.58 51.18 7.53 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1i29_c01 CSDB user 15 3 # 15 A 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 200 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 226 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 34.47 51.09 7.19 28.58 51.18 7.53 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1i29_c01 CSDB user 16 3 # 16 A 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 200 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 226 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 23.24 46.58 4.39 24.43 46.59 2.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 34.47 51.09 7.19 28.58 51.18 7.53 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1i29_c01 CSDB user 17 3 # 17 A 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 200 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 226 LYS C 68 LYS~? -2.77 O ACT C 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 34.47 51.09 7.19 28.58 51.18 7.53 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1i29_c01 CSDB user 18 3 # 18 A 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 200 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 226 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 23.24 46.58 4.39 24.43 46.59 2.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 34.47 51.09 7.19 28.58 51.18 7.53 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1i29_c01 CSDB user 19 3 # 19 A 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 200 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 226 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 34.47 51.09 7.19 28.58 51.18 7.53 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1i29_c01 CSDB user 20 3 # 20 A 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 200 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 226 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 23.24 46.58 4.39 24.43 46.59 2.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 34.47 51.09 7.19 28.58 51.18 7.53 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1i29_c01 CSDB user 21 3 # 21 A 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 200 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 226 LYS C 68 LYS~? -2.77 O ACT C 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 34.47 51.09 7.19 28.58 51.18 7.53 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1i29_c01 CSDB user 22 3 # 22 A 123 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 200 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 226 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 24.51 43.28 11.18 25.17 44.50 9.58 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 34.47 51.09 7.19 28.58 51.18 7.53 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1i29_c01 CSDB user 23 3 # 23 A 123 HIS D 56 HIS.? 17.26 O ACT D 201 A 200 ASP D 45 ASP^? 20.33 O ACT D 201 A 226 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo 23.24 46.58 4.39 24.43 46.59 2.66 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 24.51 43.28 11.18 25.17 44.50 9.58 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 34.47 51.09 7.19 28.58 51.18 7.53 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1i29_c01 CSDB user 24 3 # 24 A 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 200 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 226 LYS D 134 LYS~? 17.34 O ACT A 201 coo 23.24 46.58 4.39 24.43 46.59 2.66 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 24.51 43.28 11.18 25.17 44.50 9.58 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 34.47 51.09 7.19 28.58 51.18 7.53 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1i29_c01 CSDB user 25 3 # 25 A 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 200 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 226 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 24.51 43.28 11.18 25.17 44.50 9.58 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 34.47 51.09 7.19 28.58 51.18 7.53 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1i29_c01 CSDB user 26 3 # 26 A 123 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 200 ASP D 149 ASP.? 20.02 CH3 ACT D 201 A 226 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 23.24 46.58 4.39 24.43 46.59 2.66 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 24.51 43.28 11.18 25.17 44.50 9.58 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 34.47 51.09 7.19 28.58 51.18 7.53 -47.37 61.41 34.65 -51.85 60.71 37.83 1i29_c01 source 1i29 CSDB : 26 hits 1i29_c01 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 68 LYS~? -2.78 O ACT A 201s A 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 68 LYS~? -2.78 O ACT A 201s A 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 165 GLU C 72 GLU~? 5.32 O ACT C 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 68 LYS~? -2.78 O ACT A 201s A 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 165 GLU D 137 GLU~? 19.20 CH3 ACT A 203 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -34.89 75.05 43.86 -34.35 73.81 45.48 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 74 LYS A 68 LYS~? -2.78 O ACT A 201s A 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 74 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 74 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS C 68 LYS~? -2.77 O ACT C 201s A 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 165 GLU A 72 GLU~? 5.31 O ACT A 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS C 68 LYS~? -2.77 O ACT C 201s A 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 A 14 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 74 LYS C 68 LYS~? -2.77 O ACT C 201s A 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 A 14 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 74 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -43.29 70.99 40.99 -41.92 72.19 39.92 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 A 14 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 74 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -43.29 70.99 40.99 -41.92 72.19 39.92 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 11 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 68 LYS~? -2.78 O ACT A 201s B 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 68 LYS~? -2.78 O ACT A 201s B 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 165 GLU D 137 GLU~? 19.20 CH3 ACT A 203 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -34.89 75.05 43.86 -34.35 73.81 45.48 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 74 LYS A 68 LYS~? -2.78 O ACT A 201s B 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 74 LYS A 68 LYS~? -2.78 O ACT A 201s B 165 GLU D 137 GLU~? 19.20 CH3 ACT A 203 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -34.89 75.05 43.86 -34.35 73.81 45.48 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 74 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 74 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS C 68 LYS~? -2.77 O ACT C 201s B 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 165 GLU B 137 GLU~? 6.31 C2 EDO A 302 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -20.73 44.81 67.02 -21.84 45.98 65.65 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 B 14 LYS C 68 LYS~? -2.77 O ACT C 201s B 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 B 14 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 74 LYS C 68 LYS~? -2.77 O ACT C 201s B 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 B 14 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 74 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -43.29 70.99 40.99 -41.92 72.19 39.92 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 B 14 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 74 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -43.29 70.99 40.99 -41.92 72.19 39.92 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 11 hits 1idt_c01 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 32 SER.? 11.27 CH3 ACT A 201 A 173 ARG A 24 ARG~? 13.97 CH3 ACT A 201 A 211 ASP A 34 ASP~? 14.63 O ACT A 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -34.08 78.47 59.42 -31.66 78.25 59.14 coo 18.77 77.82 11.69 20.55 80.22 10.73 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER A 32 SER.? 11.27 CH3 ACT A 201 A 173 ARG A 147 ARG.? 13.06 CH3 ACT A 201 A 211 ASP A 34 ASP~? 14.63 O ACT A 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -34.08 78.47 59.42 -31.66 78.25 59.14 coo 18.77 77.82 11.69 20.55 80.22 10.73 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER A 101 SER.? 7.80 O2 EDO A 301 A 173 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 211 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 18.77 77.82 11.69 20.55 80.22 10.73 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1ig8_c00 HEXOKINASE PII user 4 3 # 4 A 158 SER A 101 SER.? 7.80 O2 EDO A 301 A 173 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 211 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 18.77 77.82 11.69 20.55 80.22 10.73 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1ig8_c00 HEXOKINASE PII user 5 3 # 5 A 158 SER A 101 SER.? 7.80 O2 EDO A 301 A 173 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 211 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 18.77 77.82 11.69 20.55 80.22 10.73 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1ig8_c00 HEXOKINASE PII user 6 3 # 6 A 158 SER A 101 SER.? 7.80 O2 EDO A 301 A 173 ARG D 67 ARG~? 13.15 O ACT A 203 A 211 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 18.77 77.82 11.69 20.55 80.22 10.73 -60.60 65.68 53.30 -61.45 62.86 52.44 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1ig8_c00 HEXOKINASE PII user 7 3 # 7 A 158 SER A 101 SER.? 7.80 O2 EDO A 301 A 173 ARG D 67 ARG~? 13.15 O ACT A 203 A 211 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 18.77 77.82 11.69 20.55 80.22 10.73 -60.60 65.68 53.30 -61.45 62.86 52.44 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1ig8_c00 HEXOKINASE PII user 8 3 # 8 A 158 SER A 101 SER.? 7.80 O2 EDO A 301 A 173 ARG D 67 ARG~? 13.15 O ACT A 203 A 211 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 18.77 77.82 11.69 20.55 80.22 10.73 -60.60 65.68 53.30 -61.45 62.86 52.44 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1ig8_c00 HEXOKINASE PII user 9 3 # 9 A 158 SER A 107 SER^? 6.74 O1 EDO A 301 A 173 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 211 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 18.77 77.82 11.69 20.55 80.22 10.73 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1ig8_c00 HEXOKINASE PII user 10 3 # 10 A 158 SER A 107 SER^? 6.74 O1 EDO A 301 A 173 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 211 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 18.77 77.82 11.69 20.55 80.22 10.73 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1ig8_c00 HEXOKINASE PII user 11 3 # 11 A 158 SER B 32 SER.? 11.07 CH3 ACT B 201 A 173 ARG B 24 ARG~? 14.02 CH3 ACT B 201 A 211 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -29.79 46.60 90.02 -31.32 47.94 91.35 coo 18.77 77.82 11.69 20.55 80.22 10.73 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 1ig8_c00 HEXOKINASE PII user 12 3 # 12 A 158 SER B 32 SER.? 11.07 CH3 ACT B 201 A 173 ARG B 147 ARG.? 12.52 CH3 ACT A 202 A 211 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -29.79 46.60 90.02 -31.32 47.94 91.35 coo 18.77 77.82 11.69 20.55 80.22 10.73 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 1ig8_c00 HEXOKINASE PII user 13 3 # 13 A 158 SER B 101 SER.? 19.25 O ACT C 201 A 173 ARG B 138 ARG~? 16.35 OXT ACT B 201 A 211 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 18.77 77.82 11.69 20.55 80.22 10.73 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1ig8_c00 HEXOKINASE PII user 14 3 # 14 A 158 SER B 101 SER.? 19.25 O ACT C 201 A 173 ARG C 33 ARG.? 12.41 O ACT C 201 A 211 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 18.77 77.82 11.69 20.55 80.22 10.73 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1ig8_c00 HEXOKINASE PII user 15 3 # 15 A 158 SER B 107 SER^? 7.39 OXT ACT B 201 A 173 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 211 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 18.77 77.82 11.69 20.55 80.22 10.73 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1ig8_c00 HEXOKINASE PII user 16 3 # 16 A 158 SER B 107 SER^? 7.39 OXT ACT B 201 A 173 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 211 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 18.77 77.82 11.69 20.55 80.22 10.73 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1ig8_c00 HEXOKINASE PII user 17 3 # 17 A 158 SER C 32 SER.? 11.23 CH3 ACT C 201 A 173 ARG C 24 ARG~? 14.09 CH3 ACT C 201 A 211 ASP C 34 ASP~? 14.66 O ACT C 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -32.31 40.22 56.18 -30.64 40.82 54.50 coo 18.77 77.82 11.69 20.55 80.22 10.73 -40.53 35.15 48.39 -41.31 34.14 51.19 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1ig8_c00 HEXOKINASE PII user 18 3 # 18 A 158 SER C 32 SER.? 11.23 CH3 ACT C 201 A 173 ARG C 147 ARG.? 13.23 CH3 ACT C 201 A 211 ASP C 34 ASP~? 14.66 O ACT C 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -32.31 40.22 56.18 -30.64 40.82 54.50 coo 18.77 77.82 11.69 20.55 80.22 10.73 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1ig8_c00 HEXOKINASE PII user 19 3 # 19 A 158 SER C 101 SER.? 7.85 O1 EDO A 301 A 173 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 211 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 18.77 77.82 11.69 20.55 80.22 10.73 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1ig8_c00 HEXOKINASE PII user 20 3 # 20 A 158 SER C 101 SER.? 7.85 O1 EDO A 301 A 173 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 211 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 18.77 77.82 11.69 20.55 80.22 10.73 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1ig8_c00 HEXOKINASE PII user 21 3 # 21 A 158 SER C 101 SER.? 7.85 O1 EDO A 301 A 173 ARG B 67 ARG~? 13.55 O ACT B 201 A 211 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 18.77 77.82 11.69 20.55 80.22 10.73 -45.57 49.20 81.23 -45.93 51.82 82.79 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1ig8_c00 HEXOKINASE PII user 22 3 # 22 A 158 SER C 101 SER.? 7.85 O1 EDO A 301 A 173 ARG B 67 ARG~? 13.55 O ACT B 201 A 211 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 18.77 77.82 11.69 20.55 80.22 10.73 -45.57 49.20 81.23 -45.93 51.82 82.79 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1ig8_c00 HEXOKINASE PII user 23 3 # 23 A 158 SER C 101 SER.? 7.85 O1 EDO A 301 A 173 ARG B 67 ARG~? 13.55 O ACT B 201 A 211 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 18.77 77.82 11.69 20.55 80.22 10.73 -45.57 49.20 81.23 -45.93 51.82 82.79 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1ig8_c00 HEXOKINASE PII user 24 3 # 24 A 158 SER C 101 SER.? 7.85 O1 EDO A 301 A 173 ARG C 138 ARG~? 16.31 O ACT C 201 A 211 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 18.77 77.82 11.69 20.55 80.22 10.73 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1ig8_c00 HEXOKINASE PII user 25 3 # 25 A 158 SER C 107 SER^? 6.74 O2 EDO A 301 A 173 ARG C 76 ARG^? 14.32 O ACT C 201 A 211 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 18.77 77.82 11.69 20.55 80.22 10.73 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1ig8_c00 HEXOKINASE PII user 26 3 # 26 A 158 SER C 107 SER^? 6.74 O2 EDO A 301 A 173 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 211 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 18.77 77.82 11.69 20.55 80.22 10.73 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1ig8_c00 HEXOKINASE PII user 27 3 # 27 A 158 SER D 32 SER.? 11.12 CH3 ACT D 201 A 173 ARG D 24 ARG~? 13.98 CH3 ACT D 201 A 211 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -58.03 70.18 35.81 -59.79 68.52 36.06 coo 18.77 77.82 11.69 20.55 80.22 10.73 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 1ig8_c00 HEXOKINASE PII user 28 3 # 28 A 158 SER D 32 SER.? 11.12 CH3 ACT D 201 A 173 ARG D 147 ARG.? 13.02 CH3 ACT D 201 A 211 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -58.03 70.18 35.81 -59.79 68.52 36.06 coo 18.77 77.82 11.69 20.55 80.22 10.73 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 1ig8_c00 HEXOKINASE PII user 29 3 # 29 A 158 SER D 101 SER.? 9.16 OXT ACT A 203 A 173 ARG A 33 ARG.? 12.39 O ACT A 201 A 211 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 18.77 77.82 11.69 20.55 80.22 10.73 -37.81 74.92 58.71 -38.09 77.66 57.35 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1ig8_c00 HEXOKINASE PII user 30 3 # 30 A 158 SER D 107 SER^? 7.30 OXT ACT D 201 A 173 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 211 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 18.77 77.82 11.69 20.55 80.22 10.73 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1ig8_c00 HEXOKINASE PII user 31 3 # 31 A 158 SER D 107 SER^? 7.30 OXT ACT D 201 A 173 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 211 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 18.77 77.82 11.69 20.55 80.22 10.73 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1ig8_c00 HEXOKINASE PII user 32 3 # 32 A 158 SER D 107 SER^? 7.30 OXT ACT D 201 A 173 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 211 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 18.77 77.82 11.69 20.55 80.22 10.73 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1ig8_c00 HEXOKINASE PII user 33 3 # 33 A 158 SER D 107 SER^? 7.30 OXT ACT D 201 A 173 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 211 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 18.77 77.82 11.69 20.55 80.22 10.73 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -44.77 63.42 52.85 -43.43 61.81 52.77 1ig8_c00 source 1ig8 HEXOKINASE PII : 33 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 86 ASP.? 20.24 CH3 ACT A 202 158 THR A 15 THR~? 22.99 CH3 ACT A 201 317 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -16.25 74.73 81.62 -15.60 74.59 83.62 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -22.30 82.34 82.17 -21.83 84.42 81.76 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP B 86 ASP.? 24.07 CH3 ACT B 201 158 THR B 15 THR~? 23.10 CH3 ACT B 201 317 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -28.16 75.31 91.23 -27.42 77.23 90.74 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -19.99 70.45 93.36 -19.15 70.03 95.31 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP C 86 ASP.? 24.03 CH3 ACT C 201 158 THR C 15 THR~? 22.98 CH3 ACT C 201 317 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -38.79 45.04 28.56 -40.00 45.30 26.84 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -42.08 36.63 32.38 -41.24 34.66 32.12 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 3 # 4 54 ASP D 86 ASP.? 24.19 CH3 ACT D 201 158 THR D 15 THR~? 23.13 CH3 ACT D 201 317 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -53.41 42.17 31.38 -52.32 40.44 30.82 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -50.62 48.08 24.29 -51.63 48.51 22.43 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -38.79 45.04 28.56 -40.00 45.30 26.84 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 4 hits 1inp_c02 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 100 ASP.? 9.07 O2 EDO A 301 A1134 ALA C 52 ALA.? 12.19 C2 EDO A 301 A1137 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -37.45 62.38 49.17 -37.97 63.55 50.01 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP A 130 ASP.? 4.80 O1 EDO A 301 A1134 ALA B 52 ALA.? 10.80 O1 EDO A 301 A1137 ASN A 129 ASN.? 9.65 O ACT B 201 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -42.54 59.91 74.80 -43.03 59.60 73.39 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 3 3 # 3 A1132 ASP B 130 ASP.? 9.25 OXT ACT B 201 A1134 ALA A 52 ALA.? 7.92 O2 EDO A 302 A1137 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -28.67 56.33 66.41 -29.48 55.05 66.20 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 4 3 # 4 A1132 ASP C 100 ASP.? 9.05 C1 EDO A 301 A1134 ALA A 52 ALA.? 7.92 O2 EDO A 302 A1137 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -28.67 56.33 66.41 -29.48 55.05 66.20 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 5 3 # 5 A1132 ASP C 130 ASP.? 4.74 O2 EDO A 301 A1134 ALA D 52 ALA.? 10.75 O ACT A 203 A1137 ASN C 129 ASN.? 9.72 O ACT D 201 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -52.10 56.30 54.26 -51.39 56.64 55.56 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 6 3 # 6 A1132 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A1134 ALA C 52 ALA.? 12.19 C2 EDO A 301 A1137 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -37.45 62.38 49.17 -37.97 63.55 50.01 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -42.23 60.94 49.15 -42.50 59.01 49.99 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 6 hits 1ir3_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 204 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 279 TYR A 75 TYR^? -4.52 O ACT A 201s coo 5.85 5.60 30.32 5.00 7.49 29.88 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 7.79 1.83 27.81 9.08 3.25 26.92 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 8.22 7.77 18.64 7.58 8.47 21.28 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 204 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 279 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 5.85 5.60 30.32 5.00 7.49 29.88 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 7.79 1.83 27.81 9.08 3.25 26.92 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 8.22 7.77 18.64 7.58 8.47 21.28 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 204 GLU B 36 GLU~? 17.47 CH3 ACT B 201 A 279 TYR B 42 TYR^? 9.74 CH3 ACT B 201 coo 5.85 5.60 30.32 5.00 7.49 29.88 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 7.79 1.83 27.81 9.08 3.25 26.92 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 8.22 7.77 18.64 7.58 8.47 21.28 -37.05 59.03 91.10 -34.97 58.34 89.38 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 4 3 # 4 A 202 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 204 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 279 TYR C 75 TYR^? -4.54 O ACT C 201s coo 5.85 5.60 30.32 5.00 7.49 29.88 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 7.79 1.83 27.81 9.08 3.25 26.92 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 8.22 7.77 18.64 7.58 8.47 21.28 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 5 3 # 5 A 202 ASP C 34 ASP~? 14.66 O ACT C 201 A 204 GLU C 36 GLU~? 15.95 O2 EDO A 302 A 279 TYR C 42 TYR^? 9.67 CH3 ACT C 201 coo 5.85 5.60 30.32 5.00 7.49 29.88 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 7.79 1.83 27.81 9.08 3.25 26.92 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 8.22 7.77 18.64 7.58 8.47 21.28 -29.49 47.84 44.30 -31.93 47.16 45.50 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 6 3 # 6 A 202 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 204 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 279 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 5.85 5.60 30.32 5.00 7.49 29.88 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 7.79 1.83 27.81 9.08 3.25 26.92 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 8.22 7.77 18.64 7.58 8.47 21.28 -52.06 69.71 41.47 -52.08 66.98 40.85 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 7 3 # 7 A 202 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 204 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 279 TYR D 42 TYR^? 9.84 CH3 ACT D 201 coo 5.85 5.60 30.32 5.00 7.49 29.88 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 7.79 1.83 27.81 9.08 3.25 26.92 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 8.22 7.77 18.64 7.58 8.47 21.28 -61.35 56.68 39.82 -58.87 57.88 39.36 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 7 hits 1itx_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 61 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 162 HIS A 56 HIS.? 6.76 O1 EDO A 302 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -17.96 60.58 68.89 -19.86 60.60 67.97 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -26.96 59.20 61.32 -28.18 60.32 59.98 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -17.38 60.38 62.27 -18.29 58.66 63.03 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 1 hits 1j53_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 201 HIS B 56 HIS.? 17.31 O ACT B 201 A 204 HIS A 161 HIS.? 19.24 O ACT B 201 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -48.72 65.75 79.30 -49.45 66.41 81.15 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 201 HIS B 141 HIS.? 15.94 CH3 ACT A 202 A 204 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -16.42 43.62 79.59 -14.76 44.89 79.44 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1j70_c00 ATP SULPHURYLASE user 3 3 # 3 A 197 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 201 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 204 HIS B 141 HIS.? 15.94 CH3 ACT A 202 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -16.30 48.49 82.95 -17.03 48.20 81.01 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -16.42 43.62 79.59 -14.76 44.89 79.44 ULMN 3 1j70_c00 ATP SULPHURYLASE user 4 3 # 4 A 197 ARG B 123 ARG.? 17.76 O ACT B 201 A 201 HIS A 161 HIS.? 19.24 O ACT B 201 A 204 HIS B 56 HIS.? 17.31 O ACT B 201 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -38.78 69.90 87.63 -38.44 71.99 85.40 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -48.72 65.75 79.30 -49.45 66.41 81.15 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -48.13 62.85 85.87 -48.38 63.10 83.80 ULMN 3 1j70_c00 ATP SULPHURYLASE user 5 3 # 5 A 197 ARG B 124 ARG.? -3.52 O ACT B 201s A 201 HIS A 161 HIS.? 19.24 O ACT B 201 A 204 HIS B 56 HIS.? 17.31 O ACT B 201 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -48.72 65.75 79.30 -49.45 66.41 81.15 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -48.13 62.85 85.87 -48.38 63.10 83.80 ULMN 3 1j70_c00 ATP SULPHURYLASE user 6 3 # 6 A 197 ARG B 146 ARG.? 16.58 CH3 ACT B 201 A 201 HIS B 141 HIS.? 15.94 CH3 ACT A 202 A 204 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -21.21 49.21 92.90 -18.50 50.59 92.50 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -16.42 43.62 79.59 -14.76 44.89 79.44 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -16.30 48.49 82.95 -17.03 48.20 81.01 1j70_c00 source 1j70 ATP SULPHURYLASE : 6 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG A 92 ARG^? 14.09 CH3 ACT A 201 B 201 HIS B 56 HIS.? 17.31 O ACT B 201 B 204 HIS A 161 HIS.? 19.24 O ACT B 201 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -48.72 65.75 79.30 -49.45 66.41 81.15 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG B 106 ARG^? 5.91 C1 EDO A 302 B 201 HIS B 141 HIS.? 15.94 CH3 ACT A 202 B 204 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -16.42 43.62 79.59 -14.76 44.89 79.44 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1j70_c01 ATP SULPHURYLASE user 3 3 # 3 B 197 ARG B 106 ARG^? 5.91 C1 EDO A 302 B 201 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 204 HIS B 141 HIS.? 15.94 CH3 ACT A 202 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -16.30 48.49 82.95 -17.03 48.20 81.01 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -16.42 43.62 79.59 -14.76 44.89 79.44 ULMN 3 1j70_c01 ATP SULPHURYLASE user 4 3 # 4 B 197 ARG B 123 ARG.? 17.76 O ACT B 201 B 201 HIS A 161 HIS.? 19.24 O ACT B 201 B 204 HIS B 56 HIS.? 17.31 O ACT B 201 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -38.78 69.90 87.63 -38.44 71.99 85.40 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -48.72 65.75 79.30 -49.45 66.41 81.15 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -48.13 62.85 85.87 -48.38 63.10 83.80 ULMN 3 1j70_c01 ATP SULPHURYLASE user 5 3 # 5 B 197 ARG B 124 ARG.? -3.52 O ACT B 201s B 201 HIS A 161 HIS.? 19.24 O ACT B 201 B 204 HIS B 56 HIS.? 17.31 O ACT B 201 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -48.72 65.75 79.30 -49.45 66.41 81.15 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -48.13 62.85 85.87 -48.38 63.10 83.80 ULMN 3 1j70_c01 ATP SULPHURYLASE user 6 3 # 6 B 197 ARG B 146 ARG.? 16.58 CH3 ACT B 201 B 201 HIS B 141 HIS.? 15.94 CH3 ACT A 202 B 204 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -21.21 49.21 92.90 -18.50 50.59 92.50 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -16.42 43.62 79.59 -14.76 44.89 79.44 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1j70_c01 ATP SULPHURYLASE user 7 3 # 7 B 197 ARG D 106 ARG^? 14.88 OXT ACT D 201 B 201 HIS D 141 HIS.? 18.95 OXT ACT D 201 B 204 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -42.77 77.11 33.23 -41.72 76.77 31.45 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -44.04 70.63 29.61 -43.01 70.81 31.43 ULMN 3 1j70_c01 ATP SULPHURYLASE user 8 3 # 8 B 197 ARG D 106 ARG^? 14.88 OXT ACT D 201 B 201 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 204 HIS D 141 HIS.? 18.95 OXT ACT D 201 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -44.04 70.63 29.61 -43.01 70.81 31.43 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -42.77 77.11 33.23 -41.72 76.77 31.45 ULMN 3 1j70_c01 ATP SULPHURYLASE user 9 3 # 9 B 197 ARG D 146 ARG.? 16.60 CH3 ACT D 201 B 201 HIS D 141 HIS.? 18.95 OXT ACT D 201 B 204 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -54.51 68.83 27.22 -52.30 68.02 25.26 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -42.77 77.11 33.23 -41.72 76.77 31.45 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -44.04 70.63 29.61 -43.01 70.81 31.43 1j70_c01 source 1j70 ATP SULPHURYLASE : 9 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG A 92 ARG^? 14.09 CH3 ACT A 201 C 201 HIS B 56 HIS.? 17.31 O ACT B 201 C 204 HIS A 161 HIS.? 19.24 O ACT B 201 coo 30.92 14.23 15.70 28.82 13.90 13.48 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 20.16 5.55 18.86 20.00 7.59 19.34 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 24.92 3.29 16.90 24.41 4.92 15.69 -48.72 65.75 79.30 -49.45 66.41 81.15 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG B 106 ARG^? 5.91 C1 EDO A 302 C 201 HIS B 141 HIS.? 15.94 CH3 ACT A 202 C 204 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo 30.92 14.23 15.70 28.82 13.90 13.48 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 20.16 5.55 18.86 20.00 7.59 19.34 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 24.92 3.29 16.90 24.41 4.92 15.69 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1j70_c02 ATP SULPHURYLASE user 3 3 # 3 C 197 ARG B 106 ARG^? 5.91 C1 EDO A 302 C 201 HIS B 151 HIS.? 13.45 CH3 ACT A 202 C 204 HIS B 141 HIS.? 15.94 CH3 ACT A 202 coo 30.92 14.23 15.70 28.82 13.90 13.48 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 20.16 5.55 18.86 20.00 7.59 19.34 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 24.92 3.29 16.90 24.41 4.92 15.69 -16.42 43.62 79.59 -14.76 44.89 79.44 ULMN 3 1j70_c02 ATP SULPHURYLASE user 4 3 # 4 C 197 ARG B 123 ARG.? 17.76 O ACT B 201 C 201 HIS A 161 HIS.? 19.24 O ACT B 201 C 204 HIS B 56 HIS.? 17.31 O ACT B 201 coo 30.92 14.23 15.70 28.82 13.90 13.48 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 20.16 5.55 18.86 20.00 7.59 19.34 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 24.92 3.29 16.90 24.41 4.92 15.69 -48.13 62.85 85.87 -48.38 63.10 83.80 ULMN 3 1j70_c02 ATP SULPHURYLASE user 5 3 # 5 C 197 ARG B 124 ARG.? -3.52 O ACT B 201s C 201 HIS A 161 HIS.? 19.24 O ACT B 201 C 204 HIS B 56 HIS.? 17.31 O ACT B 201 coo 30.92 14.23 15.70 28.82 13.90 13.48 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 20.16 5.55 18.86 20.00 7.59 19.34 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 24.92 3.29 16.90 24.41 4.92 15.69 -48.13 62.85 85.87 -48.38 63.10 83.80 ULMN 3 1j70_c02 ATP SULPHURYLASE user 6 3 # 6 C 197 ARG B 146 ARG.? 16.58 CH3 ACT B 201 C 201 HIS B 141 HIS.? 15.94 CH3 ACT A 202 C 204 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo 30.92 14.23 15.70 28.82 13.90 13.48 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 20.16 5.55 18.86 20.00 7.59 19.34 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 24.92 3.29 16.90 24.41 4.92 15.69 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1j70_c02 ATP SULPHURYLASE user 7 3 # 7 C 197 ARG D 106 ARG^? 14.88 OXT ACT D 201 C 201 HIS D 141 HIS.? 18.95 OXT ACT D 201 C 204 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo 30.92 14.23 15.70 28.82 13.90 13.48 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 20.16 5.55 18.86 20.00 7.59 19.34 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 24.92 3.29 16.90 24.41 4.92 15.69 -44.04 70.63 29.61 -43.01 70.81 31.43 ULMN 3 1j70_c02 ATP SULPHURYLASE user 8 3 # 8 C 197 ARG D 106 ARG^? 14.88 OXT ACT D 201 C 201 HIS D 151 HIS.? 15.66 CH3 ACT D 201 C 204 HIS D 141 HIS.? 18.95 OXT ACT D 201 coo 30.92 14.23 15.70 28.82 13.90 13.48 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 20.16 5.55 18.86 20.00 7.59 19.34 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 24.92 3.29 16.90 24.41 4.92 15.69 -42.77 77.11 33.23 -41.72 76.77 31.45 ULMN 3 1j70_c02 ATP SULPHURYLASE user 9 3 # 9 C 197 ARG D 146 ARG.? 16.60 CH3 ACT D 201 C 201 HIS D 141 HIS.? 18.95 OXT ACT D 201 C 204 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo 30.92 14.23 15.70 28.82 13.90 13.48 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 20.16 5.55 18.86 20.00 7.59 19.34 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 24.92 3.29 16.90 24.41 4.92 15.69 -44.04 70.63 29.61 -43.01 70.81 31.43 1j70_c02 source 1j70 ATP SULPHURYLASE : 9 hits 1j70_c02 naa= 3 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 49 ARG^? -3.92 O ACT A 202s A 581 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 49 ARG^? -3.92 O ACT A 202s A 581 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG A 49 ARG^? -3.92 O ACT A 202s A 581 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 713 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG A 49 ARG^? -3.92 O ACT A 202s A 581 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 713 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG A 49 ARG^? -3.92 O ACT A 202s A 581 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 713 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG A 49 ARG^? -3.92 O ACT A 202s A 581 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 7 3 # 7 A 396 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 581 ARG A 49 ARG^? -3.92 O ACT A 202s A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 8 3 # 8 A 396 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 581 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 713 ARG A 49 ARG^? -3.92 O ACT A 202s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 9 3 # 9 A 396 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 581 ARG B 49 ARG^? 10.37 O ACT B 201 A 713 ARG B 123 ARG.? 17.76 O ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 10 3 # 10 A 396 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 581 ARG B 49 ARG^? 10.37 O ACT B 201 A 713 ARG B 124 ARG.? -3.52 O ACT B 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 11 3 # 11 A 396 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 581 ARG B 123 ARG.? 17.76 O ACT B 201 A 713 ARG B 49 ARG^? 10.37 O ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 12 3 # 12 A 396 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 581 ARG B 123 ARG.? 17.76 O ACT B 201 A 713 ARG B 124 ARG.? -3.52 O ACT B 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 13 3 # 13 A 396 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 581 ARG B 124 ARG.? -3.52 O ACT B 201s A 713 ARG B 49 ARG^? 10.37 O ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 14 3 # 14 A 396 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 581 ARG B 124 ARG.? -3.52 O ACT B 201s A 713 ARG B 123 ARG.? 17.76 O ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 15 3 # 15 A 396 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 581 ARG A 49 ARG^? -3.92 O ACT A 202s A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 16 3 # 16 A 396 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 581 ARG A 49 ARG^? -3.92 O ACT A 202s A 713 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 17 3 # 17 A 396 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 581 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 713 ARG A 49 ARG^? -3.92 O ACT A 202s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 18 3 # 18 A 396 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 581 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 713 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 19 3 # 19 A 396 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 581 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 713 ARG A 49 ARG^? -3.92 O ACT A 202s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 20 3 # 20 A 396 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 581 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 21 3 # 21 A 396 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 581 ARG A 49 ARG^? -3.92 O ACT A 202s A 713 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 22 3 # 22 A 396 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 581 ARG A 49 ARG^? -3.92 O ACT A 202s A 713 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 23 3 # 23 A 396 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 581 ARG A 49 ARG^? -3.92 O ACT A 202s A 713 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 24 3 # 24 A 396 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 581 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 713 ARG A 49 ARG^? -3.92 O ACT A 202s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 25 3 # 25 A 396 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 581 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 713 ARG A 49 ARG^? -3.92 O ACT A 202s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 26 3 # 26 A 396 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 581 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 713 ARG A 49 ARG^? -3.92 O ACT A 202s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 27 3 # 27 A 396 ARG B 37 ARG~? 13.57 CH3 ACT B 201 A 581 ARG B 33 ARG.? 12.67 OXT ACT B 201 A 713 ARG B 146 ARG.? 16.58 CH3 ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -31.32 49.06 94.80 -28.26 48.93 94.55 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -21.21 49.21 92.90 -18.50 50.59 92.50 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 28 3 # 28 A 396 ARG B 37 ARG~? 13.57 CH3 ACT B 201 A 581 ARG B 146 ARG.? 16.58 CH3 ACT B 201 A 713 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -31.32 49.06 94.80 -28.26 48.93 94.55 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 29 3 # 29 A 396 ARG B 49 ARG^? 10.37 O ACT B 201 A 581 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 713 ARG B 124 ARG.? -3.52 O ACT B 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 30 3 # 30 A 396 ARG B 49 ARG^? 10.37 O ACT B 201 A 581 ARG B 51 ARG.? 7.67 O ACT B 201 A 713 ARG B 124 ARG.? -3.52 O ACT B 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 31 3 # 31 A 396 ARG B 49 ARG^? 10.37 O ACT B 201 A 581 ARG B 124 ARG.? -3.52 O ACT B 201s A 713 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 32 3 # 32 A 396 ARG B 49 ARG^? 10.37 O ACT B 201 A 581 ARG B 124 ARG.? -3.52 O ACT B 201s A 713 ARG B 51 ARG.? 7.67 O ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 33 3 # 33 A 396 ARG B 51 ARG.? 7.67 O ACT B 201 A 581 ARG B 49 ARG^? 10.37 O ACT B 201 A 713 ARG B 124 ARG.? -3.52 O ACT B 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 34 3 # 34 A 396 ARG B 51 ARG.? 7.67 O ACT B 201 A 581 ARG B 124 ARG.? -3.52 O ACT B 201s A 713 ARG B 49 ARG^? 10.37 O ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 35 3 # 35 A 396 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 581 ARG A 49 ARG^? -3.92 O ACT A 202s A 713 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 36 3 # 36 A 396 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 581 ARG A 49 ARG^? -3.92 O ACT A 202s A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 37 3 # 37 A 396 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 581 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 713 ARG A 49 ARG^? -3.92 O ACT A 202s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 38 3 # 38 A 396 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 581 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 39 3 # 39 A 396 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 581 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 713 ARG A 49 ARG^? -3.92 O ACT A 202s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 40 3 # 40 A 396 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 581 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 713 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 41 3 # 41 A 396 ARG B 123 ARG.? 17.76 O ACT B 201 A 581 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 713 ARG B 124 ARG.? -3.52 O ACT B 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 42 3 # 42 A 396 ARG B 123 ARG.? 17.76 O ACT B 201 A 581 ARG B 124 ARG.? -3.52 O ACT B 201s A 713 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 43 3 # 43 A 396 ARG B 124 ARG.? -3.52 O ACT B 201s A 581 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 713 ARG B 49 ARG^? 10.37 O ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 44 3 # 44 A 396 ARG B 124 ARG.? -3.52 O ACT B 201s A 581 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 713 ARG B 123 ARG.? 17.76 O ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 45 3 # 45 A 396 ARG B 124 ARG.? -3.52 O ACT B 201s A 581 ARG B 49 ARG^? 10.37 O ACT B 201 A 713 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 46 3 # 46 A 396 ARG B 124 ARG.? -3.52 O ACT B 201s A 581 ARG B 49 ARG^? 10.37 O ACT B 201 A 713 ARG B 51 ARG.? 7.67 O ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 47 3 # 47 A 396 ARG B 124 ARG.? -3.52 O ACT B 201s A 581 ARG B 49 ARG^? 10.37 O ACT B 201 A 713 ARG B 123 ARG.? 17.76 O ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 48 3 # 48 A 396 ARG B 124 ARG.? -3.52 O ACT B 201s A 581 ARG B 51 ARG.? 7.67 O ACT B 201 A 713 ARG B 49 ARG^? 10.37 O ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 49 3 # 49 A 396 ARG B 124 ARG.? -3.52 O ACT B 201s A 581 ARG B 123 ARG.? 17.76 O ACT B 201 A 713 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 50 3 # 50 A 396 ARG B 124 ARG.? -3.52 O ACT B 201s A 581 ARG B 123 ARG.? 17.76 O ACT B 201 A 713 ARG B 49 ARG^? 10.37 O ACT B 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 51 3 # 51 A 396 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 581 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 713 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 52 3 # 52 A 396 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 581 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 713 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 53 3 # 53 A 396 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 581 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 713 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 54 3 # 54 A 396 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 581 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 713 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 55 3 # 55 A 396 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 581 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 713 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 56 3 # 56 A 396 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 581 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 713 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 57 3 # 57 A 396 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 581 ARG D 49 ARG^? 10.44 O ACT D 201 A 713 ARG D 123 ARG.? 17.60 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 58 3 # 58 A 396 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 581 ARG D 49 ARG^? 10.44 O ACT D 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 59 3 # 59 A 396 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 581 ARG D 123 ARG.? 17.60 O ACT D 201 A 713 ARG D 49 ARG^? 10.44 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 60 3 # 60 A 396 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 581 ARG D 123 ARG.? 17.60 O ACT D 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 61 3 # 61 A 396 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 581 ARG D 124 ARG.? -3.55 O ACT D 201s A 713 ARG D 49 ARG^? 10.44 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 62 3 # 62 A 396 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 581 ARG D 124 ARG.? -3.55 O ACT D 201s A 713 ARG D 123 ARG.? 17.60 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 63 3 # 63 A 396 ARG C 123 ARG.? 17.68 OXT ACT C 201 A 581 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 713 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 64 3 # 64 A 396 ARG C 123 ARG.? 17.68 OXT ACT C 201 A 581 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 713 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 65 3 # 65 A 396 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 581 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 713 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 66 3 # 66 A 396 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 581 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 713 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 67 3 # 67 A 396 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 581 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 713 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 68 3 # 68 A 396 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 581 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 713 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 69 3 # 69 A 396 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 581 ARG C 123 ARG.? 17.68 OXT ACT C 201 A 713 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 70 3 # 70 A 396 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 581 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 713 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 71 3 # 71 A 396 ARG D 49 ARG^? 10.44 O ACT D 201 A 581 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 72 3 # 72 A 396 ARG D 49 ARG^? 10.44 O ACT D 201 A 581 ARG D 51 ARG.? 7.60 O ACT D 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 73 3 # 73 A 396 ARG D 49 ARG^? 10.44 O ACT D 201 A 581 ARG D 123 ARG.? 17.60 O ACT D 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 74 3 # 74 A 396 ARG D 49 ARG^? 10.44 O ACT D 201 A 581 ARG D 124 ARG.? -3.55 O ACT D 201s A 713 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 75 3 # 75 A 396 ARG D 49 ARG^? 10.44 O ACT D 201 A 581 ARG D 124 ARG.? -3.55 O ACT D 201s A 713 ARG D 51 ARG.? 7.60 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 76 3 # 76 A 396 ARG D 49 ARG^? 10.44 O ACT D 201 A 581 ARG D 124 ARG.? -3.55 O ACT D 201s A 713 ARG D 123 ARG.? 17.60 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 77 3 # 77 A 396 ARG D 51 ARG.? 7.60 O ACT D 201 A 581 ARG D 49 ARG^? 10.44 O ACT D 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 78 3 # 78 A 396 ARG D 51 ARG.? 7.60 O ACT D 201 A 581 ARG D 124 ARG.? -3.55 O ACT D 201s A 713 ARG D 49 ARG^? 10.44 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 79 3 # 79 A 396 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 581 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 713 ARG D 138 ARG~? 16.38 OXT ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -42.61 77.59 41.75 -44.95 78.80 40.20 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 80 3 # 80 A 396 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 581 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 713 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -40.22 67.90 41.60 -38.15 70.12 41.98 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 81 3 # 81 A 396 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 581 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 713 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 82 3 # 82 A 396 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 581 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 713 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 83 3 # 83 A 396 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 581 ARG C 123 ARG.? 17.68 OXT ACT C 201 A 713 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 84 3 # 84 A 396 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 581 ARG C 123 ARG.? 17.68 OXT ACT C 201 A 713 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 85 3 # 85 A 396 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 581 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 713 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 86 3 # 86 A 396 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 581 ARG C 124 ARG.? -3.50 OXT ACT C 201s A 713 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 87 3 # 87 A 396 ARG D 123 ARG.? 17.60 O ACT D 201 A 581 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 713 ARG D 49 ARG^? 10.44 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 88 3 # 88 A 396 ARG D 123 ARG.? 17.60 O ACT D 201 A 581 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 89 3 # 89 A 396 ARG D 123 ARG.? 17.60 O ACT D 201 A 581 ARG D 49 ARG^? 10.44 O ACT D 201 A 713 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 90 3 # 90 A 396 ARG D 123 ARG.? 17.60 O ACT D 201 A 581 ARG D 49 ARG^? 10.44 O ACT D 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 91 3 # 91 A 396 ARG D 123 ARG.? 17.60 O ACT D 201 A 581 ARG D 124 ARG.? -3.55 O ACT D 201s A 713 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 92 3 # 92 A 396 ARG D 123 ARG.? 17.60 O ACT D 201 A 581 ARG D 124 ARG.? -3.55 O ACT D 201s A 713 ARG D 49 ARG^? 10.44 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 93 3 # 93 A 396 ARG D 124 ARG.? -3.55 O ACT D 201s A 581 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 713 ARG D 49 ARG^? 10.44 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 94 3 # 94 A 396 ARG D 124 ARG.? -3.55 O ACT D 201s A 581 ARG D 49 ARG^? 10.44 O ACT D 201 A 713 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 95 3 # 95 A 396 ARG D 124 ARG.? -3.55 O ACT D 201s A 581 ARG D 49 ARG^? 10.44 O ACT D 201 A 713 ARG D 51 ARG.? 7.60 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 96 3 # 96 A 396 ARG D 124 ARG.? -3.55 O ACT D 201s A 581 ARG D 49 ARG^? 10.44 O ACT D 201 A 713 ARG D 123 ARG.? 17.60 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 97 3 # 97 A 396 ARG D 124 ARG.? -3.55 O ACT D 201s A 581 ARG D 51 ARG.? 7.60 O ACT D 201 A 713 ARG D 49 ARG^? 10.44 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 98 3 # 98 A 396 ARG D 124 ARG.? -3.55 O ACT D 201s A 581 ARG D 123 ARG.? 17.60 O ACT D 201 A 713 ARG D 49 ARG^? 10.44 O ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 99 3 # 99 A 396 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 581 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 713 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -40.22 67.90 41.60 -38.15 70.12 41.98 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 100 3 # 100 A 396 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 581 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 713 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -47.81 74.29 36.53 -48.87 77.02 37.43 1jqn_c01 source 1jqn PHOSPHOENOLPYRUVATE CARBOXYLASE : 100 hits 1jqn_c01 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 58 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 424 GLU A 72 GLU~? 5.31 O ACT A 201 coo 58.42 47.76 20.67 58.01 49.10 19.12 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 58.59 41.80 18.81 58.94 43.89 18.94 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 52.85 46.34 13.34 54.09 44.97 14.42 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 58 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 424 GLU A 72 GLU~? 5.31 O ACT A 201 coo 58.42 47.76 20.67 58.01 49.10 19.12 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 58.59 41.80 18.81 58.94 43.89 18.94 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 52.85 46.34 13.34 54.09 44.97 14.42 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 58 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 424 GLU B 72 GLU~? 5.30 OXT ACT B 201 coo 58.42 47.76 20.67 58.01 49.10 19.12 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 58.59 41.80 18.81 58.94 43.89 18.94 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 52.85 46.34 13.34 54.09 44.97 14.42 -35.13 47.70 77.85 -34.58 49.69 78.28 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 58 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 424 GLU B 72 GLU~? 5.30 OXT ACT B 201 coo 58.42 47.76 20.67 58.01 49.10 19.12 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 58.59 41.80 18.81 58.94 43.89 18.94 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 52.85 46.34 13.34 54.09 44.97 14.42 -35.13 47.70 77.85 -34.58 49.69 78.28 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 5 3 # 5 A 55 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 58 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 424 GLU C 72 GLU~? 5.32 O ACT C 201 coo 58.42 47.76 20.67 58.01 49.10 19.12 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 58.59 41.80 18.81 58.94 43.89 18.94 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 52.85 46.34 13.34 54.09 44.97 14.42 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 6 3 # 6 A 55 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 58 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 424 GLU C 72 GLU~? 5.32 O ACT C 201 coo 58.42 47.76 20.67 58.01 49.10 19.12 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 58.59 41.80 18.81 58.94 43.89 18.94 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 52.85 46.34 13.34 54.09 44.97 14.42 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 7 3 # 7 A 55 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 58 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 424 GLU D 72 GLU~? 5.29 OXT ACT D 201 coo 58.42 47.76 20.67 58.01 49.10 19.12 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 58.59 41.80 18.81 58.94 43.89 18.94 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 52.85 46.34 13.34 54.09 44.97 14.42 -51.77 69.18 47.61 -51.44 67.29 46.71 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 8 3 # 8 A 55 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 58 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 424 GLU D 72 GLU~? 5.29 OXT ACT D 201 coo 58.42 47.76 20.67 58.01 49.10 19.12 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 58.59 41.80 18.81 58.94 43.89 18.94 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 52.85 46.34 13.34 54.09 44.97 14.42 -51.77 69.18 47.61 -51.44 67.29 46.71 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 8 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 58 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 424 GLU A 72 GLU~? 5.31 O ACT A 201 coo 112.10 61.46 19.99 111.82 60.65 18.07 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 117.85 63.62 21.08 115.96 63.25 20.18 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 118.47 57.23 15.57 119.32 58.77 16.73 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 58 ASP B 100 ASP.? 15.93 OXT ACT B 201 B 424 GLU B 72 GLU~? 5.30 OXT ACT B 201 coo 112.10 61.46 19.99 111.82 60.65 18.07 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 117.85 63.62 21.08 115.96 63.25 20.18 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 118.47 57.23 15.57 119.32 58.77 16.73 -35.13 47.70 77.85 -34.58 49.69 78.28 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 3 3 # 3 B 55 ASP B 100 ASP.? 15.93 OXT ACT B 201 B 58 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 424 GLU B 72 GLU~? 5.30 OXT ACT B 201 coo 112.10 61.46 19.99 111.82 60.65 18.07 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 117.85 63.62 21.08 115.96 63.25 20.18 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 118.47 57.23 15.57 119.32 58.77 16.73 -35.13 47.70 77.85 -34.58 49.69 78.28 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 4 3 # 4 B 55 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 58 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 424 GLU C 72 GLU~? 5.32 O ACT C 201 coo 112.10 61.46 19.99 111.82 60.65 18.07 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 117.85 63.62 21.08 115.96 63.25 20.18 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 118.47 57.23 15.57 119.32 58.77 16.73 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 5 3 # 5 B 55 ASP D 100 ASP.? 7.94 OXT ACT A 203 B 58 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 424 GLU D 72 GLU~? 5.29 OXT ACT D 201 coo 112.10 61.46 19.99 111.82 60.65 18.07 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 117.85 63.62 21.08 115.96 63.25 20.18 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 118.47 57.23 15.57 119.32 58.77 16.73 -51.77 69.18 47.61 -51.44 67.29 46.71 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 5 hits 1js4_c01 naa= 3 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 A 1 CYH A 127 CYH.? 6.15 O ACT A 202 A 98 ASN A 110 ASN^? 10.87 O ACT B 201 A 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -31.19 62.06 71.95 -29.40 60.66 73.55 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -31.91 65.50 76.29 -33.35 65.88 77.83 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 A 1 CYH A 127 CYH.? 6.15 O ACT A 202 A 98 ASN B 110 ASN^? 6.46 O ACT A 202 A 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -31.19 62.06 71.95 -29.40 60.66 73.55 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -29.30 63.23 76.74 -27.50 63.37 75.59 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 3 # 3 A 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 A 98 ASN A 110 ASN^? 10.87 O ACT B 201 A 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -34.42 60.97 75.89 -35.29 63.54 75.29 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -31.91 65.50 76.29 -33.35 65.88 77.83 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 3 # 4 A 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 A 98 ASN B 110 ASN^? 6.46 O ACT A 202 A 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -34.42 60.97 75.89 -35.29 63.54 75.29 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -29.30 63.23 76.74 -27.50 63.37 75.59 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 3 # 5 A 1 CYH C 127 CYH.? 10.01 O ACT D 201 A 98 ASN C 110 ASN^? 10.92 O ACT D 201 A 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -42.49 55.99 47.19 -42.84 57.56 44.90 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -45.77 52.18 44.66 -47.80 51.56 44.77 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 3 # 6 A 1 CYH C 127 CYH.? 10.01 O ACT D 201 A 98 ASN D 110 ASN^? 10.92 OXT ACT C 201 A 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -42.49 55.99 47.19 -42.84 57.56 44.90 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -44.80 54.88 42.61 -42.77 55.08 41.96 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 7 3 # 7 A 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 A 98 ASN C 110 ASN^? 10.92 O ACT D 201 A 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -47.67 56.31 47.24 -47.42 53.67 48.08 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -45.77 52.18 44.66 -47.80 51.56 44.77 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 8 3 # 8 A 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 A 98 ASN D 110 ASN^? 10.92 OXT ACT C 201 A 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -47.67 56.31 47.24 -47.42 53.67 48.08 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -44.80 54.88 42.61 -42.77 55.08 41.96 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -45.26 59.49 43.22 -44.76 59.46 42.64 1jxa_c02 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 8 hits 1jxa_c02 naa= 3 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 C 1 CYH A 127 CYH.? 6.15 O ACT A 202 C 98 ASN A 110 ASN^? 10.87 O ACT B 201 C 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 8.21 16.91 78.64 7.09 18.75 78.67 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 11.04 18.39 74.90 10.95 17.56 74.65 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 C 1 CYH A 127 CYH.? 6.15 O ACT A 202 C 98 ASN A 129 ASN.? 9.65 O ACT B 201 C 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 8.21 16.91 78.64 7.09 18.75 78.67 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 11.04 18.39 74.90 10.95 17.56 74.65 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 3 # 3 C 1 CYH A 127 CYH.? 6.15 O ACT A 202 C 98 ASN B 110 ASN^? 6.46 O ACT A 202 C 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 8.21 16.91 78.64 7.09 18.75 78.67 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 11.04 18.39 74.90 10.95 17.56 74.65 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 3 # 4 C 1 CYH A 127 CYH.? 6.15 O ACT A 202 C 98 ASN B 129 ASN.? 9.80 OXT ACT A 201 C 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 8.21 16.91 78.64 7.09 18.75 78.67 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 11.04 18.39 74.90 10.95 17.56 74.65 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 3 # 5 C 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 C 98 ASN A 110 ASN^? 10.87 O ACT B 201 C 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 8.21 16.91 78.64 7.09 18.75 78.67 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 11.04 18.39 74.90 10.95 17.56 74.65 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 3 # 6 C 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 C 98 ASN A 129 ASN.? 9.65 O ACT B 201 C 99 GLY A 109 GLY^? 6.82 OXT ACT A 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 8.21 16.91 78.64 7.09 18.75 78.67 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 11.04 18.39 74.90 10.95 17.56 74.65 -34.97 66.16 72.79 -35.28 66.58 73.38 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 7 3 # 7 C 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 C 98 ASN B 110 ASN^? 6.46 O ACT A 202 C 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 8.21 16.91 78.64 7.09 18.75 78.67 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 11.04 18.39 74.90 10.95 17.56 74.65 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 8 3 # 8 C 1 CYH B 127 CYH.? 10.07 OXT ACT A 201 C 98 ASN B 129 ASN.? 9.80 OXT ACT A 201 C 99 GLY B 109 GLY^? 6.82 O ACT B 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 8.21 16.91 78.64 7.09 18.75 78.67 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 11.04 18.39 74.90 10.95 17.56 74.65 -29.36 58.56 76.35 -28.60 58.71 76.34 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 9 3 # 9 C 1 CYH C 127 CYH.? 10.01 O ACT D 201 C 98 ASN C 110 ASN^? 10.92 O ACT D 201 C 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 8.21 16.91 78.64 7.09 18.75 78.67 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 11.04 18.39 74.90 10.95 17.56 74.65 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 10 3 # 10 C 1 CYH C 127 CYH.? 10.01 O ACT D 201 C 98 ASN C 129 ASN.? 9.72 O ACT D 201 C 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 8.21 16.91 78.64 7.09 18.75 78.67 -47.56 56.76 52.53 -47.22 58.18 50.99 coo 11.04 18.39 74.90 10.95 17.56 74.65 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 11 3 # 11 C 1 CYH C 127 CYH.? 10.01 O ACT D 201 C 98 ASN D 110 ASN^? 10.92 OXT ACT C 201 C 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 8.21 16.91 78.64 7.09 18.75 78.67 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 11.04 18.39 74.90 10.95 17.56 74.65 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 12 3 # 12 C 1 CYH C 127 CYH.? 10.01 O ACT D 201 C 98 ASN D 129 ASN.? 9.72 OXT ACT C 201 C 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 8.21 16.91 78.64 7.09 18.75 78.67 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 11.04 18.39 74.90 10.95 17.56 74.65 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 13 3 # 13 C 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 C 98 ASN C 110 ASN^? 10.92 O ACT D 201 C 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 8.21 16.91 78.64 7.09 18.75 78.67 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 11.04 18.39 74.90 10.95 17.56 74.65 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 14 3 # 14 C 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 C 98 ASN C 129 ASN.? 9.72 O ACT D 201 C 99 GLY C 109 GLY^? 6.86 OXT ACT C 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 8.21 16.91 78.64 7.09 18.75 78.67 -47.56 56.76 52.53 -47.22 58.18 50.99 coo 11.04 18.39 74.90 10.95 17.56 74.65 -44.99 51.38 49.22 -45.52 50.84 49.05 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 15 3 # 15 C 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 C 98 ASN D 110 ASN^? 10.92 OXT ACT C 201 C 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 8.21 16.91 78.64 7.09 18.75 78.67 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 11.04 18.39 74.90 10.95 17.56 74.65 -45.26 59.49 43.22 -44.76 59.46 42.64 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 16 3 # 16 C 1 CYH D 127 CYH.? 10.01 OXT ACT C 201 C 98 ASN D 129 ASN.? 9.72 OXT ACT C 201 C 99 GLY D 109 GLY^? 6.89 O ACT D 201 coo 4.88 17.74 73.58 7.14 19.23 72.93 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 8.21 16.91 78.64 7.09 18.75 78.67 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 11.04 18.39 74.90 10.95 17.56 74.65 -45.26 59.49 43.22 -44.76 59.46 42.64 1jxa_c04 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 16 hits 1jxa_c04 naa= 3 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 1 3 # 1 A 488 ARG A 146 ARG.? 16.48 CH3 ACT A 201 A 590 ARG A 24 ARG~? 13.97 CH3 ACT A 201 A 632 HIS A 151 HIS.? 15.97 CH3 ACT A 201 coo 19.23 7.38 20.83 18.34 7.79 23.74 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 23.20 10.66 21.48 21.07 10.68 23.70 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 20.55 9.13 29.66 21.88 8.70 28.08 -43.83 81.49 70.61 -45.02 79.78 70.42 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 2 3 # 2 A 488 ARG D 146 ARG.? 16.60 CH3 ACT D 201 A 590 ARG D 24 ARG~? 13.98 CH3 ACT D 201 A 632 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo 19.23 7.38 20.83 18.34 7.79 23.74 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 23.20 10.66 21.48 21.07 10.68 23.70 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 20.55 9.13 29.66 21.88 8.70 28.08 -44.04 70.63 29.61 -43.01 70.81 31.43 1k4t_c00 source 1k4t 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-3' : 2 hits 1k4t_c00 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 56 LYS A 22 LYS~? 15.35 CH3 ACT A 201 A 258 ARG A 37 ARG~? 13.73 CH3 ACT A 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -28.83 80.54 58.97 -30.62 82.33 60.70 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU A 36 GLU~? 17.83 CH3 ACT A 201 A 56 LYS A 62 LYS~? 17.60 O ACT A 201 A 258 ARG A 8 ARG.? 15.23 CH3 ACT A 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -20.16 79.98 64.14 -22.57 80.76 62.41 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 56 LYS A 134 LYS~? 11.98 O ACT A 203 A 258 ARG B 49 ARG^? 10.37 O ACT B 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -53.24 65.33 66.31 -57.37 62.85 65.73 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 56 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 258 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 A 2 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 56 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 258 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 42.33 1.56 26.99 42.38 2.91 28.66 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 A 2 GLU A 160 GLU.? 13.50 O ACT A 201 A 56 LYS A 139 LYS.? 17.81 O ACT A 201 A 258 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 A 2 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 56 LYS B 22 LYS~? 15.43 CH3 ACT B 201 A 258 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 A 2 GLU B 36 GLU~? 17.47 CH3 ACT B 201 A 56 LYS B 62 LYS~? 17.44 OXT ACT B 201 A 258 ARG B 8 ARG.? 14.49 CH3 ACT B 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -31.04 58.38 97.06 -32.26 55.57 97.13 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 A 2 GLU B 53 GLU^? 11.09 O ACT B 201 A 56 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 258 ARG B 49 ARG^? 10.37 O ACT B 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 A 2 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 56 LYS B 134 LYS~? 12.79 C2 EDO A 302 A 258 ARG A 49 ARG^? -3.92 O ACT A 202s coo 42.33 1.56 26.99 42.38 2.91 28.66 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -24.49 42.38 66.88 -23.94 39.99 62.78 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 A 2 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 56 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 258 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 A 2 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 56 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 258 ARG B 51 ARG.? 7.67 O ACT B 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 A 2 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 56 LYS C 22 LYS~? 15.34 CH3 ACT C 201 A 258 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 A 2 GLU C 36 GLU~? 15.95 O2 EDO A 302 A 56 LYS C 62 LYS~? 12.50 O2 EDO A 302 A 258 ARG C 8 ARG.? 14.74 CH3 ACT C 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -27.18 40.10 42.21 -27.55 39.63 45.22 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 A 2 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 56 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 258 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 42.33 1.56 26.99 42.38 2.91 28.66 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 A 2 GLU C 96 GLU^? 13.00 O ACT C 201 A 56 LYS C 134 LYS~? 17.33 O2 EDO A 301 A 258 ARG D 49 ARG^? 10.44 O ACT D 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -51.34 49.79 67.51 -53.85 50.99 71.42 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 A 2 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 56 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 258 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 A 2 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 56 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 258 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 A 2 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 56 LYS D 22 LYS~? 15.49 CH3 ACT D 201 A 258 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -54.47 56.23 29.06 -59.33 54.04 30.24 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 A 2 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 56 LYS D 62 LYS~? 17.47 OXT ACT D 201 A 258 ARG D 8 ARG.? 14.56 CH3 ACT D 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -64.40 57.42 32.12 -63.44 60.33 32.35 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 21 3 # 21 A 2 GLU D 53 GLU^? 10.32 O ACT A 203 A 56 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 258 ARG D 49 ARG^? 10.44 O ACT D 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 22 3 # 22 A 2 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 56 LYS D 134 LYS~? 17.34 O ACT A 201 A 258 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -37.62 76.93 46.97 -33.08 76.47 49.79 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 23 3 # 23 A 2 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 56 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 258 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 24 3 # 24 A 2 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 56 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 258 ARG D 51 ARG.? 7.60 O ACT D 201 coo 42.33 1.56 26.99 42.38 2.91 28.66 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -49.81 61.30 50.74 -48.26 63.65 49.51 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 24 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 27 GLU~? 9.74 CH3 ACT A 201 B 56 LYS A 22 LYS~? 15.35 CH3 ACT A 201 B 258 ARG A 37 ARG~? 13.73 CH3 ACT A 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 2.64 1.83 34.81 1.56 1.13 32.02 -28.83 80.54 58.97 -30.62 82.33 60.70 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU A 36 GLU~? 17.83 CH3 ACT A 201 B 56 LYS A 62 LYS~? 17.60 O ACT A 201 B 258 ARG A 8 ARG.? 15.23 CH3 ACT A 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 2.64 1.83 34.81 1.56 1.13 32.02 -20.16 79.98 64.14 -22.57 80.76 62.41 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 56 LYS A 134 LYS~? 11.98 O ACT A 203 B 258 ARG B 49 ARG^? 10.37 O ACT B 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -53.24 65.33 66.31 -57.37 62.85 65.73 coo 2.64 1.83 34.81 1.56 1.13 32.02 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU A 111 GLU^? 4.34 CH3 ACT A 201 B 56 LYS A 79 LYS^? -3.45 CH3 ACT A 201s B 258 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 2.64 1.83 34.81 1.56 1.13 32.02 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 B 2 GLU A 111 GLU^? 4.34 CH3 ACT A 201 B 56 LYS A 79 LYS^? -3.45 CH3 ACT A 201s B 258 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 2.64 1.83 34.81 1.56 1.13 32.02 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 B 2 GLU A 160 GLU.? 13.50 O ACT A 201 B 56 LYS A 139 LYS.? 17.81 O ACT A 201 B 258 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 2.64 1.83 34.81 1.56 1.13 32.02 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 B 2 GLU B 27 GLU~? 9.83 CH3 ACT B 201 B 56 LYS B 22 LYS~? 15.43 CH3 ACT B 201 B 258 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 2.64 1.83 34.81 1.56 1.13 32.02 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 B 2 GLU B 36 GLU~? 17.47 CH3 ACT B 201 B 56 LYS B 62 LYS~? 17.44 OXT ACT B 201 B 258 ARG B 8 ARG.? 14.49 CH3 ACT B 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 2.64 1.83 34.81 1.56 1.13 32.02 -31.04 58.38 97.06 -32.26 55.57 97.13 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 B 2 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 56 LYS B 134 LYS~? 12.79 C2 EDO A 302 B 258 ARG A 49 ARG^? -3.92 O ACT A 202s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -24.49 42.38 66.88 -23.94 39.99 62.78 coo 2.64 1.83 34.81 1.56 1.13 32.02 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 B 2 GLU B 111 GLU^? 4.46 CH3 ACT B 201 B 56 LYS B 79 LYS^? -3.44 CH3 ACT B 201s B 258 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 2.64 1.83 34.81 1.56 1.13 32.02 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 B 2 GLU B 111 GLU^? 4.46 CH3 ACT B 201 B 56 LYS B 79 LYS^? -3.44 CH3 ACT B 201s B 258 ARG B 51 ARG.? 7.67 O ACT B 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 2.64 1.83 34.81 1.56 1.13 32.02 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 B 2 GLU C 27 GLU~? 9.88 CH3 ACT C 201 B 56 LYS C 22 LYS~? 15.34 CH3 ACT C 201 B 258 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 2.64 1.83 34.81 1.56 1.13 32.02 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 B 2 GLU C 36 GLU~? 15.95 O2 EDO A 302 B 56 LYS C 62 LYS~? 12.50 O2 EDO A 302 B 258 ARG C 8 ARG.? 14.74 CH3 ACT C 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 2.64 1.83 34.81 1.56 1.13 32.02 -27.18 40.10 42.21 -27.55 39.63 45.22 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 B 2 GLU C 53 GLU^? 11.18 OXT ACT C 201 B 56 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 258 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 2.64 1.83 34.81 1.56 1.13 32.02 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 B 2 GLU C 96 GLU^? 13.00 O ACT C 201 B 56 LYS C 134 LYS~? 17.33 O2 EDO A 301 B 258 ARG D 49 ARG^? 10.44 O ACT D 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -51.34 49.79 67.51 -53.85 50.99 71.42 coo 2.64 1.83 34.81 1.56 1.13 32.02 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 B 2 GLU C 111 GLU^? 4.32 CH3 ACT C 201 B 56 LYS C 79 LYS^? -3.44 CH3 ACT C 201s B 258 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 2.64 1.83 34.81 1.56 1.13 32.02 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 B 2 GLU C 111 GLU^? 4.32 CH3 ACT C 201 B 56 LYS C 79 LYS^? -3.44 CH3 ACT C 201s B 258 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 2.64 1.83 34.81 1.56 1.13 32.02 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 B 2 GLU D 27 GLU~? 9.75 CH3 ACT D 201 B 56 LYS D 22 LYS~? 15.49 CH3 ACT D 201 B 258 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -54.47 56.23 29.06 -59.33 54.04 30.24 coo 2.64 1.83 34.81 1.56 1.13 32.02 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 B 2 GLU D 36 GLU~? 17.76 CH3 ACT D 201 B 56 LYS D 62 LYS~? 17.47 OXT ACT D 201 B 258 ARG D 8 ARG.? 14.56 CH3 ACT D 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 2.64 1.83 34.81 1.56 1.13 32.02 -64.40 57.42 32.12 -63.44 60.33 32.35 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 B 2 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 56 LYS D 134 LYS~? 17.34 O ACT A 201 B 258 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -37.62 76.93 46.97 -33.08 76.47 49.79 coo 2.64 1.83 34.81 1.56 1.13 32.02 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 21 3 # 21 B 2 GLU D 111 GLU^? 4.46 CH3 ACT D 201 B 56 LYS D 79 LYS^? -3.52 CH3 ACT D 201s B 258 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 2.64 1.83 34.81 1.56 1.13 32.02 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 22 3 # 22 B 2 GLU D 111 GLU^? 4.46 CH3 ACT D 201 B 56 LYS D 79 LYS^? -3.52 CH3 ACT D 201s B 258 ARG D 51 ARG.? 7.60 O ACT D 201 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 2.64 1.83 34.81 1.56 1.13 32.02 -49.81 61.30 50.74 -48.26 63.65 49.51 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 22 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 27 GLU~? 9.74 CH3 ACT A 201 C 56 LYS A 22 LYS~? 15.35 CH3 ACT A 201 C 258 ARG A 37 ARG~? 13.73 CH3 ACT A 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -28.83 80.54 58.97 -30.62 82.33 60.70 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU A 36 GLU~? 17.83 CH3 ACT A 201 C 56 LYS A 62 LYS~? 17.60 O ACT A 201 C 258 ARG A 8 ARG.? 15.23 CH3 ACT A 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -20.16 79.98 64.14 -22.57 80.76 62.41 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU A 96 GLU^? 11.70 OXT ACT A 203 C 56 LYS A 134 LYS~? 11.98 O ACT A 203 C 258 ARG B 49 ARG^? 10.37 O ACT B 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -53.24 65.33 66.31 -57.37 62.85 65.73 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU A 111 GLU^? 4.34 CH3 ACT A 201 C 56 LYS A 79 LYS^? -3.45 CH3 ACT A 201s C 258 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 C 2 GLU A 111 GLU^? 4.34 CH3 ACT A 201 C 56 LYS A 79 LYS^? -3.45 CH3 ACT A 201s C 258 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 C 2 GLU A 160 GLU.? 13.50 O ACT A 201 C 56 LYS A 139 LYS.? 17.81 O ACT A 201 C 258 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 C 2 GLU B 27 GLU~? 9.83 CH3 ACT B 201 C 56 LYS B 22 LYS~? 15.43 CH3 ACT B 201 C 258 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 C 2 GLU B 36 GLU~? 17.47 CH3 ACT B 201 C 56 LYS B 62 LYS~? 17.44 OXT ACT B 201 C 258 ARG B 8 ARG.? 14.49 CH3 ACT B 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -31.04 58.38 97.06 -32.26 55.57 97.13 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 C 2 GLU B 96 GLU^? 10.60 C1 EDO A 302 C 56 LYS B 134 LYS~? 12.79 C2 EDO A 302 C 258 ARG A 49 ARG^? -3.92 O ACT A 202s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -24.49 42.38 66.88 -23.94 39.99 62.78 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 C 2 GLU B 111 GLU^? 4.46 CH3 ACT B 201 C 56 LYS B 79 LYS^? -3.44 CH3 ACT B 201s C 258 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 C 2 GLU B 111 GLU^? 4.46 CH3 ACT B 201 C 56 LYS B 79 LYS^? -3.44 CH3 ACT B 201s C 258 ARG B 51 ARG.? 7.67 O ACT B 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 C 2 GLU C 27 GLU~? 9.88 CH3 ACT C 201 C 56 LYS C 22 LYS~? 15.34 CH3 ACT C 201 C 258 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 C 2 GLU C 36 GLU~? 15.95 O2 EDO A 302 C 56 LYS C 62 LYS~? 12.50 O2 EDO A 302 C 258 ARG C 8 ARG.? 14.74 CH3 ACT C 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -27.18 40.10 42.21 -27.55 39.63 45.22 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 C 2 GLU C 96 GLU^? 13.00 O ACT C 201 C 56 LYS C 134 LYS~? 17.33 O2 EDO A 301 C 258 ARG D 49 ARG^? 10.44 O ACT D 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -51.34 49.79 67.51 -53.85 50.99 71.42 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 C 2 GLU C 111 GLU^? 4.32 CH3 ACT C 201 C 56 LYS C 79 LYS^? -3.44 CH3 ACT C 201s C 258 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 C 2 GLU C 111 GLU^? 4.32 CH3 ACT C 201 C 56 LYS C 79 LYS^? -3.44 CH3 ACT C 201s C 258 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 C 2 GLU D 27 GLU~? 9.75 CH3 ACT D 201 C 56 LYS D 22 LYS~? 15.49 CH3 ACT D 201 C 258 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -54.47 56.23 29.06 -59.33 54.04 30.24 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 C 2 GLU D 36 GLU~? 17.76 CH3 ACT D 201 C 56 LYS D 62 LYS~? 17.47 OXT ACT D 201 C 258 ARG D 8 ARG.? 14.56 CH3 ACT D 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -64.40 57.42 32.12 -63.44 60.33 32.35 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 C 2 GLU D 96 GLU^? 13.00 OXT ACT D 201 C 56 LYS D 134 LYS~? 17.34 O ACT A 201 C 258 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -37.62 76.93 46.97 -33.08 76.47 49.79 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 C 2 GLU D 111 GLU^? 4.46 CH3 ACT D 201 C 56 LYS D 79 LYS^? -3.52 CH3 ACT D 201s C 258 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 21 3 # 21 C 2 GLU D 111 GLU^? 4.46 CH3 ACT D 201 C 56 LYS D 79 LYS^? -3.52 CH3 ACT D 201s C 258 ARG D 51 ARG.? 7.60 O ACT D 201 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -49.81 61.30 50.74 -48.26 63.65 49.51 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 21 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 27 GLU~? 9.74 CH3 ACT A 201 D 56 LYS A 22 LYS~? 15.35 CH3 ACT A 201 D 258 ARG A 37 ARG~? 13.73 CH3 ACT A 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -28.83 80.54 58.97 -30.62 82.33 60.70 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU A 36 GLU~? 17.83 CH3 ACT A 201 D 56 LYS A 62 LYS~? 17.60 O ACT A 201 D 258 ARG A 8 ARG.? 15.23 CH3 ACT A 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -20.16 79.98 64.14 -22.57 80.76 62.41 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU A 96 GLU^? 11.70 OXT ACT A 203 D 56 LYS A 134 LYS~? 11.98 O ACT A 203 D 258 ARG B 49 ARG^? 10.37 O ACT B 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -53.24 65.33 66.31 -57.37 62.85 65.73 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU A 111 GLU^? 4.34 CH3 ACT A 201 D 56 LYS A 79 LYS^? -3.45 CH3 ACT A 201s D 258 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 D 2 GLU A 111 GLU^? 4.34 CH3 ACT A 201 D 56 LYS A 79 LYS^? -3.45 CH3 ACT A 201s D 258 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 D 2 GLU A 160 GLU.? 13.50 O ACT A 201 D 56 LYS A 139 LYS.? 17.81 O ACT A 201 D 258 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 D 2 GLU B 27 GLU~? 9.83 CH3 ACT B 201 D 56 LYS B 22 LYS~? 15.43 CH3 ACT B 201 D 258 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 D 2 GLU B 36 GLU~? 17.47 CH3 ACT B 201 D 56 LYS B 62 LYS~? 17.44 OXT ACT B 201 D 258 ARG B 8 ARG.? 14.49 CH3 ACT B 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -31.04 58.38 97.06 -32.26 55.57 97.13 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 D 2 GLU B 96 GLU^? 10.60 C1 EDO A 302 D 56 LYS B 134 LYS~? 12.79 C2 EDO A 302 D 258 ARG A 49 ARG^? -3.92 O ACT A 202s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -24.49 42.38 66.88 -23.94 39.99 62.78 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 D 2 GLU B 111 GLU^? 4.46 CH3 ACT B 201 D 56 LYS B 79 LYS^? -3.44 CH3 ACT B 201s D 258 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 D 2 GLU B 111 GLU^? 4.46 CH3 ACT B 201 D 56 LYS B 79 LYS^? -3.44 CH3 ACT B 201s D 258 ARG B 51 ARG.? 7.67 O ACT B 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 D 2 GLU C 27 GLU~? 9.88 CH3 ACT C 201 D 56 LYS C 22 LYS~? 15.34 CH3 ACT C 201 D 258 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 D 2 GLU C 36 GLU~? 15.95 O2 EDO A 302 D 56 LYS C 62 LYS~? 12.50 O2 EDO A 302 D 258 ARG C 8 ARG.? 14.74 CH3 ACT C 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -27.18 40.10 42.21 -27.55 39.63 45.22 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 D 2 GLU C 96 GLU^? 13.00 O ACT C 201 D 56 LYS C 134 LYS~? 17.33 O2 EDO A 301 D 258 ARG D 49 ARG^? 10.44 O ACT D 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -51.34 49.79 67.51 -53.85 50.99 71.42 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 D 2 GLU C 111 GLU^? 4.32 CH3 ACT C 201 D 56 LYS C 79 LYS^? -3.44 CH3 ACT C 201s D 258 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 D 2 GLU C 111 GLU^? 4.32 CH3 ACT C 201 D 56 LYS C 79 LYS^? -3.44 CH3 ACT C 201s D 258 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 D 2 GLU D 27 GLU~? 9.75 CH3 ACT D 201 D 56 LYS D 22 LYS~? 15.49 CH3 ACT D 201 D 258 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -54.47 56.23 29.06 -59.33 54.04 30.24 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 D 2 GLU D 36 GLU~? 17.76 CH3 ACT D 201 D 56 LYS D 62 LYS~? 17.47 OXT ACT D 201 D 258 ARG D 8 ARG.? 14.56 CH3 ACT D 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -64.40 57.42 32.12 -63.44 60.33 32.35 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 D 2 GLU D 96 GLU^? 13.00 OXT ACT D 201 D 56 LYS D 134 LYS~? 17.34 O ACT A 201 D 258 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -37.62 76.93 46.97 -33.08 76.47 49.79 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 D 2 GLU D 111 GLU^? 4.46 CH3 ACT D 201 D 56 LYS D 79 LYS^? -3.52 CH3 ACT D 201s D 258 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 21 3 # 21 D 2 GLU D 111 GLU^? 4.46 CH3 ACT D 201 D 56 LYS D 79 LYS^? -3.52 CH3 ACT D 201s D 258 ARG D 51 ARG.? 7.60 O ACT D 201 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -49.81 61.30 50.74 -48.26 63.65 49.51 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 21 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 163 ARG A 147 ARG.? 13.06 CH3 ACT A 201 A 222 ARG A 146 ARG.? 16.48 CH3 ACT A 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 48.06 78.22 50.94 48.51 78.27 53.98 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 54.85 84.16 52.60 54.26 81.23 53.34 -35.10 85.34 65.39 -35.74 86.54 68.15 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 163 ARG C 67 ARG~? 12.50 O2 EDO A 302 A 222 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 51.27 81.34 48.31 51.67 80.79 50.28 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 48.06 78.22 50.94 48.51 78.27 53.98 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 54.85 84.16 52.60 54.26 81.23 53.34 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 163 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 222 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 51.27 81.34 48.31 51.67 80.79 50.28 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 48.06 78.22 50.94 48.51 78.27 53.98 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 54.85 84.16 52.60 54.26 81.23 53.34 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 163 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 222 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 51.27 81.34 48.31 51.67 80.79 50.28 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 48.06 78.22 50.94 48.51 78.27 53.98 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 54.85 84.16 52.60 54.26 81.23 53.34 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1kim_c00 THYMIDINE KINASE user 5 3 # 5 A 83 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 163 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 222 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 51.27 81.34 48.31 51.67 80.79 50.28 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 48.06 78.22 50.94 48.51 78.27 53.98 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 54.85 84.16 52.60 54.26 81.23 53.34 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1kim_c00 THYMIDINE KINASE user 6 3 # 6 A 83 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 163 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 222 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 51.27 81.34 48.31 51.67 80.79 50.28 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 48.06 78.22 50.94 48.51 78.27 53.98 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 54.85 84.16 52.60 54.26 81.23 53.34 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1kim_c00 THYMIDINE KINASE user 7 3 # 7 A 83 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 163 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 222 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 51.27 81.34 48.31 51.67 80.79 50.28 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 48.06 78.22 50.94 48.51 78.27 53.98 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 54.85 84.16 52.60 54.26 81.23 53.34 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1kim_c00 THYMIDINE KINASE user 8 3 # 8 A 83 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 163 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 222 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 51.27 81.34 48.31 51.67 80.79 50.28 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 48.06 78.22 50.94 48.51 78.27 53.98 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 54.85 84.16 52.60 54.26 81.23 53.34 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1kim_c00 THYMIDINE KINASE user 9 3 # 9 A 83 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 163 ARG A 88 ARG^? 11.13 CH3 ACT A 202 A 222 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 51.27 81.34 48.31 51.67 80.79 50.28 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 48.06 78.22 50.94 48.51 78.27 53.98 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 54.85 84.16 52.60 54.26 81.23 53.34 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1kim_c00 THYMIDINE KINASE user 10 3 # 10 A 83 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 163 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 222 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo 51.27 81.34 48.31 51.67 80.79 50.28 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 48.06 78.22 50.94 48.51 78.27 53.98 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 54.85 84.16 52.60 54.26 81.23 53.34 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1kim_c00 THYMIDINE KINASE user 11 3 # 11 A 83 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 163 ARG B 147 ARG.? 12.52 CH3 ACT A 202 A 222 ARG B 146 ARG.? 16.58 CH3 ACT B 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 48.06 78.22 50.94 48.51 78.27 53.98 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 54.85 84.16 52.60 54.26 81.23 53.34 -21.21 49.21 92.90 -18.50 50.59 92.50 ULMN 3 1kim_c00 THYMIDINE KINASE user 12 3 # 12 A 83 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 163 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 222 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 51.27 81.34 48.31 51.67 80.79 50.28 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 48.06 78.22 50.94 48.51 78.27 53.98 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 54.85 84.16 52.60 54.26 81.23 53.34 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1kim_c00 THYMIDINE KINASE user 13 3 # 13 A 83 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 163 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 222 ARG B 138 ARG~? 16.35 OXT ACT B 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 48.06 78.22 50.94 48.51 78.27 53.98 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 54.85 84.16 52.60 54.26 81.23 53.34 -23.44 41.55 74.26 -23.57 39.98 76.87 ULMN 3 1kim_c00 THYMIDINE KINASE user 14 3 # 14 A 83 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 163 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 222 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 48.06 78.22 50.94 48.51 78.27 53.98 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 54.85 84.16 52.60 54.26 81.23 53.34 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1kim_c00 THYMIDINE KINASE user 15 3 # 15 A 83 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 163 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 222 ARG B 138 ARG~? 16.35 OXT ACT B 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 48.06 78.22 50.94 48.51 78.27 53.98 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 54.85 84.16 52.60 54.26 81.23 53.34 -23.44 41.55 74.26 -23.57 39.98 76.87 ULMN 3 1kim_c00 THYMIDINE KINASE user 16 3 # 16 A 83 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 163 ARG B 138 ARG~? 16.35 OXT ACT B 201 A 222 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 48.06 78.22 50.94 48.51 78.27 53.98 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 54.85 84.16 52.60 54.26 81.23 53.34 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1kim_c00 THYMIDINE KINASE user 17 3 # 17 A 83 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 163 ARG B 138 ARG~? 16.35 OXT ACT B 201 A 222 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 51.27 81.34 48.31 51.67 80.79 50.28 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 48.06 78.22 50.94 48.51 78.27 53.98 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 54.85 84.16 52.60 54.26 81.23 53.34 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1kim_c00 THYMIDINE KINASE user 18 3 # 18 A 83 GLU B 114 GLU^? 18.04 O ACT B 201 A 163 ARG B 88 ARG^? 18.43 CH3 ACT A 201 A 222 ARG B 123 ARG.? 17.76 O ACT B 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 48.06 78.22 50.94 48.51 78.27 53.98 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 54.85 84.16 52.60 54.26 81.23 53.34 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1kim_c00 THYMIDINE KINASE user 19 3 # 19 A 83 GLU B 114 GLU^? 18.04 O ACT B 201 A 163 ARG B 123 ARG.? 17.76 O ACT B 201 A 222 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 48.06 78.22 50.94 48.51 78.27 53.98 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 54.85 84.16 52.60 54.26 81.23 53.34 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 3 1kim_c00 THYMIDINE KINASE user 20 3 # 20 A 83 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 163 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 222 ARG A 49 ARG^? -3.92 O ACT A 202s coo 51.27 81.34 48.31 51.67 80.79 50.28 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 48.06 78.22 50.94 48.51 78.27 53.98 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 54.85 84.16 52.60 54.26 81.23 53.34 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1kim_c00 THYMIDINE KINASE user 21 3 # 21 A 83 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 163 ARG C 147 ARG.? 13.23 CH3 ACT C 201 A 222 ARG C 146 ARG.? 16.63 CH3 ACT C 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 48.06 78.22 50.94 48.51 78.27 53.98 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 54.85 84.16 52.60 54.26 81.23 53.34 -36.58 32.85 52.68 -38.87 31.31 51.32 ULMN 3 1kim_c00 THYMIDINE KINASE user 22 3 # 22 A 83 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 163 ARG A 67 ARG~? 13.20 O2 EDO A 302 A 222 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 51.27 81.34 48.31 51.67 80.79 50.28 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 48.06 78.22 50.94 48.51 78.27 53.98 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 54.85 84.16 52.60 54.26 81.23 53.34 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 3 1kim_c00 THYMIDINE KINASE user 23 3 # 23 A 83 GLU C 96 GLU^? 13.00 O ACT C 201 A 163 ARG C 76 ARG^? 14.32 O ACT C 201 A 222 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 51.27 81.34 48.31 51.67 80.79 50.28 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 48.06 78.22 50.94 48.51 78.27 53.98 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 54.85 84.16 52.60 54.26 81.23 53.34 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1kim_c00 THYMIDINE KINASE user 24 3 # 24 A 83 GLU C 96 GLU^? 13.00 O ACT C 201 A 163 ARG C 76 ARG^? 14.32 O ACT C 201 A 222 ARG C 138 ARG~? 16.31 O ACT C 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 48.06 78.22 50.94 48.51 78.27 53.98 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 54.85 84.16 52.60 54.26 81.23 53.34 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1kim_c00 THYMIDINE KINASE user 25 3 # 25 A 83 GLU C 96 GLU^? 13.00 O ACT C 201 A 163 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 222 ARG C 76 ARG^? 14.32 O ACT C 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 48.06 78.22 50.94 48.51 78.27 53.98 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 54.85 84.16 52.60 54.26 81.23 53.34 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1kim_c00 THYMIDINE KINASE user 26 3 # 26 A 83 GLU C 96 GLU^? 13.00 O ACT C 201 A 163 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 222 ARG C 138 ARG~? 16.31 O ACT C 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 48.06 78.22 50.94 48.51 78.27 53.98 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 54.85 84.16 52.60 54.26 81.23 53.34 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1kim_c00 THYMIDINE KINASE user 27 3 # 27 A 83 GLU C 96 GLU^? 13.00 O ACT C 201 A 163 ARG C 138 ARG~? 16.31 O ACT C 201 A 222 ARG C 76 ARG^? 14.32 O ACT C 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 48.06 78.22 50.94 48.51 78.27 53.98 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 54.85 84.16 52.60 54.26 81.23 53.34 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1kim_c00 THYMIDINE KINASE user 28 3 # 28 A 83 GLU C 96 GLU^? 13.00 O ACT C 201 A 163 ARG C 138 ARG~? 16.31 O ACT C 201 A 222 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 51.27 81.34 48.31 51.67 80.79 50.28 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 48.06 78.22 50.94 48.51 78.27 53.98 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 54.85 84.16 52.60 54.26 81.23 53.34 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1kim_c00 THYMIDINE KINASE user 29 3 # 29 A 83 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 163 ARG C 123 ARG.? 17.68 OXT ACT C 201 A 222 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 48.06 78.22 50.94 48.51 78.27 53.98 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 54.85 84.16 52.60 54.26 81.23 53.34 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 3 1kim_c00 THYMIDINE KINASE user 30 3 # 30 A 83 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 163 ARG D 147 ARG.? 13.02 CH3 ACT D 201 A 222 ARG D 146 ARG.? 16.60 CH3 ACT D 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 48.06 78.22 50.94 48.51 78.27 53.98 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 54.85 84.16 52.60 54.26 81.23 53.34 -54.51 68.83 27.22 -52.30 68.02 25.26 ULMN 3 1kim_c00 THYMIDINE KINASE user 31 3 # 31 A 83 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 163 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 222 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 48.06 78.22 50.94 48.51 78.27 53.98 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 54.85 84.16 52.60 54.26 81.23 53.34 -40.22 67.90 41.60 -38.15 70.12 41.98 ULMN 3 1kim_c00 THYMIDINE KINASE user 32 3 # 32 A 83 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 163 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 222 ARG D 138 ARG~? 16.38 OXT ACT D 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 48.06 78.22 50.94 48.51 78.27 53.98 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 54.85 84.16 52.60 54.26 81.23 53.34 -42.61 77.59 41.75 -44.95 78.80 40.20 ULMN 3 1kim_c00 THYMIDINE KINASE user 33 3 # 33 A 83 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 163 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 222 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 48.06 78.22 50.94 48.51 78.27 53.98 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 54.85 84.16 52.60 54.26 81.23 53.34 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1kim_c00 THYMIDINE KINASE user 34 3 # 34 A 83 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 163 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 222 ARG D 138 ARG~? 16.38 OXT ACT D 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 48.06 78.22 50.94 48.51 78.27 53.98 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 54.85 84.16 52.60 54.26 81.23 53.34 -42.61 77.59 41.75 -44.95 78.80 40.20 ULMN 3 1kim_c00 THYMIDINE KINASE user 35 3 # 35 A 83 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 163 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 222 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 48.06 78.22 50.94 48.51 78.27 53.98 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 54.85 84.16 52.60 54.26 81.23 53.34 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1kim_c00 THYMIDINE KINASE user 36 3 # 36 A 83 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 163 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 222 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 48.06 78.22 50.94 48.51 78.27 53.98 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 54.85 84.16 52.60 54.26 81.23 53.34 -40.22 67.90 41.60 -38.15 70.12 41.98 ULMN 3 1kim_c00 THYMIDINE KINASE user 37 3 # 37 A 83 GLU D 114 GLU^? 18.05 O ACT D 201 A 163 ARG D 88 ARG^? 18.35 CH3 ACT C 201 A 222 ARG D 123 ARG.? 17.60 O ACT D 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 48.06 78.22 50.94 48.51 78.27 53.98 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 54.85 84.16 52.60 54.26 81.23 53.34 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1kim_c00 THYMIDINE KINASE user 38 3 # 38 A 83 GLU D 114 GLU^? 18.05 O ACT D 201 A 163 ARG D 123 ARG.? 17.60 O ACT D 201 A 222 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo 51.27 81.34 48.31 51.67 80.79 50.28 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 48.06 78.22 50.94 48.51 78.27 53.98 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 54.85 84.16 52.60 54.26 81.23 53.34 -52.23 44.53 37.75 -52.43 42.56 40.08 1kim_c00 source 1kim THYMIDINE KINASE : 38 hits 1kim_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 68 LYS~? -2.78 O ACT A 201s A 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 24.97 5.82 58.78 26.79 1.97 55.46 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 19.46 3.44 61.93 23.95 1.12 60.13 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 68 LYS~? -2.78 O ACT A 201s A 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 165 GLU C 72 GLU~? 5.32 O ACT C 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 19.46 3.44 61.93 23.95 1.12 60.13 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 68 LYS~? -2.78 O ACT A 201s A 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 165 GLU D 137 GLU~? 19.20 CH3 ACT A 203 coo 24.97 5.82 58.78 26.79 1.97 55.46 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 19.46 3.44 61.93 23.95 1.12 60.13 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -34.89 75.05 43.86 -34.35 73.81 45.48 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 74 LYS A 68 LYS~? -2.78 O ACT A 201s A 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 24.97 5.82 58.78 26.79 1.97 55.46 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 19.46 3.44 61.93 23.95 1.12 60.13 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 74 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 19.46 3.44 61.93 23.95 1.12 60.13 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 74 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 19.46 3.44 61.93 23.95 1.12 60.13 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS C 68 LYS~? -2.77 O ACT C 201s A 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 165 GLU A 72 GLU~? 5.31 O ACT A 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 19.46 3.44 61.93 23.95 1.12 60.13 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS C 68 LYS~? -2.77 O ACT C 201s A 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 165 GLU B 137 GLU~? 6.31 C2 EDO A 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 19.46 3.44 61.93 23.95 1.12 60.13 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -20.73 44.81 67.02 -21.84 45.98 65.65 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS C 68 LYS~? -2.77 O ACT C 201s A 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 19.46 3.44 61.93 23.95 1.12 60.13 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 74 LYS C 68 LYS~? -2.77 O ACT C 201s A 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 19.46 3.44 61.93 23.95 1.12 60.13 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 74 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 19.46 3.44 61.93 23.95 1.12 60.13 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -43.29 70.99 40.99 -41.92 72.19 39.92 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 74 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 19.46 3.44 61.93 23.95 1.12 60.13 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -43.29 70.99 40.99 -41.92 72.19 39.92 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 12 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 68 LYS~? -2.78 O ACT A 201s B 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 4.84 5.09 23.75 3.30 1.39 27.48 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 10.43 2.88 20.75 5.72 0.41 23.95 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 68 LYS~? -2.78 O ACT A 201s B 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 165 GLU C 72 GLU~? 5.32 O ACT C 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 10.43 2.88 20.75 5.72 0.41 23.95 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 68 LYS~? -2.78 O ACT A 201s B 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 165 GLU D 137 GLU~? 19.20 CH3 ACT A 203 coo 4.84 5.09 23.75 3.30 1.39 27.48 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 10.43 2.88 20.75 5.72 0.41 23.95 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -34.89 75.05 43.86 -34.35 73.81 45.48 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 74 LYS A 68 LYS~? -2.78 O ACT A 201s B 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 4.84 5.09 23.75 3.30 1.39 27.48 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 10.43 2.88 20.75 5.72 0.41 23.95 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 74 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 10.43 2.88 20.75 5.72 0.41 23.95 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 74 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 10.43 2.88 20.75 5.72 0.41 23.95 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS C 68 LYS~? -2.77 O ACT C 201s B 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 165 GLU A 72 GLU~? 5.31 O ACT A 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 10.43 2.88 20.75 5.72 0.41 23.95 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS C 68 LYS~? -2.77 O ACT C 201s B 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 165 GLU B 137 GLU~? 6.31 C2 EDO A 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 10.43 2.88 20.75 5.72 0.41 23.95 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -20.73 44.81 67.02 -21.84 45.98 65.65 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS C 68 LYS~? -2.77 O ACT C 201s B 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 10.43 2.88 20.75 5.72 0.41 23.95 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 74 LYS C 68 LYS~? -2.77 O ACT C 201s B 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 10.43 2.88 20.75 5.72 0.41 23.95 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 74 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 10.43 2.88 20.75 5.72 0.41 23.95 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -43.29 70.99 40.99 -41.92 72.19 39.92 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 74 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 10.43 2.88 20.75 5.72 0.41 23.95 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -43.29 70.99 40.99 -41.92 72.19 39.92 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 12 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 68 LYS~? -2.78 O ACT A 201s C 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 C 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 17.59 37.25 25.80 19.64 34.15 21.60 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 12.29 34.52 28.11 16.84 32.47 25.43 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 12.06 27.10 15.56 13.23 27.02 13.80 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 68 LYS~? -2.78 O ACT A 201s C 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 C 165 GLU C 72 GLU~? 5.32 O ACT C 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 12.29 34.52 28.11 16.84 32.47 25.43 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 12.06 27.10 15.56 13.23 27.02 13.80 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS A 68 LYS~? -2.78 O ACT A 201s C 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 C 165 GLU D 137 GLU~? 19.20 CH3 ACT A 203 coo 17.59 37.25 25.80 19.64 34.15 21.60 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 12.29 34.52 28.11 16.84 32.47 25.43 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 12.06 27.10 15.56 13.23 27.02 13.80 -34.89 75.05 43.86 -34.35 73.81 45.48 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS A 71 LYS~? 4.32 C2 EDO A 301 C 74 LYS A 68 LYS~? -2.78 O ACT A 201s C 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 17.59 37.25 25.80 19.64 34.15 21.60 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 12.29 34.52 28.11 16.84 32.47 25.43 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 12.06 27.10 15.56 13.23 27.02 13.80 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS B 68 LYS~? -2.79 OXT ACT B 201s C 74 LYS B 71 LYS~? 10.83 OXT ACT B 201 C 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 12.29 34.52 28.11 16.84 32.47 25.43 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 12.06 27.10 15.56 13.23 27.02 13.80 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 C 14 LYS B 71 LYS~? 10.83 OXT ACT B 201 C 74 LYS B 68 LYS~? -2.79 OXT ACT B 201s C 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 12.29 34.52 28.11 16.84 32.47 25.43 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 12.06 27.10 15.56 13.23 27.02 13.80 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 C 14 LYS C 68 LYS~? -2.77 O ACT C 201s C 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 C 165 GLU A 72 GLU~? 5.31 O ACT A 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 12.29 34.52 28.11 16.84 32.47 25.43 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 12.06 27.10 15.56 13.23 27.02 13.80 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 C 14 LYS C 68 LYS~? -2.77 O ACT C 201s C 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 C 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 12.29 34.52 28.11 16.84 32.47 25.43 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 12.06 27.10 15.56 13.23 27.02 13.80 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 C 14 LYS C 71 LYS~? 4.19 C1 EDO A 301 C 74 LYS C 68 LYS~? -2.77 O ACT C 201s C 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 12.29 34.52 28.11 16.84 32.47 25.43 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 12.06 27.10 15.56 13.23 27.02 13.80 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 C 14 LYS D 68 LYS~? -2.80 OXT ACT D 201s C 74 LYS D 71 LYS~? -3.20 CH3 ACT A 203s C 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 12.29 34.52 28.11 16.84 32.47 25.43 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 12.06 27.10 15.56 13.23 27.02 13.80 -43.29 70.99 40.99 -41.92 72.19 39.92 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 C 14 LYS D 71 LYS~? -3.20 CH3 ACT A 203s C 74 LYS D 68 LYS~? -2.80 OXT ACT D 201s C 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 12.29 34.52 28.11 16.84 32.47 25.43 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 12.06 27.10 15.56 13.23 27.02 13.80 -43.29 70.99 40.99 -41.92 72.19 39.92 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 11 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 68 LYS~? -2.78 O ACT A 201s D 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 D 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 68 LYS~? -2.78 O ACT A 201s D 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 D 165 GLU C 72 GLU~? 5.32 O ACT C 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 68 LYS~? -2.78 O ACT A 201s D 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 D 165 GLU D 137 GLU~? 19.20 CH3 ACT A 203 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -34.89 75.05 43.86 -34.35 73.81 45.48 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS A 71 LYS~? 4.32 C2 EDO A 301 D 74 LYS A 68 LYS~? -2.78 O ACT A 201s D 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS B 68 LYS~? -2.79 OXT ACT B 201s D 74 LYS B 71 LYS~? 10.83 OXT ACT B 201 D 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS B 71 LYS~? 10.83 OXT ACT B 201 D 74 LYS B 68 LYS~? -2.79 OXT ACT B 201s D 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS C 68 LYS~? -2.77 O ACT C 201s D 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 D 165 GLU A 72 GLU~? 5.31 O ACT A 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS C 68 LYS~? -2.77 O ACT C 201s D 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 D 165 GLU B 137 GLU~? 6.31 C2 EDO A 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -20.73 44.81 67.02 -21.84 45.98 65.65 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 D 14 LYS C 68 LYS~? -2.77 O ACT C 201s D 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 D 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 D 14 LYS C 71 LYS~? 4.19 C1 EDO A 301 D 74 LYS C 68 LYS~? -2.77 O ACT C 201s D 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 D 14 LYS D 68 LYS~? -2.80 OXT ACT D 201s D 74 LYS D 71 LYS~? -3.20 CH3 ACT A 203s D 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -43.29 70.99 40.99 -41.92 72.19 39.92 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 D 14 LYS D 71 LYS~? -3.20 CH3 ACT A 203s D 74 LYS D 68 LYS~? -2.80 OXT ACT D 201s D 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -43.29 70.99 40.99 -41.92 72.19 39.92 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 12 hits 1kqc_c03 naa= 3 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 1 3 # 1 A 94 LYS A 68 LYS~? -2.78 O ACT A 201s A 197 HIS A 141 HIS.? 11.20 OXT ACT A 203 A 446 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 3.26 62.02 109.14 4.83 57.73 107.38 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 9.48 43.28 113.60 10.05 44.21 111.80 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 12.14 46.28 115.16 13.57 43.60 115.68 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 2 3 # 2 A 94 LYS A 134 LYS~? 11.98 O ACT A 203 A 197 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 446 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 3.26 62.02 109.14 4.83 57.73 107.38 -53.24 65.33 66.31 -57.37 62.85 65.73 coo 9.48 43.28 113.60 10.05 44.21 111.80 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 12.14 46.28 115.16 13.57 43.60 115.68 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 3 3 # 3 A 94 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 197 HIS C 141 HIS.? 17.85 O ACT C 201 A 446 ARG C 138 ARG~? 16.31 O ACT C 201 coo 3.26 62.02 109.14 4.83 57.73 107.38 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 9.48 43.28 113.60 10.05 44.21 111.80 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 12.14 46.28 115.16 13.57 43.60 115.68 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 4 3 # 4 A 94 LYS B 134 LYS~? 12.79 C2 EDO A 302 A 197 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 446 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo 3.26 62.02 109.14 4.83 57.73 107.38 -24.49 42.38 66.88 -23.94 39.99 62.78 coo 9.48 43.28 113.60 10.05 44.21 111.80 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 12.14 46.28 115.16 13.57 43.60 115.68 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 5 3 # 5 A 94 LYS C 68 LYS~? -2.77 O ACT C 201s A 197 HIS C 141 HIS.? 17.85 O ACT C 201 A 446 ARG C 138 ARG~? 16.31 O ACT C 201 coo 3.26 62.02 109.14 4.83 57.73 107.38 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 9.48 43.28 113.60 10.05 44.21 111.80 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 12.14 46.28 115.16 13.57 43.60 115.68 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 6 3 # 6 A 94 LYS C 134 LYS~? 17.33 O2 EDO A 301 A 197 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 446 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo 3.26 62.02 109.14 4.83 57.73 107.38 -51.34 49.79 67.51 -53.85 50.99 71.42 coo 9.48 43.28 113.60 10.05 44.21 111.80 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 12.14 46.28 115.16 13.57 43.60 115.68 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 7 3 # 7 A 94 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 197 HIS A 141 HIS.? 11.20 OXT ACT A 203 A 446 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 3.26 62.02 109.14 4.83 57.73 107.38 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 9.48 43.28 113.60 10.05 44.21 111.80 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 12.14 46.28 115.16 13.57 43.60 115.68 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 8 3 # 8 A 94 LYS D 134 LYS~? 17.34 O ACT A 201 A 197 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 446 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 3.26 62.02 109.14 4.83 57.73 107.38 -37.62 76.93 46.97 -33.08 76.47 49.79 coo 9.48 43.28 113.60 10.05 44.21 111.80 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 12.14 46.28 115.16 13.57 43.60 115.68 -46.62 68.18 31.08 -46.22 65.54 29.55 1kqf_c03 source 1kqf FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, CYTO: 8 hits 1kqf_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 28 ASP~? 12.70 CH3 ACT A 201 262 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 336 ARG A 8 ARG.? 15.23 CH3 ACT A 201 coo 61.88 50.78 12.96 63.84 50.60 13.71 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 63.59 44.40 18.32 63.20 49.74 17.95 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 72.60 57.42 15.86 71.61 56.68 18.70 -20.16 79.98 64.14 -22.57 80.76 62.41 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP A 28 ASP~? 12.70 CH3 ACT A 201 262 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 336 ARG A 33 ARG.? 12.39 O ACT A 201 coo 61.88 50.78 12.96 63.84 50.60 13.71 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 63.59 44.40 18.32 63.20 49.74 17.95 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 72.60 57.42 15.86 71.61 56.68 18.70 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP A 74 ASP^? 5.73 OXT ACT A 203 262 LYS A 71 LYS~? 4.32 C2 EDO A 301 336 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 61.88 50.78 12.96 63.84 50.60 13.71 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 63.59 44.40 18.32 63.20 49.74 17.95 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 72.60 57.42 15.86 71.61 56.68 18.70 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP A 99 ASP.? 5.71 O2 EDO A 301 262 LYS A 71 LYS~? 4.32 C2 EDO A 301 336 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 61.88 50.78 12.96 63.84 50.60 13.71 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 63.59 44.40 18.32 63.20 49.74 17.95 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 72.60 57.42 15.86 71.61 56.68 18.70 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP A 100 ASP.? 9.07 O2 EDO A 301 262 LYS A 71 LYS~? 4.32 C2 EDO A 301 336 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 61.88 50.78 12.96 63.84 50.60 13.71 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 63.59 44.40 18.32 63.20 49.74 17.95 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 72.60 57.42 15.86 71.61 56.68 18.70 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 6 3 # 6 255 ASP A 100 ASP.? 9.07 O2 EDO A 301 262 LYS A 71 LYS~? 4.32 C2 EDO A 301 336 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 61.88 50.78 12.96 63.84 50.60 13.71 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 63.59 44.40 18.32 63.20 49.74 17.95 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 72.60 57.42 15.86 71.61 56.68 18.70 -40.22 67.90 41.60 -38.15 70.12 41.98 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 7 3 # 7 255 ASP B 34 ASP~? 14.61 OXT ACT B 201 262 LYS B 62 LYS~? 17.44 OXT ACT B 201 336 ARG B 8 ARG.? 14.49 CH3 ACT B 201 coo 61.88 50.78 12.96 63.84 50.60 13.71 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 63.59 44.40 18.32 63.20 49.74 17.95 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 72.60 57.42 15.86 71.61 56.68 18.70 -31.04 58.38 97.06 -32.26 55.57 97.13 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 8 3 # 8 255 ASP B 100 ASP.? 15.93 OXT ACT B 201 262 LYS B 71 LYS~? 10.83 OXT ACT B 201 336 ARG C 76 ARG^? 14.32 O ACT C 201 coo 61.88 50.78 12.96 63.84 50.60 13.71 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 63.59 44.40 18.32 63.20 49.74 17.95 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 72.60 57.42 15.86 71.61 56.68 18.70 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 9 3 # 9 255 ASP B 100 ASP.? 15.93 OXT ACT B 201 262 LYS B 71 LYS~? 10.83 OXT ACT B 201 336 ARG C 138 ARG~? 16.31 O ACT C 201 coo 61.88 50.78 12.96 63.84 50.60 13.71 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 63.59 44.40 18.32 63.20 49.74 17.95 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 72.60 57.42 15.86 71.61 56.68 18.70 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 10 3 # 10 255 ASP C 28 ASP~? 12.80 CH3 ACT C 201 262 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 336 ARG C 8 ARG.? 14.74 CH3 ACT C 201 coo 61.88 50.78 12.96 63.84 50.60 13.71 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 63.59 44.40 18.32 63.20 49.74 17.95 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 72.60 57.42 15.86 71.61 56.68 18.70 -27.18 40.10 42.21 -27.55 39.63 45.22 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 11 3 # 11 255 ASP C 28 ASP~? 12.80 CH3 ACT C 201 262 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 336 ARG C 33 ARG.? 12.41 O ACT C 201 coo 61.88 50.78 12.96 63.84 50.60 13.71 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 63.59 44.40 18.32 63.20 49.74 17.95 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 72.60 57.42 15.86 71.61 56.68 18.70 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 12 3 # 12 255 ASP C 34 ASP~? 14.66 O ACT C 201 262 LYS C 62 LYS~? 12.50 O2 EDO A 302 336 ARG C 8 ARG.? 14.74 CH3 ACT C 201 coo 61.88 50.78 12.96 63.84 50.60 13.71 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 63.59 44.40 18.32 63.20 49.74 17.95 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 72.60 57.42 15.86 71.61 56.68 18.70 -27.18 40.10 42.21 -27.55 39.63 45.22 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 13 3 # 13 255 ASP C 74 ASP^? 14.86 O ACT C 201 262 LYS C 71 LYS~? 4.19 C1 EDO A 301 336 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 61.88 50.78 12.96 63.84 50.60 13.71 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 63.59 44.40 18.32 63.20 49.74 17.95 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 72.60 57.42 15.86 71.61 56.68 18.70 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 14 3 # 14 255 ASP C 99 ASP.? 5.79 O1 EDO A 301 262 LYS C 71 LYS~? 4.19 C1 EDO A 301 336 ARG C 138 ARG~? 16.31 O ACT C 201 coo 61.88 50.78 12.96 63.84 50.60 13.71 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 63.59 44.40 18.32 63.20 49.74 17.95 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 72.60 57.42 15.86 71.61 56.68 18.70 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 15 3 # 15 255 ASP C 100 ASP.? 9.05 C1 EDO A 301 262 LYS C 71 LYS~? 4.19 C1 EDO A 301 336 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 61.88 50.78 12.96 63.84 50.60 13.71 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 63.59 44.40 18.32 63.20 49.74 17.95 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 72.60 57.42 15.86 71.61 56.68 18.70 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 16 3 # 16 255 ASP C 100 ASP.? 9.05 C1 EDO A 301 262 LYS C 71 LYS~? 4.19 C1 EDO A 301 336 ARG C 138 ARG~? 16.31 O ACT C 201 coo 61.88 50.78 12.96 63.84 50.60 13.71 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 63.59 44.40 18.32 63.20 49.74 17.95 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 72.60 57.42 15.86 71.61 56.68 18.70 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 17 3 # 17 255 ASP D 28 ASP~? 12.70 CH3 ACT D 201 262 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 336 ARG D 8 ARG.? 14.56 CH3 ACT D 201 coo 61.88 50.78 12.96 63.84 50.60 13.71 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 63.59 44.40 18.32 63.20 49.74 17.95 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 72.60 57.42 15.86 71.61 56.68 18.70 -64.40 57.42 32.12 -63.44 60.33 32.35 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 18 3 # 18 255 ASP D 28 ASP~? 12.70 CH3 ACT D 201 262 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 336 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo 61.88 50.78 12.96 63.84 50.60 13.71 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 63.59 44.40 18.32 63.20 49.74 17.95 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 72.60 57.42 15.86 71.61 56.68 18.70 -55.21 72.58 39.53 -56.74 74.11 37.37 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 19 3 # 19 255 ASP D 100 ASP.? 7.94 OXT ACT A 203 262 LYS D 71 LYS~? -3.20 CH3 ACT A 203s 336 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 61.88 50.78 12.96 63.84 50.60 13.71 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 63.59 44.40 18.32 63.20 49.74 17.95 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 72.60 57.42 15.86 71.61 56.68 18.70 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 20 3 # 20 255 ASP D 100 ASP.? 7.94 OXT ACT A 203 262 LYS D 71 LYS~? -3.20 CH3 ACT A 203s 336 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 61.88 50.78 12.96 63.84 50.60 13.71 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 63.59 44.40 18.32 63.20 49.74 17.95 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 72.60 57.42 15.86 71.61 56.68 18.70 -50.06 71.52 64.11 -49.59 74.03 62.40 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 20 hits 1lam_c00 naa= 3 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 1 3 # 1 60 GLU A 72 GLU~? 5.31 O ACT A 201 198 CYH A 127 CYH.? 6.15 O ACT A 202 229 ASN A 50 ASN^? 5.02 OXT ACT A 201 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -28.17 63.14 65.41 -30.17 63.83 65.25 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 2 3 # 2 60 GLU A 111 GLU^? 4.34 CH3 ACT A 201 198 CYH B 127 CYH.? 10.07 OXT ACT A 201 229 ASN B 112 ASN^? 12.13 O ACT B 201 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -32.04 67.09 81.98 -30.67 67.45 80.39 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 3 3 # 3 60 GLU B 72 GLU~? 5.30 OXT ACT B 201 198 CYH B 127 CYH.? 10.07 OXT ACT A 201 229 ASN B 50 ASN^? 4.93 O ACT B 201 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -34.42 60.97 75.89 -35.29 63.54 75.29 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -39.13 57.82 80.42 -37.65 56.39 79.89 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 4 3 # 4 60 GLU B 111 GLU^? 4.46 CH3 ACT B 201 198 CYH A 127 CYH.? 6.15 O ACT A 202 229 ASN A 112 ASN^? 9.36 O ACT A 202 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -24.96 67.02 76.01 -26.38 66.67 77.57 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 5 3 # 5 60 GLU B 160 GLU.? 4.71 OXT ACT A 202 198 CYH A 127 CYH.? 6.15 O ACT A 202 229 ASN A 50 ASN^? 5.02 OXT ACT A 201 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -31.19 62.06 71.95 -29.40 60.66 73.55 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -28.17 63.14 65.41 -30.17 63.83 65.25 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 6 3 # 6 60 GLU C 72 GLU~? 5.32 O ACT C 201 198 CYH C 127 CYH.? 10.01 O ACT D 201 229 ASN C 50 ASN^? 4.97 OXT ACT C 201 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -35.45 55.77 48.86 -36.44 54.81 50.47 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 7 3 # 7 60 GLU C 111 GLU^? 4.32 CH3 ACT C 201 198 CYH D 127 CYH.? 10.01 OXT ACT C 201 229 ASN D 112 ASN^? 12.21 O ACT D 201 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -49.94 50.30 41.07 -47.80 50.26 40.97 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 8 3 # 8 60 GLU D 72 GLU~? 5.29 OXT ACT D 201 198 CYH D 127 CYH.? 10.01 OXT ACT C 201 229 ASN D 50 ASN^? 4.92 O ACT D 201 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -47.67 56.31 47.24 -47.42 53.67 48.08 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -54.56 58.39 48.20 -53.45 60.06 47.53 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 9 3 # 9 60 GLU D 111 GLU^? 4.46 CH3 ACT D 201 198 CYH C 127 CYH.? 10.01 O ACT D 201 229 ASN C 112 ASN^? 12.25 OXT ACT C 201 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -42.49 55.99 47.19 -42.84 57.56 44.90 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -41.01 51.77 39.43 -43.15 51.81 39.53 1lcb_c02 source 1lcb THYMIDYLATE SYNTHASE : 9 hits 1lcb_c02 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 49 ARG^? -3.92 O ACT A 202s 245 HIS A 56 HIS.? 6.76 O1 EDO A 302 343 THR A 46 THR^? 13.12 OXT ACT A 202 coo 18.11 85.25 41.19 18.04 83.33 43.59 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 5.34 86.23 43.48 6.16 87.26 45.12 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 9.06 92.76 42.80 7.04 92.63 42.14 -17.27 68.11 64.46 -19.35 68.72 64.20 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG B 49 ARG^? 10.37 O ACT B 201 245 HIS B 56 HIS.? 17.31 O ACT B 201 343 THR B 46 THR^? 13.06 O ACT B 201 coo 18.11 85.25 41.19 18.04 83.33 43.59 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 5.34 86.23 43.48 6.16 87.26 45.12 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 9.06 92.76 42.80 7.04 92.63 42.14 -41.83 63.03 90.93 -40.53 61.43 90.23 ULMN 3 1lci_c00 LUCIFERASE user 3 3 # 3 218 ARG C 49 ARG^? 10.47 OXT ACT C 201 245 HIS C 56 HIS.? 17.26 OXT ACT C 201 343 THR C 46 THR^? 13.10 OXT ACT C 201 coo 18.11 85.25 41.19 18.04 83.33 43.59 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 5.34 86.23 43.48 6.16 87.26 45.12 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 9.06 92.76 42.80 7.04 92.63 42.14 -27.30 52.39 40.74 -28.28 51.51 42.48 ULMN 3 1lci_c00 LUCIFERASE user 4 3 # 4 218 ARG D 49 ARG^? 10.44 O ACT D 201 245 HIS D 56 HIS.? 17.26 O ACT D 201 343 THR D 46 THR^? 13.15 O ACT D 201 coo 18.11 85.25 41.19 18.04 83.33 43.59 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 5.34 86.23 43.48 6.16 87.26 45.12 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 9.06 92.76 42.80 7.04 92.63 42.14 -63.51 52.01 43.24 -62.49 53.88 42.85 1lci_c00 source 1lci LUCIFERASE : 4 hits 1lci_c00 naa= 3 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 1 3 # 1 166 ASP A 74 ASP^? 5.73 OXT ACT A 203 169 ARG A 76 ARG^? 8.97 OXT ACT A 203 193 HIS A 98 HIS^? -3.60 C ACT A 203s coo 20.88 15.91 3.60 20.25 17.72 4.50 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 18.81 19.85 7.63 17.55 19.89 5.97 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 2 3 # 2 166 ASP A 74 ASP^? 5.73 OXT ACT A 203 169 ARG A 138 ARG~? 6.49 OXT ACT A 203 193 HIS A 98 HIS^? -3.60 C ACT A 203s coo 20.88 15.91 3.60 20.25 17.72 4.50 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 18.81 19.85 7.63 17.55 19.89 5.97 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 3 3 # 3 166 ASP A 100 ASP.? 9.07 O2 EDO A 301 169 ARG D 51 ARG.? 7.60 O ACT D 201 193 HIS A 98 HIS^? -3.60 C ACT A 203s coo 20.88 15.91 3.60 20.25 17.72 4.50 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 18.81 19.85 7.63 17.55 19.89 5.97 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 4 3 # 4 166 ASP B 74 ASP^? 14.88 OXT ACT B 201 169 ARG B 76 ARG^? 14.33 OXT ACT B 201 193 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo 20.88 15.91 3.60 20.25 17.72 4.50 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 18.81 19.85 7.63 17.55 19.89 5.97 -30.93 39.91 75.36 -31.53 38.49 76.78 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 5 3 # 5 166 ASP B 74 ASP^? 14.88 OXT ACT B 201 169 ARG B 138 ARG~? 16.35 OXT ACT B 201 193 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo 20.88 15.91 3.60 20.25 17.72 4.50 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 18.81 19.85 7.63 17.55 19.89 5.97 -30.93 39.91 75.36 -31.53 38.49 76.78 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 6 3 # 6 166 ASP C 74 ASP^? 14.86 O ACT C 201 169 ARG C 76 ARG^? 14.32 O ACT C 201 193 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 20.88 15.91 3.60 20.25 17.72 4.50 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 18.81 19.85 7.63 17.55 19.89 5.97 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 7 3 # 7 166 ASP C 74 ASP^? 14.86 O ACT C 201 169 ARG C 138 ARG~? 16.31 O ACT C 201 193 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 20.88 15.91 3.60 20.25 17.72 4.50 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 18.81 19.85 7.63 17.55 19.89 5.97 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 8 3 # 8 166 ASP C 100 ASP.? 9.05 C1 EDO A 301 169 ARG B 51 ARG.? 7.67 O ACT B 201 193 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 20.88 15.91 3.60 20.25 17.72 4.50 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 18.81 19.85 7.63 17.55 19.89 5.97 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 9 3 # 9 166 ASP D 74 ASP^? 14.85 OXT ACT D 201 169 ARG D 76 ARG^? 14.20 OXT ACT D 201 193 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo 20.88 15.91 3.60 20.25 17.72 4.50 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 18.81 19.85 7.63 17.55 19.89 5.97 -48.48 77.63 46.64 -50.12 78.90 46.30 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 10 3 # 10 166 ASP D 74 ASP^? 14.85 OXT ACT D 201 169 ARG D 138 ARG~? 16.38 OXT ACT D 201 193 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo 20.88 15.91 3.60 20.25 17.72 4.50 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 18.81 19.85 7.63 17.55 19.89 5.97 -48.48 77.63 46.64 -50.12 78.90 46.30 1ldm_c01 source 1ldm M4 LACTATE DEHYDROGENASE : 10 hits 1ldm_c01 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 26 ALA~? 8.12 CH3 ACT A 201 A 317 GLY A 29 GLY~? 9.49 CH3 ACT A 201 A 318 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -30.30 78.71 63.24 -31.02 78.43 63.55 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 26 ALA~? 8.11 CH3 ACT B 201 A 317 GLY B 29 GLY~? 9.46 CH3 ACT B 201 A 318 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -27.84 56.51 90.43 -28.15 57.77 89.64 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -29.24 51.82 91.44 -28.87 51.66 90.72 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA C 26 ALA~? 8.20 CH3 ACT C 201 A 317 GLY C 29 GLY~? 9.51 CH3 ACT C 201 A 318 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -32.89 40.21 50.79 -33.62 40.36 51.16 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1lij_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA D 26 ALA~? 8.16 CH3 ACT D 201 A 317 GLY D 29 GLY~? 9.48 CH3 ACT D 201 A 318 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -55.52 60.76 33.28 -54.94 59.51 33.93 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -57.91 65.08 34.12 -57.15 65.32 34.32 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -55.65 65.73 30.36 -54.18 65.67 28.83 1lij_c01 source 1lij ADENOSINE KINASE : 4 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 26 ALA~? 8.12 CH3 ACT A 201 A 317 GLY A 29 GLY~? 9.49 CH3 ACT A 201 A 318 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 27.04 23.54 41.85 25.72 24.19 42.18 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 27.87 23.16 38.17 28.43 22.97 38.87 -30.30 78.71 63.24 -31.02 78.43 63.55 coo 32.11 22.71 40.58 33.42 24.22 39.78 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 26 ALA~? 8.11 CH3 ACT B 201 A 317 GLY B 29 GLY~? 9.46 CH3 ACT B 201 A 318 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 27.04 23.54 41.85 25.72 24.19 42.18 -27.84 56.51 90.43 -28.15 57.77 89.64 coo 27.87 23.16 38.17 28.43 22.97 38.87 -29.24 51.82 91.44 -28.87 51.66 90.72 coo 32.11 22.71 40.58 33.42 24.22 39.78 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA C 26 ALA~? 8.20 CH3 ACT C 201 A 317 GLY C 29 GLY~? 9.51 CH3 ACT C 201 A 318 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 27.04 23.54 41.85 25.72 24.19 42.18 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 27.87 23.16 38.17 28.43 22.97 38.87 -32.89 40.21 50.79 -33.62 40.36 51.16 coo 32.11 22.71 40.58 33.42 24.22 39.78 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA D 26 ALA~? 8.16 CH3 ACT D 201 A 317 GLY D 29 GLY~? 9.48 CH3 ACT D 201 A 318 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 27.04 23.54 41.85 25.72 24.19 42.18 -55.52 60.76 33.28 -54.94 59.51 33.93 coo 27.87 23.16 38.17 28.43 22.97 38.87 -57.91 65.08 34.12 -57.15 65.32 34.32 coo 32.11 22.71 40.58 33.42 24.22 39.78 -55.65 65.73 30.36 -54.18 65.67 28.83 1lio_c01 source 1lio ADENOSINE KINASE : 4 hits 1lio_c01 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS A 161 HIS.? 19.24 O ACT B 201 A 45 HIS B 56 HIS.? 17.31 O ACT B 201 A 261 PHE B 64 PHE~? 7.22 O ACT B 201 coo 49.89 1.93 30.83 50.54 1.43 32.81 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -41.04 53.74 82.96 -38.84 53.80 81.23 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 2 3 # 2 A 44 HIS A 161 HIS.? 19.24 O ACT B 201 A 45 HIS B 56 HIS.? 17.31 O ACT B 201 A 261 PHE B 125 PHE.? 13.16 O ACT B 201 coo 49.89 1.93 30.83 50.54 1.43 32.81 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -37.18 66.81 81.74 -39.05 68.51 82.95 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 3 3 # 3 A 44 HIS B 56 HIS.? 17.31 O ACT B 201 A 45 HIS A 161 HIS.? 19.24 O ACT B 201 A 261 PHE B 125 PHE.? 13.16 O ACT B 201 coo 49.89 1.93 30.83 50.54 1.43 32.81 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -37.18 66.81 81.74 -39.05 68.51 82.95 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 3 hits 1luc_c00 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 295 GLU A 72 GLU~? 5.31 O ACT A 201 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 16.11 33.72 80.99 14.10 33.54 81.63 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 295 GLU A 72 GLU~? 5.31 O ACT A 201 A 369 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 16.11 33.72 80.99 14.10 33.54 81.63 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 12.19 31.08 87.29 11.13 32.66 86.38 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 295 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 369 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 16.11 33.72 80.99 14.10 33.54 81.63 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 295 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 369 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 16.11 33.72 80.99 14.10 33.54 81.63 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 295 GLU C 72 GLU~? 5.32 O ACT C 201 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 16.11 33.72 80.99 14.10 33.54 81.63 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 295 GLU C 72 GLU~? 5.32 O ACT C 201 A 369 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 16.11 33.72 80.99 14.10 33.54 81.63 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 12.19 31.08 87.29 11.13 32.66 86.38 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 295 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 369 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 16.11 33.72 80.99 14.10 33.54 81.63 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 12.19 31.08 87.29 11.13 32.66 86.38 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 295 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 369 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 16.11 33.72 80.99 14.10 33.54 81.63 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 12.19 31.08 87.29 11.13 32.66 86.38 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 295 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 369 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 16.11 33.72 80.99 14.10 33.54 81.63 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 295 GLU D 114 GLU^? 18.05 O ACT D 201 A 369 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 16.11 33.72 80.99 14.10 33.54 81.63 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 -53.41 42.17 31.38 -52.32 40.44 30.82 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 10 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 265 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP A 34 ASP~? 14.63 O ACT A 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 265 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP A 149 ASP.? 18.85 CH3 ACT A 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -38.64 88.42 71.14 -36.90 88.52 69.95 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 34 ASP~? 14.63 O ACT A 201 A 265 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 265 GLU A 36 GLU~? 17.83 CH3 ACT A 201 A 369 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 17.36 23.57 72.04 18.68 21.92 71.98 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 265 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 369 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 17.36 23.57 72.04 18.68 21.92 71.98 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 265 GLU D 53 GLU^? 10.32 O ACT A 203 A 369 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 17.36 23.57 72.04 18.68 21.92 71.98 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 12.19 31.08 87.29 11.13 32.66 86.38 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 265 GLU D 53 GLU^? 10.32 O ACT A 203 A 369 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 17.36 23.57 72.04 18.68 21.92 71.98 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 12.19 31.08 87.29 11.13 32.66 86.38 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 265 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 369 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 17.36 23.57 72.04 18.68 21.92 71.98 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 265 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 369 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 17.36 23.57 72.04 18.68 21.92 71.98 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 265 GLU D 137 GLU~? 19.20 CH3 ACT A 203 A 369 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 17.36 23.57 72.04 18.68 21.92 71.98 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 265 GLU D 137 GLU~? 19.20 CH3 ACT A 203 A 369 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 17.36 23.57 72.04 18.68 21.92 71.98 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 265 GLU A 137 GLU~? 14.03 O ACT A 203 A 369 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 17.36 23.57 72.04 18.68 21.92 71.98 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 265 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 265 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 265 GLU C 137 GLU~? 15.84 O2 EDO A 301 A 369 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 17.36 23.57 72.04 18.68 21.92 71.98 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 12.19 31.08 87.29 11.13 32.66 86.38 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 265 GLU C 137 GLU~? 15.84 O2 EDO A 301 A 369 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 17.36 23.57 72.04 18.68 21.92 71.98 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 265 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 17.36 23.57 72.04 18.68 21.92 71.98 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 265 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 265 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 369 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 17.36 23.57 72.04 18.68 21.92 71.98 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 265 GLU D 137 GLU~? 19.20 CH3 ACT A 203 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 17.36 23.57 72.04 18.68 21.92 71.98 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 21 3 # 21 A 241 ASP A 116 ASP.? 19.55 CH3 ACT A 201 A 265 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 369 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 17.36 23.57 72.04 18.68 21.92 71.98 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 22 3 # 22 A 241 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 265 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 369 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 17.36 23.57 72.04 18.68 21.92 71.98 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 23 3 # 23 A 241 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 265 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 24 3 # 24 A 241 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 265 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 25 3 # 25 A 241 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 265 GLU C 137 GLU~? 15.84 O2 EDO A 301 A 369 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 17.36 23.57 72.04 18.68 21.92 71.98 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 26 3 # 26 A 241 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 265 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 27 3 # 27 A 241 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 265 GLU A 160 GLU.? 13.50 O ACT A 201 A 369 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 17.36 23.57 72.04 18.68 21.92 71.98 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 12.19 31.08 87.29 11.13 32.66 86.38 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 28 3 # 28 A 241 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 265 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 369 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 17.36 23.57 72.04 18.68 21.92 71.98 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 29 3 # 29 A 241 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 265 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 369 ASP B 149 ASP.? 20.03 CH3 ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 17.36 23.57 72.04 18.68 21.92 71.98 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.67 50.22 91.33 -14.75 50.15 93.16 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 30 3 # 30 A 241 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 265 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 369 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 17.36 23.57 72.04 18.68 21.92 71.98 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 31 3 # 31 A 241 ASP B 45 ASP^? 20.35 O ACT B 201 A 265 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 369 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 17.36 23.57 72.04 18.68 21.92 71.98 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 32 3 # 32 A 241 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 265 GLU B 53 GLU^? 11.09 O ACT B 201 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 33 3 # 33 A 241 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 265 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 17.36 23.57 72.04 18.68 21.92 71.98 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 34 3 # 34 A 241 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 265 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 369 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 17.36 23.57 72.04 18.68 21.92 71.98 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 35 3 # 35 A 241 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 265 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 36 3 # 36 A 241 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 265 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 37 3 # 37 A 241 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 265 GLU B 53 GLU^? 11.09 O ACT B 201 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 38 3 # 38 A 241 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 265 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 17.36 23.57 72.04 18.68 21.92 71.98 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 39 3 # 39 A 241 ASP B 116 ASP.? 19.49 CH3 ACT B 201 A 265 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 369 ASP B 45 ASP^? 20.35 O ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 17.36 23.57 72.04 18.68 21.92 71.98 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 40 3 # 40 A 241 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 265 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 369 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 17.36 23.57 72.04 18.68 21.92 71.98 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 41 3 # 41 A 241 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 265 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 42 3 # 42 A 241 ASP B 149 ASP.? 20.03 CH3 ACT B 201 A 265 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 369 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 17.36 23.57 72.04 18.68 21.92 71.98 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 43 3 # 43 A 241 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 265 GLU C 17 GLU~? 23.53 CH3 ACT C 201 A 369 ASP C 149 ASP.? 18.79 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.57 31.78 35.88 -45.60 32.67 34.25 coo 12.19 31.08 87.29 11.13 32.66 86.38 -42.93 29.00 51.56 -40.94 29.30 50.94 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 44 3 # 44 A 241 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 265 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP C 34 ASP~? 14.66 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 45 3 # 45 A 241 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 265 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP C 149 ASP.? 18.79 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -42.93 29.00 51.56 -40.94 29.30 50.94 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 46 3 # 46 A 241 ASP C 34 ASP~? 14.66 O ACT C 201 A 265 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 47 3 # 47 A 241 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 265 GLU C 36 GLU~? 15.95 O2 EDO A 302 A 369 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 17.36 23.57 72.04 18.68 21.92 71.98 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 48 3 # 48 A 241 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 265 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 49 3 # 49 A 241 ASP C 74 ASP^? 14.86 O ACT C 201 A 265 GLU B 53 GLU^? 11.09 O ACT B 201 A 369 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 50 3 # 50 A 241 ASP C 74 ASP^? 14.86 O ACT C 201 A 265 GLU B 53 GLU^? 11.09 O ACT B 201 A 369 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 51 3 # 51 A 241 ASP C 74 ASP^? 14.86 O ACT C 201 A 265 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 369 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 17.36 23.57 72.04 18.68 21.92 71.98 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 52 3 # 52 A 241 ASP C 74 ASP^? 14.86 O ACT C 201 A 265 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 369 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 17.36 23.57 72.04 18.68 21.92 71.98 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 53 3 # 53 A 241 ASP C 74 ASP^? 14.86 O ACT C 201 A 265 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 369 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 17.36 23.57 72.04 18.68 21.92 71.98 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 54 3 # 54 A 241 ASP C 74 ASP^? 14.86 O ACT C 201 A 265 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 369 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 17.36 23.57 72.04 18.68 21.92 71.98 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 55 3 # 55 A 241 ASP C 74 ASP^? 14.86 O ACT C 201 A 265 GLU C 137 GLU~? 15.84 O2 EDO A 301 A 369 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 17.36 23.57 72.04 18.68 21.92 71.98 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 56 3 # 56 A 241 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 265 GLU C 21 GLU~? 19.29 CH3 ACT C 201 A 369 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 17.36 23.57 72.04 18.68 21.92 71.98 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 57 3 # 57 A 241 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 265 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 58 3 # 58 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 265 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 59 3 # 59 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 265 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 369 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 17.36 23.57 72.04 18.68 21.92 71.98 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 60 3 # 60 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 265 GLU A 137 GLU~? 14.03 O ACT A 203 A 369 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 17.36 23.57 72.04 18.68 21.92 71.98 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 61 3 # 61 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 265 GLU A 137 GLU~? 14.03 O ACT A 203 A 369 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 17.36 23.57 72.04 18.68 21.92 71.98 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 62 3 # 62 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 265 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 17.36 23.57 72.04 18.68 21.92 71.98 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 63 3 # 63 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 265 GLU C 137 GLU~? 15.84 O2 EDO A 301 A 369 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 17.36 23.57 72.04 18.68 21.92 71.98 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 64 3 # 64 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 265 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 369 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 17.36 23.57 72.04 18.68 21.92 71.98 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 65 3 # 65 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 265 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 369 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 17.36 23.57 72.04 18.68 21.92 71.98 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 66 3 # 66 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 265 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 17.36 23.57 72.04 18.68 21.92 71.98 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 67 3 # 67 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 265 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 68 3 # 68 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 265 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 69 3 # 69 A 241 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 265 GLU C 21 GLU~? 19.29 CH3 ACT C 201 A 369 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 12.19 31.08 87.29 11.13 32.66 86.38 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 70 3 # 70 A 241 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 265 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 71 3 # 71 A 241 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 265 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 72 3 # 72 A 241 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 265 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 73 3 # 73 A 241 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 265 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 74 3 # 74 A 241 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 265 GLU A 137 GLU~? 14.03 O ACT A 203 A 369 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 75 3 # 75 A 241 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 265 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 76 3 # 76 A 241 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 265 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 369 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 77 3 # 77 A 241 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 265 GLU C 17 GLU~? 23.53 CH3 ACT C 201 A 369 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.57 31.78 35.88 -45.60 32.67 34.25 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 78 3 # 78 A 241 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 265 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 79 3 # 79 A 241 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 265 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 369 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 17.36 23.57 72.04 18.68 21.92 71.98 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 80 3 # 80 A 241 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 265 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 369 ASP D 149 ASP.? 20.02 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 17.36 23.57 72.04 18.68 21.92 71.98 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 -48.61 69.27 22.33 -50.68 68.95 22.00 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 81 3 # 81 A 241 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 265 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 369 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 17.36 23.57 72.04 18.68 21.92 71.98 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 -55.65 65.73 30.36 -54.18 65.67 28.83 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 82 3 # 82 A 241 ASP D 45 ASP^? 20.33 O ACT D 201 A 265 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 369 ASP D 116 ASP.? 19.52 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 17.36 23.57 72.04 18.68 21.92 71.98 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -63.55 47.24 34.96 -64.48 49.07 34.39 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 83 3 # 83 A 241 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 265 GLU D 137 GLU~? 19.20 CH3 ACT A 203 A 369 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 17.36 23.57 72.04 18.68 21.92 71.98 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 84 3 # 84 A 241 ASP D 86 ASP.? 24.19 CH3 ACT D 201 A 265 GLU D 21 GLU~? 20.13 CH3 ACT D 201 A 369 ASP D 116 ASP.? 19.52 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 17.36 23.57 72.04 18.68 21.92 71.98 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 -63.55 47.24 34.96 -64.48 49.07 34.39 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 85 3 # 85 A 241 ASP D 86 ASP.? 24.19 CH3 ACT D 201 A 265 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 369 ASP D 116 ASP.? 19.52 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 17.36 23.57 72.04 18.68 21.92 71.98 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -63.55 47.24 34.96 -64.48 49.07 34.39 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 86 3 # 86 A 241 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 265 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 87 3 # 87 A 241 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 265 GLU D 53 GLU^? 10.32 O ACT A 203 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 17.36 23.57 72.04 18.68 21.92 71.98 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 88 3 # 88 A 241 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 265 GLU D 137 GLU~? 19.20 CH3 ACT A 203 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 17.36 23.57 72.04 18.68 21.92 71.98 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 89 3 # 89 A 241 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 265 GLU D 53 GLU^? 10.32 O ACT A 203 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 17.36 23.57 72.04 18.68 21.92 71.98 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 90 3 # 90 A 241 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 265 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 17.36 23.57 72.04 18.68 21.92 71.98 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 91 3 # 91 A 241 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 265 GLU D 21 GLU~? 20.13 CH3 ACT D 201 A 369 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 17.36 23.57 72.04 18.68 21.92 71.98 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 92 3 # 92 A 241 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 265 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 369 ASP D 45 ASP^? 20.33 O ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 17.36 23.57 72.04 18.68 21.92 71.98 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -67.68 49.50 43.87 -67.26 48.38 42.12 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 93 3 # 93 A 241 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 265 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 369 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 17.36 23.57 72.04 18.68 21.92 71.98 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 94 3 # 94 A 241 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 265 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 95 3 # 95 A 241 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 265 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 96 3 # 96 A 241 ASP D 149 ASP.? 20.02 CH3 ACT D 201 A 265 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 369 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 17.36 23.57 72.04 18.68 21.92 71.98 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 -55.65 65.73 30.36 -54.18 65.67 28.83 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 96 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 279 GLU A 156 GLU~? 20.10 CH3 ACT A 201 A 369 ASP A 34 ASP~? 14.63 O ACT A 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 16.54 46.37 63.94 14.77 45.79 62.95 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 34 ASP~? 14.63 O ACT A 201 A 279 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 369 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 16.54 46.37 63.94 14.77 45.79 62.95 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 34 ASP~? 14.63 O ACT A 201 A 279 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 369 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 16.54 46.37 63.94 14.77 45.79 62.95 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 279 GLU C 59 GLU~? 13.48 O2 EDO A 302 A 369 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 16.54 46.37 63.94 14.77 45.79 62.95 -20.25 53.72 49.66 -20.40 52.10 51.04 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 279 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 369 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 16.54 46.37 63.94 14.77 45.79 62.95 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 279 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 369 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 16.54 46.37 63.94 14.77 45.79 62.95 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 279 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 369 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 16.54 46.37 63.94 14.77 45.79 62.95 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 279 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 16.54 46.37 63.94 14.77 45.79 62.95 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 279 GLU C 137 GLU~? 15.84 O2 EDO A 301 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 16.54 46.37 63.94 14.77 45.79 62.95 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 279 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 369 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 16.54 46.37 63.94 14.77 45.79 62.95 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 279 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 369 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 16.54 46.37 63.94 14.77 45.79 62.95 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 279 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 369 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 16.54 46.37 63.94 14.77 45.79 62.95 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 279 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 369 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 16.54 46.37 63.94 14.77 45.79 62.95 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 279 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 16.54 46.37 63.94 14.77 45.79 62.95 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 279 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 16.54 46.37 63.94 14.77 45.79 62.95 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 279 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 16.54 46.37 63.94 14.77 45.79 62.95 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 279 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 369 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 16.54 46.37 63.94 14.77 45.79 62.95 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 12.19 31.08 87.29 11.13 32.66 86.38 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 279 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 369 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 16.54 46.37 63.94 14.77 45.79 62.95 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 12.19 31.08 87.29 11.13 32.66 86.38 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 279 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 369 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 16.54 46.37 63.94 14.77 45.79 62.95 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 279 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 369 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 16.54 46.37 63.94 14.77 45.79 62.95 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 21 3 # 21 A 241 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 279 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 369 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 16.54 46.37 63.94 14.77 45.79 62.95 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 22 3 # 22 A 241 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 279 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 369 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 16.54 46.37 63.94 14.77 45.79 62.95 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 23 3 # 23 A 241 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 279 GLU B 156 GLU~? 12.19 CH3 ACT A 202 A 369 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 16.54 46.37 63.94 14.77 45.79 62.95 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 12.19 31.08 87.29 11.13 32.66 86.38 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 24 3 # 24 A 241 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 279 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 16.54 46.37 63.94 14.77 45.79 62.95 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 25 3 # 25 A 241 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 279 GLU C 96 GLU^? 13.00 O ACT C 201 A 369 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 16.54 46.37 63.94 14.77 45.79 62.95 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 26 3 # 26 A 241 ASP B 116 ASP.? 19.49 CH3 ACT B 201 A 279 GLU B 17 GLU~? 23.60 CH3 ACT B 201 A 369 ASP B 45 ASP^? 20.35 O ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 16.54 46.37 63.94 14.77 45.79 62.95 -16.26 64.60 95.04 -14.82 64.68 96.59 coo 12.19 31.08 87.29 11.13 32.66 86.38 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 27 3 # 27 A 241 ASP B 116 ASP.? 19.49 CH3 ACT B 201 A 279 GLU B 21 GLU~? 20.11 CH3 ACT B 201 A 369 ASP B 45 ASP^? 20.35 O ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 16.54 46.37 63.94 14.77 45.79 62.95 -19.23 61.49 94.88 -18.90 62.15 96.87 coo 12.19 31.08 87.29 11.13 32.66 86.38 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 28 3 # 28 A 241 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 279 GLU A 72 GLU~? 5.31 O ACT A 201 A 369 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 16.54 46.37 63.94 14.77 45.79 62.95 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 29 3 # 29 A 241 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 279 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 369 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 16.54 46.37 63.94 14.77 45.79 62.95 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 30 3 # 30 A 241 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 279 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 16.54 46.37 63.94 14.77 45.79 62.95 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 31 3 # 31 A 241 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 279 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 16.54 46.37 63.94 14.77 45.79 62.95 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 32 3 # 32 A 241 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 279 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 369 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 16.54 46.37 63.94 14.77 45.79 62.95 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 33 3 # 33 A 241 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 279 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 369 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 16.54 46.37 63.94 14.77 45.79 62.95 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 34 3 # 34 A 241 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 279 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 16.54 46.37 63.94 14.77 45.79 62.95 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 35 3 # 35 A 241 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 279 GLU C 17 GLU~? 23.53 CH3 ACT C 201 A 369 ASP C 34 ASP~? 14.66 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 16.54 46.37 63.94 14.77 45.79 62.95 -44.57 31.78 35.88 -45.60 32.67 34.25 coo 12.19 31.08 87.29 11.13 32.66 86.38 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 36 3 # 36 A 241 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 279 GLU C 156 GLU~? 19.44 CH3 ACT C 201 A 369 ASP C 34 ASP~? 14.66 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 16.54 46.37 63.94 14.77 45.79 62.95 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 37 3 # 37 A 241 ASP C 34 ASP~? 14.66 O ACT C 201 A 279 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 369 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 16.54 46.37 63.94 14.77 45.79 62.95 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 38 3 # 38 A 241 ASP C 34 ASP~? 14.66 O ACT C 201 A 279 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 369 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 16.54 46.37 63.94 14.77 45.79 62.95 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 39 3 # 39 A 241 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 279 GLU A 59 GLU~? 18.41 O2 EDO A 302 A 369 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 16.54 46.37 63.94 14.77 45.79 62.95 -19.57 66.85 53.38 -18.14 66.20 51.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 40 3 # 40 A 241 ASP C 74 ASP^? 14.86 O ACT C 201 A 279 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 369 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 16.54 46.37 63.94 14.77 45.79 62.95 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 12.19 31.08 87.29 11.13 32.66 86.38 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 41 3 # 41 A 241 ASP C 74 ASP^? 14.86 O ACT C 201 A 279 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 16.54 46.37 63.94 14.77 45.79 62.95 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 42 3 # 42 A 241 ASP C 74 ASP^? 14.86 O ACT C 201 A 279 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 16.54 46.37 63.94 14.77 45.79 62.95 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 43 3 # 43 A 241 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 279 GLU D 17 GLU~? 23.59 CH3 ACT D 201 A 369 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 16.54 46.37 63.94 14.77 45.79 62.95 -50.49 54.35 20.83 -50.89 54.35 18.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 44 3 # 44 A 241 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 279 GLU D 21 GLU~? 20.13 CH3 ACT D 201 A 369 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 16.54 46.37 63.94 14.77 45.79 62.95 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 45 3 # 45 A 241 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 279 GLU D 114 GLU^? 18.05 O ACT D 201 A 369 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 16.54 46.37 63.94 14.77 45.79 62.95 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 46 3 # 46 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 279 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 16.54 46.37 63.94 14.77 45.79 62.95 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 47 3 # 47 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 279 GLU A 137 GLU~? 14.03 O ACT A 203 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 16.54 46.37 63.94 14.77 45.79 62.95 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 48 3 # 48 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 279 GLU A 160 GLU.? 13.50 O ACT A 201 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 16.54 46.37 63.94 14.77 45.79 62.95 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 49 3 # 49 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 279 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 369 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 16.54 46.37 63.94 14.77 45.79 62.95 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 50 3 # 50 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 279 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 369 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 16.54 46.37 63.94 14.77 45.79 62.95 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 51 3 # 51 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 279 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 369 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 16.54 46.37 63.94 14.77 45.79 62.95 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 52 3 # 52 A 241 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 279 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 369 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 16.54 46.37 63.94 14.77 45.79 62.95 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 53 3 # 53 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 279 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 16.54 46.37 63.94 14.77 45.79 62.95 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 54 3 # 54 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 279 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 16.54 46.37 63.94 14.77 45.79 62.95 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 55 3 # 55 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 279 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 369 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 16.54 46.37 63.94 14.77 45.79 62.95 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 56 3 # 56 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 279 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 16.54 46.37 63.94 14.77 45.79 62.95 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 57 3 # 57 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 279 GLU A 160 GLU.? 13.50 O ACT A 201 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 16.54 46.37 63.94 14.77 45.79 62.95 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 58 3 # 58 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 279 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 369 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 16.54 46.37 63.94 14.77 45.79 62.95 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 12.19 31.08 87.29 11.13 32.66 86.38 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 59 3 # 59 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 279 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 16.54 46.37 63.94 14.77 45.79 62.95 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 60 3 # 60 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 279 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 369 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 16.54 46.37 63.94 14.77 45.79 62.95 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 61 3 # 61 A 241 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 279 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 369 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 16.54 46.37 63.94 14.77 45.79 62.95 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 62 3 # 62 A 241 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 279 GLU C 36 GLU~? 15.95 O2 EDO A 302 A 369 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 16.54 46.37 63.94 14.77 45.79 62.95 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 63 3 # 63 A 241 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 279 GLU C 59 GLU~? 13.48 O2 EDO A 302 A 369 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 16.54 46.37 63.94 14.77 45.79 62.95 -20.25 53.72 49.66 -20.40 52.10 51.04 coo 12.19 31.08 87.29 11.13 32.66 86.38 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 64 3 # 64 A 241 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 279 GLU C 60 GLU~? 17.22 OXT ACT C 201 A 369 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 16.54 46.37 63.94 14.77 45.79 62.95 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 12.19 31.08 87.29 11.13 32.66 86.38 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 65 3 # 65 A 241 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 279 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 369 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 16.54 46.37 63.94 14.77 45.79 62.95 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 66 3 # 66 A 241 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 279 GLU C 80 GLU^? 14.47 CH3 ACT C 201 A 369 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 16.54 46.37 63.94 14.77 45.79 62.95 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 67 3 # 67 A 241 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 279 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 369 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 16.54 46.37 63.94 14.77 45.79 62.95 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 68 3 # 68 A 241 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 279 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 369 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 16.54 46.37 63.94 14.77 45.79 62.95 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 69 3 # 69 A 241 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 279 GLU D 156 GLU.? 18.36 CH3 ACT D 201 A 369 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 16.54 46.37 63.94 14.77 45.79 62.95 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 70 3 # 70 A 241 ASP D 86 ASP.? 24.19 CH3 ACT D 201 A 279 GLU C 21 GLU~? 19.29 CH3 ACT C 201 A 369 ASP D 116 ASP.? 19.52 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 16.54 46.37 63.94 14.77 45.79 62.95 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 12.19 31.08 87.29 11.13 32.66 86.38 -63.55 47.24 34.96 -64.48 49.07 34.39 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 71 3 # 71 A 241 ASP D 86 ASP.? 24.19 CH3 ACT D 201 A 279 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 369 ASP D 116 ASP.? 19.52 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 16.54 46.37 63.94 14.77 45.79 62.95 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 12.19 31.08 87.29 11.13 32.66 86.38 -63.55 47.24 34.96 -64.48 49.07 34.39 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 72 3 # 72 A 241 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 279 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 16.54 46.37 63.94 14.77 45.79 62.95 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 73 3 # 73 A 241 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 279 GLU A 137 GLU~? 14.03 O ACT A 203 A 369 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 16.54 46.37 63.94 14.77 45.79 62.95 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 74 3 # 74 A 241 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 279 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 369 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 16.54 46.37 63.94 14.77 45.79 62.95 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 75 3 # 75 A 241 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 279 GLU A 137 GLU~? 14.03 O ACT A 203 A 369 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 16.54 46.37 63.94 14.77 45.79 62.95 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 76 3 # 76 A 241 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 279 GLU D 17 GLU~? 23.59 CH3 ACT D 201 A 369 ASP D 45 ASP^? 20.33 O ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 16.54 46.37 63.94 14.77 45.79 62.95 -50.49 54.35 20.83 -50.89 54.35 18.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 -67.68 49.50 43.87 -67.26 48.38 42.12 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 77 3 # 77 A 241 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 279 GLU D 21 GLU~? 20.13 CH3 ACT D 201 A 369 ASP D 45 ASP^? 20.33 O ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 16.54 46.37 63.94 14.77 45.79 62.95 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 -67.68 49.50 43.87 -67.26 48.38 42.12 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 78 3 # 78 A 241 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 279 GLU D 36 GLU~? 17.76 CH3 ACT D 201 A 369 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 16.54 46.37 63.94 14.77 45.79 62.95 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 12.19 31.08 87.29 11.13 32.66 86.38 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 79 3 # 79 A 241 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 279 GLU D 59 GLU~? 18.52 O ACT D 201 A 369 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 16.54 46.37 63.94 14.77 45.79 62.95 -69.73 60.64 47.66 -70.08 62.16 46.23 coo 12.19 31.08 87.29 11.13 32.66 86.38 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 80 3 # 80 A 241 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 279 GLU D 60 GLU~? 17.31 O ACT D 201 A 369 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 11.74 38.14 80.19 10.63 36.40 80.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 16.54 46.37 63.94 14.77 45.79 62.95 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 12.19 31.08 87.29 11.13 32.66 86.38 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 81 3 # 81 A 241 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 279 GLU C 72 GLU~? 5.32 O ACT C 201 A 369 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 16.54 46.37 63.94 14.77 45.79 62.95 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 12.19 31.08 87.29 11.13 32.66 86.38 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 82 3 # 82 A 241 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 279 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 16.54 46.37 63.94 14.77 45.79 62.95 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 83 3 # 83 A 241 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 279 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 369 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 16.54 46.37 63.94 14.77 45.79 62.95 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 84 3 # 84 A 241 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 279 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 369 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 16.54 46.37 63.94 14.77 45.79 62.95 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 85 3 # 85 A 241 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 279 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 369 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 16.54 46.37 63.94 14.77 45.79 62.95 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 86 3 # 86 A 241 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 279 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 369 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 16.54 46.37 63.94 14.77 45.79 62.95 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 12.19 31.08 87.29 11.13 32.66 86.38 -49.03 74.78 51.99 -47.35 75.78 52.80 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 86 hits 1m53_c06 naa= 3 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 A 10 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 168 ASN B 103 ASN.? 17.21 C2 EDO A 302 A 241 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -32.39 41.19 68.51 -33.08 39.66 67.21 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 A 10 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 168 ASN D 103 ASN.? 11.64 CH3 ACT A 203 A 241 HIS A 98 HIS^? -3.60 C ACT A 203s coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -43.97 76.72 52.03 -43.49 78.26 53.43 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -46.65 67.75 58.52 -46.50 68.86 56.74 1mas_c00 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 2 hits 1mas_c00 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP D 100 ASP.? 7.94 OXT ACT A 203 B 168 ASN D 103 ASN.? 11.64 CH3 ACT A 203 B 241 HIS A 98 HIS^? -3.60 C ACT A 203s coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -43.97 76.72 52.03 -43.49 78.26 53.43 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -46.65 67.75 58.52 -46.50 68.86 56.74 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 1 hits 1mas_c01 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG C 16 ARG~? 20.89 CH3 ACT C 201 229 SER C 18 SER~? 19.83 CH3 ACT C 201 325 GLU C 17 GLU~? 23.53 CH3 ACT C 201 coo 2.54 15.84 18.57 3.24 17.85 16.30 -48.56 36.19 35.88 -49.41 34.92 38.55 coo 10.17 13.48 15.92 9.61 15.76 15.27 -39.67 35.11 36.68 -39.03 36.29 34.63 coo 5.42 13.04 19.75 5.74 13.81 17.79 -44.57 31.78 35.88 -45.60 32.67 34.25 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 1 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 68 LYS~? -2.78 O ACT A 201s 166 LYS A 71 LYS~? 4.32 C2 EDO A 301 324 SER B 107 SER^? 7.39 OXT ACT B 201 coo 25.93 8.11 25.51 26.40 7.80 19.66 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 27.27 1.43 25.09 29.18 5.25 22.89 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 46.32 14.55 19.93 45.95 12.72 21.27 -29.25 52.59 73.85 -31.29 51.35 74.31 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 68 LYS~? -2.78 O ACT A 201s 166 LYS A 71 LYS~? 4.32 C2 EDO A 301 324 SER C 39 SER~? 14.22 CH3 ACT C 201 coo 25.93 8.11 25.51 26.40 7.80 19.66 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 27.27 1.43 25.09 29.18 5.25 22.89 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 46.32 14.55 19.93 45.95 12.72 21.27 -26.65 46.46 48.19 -24.39 46.43 49.12 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 71 LYS~? 4.32 C2 EDO A 301 166 LYS A 68 LYS~? -2.78 O ACT A 201s 324 SER C 39 SER~? 14.22 CH3 ACT C 201 coo 25.93 8.11 25.51 26.40 7.80 19.66 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 27.27 1.43 25.09 29.18 5.25 22.89 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 46.32 14.55 19.93 45.95 12.72 21.27 -26.65 46.46 48.19 -24.39 46.43 49.12 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS B 68 LYS~? -2.79 OXT ACT B 201s 166 LYS B 71 LYS~? 10.83 OXT ACT B 201 324 SER A 107 SER^? 6.74 O1 EDO A 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 27.27 1.43 25.09 29.18 5.25 22.89 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 46.32 14.55 19.93 45.95 12.72 21.27 -40.35 65.45 69.21 -39.92 64.63 66.96 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS C 68 LYS~? -2.77 O ACT C 201s 166 LYS C 71 LYS~? 4.19 C1 EDO A 301 324 SER A 39 SER~? 14.37 CH3 ACT A 201 coo 25.93 8.11 25.51 26.40 7.80 19.66 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 27.27 1.43 25.09 29.18 5.25 22.89 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 46.32 14.55 19.93 45.95 12.72 21.27 -23.46 73.59 59.60 -22.83 73.90 57.26 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS C 68 LYS~? -2.77 O ACT C 201s 166 LYS C 71 LYS~? 4.19 C1 EDO A 301 324 SER D 107 SER^? 7.30 OXT ACT D 201 coo 25.93 8.11 25.51 26.40 7.80 19.66 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 27.27 1.43 25.09 29.18 5.25 22.89 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 46.32 14.55 19.93 45.95 12.72 21.27 -44.25 65.54 45.21 -46.11 66.36 46.55 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS C 71 LYS~? 4.19 C1 EDO A 301 166 LYS C 68 LYS~? -2.77 O ACT C 201s 324 SER A 39 SER~? 14.37 CH3 ACT A 201 coo 25.93 8.11 25.51 26.40 7.80 19.66 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 27.27 1.43 25.09 29.18 5.25 22.89 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 46.32 14.55 19.93 45.95 12.72 21.27 -23.46 73.59 59.60 -22.83 73.90 57.26 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS D 68 LYS~? -2.80 OXT ACT D 201s 166 LYS D 71 LYS~? -3.20 CH3 ACT A 203s 324 SER C 107 SER^? 6.74 O2 EDO A 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 27.27 1.43 25.09 29.18 5.25 22.89 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 46.32 14.55 19.93 45.95 12.72 21.27 -45.59 51.52 55.69 -43.69 52.48 56.86 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 8 hits 1mdr_c01 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP A 99 ASP.? 5.71 O2 EDO A 301 35 SER A 101 SER.? 7.80 O2 EDO A 301 215 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 20.97 14.47 32.28 19.66 15.96 31.62 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 16.04 14.72 33.82 17.27 13.71 31.95 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 20.65 22.00 33.80 20.06 20.56 32.39 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 3 # 2 32 ASP B 99 ASP.? 16.09 OXT ACT B 201 35 SER B 101 SER.? 19.25 O ACT C 201 215 ASP C 74 ASP^? 14.86 O ACT C 201 coo 20.97 14.47 32.28 19.66 15.96 31.62 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 16.04 14.72 33.82 17.27 13.71 31.95 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 20.65 22.00 33.80 20.06 20.56 32.39 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 3 3 # 3 32 ASP C 99 ASP.? 5.79 O1 EDO A 301 35 SER C 101 SER.? 7.85 O1 EDO A 301 215 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 20.97 14.47 32.28 19.66 15.96 31.62 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 16.04 14.72 33.82 17.27 13.71 31.95 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 20.65 22.00 33.80 20.06 20.56 32.39 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 4 3 # 4 32 ASP D 99 ASP.? 7.94 CH3 ACT A 203 35 SER D 101 SER.? 9.16 OXT ACT A 203 215 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 20.97 14.47 32.28 19.66 15.96 31.62 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 16.04 14.72 33.82 17.27 13.71 31.95 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 20.65 22.00 33.80 20.06 20.56 32.39 -44.71 72.29 58.72 -45.62 72.95 56.93 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 4 hits 1mpp_c04 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 29 GLY~? 9.49 CH3 ACT A 201 A 501 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 367 TYR B 93 TYR^? -4.16 CH3 ACT B 201s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -30.30 78.71 63.24 -31.02 78.43 63.55 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -27.85 57.31 80.17 -30.64 57.51 79.89 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY B 102 GLY.? 18.26 OXT ACT B 201 A 501 ASP C 28 ASP~? 12.80 CH3 ACT C 201 B 367 TYR A 108 TYR^? 12.28 O ACT A 201 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -32.65 37.69 71.75 -32.89 38.32 71.31 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY B 109 GLY^? 6.82 O ACT B 201 A 501 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 367 TYR C 95 TYR^? -3.84 O ACT C 201s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -29.36 58.56 76.35 -28.60 58.71 76.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY B 109 GLY^? 6.82 O ACT B 201 A 501 ASP B 34 ASP~? 14.61 OXT ACT B 201 B 367 TYR C 95 TYR^? -3.84 O ACT C 201s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -29.36 58.56 76.35 -28.60 58.71 76.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY B 119 GLY.? 17.96 CH3 ACT B 201 A 501 ASP B 149 ASP.? 20.03 CH3 ACT B 201 B 367 TYR A 108 TYR^? 12.28 O ACT A 201 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -31.59 64.88 97.59 -32.39 64.85 97.59 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY B 158 GLY.? 7.47 OXT ACT A 202 A 501 ASP B 28 ASP~? 12.70 CH3 ACT B 201 B 367 TYR C 75 TYR^? -4.54 O ACT C 201s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -14.69 54.85 71.91 -15.35 54.62 72.30 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY C 29 GLY~? 9.51 CH3 ACT C 201 A 501 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 367 TYR D 93 TYR^? -4.14 CH3 ACT D 201s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -32.89 40.21 50.79 -33.62 40.36 51.16 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -47.46 60.74 39.76 -48.96 60.10 42.05 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY C 119 GLY.? 17.79 CH3 ACT C 201 A 501 ASP C 149 ASP.? 18.79 CH3 ACT C 201 B 367 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -29.92 40.95 36.71 -29.36 41.52 36.74 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY D 109 GLY^? 6.89 O ACT D 201 A 501 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 367 TYR A 95 TYR^? -3.85 O ACT A 201s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -45.26 59.49 43.22 -44.76 59.46 42.64 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY D 109 GLY^? 6.89 O ACT D 201 A 501 ASP D 34 ASP~? 14.62 OXT ACT D 201 B 367 TYR A 95 TYR^? -3.85 O ACT A 201s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -45.26 59.49 43.22 -44.76 59.46 42.64 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY D 119 GLY.? 18.01 CH3 ACT D 201 A 501 ASP D 149 ASP.? 20.02 CH3 ACT D 201 B 367 TYR C 93 TYR^? -4.09 CH3 ACT C 201s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -61.89 51.27 30.98 -62.42 51.19 31.57 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -43.00 47.58 49.22 -41.38 49.87 49.22 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY D 119 GLY.? 18.01 CH3 ACT D 201 A 501 ASP D 149 ASP.? 20.02 CH3 ACT D 201 B 367 TYR C 108 TYR^? 12.28 O ACT C 201 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -61.89 51.27 30.98 -62.42 51.19 31.57 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -49.57 50.97 53.11 -51.32 50.02 55.06 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 12 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 29 GLY~? 9.49 CH3 ACT A 201 D 501 ASP D 130 ASP.? 7.40 CH3 ACT A 203 E 367 TYR B 93 TYR^? -4.16 CH3 ACT B 201s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -30.30 78.71 63.24 -31.02 78.43 63.55 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -27.85 57.31 80.17 -30.64 57.51 79.89 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY B 102 GLY.? 18.26 OXT ACT B 201 D 501 ASP C 28 ASP~? 12.80 CH3 ACT C 201 E 367 TYR A 108 TYR^? 12.28 O ACT A 201 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -32.65 37.69 71.75 -32.89 38.32 71.31 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY B 109 GLY^? 6.82 O ACT B 201 D 501 ASP A 45 ASP^? 16.09 OXT ACT A 202 E 367 TYR C 95 TYR^? -3.84 O ACT C 201s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -29.36 58.56 76.35 -28.60 58.71 76.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY B 109 GLY^? 6.82 O ACT B 201 D 501 ASP B 34 ASP~? 14.61 OXT ACT B 201 E 367 TYR C 95 TYR^? -3.84 O ACT C 201s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -29.36 58.56 76.35 -28.60 58.71 76.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY B 119 GLY.? 17.96 CH3 ACT B 201 D 501 ASP B 149 ASP.? 20.03 CH3 ACT B 201 E 367 TYR A 93 TYR^? -4.07 CH3 ACT A 201s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -31.59 64.88 97.59 -32.39 64.85 97.59 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -34.34 70.13 71.57 -32.99 68.09 70.18 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY B 119 GLY.? 17.96 CH3 ACT B 201 D 501 ASP B 149 ASP.? 20.03 CH3 ACT B 201 E 367 TYR A 108 TYR^? 12.28 O ACT A 201 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -31.59 64.88 97.59 -32.39 64.85 97.59 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY B 158 GLY.? 7.47 OXT ACT A 202 D 501 ASP B 28 ASP~? 12.70 CH3 ACT B 201 E 367 TYR C 75 TYR^? -4.54 O ACT C 201s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -14.69 54.85 71.91 -15.35 54.62 72.30 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY C 29 GLY~? 9.51 CH3 ACT C 201 D 501 ASP B 130 ASP.? 9.25 OXT ACT B 201 E 367 TYR D 93 TYR^? -4.14 CH3 ACT D 201s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -32.89 40.21 50.79 -33.62 40.36 51.16 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -47.46 60.74 39.76 -48.96 60.10 42.05 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY C 119 GLY.? 17.79 CH3 ACT C 201 D 501 ASP C 149 ASP.? 18.79 CH3 ACT C 201 E 367 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -29.92 40.95 36.71 -29.36 41.52 36.74 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY D 109 GLY^? 6.89 O ACT D 201 D 501 ASP C 45 ASP^? 20.17 OXT ACT C 201 E 367 TYR A 95 TYR^? -3.85 O ACT A 201s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -45.26 59.49 43.22 -44.76 59.46 42.64 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY D 109 GLY^? 6.89 O ACT D 201 D 501 ASP D 34 ASP~? 14.62 OXT ACT D 201 E 367 TYR A 95 TYR^? -3.85 O ACT A 201s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -45.26 59.49 43.22 -44.76 59.46 42.64 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY D 119 GLY.? 18.01 CH3 ACT D 201 D 501 ASP D 149 ASP.? 20.02 CH3 ACT D 201 E 367 TYR C 93 TYR^? -4.09 CH3 ACT C 201s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -61.89 51.27 30.98 -62.42 51.19 31.57 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -43.00 47.58 49.22 -41.38 49.87 49.22 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY D 119 GLY.? 18.01 CH3 ACT D 201 D 501 ASP D 149 ASP.? 20.02 CH3 ACT D 201 E 367 TYR C 108 TYR^? 12.28 O ACT C 201 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -61.89 51.27 30.98 -62.42 51.19 31.57 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -49.57 50.97 53.11 -51.32 50.02 55.06 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 13 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 55 TYR A 75 TYR^? -4.52 O ACT A 201s A 84 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 11.09 42.89 24.44 11.32 42.06 22.49 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 4.60 40.33 20.42 7.25 39.50 20.05 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 9.71 44.83 15.47 10.13 41.43 19.93 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 55 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 84 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 11.09 42.89 24.44 11.32 42.06 22.49 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 4.60 40.33 20.42 7.25 39.50 20.05 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 9.71 44.83 15.47 10.13 41.43 19.93 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP C 74 ASP^? 14.86 O ACT C 201 A 55 TYR C 75 TYR^? -4.54 O ACT C 201s A 84 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 11.09 42.89 24.44 11.32 42.06 22.49 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 4.60 40.33 20.42 7.25 39.50 20.05 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 9.71 44.83 15.47 10.13 41.43 19.93 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 55 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 84 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 11.09 42.89 24.44 11.32 42.06 22.49 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 4.60 40.33 20.42 7.25 39.50 20.05 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 9.71 44.83 15.47 10.13 41.43 19.93 -54.54 71.95 50.35 -50.70 67.51 52.69 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 4 hits 1mrq_c02 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 169 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 327 GLU D 53 GLU^? 10.32 O ACT A 203 coo 20.73 15.53 25.54 22.09 15.64 19.40 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 24.31 10.25 23.71 29.02 12.05 20.75 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 21.86 20.40 18.59 22.12 18.33 18.33 -56.60 59.52 53.75 -57.18 61.28 52.77 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 1 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 169 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 327 GLU D 53 GLU^? 10.32 O ACT A 203 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -56.60 59.52 53.75 -57.18 61.28 52.77 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 1 hits 1muc_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 56 HIS.? 6.76 O1 EDO A 302 A 197 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 223 ALA A 63 ALA~? 14.85 OXT ACT A 201 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -25.75 65.96 54.80 -24.85 64.81 54.40 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 98 HIS^? -3.60 C ACT A 203s A 197 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 223 ALA D 52 ALA.? 10.75 O ACT A 203 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -52.10 56.30 54.26 -51.39 56.64 55.56 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS B 56 HIS.? 17.31 O ACT B 201 A 197 ASP B 45 ASP^? 20.35 O ACT B 201 A 223 ALA B 63 ALA~? 14.82 O ACT B 201 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -44.69 50.92 87.09 -46.09 51.48 86.89 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 197 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 223 ALA B 52 ALA.? 10.80 O1 EDO A 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -42.54 59.91 74.80 -43.03 59.60 73.39 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 4 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 56 HIS.? 6.76 O1 EDO A 302 B 197 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 223 ALA A 63 ALA~? 14.85 OXT ACT A 201 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -25.75 65.96 54.80 -24.85 64.81 54.40 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 98 HIS^? -3.60 C ACT A 203s B 197 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 223 ALA D 52 ALA.? 10.75 O ACT A 203 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -52.10 56.30 54.26 -51.39 56.64 55.56 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS B 56 HIS.? 17.31 O ACT B 201 B 197 ASP B 45 ASP^? 20.35 O ACT B 201 B 223 ALA B 63 ALA~? 14.82 O ACT B 201 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -44.69 50.92 87.09 -46.09 51.48 86.89 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 197 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 223 ALA B 52 ALA.? 10.80 O1 EDO A 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -42.54 59.91 74.80 -43.03 59.60 73.39 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 4 hits 1n2t_c03 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS A 98 HIS^? -3.60 C ACT A 203s A 290 LYS A 134 LYS~? 11.98 O ACT A 203 A 405 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 41.33 25.99 28.05 41.95 26.95 29.80 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 37.11 33.75 31.82 38.72 27.95 29.90 -53.24 65.33 66.31 -57.37 62.85 65.73 coo 42.28 27.98 41.30 43.16 28.14 38.35 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 2 3 # 2 A 264 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 290 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 405 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 41.33 25.99 28.05 41.95 26.95 29.80 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 37.11 33.75 31.82 38.72 27.95 29.90 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 42.28 27.98 41.30 43.16 28.14 38.35 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 3 3 # 3 A 264 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 290 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 405 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 41.33 25.99 28.05 41.95 26.95 29.80 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 37.11 33.75 31.82 38.72 27.95 29.90 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 42.28 27.98 41.30 43.16 28.14 38.35 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 4 3 # 4 A 264 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 290 LYS B 134 LYS~? 12.79 C2 EDO A 302 A 405 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 41.33 25.99 28.05 41.95 26.95 29.80 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 37.11 33.75 31.82 38.72 27.95 29.90 -24.49 42.38 66.88 -23.94 39.99 62.78 coo 42.28 27.98 41.30 43.16 28.14 38.35 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 5 3 # 5 A 264 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 290 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 405 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 41.33 25.99 28.05 41.95 26.95 29.80 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 37.11 33.75 31.82 38.72 27.95 29.90 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 42.28 27.98 41.30 43.16 28.14 38.35 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 6 3 # 6 A 264 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 290 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 405 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 41.33 25.99 28.05 41.95 26.95 29.80 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 37.11 33.75 31.82 38.72 27.95 29.90 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 42.28 27.98 41.30 43.16 28.14 38.35 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 7 3 # 7 A 264 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 290 LYS C 134 LYS~? 17.33 O2 EDO A 301 A 405 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 41.33 25.99 28.05 41.95 26.95 29.80 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 37.11 33.75 31.82 38.72 27.95 29.90 -51.34 49.79 67.51 -53.85 50.99 71.42 coo 42.28 27.98 41.30 43.16 28.14 38.35 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 8 3 # 8 A 264 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 290 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 405 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 41.33 25.99 28.05 41.95 26.95 29.80 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 37.11 33.75 31.82 38.72 27.95 29.90 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 42.28 27.98 41.30 43.16 28.14 38.35 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 9 3 # 9 A 264 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 290 LYS D 134 LYS~? 17.34 O ACT A 201 A 405 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 41.33 25.99 28.05 41.95 26.95 29.80 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 37.11 33.75 31.82 38.72 27.95 29.90 -37.62 76.93 46.97 -33.08 76.47 49.79 coo 42.28 27.98 41.30 43.16 28.14 38.35 -40.22 67.90 41.60 -38.15 70.12 41.98 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 10 3 # 10 A 264 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 290 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 405 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 41.33 25.99 28.05 41.95 26.95 29.80 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 37.11 33.75 31.82 38.72 27.95 29.90 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 42.28 27.98 41.30 43.16 28.14 38.35 -40.22 67.90 41.60 -38.15 70.12 41.98 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 10 hits 1nhx_c00 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 137 GLU~? 14.03 O ACT A 203 B 128 HIS A 141 HIS.? 11.20 OXT ACT A 203 C 263 HIS A 98 HIS^? -3.60 C ACT A 203s coo 6.12 5.94 82.00 7.16 6.32 83.81 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 12.51 16.35 80.99 13.16 14.90 82.37 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 11.58 14.94 93.26 12.25 14.03 91.50 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU A 160 GLU.? 13.50 O ACT A 201 B 128 HIS A 162 HIS.? 14.54 O1 EDO A 301 C 263 HIS B 56 HIS.? 17.31 O ACT B 201 coo 6.12 5.94 82.00 7.16 6.32 83.81 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 12.51 16.35 80.99 13.16 14.90 82.37 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 11.58 14.94 93.26 12.25 14.03 91.50 -48.13 62.85 85.87 -48.38 63.10 83.80 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU C 137 GLU~? 15.84 O2 EDO A 301 B 128 HIS C 141 HIS.? 17.85 O ACT C 201 C 263 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 6.12 5.94 82.00 7.16 6.32 83.81 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 12.51 16.35 80.99 13.16 14.90 82.37 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 11.58 14.94 93.26 12.25 14.03 91.50 -40.81 49.03 67.16 -39.15 48.14 68.10 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 3 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 98 HIS^? -3.60 C ACT A 203s D 59 GLU A 137 GLU~? 14.03 O ACT A 203 D 128 HIS A 141 HIS.? 11.20 OXT ACT A 203 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -49.96 77.41 66.16 -51.01 75.70 66.78 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS B 56 HIS.? 17.31 O ACT B 201 D 59 GLU A 160 GLU.? 13.50 O ACT A 201 D 128 HIS A 162 HIS.? 14.54 O1 EDO A 301 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -51.28 62.77 74.01 -50.27 62.16 72.28 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 59 GLU C 137 GLU~? 15.84 O2 EDO A 301 D 128 HIS C 141 HIS.? 17.85 O ACT C 201 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -47.33 38.55 64.23 -48.23 40.22 65.13 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 3 hits 1ni4_c01 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 68 LYS~? -2.78 O ACT A 201s 631 LYS A 134 LYS~? 11.98 O ACT A 203 708 LYS A 62 LYS~? 17.60 O ACT A 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -53.24 65.33 66.31 -57.37 62.85 65.73 coo 18.16 32.86 9.85 16.06 28.20 13.56 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS A 68 LYS~? -2.78 O ACT A 201s 631 LYS D 71 LYS~? -3.20 CH3 ACT A 203s 708 LYS A 62 LYS~? 17.60 O ACT A 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 18.16 32.86 9.85 16.06 28.20 13.56 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 631 LYS A 134 LYS~? 11.98 O ACT A 203 708 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -34.66 75.11 72.84 -31.25 72.89 69.03 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -53.24 65.33 66.31 -57.37 62.85 65.73 coo 18.16 32.86 9.85 16.06 28.20 13.56 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 631 LYS C 71 LYS~? 4.19 C1 EDO A 301 708 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -34.66 75.11 72.84 -31.25 72.89 69.03 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 18.16 32.86 9.85 16.06 28.20 13.56 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 5 3 # 5 549 LYS A 134 LYS~? 11.98 O ACT A 203 631 LYS D 62 LYS~? 17.47 OXT ACT D 201 708 LYS A 139 LYS.? 17.81 O ACT A 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -53.24 65.33 66.31 -57.37 62.85 65.73 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 18.16 32.86 9.85 16.06 28.20 13.56 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 6 3 # 6 549 LYS A 139 LYS.? 17.81 O ACT A 201 631 LYS A 22 LYS~? 15.35 CH3 ACT A 201 708 LYS A 134 LYS~? 11.98 O ACT A 203 coo 8.61 33.06 11.15 10.12 29.19 8.82 -48.50 74.28 70.24 -48.23 71.73 76.05 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 18.16 32.86 9.85 16.06 28.20 13.56 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 7 3 # 7 549 LYS B 68 LYS~? -2.79 OXT ACT B 201s 631 LYS B 134 LYS~? 12.79 C2 EDO A 302 708 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -24.49 42.38 66.88 -23.94 39.99 62.78 coo 18.16 32.86 9.85 16.06 28.20 13.56 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 8 3 # 8 549 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 631 LYS B 134 LYS~? 12.79 C2 EDO A 302 708 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -23.75 57.07 83.29 -29.11 56.74 84.70 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -24.49 42.38 66.88 -23.94 39.99 62.78 coo 18.16 32.86 9.85 16.06 28.20 13.56 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 9 3 # 9 549 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 631 LYS C 71 LYS~? 4.19 C1 EDO A 301 708 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -23.75 57.07 83.29 -29.11 56.74 84.70 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 18.16 32.86 9.85 16.06 28.20 13.56 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 10 3 # 10 549 LYS B 139 LYS.? 6.99 C1 EDO A 302 631 LYS B 22 LYS~? 15.43 CH3 ACT B 201 708 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 -18.83 46.84 75.05 -16.49 49.79 71.17 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 18.16 32.86 9.85 16.06 28.20 13.56 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 11 3 # 11 549 LYS C 68 LYS~? -2.77 O ACT C 201s 631 LYS B 71 LYS~? 10.83 OXT ACT B 201 708 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 18.16 32.86 9.85 16.06 28.20 13.56 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 12 3 # 12 549 LYS C 68 LYS~? -2.77 O ACT C 201s 631 LYS C 134 LYS~? 17.33 O2 EDO A 301 708 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -51.34 49.79 67.51 -53.85 50.99 71.42 coo 18.16 32.86 9.85 16.06 28.20 13.56 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 13 3 # 13 549 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 631 LYS A 71 LYS~? 4.32 C2 EDO A 301 708 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -43.47 42.54 48.33 -38.69 45.48 48.28 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 18.16 32.86 9.85 16.06 28.20 13.56 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 14 3 # 14 549 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 631 LYS C 134 LYS~? 17.33 O2 EDO A 301 708 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -43.47 42.54 48.33 -38.69 45.48 48.28 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -51.34 49.79 67.51 -53.85 50.99 71.42 coo 18.16 32.86 9.85 16.06 28.20 13.56 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 15 3 # 15 549 LYS C 134 LYS~? 17.33 O2 EDO A 301 631 LYS B 62 LYS~? 17.44 OXT ACT B 201 708 LYS C 139 LYS.? 18.79 O ACT C 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -51.34 49.79 67.51 -53.85 50.99 71.42 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 18.16 32.86 9.85 16.06 28.20 13.56 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 16 3 # 16 549 LYS C 139 LYS.? 18.79 O ACT C 201 631 LYS C 22 LYS~? 15.34 CH3 ACT C 201 708 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 -50.26 41.49 60.64 -55.14 42.95 58.84 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 18.16 32.86 9.85 16.06 28.20 13.56 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 17 3 # 17 549 LYS D 68 LYS~? -2.80 OXT ACT D 201s 631 LYS D 134 LYS~? 17.34 O ACT A 201 708 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -37.62 76.93 46.97 -33.08 76.47 49.79 coo 18.16 32.86 9.85 16.06 28.20 13.56 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 18 3 # 18 549 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 631 LYS A 71 LYS~? 4.32 C2 EDO A 301 708 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -47.37 61.41 34.65 -51.85 60.71 37.83 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 18.16 32.86 9.85 16.06 28.20 13.56 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 19 3 # 19 549 LYS D 79 LYS^? -3.52 CH3 ACT D 201s 631 LYS D 134 LYS~? 17.34 O ACT A 201 708 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -47.37 61.41 34.65 -51.85 60.71 37.83 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -37.62 76.93 46.97 -33.08 76.47 49.79 coo 18.16 32.86 9.85 16.06 28.20 13.56 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 20 3 # 20 549 LYS D 139 LYS.? 18.54 OXT ACT D 201 631 LYS D 22 LYS~? 15.49 CH3 ACT D 201 708 LYS D 134 LYS~? 17.34 O ACT A 201 coo 8.61 33.06 11.15 10.12 29.19 8.82 -39.84 73.21 37.09 -35.07 70.74 37.87 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -54.47 56.23 29.06 -59.33 54.04 30.24 coo 18.16 32.86 9.85 16.06 28.20 13.56 -37.62 76.93 46.97 -33.08 76.47 49.79 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 20 hits 1nsf_c00 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 101 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 132 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 11.61 22.83 17.30 14.06 21.71 15.78 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 11.37 24.94 11.48 12.48 24.45 13.28 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 16.14 18.17 13.37 15.92 19.81 14.71 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 101 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 132 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 11.61 22.83 17.30 14.06 21.71 15.78 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 11.37 24.94 11.48 12.48 24.45 13.28 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 16.14 18.17 13.37 15.92 19.81 14.71 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG B 51 ARG.? 7.67 O ACT B 201 A 101 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 132 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.61 22.83 17.30 14.06 21.71 15.78 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 11.37 24.94 11.48 12.48 24.45 13.28 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 16.14 18.17 13.37 15.92 19.81 14.71 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 101 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 132 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 11.61 22.83 17.30 14.06 21.71 15.78 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 11.37 24.94 11.48 12.48 24.45 13.28 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 16.14 18.17 13.37 15.92 19.81 14.71 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 A 99 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 101 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 132 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 11.61 22.83 17.30 14.06 21.71 15.78 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 11.37 24.94 11.48 12.48 24.45 13.28 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 16.14 18.17 13.37 15.92 19.81 14.71 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 A 99 ARG D 51 ARG.? 7.60 O ACT D 201 A 101 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 132 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.61 22.83 17.30 14.06 21.71 15.78 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 11.37 24.94 11.48 12.48 24.45 13.28 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 16.14 18.17 13.37 15.92 19.81 14.71 -44.15 62.19 57.97 -45.93 61.14 58.45 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 6 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 51 ARG.? 6.25 O1 EDO A 301 B 101 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 132 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 11.61 3.43 18.38 9.11 4.29 16.86 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 11.74 0.51 12.98 10.75 1.32 14.67 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 6.93 7.52 14.08 7.18 6.08 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 51 ARG.? 6.25 O1 EDO A 301 B 101 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 132 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 11.61 3.43 18.38 9.11 4.29 16.86 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 11.74 0.51 12.98 10.75 1.32 14.67 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 6.93 7.52 14.08 7.18 6.08 15.65 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG B 51 ARG.? 7.67 O ACT B 201 B 101 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 132 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.61 3.43 18.38 9.11 4.29 16.86 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 11.74 0.51 12.98 10.75 1.32 14.67 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 6.93 7.52 14.08 7.18 6.08 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG C 51 ARG.? 6.22 O2 EDO A 301 B 101 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 132 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 11.61 3.43 18.38 9.11 4.29 16.86 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 11.74 0.51 12.98 10.75 1.32 14.67 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 6.93 7.52 14.08 7.18 6.08 15.65 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 B 99 ARG C 51 ARG.? 6.22 O2 EDO A 301 B 101 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 132 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 11.61 3.43 18.38 9.11 4.29 16.86 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 11.74 0.51 12.98 10.75 1.32 14.67 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 6.93 7.52 14.08 7.18 6.08 15.65 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 B 99 ARG D 51 ARG.? 7.60 O ACT D 201 B 101 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 132 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.61 3.43 18.38 9.11 4.29 16.86 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 11.74 0.51 12.98 10.75 1.32 14.67 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 6.93 7.52 14.08 7.18 6.08 15.65 -44.15 62.19 57.97 -45.93 61.14 58.45 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 6 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 101 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 132 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 11.50 22.77 17.24 14.00 21.62 15.86 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 11.19 25.00 11.76 12.16 24.45 13.59 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 16.04 18.11 13.43 15.88 19.70 14.83 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG B 51 ARG.? 7.67 O ACT B 201 A 101 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 132 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.50 22.77 17.24 14.00 21.62 15.86 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 11.19 25.00 11.76 12.16 24.45 13.59 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 16.04 18.11 13.43 15.88 19.70 14.83 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 101 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 132 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 11.50 22.77 17.24 14.00 21.62 15.86 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 11.19 25.00 11.76 12.16 24.45 13.59 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 16.04 18.11 13.43 15.88 19.70 14.83 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG D 51 ARG.? 7.60 O ACT D 201 A 101 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 132 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.50 22.77 17.24 14.00 21.62 15.86 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 11.19 25.00 11.76 12.16 24.45 13.59 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 16.04 18.11 13.43 15.88 19.70 14.83 -44.15 62.19 57.97 -45.93 61.14 58.45 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 24 ARG~? 13.97 CH3 ACT A 201 B 101 ASP A 28 ASP~? 12.70 CH3 ACT A 201 B 132 ASP A 149 ASP.? 18.85 CH3 ACT A 201 coo 11.48 3.09 18.25 9.01 4.07 16.77 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 11.83 0.33 13.01 10.88 1.04 14.81 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 6.85 7.33 14.07 7.10 5.88 15.60 -38.64 88.42 71.14 -36.90 88.52 69.95 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 24 ARG~? 13.97 CH3 ACT A 201 B 101 ASP A 149 ASP.? 18.85 CH3 ACT A 201 B 132 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 11.48 3.09 18.25 9.01 4.07 16.77 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 11.83 0.33 13.01 10.88 1.04 14.81 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 6.85 7.33 14.07 7.10 5.88 15.60 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG A 37 ARG~? 13.73 CH3 ACT A 201 B 101 ASP A 34 ASP~? 14.63 O ACT A 201 B 132 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 11.48 3.09 18.25 9.01 4.07 16.77 -28.83 80.54 58.97 -30.62 82.33 60.70 coo 11.83 0.33 13.01 10.88 1.04 14.81 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 6.85 7.33 14.07 7.10 5.88 15.60 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG A 51 ARG.? 6.25 O1 EDO A 301 B 101 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 132 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 11.48 3.09 18.25 9.01 4.07 16.77 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 11.83 0.33 13.01 10.88 1.04 14.81 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 6.85 7.33 14.07 7.10 5.88 15.60 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 B 99 ARG A 146 ARG.? 16.48 CH3 ACT A 201 B 101 ASP A 28 ASP~? 12.70 CH3 ACT A 201 B 132 ASP A 149 ASP.? 18.85 CH3 ACT A 201 coo 11.48 3.09 18.25 9.01 4.07 16.77 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 11.83 0.33 13.01 10.88 1.04 14.81 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 6.85 7.33 14.07 7.10 5.88 15.60 -38.64 88.42 71.14 -36.90 88.52 69.95 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 B 99 ARG B 51 ARG.? 7.67 O ACT B 201 B 101 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 132 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 11.48 3.09 18.25 9.01 4.07 16.77 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 11.83 0.33 13.01 10.88 1.04 14.81 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 6.85 7.33 14.07 7.10 5.88 15.60 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 B 99 ARG C 37 ARG~? 13.73 CH3 ACT C 201 B 101 ASP C 34 ASP~? 14.66 O ACT C 201 B 132 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 11.48 3.09 18.25 9.01 4.07 16.77 -28.52 38.86 52.29 -30.70 36.70 52.27 coo 11.83 0.33 13.01 10.88 1.04 14.81 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 6.85 7.33 14.07 7.10 5.88 15.60 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 B 99 ARG C 51 ARG.? 6.22 O2 EDO A 301 B 101 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 132 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 11.48 3.09 18.25 9.01 4.07 16.77 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 11.83 0.33 13.01 10.88 1.04 14.81 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 6.85 7.33 14.07 7.10 5.88 15.60 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 9 3 # 9 B 99 ARG D 51 ARG.? 7.60 O ACT D 201 B 101 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 132 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 11.48 3.09 18.25 9.01 4.07 16.77 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 11.83 0.33 13.01 10.88 1.04 14.81 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 6.85 7.33 14.07 7.10 5.88 15.60 -44.15 62.19 57.97 -45.93 61.14 58.45 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 9 hits 1nww_c03 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 39 SER~? 14.37 CH3 ACT A 201 A 154 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 261 ARG A 37 ARG~? 13.73 CH3 ACT A 201 coo 16.10 74.10 3.11 17.18 73.52 5.20 -23.46 73.59 59.60 -22.83 73.90 57.26 coo 16.07 84.71 8.14 15.20 82.81 8.14 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 10.59 77.85 4.81 13.09 76.36 5.76 -28.83 80.54 58.97 -30.62 82.33 60.70 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER B 39 SER~? 14.17 CH3 ACT B 201 A 154 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 261 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 16.10 74.10 3.11 17.18 73.52 5.20 -38.00 54.38 92.68 -39.49 53.00 94.02 coo 16.07 84.71 8.14 15.20 82.81 8.14 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 10.59 77.85 4.81 13.09 76.36 5.76 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER C 39 SER~? 14.22 CH3 ACT C 201 A 154 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 261 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo 16.10 74.10 3.11 17.18 73.52 5.20 -26.65 46.46 48.19 -24.39 46.43 49.12 coo 16.07 84.71 8.14 15.20 82.81 8.14 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 10.59 77.85 4.81 13.09 76.36 5.76 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER D 39 SER~? 14.16 CH3 ACT D 201 A 154 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 261 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 16.10 74.10 3.11 17.18 73.52 5.20 -63.83 60.97 39.81 -65.97 62.00 40.33 coo 16.07 84.71 8.14 15.20 82.81 8.14 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 10.59 77.85 4.81 13.09 76.36 5.76 -62.21 67.18 33.74 -60.13 67.79 31.56 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 4 hits 1o98_c00 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 34 ASP~? 14.63 O ACT A 201 A 146 TYR A 75 TYR^? -4.52 O ACT A 201s A 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 1.87 119.38 16.45 1.41 122.11 16.84 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 146 TYR A 42 TYR^? 9.79 CH3 ACT A 201 A 177 LYS A 62 LYS~? 17.60 O ACT A 201 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 1.87 119.38 16.45 1.41 122.11 16.84 -22.07 72.08 64.22 -24.60 72.36 65.39 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 146 TYR A 75 TYR^? -4.52 O ACT A 201s A 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 1.87 119.38 16.45 1.41 122.11 16.84 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 146 TYR A 75 TYR^? -4.52 O ACT A 201s A 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 1.87 119.38 16.45 1.41 122.11 16.84 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 A 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 146 TYR A 75 TYR^? -4.52 O ACT A 201s A 177 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 1.87 119.38 16.45 1.41 122.11 16.84 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 A 24 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 1.87 119.38 16.45 1.41 122.11 16.84 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 A 24 ASP B 45 ASP^? 20.35 O ACT B 201 A 146 TYR B 42 TYR^? 9.74 CH3 ACT B 201 A 177 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 1.87 119.38 16.45 1.41 122.11 16.84 -37.05 59.03 91.10 -34.97 58.34 89.38 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 A 24 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 1.87 119.38 16.45 1.41 122.11 16.84 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 A 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 1.87 119.38 16.45 1.41 122.11 16.84 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 A 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 177 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 1.87 119.38 16.45 1.41 122.11 16.84 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 A 24 ASP C 34 ASP~? 14.66 O ACT C 201 A 146 TYR C 75 TYR^? -4.54 O ACT C 201s A 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 1.87 119.38 16.45 1.41 122.11 16.84 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 A 24 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 146 TYR C 42 TYR^? 9.67 CH3 ACT C 201 A 177 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 1.87 119.38 16.45 1.41 122.11 16.84 -29.49 47.84 44.30 -31.93 47.16 45.50 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 A 24 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 146 TYR C 75 TYR^? -4.54 O ACT C 201s A 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 1.87 119.38 16.45 1.41 122.11 16.84 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 A 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 146 TYR C 75 TYR^? -4.54 O ACT C 201s A 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 1.87 119.38 16.45 1.41 122.11 16.84 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 A 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 146 TYR C 75 TYR^? -4.54 O ACT C 201s A 177 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 1.87 119.38 16.45 1.41 122.11 16.84 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 A 24 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 1.87 119.38 16.45 1.41 122.11 16.84 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 17 3 # 17 A 24 ASP D 45 ASP^? 20.33 O ACT D 201 A 146 TYR D 42 TYR^? 9.84 CH3 ACT D 201 A 177 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 1.87 119.38 16.45 1.41 122.11 16.84 -61.35 56.68 39.82 -58.87 57.88 39.36 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 18 3 # 18 A 24 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 1.87 119.38 16.45 1.41 122.11 16.84 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 19 3 # 19 A 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 1.87 119.38 16.45 1.41 122.11 16.84 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 20 3 # 20 A 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 177 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 1.87 119.38 16.45 1.41 122.11 16.84 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -54.54 71.95 50.35 -50.70 67.51 52.69 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 20 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 34 ASP~? 14.63 O ACT A 201 B 146 TYR A 75 TYR^? -4.52 O ACT A 201s B 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 146 TYR A 42 TYR^? 9.79 CH3 ACT A 201 B 177 LYS A 62 LYS~? 17.60 O ACT A 201 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -22.07 72.08 64.22 -24.60 72.36 65.39 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 146 TYR A 75 TYR^? -4.52 O ACT A 201s B 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 146 TYR A 75 TYR^? -4.52 O ACT A 201s B 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 B 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 146 TYR A 75 TYR^? -4.52 O ACT A 201s B 177 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 B 24 ASP B 34 ASP~? 14.61 OXT ACT B 201 B 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s B 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 B 24 ASP B 45 ASP^? 20.35 O ACT B 201 B 146 TYR B 42 TYR^? 9.74 CH3 ACT B 201 B 177 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -37.05 59.03 91.10 -34.97 58.34 89.38 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 B 24 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s B 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 B 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s B 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 B 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s B 177 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 B 24 ASP C 34 ASP~? 14.66 O ACT C 201 B 146 TYR C 75 TYR^? -4.54 O ACT C 201s B 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 B 24 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 146 TYR C 42 TYR^? 9.67 CH3 ACT C 201 B 177 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -29.49 47.84 44.30 -31.93 47.16 45.50 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 B 24 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 146 TYR C 75 TYR^? -4.54 O ACT C 201s B 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 B 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 146 TYR C 75 TYR^? -4.54 O ACT C 201s B 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 B 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 146 TYR C 75 TYR^? -4.54 O ACT C 201s B 177 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 B 24 ASP D 34 ASP~? 14.62 OXT ACT D 201 B 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s B 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 17 3 # 17 B 24 ASP D 45 ASP^? 20.33 O ACT D 201 B 146 TYR D 42 TYR^? 9.84 CH3 ACT D 201 B 177 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -61.35 56.68 39.82 -58.87 57.88 39.36 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 18 3 # 18 B 24 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s B 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 19 3 # 19 B 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s B 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 20 3 # 20 B 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s B 177 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -54.54 71.95 50.35 -50.70 67.51 52.69 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 20 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 34 ASP~? 14.63 O ACT A 201 C 146 TYR A 75 TYR^? -4.52 O ACT A 201s C 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -30.67 77.29 56.10 -29.14 77.80 54.72 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP A 45 ASP^? 16.09 OXT ACT A 202 C 146 TYR A 42 TYR^? 9.79 CH3 ACT A 201 C 177 LYS A 62 LYS~? 17.60 O ACT A 201 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -22.07 72.08 64.22 -24.60 72.36 65.39 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 146 TYR A 75 TYR^? -4.52 O ACT A 201s C 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 146 TYR A 75 TYR^? -4.52 O ACT A 201s C 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 C 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 146 TYR A 75 TYR^? -4.52 O ACT A 201s C 177 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 C 24 ASP B 34 ASP~? 14.61 OXT ACT B 201 C 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s C 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -34.29 46.44 92.12 -35.67 46.00 93.67 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 C 24 ASP B 45 ASP^? 20.35 O ACT B 201 C 146 TYR B 42 TYR^? 9.74 CH3 ACT B 201 C 177 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -37.05 59.03 91.10 -34.97 58.34 89.38 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 C 24 ASP B 99 ASP.? 16.09 OXT ACT B 201 C 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s C 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 C 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s C 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 C 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s C 177 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 C 24 ASP C 34 ASP~? 14.66 O ACT C 201 C 146 TYR C 75 TYR^? -4.54 O ACT C 201s C 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -27.83 42.08 55.68 -25.73 41.87 55.54 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 C 24 ASP C 45 ASP^? 20.17 OXT ACT C 201 C 146 TYR C 42 TYR^? 9.67 CH3 ACT C 201 C 177 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -29.49 47.84 44.30 -31.93 47.16 45.50 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 C 24 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 146 TYR C 75 TYR^? -4.54 O ACT C 201s C 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 C 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 146 TYR C 75 TYR^? -4.54 O ACT C 201s C 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 C 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 146 TYR C 75 TYR^? -4.54 O ACT C 201s C 177 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 C 24 ASP D 34 ASP~? 14.62 OXT ACT D 201 C 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s C 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -62.38 69.46 37.89 -64.50 69.55 37.91 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 17 3 # 17 C 24 ASP D 45 ASP^? 20.33 O ACT D 201 C 146 TYR D 42 TYR^? 9.84 CH3 ACT D 201 C 177 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -61.35 56.68 39.82 -58.87 57.88 39.36 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 18 3 # 18 C 24 ASP D 99 ASP.? 7.94 CH3 ACT A 203 C 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s C 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 19 3 # 19 C 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s C 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 20 3 # 20 C 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s C 177 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -54.54 71.95 50.35 -50.70 67.51 52.69 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 20 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 34 ASP~? 14.63 O ACT A 201 D 146 TYR A 75 TYR^? -4.52 O ACT A 201s D 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -30.67 77.29 56.10 -29.14 77.80 54.72 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP A 45 ASP^? 16.09 OXT ACT A 202 D 146 TYR A 42 TYR^? 9.79 CH3 ACT A 201 D 177 LYS A 62 LYS~? 17.60 O ACT A 201 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -22.07 72.08 64.22 -24.60 72.36 65.39 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 146 TYR A 75 TYR^? -4.52 O ACT A 201s D 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 146 TYR A 75 TYR^? -4.52 O ACT A 201s D 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 D 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 146 TYR A 75 TYR^? -4.52 O ACT A 201s D 177 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 D 24 ASP B 34 ASP~? 14.61 OXT ACT B 201 D 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s D 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -34.29 46.44 92.12 -35.67 46.00 93.67 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 D 24 ASP B 45 ASP^? 20.35 O ACT B 201 D 146 TYR B 42 TYR^? 9.74 CH3 ACT B 201 D 177 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -37.05 59.03 91.10 -34.97 58.34 89.38 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 D 24 ASP B 99 ASP.? 16.09 OXT ACT B 201 D 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s D 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 D 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s D 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 D 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s D 177 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 D 24 ASP C 34 ASP~? 14.66 O ACT C 201 D 146 TYR C 75 TYR^? -4.54 O ACT C 201s D 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -27.83 42.08 55.68 -25.73 41.87 55.54 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 D 24 ASP C 45 ASP^? 20.17 OXT ACT C 201 D 146 TYR C 42 TYR^? 9.67 CH3 ACT C 201 D 177 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -29.49 47.84 44.30 -31.93 47.16 45.50 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 D 24 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 146 TYR C 75 TYR^? -4.54 O ACT C 201s D 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 D 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 146 TYR C 75 TYR^? -4.54 O ACT C 201s D 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 D 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 146 TYR C 75 TYR^? -4.54 O ACT C 201s D 177 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 D 24 ASP D 34 ASP~? 14.62 OXT ACT D 201 D 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s D 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -62.38 69.46 37.89 -64.50 69.55 37.91 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 17 3 # 17 D 24 ASP D 45 ASP^? 20.33 O ACT D 201 D 146 TYR D 42 TYR^? 9.84 CH3 ACT D 201 D 177 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -61.35 56.68 39.82 -58.87 57.88 39.36 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 18 3 # 18 D 24 ASP D 99 ASP.? 7.94 CH3 ACT A 203 D 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s D 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 19 3 # 19 D 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s D 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 20 3 # 20 D 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s D 177 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -54.54 71.95 50.35 -50.70 67.51 52.69 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 20 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 34 ASP~? 14.63 O ACT A 201 E 146 TYR A 75 TYR^? -4.52 O ACT A 201s E 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -30.67 77.29 56.10 -29.14 77.80 54.72 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP A 45 ASP^? 16.09 OXT ACT A 202 E 146 TYR A 42 TYR^? 9.79 CH3 ACT A 201 E 177 LYS A 62 LYS~? 17.60 O ACT A 201 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -22.07 72.08 64.22 -24.60 72.36 65.39 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP A 99 ASP.? 5.71 O2 EDO A 301 E 146 TYR A 75 TYR^? -4.52 O ACT A 201s E 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 E 146 TYR A 75 TYR^? -4.52 O ACT A 201s E 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 E 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 E 146 TYR A 75 TYR^? -4.52 O ACT A 201s E 177 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 E 24 ASP B 34 ASP~? 14.61 OXT ACT B 201 E 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s E 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -34.29 46.44 92.12 -35.67 46.00 93.67 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 E 24 ASP B 45 ASP^? 20.35 O ACT B 201 E 146 TYR B 42 TYR^? 9.74 CH3 ACT B 201 E 177 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -37.05 59.03 91.10 -34.97 58.34 89.38 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 E 24 ASP B 99 ASP.? 16.09 OXT ACT B 201 E 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s E 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 E 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 E 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s E 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 E 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 E 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s E 177 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 E 24 ASP C 34 ASP~? 14.66 O ACT C 201 E 146 TYR C 75 TYR^? -4.54 O ACT C 201s E 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -27.83 42.08 55.68 -25.73 41.87 55.54 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 E 24 ASP C 45 ASP^? 20.17 OXT ACT C 201 E 146 TYR C 42 TYR^? 9.67 CH3 ACT C 201 E 177 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -29.49 47.84 44.30 -31.93 47.16 45.50 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 E 24 ASP C 99 ASP.? 5.79 O1 EDO A 301 E 146 TYR C 75 TYR^? -4.54 O ACT C 201s E 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 E 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 E 146 TYR C 75 TYR^? -4.54 O ACT C 201s E 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 E 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 E 146 TYR C 75 TYR^? -4.54 O ACT C 201s E 177 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 E 24 ASP D 34 ASP~? 14.62 OXT ACT D 201 E 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s E 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -62.38 69.46 37.89 -64.50 69.55 37.91 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 17 3 # 17 E 24 ASP D 45 ASP^? 20.33 O ACT D 201 E 146 TYR D 42 TYR^? 9.84 CH3 ACT D 201 E 177 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -61.35 56.68 39.82 -58.87 57.88 39.36 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 18 3 # 18 E 24 ASP D 99 ASP.? 7.94 CH3 ACT A 203 E 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s E 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 19 3 # 19 E 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 E 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s E 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 20 3 # 20 E 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 E 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s E 177 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -54.54 71.95 50.35 -50.70 67.51 52.69 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 20 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 34 ASP~? 14.63 O ACT A 201 F 146 TYR A 75 TYR^? -4.52 O ACT A 201s F 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -30.67 77.29 56.10 -29.14 77.80 54.72 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP A 45 ASP^? 16.09 OXT ACT A 202 F 146 TYR A 42 TYR^? 9.79 CH3 ACT A 201 F 177 LYS A 62 LYS~? 17.60 O ACT A 201 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -22.07 72.08 64.22 -24.60 72.36 65.39 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP A 99 ASP.? 5.71 O2 EDO A 301 F 146 TYR A 75 TYR^? -4.52 O ACT A 201s F 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 F 146 TYR A 75 TYR^? -4.52 O ACT A 201s F 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 F 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 F 146 TYR A 75 TYR^? -4.52 O ACT A 201s F 177 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 F 24 ASP B 34 ASP~? 14.61 OXT ACT B 201 F 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s F 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -34.29 46.44 92.12 -35.67 46.00 93.67 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 F 24 ASP B 45 ASP^? 20.35 O ACT B 201 F 146 TYR B 42 TYR^? 9.74 CH3 ACT B 201 F 177 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -37.05 59.03 91.10 -34.97 58.34 89.38 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 F 24 ASP B 99 ASP.? 16.09 OXT ACT B 201 F 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s F 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 F 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 F 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s F 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 F 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 F 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s F 177 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 F 24 ASP C 34 ASP~? 14.66 O ACT C 201 F 146 TYR C 75 TYR^? -4.54 O ACT C 201s F 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -27.83 42.08 55.68 -25.73 41.87 55.54 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 F 24 ASP C 45 ASP^? 20.17 OXT ACT C 201 F 146 TYR C 42 TYR^? 9.67 CH3 ACT C 201 F 177 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -29.49 47.84 44.30 -31.93 47.16 45.50 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 F 24 ASP C 99 ASP.? 5.79 O1 EDO A 301 F 146 TYR C 75 TYR^? -4.54 O ACT C 201s F 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 F 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 F 146 TYR C 75 TYR^? -4.54 O ACT C 201s F 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 F 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 F 146 TYR C 75 TYR^? -4.54 O ACT C 201s F 177 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 F 24 ASP D 34 ASP~? 14.62 OXT ACT D 201 F 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s F 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -62.38 69.46 37.89 -64.50 69.55 37.91 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 17 3 # 17 F 24 ASP D 45 ASP^? 20.33 O ACT D 201 F 146 TYR D 42 TYR^? 9.84 CH3 ACT D 201 F 177 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -61.35 56.68 39.82 -58.87 57.88 39.36 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 18 3 # 18 F 24 ASP D 99 ASP.? 7.94 CH3 ACT A 203 F 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s F 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 19 3 # 19 F 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 F 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s F 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 20 3 # 20 F 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 F 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s F 177 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -54.54 71.95 50.35 -50.70 67.51 52.69 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 20 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 34 ASP~? 14.63 O ACT A 201 G 146 TYR A 75 TYR^? -4.52 O ACT A 201s G 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -30.67 77.29 56.10 -29.14 77.80 54.72 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP A 45 ASP^? 16.09 OXT ACT A 202 G 146 TYR A 42 TYR^? 9.79 CH3 ACT A 201 G 177 LYS A 62 LYS~? 17.60 O ACT A 201 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -22.07 72.08 64.22 -24.60 72.36 65.39 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP A 99 ASP.? 5.71 O2 EDO A 301 G 146 TYR A 75 TYR^? -4.52 O ACT A 201s G 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 G 146 TYR A 75 TYR^? -4.52 O ACT A 201s G 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 G 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 G 146 TYR A 75 TYR^? -4.52 O ACT A 201s G 177 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 G 24 ASP B 34 ASP~? 14.61 OXT ACT B 201 G 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s G 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -34.29 46.44 92.12 -35.67 46.00 93.67 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 G 24 ASP B 45 ASP^? 20.35 O ACT B 201 G 146 TYR B 42 TYR^? 9.74 CH3 ACT B 201 G 177 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -37.05 59.03 91.10 -34.97 58.34 89.38 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 G 24 ASP B 99 ASP.? 16.09 OXT ACT B 201 G 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s G 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 G 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 G 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s G 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 G 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 G 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s G 177 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 G 24 ASP C 34 ASP~? 14.66 O ACT C 201 G 146 TYR C 75 TYR^? -4.54 O ACT C 201s G 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -27.83 42.08 55.68 -25.73 41.87 55.54 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 G 24 ASP C 45 ASP^? 20.17 OXT ACT C 201 G 146 TYR C 42 TYR^? 9.67 CH3 ACT C 201 G 177 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -29.49 47.84 44.30 -31.93 47.16 45.50 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 G 24 ASP C 99 ASP.? 5.79 O1 EDO A 301 G 146 TYR C 75 TYR^? -4.54 O ACT C 201s G 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 G 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 G 146 TYR C 75 TYR^? -4.54 O ACT C 201s G 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 G 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 G 146 TYR C 75 TYR^? -4.54 O ACT C 201s G 177 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 G 24 ASP D 34 ASP~? 14.62 OXT ACT D 201 G 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s G 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -62.38 69.46 37.89 -64.50 69.55 37.91 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 17 3 # 17 G 24 ASP D 45 ASP^? 20.33 O ACT D 201 G 146 TYR D 42 TYR^? 9.84 CH3 ACT D 201 G 177 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -61.35 56.68 39.82 -58.87 57.88 39.36 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 18 3 # 18 G 24 ASP D 99 ASP.? 7.94 CH3 ACT A 203 G 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s G 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 19 3 # 19 G 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 G 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s G 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 20 3 # 20 G 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 G 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s G 177 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -54.54 71.95 50.35 -50.70 67.51 52.69 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 20 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 34 ASP~? 14.63 O ACT A 201 H 146 TYR A 75 TYR^? -4.52 O ACT A 201s H 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -30.67 77.29 56.10 -29.14 77.80 54.72 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP A 45 ASP^? 16.09 OXT ACT A 202 H 146 TYR A 42 TYR^? 9.79 CH3 ACT A 201 H 177 LYS A 62 LYS~? 17.60 O ACT A 201 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -22.07 72.08 64.22 -24.60 72.36 65.39 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP A 99 ASP.? 5.71 O2 EDO A 301 H 146 TYR A 75 TYR^? -4.52 O ACT A 201s H 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 H 146 TYR A 75 TYR^? -4.52 O ACT A 201s H 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 H 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 H 146 TYR A 75 TYR^? -4.52 O ACT A 201s H 177 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 H 24 ASP B 34 ASP~? 14.61 OXT ACT B 201 H 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s H 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -34.29 46.44 92.12 -35.67 46.00 93.67 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 H 24 ASP B 45 ASP^? 20.35 O ACT B 201 H 146 TYR B 42 TYR^? 9.74 CH3 ACT B 201 H 177 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -37.05 59.03 91.10 -34.97 58.34 89.38 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 H 24 ASP B 99 ASP.? 16.09 OXT ACT B 201 H 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s H 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 H 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 H 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s H 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 H 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 H 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s H 177 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 H 24 ASP C 34 ASP~? 14.66 O ACT C 201 H 146 TYR C 75 TYR^? -4.54 O ACT C 201s H 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -27.83 42.08 55.68 -25.73 41.87 55.54 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 H 24 ASP C 45 ASP^? 20.17 OXT ACT C 201 H 146 TYR C 42 TYR^? 9.67 CH3 ACT C 201 H 177 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -29.49 47.84 44.30 -31.93 47.16 45.50 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 H 24 ASP C 99 ASP.? 5.79 O1 EDO A 301 H 146 TYR C 75 TYR^? -4.54 O ACT C 201s H 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 H 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 H 146 TYR C 75 TYR^? -4.54 O ACT C 201s H 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 H 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 H 146 TYR C 75 TYR^? -4.54 O ACT C 201s H 177 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 H 24 ASP D 34 ASP~? 14.62 OXT ACT D 201 H 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s H 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -62.38 69.46 37.89 -64.50 69.55 37.91 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 17 3 # 17 H 24 ASP D 45 ASP^? 20.33 O ACT D 201 H 146 TYR D 42 TYR^? 9.84 CH3 ACT D 201 H 177 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -61.35 56.68 39.82 -58.87 57.88 39.36 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 18 3 # 18 H 24 ASP D 99 ASP.? 7.94 CH3 ACT A 203 H 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s H 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 19 3 # 19 H 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 H 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s H 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 20 3 # 20 H 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 H 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s H 177 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -54.54 71.95 50.35 -50.70 67.51 52.69 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 20 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 34 ASP~? 14.63 O ACT A 201 I 146 TYR A 75 TYR^? -4.52 O ACT A 201s I 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -30.67 77.29 56.10 -29.14 77.80 54.72 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP A 45 ASP^? 16.09 OXT ACT A 202 I 146 TYR A 42 TYR^? 9.79 CH3 ACT A 201 I 177 LYS A 62 LYS~? 17.60 O ACT A 201 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -22.07 72.08 64.22 -24.60 72.36 65.39 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP A 99 ASP.? 5.71 O2 EDO A 301 I 146 TYR A 75 TYR^? -4.52 O ACT A 201s I 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 I 146 TYR A 75 TYR^? -4.52 O ACT A 201s I 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 I 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 I 146 TYR A 75 TYR^? -4.52 O ACT A 201s I 177 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 I 24 ASP B 34 ASP~? 14.61 OXT ACT B 201 I 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s I 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -34.29 46.44 92.12 -35.67 46.00 93.67 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 I 24 ASP B 45 ASP^? 20.35 O ACT B 201 I 146 TYR B 42 TYR^? 9.74 CH3 ACT B 201 I 177 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -37.05 59.03 91.10 -34.97 58.34 89.38 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 I 24 ASP B 99 ASP.? 16.09 OXT ACT B 201 I 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s I 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 I 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 I 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s I 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 I 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 I 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s I 177 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 I 24 ASP C 34 ASP~? 14.66 O ACT C 201 I 146 TYR C 75 TYR^? -4.54 O ACT C 201s I 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -27.83 42.08 55.68 -25.73 41.87 55.54 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 I 24 ASP C 45 ASP^? 20.17 OXT ACT C 201 I 146 TYR C 42 TYR^? 9.67 CH3 ACT C 201 I 177 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -29.49 47.84 44.30 -31.93 47.16 45.50 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 I 24 ASP C 99 ASP.? 5.79 O1 EDO A 301 I 146 TYR C 75 TYR^? -4.54 O ACT C 201s I 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 I 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 I 146 TYR C 75 TYR^? -4.54 O ACT C 201s I 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 I 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 I 146 TYR C 75 TYR^? -4.54 O ACT C 201s I 177 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 I 24 ASP D 34 ASP~? 14.62 OXT ACT D 201 I 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s I 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -62.38 69.46 37.89 -64.50 69.55 37.91 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 17 3 # 17 I 24 ASP D 45 ASP^? 20.33 O ACT D 201 I 146 TYR D 42 TYR^? 9.84 CH3 ACT D 201 I 177 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -61.35 56.68 39.82 -58.87 57.88 39.36 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 18 3 # 18 I 24 ASP D 99 ASP.? 7.94 CH3 ACT A 203 I 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s I 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 19 3 # 19 I 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 I 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s I 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 20 3 # 20 I 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 I 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s I 177 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -54.54 71.95 50.35 -50.70 67.51 52.69 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 20 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 34 ASP~? 14.63 O ACT A 201 J 146 TYR A 75 TYR^? -4.52 O ACT A 201s J 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -30.67 77.29 56.10 -29.14 77.80 54.72 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP A 45 ASP^? 16.09 OXT ACT A 202 J 146 TYR A 42 TYR^? 9.79 CH3 ACT A 201 J 177 LYS A 62 LYS~? 17.60 O ACT A 201 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -22.07 72.08 64.22 -24.60 72.36 65.39 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP A 99 ASP.? 5.71 O2 EDO A 301 J 146 TYR A 75 TYR^? -4.52 O ACT A 201s J 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 J 146 TYR A 75 TYR^? -4.52 O ACT A 201s J 177 LYS A 68 LYS~? -2.78 O ACT A 201s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 J 24 ASP A 130 ASP.? 4.80 O1 EDO A 301 J 146 TYR A 75 TYR^? -4.52 O ACT A 201s J 177 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 J 24 ASP B 34 ASP~? 14.61 OXT ACT B 201 J 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s J 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -34.29 46.44 92.12 -35.67 46.00 93.67 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 J 24 ASP B 45 ASP^? 20.35 O ACT B 201 J 146 TYR B 42 TYR^? 9.74 CH3 ACT B 201 J 177 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -37.05 59.03 91.10 -34.97 58.34 89.38 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 J 24 ASP B 99 ASP.? 16.09 OXT ACT B 201 J 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s J 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 J 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 J 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s J 177 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 J 24 ASP B 130 ASP.? 9.25 OXT ACT B 201 J 146 TYR B 75 TYR^? -4.59 OXT ACT B 201s J 177 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 J 24 ASP C 34 ASP~? 14.66 O ACT C 201 J 146 TYR C 75 TYR^? -4.54 O ACT C 201s J 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -27.83 42.08 55.68 -25.73 41.87 55.54 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 J 24 ASP C 45 ASP^? 20.17 OXT ACT C 201 J 146 TYR C 42 TYR^? 9.67 CH3 ACT C 201 J 177 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -29.49 47.84 44.30 -31.93 47.16 45.50 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 J 24 ASP C 99 ASP.? 5.79 O1 EDO A 301 J 146 TYR C 75 TYR^? -4.54 O ACT C 201s J 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 J 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 J 146 TYR C 75 TYR^? -4.54 O ACT C 201s J 177 LYS C 68 LYS~? -2.77 O ACT C 201s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 J 24 ASP C 130 ASP.? 4.74 O2 EDO A 301 J 146 TYR C 75 TYR^? -4.54 O ACT C 201s J 177 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 J 24 ASP D 34 ASP~? 14.62 OXT ACT D 201 J 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s J 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -62.38 69.46 37.89 -64.50 69.55 37.91 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 17 3 # 17 J 24 ASP D 45 ASP^? 20.33 O ACT D 201 J 146 TYR D 42 TYR^? 9.84 CH3 ACT D 201 J 177 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -61.35 56.68 39.82 -58.87 57.88 39.36 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 18 3 # 18 J 24 ASP D 99 ASP.? 7.94 CH3 ACT A 203 J 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s J 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 19 3 # 19 J 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 J 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s J 177 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 20 3 # 20 J 24 ASP D 130 ASP.? 7.40 CH3 ACT A 203 J 146 TYR D 75 TYR^? -4.49 OXT ACT D 201s J 177 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -54.54 71.95 50.35 -50.70 67.51 52.69 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 20 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 34 ASP~? 14.63 O ACT A 201 A 96 GLU A 72 GLU~? 5.31 O ACT A 201 A 132 LYS A 68 LYS~? -2.78 O ACT A 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 26.82 3.20 24.36 27.99 4.86 24.98 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 29.99 0.62 22.18 30.38 6.69 20.81 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 34 ASP~? 14.63 O ACT A 201 A 96 GLU A 72 GLU~? 5.31 O ACT A 201 A 132 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 26.82 3.20 24.36 27.99 4.86 24.98 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 29.99 0.62 22.18 30.38 6.69 20.81 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP A 34 ASP~? 14.63 O ACT A 201 A 96 GLU D 137 GLU~? 19.20 CH3 ACT A 203 A 132 LYS D 134 LYS~? 17.34 O ACT A 201 coo 31.23 12.29 16.44 30.82 11.56 18.39 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 26.82 3.20 24.36 27.99 4.86 24.98 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 29.99 0.62 22.18 30.38 6.69 20.81 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 96 GLU A 59 GLU~? 18.41 O2 EDO A 302 A 132 LYS A 62 LYS~? 17.60 O ACT A 201 coo 31.23 12.29 16.44 30.82 11.56 18.39 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 26.82 3.20 24.36 27.99 4.86 24.98 -19.57 66.85 53.38 -18.14 66.20 51.96 coo 29.99 0.62 22.18 30.38 6.69 20.81 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 96 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 132 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 31.23 12.29 16.44 30.82 11.56 18.39 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 26.82 3.20 24.36 27.99 4.86 24.98 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 29.99 0.62 22.18 30.38 6.69 20.81 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 96 GLU C 72 GLU~? 5.32 O ACT C 201 A 132 LYS C 68 LYS~? -2.77 O ACT C 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 26.82 3.20 24.36 27.99 4.86 24.98 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 29.99 0.62 22.18 30.38 6.69 20.81 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1onr_c00 TRANSALDOLASE B user 7 3 # 7 A 17 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 96 GLU C 72 GLU~? 5.32 O ACT C 201 A 132 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 26.82 3.20 24.36 27.99 4.86 24.98 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 29.99 0.62 22.18 30.38 6.69 20.81 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1onr_c00 TRANSALDOLASE B user 8 3 # 8 A 17 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 96 GLU A 137 GLU~? 14.03 O ACT A 203 A 132 LYS A 134 LYS~? 11.98 O ACT A 203 coo 31.23 12.29 16.44 30.82 11.56 18.39 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 26.82 3.20 24.36 27.99 4.86 24.98 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 29.99 0.62 22.18 30.38 6.69 20.81 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1onr_c00 TRANSALDOLASE B user 9 3 # 9 A 17 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 96 GLU C 72 GLU~? 5.32 O ACT C 201 A 132 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 26.82 3.20 24.36 27.99 4.86 24.98 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 29.99 0.62 22.18 30.38 6.69 20.81 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1onr_c00 TRANSALDOLASE B user 10 3 # 10 A 17 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 96 GLU A 21 GLU~? 19.20 CH3 ACT A 201 A 132 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 31.23 12.29 16.44 30.82 11.56 18.39 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 26.82 3.20 24.36 27.99 4.86 24.98 -26.74 85.39 73.13 -25.47 87.07 73.30 coo 29.99 0.62 22.18 30.38 6.69 20.81 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1onr_c00 TRANSALDOLASE B user 11 3 # 11 A 17 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 96 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 132 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 26.82 3.20 24.36 27.99 4.86 24.98 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 29.99 0.62 22.18 30.38 6.69 20.81 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1onr_c00 TRANSALDOLASE B user 12 3 # 12 A 17 ASP A 149 ASP.? 18.85 CH3 ACT A 201 A 96 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 132 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 26.82 3.20 24.36 27.99 4.86 24.98 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 29.99 0.62 22.18 30.38 6.69 20.81 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1onr_c00 TRANSALDOLASE B user 13 3 # 13 A 17 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 96 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 132 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 26.82 3.20 24.36 27.99 4.86 24.98 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 29.99 0.62 22.18 30.38 6.69 20.81 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1onr_c00 TRANSALDOLASE B user 14 3 # 14 A 17 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 96 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 132 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 31.23 12.29 16.44 30.82 11.56 18.39 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 26.82 3.20 24.36 27.99 4.86 24.98 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 29.99 0.62 22.18 30.38 6.69 20.81 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1onr_c00 TRANSALDOLASE B user 15 3 # 15 A 17 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 96 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 132 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 26.82 3.20 24.36 27.99 4.86 24.98 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 29.99 0.62 22.18 30.38 6.69 20.81 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1onr_c00 TRANSALDOLASE B user 16 3 # 16 A 17 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 96 GLU C 72 GLU~? 5.32 O ACT C 201 A 132 LYS C 68 LYS~? -2.77 O ACT C 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 26.82 3.20 24.36 27.99 4.86 24.98 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 29.99 0.62 22.18 30.38 6.69 20.81 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1onr_c00 TRANSALDOLASE B user 17 3 # 17 A 17 ASP B 149 ASP.? 20.03 CH3 ACT B 201 A 96 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 132 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 26.82 3.20 24.36 27.99 4.86 24.98 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 29.99 0.62 22.18 30.38 6.69 20.81 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1onr_c00 TRANSALDOLASE B user 18 3 # 18 A 17 ASP C 34 ASP~? 14.66 O ACT C 201 A 96 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 132 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 26.82 3.20 24.36 27.99 4.86 24.98 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 29.99 0.62 22.18 30.38 6.69 20.81 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1onr_c00 TRANSALDOLASE B user 19 3 # 19 A 17 ASP C 34 ASP~? 14.66 O ACT C 201 A 96 GLU C 72 GLU~? 5.32 O ACT C 201 A 132 LYS C 68 LYS~? -2.77 O ACT C 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 26.82 3.20 24.36 27.99 4.86 24.98 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 29.99 0.62 22.18 30.38 6.69 20.81 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1onr_c00 TRANSALDOLASE B user 20 3 # 20 A 17 ASP C 34 ASP~? 14.66 O ACT C 201 A 96 GLU C 72 GLU~? 5.32 O ACT C 201 A 132 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 26.82 3.20 24.36 27.99 4.86 24.98 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 29.99 0.62 22.18 30.38 6.69 20.81 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1onr_c00 TRANSALDOLASE B user 21 3 # 21 A 17 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 96 GLU C 59 GLU~? 13.48 O2 EDO A 302 A 132 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 26.82 3.20 24.36 27.99 4.86 24.98 -20.25 53.72 49.66 -20.40 52.10 51.04 coo 29.99 0.62 22.18 30.38 6.69 20.81 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1onr_c00 TRANSALDOLASE B user 22 3 # 22 A 17 ASP C 74 ASP^? 14.86 O ACT C 201 A 96 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 132 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 31.23 12.29 16.44 30.82 11.56 18.39 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 26.82 3.20 24.36 27.99 4.86 24.98 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 29.99 0.62 22.18 30.38 6.69 20.81 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1onr_c00 TRANSALDOLASE B user 23 3 # 23 A 17 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 96 GLU A 72 GLU~? 5.31 O ACT A 201 A 132 LYS A 68 LYS~? -2.78 O ACT A 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 26.82 3.20 24.36 27.99 4.86 24.98 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 29.99 0.62 22.18 30.38 6.69 20.81 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1onr_c00 TRANSALDOLASE B user 24 3 # 24 A 17 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 96 GLU A 72 GLU~? 5.31 O ACT A 201 A 132 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 26.82 3.20 24.36 27.99 4.86 24.98 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 29.99 0.62 22.18 30.38 6.69 20.81 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1onr_c00 TRANSALDOLASE B user 25 3 # 25 A 17 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 96 GLU A 72 GLU~? 5.31 O ACT A 201 A 132 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 26.82 3.20 24.36 27.99 4.86 24.98 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 29.99 0.62 22.18 30.38 6.69 20.81 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1onr_c00 TRANSALDOLASE B user 26 3 # 26 A 17 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 96 GLU C 137 GLU~? 15.84 O2 EDO A 301 A 132 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 26.82 3.20 24.36 27.99 4.86 24.98 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 29.99 0.62 22.18 30.38 6.69 20.81 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1onr_c00 TRANSALDOLASE B user 27 3 # 27 A 17 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 96 GLU C 21 GLU~? 19.29 CH3 ACT C 201 A 132 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 31.23 12.29 16.44 30.82 11.56 18.39 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 26.82 3.20 24.36 27.99 4.86 24.98 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 29.99 0.62 22.18 30.38 6.69 20.81 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1onr_c00 TRANSALDOLASE B user 28 3 # 28 A 17 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 96 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 132 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 26.82 3.20 24.36 27.99 4.86 24.98 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 29.99 0.62 22.18 30.38 6.69 20.81 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1onr_c00 TRANSALDOLASE B user 29 3 # 29 A 17 ASP C 149 ASP.? 18.79 CH3 ACT C 201 A 96 GLU C 80 GLU^? 14.47 CH3 ACT C 201 A 132 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 26.82 3.20 24.36 27.99 4.86 24.98 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 29.99 0.62 22.18 30.38 6.69 20.81 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1onr_c00 TRANSALDOLASE B user 30 3 # 30 A 17 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 96 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 132 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 26.82 3.20 24.36 27.99 4.86 24.98 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 29.99 0.62 22.18 30.38 6.69 20.81 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1onr_c00 TRANSALDOLASE B user 31 3 # 31 A 17 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 96 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 132 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 31.23 12.29 16.44 30.82 11.56 18.39 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 26.82 3.20 24.36 27.99 4.86 24.98 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 29.99 0.62 22.18 30.38 6.69 20.81 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1onr_c00 TRANSALDOLASE B user 32 3 # 32 A 17 ASP D 45 ASP^? 20.33 O ACT D 201 A 96 GLU D 59 GLU~? 18.52 O ACT D 201 A 132 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo 31.23 12.29 16.44 30.82 11.56 18.39 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 26.82 3.20 24.36 27.99 4.86 24.98 -69.73 60.64 47.66 -70.08 62.16 46.23 coo 29.99 0.62 22.18 30.38 6.69 20.81 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1onr_c00 TRANSALDOLASE B user 33 3 # 33 A 17 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 96 GLU A 72 GLU~? 5.31 O ACT A 201 A 132 LYS A 68 LYS~? -2.78 O ACT A 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 26.82 3.20 24.36 27.99 4.86 24.98 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 29.99 0.62 22.18 30.38 6.69 20.81 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1onr_c00 TRANSALDOLASE B user 34 3 # 34 A 17 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 96 GLU D 137 GLU~? 19.20 CH3 ACT A 203 A 132 LYS D 134 LYS~? 17.34 O ACT A 201 coo 31.23 12.29 16.44 30.82 11.56 18.39 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 26.82 3.20 24.36 27.99 4.86 24.98 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 29.99 0.62 22.18 30.38 6.69 20.81 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1onr_c00 TRANSALDOLASE B user 35 3 # 35 A 17 ASP D 149 ASP.? 20.02 CH3 ACT D 201 A 96 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 132 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 31.23 12.29 16.44 30.82 11.56 18.39 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 26.82 3.20 24.36 27.99 4.86 24.98 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 29.99 0.62 22.18 30.38 6.69 20.81 -47.37 61.41 34.65 -51.85 60.71 37.83 1onr_c00 source 1onr TRANSALDOLASE B : 35 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 34 ASP~? 14.63 O ACT A 201 B 96 GLU A 72 GLU~? 5.31 O ACT A 201 B 132 LYS A 68 LYS~? -2.78 O ACT A 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 26.69 48.45 7.18 27.85 50.13 7.74 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 29.82 45.80 5.07 30.26 51.81 3.56 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 34 ASP~? 14.63 O ACT A 201 B 96 GLU A 72 GLU~? 5.31 O ACT A 201 B 132 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 26.69 48.45 7.18 27.85 50.13 7.74 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 29.82 45.80 5.07 30.26 51.81 3.56 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP A 34 ASP~? 14.63 O ACT A 201 B 96 GLU D 137 GLU~? 19.20 CH3 ACT A 203 B 132 LYS D 134 LYS~? 17.34 O ACT A 201 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 26.69 48.45 7.18 27.85 50.13 7.74 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 29.82 45.80 5.07 30.26 51.81 3.56 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 96 GLU A 59 GLU~? 18.41 O2 EDO A 302 B 132 LYS A 62 LYS~? 17.60 O ACT A 201 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 26.69 48.45 7.18 27.85 50.13 7.74 -19.57 66.85 53.38 -18.14 66.20 51.96 coo 29.82 45.80 5.07 30.26 51.81 3.56 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 96 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 132 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 26.69 48.45 7.18 27.85 50.13 7.74 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 29.82 45.80 5.07 30.26 51.81 3.56 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 96 GLU C 72 GLU~? 5.32 O ACT C 201 B 132 LYS C 68 LYS~? -2.77 O ACT C 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 26.69 48.45 7.18 27.85 50.13 7.74 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 29.82 45.80 5.07 30.26 51.81 3.56 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1onr_c01 TRANSALDOLASE B user 7 3 # 7 B 17 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 96 GLU C 72 GLU~? 5.32 O ACT C 201 B 132 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 26.69 48.45 7.18 27.85 50.13 7.74 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 29.82 45.80 5.07 30.26 51.81 3.56 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1onr_c01 TRANSALDOLASE B user 8 3 # 8 B 17 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 96 GLU A 137 GLU~? 14.03 O ACT A 203 B 132 LYS A 134 LYS~? 11.98 O ACT A 203 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 26.69 48.45 7.18 27.85 50.13 7.74 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 29.82 45.80 5.07 30.26 51.81 3.56 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1onr_c01 TRANSALDOLASE B user 9 3 # 9 B 17 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 96 GLU C 72 GLU~? 5.32 O ACT C 201 B 132 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 26.69 48.45 7.18 27.85 50.13 7.74 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 29.82 45.80 5.07 30.26 51.81 3.56 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1onr_c01 TRANSALDOLASE B user 10 3 # 10 B 17 ASP A 149 ASP.? 18.85 CH3 ACT A 201 B 96 GLU A 21 GLU~? 19.20 CH3 ACT A 201 B 132 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 26.69 48.45 7.18 27.85 50.13 7.74 -26.74 85.39 73.13 -25.47 87.07 73.30 coo 29.82 45.80 5.07 30.26 51.81 3.56 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1onr_c01 TRANSALDOLASE B user 11 3 # 11 B 17 ASP A 149 ASP.? 18.85 CH3 ACT A 201 B 96 GLU A 27 GLU~? 9.74 CH3 ACT A 201 B 132 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 26.69 48.45 7.18 27.85 50.13 7.74 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 29.82 45.80 5.07 30.26 51.81 3.56 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1onr_c01 TRANSALDOLASE B user 12 3 # 12 B 17 ASP A 149 ASP.? 18.85 CH3 ACT A 201 B 96 GLU A 80 GLU^? 14.51 CH3 ACT A 201 B 132 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 26.69 48.45 7.18 27.85 50.13 7.74 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 29.82 45.80 5.07 30.26 51.81 3.56 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 1onr_c01 TRANSALDOLASE B user 13 3 # 13 B 17 ASP B 34 ASP~? 14.61 OXT ACT B 201 B 96 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 132 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 26.69 48.45 7.18 27.85 50.13 7.74 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 29.82 45.80 5.07 30.26 51.81 3.56 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1onr_c01 TRANSALDOLASE B user 14 3 # 14 B 17 ASP B 34 ASP~? 14.61 OXT ACT B 201 B 96 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 132 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 26.69 48.45 7.18 27.85 50.13 7.74 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 29.82 45.80 5.07 30.26 51.81 3.56 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1onr_c01 TRANSALDOLASE B user 15 3 # 15 B 17 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 96 GLU B 137 GLU~? 6.31 C2 EDO A 302 B 132 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 26.69 48.45 7.18 27.85 50.13 7.74 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 29.82 45.80 5.07 30.26 51.81 3.56 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1onr_c01 TRANSALDOLASE B user 16 3 # 16 B 17 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 96 GLU C 72 GLU~? 5.32 O ACT C 201 B 132 LYS C 68 LYS~? -2.77 O ACT C 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 26.69 48.45 7.18 27.85 50.13 7.74 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 29.82 45.80 5.07 30.26 51.81 3.56 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1onr_c01 TRANSALDOLASE B user 17 3 # 17 B 17 ASP B 149 ASP.? 20.03 CH3 ACT B 201 B 96 GLU B 27 GLU~? 9.83 CH3 ACT B 201 B 132 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 26.69 48.45 7.18 27.85 50.13 7.74 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 29.82 45.80 5.07 30.26 51.81 3.56 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 1onr_c01 TRANSALDOLASE B user 18 3 # 18 B 17 ASP C 34 ASP~? 14.66 O ACT C 201 B 96 GLU B 137 GLU~? 6.31 C2 EDO A 302 B 132 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 26.69 48.45 7.18 27.85 50.13 7.74 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 29.82 45.80 5.07 30.26 51.81 3.56 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1onr_c01 TRANSALDOLASE B user 19 3 # 19 B 17 ASP C 34 ASP~? 14.66 O ACT C 201 B 96 GLU C 72 GLU~? 5.32 O ACT C 201 B 132 LYS C 68 LYS~? -2.77 O ACT C 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 26.69 48.45 7.18 27.85 50.13 7.74 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 29.82 45.80 5.07 30.26 51.81 3.56 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1onr_c01 TRANSALDOLASE B user 20 3 # 20 B 17 ASP C 34 ASP~? 14.66 O ACT C 201 B 96 GLU C 72 GLU~? 5.32 O ACT C 201 B 132 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 26.69 48.45 7.18 27.85 50.13 7.74 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 29.82 45.80 5.07 30.26 51.81 3.56 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1onr_c01 TRANSALDOLASE B user 21 3 # 21 B 17 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 96 GLU C 59 GLU~? 13.48 O2 EDO A 302 B 132 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 26.69 48.45 7.18 27.85 50.13 7.74 -20.25 53.72 49.66 -20.40 52.10 51.04 coo 29.82 45.80 5.07 30.26 51.81 3.56 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 3 1onr_c01 TRANSALDOLASE B user 22 3 # 22 B 17 ASP C 74 ASP^? 14.86 O ACT C 201 B 96 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 132 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 26.69 48.45 7.18 27.85 50.13 7.74 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 29.82 45.80 5.07 30.26 51.81 3.56 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1onr_c01 TRANSALDOLASE B user 23 3 # 23 B 17 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 96 GLU A 72 GLU~? 5.31 O ACT A 201 B 132 LYS A 68 LYS~? -2.78 O ACT A 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 26.69 48.45 7.18 27.85 50.13 7.74 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 29.82 45.80 5.07 30.26 51.81 3.56 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1onr_c01 TRANSALDOLASE B user 24 3 # 24 B 17 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 96 GLU A 72 GLU~? 5.31 O ACT A 201 B 132 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 26.69 48.45 7.18 27.85 50.13 7.74 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 29.82 45.80 5.07 30.26 51.81 3.56 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1onr_c01 TRANSALDOLASE B user 25 3 # 25 B 17 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 96 GLU A 72 GLU~? 5.31 O ACT A 201 B 132 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 26.69 48.45 7.18 27.85 50.13 7.74 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 29.82 45.80 5.07 30.26 51.81 3.56 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1onr_c01 TRANSALDOLASE B user 26 3 # 26 B 17 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 96 GLU C 137 GLU~? 15.84 O2 EDO A 301 B 132 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 26.69 48.45 7.18 27.85 50.13 7.74 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 29.82 45.80 5.07 30.26 51.81 3.56 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1onr_c01 TRANSALDOLASE B user 27 3 # 27 B 17 ASP C 149 ASP.? 18.79 CH3 ACT C 201 B 96 GLU C 21 GLU~? 19.29 CH3 ACT C 201 B 132 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 26.69 48.45 7.18 27.85 50.13 7.74 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 29.82 45.80 5.07 30.26 51.81 3.56 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1onr_c01 TRANSALDOLASE B user 28 3 # 28 B 17 ASP C 149 ASP.? 18.79 CH3 ACT C 201 B 96 GLU C 27 GLU~? 9.88 CH3 ACT C 201 B 132 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 26.69 48.45 7.18 27.85 50.13 7.74 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 29.82 45.80 5.07 30.26 51.81 3.56 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1onr_c01 TRANSALDOLASE B user 29 3 # 29 B 17 ASP C 149 ASP.? 18.79 CH3 ACT C 201 B 96 GLU C 80 GLU^? 14.47 CH3 ACT C 201 B 132 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 26.69 48.45 7.18 27.85 50.13 7.74 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 29.82 45.80 5.07 30.26 51.81 3.56 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 1onr_c01 TRANSALDOLASE B user 30 3 # 30 B 17 ASP D 34 ASP~? 14.62 OXT ACT D 201 B 96 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 132 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 26.69 48.45 7.18 27.85 50.13 7.74 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 29.82 45.80 5.07 30.26 51.81 3.56 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1onr_c01 TRANSALDOLASE B user 31 3 # 31 B 17 ASP D 34 ASP~? 14.62 OXT ACT D 201 B 96 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 132 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 26.69 48.45 7.18 27.85 50.13 7.74 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 29.82 45.80 5.07 30.26 51.81 3.56 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1onr_c01 TRANSALDOLASE B user 32 3 # 32 B 17 ASP D 45 ASP^? 20.33 O ACT D 201 B 96 GLU D 59 GLU~? 18.52 O ACT D 201 B 132 LYS D 62 LYS~? 17.47 OXT ACT D 201 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 26.69 48.45 7.18 27.85 50.13 7.74 -69.73 60.64 47.66 -70.08 62.16 46.23 coo 29.82 45.80 5.07 30.26 51.81 3.56 -64.21 62.59 45.12 -69.12 65.87 42.83 ULMN 3 1onr_c01 TRANSALDOLASE B user 33 3 # 33 B 17 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 96 GLU A 72 GLU~? 5.31 O ACT A 201 B 132 LYS A 68 LYS~? -2.78 O ACT A 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 26.69 48.45 7.18 27.85 50.13 7.74 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 29.82 45.80 5.07 30.26 51.81 3.56 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1onr_c01 TRANSALDOLASE B user 34 3 # 34 B 17 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 96 GLU D 137 GLU~? 19.20 CH3 ACT A 203 B 132 LYS D 134 LYS~? 17.34 O ACT A 201 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 26.69 48.45 7.18 27.85 50.13 7.74 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 29.82 45.80 5.07 30.26 51.81 3.56 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 1onr_c01 TRANSALDOLASE B user 35 3 # 35 B 17 ASP D 149 ASP.? 20.02 CH3 ACT D 201 B 96 GLU D 27 GLU~? 9.75 CH3 ACT D 201 B 132 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 26.69 48.45 7.18 27.85 50.13 7.74 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 29.82 45.80 5.07 30.26 51.81 3.56 -47.37 61.41 34.65 -51.85 60.71 37.83 1onr_c01 source 1onr TRANSALDOLASE B : 35 hits 1onr_c01 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 247 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 342 GLU B 72 GLU~? 5.30 OXT ACT B 201 coo 44.36 35.68 9.71 43.29 36.20 11.51 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 41.40 28.81 12.91 40.82 30.90 12.97 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 40.37 33.11 18.06 39.99 34.93 17.06 -35.13 47.70 77.85 -34.58 49.69 78.28 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 247 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 342 GLU C 72 GLU~? 5.32 O ACT C 201 coo 44.36 35.68 9.71 43.29 36.20 11.51 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 41.40 28.81 12.91 40.82 30.90 12.97 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 40.37 33.11 18.06 39.99 34.93 17.06 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 1oyg_c00 LEVANSUCRASE user 3 3 # 3 A 86 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 247 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 342 GLU D 72 GLU~? 5.29 OXT ACT D 201 coo 44.36 35.68 9.71 43.29 36.20 11.51 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 41.40 28.81 12.91 40.82 30.90 12.97 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 40.37 33.11 18.06 39.99 34.93 17.06 -51.77 69.18 47.61 -51.44 67.29 46.71 ULMN 3 1oyg_c00 LEVANSUCRASE user 4 3 # 4 A 86 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 247 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 342 GLU D 72 GLU~? 5.29 OXT ACT D 201 coo 44.36 35.68 9.71 43.29 36.20 11.51 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 41.40 28.81 12.91 40.82 30.90 12.97 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 40.37 33.11 18.06 39.99 34.93 17.06 -51.77 69.18 47.61 -51.44 67.29 46.71 1oyg_c00 source 1oyg LEVANSUCRASE : 4 hits 1oyg_c00 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 167 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 201 LYS A 68 LYS~? -2.78 O ACT A 201s coo 26.53 8.31 20.37 28.45 8.41 19.40 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 24.92 6.08 13.38 27.75 4.33 18.83 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 29.08 5.53 11.69 30.46 5.61 17.93 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 A 102 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 167 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 201 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 26.53 8.31 20.37 28.45 8.41 19.40 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 24.92 6.08 13.38 27.75 4.33 18.83 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 29.08 5.53 11.69 30.46 5.61 17.93 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 A 102 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 167 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 201 LYS C 68 LYS~? -2.77 O ACT C 201s coo 26.53 8.31 20.37 28.45 8.41 19.40 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 24.92 6.08 13.38 27.75 4.33 18.83 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 29.08 5.53 11.69 30.46 5.61 17.93 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 A 102 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 167 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 201 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 26.53 8.31 20.37 28.45 8.41 19.40 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 24.92 6.08 13.38 27.75 4.33 18.83 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 29.08 5.53 11.69 30.46 5.61 17.93 -56.56 67.44 48.13 -52.71 65.23 44.87 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 4 hits 1p1x_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP A 99 ASP.? 5.71 O2 EDO A 301 B1167 LYS A 71 LYS~? 4.32 C2 EDO A 301 B1201 LYS A 68 LYS~? -2.78 O ACT A 201s coo 26.10 12.11 49.61 24.19 12.48 50.51 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 27.70 11.69 56.92 24.82 8.55 52.12 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 23.50 11.64 58.67 22.19 10.19 52.59 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 B1102 ASP B 99 ASP.? 16.09 OXT ACT B 201 B1167 LYS B 71 LYS~? 10.83 OXT ACT B 201 B1201 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 26.10 12.11 49.61 24.19 12.48 50.51 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 27.70 11.69 56.92 24.82 8.55 52.12 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 23.50 11.64 58.67 22.19 10.19 52.59 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 B1102 ASP C 99 ASP.? 5.79 O1 EDO A 301 B1167 LYS C 71 LYS~? 4.19 C1 EDO A 301 B1201 LYS C 68 LYS~? -2.77 O ACT C 201s coo 26.10 12.11 49.61 24.19 12.48 50.51 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 27.70 11.69 56.92 24.82 8.55 52.12 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 23.50 11.64 58.67 22.19 10.19 52.59 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 B1102 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B1167 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B1201 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 26.10 12.11 49.61 24.19 12.48 50.51 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 27.70 11.69 56.92 24.82 8.55 52.12 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 23.50 11.64 58.67 22.19 10.19 52.59 -56.56 67.44 48.13 -52.71 65.23 44.87 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 4 hits 1p1x_c01 naa= 3 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 1 3 # 1 A 16 TYR A 42 TYR^? 9.79 CH3 ACT A 201 A 38 GLU A 60 GLU~? 10.63 O2 EDO A 302 A 46 TRP A 48 TRP^? 8.95 OXT ACT A 201 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -21.95 67.01 65.30 -25.27 68.30 63.60 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 2 3 # 2 A 16 TYR A 42 TYR^? 9.79 CH3 ACT A 201 A 38 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 46 TRP A 48 TRP^? 8.95 OXT ACT A 201 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -21.95 67.01 65.30 -25.27 68.30 63.60 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 3 3 # 3 A 16 TYR A 42 TYR^? 9.79 CH3 ACT A 201 A 38 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 46 TRP A 48 TRP^? 8.95 OXT ACT A 201 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -21.95 67.01 65.30 -25.27 68.30 63.60 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 4 3 # 4 A 16 TYR A 42 TYR^? 9.79 CH3 ACT A 201 A 38 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 46 TRP A 48 TRP^? 8.95 OXT ACT A 201 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -21.95 67.01 65.30 -25.27 68.30 63.60 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 5 3 # 5 A 16 TYR B 42 TYR^? 9.74 CH3 ACT B 201 A 38 GLU B 60 GLU~? 17.33 O ACT B 201 A 46 TRP B 48 TRP^? 8.84 O ACT B 201 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -39.73 60.89 87.11 -38.13 57.34 86.55 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 6 3 # 6 A 16 TYR B 42 TYR^? 9.74 CH3 ACT B 201 A 38 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 46 TRP B 48 TRP^? 8.84 O ACT B 201 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -39.73 60.89 87.11 -38.13 57.34 86.55 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 7 3 # 7 A 16 TYR B 42 TYR^? 9.74 CH3 ACT B 201 A 38 GLU B 114 GLU^? 18.04 O ACT B 201 A 46 TRP B 48 TRP^? 8.84 O ACT B 201 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -39.73 60.89 87.11 -38.13 57.34 86.55 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 8 3 # 8 A 16 TYR C 42 TYR^? 9.67 CH3 ACT C 201 A 38 GLU C 60 GLU~? 17.22 OXT ACT C 201 A 46 TRP C 48 TRP^? 8.95 OXT ACT C 201 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -30.92 52.82 43.89 -31.53 51.16 47.40 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 9 3 # 9 A 16 TYR C 42 TYR^? 9.67 CH3 ACT C 201 A 38 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 46 TRP C 48 TRP^? 8.95 OXT ACT C 201 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -30.92 52.82 43.89 -31.53 51.16 47.40 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 10 3 # 10 A 16 TYR C 42 TYR^? 9.67 CH3 ACT C 201 A 38 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 46 TRP C 48 TRP^? 8.95 OXT ACT C 201 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -30.92 52.82 43.89 -31.53 51.16 47.40 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 11 3 # 11 A 16 TYR D 42 TYR^? 9.84 CH3 ACT D 201 A 38 GLU D 60 GLU~? 17.31 O ACT D 201 A 46 TRP D 48 TRP^? 8.90 O ACT D 201 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -59.58 54.71 44.23 -58.78 58.51 43.62 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 12 3 # 12 A 16 TYR D 42 TYR^? 9.84 CH3 ACT D 201 A 38 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 46 TRP D 48 TRP^? 8.90 O ACT D 201 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -59.58 54.71 44.23 -58.78 58.51 43.62 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 13 3 # 13 A 16 TYR D 42 TYR^? 9.84 CH3 ACT D 201 A 38 GLU D 114 GLU^? 18.05 O ACT D 201 A 46 TRP D 48 TRP^? 8.90 O ACT D 201 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -59.58 54.71 44.23 -58.78 58.51 43.62 1p7m_c00 source 1p7m DNA-3-METHYLADENINE GLYCOSYLASE I : 13 hits 1p7m_c00 naa= 3 ULMN 3 1pbg_c00 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 3 # 1 A 160 GLU A 59 GLU~? 18.41 O2 EDO A 302 A 297 ASN A 57 ASN~? 14.18 O1 EDO A 302 A 375 GLU A 60 GLU~? 10.63 O2 EDO A 302 coo 63.94 10.02 33.47 64.31 8.24 32.38 -19.57 66.85 53.38 -18.14 66.20 51.96 coo 59.99 9.39 31.17 60.97 11.14 30.52 -16.25 65.99 58.99 -17.06 64.89 57.36 coo 61.89 10.05 27.30 63.60 9.39 28.40 -19.73 62.99 57.19 -19.03 61.21 58.09 ULMN 3 1pbg_c00 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 3 # 2 A 160 GLU B 59 GLU~? 20.69 O ACT B 201 A 297 ASN B 57 ASN~? 18.11 O ACT B 201 A 375 GLU B 60 GLU~? 17.33 O ACT B 201 coo 63.94 10.02 33.47 64.31 8.24 32.38 -47.90 53.57 92.50 -49.95 53.72 93.03 coo 59.99 9.39 31.17 60.97 11.14 30.52 -46.90 59.98 91.63 -48.14 58.47 90.79 coo 61.89 10.05 27.30 63.60 9.39 28.40 -48.17 57.12 87.93 -49.17 58.57 86.76 1pbg_c00 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 2 hits 1pbg_c00 naa= 3 ULMN 3 1pbg_c01 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 3 # 1 B 160 GLU A 59 GLU~? 18.41 O2 EDO A 302 B 297 ASN A 57 ASN~? 14.18 O1 EDO A 302 B 375 GLU A 60 GLU~? 10.63 O2 EDO A 302 coo 23.66 16.69 85.20 24.17 18.76 84.94 -19.57 66.85 53.38 -18.14 66.20 51.96 coo 19.74 18.67 86.53 20.70 17.86 88.21 -16.25 65.99 58.99 -17.06 64.89 57.36 coo 21.67 20.74 89.92 23.35 20.55 88.67 -19.73 62.99 57.19 -19.03 61.21 58.09 ULMN 3 1pbg_c01 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 3 # 2 B 160 GLU B 59 GLU~? 20.69 O ACT B 201 B 297 ASN B 57 ASN~? 18.11 O ACT B 201 B 375 GLU B 60 GLU~? 17.33 O ACT B 201 coo 23.66 16.69 85.20 24.17 18.76 84.94 -47.90 53.57 92.50 -49.95 53.72 93.03 coo 19.74 18.67 86.53 20.70 17.86 88.21 -46.90 59.98 91.63 -48.14 58.47 90.79 coo 21.67 20.74 89.92 23.35 20.55 88.67 -48.17 57.12 87.93 -49.17 58.57 86.76 1pbg_c01 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 2 hits 1pbg_c01 naa= 3 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 1 3 # 1 1 8 TYR A 95 TYR^? -3.85 O ACT A 201s 1 14 ARG A 33 ARG.? 12.39 O ACT A 201 1 104 TRP A 142 TRP.? 12.79 O ACT A 201 coo -6.26 36.66 22.35 -5.62 38.66 24.20 -38.20 69.00 66.47 -37.00 66.61 65.61 coo -1.84 42.97 23.45 -1.37 45.90 22.68 -37.81 74.92 58.71 -38.09 77.66 57.35 coo -2.17 45.44 30.78 -5.80 46.76 31.55 -42.03 80.57 64.19 -41.88 78.10 67.25 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 2 3 # 2 1 8 TYR B 95 TYR^? -3.87 OXT ACT B 201s 1 14 ARG B 33 ARG.? 12.67 OXT ACT B 201 1 104 TRP B 142 TRP.? 12.90 OXT ACT B 201 coo -6.26 36.66 22.35 -5.62 38.66 24.20 -29.40 51.18 78.64 -32.01 51.78 77.83 coo -1.84 42.97 23.45 -1.37 45.90 22.68 -30.14 45.04 86.20 -29.28 42.52 87.71 coo -2.17 45.44 30.78 -5.80 46.76 31.55 -21.52 44.96 85.54 -21.40 47.93 82.96 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 3 3 # 3 1 8 TYR C 95 TYR^? -3.84 O ACT C 201s 1 14 ARG C 33 ARG.? 12.41 O ACT C 201 1 104 TRP C 142 TRP.? 12.80 O ACT C 201 coo -6.26 36.66 22.35 -5.62 38.66 24.20 -41.63 48.44 55.51 -40.56 51.04 55.32 coo -1.84 42.97 23.45 -1.37 45.90 22.68 -34.58 43.27 59.73 -33.36 40.62 60.70 coo -2.17 45.44 30.78 -5.80 46.76 31.55 -40.60 36.63 58.98 -43.29 38.84 57.12 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 4 3 # 4 1 8 TYR D 95 TYR^? -3.79 OXT ACT D 201s 1 14 ARG D 33 ARG.? 12.34 OXT ACT D 201 1 104 TRP D 142 TRP.? 12.80 OXT ACT D 201 coo -6.26 36.66 22.35 -5.62 38.66 24.20 -48.26 66.56 42.41 -49.21 65.61 44.87 coo -1.84 42.97 23.45 -1.37 45.90 22.68 -55.21 72.58 39.53 -56.74 74.11 37.37 coo -2.17 45.44 30.78 -5.80 46.76 31.55 -49.78 73.48 32.42 -47.22 70.87 33.88 1pd2_c02 source 1pd2 HEMATOPOIETIC PROSTAGLADIN D SYNTHASE : 4 hits 1pd2_c02 naa= 3 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 1 3 # 1 2 8 TYR A 95 TYR^? -3.85 O ACT A 201s 2 14 ARG A 33 ARG.? 12.39 O ACT A 201 2 104 TRP A 142 TRP.? 12.79 O ACT A 201 coo 14.82 62.39 20.28 14.73 60.21 22.02 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 10.81 55.96 22.08 10.04 53.12 21.26 -37.81 74.92 58.71 -38.09 77.66 57.35 coo 13.42 52.88 28.75 17.04 51.48 28.24 -42.03 80.57 64.19 -41.88 78.10 67.25 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 2 3 # 2 2 8 TYR B 95 TYR^? -3.87 OXT ACT B 201s 2 14 ARG B 33 ARG.? 12.67 OXT ACT B 201 2 104 TRP B 142 TRP.? 12.90 OXT ACT B 201 coo 14.82 62.39 20.28 14.73 60.21 22.02 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 10.81 55.96 22.08 10.04 53.12 21.26 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 13.42 52.88 28.75 17.04 51.48 28.24 -21.52 44.96 85.54 -21.40 47.93 82.96 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 3 3 # 3 2 8 TYR C 95 TYR^? -3.84 O ACT C 201s 2 14 ARG C 33 ARG.? 12.41 O ACT C 201 2 104 TRP C 142 TRP.? 12.80 O ACT C 201 coo 14.82 62.39 20.28 14.73 60.21 22.02 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 10.81 55.96 22.08 10.04 53.12 21.26 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 13.42 52.88 28.75 17.04 51.48 28.24 -40.60 36.63 58.98 -43.29 38.84 57.12 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 4 3 # 4 2 8 TYR D 95 TYR^? -3.79 OXT ACT D 201s 2 14 ARG D 33 ARG.? 12.34 OXT ACT D 201 2 104 TRP D 142 TRP.? 12.80 OXT ACT D 201 coo 14.82 62.39 20.28 14.73 60.21 22.02 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 10.81 55.96 22.08 10.04 53.12 21.26 -55.21 72.58 39.53 -56.74 74.11 37.37 coo 13.42 52.88 28.75 17.04 51.48 28.24 -49.78 73.48 32.42 -47.22 70.87 33.88 1pd2_c03 source 1pd2 HEMATOPOIETIC PROSTAGLADIN D SYNTHASE : 4 hits 1pd2_c03 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 101 SER.? 7.80 O2 EDO A 301 B 709 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 740 HIS A 98 HIS^? -3.60 C ACT A 203s coo 4.44 13.29 37.64 6.01 11.66 38.49 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 10.26 2.81 31.69 11.64 4.30 32.43 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 8.57 10.09 34.47 7.10 10.73 35.82 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER C 101 SER.? 7.85 O1 EDO A 301 B 709 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 740 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 4.44 13.29 37.64 6.01 11.66 38.49 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 10.26 2.81 31.69 11.64 4.30 32.43 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 8.57 10.09 34.47 7.10 10.73 35.82 -40.81 49.03 67.16 -39.15 48.14 68.10 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c03 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 19 ALA~? 16.44 CH3 ACT A 201 A 126 LEU A 81 LEU^? 15.00 CH3 ACT A 201 A 158 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -25.44 80.18 77.74 -25.49 79.27 78.96 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -30.53 77.06 79.59 -28.72 77.19 80.78 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 26 ALA~? 8.12 CH3 ACT A 201 A 126 LEU A 25 LEU~? 14.11 CH3 ACT A 201 A 158 GLU A 21 GLU~? 19.20 CH3 ACT A 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -27.50 82.26 68.63 -26.98 84.36 68.67 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -26.74 85.39 73.13 -25.47 87.07 73.30 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 41 ALA.? 11.63 CH3 ACT A 201 A 126 LEU A 40 LEU~? 16.40 CH3 ACT A 201 A 158 GLU A 36 GLU~? 17.83 CH3 ACT A 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -21.87 76.61 63.78 -23.26 76.64 64.42 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -21.49 78.02 59.34 -21.07 78.38 57.25 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -24.24 76.94 53.59 -22.34 76.00 53.73 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 83 ALA^? 17.38 O ACT A 202 A 126 LEU A 81 LEU^? 15.00 CH3 ACT A 201 A 158 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -27.44 73.39 82.90 -27.14 72.16 83.76 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -30.53 77.06 79.59 -28.72 77.19 80.78 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA A 90 ALA^? 13.57 O ACT A 202 A 126 LEU A 81 LEU^? 15.00 CH3 ACT A 201 A 158 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -27.00 70.90 78.40 -27.10 70.23 79.75 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -30.53 77.06 79.59 -28.72 77.19 80.78 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA A 94 ALA^? 9.17 CH3 ACT A 201 A 126 LEU A 77 LEU^? 4.67 CH3 ACT A 201 A 158 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -39.00 70.14 71.43 -40.24 70.27 72.30 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -36.85 74.02 66.79 -35.10 73.30 67.83 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA A 94 ALA^? 9.17 CH3 ACT A 201 A 126 LEU A 154 LEU~? 11.68 CH3 ACT A 201 A 158 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -39.00 70.14 71.43 -40.24 70.27 72.30 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -39.19 74.64 76.97 -38.88 72.97 75.63 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA A 94 ALA^? 9.17 CH3 ACT A 201 A 126 LEU A 154 LEU~? 11.68 CH3 ACT A 201 A 158 GLU A 160 GLU.? 13.50 O ACT A 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -39.00 70.14 71.43 -40.24 70.27 72.30 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -39.19 74.64 76.97 -38.88 72.97 75.63 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -45.30 71.21 75.74 -44.17 71.89 74.09 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA B 5 ALA.? 18.71 CH3 ACT B 201 A 126 LEU B 40 LEU~? 16.08 CH3 ACT B 201 A 158 GLU B 36 GLU~? 17.47 CH3 ACT B 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -37.78 58.32 101.20 -36.54 58.26 100.29 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -36.29 54.47 97.22 -37.42 52.91 98.18 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -39.08 48.65 96.43 -40.52 50.19 96.69 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA B 19 ALA~? 16.58 CH3 ACT B 201 A 126 LEU B 81 LEU^? 13.74 CH3 ACT A 202 A 158 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -22.38 65.57 91.21 -22.22 66.67 90.15 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -20.64 64.33 85.07 -20.74 66.34 85.86 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA B 26 ALA~? 8.11 CH3 ACT B 201 A 126 LEU B 25 LEU~? 14.08 CH3 ACT B 201 A 158 GLU B 21 GLU~? 20.11 CH3 ACT B 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -27.84 56.51 90.43 -28.15 57.77 89.64 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -25.39 57.02 94.16 -24.18 57.09 95.95 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -19.23 61.49 94.88 -18.90 62.15 96.87 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 A 70 ALA B 41 ALA.? 11.62 CH3 ACT B 201 A 126 LEU B 40 LEU~? 16.08 CH3 ACT B 201 A 158 GLU B 36 GLU~? 17.47 CH3 ACT B 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -34.48 57.97 94.75 -33.37 57.61 93.78 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -36.29 54.47 97.22 -37.42 52.91 98.18 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -39.08 48.65 96.43 -40.52 50.19 96.69 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 A 70 ALA B 83 ALA^? 14.78 O ACT A 202 A 126 LEU B 81 LEU^? 13.74 CH3 ACT A 202 A 158 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -22.66 69.42 83.24 -23.04 70.52 82.25 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -20.64 64.33 85.07 -20.74 66.34 85.86 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 A 70 ALA B 90 ALA^? 13.05 O ACT A 202 A 126 LEU B 81 LEU^? 13.74 CH3 ACT A 202 A 158 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -27.07 66.85 82.98 -26.70 67.91 81.96 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -20.64 64.33 85.07 -20.74 66.34 85.86 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 A 70 ALA B 94 ALA^? 5.26 CH3 ACT A 202 A 126 LEU B 77 LEU^? 4.66 CH3 ACT B 201 A 158 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -25.63 54.27 77.41 -24.43 54.15 76.47 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -26.87 51.40 83.00 -27.59 53.42 83.20 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 A 70 ALA B 94 ALA^? 5.26 CH3 ACT A 202 A 126 LEU B 154 LEU~? 4.88 CH3 ACT A 202 A 158 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -25.63 54.27 77.41 -24.43 54.15 76.47 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -19.73 57.21 79.21 -21.60 57.21 78.13 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 A 70 ALA C 19 ALA~? 16.34 CH3 ACT C 201 A 126 LEU C 81 LEU^? 15.01 CH3 ACT C 201 A 158 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -40.82 38.56 37.82 -41.88 39.43 37.15 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -45.86 40.80 40.73 -45.61 40.81 38.58 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 A 70 ALA C 26 ALA~? 8.20 CH3 ACT C 201 A 126 LEU C 25 LEU~? 14.17 CH3 ACT C 201 A 158 GLU C 21 GLU~? 19.29 CH3 ACT C 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -35.58 40.78 46.69 -36.15 41.81 45.72 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -34.79 36.68 45.03 -34.22 34.69 44.41 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -37.51 33.35 41.29 -36.60 32.00 39.94 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 A 70 ALA C 41 ALA.? 11.54 CH3 ACT C 201 A 126 LEU C 40 LEU~? 16.30 CH3 ACT C 201 A 158 GLU C 36 GLU~? 15.95 O2 EDO A 302 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -28.41 43.41 44.10 -29.77 43.16 44.76 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -24.56 42.40 46.55 -22.60 42.30 47.48 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -22.00 43.42 52.41 -21.02 44.62 50.95 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 A 70 ALA C 83 ALA^? 17.61 CH3 ACT C 201 A 126 LEU C 81 LEU^? 15.01 CH3 ACT C 201 A 158 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -46.94 44.62 36.49 -47.62 45.79 35.79 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -45.86 40.80 40.73 -45.61 40.81 38.58 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 A 70 ALA C 90 ALA^? 13.74 CH3 ACT C 201 A 126 LEU C 81 LEU^? 15.01 CH3 ACT C 201 A 158 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -43.56 47.44 39.16 -44.76 48.04 38.47 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -45.86 40.80 40.73 -45.61 40.81 38.58 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 A 70 ALA C 94 ALA^? 9.20 O ACT C 201 A 126 LEU C 77 LEU^? 4.76 CH3 ACT C 201 A 158 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -45.79 46.91 52.91 -47.22 46.56 53.32 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -40.40 43.73 53.92 -40.17 44.61 51.97 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 A 70 ALA C 94 ALA^? 9.20 O ACT C 201 A 126 LEU C 154 LEU~? 11.42 CH3 ACT C 201 A 158 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -45.79 46.91 52.91 -47.22 46.56 53.32 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -48.99 42.06 49.32 -48.47 44.12 49.71 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 A 70 ALA D 19 ALA~? 16.59 CH3 ACT D 201 A 126 LEU D 81 LEU^? 15.06 CH3 ACT D 201 A 158 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -51.23 52.67 27.89 -50.15 51.69 28.35 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -45.66 54.58 30.57 -46.07 52.52 30.02 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -42.96 58.73 31.72 -40.96 59.40 31.80 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 A 70 ALA D 26 ALA~? 8.16 CH3 ACT D 201 A 126 LEU D 25 LEU~? 14.13 CH3 ACT D 201 A 158 GLU D 21 GLU~? 20.13 CH3 ACT D 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -56.77 60.39 28.97 -57.42 60.38 26.91 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -52.88 57.10 23.42 -54.02 56.21 21.88 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 26 3 # 26 A 70 ALA D 41 ALA.? 11.61 CH3 ACT D 201 A 126 LEU D 40 LEU~? 16.21 CH3 ACT D 201 A 158 GLU D 36 GLU~? 17.76 CH3 ACT D 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -62.65 57.84 35.58 -61.25 58.43 35.41 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -66.28 60.79 35.61 -68.08 61.94 35.93 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -68.34 66.20 38.63 -69.40 64.56 39.44 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 27 3 # 27 A 70 ALA D 83 ALA^? 17.67 CH3 ACT D 201 A 126 LEU D 81 LEU^? 15.06 CH3 ACT D 201 A 158 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -44.75 49.33 32.86 -44.08 48.27 33.71 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -45.66 54.58 30.57 -46.07 52.52 30.02 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -42.96 58.73 31.72 -40.96 59.40 31.80 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 28 3 # 28 A 70 ALA D 90 ALA^? 13.83 CH3 ACT D 201 A 126 LEU D 81 LEU^? 15.06 CH3 ACT D 201 A 158 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -47.67 51.24 36.64 -46.49 50.32 36.92 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -45.66 54.58 30.57 -46.07 52.52 30.02 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -42.96 58.73 31.72 -40.96 59.40 31.80 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 29 3 # 29 A 70 ALA D 94 ALA^? 9.22 CH3 ACT D 201 A 126 LEU D 77 LEU^? 4.61 CH3 ACT D 201 A 158 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -44.41 64.30 40.02 -42.98 64.70 39.67 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -49.96 66.51 37.71 -50.27 64.38 38.00 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 30 3 # 30 A 70 ALA D 94 ALA^? 9.22 CH3 ACT D 201 A 126 LEU D 154 LEU.? 11.37 CH3 ACT D 201 A 158 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -44.41 64.30 40.02 -42.98 64.70 39.67 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -41.78 62.16 34.13 -42.22 62.04 36.24 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -42.96 58.73 31.72 -40.96 59.40 31.80 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 30 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 19 ALA~? 16.44 CH3 ACT A 201 B 126 LEU A 81 LEU^? 15.00 CH3 ACT A 201 B 158 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -25.44 80.18 77.74 -25.49 79.27 78.96 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -30.53 77.06 79.59 -28.72 77.19 80.78 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 26 ALA~? 8.12 CH3 ACT A 201 B 126 LEU A 25 LEU~? 14.11 CH3 ACT A 201 B 158 GLU A 21 GLU~? 19.20 CH3 ACT A 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -27.50 82.26 68.63 -26.98 84.36 68.67 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -26.74 85.39 73.13 -25.47 87.07 73.30 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 41 ALA.? 11.63 CH3 ACT A 201 B 126 LEU A 40 LEU~? 16.40 CH3 ACT A 201 B 158 GLU A 36 GLU~? 17.83 CH3 ACT A 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -21.87 76.61 63.78 -23.26 76.64 64.42 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -21.49 78.02 59.34 -21.07 78.38 57.25 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -24.24 76.94 53.59 -22.34 76.00 53.73 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 83 ALA^? 17.38 O ACT A 202 B 126 LEU A 81 LEU^? 15.00 CH3 ACT A 201 B 158 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -27.44 73.39 82.90 -27.14 72.16 83.76 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -30.53 77.06 79.59 -28.72 77.19 80.78 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA A 90 ALA^? 13.57 O ACT A 202 B 126 LEU A 81 LEU^? 15.00 CH3 ACT A 201 B 158 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -27.00 70.90 78.40 -27.10 70.23 79.75 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -30.53 77.06 79.59 -28.72 77.19 80.78 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA A 94 ALA^? 9.17 CH3 ACT A 201 B 126 LEU A 77 LEU^? 4.67 CH3 ACT A 201 B 158 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -39.00 70.14 71.43 -40.24 70.27 72.30 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -36.85 74.02 66.79 -35.10 73.30 67.83 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA A 94 ALA^? 9.17 CH3 ACT A 201 B 126 LEU A 154 LEU~? 11.68 CH3 ACT A 201 B 158 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -39.00 70.14 71.43 -40.24 70.27 72.30 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -39.19 74.64 76.97 -38.88 72.97 75.63 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA A 94 ALA^? 9.17 CH3 ACT A 201 B 126 LEU A 154 LEU~? 11.68 CH3 ACT A 201 B 158 GLU A 160 GLU.? 13.50 O ACT A 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -39.00 70.14 71.43 -40.24 70.27 72.30 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -39.19 74.64 76.97 -38.88 72.97 75.63 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -45.30 71.21 75.74 -44.17 71.89 74.09 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA B 5 ALA.? 18.71 CH3 ACT B 201 B 126 LEU B 40 LEU~? 16.08 CH3 ACT B 201 B 158 GLU B 36 GLU~? 17.47 CH3 ACT B 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -37.78 58.32 101.20 -36.54 58.26 100.29 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -36.29 54.47 97.22 -37.42 52.91 98.18 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -39.08 48.65 96.43 -40.52 50.19 96.69 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA B 19 ALA~? 16.58 CH3 ACT B 201 B 126 LEU B 81 LEU^? 13.74 CH3 ACT A 202 B 158 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -22.38 65.57 91.21 -22.22 66.67 90.15 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -20.64 64.33 85.07 -20.74 66.34 85.86 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA B 41 ALA.? 11.62 CH3 ACT B 201 B 126 LEU B 40 LEU~? 16.08 CH3 ACT B 201 B 158 GLU B 36 GLU~? 17.47 CH3 ACT B 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -34.48 57.97 94.75 -33.37 57.61 93.78 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -36.29 54.47 97.22 -37.42 52.91 98.18 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -39.08 48.65 96.43 -40.52 50.19 96.69 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 B 70 ALA B 83 ALA^? 14.78 O ACT A 202 B 126 LEU B 81 LEU^? 13.74 CH3 ACT A 202 B 158 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -22.66 69.42 83.24 -23.04 70.52 82.25 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -20.64 64.33 85.07 -20.74 66.34 85.86 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 B 70 ALA B 90 ALA^? 13.05 O ACT A 202 B 126 LEU B 81 LEU^? 13.74 CH3 ACT A 202 B 158 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -27.07 66.85 82.98 -26.70 67.91 81.96 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -20.64 64.33 85.07 -20.74 66.34 85.86 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 B 70 ALA B 94 ALA^? 5.26 CH3 ACT A 202 B 126 LEU B 77 LEU^? 4.66 CH3 ACT B 201 B 158 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -25.63 54.27 77.41 -24.43 54.15 76.47 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -26.87 51.40 83.00 -27.59 53.42 83.20 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 B 70 ALA B 94 ALA^? 5.26 CH3 ACT A 202 B 126 LEU B 154 LEU~? 4.88 CH3 ACT A 202 B 158 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -25.63 54.27 77.41 -24.43 54.15 76.47 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -19.73 57.21 79.21 -21.60 57.21 78.13 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 B 70 ALA C 19 ALA~? 16.34 CH3 ACT C 201 B 126 LEU C 81 LEU^? 15.01 CH3 ACT C 201 B 158 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -40.82 38.56 37.82 -41.88 39.43 37.15 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -45.86 40.80 40.73 -45.61 40.81 38.58 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 B 70 ALA C 26 ALA~? 8.20 CH3 ACT C 201 B 126 LEU C 25 LEU~? 14.17 CH3 ACT C 201 B 158 GLU C 21 GLU~? 19.29 CH3 ACT C 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -35.58 40.78 46.69 -36.15 41.81 45.72 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -34.79 36.68 45.03 -34.22 34.69 44.41 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -37.51 33.35 41.29 -36.60 32.00 39.94 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 B 70 ALA C 41 ALA.? 11.54 CH3 ACT C 201 B 126 LEU C 40 LEU~? 16.30 CH3 ACT C 201 B 158 GLU C 36 GLU~? 15.95 O2 EDO A 302 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -28.41 43.41 44.10 -29.77 43.16 44.76 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -24.56 42.40 46.55 -22.60 42.30 47.48 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -22.00 43.42 52.41 -21.02 44.62 50.95 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 B 70 ALA C 83 ALA^? 17.61 CH3 ACT C 201 B 126 LEU C 81 LEU^? 15.01 CH3 ACT C 201 B 158 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -46.94 44.62 36.49 -47.62 45.79 35.79 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -45.86 40.80 40.73 -45.61 40.81 38.58 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 B 70 ALA C 90 ALA^? 13.74 CH3 ACT C 201 B 126 LEU C 81 LEU^? 15.01 CH3 ACT C 201 B 158 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -43.56 47.44 39.16 -44.76 48.04 38.47 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -45.86 40.80 40.73 -45.61 40.81 38.58 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 B 70 ALA C 94 ALA^? 9.20 O ACT C 201 B 126 LEU C 77 LEU^? 4.76 CH3 ACT C 201 B 158 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -45.79 46.91 52.91 -47.22 46.56 53.32 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -40.40 43.73 53.92 -40.17 44.61 51.97 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 B 70 ALA C 94 ALA^? 9.20 O ACT C 201 B 126 LEU C 154 LEU~? 11.42 CH3 ACT C 201 B 158 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -45.79 46.91 52.91 -47.22 46.56 53.32 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -48.99 42.06 49.32 -48.47 44.12 49.71 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 B 70 ALA D 19 ALA~? 16.59 CH3 ACT D 201 B 126 LEU D 81 LEU^? 15.06 CH3 ACT D 201 B 158 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -51.23 52.67 27.89 -50.15 51.69 28.35 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -45.66 54.58 30.57 -46.07 52.52 30.02 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -42.96 58.73 31.72 -40.96 59.40 31.80 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 B 70 ALA D 26 ALA~? 8.16 CH3 ACT D 201 B 126 LEU D 25 LEU~? 14.13 CH3 ACT D 201 B 158 GLU D 21 GLU~? 20.13 CH3 ACT D 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -56.77 60.39 28.97 -57.42 60.38 26.91 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -52.88 57.10 23.42 -54.02 56.21 21.88 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 B 70 ALA D 41 ALA.? 11.61 CH3 ACT D 201 B 126 LEU D 40 LEU~? 16.21 CH3 ACT D 201 B 158 GLU D 36 GLU~? 17.76 CH3 ACT D 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -62.65 57.84 35.58 -61.25 58.43 35.41 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -66.28 60.79 35.61 -68.08 61.94 35.93 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -68.34 66.20 38.63 -69.40 64.56 39.44 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 26 3 # 26 B 70 ALA D 83 ALA^? 17.67 CH3 ACT D 201 B 126 LEU D 81 LEU^? 15.06 CH3 ACT D 201 B 158 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -44.75 49.33 32.86 -44.08 48.27 33.71 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -45.66 54.58 30.57 -46.07 52.52 30.02 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -42.96 58.73 31.72 -40.96 59.40 31.80 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 27 3 # 27 B 70 ALA D 90 ALA^? 13.83 CH3 ACT D 201 B 126 LEU D 81 LEU^? 15.06 CH3 ACT D 201 B 158 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -47.67 51.24 36.64 -46.49 50.32 36.92 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -45.66 54.58 30.57 -46.07 52.52 30.02 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -42.96 58.73 31.72 -40.96 59.40 31.80 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 28 3 # 28 B 70 ALA D 94 ALA^? 9.22 CH3 ACT D 201 B 126 LEU D 77 LEU^? 4.61 CH3 ACT D 201 B 158 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -44.41 64.30 40.02 -42.98 64.70 39.67 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -49.96 66.51 37.71 -50.27 64.38 38.00 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 29 3 # 29 B 70 ALA D 94 ALA^? 9.22 CH3 ACT D 201 B 126 LEU D 154 LEU.? 11.37 CH3 ACT D 201 B 158 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -44.41 64.30 40.02 -42.98 64.70 39.67 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -41.78 62.16 34.13 -42.22 62.04 36.24 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -42.96 58.73 31.72 -40.96 59.40 31.80 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 29 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 19 ALA~? 16.44 CH3 ACT A 201 C 126 LEU A 81 LEU^? 15.00 CH3 ACT A 201 C 158 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -25.44 80.18 77.74 -25.49 79.27 78.96 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -30.53 77.06 79.59 -28.72 77.19 80.78 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 26 ALA~? 8.12 CH3 ACT A 201 C 126 LEU A 25 LEU~? 14.11 CH3 ACT A 201 C 158 GLU A 21 GLU~? 19.20 CH3 ACT A 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -27.50 82.26 68.63 -26.98 84.36 68.67 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -26.74 85.39 73.13 -25.47 87.07 73.30 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 41 ALA.? 11.63 CH3 ACT A 201 C 126 LEU A 40 LEU~? 16.40 CH3 ACT A 201 C 158 GLU A 36 GLU~? 17.83 CH3 ACT A 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -21.87 76.61 63.78 -23.26 76.64 64.42 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -21.49 78.02 59.34 -21.07 78.38 57.25 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -24.24 76.94 53.59 -22.34 76.00 53.73 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 83 ALA^? 17.38 O ACT A 202 C 126 LEU A 81 LEU^? 15.00 CH3 ACT A 201 C 158 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -27.44 73.39 82.90 -27.14 72.16 83.76 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -30.53 77.06 79.59 -28.72 77.19 80.78 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA A 90 ALA^? 13.57 O ACT A 202 C 126 LEU A 81 LEU^? 15.00 CH3 ACT A 201 C 158 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -27.00 70.90 78.40 -27.10 70.23 79.75 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -30.53 77.06 79.59 -28.72 77.19 80.78 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA A 94 ALA^? 9.17 CH3 ACT A 201 C 126 LEU A 77 LEU^? 4.67 CH3 ACT A 201 C 158 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -39.00 70.14 71.43 -40.24 70.27 72.30 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -36.85 74.02 66.79 -35.10 73.30 67.83 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA A 94 ALA^? 9.17 CH3 ACT A 201 C 126 LEU A 154 LEU~? 11.68 CH3 ACT A 201 C 158 GLU A 80 GLU^? 14.51 CH3 ACT A 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -39.00 70.14 71.43 -40.24 70.27 72.30 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -39.19 74.64 76.97 -38.88 72.97 75.63 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -35.46 76.50 78.57 -37.32 76.28 79.54 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA A 94 ALA^? 9.17 CH3 ACT A 201 C 126 LEU A 154 LEU~? 11.68 CH3 ACT A 201 C 158 GLU A 160 GLU.? 13.50 O ACT A 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -39.00 70.14 71.43 -40.24 70.27 72.30 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -39.19 74.64 76.97 -38.88 72.97 75.63 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -45.30 71.21 75.74 -44.17 71.89 74.09 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA B 5 ALA.? 18.71 CH3 ACT B 201 C 126 LEU B 40 LEU~? 16.08 CH3 ACT B 201 C 158 GLU B 36 GLU~? 17.47 CH3 ACT B 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -37.78 58.32 101.20 -36.54 58.26 100.29 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -36.29 54.47 97.22 -37.42 52.91 98.18 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -39.08 48.65 96.43 -40.52 50.19 96.69 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA B 19 ALA~? 16.58 CH3 ACT B 201 C 126 LEU B 81 LEU^? 13.74 CH3 ACT A 202 C 158 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -22.38 65.57 91.21 -22.22 66.67 90.15 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -20.64 64.33 85.07 -20.74 66.34 85.86 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA B 26 ALA~? 8.11 CH3 ACT B 201 C 126 LEU B 25 LEU~? 14.08 CH3 ACT B 201 C 158 GLU B 21 GLU~? 20.11 CH3 ACT B 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -27.84 56.51 90.43 -28.15 57.77 89.64 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -25.39 57.02 94.16 -24.18 57.09 95.95 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -19.23 61.49 94.88 -18.90 62.15 96.87 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 C 70 ALA B 41 ALA.? 11.62 CH3 ACT B 201 C 126 LEU B 40 LEU~? 16.08 CH3 ACT B 201 C 158 GLU B 36 GLU~? 17.47 CH3 ACT B 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -34.48 57.97 94.75 -33.37 57.61 93.78 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -36.29 54.47 97.22 -37.42 52.91 98.18 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -39.08 48.65 96.43 -40.52 50.19 96.69 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 C 70 ALA B 83 ALA^? 14.78 O ACT A 202 C 126 LEU B 81 LEU^? 13.74 CH3 ACT A 202 C 158 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -22.66 69.42 83.24 -23.04 70.52 82.25 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -20.64 64.33 85.07 -20.74 66.34 85.86 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 C 70 ALA B 90 ALA^? 13.05 O ACT A 202 C 126 LEU B 81 LEU^? 13.74 CH3 ACT A 202 C 158 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -27.07 66.85 82.98 -26.70 67.91 81.96 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -20.64 64.33 85.07 -20.74 66.34 85.86 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 C 70 ALA B 94 ALA^? 5.26 CH3 ACT A 202 C 126 LEU B 77 LEU^? 4.66 CH3 ACT B 201 C 158 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -25.63 54.27 77.41 -24.43 54.15 76.47 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -26.87 51.40 83.00 -27.59 53.42 83.20 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 C 70 ALA B 94 ALA^? 5.26 CH3 ACT A 202 C 126 LEU B 154 LEU~? 4.88 CH3 ACT A 202 C 158 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -25.63 54.27 77.41 -24.43 54.15 76.47 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -19.73 57.21 79.21 -21.60 57.21 78.13 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 C 70 ALA C 19 ALA~? 16.34 CH3 ACT C 201 C 126 LEU C 81 LEU^? 15.01 CH3 ACT C 201 C 158 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -40.82 38.56 37.82 -41.88 39.43 37.15 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -45.86 40.80 40.73 -45.61 40.81 38.58 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 C 70 ALA C 26 ALA~? 8.20 CH3 ACT C 201 C 126 LEU C 25 LEU~? 14.17 CH3 ACT C 201 C 158 GLU C 21 GLU~? 19.29 CH3 ACT C 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -34.79 36.68 45.03 -34.22 34.69 44.41 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -37.51 33.35 41.29 -36.60 32.00 39.94 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 C 70 ALA C 41 ALA.? 11.54 CH3 ACT C 201 C 126 LEU C 40 LEU~? 16.30 CH3 ACT C 201 C 158 GLU C 36 GLU~? 15.95 O2 EDO A 302 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -28.41 43.41 44.10 -29.77 43.16 44.76 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -24.56 42.40 46.55 -22.60 42.30 47.48 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -22.00 43.42 52.41 -21.02 44.62 50.95 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 C 70 ALA C 83 ALA^? 17.61 CH3 ACT C 201 C 126 LEU C 81 LEU^? 15.01 CH3 ACT C 201 C 158 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -46.94 44.62 36.49 -47.62 45.79 35.79 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -45.86 40.80 40.73 -45.61 40.81 38.58 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 C 70 ALA C 90 ALA^? 13.74 CH3 ACT C 201 C 126 LEU C 81 LEU^? 15.01 CH3 ACT C 201 C 158 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -43.56 47.44 39.16 -44.76 48.04 38.47 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -45.86 40.80 40.73 -45.61 40.81 38.58 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 C 70 ALA C 94 ALA^? 9.20 O ACT C 201 C 126 LEU C 77 LEU^? 4.76 CH3 ACT C 201 C 158 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -45.79 46.91 52.91 -47.22 46.56 53.32 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -40.40 43.73 53.92 -40.17 44.61 51.97 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 C 70 ALA C 94 ALA^? 9.20 O ACT C 201 C 126 LEU C 154 LEU~? 11.42 CH3 ACT C 201 C 158 GLU C 80 GLU^? 14.47 CH3 ACT C 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -45.79 46.91 52.91 -47.22 46.56 53.32 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -48.99 42.06 49.32 -48.47 44.12 49.71 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -48.24 40.72 45.31 -50.16 40.73 46.15 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 C 70 ALA D 19 ALA~? 16.59 CH3 ACT D 201 C 126 LEU D 81 LEU^? 15.06 CH3 ACT D 201 C 158 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -51.23 52.67 27.89 -50.15 51.69 28.35 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -45.66 54.58 30.57 -46.07 52.52 30.02 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -42.96 58.73 31.72 -40.96 59.40 31.80 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 C 70 ALA D 26 ALA~? 8.16 CH3 ACT D 201 C 126 LEU D 25 LEU~? 14.13 CH3 ACT D 201 C 158 GLU D 21 GLU~? 20.13 CH3 ACT D 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -55.52 60.76 33.28 -54.94 59.51 33.93 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -56.77 60.39 28.97 -57.42 60.38 26.91 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -52.88 57.10 23.42 -54.02 56.21 21.88 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 26 3 # 26 C 70 ALA D 41 ALA.? 11.61 CH3 ACT D 201 C 126 LEU D 40 LEU~? 16.21 CH3 ACT D 201 C 158 GLU D 36 GLU~? 17.76 CH3 ACT D 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -62.65 57.84 35.58 -61.25 58.43 35.41 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -66.28 60.79 35.61 -68.08 61.94 35.93 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -68.34 66.20 38.63 -69.40 64.56 39.44 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 27 3 # 27 C 70 ALA D 83 ALA^? 17.67 CH3 ACT D 201 C 126 LEU D 81 LEU^? 15.06 CH3 ACT D 201 C 158 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -44.75 49.33 32.86 -44.08 48.27 33.71 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -45.66 54.58 30.57 -46.07 52.52 30.02 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -42.96 58.73 31.72 -40.96 59.40 31.80 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 28 3 # 28 C 70 ALA D 90 ALA^? 13.83 CH3 ACT D 201 C 126 LEU D 81 LEU^? 15.06 CH3 ACT D 201 C 158 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -47.67 51.24 36.64 -46.49 50.32 36.92 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -45.66 54.58 30.57 -46.07 52.52 30.02 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -42.96 58.73 31.72 -40.96 59.40 31.80 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 29 3 # 29 C 70 ALA D 94 ALA^? 9.22 CH3 ACT D 201 C 126 LEU D 77 LEU^? 4.61 CH3 ACT D 201 C 158 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -44.41 64.30 40.02 -42.98 64.70 39.67 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -49.96 66.51 37.71 -50.27 64.38 38.00 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 30 3 # 30 C 70 ALA D 94 ALA^? 9.22 CH3 ACT D 201 C 126 LEU D 154 LEU.? 11.37 CH3 ACT D 201 C 158 GLU D 80 GLU^? 14.49 CH3 ACT D 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -44.41 64.30 40.02 -42.98 64.70 39.67 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -41.78 62.16 34.13 -42.22 62.04 36.24 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -42.96 58.73 31.72 -40.96 59.40 31.80 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 30 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 270 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 382 MET A 121 MET?? 9.94 CH3 ACT A 201 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -32.24 81.95 65.60 -33.17 83.07 67.14 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -34.66 75.11 72.84 -31.25 72.89 69.03 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -19.39 73.22 68.51 -23.08 71.33 69.62 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP A 34 ASP~? 14.63 O ACT A 201 A 270 LYS A 62 LYS~? 17.60 O ACT A 201 A 382 MET D 131 MET?? 16.14 CH3 ACT A 203 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -30.67 77.29 56.10 -29.14 77.80 54.72 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -24.69 69.09 56.72 -23.65 73.04 51.86 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -39.97 67.37 49.18 -36.29 66.71 47.12 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 270 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 382 MET A 131 MET?? 12.81 O1 EDO A 301 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -44.81 61.44 70.18 -46.75 62.70 73.78 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 270 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 382 MET B 121 MET?? 10.04 CH3 ACT B 201 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -24.83 51.75 92.00 -22.77 52.17 91.83 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -23.75 57.07 83.29 -29.11 56.74 84.70 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -35.22 63.79 92.26 -33.88 62.70 88.34 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 5 3 # 5 A 248 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 270 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 382 MET B 131 MET?? 4.22 O2 EDO A 302 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -29.37 51.20 68.01 -25.59 52.57 66.52 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 6 3 # 6 A 248 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 270 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 382 MET A 131 MET?? 12.81 O1 EDO A 301 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -44.81 61.44 70.18 -46.75 62.70 73.78 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 7 3 # 7 A 248 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 270 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 382 MET C 121 MET?? 9.90 CH3 ACT C 201 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -35.43 36.60 50.52 -37.00 35.22 50.19 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -43.47 42.54 48.33 -38.69 45.48 48.28 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -30.93 46.80 39.41 -34.36 48.07 41.66 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 8 3 # 8 A 248 ASP C 34 ASP~? 14.66 O ACT C 201 A 270 LYS C 62 LYS~? 12.50 O2 EDO A 302 A 382 MET B 131 MET?? 4.22 O2 EDO A 302 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -27.83 42.08 55.68 -25.73 41.87 55.54 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -25.76 50.99 51.27 -20.80 47.54 53.29 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -29.37 51.20 68.01 -25.59 52.57 66.52 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 9 3 # 9 A 248 ASP C 74 ASP^? 14.86 O ACT C 201 A 270 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 382 MET C 131 MET?? 12.74 O2 EDO A 301 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -49.64 54.70 58.88 -53.43 52.92 57.91 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 10 3 # 10 A 248 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 270 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 382 MET D 121 MET?? 10.11 CH3 ACT D 201 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -55.65 65.73 30.36 -54.18 65.67 28.83 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -47.37 61.41 34.65 -51.85 60.71 37.83 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -60.26 52.23 37.20 -56.63 53.79 38.78 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 11 3 # 11 A 248 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 270 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 382 MET D 131 MET?? 16.14 CH3 ACT A 203 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -39.97 67.37 49.18 -36.29 66.71 47.12 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 12 3 # 12 A 248 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 270 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 382 MET C 131 MET?? 12.74 O2 EDO A 301 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -49.64 54.70 58.88 -53.43 52.92 57.91 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 12 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 270 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 382 MET A 131 MET?? 12.81 O1 EDO A 301 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -44.81 61.44 70.18 -46.75 62.70 73.78 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 270 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 382 MET C 131 MET?? 12.74 O2 EDO A 301 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -49.64 54.70 58.88 -53.43 52.92 57.91 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 2 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 47 GLN^? 9.90 O1 EDO A 302 294 GLU A 60 GLU~? 10.63 O2 EDO A 302 304 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 15.89 18.45 46.53 15.82 16.91 48.02 -15.92 64.14 66.68 -15.70 62.99 64.91 coo 22.84 13.44 52.91 20.84 13.18 52.38 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 8.71 17.11 46.51 7.23 17.64 49.20 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN B 47 GLN^? 17.37 O ACT B 201 294 GLU B 60 GLU~? 17.33 O ACT B 201 304 ARG B 123 ARG.? 17.76 O ACT B 201 coo 15.89 18.45 46.53 15.82 16.91 48.02 -43.79 66.33 88.09 -45.65 65.30 88.17 coo 22.84 13.44 52.91 20.84 13.18 52.38 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 8.71 17.11 46.51 7.23 17.64 49.20 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN C 47 GLN^? 17.31 OXT ACT C 201 294 GLU C 60 GLU~? 17.22 OXT ACT C 201 304 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 15.89 18.45 46.53 15.82 16.91 48.02 -28.71 56.50 38.57 -27.41 57.79 39.66 coo 22.84 13.44 52.91 20.84 13.18 52.38 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 8.71 17.11 46.51 7.23 17.64 49.20 -33.35 53.49 35.15 -35.34 55.60 34.14 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 3 hits 1pmi_c00 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 101 SER.? 7.80 O2 EDO A 301 B 69 ALA D 52 ALA.? 10.75 O ACT A 203 B 241 ASN C 129 ASN.? 9.72 O ACT D 201 coo 13.24 41.94 33.13 13.08 39.54 33.17 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 9.15 37.89 36.69 10.55 37.76 37.22 -52.10 56.30 54.26 -51.39 56.64 55.56 coo 10.91 43.03 38.47 11.81 41.82 36.93 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER A 107 SER^? 6.74 O1 EDO A 301 B 69 ALA B 52 ALA.? 10.80 O1 EDO A 301 B 241 ASN A 129 ASN.? 9.65 O ACT B 201 coo 13.24 41.94 33.13 13.08 39.54 33.17 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 9.15 37.89 36.69 10.55 37.76 37.22 -42.54 59.91 74.80 -43.03 59.60 73.39 coo 10.91 43.03 38.47 11.81 41.82 36.93 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER B 107 SER^? 7.39 OXT ACT B 201 B 69 ALA A 52 ALA.? 7.92 O2 EDO A 302 B 241 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 13.24 41.94 33.13 13.08 39.54 33.17 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 9.15 37.89 36.69 10.55 37.76 37.22 -28.67 56.33 66.41 -29.48 55.05 66.20 coo 10.91 43.03 38.47 11.81 41.82 36.93 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER C 101 SER.? 7.85 O1 EDO A 301 B 69 ALA B 52 ALA.? 10.80 O1 EDO A 301 B 241 ASN A 129 ASN.? 9.65 O ACT B 201 coo 13.24 41.94 33.13 13.08 39.54 33.17 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 9.15 37.89 36.69 10.55 37.76 37.22 -42.54 59.91 74.80 -43.03 59.60 73.39 coo 10.91 43.03 38.47 11.81 41.82 36.93 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 5 3 # 5 B 1 SER C 107 SER^? 6.74 O2 EDO A 301 B 69 ALA D 52 ALA.? 10.75 O ACT A 203 B 241 ASN C 129 ASN.? 9.72 O ACT D 201 coo 13.24 41.94 33.13 13.08 39.54 33.17 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 9.15 37.89 36.69 10.55 37.76 37.22 -52.10 56.30 54.26 -51.39 56.64 55.56 coo 10.91 43.03 38.47 11.81 41.82 36.93 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 6 3 # 6 B 1 SER D 107 SER^? 7.30 OXT ACT D 201 B 69 ALA C 52 ALA.? 12.19 C2 EDO A 301 B 241 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 13.24 41.94 33.13 13.08 39.54 33.17 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 9.15 37.89 36.69 10.55 37.76 37.22 -37.45 62.38 49.17 -37.97 63.55 50.01 coo 10.91 43.03 38.47 11.81 41.82 36.93 -42.23 60.94 49.15 -42.50 59.01 49.99 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 6 hits 1pnl_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 49 ARG^? -3.92 O ACT A 202s A 479 PHE A 54 PHE^? -3.83 O1 EDO A 302s A 483 GLU B 160 GLU.? 4.71 OXT ACT A 202 coo 17.33 52.29 2.24 18.71 54.03 0.18 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 20.06 57.44 1.28 18.39 56.19 3.12 -22.35 57.66 65.34 -22.90 56.19 67.67 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -17.96 60.58 68.89 -19.86 60.60 67.97 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG A 49 ARG^? -3.92 O ACT A 202s A 479 PHE A 125 PHE.? -4.61 O ACT A 202s A 483 GLU B 160 GLU.? 4.71 OXT ACT A 202 coo 17.33 52.29 2.24 18.71 54.03 0.18 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 20.06 57.44 1.28 18.39 56.19 3.12 -22.79 63.54 72.77 -20.07 62.88 72.67 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -17.96 60.58 68.89 -19.86 60.60 67.97 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 A 264 ARG A 67 ARG~? 13.20 O2 EDO A 302 A 479 PHE A 64 PHE~? 7.17 OXT ACT A 201 A 483 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo 17.33 52.29 2.24 18.71 54.03 0.18 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 20.06 57.44 1.28 18.39 56.19 3.12 -28.19 64.67 60.35 -30.23 64.79 62.27 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 A 264 ARG A 67 ARG~? 13.20 O2 EDO A 302 A 479 PHE C 64 PHE~? 7.20 OXT ACT C 201 A 483 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo 17.33 52.29 2.24 18.71 54.03 0.18 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 20.06 57.44 1.28 18.39 56.19 3.12 -31.32 54.61 52.00 -34.04 54.10 52.45 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 A 264 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 479 PHE A 140 PHE.? 11.31 O ACT A 201 A 483 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 17.33 52.29 2.24 18.71 54.03 0.18 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 20.06 57.44 1.28 18.39 56.19 3.12 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 A 264 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 479 PHE A 140 PHE.? 11.31 O ACT A 201 A 483 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 17.33 52.29 2.24 18.71 54.03 0.18 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 20.06 57.44 1.28 18.39 56.19 3.12 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 A 264 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 479 PHE A 125 PHE.? -4.61 O ACT A 202s A 483 GLU B 160 GLU.? 4.71 OXT ACT A 202 coo 17.33 52.29 2.24 18.71 54.03 0.18 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 20.06 57.44 1.28 18.39 56.19 3.12 -22.79 63.54 72.77 -20.07 62.88 72.67 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -17.96 60.58 68.89 -19.86 60.60 67.97 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 A 264 ARG B 67 ARG~? 13.55 O ACT B 201 A 479 PHE B 64 PHE~? 7.22 O ACT B 201 A 483 GLU B 53 GLU^? 11.09 O ACT B 201 coo 17.33 52.29 2.24 18.71 54.03 0.18 -45.57 49.20 81.23 -45.93 51.82 82.79 coo 20.06 57.44 1.28 18.39 56.19 3.12 -41.04 53.74 82.96 -38.84 53.80 81.23 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 9 3 # 9 A 264 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 479 PHE B 140 PHE.? 8.97 CH3 ACT A 202 A 483 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 17.33 52.29 2.24 18.71 54.03 0.18 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 20.06 57.44 1.28 18.39 56.19 3.12 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 10 3 # 10 A 264 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 479 PHE B 140 PHE.? 8.97 CH3 ACT A 202 A 483 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 17.33 52.29 2.24 18.71 54.03 0.18 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 20.06 57.44 1.28 18.39 56.19 3.12 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 11 3 # 11 A 264 ARG C 67 ARG~? 12.50 O2 EDO A 302 A 479 PHE A 64 PHE~? 7.17 OXT ACT A 201 A 483 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo 17.33 52.29 2.24 18.71 54.03 0.18 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 20.06 57.44 1.28 18.39 56.19 3.12 -28.19 64.67 60.35 -30.23 64.79 62.27 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 12 3 # 12 A 264 ARG C 67 ARG~? 12.50 O2 EDO A 302 A 479 PHE C 64 PHE~? 7.20 OXT ACT C 201 A 483 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo 17.33 52.29 2.24 18.71 54.03 0.18 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 20.06 57.44 1.28 18.39 56.19 3.12 -31.32 54.61 52.00 -34.04 54.10 52.45 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 13 3 # 13 A 264 ARG C 76 ARG^? 14.32 O ACT C 201 A 479 PHE C 140 PHE.? 11.33 O ACT C 201 A 483 GLU C 96 GLU^? 13.00 O ACT C 201 coo 17.33 52.29 2.24 18.71 54.03 0.18 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 20.06 57.44 1.28 18.39 56.19 3.12 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 14 3 # 14 A 264 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 479 PHE C 140 PHE.? 11.33 O ACT C 201 A 483 GLU C 96 GLU^? 13.00 O ACT C 201 coo 17.33 52.29 2.24 18.71 54.03 0.18 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 20.06 57.44 1.28 18.39 56.19 3.12 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 15 3 # 15 A 264 ARG D 67 ARG~? 13.15 O ACT A 203 A 479 PHE D 64 PHE~? 7.18 O ACT D 201 A 483 GLU D 53 GLU^? 10.32 O ACT A 203 coo 17.33 52.29 2.24 18.71 54.03 0.18 -60.60 65.68 53.30 -61.45 62.86 52.44 coo 20.06 57.44 1.28 18.39 56.19 3.12 -58.34 61.83 48.37 -55.63 62.31 47.87 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -56.60 59.52 53.75 -57.18 61.28 52.77 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 16 3 # 16 A 264 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 479 PHE D 140 PHE.? 11.31 OXT ACT D 201 A 483 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 17.33 52.29 2.24 18.71 54.03 0.18 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 20.06 57.44 1.28 18.39 56.19 3.12 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -43.29 70.99 40.99 -41.92 72.19 39.92 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 17 3 # 17 A 264 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 479 PHE D 140 PHE.? 11.31 OXT ACT D 201 A 483 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 17.33 52.29 2.24 18.71 54.03 0.18 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 20.06 57.44 1.28 18.39 56.19 3.12 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -43.29 70.99 40.99 -41.92 72.19 39.92 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 17 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 49 ARG^? -3.92 O ACT A 202s B 479 PHE A 54 PHE^? -3.83 O1 EDO A 302s B 483 GLU B 160 GLU.? 4.71 OXT ACT A 202 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -25.12 58.31 69.83 -26.93 60.25 71.40 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -22.35 57.66 65.34 -22.90 56.19 67.67 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -17.96 60.58 68.89 -19.86 60.60 67.97 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG A 49 ARG^? -3.92 O ACT A 202s B 479 PHE A 125 PHE.? -4.61 O ACT A 202s B 483 GLU B 160 GLU.? 4.71 OXT ACT A 202 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -25.12 58.31 69.83 -26.93 60.25 71.40 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -22.79 63.54 72.77 -20.07 62.88 72.67 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -17.96 60.58 68.89 -19.86 60.60 67.97 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 B 264 ARG A 67 ARG~? 13.20 O2 EDO A 302 B 479 PHE A 64 PHE~? 7.17 OXT ACT A 201 B 483 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -28.19 64.67 60.35 -30.23 64.79 62.27 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 B 264 ARG A 67 ARG~? 13.20 O2 EDO A 302 B 479 PHE C 64 PHE~? 7.20 OXT ACT C 201 B 483 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -31.32 54.61 52.00 -34.04 54.10 52.45 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 B 264 ARG A 76 ARG^? 8.97 OXT ACT A 203 B 479 PHE A 140 PHE.? 11.31 O ACT A 201 B 483 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -44.06 74.70 68.64 -42.76 73.46 70.80 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 B 264 ARG A 106 ARG^? 14.48 O1 EDO A 301 B 479 PHE A 140 PHE.? 11.31 O ACT A 201 B 483 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -44.60 68.65 71.93 -47.65 68.54 71.92 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -44.06 74.70 68.64 -42.76 73.46 70.80 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 B 264 ARG A 123 ARG.? 8.27 CH3 ACT A 202 B 479 PHE A 125 PHE.? -4.61 O ACT A 202s B 483 GLU B 160 GLU.? 4.71 OXT ACT A 202 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -16.75 65.40 71.93 -16.81 64.50 74.86 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -22.79 63.54 72.77 -20.07 62.88 72.67 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -17.96 60.58 68.89 -19.86 60.60 67.97 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 B 264 ARG B 67 ARG~? 13.55 O ACT B 201 B 479 PHE B 64 PHE~? 7.22 O ACT B 201 B 483 GLU B 53 GLU^? 11.09 O ACT B 201 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -45.57 49.20 81.23 -45.93 51.82 82.79 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -41.04 53.74 82.96 -38.84 53.80 81.23 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 9 3 # 9 B 264 ARG B 76 ARG^? 14.33 OXT ACT B 201 B 479 PHE B 140 PHE.? 8.97 CH3 ACT A 202 B 483 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -21.72 48.56 78.43 -22.15 51.11 77.34 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 10 3 # 10 B 264 ARG B 106 ARG^? 5.91 C1 EDO A 302 B 479 PHE B 140 PHE.? 8.97 CH3 ACT A 202 B 483 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -21.72 48.56 78.43 -22.15 51.11 77.34 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 11 3 # 11 B 264 ARG C 67 ARG~? 12.50 O2 EDO A 302 B 479 PHE A 64 PHE~? 7.17 OXT ACT A 201 B 483 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -28.19 64.67 60.35 -30.23 64.79 62.27 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 12 3 # 12 B 264 ARG C 67 ARG~? 12.50 O2 EDO A 302 B 479 PHE C 64 PHE~? 7.20 OXT ACT C 201 B 483 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -31.32 54.61 52.00 -34.04 54.10 52.45 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 13 3 # 13 B 264 ARG C 76 ARG^? 14.32 O ACT C 201 B 479 PHE C 140 PHE.? 11.33 O ACT C 201 B 483 GLU C 96 GLU^? 13.00 O ACT C 201 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -42.25 40.39 61.14 -41.06 40.24 63.98 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -46.25 41.88 58.15 -47.27 43.20 55.89 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 14 3 # 14 B 264 ARG C 106 ARG^? 14.47 O2 EDO A 301 B 479 PHE C 140 PHE.? 11.33 O ACT C 201 B 483 GLU C 96 GLU^? 13.00 O ACT C 201 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -49.78 47.48 57.01 -51.73 47.13 59.31 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -46.25 41.88 58.15 -47.27 43.20 55.89 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 15 3 # 15 B 264 ARG D 67 ARG~? 13.15 O ACT A 203 B 479 PHE D 64 PHE~? 7.18 O ACT D 201 B 483 GLU D 53 GLU^? 10.32 O ACT A 203 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -60.60 65.68 53.30 -61.45 62.86 52.44 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -58.34 61.83 48.37 -55.63 62.31 47.87 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -56.60 59.52 53.75 -57.18 61.28 52.77 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 16 3 # 16 B 264 ARG D 76 ARG^? 14.20 OXT ACT D 201 B 479 PHE D 140 PHE.? 11.31 OXT ACT D 201 B 483 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -47.81 74.29 36.53 -48.87 77.02 37.43 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -43.95 70.80 36.81 -42.95 68.23 37.34 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -43.29 70.99 40.99 -41.92 72.19 39.92 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 17 3 # 17 B 264 ARG D 106 ARG^? 14.88 OXT ACT D 201 B 479 PHE D 140 PHE.? 11.31 OXT ACT D 201 B 483 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -43.95 70.80 36.81 -42.95 68.23 37.34 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -43.29 70.99 40.99 -41.92 72.19 39.92 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 17 hits 1pow_c03 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 31 ASN~? 8.53 CH3 ACT A 201 A 192 ASP A 150 ASP.? 22.07 CH3 ACT A 201 A 195 HIS A 151 HIS.? 15.97 CH3 ACT A 201 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -36.15 78.19 63.69 -37.32 77.26 65.21 coo 2.03 47.14 19.75 1.72 46.26 21.64 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -43.83 81.49 70.61 -45.02 79.78 70.42 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN B 103 ASN.? 17.21 C2 EDO A 302 A 192 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 195 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -32.39 41.19 68.51 -33.08 39.66 67.21 coo 2.03 47.14 19.75 1.72 46.26 21.64 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 A 74 ASN B 129 ASN.? 9.80 OXT ACT A 201 A 192 ASP C 74 ASP^? 14.86 O ACT C 201 A 195 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 2.03 47.14 19.75 1.72 46.26 21.64 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 A 74 ASN C 31 ASN~? 8.68 CH3 ACT C 201 A 192 ASP C 150 ASP.? 20.99 CH3 ACT C 201 A 195 HIS C 151 HIS.? 16.03 CH3 ACT C 201 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -36.93 39.85 55.08 -38.97 40.48 55.12 coo 2.03 47.14 19.75 1.72 46.26 21.64 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -46.81 35.18 56.40 -47.74 36.88 57.21 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 A 74 ASN D 103 ASN.? 11.64 CH3 ACT A 203 A 192 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 195 HIS A 98 HIS^? -3.60 C ACT A 203s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -43.97 76.72 52.03 -43.49 78.26 53.43 coo 2.03 47.14 19.75 1.72 46.26 21.64 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 A 74 ASN D 129 ASN.? 9.72 OXT ACT C 201 A 192 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 195 HIS A 98 HIS^? -3.60 C ACT A 203s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 2.03 47.14 19.75 1.72 46.26 21.64 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -46.65 67.75 58.52 -46.50 68.86 56.74 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 6 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 31 ASN~? 8.53 CH3 ACT A 201 B 192 ASP A 150 ASP.? 22.07 CH3 ACT A 201 B 195 HIS A 151 HIS.? 15.97 CH3 ACT A 201 coo -1.08 51.41 10.34 0.65 52.62 10.17 -36.15 78.19 63.69 -37.32 77.26 65.21 coo 11.36 52.33 5.59 10.18 53.87 6.47 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 7.99 56.74 7.55 6.88 55.39 8.70 -43.83 81.49 70.61 -45.02 79.78 70.42 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN B 103 ASN.? 17.21 C2 EDO A 302 B 192 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 195 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo -1.08 51.41 10.34 0.65 52.62 10.17 -32.39 41.19 68.51 -33.08 39.66 67.21 coo 11.36 52.33 5.59 10.18 53.87 6.47 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 7.99 56.74 7.55 6.88 55.39 8.70 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 B 74 ASN B 129 ASN.? 9.80 OXT ACT A 201 B 192 ASP C 74 ASP^? 14.86 O ACT C 201 B 195 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo -1.08 51.41 10.34 0.65 52.62 10.17 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 11.36 52.33 5.59 10.18 53.87 6.47 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 7.99 56.74 7.55 6.88 55.39 8.70 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 B 74 ASN C 31 ASN~? 8.68 CH3 ACT C 201 B 192 ASP C 150 ASP.? 20.99 CH3 ACT C 201 B 195 HIS C 151 HIS.? 16.03 CH3 ACT C 201 coo -1.08 51.41 10.34 0.65 52.62 10.17 -36.93 39.85 55.08 -38.97 40.48 55.12 coo 11.36 52.33 5.59 10.18 53.87 6.47 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 7.99 56.74 7.55 6.88 55.39 8.70 -46.81 35.18 56.40 -47.74 36.88 57.21 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 B 74 ASN D 103 ASN.? 11.64 CH3 ACT A 203 B 192 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 195 HIS A 98 HIS^? -3.60 C ACT A 203s coo -1.08 51.41 10.34 0.65 52.62 10.17 -43.97 76.72 52.03 -43.49 78.26 53.43 coo 11.36 52.33 5.59 10.18 53.87 6.47 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 7.99 56.74 7.55 6.88 55.39 8.70 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 B 74 ASN D 129 ASN.? 9.72 OXT ACT C 201 B 192 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 195 HIS A 98 HIS^? -3.60 C ACT A 203s coo -1.08 51.41 10.34 0.65 52.62 10.17 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 11.36 52.33 5.59 10.18 53.87 6.47 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 7.99 56.74 7.55 6.88 55.39 8.70 -46.65 67.75 58.52 -46.50 68.86 56.74 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 6 hits 1pp4_c03 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 67 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 86 HIS A 151 HIS.? 15.97 CH3 ACT A 201 coo 18.15 3.28 18.56 20.10 2.92 19.20 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 21.52 6.83 26.64 21.22 5.53 23.85 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -43.83 81.49 70.61 -45.02 79.78 70.42 ULMN 3 1pyl_c00 RIBONUCLEASE user 2 3 # 2 A 56 GLU A 137 GLU~? 14.03 O ACT A 203 A 67 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 86 HIS A 161 HIS.? 19.24 O ACT B 201 coo 18.15 3.28 18.56 20.10 2.92 19.20 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 21.52 6.83 26.64 21.22 5.53 23.85 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -48.72 65.75 79.30 -49.45 66.41 81.15 ULMN 3 1pyl_c00 RIBONUCLEASE user 3 3 # 3 A 56 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 67 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 86 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo 18.15 3.28 18.56 20.10 2.92 19.20 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 21.52 6.83 26.64 21.22 5.53 23.85 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1pyl_c00 RIBONUCLEASE user 4 3 # 4 A 56 GLU B 53 GLU^? 11.09 O ACT B 201 A 67 ARG B 49 ARG^? 10.37 O ACT B 201 A 86 HIS A 161 HIS.? 19.24 O ACT B 201 coo 18.15 3.28 18.56 20.10 2.92 19.20 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 21.52 6.83 26.64 21.22 5.53 23.85 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -48.72 65.75 79.30 -49.45 66.41 81.15 ULMN 3 1pyl_c00 RIBONUCLEASE user 5 3 # 5 A 56 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 67 ARG B 147 ARG.? 12.52 CH3 ACT A 202 A 86 HIS B 141 HIS.? 15.94 CH3 ACT A 202 coo 18.15 3.28 18.56 20.10 2.92 19.20 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 21.52 6.83 26.64 21.22 5.53 23.85 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -16.42 43.62 79.59 -14.76 44.89 79.44 ULMN 3 1pyl_c00 RIBONUCLEASE user 6 3 # 6 A 56 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 67 ARG C 76 ARG^? 14.32 O ACT C 201 A 86 HIS C 151 HIS.? 16.03 CH3 ACT C 201 coo 18.15 3.28 18.56 20.10 2.92 19.20 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 21.52 6.83 26.64 21.22 5.53 23.85 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -46.81 35.18 56.40 -47.74 36.88 57.21 ULMN 3 1pyl_c00 RIBONUCLEASE user 7 3 # 7 A 56 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 67 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 86 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo 18.15 3.28 18.56 20.10 2.92 19.20 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 21.52 6.83 26.64 21.22 5.53 23.85 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -44.04 70.63 29.61 -43.01 70.81 31.43 ULMN 3 1pyl_c00 RIBONUCLEASE user 8 3 # 8 A 56 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 67 ARG D 147 ARG.? 13.02 CH3 ACT D 201 A 86 HIS D 141 HIS.? 18.95 OXT ACT D 201 coo 18.15 3.28 18.56 20.10 2.92 19.20 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 21.52 6.83 26.64 21.22 5.53 23.85 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -42.77 77.11 33.23 -41.72 76.77 31.45 1pyl_c00 source 1pyl RIBONUCLEASE : 8 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 27 GLU~? 9.74 CH3 ACT A 201 B 67 ARG A 76 ARG^? 8.97 OXT ACT A 203 B 86 HIS A 151 HIS.? 15.97 CH3 ACT A 201 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -43.83 81.49 70.61 -45.02 79.78 70.42 ULMN 3 1pyl_c01 RIBONUCLEASE user 2 3 # 2 B 56 GLU A 27 GLU~? 9.74 CH3 ACT A 201 B 67 ARG A 146 ARG.? 16.48 CH3 ACT A 201 B 86 HIS A 151 HIS.? 15.97 CH3 ACT A 201 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -43.83 81.49 70.61 -45.02 79.78 70.42 ULMN 3 1pyl_c01 RIBONUCLEASE user 3 3 # 3 B 56 GLU A 53 GLU^? 10.41 O2 EDO A 302 B 67 ARG A 49 ARG^? -3.92 O ACT A 202s B 86 HIS A 56 HIS.? 6.76 O1 EDO A 302 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -17.38 60.38 62.27 -18.29 58.66 63.03 ULMN 3 1pyl_c01 RIBONUCLEASE user 4 3 # 4 B 56 GLU A 72 GLU~? 5.31 O ACT A 201 B 67 ARG A 33 ARG.? 12.39 O ACT A 201 B 86 HIS A 98 HIS^? -3.60 C ACT A 203s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -37.81 74.92 58.71 -38.09 77.66 57.35 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 1pyl_c01 RIBONUCLEASE user 5 3 # 5 B 56 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 67 ARG A 147 ARG.? 13.06 CH3 ACT A 201 B 86 HIS A 141 HIS.? 11.20 OXT ACT A 203 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -49.96 77.41 66.16 -51.01 75.70 66.78 ULMN 3 1pyl_c01 RIBONUCLEASE user 6 3 # 6 B 56 GLU A 137 GLU~? 14.03 O ACT A 203 B 67 ARG A 106 ARG^? 14.48 O1 EDO A 301 B 86 HIS A 161 HIS.? 19.24 O ACT B 201 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -48.72 65.75 79.30 -49.45 66.41 81.15 ULMN 3 1pyl_c01 RIBONUCLEASE user 7 3 # 7 B 56 GLU A 160 GLU.? 13.50 O ACT A 201 B 67 ARG B 49 ARG^? 10.37 O ACT B 201 B 86 HIS A 162 HIS.? 14.54 O1 EDO A 301 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -51.28 62.77 74.01 -50.27 62.16 72.28 ULMN 3 1pyl_c01 RIBONUCLEASE user 8 3 # 8 B 56 GLU B 27 GLU~? 9.83 CH3 ACT B 201 B 67 ARG B 76 ARG^? 14.33 OXT ACT B 201 B 86 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1pyl_c01 RIBONUCLEASE user 9 3 # 9 B 56 GLU B 27 GLU~? 9.83 CH3 ACT B 201 B 67 ARG B 146 ARG.? 16.58 CH3 ACT B 201 B 86 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -21.21 49.21 92.90 -18.50 50.59 92.50 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1pyl_c01 RIBONUCLEASE user 10 3 # 10 B 56 GLU B 53 GLU^? 11.09 O ACT B 201 B 67 ARG B 49 ARG^? 10.37 O ACT B 201 B 86 HIS A 161 HIS.? 19.24 O ACT B 201 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -48.72 65.75 79.30 -49.45 66.41 81.15 ULMN 3 1pyl_c01 RIBONUCLEASE user 11 3 # 11 B 56 GLU B 53 GLU^? 11.09 O ACT B 201 B 67 ARG B 49 ARG^? 10.37 O ACT B 201 B 86 HIS A 162 HIS.? 14.54 O1 EDO A 301 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -51.28 62.77 74.01 -50.27 62.16 72.28 ULMN 3 1pyl_c01 RIBONUCLEASE user 12 3 # 12 B 56 GLU B 53 GLU^? 11.09 O ACT B 201 B 67 ARG B 49 ARG^? 10.37 O ACT B 201 B 86 HIS B 56 HIS.? 17.31 O ACT B 201 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -48.13 62.85 85.87 -48.38 63.10 83.80 ULMN 3 1pyl_c01 RIBONUCLEASE user 13 3 # 13 B 56 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 67 ARG B 147 ARG.? 12.52 CH3 ACT A 202 B 86 HIS B 141 HIS.? 15.94 CH3 ACT A 202 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -16.42 43.62 79.59 -14.76 44.89 79.44 ULMN 3 1pyl_c01 RIBONUCLEASE user 14 3 # 14 B 56 GLU C 27 GLU~? 9.88 CH3 ACT C 201 B 67 ARG C 76 ARG^? 14.32 O ACT C 201 B 86 HIS C 151 HIS.? 16.03 CH3 ACT C 201 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -46.81 35.18 56.40 -47.74 36.88 57.21 ULMN 3 1pyl_c01 RIBONUCLEASE user 15 3 # 15 B 56 GLU C 27 GLU~? 9.88 CH3 ACT C 201 B 67 ARG C 146 ARG.? 16.63 CH3 ACT C 201 B 86 HIS C 151 HIS.? 16.03 CH3 ACT C 201 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -36.58 32.85 52.68 -38.87 31.31 51.32 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -46.81 35.18 56.40 -47.74 36.88 57.21 ULMN 3 1pyl_c01 RIBONUCLEASE user 16 3 # 16 B 56 GLU C 53 GLU^? 11.18 OXT ACT C 201 B 67 ARG C 49 ARG^? 10.47 OXT ACT C 201 B 86 HIS C 56 HIS.? 17.26 OXT ACT C 201 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -26.71 60.26 42.75 -28.06 61.81 43.18 ULMN 3 1pyl_c01 RIBONUCLEASE user 17 3 # 17 B 56 GLU C 72 GLU~? 5.32 O ACT C 201 B 67 ARG C 33 ARG.? 12.41 O ACT C 201 B 86 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 1pyl_c01 RIBONUCLEASE user 18 3 # 18 B 56 GLU C 96 GLU^? 13.00 O ACT C 201 B 67 ARG C 147 ARG.? 13.23 CH3 ACT C 201 B 86 HIS C 141 HIS.? 17.85 O ACT C 201 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -47.33 38.55 64.23 -48.23 40.22 65.13 ULMN 3 1pyl_c01 RIBONUCLEASE user 19 3 # 19 B 56 GLU D 27 GLU~? 9.75 CH3 ACT D 201 B 67 ARG D 76 ARG^? 14.20 OXT ACT D 201 B 86 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -44.04 70.63 29.61 -43.01 70.81 31.43 ULMN 3 1pyl_c01 RIBONUCLEASE user 20 3 # 20 B 56 GLU D 27 GLU~? 9.75 CH3 ACT D 201 B 67 ARG D 146 ARG.? 16.60 CH3 ACT D 201 B 86 HIS D 151 HIS.? 15.66 CH3 ACT D 201 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -54.51 68.83 27.22 -52.30 68.02 25.26 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -44.04 70.63 29.61 -43.01 70.81 31.43 ULMN 3 1pyl_c01 RIBONUCLEASE user 21 3 # 21 B 56 GLU D 53 GLU^? 10.32 O ACT A 203 B 67 ARG D 49 ARG^? 10.44 O ACT D 201 B 86 HIS D 56 HIS.? 17.26 O ACT D 201 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -63.50 51.60 51.23 -61.99 51.43 52.67 ULMN 3 1pyl_c01 RIBONUCLEASE user 22 3 # 22 B 56 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 67 ARG D 33 ARG.? 12.34 OXT ACT D 201 B 86 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -55.21 72.58 39.53 -56.74 74.11 37.37 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -48.48 77.63 46.64 -50.12 78.90 46.30 ULMN 3 1pyl_c01 RIBONUCLEASE user 23 3 # 23 B 56 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 67 ARG D 147 ARG.? 13.02 CH3 ACT D 201 B 86 HIS D 141 HIS.? 18.95 OXT ACT D 201 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -42.77 77.11 33.23 -41.72 76.77 31.45 1pyl_c01 source 1pyl RIBONUCLEASE : 23 hits 1pyl_c01 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN A 129 ASN.? 9.65 O ACT B 201 A 239 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 246 TYR A 108 TYR^? 12.28 O ACT A 201 coo 2.50 7.27 18.06 0.76 7.28 16.81 -38.33 60.18 72.42 -36.71 58.96 73.06 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 2 3 # 2 A 191 ASN A 129 ASN.? 9.65 O ACT B 201 A 239 ARG B 49 ARG^? 10.37 O ACT B 201 A 246 TYR A 108 TYR^? 12.28 O ACT A 201 coo 2.50 7.27 18.06 0.76 7.28 16.81 -38.33 60.18 72.42 -36.71 58.96 73.06 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 3 3 # 3 A 191 ASN B 129 ASN.? 9.80 OXT ACT A 201 A 239 ARG A 49 ARG^? -3.92 O ACT A 202s A 246 TYR B 108 TYR^? -4.79 O ACT A 202s coo 2.50 7.27 18.06 0.76 7.28 16.81 -31.81 57.09 70.18 -32.97 58.85 69.97 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 4 3 # 4 A 191 ASN B 129 ASN.? 9.80 OXT ACT A 201 A 239 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 246 TYR B 108 TYR^? -4.79 O ACT A 202s coo 2.50 7.27 18.06 0.76 7.28 16.81 -31.81 57.09 70.18 -32.97 58.85 69.97 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 5 3 # 5 A 191 ASN C 129 ASN.? 9.72 O ACT D 201 A 239 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 246 TYR C 108 TYR^? 12.28 O ACT C 201 coo 2.50 7.27 18.06 0.76 7.28 16.81 -47.56 56.76 52.53 -47.22 58.18 50.99 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 6 3 # 6 A 191 ASN C 129 ASN.? 9.72 O ACT D 201 A 239 ARG D 49 ARG^? 10.44 O ACT D 201 A 246 TYR C 108 TYR^? 12.28 O ACT C 201 coo 2.50 7.27 18.06 0.76 7.28 16.81 -47.56 56.76 52.53 -47.22 58.18 50.99 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 7 3 # 7 A 191 ASN D 129 ASN.? 9.72 OXT ACT C 201 A 239 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 246 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 2.50 7.27 18.06 0.76 7.28 16.81 -42.23 60.94 49.15 -42.50 59.01 49.99 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 8 3 # 8 A 191 ASN D 129 ASN.? 9.72 OXT ACT C 201 A 239 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 246 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 2.50 7.27 18.06 0.76 7.28 16.81 -42.23 60.94 49.15 -42.50 59.01 49.99 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -40.41 63.05 43.73 -38.60 65.12 43.23 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 8 hits 1qaz_c00 naa= 3 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 8 ARG.? 15.23 CH3 ACT A 201 A 581 ARG A 58 ARG~? 18.13 CH3 ACT A 201 A 713 ARG A 37 ARG~? 13.73 CH3 ACT A 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -28.83 80.54 58.97 -30.62 82.33 60.70 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 49 ARG^? -3.92 O ACT A 202s A 581 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG A 49 ARG^? -3.92 O ACT A 202s A 581 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 581 ARG A 49 ARG^? -3.92 O ACT A 202s A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 581 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 713 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 581 ARG B 49 ARG^? 10.37 O ACT B 201 A 713 ARG B 123 ARG.? 17.76 O ACT B 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 7 3 # 7 A 396 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 581 ARG B 49 ARG^? 10.37 O ACT B 201 A 713 ARG B 124 ARG.? -3.52 O ACT B 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 8 3 # 8 A 396 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 581 ARG B 123 ARG.? 17.76 O ACT B 201 A 713 ARG B 49 ARG^? 10.37 O ACT B 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 9 3 # 9 A 396 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 581 ARG B 123 ARG.? 17.76 O ACT B 201 A 713 ARG B 124 ARG.? -3.52 O ACT B 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 10 3 # 10 A 396 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 581 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 713 ARG A 49 ARG^? -3.92 O ACT A 202s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 11 3 # 11 A 396 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 581 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 12 3 # 12 A 396 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 581 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 713 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 13 3 # 13 A 396 ARG B 8 ARG.? 14.49 CH3 ACT B 201 A 581 ARG B 37 ARG~? 13.57 CH3 ACT B 201 A 713 ARG B 58 ARG~? 17.86 CH3 ACT B 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -31.32 49.06 94.80 -28.26 48.93 94.55 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -41.40 56.24 95.43 -40.17 57.59 97.88 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 14 3 # 14 A 396 ARG B 33 ARG.? 12.67 OXT ACT B 201 A 581 ARG B 37 ARG~? 13.57 CH3 ACT B 201 A 713 ARG B 146 ARG.? 16.58 CH3 ACT B 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -31.32 49.06 94.80 -28.26 48.93 94.55 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -21.21 49.21 92.90 -18.50 50.59 92.50 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 15 3 # 15 A 396 ARG B 37 ARG~? 13.57 CH3 ACT B 201 A 581 ARG B 33 ARG.? 12.67 OXT ACT B 201 A 713 ARG B 146 ARG.? 16.58 CH3 ACT B 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -31.32 49.06 94.80 -28.26 48.93 94.55 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -21.21 49.21 92.90 -18.50 50.59 92.50 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 16 3 # 16 A 396 ARG B 49 ARG^? 10.37 O ACT B 201 A 581 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 713 ARG B 124 ARG.? -3.52 O ACT B 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 17 3 # 17 A 396 ARG B 49 ARG^? 10.37 O ACT B 201 A 581 ARG B 51 ARG.? 7.67 O ACT B 201 A 713 ARG B 124 ARG.? -3.52 O ACT B 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 18 3 # 18 A 396 ARG B 51 ARG.? 7.67 O ACT B 201 A 581 ARG B 49 ARG^? 10.37 O ACT B 201 A 713 ARG B 124 ARG.? -3.52 O ACT B 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 19 3 # 19 A 396 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 581 ARG B 138 ARG~? 16.35 OXT ACT B 201 A 713 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 20 3 # 20 A 396 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 581 ARG B 147 ARG.? 12.52 CH3 ACT A 202 A 713 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 21 3 # 21 A 396 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 581 ARG A 49 ARG^? -3.92 O ACT A 202s A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 22 3 # 22 A 396 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 581 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 713 ARG A 49 ARG^? -3.92 O ACT A 202s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 23 3 # 23 A 396 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 581 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 713 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 24 3 # 24 A 396 ARG B 123 ARG.? 17.76 O ACT B 201 A 581 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 713 ARG B 49 ARG^? 10.37 O ACT B 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 25 3 # 25 A 396 ARG B 123 ARG.? 17.76 O ACT B 201 A 581 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 713 ARG B 124 ARG.? -3.52 O ACT B 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 26 3 # 26 A 396 ARG B 138 ARG~? 16.35 OXT ACT B 201 A 581 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 713 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 27 3 # 27 A 396 ARG C 8 ARG.? 14.74 CH3 ACT C 201 A 581 ARG C 58 ARG~? 18.03 CH3 ACT C 201 A 713 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 28 3 # 28 A 396 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 581 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 713 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 29 3 # 29 A 396 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 581 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 713 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 30 3 # 30 A 396 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 581 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 713 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 31 3 # 31 A 396 ARG C 76 ARG^? 14.32 O ACT C 201 A 581 ARG C 138 ARG~? 16.31 O ACT C 201 A 713 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 32 3 # 32 A 396 ARG C 76 ARG^? 14.32 O ACT C 201 A 581 ARG C 147 ARG.? 13.23 CH3 ACT C 201 A 713 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 33 3 # 33 A 396 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 581 ARG D 49 ARG^? 10.44 O ACT D 201 A 713 ARG D 123 ARG.? 17.60 O ACT D 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 34 3 # 34 A 396 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 581 ARG D 49 ARG^? 10.44 O ACT D 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 35 3 # 35 A 396 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 581 ARG D 88 ARG^? 18.35 CH3 ACT C 201 A 713 ARG D 123 ARG.? 17.60 O ACT D 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 36 3 # 36 A 396 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 581 ARG D 123 ARG.? 17.60 O ACT D 201 A 713 ARG D 49 ARG^? 10.44 O ACT D 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 37 3 # 37 A 396 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 581 ARG D 123 ARG.? 17.60 O ACT D 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 38 3 # 38 A 396 ARG C 123 ARG.? 17.68 OXT ACT C 201 A 581 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 713 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 39 3 # 39 A 396 ARG C 123 ARG.? 17.68 OXT ACT C 201 A 581 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 713 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 40 3 # 40 A 396 ARG C 138 ARG~? 16.31 O ACT C 201 A 581 ARG C 76 ARG^? 14.32 O ACT C 201 A 713 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 41 3 # 41 A 396 ARG D 49 ARG^? 10.44 O ACT D 201 A 581 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 42 3 # 42 A 396 ARG D 49 ARG^? 10.44 O ACT D 201 A 581 ARG D 51 ARG.? 7.60 O ACT D 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 43 3 # 43 A 396 ARG D 51 ARG.? 7.60 O ACT D 201 A 581 ARG D 49 ARG^? 10.44 O ACT D 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 44 3 # 44 A 396 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 581 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 713 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -40.22 67.90 41.60 -38.15 70.12 41.98 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 45 3 # 45 A 396 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 581 ARG D 147 ARG.? 13.02 CH3 ACT D 201 A 713 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -40.22 67.90 41.60 -38.15 70.12 41.98 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 46 3 # 46 A 396 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 581 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 713 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 47 3 # 47 A 396 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 581 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 713 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 48 3 # 48 A 396 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 581 ARG C 123 ARG.? 17.68 OXT ACT C 201 A 713 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 49 3 # 49 A 396 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 581 ARG C 123 ARG.? 17.68 OXT ACT C 201 A 713 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 50 3 # 50 A 396 ARG D 123 ARG.? 17.60 O ACT D 201 A 581 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 713 ARG D 49 ARG^? 10.44 O ACT D 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 51 3 # 51 A 396 ARG D 123 ARG.? 17.60 O ACT D 201 A 581 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 713 ARG D 124 ARG.? -3.55 O ACT D 201s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 52 3 # 52 A 396 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 581 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 713 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -40.22 67.90 41.60 -38.15 70.12 41.98 1qb4_c01 source 1qb4 PHOSPHOENOLPYRUVATE CARBOXYLASE : 52 hits 1qb4_c01 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 A 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 A 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 55.45 46.76 42.08 57.34 46.16 42.75 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 155 HIS A 98 HIS^? -3.60 C ACT A 203s A 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 48.87 29.19 44.63 49.10 27.34 43.63 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 155 HIS A 98 HIS^? -3.60 C ACT A 203s A 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 55.45 46.76 42.08 57.34 46.16 42.75 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 48.87 29.19 44.63 49.10 27.34 43.63 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 A 236 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 47.58 17.35 41.83 51.40 20.85 40.83 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 A 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 48.87 29.19 44.63 49.10 27.34 43.63 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 47.58 17.35 41.83 51.40 20.85 40.83 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 236 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 48.87 29.19 44.63 49.10 27.34 43.63 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 47.58 17.35 41.83 51.40 20.85 40.83 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 236 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 48.87 29.19 44.63 49.10 27.34 43.63 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 47.58 17.35 41.83 51.40 20.85 40.83 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 155 HIS A 161 HIS.? 19.24 O ACT B 201 A 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 48.87 29.19 44.63 49.10 27.34 43.63 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 47.58 17.35 41.83 51.40 20.85 40.83 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 155 HIS A 161 HIS.? 19.24 O ACT B 201 A 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 48.87 29.19 44.63 49.10 27.34 43.63 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 47.58 17.35 41.83 51.40 20.85 40.83 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 155 HIS B 56 HIS.? 17.31 O ACT B 201 A 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 48.87 29.19 44.63 49.10 27.34 43.63 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 47.58 17.35 41.83 51.40 20.85 40.83 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 155 HIS B 56 HIS.? 17.31 O ACT B 201 A 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 48.87 29.19 44.63 49.10 27.34 43.63 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 A 155 HIS B 56 HIS.? 17.31 O ACT B 201 A 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 48.87 29.19 44.63 49.10 27.34 43.63 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 47.58 17.35 41.83 51.40 20.85 40.83 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 A 155 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 48.87 29.19 44.63 49.10 27.34 43.63 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 A 155 HIS B 141 HIS.? 15.94 CH3 ACT A 202 A 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 47.58 17.35 41.83 51.40 20.85 40.83 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 A 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 A 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 47.58 17.35 41.83 51.40 20.85 40.83 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 A 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 A 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 55.45 46.76 42.08 57.34 46.16 42.75 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 47.58 17.35 41.83 51.40 20.85 40.83 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 A 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 47.58 17.35 41.83 51.40 20.85 40.83 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 A 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 55.45 46.76 42.08 57.34 46.16 42.75 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 47.58 17.35 41.83 51.40 20.85 40.83 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 A 155 HIS C 141 HIS.? 17.85 O ACT C 201 A 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 48.87 29.19 44.63 49.10 27.34 43.63 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 A 155 HIS C 141 HIS.? 17.85 O ACT C 201 A 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 48.87 29.19 44.63 49.10 27.34 43.63 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 A 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 236 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 48.87 29.19 44.63 49.10 27.34 43.63 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 A 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 236 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 48.87 29.19 44.63 49.10 27.34 43.63 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 A 155 HIS D 56 HIS.? 17.26 O ACT D 201 A 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 48.87 29.19 44.63 49.10 27.34 43.63 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 A 155 HIS D 56 HIS.? 17.26 O ACT D 201 A 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 48.87 29.19 44.63 49.10 27.34 43.63 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 47.58 17.35 41.83 51.40 20.85 40.83 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 A 155 HIS D 56 HIS.? 17.26 O ACT D 201 A 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 48.87 29.19 44.63 49.10 27.34 43.63 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 47.58 17.35 41.83 51.40 20.85 40.83 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 A 155 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 236 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 47.58 17.35 41.83 51.40 20.85 40.83 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 A 155 HIS D 141 HIS.? 18.95 OXT ACT D 201 A 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 55.45 46.76 42.08 57.34 46.16 42.75 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 47.58 17.35 41.83 51.40 20.85 40.83 -33.65 65.97 58.12 -34.39 67.56 63.36 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 28 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 B 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 B 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 B 236 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 B 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 236 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 236 ASP D 100 ASP.? 7.94 OXT ACT A 203 B 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 155 HIS A 161 HIS.? 19.24 O ACT B 201 B 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 155 HIS A 161 HIS.? 19.24 O ACT B 201 B 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 155 HIS B 56 HIS.? 17.31 O ACT B 201 B 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 155 HIS B 56 HIS.? 17.31 O ACT B 201 B 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 155 HIS B 56 HIS.? 17.31 O ACT B 201 B 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 155 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 155 HIS B 141 HIS.? 15.94 CH3 ACT A 202 B 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 B 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 B 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 B 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 B 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 B 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 B 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 B 155 HIS C 141 HIS.? 17.85 O ACT C 201 B 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 B 155 HIS C 141 HIS.? 17.85 O ACT C 201 B 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 B 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 236 ASP B 100 ASP.? 15.93 OXT ACT B 201 B 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 B 155 HIS D 56 HIS.? 17.26 O ACT D 201 B 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 B 155 HIS D 56 HIS.? 17.26 O ACT D 201 B 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 B 155 HIS D 56 HIS.? 17.26 O ACT D 201 B 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 B 155 HIS D 141 HIS.? 18.95 OXT ACT D 201 B 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -33.65 65.97 58.12 -34.39 67.56 63.36 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 24 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 C 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 55.11 47.10 12.61 53.44 47.85 11.58 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 C 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 55.11 47.10 12.61 53.44 47.85 11.58 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 155 HIS A 98 HIS^? -3.60 C ACT A 203s C 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 55.11 47.10 12.61 53.44 47.85 11.58 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 45.78 31.11 9.51 44.25 30.06 10.53 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 155 HIS A 98 HIS^? -3.60 C ACT A 203s C 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 55.11 47.10 12.61 53.44 47.85 11.58 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 45.78 31.11 9.51 44.25 30.06 10.53 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 C 236 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 55.11 47.10 12.61 53.44 47.85 11.58 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 37.54 22.37 12.10 37.83 27.55 13.24 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 C 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 55.11 47.10 12.61 53.44 47.85 11.58 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 45.78 31.11 9.51 44.25 30.06 10.53 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 37.54 22.37 12.10 37.83 27.55 13.24 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 C 236 ASP D 99 ASP.? 7.94 CH3 ACT A 203 C 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 55.11 47.10 12.61 53.44 47.85 11.58 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 45.78 31.11 9.51 44.25 30.06 10.53 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 37.54 22.37 12.10 37.83 27.55 13.24 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 C 236 ASP D 100 ASP.? 7.94 OXT ACT A 203 C 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 55.11 47.10 12.61 53.44 47.85 11.58 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 45.78 31.11 9.51 44.25 30.06 10.53 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 37.54 22.37 12.10 37.83 27.55 13.24 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 C 155 HIS A 161 HIS.? 19.24 O ACT B 201 C 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 55.11 47.10 12.61 53.44 47.85 11.58 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 45.78 31.11 9.51 44.25 30.06 10.53 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 37.54 22.37 12.10 37.83 27.55 13.24 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 C 155 HIS A 161 HIS.? 19.24 O ACT B 201 C 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 55.11 47.10 12.61 53.44 47.85 11.58 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 45.78 31.11 9.51 44.25 30.06 10.53 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 37.54 22.37 12.10 37.83 27.55 13.24 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 C 155 HIS B 56 HIS.? 17.31 O ACT B 201 C 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 55.11 47.10 12.61 53.44 47.85 11.58 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 45.78 31.11 9.51 44.25 30.06 10.53 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 37.54 22.37 12.10 37.83 27.55 13.24 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 C 155 HIS B 56 HIS.? 17.31 O ACT B 201 C 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 55.11 47.10 12.61 53.44 47.85 11.58 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 45.78 31.11 9.51 44.25 30.06 10.53 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 C 155 HIS B 56 HIS.? 17.31 O ACT B 201 C 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 55.11 47.10 12.61 53.44 47.85 11.58 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 45.78 31.11 9.51 44.25 30.06 10.53 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 37.54 22.37 12.10 37.83 27.55 13.24 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 C 155 HIS B 98 HIS^? 14.98 OXT ACT B 201 C 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 55.11 47.10 12.61 53.44 47.85 11.58 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 45.78 31.11 9.51 44.25 30.06 10.53 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 C 155 HIS B 141 HIS.? 15.94 CH3 ACT A 202 C 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 55.11 47.10 12.61 53.44 47.85 11.58 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 37.54 22.37 12.10 37.83 27.55 13.24 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 C 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 C 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 55.11 47.10 12.61 53.44 47.85 11.58 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 37.54 22.37 12.10 37.83 27.55 13.24 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 C 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 C 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 55.11 47.10 12.61 53.44 47.85 11.58 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 37.54 22.37 12.10 37.83 27.55 13.24 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 C 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 55.11 47.10 12.61 53.44 47.85 11.58 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 37.54 22.37 12.10 37.83 27.55 13.24 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 C 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 55.11 47.10 12.61 53.44 47.85 11.58 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 37.54 22.37 12.10 37.83 27.55 13.24 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 C 155 HIS C 141 HIS.? 17.85 O ACT C 201 C 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 55.11 47.10 12.61 53.44 47.85 11.58 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 45.78 31.11 9.51 44.25 30.06 10.53 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 C 155 HIS C 141 HIS.? 17.85 O ACT C 201 C 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 55.11 47.10 12.61 53.44 47.85 11.58 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 45.78 31.11 9.51 44.25 30.06 10.53 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 C 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 C 236 ASP B 100 ASP.? 15.93 OXT ACT B 201 C 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 55.11 47.10 12.61 53.44 47.85 11.58 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 45.78 31.11 9.51 44.25 30.06 10.53 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 C 155 HIS D 56 HIS.? 17.26 O ACT D 201 C 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 55.11 47.10 12.61 53.44 47.85 11.58 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 45.78 31.11 9.51 44.25 30.06 10.53 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 C 155 HIS D 56 HIS.? 17.26 O ACT D 201 C 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 55.11 47.10 12.61 53.44 47.85 11.58 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 45.78 31.11 9.51 44.25 30.06 10.53 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 37.54 22.37 12.10 37.83 27.55 13.24 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 C 155 HIS D 56 HIS.? 17.26 O ACT D 201 C 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 55.11 47.10 12.61 53.44 47.85 11.58 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 45.78 31.11 9.51 44.25 30.06 10.53 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 37.54 22.37 12.10 37.83 27.55 13.24 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 C 155 HIS D 141 HIS.? 18.95 OXT ACT D 201 C 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 55.11 47.10 12.61 53.44 47.85 11.58 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 37.54 22.37 12.10 37.83 27.55 13.24 -33.65 65.97 58.12 -34.39 67.56 63.36 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 26 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 D 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 D 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 D 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 D 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 155 HIS A 98 HIS^? -3.60 C ACT A 203s D 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 155 HIS A 98 HIS^? -3.60 C ACT A 203s D 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 D 236 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 D 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 D 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 D 236 ASP D 99 ASP.? 7.94 CH3 ACT A 203 D 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 D 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 D 236 ASP D 100 ASP.? 7.94 OXT ACT A 203 D 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 D 155 HIS A 161 HIS.? 19.24 O ACT B 201 D 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 D 155 HIS A 161 HIS.? 19.24 O ACT B 201 D 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 D 155 HIS B 56 HIS.? 17.31 O ACT B 201 D 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 D 155 HIS B 56 HIS.? 17.31 O ACT B 201 D 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 D 155 HIS B 56 HIS.? 17.31 O ACT B 201 D 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 D 155 HIS B 98 HIS^? 14.98 OXT ACT B 201 D 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 D 155 HIS B 141 HIS.? 15.94 CH3 ACT A 202 D 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 D 155 HIS B 151 HIS.? 13.45 CH3 ACT A 202 D 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 D 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 D 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 D 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 D 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 D 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 D 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 D 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 D 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 D 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 D 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 D 155 HIS C 141 HIS.? 17.85 O ACT C 201 D 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 D 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 D 155 HIS C 141 HIS.? 17.85 O ACT C 201 D 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 D 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 D 236 ASP B 99 ASP.? 16.09 OXT ACT B 201 D 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 D 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 D 236 ASP B 100 ASP.? 15.93 OXT ACT B 201 D 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 D 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 D 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 D 155 HIS D 56 HIS.? 17.26 O ACT D 201 D 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 D 155 HIS D 56 HIS.? 17.26 O ACT D 201 D 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 D 155 HIS D 56 HIS.? 17.26 O ACT D 201 D 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 D 155 HIS D 98 HIS^? 13.13 CH3 ACT A 203 D 236 ASP A 99 ASP.? 5.71 O2 EDO A 301 D 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 D 155 HIS D 141 HIS.? 18.95 OXT ACT D 201 D 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -33.65 65.97 58.12 -34.39 67.56 63.36 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 34 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 E 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 E 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 E 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 E 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 155 HIS A 98 HIS^? -3.60 C ACT A 203s E 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 E 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 155 HIS A 98 HIS^? -3.60 C ACT A 203s E 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 E 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 E 236 ASP A 99 ASP.? 5.71 O2 EDO A 301 E 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 E 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 E 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 E 236 ASP D 99 ASP.? 7.94 CH3 ACT A 203 E 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 E 236 ASP D 100 ASP.? 7.94 OXT ACT A 203 E 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 155 HIS A 161 HIS.? 19.24 O ACT B 201 E 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 E 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 155 HIS A 161 HIS.? 19.24 O ACT B 201 E 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 E 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 155 HIS B 56 HIS.? 17.31 O ACT B 201 E 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 E 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 E 155 HIS B 56 HIS.? 17.31 O ACT B 201 E 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 E 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 E 155 HIS B 56 HIS.? 17.31 O ACT B 201 E 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 E 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 E 155 HIS B 98 HIS^? 14.98 OXT ACT B 201 E 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 E 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 E 155 HIS B 141 HIS.? 15.94 CH3 ACT A 202 E 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 E 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 E 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 E 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 E 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 E 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 E 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 E 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 E 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 E 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 E 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 E 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 E 155 HIS C 141 HIS.? 17.85 O ACT C 201 E 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 E 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 E 155 HIS C 141 HIS.? 17.85 O ACT C 201 E 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 E 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 E 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 E 236 ASP B 99 ASP.? 16.09 OXT ACT B 201 E 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 E 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 E 236 ASP B 100 ASP.? 15.93 OXT ACT B 201 E 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 E 155 HIS D 56 HIS.? 17.26 O ACT D 201 E 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 E 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 E 155 HIS D 56 HIS.? 17.26 O ACT D 201 E 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 E 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 E 155 HIS D 56 HIS.? 17.26 O ACT D 201 E 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 E 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 E 155 HIS D 98 HIS^? 13.13 CH3 ACT A 203 E 236 ASP A 99 ASP.? 5.71 O2 EDO A 301 E 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 E 155 HIS D 141 HIS.? 18.95 OXT ACT D 201 E 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 E 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -33.65 65.97 58.12 -34.39 67.56 63.36 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 28 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 F 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 F 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 F 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 F 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 155 HIS A 98 HIS^? -3.60 C ACT A 203s F 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 F 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 155 HIS A 98 HIS^? -3.60 C ACT A 203s F 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 F 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 F 236 ASP A 99 ASP.? 5.71 O2 EDO A 301 F 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 F 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 F 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 F 236 ASP D 99 ASP.? 7.94 CH3 ACT A 203 F 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 F 236 ASP D 100 ASP.? 7.94 OXT ACT A 203 F 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 155 HIS A 161 HIS.? 19.24 O ACT B 201 F 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 F 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 155 HIS A 161 HIS.? 19.24 O ACT B 201 F 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 F 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 155 HIS B 56 HIS.? 17.31 O ACT B 201 F 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 F 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 155 HIS B 56 HIS.? 17.31 O ACT B 201 F 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 F 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 F 155 HIS B 56 HIS.? 17.31 O ACT B 201 F 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 F 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 F 155 HIS B 98 HIS^? 14.98 OXT ACT B 201 F 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 F 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 F 155 HIS B 141 HIS.? 15.94 CH3 ACT A 202 F 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 F 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 F 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 F 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 F 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 F 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 F 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 F 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 F 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 F 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 F 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 F 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 F 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 F 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 F 155 HIS C 141 HIS.? 17.85 O ACT C 201 F 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 F 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 F 155 HIS C 141 HIS.? 17.85 O ACT C 201 F 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 F 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 F 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 F 236 ASP B 100 ASP.? 15.93 OXT ACT B 201 F 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 F 155 HIS D 56 HIS.? 17.26 O ACT D 201 F 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 F 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 F 155 HIS D 56 HIS.? 17.26 O ACT D 201 F 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 F 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 F 155 HIS D 56 HIS.? 17.26 O ACT D 201 F 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 F 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 F 155 HIS D 141 HIS.? 18.95 OXT ACT D 201 F 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 F 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -33.65 65.97 58.12 -34.39 67.56 63.36 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 26 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 G 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 G 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 G 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 G 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 155 HIS A 98 HIS^? -3.60 C ACT A 203s G 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 G 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 155 HIS A 98 HIS^? -3.60 C ACT A 203s G 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 G 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 G 236 ASP A 99 ASP.? 5.71 O2 EDO A 301 G 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 G 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 G 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 G 236 ASP D 99 ASP.? 7.94 CH3 ACT A 203 G 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 G 236 ASP D 100 ASP.? 7.94 OXT ACT A 203 G 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 G 155 HIS A 161 HIS.? 19.24 O ACT B 201 G 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 G 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 G 155 HIS A 161 HIS.? 19.24 O ACT B 201 G 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 G 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 G 155 HIS B 56 HIS.? 17.31 O ACT B 201 G 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 G 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 G 155 HIS B 56 HIS.? 17.31 O ACT B 201 G 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 G 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 G 155 HIS B 56 HIS.? 17.31 O ACT B 201 G 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 G 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 G 155 HIS B 98 HIS^? 14.98 OXT ACT B 201 G 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 G 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 G 155 HIS B 141 HIS.? 15.94 CH3 ACT A 202 G 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 G 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 G 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 G 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 G 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 G 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 G 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 G 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 G 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 G 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 G 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 G 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 G 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 G 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 G 155 HIS C 141 HIS.? 17.85 O ACT C 201 G 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 G 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 G 155 HIS C 141 HIS.? 17.85 O ACT C 201 G 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 G 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 G 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 G 236 ASP B 100 ASP.? 15.93 OXT ACT B 201 G 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 G 155 HIS D 56 HIS.? 17.26 O ACT D 201 G 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 G 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 G 155 HIS D 56 HIS.? 17.26 O ACT D 201 G 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 G 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 G 155 HIS D 56 HIS.? 17.26 O ACT D 201 G 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 G 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 G 155 HIS D 98 HIS^? 13.13 CH3 ACT A 203 G 236 ASP A 99 ASP.? 5.71 O2 EDO A 301 G 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 G 155 HIS D 141 HIS.? 18.95 OXT ACT D 201 G 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 G 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -33.65 65.97 58.12 -34.39 67.56 63.36 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 27 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 H 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 H 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 H 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 H 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 H 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 H 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 155 HIS A 56 HIS.? 6.76 O1 EDO A 302 H 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 H 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 155 HIS A 98 HIS^? -3.60 C ACT A 203s H 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 H 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 155 HIS A 98 HIS^? -3.60 C ACT A 203s H 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 H 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 H 236 ASP A 99 ASP.? 5.71 O2 EDO A 301 H 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 H 155 HIS A 141 HIS.? 11.20 OXT ACT A 203 H 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 H 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -49.96 77.41 66.16 -51.01 75.70 66.78 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 H 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 H 236 ASP D 99 ASP.? 7.94 CH3 ACT A 203 H 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 H 155 HIS A 151 HIS.? 15.97 CH3 ACT A 201 H 236 ASP D 100 ASP.? 7.94 OXT ACT A 203 H 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 H 155 HIS A 161 HIS.? 19.24 O ACT B 201 H 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 H 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 H 155 HIS A 161 HIS.? 19.24 O ACT B 201 H 236 ASP C 100 ASP.? 9.05 C1 EDO A 301 H 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 H 155 HIS B 56 HIS.? 17.31 O ACT B 201 H 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 H 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 H 155 HIS B 56 HIS.? 17.31 O ACT B 201 H 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 H 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 H 155 HIS B 56 HIS.? 17.31 O ACT B 201 H 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 H 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 H 155 HIS B 98 HIS^? 14.98 OXT ACT B 201 H 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 H 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 H 155 HIS B 141 HIS.? 15.94 CH3 ACT A 202 H 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 H 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -16.42 43.62 79.59 -14.76 44.89 79.44 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 H 155 HIS B 151 HIS.? 13.45 CH3 ACT A 202 H 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 H 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 H 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 H 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 H 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 H 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 H 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 H 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 H 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 H 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 H 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 H 155 HIS C 56 HIS.? 17.26 OXT ACT C 201 H 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 H 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 H 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 H 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 H 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 H 155 HIS C 98 HIS^? 11.61 O2 EDO A 301 H 236 ASP A 100 ASP.? 9.07 O2 EDO A 301 H 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 H 155 HIS C 141 HIS.? 17.85 O ACT C 201 H 236 ASP C 99 ASP.? 5.79 O1 EDO A 301 H 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 H 155 HIS C 141 HIS.? 17.85 O ACT C 201 H 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 H 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -47.33 38.55 64.23 -48.23 40.22 65.13 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 H 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 H 236 ASP B 99 ASP.? 16.09 OXT ACT B 201 H 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 H 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 H 236 ASP B 100 ASP.? 15.93 OXT ACT B 201 H 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 H 155 HIS C 151 HIS.? 16.03 CH3 ACT C 201 H 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 H 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 H 155 HIS D 56 HIS.? 17.26 O ACT D 201 H 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 H 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 H 155 HIS D 56 HIS.? 17.26 O ACT D 201 H 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 H 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 H 155 HIS D 56 HIS.? 17.26 O ACT D 201 H 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 H 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 H 155 HIS D 98 HIS^? 13.13 CH3 ACT A 203 H 236 ASP A 99 ASP.? 5.71 O2 EDO A 301 H 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 H 155 HIS D 141 HIS.? 18.95 OXT ACT D 201 H 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 H 261 LYS A 68 LYS~? -2.78 O ACT A 201s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -42.77 77.11 33.23 -41.72 76.77 31.45 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -33.65 65.97 58.12 -34.39 67.56 63.36 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 34 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 75 TYR^? -4.52 O ACT A 201s A 236 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 261 LYS A 139 LYS.? 17.81 O ACT A 201 coo 55.48 26.51 40.65 55.39 23.99 39.43 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 47.58 17.35 41.83 51.40 20.85 40.83 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 95 TYR^? -3.85 O ACT A 201s A 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 55.48 26.51 40.65 55.39 23.99 39.43 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 48.87 29.19 44.63 49.10 27.34 43.63 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 236 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 261 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 55.48 26.51 40.65 55.39 23.99 39.43 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 48.87 29.19 44.63 49.10 27.34 43.63 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 47.58 17.35 41.83 51.40 20.85 40.83 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 55.48 26.51 40.65 55.39 23.99 39.43 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR C 75 TYR^? -4.54 O ACT C 201s A 236 ASP C 74 ASP^? 14.86 O ACT C 201 A 261 LYS C 139 LYS.? 18.79 O ACT C 201 coo 55.48 26.51 40.65 55.39 23.99 39.43 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 48.87 29.19 44.63 49.10 27.34 43.63 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 47.58 17.35 41.83 51.40 20.85 40.83 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR C 95 TYR^? -3.84 O ACT C 201s A 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 55.48 26.51 40.65 55.39 23.99 39.43 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 48.87 29.19 44.63 49.10 27.34 43.63 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 47.58 17.35 41.83 51.40 20.85 40.83 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 236 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 261 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 55.48 26.51 40.65 55.39 23.99 39.43 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 48.87 29.19 44.63 49.10 27.34 43.63 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 47.58 17.35 41.83 51.40 20.85 40.83 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 55.48 26.51 40.65 55.39 23.99 39.43 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 47.58 17.35 41.83 51.40 20.85 40.83 -54.54 71.95 50.35 -50.70 67.51 52.69 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 75 TYR^? -4.52 O ACT A 201s B 236 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 261 LYS A 139 LYS.? 17.81 O ACT A 201 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 95 TYR^? -3.85 O ACT A 201s B 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 75 TYR^? -4.59 OXT ACT B 201s B 236 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 261 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s B 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR C 75 TYR^? -4.54 O ACT C 201s B 236 ASP C 74 ASP^? 14.86 O ACT C 201 B 261 LYS C 139 LYS.? 18.79 O ACT C 201 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR C 95 TYR^? -3.84 O ACT C 201s B 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR D 75 TYR^? -4.49 OXT ACT D 201s B 236 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 261 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s B 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -54.54 71.95 50.35 -50.70 67.51 52.69 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 75 TYR^? -4.52 O ACT A 201s C 236 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 261 LYS A 139 LYS.? 17.81 O ACT A 201 coo 39.51 34.34 13.63 37.63 32.61 14.79 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 37.54 22.37 12.10 37.83 27.55 13.24 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR A 95 TYR^? -3.85 O ACT A 201s C 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 39.51 34.34 13.63 37.63 32.61 14.79 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 45.78 31.11 9.51 44.25 30.06 10.53 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 163 TYR B 75 TYR^? -4.59 OXT ACT B 201s C 236 ASP B 74 ASP^? 14.88 OXT ACT B 201 C 261 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 39.51 34.34 13.63 37.63 32.61 14.79 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 45.78 31.11 9.51 44.25 30.06 10.53 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 37.54 22.37 12.10 37.83 27.55 13.24 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s C 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 39.51 34.34 13.63 37.63 32.61 14.79 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 163 TYR C 75 TYR^? -4.54 O ACT C 201s C 236 ASP C 74 ASP^? 14.86 O ACT C 201 C 261 LYS C 139 LYS.? 18.79 O ACT C 201 coo 39.51 34.34 13.63 37.63 32.61 14.79 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 45.78 31.11 9.51 44.25 30.06 10.53 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 37.54 22.37 12.10 37.83 27.55 13.24 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 163 TYR C 95 TYR^? -3.84 O ACT C 201s C 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 39.51 34.34 13.63 37.63 32.61 14.79 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 45.78 31.11 9.51 44.25 30.06 10.53 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 37.54 22.37 12.10 37.83 27.55 13.24 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 163 TYR D 75 TYR^? -4.49 OXT ACT D 201s C 236 ASP D 74 ASP^? 14.85 OXT ACT D 201 C 261 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 39.51 34.34 13.63 37.63 32.61 14.79 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 45.78 31.11 9.51 44.25 30.06 10.53 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 37.54 22.37 12.10 37.83 27.55 13.24 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s C 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 39.51 34.34 13.63 37.63 32.61 14.79 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 37.54 22.37 12.10 37.83 27.55 13.24 -54.54 71.95 50.35 -50.70 67.51 52.69 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 75 TYR^? -4.52 O ACT A 201s D 236 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 261 LYS A 139 LYS.? 17.81 O ACT A 201 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR A 95 TYR^? -3.85 O ACT A 201s D 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 163 TYR B 75 TYR^? -4.59 OXT ACT B 201s D 236 ASP B 74 ASP^? 14.88 OXT ACT B 201 D 261 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s D 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 163 TYR C 75 TYR^? -4.54 O ACT C 201s D 236 ASP C 74 ASP^? 14.86 O ACT C 201 D 261 LYS C 139 LYS.? 18.79 O ACT C 201 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 163 TYR C 95 TYR^? -3.84 O ACT C 201s D 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 163 TYR D 75 TYR^? -4.49 OXT ACT D 201s D 236 ASP D 74 ASP^? 14.85 OXT ACT D 201 D 261 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s D 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -54.54 71.95 50.35 -50.70 67.51 52.69 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 75 TYR^? -4.52 O ACT A 201s E 236 ASP A 74 ASP^? 5.73 OXT ACT A 203 E 261 LYS A 139 LYS.? 17.81 O ACT A 201 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 95 TYR^? -3.85 O ACT A 201s E 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 E 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 75 TYR^? -4.59 OXT ACT B 201s E 236 ASP B 74 ASP^? 14.88 OXT ACT B 201 E 261 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s E 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 E 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s E 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 E 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR C 75 TYR^? -4.54 O ACT C 201s E 236 ASP C 74 ASP^? 14.86 O ACT C 201 E 261 LYS C 139 LYS.? 18.79 O ACT C 201 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR C 95 TYR^? -3.84 O ACT C 201s E 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 E 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR D 75 TYR^? -4.49 OXT ACT D 201s E 236 ASP D 74 ASP^? 14.85 OXT ACT D 201 E 261 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s E 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 E 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s E 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 E 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -54.54 71.95 50.35 -50.70 67.51 52.69 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 10 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 75 TYR^? -4.52 O ACT A 201s F 236 ASP A 74 ASP^? 5.73 OXT ACT A 203 F 261 LYS A 139 LYS.? 17.81 O ACT A 201 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 95 TYR^? -3.85 O ACT A 201s F 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 F 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 75 TYR^? -4.59 OXT ACT B 201s F 236 ASP B 74 ASP^? 14.88 OXT ACT B 201 F 261 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s F 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 F 261 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s F 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 F 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR C 75 TYR^? -4.54 O ACT C 201s F 236 ASP C 74 ASP^? 14.86 O ACT C 201 F 261 LYS C 139 LYS.? 18.79 O ACT C 201 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR C 95 TYR^? -3.84 O ACT C 201s F 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 F 261 LYS C 68 LYS~? -2.77 O ACT C 201s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR C 95 TYR^? -3.84 O ACT C 201s F 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 F 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR D 75 TYR^? -4.49 OXT ACT D 201s F 236 ASP D 74 ASP^? 14.85 OXT ACT D 201 F 261 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s F 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 F 261 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s F 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 F 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -54.54 71.95 50.35 -50.70 67.51 52.69 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 11 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 75 TYR^? -4.52 O ACT A 201s G 236 ASP A 74 ASP^? 5.73 OXT ACT A 203 G 261 LYS A 139 LYS.? 17.81 O ACT A 201 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR A 95 TYR^? -3.85 O ACT A 201s G 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 G 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 163 TYR B 75 TYR^? -4.59 OXT ACT B 201s G 236 ASP B 74 ASP^? 14.88 OXT ACT B 201 G 261 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s G 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 G 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 163 TYR C 75 TYR^? -4.54 O ACT C 201s G 236 ASP C 74 ASP^? 14.86 O ACT C 201 G 261 LYS C 139 LYS.? 18.79 O ACT C 201 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 163 TYR C 95 TYR^? -3.84 O ACT C 201s G 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 G 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 163 TYR D 75 TYR^? -4.49 OXT ACT D 201s G 236 ASP D 74 ASP^? 14.85 OXT ACT D 201 G 261 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s G 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 G 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -54.54 71.95 50.35 -50.70 67.51 52.69 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 75 TYR^? -4.52 O ACT A 201s H 236 ASP A 74 ASP^? 5.73 OXT ACT A 203 H 261 LYS A 139 LYS.? 17.81 O ACT A 201 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR A 95 TYR^? -3.85 O ACT A 201s H 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 H 261 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 163 TYR B 75 TYR^? -4.59 OXT ACT B 201s H 236 ASP B 74 ASP^? 14.88 OXT ACT B 201 H 261 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s H 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 H 261 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 163 TYR C 75 TYR^? -4.54 O ACT C 201s H 236 ASP C 74 ASP^? 14.86 O ACT C 201 H 261 LYS C 139 LYS.? 18.79 O ACT C 201 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 163 TYR C 95 TYR^? -3.84 O ACT C 201s H 236 ASP C 130 ASP.? 4.74 O2 EDO A 301 H 261 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 163 TYR D 75 TYR^? -4.49 OXT ACT D 201s H 236 ASP D 74 ASP^? 14.85 OXT ACT D 201 H 261 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 H 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s H 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 H 261 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -54.54 71.95 50.35 -50.70 67.51 52.69 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 76 ARG^? 8.97 OXT ACT A 203 C 163 TYR A 95 TYR^? -3.85 O ACT A 201s C 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 39.01 29.77 22.02 37.48 31.30 19.84 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 39.51 34.34 13.63 37.63 32.61 14.79 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 45.78 31.11 9.51 44.25 30.06 10.53 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG B 76 ARG^? 14.33 OXT ACT B 201 C 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s C 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 39.01 29.77 22.02 37.48 31.30 19.84 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 39.51 34.34 13.63 37.63 32.61 14.79 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG D 76 ARG^? 14.20 OXT ACT D 201 C 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s C 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 39.01 29.77 22.02 37.48 31.30 19.84 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 39.51 34.34 13.63 37.63 32.61 14.79 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.22 66.27 50.20 -46.22 65.66 49.92 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 76 ARG^? 8.97 OXT ACT A 203 D 163 TYR A 95 TYR^? -3.85 O ACT A 201s D 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG B 76 ARG^? 14.33 OXT ACT B 201 D 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s D 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG D 76 ARG^? 14.20 OXT ACT D 201 D 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s D 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.22 66.27 50.20 -46.22 65.66 49.92 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 110 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 55.48 26.51 40.65 55.39 23.99 39.43 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 52.39 23.42 32.10 54.51 23.27 34.29 -23.34 44.19 81.38 -24.15 41.23 81.47 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 95 TYR^? -3.85 O ACT A 201s B 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 110 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s B 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 110 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s B 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 110 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -47.81 74.29 36.53 -48.87 77.02 37.43 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 76 ARG^? 8.97 OXT ACT A 203 G 163 TYR A 95 TYR^? -3.85 O ACT A 201s G 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG B 76 ARG^? 14.33 OXT ACT B 201 G 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s G 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG D 76 ARG^? 14.20 OXT ACT D 201 G 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s G 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.22 66.27 50.20 -46.22 65.66 49.92 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 76 ARG^? 8.97 OXT ACT A 203 H 163 TYR A 95 TYR^? -3.85 O ACT A 201s H 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 76 ARG^? 14.33 OXT ACT B 201 H 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s H 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG D 76 ARG^? 14.20 OXT ACT D 201 H 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s H 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.22 66.27 50.20 -46.22 65.66 49.92 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s E 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 G 110 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -23.34 44.19 81.38 -24.15 41.23 81.47 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 95 TYR^? -3.85 O ACT A 201s F 236 ASP A 130 ASP.? 4.80 O1 EDO A 301 H 110 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 95 TYR^? -3.87 OXT ACT B 201s F 236 ASP B 130 ASP.? 9.25 OXT ACT B 201 H 110 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR D 95 TYR^? -3.79 OXT ACT D 201s F 236 ASP D 130 ASP.? 7.40 CH3 ACT A 203 H 110 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -47.81 74.29 36.53 -48.87 77.02 37.43 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 256 GLU A 72 GLU~? 5.31 O ACT A 201 A 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 30.54 71.65 32.58 31.73 72.26 30.92 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 37.87 70.12 31.80 36.61 69.74 30.15 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 116 ASP.? 19.55 CH3 ACT A 201 A 256 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 329 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 30.54 71.65 32.58 31.73 72.26 30.92 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 37.87 70.12 31.80 36.61 69.74 30.15 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1qho_c04 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 86 ASP.? 24.07 CH3 ACT B 201 A 256 GLU B 114 GLU^? 18.04 O ACT B 201 A 329 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 30.54 71.65 32.58 31.73 72.26 30.92 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 37.87 70.12 31.80 36.61 69.74 30.15 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1qho_c04 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 256 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 329 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 30.54 71.65 32.58 31.73 72.26 30.92 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1qho_c04 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 116 ASP.? 19.49 CH3 ACT B 201 A 256 GLU B 114 GLU^? 18.04 O ACT B 201 A 329 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 30.54 71.65 32.58 31.73 72.26 30.92 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1qho_c04 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 256 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 30.54 71.65 32.58 31.73 72.26 30.92 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 37.87 70.12 31.80 36.61 69.74 30.15 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1qho_c04 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 256 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 329 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 30.54 71.65 32.58 31.73 72.26 30.92 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1qho_c04 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 256 GLU C 72 GLU~? 5.32 O ACT C 201 A 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 30.54 71.65 32.58 31.73 72.26 30.92 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 37.87 70.12 31.80 36.61 69.74 30.15 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1qho_c04 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP C 116 ASP.? 19.40 CH3 ACT C 201 A 256 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 329 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 30.54 71.65 32.58 31.73 72.26 30.92 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 37.87 70.12 31.80 36.61 69.74 30.15 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1qho_c04 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 256 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 329 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 28.46 69.88 26.74 30.40 70.70 26.53 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 30.54 71.65 32.58 31.73 72.26 30.92 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1qho_c04 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP D 116 ASP.? 19.52 CH3 ACT D 201 A 256 GLU D 114 GLU^? 18.05 O ACT D 201 A 329 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 30.54 71.65 32.58 31.73 72.26 30.92 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 37.87 70.12 31.80 36.61 69.74 30.15 -53.41 42.17 31.38 -52.32 40.44 30.82 1qho_c04 source 1qho ALPHA-AMYLASE : 11 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 261 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 329 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 34.02 79.89 42.60 34.73 78.01 41.86 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 261 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 329 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 34.02 79.89 42.60 34.73 78.01 41.86 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 261 ASP A 34 ASP~? 14.63 O ACT A 201 A 329 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 34.02 79.89 42.60 34.73 78.01 41.86 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 261 ASP C 74 ASP^? 14.86 O ACT C 201 A 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 34.02 79.89 42.60 34.73 78.01 41.86 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 261 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 329 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 34.02 79.89 42.60 34.73 78.01 41.86 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 261 ASP A 34 ASP~? 14.63 O ACT A 201 A 329 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 34.02 79.89 42.60 34.73 78.01 41.86 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 261 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 34.02 79.89 42.60 34.73 78.01 41.86 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 37.87 70.12 31.80 36.61 69.74 30.15 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 261 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 329 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 34.02 79.89 42.60 34.73 78.01 41.86 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 37.87 70.12 31.80 36.61 69.74 30.15 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 261 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 329 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 34.02 79.89 42.60 34.73 78.01 41.86 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1qho_c05 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 261 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 329 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 34.02 79.89 42.60 34.73 78.01 41.86 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1qho_c05 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 261 ASP C 34 ASP~? 14.66 O ACT C 201 A 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 34.02 79.89 42.60 34.73 78.01 41.86 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1qho_c05 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 261 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 34.02 79.89 42.60 34.73 78.01 41.86 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1qho_c05 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP B 149 ASP.? 20.03 CH3 ACT B 201 A 261 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 329 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 34.02 79.89 42.60 34.73 78.01 41.86 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 37.87 70.12 31.80 36.61 69.74 30.15 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1qho_c05 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP C 74 ASP^? 14.86 O ACT C 201 A 261 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 329 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 34.02 79.89 42.60 34.73 78.01 41.86 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 37.87 70.12 31.80 36.61 69.74 30.15 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1qho_c05 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP C 74 ASP^? 14.86 O ACT C 201 A 261 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 329 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 34.02 79.89 42.60 34.73 78.01 41.86 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1qho_c05 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 261 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 34.02 79.89 42.60 34.73 78.01 41.86 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 37.87 70.12 31.80 36.61 69.74 30.15 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1qho_c05 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 261 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 329 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 34.02 79.89 42.60 34.73 78.01 41.86 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1qho_c05 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 261 ASP C 34 ASP~? 14.66 O ACT C 201 A 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 34.02 79.89 42.60 34.73 78.01 41.86 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1qho_c05 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 261 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 34.02 79.89 42.60 34.73 78.01 41.86 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 37.87 70.12 31.80 36.61 69.74 30.15 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1qho_c05 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 261 ASP C 34 ASP~? 14.66 O ACT C 201 A 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 34.02 79.89 42.60 34.73 78.01 41.86 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1qho_c05 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 261 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 329 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 28.46 69.88 26.74 30.40 70.70 26.53 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 34.02 79.89 42.60 34.73 78.01 41.86 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 37.87 70.12 31.80 36.61 69.74 30.15 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1qho_c05 ALPHA-AMYLASE user 22 3 # 22 A 228 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 261 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 329 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 34.02 79.89 42.60 34.73 78.01 41.86 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 37.87 70.12 31.80 36.61 69.74 30.15 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1qho_c05 ALPHA-AMYLASE user 23 3 # 23 A 228 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 261 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 329 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 34.02 79.89 42.60 34.73 78.01 41.86 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 37.87 70.12 31.80 36.61 69.74 30.15 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1qho_c05 ALPHA-AMYLASE user 24 3 # 24 A 228 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 261 ASP A 34 ASP~? 14.63 O ACT A 201 A 329 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 34.02 79.89 42.60 34.73 78.01 41.86 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1qho_c05 ALPHA-AMYLASE user 25 3 # 25 A 228 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 261 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 329 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 34.02 79.89 42.60 34.73 78.01 41.86 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.71 72.29 58.72 -45.62 72.95 56.93 1qho_c05 source 1qho ALPHA-AMYLASE : 25 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 260 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 329 ASP A 34 ASP~? 14.63 O ACT A 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 30.73 81.29 37.61 31.23 82.07 35.69 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 37.87 70.12 31.80 36.61 69.74 30.15 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 260 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 329 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 30.73 81.29 37.61 31.23 82.07 35.69 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 260 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 329 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 30.73 81.29 37.61 31.23 82.07 35.69 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 260 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 329 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 30.73 81.29 37.61 31.23 82.07 35.69 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 260 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 30.73 81.29 37.61 31.23 82.07 35.69 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 37.87 70.12 31.80 36.61 69.74 30.15 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 260 ASP C 74 ASP^? 14.86 O ACT C 201 A 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 30.73 81.29 37.61 31.23 82.07 35.69 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 260 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 329 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 30.73 81.29 37.61 31.23 82.07 35.69 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 37.87 70.12 31.80 36.61 69.74 30.15 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 1qho_c07 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 260 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 329 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 30.73 81.29 37.61 31.23 82.07 35.69 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 37.87 70.12 31.80 36.61 69.74 30.15 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1qho_c07 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 260 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 329 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 30.73 81.29 37.61 31.23 82.07 35.69 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1qho_c07 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 260 ASP C 74 ASP^? 14.86 O ACT C 201 A 329 ASP C 34 ASP~? 14.66 O ACT C 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 30.73 81.29 37.61 31.23 82.07 35.69 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 1qho_c07 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP C 74 ASP^? 14.86 O ACT C 201 A 260 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 329 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.73 81.29 37.61 31.23 82.07 35.69 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1qho_c07 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP C 74 ASP^? 14.86 O ACT C 201 A 260 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 329 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.73 81.29 37.61 31.23 82.07 35.69 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1qho_c07 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 260 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 30.73 81.29 37.61 31.23 82.07 35.69 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1qho_c07 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 260 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 30.73 81.29 37.61 31.23 82.07 35.69 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 37.87 70.12 31.80 36.61 69.74 30.15 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1qho_c07 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 260 ASP C 74 ASP^? 14.86 O ACT C 201 A 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 30.73 81.29 37.61 31.23 82.07 35.69 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1qho_c07 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 260 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 329 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 30.73 81.29 37.61 31.23 82.07 35.69 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 37.87 70.12 31.80 36.61 69.74 30.15 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 1qho_c07 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 260 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 329 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 28.46 69.88 26.74 30.40 70.70 26.53 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 30.73 81.29 37.61 31.23 82.07 35.69 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 37.87 70.12 31.80 36.61 69.74 30.15 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1qho_c07 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 260 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 329 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 28.46 69.88 26.74 30.40 70.70 26.53 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 30.73 81.29 37.61 31.23 82.07 35.69 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 37.87 70.12 31.80 36.61 69.74 30.15 -50.30 76.97 42.14 -51.14 78.91 42.11 1qho_c07 source 1qho ALPHA-AMYLASE : 18 hits 1qho_c07 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 55 ALA^? 10.63 O1 EDO A 302 A 148 HIS A 56 HIS.? 6.76 O1 EDO A 302 A 163 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo 1.42 19.18 21.84 1.11 19.57 23.28 -21.44 62.27 61.83 -22.27 63.55 61.72 coo 0.71 19.67 27.92 2.43 19.16 26.83 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 7.15 16.22 27.50 6.15 18.00 27.94 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA B 55 ALA^? 12.04 O ACT B 201 A 148 HIS B 56 HIS.? 17.31 O ACT B 201 A 163 ASP B 45 ASP^? 20.35 O ACT B 201 coo 1.42 19.18 21.84 1.11 19.57 23.28 -44.97 59.71 84.97 -43.80 58.86 85.49 coo 0.71 19.67 27.92 2.43 19.16 26.83 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 7.15 16.22 27.50 6.15 18.00 27.94 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 A 51 ALA C 55 ALA^? 12.11 OXT ACT C 201 A 148 HIS C 56 HIS.? 17.26 OXT ACT C 201 A 163 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo 1.42 19.18 21.84 1.11 19.57 23.28 -28.67 57.83 45.93 -28.88 56.47 46.57 coo 0.71 19.67 27.92 2.43 19.16 26.83 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 7.15 16.22 27.50 6.15 18.00 27.94 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 A 51 ALA D 55 ALA^? 12.06 O ACT D 201 A 148 HIS D 56 HIS.? 17.26 O ACT D 201 A 163 ASP D 45 ASP^? 20.33 O ACT D 201 coo 1.42 19.18 21.84 1.11 19.57 23.28 -61.44 55.28 49.65 -61.24 56.24 48.48 coo 0.71 19.67 27.92 2.43 19.16 26.83 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 7.15 16.22 27.50 6.15 18.00 27.94 -67.68 49.50 43.87 -67.26 48.38 42.12 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 55 ALA^? 10.63 O1 EDO A 302 B 148 HIS A 56 HIS.? 6.76 O1 EDO A 302 B 163 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -21.44 62.27 61.83 -22.27 63.55 61.72 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA B 55 ALA^? 12.04 O ACT B 201 B 148 HIS B 56 HIS.? 17.31 O ACT B 201 B 163 ASP B 45 ASP^? 20.35 O ACT B 201 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -44.97 59.71 84.97 -43.80 58.86 85.49 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA C 55 ALA^? 12.11 OXT ACT C 201 B 148 HIS C 56 HIS.? 17.26 OXT ACT C 201 B 163 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -28.67 57.83 45.93 -28.88 56.47 46.57 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -26.71 60.26 42.75 -28.06 61.81 43.18 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 B 51 ALA D 55 ALA^? 12.06 O ACT D 201 B 148 HIS D 56 HIS.? 17.26 O ACT D 201 B 163 ASP D 45 ASP^? 20.33 O ACT D 201 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -61.44 55.28 49.65 -61.24 56.24 48.48 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -67.68 49.50 43.87 -67.26 48.38 42.12 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 55 ALA^? 10.63 O1 EDO A 302 C 148 HIS A 56 HIS.? 6.76 O1 EDO A 302 C 163 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -21.44 62.27 61.83 -22.27 63.55 61.72 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 C 51 ALA B 55 ALA^? 12.04 O ACT B 201 C 148 HIS B 56 HIS.? 17.31 O ACT B 201 C 163 ASP B 45 ASP^? 20.35 O ACT B 201 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -44.97 59.71 84.97 -43.80 58.86 85.49 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 C 51 ALA C 55 ALA^? 12.11 OXT ACT C 201 C 148 HIS C 56 HIS.? 17.26 OXT ACT C 201 C 163 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -28.67 57.83 45.93 -28.88 56.47 46.57 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -26.71 60.26 42.75 -28.06 61.81 43.18 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 C 51 ALA D 55 ALA^? 12.06 O ACT D 201 C 148 HIS D 56 HIS.? 17.26 O ACT D 201 C 163 ASP D 45 ASP^? 20.33 O ACT D 201 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -61.44 55.28 49.65 -61.24 56.24 48.48 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -67.68 49.50 43.87 -67.26 48.38 42.12 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 55 ALA^? 10.63 O1 EDO A 302 D 148 HIS A 56 HIS.? 6.76 O1 EDO A 302 D 163 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -21.44 62.27 61.83 -22.27 63.55 61.72 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA B 55 ALA^? 12.04 O ACT B 201 D 148 HIS B 56 HIS.? 17.31 O ACT B 201 D 163 ASP B 45 ASP^? 20.35 O ACT B 201 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -44.97 59.71 84.97 -43.80 58.86 85.49 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 D 51 ALA C 55 ALA^? 12.11 OXT ACT C 201 D 148 HIS C 56 HIS.? 17.26 OXT ACT C 201 D 163 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -28.67 57.83 45.93 -28.88 56.47 46.57 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -26.71 60.26 42.75 -28.06 61.81 43.18 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 D 51 ALA D 55 ALA^? 12.06 O ACT D 201 D 148 HIS D 56 HIS.? 17.26 O ACT D 201 D 163 ASP D 45 ASP^? 20.33 O ACT D 201 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -61.44 55.28 49.65 -61.24 56.24 48.48 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -67.68 49.50 43.87 -67.26 48.38 42.12 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 55 ALA^? 10.63 O1 EDO A 302 E 148 HIS A 56 HIS.? 6.76 O1 EDO A 302 E 163 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -21.44 62.27 61.83 -22.27 63.55 61.72 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 E 51 ALA B 55 ALA^? 12.04 O ACT B 201 E 148 HIS B 56 HIS.? 17.31 O ACT B 201 E 163 ASP B 45 ASP^? 20.35 O ACT B 201 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -44.97 59.71 84.97 -43.80 58.86 85.49 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 E 51 ALA D 55 ALA^? 12.06 O ACT D 201 E 148 HIS D 56 HIS.? 17.26 O ACT D 201 E 163 ASP D 45 ASP^? 20.33 O ACT D 201 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -61.44 55.28 49.65 -61.24 56.24 48.48 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -67.68 49.50 43.87 -67.26 48.38 42.12 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 55 ALA^? 10.63 O1 EDO A 302 F 148 HIS A 56 HIS.? 6.76 O1 EDO A 302 F 163 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -21.44 62.27 61.83 -22.27 63.55 61.72 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA B 55 ALA^? 12.04 O ACT B 201 F 148 HIS B 56 HIS.? 17.31 O ACT B 201 F 163 ASP B 45 ASP^? 20.35 O ACT B 201 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -44.97 59.71 84.97 -43.80 58.86 85.49 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 F 51 ALA C 55 ALA^? 12.11 OXT ACT C 201 F 148 HIS C 56 HIS.? 17.26 OXT ACT C 201 F 163 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -28.67 57.83 45.93 -28.88 56.47 46.57 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 F 51 ALA D 55 ALA^? 12.06 O ACT D 201 F 148 HIS D 56 HIS.? 17.26 O ACT D 201 F 163 ASP D 45 ASP^? 20.33 O ACT D 201 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -61.44 55.28 49.65 -61.24 56.24 48.48 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -67.68 49.50 43.87 -67.26 48.38 42.12 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 55 ALA^? 10.63 O1 EDO A 302 G 148 HIS A 56 HIS.? 6.76 O1 EDO A 302 G 163 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -21.44 62.27 61.83 -22.27 63.55 61.72 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA B 55 ALA^? 12.04 O ACT B 201 G 148 HIS B 56 HIS.? 17.31 O ACT B 201 G 163 ASP B 45 ASP^? 20.35 O ACT B 201 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -44.97 59.71 84.97 -43.80 58.86 85.49 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 G 51 ALA D 55 ALA^? 12.06 O ACT D 201 G 148 HIS D 56 HIS.? 17.26 O ACT D 201 G 163 ASP D 45 ASP^? 20.33 O ACT D 201 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -61.44 55.28 49.65 -61.24 56.24 48.48 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -67.68 49.50 43.87 -67.26 48.38 42.12 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 55 ALA^? 10.63 O1 EDO A 302 H 148 HIS A 56 HIS.? 6.76 O1 EDO A 302 H 163 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -21.44 62.27 61.83 -22.27 63.55 61.72 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA B 55 ALA^? 12.04 O ACT B 201 H 148 HIS B 56 HIS.? 17.31 O ACT B 201 H 163 ASP B 45 ASP^? 20.35 O ACT B 201 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -44.97 59.71 84.97 -43.80 58.86 85.49 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 H 51 ALA C 55 ALA^? 12.11 OXT ACT C 201 H 148 HIS C 56 HIS.? 17.26 OXT ACT C 201 H 163 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -28.67 57.83 45.93 -28.88 56.47 46.57 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -26.71 60.26 42.75 -28.06 61.81 43.18 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 H 51 ALA D 55 ALA^? 12.06 O ACT D 201 H 148 HIS D 56 HIS.? 17.26 O ACT D 201 H 163 ASP D 45 ASP^? 20.33 O ACT D 201 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -61.44 55.28 49.65 -61.24 56.24 48.48 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -67.68 49.50 43.87 -67.26 48.38 42.12 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c07 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 56 HIS.? 6.76 O1 EDO A 302 A 646 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 739 GLY B 158 GLY.? 7.47 OXT ACT A 202 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -14.69 54.85 71.91 -15.35 54.62 72.30 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS A 98 HIS^? -3.60 C ACT A 203s A 646 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 739 GLY D 102 GLY.? 12.85 CH3 ACT A 203 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -46.87 80.08 50.24 -46.64 79.47 50.70 ULMN 3 1qrz_c20 PLASMINOGEN user 3 3 # 3 A 603 HIS B 56 HIS.? 17.31 O ACT B 201 A 646 ASP B 45 ASP^? 20.35 O ACT B 201 A 739 GLY A 158 GLY~? 18.81 CH3 ACT A 201 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -45.28 73.93 80.63 -45.09 73.75 79.84 ULMN 3 1qrz_c20 PLASMINOGEN user 4 3 # 4 A 603 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 646 ASP B 150 ASP.? 20.21 CH3 ACT A 202 A 739 GLY B 158 GLY.? 7.47 OXT ACT A 202 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -16.30 48.49 82.95 -17.03 48.20 81.01 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -10.73 49.15 87.46 -11.06 47.07 87.30 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -14.69 54.85 71.91 -15.35 54.62 72.30 ULMN 3 1qrz_c20 PLASMINOGEN user 5 3 # 5 A 603 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 646 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 739 GLY B 102 GLY.? 18.26 OXT ACT B 201 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -32.65 37.69 71.75 -32.89 38.32 71.31 ULMN 3 1qrz_c20 PLASMINOGEN user 6 3 # 6 A 603 HIS D 56 HIS.? 17.26 O ACT D 201 A 646 ASP D 45 ASP^? 20.33 O ACT D 201 A 739 GLY C 158 GLY.? 19.51 CH3 ACT C 201 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -56.88 42.22 53.54 -56.09 42.41 53.65 1qrz_c20 source 1qrz PLASMINOGEN : 6 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 98 HIS^? -3.60 C ACT A 203s B 646 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 739 GLY D 102 GLY.? 12.85 CH3 ACT A 203 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -46.87 80.08 50.24 -46.64 79.47 50.70 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS A 98 HIS^? -3.60 C ACT A 203s B 646 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 739 GLY A 145 GLY.? 13.13 O ACT A 201 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -38.43 80.69 60.76 -38.91 80.43 61.42 ULMN 3 1qrz_c21 PLASMINOGEN user 3 3 # 3 B 603 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 646 ASP A 150 ASP.? 22.07 CH3 ACT A 201 B 739 GLY A 158 GLY~? 18.81 CH3 ACT A 201 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -43.83 81.49 70.61 -45.02 79.78 70.42 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.95 88.27 71.85 -43.22 89.50 70.29 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -45.28 73.93 80.63 -45.09 73.75 79.84 ULMN 3 1qrz_c21 PLASMINOGEN user 4 3 # 4 B 603 HIS B 56 HIS.? 17.31 O ACT B 201 B 646 ASP B 45 ASP^? 20.35 O ACT B 201 B 739 GLY A 158 GLY~? 18.81 CH3 ACT A 201 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -45.28 73.93 80.63 -45.09 73.75 79.84 ULMN 3 1qrz_c21 PLASMINOGEN user 5 3 # 5 B 603 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 646 ASP B 150 ASP.? 20.21 CH3 ACT A 202 B 739 GLY B 158 GLY.? 7.47 OXT ACT A 202 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -16.30 48.49 82.95 -17.03 48.20 81.01 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -10.73 49.15 87.46 -11.06 47.07 87.30 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -14.69 54.85 71.91 -15.35 54.62 72.30 ULMN 3 1qrz_c21 PLASMINOGEN user 6 3 # 6 B 603 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 646 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 739 GLY C 145 GLY.? 13.18 O ACT C 201 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -35.71 37.24 58.49 -36.57 37.39 58.47 ULMN 3 1qrz_c21 PLASMINOGEN user 7 3 # 7 B 603 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 646 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 739 GLY B 102 GLY.? 18.26 OXT ACT B 201 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -32.65 37.69 71.75 -32.89 38.32 71.31 ULMN 3 1qrz_c21 PLASMINOGEN user 8 3 # 8 B 603 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 646 ASP C 150 ASP.? 20.99 CH3 ACT C 201 B 739 GLY C 158 GLY.? 19.51 CH3 ACT C 201 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -46.81 35.18 56.40 -47.74 36.88 57.21 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -46.61 28.46 55.57 -45.54 29.27 57.21 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -56.88 42.22 53.54 -56.09 42.41 53.65 ULMN 3 1qrz_c21 PLASMINOGEN user 9 3 # 9 B 603 HIS D 56 HIS.? 17.26 O ACT D 201 B 646 ASP D 45 ASP^? 20.33 O ACT D 201 B 739 GLY C 158 GLY.? 19.51 CH3 ACT C 201 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -56.88 42.22 53.54 -56.09 42.41 53.65 1qrz_c21 source 1qrz PLASMINOGEN : 9 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 56 HIS.? 6.76 O1 EDO A 302 C 646 ASP A 45 ASP^? 16.09 OXT ACT A 202 C 739 GLY B 158 GLY.? 7.47 OXT ACT A 202 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 7.82 1.25 3.03 7.30 1.31 3.65 -14.69 54.85 71.91 -15.35 54.62 72.30 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS A 98 HIS^? -3.60 C ACT A 203s C 646 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 739 GLY D 102 GLY.? 12.85 CH3 ACT A 203 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 7.82 1.25 3.03 7.30 1.31 3.65 -46.87 80.08 50.24 -46.64 79.47 50.70 ULMN 3 1qrz_c22 PLASMINOGEN user 3 3 # 3 C 603 HIS A 151 HIS.? 15.97 CH3 ACT A 201 C 646 ASP A 150 ASP.? 22.07 CH3 ACT A 201 C 739 GLY A 158 GLY~? 18.81 CH3 ACT A 201 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 7.82 1.25 3.03 7.30 1.31 3.65 -45.28 73.93 80.63 -45.09 73.75 79.84 ULMN 3 1qrz_c22 PLASMINOGEN user 4 3 # 4 C 603 HIS B 56 HIS.? 17.31 O ACT B 201 C 646 ASP B 45 ASP^? 20.35 O ACT B 201 C 739 GLY A 158 GLY~? 18.81 CH3 ACT A 201 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 7.82 1.25 3.03 7.30 1.31 3.65 -45.28 73.93 80.63 -45.09 73.75 79.84 ULMN 3 1qrz_c22 PLASMINOGEN user 5 3 # 5 C 603 HIS B 151 HIS.? 13.45 CH3 ACT A 202 C 646 ASP B 150 ASP.? 20.21 CH3 ACT A 202 C 739 GLY B 158 GLY.? 7.47 OXT ACT A 202 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 7.82 1.25 3.03 7.30 1.31 3.65 -14.69 54.85 71.91 -15.35 54.62 72.30 ULMN 3 1qrz_c22 PLASMINOGEN user 6 3 # 6 C 603 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 646 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 739 GLY B 102 GLY.? 18.26 OXT ACT B 201 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 7.82 1.25 3.03 7.30 1.31 3.65 -32.65 37.69 71.75 -32.89 38.32 71.31 ULMN 3 1qrz_c22 PLASMINOGEN user 7 3 # 7 C 603 HIS D 56 HIS.? 17.26 O ACT D 201 C 646 ASP D 45 ASP^? 20.33 O ACT D 201 C 739 GLY C 158 GLY.? 19.51 CH3 ACT C 201 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 7.82 1.25 3.03 7.30 1.31 3.65 -56.88 42.22 53.54 -56.09 42.41 53.65 ULMN 3 1qrz_c22 PLASMINOGEN user 8 3 # 8 C 603 HIS D 151 HIS.? 15.66 CH3 ACT D 201 C 646 ASP D 150 ASP.? 21.68 CH3 ACT D 201 C 739 GLY D 145 GLY.? 13.27 OXT ACT D 201 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 7.82 1.25 3.03 7.30 1.31 3.65 -54.58 73.10 33.20 -53.72 72.98 33.25 1qrz_c22 source 1qrz PLASMINOGEN : 8 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 56 HIS.? 6.76 O1 EDO A 302 D 646 ASP A 45 ASP^? 16.09 OXT ACT A 202 D 739 GLY B 158 GLY.? 7.47 OXT ACT A 202 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -14.69 54.85 71.91 -15.35 54.62 72.30 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS A 98 HIS^? -3.60 C ACT A 203s D 646 ASP A 100 ASP.? 9.07 O2 EDO A 301 D 739 GLY D 102 GLY.? 12.85 CH3 ACT A 203 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -46.87 80.08 50.24 -46.64 79.47 50.70 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS B 56 HIS.? 17.31 O ACT B 201 D 646 ASP B 45 ASP^? 20.35 O ACT B 201 D 739 GLY A 158 GLY~? 18.81 CH3 ACT A 201 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -45.28 73.93 80.63 -45.09 73.75 79.84 ULMN 3 1qrz_c23 PLASMINOGEN user 4 3 # 4 D 603 HIS B 151 HIS.? 13.45 CH3 ACT A 202 D 646 ASP B 150 ASP.? 20.21 CH3 ACT A 202 D 739 GLY B 145 GLY.? 13.34 OXT ACT B 201 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -16.30 48.49 82.95 -17.03 48.20 81.01 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -10.73 49.15 87.46 -11.06 47.07 87.30 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -25.17 44.53 88.88 -24.74 44.79 88.19 ULMN 3 1qrz_c23 PLASMINOGEN user 5 3 # 5 D 603 HIS B 151 HIS.? 13.45 CH3 ACT A 202 D 646 ASP B 150 ASP.? 20.21 CH3 ACT A 202 D 739 GLY B 158 GLY.? 7.47 OXT ACT A 202 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -16.30 48.49 82.95 -17.03 48.20 81.01 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -10.73 49.15 87.46 -11.06 47.07 87.30 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -14.69 54.85 71.91 -15.35 54.62 72.30 ULMN 3 1qrz_c23 PLASMINOGEN user 6 3 # 6 D 603 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 646 ASP C 100 ASP.? 9.05 C1 EDO A 301 D 739 GLY B 102 GLY.? 18.26 OXT ACT B 201 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -32.65 37.69 71.75 -32.89 38.32 71.31 ULMN 3 1qrz_c23 PLASMINOGEN user 7 3 # 7 D 603 HIS D 56 HIS.? 17.26 O ACT D 201 D 646 ASP D 45 ASP^? 20.33 O ACT D 201 D 739 GLY C 158 GLY.? 19.51 CH3 ACT C 201 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -56.88 42.22 53.54 -56.09 42.41 53.65 ULMN 3 1qrz_c23 PLASMINOGEN user 8 3 # 8 D 603 HIS D 151 HIS.? 15.66 CH3 ACT D 201 D 646 ASP D 150 ASP.? 21.68 CH3 ACT D 201 D 739 GLY D 145 GLY.? 13.27 OXT ACT D 201 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -44.04 70.63 29.61 -43.01 70.81 31.43 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -44.02 71.14 22.58 -44.47 73.01 23.46 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -54.58 73.10 33.20 -53.72 72.98 33.25 1qrz_c23 source 1qrz PLASMINOGEN : 8 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 84 PHE^? 19.84 CH3 ACT A 201 A 201 ASP A 86 ASP.? 20.24 CH3 ACT A 202 A 227 LYS A 22 LYS~? 15.35 CH3 ACT A 201 coo 23.39 49.81 32.16 21.33 51.68 32.26 -24.05 77.11 82.23 -23.91 79.14 84.16 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 12.68 46.83 36.69 18.26 48.67 34.51 -25.90 80.72 72.77 -21.11 80.01 70.15 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 201 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 227 LYS A 68 LYS~? -2.78 O ACT A 201s coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 12.68 46.83 36.69 18.26 48.67 34.51 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 201 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 227 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 12.68 46.83 36.69 18.26 48.67 34.51 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 201 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 227 LYS A 68 LYS~? -2.78 O ACT A 201s coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 25.52 45.12 37.98 23.98 46.65 37.85 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 12.68 46.83 36.69 18.26 48.67 34.51 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 201 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 227 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 25.52 45.12 37.98 23.98 46.65 37.85 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 12.68 46.83 36.69 18.26 48.67 34.51 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 201 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 227 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 25.52 45.12 37.98 23.98 46.65 37.85 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 12.68 46.83 36.69 18.26 48.67 34.51 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qz9_c02 KYNURENINASE user 7 3 # 7 A 129 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 201 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 227 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 25.52 45.12 37.98 23.98 46.65 37.85 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 12.68 46.83 36.69 18.26 48.67 34.51 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qz9_c02 KYNURENINASE user 8 3 # 8 A 129 PHE B 84 PHE^? 19.62 CH3 ACT A 202 A 201 ASP B 86 ASP.? 24.07 CH3 ACT B 201 A 227 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 23.39 49.81 32.16 21.33 51.68 32.26 -22.29 70.30 88.22 -19.89 71.38 89.16 coo 25.52 45.12 37.98 23.98 46.65 37.85 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 12.68 46.83 36.69 18.26 48.67 34.51 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 1qz9_c02 KYNURENINASE user 9 3 # 9 A 129 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 201 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 227 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 23.39 49.81 32.16 21.33 51.68 32.26 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 25.52 45.12 37.98 23.98 46.65 37.85 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 12.68 46.83 36.69 18.26 48.67 34.51 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qz9_c02 KYNURENINASE user 10 3 # 10 A 129 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 201 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 227 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 25.52 45.12 37.98 23.98 46.65 37.85 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 12.68 46.83 36.69 18.26 48.67 34.51 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qz9_c02 KYNURENINASE user 11 3 # 11 A 129 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 201 ASP C 74 ASP^? 14.86 O ACT C 201 A 227 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 23.39 49.81 32.16 21.33 51.68 32.26 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 25.52 45.12 37.98 23.98 46.65 37.85 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 12.68 46.83 36.69 18.26 48.67 34.51 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qz9_c02 KYNURENINASE user 12 3 # 12 A 129 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 201 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 227 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 23.39 49.81 32.16 21.33 51.68 32.26 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 25.52 45.12 37.98 23.98 46.65 37.85 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 12.68 46.83 36.69 18.26 48.67 34.51 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 1qz9_c02 KYNURENINASE user 13 3 # 13 A 129 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 201 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 227 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 23.39 49.81 32.16 21.33 51.68 32.26 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 25.52 45.12 37.98 23.98 46.65 37.85 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 12.68 46.83 36.69 18.26 48.67 34.51 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 1qz9_c02 KYNURENINASE user 14 3 # 14 A 129 PHE C 84 PHE^? 19.83 CH3 ACT C 201 A 201 ASP C 86 ASP.? 24.03 CH3 ACT C 201 A 227 LYS C 22 LYS~? 15.34 CH3 ACT C 201 coo 23.39 49.81 32.16 21.33 51.68 32.26 -43.84 41.52 34.02 -45.03 39.44 32.58 coo 25.52 45.12 37.98 23.98 46.65 37.85 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 12.68 46.83 36.69 18.26 48.67 34.51 -37.27 38.20 41.22 -32.34 39.66 39.29 ULMN 3 1qz9_c02 KYNURENINASE user 15 3 # 15 A 129 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 201 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 227 LYS C 68 LYS~? -2.77 O ACT C 201s coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 12.68 46.83 36.69 18.26 48.67 34.51 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qz9_c02 KYNURENINASE user 16 3 # 16 A 129 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 201 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 227 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 12.68 46.83 36.69 18.26 48.67 34.51 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qz9_c02 KYNURENINASE user 17 3 # 17 A 129 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 201 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 227 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 25.52 45.12 37.98 23.98 46.65 37.85 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 12.68 46.83 36.69 18.26 48.67 34.51 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qz9_c02 KYNURENINASE user 18 3 # 18 A 129 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 201 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 227 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 25.52 45.12 37.98 23.98 46.65 37.85 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 12.68 46.83 36.69 18.26 48.67 34.51 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1qz9_c02 KYNURENINASE user 19 3 # 19 A 129 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 201 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 227 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 25.52 45.12 37.98 23.98 46.65 37.85 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 12.68 46.83 36.69 18.26 48.67 34.51 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1qz9_c02 KYNURENINASE user 20 3 # 20 A 129 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 201 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 227 LYS C 68 LYS~? -2.77 O ACT C 201s coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 25.52 45.12 37.98 23.98 46.65 37.85 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 12.68 46.83 36.69 18.26 48.67 34.51 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 1qz9_c02 KYNURENINASE user 21 3 # 21 A 129 PHE D 84 PHE^? 19.80 CH3 ACT D 201 A 201 ASP D 86 ASP.? 24.19 CH3 ACT D 201 A 227 LYS D 22 LYS~? 15.49 CH3 ACT D 201 coo 23.39 49.81 32.16 21.33 51.68 32.26 -48.20 48.22 29.39 -47.23 47.53 26.85 coo 25.52 45.12 37.98 23.98 46.65 37.85 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 12.68 46.83 36.69 18.26 48.67 34.51 -54.47 56.23 29.06 -59.33 54.04 30.24 ULMN 3 1qz9_c02 KYNURENINASE user 22 3 # 22 A 129 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 201 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 227 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 12.68 46.83 36.69 18.26 48.67 34.51 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qz9_c02 KYNURENINASE user 23 3 # 23 A 129 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 201 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 227 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 12.68 46.83 36.69 18.26 48.67 34.51 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 1qz9_c02 KYNURENINASE user 24 3 # 24 A 129 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 201 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 227 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 12.68 46.83 36.69 18.26 48.67 34.51 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 1qz9_c02 KYNURENINASE user 25 3 # 25 A 129 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 201 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 227 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 23.39 49.81 32.16 21.33 51.68 32.26 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 25.52 45.12 37.98 23.98 46.65 37.85 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 12.68 46.83 36.69 18.26 48.67 34.51 -56.56 67.44 48.13 -52.71 65.23 44.87 1qz9_c02 source 1qz9 KYNURENINASE : 25 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 34 ASP~? 14.63 O ACT A 201 A 186 ASN A 31 ASN~? 8.53 CH3 ACT A 201 A 260 ALA A 26 ALA~? 8.12 CH3 ACT A 201 coo 11.81 33.10 11.71 13.07 31.45 11.40 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 11.43 26.53 7.41 13.01 27.56 8.43 -36.15 78.19 63.69 -37.32 77.26 65.21 coo 21.53 26.33 6.96 20.26 25.69 7.52 -28.72 78.00 67.87 -28.24 76.96 68.88 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 186 ASN C 129 ASN.? 9.72 O ACT D 201 A 260 ALA C 52 ALA.? 12.19 C2 EDO A 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 11.43 26.53 7.41 13.01 27.56 8.43 -47.56 56.76 52.53 -47.22 58.18 50.99 coo 21.53 26.33 6.96 20.26 25.69 7.52 -37.45 62.38 49.17 -37.97 63.55 50.01 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 186 ASN C 129 ASN.? 9.72 O ACT D 201 A 260 ALA C 126 ALA.? 5.02 OXT ACT C 201 coo 11.81 33.10 11.71 13.07 31.45 11.40 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 11.43 26.53 7.41 13.01 27.56 8.43 -47.56 56.76 52.53 -47.22 58.18 50.99 coo 21.53 26.33 6.96 20.26 25.69 7.52 -39.67 53.99 45.62 -38.91 53.15 46.65 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 186 ASN C 129 ASN.? 9.72 O ACT D 201 A 260 ALA D 126 ALA.? 5.05 O ACT D 201 coo 11.81 33.10 11.71 13.07 31.45 11.40 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 11.43 26.53 7.41 13.01 27.56 8.43 -47.56 56.76 52.53 -47.22 58.18 50.99 coo 21.53 26.33 6.96 20.26 25.69 7.52 -50.75 55.53 45.15 -51.51 56.79 44.72 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 186 ASN A 103 ASN.? 7.23 O2 EDO A 301 A 260 ALA A 135 ALA~? 6.35 OXT ACT A 203 coo 11.81 33.10 11.71 13.07 31.45 11.40 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 11.43 26.53 7.41 13.01 27.56 8.43 -48.04 61.08 60.88 -48.95 59.43 59.91 coo 21.53 26.33 6.96 20.26 25.69 7.52 -52.93 68.60 64.38 -53.51 68.88 63.01 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 186 ASN B 31 ASN~? 8.56 CH3 ACT B 201 A 260 ALA B 26 ALA~? 8.11 CH3 ACT B 201 coo 11.81 33.10 11.71 13.07 31.45 11.40 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 11.43 26.53 7.41 13.01 27.56 8.43 -26.33 48.60 87.43 -25.42 49.22 85.60 coo 21.53 26.33 6.96 20.26 25.69 7.52 -27.84 56.51 90.43 -28.15 57.77 89.64 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 7 3 # 7 A 10 ASP C 34 ASP~? 14.66 O ACT C 201 A 186 ASN C 31 ASN~? 8.68 CH3 ACT C 201 A 260 ALA C 26 ALA~? 8.20 CH3 ACT C 201 coo 11.81 33.10 11.71 13.07 31.45 11.40 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 11.43 26.53 7.41 13.01 27.56 8.43 -36.93 39.85 55.08 -38.97 40.48 55.12 coo 21.53 26.33 6.96 20.26 25.69 7.52 -35.58 40.78 46.69 -36.15 41.81 45.72 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 8 3 # 8 A 10 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 186 ASN A 129 ASN.? 9.65 O ACT B 201 A 260 ALA A 52 ALA.? 7.92 O2 EDO A 302 coo 11.81 33.10 11.71 13.07 31.45 11.40 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 11.43 26.53 7.41 13.01 27.56 8.43 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 21.53 26.33 6.96 20.26 25.69 7.52 -28.67 56.33 66.41 -29.48 55.05 66.20 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 9 3 # 9 A 10 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 186 ASN A 129 ASN.? 9.65 O ACT B 201 A 260 ALA A 126 ALA.? 5.06 OXT ACT A 201 coo 11.81 33.10 11.71 13.07 31.45 11.40 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 11.43 26.53 7.41 13.01 27.56 8.43 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 21.53 26.33 6.96 20.26 25.69 7.52 -28.54 64.52 70.82 -28.98 65.37 69.63 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 10 3 # 10 A 10 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 186 ASN A 129 ASN.? 9.65 O ACT B 201 A 260 ALA B 126 ALA.? 5.01 O ACT B 201 coo 11.81 33.10 11.71 13.07 31.45 11.40 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 11.43 26.53 7.41 13.01 27.56 8.43 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 21.53 26.33 6.96 20.26 25.69 7.52 -34.85 61.51 79.63 -34.73 60.21 80.42 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 11 3 # 11 A 10 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 186 ASN C 103 ASN.? 7.35 O1 EDO A 301 A 260 ALA C 135 ALA~? 15.67 O2 EDO A 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 11.43 26.53 7.41 13.01 27.56 8.43 -44.48 55.23 67.22 -44.54 56.80 68.65 coo 21.53 26.33 6.96 20.26 25.69 7.52 -49.12 46.81 68.31 -48.42 46.56 69.64 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 12 3 # 12 A 10 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 186 ASN D 31 ASN~? 8.51 CH3 ACT D 201 A 260 ALA D 26 ALA~? 8.16 CH3 ACT D 201 coo 11.81 33.10 11.71 13.07 31.45 11.40 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 11.43 26.53 7.41 13.01 27.56 8.43 -53.58 68.96 34.68 -51.50 68.66 35.10 coo 21.53 26.33 6.96 20.26 25.69 7.52 -55.52 60.76 33.28 -54.94 59.51 33.93 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 12 hits 1r4f_c00 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 41 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 119 HIS A 141 HIS.? 11.20 OXT ACT A 203 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -49.96 77.41 66.16 -51.01 75.70 66.78 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 2 3 # 2 A 12 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 41 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 119 HIS C 141 HIS.? 17.85 O ACT C 201 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -47.33 38.55 64.23 -48.23 40.22 65.13 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 3 3 # 3 A 12 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 41 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 119 HIS D 141 HIS.? 18.95 OXT ACT D 201 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -42.77 77.11 33.23 -41.72 76.77 31.45 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 3 hits 1rbn_c01 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 610 HIS A 98 HIS^? -3.60 C ACT A 203s A 661 HIS A 141 HIS.? 11.20 OXT ACT A 203 coo 75.99 81.56 1.86 73.91 81.34 2.28 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 71.04 78.84 0.46 71.54 76.90 1.02 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 75.40 81.38 12.06 74.88 79.42 12.63 -49.96 77.41 66.16 -51.01 75.70 66.78 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP C 74 ASP^? 14.86 O ACT C 201 A 610 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 661 HIS C 141 HIS.? 17.85 O ACT C 201 coo 75.99 81.56 1.86 73.91 81.34 2.28 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 71.04 78.84 0.46 71.54 76.90 1.02 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 75.40 81.38 12.06 74.88 79.42 12.63 -47.33 38.55 64.23 -48.23 40.22 65.13 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 3 3 # 3 A 608 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 610 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 661 HIS D 141 HIS.? 18.95 OXT ACT D 201 coo 75.99 81.56 1.86 73.91 81.34 2.28 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 71.04 78.84 0.46 71.54 76.90 1.02 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 75.40 81.38 12.06 74.88 79.42 12.63 -42.77 77.11 33.23 -41.72 76.77 31.45 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 3 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 610 HIS A 98 HIS^? -3.60 C ACT A 203s C 661 HIS A 141 HIS.? 11.20 OXT ACT A 203 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -49.96 77.41 66.16 -51.01 75.70 66.78 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP C 74 ASP^? 14.86 O ACT C 201 C 610 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 661 HIS C 141 HIS.? 17.85 O ACT C 201 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -47.33 38.55 64.23 -48.23 40.22 65.13 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 3 3 # 3 C 608 ASP D 74 ASP^? 14.85 OXT ACT D 201 C 610 HIS D 98 HIS^? 13.13 CH3 ACT A 203 C 661 HIS D 141 HIS.? 18.95 OXT ACT D 201 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -42.77 77.11 33.23 -41.72 76.77 31.45 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 3 hits 1req_c11 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 84 ASP A 150 ASP.? 22.07 CH3 ACT A 201 B 140 GLY A 145 GLY.? 13.13 O ACT A 201 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -38.43 80.69 60.76 -38.91 80.43 61.42 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 84 ASP A 150 ASP.? 22.07 CH3 ACT A 201 B 140 GLY A 158 GLY~? 18.81 CH3 ACT A 201 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -45.28 73.93 80.63 -45.09 73.75 79.84 ULMN 3 1rgq_c01 NS4A PEPTIDE user 3 3 # 3 B 60 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 84 ASP B 150 ASP.? 20.21 CH3 ACT A 202 B 140 GLY B 145 GLY.? 13.34 OXT ACT B 201 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -25.17 44.53 88.88 -24.74 44.79 88.19 ULMN 3 1rgq_c01 NS4A PEPTIDE user 4 3 # 4 B 60 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 84 ASP B 150 ASP.? 20.21 CH3 ACT A 202 B 140 GLY B 158 GLY.? 7.47 OXT ACT A 202 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -14.69 54.85 71.91 -15.35 54.62 72.30 ULMN 3 1rgq_c01 NS4A PEPTIDE user 5 3 # 5 B 60 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 84 ASP C 150 ASP.? 20.99 CH3 ACT C 201 B 140 GLY C 145 GLY.? 13.18 O ACT C 201 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -35.71 37.24 58.49 -36.57 37.39 58.47 ULMN 3 1rgq_c01 NS4A PEPTIDE user 6 3 # 6 B 60 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 84 ASP C 150 ASP.? 20.99 CH3 ACT C 201 B 140 GLY C 158 GLY.? 19.51 CH3 ACT C 201 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -56.88 42.22 53.54 -56.09 42.41 53.65 ULMN 3 1rgq_c01 NS4A PEPTIDE user 7 3 # 7 B 60 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 84 ASP D 150 ASP.? 21.68 CH3 ACT D 201 B 140 GLY D 145 GLY.? 13.27 OXT ACT D 201 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -54.58 73.10 33.20 -53.72 72.98 33.25 1rgq_c01 source 1rgq NS4A PEPTIDE : 7 hits 1rgq_c01 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 99 ASP.? 5.71 O2 EDO A 301 35 SER A 101 SER.? 7.80 O2 EDO A 301 215 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 11.85 17.24 72.81 11.09 15.37 72.36 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 12.20 12.71 75.45 13.69 13.84 74.03 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 5.22 15.03 71.43 7.19 14.88 70.83 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP B 99 ASP.? 16.09 OXT ACT B 201 35 SER B 101 SER.? 19.25 O ACT C 201 215 ASP C 74 ASP^? 14.86 O ACT C 201 coo 11.85 17.24 72.81 11.09 15.37 72.36 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 12.20 12.71 75.45 13.69 13.84 74.03 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 5.22 15.03 71.43 7.19 14.88 70.83 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 3 # 3 32 ASP C 99 ASP.? 5.79 O1 EDO A 301 35 SER C 101 SER.? 7.85 O1 EDO A 301 215 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 11.85 17.24 72.81 11.09 15.37 72.36 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 12.20 12.71 75.45 13.69 13.84 74.03 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 5.22 15.03 71.43 7.19 14.88 70.83 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 4 3 # 4 32 ASP D 99 ASP.? 7.94 CH3 ACT A 203 35 SER D 101 SER.? 9.16 OXT ACT A 203 215 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 11.85 17.24 72.81 11.09 15.37 72.36 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 12.20 12.71 75.45 13.69 13.84 74.03 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 5.22 15.03 71.43 7.19 14.88 70.83 -44.71 72.29 58.72 -45.62 72.95 56.93 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 4 hits 1rne_c04 naa= 3 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 1 3 # 1 D 129 ARG D 138 ARG~? 16.38 OXT ACT D 201 D 156 TYR D 75 TYR^? -4.49 OXT ACT D 201s D 188 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 -42.61 77.59 41.75 -44.95 78.80 40.20 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 -48.48 77.63 46.64 -50.12 78.90 46.30 1ro7_c03 source 1ro7 ALPHA-2,3/8-SIALYLTRANSFERASE : 1 hits 1ro7_c03 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 288 HIS A 98 HIS^? -3.60 C ACT A 203s A 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 29.27 18.78 14.99 27.16 18.62 14.76 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 49.52 10.06 10.36 50.99 9.65 8.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 57.80 12.92 13.83 53.77 8.42 12.15 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 288 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 329 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 29.27 18.78 14.99 27.16 18.62 14.76 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 49.52 10.06 10.36 50.99 9.65 8.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 57.80 12.92 13.83 53.77 8.42 12.15 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU B 53 GLU^? 11.09 O ACT B 201 A 288 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 329 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 29.27 18.78 14.99 27.16 18.62 14.76 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 49.52 10.06 10.36 50.99 9.65 8.92 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 57.80 12.92 13.83 53.77 8.42 12.15 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 A 137 GLU B 59 GLU~? 20.69 O ACT B 201 A 288 HIS A 162 HIS.? 14.54 O1 EDO A 301 A 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 29.27 18.78 14.99 27.16 18.62 14.76 -47.90 53.57 92.50 -49.95 53.72 93.03 coo 49.52 10.06 10.36 50.99 9.65 8.92 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 57.80 12.92 13.83 53.77 8.42 12.15 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 A 137 GLU B 60 GLU~? 17.33 O ACT B 201 A 288 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 29.27 18.78 14.99 27.16 18.62 14.76 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 49.52 10.06 10.36 50.99 9.65 8.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 57.80 12.92 13.83 53.77 8.42 12.15 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 A 137 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 288 HIS A 162 HIS.? 14.54 O1 EDO A 301 A 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 29.27 18.78 14.99 27.16 18.62 14.76 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 49.52 10.06 10.36 50.99 9.65 8.92 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 57.80 12.92 13.83 53.77 8.42 12.15 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 A 137 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 288 HIS A 162 HIS.? 14.54 O1 EDO A 301 A 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 29.27 18.78 14.99 27.16 18.62 14.76 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 49.52 10.06 10.36 50.99 9.65 8.92 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 57.80 12.92 13.83 53.77 8.42 12.15 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 A 137 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 288 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 329 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 29.27 18.78 14.99 27.16 18.62 14.76 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 49.52 10.06 10.36 50.99 9.65 8.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 57.80 12.92 13.83 53.77 8.42 12.15 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 A 137 GLU B 114 GLU^? 18.04 O ACT B 201 A 288 HIS A 162 HIS.? 14.54 O1 EDO A 301 A 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 29.27 18.78 14.99 27.16 18.62 14.76 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 49.52 10.06 10.36 50.99 9.65 8.92 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 57.80 12.92 13.83 53.77 8.42 12.15 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 A 137 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 288 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 329 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 29.27 18.78 14.99 27.16 18.62 14.76 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 49.52 10.06 10.36 50.99 9.65 8.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 57.80 12.92 13.83 53.77 8.42 12.15 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 A 137 GLU C 17 GLU~? 23.53 CH3 ACT C 201 A 288 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 329 LYS C 139 LYS.? 18.79 O ACT C 201 coo 29.27 18.78 14.99 27.16 18.62 14.76 -44.57 31.78 35.88 -45.60 32.67 34.25 coo 49.52 10.06 10.36 50.99 9.65 8.92 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 57.80 12.92 13.83 53.77 8.42 12.15 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 12 3 # 12 A 137 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 288 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 329 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 29.27 18.78 14.99 27.16 18.62 14.76 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 49.52 10.06 10.36 50.99 9.65 8.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 57.80 12.92 13.83 53.77 8.42 12.15 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 13 3 # 13 A 137 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 288 HIS A 98 HIS^? -3.60 C ACT A 203s A 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 29.27 18.78 14.99 27.16 18.62 14.76 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 49.52 10.06 10.36 50.99 9.65 8.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 57.80 12.92 13.83 53.77 8.42 12.15 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 14 3 # 14 A 137 GLU D 60 GLU~? 17.31 O ACT D 201 A 288 HIS A 98 HIS^? -3.60 C ACT A 203s A 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 29.27 18.78 14.99 27.16 18.62 14.76 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 49.52 10.06 10.36 50.99 9.65 8.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 57.80 12.92 13.83 53.77 8.42 12.15 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 15 3 # 15 A 137 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 288 HIS A 98 HIS^? -3.60 C ACT A 203s A 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 29.27 18.78 14.99 27.16 18.62 14.76 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 49.52 10.06 10.36 50.99 9.65 8.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 57.80 12.92 13.83 53.77 8.42 12.15 -53.24 65.33 66.31 -57.37 62.85 65.73 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 15 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 53 GLU^? 10.41 O2 EDO A 302 B 288 HIS A 98 HIS^? -3.60 C ACT A 203s B 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 111 GLU^? 4.34 CH3 ACT A 201 B 288 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 329 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU B 53 GLU^? 11.09 O ACT B 201 B 288 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 329 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU B 59 GLU~? 20.69 O ACT B 201 B 288 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -47.90 53.57 92.50 -49.95 53.72 93.03 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 B 137 GLU B 60 GLU~? 17.33 O ACT B 201 B 288 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 329 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 B 137 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 288 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 B 137 GLU B 111 GLU^? 4.46 CH3 ACT B 201 B 288 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 B 137 GLU B 111 GLU^? 4.46 CH3 ACT B 201 B 288 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 329 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 B 137 GLU B 114 GLU^? 18.04 O ACT B 201 B 288 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 B 137 GLU C 53 GLU^? 11.18 OXT ACT C 201 B 288 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 329 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 B 137 GLU C 111 GLU^? 4.32 CH3 ACT C 201 B 288 HIS A 98 HIS^? -3.60 C ACT A 203s B 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 12 3 # 12 B 137 GLU D 60 GLU~? 17.31 O ACT D 201 B 288 HIS A 98 HIS^? -3.60 C ACT A 203s B 329 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 13 3 # 13 B 137 GLU D 111 GLU^? 4.46 CH3 ACT D 201 B 288 HIS A 98 HIS^? -3.60 C ACT A 203s B 329 LYS A 134 LYS~? 11.98 O ACT A 203 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -53.24 65.33 66.31 -57.37 62.85 65.73 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 13 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 102 ASP A 150 ASP.? 22.07 CH3 ACT A 201 B 193 GLY A 145 GLY.? 13.13 O ACT A 201 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -43.83 81.49 70.61 -45.02 79.78 70.42 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -43.95 88.27 71.85 -43.22 89.50 70.29 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -38.43 80.69 60.76 -38.91 80.43 61.42 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 102 ASP B 150 ASP.? 20.21 CH3 ACT A 202 B 193 GLY B 145 GLY.? 13.34 OXT ACT B 201 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -16.30 48.49 82.95 -17.03 48.20 81.01 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -10.73 49.15 87.46 -11.06 47.07 87.30 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -25.17 44.53 88.88 -24.74 44.79 88.19 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 102 ASP C 150 ASP.? 20.99 CH3 ACT C 201 B 193 GLY C 145 GLY.? 13.18 O ACT C 201 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -46.81 35.18 56.40 -47.74 36.88 57.21 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -46.61 28.46 55.57 -45.54 29.27 57.21 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -35.71 37.24 58.49 -36.57 37.39 58.47 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 102 ASP D 150 ASP.? 21.68 CH3 ACT D 201 B 193 GLY D 145 GLY.? 13.27 OXT ACT D 201 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -44.04 70.63 29.61 -43.01 70.81 31.43 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -44.02 71.14 22.58 -44.47 73.01 23.46 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -54.58 73.10 33.20 -53.72 72.98 33.25 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 4 hits 1rtf_c06 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 74 ASP^? 5.73 OXT ACT A 203 64 HIS A 98 HIS^? -3.60 C ACT A 203s 155 ASN C 129 ASN.? 9.72 O ACT D 201 coo 80.16 73.25 62.48 80.01 71.25 61.82 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 78.27 67.69 61.83 79.58 67.76 60.19 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 80.34 61.88 52.75 81.25 63.19 54.35 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 74 ASP^? 5.73 OXT ACT A 203 64 HIS A 98 HIS^? -3.60 C ACT A 203s 155 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 80.16 73.25 62.48 80.01 71.25 61.82 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 78.27 67.69 61.83 79.58 67.76 60.19 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 80.34 61.88 52.75 81.25 63.19 54.35 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP A 99 ASP.? 5.71 O2 EDO A 301 64 HIS A 98 HIS^? -3.60 C ACT A 203s 155 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 80.16 73.25 62.48 80.01 71.25 61.82 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 78.27 67.69 61.83 79.58 67.76 60.19 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 80.34 61.88 52.75 81.25 63.19 54.35 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP A 100 ASP.? 9.07 O2 EDO A 301 64 HIS A 98 HIS^? -3.60 C ACT A 203s 155 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 80.16 73.25 62.48 80.01 71.25 61.82 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 78.27 67.69 61.83 79.58 67.76 60.19 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 80.34 61.88 52.75 81.25 63.19 54.35 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 5 3 # 5 32 ASP A 150 ASP.? 22.07 CH3 ACT A 201 64 HIS A 151 HIS.? 15.97 CH3 ACT A 201 155 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 80.16 73.25 62.48 80.01 71.25 61.82 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 78.27 67.69 61.83 79.58 67.76 60.19 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 80.34 61.88 52.75 81.25 63.19 54.35 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 6 3 # 6 32 ASP B 150 ASP.? 20.21 CH3 ACT A 202 64 HIS B 151 HIS.? 13.45 CH3 ACT A 202 155 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo 80.16 73.25 62.48 80.01 71.25 61.82 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 78.27 67.69 61.83 79.58 67.76 60.19 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 80.34 61.88 52.75 81.25 63.19 54.35 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 7 3 # 7 32 ASP C 74 ASP^? 14.86 O ACT C 201 64 HIS C 98 HIS^? 11.61 O2 EDO A 301 155 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 80.16 73.25 62.48 80.01 71.25 61.82 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 78.27 67.69 61.83 79.58 67.76 60.19 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 80.34 61.88 52.75 81.25 63.19 54.35 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 8 3 # 8 32 ASP C 99 ASP.? 5.79 O1 EDO A 301 64 HIS C 98 HIS^? 11.61 O2 EDO A 301 155 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 80.16 73.25 62.48 80.01 71.25 61.82 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 78.27 67.69 61.83 79.58 67.76 60.19 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 80.34 61.88 52.75 81.25 63.19 54.35 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 9 3 # 9 32 ASP C 100 ASP.? 9.05 C1 EDO A 301 64 HIS C 98 HIS^? 11.61 O2 EDO A 301 155 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 80.16 73.25 62.48 80.01 71.25 61.82 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 78.27 67.69 61.83 79.58 67.76 60.19 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 80.34 61.88 52.75 81.25 63.19 54.35 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 10 3 # 10 32 ASP C 150 ASP.? 20.99 CH3 ACT C 201 64 HIS C 151 HIS.? 16.03 CH3 ACT C 201 155 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo 80.16 73.25 62.48 80.01 71.25 61.82 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 78.27 67.69 61.83 79.58 67.76 60.19 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 80.34 61.88 52.75 81.25 63.19 54.35 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 11 3 # 11 32 ASP D 150 ASP.? 21.68 CH3 ACT D 201 64 HIS D 151 HIS.? 15.66 CH3 ACT D 201 155 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 80.16 73.25 62.48 80.01 71.25 61.82 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 78.27 67.69 61.83 79.58 67.76 60.19 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 80.34 61.88 52.75 81.25 63.19 54.35 -53.58 68.96 34.68 -51.50 68.66 35.10 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 11 hits 1sca_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 74 ASP^? 5.73 OXT ACT A 203 595 GLU A 72 GLU~? 5.31 O ACT A 201 713 TYR A 95 TYR^? -3.85 O ACT A 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 4.35 13.73 37.63 3.39 12.18 36.55 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 3.76 10.25 31.38 3.16 9.87 34.10 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP A 74 ASP^? 5.73 OXT ACT A 203 595 GLU A 96 GLU^? 11.70 OXT ACT A 203 713 TYR A 95 TYR^? -3.85 O ACT A 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 4.35 13.73 37.63 3.39 12.18 36.55 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 3.76 10.25 31.38 3.16 9.87 34.10 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP A 100 ASP.? 9.07 O2 EDO A 301 595 GLU D 72 GLU~? 5.29 OXT ACT D 201 713 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 4.35 13.73 37.63 3.39 12.18 36.55 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 3.76 10.25 31.38 3.16 9.87 34.10 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1sll_c00 SIALIDASE L user 4 3 # 4 318 ASP A 130 ASP.? 4.80 O1 EDO A 301 595 GLU A 72 GLU~? 5.31 O ACT A 201 713 TYR A 75 TYR^? -4.52 O ACT A 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 4.35 13.73 37.63 3.39 12.18 36.55 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 3.76 10.25 31.38 3.16 9.87 34.10 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1sll_c00 SIALIDASE L user 5 3 # 5 318 ASP A 130 ASP.? 4.80 O1 EDO A 301 595 GLU A 72 GLU~? 5.31 O ACT A 201 713 TYR A 95 TYR^? -3.85 O ACT A 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 4.35 13.73 37.63 3.39 12.18 36.55 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 3.76 10.25 31.38 3.16 9.87 34.10 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1sll_c00 SIALIDASE L user 6 3 # 6 318 ASP A 130 ASP.? 4.80 O1 EDO A 301 595 GLU A 96 GLU^? 11.70 OXT ACT A 203 713 TYR A 75 TYR^? -4.52 O ACT A 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 4.35 13.73 37.63 3.39 12.18 36.55 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 3.76 10.25 31.38 3.16 9.87 34.10 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1sll_c00 SIALIDASE L user 7 3 # 7 318 ASP A 130 ASP.? 4.80 O1 EDO A 301 595 GLU A 96 GLU^? 11.70 OXT ACT A 203 713 TYR A 95 TYR^? -3.85 O ACT A 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 4.35 13.73 37.63 3.39 12.18 36.55 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 3.76 10.25 31.38 3.16 9.87 34.10 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 1sll_c00 SIALIDASE L user 8 3 # 8 318 ASP B 74 ASP^? 14.88 OXT ACT B 201 595 GLU B 72 GLU~? 5.30 OXT ACT B 201 713 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 4.35 13.73 37.63 3.39 12.18 36.55 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 3.76 10.25 31.38 3.16 9.87 34.10 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1sll_c00 SIALIDASE L user 9 3 # 9 318 ASP B 74 ASP^? 14.88 OXT ACT B 201 595 GLU B 96 GLU^? 10.60 C1 EDO A 302 713 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 4.35 13.73 37.63 3.39 12.18 36.55 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 3.76 10.25 31.38 3.16 9.87 34.10 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1sll_c00 SIALIDASE L user 10 3 # 10 318 ASP B 99 ASP.? 16.09 OXT ACT B 201 595 GLU B 96 GLU^? 10.60 C1 EDO A 302 713 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 4.35 13.73 37.63 3.39 12.18 36.55 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 3.76 10.25 31.38 3.16 9.87 34.10 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1sll_c00 SIALIDASE L user 11 3 # 11 318 ASP B 99 ASP.? 16.09 OXT ACT B 201 595 GLU B 96 GLU^? 10.60 C1 EDO A 302 713 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 4.35 13.73 37.63 3.39 12.18 36.55 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 3.76 10.25 31.38 3.16 9.87 34.10 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1sll_c00 SIALIDASE L user 12 3 # 12 318 ASP B 130 ASP.? 9.25 OXT ACT B 201 595 GLU B 96 GLU^? 10.60 C1 EDO A 302 713 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 4.35 13.73 37.63 3.39 12.18 36.55 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 3.76 10.25 31.38 3.16 9.87 34.10 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1sll_c00 SIALIDASE L user 13 3 # 13 318 ASP B 130 ASP.? 9.25 OXT ACT B 201 595 GLU B 96 GLU^? 10.60 C1 EDO A 302 713 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 4.35 13.73 37.63 3.39 12.18 36.55 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 3.76 10.25 31.38 3.16 9.87 34.10 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1sll_c00 SIALIDASE L user 14 3 # 14 318 ASP C 74 ASP^? 14.86 O ACT C 201 595 GLU C 72 GLU~? 5.32 O ACT C 201 713 TYR C 95 TYR^? -3.84 O ACT C 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 4.35 13.73 37.63 3.39 12.18 36.55 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 3.76 10.25 31.38 3.16 9.87 34.10 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1sll_c00 SIALIDASE L user 15 3 # 15 318 ASP C 74 ASP^? 14.86 O ACT C 201 595 GLU C 96 GLU^? 13.00 O ACT C 201 713 TYR C 95 TYR^? -3.84 O ACT C 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 4.35 13.73 37.63 3.39 12.18 36.55 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 3.76 10.25 31.38 3.16 9.87 34.10 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1sll_c00 SIALIDASE L user 16 3 # 16 318 ASP C 100 ASP.? 9.05 C1 EDO A 301 595 GLU B 72 GLU~? 5.30 OXT ACT B 201 713 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 4.35 13.73 37.63 3.39 12.18 36.55 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 3.76 10.25 31.38 3.16 9.87 34.10 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1sll_c00 SIALIDASE L user 17 3 # 17 318 ASP C 130 ASP.? 4.74 O2 EDO A 301 595 GLU C 72 GLU~? 5.32 O ACT C 201 713 TYR C 75 TYR^? -4.54 O ACT C 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 4.35 13.73 37.63 3.39 12.18 36.55 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 3.76 10.25 31.38 3.16 9.87 34.10 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1sll_c00 SIALIDASE L user 18 3 # 18 318 ASP C 130 ASP.? 4.74 O2 EDO A 301 595 GLU C 72 GLU~? 5.32 O ACT C 201 713 TYR C 95 TYR^? -3.84 O ACT C 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 4.35 13.73 37.63 3.39 12.18 36.55 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 3.76 10.25 31.38 3.16 9.87 34.10 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1sll_c00 SIALIDASE L user 19 3 # 19 318 ASP C 130 ASP.? 4.74 O2 EDO A 301 595 GLU C 96 GLU^? 13.00 O ACT C 201 713 TYR C 75 TYR^? -4.54 O ACT C 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 4.35 13.73 37.63 3.39 12.18 36.55 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 3.76 10.25 31.38 3.16 9.87 34.10 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1sll_c00 SIALIDASE L user 20 3 # 20 318 ASP C 130 ASP.? 4.74 O2 EDO A 301 595 GLU C 96 GLU^? 13.00 O ACT C 201 713 TYR C 95 TYR^? -3.84 O ACT C 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 4.35 13.73 37.63 3.39 12.18 36.55 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 3.76 10.25 31.38 3.16 9.87 34.10 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1sll_c00 SIALIDASE L user 21 3 # 21 318 ASP D 74 ASP^? 14.85 OXT ACT D 201 595 GLU D 72 GLU~? 5.29 OXT ACT D 201 713 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 4.35 13.73 37.63 3.39 12.18 36.55 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 3.76 10.25 31.38 3.16 9.87 34.10 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1sll_c00 SIALIDASE L user 22 3 # 22 318 ASP D 74 ASP^? 14.85 OXT ACT D 201 595 GLU D 96 GLU^? 13.00 OXT ACT D 201 713 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 4.35 13.73 37.63 3.39 12.18 36.55 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 3.76 10.25 31.38 3.16 9.87 34.10 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1sll_c00 SIALIDASE L user 23 3 # 23 318 ASP D 99 ASP.? 7.94 CH3 ACT A 203 595 GLU D 96 GLU^? 13.00 OXT ACT D 201 713 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 4.35 13.73 37.63 3.39 12.18 36.55 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 3.76 10.25 31.38 3.16 9.87 34.10 -52.06 69.71 41.47 -52.08 66.98 40.85 ULMN 3 1sll_c00 SIALIDASE L user 24 3 # 24 318 ASP D 130 ASP.? 7.40 CH3 ACT A 203 595 GLU D 96 GLU^? 13.00 OXT ACT D 201 713 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 4.35 13.73 37.63 3.39 12.18 36.55 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 3.76 10.25 31.38 3.16 9.87 34.10 -52.06 69.71 41.47 -52.08 66.98 40.85 ULMN 3 1sll_c00 SIALIDASE L user 25 3 # 25 318 ASP D 130 ASP.? 7.40 CH3 ACT A 203 595 GLU D 96 GLU^? 13.00 OXT ACT D 201 713 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 5.64 2.82 38.49 4.59 4.19 37.25 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 4.35 13.73 37.63 3.39 12.18 36.55 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 3.76 10.25 31.38 3.16 9.87 34.10 -48.26 66.56 42.41 -49.21 65.61 44.87 1sll_c00 source 1sll SIALIDASE L : 25 hits 1sll_c00 naa= 3 ULMN 3 1sme_c04 PLASMEPSIN II user 1 3 # 1 A 34 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 37 SER A 101 SER.? 7.80 O2 EDO A 301 A 214 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 51.75 60.57 19.10 52.05 60.90 21.19 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 51.10 65.11 20.73 52.62 63.74 19.42 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 48.59 58.89 25.78 50.13 59.74 24.61 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1sme_c04 PLASMEPSIN II user 2 3 # 2 A 34 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 37 SER B 101 SER.? 19.25 O ACT C 201 A 214 ASP C 74 ASP^? 14.86 O ACT C 201 coo 51.75 60.57 19.10 52.05 60.90 21.19 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 51.10 65.11 20.73 52.62 63.74 19.42 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 48.59 58.89 25.78 50.13 59.74 24.61 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1sme_c04 PLASMEPSIN II user 3 3 # 3 A 34 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 37 SER C 101 SER.? 7.85 O1 EDO A 301 A 214 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 51.75 60.57 19.10 52.05 60.90 21.19 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 51.10 65.11 20.73 52.62 63.74 19.42 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 48.59 58.89 25.78 50.13 59.74 24.61 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1sme_c04 PLASMEPSIN II user 4 3 # 4 A 34 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 37 SER D 101 SER.? 9.16 OXT ACT A 203 A 214 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 51.75 60.57 19.10 52.05 60.90 21.19 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 51.10 65.11 20.73 52.62 63.74 19.42 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 48.59 58.89 25.78 50.13 59.74 24.61 -44.71 72.29 58.72 -45.62 72.95 56.93 1sme_c04 source 1sme PLASMEPSIN II : 4 hits 1sme_c04 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 37 SER A 101 SER.? 7.80 O2 EDO A 301 B 214 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 17.69 97.58 52.73 17.33 97.19 54.77 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 20.67 100.44 55.84 20.21 98.51 54.45 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 12.41 98.71 58.47 14.37 98.17 58.05 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1sme_c05 PLASMEPSIN II user 2 3 # 2 B 34 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 37 SER B 101 SER.? 19.25 O ACT C 201 B 214 ASP C 74 ASP^? 14.86 O ACT C 201 coo 17.69 97.58 52.73 17.33 97.19 54.77 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 20.67 100.44 55.84 20.21 98.51 54.45 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 12.41 98.71 58.47 14.37 98.17 58.05 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1sme_c05 PLASMEPSIN II user 3 3 # 3 B 34 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 37 SER C 101 SER.? 7.85 O1 EDO A 301 B 214 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 17.69 97.58 52.73 17.33 97.19 54.77 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 20.67 100.44 55.84 20.21 98.51 54.45 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 12.41 98.71 58.47 14.37 98.17 58.05 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1sme_c05 PLASMEPSIN II user 4 3 # 4 B 34 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 37 SER D 101 SER.? 9.16 OXT ACT A 203 B 214 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 17.69 97.58 52.73 17.33 97.19 54.77 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 20.67 100.44 55.84 20.21 98.51 54.45 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 12.41 98.71 58.47 14.37 98.17 58.05 -44.71 72.29 58.72 -45.62 72.95 56.93 1sme_c05 source 1sme PLASMEPSIN II : 4 hits 1sme_c05 naa= 3 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 A 87 ARG A 24 ARG~? 13.97 CH3 ACT A 201 A 89 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 119 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 28.44 23.52 73.95 30.13 24.84 76.11 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 21.34 20.13 69.47 22.14 19.11 71.12 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 19.69 29.00 71.61 19.80 26.98 72.20 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 A 87 ARG B 24 ARG~? 14.02 CH3 ACT B 201 A 89 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 119 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo 28.44 23.52 73.95 30.13 24.84 76.11 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 21.34 20.13 69.47 22.14 19.11 71.12 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 19.69 29.00 71.61 19.80 26.98 72.20 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 A 87 ARG C 24 ARG~? 14.09 CH3 ACT C 201 A 89 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 119 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo 28.44 23.52 73.95 30.13 24.84 76.11 -40.53 35.15 48.39 -41.31 34.14 51.19 coo 21.34 20.13 69.47 22.14 19.11 71.12 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 19.69 29.00 71.61 19.80 26.98 72.20 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 A 87 ARG D 24 ARG~? 13.98 CH3 ACT D 201 A 89 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 119 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 28.44 23.52 73.95 30.13 24.84 76.11 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 21.34 20.13 69.47 22.14 19.11 71.12 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 19.69 29.00 71.61 19.80 26.98 72.20 -53.58 68.96 34.68 -51.50 68.66 35.10 1smn_c00 source 1smn EXTRACELLULAR ENDONUCLEASE : 4 hits 1smn_c00 naa= 3 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 B 87 ARG A 24 ARG~? 13.97 CH3 ACT A 201 B 89 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 119 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -33.88 82.79 71.01 -36.66 83.48 69.87 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -43.83 81.49 70.61 -45.02 79.78 70.42 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 B 87 ARG A 76 ARG^? 8.97 OXT ACT A 203 B 89 HIS A 98 HIS^? -3.60 C ACT A 203s B 119 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 B 87 ARG B 24 ARG~? 14.02 CH3 ACT B 201 B 89 HIS B 151 HIS.? 13.45 CH3 ACT A 202 B 119 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -20.35 54.64 90.03 -19.09 51.96 89.19 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -16.30 48.49 82.95 -17.03 48.20 81.01 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 B 87 ARG C 24 ARG~? 14.09 CH3 ACT C 201 B 89 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 119 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -40.53 35.15 48.39 -41.31 34.14 51.19 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -46.81 35.18 56.40 -47.74 36.88 57.21 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 5 3 # 5 B 87 ARG D 24 ARG~? 13.98 CH3 ACT D 201 B 89 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 119 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -50.90 63.83 27.93 -49.90 66.74 27.73 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -44.04 70.63 29.61 -43.01 70.81 31.43 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -53.58 68.96 34.68 -51.50 68.66 35.10 1smn_c01 source 1smn EXTRACELLULAR ENDONUCLEASE : 5 hits 1smn_c01 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 102 ASP A 150 ASP.? 22.07 CH3 ACT A 201 A 193 GLY A 145 GLY.? 13.13 O ACT A 201 coo 15.02 29.17 19.44 15.63 29.96 17.60 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 19.67 30.58 22.61 18.30 29.87 21.17 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 14.52 29.10 10.01 15.08 29.66 10.19 -38.43 80.69 60.76 -38.91 80.43 61.42 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 102 ASP B 150 ASP.? 20.21 CH3 ACT A 202 A 193 GLY B 145 GLY.? 13.34 OXT ACT B 201 coo 15.02 29.17 19.44 15.63 29.96 17.60 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 19.67 30.58 22.61 18.30 29.87 21.17 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 14.52 29.10 10.01 15.08 29.66 10.19 -25.17 44.53 88.88 -24.74 44.79 88.19 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 2 hits 1ssx_c02 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 56 HIS.? 6.76 O1 EDO A 302 B 80 GLU A 60 GLU~? 10.63 O2 EDO A 302 B 223 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -19.73 62.99 57.19 -19.03 61.21 58.09 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS A 56 HIS.? 6.76 O1 EDO A 302 B 80 GLU A 60 GLU~? 10.63 O2 EDO A 302 B 223 ARG C 76 ARG^? 14.32 O ACT C 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -19.73 62.99 57.19 -19.03 61.21 58.09 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS A 56 HIS.? 6.76 O1 EDO A 302 B 80 GLU A 60 GLU~? 10.63 O2 EDO A 302 B 223 ARG C 138 ARG~? 16.31 O ACT C 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -19.73 62.99 57.19 -19.03 61.21 58.09 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS A 56 HIS.? 6.76 O1 EDO A 302 B 80 GLU B 160 GLU.? 4.71 OXT ACT A 202 B 223 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -17.96 60.58 68.89 -19.86 60.60 67.97 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 5 3 # 5 B 8 HIS A 56 HIS.? 6.76 O1 EDO A 302 B 80 GLU B 160 GLU.? 4.71 OXT ACT A 202 B 223 ARG C 76 ARG^? 14.32 O ACT C 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -17.96 60.58 68.89 -19.86 60.60 67.97 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 6 3 # 6 B 8 HIS A 56 HIS.? 6.76 O1 EDO A 302 B 80 GLU B 160 GLU.? 4.71 OXT ACT A 202 B 223 ARG C 138 ARG~? 16.31 O ACT C 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -17.38 60.38 62.27 -18.29 58.66 63.03 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -17.96 60.58 68.89 -19.86 60.60 67.97 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 7 3 # 7 B 8 HIS A 161 HIS.? 19.24 O ACT B 201 B 80 GLU A 160 GLU.? 13.50 O ACT A 201 B 223 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -48.72 65.75 79.30 -49.45 66.41 81.15 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -45.30 71.21 75.74 -44.17 71.89 74.09 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -20.35 54.64 90.03 -19.09 51.96 89.19 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 8 3 # 8 B 8 HIS A 161 HIS.? 19.24 O ACT B 201 B 80 GLU A 160 GLU.? 13.50 O ACT A 201 B 223 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -48.72 65.75 79.30 -49.45 66.41 81.15 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -45.30 71.21 75.74 -44.17 71.89 74.09 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 9 3 # 9 B 8 HIS A 161 HIS.? 19.24 O ACT B 201 B 80 GLU A 160 GLU.? 13.50 O ACT A 201 B 223 ARG C 33 ARG.? 12.41 O ACT C 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -48.72 65.75 79.30 -49.45 66.41 81.15 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -45.30 71.21 75.74 -44.17 71.89 74.09 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 10 3 # 10 B 8 HIS A 161 HIS.? 19.24 O ACT B 201 B 80 GLU A 160 GLU.? 13.50 O ACT A 201 B 223 ARG C 76 ARG^? 14.32 O ACT C 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -48.72 65.75 79.30 -49.45 66.41 81.15 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -45.30 71.21 75.74 -44.17 71.89 74.09 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 11 3 # 11 B 8 HIS A 161 HIS.? 19.24 O ACT B 201 B 80 GLU A 160 GLU.? 13.50 O ACT A 201 B 223 ARG D 49 ARG^? 10.44 O ACT D 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -48.72 65.75 79.30 -49.45 66.41 81.15 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -45.30 71.21 75.74 -44.17 71.89 74.09 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 12 3 # 12 B 8 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 80 GLU A 137 GLU~? 14.03 O ACT A 203 B 223 ARG A 16 ARG~? 19.68 CH3 ACT A 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -51.28 62.77 74.01 -50.27 62.16 72.28 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -53.30 67.06 70.37 -52.56 65.17 70.96 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -29.16 81.79 84.92 -31.07 79.42 84.55 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 13 3 # 13 B 8 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 80 GLU A 137 GLU~? 14.03 O ACT A 203 B 223 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -51.28 62.77 74.01 -50.27 62.16 72.28 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -53.30 67.06 70.37 -52.56 65.17 70.96 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 14 3 # 14 B 8 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 80 GLU A 137 GLU~? 14.03 O ACT A 203 B 223 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -51.28 62.77 74.01 -50.27 62.16 72.28 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -53.30 67.06 70.37 -52.56 65.17 70.96 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 15 3 # 15 B 8 HIS A 162 HIS.? 14.54 O1 EDO A 301 B 80 GLU A 137 GLU~? 14.03 O ACT A 203 B 223 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -51.28 62.77 74.01 -50.27 62.16 72.28 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -53.30 67.06 70.37 -52.56 65.17 70.96 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 16 3 # 16 B 8 HIS B 56 HIS.? 17.31 O ACT B 201 B 80 GLU B 60 GLU~? 17.33 O ACT B 201 B 223 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -48.17 57.12 87.93 -49.17 58.57 86.76 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 17 3 # 17 B 8 HIS B 56 HIS.? 17.31 O ACT B 201 B 80 GLU B 60 GLU~? 17.33 O ACT B 201 B 223 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -48.13 62.85 85.87 -48.38 63.10 83.80 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -48.17 57.12 87.93 -49.17 58.57 86.76 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 18 3 # 18 B 8 HIS C 56 HIS.? 17.26 OXT ACT C 201 B 80 GLU C 60 GLU~? 17.22 OXT ACT C 201 B 223 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -26.71 60.26 42.75 -28.06 61.81 43.18 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -23.89 57.63 47.43 -24.47 59.50 46.62 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 19 3 # 19 B 8 HIS C 56 HIS.? 17.26 OXT ACT C 201 B 80 GLU C 60 GLU~? 17.22 OXT ACT C 201 B 223 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -26.71 60.26 42.75 -28.06 61.81 43.18 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -23.89 57.63 47.43 -24.47 59.50 46.62 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 20 3 # 20 B 8 HIS C 56 HIS.? 17.26 OXT ACT C 201 B 80 GLU C 60 GLU~? 17.22 OXT ACT C 201 B 223 ARG C 16 ARG~? 20.89 CH3 ACT C 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -26.71 60.26 42.75 -28.06 61.81 43.18 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -23.89 57.63 47.43 -24.47 59.50 46.62 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -48.56 36.19 35.88 -49.41 34.92 38.55 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 21 3 # 21 B 8 HIS C 56 HIS.? 17.26 OXT ACT C 201 B 80 GLU C 60 GLU~? 17.22 OXT ACT C 201 B 223 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -26.71 60.26 42.75 -28.06 61.81 43.18 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -23.89 57.63 47.43 -24.47 59.50 46.62 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -52.23 44.53 37.75 -52.43 42.56 40.08 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 22 3 # 22 B 8 HIS D 56 HIS.? 17.26 O ACT D 201 B 80 GLU D 60 GLU~? 17.31 O ACT D 201 B 223 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -66.09 57.03 50.37 -65.56 55.61 51.84 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 23 3 # 23 B 8 HIS D 56 HIS.? 17.26 O ACT D 201 B 80 GLU D 60 GLU~? 17.31 O ACT D 201 B 223 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -66.09 57.03 50.37 -65.56 55.61 51.84 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 24 3 # 24 B 8 HIS D 56 HIS.? 17.26 O ACT D 201 B 80 GLU D 60 GLU~? 17.31 O ACT D 201 B 223 ARG D 16 ARG~? 19.88 CH3 ACT D 201 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -63.50 51.60 51.23 -61.99 51.43 52.67 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -66.09 57.03 50.37 -65.56 55.61 51.84 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -43.87 51.07 24.49 -42.60 51.26 27.28 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 24 hits 1t0u_c01 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 98 HIS^? -3.60 C ACT A 203s A 174 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS A 98 HIS^? -3.60 C ACT A 203s A 174 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 A 144 HIS A 98 HIS^? -3.60 C ACT A 203s A 174 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 A 144 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 174 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 404 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 A 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 174 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 A 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 174 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 A 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 174 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 A 144 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 174 ASP D 100 ASP.? 7.94 OXT ACT A 203 A 404 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -52.06 69.71 41.47 -52.08 66.98 40.85 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 8 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 98 HIS^? -3.60 C ACT A 203s C 174 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS A 98 HIS^? -3.60 C ACT A 203s C 174 ASP D 99 ASP.? 7.94 CH3 ACT A 203 C 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 C 144 HIS A 98 HIS^? -3.60 C ACT A 203s C 174 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 C 144 HIS B 98 HIS^? 14.98 OXT ACT B 201 C 174 ASP B 100 ASP.? 15.93 OXT ACT B 201 C 404 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 C 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 174 ASP B 99 ASP.? 16.09 OXT ACT B 201 C 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 C 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 174 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 C 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 174 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 C 144 HIS D 98 HIS^? 13.13 CH3 ACT A 203 C 174 ASP D 100 ASP.? 7.94 OXT ACT A 203 C 404 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -52.06 69.71 41.47 -52.08 66.98 40.85 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 8 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 98 HIS^? -3.60 C ACT A 203s E 174 ASP A 100 ASP.? 9.07 O2 EDO A 301 E 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo -7.53-107.59 75.19 -8.14-106.04 76.47 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS A 98 HIS^? -3.60 C ACT A 203s E 174 ASP D 99 ASP.? 7.94 CH3 ACT A 203 E 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo -7.53-107.59 75.19 -8.14-106.04 76.47 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 E 144 HIS A 98 HIS^? -3.60 C ACT A 203s E 174 ASP D 130 ASP.? 7.40 CH3 ACT A 203 E 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo -7.53-107.59 75.19 -8.14-106.04 76.47 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 E 144 HIS B 98 HIS^? 14.98 OXT ACT B 201 E 174 ASP B 100 ASP.? 15.93 OXT ACT B 201 E 404 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo -7.53-107.59 75.19 -8.14-106.04 76.47 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 E 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 174 ASP B 99 ASP.? 16.09 OXT ACT B 201 E 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo -7.53-107.59 75.19 -8.14-106.04 76.47 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 E 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 174 ASP B 130 ASP.? 9.25 OXT ACT B 201 E 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo -7.53-107.59 75.19 -8.14-106.04 76.47 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 E 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 174 ASP C 100 ASP.? 9.05 C1 EDO A 301 E 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo -7.53-107.59 75.19 -8.14-106.04 76.47 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 E 144 HIS D 98 HIS^? 13.13 CH3 ACT A 203 E 174 ASP D 100 ASP.? 7.94 OXT ACT A 203 E 404 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo -7.53-107.59 75.19 -8.14-106.04 76.47 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -52.06 69.71 41.47 -52.08 66.98 40.85 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 8 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 98 HIS^? -3.60 C ACT A 203s G 174 ASP A 100 ASP.? 9.07 O2 EDO A 301 G 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo 60.48-101.16 45.95 60.56-101.20 43.85 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 58.10-108.15 40.62 59.57-106.86 41.51 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS A 98 HIS^? -3.60 C ACT A 203s G 174 ASP D 99 ASP.? 7.94 CH3 ACT A 203 G 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo 60.48-101.16 45.95 60.56-101.20 43.85 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 58.10-108.15 40.62 59.57-106.86 41.51 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 G 144 HIS A 98 HIS^? -3.60 C ACT A 203s G 174 ASP D 130 ASP.? 7.40 CH3 ACT A 203 G 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo 60.48-101.16 45.95 60.56-101.20 43.85 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 58.10-108.15 40.62 59.57-106.86 41.51 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 G 144 HIS B 98 HIS^? 14.98 OXT ACT B 201 G 174 ASP B 100 ASP.? 15.93 OXT ACT B 201 G 404 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 60.48-101.16 45.95 60.56-101.20 43.85 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 58.10-108.15 40.62 59.57-106.86 41.51 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 G 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 G 174 ASP B 99 ASP.? 16.09 OXT ACT B 201 G 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo 60.48-101.16 45.95 60.56-101.20 43.85 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 58.10-108.15 40.62 59.57-106.86 41.51 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 G 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 G 174 ASP B 130 ASP.? 9.25 OXT ACT B 201 G 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo 60.48-101.16 45.95 60.56-101.20 43.85 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 58.10-108.15 40.62 59.57-106.86 41.51 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 G 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 G 174 ASP C 100 ASP.? 9.05 C1 EDO A 301 G 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo 60.48-101.16 45.95 60.56-101.20 43.85 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 58.10-108.15 40.62 59.57-106.86 41.51 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 G 144 HIS D 98 HIS^? 13.13 CH3 ACT A 203 G 174 ASP D 100 ASP.? 7.94 OXT ACT A 203 G 404 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 60.48-101.16 45.95 60.56-101.20 43.85 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 58.10-108.15 40.62 59.57-106.86 41.51 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -52.06 69.71 41.47 -52.08 66.98 40.85 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 8 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 98 HIS^? -3.60 C ACT A 203s I 174 ASP A 100 ASP.? 9.07 O2 EDO A 301 I 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS A 98 HIS^? -3.60 C ACT A 203s I 174 ASP D 99 ASP.? 7.94 CH3 ACT A 203 I 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 I 144 HIS A 98 HIS^? -3.60 C ACT A 203s I 174 ASP D 130 ASP.? 7.40 CH3 ACT A 203 I 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 I 144 HIS B 98 HIS^? 14.98 OXT ACT B 201 I 174 ASP B 100 ASP.? 15.93 OXT ACT B 201 I 404 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 I 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 I 174 ASP B 99 ASP.? 16.09 OXT ACT B 201 I 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 I 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 I 174 ASP B 130 ASP.? 9.25 OXT ACT B 201 I 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 I 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 I 174 ASP C 100 ASP.? 9.05 C1 EDO A 301 I 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 I 144 HIS D 98 HIS^? 13.13 CH3 ACT A 203 I 174 ASP D 100 ASP.? 7.94 OXT ACT A 203 I 404 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -52.06 69.71 41.47 -52.08 66.98 40.85 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 8 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 98 HIS^? -3.60 C ACT A 203s K 174 ASP A 100 ASP.? 9.07 O2 EDO A 301 K 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo 100.18 26.45 -1.32 99.24 26.12 0.53 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 102.36 30.86 6.31 102.45 29.08 5.12 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS A 98 HIS^? -3.60 C ACT A 203s K 174 ASP D 99 ASP.? 7.94 CH3 ACT A 203 K 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo 100.18 26.45 -1.32 99.24 26.12 0.53 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 102.36 30.86 6.31 102.45 29.08 5.12 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 K 144 HIS A 98 HIS^? -3.60 C ACT A 203s K 174 ASP D 130 ASP.? 7.40 CH3 ACT A 203 K 404 TYR A 75 TYR^? -4.52 O ACT A 201s coo 100.18 26.45 -1.32 99.24 26.12 0.53 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 102.36 30.86 6.31 102.45 29.08 5.12 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 K 144 HIS B 98 HIS^? 14.98 OXT ACT B 201 K 174 ASP B 100 ASP.? 15.93 OXT ACT B 201 K 404 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 100.18 26.45 -1.32 99.24 26.12 0.53 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 102.36 30.86 6.31 102.45 29.08 5.12 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 K 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 K 174 ASP B 99 ASP.? 16.09 OXT ACT B 201 K 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo 100.18 26.45 -1.32 99.24 26.12 0.53 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 102.36 30.86 6.31 102.45 29.08 5.12 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 K 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 K 174 ASP B 130 ASP.? 9.25 OXT ACT B 201 K 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo 100.18 26.45 -1.32 99.24 26.12 0.53 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 102.36 30.86 6.31 102.45 29.08 5.12 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 K 144 HIS C 98 HIS^? 11.61 O2 EDO A 301 K 174 ASP C 100 ASP.? 9.05 C1 EDO A 301 K 404 TYR C 75 TYR^? -4.54 O ACT C 201s coo 100.18 26.45 -1.32 99.24 26.12 0.53 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 102.36 30.86 6.31 102.45 29.08 5.12 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 K 144 HIS D 98 HIS^? 13.13 CH3 ACT A 203 K 174 ASP D 100 ASP.? 7.94 OXT ACT A 203 K 404 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 100.18 26.45 -1.32 99.24 26.12 0.53 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 102.36 30.86 6.31 102.45 29.08 5.12 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -52.06 69.71 41.47 -52.08 66.98 40.85 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 8 hits 1ti6_c11 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 26 ALA~? 8.12 CH3 ACT A 201 A 251 GLY A 29 GLY~? 9.49 CH3 ACT A 201 A 252 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -30.30 78.71 63.24 -31.02 78.43 63.55 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA B 26 ALA~? 8.11 CH3 ACT B 201 A 251 GLY B 29 GLY~? 9.46 CH3 ACT B 201 A 252 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -27.84 56.51 90.43 -28.15 57.77 89.64 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -29.24 51.82 91.44 -28.87 51.66 90.72 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 3 3 # 3 A 250 ALA C 26 ALA~? 8.20 CH3 ACT C 201 A 251 GLY C 29 GLY~? 9.51 CH3 ACT C 201 A 252 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -32.89 40.21 50.79 -33.62 40.36 51.16 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 4 3 # 4 A 250 ALA D 26 ALA~? 8.16 CH3 ACT D 201 A 251 GLY D 29 GLY~? 9.48 CH3 ACT D 201 A 252 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -55.52 60.76 33.28 -54.94 59.51 33.93 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -57.91 65.08 34.12 -57.15 65.32 34.32 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -55.65 65.73 30.36 -54.18 65.67 28.83 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 4 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 26 ALA~? 8.12 CH3 ACT A 201 B 251 GLY A 29 GLY~? 9.49 CH3 ACT A 201 B 252 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -30.30 78.71 63.24 -31.02 78.43 63.55 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA B 26 ALA~? 8.11 CH3 ACT B 201 B 251 GLY B 29 GLY~? 9.46 CH3 ACT B 201 B 252 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -27.84 56.51 90.43 -28.15 57.77 89.64 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -29.24 51.82 91.44 -28.87 51.66 90.72 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 3 3 # 3 B 250 ALA C 26 ALA~? 8.20 CH3 ACT C 201 B 251 GLY C 29 GLY~? 9.51 CH3 ACT C 201 B 252 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -32.89 40.21 50.79 -33.62 40.36 51.16 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 4 3 # 4 B 250 ALA D 26 ALA~? 8.16 CH3 ACT D 201 B 251 GLY D 29 GLY~? 9.48 CH3 ACT D 201 B 252 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -55.52 60.76 33.28 -54.94 59.51 33.93 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -57.91 65.08 34.12 -57.15 65.32 34.32 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -55.65 65.73 30.36 -54.18 65.67 28.83 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 4 hits 1tz3_c03 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS A 79 LYS^? -3.45 CH3 ACT A 201s 138 ASN A 31 ASN~? 8.53 CH3 ACT A 201 183 HIS A 151 HIS.? 15.97 CH3 ACT A 201 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -36.15 78.19 63.69 -37.32 77.26 65.21 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -43.83 81.49 70.61 -45.02 79.78 70.42 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 2 3 # 2 115 LYS B 79 LYS^? -3.44 CH3 ACT B 201s 138 ASN B 31 ASN~? 8.56 CH3 ACT B 201 183 HIS B 151 HIS.? 13.45 CH3 ACT A 202 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -26.33 48.60 87.43 -25.42 49.22 85.60 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -16.30 48.49 82.95 -17.03 48.20 81.01 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 3 3 # 3 115 LYS C 79 LYS^? -3.44 CH3 ACT C 201s 138 ASN C 31 ASN~? 8.68 CH3 ACT C 201 183 HIS C 151 HIS.? 16.03 CH3 ACT C 201 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -36.93 39.85 55.08 -38.97 40.48 55.12 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -46.81 35.18 56.40 -47.74 36.88 57.21 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 4 3 # 4 115 LYS C 134 LYS~? 17.33 O2 EDO A 301 138 ASN C 103 ASN.? 7.35 O1 EDO A 301 183 HIS A 162 HIS.? 14.54 O1 EDO A 301 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -51.34 49.79 67.51 -53.85 50.99 71.42 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -44.48 55.23 67.22 -44.54 56.80 68.65 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -51.28 62.77 74.01 -50.27 62.16 72.28 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 4 hits 1uag_c01 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 126 LYS A 22 LYS~? 15.35 CH3 ACT A 201 A 171 ALA A 26 ALA~? 8.12 CH3 ACT A 201 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -25.90 80.72 72.77 -21.11 80.01 70.15 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -28.72 78.00 67.87 -28.24 76.96 68.88 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 126 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 171 ALA A 52 ALA.? 7.92 O2 EDO A 302 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -28.67 56.33 66.41 -29.48 55.05 66.20 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU A 60 GLU~? 10.63 O2 EDO A 302 A 126 LYS A 62 LYS~? 17.60 O ACT A 201 A 171 ALA A 55 ALA^? 10.63 O1 EDO A 302 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -21.44 62.27 61.83 -22.27 63.55 61.72 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 A 46 GLU A 137 GLU~? 14.03 O ACT A 203 A 126 LYS A 139 LYS.? 17.81 O ACT A 201 A 171 ALA A 135 ALA~? 6.35 OXT ACT A 203 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -52.93 68.60 64.38 -53.51 68.88 63.01 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 A 46 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 126 LYS B 22 LYS~? 15.43 CH3 ACT B 201 A 171 ALA B 26 ALA~? 8.11 CH3 ACT B 201 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -27.84 56.51 90.43 -28.15 57.77 89.64 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 A 46 GLU B 60 GLU~? 17.33 O ACT B 201 A 126 LYS B 62 LYS~? 17.44 OXT ACT B 201 A 171 ALA B 55 ALA^? 12.04 O ACT B 201 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -44.97 59.71 84.97 -43.80 58.86 85.49 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 7 3 # 7 A 46 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 126 LYS B 139 LYS.? 6.99 C1 EDO A 302 A 171 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -18.83 46.84 75.05 -16.49 49.79 71.17 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 8 3 # 8 A 46 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 126 LYS C 22 LYS~? 15.34 CH3 ACT C 201 A 171 ALA C 26 ALA~? 8.20 CH3 ACT C 201 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -37.27 38.20 41.22 -32.34 39.66 39.29 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -35.58 40.78 46.69 -36.15 41.81 45.72 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 9 3 # 9 A 46 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 126 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 171 ALA C 52 ALA.? 12.19 C2 EDO A 301 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -37.45 62.38 49.17 -37.97 63.55 50.01 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 10 3 # 10 A 46 GLU C 60 GLU~? 17.22 OXT ACT C 201 A 126 LYS C 62 LYS~? 12.50 O2 EDO A 302 A 171 ALA C 55 ALA^? 12.11 OXT ACT C 201 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -28.67 57.83 45.93 -28.88 56.47 46.57 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 11 3 # 11 A 46 GLU C 137 GLU~? 15.84 O2 EDO A 301 A 126 LYS C 139 LYS.? 18.79 O ACT C 201 A 171 ALA C 135 ALA~? 15.67 O2 EDO A 301 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -50.26 41.49 60.64 -55.14 42.95 58.84 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -49.12 46.81 68.31 -48.42 46.56 69.64 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 12 3 # 12 A 46 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 126 LYS D 22 LYS~? 15.49 CH3 ACT D 201 A 171 ALA D 26 ALA~? 8.16 CH3 ACT D 201 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -54.47 56.23 29.06 -59.33 54.04 30.24 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -55.52 60.76 33.28 -54.94 59.51 33.93 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 13 3 # 13 A 46 GLU D 60 GLU~? 17.31 O ACT D 201 A 126 LYS D 62 LYS~? 17.47 OXT ACT D 201 A 171 ALA D 55 ALA^? 12.06 O ACT D 201 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -61.44 55.28 49.65 -61.24 56.24 48.48 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 14 3 # 14 A 46 GLU D 137 GLU~? 19.20 CH3 ACT A 203 A 126 LYS D 139 LYS.? 18.54 OXT ACT D 201 A 171 ALA D 135 ALA~? 18.41 CH3 ACT A 203 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -39.84 73.21 37.09 -35.07 70.74 37.87 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -39.82 78.98 44.65 -40.33 80.39 44.94 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 14 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 53 GLU^? 10.41 O2 EDO A 302 B 126 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 171 ALA A 52 ALA.? 7.92 O2 EDO A 302 coo 20.47 87.42 16.54 20.16 87.17 14.45 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 24.73 94.37 14.59 21.08 89.84 11.98 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 24.38 86.32 12.71 22.88 86.54 12.71 -28.67 56.33 66.41 -29.48 55.05 66.20 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU A 60 GLU~? 10.63 O2 EDO A 302 B 126 LYS A 62 LYS~? 17.60 O ACT A 201 B 171 ALA A 55 ALA^? 10.63 O1 EDO A 302 coo 20.47 87.42 16.54 20.16 87.17 14.45 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 24.73 94.37 14.59 21.08 89.84 11.98 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 24.38 86.32 12.71 22.88 86.54 12.71 -21.44 62.27 61.83 -22.27 63.55 61.72 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU A 137 GLU~? 14.03 O ACT A 203 B 126 LYS A 139 LYS.? 17.81 O ACT A 201 B 171 ALA A 135 ALA~? 6.35 OXT ACT A 203 coo 20.47 87.42 16.54 20.16 87.17 14.45 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 24.73 94.37 14.59 21.08 89.84 11.98 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 24.38 86.32 12.71 22.88 86.54 12.71 -52.93 68.60 64.38 -53.51 68.88 63.01 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 B 46 GLU B 27 GLU~? 9.83 CH3 ACT B 201 B 126 LYS B 22 LYS~? 15.43 CH3 ACT B 201 B 171 ALA B 26 ALA~? 8.11 CH3 ACT B 201 coo 20.47 87.42 16.54 20.16 87.17 14.45 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 24.73 94.37 14.59 21.08 89.84 11.98 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 24.38 86.32 12.71 22.88 86.54 12.71 -27.84 56.51 90.43 -28.15 57.77 89.64 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 B 46 GLU B 60 GLU~? 17.33 O ACT B 201 B 126 LYS B 62 LYS~? 17.44 OXT ACT B 201 B 171 ALA B 55 ALA^? 12.04 O ACT B 201 coo 20.47 87.42 16.54 20.16 87.17 14.45 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 24.73 94.37 14.59 21.08 89.84 11.98 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 24.38 86.32 12.71 22.88 86.54 12.71 -44.97 59.71 84.97 -43.80 58.86 85.49 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 B 46 GLU B 137 GLU~? 6.31 C2 EDO A 302 B 126 LYS B 139 LYS.? 6.99 C1 EDO A 302 B 171 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo 20.47 87.42 16.54 20.16 87.17 14.45 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 24.73 94.37 14.59 21.08 89.84 11.98 -18.83 46.84 75.05 -16.49 49.79 71.17 coo 24.38 86.32 12.71 22.88 86.54 12.71 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 7 3 # 7 B 46 GLU C 53 GLU^? 11.18 OXT ACT C 201 B 126 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 171 ALA C 52 ALA.? 12.19 C2 EDO A 301 coo 20.47 87.42 16.54 20.16 87.17 14.45 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 24.73 94.37 14.59 21.08 89.84 11.98 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 24.38 86.32 12.71 22.88 86.54 12.71 -37.45 62.38 49.17 -37.97 63.55 50.01 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 8 3 # 8 B 46 GLU C 60 GLU~? 17.22 OXT ACT C 201 B 126 LYS C 62 LYS~? 12.50 O2 EDO A 302 B 171 ALA C 55 ALA^? 12.11 OXT ACT C 201 coo 20.47 87.42 16.54 20.16 87.17 14.45 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 24.73 94.37 14.59 21.08 89.84 11.98 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 24.38 86.32 12.71 22.88 86.54 12.71 -28.67 57.83 45.93 -28.88 56.47 46.57 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 9 3 # 9 B 46 GLU C 137 GLU~? 15.84 O2 EDO A 301 B 126 LYS C 139 LYS.? 18.79 O ACT C 201 B 171 ALA C 135 ALA~? 15.67 O2 EDO A 301 coo 20.47 87.42 16.54 20.16 87.17 14.45 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 24.73 94.37 14.59 21.08 89.84 11.98 -50.26 41.49 60.64 -55.14 42.95 58.84 coo 24.38 86.32 12.71 22.88 86.54 12.71 -49.12 46.81 68.31 -48.42 46.56 69.64 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 10 3 # 10 B 46 GLU D 60 GLU~? 17.31 O ACT D 201 B 126 LYS D 62 LYS~? 17.47 OXT ACT D 201 B 171 ALA D 55 ALA^? 12.06 O ACT D 201 coo 20.47 87.42 16.54 20.16 87.17 14.45 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 24.73 94.37 14.59 21.08 89.84 11.98 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 24.38 86.32 12.71 22.88 86.54 12.71 -61.44 55.28 49.65 -61.24 56.24 48.48 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 11 3 # 11 B 46 GLU D 137 GLU~? 19.20 CH3 ACT A 203 B 126 LYS D 139 LYS.? 18.54 OXT ACT D 201 B 171 ALA D 135 ALA~? 18.41 CH3 ACT A 203 coo 20.47 87.42 16.54 20.16 87.17 14.45 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 24.73 94.37 14.59 21.08 89.84 11.98 -39.84 73.21 37.09 -35.07 70.74 37.87 coo 24.38 86.32 12.71 22.88 86.54 12.71 -39.82 78.98 44.65 -40.33 80.39 44.94 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 11 hits 1uf7_c01 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 56 HIS.? 6.76 O1 EDO A 302 89 GLU A 60 GLU~? 10.63 O2 EDO A 302 243 ASN A 112 ASN^? 9.36 O ACT A 202 coo 5.83 15.74 17.38 6.41 17.70 17.86 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 3.11 16.19 13.44 4.96 17.09 13.42 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 0.53 21.81 31.33 1.05 20.47 29.70 -24.96 67.02 76.01 -26.38 66.67 77.57 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS A 56 HIS.? 6.76 O1 EDO A 302 89 GLU A 60 GLU~? 10.63 O2 EDO A 302 243 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 5.83 15.74 17.38 6.41 17.70 17.86 -17.38 60.38 62.27 -18.29 58.66 63.03 coo 3.11 16.19 13.44 4.96 17.09 13.42 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 0.53 21.81 31.33 1.05 20.47 29.70 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 3 3 # 3 86 HIS A 162 HIS.? 14.54 O1 EDO A 301 89 GLU A 137 GLU~? 14.03 O ACT A 203 243 ASN B 50 ASN^? 4.93 O ACT B 201 coo 5.83 15.74 17.38 6.41 17.70 17.86 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 3.11 16.19 13.44 4.96 17.09 13.42 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 0.53 21.81 31.33 1.05 20.47 29.70 -39.13 57.82 80.42 -37.65 56.39 79.89 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 4 3 # 4 86 HIS B 56 HIS.? 17.31 O ACT B 201 89 GLU B 60 GLU~? 17.33 O ACT B 201 243 ASN A 129 ASN.? 9.65 O ACT B 201 coo 5.83 15.74 17.38 6.41 17.70 17.86 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 3.11 16.19 13.44 4.96 17.09 13.42 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 0.53 21.81 31.33 1.05 20.47 29.70 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 5 3 # 5 86 HIS B 56 HIS.? 17.31 O ACT B 201 89 GLU B 60 GLU~? 17.33 O ACT B 201 243 ASN B 112 ASN^? 12.13 O ACT B 201 coo 5.83 15.74 17.38 6.41 17.70 17.86 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 3.11 16.19 13.44 4.96 17.09 13.42 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 0.53 21.81 31.33 1.05 20.47 29.70 -32.04 67.09 81.98 -30.67 67.45 80.39 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 6 3 # 6 86 HIS C 56 HIS.? 17.26 OXT ACT C 201 89 GLU C 60 GLU~? 17.22 OXT ACT C 201 243 ASN C 112 ASN^? 12.25 OXT ACT C 201 coo 5.83 15.74 17.38 6.41 17.70 17.86 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 3.11 16.19 13.44 4.96 17.09 13.42 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 0.53 21.81 31.33 1.05 20.47 29.70 -41.01 51.77 39.43 -43.15 51.81 39.53 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 7 3 # 7 86 HIS C 56 HIS.? 17.26 OXT ACT C 201 89 GLU C 60 GLU~? 17.22 OXT ACT C 201 243 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 5.83 15.74 17.38 6.41 17.70 17.86 -26.71 60.26 42.75 -28.06 61.81 43.18 coo 3.11 16.19 13.44 4.96 17.09 13.42 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 0.53 21.81 31.33 1.05 20.47 29.70 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 8 3 # 8 86 HIS D 56 HIS.? 17.26 O ACT D 201 89 GLU D 60 GLU~? 17.31 O ACT D 201 243 ASN C 129 ASN.? 9.72 O ACT D 201 coo 5.83 15.74 17.38 6.41 17.70 17.86 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 3.11 16.19 13.44 4.96 17.09 13.42 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 0.53 21.81 31.33 1.05 20.47 29.70 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 9 3 # 9 86 HIS D 56 HIS.? 17.26 O ACT D 201 89 GLU D 60 GLU~? 17.31 O ACT D 201 243 ASN D 112 ASN^? 12.21 O ACT D 201 coo 5.83 15.74 17.38 6.41 17.70 17.86 -63.50 51.60 51.23 -61.99 51.43 52.67 coo 3.11 16.19 13.44 4.96 17.09 13.42 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 0.53 21.81 31.33 1.05 20.47 29.70 -49.94 50.30 41.07 -47.80 50.26 40.97 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 9 hits 1ula_c00 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 99 ASP.? 5.71 O2 EDO A 301 255 GLU A 72 GLU~? 5.31 O ACT A 201 329 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 52.57 37.12 10.17 53.37 35.95 11.75 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 99 ASP.? 5.71 O2 EDO A 301 255 GLU A 72 GLU~? 5.31 O ACT A 201 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 52.57 37.12 10.17 53.37 35.95 11.75 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 116 ASP.? 19.55 CH3 ACT A 201 255 GLU A 114 GLU^? 11.87 CH3 ACT A 202 329 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 52.57 37.12 10.17 53.37 35.95 11.75 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 86 ASP.? 24.07 CH3 ACT B 201 255 GLU B 114 GLU^? 18.04 O ACT B 201 329 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 52.57 37.12 10.17 53.37 35.95 11.75 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 99 ASP.? 16.09 OXT ACT B 201 255 GLU B 72 GLU~? 5.30 OXT ACT B 201 329 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 52.57 37.12 10.17 53.37 35.95 11.75 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 116 ASP.? 19.49 CH3 ACT B 201 255 GLU B 114 GLU^? 18.04 O ACT B 201 329 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 52.57 37.12 10.17 53.37 35.95 11.75 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 130 ASP.? 9.25 OXT ACT B 201 255 GLU B 72 GLU~? 5.30 OXT ACT B 201 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 52.57 37.12 10.17 53.37 35.95 11.75 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP C 86 ASP.? 24.03 CH3 ACT C 201 255 GLU C 114 GLU^? 18.18 OXT ACT C 201 329 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 52.57 37.12 10.17 53.37 35.95 11.75 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 255 GLU C 72 GLU~? 5.32 O ACT C 201 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 52.57 37.12 10.17 53.37 35.95 11.75 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP C 116 ASP.? 19.40 CH3 ACT C 201 255 GLU C 114 GLU^? 18.18 OXT ACT C 201 329 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 52.57 37.12 10.17 53.37 35.95 11.75 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP D 99 ASP.? 7.94 CH3 ACT A 203 255 GLU D 72 GLU~? 5.29 OXT ACT D 201 329 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 52.57 37.12 10.17 53.37 35.95 11.75 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP D 116 ASP.? 19.52 CH3 ACT D 201 255 GLU D 114 GLU^? 18.05 O ACT D 201 329 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 52.57 37.12 10.17 53.37 35.95 11.75 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 -53.41 42.17 31.38 -52.32 40.44 30.82 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 12 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 34 ASP~? 14.63 O ACT A 201 218 GLU B 80 GLU^? 7.87 CH3 ACT A 202 329 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 34 ASP~? 14.63 O ACT A 201 218 GLU B 111 GLU^? 4.46 CH3 ACT B 201 329 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 45 ASP^? 16.09 OXT ACT A 202 218 GLU B 17 GLU~? 23.60 CH3 ACT B 201 329 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 70.09 11.71 8.46 70.56 12.89 6.77 -16.26 64.60 95.04 -14.82 64.68 96.59 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 45 ASP^? 16.09 OXT ACT A 202 218 GLU B 21 GLU~? 20.11 CH3 ACT B 201 329 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.23 61.49 94.88 -18.90 62.15 96.87 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 218 GLU B 60 GLU~? 17.33 O ACT B 201 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 70.09 11.71 8.46 70.56 12.89 6.77 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 218 GLU B 111 GLU^? 4.46 CH3 ACT B 201 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 218 GLU B 160 GLU.? 4.71 OXT ACT A 202 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 70.09 11.71 8.46 70.56 12.89 6.77 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 218 GLU C 59 GLU~? 13.48 O2 EDO A 302 329 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 70.09 11.71 8.46 70.56 12.89 6.77 -20.25 53.72 49.66 -20.40 52.10 51.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 218 GLU D 36 GLU~? 17.76 CH3 ACT D 201 329 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 70.09 11.71 8.46 70.56 12.89 6.77 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 218 GLU D 80 GLU^? 14.49 CH3 ACT D 201 329 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 70.09 11.71 8.46 70.56 12.89 6.77 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 218 GLU D 156 GLU.? 18.36 CH3 ACT D 201 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 70.09 11.71 8.46 70.56 12.89 6.77 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP A 86 ASP.? 20.24 CH3 ACT A 202 218 GLU A 72 GLU~? 5.31 O ACT A 201 329 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 70.09 11.71 8.46 70.56 12.89 6.77 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP A 99 ASP.? 5.71 O2 EDO A 301 218 GLU A 21 GLU~? 19.20 CH3 ACT A 201 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 70.09 11.71 8.46 70.56 12.89 6.77 -26.74 85.39 73.13 -25.47 87.07 73.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP A 99 ASP.? 5.71 O2 EDO A 301 218 GLU A 114 GLU^? 11.87 CH3 ACT A 202 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 70.09 11.71 8.46 70.56 12.89 6.77 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP A 99 ASP.? 5.71 O2 EDO A 301 218 GLU B 114 GLU^? 18.04 O ACT B 201 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 70.09 11.71 8.46 70.56 12.89 6.77 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP A 100 ASP.? 9.07 O2 EDO A 301 218 GLU A 80 GLU^? 14.51 CH3 ACT A 201 329 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP A 100 ASP.? 9.07 O2 EDO A 301 218 GLU A 156 GLU~? 20.10 CH3 ACT A 201 329 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP A 100 ASP.? 9.07 O2 EDO A 301 218 GLU B 111 GLU^? 4.46 CH3 ACT B 201 329 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP A 100 ASP.? 9.07 O2 EDO A 301 218 GLU B 111 GLU^? 4.46 CH3 ACT B 201 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP A 100 ASP.? 9.07 O2 EDO A 301 218 GLU B 137 GLU~? 6.31 C2 EDO A 302 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP A 100 ASP.? 9.07 O2 EDO A 301 218 GLU B 160 GLU.? 4.71 OXT ACT A 202 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP A 100 ASP.? 9.07 O2 EDO A 301 218 GLU C 21 GLU~? 19.29 CH3 ACT C 201 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP A 100 ASP.? 9.07 O2 EDO A 301 218 GLU C 36 GLU~? 15.95 O2 EDO A 302 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP A 116 ASP.? 19.55 CH3 ACT A 201 218 GLU A 156 GLU~? 20.10 CH3 ACT A 201 329 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 70.09 11.71 8.46 70.56 12.89 6.77 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP A 116 ASP.? 19.55 CH3 ACT A 201 218 GLU A 160 GLU.? 13.50 O ACT A 201 329 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 70.09 11.71 8.46 70.56 12.89 6.77 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 26 3 # 26 199 ASP A 116 ASP.? 19.55 CH3 ACT A 201 218 GLU D 137 GLU~? 19.20 CH3 ACT A 203 329 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 70.09 11.71 8.46 70.56 12.89 6.77 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 59.16 37.82 13.95 57.63 37.03 15.12 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 27 3 # 27 199 ASP A 130 ASP.? 4.80 O1 EDO A 301 218 GLU B 36 GLU~? 17.47 CH3 ACT B 201 329 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 70.09 11.71 8.46 70.56 12.89 6.77 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 28 3 # 28 199 ASP A 130 ASP.? 4.80 O1 EDO A 301 218 GLU C 80 GLU^? 14.47 CH3 ACT C 201 329 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 70.09 11.71 8.46 70.56 12.89 6.77 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 29 3 # 29 199 ASP A 130 ASP.? 4.80 O1 EDO A 301 218 GLU C 156 GLU~? 19.44 CH3 ACT C 201 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 70.09 11.71 8.46 70.56 12.89 6.77 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 30 3 # 30 199 ASP A 149 ASP.? 18.85 CH3 ACT A 201 218 GLU B 111 GLU^? 4.46 CH3 ACT B 201 329 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 31 3 # 31 199 ASP A 149 ASP.? 18.85 CH3 ACT A 201 218 GLU D 72 GLU~? 5.29 OXT ACT D 201 329 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 70.09 11.71 8.46 70.56 12.89 6.77 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 59.16 37.82 13.95 57.63 37.03 15.12 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 32 3 # 32 199 ASP B 34 ASP~? 14.61 OXT ACT B 201 218 GLU A 80 GLU^? 14.51 CH3 ACT A 201 329 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 70.09 11.71 8.46 70.56 12.89 6.77 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 33 3 # 33 199 ASP B 34 ASP~? 14.61 OXT ACT B 201 218 GLU A 111 GLU^? 4.34 CH3 ACT A 201 329 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 34 3 # 34 199 ASP B 45 ASP^? 20.35 O ACT B 201 218 GLU A 17 GLU~? 23.86 CH3 ACT A 201 329 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 70.09 11.71 8.46 70.56 12.89 6.77 -26.80 87.18 79.85 -26.18 89.13 80.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 35 3 # 35 199 ASP B 45 ASP^? 20.35 O ACT B 201 218 GLU A 27 GLU~? 9.74 CH3 ACT A 201 329 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 70.09 11.71 8.46 70.56 12.89 6.77 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 59.16 37.82 13.95 57.63 37.03 15.12 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 36 3 # 36 199 ASP B 74 ASP^? 14.88 OXT ACT B 201 218 GLU A 60 GLU~? 10.63 O2 EDO A 302 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 37 3 # 37 199 ASP B 74 ASP^? 14.88 OXT ACT B 201 218 GLU A 72 GLU~? 5.31 O ACT A 201 329 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 70.09 11.71 8.46 70.56 12.89 6.77 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 38 3 # 38 199 ASP B 74 ASP^? 14.88 OXT ACT B 201 218 GLU A 111 GLU^? 4.34 CH3 ACT A 201 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 39 3 # 39 199 ASP B 74 ASP^? 14.88 OXT ACT B 201 218 GLU C 59 GLU~? 13.48 O2 EDO A 302 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 70.09 11.71 8.46 70.56 12.89 6.77 -20.25 53.72 49.66 -20.40 52.10 51.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 40 3 # 40 199 ASP B 86 ASP.? 24.07 CH3 ACT B 201 218 GLU B 72 GLU~? 5.30 OXT ACT B 201 329 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 70.09 11.71 8.46 70.56 12.89 6.77 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 41 3 # 41 199 ASP B 99 ASP.? 16.09 OXT ACT B 201 218 GLU A 60 GLU~? 10.63 O2 EDO A 302 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 42 3 # 42 199 ASP B 99 ASP.? 16.09 OXT ACT B 201 218 GLU A 137 GLU~? 14.03 O ACT A 203 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 70.09 11.71 8.46 70.56 12.89 6.77 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 43 3 # 43 199 ASP B 99 ASP.? 16.09 OXT ACT B 201 218 GLU A 160 GLU.? 13.50 O ACT A 201 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 70.09 11.71 8.46 70.56 12.89 6.77 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 44 3 # 44 199 ASP B 99 ASP.? 16.09 OXT ACT B 201 218 GLU B 21 GLU~? 20.11 CH3 ACT B 201 329 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.23 61.49 94.88 -18.90 62.15 96.87 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 45 3 # 45 199 ASP B 99 ASP.? 16.09 OXT ACT B 201 218 GLU B 21 GLU~? 20.11 CH3 ACT B 201 329 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.23 61.49 94.88 -18.90 62.15 96.87 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 46 3 # 46 199 ASP B 99 ASP.? 16.09 OXT ACT B 201 218 GLU D 53 GLU^? 10.32 O ACT A 203 329 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 70.09 11.71 8.46 70.56 12.89 6.77 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 47 3 # 47 199 ASP B 100 ASP.? 15.93 OXT ACT B 201 218 GLU A 111 GLU^? 4.34 CH3 ACT A 201 329 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 48 3 # 48 199 ASP B 100 ASP.? 15.93 OXT ACT B 201 218 GLU A 111 GLU^? 4.34 CH3 ACT A 201 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 49 3 # 49 199 ASP B 100 ASP.? 15.93 OXT ACT B 201 218 GLU A 137 GLU~? 14.03 O ACT A 203 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 70.09 11.71 8.46 70.56 12.89 6.77 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 50 3 # 50 199 ASP B 100 ASP.? 15.93 OXT ACT B 201 218 GLU A 160 GLU.? 13.50 O ACT A 201 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 70.09 11.71 8.46 70.56 12.89 6.77 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 51 3 # 51 199 ASP B 100 ASP.? 15.93 OXT ACT B 201 218 GLU B 80 GLU^? 7.87 CH3 ACT A 202 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 52 3 # 52 199 ASP B 116 ASP.? 19.49 CH3 ACT B 201 218 GLU B 156 GLU~? 12.19 CH3 ACT A 202 329 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 70.09 11.71 8.46 70.56 12.89 6.77 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 53 3 # 53 199 ASP B 130 ASP.? 9.25 OXT ACT B 201 218 GLU A 36 GLU~? 17.83 CH3 ACT A 201 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 70.09 11.71 8.46 70.56 12.89 6.77 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 54 3 # 54 199 ASP B 130 ASP.? 9.25 OXT ACT B 201 218 GLU A 156 GLU~? 20.10 CH3 ACT A 201 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 70.09 11.71 8.46 70.56 12.89 6.77 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 55 3 # 55 199 ASP B 130 ASP.? 9.25 OXT ACT B 201 218 GLU C 80 GLU^? 14.47 CH3 ACT C 201 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 70.09 11.71 8.46 70.56 12.89 6.77 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 56 3 # 56 199 ASP B 130 ASP.? 9.25 OXT ACT B 201 218 GLU C 156 GLU~? 19.44 CH3 ACT C 201 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 70.09 11.71 8.46 70.56 12.89 6.77 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 57 3 # 57 199 ASP B 130 ASP.? 9.25 OXT ACT B 201 218 GLU C 156 GLU~? 19.44 CH3 ACT C 201 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 70.09 11.71 8.46 70.56 12.89 6.77 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 58 3 # 58 199 ASP B 149 ASP.? 20.03 CH3 ACT B 201 218 GLU A 111 GLU^? 4.34 CH3 ACT A 201 329 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 59 3 # 59 199 ASP C 34 ASP~? 14.66 O ACT C 201 218 GLU D 80 GLU^? 14.49 CH3 ACT D 201 329 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 70.09 11.71 8.46 70.56 12.89 6.77 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 60 3 # 60 199 ASP C 34 ASP~? 14.66 O ACT C 201 218 GLU D 111 GLU^? 4.46 CH3 ACT D 201 329 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 70.09 11.71 8.46 70.56 12.89 6.77 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 61 3 # 61 199 ASP C 45 ASP^? 20.17 OXT ACT C 201 218 GLU D 17 GLU~? 23.59 CH3 ACT D 201 329 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 70.09 11.71 8.46 70.56 12.89 6.77 -50.49 54.35 20.83 -50.89 54.35 18.75 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 62 3 # 62 199 ASP C 45 ASP^? 20.17 OXT ACT C 201 218 GLU D 21 GLU~? 20.13 CH3 ACT D 201 329 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 70.09 11.71 8.46 70.56 12.89 6.77 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 63 3 # 63 199 ASP C 74 ASP^? 14.86 O ACT C 201 218 GLU A 59 GLU~? 18.41 O2 EDO A 302 329 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.57 66.85 53.38 -18.14 66.20 51.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 64 3 # 64 199 ASP C 74 ASP^? 14.86 O ACT C 201 218 GLU B 36 GLU~? 17.47 CH3 ACT B 201 329 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 70.09 11.71 8.46 70.56 12.89 6.77 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 65 3 # 65 199 ASP C 74 ASP^? 14.86 O ACT C 201 218 GLU B 80 GLU^? 7.87 CH3 ACT A 202 329 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 66 3 # 66 199 ASP C 74 ASP^? 14.86 O ACT C 201 218 GLU B 156 GLU~? 12.19 CH3 ACT A 202 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 70.09 11.71 8.46 70.56 12.89 6.77 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 67 3 # 67 199 ASP C 74 ASP^? 14.86 O ACT C 201 218 GLU B 156 GLU~? 12.19 CH3 ACT A 202 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 70.09 11.71 8.46 70.56 12.89 6.77 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 68 3 # 68 199 ASP C 74 ASP^? 14.86 O ACT C 201 218 GLU D 60 GLU~? 17.31 O ACT D 201 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 70.09 11.71 8.46 70.56 12.89 6.77 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 69 3 # 69 199 ASP C 74 ASP^? 14.86 O ACT C 201 218 GLU D 111 GLU^? 4.46 CH3 ACT D 201 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 70.09 11.71 8.46 70.56 12.89 6.77 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 70 3 # 70 199 ASP C 86 ASP.? 24.03 CH3 ACT C 201 218 GLU C 72 GLU~? 5.32 O ACT C 201 329 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 70.09 11.71 8.46 70.56 12.89 6.77 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 71 3 # 71 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 218 GLU C 21 GLU~? 19.29 CH3 ACT C 201 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 70.09 11.71 8.46 70.56 12.89 6.77 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 72 3 # 72 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 218 GLU C 114 GLU^? 18.18 OXT ACT C 201 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 70.09 11.71 8.46 70.56 12.89 6.77 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 73 3 # 73 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 218 GLU C 114 GLU^? 18.18 OXT ACT C 201 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 70.09 11.71 8.46 70.56 12.89 6.77 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 74 3 # 74 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 218 GLU D 114 GLU^? 18.05 O ACT D 201 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 70.09 11.71 8.46 70.56 12.89 6.77 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 75 3 # 75 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 218 GLU A 21 GLU~? 19.20 CH3 ACT A 201 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 70.09 11.71 8.46 70.56 12.89 6.77 -26.74 85.39 73.13 -25.47 87.07 73.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 76 3 # 76 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 218 GLU A 36 GLU~? 17.83 CH3 ACT A 201 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 70.09 11.71 8.46 70.56 12.89 6.77 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 77 3 # 77 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 218 GLU C 80 GLU^? 14.47 CH3 ACT C 201 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 70.09 11.71 8.46 70.56 12.89 6.77 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 78 3 # 78 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 218 GLU C 156 GLU~? 19.44 CH3 ACT C 201 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 70.09 11.71 8.46 70.56 12.89 6.77 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 79 3 # 79 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 218 GLU D 96 GLU^? 13.00 OXT ACT D 201 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 70.09 11.71 8.46 70.56 12.89 6.77 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 80 3 # 80 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 218 GLU D 111 GLU^? 4.46 CH3 ACT D 201 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 70.09 11.71 8.46 70.56 12.89 6.77 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 81 3 # 81 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 218 GLU D 111 GLU^? 4.46 CH3 ACT D 201 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 70.09 11.71 8.46 70.56 12.89 6.77 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 82 3 # 82 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 218 GLU D 137 GLU~? 19.20 CH3 ACT A 203 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 70.09 11.71 8.46 70.56 12.89 6.77 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 83 3 # 83 199 ASP C 116 ASP.? 19.40 CH3 ACT C 201 218 GLU B 137 GLU~? 6.31 C2 EDO A 302 329 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 70.09 11.71 8.46 70.56 12.89 6.77 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 59.16 37.82 13.95 57.63 37.03 15.12 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 84 3 # 84 199 ASP C 116 ASP.? 19.40 CH3 ACT C 201 218 GLU C 156 GLU~? 19.44 CH3 ACT C 201 329 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 70.09 11.71 8.46 70.56 12.89 6.77 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 85 3 # 85 199 ASP C 116 ASP.? 19.40 CH3 ACT C 201 218 GLU D 96 GLU^? 13.00 OXT ACT D 201 329 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 70.09 11.71 8.46 70.56 12.89 6.77 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 86 3 # 86 199 ASP C 130 ASP.? 4.74 O2 EDO A 301 218 GLU A 80 GLU^? 14.51 CH3 ACT A 201 329 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 70.09 11.71 8.46 70.56 12.89 6.77 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 87 3 # 87 199 ASP C 130 ASP.? 4.74 O2 EDO A 301 218 GLU A 156 GLU~? 20.10 CH3 ACT A 201 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 70.09 11.71 8.46 70.56 12.89 6.77 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 88 3 # 88 199 ASP C 130 ASP.? 4.74 O2 EDO A 301 218 GLU D 36 GLU~? 17.76 CH3 ACT D 201 329 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 70.09 11.71 8.46 70.56 12.89 6.77 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 89 3 # 89 199 ASP C 149 ASP.? 18.79 CH3 ACT C 201 218 GLU B 72 GLU~? 5.30 OXT ACT B 201 329 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 90 3 # 90 199 ASP C 149 ASP.? 18.79 CH3 ACT C 201 218 GLU D 111 GLU^? 4.46 CH3 ACT D 201 329 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 91 3 # 91 199 ASP D 34 ASP~? 14.62 OXT ACT D 201 218 GLU C 80 GLU^? 14.47 CH3 ACT C 201 329 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 70.09 11.71 8.46 70.56 12.89 6.77 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -55.65 65.73 30.36 -54.18 65.67 28.83 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 92 3 # 92 199 ASP D 34 ASP~? 14.62 OXT ACT D 201 218 GLU C 111 GLU^? 4.32 CH3 ACT C 201 329 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 70.09 11.71 8.46 70.56 12.89 6.77 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 -55.65 65.73 30.36 -54.18 65.67 28.83 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 93 3 # 93 199 ASP D 74 ASP^? 14.85 OXT ACT D 201 218 GLU C 60 GLU~? 17.22 OXT ACT C 201 329 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 70.09 11.71 8.46 70.56 12.89 6.77 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 59.16 37.82 13.95 57.63 37.03 15.12 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 94 3 # 94 199 ASP D 74 ASP^? 14.85 OXT ACT D 201 218 GLU C 111 GLU^? 4.32 CH3 ACT C 201 329 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 70.09 11.71 8.46 70.56 12.89 6.77 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 95 3 # 95 199 ASP D 86 ASP.? 24.19 CH3 ACT D 201 218 GLU D 72 GLU~? 5.29 OXT ACT D 201 329 ASP D 116 ASP.? 19.52 CH3 ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 70.09 11.71 8.46 70.56 12.89 6.77 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 59.16 37.82 13.95 57.63 37.03 15.12 -63.55 47.24 34.96 -64.48 49.07 34.39 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 96 3 # 96 199 ASP D 99 ASP.? 7.94 CH3 ACT A 203 218 GLU B 53 GLU^? 11.09 O ACT B 201 329 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 70.09 11.71 8.46 70.56 12.89 6.77 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 97 3 # 97 199 ASP D 99 ASP.? 7.94 CH3 ACT A 203 218 GLU B 53 GLU^? 11.09 O ACT B 201 329 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 70.09 11.71 8.46 70.56 12.89 6.77 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 98 3 # 98 199 ASP D 99 ASP.? 7.94 CH3 ACT A 203 218 GLU D 21 GLU~? 20.13 CH3 ACT D 201 329 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 70.09 11.71 8.46 70.56 12.89 6.77 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 99 3 # 99 199 ASP D 99 ASP.? 7.94 CH3 ACT A 203 218 GLU D 21 GLU~? 20.13 CH3 ACT D 201 329 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 70.09 11.71 8.46 70.56 12.89 6.77 -52.88 57.10 23.42 -54.02 56.21 21.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 100 3 # 100 199 ASP D 100 ASP.? 7.94 OXT ACT A 203 218 GLU C 111 GLU^? 4.32 CH3 ACT C 201 329 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 101 3 # 101 199 ASP D 100 ASP.? 7.94 OXT ACT A 203 218 GLU C 111 GLU^? 4.32 CH3 ACT C 201 329 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 102 3 # 102 199 ASP D 100 ASP.? 7.94 OXT ACT A 203 218 GLU C 137 GLU~? 15.84 O2 EDO A 301 329 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 103 3 # 103 199 ASP D 100 ASP.? 7.94 OXT ACT A 203 218 GLU D 80 GLU^? 14.49 CH3 ACT D 201 329 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 104 3 # 104 199 ASP D 116 ASP.? 19.52 CH3 ACT D 201 218 GLU D 156 GLU.? 18.36 CH3 ACT D 201 329 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 70.09 11.71 8.46 70.56 12.89 6.77 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 105 3 # 105 199 ASP D 130 ASP.? 7.40 CH3 ACT A 203 218 GLU A 80 GLU^? 14.51 CH3 ACT A 201 329 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 70.09 11.71 8.46 70.56 12.89 6.77 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 106 3 # 106 199 ASP D 130 ASP.? 7.40 CH3 ACT A 203 218 GLU A 156 GLU~? 20.10 CH3 ACT A 201 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 70.09 11.71 8.46 70.56 12.89 6.77 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 107 3 # 107 199 ASP D 130 ASP.? 7.40 CH3 ACT A 203 218 GLU A 156 GLU~? 20.10 CH3 ACT A 201 329 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 70.09 11.71 8.46 70.56 12.89 6.77 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 108 3 # 108 199 ASP D 130 ASP.? 7.40 CH3 ACT A 203 218 GLU B 160 GLU.? 4.71 OXT ACT A 202 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 70.09 11.71 8.46 70.56 12.89 6.77 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 109 3 # 109 199 ASP D 130 ASP.? 7.40 CH3 ACT A 203 218 GLU C 36 GLU~? 15.95 O2 EDO A 302 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 70.09 11.71 8.46 70.56 12.89 6.77 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 110 3 # 110 199 ASP D 130 ASP.? 7.40 CH3 ACT A 203 218 GLU C 156 GLU~? 19.44 CH3 ACT C 201 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 70.09 11.71 8.46 70.56 12.89 6.77 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 111 3 # 111 199 ASP D 149 ASP.? 20.02 CH3 ACT D 201 218 GLU C 111 GLU^? 4.32 CH3 ACT C 201 329 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 70.09 11.71 8.46 70.56 12.89 6.77 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 -55.65 65.73 30.36 -54.18 65.67 28.83 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 111 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 28 ASP~? 12.70 CH3 ACT A 201 242 GLU A 114 GLU^? 11.87 CH3 ACT A 202 329 ASP A 149 ASP.? 18.85 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 30.42 34.74 5.00 29.09 35.09 3.38 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.64 88.42 71.14 -36.90 88.52 69.95 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 28 ASP~? 12.70 CH3 ACT A 201 242 GLU D 137 GLU~? 19.20 CH3 ACT A 203 329 ASP A 149 ASP.? 18.85 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 30.42 34.74 5.00 29.09 35.09 3.38 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.64 88.42 71.14 -36.90 88.52 69.95 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 34 ASP~? 14.63 O ACT A 201 242 GLU C 60 GLU~? 17.22 OXT ACT C 201 329 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 30.42 34.74 5.00 29.09 35.09 3.38 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 59.16 37.82 13.95 57.63 37.03 15.12 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 34 ASP~? 14.63 O ACT A 201 242 GLU D 96 GLU^? 13.00 OXT ACT D 201 329 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 30.42 34.74 5.00 29.09 35.09 3.38 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 59.16 37.82 13.95 57.63 37.03 15.12 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 45 ASP^? 16.09 OXT ACT A 202 242 GLU C 59 GLU~? 13.48 O2 EDO A 302 329 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 30.42 34.74 5.00 29.09 35.09 3.38 -20.25 53.72 49.66 -20.40 52.10 51.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 45 ASP^? 16.09 OXT ACT A 202 242 GLU C 60 GLU~? 17.22 OXT ACT C 201 329 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 30.42 34.74 5.00 29.09 35.09 3.38 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 242 GLU A 36 GLU~? 17.83 CH3 ACT A 201 329 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 242 GLU A 80 GLU^? 14.51 CH3 ACT A 201 329 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 30.42 34.74 5.00 29.09 35.09 3.38 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 242 GLU A 80 GLU^? 14.51 CH3 ACT A 201 329 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 30.42 34.74 5.00 29.09 35.09 3.38 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 242 GLU A 80 GLU^? 14.51 CH3 ACT A 201 329 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 30.42 34.74 5.00 29.09 35.09 3.38 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 242 GLU A 111 GLU^? 4.34 CH3 ACT A 201 329 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 30.42 34.74 5.00 29.09 35.09 3.38 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 242 GLU A 156 GLU~? 20.10 CH3 ACT A 201 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 30.42 34.74 5.00 29.09 35.09 3.38 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 242 GLU A 156 GLU~? 20.10 CH3 ACT A 201 329 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 30.42 34.74 5.00 29.09 35.09 3.38 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 242 GLU A 156 GLU~? 20.10 CH3 ACT A 201 329 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 30.42 34.74 5.00 29.09 35.09 3.38 -42.77 81.40 79.58 -42.85 83.31 78.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 242 GLU C 72 GLU~? 5.32 O ACT C 201 329 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 30.42 34.74 5.00 29.09 35.09 3.38 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP A 86 ASP.? 20.24 CH3 ACT A 202 242 GLU B 27 GLU~? 9.83 CH3 ACT B 201 329 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP A 86 ASP.? 20.24 CH3 ACT A 202 242 GLU B 114 GLU^? 18.04 O ACT B 201 329 ASP A 116 ASP.? 19.55 CH3 ACT A 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 30.42 34.74 5.00 29.09 35.09 3.38 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.42 74.73 69.90 -14.01 76.08 68.36 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP A 99 ASP.? 5.71 O2 EDO A 301 242 GLU B 53 GLU^? 11.09 O ACT B 201 329 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP A 99 ASP.? 5.71 O2 EDO A 301 242 GLU D 111 GLU^? 4.46 CH3 ACT D 201 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP A 99 ASP.? 5.71 O2 EDO A 301 242 GLU D 111 GLU^? 4.46 CH3 ACT D 201 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP A 99 ASP.? 5.71 O2 EDO A 301 242 GLU D 137 GLU~? 19.20 CH3 ACT A 203 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP A 99 ASP.? 5.71 O2 EDO A 301 242 GLU D 137 GLU~? 19.20 CH3 ACT A 203 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP A 100 ASP.? 9.07 O2 EDO A 301 242 GLU A 53 GLU^? 10.41 O2 EDO A 302 329 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 30.42 34.74 5.00 29.09 35.09 3.38 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP A 100 ASP.? 9.07 O2 EDO A 301 242 GLU C 60 GLU~? 17.22 OXT ACT C 201 329 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 30.42 34.74 5.00 29.09 35.09 3.38 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 59.16 37.82 13.95 57.63 37.03 15.12 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP A 100 ASP.? 9.07 O2 EDO A 301 242 GLU C 137 GLU~? 15.84 O2 EDO A 301 329 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 30.42 34.74 5.00 29.09 35.09 3.38 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 59.16 37.82 13.95 57.63 37.03 15.12 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 26 3 # 26 199 ASP A 100 ASP.? 9.07 O2 EDO A 301 242 GLU D 80 GLU^? 14.49 CH3 ACT D 201 329 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 30.42 34.74 5.00 29.09 35.09 3.38 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 27 3 # 27 199 ASP A 116 ASP.? 19.55 CH3 ACT A 201 242 GLU A 17 GLU~? 23.86 CH3 ACT A 201 329 ASP A 45 ASP^? 16.09 OXT ACT A 202 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 30.42 34.74 5.00 29.09 35.09 3.38 -26.80 87.18 79.85 -26.18 89.13 80.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 -12.72 67.64 62.66 -11.94 68.82 64.26 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 28 3 # 28 199 ASP A 116 ASP.? 19.55 CH3 ACT A 201 242 GLU A 36 GLU~? 17.83 CH3 ACT A 201 329 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.24 76.94 53.59 -22.34 76.00 53.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 29 3 # 29 199 ASP A 116 ASP.? 19.55 CH3 ACT A 201 242 GLU A 59 GLU~? 18.41 O2 EDO A 302 329 ASP A 86 ASP.? 20.24 CH3 ACT A 202 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.42 74.73 69.90 -14.01 76.08 68.36 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.57 66.85 53.38 -18.14 66.20 51.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -16.25 74.73 81.62 -15.60 74.59 83.62 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 30 3 # 30 199 ASP A 130 ASP.? 4.80 O1 EDO A 301 242 GLU A 80 GLU^? 14.51 CH3 ACT A 201 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 30.42 34.74 5.00 29.09 35.09 3.38 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 31 3 # 31 199 ASP A 130 ASP.? 4.80 O1 EDO A 301 242 GLU B 60 GLU~? 17.33 O ACT B 201 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 32 3 # 32 199 ASP A 130 ASP.? 4.80 O1 EDO A 301 242 GLU B 60 GLU~? 17.33 O ACT B 201 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 33 3 # 33 199 ASP A 130 ASP.? 4.80 O1 EDO A 301 242 GLU B 96 GLU^? 10.60 C1 EDO A 302 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 34 3 # 34 199 ASP A 130 ASP.? 4.80 O1 EDO A 301 242 GLU B 96 GLU^? 10.60 C1 EDO A 302 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 35 3 # 35 199 ASP A 130 ASP.? 4.80 O1 EDO A 301 242 GLU B 160 GLU.? 4.71 OXT ACT A 202 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 30.42 34.74 5.00 29.09 35.09 3.38 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 36 3 # 36 199 ASP A 130 ASP.? 4.80 O1 EDO A 301 242 GLU B 160 GLU.? 4.71 OXT ACT A 202 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 30.42 34.74 5.00 29.09 35.09 3.38 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 37 3 # 37 199 ASP B 28 ASP~? 12.70 CH3 ACT B 201 242 GLU B 114 GLU^? 18.04 O ACT B 201 329 ASP B 149 ASP.? 20.03 CH3 ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 30.42 34.74 5.00 29.09 35.09 3.38 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.67 50.22 91.33 -14.75 50.15 93.16 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 38 3 # 38 199 ASP B 74 ASP^? 14.88 OXT ACT B 201 242 GLU B 80 GLU^? 7.87 CH3 ACT A 202 329 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 39 3 # 39 199 ASP B 74 ASP^? 14.88 OXT ACT B 201 242 GLU B 156 GLU~? 12.19 CH3 ACT A 202 329 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 30.42 34.74 5.00 29.09 35.09 3.38 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 40 3 # 40 199 ASP B 86 ASP.? 24.07 CH3 ACT B 201 242 GLU A 21 GLU~? 19.20 CH3 ACT A 201 329 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 30.42 34.74 5.00 29.09 35.09 3.38 -26.74 85.39 73.13 -25.47 87.07 73.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 41 3 # 41 199 ASP B 86 ASP.? 24.07 CH3 ACT B 201 242 GLU A 114 GLU^? 11.87 CH3 ACT A 202 329 ASP B 116 ASP.? 19.49 CH3 ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 30.42 34.74 5.00 29.09 35.09 3.38 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 -36.38 68.31 96.56 -36.18 66.45 97.55 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 42 3 # 42 199 ASP B 99 ASP.? 16.09 OXT ACT B 201 242 GLU C 27 GLU~? 9.88 CH3 ACT C 201 329 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 30.42 34.74 5.00 29.09 35.09 3.38 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 43 3 # 43 199 ASP B 99 ASP.? 16.09 OXT ACT B 201 242 GLU C 137 GLU~? 15.84 O2 EDO A 301 329 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 30.42 34.74 5.00 29.09 35.09 3.38 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 44 3 # 44 199 ASP B 100 ASP.? 15.93 OXT ACT B 201 242 GLU C 137 GLU~? 15.84 O2 EDO A 301 329 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 30.42 34.74 5.00 29.09 35.09 3.38 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 45 3 # 45 199 ASP B 116 ASP.? 19.49 CH3 ACT B 201 242 GLU B 17 GLU~? 23.60 CH3 ACT B 201 329 ASP B 45 ASP^? 20.35 O ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 30.42 34.74 5.00 29.09 35.09 3.38 -16.26 64.60 95.04 -14.82 64.68 96.59 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.52 64.51 93.81 -44.25 65.94 94.72 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 46 3 # 46 199 ASP B 116 ASP.? 19.49 CH3 ACT B 201 242 GLU B 36 GLU~? 17.47 CH3 ACT B 201 329 ASP B 86 ASP.? 24.07 CH3 ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -36.38 68.31 96.56 -36.18 66.45 97.55 coo 30.42 34.74 5.00 29.09 35.09 3.38 -39.08 48.65 96.43 -40.52 50.19 96.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.16 75.31 91.23 -27.42 77.23 90.74 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 47 3 # 47 199 ASP B 130 ASP.? 9.25 OXT ACT B 201 242 GLU A 60 GLU~? 10.63 O2 EDO A 302 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 48 3 # 48 199 ASP B 130 ASP.? 9.25 OXT ACT B 201 242 GLU A 96 GLU^? 11.70 OXT ACT A 203 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 30.42 34.74 5.00 29.09 35.09 3.38 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 49 3 # 49 199 ASP B 130 ASP.? 9.25 OXT ACT B 201 242 GLU B 80 GLU^? 7.87 CH3 ACT A 202 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 50 3 # 50 199 ASP B 130 ASP.? 9.25 OXT ACT B 201 242 GLU B 156 GLU~? 12.19 CH3 ACT A 202 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 30.42 34.74 5.00 29.09 35.09 3.38 -12.52 56.39 79.83 -10.80 57.54 79.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 51 3 # 51 199 ASP C 28 ASP~? 12.80 CH3 ACT C 201 242 GLU C 114 GLU^? 18.18 OXT ACT C 201 329 ASP C 149 ASP.? 18.79 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 30.42 34.74 5.00 29.09 35.09 3.38 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 -42.93 29.00 51.56 -40.94 29.30 50.94 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 52 3 # 52 199 ASP C 34 ASP~? 14.66 O ACT C 201 242 GLU A 60 GLU~? 10.63 O2 EDO A 302 329 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 53 3 # 53 199 ASP C 34 ASP~? 14.66 O ACT C 201 242 GLU B 96 GLU^? 10.60 C1 EDO A 302 329 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 54 3 # 54 199 ASP C 45 ASP^? 20.17 OXT ACT C 201 242 GLU A 59 GLU~? 18.41 O2 EDO A 302 329 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.57 66.85 53.38 -18.14 66.20 51.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 55 3 # 55 199 ASP C 45 ASP^? 20.17 OXT ACT C 201 242 GLU A 60 GLU~? 10.63 O2 EDO A 302 329 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 56 3 # 56 199 ASP C 74 ASP^? 14.86 O ACT C 201 242 GLU A 72 GLU~? 5.31 O ACT A 201 329 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.42 34.74 5.00 29.09 35.09 3.38 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 57 3 # 57 199 ASP C 74 ASP^? 14.86 O ACT C 201 242 GLU C 80 GLU^? 14.47 CH3 ACT C 201 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 58 3 # 58 199 ASP C 74 ASP^? 14.86 O ACT C 201 242 GLU C 80 GLU^? 14.47 CH3 ACT C 201 329 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 59 3 # 59 199 ASP C 74 ASP^? 14.86 O ACT C 201 242 GLU C 80 GLU^? 14.47 CH3 ACT C 201 329 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 60 3 # 60 199 ASP C 74 ASP^? 14.86 O ACT C 201 242 GLU C 80 GLU^? 14.47 CH3 ACT C 201 329 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 61 3 # 61 199 ASP C 74 ASP^? 14.86 O ACT C 201 242 GLU C 111 GLU^? 4.32 CH3 ACT C 201 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.42 34.74 5.00 29.09 35.09 3.38 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 62 3 # 62 199 ASP C 74 ASP^? 14.86 O ACT C 201 242 GLU C 111 GLU^? 4.32 CH3 ACT C 201 329 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.42 34.74 5.00 29.09 35.09 3.38 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 63 3 # 63 199 ASP C 74 ASP^? 14.86 O ACT C 201 242 GLU C 156 GLU~? 19.44 CH3 ACT C 201 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.42 34.74 5.00 29.09 35.09 3.38 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 64 3 # 64 199 ASP C 74 ASP^? 14.86 O ACT C 201 242 GLU C 156 GLU~? 19.44 CH3 ACT C 201 329 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.42 34.74 5.00 29.09 35.09 3.38 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 65 3 # 65 199 ASP C 74 ASP^? 14.86 O ACT C 201 242 GLU C 156 GLU~? 19.44 CH3 ACT C 201 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.42 34.74 5.00 29.09 35.09 3.38 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 66 3 # 66 199 ASP C 74 ASP^? 14.86 O ACT C 201 242 GLU C 156 GLU~? 19.44 CH3 ACT C 201 329 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 30.42 34.74 5.00 29.09 35.09 3.38 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 67 3 # 67 199 ASP C 86 ASP.? 24.03 CH3 ACT C 201 242 GLU D 114 GLU^? 18.05 O ACT D 201 329 ASP C 116 ASP.? 19.40 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 30.42 34.74 5.00 29.09 35.09 3.38 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.04 45.85 33.79 -27.08 44.69 35.29 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 68 3 # 68 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 242 GLU A 160 GLU.? 13.50 O ACT A 201 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 30.42 34.74 5.00 29.09 35.09 3.38 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 69 3 # 69 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 242 GLU B 96 GLU^? 10.60 C1 EDO A 302 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 70 3 # 70 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 242 GLU B 96 GLU^? 10.60 C1 EDO A 302 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 71 3 # 71 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 242 GLU B 111 GLU^? 4.46 CH3 ACT B 201 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 30.42 34.74 5.00 29.09 35.09 3.38 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 72 3 # 72 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 242 GLU B 111 GLU^? 4.46 CH3 ACT B 201 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 30.42 34.74 5.00 29.09 35.09 3.38 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 73 3 # 73 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 242 GLU B 137 GLU~? 6.31 C2 EDO A 302 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 30.42 34.74 5.00 29.09 35.09 3.38 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 74 3 # 74 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 242 GLU B 137 GLU~? 6.31 C2 EDO A 302 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 30.42 34.74 5.00 29.09 35.09 3.38 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 75 3 # 75 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 242 GLU B 160 GLU.? 4.71 OXT ACT A 202 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 30.42 34.74 5.00 29.09 35.09 3.38 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 76 3 # 76 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 242 GLU B 160 GLU.? 4.71 OXT ACT A 202 329 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 30.42 34.74 5.00 29.09 35.09 3.38 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 59.16 37.82 13.95 57.63 37.03 15.12 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 77 3 # 77 199 ASP C 99 ASP.? 5.79 O1 EDO A 301 242 GLU D 53 GLU^? 10.32 O ACT A 203 329 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 30.42 34.74 5.00 29.09 35.09 3.38 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 78 3 # 78 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 242 GLU A 60 GLU~? 10.63 O2 EDO A 302 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 79 3 # 79 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 242 GLU A 137 GLU~? 14.03 O ACT A 203 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 30.42 34.74 5.00 29.09 35.09 3.38 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 80 3 # 80 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 242 GLU A 160 GLU.? 13.50 O ACT A 201 329 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 30.42 34.74 5.00 29.09 35.09 3.38 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 81 3 # 81 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 242 GLU A 160 GLU.? 13.50 O ACT A 201 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 30.42 34.74 5.00 29.09 35.09 3.38 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 82 3 # 82 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 242 GLU B 80 GLU^? 7.87 CH3 ACT A 202 329 ASP C 74 ASP^? 14.86 O ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 83 3 # 83 199 ASP C 116 ASP.? 19.40 CH3 ACT C 201 242 GLU C 17 GLU~? 23.53 CH3 ACT C 201 329 ASP C 45 ASP^? 20.17 OXT ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 30.42 34.74 5.00 29.09 35.09 3.38 -44.57 31.78 35.88 -45.60 32.67 34.25 coo 59.16 37.82 13.95 57.63 37.03 15.12 -23.26 53.52 38.24 -24.05 52.31 36.68 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 84 3 # 84 199 ASP C 116 ASP.? 19.40 CH3 ACT C 201 242 GLU C 36 GLU~? 15.95 O2 EDO A 302 329 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 30.42 34.74 5.00 29.09 35.09 3.38 -22.00 43.42 52.41 -21.02 44.62 50.95 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 85 3 # 85 199 ASP C 116 ASP.? 19.40 CH3 ACT C 201 242 GLU C 59 GLU~? 13.48 O2 EDO A 302 329 ASP C 86 ASP.? 24.03 CH3 ACT C 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.04 45.85 33.79 -27.08 44.69 35.29 coo 30.42 34.74 5.00 29.09 35.09 3.38 -20.25 53.72 49.66 -20.40 52.10 51.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.79 45.04 28.56 -40.00 45.30 26.84 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 86 3 # 86 199 ASP C 130 ASP.? 4.74 O2 EDO A 301 242 GLU C 80 GLU^? 14.47 CH3 ACT C 201 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 87 3 # 87 199 ASP C 130 ASP.? 4.74 O2 EDO A 301 242 GLU C 156 GLU~? 19.44 CH3 ACT C 201 329 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 88 3 # 88 199 ASP C 130 ASP.? 4.74 O2 EDO A 301 242 GLU C 156 GLU~? 19.44 CH3 ACT C 201 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -53.30 36.17 49.35 -52.27 34.34 49.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 89 3 # 89 199 ASP C 130 ASP.? 4.74 O2 EDO A 301 242 GLU D 60 GLU~? 17.31 O ACT D 201 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 90 3 # 90 199 ASP C 130 ASP.? 4.74 O2 EDO A 301 242 GLU D 60 GLU~? 17.31 O ACT D 201 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 91 3 # 91 199 ASP C 130 ASP.? 4.74 O2 EDO A 301 242 GLU D 96 GLU^? 13.00 OXT ACT D 201 329 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 92 3 # 92 199 ASP C 130 ASP.? 4.74 O2 EDO A 301 242 GLU D 96 GLU^? 13.00 OXT ACT D 201 329 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 93 3 # 93 199 ASP D 28 ASP~? 12.70 CH3 ACT D 201 242 GLU D 114 GLU^? 18.05 O ACT D 201 329 ASP D 149 ASP.? 20.02 CH3 ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 30.42 34.74 5.00 29.09 35.09 3.38 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 -48.61 69.27 22.33 -50.68 68.95 22.00 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 94 3 # 94 199 ASP D 74 ASP^? 14.85 OXT ACT D 201 242 GLU D 80 GLU^? 14.49 CH3 ACT D 201 329 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 30.42 34.74 5.00 29.09 35.09 3.38 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 95 3 # 95 199 ASP D 74 ASP^? 14.85 OXT ACT D 201 242 GLU D 156 GLU.? 18.36 CH3 ACT D 201 329 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 30.42 34.74 5.00 29.09 35.09 3.38 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 96 3 # 96 199 ASP D 86 ASP.? 24.19 CH3 ACT D 201 242 GLU C 21 GLU~? 19.29 CH3 ACT C 201 329 ASP D 116 ASP.? 19.52 CH3 ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 30.42 34.74 5.00 29.09 35.09 3.38 -37.51 33.35 41.29 -36.60 32.00 39.94 coo 59.16 37.82 13.95 57.63 37.03 15.12 -63.55 47.24 34.96 -64.48 49.07 34.39 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 97 3 # 97 199 ASP D 86 ASP.? 24.19 CH3 ACT D 201 242 GLU C 114 GLU^? 18.18 OXT ACT C 201 329 ASP D 116 ASP.? 19.52 CH3 ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 30.42 34.74 5.00 29.09 35.09 3.38 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 -63.55 47.24 34.96 -64.48 49.07 34.39 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 98 3 # 98 199 ASP D 99 ASP.? 7.94 CH3 ACT A 203 242 GLU A 27 GLU~? 9.74 CH3 ACT A 201 329 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 30.42 34.74 5.00 29.09 35.09 3.38 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 59.16 37.82 13.95 57.63 37.03 15.12 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 99 3 # 99 199 ASP D 99 ASP.? 7.94 CH3 ACT A 203 242 GLU A 137 GLU~? 14.03 O ACT A 203 329 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 30.42 34.74 5.00 29.09 35.09 3.38 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 100 3 # 100 199 ASP D 100 ASP.? 7.94 OXT ACT A 203 242 GLU A 137 GLU~? 14.03 O ACT A 203 329 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 30.42 34.74 5.00 29.09 35.09 3.38 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 101 3 # 101 199 ASP D 116 ASP.? 19.52 CH3 ACT D 201 242 GLU D 17 GLU~? 23.59 CH3 ACT D 201 329 ASP D 45 ASP^? 20.33 O ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 30.42 34.74 5.00 29.09 35.09 3.38 -50.49 54.35 20.83 -50.89 54.35 18.75 coo 59.16 37.82 13.95 57.63 37.03 15.12 -67.68 49.50 43.87 -67.26 48.38 42.12 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 102 3 # 102 199 ASP D 116 ASP.? 19.52 CH3 ACT D 201 242 GLU D 36 GLU~? 17.76 CH3 ACT D 201 329 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 30.42 34.74 5.00 29.09 35.09 3.38 -68.34 66.20 38.63 -69.40 64.56 39.44 coo 59.16 37.82 13.95 57.63 37.03 15.12 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 103 3 # 103 199 ASP D 116 ASP.? 19.52 CH3 ACT D 201 242 GLU D 59 GLU~? 18.52 O ACT D 201 329 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 49.16 35.16 15.19 51.08 34.43 15.65 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 30.42 34.74 5.00 29.09 35.09 3.38 -69.73 60.64 47.66 -70.08 62.16 46.23 coo 59.16 37.82 13.95 57.63 37.03 15.12 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 104 3 # 104 199 ASP D 130 ASP.? 7.40 CH3 ACT A 203 242 GLU A 53 GLU^? 10.41 O2 EDO A 302 329 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 30.42 34.74 5.00 29.09 35.09 3.38 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 105 3 # 105 199 ASP D 130 ASP.? 7.40 CH3 ACT A 203 242 GLU C 60 GLU~? 17.22 OXT ACT C 201 329 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 30.42 34.74 5.00 29.09 35.09 3.38 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 59.16 37.82 13.95 57.63 37.03 15.12 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 106 3 # 106 199 ASP D 130 ASP.? 7.40 CH3 ACT A 203 242 GLU C 96 GLU^? 13.00 O ACT C 201 329 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 30.42 34.74 5.00 29.09 35.09 3.38 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 107 3 # 107 199 ASP D 130 ASP.? 7.40 CH3 ACT A 203 242 GLU D 80 GLU^? 14.49 CH3 ACT D 201 329 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 30.42 34.74 5.00 29.09 35.09 3.38 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 108 3 # 108 199 ASP D 130 ASP.? 7.40 CH3 ACT A 203 242 GLU D 156 GLU.? 18.36 CH3 ACT D 201 329 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 30.42 34.74 5.00 29.09 35.09 3.38 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 109 3 # 109 199 ASP D 130 ASP.? 7.40 CH3 ACT A 203 242 GLU D 156 GLU.? 18.36 CH3 ACT D 201 329 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 30.42 34.74 5.00 29.09 35.09 3.38 -37.15 64.72 28.61 -38.97 63.94 27.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.15 62.19 57.97 -45.93 61.14 58.45 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 109 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 596 ARG A 147 ARG.? 13.06 CH3 ACT A 201 A 647 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 69.13 32.20 28.58 68.39 32.96 30.44 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 70.89 37.31 29.70 69.54 36.29 32.39 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 66.09 40.54 34.70 66.92 37.69 35.49 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 596 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 647 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 70.89 37.31 29.70 69.54 36.29 32.39 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 66.09 40.54 34.70 66.92 37.69 35.49 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 596 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 647 ARG B 123 ARG.? 17.76 O ACT B 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 70.89 37.31 29.70 69.54 36.29 32.39 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 66.09 40.54 34.70 66.92 37.69 35.49 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 4 3 # 4 A 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 596 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 647 ARG A 33 ARG.? 12.39 O ACT A 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 70.89 37.31 29.70 69.54 36.29 32.39 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 66.09 40.54 34.70 66.92 37.69 35.49 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 5 3 # 5 A 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 596 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 647 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 70.89 37.31 29.70 69.54 36.29 32.39 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 66.09 40.54 34.70 66.92 37.69 35.49 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 6 3 # 6 A 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 596 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 647 ARG B 49 ARG^? 10.37 O ACT B 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 70.89 37.31 29.70 69.54 36.29 32.39 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 66.09 40.54 34.70 66.92 37.69 35.49 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 7 3 # 7 A 581 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 596 ARG A 88 ARG^? 11.13 CH3 ACT A 202 A 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 69.13 32.20 28.58 68.39 32.96 30.44 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 70.89 37.31 29.70 69.54 36.29 32.39 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 66.09 40.54 34.70 66.92 37.69 35.49 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 8 3 # 8 A 581 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 596 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 69.13 32.20 28.58 68.39 32.96 30.44 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 70.89 37.31 29.70 69.54 36.29 32.39 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 66.09 40.54 34.70 66.92 37.69 35.49 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 9 3 # 9 A 581 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 596 ARG B 147 ARG.? 12.52 CH3 ACT A 202 A 647 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 70.89 37.31 29.70 69.54 36.29 32.39 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 66.09 40.54 34.70 66.92 37.69 35.49 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 10 3 # 10 A 581 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 596 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 647 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo 69.13 32.20 28.58 68.39 32.96 30.44 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 70.89 37.31 29.70 69.54 36.29 32.39 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 66.09 40.54 34.70 66.92 37.69 35.49 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 11 3 # 11 A 581 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 596 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 647 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 69.13 32.20 28.58 68.39 32.96 30.44 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 70.89 37.31 29.70 69.54 36.29 32.39 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 66.09 40.54 34.70 66.92 37.69 35.49 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 12 3 # 12 A 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 596 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 647 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 70.89 37.31 29.70 69.54 36.29 32.39 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 66.09 40.54 34.70 66.92 37.69 35.49 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 13 3 # 13 A 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 596 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 647 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo 69.13 32.20 28.58 68.39 32.96 30.44 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 70.89 37.31 29.70 69.54 36.29 32.39 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 66.09 40.54 34.70 66.92 37.69 35.49 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 14 3 # 14 A 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 596 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 647 ARG A 49 ARG^? -3.92 O ACT A 202s coo 69.13 32.20 28.58 68.39 32.96 30.44 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 70.89 37.31 29.70 69.54 36.29 32.39 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 66.09 40.54 34.70 66.92 37.69 35.49 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 15 3 # 15 A 581 GLU B 114 GLU^? 18.04 O ACT B 201 A 596 ARG B 88 ARG^? 18.43 CH3 ACT A 201 A 647 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 70.89 37.31 29.70 69.54 36.29 32.39 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 66.09 40.54 34.70 66.92 37.69 35.49 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 16 3 # 16 A 581 GLU B 114 GLU^? 18.04 O ACT B 201 A 596 ARG B 123 ARG.? 17.76 O ACT B 201 A 647 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 70.89 37.31 29.70 69.54 36.29 32.39 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 66.09 40.54 34.70 66.92 37.69 35.49 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 17 3 # 17 A 581 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 596 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 69.13 32.20 28.58 68.39 32.96 30.44 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 70.89 37.31 29.70 69.54 36.29 32.39 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 66.09 40.54 34.70 66.92 37.69 35.49 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 18 3 # 18 A 581 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 596 ARG C 147 ARG.? 13.23 CH3 ACT C 201 A 647 ARG C 76 ARG^? 14.32 O ACT C 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 70.89 37.31 29.70 69.54 36.29 32.39 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 66.09 40.54 34.70 66.92 37.69 35.49 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 19 3 # 19 A 581 GLU C 80 GLU^? 14.47 CH3 ACT C 201 A 596 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 647 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 70.89 37.31 29.70 69.54 36.29 32.39 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 66.09 40.54 34.70 66.92 37.69 35.49 -52.23 44.53 37.75 -52.43 42.56 40.08 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 20 3 # 20 A 581 GLU C 80 GLU^? 14.47 CH3 ACT C 201 A 596 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 647 ARG D 123 ARG.? 17.60 O ACT D 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 70.89 37.31 29.70 69.54 36.29 32.39 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 66.09 40.54 34.70 66.92 37.69 35.49 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 21 3 # 21 A 581 GLU C 96 GLU^? 13.00 O ACT C 201 A 596 ARG C 76 ARG^? 14.32 O ACT C 201 A 647 ARG C 33 ARG.? 12.41 O ACT C 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 70.89 37.31 29.70 69.54 36.29 32.39 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 66.09 40.54 34.70 66.92 37.69 35.49 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 22 3 # 22 A 581 GLU C 96 GLU^? 13.00 O ACT C 201 A 596 ARG C 76 ARG^? 14.32 O ACT C 201 A 647 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 70.89 37.31 29.70 69.54 36.29 32.39 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 66.09 40.54 34.70 66.92 37.69 35.49 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 23 3 # 23 A 581 GLU C 96 GLU^? 13.00 O ACT C 201 A 596 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 647 ARG D 49 ARG^? 10.44 O ACT D 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 70.89 37.31 29.70 69.54 36.29 32.39 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 66.09 40.54 34.70 66.92 37.69 35.49 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 24 3 # 24 A 581 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 596 ARG C 88 ARG^? 18.42 CH3 ACT D 201 A 647 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 70.89 37.31 29.70 69.54 36.29 32.39 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 66.09 40.54 34.70 66.92 37.69 35.49 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 25 3 # 25 A 581 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 596 ARG C 123 ARG.? 17.68 OXT ACT C 201 A 647 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 70.89 37.31 29.70 69.54 36.29 32.39 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 66.09 40.54 34.70 66.92 37.69 35.49 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 26 3 # 26 A 581 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 596 ARG D 147 ARG.? 13.02 CH3 ACT D 201 A 647 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 70.89 37.31 29.70 69.54 36.29 32.39 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 66.09 40.54 34.70 66.92 37.69 35.49 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 27 3 # 27 A 581 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 596 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 647 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 70.89 37.31 29.70 69.54 36.29 32.39 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 66.09 40.54 34.70 66.92 37.69 35.49 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 28 3 # 28 A 581 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 596 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 647 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 70.89 37.31 29.70 69.54 36.29 32.39 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 66.09 40.54 34.70 66.92 37.69 35.49 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 29 3 # 29 A 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 596 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 647 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 70.89 37.31 29.70 69.54 36.29 32.39 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 66.09 40.54 34.70 66.92 37.69 35.49 -55.21 72.58 39.53 -56.74 74.11 37.37 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 30 3 # 30 A 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 596 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 647 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 70.89 37.31 29.70 69.54 36.29 32.39 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 66.09 40.54 34.70 66.92 37.69 35.49 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 31 3 # 31 A 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 596 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 647 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 70.89 37.31 29.70 69.54 36.29 32.39 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 66.09 40.54 34.70 66.92 37.69 35.49 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 32 3 # 32 A 581 GLU D 114 GLU^? 18.05 O ACT D 201 A 596 ARG D 88 ARG^? 18.35 CH3 ACT C 201 A 647 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 70.89 37.31 29.70 69.54 36.29 32.39 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 66.09 40.54 34.70 66.92 37.69 35.49 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 33 3 # 33 A 581 GLU D 114 GLU^? 18.05 O ACT D 201 A 596 ARG D 123 ARG.? 17.60 O ACT D 201 A 647 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 69.13 32.20 28.58 68.39 32.96 30.44 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 70.89 37.31 29.70 69.54 36.29 32.39 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 66.09 40.54 34.70 66.92 37.69 35.49 -49.94 47.28 44.16 -51.45 46.27 46.66 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 33 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 27 GLU~? 9.74 CH3 ACT A 201 B 596 ARG A 147 ARG.? 13.06 CH3 ACT A 201 B 647 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 38.22 57.83 70.36 36.82 56.74 69.18 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 34.24 60.89 68.08 33.31 57.93 67.63 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 31.43 57.38 61.97 31.90 55.58 64.41 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU A 80 GLU^? 14.51 CH3 ACT A 201 B 596 ARG A 92 ARG^? 14.09 CH3 ACT A 201 B 647 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 34.24 60.89 68.08 33.31 57.93 67.63 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 31.43 57.38 61.97 31.90 55.58 64.41 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU A 80 GLU^? 14.51 CH3 ACT A 201 B 596 ARG A 92 ARG^? 14.09 CH3 ACT A 201 B 647 ARG B 123 ARG.? 17.76 O ACT B 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 34.24 60.89 68.08 33.31 57.93 67.63 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 31.43 57.38 61.97 31.90 55.58 64.41 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 4 3 # 4 B 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 596 ARG A 76 ARG^? 8.97 OXT ACT A 203 B 647 ARG A 33 ARG.? 12.39 O ACT A 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 34.24 60.89 68.08 33.31 57.93 67.63 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 31.43 57.38 61.97 31.90 55.58 64.41 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 5 3 # 5 B 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 596 ARG A 76 ARG^? 8.97 OXT ACT A 203 B 647 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 34.24 60.89 68.08 33.31 57.93 67.63 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 31.43 57.38 61.97 31.90 55.58 64.41 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 6 3 # 6 B 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 596 ARG A 106 ARG^? 14.48 O1 EDO A 301 B 647 ARG B 49 ARG^? 10.37 O ACT B 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 34.24 60.89 68.08 33.31 57.93 67.63 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 31.43 57.38 61.97 31.90 55.58 64.41 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 7 3 # 7 B 581 GLU A 114 GLU^? 11.87 CH3 ACT A 202 B 596 ARG A 88 ARG^? 11.13 CH3 ACT A 202 B 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 38.22 57.83 70.36 36.82 56.74 69.18 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 34.24 60.89 68.08 33.31 57.93 67.63 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 31.43 57.38 61.97 31.90 55.58 64.41 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 8 3 # 8 B 581 GLU A 114 GLU^? 11.87 CH3 ACT A 202 B 596 ARG A 123 ARG.? 8.27 CH3 ACT A 202 B 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 38.22 57.83 70.36 36.82 56.74 69.18 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 34.24 60.89 68.08 33.31 57.93 67.63 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 31.43 57.38 61.97 31.90 55.58 64.41 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 9 3 # 9 B 581 GLU B 27 GLU~? 9.83 CH3 ACT B 201 B 596 ARG B 147 ARG.? 12.52 CH3 ACT A 202 B 647 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 34.24 60.89 68.08 33.31 57.93 67.63 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 31.43 57.38 61.97 31.90 55.58 64.41 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 10 3 # 10 B 581 GLU B 80 GLU^? 7.87 CH3 ACT A 202 B 596 ARG B 92 ARG^? -3.69 CH3 ACT A 202s B 647 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo 38.22 57.83 70.36 36.82 56.74 69.18 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 34.24 60.89 68.08 33.31 57.93 67.63 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 31.43 57.38 61.97 31.90 55.58 64.41 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 11 3 # 11 B 581 GLU B 80 GLU^? 7.87 CH3 ACT A 202 B 596 ARG B 92 ARG^? -3.69 CH3 ACT A 202s B 647 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 38.22 57.83 70.36 36.82 56.74 69.18 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 34.24 60.89 68.08 33.31 57.93 67.63 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 31.43 57.38 61.97 31.90 55.58 64.41 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 12 3 # 12 B 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 596 ARG B 76 ARG^? 14.33 OXT ACT B 201 B 647 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 34.24 60.89 68.08 33.31 57.93 67.63 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 31.43 57.38 61.97 31.90 55.58 64.41 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 13 3 # 13 B 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 596 ARG B 76 ARG^? 14.33 OXT ACT B 201 B 647 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo 38.22 57.83 70.36 36.82 56.74 69.18 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 34.24 60.89 68.08 33.31 57.93 67.63 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 31.43 57.38 61.97 31.90 55.58 64.41 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 14 3 # 14 B 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 596 ARG B 106 ARG^? 5.91 C1 EDO A 302 B 647 ARG A 49 ARG^? -3.92 O ACT A 202s coo 38.22 57.83 70.36 36.82 56.74 69.18 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 34.24 60.89 68.08 33.31 57.93 67.63 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 31.43 57.38 61.97 31.90 55.58 64.41 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 15 3 # 15 B 581 GLU B 114 GLU^? 18.04 O ACT B 201 B 596 ARG B 88 ARG^? 18.43 CH3 ACT A 201 B 647 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 34.24 60.89 68.08 33.31 57.93 67.63 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 31.43 57.38 61.97 31.90 55.58 64.41 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 16 3 # 16 B 581 GLU B 114 GLU^? 18.04 O ACT B 201 B 596 ARG B 123 ARG.? 17.76 O ACT B 201 B 647 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 34.24 60.89 68.08 33.31 57.93 67.63 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 31.43 57.38 61.97 31.90 55.58 64.41 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 17 3 # 17 B 581 GLU B 160 GLU.? 4.71 OXT ACT A 202 B 596 ARG A 123 ARG.? 8.27 CH3 ACT A 202 B 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 38.22 57.83 70.36 36.82 56.74 69.18 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 34.24 60.89 68.08 33.31 57.93 67.63 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 31.43 57.38 61.97 31.90 55.58 64.41 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 18 3 # 18 B 581 GLU C 27 GLU~? 9.88 CH3 ACT C 201 B 596 ARG C 147 ARG.? 13.23 CH3 ACT C 201 B 647 ARG C 76 ARG^? 14.32 O ACT C 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 34.24 60.89 68.08 33.31 57.93 67.63 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 31.43 57.38 61.97 31.90 55.58 64.41 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 19 3 # 19 B 581 GLU C 80 GLU^? 14.47 CH3 ACT C 201 B 596 ARG C 92 ARG^? 13.71 CH3 ACT C 201 B 647 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 34.24 60.89 68.08 33.31 57.93 67.63 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 31.43 57.38 61.97 31.90 55.58 64.41 -52.23 44.53 37.75 -52.43 42.56 40.08 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 20 3 # 20 B 581 GLU C 80 GLU^? 14.47 CH3 ACT C 201 B 596 ARG C 92 ARG^? 13.71 CH3 ACT C 201 B 647 ARG D 123 ARG.? 17.60 O ACT D 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 34.24 60.89 68.08 33.31 57.93 67.63 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 31.43 57.38 61.97 31.90 55.58 64.41 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 21 3 # 21 B 581 GLU C 96 GLU^? 13.00 O ACT C 201 B 596 ARG C 76 ARG^? 14.32 O ACT C 201 B 647 ARG C 33 ARG.? 12.41 O ACT C 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 34.24 60.89 68.08 33.31 57.93 67.63 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 31.43 57.38 61.97 31.90 55.58 64.41 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 22 3 # 22 B 581 GLU C 96 GLU^? 13.00 O ACT C 201 B 596 ARG C 76 ARG^? 14.32 O ACT C 201 B 647 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 34.24 60.89 68.08 33.31 57.93 67.63 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 31.43 57.38 61.97 31.90 55.58 64.41 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 23 3 # 23 B 581 GLU C 96 GLU^? 13.00 O ACT C 201 B 596 ARG C 106 ARG^? 14.47 O2 EDO A 301 B 647 ARG D 49 ARG^? 10.44 O ACT D 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 34.24 60.89 68.08 33.31 57.93 67.63 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 31.43 57.38 61.97 31.90 55.58 64.41 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 24 3 # 24 B 581 GLU C 114 GLU^? 18.18 OXT ACT C 201 B 596 ARG C 88 ARG^? 18.42 CH3 ACT D 201 B 647 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 34.24 60.89 68.08 33.31 57.93 67.63 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 31.43 57.38 61.97 31.90 55.58 64.41 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 25 3 # 25 B 581 GLU C 114 GLU^? 18.18 OXT ACT C 201 B 596 ARG C 123 ARG.? 17.68 OXT ACT C 201 B 647 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 34.24 60.89 68.08 33.31 57.93 67.63 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 31.43 57.38 61.97 31.90 55.58 64.41 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 26 3 # 26 B 581 GLU D 27 GLU~? 9.75 CH3 ACT D 201 B 596 ARG D 147 ARG.? 13.02 CH3 ACT D 201 B 647 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 34.24 60.89 68.08 33.31 57.93 67.63 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 31.43 57.38 61.97 31.90 55.58 64.41 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 27 3 # 27 B 581 GLU D 80 GLU^? 14.49 CH3 ACT D 201 B 596 ARG D 92 ARG^? 13.56 CH3 ACT D 201 B 647 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 34.24 60.89 68.08 33.31 57.93 67.63 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 31.43 57.38 61.97 31.90 55.58 64.41 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 28 3 # 28 B 581 GLU D 80 GLU^? 14.49 CH3 ACT D 201 B 596 ARG D 92 ARG^? 13.56 CH3 ACT D 201 B 647 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 34.24 60.89 68.08 33.31 57.93 67.63 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 31.43 57.38 61.97 31.90 55.58 64.41 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 29 3 # 29 B 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 596 ARG D 76 ARG^? 14.20 OXT ACT D 201 B 647 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 34.24 60.89 68.08 33.31 57.93 67.63 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 31.43 57.38 61.97 31.90 55.58 64.41 -55.21 72.58 39.53 -56.74 74.11 37.37 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 30 3 # 30 B 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 596 ARG D 76 ARG^? 14.20 OXT ACT D 201 B 647 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 34.24 60.89 68.08 33.31 57.93 67.63 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 31.43 57.38 61.97 31.90 55.58 64.41 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 31 3 # 31 B 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 596 ARG D 106 ARG^? 14.88 OXT ACT D 201 B 647 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 34.24 60.89 68.08 33.31 57.93 67.63 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 31.43 57.38 61.97 31.90 55.58 64.41 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 32 3 # 32 B 581 GLU D 114 GLU^? 18.05 O ACT D 201 B 596 ARG D 88 ARG^? 18.35 CH3 ACT C 201 B 647 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 34.24 60.89 68.08 33.31 57.93 67.63 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 31.43 57.38 61.97 31.90 55.58 64.41 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 33 3 # 33 B 581 GLU D 114 GLU^? 18.05 O ACT D 201 B 596 ARG D 123 ARG.? 17.60 O ACT D 201 B 647 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 38.22 57.83 70.36 36.82 56.74 69.18 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 34.24 60.89 68.08 33.31 57.93 67.63 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 31.43 57.38 61.97 31.90 55.58 64.41 -49.94 47.28 44.16 -51.45 46.27 46.66 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 33 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 27 GLU~? 9.74 CH3 ACT A 201 C 596 ARG A 147 ARG.? 13.06 CH3 ACT A 201 C 647 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 11.31 31.26 27.00 13.31 30.71 26.58 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 13.44 32.78 22.07 15.56 30.91 23.37 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 21.00 33.35 22.82 19.83 30.82 24.09 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU A 80 GLU^? 14.51 CH3 ACT A 201 C 596 ARG A 92 ARG^? 14.09 CH3 ACT A 201 C 647 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 13.44 32.78 22.07 15.56 30.91 23.37 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 21.00 33.35 22.82 19.83 30.82 24.09 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU A 80 GLU^? 14.51 CH3 ACT A 201 C 596 ARG A 92 ARG^? 14.09 CH3 ACT A 201 C 647 ARG B 123 ARG.? 17.76 O ACT B 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 13.44 32.78 22.07 15.56 30.91 23.37 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 21.00 33.35 22.82 19.83 30.82 24.09 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 4 3 # 4 C 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 C 596 ARG A 76 ARG^? 8.97 OXT ACT A 203 C 647 ARG A 33 ARG.? 12.39 O ACT A 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 13.44 32.78 22.07 15.56 30.91 23.37 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 21.00 33.35 22.82 19.83 30.82 24.09 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 5 3 # 5 C 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 C 596 ARG A 76 ARG^? 8.97 OXT ACT A 203 C 647 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 13.44 32.78 22.07 15.56 30.91 23.37 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 21.00 33.35 22.82 19.83 30.82 24.09 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 6 3 # 6 C 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 C 596 ARG A 106 ARG^? 14.48 O1 EDO A 301 C 647 ARG B 49 ARG^? 10.37 O ACT B 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 13.44 32.78 22.07 15.56 30.91 23.37 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 21.00 33.35 22.82 19.83 30.82 24.09 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 7 3 # 7 C 581 GLU A 114 GLU^? 11.87 CH3 ACT A 202 C 596 ARG A 88 ARG^? 11.13 CH3 ACT A 202 C 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 11.31 31.26 27.00 13.31 30.71 26.58 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 13.44 32.78 22.07 15.56 30.91 23.37 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 21.00 33.35 22.82 19.83 30.82 24.09 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 8 3 # 8 C 581 GLU A 114 GLU^? 11.87 CH3 ACT A 202 C 596 ARG A 123 ARG.? 8.27 CH3 ACT A 202 C 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 11.31 31.26 27.00 13.31 30.71 26.58 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 13.44 32.78 22.07 15.56 30.91 23.37 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 21.00 33.35 22.82 19.83 30.82 24.09 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 9 3 # 9 C 581 GLU B 27 GLU~? 9.83 CH3 ACT B 201 C 596 ARG B 147 ARG.? 12.52 CH3 ACT A 202 C 647 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 13.44 32.78 22.07 15.56 30.91 23.37 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 21.00 33.35 22.82 19.83 30.82 24.09 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 10 3 # 10 C 581 GLU B 80 GLU^? 7.87 CH3 ACT A 202 C 596 ARG B 92 ARG^? -3.69 CH3 ACT A 202s C 647 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo 11.31 31.26 27.00 13.31 30.71 26.58 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 13.44 32.78 22.07 15.56 30.91 23.37 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 21.00 33.35 22.82 19.83 30.82 24.09 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 11 3 # 11 C 581 GLU B 80 GLU^? 7.87 CH3 ACT A 202 C 596 ARG B 92 ARG^? -3.69 CH3 ACT A 202s C 647 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 11.31 31.26 27.00 13.31 30.71 26.58 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 13.44 32.78 22.07 15.56 30.91 23.37 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 21.00 33.35 22.82 19.83 30.82 24.09 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 12 3 # 12 C 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 C 596 ARG B 76 ARG^? 14.33 OXT ACT B 201 C 647 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 13.44 32.78 22.07 15.56 30.91 23.37 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 21.00 33.35 22.82 19.83 30.82 24.09 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 13 3 # 13 C 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 C 596 ARG B 76 ARG^? 14.33 OXT ACT B 201 C 647 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo 11.31 31.26 27.00 13.31 30.71 26.58 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 13.44 32.78 22.07 15.56 30.91 23.37 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 21.00 33.35 22.82 19.83 30.82 24.09 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 14 3 # 14 C 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 C 596 ARG B 106 ARG^? 5.91 C1 EDO A 302 C 647 ARG A 49 ARG^? -3.92 O ACT A 202s coo 11.31 31.26 27.00 13.31 30.71 26.58 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 13.44 32.78 22.07 15.56 30.91 23.37 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 21.00 33.35 22.82 19.83 30.82 24.09 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 15 3 # 15 C 581 GLU B 114 GLU^? 18.04 O ACT B 201 C 596 ARG B 88 ARG^? 18.43 CH3 ACT A 201 C 647 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 13.44 32.78 22.07 15.56 30.91 23.37 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 21.00 33.35 22.82 19.83 30.82 24.09 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 16 3 # 16 C 581 GLU B 114 GLU^? 18.04 O ACT B 201 C 596 ARG B 123 ARG.? 17.76 O ACT B 201 C 647 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 13.44 32.78 22.07 15.56 30.91 23.37 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 21.00 33.35 22.82 19.83 30.82 24.09 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 17 3 # 17 C 581 GLU B 160 GLU.? 4.71 OXT ACT A 202 C 596 ARG A 49 ARG^? -3.92 O ACT A 202s C 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 11.31 31.26 27.00 13.31 30.71 26.58 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 13.44 32.78 22.07 15.56 30.91 23.37 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 21.00 33.35 22.82 19.83 30.82 24.09 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 18 3 # 18 C 581 GLU B 160 GLU.? 4.71 OXT ACT A 202 C 596 ARG A 49 ARG^? -3.92 O ACT A 202s C 647 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 11.31 31.26 27.00 13.31 30.71 26.58 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 13.44 32.78 22.07 15.56 30.91 23.37 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 21.00 33.35 22.82 19.83 30.82 24.09 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 19 3 # 19 C 581 GLU B 160 GLU.? 4.71 OXT ACT A 202 C 596 ARG A 123 ARG.? 8.27 CH3 ACT A 202 C 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 11.31 31.26 27.00 13.31 30.71 26.58 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 13.44 32.78 22.07 15.56 30.91 23.37 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 21.00 33.35 22.82 19.83 30.82 24.09 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 20 3 # 20 C 581 GLU C 27 GLU~? 9.88 CH3 ACT C 201 C 596 ARG C 147 ARG.? 13.23 CH3 ACT C 201 C 647 ARG C 76 ARG^? 14.32 O ACT C 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 13.44 32.78 22.07 15.56 30.91 23.37 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 21.00 33.35 22.82 19.83 30.82 24.09 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 21 3 # 21 C 581 GLU C 80 GLU^? 14.47 CH3 ACT C 201 C 596 ARG C 92 ARG^? 13.71 CH3 ACT C 201 C 647 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 13.44 32.78 22.07 15.56 30.91 23.37 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 21.00 33.35 22.82 19.83 30.82 24.09 -52.23 44.53 37.75 -52.43 42.56 40.08 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 22 3 # 22 C 581 GLU C 80 GLU^? 14.47 CH3 ACT C 201 C 596 ARG C 92 ARG^? 13.71 CH3 ACT C 201 C 647 ARG D 123 ARG.? 17.60 O ACT D 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 13.44 32.78 22.07 15.56 30.91 23.37 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 21.00 33.35 22.82 19.83 30.82 24.09 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 23 3 # 23 C 581 GLU C 96 GLU^? 13.00 O ACT C 201 C 596 ARG C 76 ARG^? 14.32 O ACT C 201 C 647 ARG C 33 ARG.? 12.41 O ACT C 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 13.44 32.78 22.07 15.56 30.91 23.37 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 21.00 33.35 22.82 19.83 30.82 24.09 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 24 3 # 24 C 581 GLU C 96 GLU^? 13.00 O ACT C 201 C 596 ARG C 76 ARG^? 14.32 O ACT C 201 C 647 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 13.44 32.78 22.07 15.56 30.91 23.37 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 21.00 33.35 22.82 19.83 30.82 24.09 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 25 3 # 25 C 581 GLU C 96 GLU^? 13.00 O ACT C 201 C 596 ARG C 106 ARG^? 14.47 O2 EDO A 301 C 647 ARG D 49 ARG^? 10.44 O ACT D 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 13.44 32.78 22.07 15.56 30.91 23.37 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 21.00 33.35 22.82 19.83 30.82 24.09 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 26 3 # 26 C 581 GLU C 114 GLU^? 18.18 OXT ACT C 201 C 596 ARG C 88 ARG^? 18.42 CH3 ACT D 201 C 647 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 13.44 32.78 22.07 15.56 30.91 23.37 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 21.00 33.35 22.82 19.83 30.82 24.09 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 27 3 # 27 C 581 GLU C 114 GLU^? 18.18 OXT ACT C 201 C 596 ARG C 123 ARG.? 17.68 OXT ACT C 201 C 647 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 13.44 32.78 22.07 15.56 30.91 23.37 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 21.00 33.35 22.82 19.83 30.82 24.09 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 28 3 # 28 C 581 GLU D 27 GLU~? 9.75 CH3 ACT D 201 C 596 ARG D 147 ARG.? 13.02 CH3 ACT D 201 C 647 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 13.44 32.78 22.07 15.56 30.91 23.37 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 21.00 33.35 22.82 19.83 30.82 24.09 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 29 3 # 29 C 581 GLU D 80 GLU^? 14.49 CH3 ACT D 201 C 596 ARG D 92 ARG^? 13.56 CH3 ACT D 201 C 647 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 13.44 32.78 22.07 15.56 30.91 23.37 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 21.00 33.35 22.82 19.83 30.82 24.09 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 30 3 # 30 C 581 GLU D 80 GLU^? 14.49 CH3 ACT D 201 C 596 ARG D 92 ARG^? 13.56 CH3 ACT D 201 C 647 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 13.44 32.78 22.07 15.56 30.91 23.37 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 21.00 33.35 22.82 19.83 30.82 24.09 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 31 3 # 31 C 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 C 596 ARG D 76 ARG^? 14.20 OXT ACT D 201 C 647 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 13.44 32.78 22.07 15.56 30.91 23.37 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 21.00 33.35 22.82 19.83 30.82 24.09 -55.21 72.58 39.53 -56.74 74.11 37.37 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 32 3 # 32 C 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 C 596 ARG D 76 ARG^? 14.20 OXT ACT D 201 C 647 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 13.44 32.78 22.07 15.56 30.91 23.37 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 21.00 33.35 22.82 19.83 30.82 24.09 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 33 3 # 33 C 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 C 596 ARG D 106 ARG^? 14.88 OXT ACT D 201 C 647 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 13.44 32.78 22.07 15.56 30.91 23.37 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 21.00 33.35 22.82 19.83 30.82 24.09 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 34 3 # 34 C 581 GLU D 114 GLU^? 18.05 O ACT D 201 C 596 ARG D 88 ARG^? 18.35 CH3 ACT C 201 C 647 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 13.44 32.78 22.07 15.56 30.91 23.37 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 21.00 33.35 22.82 19.83 30.82 24.09 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 35 3 # 35 C 581 GLU D 114 GLU^? 18.05 O ACT D 201 C 596 ARG D 123 ARG.? 17.60 O ACT D 201 C 647 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 11.31 31.26 27.00 13.31 30.71 26.58 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 13.44 32.78 22.07 15.56 30.91 23.37 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 21.00 33.35 22.82 19.83 30.82 24.09 -49.94 47.28 44.16 -51.45 46.27 46.66 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 35 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 27 GLU~? 9.74 CH3 ACT A 201 D 596 ARG A 147 ARG.? 13.06 CH3 ACT A 201 D 647 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -34.88 77.89 68.90 -36.12 78.93 70.26 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -40.14 80.19 70.35 -38.27 80.75 72.73 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU A 80 GLU^? 14.51 CH3 ACT A 201 D 596 ARG A 92 ARG^? 14.09 CH3 ACT A 201 D 647 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -35.46 76.50 78.57 -37.32 76.28 79.54 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU A 80 GLU^? 14.51 CH3 ACT A 201 D 596 ARG A 92 ARG^? 14.09 CH3 ACT A 201 D 647 ARG B 123 ARG.? 17.76 O ACT B 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -35.46 76.50 78.57 -37.32 76.28 79.54 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 4 3 # 4 D 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 D 596 ARG A 76 ARG^? 8.97 OXT ACT A 203 D 647 ARG A 33 ARG.? 12.39 O ACT A 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -44.74 70.71 67.91 -46.53 71.68 68.48 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 5 3 # 5 D 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 D 596 ARG A 76 ARG^? 8.97 OXT ACT A 203 D 647 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -44.74 70.71 67.91 -46.53 71.68 68.48 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 6 3 # 6 D 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 D 596 ARG A 106 ARG^? 14.48 O1 EDO A 301 D 647 ARG B 49 ARG^? 10.37 O ACT B 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -44.74 70.71 67.91 -46.53 71.68 68.48 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -44.60 68.65 71.93 -47.65 68.54 71.92 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 7 3 # 7 D 581 GLU A 114 GLU^? 11.87 CH3 ACT A 202 D 596 ARG A 88 ARG^? 11.13 CH3 ACT A 202 D 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -17.01 70.06 74.63 -16.05 68.26 75.13 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -18.98 69.22 79.04 -17.48 66.59 79.46 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 8 3 # 8 D 581 GLU A 114 GLU^? 11.87 CH3 ACT A 202 D 596 ARG A 123 ARG.? 8.27 CH3 ACT A 202 D 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -17.01 70.06 74.63 -16.05 68.26 75.13 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -16.75 65.40 71.93 -16.81 64.50 74.86 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 9 3 # 9 D 581 GLU B 27 GLU~? 9.83 CH3 ACT B 201 D 596 ARG B 147 ARG.? 12.52 CH3 ACT A 202 D 647 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -24.11 53.46 86.45 -22.04 53.54 86.08 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -19.28 50.88 84.48 -18.42 53.72 85.30 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 10 3 # 10 D 581 GLU B 80 GLU^? 7.87 CH3 ACT A 202 D 596 ARG B 92 ARG^? -3.69 CH3 ACT A 202s D 647 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -19.12 60.55 81.96 -17.78 60.17 80.39 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 11 3 # 11 D 581 GLU B 80 GLU^? 7.87 CH3 ACT A 202 D 596 ARG B 92 ARG^? -3.69 CH3 ACT A 202s D 647 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -19.12 60.55 81.96 -17.78 60.17 80.39 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 12 3 # 12 D 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 D 596 ARG B 76 ARG^? 14.33 OXT ACT B 201 D 647 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -24.44 47.78 75.39 -22.51 46.98 75.05 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 13 3 # 13 D 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 D 596 ARG B 76 ARG^? 14.33 OXT ACT B 201 D 647 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -24.44 47.78 75.39 -22.51 46.98 75.05 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 14 3 # 14 D 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 D 596 ARG B 106 ARG^? 5.91 C1 EDO A 302 D 647 ARG A 49 ARG^? -3.92 O ACT A 202s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -24.44 47.78 75.39 -22.51 46.98 75.05 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 15 3 # 15 D 581 GLU B 114 GLU^? 18.04 O ACT B 201 D 596 ARG B 88 ARG^? 18.43 CH3 ACT A 201 D 647 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -34.74 70.41 89.54 -36.11 71.74 88.69 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -31.74 72.75 86.26 -33.87 74.56 85.05 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 16 3 # 16 D 581 GLU B 114 GLU^? 18.04 O ACT B 201 D 596 ARG B 123 ARG.? 17.76 O ACT B 201 D 647 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -34.74 70.41 89.54 -36.11 71.74 88.69 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -38.78 69.90 87.63 -38.44 71.99 85.40 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 17 3 # 17 D 581 GLU B 160 GLU.? 4.71 OXT ACT A 202 D 596 ARG A 123 ARG.? 8.27 CH3 ACT A 202 D 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -17.96 60.58 68.89 -19.86 60.60 67.97 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -16.75 65.40 71.93 -16.81 64.50 74.86 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 18 3 # 18 D 581 GLU C 27 GLU~? 9.88 CH3 ACT C 201 D 596 ARG C 147 ARG.? 13.23 CH3 ACT C 201 D 647 ARG C 76 ARG^? 14.32 O ACT C 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -40.23 39.97 50.79 -41.89 38.66 50.83 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -44.23 36.97 53.78 -44.90 36.38 50.84 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 19 3 # 19 D 581 GLU C 80 GLU^? 14.47 CH3 ACT C 201 D 596 ARG C 92 ARG^? 13.71 CH3 ACT C 201 D 647 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -48.24 40.72 45.31 -50.16 40.73 46.15 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -52.23 44.53 37.75 -52.43 42.56 40.08 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 20 3 # 20 D 581 GLU C 80 GLU^? 14.47 CH3 ACT C 201 D 596 ARG C 92 ARG^? 13.71 CH3 ACT C 201 D 647 ARG D 123 ARG.? 17.60 O ACT D 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -48.24 40.72 45.31 -50.16 40.73 46.15 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 21 3 # 21 D 581 GLU C 96 GLU^? 13.00 O ACT C 201 D 596 ARG C 76 ARG^? 14.32 O ACT C 201 D 647 ARG C 33 ARG.? 12.41 O ACT C 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -46.59 45.81 59.59 -47.94 44.44 60.43 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -42.25 40.39 61.14 -41.06 40.24 63.98 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 22 3 # 22 D 581 GLU C 96 GLU^? 13.00 O ACT C 201 D 596 ARG C 76 ARG^? 14.32 O ACT C 201 D 647 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -46.59 45.81 59.59 -47.94 44.44 60.43 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -42.25 40.39 61.14 -41.06 40.24 63.98 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 23 3 # 23 D 581 GLU C 96 GLU^? 13.00 O ACT C 201 D 596 ARG C 106 ARG^? 14.47 O2 EDO A 301 D 647 ARG D 49 ARG^? 10.44 O ACT D 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -46.59 45.81 59.59 -47.94 44.44 60.43 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -49.78 47.48 57.01 -51.73 47.13 59.31 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 24 3 # 24 D 581 GLU C 114 GLU^? 18.18 OXT ACT C 201 D 596 ARG C 88 ARG^? 18.42 CH3 ACT D 201 D 647 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -34.62 49.81 33.93 -34.65 51.69 32.98 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -39.31 50.22 32.74 -39.14 52.99 31.45 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 25 3 # 25 D 581 GLU C 114 GLU^? 18.18 OXT ACT C 201 D 596 ARG C 123 ARG.? 17.68 OXT ACT C 201 D 647 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -34.62 49.81 33.93 -34.65 51.69 32.98 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -33.35 53.49 35.15 -35.34 55.60 34.14 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 26 3 # 26 D 581 GLU D 27 GLU~? 9.75 CH3 ACT D 201 D 596 ARG D 147 ARG.? 13.02 CH3 ACT D 201 D 647 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -50.66 64.65 33.24 -49.08 64.98 31.89 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -46.62 68.18 31.08 -46.22 65.54 29.55 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 27 3 # 27 D 581 GLU D 80 GLU^? 14.49 CH3 ACT D 201 D 596 ARG D 92 ARG^? 13.56 CH3 ACT D 201 D 647 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -42.96 58.73 31.72 -40.96 59.40 31.80 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 28 3 # 28 D 581 GLU D 80 GLU^? 14.49 CH3 ACT D 201 D 596 ARG D 92 ARG^? 13.56 CH3 ACT D 201 D 647 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -42.96 58.73 31.72 -40.96 59.40 31.80 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 29 3 # 29 D 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 D 596 ARG D 76 ARG^? 14.20 OXT ACT D 201 D 647 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -43.29 70.99 40.99 -41.92 72.19 39.92 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -47.81 74.29 36.53 -48.87 77.02 37.43 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -55.21 72.58 39.53 -56.74 74.11 37.37 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 30 3 # 30 D 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 D 596 ARG D 76 ARG^? 14.20 OXT ACT D 201 D 647 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -43.29 70.99 40.99 -41.92 72.19 39.92 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -47.81 74.29 36.53 -48.87 77.02 37.43 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 31 3 # 31 D 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 D 596 ARG D 106 ARG^? 14.88 OXT ACT D 201 D 647 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -43.29 70.99 40.99 -41.92 72.19 39.92 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 32 3 # 32 D 581 GLU D 114 GLU^? 18.05 O ACT D 201 D 596 ARG D 88 ARG^? 18.35 CH3 ACT C 201 D 647 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -56.92 45.97 38.27 -56.84 44.55 39.82 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -52.23 44.53 37.75 -52.43 42.56 40.08 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 33 3 # 33 D 581 GLU D 114 GLU^? 18.05 O ACT D 201 D 596 ARG D 123 ARG.? 17.60 O ACT D 201 D 647 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -56.92 45.97 38.27 -56.84 44.55 39.82 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -58.14 46.42 43.58 -55.81 44.43 43.54 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -49.94 47.28 44.16 -51.45 46.27 46.66 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 33 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 27 GLU~? 9.74 CH3 ACT A 201 E 596 ARG A 147 ARG.? 13.06 CH3 ACT A 201 E 647 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU A 80 GLU^? 14.51 CH3 ACT A 201 E 596 ARG A 92 ARG^? 14.09 CH3 ACT A 201 E 647 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU A 80 GLU^? 14.51 CH3 ACT A 201 E 596 ARG A 92 ARG^? 14.09 CH3 ACT A 201 E 647 ARG B 123 ARG.? 17.76 O ACT B 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 4 3 # 4 E 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 E 596 ARG A 76 ARG^? 8.97 OXT ACT A 203 E 647 ARG A 33 ARG.? 12.39 O ACT A 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 5 3 # 5 E 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 E 596 ARG A 76 ARG^? 8.97 OXT ACT A 203 E 647 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 6 3 # 6 E 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 E 596 ARG A 106 ARG^? 14.48 O1 EDO A 301 E 647 ARG B 49 ARG^? 10.37 O ACT B 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 7 3 # 7 E 581 GLU A 114 GLU^? 11.87 CH3 ACT A 202 E 596 ARG A 88 ARG^? 11.13 CH3 ACT A 202 E 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 8 3 # 8 E 581 GLU A 114 GLU^? 11.87 CH3 ACT A 202 E 596 ARG A 123 ARG.? 8.27 CH3 ACT A 202 E 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 9 3 # 9 E 581 GLU B 27 GLU~? 9.83 CH3 ACT B 201 E 596 ARG B 147 ARG.? 12.52 CH3 ACT A 202 E 647 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 10 3 # 10 E 581 GLU B 80 GLU^? 7.87 CH3 ACT A 202 E 596 ARG B 92 ARG^? -3.69 CH3 ACT A 202s E 647 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 11 3 # 11 E 581 GLU B 80 GLU^? 7.87 CH3 ACT A 202 E 596 ARG B 92 ARG^? -3.69 CH3 ACT A 202s E 647 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 12 3 # 12 E 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 E 596 ARG B 76 ARG^? 14.33 OXT ACT B 201 E 647 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 13 3 # 13 E 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 E 596 ARG B 76 ARG^? 14.33 OXT ACT B 201 E 647 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 14 3 # 14 E 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 E 596 ARG B 106 ARG^? 5.91 C1 EDO A 302 E 647 ARG A 49 ARG^? -3.92 O ACT A 202s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 15 3 # 15 E 581 GLU B 114 GLU^? 18.04 O ACT B 201 E 596 ARG B 88 ARG^? 18.43 CH3 ACT A 201 E 647 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 16 3 # 16 E 581 GLU B 114 GLU^? 18.04 O ACT B 201 E 596 ARG B 123 ARG.? 17.76 O ACT B 201 E 647 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 17 3 # 17 E 581 GLU B 160 GLU.? 4.71 OXT ACT A 202 E 596 ARG A 123 ARG.? 8.27 CH3 ACT A 202 E 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 18 3 # 18 E 581 GLU C 27 GLU~? 9.88 CH3 ACT C 201 E 596 ARG C 147 ARG.? 13.23 CH3 ACT C 201 E 647 ARG C 76 ARG^? 14.32 O ACT C 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 19 3 # 19 E 581 GLU C 80 GLU^? 14.47 CH3 ACT C 201 E 596 ARG C 92 ARG^? 13.71 CH3 ACT C 201 E 647 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -52.23 44.53 37.75 -52.43 42.56 40.08 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 20 3 # 20 E 581 GLU C 80 GLU^? 14.47 CH3 ACT C 201 E 596 ARG C 92 ARG^? 13.71 CH3 ACT C 201 E 647 ARG D 123 ARG.? 17.60 O ACT D 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 21 3 # 21 E 581 GLU C 96 GLU^? 13.00 O ACT C 201 E 596 ARG C 76 ARG^? 14.32 O ACT C 201 E 647 ARG C 33 ARG.? 12.41 O ACT C 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 22 3 # 22 E 581 GLU C 96 GLU^? 13.00 O ACT C 201 E 596 ARG C 76 ARG^? 14.32 O ACT C 201 E 647 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 23 3 # 23 E 581 GLU C 96 GLU^? 13.00 O ACT C 201 E 596 ARG C 106 ARG^? 14.47 O2 EDO A 301 E 647 ARG D 49 ARG^? 10.44 O ACT D 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 24 3 # 24 E 581 GLU C 114 GLU^? 18.18 OXT ACT C 201 E 596 ARG C 88 ARG^? 18.42 CH3 ACT D 201 E 647 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 25 3 # 25 E 581 GLU C 114 GLU^? 18.18 OXT ACT C 201 E 596 ARG C 123 ARG.? 17.68 OXT ACT C 201 E 647 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 26 3 # 26 E 581 GLU D 27 GLU~? 9.75 CH3 ACT D 201 E 596 ARG D 147 ARG.? 13.02 CH3 ACT D 201 E 647 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 27 3 # 27 E 581 GLU D 80 GLU^? 14.49 CH3 ACT D 201 E 596 ARG D 92 ARG^? 13.56 CH3 ACT D 201 E 647 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 28 3 # 28 E 581 GLU D 80 GLU^? 14.49 CH3 ACT D 201 E 596 ARG D 92 ARG^? 13.56 CH3 ACT D 201 E 647 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 29 3 # 29 E 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 E 596 ARG D 76 ARG^? 14.20 OXT ACT D 201 E 647 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -55.21 72.58 39.53 -56.74 74.11 37.37 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 30 3 # 30 E 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 E 596 ARG D 76 ARG^? 14.20 OXT ACT D 201 E 647 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 31 3 # 31 E 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 E 596 ARG D 106 ARG^? 14.88 OXT ACT D 201 E 647 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 32 3 # 32 E 581 GLU D 114 GLU^? 18.05 O ACT D 201 E 596 ARG D 88 ARG^? 18.35 CH3 ACT C 201 E 647 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 33 3 # 33 E 581 GLU D 114 GLU^? 18.05 O ACT D 201 E 596 ARG D 123 ARG.? 17.60 O ACT D 201 E 647 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -58.14 46.42 43.58 -55.81 44.43 43.54 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -49.94 47.28 44.16 -51.45 46.27 46.66 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 33 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 27 GLU~? 9.74 CH3 ACT A 201 F 596 ARG A 147 ARG.? 13.06 CH3 ACT A 201 F 647 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -34.88 77.89 68.90 -36.12 78.93 70.26 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -40.14 80.19 70.35 -38.27 80.75 72.73 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU A 80 GLU^? 14.51 CH3 ACT A 201 F 596 ARG A 92 ARG^? 14.09 CH3 ACT A 201 F 647 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -35.46 76.50 78.57 -37.32 76.28 79.54 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 3 3 # 3 F 581 GLU A 80 GLU^? 14.51 CH3 ACT A 201 F 596 ARG A 92 ARG^? 14.09 CH3 ACT A 201 F 647 ARG B 123 ARG.? 17.76 O ACT B 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -35.46 76.50 78.57 -37.32 76.28 79.54 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 4 3 # 4 F 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 F 596 ARG A 76 ARG^? 8.97 OXT ACT A 203 F 647 ARG A 33 ARG.? 12.39 O ACT A 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -44.74 70.71 67.91 -46.53 71.68 68.48 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 5 3 # 5 F 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 F 596 ARG A 76 ARG^? 8.97 OXT ACT A 203 F 647 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -44.74 70.71 67.91 -46.53 71.68 68.48 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 6 3 # 6 F 581 GLU A 96 GLU^? 11.70 OXT ACT A 203 F 596 ARG A 106 ARG^? 14.48 O1 EDO A 301 F 647 ARG B 49 ARG^? 10.37 O ACT B 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -44.74 70.71 67.91 -46.53 71.68 68.48 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -44.60 68.65 71.93 -47.65 68.54 71.92 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 7 3 # 7 F 581 GLU A 114 GLU^? 11.87 CH3 ACT A 202 F 596 ARG A 88 ARG^? 11.13 CH3 ACT A 202 F 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -17.01 70.06 74.63 -16.05 68.26 75.13 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -18.98 69.22 79.04 -17.48 66.59 79.46 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 8 3 # 8 F 581 GLU A 114 GLU^? 11.87 CH3 ACT A 202 F 596 ARG A 123 ARG.? 8.27 CH3 ACT A 202 F 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -17.01 70.06 74.63 -16.05 68.26 75.13 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -16.75 65.40 71.93 -16.81 64.50 74.86 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 9 3 # 9 F 581 GLU B 27 GLU~? 9.83 CH3 ACT B 201 F 596 ARG B 147 ARG.? 12.52 CH3 ACT A 202 F 647 ARG B 76 ARG^? 14.33 OXT ACT B 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -24.11 53.46 86.45 -22.04 53.54 86.08 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -19.28 50.88 84.48 -18.42 53.72 85.30 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -23.34 44.19 81.38 -24.15 41.23 81.47 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 10 3 # 10 F 581 GLU B 80 GLU^? 7.87 CH3 ACT A 202 F 596 ARG B 92 ARG^? -3.69 CH3 ACT A 202s F 647 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -19.12 60.55 81.96 -17.78 60.17 80.39 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 11 3 # 11 F 581 GLU B 80 GLU^? 7.87 CH3 ACT A 202 F 596 ARG B 92 ARG^? -3.69 CH3 ACT A 202s F 647 ARG A 123 ARG.? 8.27 CH3 ACT A 202 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -19.12 60.55 81.96 -17.78 60.17 80.39 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -16.75 65.40 71.93 -16.81 64.50 74.86 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 12 3 # 12 F 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 F 596 ARG B 76 ARG^? 14.33 OXT ACT B 201 F 647 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -24.44 47.78 75.39 -22.51 46.98 75.05 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 13 3 # 13 F 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 F 596 ARG B 76 ARG^? 14.33 OXT ACT B 201 F 647 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -24.44 47.78 75.39 -22.51 46.98 75.05 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 14 3 # 14 F 581 GLU B 96 GLU^? 10.60 C1 EDO A 302 F 596 ARG B 106 ARG^? 5.91 C1 EDO A 302 F 647 ARG A 49 ARG^? -3.92 O ACT A 202s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -24.44 47.78 75.39 -22.51 46.98 75.05 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 15 3 # 15 F 581 GLU B 114 GLU^? 18.04 O ACT B 201 F 596 ARG B 88 ARG^? 18.43 CH3 ACT A 201 F 647 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -34.74 70.41 89.54 -36.11 71.74 88.69 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -31.74 72.75 86.26 -33.87 74.56 85.05 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 16 3 # 16 F 581 GLU B 114 GLU^? 18.04 O ACT B 201 F 596 ARG B 123 ARG.? 17.76 O ACT B 201 F 647 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -34.74 70.41 89.54 -36.11 71.74 88.69 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -38.78 69.90 87.63 -38.44 71.99 85.40 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 17 3 # 17 F 581 GLU B 160 GLU.? 4.71 OXT ACT A 202 F 596 ARG A 123 ARG.? 8.27 CH3 ACT A 202 F 647 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -17.96 60.58 68.89 -19.86 60.60 67.97 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -16.75 65.40 71.93 -16.81 64.50 74.86 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 18 3 # 18 F 581 GLU C 27 GLU~? 9.88 CH3 ACT C 201 F 596 ARG C 147 ARG.? 13.23 CH3 ACT C 201 F 647 ARG C 76 ARG^? 14.32 O ACT C 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -40.23 39.97 50.79 -41.89 38.66 50.83 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -44.23 36.97 53.78 -44.90 36.38 50.84 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 19 3 # 19 F 581 GLU C 80 GLU^? 14.47 CH3 ACT C 201 F 596 ARG C 92 ARG^? 13.71 CH3 ACT C 201 F 647 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -48.24 40.72 45.31 -50.16 40.73 46.15 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -52.23 44.53 37.75 -52.43 42.56 40.08 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 20 3 # 20 F 581 GLU C 80 GLU^? 14.47 CH3 ACT C 201 F 596 ARG C 92 ARG^? 13.71 CH3 ACT C 201 F 647 ARG D 123 ARG.? 17.60 O ACT D 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -48.24 40.72 45.31 -50.16 40.73 46.15 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 21 3 # 21 F 581 GLU C 96 GLU^? 13.00 O ACT C 201 F 596 ARG C 76 ARG^? 14.32 O ACT C 201 F 647 ARG C 33 ARG.? 12.41 O ACT C 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -46.59 45.81 59.59 -47.94 44.44 60.43 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -42.25 40.39 61.14 -41.06 40.24 63.98 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 22 3 # 22 F 581 GLU C 96 GLU^? 13.00 O ACT C 201 F 596 ARG C 76 ARG^? 14.32 O ACT C 201 F 647 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -46.59 45.81 59.59 -47.94 44.44 60.43 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -42.25 40.39 61.14 -41.06 40.24 63.98 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 23 3 # 23 F 581 GLU C 96 GLU^? 13.00 O ACT C 201 F 596 ARG C 106 ARG^? 14.47 O2 EDO A 301 F 647 ARG D 49 ARG^? 10.44 O ACT D 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -46.59 45.81 59.59 -47.94 44.44 60.43 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -49.78 47.48 57.01 -51.73 47.13 59.31 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 24 3 # 24 F 581 GLU C 114 GLU^? 18.18 OXT ACT C 201 F 596 ARG C 88 ARG^? 18.42 CH3 ACT D 201 F 647 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -34.62 49.81 33.93 -34.65 51.69 32.98 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -39.31 50.22 32.74 -39.14 52.99 31.45 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 25 3 # 25 F 581 GLU C 114 GLU^? 18.18 OXT ACT C 201 F 596 ARG C 123 ARG.? 17.68 OXT ACT C 201 F 647 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -34.62 49.81 33.93 -34.65 51.69 32.98 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -33.35 53.49 35.15 -35.34 55.60 34.14 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 26 3 # 26 F 581 GLU D 27 GLU~? 9.75 CH3 ACT D 201 F 596 ARG D 147 ARG.? 13.02 CH3 ACT D 201 F 647 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -50.66 64.65 33.24 -49.08 64.98 31.89 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -46.62 68.18 31.08 -46.22 65.54 29.55 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 27 3 # 27 F 581 GLU D 80 GLU^? 14.49 CH3 ACT D 201 F 596 ARG D 92 ARG^? 13.56 CH3 ACT D 201 F 647 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -42.96 58.73 31.72 -40.96 59.40 31.80 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 28 3 # 28 F 581 GLU D 80 GLU^? 14.49 CH3 ACT D 201 F 596 ARG D 92 ARG^? 13.56 CH3 ACT D 201 F 647 ARG C 123 ARG.? 17.68 OXT ACT C 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -42.96 58.73 31.72 -40.96 59.40 31.80 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -33.35 53.49 35.15 -35.34 55.60 34.14 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 29 3 # 29 F 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 F 596 ARG D 76 ARG^? 14.20 OXT ACT D 201 F 647 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -43.29 70.99 40.99 -41.92 72.19 39.92 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -47.81 74.29 36.53 -48.87 77.02 37.43 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -55.21 72.58 39.53 -56.74 74.11 37.37 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 30 3 # 30 F 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 F 596 ARG D 76 ARG^? 14.20 OXT ACT D 201 F 647 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -43.29 70.99 40.99 -41.92 72.19 39.92 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -47.81 74.29 36.53 -48.87 77.02 37.43 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 31 3 # 31 F 581 GLU D 96 GLU^? 13.00 OXT ACT D 201 F 596 ARG D 106 ARG^? 14.88 OXT ACT D 201 F 647 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -43.29 70.99 40.99 -41.92 72.19 39.92 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 32 3 # 32 F 581 GLU D 114 GLU^? 18.05 O ACT D 201 F 596 ARG D 88 ARG^? 18.35 CH3 ACT C 201 F 647 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -56.92 45.97 38.27 -56.84 44.55 39.82 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -52.23 44.53 37.75 -52.43 42.56 40.08 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 33 3 # 33 F 581 GLU D 114 GLU^? 18.05 O ACT D 201 F 596 ARG D 123 ARG.? 17.60 O ACT D 201 F 647 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -56.92 45.97 38.27 -56.84 44.55 39.82 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -58.14 46.42 43.58 -55.81 44.43 43.54 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -49.94 47.28 44.16 -51.45 46.27 46.66 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 33 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 50 ASN^? 5.02 OXT ACT A 201 457 GLY A 109 GLY^? 6.82 OXT ACT A 201 459 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -28.17 63.14 65.41 -30.17 63.83 65.25 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -34.97 66.16 72.79 -35.28 66.58 73.38 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 87 ASN.? 16.46 O ACT A 202 457 GLY A 119 GLY.? 17.82 CH3 ACT A 201 459 GLU A 117 GLU.? 20.82 OXT ACT A 202 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -16.21 74.81 76.88 -15.45 72.83 77.10 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -17.44 79.22 69.94 -17.03 78.76 69.44 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -10.16 77.53 73.12 -10.08 75.57 72.28 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN A 110 ASN^? 10.87 O ACT B 201 457 GLY B 109 GLY^? 6.82 O ACT B 201 459 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -29.36 58.56 76.35 -28.60 58.71 76.34 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN A 112 ASN^? 9.36 O ACT A 202 457 GLY B 109 GLY^? 6.82 O ACT B 201 459 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -24.96 67.02 76.01 -26.38 66.67 77.57 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -29.36 58.56 76.35 -28.60 58.71 76.34 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1vom_c00 MYOSIN user 5 3 # 5 233 ASN B 50 ASN^? 4.93 O ACT B 201 457 GLY B 109 GLY^? 6.82 O ACT B 201 459 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -39.13 57.82 80.42 -37.65 56.39 79.89 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -29.36 58.56 76.35 -28.60 58.71 76.34 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1vom_c00 MYOSIN user 6 3 # 6 233 ASN B 87 ASN.? 20.06 CH3 ACT B 201 457 GLY B 119 GLY.? 17.96 CH3 ACT B 201 459 GLU B 117 GLU.? 26.48 CH3 ACT B 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -30.91 71.77 92.72 -32.40 72.79 91.60 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -31.59 64.88 97.59 -32.39 64.85 97.59 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -33.80 72.26 99.63 -34.50 73.71 100.99 ULMN 3 1vom_c00 MYOSIN user 7 3 # 7 233 ASN B 110 ASN^? 6.46 O ACT A 202 457 GLY A 109 GLY^? 6.82 OXT ACT A 201 459 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -34.97 66.16 72.79 -35.28 66.58 73.38 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1vom_c00 MYOSIN user 8 3 # 8 233 ASN B 112 ASN^? 12.13 O ACT B 201 457 GLY A 109 GLY^? 6.82 OXT ACT A 201 459 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -32.04 67.09 81.98 -30.67 67.45 80.39 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -34.97 66.16 72.79 -35.28 66.58 73.38 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1vom_c00 MYOSIN user 9 3 # 9 233 ASN C 50 ASN^? 4.97 OXT ACT C 201 457 GLY C 109 GLY^? 6.86 OXT ACT C 201 459 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -35.45 55.77 48.86 -36.44 54.81 50.47 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -44.99 51.38 49.22 -45.52 50.84 49.05 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1vom_c00 MYOSIN user 10 3 # 10 233 ASN C 110 ASN^? 10.92 O ACT D 201 457 GLY D 109 GLY^? 6.89 O ACT D 201 459 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -45.26 59.49 43.22 -44.76 59.46 42.64 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1vom_c00 MYOSIN user 11 3 # 11 233 ASN C 112 ASN^? 12.25 OXT ACT C 201 457 GLY D 109 GLY^? 6.89 O ACT D 201 459 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -45.26 59.49 43.22 -44.76 59.46 42.64 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1vom_c00 MYOSIN user 12 3 # 12 233 ASN D 50 ASN^? 4.92 O ACT D 201 457 GLY D 109 GLY^? 6.89 O ACT D 201 459 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -54.56 58.39 48.20 -53.45 60.06 47.53 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -45.26 59.49 43.22 -44.76 59.46 42.64 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1vom_c00 MYOSIN user 13 3 # 13 233 ASN D 87 ASN.? 20.13 CH3 ACT D 201 457 GLY D 119 GLY.? 18.01 CH3 ACT D 201 459 GLU D 117 GLU.? 26.53 CH3 ACT D 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -56.77 45.04 33.02 -56.64 43.87 34.78 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -61.89 51.27 30.98 -62.42 51.19 31.57 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -63.64 43.50 30.85 -64.87 41.85 30.41 ULMN 3 1vom_c00 MYOSIN user 14 3 # 14 233 ASN D 110 ASN^? 10.92 OXT ACT C 201 457 GLY C 109 GLY^? 6.86 OXT ACT C 201 459 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -44.99 51.38 49.22 -45.52 50.84 49.05 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1vom_c00 MYOSIN user 15 3 # 15 233 ASN D 112 ASN^? 12.21 O ACT D 201 457 GLY C 109 GLY^? 6.86 OXT ACT C 201 459 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -44.99 51.38 49.22 -45.52 50.84 49.05 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -40.57 48.44 44.93 -39.46 47.54 46.50 1vom_c00 source 1vom MYOSIN : 15 hits 1vom_c00 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE A 115 PHE^? 13.56 CH3 ACT A 201 A 197 ASN A 87 ASN.? 16.46 O ACT A 202 A 198 PRO A 13 PRO.? 23.47 CH3 ACT A 201 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -19.74 75.51 72.32 -22.50 75.42 71.86 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -16.21 74.81 76.88 -15.45 72.83 77.10 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -14.97 80.56 80.70 -16.08 79.85 78.92 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE B 115 PHE^? 13.53 CH3 ACT B 201 A 197 ASN B 87 ASN.? 20.06 CH3 ACT B 201 A 198 PRO B 13 PRO.? 23.65 CH3 ACT B 201 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -31.33 65.89 92.58 -30.23 63.92 90.93 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -30.91 71.77 92.72 -32.40 72.79 91.60 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -25.45 74.29 96.81 -26.49 72.45 96.11 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 A 100 PHE C 115 PHE^? 13.47 CH3 ACT C 201 A 197 ASN C 87 ASN.? 20.02 CH3 ACT C 201 A 198 PRO C 13 PRO.? 23.45 CH3 ACT C 201 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -33.76 44.24 37.19 -35.14 43.97 39.60 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -35.14 45.16 31.53 -35.06 47.21 30.96 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -36.61 39.35 27.82 -35.99 40.04 29.83 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 A 100 PHE D 115 PHE^? 13.59 CH3 ACT D 201 A 197 ASN D 87 ASN.? 20.13 CH3 ACT D 201 A 198 PRO D 13 PRO.? 23.80 CH3 ACT D 201 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -57.80 50.74 33.88 -56.32 53.08 34.25 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -56.77 45.04 33.02 -56.64 43.87 34.78 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -55.99 43.19 25.76 -56.41 44.79 27.24 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 4 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 115 PHE^? 13.56 CH3 ACT A 201 B 197 ASN A 87 ASN.? 16.46 O ACT A 202 B 198 PRO A 13 PRO.? 23.47 CH3 ACT A 201 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -19.74 75.51 72.32 -22.50 75.42 71.86 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -16.21 74.81 76.88 -15.45 72.83 77.10 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -14.97 80.56 80.70 -16.08 79.85 78.92 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE B 115 PHE^? 13.53 CH3 ACT B 201 B 197 ASN B 87 ASN.? 20.06 CH3 ACT B 201 B 198 PRO B 13 PRO.? 23.65 CH3 ACT B 201 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -31.33 65.89 92.58 -30.23 63.92 90.93 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -30.91 71.77 92.72 -32.40 72.79 91.60 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -25.45 74.29 96.81 -26.49 72.45 96.11 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 B 100 PHE C 115 PHE^? 13.47 CH3 ACT C 201 B 197 ASN C 87 ASN.? 20.02 CH3 ACT C 201 B 198 PRO C 13 PRO.? 23.45 CH3 ACT C 201 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -33.76 44.24 37.19 -35.14 43.97 39.60 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -35.14 45.16 31.53 -35.06 47.21 30.96 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -36.61 39.35 27.82 -35.99 40.04 29.83 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 B 100 PHE D 115 PHE^? 13.59 CH3 ACT D 201 B 197 ASN D 87 ASN.? 20.13 CH3 ACT D 201 B 198 PRO D 13 PRO.? 23.80 CH3 ACT D 201 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -57.80 50.74 33.88 -56.32 53.08 34.25 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -56.77 45.04 33.02 -56.64 43.87 34.78 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -55.99 43.19 25.76 -56.41 44.79 27.24 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 4 hits 1vq1_c01 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 75 TYR^? -4.52 O ACT A 201s A 317 GLU A 72 GLU~? 5.31 O ACT A 201 A 365 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 1.77 6.56 57.05 3.05 7.44 59.37 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 3.06 2.85 52.79 4.83 3.89 53.24 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 3.82 17.09 49.56 4.09 14.32 50.84 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR A 75 TYR^? -4.52 O ACT A 201s A 317 GLU A 72 GLU~? 5.31 O ACT A 201 A 365 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 1.77 6.56 57.05 3.05 7.44 59.37 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 3.06 2.85 52.79 4.83 3.89 53.24 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 3.82 17.09 49.56 4.09 14.32 50.84 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR A 75 TYR^? -4.52 O ACT A 201s A 317 GLU A 72 GLU~? 5.31 O ACT A 201 A 365 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 1.77 6.56 57.05 3.05 7.44 59.37 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 3.06 2.85 52.79 4.83 3.89 53.24 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 3.82 17.09 49.56 4.09 14.32 50.84 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1vzx_c02 2.04.01.0087 user 4 3 # 4 A 314 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 317 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 365 ARG A 24 ARG~? 13.97 CH3 ACT A 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 3.06 2.85 52.79 4.83 3.89 53.24 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 3.82 17.09 49.56 4.09 14.32 50.84 -33.88 82.79 71.01 -36.66 83.48 69.87 ULMN 3 1vzx_c02 2.04.01.0087 user 5 3 # 5 A 314 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 317 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 365 ARG A 49 ARG^? -3.92 O ACT A 202s coo 1.77 6.56 57.05 3.05 7.44 59.37 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 3.06 2.85 52.79 4.83 3.89 53.24 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 3.82 17.09 49.56 4.09 14.32 50.84 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1vzx_c02 2.04.01.0087 user 6 3 # 6 A 314 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 317 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 365 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 3.06 2.85 52.79 4.83 3.89 53.24 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 3.82 17.09 49.56 4.09 14.32 50.84 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1vzx_c02 2.04.01.0087 user 7 3 # 7 A 314 TYR A 95 TYR^? -3.85 O ACT A 201s A 317 GLU A 72 GLU~? 5.31 O ACT A 201 A 365 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 1.77 6.56 57.05 3.05 7.44 59.37 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 3.06 2.85 52.79 4.83 3.89 53.24 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 3.82 17.09 49.56 4.09 14.32 50.84 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1vzx_c02 2.04.01.0087 user 8 3 # 8 A 314 TYR A 95 TYR^? -3.85 O ACT A 201s A 317 GLU A 72 GLU~? 5.31 O ACT A 201 A 365 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 1.77 6.56 57.05 3.05 7.44 59.37 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 3.06 2.85 52.79 4.83 3.89 53.24 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 3.82 17.09 49.56 4.09 14.32 50.84 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1vzx_c02 2.04.01.0087 user 9 3 # 9 A 314 TYR A 95 TYR^? -3.85 O ACT A 201s A 317 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 365 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 3.06 2.85 52.79 4.83 3.89 53.24 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 3.82 17.09 49.56 4.09 14.32 50.84 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1vzx_c02 2.04.01.0087 user 10 3 # 10 A 314 TYR A 108 TYR^? 12.28 O ACT A 201 A 317 GLU A 160 GLU.? 13.50 O ACT A 201 A 365 ARG B 123 ARG.? 17.76 O ACT B 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 3.06 2.85 52.79 4.83 3.89 53.24 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 3.82 17.09 49.56 4.09 14.32 50.84 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1vzx_c02 2.04.01.0087 user 11 3 # 11 A 314 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 317 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 365 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 1.77 6.56 57.05 3.05 7.44 59.37 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 3.06 2.85 52.79 4.83 3.89 53.24 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 3.82 17.09 49.56 4.09 14.32 50.84 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1vzx_c02 2.04.01.0087 user 12 3 # 12 A 314 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 317 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 365 ARG B 124 ARG.? -3.52 O ACT B 201s coo 1.77 6.56 57.05 3.05 7.44 59.37 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 3.06 2.85 52.79 4.83 3.89 53.24 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 3.82 17.09 49.56 4.09 14.32 50.84 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1vzx_c02 2.04.01.0087 user 13 3 # 13 A 314 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 317 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 365 ARG B 138 ARG~? 16.35 OXT ACT B 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 3.06 2.85 52.79 4.83 3.89 53.24 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 3.82 17.09 49.56 4.09 14.32 50.84 -23.44 41.55 74.26 -23.57 39.98 76.87 ULMN 3 1vzx_c02 2.04.01.0087 user 14 3 # 14 A 314 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 317 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 365 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo 1.77 6.56 57.05 3.05 7.44 59.37 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 3.06 2.85 52.79 4.83 3.89 53.24 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 3.82 17.09 49.56 4.09 14.32 50.84 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1vzx_c02 2.04.01.0087 user 15 3 # 15 A 314 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 317 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 365 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 3.06 2.85 52.79 4.83 3.89 53.24 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 3.82 17.09 49.56 4.09 14.32 50.84 -20.35 54.64 90.03 -19.09 51.96 89.19 ULMN 3 1vzx_c02 2.04.01.0087 user 16 3 # 16 A 314 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 317 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 365 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 3.06 2.85 52.79 4.83 3.89 53.24 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 3.82 17.09 49.56 4.09 14.32 50.84 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1vzx_c02 2.04.01.0087 user 17 3 # 17 A 314 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 317 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 365 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo 1.77 6.56 57.05 3.05 7.44 59.37 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 3.06 2.85 52.79 4.83 3.89 53.24 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 3.82 17.09 49.56 4.09 14.32 50.84 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1vzx_c02 2.04.01.0087 user 18 3 # 18 A 314 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 317 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 365 ARG B 124 ARG.? -3.52 O ACT B 201s coo 1.77 6.56 57.05 3.05 7.44 59.37 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 3.06 2.85 52.79 4.83 3.89 53.24 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 3.82 17.09 49.56 4.09 14.32 50.84 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1vzx_c02 2.04.01.0087 user 19 3 # 19 A 314 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 317 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 365 ARG B 138 ARG~? 16.35 OXT ACT B 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 3.06 2.85 52.79 4.83 3.89 53.24 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 3.82 17.09 49.56 4.09 14.32 50.84 -23.44 41.55 74.26 -23.57 39.98 76.87 ULMN 3 1vzx_c02 2.04.01.0087 user 20 3 # 20 A 314 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 317 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 365 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 1.77 6.56 57.05 3.05 7.44 59.37 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 3.06 2.85 52.79 4.83 3.89 53.24 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 3.82 17.09 49.56 4.09 14.32 50.84 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1vzx_c02 2.04.01.0087 user 21 3 # 21 A 314 TYR C 75 TYR^? -4.54 O ACT C 201s A 317 GLU C 72 GLU~? 5.32 O ACT C 201 A 365 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 1.77 6.56 57.05 3.05 7.44 59.37 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 3.06 2.85 52.79 4.83 3.89 53.24 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 3.82 17.09 49.56 4.09 14.32 50.84 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1vzx_c02 2.04.01.0087 user 22 3 # 22 A 314 TYR C 75 TYR^? -4.54 O ACT C 201s A 317 GLU C 72 GLU~? 5.32 O ACT C 201 A 365 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 1.77 6.56 57.05 3.05 7.44 59.37 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 3.06 2.85 52.79 4.83 3.89 53.24 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 3.82 17.09 49.56 4.09 14.32 50.84 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1vzx_c02 2.04.01.0087 user 23 3 # 23 A 314 TYR C 75 TYR^? -4.54 O ACT C 201s A 317 GLU C 72 GLU~? 5.32 O ACT C 201 A 365 ARG C 138 ARG~? 16.31 O ACT C 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 3.06 2.85 52.79 4.83 3.89 53.24 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 3.82 17.09 49.56 4.09 14.32 50.84 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1vzx_c02 2.04.01.0087 user 24 3 # 24 A 314 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 317 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 365 ARG C 24 ARG~? 14.09 CH3 ACT C 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 3.06 2.85 52.79 4.83 3.89 53.24 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 3.82 17.09 49.56 4.09 14.32 50.84 -40.53 35.15 48.39 -41.31 34.14 51.19 ULMN 3 1vzx_c02 2.04.01.0087 user 25 3 # 25 A 314 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 317 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 365 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 3.06 2.85 52.79 4.83 3.89 53.24 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 3.82 17.09 49.56 4.09 14.32 50.84 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 1vzx_c02 2.04.01.0087 user 26 3 # 26 A 314 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 317 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 365 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 3.06 2.85 52.79 4.83 3.89 53.24 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 3.82 17.09 49.56 4.09 14.32 50.84 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1vzx_c02 2.04.01.0087 user 27 3 # 27 A 314 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 317 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 365 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 3.06 2.85 52.79 4.83 3.89 53.24 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 3.82 17.09 49.56 4.09 14.32 50.84 -52.23 44.53 37.75 -52.43 42.56 40.08 ULMN 3 1vzx_c02 2.04.01.0087 user 28 3 # 28 A 314 TYR C 95 TYR^? -3.84 O ACT C 201s A 317 GLU C 72 GLU~? 5.32 O ACT C 201 A 365 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 1.77 6.56 57.05 3.05 7.44 59.37 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 3.06 2.85 52.79 4.83 3.89 53.24 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 3.82 17.09 49.56 4.09 14.32 50.84 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1vzx_c02 2.04.01.0087 user 29 3 # 29 A 314 TYR C 95 TYR^? -3.84 O ACT C 201s A 317 GLU C 72 GLU~? 5.32 O ACT C 201 A 365 ARG C 138 ARG~? 16.31 O ACT C 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 3.06 2.85 52.79 4.83 3.89 53.24 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 3.82 17.09 49.56 4.09 14.32 50.84 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1vzx_c02 2.04.01.0087 user 30 3 # 30 A 314 TYR C 95 TYR^? -3.84 O ACT C 201s A 317 GLU C 96 GLU^? 13.00 O ACT C 201 A 365 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 3.06 2.85 52.79 4.83 3.89 53.24 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 3.82 17.09 49.56 4.09 14.32 50.84 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1vzx_c02 2.04.01.0087 user 31 3 # 31 A 314 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 317 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 365 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 3.06 2.85 52.79 4.83 3.89 53.24 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 3.82 17.09 49.56 4.09 14.32 50.84 -40.22 67.90 41.60 -38.15 70.12 41.98 ULMN 3 1vzx_c02 2.04.01.0087 user 32 3 # 32 A 314 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 317 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 365 ARG D 124 ARG.? -3.55 O ACT D 201s coo 1.77 6.56 57.05 3.05 7.44 59.37 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 3.06 2.85 52.79 4.83 3.89 53.24 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 3.82 17.09 49.56 4.09 14.32 50.84 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1vzx_c02 2.04.01.0087 user 33 3 # 33 A 314 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 317 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 365 ARG D 138 ARG~? 16.38 OXT ACT D 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 3.06 2.85 52.79 4.83 3.89 53.24 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 3.82 17.09 49.56 4.09 14.32 50.84 -42.61 77.59 41.75 -44.95 78.80 40.20 ULMN 3 1vzx_c02 2.04.01.0087 user 34 3 # 34 A 314 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 317 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 365 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 3.06 2.85 52.79 4.83 3.89 53.24 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 3.82 17.09 49.56 4.09 14.32 50.84 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 3 1vzx_c02 2.04.01.0087 user 35 3 # 35 A 314 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 317 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 365 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 3.06 2.85 52.79 4.83 3.89 53.24 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 3.82 17.09 49.56 4.09 14.32 50.84 -50.90 63.83 27.93 -49.90 66.74 27.73 ULMN 3 1vzx_c02 2.04.01.0087 user 36 3 # 36 A 314 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 317 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 365 ARG D 49 ARG^? 10.44 O ACT D 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 3.06 2.85 52.79 4.83 3.89 53.24 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 3.82 17.09 49.56 4.09 14.32 50.84 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 3 1vzx_c02 2.04.01.0087 user 37 3 # 37 A 314 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 317 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 365 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 3.06 2.85 52.79 4.83 3.89 53.24 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 3.82 17.09 49.56 4.09 14.32 50.84 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 3 1vzx_c02 2.04.01.0087 user 38 3 # 38 A 314 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 317 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 365 ARG D 124 ARG.? -3.55 O ACT D 201s coo 1.77 6.56 57.05 3.05 7.44 59.37 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 3.06 2.85 52.79 4.83 3.89 53.24 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 3.82 17.09 49.56 4.09 14.32 50.84 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1vzx_c02 2.04.01.0087 user 39 3 # 39 A 314 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 317 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 365 ARG D 138 ARG~? 16.38 OXT ACT D 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 3.06 2.85 52.79 4.83 3.89 53.24 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 3.82 17.09 49.56 4.09 14.32 50.84 -42.61 77.59 41.75 -44.95 78.80 40.20 ULMN 3 1vzx_c02 2.04.01.0087 user 40 3 # 40 A 314 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 317 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 365 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 1.77 6.56 57.05 3.05 7.44 59.37 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 3.06 2.85 52.79 4.83 3.89 53.24 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 3.82 17.09 49.56 4.09 14.32 50.84 -40.97 55.58 37.41 -39.40 58.23 37.46 1vzx_c02 source 1vzx 2.04.01.0087 : 40 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 75 TYR^? -4.52 O ACT A 201s B1317 GLU A 72 GLU~? 5.31 O ACT A 201 B1365 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR A 75 TYR^? -4.52 O ACT A 201s B1317 GLU A 72 GLU~? 5.31 O ACT A 201 B1365 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR A 75 TYR^? -4.52 O ACT A 201s B1317 GLU A 72 GLU~? 5.31 O ACT A 201 B1365 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR A 93 TYR^? -4.07 CH3 ACT A 201s B1317 GLU A 111 GLU^? 4.34 CH3 ACT A 201 B1365 ARG A 24 ARG~? 13.97 CH3 ACT A 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -33.88 82.79 71.01 -36.66 83.48 69.87 ULMN 3 1vzx_c03 2.04.01.0087 user 5 3 # 5 B1314 TYR A 93 TYR^? -4.07 CH3 ACT A 201s B1317 GLU A 111 GLU^? 4.34 CH3 ACT A 201 B1365 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 3 1vzx_c03 2.04.01.0087 user 6 3 # 6 B1314 TYR A 95 TYR^? -3.85 O ACT A 201s B1317 GLU A 72 GLU~? 5.31 O ACT A 201 B1365 ARG A 124 ARG.? -3.54 OXT ACT A 201s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -25.78 68.55 67.34 -28.71 67.64 66.97 ULMN 3 1vzx_c03 2.04.01.0087 user 7 3 # 7 B1314 TYR A 95 TYR^? -3.85 O ACT A 201s B1317 GLU A 72 GLU~? 5.31 O ACT A 201 B1365 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1vzx_c03 2.04.01.0087 user 8 3 # 8 B1314 TYR A 95 TYR^? -3.85 O ACT A 201s B1317 GLU A 96 GLU^? 11.70 OXT ACT A 203 B1365 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1vzx_c03 2.04.01.0087 user 9 3 # 9 B1314 TYR A 108 TYR^? 12.28 O ACT A 201 B1317 GLU A 160 GLU.? 13.50 O ACT A 201 B1365 ARG B 123 ARG.? 17.76 O ACT B 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1vzx_c03 2.04.01.0087 user 10 3 # 10 B1314 TYR B 75 TYR^? -4.59 OXT ACT B 201s B1317 GLU B 72 GLU~? 5.30 OXT ACT B 201 B1365 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1vzx_c03 2.04.01.0087 user 11 3 # 11 B1314 TYR B 75 TYR^? -4.59 OXT ACT B 201s B1317 GLU B 72 GLU~? 5.30 OXT ACT B 201 B1365 ARG B 124 ARG.? -3.52 O ACT B 201s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1vzx_c03 2.04.01.0087 user 12 3 # 12 B1314 TYR B 75 TYR^? -4.59 OXT ACT B 201s B1317 GLU B 72 GLU~? 5.30 OXT ACT B 201 B1365 ARG B 138 ARG~? 16.35 OXT ACT B 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -23.44 41.55 74.26 -23.57 39.98 76.87 ULMN 3 1vzx_c03 2.04.01.0087 user 13 3 # 13 B1314 TYR B 93 TYR^? -4.16 CH3 ACT B 201s B1317 GLU B 111 GLU^? 4.46 CH3 ACT B 201 B1365 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1vzx_c03 2.04.01.0087 user 14 3 # 14 B1314 TYR B 93 TYR^? -4.16 CH3 ACT B 201s B1317 GLU B 111 GLU^? 4.46 CH3 ACT B 201 B1365 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -20.35 54.64 90.03 -19.09 51.96 89.19 ULMN 3 1vzx_c03 2.04.01.0087 user 15 3 # 15 B1314 TYR B 93 TYR^? -4.16 CH3 ACT B 201s B1317 GLU B 111 GLU^? 4.46 CH3 ACT B 201 B1365 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 1vzx_c03 2.04.01.0087 user 16 3 # 16 B1314 TYR B 93 TYR^? -4.16 CH3 ACT B 201s B1317 GLU B 111 GLU^? 4.46 CH3 ACT B 201 B1365 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1vzx_c03 2.04.01.0087 user 17 3 # 17 B1314 TYR B 95 TYR^? -3.87 OXT ACT B 201s B1317 GLU B 72 GLU~? 5.30 OXT ACT B 201 B1365 ARG A 49 ARG^? -3.92 O ACT A 202s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 1vzx_c03 2.04.01.0087 user 18 3 # 18 B1314 TYR B 95 TYR^? -3.87 OXT ACT B 201s B1317 GLU B 72 GLU~? 5.30 OXT ACT B 201 B1365 ARG B 124 ARG.? -3.52 O ACT B 201s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1vzx_c03 2.04.01.0087 user 19 3 # 19 B1314 TYR B 95 TYR^? -3.87 OXT ACT B 201s B1317 GLU B 72 GLU~? 5.30 OXT ACT B 201 B1365 ARG B 138 ARG~? 16.35 OXT ACT B 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -23.44 41.55 74.26 -23.57 39.98 76.87 ULMN 3 1vzx_c03 2.04.01.0087 user 20 3 # 20 B1314 TYR B 95 TYR^? -3.87 OXT ACT B 201s B1317 GLU B 96 GLU^? 10.60 C1 EDO A 302 B1365 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -20.35 54.64 90.03 -19.09 51.96 89.19 ULMN 3 1vzx_c03 2.04.01.0087 user 21 3 # 21 B1314 TYR B 95 TYR^? -3.87 OXT ACT B 201s B1317 GLU B 96 GLU^? 10.60 C1 EDO A 302 B1365 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 3 1vzx_c03 2.04.01.0087 user 22 3 # 22 B1314 TYR C 75 TYR^? -4.54 O ACT C 201s B1317 GLU C 72 GLU~? 5.32 O ACT C 201 B1365 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1vzx_c03 2.04.01.0087 user 23 3 # 23 B1314 TYR C 75 TYR^? -4.54 O ACT C 201s B1317 GLU C 72 GLU~? 5.32 O ACT C 201 B1365 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1vzx_c03 2.04.01.0087 user 24 3 # 24 B1314 TYR C 75 TYR^? -4.54 O ACT C 201s B1317 GLU C 72 GLU~? 5.32 O ACT C 201 B1365 ARG C 138 ARG~? 16.31 O ACT C 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1vzx_c03 2.04.01.0087 user 25 3 # 25 B1314 TYR C 93 TYR^? -4.09 CH3 ACT C 201s B1317 GLU C 111 GLU^? 4.32 CH3 ACT C 201 B1365 ARG C 24 ARG~? 14.09 CH3 ACT C 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -40.53 35.15 48.39 -41.31 34.14 51.19 ULMN 3 1vzx_c03 2.04.01.0087 user 26 3 # 26 B1314 TYR C 93 TYR^? -4.09 CH3 ACT C 201s B1317 GLU C 111 GLU^? 4.32 CH3 ACT C 201 B1365 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 3 1vzx_c03 2.04.01.0087 user 27 3 # 27 B1314 TYR C 95 TYR^? -3.84 O ACT C 201s B1317 GLU C 72 GLU~? 5.32 O ACT C 201 B1365 ARG C 124 ARG.? -3.50 OXT ACT C 201s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -34.72 50.67 45.47 -36.40 51.18 47.99 ULMN 3 1vzx_c03 2.04.01.0087 user 28 3 # 28 B1314 TYR C 95 TYR^? -3.84 O ACT C 201s B1317 GLU C 72 GLU~? 5.32 O ACT C 201 B1365 ARG C 138 ARG~? 16.31 O ACT C 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1vzx_c03 2.04.01.0087 user 29 3 # 29 B1314 TYR C 95 TYR^? -3.84 O ACT C 201s B1317 GLU C 96 GLU^? 13.00 O ACT C 201 B1365 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1vzx_c03 2.04.01.0087 user 30 3 # 30 B1314 TYR D 75 TYR^? -4.49 OXT ACT D 201s B1317 GLU D 72 GLU~? 5.29 OXT ACT D 201 B1365 ARG D 106 ARG^? 14.88 OXT ACT D 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -40.22 67.90 41.60 -38.15 70.12 41.98 ULMN 3 1vzx_c03 2.04.01.0087 user 31 3 # 31 B1314 TYR D 75 TYR^? -4.49 OXT ACT D 201s B1317 GLU D 72 GLU~? 5.29 OXT ACT D 201 B1365 ARG D 124 ARG.? -3.55 O ACT D 201s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1vzx_c03 2.04.01.0087 user 32 3 # 32 B1314 TYR D 75 TYR^? -4.49 OXT ACT D 201s B1317 GLU D 72 GLU~? 5.29 OXT ACT D 201 B1365 ARG D 138 ARG~? 16.38 OXT ACT D 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -42.61 77.59 41.75 -44.95 78.80 40.20 ULMN 3 1vzx_c03 2.04.01.0087 user 33 3 # 33 B1314 TYR D 93 TYR^? -4.14 CH3 ACT D 201s B1317 GLU D 111 GLU^? 4.46 CH3 ACT D 201 B1365 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -50.90 63.83 27.93 -49.90 66.74 27.73 ULMN 3 1vzx_c03 2.04.01.0087 user 34 3 # 34 B1314 TYR D 93 TYR^? -4.14 CH3 ACT D 201s B1317 GLU D 111 GLU^? 4.46 CH3 ACT D 201 B1365 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 3 1vzx_c03 2.04.01.0087 user 35 3 # 35 B1314 TYR D 95 TYR^? -3.79 OXT ACT D 201s B1317 GLU D 72 GLU~? 5.29 OXT ACT D 201 B1365 ARG D 124 ARG.? -3.55 O ACT D 201s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1vzx_c03 2.04.01.0087 user 36 3 # 36 B1314 TYR D 95 TYR^? -3.79 OXT ACT D 201s B1317 GLU D 72 GLU~? 5.29 OXT ACT D 201 B1365 ARG D 138 ARG~? 16.38 OXT ACT D 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -42.61 77.59 41.75 -44.95 78.80 40.20 ULMN 3 1vzx_c03 2.04.01.0087 user 37 3 # 37 B1314 TYR D 95 TYR^? -3.79 OXT ACT D 201s B1317 GLU D 96 GLU^? 13.00 OXT ACT D 201 B1365 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -40.97 55.58 37.41 -39.40 58.23 37.46 1vzx_c03 source 1vzx 2.04.01.0087 : 37 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 42 TYR^? 9.79 CH3 ACT A 201 A 40 ASP A 34 ASP~? 14.63 O ACT A 201 A 103 LEU A 40 LEU~? 16.40 CH3 ACT A 201 coo 12.09 16.13 10.57 11.28 18.80 10.73 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 7.55 25.51 14.34 9.65 25.73 14.24 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 11.83 18.73 16.99 10.99 19.71 15.26 -21.49 78.02 59.34 -21.07 78.38 57.25 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 42 TYR^? 9.79 CH3 ACT A 201 A 40 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 103 LEU A 120 LEU.? 17.31 CH3 ACT A 201 coo 12.09 16.13 10.57 11.28 18.80 10.73 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 7.55 25.51 14.34 9.65 25.73 14.24 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 11.83 18.73 16.99 10.99 19.71 15.26 -16.79 76.18 66.21 -16.58 77.34 64.41 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 75 TYR^? -4.52 O ACT A 201s A 40 ASP A 28 ASP~? 12.70 CH3 ACT A 201 A 103 LEU A 77 LEU^? 4.67 CH3 ACT A 201 coo 12.09 16.13 10.57 11.28 18.80 10.73 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 7.55 25.51 14.34 9.65 25.73 14.24 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 11.83 18.73 16.99 10.99 19.71 15.26 -36.85 74.02 66.79 -35.10 73.30 67.83 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR A 75 TYR^? -4.52 O ACT A 201s A 40 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 103 LEU A 73 LEU^? 7.24 CH3 ACT A 203 coo 12.09 16.13 10.57 11.28 18.80 10.73 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 7.55 25.51 14.34 9.65 25.73 14.24 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 11.83 18.73 16.99 10.99 19.71 15.26 -43.00 68.59 56.18 -42.43 67.52 54.38 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR B 42 TYR^? 9.74 CH3 ACT B 201 A 40 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 103 LEU B 40 LEU~? 16.08 CH3 ACT B 201 coo 12.09 16.13 10.57 11.28 18.80 10.73 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 7.55 25.51 14.34 9.65 25.73 14.24 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 11.83 18.73 16.99 10.99 19.71 15.26 -36.29 54.47 97.22 -37.42 52.91 98.18 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR B 42 TYR^? 9.74 CH3 ACT B 201 A 40 ASP B 45 ASP^? 20.35 O ACT B 201 A 103 LEU B 120 LEU.? 17.11 CH3 ACT B 201 coo 12.09 16.13 10.57 11.28 18.80 10.73 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 7.55 25.51 14.34 9.65 25.73 14.24 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 11.83 18.73 16.99 10.99 19.71 15.26 -35.92 62.93 96.67 -36.17 61.35 98.13 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 40 ASP B 28 ASP~? 12.70 CH3 ACT B 201 A 103 LEU B 77 LEU^? 4.66 CH3 ACT B 201 coo 12.09 16.13 10.57 11.28 18.80 10.73 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 7.55 25.51 14.34 9.65 25.73 14.24 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 11.83 18.73 16.99 10.99 19.71 15.26 -26.87 51.40 83.00 -27.59 53.42 83.20 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 40 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 103 LEU B 73 LEU^? 13.29 OXT ACT B 201 coo 12.09 16.13 10.57 11.28 18.80 10.73 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 7.55 25.51 14.34 9.65 25.73 14.24 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 11.83 18.73 16.99 10.99 19.71 15.26 -33.40 40.68 78.73 -35.47 40.03 78.71 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR C 42 TYR^? 9.67 CH3 ACT C 201 A 40 ASP C 34 ASP~? 14.66 O ACT C 201 A 103 LEU C 40 LEU~? 16.30 CH3 ACT C 201 coo 12.09 16.13 10.57 11.28 18.80 10.73 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 7.55 25.51 14.34 9.65 25.73 14.24 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 11.83 18.73 16.99 10.99 19.71 15.26 -24.56 42.40 46.55 -22.60 42.30 47.48 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR C 42 TYR^? 9.67 CH3 ACT C 201 A 40 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 103 LEU C 120 LEU.? 17.09 CH3 ACT C 201 coo 12.09 16.13 10.57 11.28 18.80 10.73 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 7.55 25.51 14.34 9.65 25.73 14.24 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 11.83 18.73 16.99 10.99 19.71 15.26 -27.17 44.35 38.78 -25.60 43.27 39.79 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR C 75 TYR^? -4.54 O ACT C 201s A 40 ASP C 28 ASP~? 12.80 CH3 ACT C 201 A 103 LEU C 77 LEU^? 4.76 CH3 ACT C 201 coo 12.09 16.13 10.57 11.28 18.80 10.73 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 7.55 25.51 14.34 9.65 25.73 14.24 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 11.83 18.73 16.99 10.99 19.71 15.26 -40.40 43.73 53.92 -40.17 44.61 51.97 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 12 3 # 12 A 16 TYR C 75 TYR^? -4.54 O ACT C 201s A 40 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 103 LEU C 73 LEU^? 11.22 C1 EDO A 301 coo 12.09 16.13 10.57 11.28 18.80 10.73 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 7.55 25.51 14.34 9.65 25.73 14.24 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 11.83 18.73 16.99 10.99 19.71 15.26 -36.65 48.81 65.70 -35.04 50.07 66.44 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 13 3 # 13 A 16 TYR D 42 TYR^? 9.84 CH3 ACT D 201 A 40 ASP D 34 ASP~? 14.62 OXT ACT D 201 A 103 LEU D 40 LEU~? 16.21 CH3 ACT D 201 coo 12.09 16.13 10.57 11.28 18.80 10.73 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 7.55 25.51 14.34 9.65 25.73 14.24 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 11.83 18.73 16.99 10.99 19.71 15.26 -66.28 60.79 35.61 -68.08 61.94 35.93 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 14 3 # 14 A 16 TYR D 42 TYR^? 9.84 CH3 ACT D 201 A 40 ASP D 45 ASP^? 20.33 O ACT D 201 A 103 LEU D 120 LEU.? 17.36 CH3 ACT D 201 coo 12.09 16.13 10.57 11.28 18.80 10.73 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 7.55 25.51 14.34 9.65 25.73 14.24 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 11.83 18.73 16.99 10.99 19.71 15.26 -64.24 52.49 35.03 -65.88 53.68 34.30 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 15 3 # 15 A 16 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 40 ASP D 28 ASP~? 12.70 CH3 ACT D 201 A 103 LEU D 77 LEU^? 4.61 CH3 ACT D 201 coo 12.09 16.13 10.57 11.28 18.80 10.73 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 7.55 25.51 14.34 9.65 25.73 14.24 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 11.83 18.73 16.99 10.99 19.71 15.26 -49.96 66.51 37.71 -50.27 64.38 38.00 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 16 3 # 16 A 16 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 40 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 103 LEU D 73 LEU^? 11.88 CH3 ACT A 203 coo 12.09 16.13 10.57 11.28 18.80 10.73 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 7.55 25.51 14.34 9.65 25.73 14.24 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 11.83 18.73 16.99 10.99 19.71 15.26 -52.49 76.30 46.34 -53.95 76.66 47.89 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 16 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 42 TYR^? 9.79 CH3 ACT A 201 B 40 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 103 LEU A 120 LEU.? 17.31 CH3 ACT A 201 coo 14.25 20.09 37.35 13.48 17.40 37.38 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 9.39 10.77 34.53 11.50 10.63 34.41 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 12.89 17.60 31.13 12.34 16.51 32.90 -16.79 76.18 66.21 -16.58 77.34 64.41 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 75 TYR^? -4.52 O ACT A 201s B 40 ASP A 28 ASP~? 12.70 CH3 ACT A 201 B 103 LEU A 77 LEU^? 4.67 CH3 ACT A 201 coo 14.25 20.09 37.35 13.48 17.40 37.38 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 9.39 10.77 34.53 11.50 10.63 34.41 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 12.89 17.60 31.13 12.34 16.51 32.90 -36.85 74.02 66.79 -35.10 73.30 67.83 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 75 TYR^? -4.52 O ACT A 201s B 40 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 103 LEU A 73 LEU^? 7.24 CH3 ACT A 203 coo 14.25 20.09 37.35 13.48 17.40 37.38 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 9.39 10.77 34.53 11.50 10.63 34.41 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 12.89 17.60 31.13 12.34 16.51 32.90 -43.00 68.59 56.18 -42.43 67.52 54.38 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 42 TYR^? 9.74 CH3 ACT B 201 B 40 ASP B 45 ASP^? 20.35 O ACT B 201 B 103 LEU B 120 LEU.? 17.11 CH3 ACT B 201 coo 14.25 20.09 37.35 13.48 17.40 37.38 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 9.39 10.77 34.53 11.50 10.63 34.41 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 12.89 17.60 31.13 12.34 16.51 32.90 -35.92 62.93 96.67 -36.17 61.35 98.13 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR B 75 TYR^? -4.59 OXT ACT B 201s B 40 ASP B 28 ASP~? 12.70 CH3 ACT B 201 B 103 LEU B 77 LEU^? 4.66 CH3 ACT B 201 coo 14.25 20.09 37.35 13.48 17.40 37.38 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 9.39 10.77 34.53 11.50 10.63 34.41 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 12.89 17.60 31.13 12.34 16.51 32.90 -26.87 51.40 83.00 -27.59 53.42 83.20 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR B 75 TYR^? -4.59 OXT ACT B 201s B 40 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 103 LEU B 73 LEU^? 13.29 OXT ACT B 201 coo 14.25 20.09 37.35 13.48 17.40 37.38 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 9.39 10.77 34.53 11.50 10.63 34.41 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 12.89 17.60 31.13 12.34 16.51 32.90 -33.40 40.68 78.73 -35.47 40.03 78.71 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR C 42 TYR^? 9.67 CH3 ACT C 201 B 40 ASP C 34 ASP~? 14.66 O ACT C 201 B 103 LEU C 40 LEU~? 16.30 CH3 ACT C 201 coo 14.25 20.09 37.35 13.48 17.40 37.38 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 9.39 10.77 34.53 11.50 10.63 34.41 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 12.89 17.60 31.13 12.34 16.51 32.90 -24.56 42.40 46.55 -22.60 42.30 47.48 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR C 42 TYR^? 9.67 CH3 ACT C 201 B 40 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 103 LEU C 120 LEU.? 17.09 CH3 ACT C 201 coo 14.25 20.09 37.35 13.48 17.40 37.38 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 9.39 10.77 34.53 11.50 10.63 34.41 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 12.89 17.60 31.13 12.34 16.51 32.90 -27.17 44.35 38.78 -25.60 43.27 39.79 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR C 75 TYR^? -4.54 O ACT C 201s B 40 ASP C 28 ASP~? 12.80 CH3 ACT C 201 B 103 LEU C 77 LEU^? 4.76 CH3 ACT C 201 coo 14.25 20.09 37.35 13.48 17.40 37.38 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 9.39 10.77 34.53 11.50 10.63 34.41 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 12.89 17.60 31.13 12.34 16.51 32.90 -40.40 43.73 53.92 -40.17 44.61 51.97 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR C 75 TYR^? -4.54 O ACT C 201s B 40 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 103 LEU C 73 LEU^? 11.22 C1 EDO A 301 coo 14.25 20.09 37.35 13.48 17.40 37.38 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 9.39 10.77 34.53 11.50 10.63 34.41 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 12.89 17.60 31.13 12.34 16.51 32.90 -36.65 48.81 65.70 -35.04 50.07 66.44 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 11 3 # 11 B 16 TYR D 42 TYR^? 9.84 CH3 ACT D 201 B 40 ASP D 45 ASP^? 20.33 O ACT D 201 B 103 LEU D 120 LEU.? 17.36 CH3 ACT D 201 coo 14.25 20.09 37.35 13.48 17.40 37.38 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 9.39 10.77 34.53 11.50 10.63 34.41 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 12.89 17.60 31.13 12.34 16.51 32.90 -64.24 52.49 35.03 -65.88 53.68 34.30 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 12 3 # 12 B 16 TYR D 75 TYR^? -4.49 OXT ACT D 201s B 40 ASP D 28 ASP~? 12.70 CH3 ACT D 201 B 103 LEU D 77 LEU^? 4.61 CH3 ACT D 201 coo 14.25 20.09 37.35 13.48 17.40 37.38 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 9.39 10.77 34.53 11.50 10.63 34.41 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 12.89 17.60 31.13 12.34 16.51 32.90 -49.96 66.51 37.71 -50.27 64.38 38.00 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 13 3 # 13 B 16 TYR D 75 TYR^? -4.49 OXT ACT D 201s B 40 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 103 LEU D 73 LEU^? 11.88 CH3 ACT A 203 coo 14.25 20.09 37.35 13.48 17.40 37.38 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 9.39 10.77 34.53 11.50 10.63 34.41 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 12.89 17.60 31.13 12.34 16.51 32.90 -52.49 76.30 46.34 -53.95 76.66 47.89 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 13 hits 1vzz_c01 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 B 126 ARG A 8 ARG.? 15.23 CH3 ACT A 201 B 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 2.45 5.53 11.28 3.59 7.56 13.29 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 6.10 2.00 25.24 6.12 1.84 23.13 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 B 126 ARG A 8 ARG.? 15.23 CH3 ACT A 201 B 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 2.45 5.53 11.28 3.59 7.56 13.29 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 6.10 2.00 25.24 6.12 1.84 23.13 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 B 126 ARG A 24 ARG~? 13.97 CH3 ACT A 201 B 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 2.45 5.53 11.28 3.59 7.56 13.29 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 6.10 2.00 25.24 6.12 1.84 23.13 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 B 126 ARG A 37 ARG~? 13.73 CH3 ACT A 201 B 138 GLU A 21 GLU~? 19.20 CH3 ACT A 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 2.45 5.53 11.28 3.59 7.56 13.29 -28.83 80.54 58.97 -30.62 82.33 60.70 coo 6.10 2.00 25.24 6.12 1.84 23.13 -26.74 85.39 73.13 -25.47 87.07 73.30 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 B 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 B 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s B 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 2.45 5.53 11.28 3.59 7.56 13.29 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 6.10 2.00 25.24 6.12 1.84 23.13 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 B 124 ALA A 52 ALA.? 7.92 O2 EDO A 302 B 126 ARG B 106 ARG^? 5.91 C1 EDO A 302 B 138 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 -28.67 56.33 66.41 -29.48 55.05 66.20 coo 2.45 5.53 11.28 3.59 7.56 13.29 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 6.10 2.00 25.24 6.12 1.84 23.13 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 B 124 ALA A 55 ALA^? 10.63 O1 EDO A 302 B 126 ARG C 67 ARG~? 12.50 O2 EDO A 302 B 138 GLU B 160 GLU.? 4.71 OXT ACT A 202 coo 2.11 4.00 19.31 3.14 4.86 19.99 -21.44 62.27 61.83 -22.27 63.55 61.72 coo 2.45 5.53 11.28 3.59 7.56 13.29 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 6.10 2.00 25.24 6.12 1.84 23.13 -17.96 60.58 68.89 -19.86 60.60 67.97 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 B 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 B 126 ARG A 58 ARG~? 18.13 CH3 ACT A 201 B 138 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 -23.47 66.96 59.63 -22.85 67.97 60.60 coo 2.45 5.53 11.28 3.59 7.56 13.29 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 6.10 2.00 25.24 6.12 1.84 23.13 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 B 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 B 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s B 138 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 -23.47 66.96 59.63 -22.85 67.97 60.60 coo 2.45 5.53 11.28 3.59 7.56 13.29 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 6.10 2.00 25.24 6.12 1.84 23.13 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 B 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 B 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s B 138 GLU A 60 GLU~? 10.63 O2 EDO A 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 -23.47 66.96 59.63 -22.85 67.97 60.60 coo 2.45 5.53 11.28 3.59 7.56 13.29 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 6.10 2.00 25.24 6.12 1.84 23.13 -19.73 62.99 57.19 -19.03 61.21 58.09 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 B 124 ALA A 63 ALA~? 14.85 OXT ACT A 201 B 126 ARG C 67 ARG~? 12.50 O2 EDO A 302 B 138 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 -25.75 65.96 54.80 -24.85 64.81 54.40 coo 2.45 5.53 11.28 3.59 7.56 13.29 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 6.10 2.00 25.24 6.12 1.84 23.13 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 B 124 ALA A 90 ALA^? 13.57 O ACT A 202 B 126 ARG B 88 ARG^? 18.43 CH3 ACT A 201 B 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -27.00 70.90 78.40 -27.10 70.23 79.75 coo 2.45 5.53 11.28 3.59 7.56 13.29 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 6.10 2.00 25.24 6.12 1.84 23.13 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 B 124 ALA A 94 ALA^? 9.17 CH3 ACT A 201 B 126 ARG A 92 ARG^? 14.09 CH3 ACT A 201 B 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -39.00 70.14 71.43 -40.24 70.27 72.30 coo 2.45 5.53 11.28 3.59 7.56 13.29 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 6.10 2.00 25.24 6.12 1.84 23.13 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 B 124 ALA A 94 ALA^? 9.17 CH3 ACT A 201 B 126 ARG A 92 ARG^? 14.09 CH3 ACT A 201 B 138 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 2.11 4.00 19.31 3.14 4.86 19.99 -39.00 70.14 71.43 -40.24 70.27 72.30 coo 2.45 5.53 11.28 3.59 7.56 13.29 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 6.10 2.00 25.24 6.12 1.84 23.13 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 B 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 B 126 ARG B 8 ARG.? 14.49 CH3 ACT B 201 B 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -27.84 56.51 90.43 -28.15 57.77 89.64 coo 2.45 5.53 11.28 3.59 7.56 13.29 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 6.10 2.00 25.24 6.12 1.84 23.13 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 B 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 B 126 ARG B 8 ARG.? 14.49 CH3 ACT B 201 B 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -27.84 56.51 90.43 -28.15 57.77 89.64 coo 2.45 5.53 11.28 3.59 7.56 13.29 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 6.10 2.00 25.24 6.12 1.84 23.13 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 3 # 17 B 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 B 126 ARG B 24 ARG~? 14.02 CH3 ACT B 201 B 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -27.84 56.51 90.43 -28.15 57.77 89.64 coo 2.45 5.53 11.28 3.59 7.56 13.29 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 6.10 2.00 25.24 6.12 1.84 23.13 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 3 # 18 B 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 B 126 ARG B 124 ARG.? -3.52 O ACT B 201s B 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -27.84 56.51 90.43 -28.15 57.77 89.64 coo 2.45 5.53 11.28 3.59 7.56 13.29 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 6.10 2.00 25.24 6.12 1.84 23.13 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 3 # 19 B 124 ALA B 52 ALA.? 10.80 O1 EDO A 301 B 126 ARG A 106 ARG^? 14.48 O1 EDO A 301 B 138 GLU B 53 GLU^? 11.09 O ACT B 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -42.54 59.91 74.80 -43.03 59.60 73.39 coo 2.45 5.53 11.28 3.59 7.56 13.29 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 6.10 2.00 25.24 6.12 1.84 23.13 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 20 3 # 20 B 124 ALA B 61 ALA~? 11.33 O ACT B 201 B 126 ARG B 58 ARG~? 17.86 CH3 ACT B 201 B 138 GLU B 53 GLU^? 11.09 O ACT B 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -42.38 55.75 87.87 -41.49 56.65 88.72 coo 2.45 5.53 11.28 3.59 7.56 13.29 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 6.10 2.00 25.24 6.12 1.84 23.13 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 21 3 # 21 B 124 ALA B 61 ALA~? 11.33 O ACT B 201 B 126 ARG B 124 ARG.? -3.52 O ACT B 201s B 138 GLU B 59 GLU~? 20.69 O ACT B 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -42.38 55.75 87.87 -41.49 56.65 88.72 coo 2.45 5.53 11.28 3.59 7.56 13.29 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 6.10 2.00 25.24 6.12 1.84 23.13 -47.90 53.57 92.50 -49.95 53.72 93.03 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 22 3 # 22 B 124 ALA B 61 ALA~? 11.33 O ACT B 201 B 126 ARG B 124 ARG.? -3.52 O ACT B 201s B 138 GLU B 60 GLU~? 17.33 O ACT B 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -42.38 55.75 87.87 -41.49 56.65 88.72 coo 2.45 5.53 11.28 3.59 7.56 13.29 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 6.10 2.00 25.24 6.12 1.84 23.13 -48.17 57.12 87.93 -49.17 58.57 86.76 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 23 3 # 23 B 124 ALA B 90 ALA^? 13.05 O ACT A 202 B 126 ARG A 88 ARG^? 11.13 CH3 ACT A 202 B 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -27.07 66.85 82.98 -26.70 67.91 81.96 coo 2.45 5.53 11.28 3.59 7.56 13.29 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 6.10 2.00 25.24 6.12 1.84 23.13 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 24 3 # 24 B 124 ALA B 94 ALA^? 5.26 CH3 ACT A 202 B 126 ARG B 92 ARG^? -3.69 CH3 ACT A 202s B 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -25.63 54.27 77.41 -24.43 54.15 76.47 coo 2.45 5.53 11.28 3.59 7.56 13.29 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 6.10 2.00 25.24 6.12 1.84 23.13 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 25 3 # 25 B 124 ALA B 94 ALA^? 5.26 CH3 ACT A 202 B 126 ARG B 92 ARG^? -3.69 CH3 ACT A 202s B 138 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 -25.63 54.27 77.41 -24.43 54.15 76.47 coo 2.45 5.53 11.28 3.59 7.56 13.29 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 6.10 2.00 25.24 6.12 1.84 23.13 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 26 3 # 26 B 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 B 126 ARG C 8 ARG.? 14.74 CH3 ACT C 201 B 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 2.45 5.53 11.28 3.59 7.56 13.29 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 6.10 2.00 25.24 6.12 1.84 23.13 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 27 3 # 27 B 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 B 126 ARG C 8 ARG.? 14.74 CH3 ACT C 201 B 138 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 2.45 5.53 11.28 3.59 7.56 13.29 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 6.10 2.00 25.24 6.12 1.84 23.13 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 28 3 # 28 B 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 B 126 ARG C 24 ARG~? 14.09 CH3 ACT C 201 B 138 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 2.45 5.53 11.28 3.59 7.56 13.29 -40.53 35.15 48.39 -41.31 34.14 51.19 coo 6.10 2.00 25.24 6.12 1.84 23.13 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 29 3 # 29 B 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 B 126 ARG C 37 ARG~? 13.73 CH3 ACT C 201 B 138 GLU C 21 GLU~? 19.29 CH3 ACT C 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 2.45 5.53 11.28 3.59 7.56 13.29 -28.52 38.86 52.29 -30.70 36.70 52.27 coo 6.10 2.00 25.24 6.12 1.84 23.13 -37.51 33.35 41.29 -36.60 32.00 39.94 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 30 3 # 30 B 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 B 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s B 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 2.45 5.53 11.28 3.59 7.56 13.29 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 6.10 2.00 25.24 6.12 1.84 23.13 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 31 3 # 31 B 124 ALA C 52 ALA.? 12.19 C2 EDO A 301 B 126 ARG D 106 ARG^? 14.88 OXT ACT D 201 B 138 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -37.45 62.38 49.17 -37.97 63.55 50.01 coo 2.45 5.53 11.28 3.59 7.56 13.29 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 6.10 2.00 25.24 6.12 1.84 23.13 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 32 3 # 32 B 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 B 126 ARG C 58 ARG~? 18.03 CH3 ACT C 201 B 138 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -27.55 53.08 48.63 -27.85 52.13 47.47 coo 2.45 5.53 11.28 3.59 7.56 13.29 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 6.10 2.00 25.24 6.12 1.84 23.13 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 33 3 # 33 B 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 B 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s B 138 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 -27.55 53.08 48.63 -27.85 52.13 47.47 coo 2.45 5.53 11.28 3.59 7.56 13.29 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 6.10 2.00 25.24 6.12 1.84 23.13 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 34 3 # 34 B 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 B 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s B 138 GLU C 60 GLU~? 17.22 OXT ACT C 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -27.55 53.08 48.63 -27.85 52.13 47.47 coo 2.45 5.53 11.28 3.59 7.56 13.29 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 6.10 2.00 25.24 6.12 1.84 23.13 -23.89 57.63 47.43 -24.47 59.50 46.62 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 35 3 # 35 B 124 ALA C 63 ALA~? 11.78 O2 EDO A 302 B 126 ARG A 67 ARG~? 13.20 O2 EDO A 302 B 138 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 -25.32 54.06 53.50 -24.62 55.35 53.10 coo 2.45 5.53 11.28 3.59 7.56 13.29 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 6.10 2.00 25.24 6.12 1.84 23.13 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 36 3 # 36 B 124 ALA C 90 ALA^? 13.74 CH3 ACT C 201 B 126 ARG D 88 ARG^? 18.35 CH3 ACT C 201 B 138 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -43.56 47.44 39.16 -44.76 48.04 38.47 coo 2.45 5.53 11.28 3.59 7.56 13.29 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 6.10 2.00 25.24 6.12 1.84 23.13 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 37 3 # 37 B 124 ALA C 94 ALA^? 9.20 O ACT C 201 B 126 ARG C 92 ARG^? 13.71 CH3 ACT C 201 B 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -45.79 46.91 52.91 -47.22 46.56 53.32 coo 2.45 5.53 11.28 3.59 7.56 13.29 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 6.10 2.00 25.24 6.12 1.84 23.13 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 38 3 # 38 B 124 ALA C 94 ALA^? 9.20 O ACT C 201 B 126 ARG C 92 ARG^? 13.71 CH3 ACT C 201 B 138 GLU C 96 GLU^? 13.00 O ACT C 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -45.79 46.91 52.91 -47.22 46.56 53.32 coo 2.45 5.53 11.28 3.59 7.56 13.29 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 6.10 2.00 25.24 6.12 1.84 23.13 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 39 3 # 39 B 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 B 126 ARG D 8 ARG.? 14.56 CH3 ACT D 201 B 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -55.52 60.76 33.28 -54.94 59.51 33.93 coo 2.45 5.53 11.28 3.59 7.56 13.29 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 6.10 2.00 25.24 6.12 1.84 23.13 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 40 3 # 40 B 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 B 126 ARG D 8 ARG.? 14.56 CH3 ACT D 201 B 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -55.52 60.76 33.28 -54.94 59.51 33.93 coo 2.45 5.53 11.28 3.59 7.56 13.29 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 6.10 2.00 25.24 6.12 1.84 23.13 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 41 3 # 41 B 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 B 126 ARG D 24 ARG~? 13.98 CH3 ACT D 201 B 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -55.52 60.76 33.28 -54.94 59.51 33.93 coo 2.45 5.53 11.28 3.59 7.56 13.29 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 6.10 2.00 25.24 6.12 1.84 23.13 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 42 3 # 42 B 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 B 126 ARG D 124 ARG.? -3.55 O ACT D 201s B 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -55.52 60.76 33.28 -54.94 59.51 33.93 coo 2.45 5.53 11.28 3.59 7.56 13.29 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 6.10 2.00 25.24 6.12 1.84 23.13 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 43 3 # 43 B 124 ALA D 52 ALA.? 10.75 O ACT A 203 B 126 ARG C 106 ARG^? 14.47 O2 EDO A 301 B 138 GLU D 53 GLU^? 10.32 O ACT A 203 coo 2.11 4.00 19.31 3.14 4.86 19.99 -52.10 56.30 54.26 -51.39 56.64 55.56 coo 2.45 5.53 11.28 3.59 7.56 13.29 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 6.10 2.00 25.24 6.12 1.84 23.13 -56.60 59.52 53.75 -57.18 61.28 52.77 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 44 3 # 44 B 124 ALA D 61 ALA~? 11.20 O ACT D 201 B 126 ARG D 124 ARG.? -3.55 O ACT D 201s B 138 GLU D 59 GLU~? 18.52 O ACT D 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -62.57 59.32 46.16 -62.47 58.52 44.86 coo 2.45 5.53 11.28 3.59 7.56 13.29 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 6.10 2.00 25.24 6.12 1.84 23.13 -69.73 60.64 47.66 -70.08 62.16 46.23 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 45 3 # 45 B 124 ALA D 61 ALA~? 11.20 O ACT D 201 B 126 ARG D 124 ARG.? -3.55 O ACT D 201s B 138 GLU D 60 GLU~? 17.31 O ACT D 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -62.57 59.32 46.16 -62.47 58.52 44.86 coo 2.45 5.53 11.28 3.59 7.56 13.29 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 6.10 2.00 25.24 6.12 1.84 23.13 -66.09 57.03 50.37 -65.56 55.61 51.84 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 46 3 # 46 B 124 ALA D 90 ALA^? 13.83 CH3 ACT D 201 B 126 ARG C 88 ARG^? 18.42 CH3 ACT D 201 B 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -47.67 51.24 36.64 -46.49 50.32 36.92 coo 2.45 5.53 11.28 3.59 7.56 13.29 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 6.10 2.00 25.24 6.12 1.84 23.13 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 47 3 # 47 B 124 ALA D 94 ALA^? 9.22 CH3 ACT D 201 B 126 ARG D 92 ARG^? 13.56 CH3 ACT D 201 B 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -44.41 64.30 40.02 -42.98 64.70 39.67 coo 2.45 5.53 11.28 3.59 7.56 13.29 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 6.10 2.00 25.24 6.12 1.84 23.13 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 48 3 # 48 B 124 ALA D 94 ALA^? 9.22 CH3 ACT D 201 B 126 ARG D 92 ARG^? 13.56 CH3 ACT D 201 B 138 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 2.11 4.00 19.31 3.14 4.86 19.99 -44.41 64.30 40.02 -42.98 64.70 39.67 coo 2.45 5.53 11.28 3.59 7.56 13.29 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 6.10 2.00 25.24 6.12 1.84 23.13 -43.29 70.99 40.99 -41.92 72.19 39.92 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 48 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 C 126 ARG A 8 ARG.? 15.23 CH3 ACT A 201 C 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -20.16 79.98 64.14 -22.57 80.76 62.41 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 C 126 ARG A 8 ARG.? 15.23 CH3 ACT A 201 C 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -20.16 79.98 64.14 -22.57 80.76 62.41 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 C 126 ARG A 24 ARG~? 13.97 CH3 ACT A 201 C 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -33.88 82.79 71.01 -36.66 83.48 69.87 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 C 126 ARG A 37 ARG~? 13.73 CH3 ACT A 201 C 138 GLU A 21 GLU~? 19.20 CH3 ACT A 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -28.83 80.54 58.97 -30.62 82.33 60.70 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -26.74 85.39 73.13 -25.47 87.07 73.30 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 C 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 C 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s C 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 C 124 ALA A 52 ALA.? 7.92 O2 EDO A 302 C 126 ARG B 106 ARG^? 5.91 C1 EDO A 302 C 138 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -28.67 56.33 66.41 -29.48 55.05 66.20 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 C 124 ALA A 55 ALA^? 10.63 O1 EDO A 302 C 126 ARG C 67 ARG~? 12.50 O2 EDO A 302 C 138 GLU B 160 GLU.? 4.71 OXT ACT A 202 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -21.44 62.27 61.83 -22.27 63.55 61.72 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -17.96 60.58 68.89 -19.86 60.60 67.97 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 C 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 C 126 ARG A 58 ARG~? 18.13 CH3 ACT A 201 C 138 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -23.47 66.96 59.63 -22.85 67.97 60.60 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -18.95 73.08 58.27 -17.11 75.32 59.26 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 C 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 C 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s C 138 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -23.47 66.96 59.63 -22.85 67.97 60.60 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 C 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 C 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s C 138 GLU A 60 GLU~? 10.63 O2 EDO A 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -23.47 66.96 59.63 -22.85 67.97 60.60 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -19.73 62.99 57.19 -19.03 61.21 58.09 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 C 124 ALA A 63 ALA~? 14.85 OXT ACT A 201 C 126 ARG C 67 ARG~? 12.50 O2 EDO A 302 C 138 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -25.75 65.96 54.80 -24.85 64.81 54.40 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 C 124 ALA A 90 ALA^? 13.57 O ACT A 202 C 126 ARG B 88 ARG^? 18.43 CH3 ACT A 201 C 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -27.00 70.90 78.40 -27.10 70.23 79.75 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -31.74 72.75 86.26 -33.87 74.56 85.05 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 C 124 ALA A 94 ALA^? 9.17 CH3 ACT A 201 C 126 ARG A 92 ARG^? 14.09 CH3 ACT A 201 C 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -39.00 70.14 71.43 -40.24 70.27 72.30 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 C 124 ALA A 94 ALA^? 9.17 CH3 ACT A 201 C 126 ARG A 92 ARG^? 14.09 CH3 ACT A 201 C 138 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -39.00 70.14 71.43 -40.24 70.27 72.30 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 C 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 C 126 ARG B 8 ARG.? 14.49 CH3 ACT B 201 C 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -27.84 56.51 90.43 -28.15 57.77 89.64 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -31.04 58.38 97.06 -32.26 55.57 97.13 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 C 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 C 126 ARG B 8 ARG.? 14.49 CH3 ACT B 201 C 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -27.84 56.51 90.43 -28.15 57.77 89.64 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -31.04 58.38 97.06 -32.26 55.57 97.13 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 3 # 17 C 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 C 126 ARG B 24 ARG~? 14.02 CH3 ACT B 201 C 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -27.84 56.51 90.43 -28.15 57.77 89.64 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -20.35 54.64 90.03 -19.09 51.96 89.19 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 3 # 18 C 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 C 126 ARG B 124 ARG.? -3.52 O ACT B 201s C 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -27.84 56.51 90.43 -28.15 57.77 89.64 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 3 # 19 C 124 ALA B 52 ALA.? 10.80 O1 EDO A 301 C 126 ARG A 106 ARG^? 14.48 O1 EDO A 301 C 138 GLU B 53 GLU^? 11.09 O ACT B 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -42.54 59.91 74.80 -43.03 59.60 73.39 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -44.60 68.65 71.93 -47.65 68.54 71.92 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 20 3 # 20 C 124 ALA B 61 ALA~? 11.33 O ACT B 201 C 126 ARG B 58 ARG~? 17.86 CH3 ACT B 201 C 138 GLU B 53 GLU^? 11.09 O ACT B 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -42.38 55.75 87.87 -41.49 56.65 88.72 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -41.40 56.24 95.43 -40.17 57.59 97.88 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 21 3 # 21 C 124 ALA B 61 ALA~? 11.33 O ACT B 201 C 126 ARG B 124 ARG.? -3.52 O ACT B 201s C 138 GLU B 59 GLU~? 20.69 O ACT B 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -42.38 55.75 87.87 -41.49 56.65 88.72 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -47.90 53.57 92.50 -49.95 53.72 93.03 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 22 3 # 22 C 124 ALA B 61 ALA~? 11.33 O ACT B 201 C 126 ARG B 124 ARG.? -3.52 O ACT B 201s C 138 GLU B 60 GLU~? 17.33 O ACT B 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -42.38 55.75 87.87 -41.49 56.65 88.72 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -48.17 57.12 87.93 -49.17 58.57 86.76 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 23 3 # 23 C 124 ALA B 90 ALA^? 13.05 O ACT A 202 C 126 ARG A 88 ARG^? 11.13 CH3 ACT A 202 C 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -27.07 66.85 82.98 -26.70 67.91 81.96 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -18.98 69.22 79.04 -17.48 66.59 79.46 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 24 3 # 24 C 124 ALA B 94 ALA^? 5.26 CH3 ACT A 202 C 126 ARG B 92 ARG^? -3.69 CH3 ACT A 202s C 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -25.63 54.27 77.41 -24.43 54.15 76.47 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 25 3 # 25 C 124 ALA B 94 ALA^? 5.26 CH3 ACT A 202 C 126 ARG B 92 ARG^? -3.69 CH3 ACT A 202s C 138 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -25.63 54.27 77.41 -24.43 54.15 76.47 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 26 3 # 26 C 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 C 126 ARG C 8 ARG.? 14.74 CH3 ACT C 201 C 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -35.58 40.78 46.69 -36.15 41.81 45.72 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -27.18 40.10 42.21 -27.55 39.63 45.22 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 27 3 # 27 C 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 C 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s C 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -35.58 40.78 46.69 -36.15 41.81 45.72 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -34.72 50.67 45.47 -36.40 51.18 47.99 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 28 3 # 28 C 124 ALA C 52 ALA.? 12.19 C2 EDO A 301 C 126 ARG D 106 ARG^? 14.88 OXT ACT D 201 C 138 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -37.45 62.38 49.17 -37.97 63.55 50.01 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 29 3 # 29 C 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 C 126 ARG C 58 ARG~? 18.03 CH3 ACT C 201 C 138 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -27.55 53.08 48.63 -27.85 52.13 47.47 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -22.97 47.67 45.60 -22.11 45.78 43.37 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 30 3 # 30 C 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 C 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s C 138 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -27.55 53.08 48.63 -27.85 52.13 47.47 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -34.72 50.67 45.47 -36.40 51.18 47.99 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 31 3 # 31 C 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 C 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s C 138 GLU C 60 GLU~? 17.22 OXT ACT C 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -27.55 53.08 48.63 -27.85 52.13 47.47 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -34.72 50.67 45.47 -36.40 51.18 47.99 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -23.89 57.63 47.43 -24.47 59.50 46.62 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 32 3 # 32 C 124 ALA C 63 ALA~? 11.78 O2 EDO A 302 C 126 ARG A 67 ARG~? 13.20 O2 EDO A 302 C 138 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -25.32 54.06 53.50 -24.62 55.35 53.10 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 33 3 # 33 C 124 ALA C 90 ALA^? 13.74 CH3 ACT C 201 C 126 ARG D 88 ARG^? 18.35 CH3 ACT C 201 C 138 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -43.56 47.44 39.16 -44.76 48.04 38.47 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -52.23 44.53 37.75 -52.43 42.56 40.08 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 34 3 # 34 C 124 ALA C 94 ALA^? 9.20 O ACT C 201 C 126 ARG C 92 ARG^? 13.71 CH3 ACT C 201 C 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -45.79 46.91 52.91 -47.22 46.56 53.32 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 35 3 # 35 C 124 ALA C 94 ALA^? 9.20 O ACT C 201 C 126 ARG C 92 ARG^? 13.71 CH3 ACT C 201 C 138 GLU C 96 GLU^? 13.00 O ACT C 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -45.79 46.91 52.91 -47.22 46.56 53.32 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 36 3 # 36 C 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 C 126 ARG D 8 ARG.? 14.56 CH3 ACT D 201 C 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -64.40 57.42 32.12 -63.44 60.33 32.35 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 37 3 # 37 C 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 C 126 ARG D 8 ARG.? 14.56 CH3 ACT D 201 C 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -64.40 57.42 32.12 -63.44 60.33 32.35 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 38 3 # 38 C 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 C 126 ARG D 24 ARG~? 13.98 CH3 ACT D 201 C 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -50.90 63.83 27.93 -49.90 66.74 27.73 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 39 3 # 39 C 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 C 126 ARG D 124 ARG.? -3.55 O ACT D 201s C 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 40 3 # 40 C 124 ALA D 52 ALA.? 10.75 O ACT A 203 C 126 ARG C 106 ARG^? 14.47 O2 EDO A 301 C 138 GLU D 53 GLU^? 10.32 O ACT A 203 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -52.10 56.30 54.26 -51.39 56.64 55.56 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -49.78 47.48 57.01 -51.73 47.13 59.31 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -56.60 59.52 53.75 -57.18 61.28 52.77 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 41 3 # 41 C 124 ALA D 61 ALA~? 11.20 O ACT D 201 C 126 ARG D 124 ARG.? -3.55 O ACT D 201s C 138 GLU D 59 GLU~? 18.52 O ACT D 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -62.57 59.32 46.16 -62.47 58.52 44.86 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -69.73 60.64 47.66 -70.08 62.16 46.23 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 42 3 # 42 C 124 ALA D 61 ALA~? 11.20 O ACT D 201 C 126 ARG D 124 ARG.? -3.55 O ACT D 201s C 138 GLU D 60 GLU~? 17.31 O ACT D 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -62.57 59.32 46.16 -62.47 58.52 44.86 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -66.09 57.03 50.37 -65.56 55.61 51.84 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 43 3 # 43 C 124 ALA D 90 ALA^? 13.83 CH3 ACT D 201 C 126 ARG C 88 ARG^? 18.42 CH3 ACT D 201 C 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -47.67 51.24 36.64 -46.49 50.32 36.92 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -39.31 50.22 32.74 -39.14 52.99 31.45 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 44 3 # 44 C 124 ALA D 94 ALA^? 9.22 CH3 ACT D 201 C 126 ARG D 92 ARG^? 13.56 CH3 ACT D 201 C 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -44.41 64.30 40.02 -42.98 64.70 39.67 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 45 3 # 45 C 124 ALA D 94 ALA^? 9.22 CH3 ACT D 201 C 126 ARG D 92 ARG^? 13.56 CH3 ACT D 201 C 138 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -44.41 64.30 40.02 -42.98 64.70 39.67 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -43.29 70.99 40.99 -41.92 72.19 39.92 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 45 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 D 126 ARG A 8 ARG.? 15.23 CH3 ACT A 201 D 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 6.23 0.50 57.10 5.93 0.72 59.19 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 D 126 ARG A 8 ARG.? 15.23 CH3 ACT A 201 D 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 6.23 0.50 57.10 5.93 0.72 59.19 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 D 126 ARG A 24 ARG~? 13.97 CH3 ACT A 201 D 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 6.23 0.50 57.10 5.93 0.72 59.19 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 D 126 ARG A 37 ARG~? 13.73 CH3 ACT A 201 D 138 GLU A 21 GLU~? 19.20 CH3 ACT A 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -28.83 80.54 58.97 -30.62 82.33 60.70 coo 6.23 0.50 57.10 5.93 0.72 59.19 -26.74 85.39 73.13 -25.47 87.07 73.30 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 D 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 D 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s D 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -28.72 78.00 67.87 -28.24 76.96 68.88 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 6.23 0.50 57.10 5.93 0.72 59.19 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 D 124 ALA A 52 ALA.? 7.92 O2 EDO A 302 D 126 ARG B 106 ARG^? 5.91 C1 EDO A 302 D 138 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -28.67 56.33 66.41 -29.48 55.05 66.20 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 6.23 0.50 57.10 5.93 0.72 59.19 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 D 124 ALA A 55 ALA^? 10.63 O1 EDO A 302 D 126 ARG C 67 ARG~? 12.50 O2 EDO A 302 D 138 GLU B 160 GLU.? 4.71 OXT ACT A 202 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -21.44 62.27 61.83 -22.27 63.55 61.72 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 6.23 0.50 57.10 5.93 0.72 59.19 -17.96 60.58 68.89 -19.86 60.60 67.97 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 D 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 D 126 ARG A 58 ARG~? 18.13 CH3 ACT A 201 D 138 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -23.47 66.96 59.63 -22.85 67.97 60.60 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 6.23 0.50 57.10 5.93 0.72 59.19 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 D 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 D 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s D 138 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -23.47 66.96 59.63 -22.85 67.97 60.60 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 6.23 0.50 57.10 5.93 0.72 59.19 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 D 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 D 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s D 138 GLU A 60 GLU~? 10.63 O2 EDO A 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -23.47 66.96 59.63 -22.85 67.97 60.60 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 6.23 0.50 57.10 5.93 0.72 59.19 -19.73 62.99 57.19 -19.03 61.21 58.09 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 D 124 ALA A 63 ALA~? 14.85 OXT ACT A 201 D 126 ARG C 67 ARG~? 12.50 O2 EDO A 302 D 138 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -25.75 65.96 54.80 -24.85 64.81 54.40 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 6.23 0.50 57.10 5.93 0.72 59.19 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 D 124 ALA A 90 ALA^? 13.57 O ACT A 202 D 126 ARG B 88 ARG^? 18.43 CH3 ACT A 201 D 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -27.00 70.90 78.40 -27.10 70.23 79.75 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 6.23 0.50 57.10 5.93 0.72 59.19 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 D 124 ALA A 94 ALA^? 9.17 CH3 ACT A 201 D 126 ARG A 92 ARG^? 14.09 CH3 ACT A 201 D 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -39.00 70.14 71.43 -40.24 70.27 72.30 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 6.23 0.50 57.10 5.93 0.72 59.19 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 D 124 ALA A 94 ALA^? 9.17 CH3 ACT A 201 D 126 ARG A 92 ARG^? 14.09 CH3 ACT A 201 D 138 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -39.00 70.14 71.43 -40.24 70.27 72.30 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 6.23 0.50 57.10 5.93 0.72 59.19 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 D 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 D 126 ARG B 8 ARG.? 14.49 CH3 ACT B 201 D 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -27.84 56.51 90.43 -28.15 57.77 89.64 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 6.23 0.50 57.10 5.93 0.72 59.19 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 D 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 D 126 ARG B 8 ARG.? 14.49 CH3 ACT B 201 D 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -27.84 56.51 90.43 -28.15 57.77 89.64 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 6.23 0.50 57.10 5.93 0.72 59.19 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 3 # 17 D 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 D 126 ARG B 24 ARG~? 14.02 CH3 ACT B 201 D 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -27.84 56.51 90.43 -28.15 57.77 89.64 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 6.23 0.50 57.10 5.93 0.72 59.19 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 3 # 18 D 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 D 126 ARG B 124 ARG.? -3.52 O ACT B 201s D 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -27.84 56.51 90.43 -28.15 57.77 89.64 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 6.23 0.50 57.10 5.93 0.72 59.19 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 3 # 19 D 124 ALA B 52 ALA.? 10.80 O1 EDO A 301 D 126 ARG A 106 ARG^? 14.48 O1 EDO A 301 D 138 GLU B 53 GLU^? 11.09 O ACT B 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -42.54 59.91 74.80 -43.03 59.60 73.39 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 6.23 0.50 57.10 5.93 0.72 59.19 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 20 3 # 20 D 124 ALA B 61 ALA~? 11.33 O ACT B 201 D 126 ARG B 58 ARG~? 17.86 CH3 ACT B 201 D 138 GLU B 53 GLU^? 11.09 O ACT B 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -42.38 55.75 87.87 -41.49 56.65 88.72 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 6.23 0.50 57.10 5.93 0.72 59.19 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 21 3 # 21 D 124 ALA B 61 ALA~? 11.33 O ACT B 201 D 126 ARG B 124 ARG.? -3.52 O ACT B 201s D 138 GLU B 59 GLU~? 20.69 O ACT B 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -42.38 55.75 87.87 -41.49 56.65 88.72 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 6.23 0.50 57.10 5.93 0.72 59.19 -47.90 53.57 92.50 -49.95 53.72 93.03 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 22 3 # 22 D 124 ALA B 61 ALA~? 11.33 O ACT B 201 D 126 ARG B 124 ARG.? -3.52 O ACT B 201s D 138 GLU B 60 GLU~? 17.33 O ACT B 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -42.38 55.75 87.87 -41.49 56.65 88.72 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -35.55 59.87 85.38 -34.97 57.89 83.09 coo 6.23 0.50 57.10 5.93 0.72 59.19 -48.17 57.12 87.93 -49.17 58.57 86.76 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 23 3 # 23 D 124 ALA B 90 ALA^? 13.05 O ACT A 202 D 126 ARG A 88 ARG^? 11.13 CH3 ACT A 202 D 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -27.07 66.85 82.98 -26.70 67.91 81.96 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 6.23 0.50 57.10 5.93 0.72 59.19 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 24 3 # 24 D 124 ALA B 94 ALA^? 5.26 CH3 ACT A 202 D 126 ARG B 92 ARG^? -3.69 CH3 ACT A 202s D 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -25.63 54.27 77.41 -24.43 54.15 76.47 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 6.23 0.50 57.10 5.93 0.72 59.19 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 25 3 # 25 D 124 ALA B 94 ALA^? 5.26 CH3 ACT A 202 D 126 ARG B 92 ARG^? -3.69 CH3 ACT A 202s D 138 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -25.63 54.27 77.41 -24.43 54.15 76.47 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 6.23 0.50 57.10 5.93 0.72 59.19 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 26 3 # 26 D 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 D 126 ARG C 8 ARG.? 14.74 CH3 ACT C 201 D 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 6.23 0.50 57.10 5.93 0.72 59.19 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 27 3 # 27 D 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 D 126 ARG C 8 ARG.? 14.74 CH3 ACT C 201 D 138 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 6.23 0.50 57.10 5.93 0.72 59.19 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 28 3 # 28 D 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 D 126 ARG C 24 ARG~? 14.09 CH3 ACT C 201 D 138 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -40.53 35.15 48.39 -41.31 34.14 51.19 coo 6.23 0.50 57.10 5.93 0.72 59.19 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 29 3 # 29 D 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 D 126 ARG C 37 ARG~? 13.73 CH3 ACT C 201 D 138 GLU C 21 GLU~? 19.29 CH3 ACT C 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -28.52 38.86 52.29 -30.70 36.70 52.27 coo 6.23 0.50 57.10 5.93 0.72 59.19 -37.51 33.35 41.29 -36.60 32.00 39.94 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 30 3 # 30 D 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 D 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s D 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -35.58 40.78 46.69 -36.15 41.81 45.72 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 6.23 0.50 57.10 5.93 0.72 59.19 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 31 3 # 31 D 124 ALA C 52 ALA.? 12.19 C2 EDO A 301 D 126 ARG D 106 ARG^? 14.88 OXT ACT D 201 D 138 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -37.45 62.38 49.17 -37.97 63.55 50.01 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 6.23 0.50 57.10 5.93 0.72 59.19 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 32 3 # 32 D 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 D 126 ARG C 58 ARG~? 18.03 CH3 ACT C 201 D 138 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -27.55 53.08 48.63 -27.85 52.13 47.47 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 6.23 0.50 57.10 5.93 0.72 59.19 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 33 3 # 33 D 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 D 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s D 138 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -27.55 53.08 48.63 -27.85 52.13 47.47 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 6.23 0.50 57.10 5.93 0.72 59.19 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 34 3 # 34 D 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 D 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s D 138 GLU C 60 GLU~? 17.22 OXT ACT C 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -27.55 53.08 48.63 -27.85 52.13 47.47 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 6.23 0.50 57.10 5.93 0.72 59.19 -23.89 57.63 47.43 -24.47 59.50 46.62 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 35 3 # 35 D 124 ALA C 63 ALA~? 11.78 O2 EDO A 302 D 126 ARG A 67 ARG~? 13.20 O2 EDO A 302 D 138 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -25.32 54.06 53.50 -24.62 55.35 53.10 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 6.23 0.50 57.10 5.93 0.72 59.19 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 36 3 # 36 D 124 ALA C 90 ALA^? 13.74 CH3 ACT C 201 D 126 ARG D 88 ARG^? 18.35 CH3 ACT C 201 D 138 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -43.56 47.44 39.16 -44.76 48.04 38.47 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 6.23 0.50 57.10 5.93 0.72 59.19 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 37 3 # 37 D 124 ALA C 94 ALA^? 9.20 O ACT C 201 D 126 ARG C 92 ARG^? 13.71 CH3 ACT C 201 D 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -45.79 46.91 52.91 -47.22 46.56 53.32 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 6.23 0.50 57.10 5.93 0.72 59.19 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 38 3 # 38 D 124 ALA C 94 ALA^? 9.20 O ACT C 201 D 126 ARG C 92 ARG^? 13.71 CH3 ACT C 201 D 138 GLU C 96 GLU^? 13.00 O ACT C 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -45.79 46.91 52.91 -47.22 46.56 53.32 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 6.23 0.50 57.10 5.93 0.72 59.19 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 39 3 # 39 D 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 D 126 ARG D 8 ARG.? 14.56 CH3 ACT D 201 D 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -55.52 60.76 33.28 -54.94 59.51 33.93 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 6.23 0.50 57.10 5.93 0.72 59.19 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 40 3 # 40 D 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 D 126 ARG D 8 ARG.? 14.56 CH3 ACT D 201 D 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -55.52 60.76 33.28 -54.94 59.51 33.93 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 6.23 0.50 57.10 5.93 0.72 59.19 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 41 3 # 41 D 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 D 126 ARG D 24 ARG~? 13.98 CH3 ACT D 201 D 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -55.52 60.76 33.28 -54.94 59.51 33.93 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 6.23 0.50 57.10 5.93 0.72 59.19 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 42 3 # 42 D 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 D 126 ARG D 124 ARG.? -3.55 O ACT D 201s D 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -55.52 60.76 33.28 -54.94 59.51 33.93 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 6.23 0.50 57.10 5.93 0.72 59.19 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 43 3 # 43 D 124 ALA D 52 ALA.? 10.75 O ACT A 203 D 126 ARG C 106 ARG^? 14.47 O2 EDO A 301 D 138 GLU D 53 GLU^? 10.32 O ACT A 203 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -52.10 56.30 54.26 -51.39 56.64 55.56 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 6.23 0.50 57.10 5.93 0.72 59.19 -56.60 59.52 53.75 -57.18 61.28 52.77 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 44 3 # 44 D 124 ALA D 61 ALA~? 11.20 O ACT D 201 D 126 ARG D 124 ARG.? -3.55 O ACT D 201s D 138 GLU D 59 GLU~? 18.52 O ACT D 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -62.57 59.32 46.16 -62.47 58.52 44.86 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 6.23 0.50 57.10 5.93 0.72 59.19 -69.73 60.64 47.66 -70.08 62.16 46.23 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 45 3 # 45 D 124 ALA D 61 ALA~? 11.20 O ACT D 201 D 126 ARG D 124 ARG.? -3.55 O ACT D 201s D 138 GLU D 60 GLU~? 17.31 O ACT D 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -62.57 59.32 46.16 -62.47 58.52 44.86 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -55.86 56.60 42.20 -53.99 58.76 43.32 coo 6.23 0.50 57.10 5.93 0.72 59.19 -66.09 57.03 50.37 -65.56 55.61 51.84 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 46 3 # 46 D 124 ALA D 90 ALA^? 13.83 CH3 ACT D 201 D 126 ARG C 88 ARG^? 18.42 CH3 ACT D 201 D 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -47.67 51.24 36.64 -46.49 50.32 36.92 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 6.23 0.50 57.10 5.93 0.72 59.19 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 47 3 # 47 D 124 ALA D 94 ALA^? 9.22 CH3 ACT D 201 D 126 ARG D 92 ARG^? 13.56 CH3 ACT D 201 D 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -44.41 64.30 40.02 -42.98 64.70 39.67 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 6.23 0.50 57.10 5.93 0.72 59.19 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 48 3 # 48 D 124 ALA D 94 ALA^? 9.22 CH3 ACT D 201 D 126 ARG D 92 ARG^? 13.56 CH3 ACT D 201 D 138 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -44.41 64.30 40.02 -42.98 64.70 39.67 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 6.23 0.50 57.10 5.93 0.72 59.19 -43.29 70.99 40.99 -41.92 72.19 39.92 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 48 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 E 126 ARG A 8 ARG.? 15.23 CH3 ACT A 201 E 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -20.16 79.98 64.14 -22.57 80.76 62.41 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 E 126 ARG A 8 ARG.? 15.23 CH3 ACT A 201 E 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -20.16 79.98 64.14 -22.57 80.76 62.41 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 E 126 ARG A 24 ARG~? 13.97 CH3 ACT A 201 E 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -33.88 82.79 71.01 -36.66 83.48 69.87 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 E 126 ARG A 37 ARG~? 13.73 CH3 ACT A 201 E 138 GLU A 21 GLU~? 19.20 CH3 ACT A 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -28.83 80.54 58.97 -30.62 82.33 60.70 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -26.74 85.39 73.13 -25.47 87.07 73.30 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 E 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 E 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s E 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 E 124 ALA A 52 ALA.? 7.92 O2 EDO A 302 E 126 ARG B 106 ARG^? 5.91 C1 EDO A 302 E 138 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -28.67 56.33 66.41 -29.48 55.05 66.20 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 E 124 ALA A 55 ALA^? 10.63 O1 EDO A 302 E 126 ARG C 67 ARG~? 12.50 O2 EDO A 302 E 138 GLU B 160 GLU.? 4.71 OXT ACT A 202 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -21.44 62.27 61.83 -22.27 63.55 61.72 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -17.96 60.58 68.89 -19.86 60.60 67.97 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 E 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 E 126 ARG A 58 ARG~? 18.13 CH3 ACT A 201 E 138 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -23.47 66.96 59.63 -22.85 67.97 60.60 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -18.95 73.08 58.27 -17.11 75.32 59.26 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 E 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 E 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s E 138 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -23.47 66.96 59.63 -22.85 67.97 60.60 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 E 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 E 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s E 138 GLU A 60 GLU~? 10.63 O2 EDO A 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -23.47 66.96 59.63 -22.85 67.97 60.60 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -19.73 62.99 57.19 -19.03 61.21 58.09 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 E 124 ALA A 63 ALA~? 14.85 OXT ACT A 201 E 126 ARG C 67 ARG~? 12.50 O2 EDO A 302 E 138 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -25.75 65.96 54.80 -24.85 64.81 54.40 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 E 124 ALA A 90 ALA^? 13.57 O ACT A 202 E 126 ARG B 88 ARG^? 18.43 CH3 ACT A 201 E 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -27.00 70.90 78.40 -27.10 70.23 79.75 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -31.74 72.75 86.26 -33.87 74.56 85.05 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 E 124 ALA A 94 ALA^? 9.17 CH3 ACT A 201 E 126 ARG A 92 ARG^? 14.09 CH3 ACT A 201 E 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -39.00 70.14 71.43 -40.24 70.27 72.30 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 E 124 ALA A 94 ALA^? 9.17 CH3 ACT A 201 E 126 ARG A 92 ARG^? 14.09 CH3 ACT A 201 E 138 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -39.00 70.14 71.43 -40.24 70.27 72.30 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 E 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 E 126 ARG B 8 ARG.? 14.49 CH3 ACT B 201 E 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -27.84 56.51 90.43 -28.15 57.77 89.64 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -31.04 58.38 97.06 -32.26 55.57 97.13 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 E 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 E 126 ARG B 8 ARG.? 14.49 CH3 ACT B 201 E 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -27.84 56.51 90.43 -28.15 57.77 89.64 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -31.04 58.38 97.06 -32.26 55.57 97.13 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 3 # 17 E 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 E 126 ARG B 24 ARG~? 14.02 CH3 ACT B 201 E 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -27.84 56.51 90.43 -28.15 57.77 89.64 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -20.35 54.64 90.03 -19.09 51.96 89.19 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 3 # 18 E 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 E 126 ARG B 124 ARG.? -3.52 O ACT B 201s E 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -27.84 56.51 90.43 -28.15 57.77 89.64 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 3 # 19 E 124 ALA B 52 ALA.? 10.80 O1 EDO A 301 E 126 ARG A 106 ARG^? 14.48 O1 EDO A 301 E 138 GLU B 53 GLU^? 11.09 O ACT B 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -42.54 59.91 74.80 -43.03 59.60 73.39 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -44.60 68.65 71.93 -47.65 68.54 71.92 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 20 3 # 20 E 124 ALA B 61 ALA~? 11.33 O ACT B 201 E 126 ARG B 58 ARG~? 17.86 CH3 ACT B 201 E 138 GLU B 53 GLU^? 11.09 O ACT B 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -42.38 55.75 87.87 -41.49 56.65 88.72 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -41.40 56.24 95.43 -40.17 57.59 97.88 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 21 3 # 21 E 124 ALA B 61 ALA~? 11.33 O ACT B 201 E 126 ARG B 124 ARG.? -3.52 O ACT B 201s E 138 GLU B 59 GLU~? 20.69 O ACT B 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -42.38 55.75 87.87 -41.49 56.65 88.72 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -47.90 53.57 92.50 -49.95 53.72 93.03 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 22 3 # 22 E 124 ALA B 61 ALA~? 11.33 O ACT B 201 E 126 ARG B 124 ARG.? -3.52 O ACT B 201s E 138 GLU B 60 GLU~? 17.33 O ACT B 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -42.38 55.75 87.87 -41.49 56.65 88.72 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -48.17 57.12 87.93 -49.17 58.57 86.76 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 23 3 # 23 E 124 ALA B 90 ALA^? 13.05 O ACT A 202 E 126 ARG A 88 ARG^? 11.13 CH3 ACT A 202 E 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -27.07 66.85 82.98 -26.70 67.91 81.96 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -18.98 69.22 79.04 -17.48 66.59 79.46 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 24 3 # 24 E 124 ALA B 94 ALA^? 5.26 CH3 ACT A 202 E 126 ARG B 92 ARG^? -3.69 CH3 ACT A 202s E 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -25.63 54.27 77.41 -24.43 54.15 76.47 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 25 3 # 25 E 124 ALA B 94 ALA^? 5.26 CH3 ACT A 202 E 126 ARG B 92 ARG^? -3.69 CH3 ACT A 202s E 138 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -25.63 54.27 77.41 -24.43 54.15 76.47 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 26 3 # 26 E 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 E 126 ARG C 8 ARG.? 14.74 CH3 ACT C 201 E 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -35.58 40.78 46.69 -36.15 41.81 45.72 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -27.18 40.10 42.21 -27.55 39.63 45.22 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 27 3 # 27 E 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 E 126 ARG C 8 ARG.? 14.74 CH3 ACT C 201 E 138 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -35.58 40.78 46.69 -36.15 41.81 45.72 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -27.18 40.10 42.21 -27.55 39.63 45.22 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 28 3 # 28 E 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 E 126 ARG C 24 ARG~? 14.09 CH3 ACT C 201 E 138 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -35.58 40.78 46.69 -36.15 41.81 45.72 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -40.53 35.15 48.39 -41.31 34.14 51.19 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 29 3 # 29 E 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 E 126 ARG C 37 ARG~? 13.73 CH3 ACT C 201 E 138 GLU C 21 GLU~? 19.29 CH3 ACT C 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -35.58 40.78 46.69 -36.15 41.81 45.72 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -28.52 38.86 52.29 -30.70 36.70 52.27 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -37.51 33.35 41.29 -36.60 32.00 39.94 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 30 3 # 30 E 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 E 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s E 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -35.58 40.78 46.69 -36.15 41.81 45.72 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -34.72 50.67 45.47 -36.40 51.18 47.99 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 31 3 # 31 E 124 ALA C 52 ALA.? 12.19 C2 EDO A 301 E 126 ARG D 106 ARG^? 14.88 OXT ACT D 201 E 138 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -37.45 62.38 49.17 -37.97 63.55 50.01 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 32 3 # 32 E 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 E 126 ARG C 58 ARG~? 18.03 CH3 ACT C 201 E 138 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -27.55 53.08 48.63 -27.85 52.13 47.47 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -22.97 47.67 45.60 -22.11 45.78 43.37 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 33 3 # 33 E 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 E 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s E 138 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -27.55 53.08 48.63 -27.85 52.13 47.47 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -34.72 50.67 45.47 -36.40 51.18 47.99 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 34 3 # 34 E 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 E 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s E 138 GLU C 60 GLU~? 17.22 OXT ACT C 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -27.55 53.08 48.63 -27.85 52.13 47.47 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -34.72 50.67 45.47 -36.40 51.18 47.99 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -23.89 57.63 47.43 -24.47 59.50 46.62 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 35 3 # 35 E 124 ALA C 63 ALA~? 11.78 O2 EDO A 302 E 126 ARG A 67 ARG~? 13.20 O2 EDO A 302 E 138 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -25.32 54.06 53.50 -24.62 55.35 53.10 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 36 3 # 36 E 124 ALA C 90 ALA^? 13.74 CH3 ACT C 201 E 126 ARG D 88 ARG^? 18.35 CH3 ACT C 201 E 138 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -43.56 47.44 39.16 -44.76 48.04 38.47 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -52.23 44.53 37.75 -52.43 42.56 40.08 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 37 3 # 37 E 124 ALA C 94 ALA^? 9.20 O ACT C 201 E 126 ARG C 92 ARG^? 13.71 CH3 ACT C 201 E 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -45.79 46.91 52.91 -47.22 46.56 53.32 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 38 3 # 38 E 124 ALA C 94 ALA^? 9.20 O ACT C 201 E 126 ARG C 92 ARG^? 13.71 CH3 ACT C 201 E 138 GLU C 96 GLU^? 13.00 O ACT C 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -45.79 46.91 52.91 -47.22 46.56 53.32 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 39 3 # 39 E 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 E 126 ARG D 8 ARG.? 14.56 CH3 ACT D 201 E 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -64.40 57.42 32.12 -63.44 60.33 32.35 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 40 3 # 40 E 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 E 126 ARG D 8 ARG.? 14.56 CH3 ACT D 201 E 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -64.40 57.42 32.12 -63.44 60.33 32.35 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 41 3 # 41 E 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 E 126 ARG D 24 ARG~? 13.98 CH3 ACT D 201 E 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -50.90 63.83 27.93 -49.90 66.74 27.73 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 42 3 # 42 E 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 E 126 ARG D 124 ARG.? -3.55 O ACT D 201s E 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 43 3 # 43 E 124 ALA D 52 ALA.? 10.75 O ACT A 203 E 126 ARG C 106 ARG^? 14.47 O2 EDO A 301 E 138 GLU D 53 GLU^? 10.32 O ACT A 203 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -52.10 56.30 54.26 -51.39 56.64 55.56 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -49.78 47.48 57.01 -51.73 47.13 59.31 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -56.60 59.52 53.75 -57.18 61.28 52.77 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 44 3 # 44 E 124 ALA D 61 ALA~? 11.20 O ACT D 201 E 126 ARG D 124 ARG.? -3.55 O ACT D 201s E 138 GLU D 59 GLU~? 18.52 O ACT D 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -62.57 59.32 46.16 -62.47 58.52 44.86 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -69.73 60.64 47.66 -70.08 62.16 46.23 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 45 3 # 45 E 124 ALA D 61 ALA~? 11.20 O ACT D 201 E 126 ARG D 124 ARG.? -3.55 O ACT D 201s E 138 GLU D 60 GLU~? 17.31 O ACT D 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -62.57 59.32 46.16 -62.47 58.52 44.86 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -66.09 57.03 50.37 -65.56 55.61 51.84 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 46 3 # 46 E 124 ALA D 90 ALA^? 13.83 CH3 ACT D 201 E 126 ARG C 88 ARG^? 18.42 CH3 ACT D 201 E 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -47.67 51.24 36.64 -46.49 50.32 36.92 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -39.31 50.22 32.74 -39.14 52.99 31.45 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 47 3 # 47 E 124 ALA D 94 ALA^? 9.22 CH3 ACT D 201 E 126 ARG D 92 ARG^? 13.56 CH3 ACT D 201 E 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -44.41 64.30 40.02 -42.98 64.70 39.67 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 48 3 # 48 E 124 ALA D 94 ALA^? 9.22 CH3 ACT D 201 E 126 ARG D 92 ARG^? 13.56 CH3 ACT D 201 E 138 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -44.41 64.30 40.02 -42.98 64.70 39.67 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -43.29 70.99 40.99 -41.92 72.19 39.92 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 48 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 F 126 ARG A 8 ARG.? 15.23 CH3 ACT A 201 F 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -20.16 79.98 64.14 -22.57 80.76 62.41 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 F 126 ARG A 8 ARG.? 15.23 CH3 ACT A 201 F 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -20.16 79.98 64.14 -22.57 80.76 62.41 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 F 126 ARG A 24 ARG~? 13.97 CH3 ACT A 201 F 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -33.88 82.79 71.01 -36.66 83.48 69.87 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 F 126 ARG A 37 ARG~? 13.73 CH3 ACT A 201 F 138 GLU A 21 GLU~? 19.20 CH3 ACT A 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -28.83 80.54 58.97 -30.62 82.33 60.70 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -26.74 85.39 73.13 -25.47 87.07 73.30 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 F 124 ALA A 26 ALA~? 8.12 CH3 ACT A 201 F 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s F 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -28.72 78.00 67.87 -28.24 76.96 68.88 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 F 124 ALA A 52 ALA.? 7.92 O2 EDO A 302 F 126 ARG B 106 ARG^? 5.91 C1 EDO A 302 F 138 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -28.67 56.33 66.41 -29.48 55.05 66.20 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 F 124 ALA A 55 ALA^? 10.63 O1 EDO A 302 F 126 ARG C 67 ARG~? 12.50 O2 EDO A 302 F 138 GLU B 160 GLU.? 4.71 OXT ACT A 202 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -21.44 62.27 61.83 -22.27 63.55 61.72 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -17.96 60.58 68.89 -19.86 60.60 67.97 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 F 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 F 126 ARG A 58 ARG~? 18.13 CH3 ACT A 201 F 138 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -23.47 66.96 59.63 -22.85 67.97 60.60 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -18.95 73.08 58.27 -17.11 75.32 59.26 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 F 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 F 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s F 138 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -23.47 66.96 59.63 -22.85 67.97 60.60 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 F 124 ALA A 61 ALA~? 11.27 OXT ACT A 201 F 126 ARG A 124 ARG.? -3.54 OXT ACT A 201s F 138 GLU A 60 GLU~? 10.63 O2 EDO A 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -23.47 66.96 59.63 -22.85 67.97 60.60 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -19.73 62.99 57.19 -19.03 61.21 58.09 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 F 124 ALA A 63 ALA~? 14.85 OXT ACT A 201 F 126 ARG C 67 ARG~? 12.50 O2 EDO A 302 F 138 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -25.75 65.96 54.80 -24.85 64.81 54.40 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 F 124 ALA A 90 ALA^? 13.57 O ACT A 202 F 126 ARG B 88 ARG^? 18.43 CH3 ACT A 201 F 138 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -27.00 70.90 78.40 -27.10 70.23 79.75 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -31.74 72.75 86.26 -33.87 74.56 85.05 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 F 124 ALA A 94 ALA^? 9.17 CH3 ACT A 201 F 126 ARG A 92 ARG^? 14.09 CH3 ACT A 201 F 138 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -39.00 70.14 71.43 -40.24 70.27 72.30 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 F 124 ALA A 94 ALA^? 9.17 CH3 ACT A 201 F 126 ARG A 92 ARG^? 14.09 CH3 ACT A 201 F 138 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -39.00 70.14 71.43 -40.24 70.27 72.30 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 F 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 F 126 ARG B 8 ARG.? 14.49 CH3 ACT B 201 F 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -27.84 56.51 90.43 -28.15 57.77 89.64 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -31.04 58.38 97.06 -32.26 55.57 97.13 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 F 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 F 126 ARG B 8 ARG.? 14.49 CH3 ACT B 201 F 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -27.84 56.51 90.43 -28.15 57.77 89.64 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -31.04 58.38 97.06 -32.26 55.57 97.13 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 3 # 17 F 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 F 126 ARG B 24 ARG~? 14.02 CH3 ACT B 201 F 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -27.84 56.51 90.43 -28.15 57.77 89.64 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -20.35 54.64 90.03 -19.09 51.96 89.19 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 3 # 18 F 124 ALA B 26 ALA~? 8.11 CH3 ACT B 201 F 126 ARG B 124 ARG.? -3.52 O ACT B 201s F 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -27.84 56.51 90.43 -28.15 57.77 89.64 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 3 # 19 F 124 ALA B 52 ALA.? 10.80 O1 EDO A 301 F 126 ARG A 106 ARG^? 14.48 O1 EDO A 301 F 138 GLU B 53 GLU^? 11.09 O ACT B 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -42.54 59.91 74.80 -43.03 59.60 73.39 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -44.60 68.65 71.93 -47.65 68.54 71.92 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 20 3 # 20 F 124 ALA B 61 ALA~? 11.33 O ACT B 201 F 126 ARG B 58 ARG~? 17.86 CH3 ACT B 201 F 138 GLU B 53 GLU^? 11.09 O ACT B 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -42.38 55.75 87.87 -41.49 56.65 88.72 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -41.40 56.24 95.43 -40.17 57.59 97.88 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -44.66 56.42 79.28 -43.94 54.52 79.83 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 21 3 # 21 F 124 ALA B 61 ALA~? 11.33 O ACT B 201 F 126 ARG B 124 ARG.? -3.52 O ACT B 201s F 138 GLU B 59 GLU~? 20.69 O ACT B 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -42.38 55.75 87.87 -41.49 56.65 88.72 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -47.90 53.57 92.50 -49.95 53.72 93.03 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 22 3 # 22 F 124 ALA B 61 ALA~? 11.33 O ACT B 201 F 126 ARG B 124 ARG.? -3.52 O ACT B 201s F 138 GLU B 60 GLU~? 17.33 O ACT B 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -42.38 55.75 87.87 -41.49 56.65 88.72 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -48.17 57.12 87.93 -49.17 58.57 86.76 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 23 3 # 23 F 124 ALA B 90 ALA^? 13.05 O ACT A 202 F 126 ARG A 88 ARG^? 11.13 CH3 ACT A 202 F 138 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -27.07 66.85 82.98 -26.70 67.91 81.96 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -18.98 69.22 79.04 -17.48 66.59 79.46 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 24 3 # 24 F 124 ALA B 94 ALA^? 5.26 CH3 ACT A 202 F 126 ARG B 92 ARG^? -3.69 CH3 ACT A 202s F 138 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -25.63 54.27 77.41 -24.43 54.15 76.47 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 25 3 # 25 F 124 ALA B 94 ALA^? 5.26 CH3 ACT A 202 F 126 ARG B 92 ARG^? -3.69 CH3 ACT A 202s F 138 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -25.63 54.27 77.41 -24.43 54.15 76.47 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 26 3 # 26 F 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 F 126 ARG C 8 ARG.? 14.74 CH3 ACT C 201 F 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -35.58 40.78 46.69 -36.15 41.81 45.72 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -27.18 40.10 42.21 -27.55 39.63 45.22 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 27 3 # 27 F 124 ALA C 26 ALA~? 8.20 CH3 ACT C 201 F 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s F 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -35.58 40.78 46.69 -36.15 41.81 45.72 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -34.72 50.67 45.47 -36.40 51.18 47.99 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 28 3 # 28 F 124 ALA C 52 ALA.? 12.19 C2 EDO A 301 F 126 ARG D 106 ARG^? 14.88 OXT ACT D 201 F 138 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -37.45 62.38 49.17 -37.97 63.55 50.01 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 29 3 # 29 F 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 F 126 ARG C 58 ARG~? 18.03 CH3 ACT C 201 F 138 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -27.55 53.08 48.63 -27.85 52.13 47.47 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -22.97 47.67 45.60 -22.11 45.78 43.37 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 30 3 # 30 F 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 F 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s F 138 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -27.55 53.08 48.63 -27.85 52.13 47.47 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -34.72 50.67 45.47 -36.40 51.18 47.99 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 31 3 # 31 F 124 ALA C 61 ALA~? 11.19 OXT ACT C 201 F 126 ARG C 124 ARG.? -3.50 OXT ACT C 201s F 138 GLU C 60 GLU~? 17.22 OXT ACT C 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -27.55 53.08 48.63 -27.85 52.13 47.47 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -34.72 50.67 45.47 -36.40 51.18 47.99 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -23.89 57.63 47.43 -24.47 59.50 46.62 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 32 3 # 32 F 124 ALA C 63 ALA~? 11.78 O2 EDO A 302 F 126 ARG A 67 ARG~? 13.20 O2 EDO A 302 F 138 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -25.32 54.06 53.50 -24.62 55.35 53.10 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 33 3 # 33 F 124 ALA C 90 ALA^? 13.74 CH3 ACT C 201 F 126 ARG D 88 ARG^? 18.35 CH3 ACT C 201 F 138 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -43.56 47.44 39.16 -44.76 48.04 38.47 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -52.23 44.53 37.75 -52.43 42.56 40.08 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 34 3 # 34 F 124 ALA C 94 ALA^? 9.20 O ACT C 201 F 126 ARG C 92 ARG^? 13.71 CH3 ACT C 201 F 138 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -45.79 46.91 52.91 -47.22 46.56 53.32 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 35 3 # 35 F 124 ALA C 94 ALA^? 9.20 O ACT C 201 F 126 ARG C 92 ARG^? 13.71 CH3 ACT C 201 F 138 GLU C 96 GLU^? 13.00 O ACT C 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -45.79 46.91 52.91 -47.22 46.56 53.32 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 36 3 # 36 F 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 F 126 ARG D 8 ARG.? 14.56 CH3 ACT D 201 F 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -64.40 57.42 32.12 -63.44 60.33 32.35 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 37 3 # 37 F 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 F 126 ARG D 8 ARG.? 14.56 CH3 ACT D 201 F 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -64.40 57.42 32.12 -63.44 60.33 32.35 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 38 3 # 38 F 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 F 126 ARG D 24 ARG~? 13.98 CH3 ACT D 201 F 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -50.90 63.83 27.93 -49.90 66.74 27.73 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 39 3 # 39 F 124 ALA D 26 ALA~? 8.16 CH3 ACT D 201 F 126 ARG D 124 ARG.? -3.55 O ACT D 201s F 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -55.52 60.76 33.28 -54.94 59.51 33.93 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 40 3 # 40 F 124 ALA D 52 ALA.? 10.75 O ACT A 203 F 126 ARG C 106 ARG^? 14.47 O2 EDO A 301 F 138 GLU D 53 GLU^? 10.32 O ACT A 203 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -52.10 56.30 54.26 -51.39 56.64 55.56 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -49.78 47.48 57.01 -51.73 47.13 59.31 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -56.60 59.52 53.75 -57.18 61.28 52.77 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 41 3 # 41 F 124 ALA D 61 ALA~? 11.20 O ACT D 201 F 126 ARG D 124 ARG.? -3.55 O ACT D 201s F 138 GLU D 59 GLU~? 18.52 O ACT D 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -62.57 59.32 46.16 -62.47 58.52 44.86 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -69.73 60.64 47.66 -70.08 62.16 46.23 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 42 3 # 42 F 124 ALA D 61 ALA~? 11.20 O ACT D 201 F 126 ARG D 124 ARG.? -3.55 O ACT D 201s F 138 GLU D 60 GLU~? 17.31 O ACT D 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -62.57 59.32 46.16 -62.47 58.52 44.86 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -66.09 57.03 50.37 -65.56 55.61 51.84 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 43 3 # 43 F 124 ALA D 90 ALA^? 13.83 CH3 ACT D 201 F 126 ARG C 88 ARG^? 18.42 CH3 ACT D 201 F 138 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -47.67 51.24 36.64 -46.49 50.32 36.92 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -39.31 50.22 32.74 -39.14 52.99 31.45 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 44 3 # 44 F 124 ALA D 94 ALA^? 9.22 CH3 ACT D 201 F 126 ARG D 92 ARG^? 13.56 CH3 ACT D 201 F 138 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -44.41 64.30 40.02 -42.98 64.70 39.67 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 45 3 # 45 F 124 ALA D 94 ALA^? 9.22 CH3 ACT D 201 F 126 ARG D 92 ARG^? 13.56 CH3 ACT D 201 F 138 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -44.41 64.30 40.02 -42.98 64.70 39.67 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -43.29 70.99 40.99 -41.92 72.19 39.92 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 45 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 29 GLY~? 9.49 CH3 ACT A 201 B 175 ARG A 8 ARG.? 15.23 CH3 ACT A 201 B 242 TYR A 42 TYR^? 9.79 CH3 ACT A 201 coo 99.45 58.28 3.33 99.57 58.61 4.10 -30.30 78.71 63.24 -31.02 78.43 63.55 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 100.93 69.04 4.38 99.52 68.48 2.09 -22.07 72.08 64.22 -24.60 72.36 65.39 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 145 GLY.? 13.13 O ACT A 201 B 175 ARG A 76 ARG^? 8.97 OXT ACT A 203 B 242 TYR A 75 TYR^? -4.52 O ACT A 201s coo 99.45 58.28 3.33 99.57 58.61 4.10 -38.43 80.69 60.76 -38.91 80.43 61.42 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 100.93 69.04 4.38 99.52 68.48 2.09 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY A 158 GLY~? 18.81 CH3 ACT A 201 B 175 ARG A 92 ARG^? 14.09 CH3 ACT A 201 B 242 TYR A 108 TYR^? 12.28 O ACT A 201 coo 99.45 58.28 3.33 99.57 58.61 4.10 -45.28 73.93 80.63 -45.09 73.75 79.84 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 100.93 69.04 4.38 99.52 68.48 2.09 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY B 29 GLY~? 9.46 CH3 ACT B 201 B 175 ARG B 8 ARG.? 14.49 CH3 ACT B 201 B 242 TYR B 42 TYR^? 9.74 CH3 ACT B 201 coo 99.45 58.28 3.33 99.57 58.61 4.10 -29.24 51.82 91.44 -28.87 51.66 90.72 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 100.93 69.04 4.38 99.52 68.48 2.09 -37.05 59.03 91.10 -34.97 58.34 89.38 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY B 29 GLY~? 9.46 CH3 ACT B 201 B 175 ARG B 33 ARG.? 12.67 OXT ACT B 201 B 242 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 99.45 58.28 3.33 99.57 58.61 4.10 -29.24 51.82 91.44 -28.87 51.66 90.72 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 100.93 69.04 4.38 99.52 68.48 2.09 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY B 145 GLY.? 13.34 OXT ACT B 201 B 175 ARG B 76 ARG^? 14.33 OXT ACT B 201 B 242 TYR B 75 TYR^? -4.59 OXT ACT B 201s coo 99.45 58.28 3.33 99.57 58.61 4.10 -25.17 44.53 88.88 -24.74 44.79 88.19 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 100.93 69.04 4.38 99.52 68.48 2.09 -30.51 47.57 81.98 -30.49 50.30 82.57 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 7 3 # 7 B 137 GLY C 29 GLY~? 9.51 CH3 ACT C 201 B 175 ARG C 8 ARG.? 14.74 CH3 ACT C 201 B 242 TYR C 42 TYR^? 9.67 CH3 ACT C 201 coo 99.45 58.28 3.33 99.57 58.61 4.10 -32.89 40.21 50.79 -33.62 40.36 51.16 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 100.93 69.04 4.38 99.52 68.48 2.09 -29.49 47.84 44.30 -31.93 47.16 45.50 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 8 3 # 8 B 137 GLY C 29 GLY~? 9.51 CH3 ACT C 201 B 175 ARG C 33 ARG.? 12.41 O ACT C 201 B 242 TYR C 95 TYR^? -3.84 O ACT C 201s coo 99.45 58.28 3.33 99.57 58.61 4.10 -32.89 40.21 50.79 -33.62 40.36 51.16 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 100.93 69.04 4.38 99.52 68.48 2.09 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 9 3 # 9 B 137 GLY C 145 GLY.? 13.18 O ACT C 201 B 175 ARG C 76 ARG^? 14.32 O ACT C 201 B 242 TYR C 75 TYR^? -4.54 O ACT C 201s coo 99.45 58.28 3.33 99.57 58.61 4.10 -35.71 37.24 58.49 -36.57 37.39 58.47 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 100.93 69.04 4.38 99.52 68.48 2.09 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 10 3 # 10 B 137 GLY D 29 GLY~? 9.48 CH3 ACT D 201 B 175 ARG D 8 ARG.? 14.56 CH3 ACT D 201 B 242 TYR D 42 TYR^? 9.84 CH3 ACT D 201 coo 99.45 58.28 3.33 99.57 58.61 4.10 -57.91 65.08 34.12 -57.15 65.32 34.32 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -64.40 57.42 32.12 -63.44 60.33 32.35 coo 100.93 69.04 4.38 99.52 68.48 2.09 -61.35 56.68 39.82 -58.87 57.88 39.36 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 11 3 # 11 B 137 GLY D 29 GLY~? 9.48 CH3 ACT D 201 B 175 ARG D 33 ARG.? 12.34 OXT ACT D 201 B 242 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 99.45 58.28 3.33 99.57 58.61 4.10 -57.91 65.08 34.12 -57.15 65.32 34.32 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -55.21 72.58 39.53 -56.74 74.11 37.37 coo 100.93 69.04 4.38 99.52 68.48 2.09 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 12 3 # 12 B 137 GLY D 145 GLY.? 13.27 OXT ACT D 201 B 175 ARG D 76 ARG^? 14.20 OXT ACT D 201 B 242 TYR D 75 TYR^? -4.49 OXT ACT D 201s coo 99.45 58.28 3.33 99.57 58.61 4.10 -54.58 73.10 33.20 -53.72 72.98 33.25 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 100.93 69.04 4.38 99.52 68.48 2.09 -52.06 69.71 41.47 -52.08 66.98 40.85 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 12 hits 1xva_c03 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 68 LYS~? -2.78 O ACT A 201s A 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 18.28 7.83 36.39 22.82 8.75 39.52 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 14.16 13.09 37.03 20.00 12.44 37.49 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 22.22 16.06 48.76 23.94 15.33 49.78 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 68 LYS~? -2.78 O ACT A 201s A 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 165 GLU C 72 GLU~? 5.32 O ACT C 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 14.16 13.09 37.03 20.00 12.44 37.49 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 22.22 16.06 48.76 23.94 15.33 49.78 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 68 LYS~? -2.78 O ACT A 201s A 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 165 GLU D 137 GLU~? 19.20 CH3 ACT A 203 coo 18.28 7.83 36.39 22.82 8.75 39.52 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 14.16 13.09 37.03 20.00 12.44 37.49 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 22.22 16.06 48.76 23.94 15.33 49.78 -34.89 75.05 43.86 -34.35 73.81 45.48 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 74 LYS A 68 LYS~? -2.78 O ACT A 201s A 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 18.28 7.83 36.39 22.82 8.75 39.52 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 14.16 13.09 37.03 20.00 12.44 37.49 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 22.22 16.06 48.76 23.94 15.33 49.78 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 74 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 14.16 13.09 37.03 20.00 12.44 37.49 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 22.22 16.06 48.76 23.94 15.33 49.78 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 74 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 14.16 13.09 37.03 20.00 12.44 37.49 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 22.22 16.06 48.76 23.94 15.33 49.78 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS C 68 LYS~? -2.77 O ACT C 201s A 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 165 GLU A 72 GLU~? 5.31 O ACT A 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 14.16 13.09 37.03 20.00 12.44 37.49 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 22.22 16.06 48.76 23.94 15.33 49.78 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS C 68 LYS~? -2.77 O ACT C 201s A 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 14.16 13.09 37.03 20.00 12.44 37.49 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 22.22 16.06 48.76 23.94 15.33 49.78 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 74 LYS C 68 LYS~? -2.77 O ACT C 201s A 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 14.16 13.09 37.03 20.00 12.44 37.49 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 22.22 16.06 48.76 23.94 15.33 49.78 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 74 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 14.16 13.09 37.03 20.00 12.44 37.49 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 22.22 16.06 48.76 23.94 15.33 49.78 -43.29 70.99 40.99 -41.92 72.19 39.92 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 74 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 14.16 13.09 37.03 20.00 12.44 37.49 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 22.22 16.06 48.76 23.94 15.33 49.78 -43.29 70.99 40.99 -41.92 72.19 39.92 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 11 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 68 LYS~? -2.78 O ACT A 201s B 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 13.51 0.92 76.10 12.98 6.13 74.68 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 21.39 11.56 68.52 20.24 13.13 67.73 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 68 LYS~? -2.78 O ACT A 201s B 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 165 GLU C 72 GLU~? 5.32 O ACT C 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 21.39 11.56 68.52 20.24 13.13 67.73 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 68 LYS~? -2.78 O ACT A 201s B 74 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 165 GLU D 137 GLU~? 19.20 CH3 ACT A 203 coo 13.51 0.92 76.10 12.98 6.13 74.68 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 21.39 11.56 68.52 20.24 13.13 67.73 -34.89 75.05 43.86 -34.35 73.81 45.48 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 74 LYS A 68 LYS~? -2.78 O ACT A 201s B 165 GLU A 96 GLU^? 11.70 OXT ACT A 203 coo 13.51 0.92 76.10 12.98 6.13 74.68 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 21.39 11.56 68.52 20.24 13.13 67.73 -44.74 70.71 67.91 -46.53 71.68 68.48 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 74 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 21.39 11.56 68.52 20.24 13.13 67.73 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 74 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 165 GLU B 96 GLU^? 10.60 C1 EDO A 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 21.39 11.56 68.52 20.24 13.13 67.73 -24.44 47.78 75.39 -22.51 46.98 75.05 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS C 68 LYS~? -2.77 O ACT C 201s B 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 165 GLU A 72 GLU~? 5.31 O ACT A 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 21.39 11.56 68.52 20.24 13.13 67.73 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS C 68 LYS~? -2.77 O ACT C 201s B 74 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 21.39 11.56 68.52 20.24 13.13 67.73 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 74 LYS C 68 LYS~? -2.77 O ACT C 201s B 165 GLU C 96 GLU^? 13.00 O ACT C 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 21.39 11.56 68.52 20.24 13.13 67.73 -46.59 45.81 59.59 -47.94 44.44 60.43 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 74 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 21.39 11.56 68.52 20.24 13.13 67.73 -43.29 70.99 40.99 -41.92 72.19 39.92 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 74 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 165 GLU D 96 GLU^? 13.00 OXT ACT D 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 21.39 11.56 68.52 20.24 13.13 67.73 -43.29 70.99 40.99 -41.92 72.19 39.92 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 11 hits 1ylu_c01 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 30 TRP~? -4.28 CH3 ACT A 201s 223 ASP A 28 ASP~? 12.70 CH3 ACT A 201 258 ALA A 19 ALA~? 16.44 CH3 ACT A 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 127.91 41.73 23.55 129.18 40.35 24.44 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 141.00 37.49 25.74 139.80 37.53 24.78 -25.44 80.18 77.74 -25.49 79.27 78.96 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 3 # 2 142 TRP A 30 TRP~? -4.28 CH3 ACT A 201s 223 ASP A 28 ASP~? 12.70 CH3 ACT A 201 258 ALA A 94 ALA^? 9.17 CH3 ACT A 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 127.91 41.73 23.55 129.18 40.35 24.44 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 141.00 37.49 25.74 139.80 37.53 24.78 -39.00 70.14 71.43 -40.24 70.27 72.30 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 3 3 # 3 142 TRP A 30 TRP~? -4.28 CH3 ACT A 201s 223 ASP A 34 ASP~? 14.63 O ACT A 201 258 ALA A 63 ALA~? 14.85 OXT ACT A 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 127.91 41.73 23.55 129.18 40.35 24.44 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 141.00 37.49 25.74 139.80 37.53 24.78 -25.75 65.96 54.80 -24.85 64.81 54.40 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 4 3 # 4 142 TRP A 30 TRP~? -4.28 CH3 ACT A 201s 223 ASP A 34 ASP~? 14.63 O ACT A 201 258 ALA A 70 ALA~? 12.37 C2 EDO A 301 coo 128.40 33.01 26.67 128.12 36.28 28.81 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 127.91 41.73 23.55 129.18 40.35 24.44 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 141.00 37.49 25.74 139.80 37.53 24.78 -36.52 66.89 53.48 -35.54 66.12 52.61 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 5 3 # 5 142 TRP A 69 TRP~? 6.39 O ACT A 201 223 ASP A 34 ASP~? 14.63 O ACT A 201 258 ALA A 26 ALA~? 8.12 CH3 ACT A 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 127.91 41.73 23.55 129.18 40.35 24.44 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 141.00 37.49 25.74 139.80 37.53 24.78 -28.72 78.00 67.87 -28.24 76.96 68.88 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 6 3 # 6 142 TRP A 69 TRP~? 6.39 O ACT A 201 223 ASP A 34 ASP~? 14.63 O ACT A 201 258 ALA A 61 ALA~? 11.27 OXT ACT A 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 127.91 41.73 23.55 129.18 40.35 24.44 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 141.00 37.49 25.74 139.80 37.53 24.78 -23.47 66.96 59.63 -22.85 67.97 60.60 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 7 3 # 7 142 TRP A 69 TRP~? 6.39 O ACT A 201 223 ASP A 34 ASP~? 14.63 O ACT A 201 258 ALA A 63 ALA~? 14.85 OXT ACT A 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 127.91 41.73 23.55 129.18 40.35 24.44 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 141.00 37.49 25.74 139.80 37.53 24.78 -25.75 65.96 54.80 -24.85 64.81 54.40 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 8 3 # 8 142 TRP A 69 TRP~? 6.39 O ACT A 201 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 258 ALA A 94 ALA^? 9.17 CH3 ACT A 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 127.91 41.73 23.55 129.18 40.35 24.44 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 141.00 37.49 25.74 139.80 37.53 24.78 -39.00 70.14 71.43 -40.24 70.27 72.30 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 9 3 # 9 142 TRP A 69 TRP~? 6.39 O ACT A 201 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 258 ALA C 52 ALA.? 12.19 C2 EDO A 301 coo 128.40 33.01 26.67 128.12 36.28 28.81 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 127.91 41.73 23.55 129.18 40.35 24.44 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 141.00 37.49 25.74 139.80 37.53 24.78 -37.45 62.38 49.17 -37.97 63.55 50.01 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 10 3 # 10 142 TRP A 82 TRP^? 14.68 O ACT B 201 223 ASP B 86 ASP.? 24.07 CH3 ACT B 201 258 ALA A 19 ALA~? 16.44 CH3 ACT A 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -30.38 69.86 83.05 -34.07 70.22 84.37 coo 127.91 41.73 23.55 129.18 40.35 24.44 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 141.00 37.49 25.74 139.80 37.53 24.78 -25.44 80.18 77.74 -25.49 79.27 78.96 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 11 3 # 11 142 TRP A 82 TRP^? 14.68 O ACT B 201 223 ASP B 86 ASP.? 24.07 CH3 ACT B 201 258 ALA B 122 ALA.? 16.89 O ACT B 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -30.38 69.86 83.05 -34.07 70.22 84.37 coo 127.91 41.73 23.55 129.18 40.35 24.44 -28.16 75.31 91.23 -27.42 77.23 90.74 coo 141.00 37.49 25.74 139.80 37.53 24.78 -38.29 65.93 91.61 -38.40 67.34 92.16 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 12 3 # 12 142 TRP A 97 TRP^? -5.71 O1 EDO A 301s 223 ASP A 99 ASP.? 5.71 O2 EDO A 301 258 ALA A 135 ALA~? 6.35 OXT ACT A 203 coo 128.40 33.01 26.67 128.12 36.28 28.81 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 127.91 41.73 23.55 129.18 40.35 24.44 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 141.00 37.49 25.74 139.80 37.53 24.78 -52.93 68.60 64.38 -53.51 68.88 63.01 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 13 3 # 13 142 TRP A 104 TRP^? -4.29 OXT ACT A 203s 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 258 ALA A 94 ALA^? 9.17 CH3 ACT A 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 127.91 41.73 23.55 129.18 40.35 24.44 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 141.00 37.49 25.74 139.80 37.53 24.78 -39.00 70.14 71.43 -40.24 70.27 72.30 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 14 3 # 14 142 TRP A 142 TRP.? 12.79 O ACT A 201 223 ASP A 28 ASP~? 12.70 CH3 ACT A 201 258 ALA A 94 ALA^? 9.17 CH3 ACT A 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -42.03 80.57 64.19 -41.88 78.10 67.25 coo 127.91 41.73 23.55 129.18 40.35 24.44 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 141.00 37.49 25.74 139.80 37.53 24.78 -39.00 70.14 71.43 -40.24 70.27 72.30 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 15 3 # 15 142 TRP A 142 TRP.? 12.79 O ACT A 201 223 ASP A 74 ASP^? 5.73 OXT ACT A 203 258 ALA A 94 ALA^? 9.17 CH3 ACT A 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -42.03 80.57 64.19 -41.88 78.10 67.25 coo 127.91 41.73 23.55 129.18 40.35 24.44 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 141.00 37.49 25.74 139.80 37.53 24.78 -39.00 70.14 71.43 -40.24 70.27 72.30 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 16 3 # 16 142 TRP A 142 TRP.? 12.79 O ACT A 201 223 ASP A 149 ASP.? 18.85 CH3 ACT A 201 258 ALA A 26 ALA~? 8.12 CH3 ACT A 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -42.03 80.57 64.19 -41.88 78.10 67.25 coo 127.91 41.73 23.55 129.18 40.35 24.44 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 141.00 37.49 25.74 139.80 37.53 24.78 -28.72 78.00 67.87 -28.24 76.96 68.88 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 17 3 # 17 142 TRP B 30 TRP~? -4.15 CH3 ACT B 201s 223 ASP B 28 ASP~? 12.70 CH3 ACT B 201 258 ALA B 19 ALA~? 16.58 CH3 ACT B 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -31.05 54.49 87.84 -34.09 54.74 85.35 coo 127.91 41.73 23.55 129.18 40.35 24.44 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 141.00 37.49 25.74 139.80 37.53 24.78 -22.38 65.57 91.21 -22.22 66.67 90.15 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 18 3 # 18 142 TRP B 30 TRP~? -4.15 CH3 ACT B 201s 223 ASP B 28 ASP~? 12.70 CH3 ACT B 201 258 ALA B 94 ALA^? 5.26 CH3 ACT A 202 coo 128.40 33.01 26.67 128.12 36.28 28.81 -31.05 54.49 87.84 -34.09 54.74 85.35 coo 127.91 41.73 23.55 129.18 40.35 24.44 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 141.00 37.49 25.74 139.80 37.53 24.78 -25.63 54.27 77.41 -24.43 54.15 76.47 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 19 3 # 19 142 TRP B 30 TRP~? -4.15 CH3 ACT B 201s 223 ASP B 34 ASP~? 14.61 OXT ACT B 201 258 ALA B 63 ALA~? 14.82 O ACT B 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -31.05 54.49 87.84 -34.09 54.74 85.35 coo 127.91 41.73 23.55 129.18 40.35 24.44 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 141.00 37.49 25.74 139.80 37.53 24.78 -44.69 50.92 87.09 -46.09 51.48 86.89 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 20 3 # 20 142 TRP B 48 TRP^? 8.84 O ACT B 201 223 ASP B 45 ASP^? 20.35 O ACT B 201 258 ALA B 5 ALA.? 18.71 CH3 ACT B 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -39.73 60.89 87.11 -38.13 57.34 86.55 coo 127.91 41.73 23.55 129.18 40.35 24.44 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 141.00 37.49 25.74 139.80 37.53 24.78 -37.78 58.32 101.20 -36.54 58.26 100.29 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 21 3 # 21 142 TRP B 69 TRP~? 6.43 OXT ACT B 201 223 ASP B 34 ASP~? 14.61 OXT ACT B 201 258 ALA B 26 ALA~? 8.11 CH3 ACT B 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -34.09 46.73 83.20 -34.39 49.33 86.13 coo 127.91 41.73 23.55 129.18 40.35 24.44 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 141.00 37.49 25.74 139.80 37.53 24.78 -27.84 56.51 90.43 -28.15 57.77 89.64 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 22 3 # 22 142 TRP B 69 TRP~? 6.43 OXT ACT B 201 223 ASP B 34 ASP~? 14.61 OXT ACT B 201 258 ALA B 61 ALA~? 11.33 O ACT B 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -34.09 46.73 83.20 -34.39 49.33 86.13 coo 127.91 41.73 23.55 129.18 40.35 24.44 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 141.00 37.49 25.74 139.80 37.53 24.78 -42.38 55.75 87.87 -41.49 56.65 88.72 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 23 3 # 23 142 TRP B 69 TRP~? 6.43 OXT ACT B 201 223 ASP B 34 ASP~? 14.61 OXT ACT B 201 258 ALA B 63 ALA~? 14.82 O ACT B 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -34.09 46.73 83.20 -34.39 49.33 86.13 coo 127.91 41.73 23.55 129.18 40.35 24.44 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 141.00 37.49 25.74 139.80 37.53 24.78 -44.69 50.92 87.09 -46.09 51.48 86.89 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 24 3 # 24 142 TRP B 69 TRP~? 6.43 OXT ACT B 201 223 ASP B 74 ASP^? 14.88 OXT ACT B 201 258 ALA B 94 ALA^? 5.26 CH3 ACT A 202 coo 128.40 33.01 26.67 128.12 36.28 28.81 -34.09 46.73 83.20 -34.39 49.33 86.13 coo 127.91 41.73 23.55 129.18 40.35 24.44 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 141.00 37.49 25.74 139.80 37.53 24.78 -25.63 54.27 77.41 -24.43 54.15 76.47 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 25 3 # 25 142 TRP B 82 TRP^? 9.86 O ACT A 202 223 ASP A 86 ASP.? 20.24 CH3 ACT A 202 258 ALA A 122 ALA.? 13.78 OXT ACT A 202 coo 128.40 33.01 26.67 128.12 36.28 28.81 -23.37 68.40 78.71 -20.56 66.90 76.39 coo 127.91 41.73 23.55 129.18 40.35 24.44 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 141.00 37.49 25.74 139.80 37.53 24.78 -16.88 70.35 68.54 -15.61 70.41 69.38 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 26 3 # 26 142 TRP B 82 TRP^? 9.86 O ACT A 202 223 ASP A 86 ASP.? 20.24 CH3 ACT A 202 258 ALA B 19 ALA~? 16.58 CH3 ACT B 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -23.37 68.40 78.71 -20.56 66.90 76.39 coo 127.91 41.73 23.55 129.18 40.35 24.44 -16.25 74.73 81.62 -15.60 74.59 83.62 coo 141.00 37.49 25.74 139.80 37.53 24.78 -22.38 65.57 91.21 -22.22 66.67 90.15 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 27 3 # 27 142 TRP B 97 TRP^? 8.79 OXT ACT B 201 223 ASP B 99 ASP.? 16.09 OXT ACT B 201 258 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo 128.40 33.01 26.67 128.12 36.28 28.81 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 127.91 41.73 23.55 129.18 40.35 24.44 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 141.00 37.49 25.74 139.80 37.53 24.78 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 28 3 # 28 142 TRP B 97 TRP^? 8.79 OXT ACT B 201 223 ASP B 99 ASP.? 16.09 OXT ACT B 201 258 ALA C 70 ALA~? 7.91 O2 EDO A 302 coo 128.40 33.01 26.67 128.12 36.28 28.81 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 127.91 41.73 23.55 129.18 40.35 24.44 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 141.00 37.49 25.74 139.80 37.53 24.78 -30.85 51.65 62.62 -29.67 52.60 62.50 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 29 3 # 29 142 TRP B 97 TRP^? 8.79 OXT ACT B 201 223 ASP C 100 ASP.? 9.05 C1 EDO A 301 258 ALA B 126 ALA.? 5.01 O ACT B 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -30.79 47.88 75.76 -34.11 46.82 73.93 coo 127.91 41.73 23.55 129.18 40.35 24.44 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 141.00 37.49 25.74 139.80 37.53 24.78 -34.85 61.51 79.63 -34.73 60.21 80.42 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 30 3 # 30 142 TRP B 104 TRP^? 15.21 C2 EDO A 302 223 ASP B 74 ASP^? 14.88 OXT ACT B 201 258 ALA B 94 ALA^? 5.26 CH3 ACT A 202 coo 128.40 33.01 26.67 128.12 36.28 28.81 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 127.91 41.73 23.55 129.18 40.35 24.44 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 141.00 37.49 25.74 139.80 37.53 24.78 -25.63 54.27 77.41 -24.43 54.15 76.47 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 31 3 # 31 142 TRP B 104 TRP^? 15.21 C2 EDO A 302 223 ASP B 99 ASP.? 16.09 OXT ACT B 201 258 ALA C 70 ALA~? 7.91 O2 EDO A 302 coo 128.40 33.01 26.67 128.12 36.28 28.81 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 127.91 41.73 23.55 129.18 40.35 24.44 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 141.00 37.49 25.74 139.80 37.53 24.78 -30.85 51.65 62.62 -29.67 52.60 62.50 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 32 3 # 32 142 TRP B 142 TRP.? 12.90 OXT ACT B 201 223 ASP B 28 ASP~? 12.70 CH3 ACT B 201 258 ALA B 94 ALA^? 5.26 CH3 ACT A 202 coo 128.40 33.01 26.67 128.12 36.28 28.81 -21.52 44.96 85.54 -21.40 47.93 82.96 coo 127.91 41.73 23.55 129.18 40.35 24.44 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 141.00 37.49 25.74 139.80 37.53 24.78 -25.63 54.27 77.41 -24.43 54.15 76.47 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 33 3 # 33 142 TRP B 142 TRP.? 12.90 OXT ACT B 201 223 ASP B 74 ASP^? 14.88 OXT ACT B 201 258 ALA B 94 ALA^? 5.26 CH3 ACT A 202 coo 128.40 33.01 26.67 128.12 36.28 28.81 -21.52 44.96 85.54 -21.40 47.93 82.96 coo 127.91 41.73 23.55 129.18 40.35 24.44 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 141.00 37.49 25.74 139.80 37.53 24.78 -25.63 54.27 77.41 -24.43 54.15 76.47 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 34 3 # 34 142 TRP B 142 TRP.? 12.90 OXT ACT B 201 223 ASP B 149 ASP.? 20.03 CH3 ACT B 201 258 ALA B 26 ALA~? 8.11 CH3 ACT B 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -21.52 44.96 85.54 -21.40 47.93 82.96 coo 127.91 41.73 23.55 129.18 40.35 24.44 -13.67 50.22 91.33 -14.75 50.15 93.16 coo 141.00 37.49 25.74 139.80 37.53 24.78 -27.84 56.51 90.43 -28.15 57.77 89.64 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 35 3 # 35 142 TRP C 30 TRP~? -4.24 CH3 ACT C 201s 223 ASP C 28 ASP~? 12.80 CH3 ACT C 201 258 ALA C 19 ALA~? 16.34 CH3 ACT C 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 127.91 41.73 23.55 129.18 40.35 24.44 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 141.00 37.49 25.74 139.80 37.53 24.78 -40.82 38.56 37.82 -41.88 39.43 37.15 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 36 3 # 36 142 TRP C 30 TRP~? -4.24 CH3 ACT C 201s 223 ASP C 28 ASP~? 12.80 CH3 ACT C 201 258 ALA C 94 ALA^? 9.20 O ACT C 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 127.91 41.73 23.55 129.18 40.35 24.44 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 141.00 37.49 25.74 139.80 37.53 24.78 -45.79 46.91 52.91 -47.22 46.56 53.32 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 37 3 # 37 142 TRP C 30 TRP~? -4.24 CH3 ACT C 201s 223 ASP C 34 ASP~? 14.66 O ACT C 201 258 ALA C 63 ALA~? 11.78 O2 EDO A 302 coo 128.40 33.01 26.67 128.12 36.28 28.81 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 127.91 41.73 23.55 129.18 40.35 24.44 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 141.00 37.49 25.74 139.80 37.53 24.78 -25.32 54.06 53.50 -24.62 55.35 53.10 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 38 3 # 38 142 TRP C 69 TRP~? 6.41 O ACT C 201 223 ASP C 34 ASP~? 14.66 O ACT C 201 258 ALA C 26 ALA~? 8.20 CH3 ACT C 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 127.91 41.73 23.55 129.18 40.35 24.44 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 141.00 37.49 25.74 139.80 37.53 24.78 -35.58 40.78 46.69 -36.15 41.81 45.72 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 39 3 # 39 142 TRP C 69 TRP~? 6.41 O ACT C 201 223 ASP C 34 ASP~? 14.66 O ACT C 201 258 ALA C 61 ALA~? 11.19 OXT ACT C 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 127.91 41.73 23.55 129.18 40.35 24.44 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 141.00 37.49 25.74 139.80 37.53 24.78 -27.55 53.08 48.63 -27.85 52.13 47.47 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 40 3 # 40 142 TRP C 69 TRP~? 6.41 O ACT C 201 223 ASP C 34 ASP~? 14.66 O ACT C 201 258 ALA C 63 ALA~? 11.78 O2 EDO A 302 coo 128.40 33.01 26.67 128.12 36.28 28.81 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 127.91 41.73 23.55 129.18 40.35 24.44 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 141.00 37.49 25.74 139.80 37.53 24.78 -25.32 54.06 53.50 -24.62 55.35 53.10 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 41 3 # 41 142 TRP C 69 TRP~? 6.41 O ACT C 201 223 ASP C 74 ASP^? 14.86 O ACT C 201 258 ALA A 52 ALA.? 7.92 O2 EDO A 302 coo 128.40 33.01 26.67 128.12 36.28 28.81 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 127.91 41.73 23.55 129.18 40.35 24.44 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 141.00 37.49 25.74 139.80 37.53 24.78 -28.67 56.33 66.41 -29.48 55.05 66.20 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 42 3 # 42 142 TRP C 69 TRP~? 6.41 O ACT C 201 223 ASP C 74 ASP^? 14.86 O ACT C 201 258 ALA C 94 ALA^? 9.20 O ACT C 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 127.91 41.73 23.55 129.18 40.35 24.44 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 141.00 37.49 25.74 139.80 37.53 24.78 -45.79 46.91 52.91 -47.22 46.56 53.32 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 43 3 # 43 142 TRP C 82 TRP^? 14.73 O ACT D 201 223 ASP D 86 ASP.? 24.19 CH3 ACT D 201 258 ALA C 19 ALA~? 16.34 CH3 ACT C 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -49.41 47.73 38.89 -52.68 46.73 40.85 coo 127.91 41.73 23.55 129.18 40.35 24.44 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 141.00 37.49 25.74 139.80 37.53 24.78 -40.82 38.56 37.82 -41.88 39.43 37.15 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 44 3 # 44 142 TRP C 82 TRP^? 14.73 O ACT D 201 223 ASP D 86 ASP.? 24.19 CH3 ACT D 201 258 ALA D 122 ALA.? 16.93 O ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -49.41 47.73 38.89 -52.68 46.73 40.85 coo 127.91 41.73 23.55 129.18 40.35 24.44 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 141.00 37.49 25.74 139.80 37.53 24.78 -61.37 49.71 39.82 -61.60 48.25 39.46 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 45 3 # 45 142 TRP C 97 TRP^? -5.77 O2 EDO A 301s 223 ASP C 99 ASP.? 5.79 O1 EDO A 301 258 ALA C 135 ALA~? 15.67 O2 EDO A 301 coo 128.40 33.01 26.67 128.12 36.28 28.81 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 127.91 41.73 23.55 129.18 40.35 24.44 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 141.00 37.49 25.74 139.80 37.53 24.78 -49.12 46.81 68.31 -48.42 46.56 69.64 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 46 3 # 46 142 TRP C 104 TRP^? 12.40 O2 EDO A 301 223 ASP C 74 ASP^? 14.86 O ACT C 201 258 ALA C 94 ALA^? 9.20 O ACT C 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 127.91 41.73 23.55 129.18 40.35 24.44 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 141.00 37.49 25.74 139.80 37.53 24.78 -45.79 46.91 52.91 -47.22 46.56 53.32 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 47 3 # 47 142 TRP C 142 TRP.? 12.80 O ACT C 201 223 ASP C 28 ASP~? 12.80 CH3 ACT C 201 258 ALA C 94 ALA^? 9.20 O ACT C 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -40.60 36.63 58.98 -43.29 38.84 57.12 coo 127.91 41.73 23.55 129.18 40.35 24.44 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 141.00 37.49 25.74 139.80 37.53 24.78 -45.79 46.91 52.91 -47.22 46.56 53.32 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 48 3 # 48 142 TRP C 142 TRP.? 12.80 O ACT C 201 223 ASP C 74 ASP^? 14.86 O ACT C 201 258 ALA C 94 ALA^? 9.20 O ACT C 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -40.60 36.63 58.98 -43.29 38.84 57.12 coo 127.91 41.73 23.55 129.18 40.35 24.44 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 141.00 37.49 25.74 139.80 37.53 24.78 -45.79 46.91 52.91 -47.22 46.56 53.32 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 49 3 # 49 142 TRP C 142 TRP.? 12.80 O ACT C 201 223 ASP C 149 ASP.? 18.79 CH3 ACT C 201 258 ALA C 26 ALA~? 8.20 CH3 ACT C 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -40.60 36.63 58.98 -43.29 38.84 57.12 coo 127.91 41.73 23.55 129.18 40.35 24.44 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 141.00 37.49 25.74 139.80 37.53 24.78 -35.58 40.78 46.69 -36.15 41.81 45.72 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 50 3 # 50 142 TRP D 30 TRP~? -4.23 CH3 ACT D 201s 223 ASP D 28 ASP~? 12.70 CH3 ACT D 201 258 ALA D 19 ALA~? 16.59 CH3 ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -55.89 62.34 37.62 -55.77 61.79 41.52 coo 127.91 41.73 23.55 129.18 40.35 24.44 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 141.00 37.49 25.74 139.80 37.53 24.78 -51.23 52.67 27.89 -50.15 51.69 28.35 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 51 3 # 51 142 TRP D 30 TRP~? -4.23 CH3 ACT D 201s 223 ASP D 28 ASP~? 12.70 CH3 ACT D 201 258 ALA D 94 ALA^? 9.22 CH3 ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -55.89 62.34 37.62 -55.77 61.79 41.52 coo 127.91 41.73 23.55 129.18 40.35 24.44 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 141.00 37.49 25.74 139.80 37.53 24.78 -44.41 64.30 40.02 -42.98 64.70 39.67 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 52 3 # 52 142 TRP D 30 TRP~? -4.23 CH3 ACT D 201s 223 ASP D 34 ASP~? 14.62 OXT ACT D 201 258 ALA D 63 ALA~? 14.77 O ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -55.89 62.34 37.62 -55.77 61.79 41.52 coo 127.91 41.73 23.55 129.18 40.35 24.44 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 141.00 37.49 25.74 139.80 37.53 24.78 -64.21 63.78 48.75 -64.86 63.06 49.92 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 53 3 # 53 142 TRP D 69 TRP~? 6.43 OXT ACT D 201 223 ASP D 34 ASP~? 14.62 OXT ACT D 201 258 ALA D 26 ALA~? 8.16 CH3 ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -55.42 69.82 43.51 -57.48 67.10 41.55 coo 127.91 41.73 23.55 129.18 40.35 24.44 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 141.00 37.49 25.74 139.80 37.53 24.78 -55.52 60.76 33.28 -54.94 59.51 33.93 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 54 3 # 54 142 TRP D 69 TRP~? 6.43 OXT ACT D 201 223 ASP D 34 ASP~? 14.62 OXT ACT D 201 258 ALA D 61 ALA~? 11.20 O ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -55.42 69.82 43.51 -57.48 67.10 41.55 coo 127.91 41.73 23.55 129.18 40.35 24.44 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 141.00 37.49 25.74 139.80 37.53 24.78 -62.57 59.32 46.16 -62.47 58.52 44.86 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 55 3 # 55 142 TRP D 69 TRP~? 6.43 OXT ACT D 201 223 ASP D 34 ASP~? 14.62 OXT ACT D 201 258 ALA D 63 ALA~? 14.77 O ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -55.42 69.82 43.51 -57.48 67.10 41.55 coo 127.91 41.73 23.55 129.18 40.35 24.44 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 141.00 37.49 25.74 139.80 37.53 24.78 -64.21 63.78 48.75 -64.86 63.06 49.92 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 56 3 # 56 142 TRP D 69 TRP~? 6.43 OXT ACT D 201 223 ASP D 74 ASP^? 14.85 OXT ACT D 201 258 ALA D 94 ALA^? 9.22 CH3 ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -55.42 69.82 43.51 -57.48 67.10 41.55 coo 127.91 41.73 23.55 129.18 40.35 24.44 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 141.00 37.49 25.74 139.80 37.53 24.78 -44.41 64.30 40.02 -42.98 64.70 39.67 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 57 3 # 57 142 TRP D 82 TRP^? 14.82 OXT ACT C 201 223 ASP C 86 ASP.? 24.03 CH3 ACT C 201 258 ALA C 122 ALA.? 16.96 OXT ACT C 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -41.91 50.50 36.33 -38.54 52.46 35.78 coo 127.91 41.73 23.55 129.18 40.35 24.44 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 141.00 37.49 25.74 139.80 37.53 24.78 -29.78 49.99 37.71 -29.62 50.07 36.19 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 58 3 # 58 142 TRP D 82 TRP^? 14.82 OXT ACT C 201 223 ASP C 86 ASP.? 24.03 CH3 ACT C 201 258 ALA D 19 ALA~? 16.59 CH3 ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -41.91 50.50 36.33 -38.54 52.46 35.78 coo 127.91 41.73 23.55 129.18 40.35 24.44 -38.79 45.04 28.56 -40.00 45.30 26.84 coo 141.00 37.49 25.74 139.80 37.53 24.78 -51.23 52.67 27.89 -50.15 51.69 28.35 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 59 3 # 59 142 TRP D 97 TRP^? 8.35 CH3 ACT A 203 223 ASP A 100 ASP.? 9.07 O2 EDO A 301 258 ALA D 126 ALA.? 5.05 O ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 127.91 41.73 23.55 129.18 40.35 24.44 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 141.00 37.49 25.74 139.80 37.53 24.78 -50.75 55.53 45.15 -51.51 56.79 44.72 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 60 3 # 60 142 TRP D 97 TRP^? 8.35 CH3 ACT A 203 223 ASP D 99 ASP.? 7.94 CH3 ACT A 203 258 ALA A 70 ALA~? 12.37 C2 EDO A 301 coo 128.40 33.01 26.67 128.12 36.28 28.81 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 127.91 41.73 23.55 129.18 40.35 24.44 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 141.00 37.49 25.74 139.80 37.53 24.78 -36.52 66.89 53.48 -35.54 66.12 52.61 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 61 3 # 61 142 TRP D 97 TRP^? 8.35 CH3 ACT A 203 223 ASP D 99 ASP.? 7.94 CH3 ACT A 203 258 ALA D 135 ALA~? 18.41 CH3 ACT A 203 coo 128.40 33.01 26.67 128.12 36.28 28.81 -47.45 69.73 45.65 -48.25 70.38 49.44 coo 127.91 41.73 23.55 129.18 40.35 24.44 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 141.00 37.49 25.74 139.80 37.53 24.78 -39.82 78.98 44.65 -40.33 80.39 44.94 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 62 3 # 62 142 TRP D 104 TRP^? 14.89 CH3 ACT A 203 223 ASP D 74 ASP^? 14.85 OXT ACT D 201 258 ALA D 94 ALA^? 9.22 CH3 ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 127.91 41.73 23.55 129.18 40.35 24.44 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 141.00 37.49 25.74 139.80 37.53 24.78 -44.41 64.30 40.02 -42.98 64.70 39.67 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 63 3 # 63 142 TRP D 104 TRP^? 14.89 CH3 ACT A 203 223 ASP D 99 ASP.? 7.94 CH3 ACT A 203 258 ALA A 70 ALA~? 12.37 C2 EDO A 301 coo 128.40 33.01 26.67 128.12 36.28 28.81 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 127.91 41.73 23.55 129.18 40.35 24.44 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 141.00 37.49 25.74 139.80 37.53 24.78 -36.52 66.89 53.48 -35.54 66.12 52.61 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 64 3 # 64 142 TRP D 142 TRP.? 12.80 OXT ACT D 201 223 ASP D 28 ASP~? 12.70 CH3 ACT D 201 258 ALA D 94 ALA^? 9.22 CH3 ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -49.78 73.48 32.42 -47.22 70.87 33.88 coo 127.91 41.73 23.55 129.18 40.35 24.44 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 141.00 37.49 25.74 139.80 37.53 24.78 -44.41 64.30 40.02 -42.98 64.70 39.67 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 65 3 # 65 142 TRP D 142 TRP.? 12.80 OXT ACT D 201 223 ASP D 74 ASP^? 14.85 OXT ACT D 201 258 ALA D 94 ALA^? 9.22 CH3 ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -49.78 73.48 32.42 -47.22 70.87 33.88 coo 127.91 41.73 23.55 129.18 40.35 24.44 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 141.00 37.49 25.74 139.80 37.53 24.78 -44.41 64.30 40.02 -42.98 64.70 39.67 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 66 3 # 66 142 TRP D 142 TRP.? 12.80 OXT ACT D 201 223 ASP D 149 ASP.? 20.02 CH3 ACT D 201 258 ALA D 26 ALA~? 8.16 CH3 ACT D 201 coo 128.40 33.01 26.67 128.12 36.28 28.81 -49.78 73.48 32.42 -47.22 70.87 33.88 coo 127.91 41.73 23.55 129.18 40.35 24.44 -48.61 69.27 22.33 -50.68 68.95 22.00 coo 141.00 37.49 25.74 139.80 37.53 24.78 -55.52 60.76 33.28 -54.94 59.51 33.93 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 66 hits 2aat_c01 naa= 3 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 1 3 # 1 A 43 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 48 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 77 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 13.04 30.41 72.50 12.95 30.65 70.36 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 12.77 23.50 68.33 13.58 25.42 68.49 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 7.53 29.84 65.06 12.29 29.41 67.79 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 2 3 # 2 A 43 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 48 HIS A 98 HIS^? -3.60 C ACT A 203s A 77 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 13.04 30.41 72.50 12.95 30.65 70.36 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 12.77 23.50 68.33 13.58 25.42 68.49 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 7.53 29.84 65.06 12.29 29.41 67.79 -38.35 64.60 55.93 -41.15 60.07 56.77 2acu_c01 source 2acu ALDOSE REDUCTASE (E.C.1.1.1.21) MUTANT WITH TY: 2 hits 2acu_c01 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS B 56 HIS.? 17.31 O ACT B 201 B 50 GLU A 160 GLU.? 13.50 O ACT A 201 B 113 GLN B 47 GLN^? 17.37 O ACT B 201 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -43.79 66.33 88.09 -45.65 65.30 88.17 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS B 56 HIS.? 17.31 O ACT B 201 B 50 GLU A 160 GLU.? 13.50 O ACT A 201 B 113 GLN B 47 GLN^? 17.37 O ACT B 201 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -43.79 66.33 88.09 -45.65 65.30 88.17 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS B 56 HIS.? 17.31 O ACT B 201 A 50 GLU A 160 GLU.? 13.50 O ACT A 201 A 113 GLN B 47 GLN^? 17.37 O ACT B 201 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -43.79 66.33 88.09 -45.65 65.30 88.17 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS B 56 HIS.? 17.31 O ACT B 201 C 50 GLU A 160 GLU.? 13.50 O ACT A 201 C 113 GLN B 47 GLN^? 17.37 O ACT B 201 coo 74.92 8.52 28.42 74.88 6.86 29.70 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 65.25 15.95 28.73 65.73 15.63 30.78 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 70.80 6.73 32.72 71.88 8.55 32.53 -43.79 66.33 88.09 -45.65 65.30 88.17 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS B 56 HIS.? 17.31 O ACT B 201 D 50 GLU A 160 GLU.? 13.50 O ACT A 201 D 113 GLN B 47 GLN^? 17.37 O ACT B 201 coo 38.66 11.31 27.15 38.67 12.13 25.22 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 48.72 12.85 33.83 48.36 14.77 32.95 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 42.85 14.77 24.15 41.85 15.11 26.02 -43.79 66.33 88.09 -45.65 65.30 88.17 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c11 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 99 ASP.? 5.71 O2 EDO A 301 219 GLU A 72 GLU~? 5.31 O ACT A 201 294 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 25.84 105.87 9.06 27.86 105.55 8.74 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 33.16 106.80 7.72 33.34 104.87 6.92 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 130 ASP.? 4.80 O1 EDO A 301 219 GLU A 72 GLU~? 5.31 O ACT A 201 294 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 25.84 105.87 9.06 27.86 105.55 8.74 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 33.16 106.80 7.72 33.34 104.87 6.92 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP B 99 ASP.? 16.09 OXT ACT B 201 219 GLU B 72 GLU~? 5.30 OXT ACT B 201 294 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 25.84 105.87 9.06 27.86 105.55 8.74 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP B 130 ASP.? 9.25 OXT ACT B 201 219 GLU B 72 GLU~? 5.30 OXT ACT B 201 294 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 25.84 105.87 9.06 27.86 105.55 8.74 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 33.16 106.80 7.72 33.34 104.87 6.92 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP C 99 ASP.? 5.79 O1 EDO A 301 219 GLU C 72 GLU~? 5.32 O ACT C 201 294 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 25.84 105.87 9.06 27.86 105.55 8.74 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 33.16 106.80 7.72 33.34 104.87 6.92 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP C 130 ASP.? 4.74 O2 EDO A 301 219 GLU C 72 GLU~? 5.32 O ACT C 201 294 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 25.84 105.87 9.06 27.86 105.55 8.74 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 33.16 106.80 7.72 33.34 104.87 6.92 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP D 86 ASP.? 24.19 CH3 ACT D 201 219 GLU D 114 GLU^? 18.05 O ACT D 201 294 ASP D 116 ASP.? 19.52 CH3 ACT D 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -53.41 42.17 31.38 -52.32 40.44 30.82 coo 25.84 105.87 9.06 27.86 105.55 8.74 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 33.16 106.80 7.72 33.34 104.87 6.92 -63.55 47.24 34.96 -64.48 49.07 34.39 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP D 99 ASP.? 7.94 CH3 ACT A 203 219 GLU D 72 GLU~? 5.29 OXT ACT D 201 294 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 27.89 102.52 14.98 29.35 101.92 13.57 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 25.84 105.87 9.06 27.86 105.55 8.74 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 33.16 106.80 7.72 33.34 104.87 6.92 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP D 116 ASP.? 19.52 CH3 ACT D 201 219 GLU D 114 GLU^? 18.05 O ACT D 201 294 ASP D 86 ASP.? 24.19 CH3 ACT D 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -63.55 47.24 34.96 -64.48 49.07 34.39 coo 25.84 105.87 9.06 27.86 105.55 8.74 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 33.16 106.80 7.72 33.34 104.87 6.92 -53.41 42.17 31.38 -52.32 40.44 30.82 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP D 130 ASP.? 7.40 CH3 ACT A 203 219 GLU D 72 GLU~? 5.29 OXT ACT D 201 294 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 25.84 105.87 9.06 27.86 105.55 8.74 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 33.16 106.80 7.72 33.34 104.87 6.92 -49.03 74.78 51.99 -47.35 75.78 52.80 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 10 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 28 ASP~? 12.70 CH3 ACT A 201 231 ASP A 130 ASP.? 4.80 O1 EDO A 301 294 ASP A 34 ASP~? 14.63 O ACT A 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 33.16 106.80 7.72 33.34 104.87 6.92 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 28 ASP~? 12.70 CH3 ACT A 201 231 ASP D 99 ASP.? 7.94 CH3 ACT A 203 294 ASP A 149 ASP.? 18.85 CH3 ACT A 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 33.16 106.80 7.72 33.34 104.87 6.92 -38.64 88.42 71.14 -36.90 88.52 69.95 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 28 ASP~? 12.70 CH3 ACT A 201 231 ASP D 100 ASP.? 7.94 OXT ACT A 203 294 ASP A 149 ASP.? 18.85 CH3 ACT A 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 33.16 106.80 7.72 33.34 104.87 6.92 -38.64 88.42 71.14 -36.90 88.52 69.95 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 34 ASP~? 14.63 O ACT A 201 231 ASP A 45 ASP^? 16.09 OXT ACT A 202 294 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 33.16 106.80 7.72 33.34 104.87 6.92 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP A 34 ASP~? 14.63 O ACT A 201 231 ASP A 130 ASP.? 4.80 O1 EDO A 301 294 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 33.16 106.80 7.72 33.34 104.87 6.92 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP A 34 ASP~? 14.63 O ACT A 201 231 ASP D 100 ASP.? 7.94 OXT ACT A 203 294 ASP A 28 ASP~? 12.70 CH3 ACT A 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 33.16 106.80 7.72 33.34 104.87 6.92 -32.24 81.95 65.60 -33.17 83.07 67.14 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP A 74 ASP^? 5.73 OXT ACT A 203 231 ASP A 149 ASP.? 18.85 CH3 ACT A 201 294 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 33.16 106.80 7.72 33.34 104.87 6.92 -49.03 74.78 51.99 -47.35 75.78 52.80 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP A 74 ASP^? 5.73 OXT ACT A 203 231 ASP A 149 ASP.? 18.85 CH3 ACT A 201 294 ASP D 100 ASP.? 7.94 OXT ACT A 203 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -38.64 88.42 71.14 -36.90 88.52 69.95 coo 33.16 106.80 7.72 33.34 104.87 6.92 -52.87 78.07 53.10 -52.52 76.84 54.77 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP A 74 ASP^? 5.73 OXT ACT A 203 231 ASP C 100 ASP.? 9.05 C1 EDO A 301 294 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 33.16 106.80 7.72 33.34 104.87 6.92 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP A 99 ASP.? 5.71 O2 EDO A 301 231 ASP A 28 ASP~? 12.70 CH3 ACT A 201 294 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 33.16 106.80 7.72 33.34 104.87 6.92 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP A 99 ASP.? 5.71 O2 EDO A 301 231 ASP A 28 ASP~? 12.70 CH3 ACT A 201 294 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 33.16 106.80 7.72 33.34 104.87 6.92 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP A 100 ASP.? 9.07 O2 EDO A 301 231 ASP C 100 ASP.? 9.05 C1 EDO A 301 294 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 33.16 106.80 7.72 33.34 104.87 6.92 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP A 130 ASP.? 4.80 O1 EDO A 301 231 ASP A 28 ASP~? 12.70 CH3 ACT A 201 294 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 33.16 106.80 7.72 33.34 104.87 6.92 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 14 3 # 14 193 ASP A 130 ASP.? 4.80 O1 EDO A 301 231 ASP A 34 ASP~? 14.63 O ACT A 201 294 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 33.16 106.80 7.72 33.34 104.87 6.92 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 15 3 # 15 193 ASP A 130 ASP.? 4.80 O1 EDO A 301 231 ASP B 100 ASP.? 15.93 OXT ACT B 201 294 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 33.16 106.80 7.72 33.34 104.87 6.92 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 16 3 # 16 193 ASP B 34 ASP~? 14.61 OXT ACT B 201 231 ASP B 45 ASP^? 20.35 O ACT B 201 294 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 33.16 106.80 7.72 33.34 104.87 6.92 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 17 3 # 17 193 ASP B 34 ASP~? 14.61 OXT ACT B 201 231 ASP B 130 ASP.? 9.25 OXT ACT B 201 294 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 33.16 106.80 7.72 33.34 104.87 6.92 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 18 3 # 18 193 ASP B 34 ASP~? 14.61 OXT ACT B 201 231 ASP C 100 ASP.? 9.05 C1 EDO A 301 294 ASP B 28 ASP~? 12.70 CH3 ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 33.16 106.80 7.72 33.34 104.87 6.92 -24.83 51.75 92.00 -22.77 52.17 91.83 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 19 3 # 19 193 ASP B 99 ASP.? 16.09 OXT ACT B 201 231 ASP B 28 ASP~? 12.70 CH3 ACT B 201 294 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 20 3 # 20 193 ASP B 99 ASP.? 16.09 OXT ACT B 201 231 ASP B 28 ASP~? 12.70 CH3 ACT B 201 294 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 21 3 # 21 193 ASP B 99 ASP.? 16.09 OXT ACT B 201 231 ASP C 28 ASP~? 12.80 CH3 ACT C 201 294 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 22 3 # 22 193 ASP B 99 ASP.? 16.09 OXT ACT B 201 231 ASP C 28 ASP~? 12.80 CH3 ACT C 201 294 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 23 3 # 23 193 ASP B 100 ASP.? 15.93 OXT ACT B 201 231 ASP A 130 ASP.? 4.80 O1 EDO A 301 294 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 33.16 106.80 7.72 33.34 104.87 6.92 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 24 3 # 24 193 ASP B 100 ASP.? 15.93 OXT ACT B 201 231 ASP C 34 ASP~? 14.66 O ACT C 201 294 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 33.16 106.80 7.72 33.34 104.87 6.92 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 25 3 # 25 193 ASP B 130 ASP.? 9.25 OXT ACT B 201 231 ASP A 100 ASP.? 9.07 O2 EDO A 301 294 ASP C 74 ASP^? 14.86 O ACT C 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 33.16 106.80 7.72 33.34 104.87 6.92 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 26 3 # 26 193 ASP B 130 ASP.? 9.25 OXT ACT B 201 231 ASP B 28 ASP~? 12.70 CH3 ACT B 201 294 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.83 51.75 92.00 -22.77 52.17 91.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 27 3 # 27 193 ASP C 28 ASP~? 12.80 CH3 ACT C 201 231 ASP B 99 ASP.? 16.09 OXT ACT B 201 294 ASP C 149 ASP.? 18.79 CH3 ACT C 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 33.16 106.80 7.72 33.34 104.87 6.92 -42.93 29.00 51.56 -40.94 29.30 50.94 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 28 3 # 28 193 ASP C 28 ASP~? 12.80 CH3 ACT C 201 231 ASP B 100 ASP.? 15.93 OXT ACT B 201 294 ASP C 149 ASP.? 18.79 CH3 ACT C 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 33.16 106.80 7.72 33.34 104.87 6.92 -42.93 29.00 51.56 -40.94 29.30 50.94 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 29 3 # 29 193 ASP C 34 ASP~? 14.66 O ACT C 201 231 ASP B 100 ASP.? 15.93 OXT ACT B 201 294 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 33.16 106.80 7.72 33.34 104.87 6.92 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 30 3 # 30 193 ASP C 34 ASP~? 14.66 O ACT C 201 231 ASP C 45 ASP^? 20.17 OXT ACT C 201 294 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 33.16 106.80 7.72 33.34 104.87 6.92 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 31 3 # 31 193 ASP C 34 ASP~? 14.66 O ACT C 201 231 ASP C 130 ASP.? 4.74 O2 EDO A 301 294 ASP C 28 ASP~? 12.80 CH3 ACT C 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 33.16 106.80 7.72 33.34 104.87 6.92 -35.43 36.60 50.52 -37.00 35.22 50.19 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 32 3 # 32 193 ASP C 74 ASP^? 14.86 O ACT C 201 231 ASP A 100 ASP.? 9.07 O2 EDO A 301 294 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 33 3 # 33 193 ASP C 74 ASP^? 14.86 O ACT C 201 231 ASP C 149 ASP.? 18.79 CH3 ACT C 201 294 ASP B 99 ASP.? 16.09 OXT ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 33.16 106.80 7.72 33.34 104.87 6.92 -35.72 42.46 72.53 -35.18 41.59 70.69 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 34 3 # 34 193 ASP C 74 ASP^? 14.86 O ACT C 201 231 ASP C 149 ASP.? 18.79 CH3 ACT C 201 294 ASP B 100 ASP.? 15.93 OXT ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -42.93 29.00 51.56 -40.94 29.30 50.94 coo 33.16 106.80 7.72 33.34 104.87 6.92 -38.83 38.92 74.28 -39.60 40.38 75.58 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 35 3 # 35 193 ASP C 99 ASP.? 5.79 O1 EDO A 301 231 ASP C 28 ASP~? 12.80 CH3 ACT C 201 294 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 36 3 # 36 193 ASP C 99 ASP.? 5.79 O1 EDO A 301 231 ASP C 28 ASP~? 12.80 CH3 ACT C 201 294 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 37 3 # 37 193 ASP C 100 ASP.? 9.05 C1 EDO A 301 231 ASP A 100 ASP.? 9.07 O2 EDO A 301 294 ASP C 74 ASP^? 14.86 O ACT C 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 33.16 106.80 7.72 33.34 104.87 6.92 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 38 3 # 38 193 ASP C 130 ASP.? 4.74 O2 EDO A 301 231 ASP B 100 ASP.? 15.93 OXT ACT B 201 294 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 33.16 106.80 7.72 33.34 104.87 6.92 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 39 3 # 39 193 ASP C 130 ASP.? 4.74 O2 EDO A 301 231 ASP C 28 ASP~? 12.80 CH3 ACT C 201 294 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -35.43 36.60 50.52 -37.00 35.22 50.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 40 3 # 40 193 ASP C 130 ASP.? 4.74 O2 EDO A 301 231 ASP C 34 ASP~? 14.66 O ACT C 201 294 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 33.16 106.80 7.72 33.34 104.87 6.92 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 41 3 # 41 193 ASP C 130 ASP.? 4.74 O2 EDO A 301 231 ASP D 100 ASP.? 7.94 OXT ACT A 203 294 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 33.16 106.80 7.72 33.34 104.87 6.92 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 42 3 # 42 193 ASP D 34 ASP~? 14.62 OXT ACT D 201 231 ASP A 100 ASP.? 9.07 O2 EDO A 301 294 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 33.16 106.80 7.72 33.34 104.87 6.92 -55.65 65.73 30.36 -54.18 65.67 28.83 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 43 3 # 43 193 ASP D 34 ASP~? 14.62 OXT ACT D 201 231 ASP D 45 ASP^? 20.33 O ACT D 201 294 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 33.16 106.80 7.72 33.34 104.87 6.92 -55.65 65.73 30.36 -54.18 65.67 28.83 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 44 3 # 44 193 ASP D 34 ASP~? 14.62 OXT ACT D 201 231 ASP D 130 ASP.? 7.40 CH3 ACT A 203 294 ASP D 28 ASP~? 12.70 CH3 ACT D 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 33.16 106.80 7.72 33.34 104.87 6.92 -55.65 65.73 30.36 -54.18 65.67 28.83 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 45 3 # 45 193 ASP D 99 ASP.? 7.94 CH3 ACT A 203 231 ASP A 28 ASP~? 12.70 CH3 ACT A 201 294 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 27.89 102.52 14.98 29.35 101.92 13.57 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -32.24 81.95 65.60 -33.17 83.07 67.14 coo 33.16 106.80 7.72 33.34 104.87 6.92 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 46 3 # 46 193 ASP D 99 ASP.? 7.94 CH3 ACT A 203 231 ASP D 28 ASP~? 12.70 CH3 ACT D 201 294 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 27.89 102.52 14.98 29.35 101.92 13.57 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 47 3 # 47 193 ASP D 100 ASP.? 7.94 OXT ACT A 203 231 ASP A 34 ASP~? 14.63 O ACT A 201 294 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 33.16 106.80 7.72 33.34 104.87 6.92 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 48 3 # 48 193 ASP D 100 ASP.? 7.94 OXT ACT A 203 231 ASP C 130 ASP.? 4.74 O2 EDO A 301 294 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 27.89 102.52 14.98 29.35 101.92 13.57 -52.87 78.07 53.10 -52.52 76.84 54.77 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 33.16 106.80 7.72 33.34 104.87 6.92 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 49 3 # 49 193 ASP D 130 ASP.? 7.40 CH3 ACT A 203 231 ASP C 100 ASP.? 9.05 C1 EDO A 301 294 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 33.16 106.80 7.72 33.34 104.87 6.92 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 50 3 # 50 193 ASP D 130 ASP.? 7.40 CH3 ACT A 203 231 ASP D 28 ASP~? 12.70 CH3 ACT D 201 294 ASP D 99 ASP.? 7.94 CH3 ACT A 203 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -55.65 65.73 30.36 -54.18 65.67 28.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 -49.03 74.78 51.99 -47.35 75.78 52.80 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 50 hits 2amg_c06 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP A 99 ASP.? 5.71 O2 EDO A 301 38 SER A 101 SER.? 7.80 O2 EDO A 301 218 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 41.14 58.72 105.19 42.39 59.85 103.92 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 46.04 57.35 103.96 44.97 58.52 105.78 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 41.33 60.20 97.63 42.00 60.96 99.49 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 3 # 2 35 ASP B 99 ASP.? 16.09 OXT ACT B 201 38 SER B 101 SER.? 19.25 O ACT C 201 218 ASP C 74 ASP^? 14.86 O ACT C 201 coo 41.14 58.72 105.19 42.39 59.85 103.92 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 46.04 57.35 103.96 44.97 58.52 105.78 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 41.33 60.20 97.63 42.00 60.96 99.49 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 3 3 # 3 35 ASP C 99 ASP.? 5.79 O1 EDO A 301 38 SER C 101 SER.? 7.85 O1 EDO A 301 218 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 41.14 58.72 105.19 42.39 59.85 103.92 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 46.04 57.35 103.96 44.97 58.52 105.78 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 41.33 60.20 97.63 42.00 60.96 99.49 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 4 3 # 4 35 ASP D 99 ASP.? 7.94 CH3 ACT A 203 38 SER D 101 SER.? 9.16 OXT ACT A 203 218 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 41.14 58.72 105.19 42.39 59.85 103.92 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 46.04 57.35 103.96 44.97 58.52 105.78 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 41.33 60.20 97.63 42.00 60.96 99.49 -44.71 72.29 58.72 -45.62 72.95 56.93 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 4 hits 2apr_c04 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 67 ARG~? 13.20 O2 EDO A 302 A 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 174 TYR A 95 TYR^? -3.85 O ACT A 201s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 67 ARG~? 13.20 O2 EDO A 302 A 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 174 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 174 TYR A 108 TYR^? 12.28 O ACT A 201 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 174 TYR A 95 TYR^? -3.85 O ACT A 201s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 5 3 # 5 A 14 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 174 TYR A 108 TYR^? 12.28 O ACT A 201 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 6 3 # 6 A 14 ARG B 67 ARG~? 13.55 O ACT B 201 A 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 174 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -45.57 49.20 81.23 -45.93 51.82 82.79 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 7 3 # 7 A 14 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 174 TYR B 108 TYR^? -4.79 O ACT A 202s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 8 3 # 8 A 14 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 174 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 9 3 # 9 A 14 ARG B 138 ARG~? 16.35 OXT ACT B 201 A 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 174 TYR B 108 TYR^? -4.79 O ACT A 202s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 10 3 # 10 A 14 ARG C 67 ARG~? 12.50 O2 EDO A 302 A 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 174 TYR B 108 TYR^? -4.79 O ACT A 202s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 11 3 # 11 A 14 ARG C 67 ARG~? 12.50 O2 EDO A 302 A 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 174 TYR C 95 TYR^? -3.84 O ACT C 201s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 12 3 # 12 A 14 ARG C 76 ARG^? 14.32 O ACT C 201 A 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 174 TYR C 108 TYR^? 12.28 O ACT C 201 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 13 3 # 13 A 14 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 174 TYR C 95 TYR^? -3.84 O ACT C 201s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 14 3 # 14 A 14 ARG C 138 ARG~? 16.31 O ACT C 201 A 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 174 TYR C 108 TYR^? 12.28 O ACT C 201 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 15 3 # 15 A 14 ARG D 67 ARG~? 13.15 O ACT A 203 A 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 174 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -60.60 65.68 53.30 -61.45 62.86 52.44 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 16 3 # 16 A 14 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 174 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 17 3 # 17 A 14 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 174 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 18 3 # 18 A 14 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 174 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -40.41 63.05 43.73 -38.60 65.12 43.23 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 18 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 67 ARG~? 13.20 O2 EDO A 302 B 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 174 TYR A 95 TYR^? -3.85 O ACT A 201s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 67 ARG~? 13.20 O2 EDO A 302 B 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 174 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG A 76 ARG^? 8.97 OXT ACT A 203 B 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 174 TYR A 108 TYR^? 12.28 O ACT A 201 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG A 92 ARG^? 14.09 CH3 ACT A 201 B 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 174 TYR A 95 TYR^? -3.85 O ACT A 201s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 5 3 # 5 B 14 ARG A 138 ARG~? 6.49 OXT ACT A 203 B 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 174 TYR A 108 TYR^? 12.28 O ACT A 201 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -50.06 71.52 64.11 -49.59 74.03 62.40 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 6 3 # 6 B 14 ARG B 67 ARG~? 13.55 O ACT B 201 B 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 174 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -45.57 49.20 81.23 -45.93 51.82 82.79 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 7 3 # 7 B 14 ARG B 76 ARG^? 14.33 OXT ACT B 201 B 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 174 TYR B 108 TYR^? -4.79 O ACT A 202s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 8 3 # 8 B 14 ARG B 92 ARG^? -3.69 CH3 ACT A 202s B 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 174 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 9 3 # 9 B 14 ARG B 124 ARG.? -3.52 O ACT B 201s B 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 174 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 10 3 # 10 B 14 ARG B 138 ARG~? 16.35 OXT ACT B 201 B 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 174 TYR B 108 TYR^? -4.79 O ACT A 202s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -23.44 41.55 74.26 -23.57 39.98 76.87 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 11 3 # 11 B 14 ARG C 67 ARG~? 12.50 O2 EDO A 302 B 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 174 TYR B 108 TYR^? -4.79 O ACT A 202s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 12 3 # 12 B 14 ARG C 67 ARG~? 12.50 O2 EDO A 302 B 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 174 TYR C 95 TYR^? -3.84 O ACT C 201s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 13 3 # 13 B 14 ARG C 76 ARG^? 14.32 O ACT C 201 B 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 174 TYR C 108 TYR^? 12.28 O ACT C 201 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -42.25 40.39 61.14 -41.06 40.24 63.98 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 14 3 # 14 B 14 ARG C 92 ARG^? 13.71 CH3 ACT C 201 B 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 174 TYR C 95 TYR^? -3.84 O ACT C 201s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 15 3 # 15 B 14 ARG C 138 ARG~? 16.31 O ACT C 201 B 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 174 TYR C 108 TYR^? 12.28 O ACT C 201 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -46.75 44.46 65.88 -44.64 42.30 66.40 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 16 3 # 16 B 14 ARG D 67 ARG~? 13.15 O ACT A 203 B 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 174 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -60.60 65.68 53.30 -61.45 62.86 52.44 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 17 3 # 17 B 14 ARG D 76 ARG^? 14.20 OXT ACT D 201 B 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 174 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -47.81 74.29 36.53 -48.87 77.02 37.43 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 18 3 # 18 B 14 ARG D 92 ARG^? 13.56 CH3 ACT D 201 B 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 174 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 19 3 # 19 B 14 ARG D 138 ARG~? 16.38 OXT ACT D 201 B 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 174 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -42.61 77.59 41.75 -44.95 78.80 40.20 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -40.41 63.05 43.73 -38.60 65.12 43.23 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 19 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 51 ARG.? 6.25 O1 EDO A 301 C 161 ASP C 74 ASP^? 14.86 O ACT C 201 C 174 TYR C 75 TYR^? -4.54 O ACT C 201s coo 2.84 19.43 40.34 1.59 20.35 37.65 -33.46 60.54 65.68 -36.32 61.50 66.33 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 5.94 13.28 27.17 3.53 13.05 28.58 -37.81 46.19 57.99 -37.99 46.43 55.20 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 67 ARG~? 13.20 O2 EDO A 302 C 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 174 TYR A 95 TYR^? -3.85 O ACT A 201s coo 2.84 19.43 40.34 1.59 20.35 37.65 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 5.94 13.28 27.17 3.53 13.05 28.58 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG A 67 ARG~? 13.20 O2 EDO A 302 C 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 174 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 2.84 19.43 40.34 1.59 20.35 37.65 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 5.94 13.28 27.17 3.53 13.05 28.58 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG A 76 ARG^? 8.97 OXT ACT A 203 C 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 174 TYR A 108 TYR^? 12.28 O ACT A 201 coo 2.84 19.43 40.34 1.59 20.35 37.65 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 5.94 13.28 27.17 3.53 13.05 28.58 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 5 3 # 5 C 14 ARG A 92 ARG^? 14.09 CH3 ACT A 201 C 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 174 TYR A 95 TYR^? -3.85 O ACT A 201s coo 2.84 19.43 40.34 1.59 20.35 37.65 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 5.94 13.28 27.17 3.53 13.05 28.58 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 6 3 # 6 C 14 ARG A 124 ARG.? -3.54 OXT ACT A 201s C 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 174 TYR A 108 TYR^? 12.28 O ACT A 201 coo 2.84 19.43 40.34 1.59 20.35 37.65 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 5.94 13.28 27.17 3.53 13.05 28.58 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 7 3 # 7 C 14 ARG A 138 ARG~? 6.49 OXT ACT A 203 C 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 174 TYR A 108 TYR^? 12.28 O ACT A 201 coo 2.84 19.43 40.34 1.59 20.35 37.65 -50.06 71.52 64.11 -49.59 74.03 62.40 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 5.94 13.28 27.17 3.53 13.05 28.58 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 8 3 # 8 C 14 ARG B 67 ARG~? 13.55 O ACT B 201 C 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 174 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 2.84 19.43 40.34 1.59 20.35 37.65 -45.57 49.20 81.23 -45.93 51.82 82.79 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 5.94 13.28 27.17 3.53 13.05 28.58 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 9 3 # 9 C 14 ARG B 76 ARG^? 14.33 OXT ACT B 201 C 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 174 TYR B 108 TYR^? -4.79 O ACT A 202s coo 2.84 19.43 40.34 1.59 20.35 37.65 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 5.94 13.28 27.17 3.53 13.05 28.58 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 10 3 # 10 C 14 ARG B 92 ARG^? -3.69 CH3 ACT A 202s C 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 174 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo 2.84 19.43 40.34 1.59 20.35 37.65 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 5.94 13.28 27.17 3.53 13.05 28.58 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 11 3 # 11 C 14 ARG B 124 ARG.? -3.52 O ACT B 201s C 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 174 TYR B 108 TYR^? -4.79 O ACT A 202s coo 2.84 19.43 40.34 1.59 20.35 37.65 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 5.94 13.28 27.17 3.53 13.05 28.58 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 12 3 # 12 C 14 ARG B 138 ARG~? 16.35 OXT ACT B 201 C 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 174 TYR B 108 TYR^? -4.79 O ACT A 202s coo 2.84 19.43 40.34 1.59 20.35 37.65 -23.44 41.55 74.26 -23.57 39.98 76.87 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 5.94 13.28 27.17 3.53 13.05 28.58 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 13 3 # 13 C 14 ARG C 51 ARG.? 6.22 O2 EDO A 301 C 161 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 174 TYR A 75 TYR^? -4.52 O ACT A 201s coo 2.84 19.43 40.34 1.59 20.35 37.65 -39.28 57.54 52.97 -41.40 56.18 54.75 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 5.94 13.28 27.17 3.53 13.05 28.58 -38.06 71.60 62.08 -35.99 71.56 63.96 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 14 3 # 14 C 14 ARG C 67 ARG~? 12.50 O2 EDO A 302 C 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 C 174 TYR B 108 TYR^? -4.79 O ACT A 202s coo 2.84 19.43 40.34 1.59 20.35 37.65 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 5.94 13.28 27.17 3.53 13.05 28.58 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 15 3 # 15 C 14 ARG C 67 ARG~? 12.50 O2 EDO A 302 C 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 174 TYR C 95 TYR^? -3.84 O ACT C 201s coo 2.84 19.43 40.34 1.59 20.35 37.65 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 5.94 13.28 27.17 3.53 13.05 28.58 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 16 3 # 16 C 14 ARG C 76 ARG^? 14.32 O ACT C 201 C 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 174 TYR C 108 TYR^? 12.28 O ACT C 201 coo 2.84 19.43 40.34 1.59 20.35 37.65 -42.25 40.39 61.14 -41.06 40.24 63.98 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 5.94 13.28 27.17 3.53 13.05 28.58 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 17 3 # 17 C 14 ARG C 92 ARG^? 13.71 CH3 ACT C 201 C 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 174 TYR C 95 TYR^? -3.84 O ACT C 201s coo 2.84 19.43 40.34 1.59 20.35 37.65 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 5.94 13.28 27.17 3.53 13.05 28.58 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 18 3 # 18 C 14 ARG C 124 ARG.? -3.50 OXT ACT C 201s C 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 174 TYR C 108 TYR^? 12.28 O ACT C 201 coo 2.84 19.43 40.34 1.59 20.35 37.65 -34.72 50.67 45.47 -36.40 51.18 47.99 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 5.94 13.28 27.17 3.53 13.05 28.58 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 19 3 # 19 C 14 ARG C 138 ARG~? 16.31 O ACT C 201 C 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 174 TYR C 108 TYR^? 12.28 O ACT C 201 coo 2.84 19.43 40.34 1.59 20.35 37.65 -46.75 44.46 65.88 -44.64 42.30 66.40 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 5.94 13.28 27.17 3.53 13.05 28.58 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 20 3 # 20 C 14 ARG D 67 ARG~? 13.15 O ACT A 203 C 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 174 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 2.84 19.43 40.34 1.59 20.35 37.65 -60.60 65.68 53.30 -61.45 62.86 52.44 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 5.94 13.28 27.17 3.53 13.05 28.58 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 21 3 # 21 C 14 ARG D 76 ARG^? 14.20 OXT ACT D 201 C 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 174 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 2.84 19.43 40.34 1.59 20.35 37.65 -47.81 74.29 36.53 -48.87 77.02 37.43 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 5.94 13.28 27.17 3.53 13.05 28.58 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 22 3 # 22 C 14 ARG D 92 ARG^? 13.56 CH3 ACT D 201 C 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 174 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo 2.84 19.43 40.34 1.59 20.35 37.65 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 5.94 13.28 27.17 3.53 13.05 28.58 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 23 3 # 23 C 14 ARG D 124 ARG.? -3.55 O ACT D 201s C 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 174 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 2.84 19.43 40.34 1.59 20.35 37.65 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 5.94 13.28 27.17 3.53 13.05 28.58 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 24 3 # 24 C 14 ARG D 138 ARG~? 16.38 OXT ACT D 201 C 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 C 174 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo 2.84 19.43 40.34 1.59 20.35 37.65 -42.61 77.59 41.75 -44.95 78.80 40.20 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 5.94 13.28 27.17 3.53 13.05 28.58 -40.41 63.05 43.73 -38.60 65.12 43.23 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 24 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 67 ARG~? 13.20 O2 EDO A 302 D 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 174 TYR A 95 TYR^? -3.85 O ACT A 201s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 67 ARG~? 13.20 O2 EDO A 302 D 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 174 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG A 76 ARG^? 8.97 OXT ACT A 203 D 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 174 TYR A 108 TYR^? 12.28 O ACT A 201 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG A 92 ARG^? 14.09 CH3 ACT A 201 D 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 174 TYR A 95 TYR^? -3.85 O ACT A 201s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 5 3 # 5 D 14 ARG A 138 ARG~? 6.49 OXT ACT A 203 D 161 ASP A 130 ASP.? 4.80 O1 EDO A 301 D 174 TYR A 108 TYR^? 12.28 O ACT A 201 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -50.06 71.52 64.11 -49.59 74.03 62.40 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -40.87 65.49 73.93 -43.61 66.01 74.07 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 6 3 # 6 D 14 ARG B 67 ARG~? 13.55 O ACT B 201 D 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 174 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -45.57 49.20 81.23 -45.93 51.82 82.79 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 7 3 # 7 D 14 ARG B 76 ARG^? 14.33 OXT ACT B 201 D 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 174 TYR B 108 TYR^? -4.79 O ACT A 202s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 8 3 # 8 D 14 ARG B 92 ARG^? -3.69 CH3 ACT A 202s D 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 174 TYR B 95 TYR^? -3.87 OXT ACT B 201s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -29.40 51.18 78.64 -32.01 51.78 77.83 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 9 3 # 9 D 14 ARG B 138 ARG~? 16.35 OXT ACT B 201 D 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 174 TYR B 108 TYR^? -4.79 O ACT A 202s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -23.44 41.55 74.26 -23.57 39.98 76.87 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 10 3 # 10 D 14 ARG C 67 ARG~? 12.50 O2 EDO A 302 D 161 ASP B 130 ASP.? 9.25 OXT ACT B 201 D 174 TYR B 108 TYR^? -4.79 O ACT A 202s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -26.20 55.78 72.02 -24.40 54.06 70.73 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 11 3 # 11 D 14 ARG C 67 ARG~? 12.50 O2 EDO A 302 D 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 174 TYR C 95 TYR^? -3.84 O ACT C 201s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 12 3 # 12 D 14 ARG C 76 ARG^? 14.32 O ACT C 201 D 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 174 TYR C 108 TYR^? 12.28 O ACT C 201 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -42.25 40.39 61.14 -41.06 40.24 63.98 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 13 3 # 13 D 14 ARG C 92 ARG^? 13.71 CH3 ACT C 201 D 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 174 TYR C 95 TYR^? -3.84 O ACT C 201s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -41.63 48.44 55.51 -40.56 51.04 55.32 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 14 3 # 14 D 14 ARG C 138 ARG~? 16.31 O ACT C 201 D 161 ASP C 130 ASP.? 4.74 O2 EDO A 301 D 174 TYR C 108 TYR^? 12.28 O ACT C 201 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -46.75 44.46 65.88 -44.64 42.30 66.40 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -49.57 50.97 53.11 -51.32 50.02 55.06 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 15 3 # 15 D 14 ARG D 67 ARG~? 13.15 O ACT A 203 D 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 174 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -60.60 65.68 53.30 -61.45 62.86 52.44 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 16 3 # 16 D 14 ARG D 76 ARG^? 14.20 OXT ACT D 201 D 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 174 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -47.81 74.29 36.53 -48.87 77.02 37.43 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -40.41 63.05 43.73 -38.60 65.12 43.23 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 17 3 # 17 D 14 ARG D 92 ARG^? 13.56 CH3 ACT D 201 D 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 174 TYR D 95 TYR^? -3.79 OXT ACT D 201s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -48.26 66.56 42.41 -49.21 65.61 44.87 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 18 3 # 18 D 14 ARG D 138 ARG~? 16.38 OXT ACT D 201 D 161 ASP D 130 ASP.? 7.40 CH3 ACT A 203 D 174 TYR D 108 TYR^? 12.28 OXT ACT D 201 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -42.61 77.59 41.75 -44.95 78.80 40.20 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -40.41 63.05 43.73 -38.60 65.12 43.23 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 18 hits 2c7v_c11 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 72 GLU~? 5.31 O ACT A 201 A 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 194 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 67.47 20.07 1.34 65.99 20.06 2.88 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 67.44 25.26 13.91 67.54 23.65 15.28 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 72 GLU~? 5.31 O ACT A 201 A 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 194 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 67.47 20.07 1.34 65.99 20.06 2.88 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 67.44 25.26 13.91 67.54 23.65 15.28 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 72 GLU~? 5.31 O ACT A 201 A 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 194 ASN A 129 ASN.? 9.65 O ACT B 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 67.47 20.07 1.34 65.99 20.06 2.88 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 67.44 25.26 13.91 67.54 23.65 15.28 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU A 72 GLU~? 5.31 O ACT A 201 A 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 194 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 67.47 20.07 1.34 65.99 20.06 2.88 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 67.44 25.26 13.91 67.54 23.65 15.28 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 156 GLU A 27 GLU~? 9.74 CH3 ACT A 201 A 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 67.47 20.07 1.34 65.99 20.06 2.88 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 67.44 25.26 13.91 67.54 23.65 15.28 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 156 GLU A 160 GLU.? 13.50 O ACT A 201 A 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 67.47 20.07 1.34 65.99 20.06 2.88 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 67.44 25.26 13.91 67.54 23.65 15.28 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 156 GLU B 114 GLU^? 18.04 O ACT B 201 A 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 67.47 20.07 1.34 65.99 20.06 2.88 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 67.44 25.26 13.91 67.54 23.65 15.28 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 156 GLU A 72 GLU~? 5.31 O ACT A 201 A 194 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 67.47 20.07 1.34 65.99 20.06 2.88 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 67.44 25.26 13.91 67.54 23.65 15.28 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 2dbt_c00 CHITINASE C user 9 3 # 9 A 147 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 156 GLU A 72 GLU~? 5.31 O ACT A 201 A 194 ASN A 129 ASN.? 9.65 O ACT B 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 67.47 20.07 1.34 65.99 20.06 2.88 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 67.44 25.26 13.91 67.54 23.65 15.28 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 2dbt_c00 CHITINASE C user 10 3 # 10 A 147 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 156 GLU A 137 GLU~? 14.03 O ACT A 203 A 194 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 67.47 20.07 1.34 65.99 20.06 2.88 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 67.44 25.26 13.91 67.54 23.65 15.28 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 2dbt_c00 CHITINASE C user 11 3 # 11 A 147 GLU A 111 GLU^? 4.34 CH3 ACT A 201 A 156 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 194 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 67.47 20.07 1.34 65.99 20.06 2.88 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 67.44 25.26 13.91 67.54 23.65 15.28 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 2dbt_c00 CHITINASE C user 12 3 # 12 A 147 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 156 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 74.14 15.91 8.55 72.08 15.36 8.63 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 67.47 20.07 1.34 65.99 20.06 2.88 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 67.44 25.26 13.91 67.54 23.65 15.28 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c00 CHITINASE C user 13 3 # 13 A 147 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 156 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 74.14 15.91 8.55 72.08 15.36 8.63 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 67.47 20.07 1.34 65.99 20.06 2.88 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 67.44 25.26 13.91 67.54 23.65 15.28 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c00 CHITINASE C user 14 3 # 14 A 147 GLU A 137 GLU~? 14.03 O ACT A 203 A 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 A 194 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 67.47 20.07 1.34 65.99 20.06 2.88 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 67.44 25.26 13.91 67.54 23.65 15.28 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 2dbt_c00 CHITINASE C user 15 3 # 15 A 147 GLU A 160 GLU.? 13.50 O ACT A 201 A 156 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 67.47 20.07 1.34 65.99 20.06 2.88 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 67.44 25.26 13.91 67.54 23.65 15.28 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c00 CHITINASE C user 16 3 # 16 A 147 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 156 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 194 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 67.47 20.07 1.34 65.99 20.06 2.88 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 67.44 25.26 13.91 67.54 23.65 15.28 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 3 2dbt_c00 CHITINASE C user 17 3 # 17 A 147 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 156 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 194 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 74.14 15.91 8.55 72.08 15.36 8.63 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 67.47 20.07 1.34 65.99 20.06 2.88 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 67.44 25.26 13.91 67.54 23.65 15.28 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 2dbt_c00 CHITINASE C user 18 3 # 18 A 147 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 156 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 194 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 67.47 20.07 1.34 65.99 20.06 2.88 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 67.44 25.26 13.91 67.54 23.65 15.28 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 2dbt_c00 CHITINASE C user 19 3 # 19 A 147 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 156 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 74.14 15.91 8.55 72.08 15.36 8.63 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 67.47 20.07 1.34 65.99 20.06 2.88 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 67.44 25.26 13.91 67.54 23.65 15.28 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c00 CHITINASE C user 20 3 # 20 A 147 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 156 GLU B 27 GLU~? 9.83 CH3 ACT B 201 A 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 74.14 15.91 8.55 72.08 15.36 8.63 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 67.47 20.07 1.34 65.99 20.06 2.88 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 67.44 25.26 13.91 67.54 23.65 15.28 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c00 CHITINASE C user 21 3 # 21 A 147 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 156 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 194 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 67.47 20.07 1.34 65.99 20.06 2.88 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 67.44 25.26 13.91 67.54 23.65 15.28 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 3 2dbt_c00 CHITINASE C user 22 3 # 22 A 147 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 156 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 194 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 74.14 15.91 8.55 72.08 15.36 8.63 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 67.47 20.07 1.34 65.99 20.06 2.88 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 67.44 25.26 13.91 67.54 23.65 15.28 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 2dbt_c00 CHITINASE C user 23 3 # 23 A 147 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 156 GLU B 72 GLU~? 5.30 OXT ACT B 201 A 194 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 67.47 20.07 1.34 65.99 20.06 2.88 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 67.44 25.26 13.91 67.54 23.65 15.28 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 2dbt_c00 CHITINASE C user 24 3 # 24 A 147 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 156 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 194 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 74.14 15.91 8.55 72.08 15.36 8.63 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 67.47 20.07 1.34 65.99 20.06 2.88 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 67.44 25.26 13.91 67.54 23.65 15.28 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 2dbt_c00 CHITINASE C user 25 3 # 25 A 147 GLU B 111 GLU^? 4.46 CH3 ACT B 201 A 156 GLU B 80 GLU^? 7.87 CH3 ACT A 202 A 194 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 67.47 20.07 1.34 65.99 20.06 2.88 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 67.44 25.26 13.91 67.54 23.65 15.28 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 3 2dbt_c00 CHITINASE C user 26 3 # 26 A 147 GLU B 114 GLU^? 18.04 O ACT B 201 A 156 GLU A 80 GLU^? 14.51 CH3 ACT A 201 A 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 67.47 20.07 1.34 65.99 20.06 2.88 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 67.44 25.26 13.91 67.54 23.65 15.28 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c00 CHITINASE C user 27 3 # 27 A 147 GLU B 137 GLU~? 6.31 C2 EDO A 302 A 156 GLU B 96 GLU^? 10.60 C1 EDO A 302 A 194 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 74.14 15.91 8.55 72.08 15.36 8.63 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 67.47 20.07 1.34 65.99 20.06 2.88 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 67.44 25.26 13.91 67.54 23.65 15.28 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 2dbt_c00 CHITINASE C user 28 3 # 28 A 147 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 156 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 194 ASN A 57 ASN~? 14.18 O1 EDO A 302 coo 74.14 15.91 8.55 72.08 15.36 8.63 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 67.47 20.07 1.34 65.99 20.06 2.88 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 67.44 25.26 13.91 67.54 23.65 15.28 -16.25 65.99 58.99 -17.06 64.89 57.36 ULMN 3 2dbt_c00 CHITINASE C user 29 3 # 29 A 147 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 156 GLU A 60 GLU~? 10.63 O2 EDO A 302 A 194 ASN A 50 ASN^? 5.02 OXT ACT A 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 67.47 20.07 1.34 65.99 20.06 2.88 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 67.44 25.26 13.91 67.54 23.65 15.28 -28.17 63.14 65.41 -30.17 63.83 65.25 ULMN 3 2dbt_c00 CHITINASE C user 30 3 # 30 A 147 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 156 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 74.14 15.91 8.55 72.08 15.36 8.63 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 67.47 20.07 1.34 65.99 20.06 2.88 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 67.44 25.26 13.91 67.54 23.65 15.28 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c00 CHITINASE C user 31 3 # 31 A 147 GLU C 72 GLU~? 5.32 O ACT C 201 A 156 GLU C 96 GLU^? 13.00 O ACT C 201 A 194 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 67.47 20.07 1.34 65.99 20.06 2.88 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 67.44 25.26 13.91 67.54 23.65 15.28 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 2dbt_c00 CHITINASE C user 32 3 # 32 A 147 GLU C 72 GLU~? 5.32 O ACT C 201 A 156 GLU C 96 GLU^? 13.00 O ACT C 201 A 194 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 67.47 20.07 1.34 65.99 20.06 2.88 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 67.44 25.26 13.91 67.54 23.65 15.28 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 3 2dbt_c00 CHITINASE C user 33 3 # 33 A 147 GLU C 72 GLU~? 5.32 O ACT C 201 A 156 GLU C 96 GLU^? 13.00 O ACT C 201 A 194 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 67.47 20.07 1.34 65.99 20.06 2.88 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 67.44 25.26 13.91 67.54 23.65 15.28 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 2dbt_c00 CHITINASE C user 34 3 # 34 A 147 GLU C 72 GLU~? 5.32 O ACT C 201 A 156 GLU C 96 GLU^? 13.00 O ACT C 201 A 194 ASN C 129 ASN.? 9.72 O ACT D 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 67.47 20.07 1.34 65.99 20.06 2.88 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 67.44 25.26 13.91 67.54 23.65 15.28 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 2dbt_c00 CHITINASE C user 35 3 # 35 A 147 GLU C 80 GLU^? 14.47 CH3 ACT C 201 A 156 GLU C 27 GLU~? 9.88 CH3 ACT C 201 A 194 ASN C 110 ASN^? 10.92 O ACT D 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 67.47 20.07 1.34 65.99 20.06 2.88 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 67.44 25.26 13.91 67.54 23.65 15.28 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 2dbt_c00 CHITINASE C user 36 3 # 36 A 147 GLU C 80 GLU^? 14.47 CH3 ACT C 201 A 156 GLU D 114 GLU^? 18.05 O ACT D 201 A 194 ASN C 110 ASN^? 10.92 O ACT D 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 67.47 20.07 1.34 65.99 20.06 2.88 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 67.44 25.26 13.91 67.54 23.65 15.28 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 2dbt_c00 CHITINASE C user 37 3 # 37 A 147 GLU C 96 GLU^? 13.00 O ACT C 201 A 156 GLU C 72 GLU~? 5.32 O ACT C 201 A 194 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 67.47 20.07 1.34 65.99 20.06 2.88 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 67.44 25.26 13.91 67.54 23.65 15.28 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 3 2dbt_c00 CHITINASE C user 38 3 # 38 A 147 GLU C 96 GLU^? 13.00 O ACT C 201 A 156 GLU C 72 GLU~? 5.32 O ACT C 201 A 194 ASN C 129 ASN.? 9.72 O ACT D 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 67.47 20.07 1.34 65.99 20.06 2.88 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 67.44 25.26 13.91 67.54 23.65 15.28 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 2dbt_c00 CHITINASE C user 39 3 # 39 A 147 GLU C 96 GLU^? 13.00 O ACT C 201 A 156 GLU C 137 GLU~? 15.84 O2 EDO A 301 A 194 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 67.47 20.07 1.34 65.99 20.06 2.88 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 67.44 25.26 13.91 67.54 23.65 15.28 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 2dbt_c00 CHITINASE C user 40 3 # 40 A 147 GLU C 111 GLU^? 4.32 CH3 ACT C 201 A 156 GLU C 80 GLU^? 14.47 CH3 ACT C 201 A 194 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 67.47 20.07 1.34 65.99 20.06 2.88 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 67.44 25.26 13.91 67.54 23.65 15.28 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 3 2dbt_c00 CHITINASE C user 41 3 # 41 A 147 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 156 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 194 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 67.47 20.07 1.34 65.99 20.06 2.88 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 67.44 25.26 13.91 67.54 23.65 15.28 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 2dbt_c00 CHITINASE C user 42 3 # 42 A 147 GLU C 137 GLU~? 15.84 O2 EDO A 301 A 156 GLU C 96 GLU^? 13.00 O ACT C 201 A 194 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 67.47 20.07 1.34 65.99 20.06 2.88 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 67.44 25.26 13.91 67.54 23.65 15.28 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 2dbt_c00 CHITINASE C user 43 3 # 43 A 147 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 156 GLU D 53 GLU^? 10.32 O ACT A 203 A 194 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 67.47 20.07 1.34 65.99 20.06 2.88 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 67.44 25.26 13.91 67.54 23.65 15.28 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 2dbt_c00 CHITINASE C user 44 3 # 44 A 147 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 156 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 194 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 67.47 20.07 1.34 65.99 20.06 2.88 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 67.44 25.26 13.91 67.54 23.65 15.28 -53.58 68.96 34.68 -51.50 68.66 35.10 ULMN 3 2dbt_c00 CHITINASE C user 45 3 # 45 A 147 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 156 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 194 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 74.14 15.91 8.55 72.08 15.36 8.63 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 67.47 20.07 1.34 65.99 20.06 2.88 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 67.44 25.26 13.91 67.54 23.65 15.28 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 2dbt_c00 CHITINASE C user 46 3 # 46 A 147 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 156 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 194 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 67.47 20.07 1.34 65.99 20.06 2.88 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 67.44 25.26 13.91 67.54 23.65 15.28 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 2dbt_c00 CHITINASE C user 47 3 # 47 A 147 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 156 GLU C 114 GLU^? 18.18 OXT ACT C 201 A 194 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 67.47 20.07 1.34 65.99 20.06 2.88 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 67.44 25.26 13.91 67.54 23.65 15.28 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 2dbt_c00 CHITINASE C user 48 3 # 48 A 147 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 156 GLU D 27 GLU~? 9.75 CH3 ACT D 201 A 194 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 67.47 20.07 1.34 65.99 20.06 2.88 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 67.44 25.26 13.91 67.54 23.65 15.28 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 2dbt_c00 CHITINASE C user 49 3 # 49 A 147 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 156 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 194 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 67.47 20.07 1.34 65.99 20.06 2.88 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 67.44 25.26 13.91 67.54 23.65 15.28 -53.58 68.96 34.68 -51.50 68.66 35.10 ULMN 3 2dbt_c00 CHITINASE C user 50 3 # 50 A 147 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 156 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 194 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 74.14 15.91 8.55 72.08 15.36 8.63 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 67.47 20.07 1.34 65.99 20.06 2.88 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 67.44 25.26 13.91 67.54 23.65 15.28 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 2dbt_c00 CHITINASE C user 51 3 # 51 A 147 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 156 GLU D 72 GLU~? 5.29 OXT ACT D 201 A 194 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 67.47 20.07 1.34 65.99 20.06 2.88 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 67.44 25.26 13.91 67.54 23.65 15.28 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 2dbt_c00 CHITINASE C user 52 3 # 52 A 147 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 156 GLU D 137 GLU~? 19.20 CH3 ACT A 203 A 194 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 74.14 15.91 8.55 72.08 15.36 8.63 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 67.47 20.07 1.34 65.99 20.06 2.88 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 67.44 25.26 13.91 67.54 23.65 15.28 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 2dbt_c00 CHITINASE C user 53 3 # 53 A 147 GLU D 111 GLU^? 4.46 CH3 ACT D 201 A 156 GLU D 80 GLU^? 14.49 CH3 ACT D 201 A 194 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 67.47 20.07 1.34 65.99 20.06 2.88 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 67.44 25.26 13.91 67.54 23.65 15.28 -53.58 68.96 34.68 -51.50 68.66 35.10 ULMN 3 2dbt_c00 CHITINASE C user 54 3 # 54 A 147 GLU D 114 GLU^? 18.05 O ACT D 201 A 156 GLU C 80 GLU^? 14.47 CH3 ACT C 201 A 194 ASN C 110 ASN^? 10.92 O ACT D 201 coo 74.14 15.91 8.55 72.08 15.36 8.63 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 67.47 20.07 1.34 65.99 20.06 2.88 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 67.44 25.26 13.91 67.54 23.65 15.28 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 2dbt_c00 CHITINASE C user 55 3 # 55 A 147 GLU D 137 GLU~? 19.20 CH3 ACT A 203 A 156 GLU D 96 GLU^? 13.00 OXT ACT D 201 A 194 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 74.14 15.91 8.55 72.08 15.36 8.63 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 67.47 20.07 1.34 65.99 20.06 2.88 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 67.44 25.26 13.91 67.54 23.65 15.28 -43.97 76.72 52.03 -43.49 78.26 53.43 2dbt_c00 source 2dbt CHITINASE C : 55 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 27 GLU~? 9.74 CH3 ACT A 201 B 156 GLU A 80 GLU^? 14.51 CH3 ACT A 201 B 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 54.43 67.89 19.82 55.62 67.90 18.07 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 49.79 70.75 7.78 50.10 68.90 6.86 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 53 GLU^? 10.41 O2 EDO A 302 B 156 GLU B 160 GLU.? 4.71 OXT ACT A 202 B 194 ASN A 57 ASN~? 14.18 O1 EDO A 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 54.43 67.89 19.82 55.62 67.90 18.07 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 49.79 70.75 7.78 50.10 68.90 6.86 -16.25 65.99 58.99 -17.06 64.89 57.36 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 72 GLU~? 5.31 O ACT A 201 B 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 194 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 54.43 67.89 19.82 55.62 67.90 18.07 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 49.79 70.75 7.78 50.10 68.90 6.86 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU A 72 GLU~? 5.31 O ACT A 201 B 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 194 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 54.43 67.89 19.82 55.62 67.90 18.07 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 49.79 70.75 7.78 50.10 68.90 6.86 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU A 72 GLU~? 5.31 O ACT A 201 B 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 194 ASN A 129 ASN.? 9.65 O ACT B 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 54.43 67.89 19.82 55.62 67.90 18.07 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 49.79 70.75 7.78 50.10 68.90 6.86 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU A 80 GLU^? 14.51 CH3 ACT A 201 B 156 GLU A 27 GLU~? 9.74 CH3 ACT A 201 B 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 54.43 67.89 19.82 55.62 67.90 18.07 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 49.79 70.75 7.78 50.10 68.90 6.86 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU A 80 GLU^? 14.51 CH3 ACT A 201 B 156 GLU A 160 GLU.? 13.50 O ACT A 201 B 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 54.43 67.89 19.82 55.62 67.90 18.07 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 49.79 70.75 7.78 50.10 68.90 6.86 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 156 GLU A 72 GLU~? 5.31 O ACT A 201 B 194 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 54.43 67.89 19.82 55.62 67.90 18.07 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 49.79 70.75 7.78 50.10 68.90 6.86 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 2dbt_c01 CHITINASE C user 9 3 # 9 B 147 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 156 GLU A 72 GLU~? 5.31 O ACT A 201 B 194 ASN A 129 ASN.? 9.65 O ACT B 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 54.43 67.89 19.82 55.62 67.90 18.07 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 49.79 70.75 7.78 50.10 68.90 6.86 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 2dbt_c01 CHITINASE C user 10 3 # 10 B 147 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 156 GLU A 137 GLU~? 14.03 O ACT A 203 B 194 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 54.43 67.89 19.82 55.62 67.90 18.07 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 49.79 70.75 7.78 50.10 68.90 6.86 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 2dbt_c01 CHITINASE C user 11 3 # 11 B 147 GLU A 111 GLU^? 4.34 CH3 ACT A 201 B 156 GLU A 80 GLU^? 14.51 CH3 ACT A 201 B 194 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 54.43 67.89 19.82 55.62 67.90 18.07 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 49.79 70.75 7.78 50.10 68.90 6.86 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 2dbt_c01 CHITINASE C user 12 3 # 12 B 147 GLU A 114 GLU^? 11.87 CH3 ACT A 202 B 156 GLU B 80 GLU^? 7.87 CH3 ACT A 202 B 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 45.64 63.11 17.20 47.48 62.43 16.45 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 54.43 67.89 19.82 55.62 67.90 18.07 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 49.79 70.75 7.78 50.10 68.90 6.86 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c01 CHITINASE C user 13 3 # 13 B 147 GLU A 114 GLU^? 11.87 CH3 ACT A 202 B 156 GLU B 160 GLU.? 4.71 OXT ACT A 202 B 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 45.64 63.11 17.20 47.48 62.43 16.45 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 54.43 67.89 19.82 55.62 67.90 18.07 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 49.79 70.75 7.78 50.10 68.90 6.86 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c01 CHITINASE C user 14 3 # 14 B 147 GLU A 137 GLU~? 14.03 O ACT A 203 B 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 B 194 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 54.43 67.89 19.82 55.62 67.90 18.07 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 49.79 70.75 7.78 50.10 68.90 6.86 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 2dbt_c01 CHITINASE C user 15 3 # 15 B 147 GLU A 160 GLU.? 13.50 O ACT A 201 B 156 GLU A 80 GLU^? 14.51 CH3 ACT A 201 B 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 54.43 67.89 19.82 55.62 67.90 18.07 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 49.79 70.75 7.78 50.10 68.90 6.86 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c01 CHITINASE C user 16 3 # 16 B 147 GLU B 27 GLU~? 9.83 CH3 ACT B 201 B 156 GLU B 80 GLU^? 7.87 CH3 ACT A 202 B 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 45.64 63.11 17.20 47.48 62.43 16.45 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 54.43 67.89 19.82 55.62 67.90 18.07 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 49.79 70.75 7.78 50.10 68.90 6.86 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c01 CHITINASE C user 17 3 # 17 B 147 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 156 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 194 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 54.43 67.89 19.82 55.62 67.90 18.07 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 49.79 70.75 7.78 50.10 68.90 6.86 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 3 2dbt_c01 CHITINASE C user 18 3 # 18 B 147 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 156 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 194 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 54.43 67.89 19.82 55.62 67.90 18.07 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 49.79 70.75 7.78 50.10 68.90 6.86 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 2dbt_c01 CHITINASE C user 19 3 # 19 B 147 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 156 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 194 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 54.43 67.89 19.82 55.62 67.90 18.07 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 49.79 70.75 7.78 50.10 68.90 6.86 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 2dbt_c01 CHITINASE C user 20 3 # 20 B 147 GLU B 80 GLU^? 7.87 CH3 ACT A 202 B 156 GLU A 114 GLU^? 11.87 CH3 ACT A 202 B 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 45.64 63.11 17.20 47.48 62.43 16.45 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 54.43 67.89 19.82 55.62 67.90 18.07 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 49.79 70.75 7.78 50.10 68.90 6.86 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c01 CHITINASE C user 21 3 # 21 B 147 GLU B 80 GLU^? 7.87 CH3 ACT A 202 B 156 GLU B 27 GLU~? 9.83 CH3 ACT B 201 B 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 45.64 63.11 17.20 47.48 62.43 16.45 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 54.43 67.89 19.82 55.62 67.90 18.07 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 49.79 70.75 7.78 50.10 68.90 6.86 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c01 CHITINASE C user 22 3 # 22 B 147 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 156 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 194 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 54.43 67.89 19.82 55.62 67.90 18.07 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 49.79 70.75 7.78 50.10 68.90 6.86 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 3 2dbt_c01 CHITINASE C user 23 3 # 23 B 147 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 156 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 194 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 54.43 67.89 19.82 55.62 67.90 18.07 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 49.79 70.75 7.78 50.10 68.90 6.86 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 2dbt_c01 CHITINASE C user 24 3 # 24 B 147 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 156 GLU B 72 GLU~? 5.30 OXT ACT B 201 B 194 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 54.43 67.89 19.82 55.62 67.90 18.07 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 49.79 70.75 7.78 50.10 68.90 6.86 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 2dbt_c01 CHITINASE C user 25 3 # 25 B 147 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 156 GLU B 137 GLU~? 6.31 C2 EDO A 302 B 194 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 54.43 67.89 19.82 55.62 67.90 18.07 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 49.79 70.75 7.78 50.10 68.90 6.86 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 2dbt_c01 CHITINASE C user 26 3 # 26 B 147 GLU B 111 GLU^? 4.46 CH3 ACT B 201 B 156 GLU B 80 GLU^? 7.87 CH3 ACT A 202 B 194 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 54.43 67.89 19.82 55.62 67.90 18.07 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 49.79 70.75 7.78 50.10 68.90 6.86 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 3 2dbt_c01 CHITINASE C user 27 3 # 27 B 147 GLU B 137 GLU~? 6.31 C2 EDO A 302 B 156 GLU B 96 GLU^? 10.60 C1 EDO A 302 B 194 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 54.43 67.89 19.82 55.62 67.90 18.07 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 49.79 70.75 7.78 50.10 68.90 6.86 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 2dbt_c01 CHITINASE C user 28 3 # 28 B 147 GLU B 160 GLU.? 4.71 OXT ACT A 202 B 156 GLU A 53 GLU^? 10.41 O2 EDO A 302 B 194 ASN A 57 ASN~? 14.18 O1 EDO A 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 54.43 67.89 19.82 55.62 67.90 18.07 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 49.79 70.75 7.78 50.10 68.90 6.86 -16.25 65.99 58.99 -17.06 64.89 57.36 ULMN 3 2dbt_c01 CHITINASE C user 29 3 # 29 B 147 GLU B 160 GLU.? 4.71 OXT ACT A 202 B 156 GLU A 60 GLU~? 10.63 O2 EDO A 302 B 194 ASN A 50 ASN^? 5.02 OXT ACT A 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 54.43 67.89 19.82 55.62 67.90 18.07 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 49.79 70.75 7.78 50.10 68.90 6.86 -28.17 63.14 65.41 -30.17 63.83 65.25 ULMN 3 2dbt_c01 CHITINASE C user 30 3 # 30 B 147 GLU B 160 GLU.? 4.71 OXT ACT A 202 B 156 GLU A 114 GLU^? 11.87 CH3 ACT A 202 B 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 45.64 63.11 17.20 47.48 62.43 16.45 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 54.43 67.89 19.82 55.62 67.90 18.07 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 49.79 70.75 7.78 50.10 68.90 6.86 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c01 CHITINASE C user 31 3 # 31 B 147 GLU C 27 GLU~? 9.88 CH3 ACT C 201 B 156 GLU C 80 GLU^? 14.47 CH3 ACT C 201 B 194 ASN C 110 ASN^? 10.92 O ACT D 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 54.43 67.89 19.82 55.62 67.90 18.07 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 49.79 70.75 7.78 50.10 68.90 6.86 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 2dbt_c01 CHITINASE C user 32 3 # 32 B 147 GLU C 72 GLU~? 5.32 O ACT C 201 B 156 GLU C 96 GLU^? 13.00 O ACT C 201 B 194 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 54.43 67.89 19.82 55.62 67.90 18.07 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 49.79 70.75 7.78 50.10 68.90 6.86 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 3 2dbt_c01 CHITINASE C user 33 3 # 33 B 147 GLU C 72 GLU~? 5.32 O ACT C 201 B 156 GLU C 96 GLU^? 13.00 O ACT C 201 B 194 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 54.43 67.89 19.82 55.62 67.90 18.07 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 49.79 70.75 7.78 50.10 68.90 6.86 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 2dbt_c01 CHITINASE C user 34 3 # 34 B 147 GLU C 72 GLU~? 5.32 O ACT C 201 B 156 GLU C 96 GLU^? 13.00 O ACT C 201 B 194 ASN C 129 ASN.? 9.72 O ACT D 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 54.43 67.89 19.82 55.62 67.90 18.07 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 49.79 70.75 7.78 50.10 68.90 6.86 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 2dbt_c01 CHITINASE C user 35 3 # 35 B 147 GLU C 80 GLU^? 14.47 CH3 ACT C 201 B 156 GLU C 27 GLU~? 9.88 CH3 ACT C 201 B 194 ASN C 110 ASN^? 10.92 O ACT D 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 54.43 67.89 19.82 55.62 67.90 18.07 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 49.79 70.75 7.78 50.10 68.90 6.86 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 2dbt_c01 CHITINASE C user 36 3 # 36 B 147 GLU C 96 GLU^? 13.00 O ACT C 201 B 156 GLU C 72 GLU~? 5.32 O ACT C 201 B 194 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 54.43 67.89 19.82 55.62 67.90 18.07 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 49.79 70.75 7.78 50.10 68.90 6.86 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 3 2dbt_c01 CHITINASE C user 37 3 # 37 B 147 GLU C 96 GLU^? 13.00 O ACT C 201 B 156 GLU C 72 GLU~? 5.32 O ACT C 201 B 194 ASN C 129 ASN.? 9.72 O ACT D 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 54.43 67.89 19.82 55.62 67.90 18.07 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 49.79 70.75 7.78 50.10 68.90 6.86 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 2dbt_c01 CHITINASE C user 38 3 # 38 B 147 GLU C 96 GLU^? 13.00 O ACT C 201 B 156 GLU C 137 GLU~? 15.84 O2 EDO A 301 B 194 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 54.43 67.89 19.82 55.62 67.90 18.07 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 49.79 70.75 7.78 50.10 68.90 6.86 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 2dbt_c01 CHITINASE C user 39 3 # 39 B 147 GLU C 111 GLU^? 4.32 CH3 ACT C 201 B 156 GLU C 80 GLU^? 14.47 CH3 ACT C 201 B 194 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 54.43 67.89 19.82 55.62 67.90 18.07 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 49.79 70.75 7.78 50.10 68.90 6.86 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 3 2dbt_c01 CHITINASE C user 40 3 # 40 B 147 GLU C 137 GLU~? 15.84 O2 EDO A 301 B 156 GLU C 96 GLU^? 13.00 O ACT C 201 B 194 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 54.43 67.89 19.82 55.62 67.90 18.07 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 49.79 70.75 7.78 50.10 68.90 6.86 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 2dbt_c01 CHITINASE C user 41 3 # 41 B 147 GLU D 27 GLU~? 9.75 CH3 ACT D 201 B 156 GLU D 80 GLU^? 14.49 CH3 ACT D 201 B 194 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 54.43 67.89 19.82 55.62 67.90 18.07 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 49.79 70.75 7.78 50.10 68.90 6.86 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 2dbt_c01 CHITINASE C user 42 3 # 42 B 147 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 156 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 194 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 54.43 67.89 19.82 55.62 67.90 18.07 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 49.79 70.75 7.78 50.10 68.90 6.86 -53.58 68.96 34.68 -51.50 68.66 35.10 ULMN 3 2dbt_c01 CHITINASE C user 43 3 # 43 B 147 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 156 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 194 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 45.64 63.11 17.20 47.48 62.43 16.45 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 54.43 67.89 19.82 55.62 67.90 18.07 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 49.79 70.75 7.78 50.10 68.90 6.86 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 2dbt_c01 CHITINASE C user 44 3 # 44 B 147 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 156 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 194 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 54.43 67.89 19.82 55.62 67.90 18.07 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 49.79 70.75 7.78 50.10 68.90 6.86 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 2dbt_c01 CHITINASE C user 45 3 # 45 B 147 GLU D 80 GLU^? 14.49 CH3 ACT D 201 B 156 GLU D 27 GLU~? 9.75 CH3 ACT D 201 B 194 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 54.43 67.89 19.82 55.62 67.90 18.07 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 49.79 70.75 7.78 50.10 68.90 6.86 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 2dbt_c01 CHITINASE C user 46 3 # 46 B 147 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 156 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 194 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 54.43 67.89 19.82 55.62 67.90 18.07 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 49.79 70.75 7.78 50.10 68.90 6.86 -53.58 68.96 34.68 -51.50 68.66 35.10 ULMN 3 2dbt_c01 CHITINASE C user 47 3 # 47 B 147 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 156 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 194 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 45.64 63.11 17.20 47.48 62.43 16.45 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 54.43 67.89 19.82 55.62 67.90 18.07 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 49.79 70.75 7.78 50.10 68.90 6.86 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 2dbt_c01 CHITINASE C user 48 3 # 48 B 147 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 156 GLU D 72 GLU~? 5.29 OXT ACT D 201 B 194 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 54.43 67.89 19.82 55.62 67.90 18.07 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 49.79 70.75 7.78 50.10 68.90 6.86 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 2dbt_c01 CHITINASE C user 49 3 # 49 B 147 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 156 GLU D 137 GLU~? 19.20 CH3 ACT A 203 B 194 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 45.64 63.11 17.20 47.48 62.43 16.45 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 54.43 67.89 19.82 55.62 67.90 18.07 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 49.79 70.75 7.78 50.10 68.90 6.86 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 2dbt_c01 CHITINASE C user 50 3 # 50 B 147 GLU D 111 GLU^? 4.46 CH3 ACT D 201 B 156 GLU D 80 GLU^? 14.49 CH3 ACT D 201 B 194 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 45.64 63.11 17.20 47.48 62.43 16.45 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 54.43 67.89 19.82 55.62 67.90 18.07 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 49.79 70.75 7.78 50.10 68.90 6.86 -53.58 68.96 34.68 -51.50 68.66 35.10 ULMN 3 2dbt_c01 CHITINASE C user 51 3 # 51 B 147 GLU D 137 GLU~? 19.20 CH3 ACT A 203 B 156 GLU D 96 GLU^? 13.00 OXT ACT D 201 B 194 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 45.64 63.11 17.20 47.48 62.43 16.45 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 54.43 67.89 19.82 55.62 67.90 18.07 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 49.79 70.75 7.78 50.10 68.90 6.86 -43.97 76.72 52.03 -43.49 78.26 53.43 2dbt_c01 source 2dbt CHITINASE C : 51 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 27 GLU~? 9.74 CH3 ACT A 201 C 156 GLU A 80 GLU^? 14.51 CH3 ACT A 201 C 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 44.75 23.09 5.51 46.77 22.91 6.12 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 49.75 21.00 18.12 50.45 23.02 18.26 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 72 GLU~? 5.31 O ACT A 201 C 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 C 194 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 44.75 23.09 5.51 46.77 22.91 6.12 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 49.75 21.00 18.12 50.45 23.02 18.26 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 72 GLU~? 5.31 O ACT A 201 C 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 C 194 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 44.75 23.09 5.51 46.77 22.91 6.12 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 49.75 21.00 18.12 50.45 23.02 18.26 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU A 72 GLU~? 5.31 O ACT A 201 C 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 C 194 ASN A 129 ASN.? 9.65 O ACT B 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 44.75 23.09 5.51 46.77 22.91 6.12 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 49.75 21.00 18.12 50.45 23.02 18.26 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU A 72 GLU~? 5.31 O ACT A 201 C 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 C 194 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 44.75 23.09 5.51 46.77 22.91 6.12 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 49.75 21.00 18.12 50.45 23.02 18.26 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU A 80 GLU^? 14.51 CH3 ACT A 201 C 156 GLU A 27 GLU~? 9.74 CH3 ACT A 201 C 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 44.75 23.09 5.51 46.77 22.91 6.12 -34.88 77.89 68.90 -36.12 78.93 70.26 coo 49.75 21.00 18.12 50.45 23.02 18.26 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU A 80 GLU^? 14.51 CH3 ACT A 201 C 156 GLU A 160 GLU.? 13.50 O ACT A 201 C 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 44.75 23.09 5.51 46.77 22.91 6.12 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 49.75 21.00 18.12 50.45 23.02 18.26 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU A 80 GLU^? 14.51 CH3 ACT A 201 C 156 GLU B 114 GLU^? 18.04 O ACT B 201 C 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 44.75 23.09 5.51 46.77 22.91 6.12 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 49.75 21.00 18.12 50.45 23.02 18.26 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU A 80 GLU^? 14.51 CH3 ACT A 201 C 156 GLU B 114 GLU^? 18.04 O ACT B 201 C 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 41.23 29.31 13.28 43.03 29.85 12.29 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 44.75 23.09 5.51 46.77 22.91 6.12 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 49.75 21.00 18.12 50.45 23.02 18.26 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c02 CHITINASE C user 10 3 # 10 C 147 GLU A 96 GLU^? 11.70 OXT ACT A 203 C 156 GLU A 72 GLU~? 5.31 O ACT A 201 C 194 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 44.75 23.09 5.51 46.77 22.91 6.12 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 49.75 21.00 18.12 50.45 23.02 18.26 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 2dbt_c02 CHITINASE C user 11 3 # 11 C 147 GLU A 96 GLU^? 11.70 OXT ACT A 203 C 156 GLU A 72 GLU~? 5.31 O ACT A 201 C 194 ASN A 129 ASN.? 9.65 O ACT B 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 44.75 23.09 5.51 46.77 22.91 6.12 -38.02 65.72 60.64 -36.78 66.00 62.33 coo 49.75 21.00 18.12 50.45 23.02 18.26 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 3 2dbt_c02 CHITINASE C user 12 3 # 12 C 147 GLU A 96 GLU^? 11.70 OXT ACT A 203 C 156 GLU A 137 GLU~? 14.03 O ACT A 203 C 194 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 44.75 23.09 5.51 46.77 22.91 6.12 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 49.75 21.00 18.12 50.45 23.02 18.26 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 2dbt_c02 CHITINASE C user 13 3 # 13 C 147 GLU A 111 GLU^? 4.34 CH3 ACT A 201 C 156 GLU A 80 GLU^? 14.51 CH3 ACT A 201 C 194 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -29.42 69.91 72.34 -30.01 70.85 70.54 coo 44.75 23.09 5.51 46.77 22.91 6.12 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 49.75 21.00 18.12 50.45 23.02 18.26 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 3 2dbt_c02 CHITINASE C user 14 3 # 14 C 147 GLU A 114 GLU^? 11.87 CH3 ACT A 202 C 156 GLU B 80 GLU^? 7.87 CH3 ACT A 202 C 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 41.23 29.31 13.28 43.03 29.85 12.29 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 44.75 23.09 5.51 46.77 22.91 6.12 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 49.75 21.00 18.12 50.45 23.02 18.26 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c02 CHITINASE C user 15 3 # 15 C 147 GLU A 114 GLU^? 11.87 CH3 ACT A 202 C 156 GLU B 160 GLU.? 4.71 OXT ACT A 202 C 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 41.23 29.31 13.28 43.03 29.85 12.29 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 44.75 23.09 5.51 46.77 22.91 6.12 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 49.75 21.00 18.12 50.45 23.02 18.26 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c02 CHITINASE C user 16 3 # 16 C 147 GLU A 137 GLU~? 14.03 O ACT A 203 C 156 GLU A 96 GLU^? 11.70 OXT ACT A 203 C 194 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -53.30 67.06 70.37 -52.56 65.17 70.96 coo 44.75 23.09 5.51 46.77 22.91 6.12 -44.74 70.71 67.91 -46.53 71.68 68.48 coo 49.75 21.00 18.12 50.45 23.02 18.26 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 2dbt_c02 CHITINASE C user 17 3 # 17 C 147 GLU A 160 GLU.? 13.50 O ACT A 201 C 156 GLU A 80 GLU^? 14.51 CH3 ACT A 201 C 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 44.75 23.09 5.51 46.77 22.91 6.12 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 49.75 21.00 18.12 50.45 23.02 18.26 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c02 CHITINASE C user 18 3 # 18 C 147 GLU B 27 GLU~? 9.83 CH3 ACT B 201 C 156 GLU B 80 GLU^? 7.87 CH3 ACT A 202 C 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 41.23 29.31 13.28 43.03 29.85 12.29 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 44.75 23.09 5.51 46.77 22.91 6.12 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 49.75 21.00 18.12 50.45 23.02 18.26 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c02 CHITINASE C user 19 3 # 19 C 147 GLU B 72 GLU~? 5.30 OXT ACT B 201 C 156 GLU B 96 GLU^? 10.60 C1 EDO A 302 C 194 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 44.75 23.09 5.51 46.77 22.91 6.12 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 49.75 21.00 18.12 50.45 23.02 18.26 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 3 2dbt_c02 CHITINASE C user 20 3 # 20 C 147 GLU B 72 GLU~? 5.30 OXT ACT B 201 C 156 GLU B 96 GLU^? 10.60 C1 EDO A 302 C 194 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 41.23 29.31 13.28 43.03 29.85 12.29 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 44.75 23.09 5.51 46.77 22.91 6.12 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 49.75 21.00 18.12 50.45 23.02 18.26 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 2dbt_c02 CHITINASE C user 21 3 # 21 C 147 GLU B 72 GLU~? 5.30 OXT ACT B 201 C 156 GLU B 96 GLU^? 10.60 C1 EDO A 302 C 194 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 44.75 23.09 5.51 46.77 22.91 6.12 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 49.75 21.00 18.12 50.45 23.02 18.26 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 2dbt_c02 CHITINASE C user 22 3 # 22 C 147 GLU B 80 GLU^? 7.87 CH3 ACT A 202 C 156 GLU A 114 GLU^? 11.87 CH3 ACT A 202 C 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 41.23 29.31 13.28 43.03 29.85 12.29 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 44.75 23.09 5.51 46.77 22.91 6.12 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 49.75 21.00 18.12 50.45 23.02 18.26 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c02 CHITINASE C user 23 3 # 23 C 147 GLU B 80 GLU^? 7.87 CH3 ACT A 202 C 156 GLU B 27 GLU~? 9.83 CH3 ACT B 201 C 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 41.23 29.31 13.28 43.03 29.85 12.29 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 44.75 23.09 5.51 46.77 22.91 6.12 -24.11 53.46 86.45 -22.04 53.54 86.08 coo 49.75 21.00 18.12 50.45 23.02 18.26 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c02 CHITINASE C user 24 3 # 24 C 147 GLU B 96 GLU^? 10.60 C1 EDO A 302 C 156 GLU B 72 GLU~? 5.30 OXT ACT B 201 C 194 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 44.75 23.09 5.51 46.77 22.91 6.12 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 49.75 21.00 18.12 50.45 23.02 18.26 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 3 2dbt_c02 CHITINASE C user 25 3 # 25 C 147 GLU B 96 GLU^? 10.60 C1 EDO A 302 C 156 GLU B 72 GLU~? 5.30 OXT ACT B 201 C 194 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 41.23 29.31 13.28 43.03 29.85 12.29 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 44.75 23.09 5.51 46.77 22.91 6.12 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 49.75 21.00 18.12 50.45 23.02 18.26 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 2dbt_c02 CHITINASE C user 26 3 # 26 C 147 GLU B 96 GLU^? 10.60 C1 EDO A 302 C 156 GLU B 72 GLU~? 5.30 OXT ACT B 201 C 194 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 44.75 23.09 5.51 46.77 22.91 6.12 -35.13 47.70 77.85 -34.58 49.69 78.28 coo 49.75 21.00 18.12 50.45 23.02 18.26 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 2dbt_c02 CHITINASE C user 27 3 # 27 C 147 GLU B 96 GLU^? 10.60 C1 EDO A 302 C 156 GLU B 137 GLU~? 6.31 C2 EDO A 302 C 194 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 41.23 29.31 13.28 43.03 29.85 12.29 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 44.75 23.09 5.51 46.77 22.91 6.12 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 49.75 21.00 18.12 50.45 23.02 18.26 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 2dbt_c02 CHITINASE C user 28 3 # 28 C 147 GLU B 111 GLU^? 4.46 CH3 ACT B 201 C 156 GLU B 80 GLU^? 7.87 CH3 ACT A 202 C 194 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -29.98 61.01 82.70 -30.12 59.10 83.58 coo 44.75 23.09 5.51 46.77 22.91 6.12 -19.12 60.55 81.96 -17.78 60.17 80.39 coo 49.75 21.00 18.12 50.45 23.02 18.26 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 3 2dbt_c02 CHITINASE C user 29 3 # 29 C 147 GLU B 114 GLU^? 18.04 O ACT B 201 C 156 GLU A 80 GLU^? 14.51 CH3 ACT A 201 C 194 ASN A 110 ASN^? 10.87 O ACT B 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 44.75 23.09 5.51 46.77 22.91 6.12 -35.46 76.50 78.57 -37.32 76.28 79.54 coo 49.75 21.00 18.12 50.45 23.02 18.26 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 2dbt_c02 CHITINASE C user 30 3 # 30 C 147 GLU B 137 GLU~? 6.31 C2 EDO A 302 C 156 GLU B 96 GLU^? 10.60 C1 EDO A 302 C 194 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 41.23 29.31 13.28 43.03 29.85 12.29 -20.73 44.81 67.02 -21.84 45.98 65.65 coo 44.75 23.09 5.51 46.77 22.91 6.12 -24.44 47.78 75.39 -22.51 46.98 75.05 coo 49.75 21.00 18.12 50.45 23.02 18.26 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 3 2dbt_c02 CHITINASE C user 31 3 # 31 C 147 GLU B 160 GLU.? 4.71 OXT ACT A 202 C 156 GLU A 53 GLU^? 10.41 O2 EDO A 302 C 194 ASN A 57 ASN~? 14.18 O1 EDO A 302 coo 41.23 29.31 13.28 43.03 29.85 12.29 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 44.75 23.09 5.51 46.77 22.91 6.12 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 49.75 21.00 18.12 50.45 23.02 18.26 -16.25 65.99 58.99 -17.06 64.89 57.36 ULMN 3 2dbt_c02 CHITINASE C user 32 3 # 32 C 147 GLU B 160 GLU.? 4.71 OXT ACT A 202 C 156 GLU A 60 GLU~? 10.63 O2 EDO A 302 C 194 ASN A 50 ASN^? 5.02 OXT ACT A 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 44.75 23.09 5.51 46.77 22.91 6.12 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 49.75 21.00 18.12 50.45 23.02 18.26 -28.17 63.14 65.41 -30.17 63.83 65.25 ULMN 3 2dbt_c02 CHITINASE C user 33 3 # 33 C 147 GLU B 160 GLU.? 4.71 OXT ACT A 202 C 156 GLU A 114 GLU^? 11.87 CH3 ACT A 202 C 194 ASN B 110 ASN^? 6.46 O ACT A 202 coo 41.23 29.31 13.28 43.03 29.85 12.29 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 44.75 23.09 5.51 46.77 22.91 6.12 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 49.75 21.00 18.12 50.45 23.02 18.26 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 2dbt_c02 CHITINASE C user 34 3 # 34 C 147 GLU C 27 GLU~? 9.88 CH3 ACT C 201 C 156 GLU C 80 GLU^? 14.47 CH3 ACT C 201 C 194 ASN C 110 ASN^? 10.92 O ACT D 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 44.75 23.09 5.51 46.77 22.91 6.12 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 49.75 21.00 18.12 50.45 23.02 18.26 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 2dbt_c02 CHITINASE C user 35 3 # 35 C 147 GLU C 72 GLU~? 5.32 O ACT C 201 C 156 GLU C 96 GLU^? 13.00 O ACT C 201 C 194 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 44.75 23.09 5.51 46.77 22.91 6.12 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 49.75 21.00 18.12 50.45 23.02 18.26 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 3 2dbt_c02 CHITINASE C user 36 3 # 36 C 147 GLU C 72 GLU~? 5.32 O ACT C 201 C 156 GLU C 96 GLU^? 13.00 O ACT C 201 C 194 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 44.75 23.09 5.51 46.77 22.91 6.12 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 49.75 21.00 18.12 50.45 23.02 18.26 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 3 2dbt_c02 CHITINASE C user 37 3 # 37 C 147 GLU C 72 GLU~? 5.32 O ACT C 201 C 156 GLU C 96 GLU^? 13.00 O ACT C 201 C 194 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 44.75 23.09 5.51 46.77 22.91 6.12 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 49.75 21.00 18.12 50.45 23.02 18.26 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 2dbt_c02 CHITINASE C user 38 3 # 38 C 147 GLU C 72 GLU~? 5.32 O ACT C 201 C 156 GLU C 96 GLU^? 13.00 O ACT C 201 C 194 ASN C 129 ASN.? 9.72 O ACT D 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 44.75 23.09 5.51 46.77 22.91 6.12 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 49.75 21.00 18.12 50.45 23.02 18.26 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 2dbt_c02 CHITINASE C user 39 3 # 39 C 147 GLU C 80 GLU^? 14.47 CH3 ACT C 201 C 156 GLU C 27 GLU~? 9.88 CH3 ACT C 201 C 194 ASN C 110 ASN^? 10.92 O ACT D 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 44.75 23.09 5.51 46.77 22.91 6.12 -40.23 39.97 50.79 -41.89 38.66 50.83 coo 49.75 21.00 18.12 50.45 23.02 18.26 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 2dbt_c02 CHITINASE C user 40 3 # 40 C 147 GLU C 80 GLU^? 14.47 CH3 ACT C 201 C 156 GLU D 114 GLU^? 18.05 O ACT D 201 C 194 ASN C 110 ASN^? 10.92 O ACT D 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 44.75 23.09 5.51 46.77 22.91 6.12 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 49.75 21.00 18.12 50.45 23.02 18.26 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 2dbt_c02 CHITINASE C user 41 3 # 41 C 147 GLU C 96 GLU^? 13.00 O ACT C 201 C 156 GLU C 72 GLU~? 5.32 O ACT C 201 C 194 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 44.75 23.09 5.51 46.77 22.91 6.12 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 49.75 21.00 18.12 50.45 23.02 18.26 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 3 2dbt_c02 CHITINASE C user 42 3 # 42 C 147 GLU C 96 GLU^? 13.00 O ACT C 201 C 156 GLU C 72 GLU~? 5.32 O ACT C 201 C 194 ASN C 129 ASN.? 9.72 O ACT D 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 44.75 23.09 5.51 46.77 22.91 6.12 -37.42 52.13 59.26 -38.02 51.91 57.25 coo 49.75 21.00 18.12 50.45 23.02 18.26 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 3 2dbt_c02 CHITINASE C user 43 3 # 43 C 147 GLU C 96 GLU^? 13.00 O ACT C 201 C 156 GLU C 137 GLU~? 15.84 O2 EDO A 301 C 194 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 44.75 23.09 5.51 46.77 22.91 6.12 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 49.75 21.00 18.12 50.45 23.02 18.26 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 2dbt_c02 CHITINASE C user 44 3 # 44 C 147 GLU C 111 GLU^? 4.32 CH3 ACT C 201 C 156 GLU C 80 GLU^? 14.47 CH3 ACT C 201 C 194 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -40.57 48.44 44.93 -39.46 47.54 46.50 coo 44.75 23.09 5.51 46.77 22.91 6.12 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 49.75 21.00 18.12 50.45 23.02 18.26 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 3 2dbt_c02 CHITINASE C user 45 3 # 45 C 147 GLU C 137 GLU~? 15.84 O2 EDO A 301 C 156 GLU C 96 GLU^? 13.00 O ACT C 201 C 194 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -54.51 47.57 65.07 -55.01 49.56 64.57 coo 44.75 23.09 5.51 46.77 22.91 6.12 -46.59 45.81 59.59 -47.94 44.44 60.43 coo 49.75 21.00 18.12 50.45 23.02 18.26 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 3 2dbt_c02 CHITINASE C user 46 3 # 46 C 147 GLU D 72 GLU~? 5.29 OXT ACT D 201 C 156 GLU D 53 GLU^? 10.32 O ACT A 203 C 194 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 44.75 23.09 5.51 46.77 22.91 6.12 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 49.75 21.00 18.12 50.45 23.02 18.26 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 2dbt_c02 CHITINASE C user 47 3 # 47 C 147 GLU D 72 GLU~? 5.29 OXT ACT D 201 C 156 GLU D 96 GLU^? 13.00 OXT ACT D 201 C 194 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 44.75 23.09 5.51 46.77 22.91 6.12 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 49.75 21.00 18.12 50.45 23.02 18.26 -53.58 68.96 34.68 -51.50 68.66 35.10 ULMN 3 2dbt_c02 CHITINASE C user 48 3 # 48 C 147 GLU D 72 GLU~? 5.29 OXT ACT D 201 C 156 GLU D 96 GLU^? 13.00 OXT ACT D 201 C 194 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 41.23 29.31 13.28 43.03 29.85 12.29 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 44.75 23.09 5.51 46.77 22.91 6.12 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 49.75 21.00 18.12 50.45 23.02 18.26 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 2dbt_c02 CHITINASE C user 49 3 # 49 C 147 GLU D 72 GLU~? 5.29 OXT ACT D 201 C 156 GLU D 96 GLU^? 13.00 OXT ACT D 201 C 194 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 44.75 23.09 5.51 46.77 22.91 6.12 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 49.75 21.00 18.12 50.45 23.02 18.26 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 2dbt_c02 CHITINASE C user 50 3 # 50 C 147 GLU D 80 GLU^? 14.49 CH3 ACT D 201 C 156 GLU C 114 GLU^? 18.18 OXT ACT C 201 C 194 ASN C 110 ASN^? 10.92 O ACT D 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 44.75 23.09 5.51 46.77 22.91 6.12 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 49.75 21.00 18.12 50.45 23.02 18.26 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 2dbt_c02 CHITINASE C user 51 3 # 51 C 147 GLU D 80 GLU^? 14.49 CH3 ACT D 201 C 156 GLU C 114 GLU^? 18.18 OXT ACT C 201 C 194 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 44.75 23.09 5.51 46.77 22.91 6.12 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 49.75 21.00 18.12 50.45 23.02 18.26 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 2dbt_c02 CHITINASE C user 52 3 # 52 C 147 GLU D 80 GLU^? 14.49 CH3 ACT D 201 C 156 GLU D 27 GLU~? 9.75 CH3 ACT D 201 C 194 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 44.75 23.09 5.51 46.77 22.91 6.12 -50.66 64.65 33.24 -49.08 64.98 31.89 coo 49.75 21.00 18.12 50.45 23.02 18.26 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 2dbt_c02 CHITINASE C user 53 3 # 53 C 147 GLU D 96 GLU^? 13.00 OXT ACT D 201 C 156 GLU D 72 GLU~? 5.29 OXT ACT D 201 C 194 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 44.75 23.09 5.51 46.77 22.91 6.12 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 49.75 21.00 18.12 50.45 23.02 18.26 -53.58 68.96 34.68 -51.50 68.66 35.10 ULMN 3 2dbt_c02 CHITINASE C user 54 3 # 54 C 147 GLU D 96 GLU^? 13.00 OXT ACT D 201 C 156 GLU D 72 GLU~? 5.29 OXT ACT D 201 C 194 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 41.23 29.31 13.28 43.03 29.85 12.29 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 44.75 23.09 5.51 46.77 22.91 6.12 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 49.75 21.00 18.12 50.45 23.02 18.26 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 2dbt_c02 CHITINASE C user 55 3 # 55 C 147 GLU D 96 GLU^? 13.00 OXT ACT D 201 C 156 GLU D 72 GLU~? 5.29 OXT ACT D 201 C 194 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 44.75 23.09 5.51 46.77 22.91 6.12 -51.77 69.18 47.61 -51.44 67.29 46.71 coo 49.75 21.00 18.12 50.45 23.02 18.26 -42.23 60.94 49.15 -42.50 59.01 49.99 ULMN 3 2dbt_c02 CHITINASE C user 56 3 # 56 C 147 GLU D 96 GLU^? 13.00 OXT ACT D 201 C 156 GLU D 137 GLU~? 19.20 CH3 ACT A 203 C 194 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 41.23 29.31 13.28 43.03 29.85 12.29 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 44.75 23.09 5.51 46.77 22.91 6.12 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 49.75 21.00 18.12 50.45 23.02 18.26 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 3 2dbt_c02 CHITINASE C user 57 3 # 57 C 147 GLU D 111 GLU^? 4.46 CH3 ACT D 201 C 156 GLU D 80 GLU^? 14.49 CH3 ACT D 201 C 194 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -50.16 56.56 39.52 -51.23 58.35 39.21 coo 44.75 23.09 5.51 46.77 22.91 6.12 -42.96 58.73 31.72 -40.96 59.40 31.80 coo 49.75 21.00 18.12 50.45 23.02 18.26 -53.58 68.96 34.68 -51.50 68.66 35.10 ULMN 3 2dbt_c02 CHITINASE C user 58 3 # 58 C 147 GLU D 114 GLU^? 18.05 O ACT D 201 C 156 GLU C 80 GLU^? 14.47 CH3 ACT C 201 C 194 ASN C 110 ASN^? 10.92 O ACT D 201 coo 41.23 29.31 13.28 43.03 29.85 12.29 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 44.75 23.09 5.51 46.77 22.91 6.12 -48.24 40.72 45.31 -50.16 40.73 46.15 coo 49.75 21.00 18.12 50.45 23.02 18.26 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 2dbt_c02 CHITINASE C user 59 3 # 59 C 147 GLU D 137 GLU~? 19.20 CH3 ACT A 203 C 156 GLU D 96 GLU^? 13.00 OXT ACT D 201 C 194 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 41.23 29.31 13.28 43.03 29.85 12.29 -34.89 75.05 43.86 -34.35 73.81 45.48 coo 44.75 23.09 5.51 46.77 22.91 6.12 -43.29 70.99 40.99 -41.92 72.19 39.92 coo 49.75 21.00 18.12 50.45 23.02 18.26 -43.97 76.72 52.03 -43.49 78.26 53.43 2dbt_c02 source 2dbt CHITINASE C : 59 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 68 LYS~? -2.78 O ACT A 201s A 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo 5.98 42.76 7.73 10.19 38.62 9.02 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 2.77 37.17 4.99 6.33 34.76 8.06 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 2 3 # 2 A 182 LYS A 68 LYS~? -2.78 O ACT A 201s A 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 2.77 37.17 4.99 6.33 34.76 8.06 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 3 3 # 3 A 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 184 LYS A 68 LYS~? -2.78 O ACT A 201s A 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 2.77 37.17 4.99 6.33 34.76 8.06 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 4 3 # 4 A 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 184 LYS A 68 LYS~? -2.78 O ACT A 201s A 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 2.77 37.17 4.99 6.33 34.76 8.06 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 5 3 # 5 A 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 184 LYS A 68 LYS~? -2.78 O ACT A 201s A 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 2.77 37.17 4.99 6.33 34.76 8.06 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 6 3 # 6 A 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 5.98 42.76 7.73 10.19 38.62 9.02 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 2.77 37.17 4.99 6.33 34.76 8.06 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 7 3 # 7 A 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 2.77 37.17 4.99 6.33 34.76 8.06 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 8 3 # 8 A 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 345 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 5.98 42.76 7.73 10.19 38.62 9.02 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 2.77 37.17 4.99 6.33 34.76 8.06 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 9 3 # 9 A 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 A 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s A 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 2.77 37.17 4.99 6.33 34.76 8.06 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 10 3 # 10 A 182 LYS C 68 LYS~? -2.77 O ACT C 201s A 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo 5.98 42.76 7.73 10.19 38.62 9.02 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 2.77 37.17 4.99 6.33 34.76 8.06 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 11 3 # 11 A 182 LYS C 68 LYS~? -2.77 O ACT C 201s A 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 2.77 37.17 4.99 6.33 34.76 8.06 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 12 3 # 12 A 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 184 LYS C 68 LYS~? -2.77 O ACT C 201s A 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 2.77 37.17 4.99 6.33 34.76 8.06 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 13 3 # 13 A 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 184 LYS C 68 LYS~? -2.77 O ACT C 201s A 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 2.77 37.17 4.99 6.33 34.76 8.06 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 14 3 # 14 A 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 184 LYS C 68 LYS~? -2.77 O ACT C 201s A 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 2.77 37.17 4.99 6.33 34.76 8.06 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 15 3 # 15 A 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 2.77 37.17 4.99 6.33 34.76 8.06 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 16 3 # 16 A 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 5.98 42.76 7.73 10.19 38.62 9.02 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 2.77 37.17 4.99 6.33 34.76 8.06 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 17 3 # 17 A 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 2.77 37.17 4.99 6.33 34.76 8.06 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 18 3 # 18 A 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s A 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s A 345 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 5.98 42.76 7.73 10.19 38.62 9.02 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 2.77 37.17 4.99 6.33 34.76 8.06 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -44.22 66.27 50.20 -46.22 65.66 49.92 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 18 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 68 LYS~? -2.78 O ACT A 201s B 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo 38.76 2.27 4.00 34.00 5.99 4.37 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 40.63 7.13 9.06 35.85 7.36 8.95 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 68 LYS~? -2.78 O ACT A 201s B 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 38.76 2.27 4.00 34.00 5.99 4.37 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 40.63 7.13 9.06 35.85 7.36 8.95 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 B 184 LYS A 68 LYS~? -2.78 O ACT A 201s B 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 38.76 2.27 4.00 34.00 5.99 4.37 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 40.63 7.13 9.06 35.85 7.36 8.95 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 38.76 2.27 4.00 34.00 5.99 4.37 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 40.63 7.13 9.06 35.85 7.36 8.95 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 5 3 # 5 B 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 B 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s B 345 ASP C 74 ASP^? 14.86 O ACT C 201 coo 38.76 2.27 4.00 34.00 5.99 4.37 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 40.63 7.13 9.06 35.85 7.36 8.95 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 6 3 # 6 B 182 LYS C 68 LYS~? -2.77 O ACT C 201s B 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 38.76 2.27 4.00 34.00 5.99 4.37 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 40.63 7.13 9.06 35.85 7.36 8.95 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 7 3 # 7 B 182 LYS C 68 LYS~? -2.77 O ACT C 201s B 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo 38.76 2.27 4.00 34.00 5.99 4.37 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 40.63 7.13 9.06 35.85 7.36 8.95 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 8 3 # 8 B 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 B 184 LYS C 68 LYS~? -2.77 O ACT C 201s B 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 38.76 2.27 4.00 34.00 5.99 4.37 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 40.63 7.13 9.06 35.85 7.36 8.95 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 9 3 # 9 B 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 38.76 2.27 4.00 34.00 5.99 4.37 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 40.63 7.13 9.06 35.85 7.36 8.95 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 10 3 # 10 B 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s B 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s B 345 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 38.76 2.27 4.00 34.00 5.99 4.37 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 40.63 7.13 9.06 35.85 7.36 8.95 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -44.71 72.29 58.72 -45.62 72.95 56.93 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 10 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 68 LYS~? -2.78 O ACT A 201s C 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 C 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 0.95 12.72 73.51 1.58 12.72 68.31 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 2 3 # 2 C 182 LYS A 68 LYS~? -2.78 O ACT A 201s C 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 C 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 0.95 12.72 73.51 1.58 12.72 68.31 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 3 3 # 3 C 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 C 184 LYS A 68 LYS~? -2.78 O ACT A 201s C 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 0.95 12.72 73.51 1.58 12.72 68.31 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 4 3 # 4 C 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 C 184 LYS A 68 LYS~? -2.78 O ACT A 201s C 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 0.95 12.72 73.51 1.58 12.72 68.31 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 5 3 # 5 C 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 C 184 LYS A 68 LYS~? -2.78 O ACT A 201s C 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 0.95 12.72 73.51 1.58 12.72 68.31 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 6 3 # 6 C 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s C 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 C 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 0.95 12.72 73.51 1.58 12.72 68.31 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 7 3 # 7 C 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s C 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 C 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 0.95 12.72 73.51 1.58 12.72 68.31 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 8 3 # 8 C 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 C 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s C 345 ASP C 74 ASP^? 14.86 O ACT C 201 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 0.95 12.72 73.51 1.58 12.72 68.31 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 9 3 # 9 C 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 C 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s C 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 0.95 12.72 73.51 1.58 12.72 68.31 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 10 3 # 10 C 182 LYS C 68 LYS~? -2.77 O ACT C 201s C 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 C 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 0.95 12.72 73.51 1.58 12.72 68.31 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 11 3 # 11 C 182 LYS C 68 LYS~? -2.77 O ACT C 201s C 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 C 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 0.95 12.72 73.51 1.58 12.72 68.31 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 12 3 # 12 C 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 C 184 LYS C 68 LYS~? -2.77 O ACT C 201s C 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 0.95 12.72 73.51 1.58 12.72 68.31 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 13 3 # 13 C 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 C 184 LYS C 68 LYS~? -2.77 O ACT C 201s C 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 0.95 12.72 73.51 1.58 12.72 68.31 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 14 3 # 14 C 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 C 184 LYS C 68 LYS~? -2.77 O ACT C 201s C 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 0.95 12.72 73.51 1.58 12.72 68.31 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 15 3 # 15 C 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s C 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s C 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 0.95 12.72 73.51 1.58 12.72 68.31 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 16 3 # 16 C 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s C 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s C 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 0.95 12.72 73.51 1.58 12.72 68.31 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 17 3 # 17 C 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s C 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s C 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 0.95 12.72 73.51 1.58 12.72 68.31 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 18 3 # 18 C 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s C 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s C 345 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 0.95 12.72 73.51 1.58 12.72 68.31 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -44.22 66.27 50.20 -46.22 65.66 49.92 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 18 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 68 LYS~? -2.78 O ACT A 201s D 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 D 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS A 68 LYS~? -2.78 O ACT A 201s D 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 D 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 3 3 # 3 D 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 D 184 LYS A 68 LYS~? -2.78 O ACT A 201s D 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 4 3 # 4 D 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 D 184 LYS A 68 LYS~? -2.78 O ACT A 201s D 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 5 3 # 5 D 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 D 184 LYS A 68 LYS~? -2.78 O ACT A 201s D 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 6 3 # 6 D 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s D 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 D 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 7 3 # 7 D 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s D 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 D 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 8 3 # 8 D 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 D 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s D 345 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 9 3 # 9 D 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 D 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s D 345 ASP C 74 ASP^? 14.86 O ACT C 201 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 10 3 # 10 D 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 D 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s D 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 11 3 # 11 D 182 LYS C 68 LYS~? -2.77 O ACT C 201s D 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 D 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 12 3 # 12 D 182 LYS C 68 LYS~? -2.77 O ACT C 201s D 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 D 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 13 3 # 13 D 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 D 184 LYS C 68 LYS~? -2.77 O ACT C 201s D 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 14 3 # 14 D 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 D 184 LYS C 68 LYS~? -2.77 O ACT C 201s D 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 15 3 # 15 D 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 D 184 LYS C 68 LYS~? -2.77 O ACT C 201s D 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 16 3 # 16 D 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s D 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s D 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 17 3 # 17 D 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s D 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s D 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 18 3 # 18 D 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s D 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s D 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 19 3 # 19 D 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s D 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s D 345 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 20 3 # 20 D 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s D 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s D 345 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -44.22 66.27 50.20 -46.22 65.66 49.92 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 20 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 68 LYS~? -2.78 O ACT A 201s E 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 E 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS A 68 LYS~? -2.78 O ACT A 201s E 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 E 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 3 3 # 3 E 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 E 184 LYS A 68 LYS~? -2.78 O ACT A 201s E 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 4 3 # 4 E 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 E 184 LYS A 68 LYS~? -2.78 O ACT A 201s E 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 5 3 # 5 E 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 E 184 LYS A 68 LYS~? -2.78 O ACT A 201s E 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 6 3 # 6 E 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s E 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 E 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 7 3 # 7 E 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s E 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 E 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 8 3 # 8 E 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 E 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s E 345 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 9 3 # 9 E 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 E 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s E 345 ASP C 74 ASP^? 14.86 O ACT C 201 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 10 3 # 10 E 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 E 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s E 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 11 3 # 11 E 182 LYS C 68 LYS~? -2.77 O ACT C 201s E 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 E 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 12 3 # 12 E 182 LYS C 68 LYS~? -2.77 O ACT C 201s E 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 E 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 13 3 # 13 E 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 E 184 LYS C 68 LYS~? -2.77 O ACT C 201s E 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 14 3 # 14 E 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 E 184 LYS C 68 LYS~? -2.77 O ACT C 201s E 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 15 3 # 15 E 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 E 184 LYS C 68 LYS~? -2.77 O ACT C 201s E 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 16 3 # 16 E 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s E 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s E 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 17 3 # 17 E 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s E 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s E 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 18 3 # 18 E 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s E 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s E 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 19 3 # 19 E 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s E 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s E 345 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 20 3 # 20 E 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s E 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s E 345 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -44.22 66.27 50.20 -46.22 65.66 49.92 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 20 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 68 LYS~? -2.78 O ACT A 201s F 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 F 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 13.75 39.76 94.12 11.42 37.23 97.89 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 16.35 26.90 99.56 16.81 25.90 97.75 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS A 68 LYS~? -2.78 O ACT A 201s F 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 F 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 13.75 39.76 94.12 11.42 37.23 97.89 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 16.35 26.90 99.56 16.81 25.90 97.75 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 F 184 LYS A 68 LYS~? -2.78 O ACT A 201s F 345 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 10.64 34.02 91.30 6.30 35.60 95.11 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 13.75 39.76 94.12 11.42 37.23 97.89 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 16.35 26.90 99.56 16.81 25.90 97.75 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 4 3 # 4 F 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 F 184 LYS A 68 LYS~? -2.78 O ACT A 201s F 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 13.75 39.76 94.12 11.42 37.23 97.89 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 16.35 26.90 99.56 16.81 25.90 97.75 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 5 3 # 5 F 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 F 184 LYS A 68 LYS~? -2.78 O ACT A 201s F 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 13.75 39.76 94.12 11.42 37.23 97.89 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 16.35 26.90 99.56 16.81 25.90 97.75 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 6 3 # 6 F 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 F 184 LYS A 68 LYS~? -2.78 O ACT A 201s F 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 13.75 39.76 94.12 11.42 37.23 97.89 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 16.35 26.90 99.56 16.81 25.90 97.75 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 7 3 # 7 F 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s F 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 F 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 13.75 39.76 94.12 11.42 37.23 97.89 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 16.35 26.90 99.56 16.81 25.90 97.75 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 8 3 # 8 F 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s F 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 F 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 13.75 39.76 94.12 11.42 37.23 97.89 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 16.35 26.90 99.56 16.81 25.90 97.75 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 9 3 # 9 F 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 F 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s F 345 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 13.75 39.76 94.12 11.42 37.23 97.89 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 16.35 26.90 99.56 16.81 25.90 97.75 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 10 3 # 10 F 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 F 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s F 345 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 13.75 39.76 94.12 11.42 37.23 97.89 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 16.35 26.90 99.56 16.81 25.90 97.75 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 11 3 # 11 F 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 F 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s F 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 13.75 39.76 94.12 11.42 37.23 97.89 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 16.35 26.90 99.56 16.81 25.90 97.75 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 12 3 # 12 F 182 LYS C 68 LYS~? -2.77 O ACT C 201s F 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 F 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 13.75 39.76 94.12 11.42 37.23 97.89 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 16.35 26.90 99.56 16.81 25.90 97.75 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 13 3 # 13 F 182 LYS C 68 LYS~? -2.77 O ACT C 201s F 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 F 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 13.75 39.76 94.12 11.42 37.23 97.89 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 16.35 26.90 99.56 16.81 25.90 97.75 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 14 3 # 14 F 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 F 184 LYS C 68 LYS~? -2.77 O ACT C 201s F 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 13.75 39.76 94.12 11.42 37.23 97.89 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 16.35 26.90 99.56 16.81 25.90 97.75 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 15 3 # 15 F 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 F 184 LYS C 68 LYS~? -2.77 O ACT C 201s F 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 13.75 39.76 94.12 11.42 37.23 97.89 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 16.35 26.90 99.56 16.81 25.90 97.75 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 16 3 # 16 F 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 F 184 LYS C 68 LYS~? -2.77 O ACT C 201s F 345 ASP C 74 ASP^? 14.86 O ACT C 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 13.75 39.76 94.12 11.42 37.23 97.89 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 16.35 26.90 99.56 16.81 25.90 97.75 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 17 3 # 17 F 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 F 184 LYS C 68 LYS~? -2.77 O ACT C 201s F 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 13.75 39.76 94.12 11.42 37.23 97.89 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 16.35 26.90 99.56 16.81 25.90 97.75 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 18 3 # 18 F 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s F 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s F 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 13.75 39.76 94.12 11.42 37.23 97.89 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 16.35 26.90 99.56 16.81 25.90 97.75 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 19 3 # 19 F 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s F 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s F 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 13.75 39.76 94.12 11.42 37.23 97.89 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 16.35 26.90 99.56 16.81 25.90 97.75 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 20 3 # 20 F 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s F 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s F 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 13.75 39.76 94.12 11.42 37.23 97.89 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 16.35 26.90 99.56 16.81 25.90 97.75 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 21 3 # 21 F 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s F 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s F 345 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 10.64 34.02 91.30 6.30 35.60 95.11 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 13.75 39.76 94.12 11.42 37.23 97.89 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 16.35 26.90 99.56 16.81 25.90 97.75 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 22 3 # 22 F 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s F 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s F 345 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 10.64 34.02 91.30 6.30 35.60 95.11 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 13.75 39.76 94.12 11.42 37.23 97.89 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 16.35 26.90 99.56 16.81 25.90 97.75 -44.22 66.27 50.20 -46.22 65.66 49.92 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 22 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 68 LYS~? -2.78 O ACT A 201s G 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 G 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo 39.68 42.04 76.11 43.42 46.43 74.96 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 36.69 47.69 78.93 39.38 50.40 75.35 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 33.43 44.37 65.47 33.10 42.30 65.37 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS A 68 LYS~? -2.78 O ACT A 201s G 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 G 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 36.69 47.69 78.93 39.38 50.40 75.35 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 33.43 44.37 65.47 33.10 42.30 65.37 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 3 3 # 3 G 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 G 184 LYS A 68 LYS~? -2.78 O ACT A 201s G 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 36.69 47.69 78.93 39.38 50.40 75.35 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 33.43 44.37 65.47 33.10 42.30 65.37 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 4 3 # 4 G 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 G 184 LYS A 68 LYS~? -2.78 O ACT A 201s G 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 36.69 47.69 78.93 39.38 50.40 75.35 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 33.43 44.37 65.47 33.10 42.30 65.37 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 5 3 # 5 G 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 G 184 LYS A 68 LYS~? -2.78 O ACT A 201s G 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 36.69 47.69 78.93 39.38 50.40 75.35 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 33.43 44.37 65.47 33.10 42.30 65.37 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 6 3 # 6 G 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s G 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 G 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 39.68 42.04 76.11 43.42 46.43 74.96 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 36.69 47.69 78.93 39.38 50.40 75.35 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 33.43 44.37 65.47 33.10 42.30 65.37 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 7 3 # 7 G 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s G 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 G 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 36.69 47.69 78.93 39.38 50.40 75.35 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 33.43 44.37 65.47 33.10 42.30 65.37 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 8 3 # 8 G 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 G 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s G 345 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 39.68 42.04 76.11 43.42 46.43 74.96 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 36.69 47.69 78.93 39.38 50.40 75.35 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 33.43 44.37 65.47 33.10 42.30 65.37 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 9 3 # 9 G 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 G 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s G 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 36.69 47.69 78.93 39.38 50.40 75.35 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 33.43 44.37 65.47 33.10 42.30 65.37 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 10 3 # 10 G 182 LYS C 68 LYS~? -2.77 O ACT C 201s G 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 G 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo 39.68 42.04 76.11 43.42 46.43 74.96 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 36.69 47.69 78.93 39.38 50.40 75.35 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 33.43 44.37 65.47 33.10 42.30 65.37 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 11 3 # 11 G 182 LYS C 68 LYS~? -2.77 O ACT C 201s G 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 G 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 36.69 47.69 78.93 39.38 50.40 75.35 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 33.43 44.37 65.47 33.10 42.30 65.37 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 12 3 # 12 G 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 G 184 LYS C 68 LYS~? -2.77 O ACT C 201s G 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 36.69 47.69 78.93 39.38 50.40 75.35 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 33.43 44.37 65.47 33.10 42.30 65.37 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 13 3 # 13 G 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 G 184 LYS C 68 LYS~? -2.77 O ACT C 201s G 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 36.69 47.69 78.93 39.38 50.40 75.35 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 33.43 44.37 65.47 33.10 42.30 65.37 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 14 3 # 14 G 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 G 184 LYS C 68 LYS~? -2.77 O ACT C 201s G 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 36.69 47.69 78.93 39.38 50.40 75.35 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 33.43 44.37 65.47 33.10 42.30 65.37 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 15 3 # 15 G 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s G 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s G 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 36.69 47.69 78.93 39.38 50.40 75.35 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 33.43 44.37 65.47 33.10 42.30 65.37 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 16 3 # 16 G 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s G 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s G 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 39.68 42.04 76.11 43.42 46.43 74.96 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 36.69 47.69 78.93 39.38 50.40 75.35 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 33.43 44.37 65.47 33.10 42.30 65.37 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 17 3 # 17 G 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s G 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s G 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 36.69 47.69 78.93 39.38 50.40 75.35 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 33.43 44.37 65.47 33.10 42.30 65.37 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 18 3 # 18 G 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s G 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s G 345 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 39.68 42.04 76.11 43.42 46.43 74.96 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 36.69 47.69 78.93 39.38 50.40 75.35 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 33.43 44.37 65.47 33.10 42.30 65.37 -44.22 66.27 50.20 -46.22 65.66 49.92 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 18 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 68 LYS~? -2.78 O ACT A 201s H 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 H 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo 71.58 83.18 80.51 66.88 79.77 79.84 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 73.65 78.64 75.66 68.14 79.07 75.04 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 67.43 90.73 71.39 68.27 92.30 72.52 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS A 68 LYS~? -2.78 O ACT A 201s H 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 H 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 73.65 78.64 75.66 68.14 79.07 75.04 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 67.43 90.73 71.39 68.27 92.30 72.52 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 3 3 # 3 H 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 H 184 LYS A 68 LYS~? -2.78 O ACT A 201s H 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 73.65 78.64 75.66 68.14 79.07 75.04 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 67.43 90.73 71.39 68.27 92.30 72.52 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 4 3 # 4 H 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 H 184 LYS A 68 LYS~? -2.78 O ACT A 201s H 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 73.65 78.64 75.66 68.14 79.07 75.04 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 67.43 90.73 71.39 68.27 92.30 72.52 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 5 3 # 5 H 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 H 184 LYS A 68 LYS~? -2.78 O ACT A 201s H 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 73.65 78.64 75.66 68.14 79.07 75.04 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 67.43 90.73 71.39 68.27 92.30 72.52 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 6 3 # 6 H 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s H 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 H 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 71.58 83.18 80.51 66.88 79.77 79.84 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 73.65 78.64 75.66 68.14 79.07 75.04 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 67.43 90.73 71.39 68.27 92.30 72.52 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 7 3 # 7 H 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s H 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 H 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 73.65 78.64 75.66 68.14 79.07 75.04 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 67.43 90.73 71.39 68.27 92.30 72.52 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 8 3 # 8 H 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 H 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s H 345 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 71.58 83.18 80.51 66.88 79.77 79.84 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 73.65 78.64 75.66 68.14 79.07 75.04 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 67.43 90.73 71.39 68.27 92.30 72.52 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 9 3 # 9 H 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 H 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s H 345 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 71.58 83.18 80.51 66.88 79.77 79.84 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 73.65 78.64 75.66 68.14 79.07 75.04 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 67.43 90.73 71.39 68.27 92.30 72.52 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 10 3 # 10 H 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 H 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s H 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 73.65 78.64 75.66 68.14 79.07 75.04 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 67.43 90.73 71.39 68.27 92.30 72.52 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 11 3 # 11 H 182 LYS C 68 LYS~? -2.77 O ACT C 201s H 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 H 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo 71.58 83.18 80.51 66.88 79.77 79.84 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 73.65 78.64 75.66 68.14 79.07 75.04 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 67.43 90.73 71.39 68.27 92.30 72.52 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 12 3 # 12 H 182 LYS C 68 LYS~? -2.77 O ACT C 201s H 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 H 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 73.65 78.64 75.66 68.14 79.07 75.04 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 67.43 90.73 71.39 68.27 92.30 72.52 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 13 3 # 13 H 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 H 184 LYS C 68 LYS~? -2.77 O ACT C 201s H 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 73.65 78.64 75.66 68.14 79.07 75.04 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 67.43 90.73 71.39 68.27 92.30 72.52 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 14 3 # 14 H 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 H 184 LYS C 68 LYS~? -2.77 O ACT C 201s H 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 73.65 78.64 75.66 68.14 79.07 75.04 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 67.43 90.73 71.39 68.27 92.30 72.52 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 15 3 # 15 H 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 H 184 LYS C 68 LYS~? -2.77 O ACT C 201s H 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 73.65 78.64 75.66 68.14 79.07 75.04 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 67.43 90.73 71.39 68.27 92.30 72.52 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 16 3 # 16 H 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s H 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s H 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 73.65 78.64 75.66 68.14 79.07 75.04 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 67.43 90.73 71.39 68.27 92.30 72.52 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 17 3 # 17 H 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s H 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s H 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 71.58 83.18 80.51 66.88 79.77 79.84 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 73.65 78.64 75.66 68.14 79.07 75.04 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 67.43 90.73 71.39 68.27 92.30 72.52 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 18 3 # 18 H 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s H 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s H 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 73.65 78.64 75.66 68.14 79.07 75.04 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 67.43 90.73 71.39 68.27 92.30 72.52 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 19 3 # 19 H 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s H 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s H 345 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 71.58 83.18 80.51 66.88 79.77 79.84 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 73.65 78.64 75.66 68.14 79.07 75.04 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 67.43 90.73 71.39 68.27 92.30 72.52 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 20 3 # 20 H 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s H 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s H 345 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 71.58 83.18 80.51 66.88 79.77 79.84 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 73.65 78.64 75.66 68.14 79.07 75.04 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 67.43 90.73 71.39 68.27 92.30 72.52 -44.22 66.27 50.20 -46.22 65.66 49.92 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 20 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 68 LYS~? -2.78 O ACT A 201s I 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 I 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo 60.20 96.92 42.53 57.60 93.13 38.67 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 54.31 95.46 46.01 55.34 91.59 42.65 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 66.35 87.81 48.53 68.10 89.01 48.77 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS A 68 LYS~? -2.78 O ACT A 201s I 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 I 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 54.31 95.46 46.01 55.34 91.59 42.65 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 66.35 87.81 48.53 68.10 89.01 48.77 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 3 3 # 3 I 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 I 184 LYS A 68 LYS~? -2.78 O ACT A 201s I 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 54.31 95.46 46.01 55.34 91.59 42.65 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 66.35 87.81 48.53 68.10 89.01 48.77 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 4 3 # 4 I 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 I 184 LYS A 68 LYS~? -2.78 O ACT A 201s I 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 54.31 95.46 46.01 55.34 91.59 42.65 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 66.35 87.81 48.53 68.10 89.01 48.77 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 5 3 # 5 I 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 I 184 LYS A 68 LYS~? -2.78 O ACT A 201s I 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 54.31 95.46 46.01 55.34 91.59 42.65 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 66.35 87.81 48.53 68.10 89.01 48.77 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 6 3 # 6 I 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s I 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 I 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 60.20 96.92 42.53 57.60 93.13 38.67 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 54.31 95.46 46.01 55.34 91.59 42.65 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 66.35 87.81 48.53 68.10 89.01 48.77 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 7 3 # 7 I 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s I 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 I 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 54.31 95.46 46.01 55.34 91.59 42.65 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 66.35 87.81 48.53 68.10 89.01 48.77 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 8 3 # 8 I 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 I 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s I 345 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 60.20 96.92 42.53 57.60 93.13 38.67 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 54.31 95.46 46.01 55.34 91.59 42.65 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 66.35 87.81 48.53 68.10 89.01 48.77 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 9 3 # 9 I 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 I 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s I 345 ASP C 74 ASP^? 14.86 O ACT C 201 coo 60.20 96.92 42.53 57.60 93.13 38.67 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 54.31 95.46 46.01 55.34 91.59 42.65 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 66.35 87.81 48.53 68.10 89.01 48.77 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 10 3 # 10 I 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 I 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s I 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 54.31 95.46 46.01 55.34 91.59 42.65 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 66.35 87.81 48.53 68.10 89.01 48.77 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 11 3 # 11 I 182 LYS C 68 LYS~? -2.77 O ACT C 201s I 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 I 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo 60.20 96.92 42.53 57.60 93.13 38.67 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 54.31 95.46 46.01 55.34 91.59 42.65 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 66.35 87.81 48.53 68.10 89.01 48.77 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 12 3 # 12 I 182 LYS C 68 LYS~? -2.77 O ACT C 201s I 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 I 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 54.31 95.46 46.01 55.34 91.59 42.65 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 66.35 87.81 48.53 68.10 89.01 48.77 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 13 3 # 13 I 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 I 184 LYS C 68 LYS~? -2.77 O ACT C 201s I 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 54.31 95.46 46.01 55.34 91.59 42.65 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 66.35 87.81 48.53 68.10 89.01 48.77 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 14 3 # 14 I 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 I 184 LYS C 68 LYS~? -2.77 O ACT C 201s I 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 54.31 95.46 46.01 55.34 91.59 42.65 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 66.35 87.81 48.53 68.10 89.01 48.77 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 15 3 # 15 I 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 I 184 LYS C 68 LYS~? -2.77 O ACT C 201s I 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 54.31 95.46 46.01 55.34 91.59 42.65 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 66.35 87.81 48.53 68.10 89.01 48.77 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 16 3 # 16 I 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s I 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s I 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 54.31 95.46 46.01 55.34 91.59 42.65 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 66.35 87.81 48.53 68.10 89.01 48.77 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 17 3 # 17 I 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s I 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s I 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 60.20 96.92 42.53 57.60 93.13 38.67 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 54.31 95.46 46.01 55.34 91.59 42.65 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 66.35 87.81 48.53 68.10 89.01 48.77 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 18 3 # 18 I 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s I 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s I 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 54.31 95.46 46.01 55.34 91.59 42.65 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 66.35 87.81 48.53 68.10 89.01 48.77 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 19 3 # 19 I 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s I 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s I 345 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 60.20 96.92 42.53 57.60 93.13 38.67 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 54.31 95.46 46.01 55.34 91.59 42.65 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 66.35 87.81 48.53 68.10 89.01 48.77 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 20 3 # 20 I 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s I 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s I 345 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 60.20 96.92 42.53 57.60 93.13 38.67 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 54.31 95.46 46.01 55.34 91.59 42.65 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 66.35 87.81 48.53 68.10 89.01 48.77 -44.22 66.27 50.20 -46.22 65.66 49.92 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 20 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 68 LYS~? -2.78 O ACT A 201s J 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 J 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo 25.22 70.55 14.03 27.64 73.07 18.65 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 31.73 69.87 11.50 32.73 70.19 16.40 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 25.87 58.42 18.79 23.95 58.54 17.90 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS A 68 LYS~? -2.78 O ACT A 201s J 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 J 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 31.73 69.87 11.50 32.73 70.19 16.40 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 25.87 58.42 18.79 23.95 58.54 17.90 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 J 184 LYS A 68 LYS~? -2.78 O ACT A 201s J 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 31.73 69.87 11.50 32.73 70.19 16.40 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 25.87 58.42 18.79 23.95 58.54 17.90 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 4 3 # 4 J 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 J 184 LYS A 68 LYS~? -2.78 O ACT A 201s J 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 31.73 69.87 11.50 32.73 70.19 16.40 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 25.87 58.42 18.79 23.95 58.54 17.90 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 5 3 # 5 J 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 J 184 LYS A 68 LYS~? -2.78 O ACT A 201s J 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 31.73 69.87 11.50 32.73 70.19 16.40 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 25.87 58.42 18.79 23.95 58.54 17.90 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 6 3 # 6 J 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s J 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 J 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 25.22 70.55 14.03 27.64 73.07 18.65 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 31.73 69.87 11.50 32.73 70.19 16.40 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 25.87 58.42 18.79 23.95 58.54 17.90 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 7 3 # 7 J 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s J 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 J 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 31.73 69.87 11.50 32.73 70.19 16.40 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 25.87 58.42 18.79 23.95 58.54 17.90 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 8 3 # 8 J 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 J 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s J 345 ASP C 74 ASP^? 14.86 O ACT C 201 coo 25.22 70.55 14.03 27.64 73.07 18.65 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 31.73 69.87 11.50 32.73 70.19 16.40 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 25.87 58.42 18.79 23.95 58.54 17.90 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 9 3 # 9 J 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 J 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s J 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 31.73 69.87 11.50 32.73 70.19 16.40 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 25.87 58.42 18.79 23.95 58.54 17.90 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 10 3 # 10 J 182 LYS C 68 LYS~? -2.77 O ACT C 201s J 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 J 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 31.73 69.87 11.50 32.73 70.19 16.40 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 25.87 58.42 18.79 23.95 58.54 17.90 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 11 3 # 11 J 182 LYS C 68 LYS~? -2.77 O ACT C 201s J 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 J 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo 25.22 70.55 14.03 27.64 73.07 18.65 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 31.73 69.87 11.50 32.73 70.19 16.40 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 25.87 58.42 18.79 23.95 58.54 17.90 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 12 3 # 12 J 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 J 184 LYS C 68 LYS~? -2.77 O ACT C 201s J 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 31.73 69.87 11.50 32.73 70.19 16.40 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 25.87 58.42 18.79 23.95 58.54 17.90 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 13 3 # 13 J 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 J 184 LYS C 68 LYS~? -2.77 O ACT C 201s J 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 31.73 69.87 11.50 32.73 70.19 16.40 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 25.87 58.42 18.79 23.95 58.54 17.90 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 14 3 # 14 J 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 J 184 LYS C 68 LYS~? -2.77 O ACT C 201s J 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 31.73 69.87 11.50 32.73 70.19 16.40 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 25.87 58.42 18.79 23.95 58.54 17.90 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 15 3 # 15 J 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s J 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s J 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 31.73 69.87 11.50 32.73 70.19 16.40 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 25.87 58.42 18.79 23.95 58.54 17.90 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 16 3 # 16 J 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s J 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s J 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 25.22 70.55 14.03 27.64 73.07 18.65 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 31.73 69.87 11.50 32.73 70.19 16.40 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 25.87 58.42 18.79 23.95 58.54 17.90 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 17 3 # 17 J 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s J 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s J 345 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 25.22 70.55 14.03 27.64 73.07 18.65 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 31.73 69.87 11.50 32.73 70.19 16.40 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 25.87 58.42 18.79 23.95 58.54 17.90 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 18 3 # 18 J 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s J 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s J 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 31.73 69.87 11.50 32.73 70.19 16.40 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 25.87 58.42 18.79 23.95 58.54 17.90 -44.77 63.42 52.85 -43.43 61.81 52.77 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 18 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 68 LYS~? -2.78 O ACT A 201s K 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 K 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 K 184 LYS A 68 LYS~? -2.78 O ACT A 201s K 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 3 3 # 3 K 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 K 184 LYS A 68 LYS~? -2.78 O ACT A 201s K 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 4 3 # 4 K 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 K 184 LYS A 68 LYS~? -2.78 O ACT A 201s K 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 5 3 # 5 K 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s K 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 K 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 6 3 # 6 K 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s K 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 K 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 7 3 # 7 K 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 K 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s K 345 ASP C 74 ASP^? 14.86 O ACT C 201 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 8 3 # 8 K 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 K 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s K 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 9 3 # 9 K 182 LYS C 68 LYS~? -2.77 O ACT C 201s K 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 K 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 10 3 # 10 K 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 K 184 LYS C 68 LYS~? -2.77 O ACT C 201s K 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 11 3 # 11 K 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 K 184 LYS C 68 LYS~? -2.77 O ACT C 201s K 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 12 3 # 12 K 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 K 184 LYS C 68 LYS~? -2.77 O ACT C 201s K 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 13 3 # 13 K 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s K 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s K 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 14 3 # 14 K 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s K 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s K 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 15 3 # 15 K 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s K 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s K 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -44.77 63.42 52.85 -43.43 61.81 52.77 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 15 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 68 LYS~? -2.78 O ACT A 201s L 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 L 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 68 LYS~? -2.78 O ACT A 201s L 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 L 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 L 184 LYS A 68 LYS~? -2.78 O ACT A 201s L 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s L 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 L 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 5 3 # 5 L 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 L 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s L 345 ASP C 74 ASP^? 14.86 O ACT C 201 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 6 3 # 6 L 182 LYS C 68 LYS~? -2.77 O ACT C 201s L 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 L 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 7 3 # 7 L 182 LYS C 68 LYS~? -2.77 O ACT C 201s L 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 L 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 8 3 # 8 L 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 L 184 LYS C 68 LYS~? -2.77 O ACT C 201s L 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 9 3 # 9 L 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s L 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s L 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 10 3 # 10 L 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s L 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s L 345 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -44.71 72.29 58.72 -45.62 72.95 56.93 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 10 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 68 LYS~? -2.78 O ACT A 201s M 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 M 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 M 184 LYS A 68 LYS~? -2.78 O ACT A 201s M 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s M 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 M 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 M 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s M 345 ASP C 74 ASP^? 14.86 O ACT C 201 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -38.47 44.35 77.96 -37.73 47.88 73.83 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -38.81 48.53 81.27 -34.33 51.66 80.64 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 5 3 # 5 M 182 LYS C 68 LYS~? -2.77 O ACT C 201s M 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 M 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 6 3 # 6 M 182 LYS C 68 LYS~? -2.77 O ACT C 201s M 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 M 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 7 3 # 7 M 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 M 184 LYS C 68 LYS~? -2.77 O ACT C 201s M 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 8 3 # 8 M 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s M 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s M 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 9 3 # 9 M 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s M 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s M 345 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -54.54 71.95 50.35 -50.70 67.51 52.69 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -56.56 67.44 48.13 -52.71 65.23 44.87 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -44.71 72.29 58.72 -45.62 72.95 56.93 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS A 68 LYS~? -2.78 O ACT A 201s N 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 N 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS A 68 LYS~? -2.78 O ACT A 201s N 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 N 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 3 3 # 3 N 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 N 184 LYS A 68 LYS~? -2.78 O ACT A 201s N 345 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 4 3 # 4 N 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 N 184 LYS A 68 LYS~? -2.78 O ACT A 201s N 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 5 3 # 5 N 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 N 184 LYS A 68 LYS~? -2.78 O ACT A 201s N 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 6 3 # 6 N 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 N 184 LYS A 68 LYS~? -2.78 O ACT A 201s N 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 7 3 # 7 N 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s N 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 N 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 8 3 # 8 N 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s N 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 N 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 9 3 # 9 N 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 N 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s N 345 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 10 3 # 10 N 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 N 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s N 345 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 11 3 # 11 N 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 N 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s N 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 12 3 # 12 N 182 LYS C 68 LYS~? -2.77 O ACT C 201s N 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 N 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 13 3 # 13 N 182 LYS C 68 LYS~? -2.77 O ACT C 201s N 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 N 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 14 3 # 14 N 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 N 184 LYS C 68 LYS~? -2.77 O ACT C 201s N 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 15 3 # 15 N 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 N 184 LYS C 68 LYS~? -2.77 O ACT C 201s N 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 16 3 # 16 N 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 N 184 LYS C 68 LYS~? -2.77 O ACT C 201s N 345 ASP C 74 ASP^? 14.86 O ACT C 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 17 3 # 17 N 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 N 184 LYS C 68 LYS~? -2.77 O ACT C 201s N 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 18 3 # 18 N 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s N 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s N 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 19 3 # 19 N 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s N 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s N 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 20 3 # 20 N 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s N 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s N 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 21 3 # 21 N 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s N 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s N 345 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -50.30 76.97 42.14 -51.14 78.91 42.11 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 22 3 # 22 N 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s N 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s N 345 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -44.22 66.27 50.20 -46.22 65.66 49.92 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 22 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 68 LYS~? -2.78 O ACT A 201s O 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 O 345 ASP A 34 ASP~? 14.63 O ACT A 201 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 O 184 LYS A 68 LYS~? -2.78 O ACT A 201s O 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 3 3 # 3 O 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 O 184 LYS A 68 LYS~? -2.78 O ACT A 201s O 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 4 3 # 4 O 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 O 184 LYS A 68 LYS~? -2.78 O ACT A 201s O 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 5 3 # 5 O 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s O 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 O 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 6 3 # 6 O 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s O 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 O 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 7 3 # 7 O 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 O 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s O 345 ASP C 74 ASP^? 14.86 O ACT C 201 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 8 3 # 8 O 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 O 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s O 345 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 9 3 # 9 O 182 LYS C 68 LYS~? -2.77 O ACT C 201s O 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 O 345 ASP C 34 ASP~? 14.66 O ACT C 201 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 10 3 # 10 O 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 O 184 LYS C 68 LYS~? -2.77 O ACT C 201s O 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 11 3 # 11 O 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 O 184 LYS C 68 LYS~? -2.77 O ACT C 201s O 345 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 12 3 # 12 O 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 O 184 LYS C 68 LYS~? -2.77 O ACT C 201s O 345 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 13 3 # 13 O 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s O 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s O 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 14 3 # 14 O 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s O 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s O 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 15 3 # 15 O 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s O 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s O 345 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -44.77 63.42 52.85 -43.43 61.81 52.77 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 15 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 68 LYS~? -2.78 O ACT A 201s P 184 LYS A 71 LYS~? 4.32 C2 EDO A 301 P 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 71 LYS~? 4.32 C2 EDO A 301 P 184 LYS A 68 LYS~? -2.78 O ACT A 201s P 345 ASP C 99 ASP.? 5.79 O1 EDO A 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -39.68 54.89 65.92 -41.28 55.63 67.10 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS B 68 LYS~? -2.79 OXT ACT B 201s P 184 LYS B 71 LYS~? 10.83 OXT ACT B 201 P 345 ASP B 34 ASP~? 14.61 OXT ACT B 201 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -34.29 46.44 92.12 -35.67 46.00 93.67 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS B 71 LYS~? 10.83 OXT ACT B 201 P 184 LYS B 68 LYS~? -2.79 OXT ACT B 201s P 345 ASP C 74 ASP^? 14.86 O ACT C 201 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -38.81 48.53 81.27 -34.33 51.66 80.64 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 5 3 # 5 P 182 LYS C 68 LYS~? -2.77 O ACT C 201s P 184 LYS C 71 LYS~? 4.19 C1 EDO A 301 P 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 6 3 # 6 P 182 LYS C 71 LYS~? 4.19 C1 EDO A 301 P 184 LYS C 68 LYS~? -2.77 O ACT C 201s P 345 ASP A 99 ASP.? 5.71 O2 EDO A 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -44.15 62.19 57.97 -45.93 61.14 58.45 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 7 3 # 7 P 182 LYS D 68 LYS~? -2.80 OXT ACT D 201s P 184 LYS D 71 LYS~? -3.20 CH3 ACT A 203s P 345 ASP D 34 ASP~? 14.62 OXT ACT D 201 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -62.38 69.46 37.89 -64.50 69.55 37.91 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 8 3 # 8 P 182 LYS D 71 LYS~? -3.20 CH3 ACT A 203s P 184 LYS D 68 LYS~? -2.80 OXT ACT D 201s P 345 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -56.56 67.44 48.13 -52.71 65.23 44.87 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -44.71 72.29 58.72 -45.62 72.95 56.93 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c47 naa= 3 ULMN 3 2esd_c00 1.02.01.0009 user 1 3 # 1 A 154 ASN A 112 ASN^? 9.36 O ACT A 202 A 250 ALA B 126 ALA.? 5.01 O ACT B 201 A 284 CYH A 127 CYH.? 6.15 O ACT A 202 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -24.96 67.02 76.01 -26.38 66.67 77.57 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -34.85 61.51 79.63 -34.73 60.21 80.42 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 2esd_c00 1.02.01.0009 user 2 3 # 2 A 154 ASN A 129 ASN.? 9.65 O ACT B 201 A 250 ALA A 52 ALA.? 7.92 O2 EDO A 302 A 284 CYH A 127 CYH.? 6.15 O ACT A 202 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -38.33 60.18 72.42 -36.71 58.96 73.06 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -28.67 56.33 66.41 -29.48 55.05 66.20 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 2esd_c00 1.02.01.0009 user 3 3 # 3 A 154 ASN B 110 ASN^? 6.46 O ACT A 202 A 250 ALA B 52 ALA.? 10.80 O1 EDO A 301 A 284 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -29.30 63.23 76.74 -27.50 63.37 75.59 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -42.54 59.91 74.80 -43.03 59.60 73.39 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 2esd_c00 1.02.01.0009 user 4 3 # 4 A 154 ASN B 112 ASN^? 12.13 O ACT B 201 A 250 ALA A 126 ALA.? 5.06 OXT ACT A 201 A 284 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -32.04 67.09 81.98 -30.67 67.45 80.39 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -28.54 64.52 70.82 -28.98 65.37 69.63 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 2esd_c00 1.02.01.0009 user 5 3 # 5 A 154 ASN B 129 ASN.? 9.80 OXT ACT A 201 A 250 ALA B 52 ALA.? 10.80 O1 EDO A 301 A 284 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -31.81 57.09 70.18 -32.97 58.85 69.97 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -42.54 59.91 74.80 -43.03 59.60 73.39 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 2esd_c00 1.02.01.0009 user 6 3 # 6 A 154 ASN C 110 ASN^? 10.92 O ACT D 201 A 250 ALA C 52 ALA.? 12.19 C2 EDO A 301 A 284 CYH C 127 CYH.? 10.01 O ACT D 201 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -45.77 52.18 44.66 -47.80 51.56 44.77 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -37.45 62.38 49.17 -37.97 63.55 50.01 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 2esd_c00 1.02.01.0009 user 7 3 # 7 A 154 ASN C 112 ASN^? 12.25 OXT ACT C 201 A 250 ALA D 126 ALA.? 5.05 O ACT D 201 A 284 CYH C 127 CYH.? 10.01 O ACT D 201 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -41.01 51.77 39.43 -43.15 51.81 39.53 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -50.75 55.53 45.15 -51.51 56.79 44.72 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 2esd_c00 1.02.01.0009 user 8 3 # 8 A 154 ASN C 129 ASN.? 9.72 O ACT D 201 A 250 ALA C 52 ALA.? 12.19 C2 EDO A 301 A 284 CYH C 127 CYH.? 10.01 O ACT D 201 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -47.56 56.76 52.53 -47.22 58.18 50.99 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -37.45 62.38 49.17 -37.97 63.55 50.01 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 2esd_c00 1.02.01.0009 user 9 3 # 9 A 154 ASN D 110 ASN^? 10.92 OXT ACT C 201 A 250 ALA D 52 ALA.? 10.75 O ACT A 203 A 284 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -44.80 54.88 42.61 -42.77 55.08 41.96 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -52.10 56.30 54.26 -51.39 56.64 55.56 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -47.67 56.31 47.24 -47.42 53.67 48.08 ULMN 3 2esd_c00 1.02.01.0009 user 10 3 # 10 A 154 ASN D 112 ASN^? 12.21 O ACT D 201 A 250 ALA C 126 ALA.? 5.02 OXT ACT C 201 A 284 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -49.94 50.30 41.07 -47.80 50.26 40.97 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -39.67 53.99 45.62 -38.91 53.15 46.65 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -47.67 56.31 47.24 -47.42 53.67 48.08 ULMN 3 2esd_c00 1.02.01.0009 user 11 3 # 11 A 154 ASN D 129 ASN.? 9.72 OXT ACT C 201 A 250 ALA D 52 ALA.? 10.75 O ACT A 203 A 284 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -42.23 60.94 49.15 -42.50 59.01 49.99 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -52.10 56.30 54.26 -51.39 56.64 55.56 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -47.67 56.31 47.24 -47.42 53.67 48.08 2esd_c00 source 2esd 1.02.01.0009 : 11 hits 2esd_c00 naa= 3 ULMN 3 2esd_c01 1.02.01.0009 user 1 3 # 1 B 154 ASN A 112 ASN^? 9.36 O ACT A 202 B 250 ALA B 126 ALA.? 5.01 O ACT B 201 B 284 CYH A 127 CYH.? 6.15 O ACT A 202 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -24.96 67.02 76.01 -26.38 66.67 77.57 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -34.85 61.51 79.63 -34.73 60.21 80.42 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 2esd_c01 1.02.01.0009 user 2 3 # 2 B 154 ASN A 129 ASN.? 9.65 O ACT B 201 B 250 ALA A 52 ALA.? 7.92 O2 EDO A 302 B 284 CYH A 127 CYH.? 6.15 O ACT A 202 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -38.33 60.18 72.42 -36.71 58.96 73.06 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -28.67 56.33 66.41 -29.48 55.05 66.20 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 2esd_c01 1.02.01.0009 user 3 3 # 3 B 154 ASN B 110 ASN^? 6.46 O ACT A 202 B 250 ALA B 52 ALA.? 10.80 O1 EDO A 301 B 284 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -29.30 63.23 76.74 -27.50 63.37 75.59 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -42.54 59.91 74.80 -43.03 59.60 73.39 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 2esd_c01 1.02.01.0009 user 4 3 # 4 B 154 ASN B 112 ASN^? 12.13 O ACT B 201 B 250 ALA A 126 ALA.? 5.06 OXT ACT A 201 B 284 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -32.04 67.09 81.98 -30.67 67.45 80.39 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -28.54 64.52 70.82 -28.98 65.37 69.63 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 2esd_c01 1.02.01.0009 user 5 3 # 5 B 154 ASN B 129 ASN.? 9.80 OXT ACT A 201 B 250 ALA B 52 ALA.? 10.80 O1 EDO A 301 B 284 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -31.81 57.09 70.18 -32.97 58.85 69.97 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -42.54 59.91 74.80 -43.03 59.60 73.39 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 2esd_c01 1.02.01.0009 user 6 3 # 6 B 154 ASN C 110 ASN^? 10.92 O ACT D 201 B 250 ALA C 52 ALA.? 12.19 C2 EDO A 301 B 284 CYH C 127 CYH.? 10.01 O ACT D 201 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -45.77 52.18 44.66 -47.80 51.56 44.77 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -37.45 62.38 49.17 -37.97 63.55 50.01 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 2esd_c01 1.02.01.0009 user 7 3 # 7 B 154 ASN C 112 ASN^? 12.25 OXT ACT C 201 B 250 ALA D 126 ALA.? 5.05 O ACT D 201 B 284 CYH C 127 CYH.? 10.01 O ACT D 201 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -41.01 51.77 39.43 -43.15 51.81 39.53 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -50.75 55.53 45.15 -51.51 56.79 44.72 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 2esd_c01 1.02.01.0009 user 8 3 # 8 B 154 ASN C 129 ASN.? 9.72 O ACT D 201 B 250 ALA C 52 ALA.? 12.19 C2 EDO A 301 B 284 CYH C 127 CYH.? 10.01 O ACT D 201 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -47.56 56.76 52.53 -47.22 58.18 50.99 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -37.45 62.38 49.17 -37.97 63.55 50.01 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 2esd_c01 1.02.01.0009 user 9 3 # 9 B 154 ASN D 110 ASN^? 10.92 OXT ACT C 201 B 250 ALA D 52 ALA.? 10.75 O ACT A 203 B 284 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -44.80 54.88 42.61 -42.77 55.08 41.96 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -52.10 56.30 54.26 -51.39 56.64 55.56 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -47.67 56.31 47.24 -47.42 53.67 48.08 ULMN 3 2esd_c01 1.02.01.0009 user 10 3 # 10 B 154 ASN D 112 ASN^? 12.21 O ACT D 201 B 250 ALA C 126 ALA.? 5.02 OXT ACT C 201 B 284 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -49.94 50.30 41.07 -47.80 50.26 40.97 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -39.67 53.99 45.62 -38.91 53.15 46.65 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -47.67 56.31 47.24 -47.42 53.67 48.08 ULMN 3 2esd_c01 1.02.01.0009 user 11 3 # 11 B 154 ASN D 129 ASN.? 9.72 OXT ACT C 201 B 250 ALA D 52 ALA.? 10.75 O ACT A 203 B 284 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -42.23 60.94 49.15 -42.50 59.01 49.99 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -52.10 56.30 54.26 -51.39 56.64 55.56 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -47.67 56.31 47.24 -47.42 53.67 48.08 2esd_c01 source 2esd 1.02.01.0009 : 11 hits 2esd_c01 naa= 3 ULMN 3 2esd_c02 1.02.01.0009 user 1 3 # 1 C 154 ASN A 112 ASN^? 9.36 O ACT A 202 C 250 ALA B 126 ALA.? 5.01 O ACT B 201 C 284 CYH A 127 CYH.? 6.15 O ACT A 202 coo -155.36 18.42 28.93 -154.49 20.30 29.39 -24.96 67.02 76.01 -26.38 66.67 77.57 coo -150.95 29.02 32.87 -150.10 27.86 32.40 -34.85 61.51 79.63 -34.73 60.21 80.42 coo -155.22 25.64 26.33 -154.78 25.20 29.09 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 2esd_c02 1.02.01.0009 user 2 3 # 2 C 154 ASN A 129 ASN.? 9.65 O ACT B 201 C 250 ALA A 52 ALA.? 7.92 O2 EDO A 302 C 284 CYH A 127 CYH.? 6.15 O ACT A 202 coo -155.36 18.42 28.93 -154.49 20.30 29.39 -38.33 60.18 72.42 -36.71 58.96 73.06 coo -150.95 29.02 32.87 -150.10 27.86 32.40 -28.67 56.33 66.41 -29.48 55.05 66.20 coo -155.22 25.64 26.33 -154.78 25.20 29.09 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 2esd_c02 1.02.01.0009 user 3 3 # 3 C 154 ASN B 112 ASN^? 12.13 O ACT B 201 C 250 ALA A 126 ALA.? 5.06 OXT ACT A 201 C 284 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -155.36 18.42 28.93 -154.49 20.30 29.39 -32.04 67.09 81.98 -30.67 67.45 80.39 coo -150.95 29.02 32.87 -150.10 27.86 32.40 -28.54 64.52 70.82 -28.98 65.37 69.63 coo -155.22 25.64 26.33 -154.78 25.20 29.09 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 2esd_c02 1.02.01.0009 user 4 3 # 4 C 154 ASN B 129 ASN.? 9.80 OXT ACT A 201 C 250 ALA B 52 ALA.? 10.80 O1 EDO A 301 C 284 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -155.36 18.42 28.93 -154.49 20.30 29.39 -31.81 57.09 70.18 -32.97 58.85 69.97 coo -150.95 29.02 32.87 -150.10 27.86 32.40 -42.54 59.91 74.80 -43.03 59.60 73.39 coo -155.22 25.64 26.33 -154.78 25.20 29.09 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 2esd_c02 1.02.01.0009 user 5 3 # 5 C 154 ASN C 112 ASN^? 12.25 OXT ACT C 201 C 250 ALA D 126 ALA.? 5.05 O ACT D 201 C 284 CYH C 127 CYH.? 10.01 O ACT D 201 coo -155.36 18.42 28.93 -154.49 20.30 29.39 -41.01 51.77 39.43 -43.15 51.81 39.53 coo -150.95 29.02 32.87 -150.10 27.86 32.40 -50.75 55.53 45.15 -51.51 56.79 44.72 coo -155.22 25.64 26.33 -154.78 25.20 29.09 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 2esd_c02 1.02.01.0009 user 6 3 # 6 C 154 ASN C 129 ASN.? 9.72 O ACT D 201 C 250 ALA C 52 ALA.? 12.19 C2 EDO A 301 C 284 CYH C 127 CYH.? 10.01 O ACT D 201 coo -155.36 18.42 28.93 -154.49 20.30 29.39 -47.56 56.76 52.53 -47.22 58.18 50.99 coo -150.95 29.02 32.87 -150.10 27.86 32.40 -37.45 62.38 49.17 -37.97 63.55 50.01 coo -155.22 25.64 26.33 -154.78 25.20 29.09 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 2esd_c02 1.02.01.0009 user 7 3 # 7 C 154 ASN D 112 ASN^? 12.21 O ACT D 201 C 250 ALA C 126 ALA.? 5.02 OXT ACT C 201 C 284 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -155.36 18.42 28.93 -154.49 20.30 29.39 -49.94 50.30 41.07 -47.80 50.26 40.97 coo -150.95 29.02 32.87 -150.10 27.86 32.40 -39.67 53.99 45.62 -38.91 53.15 46.65 coo -155.22 25.64 26.33 -154.78 25.20 29.09 -47.67 56.31 47.24 -47.42 53.67 48.08 ULMN 3 2esd_c02 1.02.01.0009 user 8 3 # 8 C 154 ASN D 129 ASN.? 9.72 OXT ACT C 201 C 250 ALA D 52 ALA.? 10.75 O ACT A 203 C 284 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -155.36 18.42 28.93 -154.49 20.30 29.39 -42.23 60.94 49.15 -42.50 59.01 49.99 coo -150.95 29.02 32.87 -150.10 27.86 32.40 -52.10 56.30 54.26 -51.39 56.64 55.56 coo -155.22 25.64 26.33 -154.78 25.20 29.09 -47.67 56.31 47.24 -47.42 53.67 48.08 2esd_c02 source 2esd 1.02.01.0009 : 8 hits 2esd_c02 naa= 3 ULMN 3 2esd_c03 1.02.01.0009 user 1 3 # 1 D 154 ASN A 112 ASN^? 9.36 O ACT A 202 D 250 ALA B 126 ALA.? 5.01 O ACT B 201 D 284 CYH A 127 CYH.? 6.15 O ACT A 202 coo -138.05 57.23 54.59 -137.96 55.47 53.43 -24.96 67.02 76.01 -26.38 66.67 77.57 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -34.85 61.51 79.63 -34.73 60.21 80.42 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 2esd_c03 1.02.01.0009 user 2 3 # 2 D 154 ASN A 129 ASN.? 9.65 O ACT B 201 D 250 ALA A 52 ALA.? 7.92 O2 EDO A 302 D 284 CYH A 127 CYH.? 6.15 O ACT A 202 coo -138.05 57.23 54.59 -137.96 55.47 53.43 -38.33 60.18 72.42 -36.71 58.96 73.06 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -28.67 56.33 66.41 -29.48 55.05 66.20 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -31.19 62.06 71.95 -29.40 60.66 73.55 ULMN 3 2esd_c03 1.02.01.0009 user 3 3 # 3 D 154 ASN B 112 ASN^? 12.13 O ACT B 201 D 250 ALA A 126 ALA.? 5.06 OXT ACT A 201 D 284 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -138.05 57.23 54.59 -137.96 55.47 53.43 -32.04 67.09 81.98 -30.67 67.45 80.39 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -28.54 64.52 70.82 -28.98 65.37 69.63 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 2esd_c03 1.02.01.0009 user 4 3 # 4 D 154 ASN B 129 ASN.? 9.80 OXT ACT A 201 D 250 ALA B 52 ALA.? 10.80 O1 EDO A 301 D 284 CYH B 127 CYH.? 10.07 OXT ACT A 201 coo -138.05 57.23 54.59 -137.96 55.47 53.43 -31.81 57.09 70.18 -32.97 58.85 69.97 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -42.54 59.91 74.80 -43.03 59.60 73.39 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -34.42 60.97 75.89 -35.29 63.54 75.29 ULMN 3 2esd_c03 1.02.01.0009 user 5 3 # 5 D 154 ASN C 112 ASN^? 12.25 OXT ACT C 201 D 250 ALA D 126 ALA.? 5.05 O ACT D 201 D 284 CYH C 127 CYH.? 10.01 O ACT D 201 coo -138.05 57.23 54.59 -137.96 55.47 53.43 -41.01 51.77 39.43 -43.15 51.81 39.53 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -50.75 55.53 45.15 -51.51 56.79 44.72 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 2esd_c03 1.02.01.0009 user 6 3 # 6 D 154 ASN C 129 ASN.? 9.72 O ACT D 201 D 250 ALA C 52 ALA.? 12.19 C2 EDO A 301 D 284 CYH C 127 CYH.? 10.01 O ACT D 201 coo -138.05 57.23 54.59 -137.96 55.47 53.43 -47.56 56.76 52.53 -47.22 58.18 50.99 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -37.45 62.38 49.17 -37.97 63.55 50.01 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -42.49 55.99 47.19 -42.84 57.56 44.90 ULMN 3 2esd_c03 1.02.01.0009 user 7 3 # 7 D 154 ASN D 112 ASN^? 12.21 O ACT D 201 D 250 ALA C 126 ALA.? 5.02 OXT ACT C 201 D 284 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -138.05 57.23 54.59 -137.96 55.47 53.43 -49.94 50.30 41.07 -47.80 50.26 40.97 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -39.67 53.99 45.62 -38.91 53.15 46.65 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -47.67 56.31 47.24 -47.42 53.67 48.08 ULMN 3 2esd_c03 1.02.01.0009 user 8 3 # 8 D 154 ASN D 129 ASN.? 9.72 OXT ACT C 201 D 250 ALA D 52 ALA.? 10.75 O ACT A 203 D 284 CYH D 127 CYH.? 10.01 OXT ACT C 201 coo -138.05 57.23 54.59 -137.96 55.47 53.43 -42.23 60.94 49.15 -42.50 59.01 49.99 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -52.10 56.30 54.26 -51.39 56.64 55.56 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -47.67 56.31 47.24 -47.42 53.67 48.08 2esd_c03 source 2esd 1.02.01.0009 : 8 hits 2esd_c03 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 75 TYR^? -4.52 O ACT A 201s A 245 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 273 LYS A 139 LYS.? 17.81 O ACT A 201 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -38.06 71.60 62.08 -35.99 71.56 63.96 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR A 95 TYR^? -3.85 O ACT A 201s A 245 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 273 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR A 95 TYR^? -3.85 O ACT A 201s A 245 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 273 LYS A 139 LYS.? 17.81 O ACT A 201 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR A 95 TYR^? -3.85 O ACT A 201s A 245 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 273 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 150 TYR A 108 TYR^? 12.28 O ACT A 201 A 245 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 273 LYS A 134 LYS~? 11.98 O ACT A 203 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 150 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 245 ASP B 34 ASP~? 14.61 OXT ACT B 201 A 273 LYS B 62 LYS~? 17.44 OXT ACT B 201 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -34.29 46.44 92.12 -35.67 46.00 93.67 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -42.04 52.32 89.45 -42.77 48.33 94.37 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 150 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 245 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 273 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 150 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 245 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 273 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 150 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 245 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 273 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 150 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 245 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 273 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 150 TYR B 108 TYR^? -4.79 O ACT A 202s A 245 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 273 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -26.20 55.78 72.02 -24.40 54.06 70.73 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 12 3 # 12 A 150 TYR C 75 TYR^? -4.54 O ACT C 201s A 245 ASP C 74 ASP^? 14.86 O ACT C 201 A 273 LYS C 139 LYS.? 18.79 O ACT C 201 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -37.81 46.19 57.99 -37.99 46.43 55.20 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 13 3 # 13 A 150 TYR C 95 TYR^? -3.84 O ACT C 201s A 245 ASP C 74 ASP^? 14.86 O ACT C 201 A 273 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 14 3 # 14 A 150 TYR C 95 TYR^? -3.84 O ACT C 201s A 245 ASP C 74 ASP^? 14.86 O ACT C 201 A 273 LYS C 139 LYS.? 18.79 O ACT C 201 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 15 3 # 15 A 150 TYR C 95 TYR^? -3.84 O ACT C 201s A 245 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 273 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 16 3 # 16 A 150 TYR C 108 TYR^? 12.28 O ACT C 201 A 245 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 273 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -49.57 50.97 53.11 -51.32 50.02 55.06 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 17 3 # 17 A 150 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 245 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 273 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 18 3 # 18 A 150 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 245 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 273 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 19 3 # 19 A 150 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 245 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 273 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 20 3 # 20 A 150 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 245 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 273 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 21 3 # 21 A 150 TYR D 108 TYR^? 12.28 OXT ACT D 201 A 245 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 273 LYS D 134 LYS~? 17.34 O ACT A 201 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -40.41 63.05 43.73 -38.60 65.12 43.23 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -37.62 76.93 46.97 -33.08 76.47 49.79 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 21 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 245 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 273 LYS C 68 LYS~? -2.77 O ACT C 201s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 245 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 273 LYS C 68 LYS~? -2.77 O ACT C 201s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE A 140 PHE.? 11.31 O ACT A 201 A 245 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 273 LYS A 68 LYS~? -2.78 O ACT A 201s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE A 140 PHE.? 11.31 O ACT A 201 A 245 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 273 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 157 PHE B 140 PHE.? 8.97 CH3 ACT A 202 A 245 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 273 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 157 PHE B 140 PHE.? 8.97 CH3 ACT A 202 A 245 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 273 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 157 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 245 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 273 LYS A 68 LYS~? -2.78 O ACT A 201s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 157 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 245 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 273 LYS A 68 LYS~? -2.78 O ACT A 201s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 157 PHE C 140 PHE.? 11.33 O ACT C 201 A 245 ASP C 74 ASP^? 14.86 O ACT C 201 A 273 LYS C 68 LYS~? -2.77 O ACT C 201s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 157 PHE C 140 PHE.? 11.33 O ACT C 201 A 245 ASP C 74 ASP^? 14.86 O ACT C 201 A 273 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 157 PHE D 140 PHE.? 11.31 OXT ACT D 201 A 245 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 273 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 12 3 # 12 A 157 PHE D 140 PHE.? 11.31 OXT ACT D 201 A 245 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 273 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -54.54 71.95 50.35 -50.70 67.51 52.69 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 12 hits 2gsa_c04 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS B 56 HIS.? 17.31 O ACT B 201 A 341 GLU B 60 GLU~? 17.33 O ACT B 201 A 356 HIS A 161 HIS.? 19.24 O ACT B 201 coo 121.00 36.37 19.26 121.57 38.37 19.56 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 125.72 32.70 19.75 124.44 34.16 18.84 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 124.34 41.73 25.55 123.79 42.60 23.72 -48.72 65.75 79.30 -49.45 66.41 81.15 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 1 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS B 56 HIS.? 17.31 O ACT B 201 B 341 GLU B 60 GLU~? 17.33 O ACT B 201 B 356 HIS A 161 HIS.? 19.24 O ACT B 201 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -48.13 62.85 85.87 -48.38 63.10 83.80 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -48.72 65.75 79.30 -49.45 66.41 81.15 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 1 hits 2isd_c01 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 35 SER A 101 SER.? 7.80 O2 EDO A 301 A 215 ASP D 130 ASP.? 7.40 CH3 ACT A 203 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -48.36 60.96 55.15 -47.04 58.94 54.93 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -44.22 66.27 50.20 -46.22 65.66 49.92 ULMN 3 2jxr_c04 LIGAND CP-081282 user 2 3 # 2 A 32 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 35 SER B 101 SER.? 19.25 O ACT C 201 A 215 ASP C 74 ASP^? 14.86 O ACT C 201 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -36.32 37.86 70.76 -37.96 39.10 69.46 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2jxr_c04 LIGAND CP-081282 user 3 3 # 3 A 32 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 35 SER C 101 SER.? 7.85 O1 EDO A 301 A 215 ASP B 130 ASP.? 9.25 OXT ACT B 201 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -40.26 55.74 71.04 -39.54 57.94 70.33 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -33.09 51.46 70.73 -34.18 51.80 72.52 ULMN 3 2jxr_c04 LIGAND CP-081282 user 4 3 # 4 A 32 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 35 SER D 101 SER.? 9.16 OXT ACT A 203 A 215 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -48.40 79.65 53.68 -48.43 78.54 55.84 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -44.71 72.29 58.72 -45.62 72.95 56.93 2jxr_c04 source 2jxr LIGAND CP-081282 : 4 hits 2jxr_c04 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 102 ASP A 150 ASP.? 22.07 CH3 ACT A 201 A 193 GLY A 145 GLY.? 13.13 O ACT A 201 coo 14.96 29.22 19.55 15.62 29.93 17.67 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 19.64 30.69 22.61 18.18 29.94 21.25 -43.95 88.27 71.85 -43.22 89.50 70.29 coo 14.54 28.99 9.76 15.06 29.59 10.02 -38.43 80.69 60.76 -38.91 80.43 61.42 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 151 HIS.? 13.45 CH3 ACT A 202 A 102 ASP B 150 ASP.? 20.21 CH3 ACT A 202 A 193 GLY B 145 GLY.? 13.34 OXT ACT B 201 coo 14.96 29.22 19.55 15.62 29.93 17.67 -16.30 48.49 82.95 -17.03 48.20 81.01 coo 19.64 30.69 22.61 18.18 29.94 21.25 -10.73 49.15 87.46 -11.06 47.07 87.30 coo 14.54 28.99 9.76 15.06 29.59 10.02 -25.17 44.53 88.88 -24.74 44.79 88.19 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 102 ASP C 150 ASP.? 20.99 CH3 ACT C 201 A 193 GLY C 145 GLY.? 13.18 O ACT C 201 coo 14.96 29.22 19.55 15.62 29.93 17.67 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 19.64 30.69 22.61 18.18 29.94 21.25 -46.61 28.46 55.57 -45.54 29.27 57.21 coo 14.54 28.99 9.76 15.06 29.59 10.02 -35.71 37.24 58.49 -36.57 37.39 58.47 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 102 ASP D 150 ASP.? 21.68 CH3 ACT D 201 A 193 GLY D 145 GLY.? 13.27 OXT ACT D 201 coo 14.96 29.22 19.55 15.62 29.93 17.67 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 19.64 30.69 22.61 18.18 29.94 21.25 -44.02 71.14 22.58 -44.47 73.01 23.46 coo 14.54 28.99 9.76 15.06 29.59 10.02 -54.58 73.10 33.20 -53.72 72.98 33.25 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 4 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 63.95 45.30 16.71 59.11 49.15 16.05 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 292 LYS A 139 LYS.? 17.81 O ACT A 201 coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 63.95 45.30 16.71 59.11 49.15 16.05 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 263 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 292 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 54.43 44.82 23.74 55.21 45.06 21.80 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 63.95 45.30 16.71 59.11 49.15 16.05 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 263 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 292 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 54.43 44.82 23.74 55.21 45.06 21.80 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 A 263 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 292 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 54.43 44.82 23.74 55.21 45.06 21.80 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE A 140 PHE.? 11.31 O ACT A 201 A 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 292 LYS A 134 LYS~? 11.98 O ACT A 203 coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 63.95 45.30 16.71 59.11 49.15 16.05 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 54.43 44.82 23.74 55.21 45.06 21.80 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 63.95 45.30 16.71 59.11 49.15 16.05 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 292 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 54.43 44.82 23.74 55.21 45.06 21.80 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 63.95 45.30 16.71 59.11 49.15 16.05 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 A 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 263 ASP B 100 ASP.? 15.93 OXT ACT B 201 A 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 54.43 44.82 23.74 55.21 45.06 21.80 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 63.95 45.30 16.71 59.11 49.15 16.05 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 A 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 263 ASP C 74 ASP^? 14.86 O ACT C 201 A 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 54.43 44.82 23.74 55.21 45.06 21.80 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 63.95 45.30 16.71 59.11 49.15 16.05 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 A 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 263 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 54.43 44.82 23.74 55.21 45.06 21.80 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 63.95 45.30 16.71 59.11 49.15 16.05 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 A 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 A 263 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 54.43 44.82 23.74 55.21 45.06 21.80 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 63.95 45.30 16.71 59.11 49.15 16.05 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 A 177 PHE B 140 PHE.? 8.97 CH3 ACT A 202 A 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 292 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 54.43 44.82 23.74 55.21 45.06 21.80 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 63.95 45.30 16.71 59.11 49.15 16.05 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 A 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 263 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 292 LYS A 134 LYS~? 11.98 O ACT A 203 coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 63.95 45.30 16.71 59.11 49.15 16.05 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 A 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 263 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 292 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 54.43 44.82 23.74 55.21 45.06 21.80 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 63.95 45.30 16.71 59.11 49.15 16.05 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 A 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 263 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 292 LYS A 134 LYS~? 11.98 O ACT A 203 coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 54.43 44.82 23.74 55.21 45.06 21.80 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 63.95 45.30 16.71 59.11 49.15 16.05 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 A 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 263 ASP C 74 ASP^? 14.86 O ACT C 201 A 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 54.43 44.82 23.74 55.21 45.06 21.80 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 63.95 45.30 16.71 59.11 49.15 16.05 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 18 3 # 18 A 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 A 263 ASP C 74 ASP^? 14.86 O ACT C 201 A 292 LYS C 139 LYS.? 18.79 O ACT C 201 coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 54.43 44.82 23.74 55.21 45.06 21.80 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 63.95 45.30 16.71 59.11 49.15 16.05 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 19 3 # 19 A 177 PHE C 140 PHE.? 11.33 O ACT C 201 A 263 ASP C 74 ASP^? 14.86 O ACT C 201 A 292 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 54.43 44.82 23.74 55.21 45.06 21.80 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 63.95 45.30 16.71 59.11 49.15 16.05 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 20 3 # 20 A 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 63.95 45.30 16.71 59.11 49.15 16.05 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 21 3 # 21 A 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 263 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 63.95 45.30 16.71 59.11 49.15 16.05 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 22 3 # 22 A 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 263 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 292 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 63.95 45.30 16.71 59.11 49.15 16.05 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 23 3 # 23 A 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 292 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 54.43 44.82 23.74 55.21 45.06 21.80 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 63.95 45.30 16.71 59.11 49.15 16.05 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 24 3 # 24 A 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 A 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 292 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 51.51 50.32 16.39 52.13 49.68 13.75 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 54.43 44.82 23.74 55.21 45.06 21.80 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 63.95 45.30 16.71 59.11 49.15 16.05 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 25 3 # 25 A 177 PHE D 140 PHE.? 11.31 OXT ACT D 201 A 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 292 LYS D 134 LYS~? 17.34 O ACT A 201 coo 51.51 50.32 16.39 52.13 49.68 13.75 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 54.43 44.82 23.74 55.21 45.06 21.80 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 63.95 45.30 16.71 59.11 49.15 16.05 -37.62 76.93 46.97 -33.08 76.47 49.79 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 25 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 60.53 31.67 0.97 57.79 27.51 3.63 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 292 LYS A 139 LYS.? 17.81 O ACT A 201 coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 60.53 31.67 0.97 57.79 27.51 3.63 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 263 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 292 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 60.53 31.67 0.97 57.79 27.51 3.63 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 263 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 292 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 60.53 31.67 0.97 57.79 27.51 3.63 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 B 263 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 292 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 60.53 31.67 0.97 57.79 27.51 3.63 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE A 140 PHE.? 11.31 O ACT A 201 B 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 292 LYS A 134 LYS~? 11.98 O ACT A 203 coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 60.53 31.67 0.97 57.79 27.51 3.63 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 60.53 31.67 0.97 57.79 27.51 3.63 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 292 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 60.53 31.67 0.97 57.79 27.51 3.63 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 263 ASP B 100 ASP.? 15.93 OXT ACT B 201 B 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 60.53 31.67 0.97 57.79 27.51 3.63 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 B 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 263 ASP C 74 ASP^? 14.86 O ACT C 201 B 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 60.53 31.67 0.97 57.79 27.51 3.63 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 B 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 263 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 60.53 31.67 0.97 57.79 27.51 3.63 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 B 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 B 263 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 60.53 31.67 0.97 57.79 27.51 3.63 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 B 177 PHE B 140 PHE.? 8.97 CH3 ACT A 202 B 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 292 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 60.53 31.67 0.97 57.79 27.51 3.63 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 B 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 263 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 292 LYS A 134 LYS~? 11.98 O ACT A 203 coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 60.53 31.67 0.97 57.79 27.51 3.63 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 B 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 263 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 292 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 60.53 31.67 0.97 57.79 27.51 3.63 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 B 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 263 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 292 LYS A 134 LYS~? 11.98 O ACT A 203 coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 60.53 31.67 0.97 57.79 27.51 3.63 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 B 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 263 ASP C 74 ASP^? 14.86 O ACT C 201 B 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 60.53 31.67 0.97 57.79 27.51 3.63 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 18 3 # 18 B 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 B 263 ASP C 74 ASP^? 14.86 O ACT C 201 B 292 LYS C 139 LYS.? 18.79 O ACT C 201 coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 60.53 31.67 0.97 57.79 27.51 3.63 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 19 3 # 19 B 177 PHE C 140 PHE.? 11.33 O ACT C 201 B 263 ASP C 74 ASP^? 14.86 O ACT C 201 B 292 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 60.53 31.67 0.97 57.79 27.51 3.63 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 20 3 # 20 B 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 60.53 31.67 0.97 57.79 27.51 3.63 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 21 3 # 21 B 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 263 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 60.53 31.67 0.97 57.79 27.51 3.63 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 22 3 # 22 B 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 263 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 292 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 60.53 31.67 0.97 57.79 27.51 3.63 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 23 3 # 23 B 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 292 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 60.53 31.67 0.97 57.79 27.51 3.63 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 24 3 # 24 B 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 B 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 292 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 49.99 26.05 6.28 51.46 26.87 8.49 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 60.53 31.67 0.97 57.79 27.51 3.63 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 25 3 # 25 B 177 PHE D 140 PHE.? 11.31 OXT ACT D 201 B 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 292 LYS D 134 LYS~? 17.34 O ACT A 201 coo 49.99 26.05 6.28 51.46 26.87 8.49 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 60.53 31.67 0.97 57.79 27.51 3.63 -37.62 76.93 46.97 -33.08 76.47 49.79 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 25 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 C 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 12.82 3.49 4.98 17.80 5.59 1.90 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 C 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 292 LYS A 139 LYS.? 17.81 O ACT A 201 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 12.82 3.49 4.98 17.80 5.59 1.90 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 C 263 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 292 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 19.84 12.02 9.33 18.68 11.23 7.75 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 12.82 3.49 4.98 17.80 5.59 1.90 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 C 263 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 292 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 19.84 12.02 9.33 18.68 11.23 7.75 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 12.82 3.49 4.98 17.80 5.59 1.90 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE A 105 PHE^? 4.28 O1 EDO A 301 C 263 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 292 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.46 62.63 64.59 -44.88 60.33 63.05 coo 19.84 12.02 9.33 18.68 11.23 7.75 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 12.82 3.49 4.98 17.80 5.59 1.90 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE A 140 PHE.? 11.31 O ACT A 201 C 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 292 LYS A 134 LYS~? 11.98 O ACT A 203 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.06 74.70 68.64 -42.76 73.46 70.80 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 12.82 3.49 4.98 17.80 5.59 1.90 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 C 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 C 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 19.84 12.02 9.33 18.68 11.23 7.75 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 12.82 3.49 4.98 17.80 5.59 1.90 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 C 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 C 292 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 19.84 12.02 9.33 18.68 11.23 7.75 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 12.82 3.49 4.98 17.80 5.59 1.90 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 C 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 C 263 ASP B 100 ASP.? 15.93 OXT ACT B 201 C 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 19.84 12.02 9.33 18.68 11.23 7.75 -38.83 38.92 74.28 -39.60 40.38 75.58 coo 12.82 3.49 4.98 17.80 5.59 1.90 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 C 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 C 263 ASP C 74 ASP^? 14.86 O ACT C 201 C 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 19.84 12.02 9.33 18.68 11.23 7.75 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 12.82 3.49 4.98 17.80 5.59 1.90 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 C 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 C 263 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 19.84 12.02 9.33 18.68 11.23 7.75 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 12.82 3.49 4.98 17.80 5.59 1.90 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 C 177 PHE B 105 PHE^? 13.39 C2 EDO A 302 C 263 ASP C 100 ASP.? 9.05 C1 EDO A 301 C 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.64 46.86 70.65 -33.68 45.82 69.04 coo 19.84 12.02 9.33 18.68 11.23 7.75 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 12.82 3.49 4.98 17.80 5.59 1.90 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 C 177 PHE B 140 PHE.? 8.97 CH3 ACT A 202 C 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 C 292 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -21.72 48.56 78.43 -22.15 51.11 77.34 coo 19.84 12.02 9.33 18.68 11.23 7.75 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 12.82 3.49 4.98 17.80 5.59 1.90 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 C 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 C 263 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 292 LYS A 134 LYS~? 11.98 O ACT A 203 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 12.82 3.49 4.98 17.80 5.59 1.90 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 C 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 C 263 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 292 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 19.84 12.02 9.33 18.68 11.23 7.75 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 12.82 3.49 4.98 17.80 5.59 1.90 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 C 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 C 263 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 292 LYS A 134 LYS~? 11.98 O ACT A 203 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 19.84 12.02 9.33 18.68 11.23 7.75 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 12.82 3.49 4.98 17.80 5.59 1.90 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 C 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 C 263 ASP C 74 ASP^? 14.86 O ACT C 201 C 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 19.84 12.02 9.33 18.68 11.23 7.75 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 12.82 3.49 4.98 17.80 5.59 1.90 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 18 3 # 18 C 177 PHE C 105 PHE^? 4.31 O2 EDO A 301 C 263 ASP C 74 ASP^? 14.86 O ACT C 201 C 292 LYS C 139 LYS.? 18.79 O ACT C 201 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.99 53.92 62.00 -44.50 56.25 63.46 coo 19.84 12.02 9.33 18.68 11.23 7.75 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 12.82 3.49 4.98 17.80 5.59 1.90 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 19 3 # 19 C 177 PHE C 140 PHE.? 11.33 O ACT C 201 C 263 ASP C 74 ASP^? 14.86 O ACT C 201 C 292 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -46.25 41.88 58.15 -47.27 43.20 55.89 coo 19.84 12.02 9.33 18.68 11.23 7.75 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 12.82 3.49 4.98 17.80 5.59 1.90 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 20 3 # 20 C 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 C 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 12.82 3.49 4.98 17.80 5.59 1.90 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 21 3 # 21 C 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 C 263 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 12.82 3.49 4.98 17.80 5.59 1.90 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 22 3 # 22 C 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 C 263 ASP A 100 ASP.? 9.07 O2 EDO A 301 C 292 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 12.82 3.49 4.98 17.80 5.59 1.90 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 23 3 # 23 C 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 C 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 C 292 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 19.84 12.02 9.33 18.68 11.23 7.75 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 12.82 3.49 4.98 17.80 5.59 1.90 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 24 3 # 24 C 177 PHE D 105 PHE^? 7.74 CH3 ACT A 203 C 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 C 292 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -44.21 71.05 49.68 -44.30 71.93 52.33 coo 19.84 12.02 9.33 18.68 11.23 7.75 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 12.82 3.49 4.98 17.80 5.59 1.90 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 25 3 # 25 C 177 PHE D 140 PHE.? 11.31 OXT ACT D 201 C 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 C 292 LYS D 134 LYS~? 17.34 O ACT A 201 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -43.95 70.80 36.81 -42.95 68.23 37.34 coo 19.84 12.02 9.33 18.68 11.23 7.75 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 12.82 3.49 4.98 17.80 5.59 1.90 -37.62 76.93 46.97 -33.08 76.47 49.79 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 25 hits 2oat_c05 naa= 3 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 178 TRP A 69 TRP~? 6.39 O ACT A 201 A 263 ASP A 34 ASP~? 14.63 O ACT A 201 A 292 LYS D 134 LYS~? 17.34 O ACT A 201 coo 48.96 45.07 19.49 48.62 41.39 18.16 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 54.43 44.82 23.74 55.21 45.06 21.80 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 63.95 45.30 16.71 59.11 49.15 16.05 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 178 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 263 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 292 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 48.96 45.07 19.49 48.62 41.39 18.16 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 54.43 44.82 23.74 55.21 45.06 21.80 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 63.95 45.30 16.71 59.11 49.15 16.05 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 178 TRP A 104 TRP^? -4.29 OXT ACT A 203s A 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 48.96 45.07 19.49 48.62 41.39 18.16 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 63.95 45.30 16.71 59.11 49.15 16.05 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 178 TRP A 104 TRP^? -4.29 OXT ACT A 203s A 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 292 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 48.96 45.07 19.49 48.62 41.39 18.16 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 63.95 45.30 16.71 59.11 49.15 16.05 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 178 TRP A 104 TRP^? -4.29 OXT ACT A 203s A 263 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 48.96 45.07 19.49 48.62 41.39 18.16 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 63.95 45.30 16.71 59.11 49.15 16.05 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 178 TRP B 104 TRP^? 15.21 C2 EDO A 302 A 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 48.96 45.07 19.49 48.62 41.39 18.16 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 54.43 44.82 23.74 55.21 45.06 21.80 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 63.95 45.30 16.71 59.11 49.15 16.05 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 178 TRP B 104 TRP^? 15.21 C2 EDO A 302 A 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 292 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 48.96 45.07 19.49 48.62 41.39 18.16 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 54.43 44.82 23.74 55.21 45.06 21.80 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 63.95 45.30 16.71 59.11 49.15 16.05 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 178 TRP B 104 TRP^? 15.21 C2 EDO A 302 A 263 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 48.96 45.07 19.49 48.62 41.39 18.16 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 54.43 44.82 23.74 55.21 45.06 21.80 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 63.95 45.30 16.71 59.11 49.15 16.05 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 A 178 TRP C 69 TRP~? 6.41 O ACT C 201 A 263 ASP C 34 ASP~? 14.66 O ACT C 201 A 292 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 48.96 45.07 19.49 48.62 41.39 18.16 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 54.43 44.82 23.74 55.21 45.06 21.80 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 A 178 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 263 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 292 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 48.96 45.07 19.49 48.62 41.39 18.16 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 54.43 44.82 23.74 55.21 45.06 21.80 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 A 178 TRP C 104 TRP^? 12.40 O2 EDO A 301 A 263 ASP C 74 ASP^? 14.86 O ACT C 201 A 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 48.96 45.07 19.49 48.62 41.39 18.16 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 54.43 44.82 23.74 55.21 45.06 21.80 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 63.95 45.30 16.71 59.11 49.15 16.05 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 A 178 TRP C 104 TRP^? 12.40 O2 EDO A 301 A 263 ASP C 74 ASP^? 14.86 O ACT C 201 A 292 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 48.96 45.07 19.49 48.62 41.39 18.16 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 54.43 44.82 23.74 55.21 45.06 21.80 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 63.95 45.30 16.71 59.11 49.15 16.05 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 A 178 TRP C 104 TRP^? 12.40 O2 EDO A 301 A 263 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 48.96 45.07 19.49 48.62 41.39 18.16 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 54.43 44.82 23.74 55.21 45.06 21.80 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 63.95 45.30 16.71 59.11 49.15 16.05 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 A 178 TRP D 104 TRP^? 14.89 CH3 ACT A 203 A 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 292 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 48.96 45.07 19.49 48.62 41.39 18.16 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 54.43 44.82 23.74 55.21 45.06 21.80 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 63.95 45.30 16.71 59.11 49.15 16.05 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 A 178 TRP D 104 TRP^? 14.89 CH3 ACT A 203 A 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 292 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 48.96 45.07 19.49 48.62 41.39 18.16 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 54.43 44.82 23.74 55.21 45.06 21.80 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 63.95 45.30 16.71 59.11 49.15 16.05 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 A 178 TRP D 104 TRP^? 14.89 CH3 ACT A 203 A 263 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 292 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 48.96 45.07 19.49 48.62 41.39 18.16 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 54.43 44.82 23.74 55.21 45.06 21.80 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 63.95 45.30 16.71 59.11 49.15 16.05 -56.56 67.44 48.13 -52.71 65.23 44.87 2oat_c06 source 2oat ORNITHINE AMINOTRANSFERASE : 16 hits 2oat_c06 naa= 3 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 178 TRP A 69 TRP~? 6.39 O ACT A 201 B 263 ASP A 34 ASP~? 14.63 O ACT A 201 B 292 LYS D 134 LYS~? 17.34 O ACT A 201 coo 45.83 31.15 4.65 45.88 34.74 6.24 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 60.53 31.67 0.97 57.79 27.51 3.63 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 178 TRP A 97 TRP^? -5.71 O1 EDO A 301s B 263 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 292 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 45.83 31.15 4.65 45.88 34.74 6.24 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 60.53 31.67 0.97 57.79 27.51 3.63 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 178 TRP A 104 TRP^? -4.29 OXT ACT A 203s B 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 45.83 31.15 4.65 45.88 34.74 6.24 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 60.53 31.67 0.97 57.79 27.51 3.63 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 178 TRP A 104 TRP^? -4.29 OXT ACT A 203s B 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 292 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 45.83 31.15 4.65 45.88 34.74 6.24 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 60.53 31.67 0.97 57.79 27.51 3.63 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 178 TRP A 104 TRP^? -4.29 OXT ACT A 203s B 263 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 45.83 31.15 4.65 45.88 34.74 6.24 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 60.53 31.67 0.97 57.79 27.51 3.63 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 178 TRP B 104 TRP^? 15.21 C2 EDO A 302 B 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 45.83 31.15 4.65 45.88 34.74 6.24 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 60.53 31.67 0.97 57.79 27.51 3.63 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 178 TRP B 104 TRP^? 15.21 C2 EDO A 302 B 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 292 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 45.83 31.15 4.65 45.88 34.74 6.24 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 60.53 31.67 0.97 57.79 27.51 3.63 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 178 TRP B 104 TRP^? 15.21 C2 EDO A 302 B 263 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 45.83 31.15 4.65 45.88 34.74 6.24 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 60.53 31.67 0.97 57.79 27.51 3.63 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 178 TRP C 69 TRP~? 6.41 O ACT C 201 B 263 ASP C 34 ASP~? 14.66 O ACT C 201 B 292 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 45.83 31.15 4.65 45.88 34.74 6.24 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 60.53 31.67 0.97 57.79 27.51 3.63 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 B 178 TRP C 97 TRP^? -5.77 O2 EDO A 301s B 263 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 292 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 45.83 31.15 4.65 45.88 34.74 6.24 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 60.53 31.67 0.97 57.79 27.51 3.63 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 B 178 TRP C 104 TRP^? 12.40 O2 EDO A 301 B 263 ASP C 74 ASP^? 14.86 O ACT C 201 B 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 45.83 31.15 4.65 45.88 34.74 6.24 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 60.53 31.67 0.97 57.79 27.51 3.63 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 B 178 TRP C 104 TRP^? 12.40 O2 EDO A 301 B 263 ASP C 74 ASP^? 14.86 O ACT C 201 B 292 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 45.83 31.15 4.65 45.88 34.74 6.24 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 60.53 31.67 0.97 57.79 27.51 3.63 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 B 178 TRP C 104 TRP^? 12.40 O2 EDO A 301 B 263 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 45.83 31.15 4.65 45.88 34.74 6.24 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 60.53 31.67 0.97 57.79 27.51 3.63 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 B 178 TRP D 104 TRP^? 14.89 CH3 ACT A 203 B 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 292 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 45.83 31.15 4.65 45.88 34.74 6.24 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 60.53 31.67 0.97 57.79 27.51 3.63 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 B 178 TRP D 104 TRP^? 14.89 CH3 ACT A 203 B 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 292 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 45.83 31.15 4.65 45.88 34.74 6.24 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 60.53 31.67 0.97 57.79 27.51 3.63 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 B 178 TRP D 104 TRP^? 14.89 CH3 ACT A 203 B 263 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 292 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 45.83 31.15 4.65 45.88 34.74 6.24 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 60.53 31.67 0.97 57.79 27.51 3.63 -56.56 67.44 48.13 -52.71 65.23 44.87 2oat_c07 source 2oat ORNITHINE AMINOTRANSFERASE : 16 hits 2oat_c07 naa= 3 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 178 TRP A 69 TRP~? 6.39 O ACT A 201 C 263 ASP A 34 ASP~? 14.63 O ACT A 201 C 292 LYS D 134 LYS~? 17.34 O ACT A 201 coo 20.52 16.65 4.15 17.32 18.91 4.39 -35.84 70.67 59.04 -32.31 72.13 59.98 coo 19.84 12.02 9.33 18.68 11.23 7.75 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 12.82 3.49 4.98 17.80 5.59 1.90 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 178 TRP A 97 TRP^? -5.71 O1 EDO A 301s C 263 ASP A 130 ASP.? 4.80 O1 EDO A 301 C 292 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 20.52 16.65 4.15 17.32 18.91 4.39 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 19.84 12.02 9.33 18.68 11.23 7.75 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 12.82 3.49 4.98 17.80 5.59 1.90 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 178 TRP A 104 TRP^? -4.29 OXT ACT A 203s C 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 20.52 16.65 4.15 17.32 18.91 4.39 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 12.82 3.49 4.98 17.80 5.59 1.90 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 178 TRP A 104 TRP^? -4.29 OXT ACT A 203s C 263 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 292 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 20.52 16.65 4.15 17.32 18.91 4.39 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 12.82 3.49 4.98 17.80 5.59 1.90 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 178 TRP A 104 TRP^? -4.29 OXT ACT A 203s C 263 ASP A 99 ASP.? 5.71 O2 EDO A 301 C 292 LYS A 68 LYS~? -2.78 O ACT A 201s coo 20.52 16.65 4.15 17.32 18.91 4.39 -50.36 67.21 61.67 -48.01 70.37 61.54 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.15 62.19 57.97 -45.93 61.14 58.45 coo 12.82 3.49 4.98 17.80 5.59 1.90 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 178 TRP B 104 TRP^? 15.21 C2 EDO A 302 C 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 C 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 20.52 16.65 4.15 17.32 18.91 4.39 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 19.84 12.02 9.33 18.68 11.23 7.75 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 12.82 3.49 4.98 17.80 5.59 1.90 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 178 TRP B 104 TRP^? 15.21 C2 EDO A 302 C 263 ASP B 74 ASP^? 14.88 OXT ACT B 201 C 292 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo 20.52 16.65 4.15 17.32 18.91 4.39 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 19.84 12.02 9.33 18.68 11.23 7.75 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 12.82 3.49 4.98 17.80 5.59 1.90 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 178 TRP B 104 TRP^? 15.21 C2 EDO A 302 C 263 ASP B 99 ASP.? 16.09 OXT ACT B 201 C 292 LYS B 68 LYS~? -2.79 OXT ACT B 201s coo 20.52 16.65 4.15 17.32 18.91 4.39 -27.28 40.31 71.75 -26.80 41.20 75.55 coo 19.84 12.02 9.33 18.68 11.23 7.75 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 12.82 3.49 4.98 17.80 5.59 1.90 -38.81 48.53 81.27 -34.33 51.66 80.64 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 C 178 TRP C 69 TRP~? 6.41 O ACT C 201 C 263 ASP C 34 ASP~? 14.66 O ACT C 201 C 292 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 20.52 16.65 4.15 17.32 18.91 4.39 -34.18 47.68 58.31 -32.60 46.63 54.87 coo 19.84 12.02 9.33 18.68 11.23 7.75 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 12.82 3.49 4.98 17.80 5.59 1.90 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 C 178 TRP C 97 TRP^? -5.77 O2 EDO A 301s C 263 ASP C 130 ASP.? 4.74 O2 EDO A 301 C 292 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 20.52 16.65 4.15 17.32 18.91 4.39 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 19.84 12.02 9.33 18.68 11.23 7.75 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 12.82 3.49 4.98 17.80 5.59 1.90 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 C 178 TRP C 104 TRP^? 12.40 O2 EDO A 301 C 263 ASP C 74 ASP^? 14.86 O ACT C 201 C 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 20.52 16.65 4.15 17.32 18.91 4.39 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 19.84 12.02 9.33 18.68 11.23 7.75 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 12.82 3.49 4.98 17.80 5.59 1.90 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 C 178 TRP C 104 TRP^? 12.40 O2 EDO A 301 C 263 ASP C 74 ASP^? 14.86 O ACT C 201 C 292 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 20.52 16.65 4.15 17.32 18.91 4.39 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 19.84 12.02 9.33 18.68 11.23 7.75 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 12.82 3.49 4.98 17.80 5.59 1.90 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 C 178 TRP C 104 TRP^? 12.40 O2 EDO A 301 C 263 ASP C 99 ASP.? 5.79 O1 EDO A 301 C 292 LYS C 68 LYS~? -2.77 O ACT C 201s coo 20.52 16.65 4.15 17.32 18.91 4.39 -45.60 48.75 68.07 -43.56 46.02 66.09 coo 19.84 12.02 9.33 18.68 11.23 7.75 -39.68 54.89 65.92 -41.28 55.63 67.10 coo 12.82 3.49 4.98 17.80 5.59 1.90 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 C 178 TRP D 69 TRP~? 6.43 OXT ACT D 201 C 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 C 292 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 20.52 16.65 4.15 17.32 18.91 4.39 -55.42 69.82 43.51 -57.48 67.10 41.55 coo 19.84 12.02 9.33 18.68 11.23 7.75 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 12.82 3.49 4.98 17.80 5.59 1.90 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 C 178 TRP D 104 TRP^? 14.89 CH3 ACT A 203 C 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 C 292 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 20.52 16.65 4.15 17.32 18.91 4.39 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 19.84 12.02 9.33 18.68 11.23 7.75 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 12.82 3.49 4.98 17.80 5.59 1.90 -56.56 67.44 48.13 -52.71 65.23 44.87 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 C 178 TRP D 104 TRP^? 14.89 CH3 ACT A 203 C 263 ASP D 74 ASP^? 14.85 OXT ACT D 201 C 292 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo 20.52 16.65 4.15 17.32 18.91 4.39 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 19.84 12.02 9.33 18.68 11.23 7.75 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 12.82 3.49 4.98 17.80 5.59 1.90 -54.54 71.95 50.35 -50.70 67.51 52.69 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 C 178 TRP D 104 TRP^? 14.89 CH3 ACT A 203 C 263 ASP D 99 ASP.? 7.94 CH3 ACT A 203 C 292 LYS D 68 LYS~? -2.80 OXT ACT D 201s coo 20.52 16.65 4.15 17.32 18.91 4.39 -43.40 78.09 46.19 -45.95 77.16 43.34 coo 19.84 12.02 9.33 18.68 11.23 7.75 -49.03 74.78 51.99 -47.35 75.78 52.80 coo 12.82 3.49 4.98 17.80 5.59 1.90 -56.56 67.44 48.13 -52.71 65.23 44.87 2oat_c08 source 2oat ORNITHINE AMINOTRANSFERASE : 17 hits 2oat_c08 naa= 3 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 1 3 # 1 10 ASN A 103 ASN.? 7.23 O2 EDO A 301 20 HIS A 98 HIS^? -3.60 C ACT A 203s 93 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 45.21 45.27 48.24 46.79 44.92 46.88 -48.04 61.08 60.88 -48.95 59.43 59.91 coo 47.05 39.55 45.24 48.99 39.30 44.46 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 46.96 34.22 47.29 47.91 35.95 46.52 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 2 3 # 2 10 ASN B 103 ASN.? 17.21 C2 EDO A 302 20 HIS B 98 HIS^? 14.98 OXT ACT B 201 93 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 45.21 45.27 48.24 46.79 44.92 46.88 -32.39 41.19 68.51 -33.08 39.66 67.21 coo 47.05 39.55 45.24 48.99 39.30 44.46 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 46.96 34.22 47.29 47.91 35.95 46.52 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 3 3 # 3 10 ASN C 103 ASN.? 7.35 O1 EDO A 301 20 HIS C 98 HIS^? 11.61 O2 EDO A 301 93 ASP C 74 ASP^? 14.86 O ACT C 201 coo 45.21 45.27 48.24 46.79 44.92 46.88 -44.48 55.23 67.22 -44.54 56.80 68.65 coo 47.05 39.55 45.24 48.99 39.30 44.46 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 46.96 34.22 47.29 47.91 35.95 46.52 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 4 3 # 4 10 ASN D 103 ASN.? 11.64 CH3 ACT A 203 20 HIS D 98 HIS^? 13.13 CH3 ACT A 203 93 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 45.21 45.27 48.24 46.79 44.92 46.88 -43.97 76.72 52.03 -43.49 78.26 53.43 coo 47.05 39.55 45.24 48.99 39.30 44.46 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 46.96 34.22 47.29 47.91 35.95 46.52 -50.30 76.97 42.14 -51.14 78.91 42.11 2pth_c00 source 2pth PEPTIDYL-TRNA HYDROLASE : 4 hits 2pth_c00 naa= 3 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 1 3 # 1 A 12 HIS A 151 HIS.? 15.97 CH3 ACT A 201 A 40 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 116 HIS A 141 HIS.? 11.20 OXT ACT A 203 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -43.83 81.49 70.61 -45.02 79.78 70.42 coo 18.50 3.53 20.10 16.17 2.61 14.41 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 14.70 6.01 5.61 14.27 7.69 6.78 -49.96 77.41 66.16 -51.01 75.70 66.78 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 2 3 # 2 A 12 HIS C 151 HIS.? 16.03 CH3 ACT C 201 A 40 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 116 HIS C 141 HIS.? 17.85 O ACT C 201 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -46.81 35.18 56.40 -47.74 36.88 57.21 coo 18.50 3.53 20.10 16.17 2.61 14.41 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 14.70 6.01 5.61 14.27 7.69 6.78 -47.33 38.55 64.23 -48.23 40.22 65.13 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 3 3 # 3 A 12 HIS D 151 HIS.? 15.66 CH3 ACT D 201 A 40 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 116 HIS D 141 HIS.? 18.95 OXT ACT D 201 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -44.04 70.63 29.61 -43.01 70.81 31.43 coo 18.50 3.53 20.10 16.17 2.61 14.41 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 14.70 6.01 5.61 14.27 7.69 6.78 -42.77 77.11 33.23 -41.72 76.77 31.45 2rnf_c02 source 2rnf RIBONUCLEASE 4 : 3 hits 2rnf_c02 naa= 3 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 1 3 # 1 B 12 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 40 LYS A 79 LYS^? -3.45 CH3 ACT A 201s B 116 HIS A 141 HIS.? 11.20 OXT ACT A 203 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -43.83 81.49 70.61 -45.02 79.78 70.42 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -34.66 75.11 72.84 -31.25 72.89 69.03 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -49.96 77.41 66.16 -51.01 75.70 66.78 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 2 3 # 2 B 12 HIS C 151 HIS.? 16.03 CH3 ACT C 201 B 40 LYS C 79 LYS^? -3.44 CH3 ACT C 201s B 116 HIS C 141 HIS.? 17.85 O ACT C 201 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -46.81 35.18 56.40 -47.74 36.88 57.21 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -43.47 42.54 48.33 -38.69 45.48 48.28 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -47.33 38.55 64.23 -48.23 40.22 65.13 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 3 3 # 3 B 12 HIS D 151 HIS.? 15.66 CH3 ACT D 201 B 40 LYS D 79 LYS^? -3.52 CH3 ACT D 201s B 116 HIS D 141 HIS.? 18.95 OXT ACT D 201 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -44.04 70.63 29.61 -43.01 70.81 31.43 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -47.37 61.41 34.65 -51.85 60.71 37.83 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -42.77 77.11 33.23 -41.72 76.77 31.45 2rnf_c03 source 2rnf RIBONUCLEASE 4 : 3 hits 2rnf_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 34 ASP~? 14.63 O ACT A 201 166 GLY A 119 GLY.? 17.82 CH3 ACT A 201 169 GLU A 114 GLU^? 11.87 CH3 ACT A 202 coo 8.28 6.87 1.62 10.08 5.77 1.34 -30.67 77.29 56.10 -29.14 77.80 54.72 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -17.44 79.22 69.94 -17.03 78.76 69.44 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -17.01 70.06 74.63 -16.05 68.26 75.13 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 34 ASP~? 14.63 O ACT A 201 166 GLY A 119 GLY.? 17.82 CH3 ACT A 201 169 GLU A 117 GLU.? 20.82 OXT ACT A 202 coo 8.28 6.87 1.62 10.08 5.77 1.34 -30.67 77.29 56.10 -29.14 77.80 54.72 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -17.44 79.22 69.94 -17.03 78.76 69.44 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -10.16 77.53 73.12 -10.08 75.57 72.28 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 86 ASP.? 20.24 CH3 ACT A 202 166 GLY B 153 GLY~? 9.95 CH3 ACT A 202 169 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -16.25 74.73 81.62 -15.60 74.59 83.62 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -16.29 55.07 81.81 -15.94 54.76 81.13 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 100 ASP.? 9.07 O2 EDO A 301 166 GLY A 145 GLY.? 13.13 O ACT A 201 169 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -38.43 80.69 60.76 -38.91 80.43 61.42 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 130 ASP.? 4.80 O1 EDO A 301 166 GLY A 158 GLY~? 18.81 CH3 ACT A 201 169 GLU A 156 GLU~? 20.10 CH3 ACT A 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -45.28 73.93 80.63 -45.09 73.75 79.84 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -42.77 81.40 79.58 -42.85 83.31 78.67 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP B 34 ASP~? 14.61 OXT ACT B 201 166 GLY B 119 GLY.? 17.96 CH3 ACT B 201 169 GLU B 114 GLU^? 18.04 O ACT B 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -34.29 46.44 92.12 -35.67 46.00 93.67 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -31.59 64.88 97.59 -32.39 64.85 97.59 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -34.74 70.41 89.54 -36.11 71.74 88.69 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP B 34 ASP~? 14.61 OXT ACT B 201 166 GLY B 119 GLY.? 17.96 CH3 ACT B 201 169 GLU B 117 GLU.? 26.48 CH3 ACT B 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -34.29 46.44 92.12 -35.67 46.00 93.67 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -31.59 64.88 97.59 -32.39 64.85 97.59 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -33.80 72.26 99.63 -34.50 73.71 100.99 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP B 100 ASP.? 15.93 OXT ACT B 201 166 GLY C 145 GLY.? 13.18 O ACT C 201 169 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -38.83 38.92 74.28 -39.60 40.38 75.58 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -35.71 37.24 58.49 -36.57 37.39 58.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP B 130 ASP.? 9.25 OXT ACT B 201 166 GLY B 158 GLY.? 7.47 OXT ACT A 202 169 GLU B 156 GLU~? 12.19 CH3 ACT A 202 coo 8.28 6.87 1.62 10.08 5.77 1.34 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -14.69 54.85 71.91 -15.35 54.62 72.30 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -12.52 56.39 79.83 -10.80 57.54 79.39 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP B 130 ASP.? 9.25 OXT ACT B 201 166 GLY C 145 GLY.? 13.18 O ACT C 201 169 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -35.71 37.24 58.49 -36.57 37.39 58.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP C 34 ASP~? 14.66 O ACT C 201 166 GLY C 119 GLY.? 17.79 CH3 ACT C 201 169 GLU C 114 GLU^? 18.18 OXT ACT C 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -27.83 42.08 55.68 -25.73 41.87 55.54 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -29.92 40.95 36.71 -29.36 41.52 36.74 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -34.62 49.81 33.93 -34.65 51.69 32.98 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP C 34 ASP~? 14.66 O ACT C 201 166 GLY C 119 GLY.? 17.79 CH3 ACT C 201 169 GLU C 117 GLU.? 26.34 CH3 ACT C 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -27.83 42.08 55.68 -25.73 41.87 55.54 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -29.92 40.95 36.71 -29.36 41.52 36.74 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -28.65 43.01 29.05 -27.69 42.85 27.18 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP C 86 ASP.? 24.03 CH3 ACT C 201 166 GLY D 153 GLY.? 14.87 CH3 ACT D 201 169 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -38.79 45.04 28.56 -40.00 45.30 26.84 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.01 64.47 29.92 -41.35 64.91 30.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP C 100 ASP.? 9.05 C1 EDO A 301 166 GLY C 145 GLY.? 13.18 O ACT C 201 169 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -35.71 37.24 58.49 -36.57 37.39 58.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP D 34 ASP~? 14.62 OXT ACT D 201 166 GLY D 119 GLY.? 18.01 CH3 ACT D 201 169 GLU D 114 GLU^? 18.05 O ACT D 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -62.38 69.46 37.89 -64.50 69.55 37.91 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -61.89 51.27 30.98 -62.42 51.19 31.57 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -56.92 45.97 38.27 -56.84 44.55 39.82 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP D 34 ASP~? 14.62 OXT ACT D 201 166 GLY D 119 GLY.? 18.01 CH3 ACT D 201 169 GLU D 117 GLU.? 26.53 CH3 ACT D 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -62.38 69.46 37.89 -64.50 69.55 37.91 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -61.89 51.27 30.98 -62.42 51.19 31.57 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -63.64 43.50 30.85 -64.87 41.85 30.41 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP D 100 ASP.? 7.94 OXT ACT A 203 166 GLY A 145 GLY.? 13.13 O ACT A 201 169 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -52.87 78.07 53.10 -52.52 76.84 54.77 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -38.43 80.69 60.76 -38.91 80.43 61.42 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 18 3 # 18 141 ASP D 130 ASP.? 7.40 CH3 ACT A 203 166 GLY A 145 GLY.? 13.13 O ACT A 201 169 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 8.28 6.87 1.62 10.08 5.77 1.34 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -38.43 80.69 60.76 -38.91 80.43 61.42 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -34.88 77.89 68.90 -36.12 78.93 70.26 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 18 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 75 TYR^? -4.52 O ACT A 201s A 214 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 256 LYS C 68 LYS~? -2.77 O ACT C 201s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 75 TYR^? -4.52 O ACT A 201s A 214 ASP A 99 ASP.? 5.71 O2 EDO A 301 A 256 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 214 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 256 LYS A 134 LYS~? 11.98 O ACT A 203 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -34.34 70.13 71.57 -32.99 68.09 70.18 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR A 95 TYR^? -3.85 O ACT A 201s A 214 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 256 LYS D 134 LYS~? 17.34 O ACT A 201 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -38.20 69.00 66.47 -37.00 66.61 65.61 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR A 95 TYR^? -3.85 O ACT A 201s A 214 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 256 LYS C 68 LYS~? -2.77 O ACT C 201s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -38.20 69.00 66.47 -37.00 66.61 65.61 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 6 3 # 6 A 122 TYR B 75 TYR^? -4.59 OXT ACT B 201s A 214 ASP B 99 ASP.? 16.09 OXT ACT B 201 A 256 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 7 3 # 7 A 122 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 214 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 256 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -27.85 57.31 80.17 -30.64 57.51 79.89 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 8 3 # 8 A 122 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 214 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 256 LYS C 68 LYS~? -2.77 O ACT C 201s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -29.40 51.18 78.64 -32.01 51.78 77.83 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 9 3 # 9 A 122 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 214 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 256 LYS C 68 LYS~? -2.77 O ACT C 201s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -29.40 51.18 78.64 -32.01 51.78 77.83 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 10 3 # 10 A 122 TYR B 108 TYR^? -4.79 O ACT A 202s A 214 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 256 LYS B 71 LYS~? 10.83 OXT ACT B 201 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -26.20 55.78 72.02 -24.40 54.06 70.73 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -38.47 44.35 77.96 -37.73 47.88 73.83 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 11 3 # 11 A 122 TYR C 75 TYR^? -4.54 O ACT C 201s A 214 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 256 LYS A 68 LYS~? -2.78 O ACT A 201s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 12 3 # 12 A 122 TYR C 75 TYR^? -4.54 O ACT C 201s A 214 ASP C 99 ASP.? 5.79 O1 EDO A 301 A 256 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 13 3 # 13 A 122 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 214 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 256 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -43.00 47.58 49.22 -41.38 49.87 49.22 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 14 3 # 14 A 122 TYR C 95 TYR^? -3.84 O ACT C 201s A 214 ASP C 74 ASP^? 14.86 O ACT C 201 A 256 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -41.63 48.44 55.51 -40.56 51.04 55.32 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 15 3 # 15 A 122 TYR C 95 TYR^? -3.84 O ACT C 201s A 214 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 256 LYS A 68 LYS~? -2.78 O ACT A 201s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -41.63 48.44 55.51 -40.56 51.04 55.32 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 16 3 # 16 A 122 TYR D 75 TYR^? -4.49 OXT ACT D 201s A 214 ASP D 99 ASP.? 7.94 CH3 ACT A 203 A 256 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 17 3 # 17 A 122 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 214 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 256 LYS D 134 LYS~? 17.34 O ACT A 201 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -47.46 60.74 39.76 -48.96 60.10 42.05 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 18 3 # 18 A 122 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 214 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 256 LYS A 68 LYS~? -2.78 O ACT A 201s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -48.26 66.56 42.41 -49.21 65.61 44.87 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 19 3 # 19 A 122 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 214 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 256 LYS A 68 LYS~? -2.78 O ACT A 201s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -48.26 66.56 42.41 -49.21 65.61 44.87 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 20 3 # 20 A 122 TYR D 108 TYR^? 12.28 OXT ACT D 201 A 214 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 256 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -40.41 63.05 43.73 -38.60 65.12 43.23 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -54.54 71.95 50.35 -50.70 67.51 52.69 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 20 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 75 TYR^? -4.52 O ACT A 201s B 214 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 256 LYS C 68 LYS~? -2.77 O ACT C 201s coo -32.67 22.74 10.17 -32.85 23.98 7.70 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 75 TYR^? -4.52 O ACT A 201s B 214 ASP A 99 ASP.? 5.71 O2 EDO A 301 B 256 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -38.06 71.60 62.08 -35.99 71.56 63.96 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR A 93 TYR^? -4.07 CH3 ACT A 201s B 214 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 256 LYS A 134 LYS~? 11.98 O ACT A 203 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -34.34 70.13 71.57 -32.99 68.09 70.18 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR A 95 TYR^? -3.85 O ACT A 201s B 214 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 256 LYS D 134 LYS~? 17.34 O ACT A 201 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -38.20 69.00 66.47 -37.00 66.61 65.61 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR A 95 TYR^? -3.85 O ACT A 201s B 214 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 256 LYS C 68 LYS~? -2.77 O ACT C 201s coo -32.67 22.74 10.17 -32.85 23.98 7.70 -38.20 69.00 66.47 -37.00 66.61 65.61 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 6 3 # 6 B 122 TYR B 75 TYR^? -4.59 OXT ACT B 201s B 214 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 256 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 7 3 # 7 B 122 TYR B 93 TYR^? -4.16 CH3 ACT B 201s B 214 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 256 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -27.85 57.31 80.17 -30.64 57.51 79.89 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 8 3 # 8 B 122 TYR B 95 TYR^? -3.87 OXT ACT B 201s B 214 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 256 LYS C 68 LYS~? -2.77 O ACT C 201s coo -32.67 22.74 10.17 -32.85 23.98 7.70 -29.40 51.18 78.64 -32.01 51.78 77.83 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 9 3 # 9 B 122 TYR B 95 TYR^? -3.87 OXT ACT B 201s B 214 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 256 LYS C 68 LYS~? -2.77 O ACT C 201s coo -32.67 22.74 10.17 -32.85 23.98 7.70 -29.40 51.18 78.64 -32.01 51.78 77.83 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 10 3 # 10 B 122 TYR C 75 TYR^? -4.54 O ACT C 201s B 214 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 256 LYS A 68 LYS~? -2.78 O ACT A 201s coo -32.67 22.74 10.17 -32.85 23.98 7.70 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 11 3 # 11 B 122 TYR C 75 TYR^? -4.54 O ACT C 201s B 214 ASP C 99 ASP.? 5.79 O1 EDO A 301 B 256 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -37.81 46.19 57.99 -37.99 46.43 55.20 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 12 3 # 12 B 122 TYR C 93 TYR^? -4.09 CH3 ACT C 201s B 214 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 256 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -43.00 47.58 49.22 -41.38 49.87 49.22 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 13 3 # 13 B 122 TYR C 95 TYR^? -3.84 O ACT C 201s B 214 ASP C 74 ASP^? 14.86 O ACT C 201 B 256 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -41.63 48.44 55.51 -40.56 51.04 55.32 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 14 3 # 14 B 122 TYR C 95 TYR^? -3.84 O ACT C 201s B 214 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 256 LYS A 68 LYS~? -2.78 O ACT A 201s coo -32.67 22.74 10.17 -32.85 23.98 7.70 -41.63 48.44 55.51 -40.56 51.04 55.32 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 15 3 # 15 B 122 TYR D 75 TYR^? -4.49 OXT ACT D 201s B 214 ASP D 99 ASP.? 7.94 CH3 ACT A 203 B 256 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 16 3 # 16 B 122 TYR D 93 TYR^? -4.14 CH3 ACT D 201s B 214 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 256 LYS D 134 LYS~? 17.34 O ACT A 201 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -47.46 60.74 39.76 -48.96 60.10 42.05 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 17 3 # 17 B 122 TYR D 95 TYR^? -3.79 OXT ACT D 201s B 214 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 256 LYS A 68 LYS~? -2.78 O ACT A 201s coo -32.67 22.74 10.17 -32.85 23.98 7.70 -48.26 66.56 42.41 -49.21 65.61 44.87 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 18 3 # 18 B 122 TYR D 95 TYR^? -3.79 OXT ACT D 201s B 214 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 256 LYS A 68 LYS~? -2.78 O ACT A 201s coo -32.67 22.74 10.17 -32.85 23.98 7.70 -48.26 66.56 42.41 -49.21 65.61 44.87 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 19 3 # 19 B 122 TYR D 108 TYR^? 12.28 OXT ACT D 201 B 214 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 256 LYS D 71 LYS~? -3.20 CH3 ACT A 203s coo -32.67 22.74 10.17 -32.85 23.98 7.70 -40.41 63.05 43.73 -38.60 65.12 43.23 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -54.54 71.95 50.35 -50.70 67.51 52.69 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 19 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 24 ARG~? 13.97 CH3 ACT A 201 A 130 SER A 18 SER~? 19.91 CH3 ACT A 201 A 159 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 15.14 43.67 10.77 15.61 44.43 13.04 -24.38 83.84 77.64 -22.19 83.01 78.40 coo 11.57 48.49 22.18 13.51 49.99 17.21 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG A 24 ARG~? 13.97 CH3 ACT A 201 A 130 SER A 32 SER.? 11.27 CH3 ACT A 201 A 159 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 15.14 43.67 10.77 15.61 44.43 13.04 -34.08 78.47 59.42 -31.66 78.25 59.14 coo 11.57 48.49 22.18 13.51 49.99 17.21 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 A 59 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 130 SER A 107 SER^? 6.74 O1 EDO A 301 A 159 LYS A 68 LYS~? -2.78 O ACT A 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 15.14 43.67 10.77 15.61 44.43 13.04 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 11.57 48.49 22.18 13.51 49.99 17.21 -33.65 65.97 58.12 -34.39 67.56 63.36 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 A 59 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 130 SER B 107 SER^? 7.39 OXT ACT B 201 A 159 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 18.35 45.84 20.99 16.20 47.83 21.89 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 15.14 43.67 10.77 15.61 44.43 13.04 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 11.57 48.49 22.18 13.51 49.99 17.21 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 A 59 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 130 SER A 107 SER^? 6.74 O1 EDO A 301 A 159 LYS A 139 LYS.? 17.81 O ACT A 201 coo 18.35 45.84 20.99 16.20 47.83 21.89 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 15.14 43.67 10.77 15.61 44.43 13.04 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 11.57 48.49 22.18 13.51 49.99 17.21 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 6 3 # 6 A 59 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 130 SER A 155 SER~? 16.89 CH3 ACT A 201 A 159 LYS A 139 LYS.? 17.81 O ACT A 201 coo 18.35 45.84 20.99 16.20 47.83 21.89 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 15.14 43.67 10.77 15.61 44.43 13.04 -40.89 76.76 80.50 -38.67 76.97 81.48 coo 11.57 48.49 22.18 13.51 49.99 17.21 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 7 3 # 7 A 59 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 130 SER A 107 SER^? 6.74 O1 EDO A 301 A 159 LYS A 134 LYS~? 11.98 O ACT A 203 coo 18.35 45.84 20.99 16.20 47.83 21.89 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 15.14 43.67 10.77 15.61 44.43 13.04 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 11.57 48.49 22.18 13.51 49.99 17.21 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 8 3 # 8 A 59 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 130 SER A 107 SER^? 6.74 O1 EDO A 301 A 159 LYS A 139 LYS.? 17.81 O ACT A 201 coo 18.35 45.84 20.99 16.20 47.83 21.89 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 15.14 43.67 10.77 15.61 44.43 13.04 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 11.57 48.49 22.18 13.51 49.99 17.21 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 9 3 # 9 A 59 ARG A 147 ARG.? 13.06 CH3 ACT A 201 A 130 SER A 32 SER.? 11.27 CH3 ACT A 201 A 159 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 15.14 43.67 10.77 15.61 44.43 13.04 -34.08 78.47 59.42 -31.66 78.25 59.14 coo 11.57 48.49 22.18 13.51 49.99 17.21 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 10 3 # 10 A 59 ARG B 24 ARG~? 14.02 CH3 ACT B 201 A 130 SER B 18 SER~? 19.96 CH3 ACT B 201 A 159 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 15.14 43.67 10.77 15.61 44.43 13.04 -20.65 65.45 94.60 -21.88 67.54 95.01 coo 11.57 48.49 22.18 13.51 49.99 17.21 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 11 3 # 11 A 59 ARG B 24 ARG~? 14.02 CH3 ACT B 201 A 130 SER B 32 SER.? 11.07 CH3 ACT B 201 A 159 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 15.14 43.67 10.77 15.61 44.43 13.04 -29.79 46.60 90.02 -31.32 47.94 91.35 coo 11.57 48.49 22.18 13.51 49.99 17.21 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 12 3 # 12 A 59 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 130 SER B 107 SER^? 7.39 OXT ACT B 201 A 159 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 18.35 45.84 20.99 16.20 47.83 21.89 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 15.14 43.67 10.77 15.61 44.43 13.04 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 11.57 48.49 22.18 13.51 49.99 17.21 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 13 3 # 13 A 59 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 130 SER B 107 SER^? 7.39 OXT ACT B 201 A 159 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 15.14 43.67 10.77 15.61 44.43 13.04 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 11.57 48.49 22.18 13.51 49.99 17.21 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 14 3 # 14 A 59 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 130 SER B 155 SER~? 6.88 CH3 ACT A 202 A 159 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 18.35 45.84 20.99 16.20 47.83 21.89 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 15.14 43.67 10.77 15.61 44.43 13.04 -15.94 58.44 77.26 -16.71 60.70 77.77 coo 11.57 48.49 22.18 13.51 49.99 17.21 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 15 3 # 15 A 59 ARG B 138 ARG~? 16.35 OXT ACT B 201 A 130 SER B 107 SER^? 7.39 OXT ACT B 201 A 159 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 18.35 45.84 20.99 16.20 47.83 21.89 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 15.14 43.67 10.77 15.61 44.43 13.04 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 11.57 48.49 22.18 13.51 49.99 17.21 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 16 3 # 16 A 59 ARG B 138 ARG~? 16.35 OXT ACT B 201 A 130 SER B 107 SER^? 7.39 OXT ACT B 201 A 159 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 18.35 45.84 20.99 16.20 47.83 21.89 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 15.14 43.67 10.77 15.61 44.43 13.04 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 11.57 48.49 22.18 13.51 49.99 17.21 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 17 3 # 17 A 59 ARG B 147 ARG.? 12.52 CH3 ACT A 202 A 130 SER B 32 SER.? 11.07 CH3 ACT B 201 A 159 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 15.14 43.67 10.77 15.61 44.43 13.04 -29.79 46.60 90.02 -31.32 47.94 91.35 coo 11.57 48.49 22.18 13.51 49.99 17.21 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 18 3 # 18 A 59 ARG C 24 ARG~? 14.09 CH3 ACT C 201 A 130 SER C 18 SER~? 19.83 CH3 ACT C 201 A 159 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -40.53 35.15 48.39 -41.31 34.14 51.19 coo 15.14 43.67 10.77 15.61 44.43 13.04 -39.67 35.11 36.68 -39.03 36.29 34.63 coo 11.57 48.49 22.18 13.51 49.99 17.21 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 19 3 # 19 A 59 ARG C 24 ARG~? 14.09 CH3 ACT C 201 A 130 SER C 32 SER.? 11.23 CH3 ACT C 201 A 159 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -40.53 35.15 48.39 -41.31 34.14 51.19 coo 15.14 43.67 10.77 15.61 44.43 13.04 -32.31 40.22 56.18 -30.64 40.82 54.50 coo 11.57 48.49 22.18 13.51 49.99 17.21 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 20 3 # 20 A 59 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 130 SER C 107 SER^? 6.74 O2 EDO A 301 A 159 LYS C 68 LYS~? -2.77 O ACT C 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 15.14 43.67 10.77 15.61 44.43 13.04 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 11.57 48.49 22.18 13.51 49.99 17.21 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 21 3 # 21 A 59 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 130 SER D 107 SER^? 7.30 OXT ACT D 201 A 159 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 18.35 45.84 20.99 16.20 47.83 21.89 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 15.14 43.67 10.77 15.61 44.43 13.04 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 11.57 48.49 22.18 13.51 49.99 17.21 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 22 3 # 22 A 59 ARG C 76 ARG^? 14.32 O ACT C 201 A 130 SER C 107 SER^? 6.74 O2 EDO A 301 A 159 LYS C 139 LYS.? 18.79 O ACT C 201 coo 18.35 45.84 20.99 16.20 47.83 21.89 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 15.14 43.67 10.77 15.61 44.43 13.04 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 11.57 48.49 22.18 13.51 49.99 17.21 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 23 3 # 23 A 59 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 130 SER C 155 SER~? 16.28 CH3 ACT C 201 A 159 LYS C 139 LYS.? 18.79 O ACT C 201 coo 18.35 45.84 20.99 16.20 47.83 21.89 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 15.14 43.67 10.77 15.61 44.43 13.04 -53.12 40.76 48.56 -52.79 41.59 46.30 coo 11.57 48.49 22.18 13.51 49.99 17.21 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 24 3 # 24 A 59 ARG C 138 ARG~? 16.31 O ACT C 201 A 130 SER C 107 SER^? 6.74 O2 EDO A 301 A 159 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 18.35 45.84 20.99 16.20 47.83 21.89 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 15.14 43.67 10.77 15.61 44.43 13.04 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 11.57 48.49 22.18 13.51 49.99 17.21 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 25 3 # 25 A 59 ARG C 138 ARG~? 16.31 O ACT C 201 A 130 SER C 107 SER^? 6.74 O2 EDO A 301 A 159 LYS C 139 LYS.? 18.79 O ACT C 201 coo 18.35 45.84 20.99 16.20 47.83 21.89 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 15.14 43.67 10.77 15.61 44.43 13.04 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 11.57 48.49 22.18 13.51 49.99 17.21 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 26 3 # 26 A 59 ARG C 147 ARG.? 13.23 CH3 ACT C 201 A 130 SER C 32 SER.? 11.23 CH3 ACT C 201 A 159 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 15.14 43.67 10.77 15.61 44.43 13.04 -32.31 40.22 56.18 -30.64 40.82 54.50 coo 11.57 48.49 22.18 13.51 49.99 17.21 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 27 3 # 27 A 59 ARG D 24 ARG~? 13.98 CH3 ACT D 201 A 130 SER D 18 SER~? 20.00 CH3 ACT D 201 A 159 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 15.14 43.67 10.77 15.61 44.43 13.04 -52.79 52.80 24.41 -53.57 50.53 24.92 coo 11.57 48.49 22.18 13.51 49.99 17.21 -47.37 61.41 34.65 -51.85 60.71 37.83 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 28 3 # 28 A 59 ARG D 24 ARG~? 13.98 CH3 ACT D 201 A 130 SER D 32 SER.? 11.12 CH3 ACT D 201 A 159 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 15.14 43.67 10.77 15.61 44.43 13.04 -58.03 70.18 35.81 -59.79 68.52 36.06 coo 11.57 48.49 22.18 13.51 49.99 17.21 -47.37 61.41 34.65 -51.85 60.71 37.83 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 29 3 # 29 A 59 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 130 SER D 107 SER^? 7.30 OXT ACT D 201 A 159 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 18.35 45.84 20.99 16.20 47.83 21.89 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 15.14 43.67 10.77 15.61 44.43 13.04 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 11.57 48.49 22.18 13.51 49.99 17.21 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 30 3 # 30 A 59 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 130 SER D 155 SER.? 16.53 CH3 ACT D 201 A 159 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 18.35 45.84 20.99 16.20 47.83 21.89 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 15.14 43.67 10.77 15.61 44.43 13.04 -37.80 61.65 32.35 -38.17 59.27 32.14 coo 11.57 48.49 22.18 13.51 49.99 17.21 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 31 3 # 31 A 59 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 130 SER D 107 SER^? 7.30 OXT ACT D 201 A 159 LYS D 134 LYS~? 17.34 O ACT A 201 coo 18.35 45.84 20.99 16.20 47.83 21.89 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 15.14 43.67 10.77 15.61 44.43 13.04 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 11.57 48.49 22.18 13.51 49.99 17.21 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 32 3 # 32 A 59 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 130 SER D 107 SER^? 7.30 OXT ACT D 201 A 159 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 18.35 45.84 20.99 16.20 47.83 21.89 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 15.14 43.67 10.77 15.61 44.43 13.04 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 11.57 48.49 22.18 13.51 49.99 17.21 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 33 3 # 33 A 59 ARG D 147 ARG.? 13.02 CH3 ACT D 201 A 130 SER D 32 SER.? 11.12 CH3 ACT D 201 A 159 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 18.35 45.84 20.99 16.20 47.83 21.89 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 15.14 43.67 10.77 15.61 44.43 13.04 -58.03 70.18 35.81 -59.79 68.52 36.06 coo 11.57 48.49 22.18 13.51 49.99 17.21 -47.37 61.41 34.65 -51.85 60.71 37.83 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 33 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 24 ARG~? 13.97 CH3 ACT A 201 B 130 SER A 18 SER~? 19.91 CH3 ACT A 201 B 159 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 61.66 35.17 10.39 61.29 34.14 12.56 -24.38 83.84 77.64 -22.19 83.01 78.40 coo 65.38 28.77 21.17 63.49 28.03 16.12 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG A 24 ARG~? 13.97 CH3 ACT A 201 B 130 SER A 32 SER.? 11.27 CH3 ACT A 201 B 159 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 61.66 35.17 10.39 61.29 34.14 12.56 -34.08 78.47 59.42 -31.66 78.25 59.14 coo 65.38 28.77 21.17 63.49 28.03 16.12 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG A 51 ARG.? 6.25 O1 EDO A 301 B 130 SER A 107 SER^? 6.74 O1 EDO A 301 B 159 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 58.72 31.58 20.45 60.80 29.39 20.94 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 61.66 35.17 10.39 61.29 34.14 12.56 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 65.38 28.77 21.17 63.49 28.03 16.12 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 B 59 ARG A 51 ARG.? 6.25 O1 EDO A 301 B 130 SER B 107 SER^? 7.39 OXT ACT B 201 B 159 LYS C 71 LYS~? 4.19 C1 EDO A 301 coo 58.72 31.58 20.45 60.80 29.39 20.94 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 61.66 35.17 10.39 61.29 34.14 12.56 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 65.38 28.77 21.17 63.49 28.03 16.12 -34.21 53.47 62.64 -37.24 57.55 64.61 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 B 59 ARG A 76 ARG^? 8.97 OXT ACT A 203 B 130 SER A 107 SER^? 6.74 O1 EDO A 301 B 159 LYS A 139 LYS.? 17.81 O ACT A 201 coo 58.72 31.58 20.45 60.80 29.39 20.94 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 61.66 35.17 10.39 61.29 34.14 12.56 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 65.38 28.77 21.17 63.49 28.03 16.12 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 6 3 # 6 B 59 ARG A 92 ARG^? 14.09 CH3 ACT A 201 B 130 SER A 107 SER^? 6.74 O1 EDO A 301 B 159 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 61.66 35.17 10.39 61.29 34.14 12.56 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 65.38 28.77 21.17 63.49 28.03 16.12 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 7 3 # 7 B 59 ARG A 106 ARG^? 14.48 O1 EDO A 301 B 130 SER A 155 SER~? 16.89 CH3 ACT A 201 B 159 LYS A 139 LYS.? 17.81 O ACT A 201 coo 58.72 31.58 20.45 60.80 29.39 20.94 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 61.66 35.17 10.39 61.29 34.14 12.56 -40.89 76.76 80.50 -38.67 76.97 81.48 coo 65.38 28.77 21.17 63.49 28.03 16.12 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 8 3 # 8 B 59 ARG A 138 ARG~? 6.49 OXT ACT A 203 B 130 SER A 107 SER^? 6.74 O1 EDO A 301 B 159 LYS A 134 LYS~? 11.98 O ACT A 203 coo 58.72 31.58 20.45 60.80 29.39 20.94 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 61.66 35.17 10.39 61.29 34.14 12.56 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 65.38 28.77 21.17 63.49 28.03 16.12 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 9 3 # 9 B 59 ARG A 138 ARG~? 6.49 OXT ACT A 203 B 130 SER A 107 SER^? 6.74 O1 EDO A 301 B 159 LYS A 139 LYS.? 17.81 O ACT A 201 coo 58.72 31.58 20.45 60.80 29.39 20.94 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 61.66 35.17 10.39 61.29 34.14 12.56 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 65.38 28.77 21.17 63.49 28.03 16.12 -48.50 74.28 70.24 -48.23 71.73 76.05 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 10 3 # 10 B 59 ARG A 147 ARG.? 13.06 CH3 ACT A 201 B 130 SER A 32 SER.? 11.27 CH3 ACT A 201 B 159 LYS A 79 LYS^? -3.45 CH3 ACT A 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 61.66 35.17 10.39 61.29 34.14 12.56 -34.08 78.47 59.42 -31.66 78.25 59.14 coo 65.38 28.77 21.17 63.49 28.03 16.12 -34.66 75.11 72.84 -31.25 72.89 69.03 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 11 3 # 11 B 59 ARG B 8 ARG.? 14.49 CH3 ACT B 201 B 130 SER B 39 SER~? 14.17 CH3 ACT B 201 B 159 LYS B 22 LYS~? 15.43 CH3 ACT B 201 coo 58.72 31.58 20.45 60.80 29.39 20.94 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 61.66 35.17 10.39 61.29 34.14 12.56 -38.00 54.38 92.68 -39.49 53.00 94.02 coo 65.38 28.77 21.17 63.49 28.03 16.12 -24.70 61.49 92.69 -28.99 62.66 95.83 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 12 3 # 12 B 59 ARG B 24 ARG~? 14.02 CH3 ACT B 201 B 130 SER B 18 SER~? 19.96 CH3 ACT B 201 B 159 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 61.66 35.17 10.39 61.29 34.14 12.56 -20.65 65.45 94.60 -21.88 67.54 95.01 coo 65.38 28.77 21.17 63.49 28.03 16.12 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 13 3 # 13 B 59 ARG B 24 ARG~? 14.02 CH3 ACT B 201 B 130 SER B 32 SER.? 11.07 CH3 ACT B 201 B 159 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 61.66 35.17 10.39 61.29 34.14 12.56 -29.79 46.60 90.02 -31.32 47.94 91.35 coo 65.38 28.77 21.17 63.49 28.03 16.12 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 14 3 # 14 B 59 ARG B 76 ARG^? 14.33 OXT ACT B 201 B 130 SER B 107 SER^? 7.39 OXT ACT B 201 B 159 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 58.72 31.58 20.45 60.80 29.39 20.94 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 61.66 35.17 10.39 61.29 34.14 12.56 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 65.38 28.77 21.17 63.49 28.03 16.12 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 15 3 # 15 B 59 ARG B 92 ARG^? -3.69 CH3 ACT A 202s B 130 SER B 107 SER^? 7.39 OXT ACT B 201 B 159 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 61.66 35.17 10.39 61.29 34.14 12.56 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 65.38 28.77 21.17 63.49 28.03 16.12 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 16 3 # 16 B 59 ARG B 106 ARG^? 5.91 C1 EDO A 302 B 130 SER B 155 SER~? 6.88 CH3 ACT A 202 B 159 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 58.72 31.58 20.45 60.80 29.39 20.94 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 61.66 35.17 10.39 61.29 34.14 12.56 -15.94 58.44 77.26 -16.71 60.70 77.77 coo 65.38 28.77 21.17 63.49 28.03 16.12 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 17 3 # 17 B 59 ARG B 138 ARG~? 16.35 OXT ACT B 201 B 130 SER B 107 SER^? 7.39 OXT ACT B 201 B 159 LYS B 134 LYS~? 12.79 C2 EDO A 302 coo 58.72 31.58 20.45 60.80 29.39 20.94 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 61.66 35.17 10.39 61.29 34.14 12.56 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 65.38 28.77 21.17 63.49 28.03 16.12 -24.49 42.38 66.88 -23.94 39.99 62.78 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 18 3 # 18 B 59 ARG B 138 ARG~? 16.35 OXT ACT B 201 B 130 SER B 107 SER^? 7.39 OXT ACT B 201 B 159 LYS B 139 LYS.? 6.99 C1 EDO A 302 coo 58.72 31.58 20.45 60.80 29.39 20.94 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 61.66 35.17 10.39 61.29 34.14 12.56 -29.25 52.59 73.85 -31.29 51.35 74.31 coo 65.38 28.77 21.17 63.49 28.03 16.12 -18.83 46.84 75.05 -16.49 49.79 71.17 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 19 3 # 19 B 59 ARG B 147 ARG.? 12.52 CH3 ACT A 202 B 130 SER B 32 SER.? 11.07 CH3 ACT B 201 B 159 LYS B 79 LYS^? -3.44 CH3 ACT B 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 61.66 35.17 10.39 61.29 34.14 12.56 -29.79 46.60 90.02 -31.32 47.94 91.35 coo 65.38 28.77 21.17 63.49 28.03 16.12 -23.75 57.07 83.29 -29.11 56.74 84.70 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 20 3 # 20 B 59 ARG C 24 ARG~? 14.09 CH3 ACT C 201 B 130 SER C 18 SER~? 19.83 CH3 ACT C 201 B 159 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -40.53 35.15 48.39 -41.31 34.14 51.19 coo 61.66 35.17 10.39 61.29 34.14 12.56 -39.67 35.11 36.68 -39.03 36.29 34.63 coo 65.38 28.77 21.17 63.49 28.03 16.12 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 21 3 # 21 B 59 ARG C 24 ARG~? 14.09 CH3 ACT C 201 B 130 SER C 32 SER.? 11.23 CH3 ACT C 201 B 159 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -40.53 35.15 48.39 -41.31 34.14 51.19 coo 61.66 35.17 10.39 61.29 34.14 12.56 -32.31 40.22 56.18 -30.64 40.82 54.50 coo 65.38 28.77 21.17 63.49 28.03 16.12 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 22 3 # 22 B 59 ARG C 51 ARG.? 6.22 O2 EDO A 301 B 130 SER C 107 SER^? 6.74 O2 EDO A 301 B 159 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 58.72 31.58 20.45 60.80 29.39 20.94 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 61.66 35.17 10.39 61.29 34.14 12.56 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 65.38 28.77 21.17 63.49 28.03 16.12 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 23 3 # 23 B 59 ARG C 51 ARG.? 6.22 O2 EDO A 301 B 130 SER C 107 SER^? 6.74 O2 EDO A 301 B 159 LYS C 68 LYS~? -2.77 O ACT C 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 61.66 35.17 10.39 61.29 34.14 12.56 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 65.38 28.77 21.17 63.49 28.03 16.12 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 24 3 # 24 B 59 ARG C 51 ARG.? 6.22 O2 EDO A 301 B 130 SER D 107 SER^? 7.30 OXT ACT D 201 B 159 LYS A 71 LYS~? 4.32 C2 EDO A 301 coo 58.72 31.58 20.45 60.80 29.39 20.94 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 61.66 35.17 10.39 61.29 34.14 12.56 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 65.38 28.77 21.17 63.49 28.03 16.12 -38.35 64.60 55.93 -41.15 60.07 56.77 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 25 3 # 25 B 59 ARG C 76 ARG^? 14.32 O ACT C 201 B 130 SER C 107 SER^? 6.74 O2 EDO A 301 B 159 LYS C 139 LYS.? 18.79 O ACT C 201 coo 58.72 31.58 20.45 60.80 29.39 20.94 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 61.66 35.17 10.39 61.29 34.14 12.56 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 65.38 28.77 21.17 63.49 28.03 16.12 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 26 3 # 26 B 59 ARG C 92 ARG^? 13.71 CH3 ACT C 201 B 130 SER C 107 SER^? 6.74 O2 EDO A 301 B 159 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 61.66 35.17 10.39 61.29 34.14 12.56 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 65.38 28.77 21.17 63.49 28.03 16.12 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 27 3 # 27 B 59 ARG C 106 ARG^? 14.47 O2 EDO A 301 B 130 SER C 155 SER~? 16.28 CH3 ACT C 201 B 159 LYS C 139 LYS.? 18.79 O ACT C 201 coo 58.72 31.58 20.45 60.80 29.39 20.94 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 61.66 35.17 10.39 61.29 34.14 12.56 -53.12 40.76 48.56 -52.79 41.59 46.30 coo 65.38 28.77 21.17 63.49 28.03 16.12 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 28 3 # 28 B 59 ARG C 138 ARG~? 16.31 O ACT C 201 B 130 SER C 107 SER^? 6.74 O2 EDO A 301 B 159 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 58.72 31.58 20.45 60.80 29.39 20.94 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 61.66 35.17 10.39 61.29 34.14 12.56 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 65.38 28.77 21.17 63.49 28.03 16.12 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 29 3 # 29 B 59 ARG C 138 ARG~? 16.31 O ACT C 201 B 130 SER C 107 SER^? 6.74 O2 EDO A 301 B 159 LYS C 139 LYS.? 18.79 O ACT C 201 coo 58.72 31.58 20.45 60.80 29.39 20.94 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 61.66 35.17 10.39 61.29 34.14 12.56 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 65.38 28.77 21.17 63.49 28.03 16.12 -50.26 41.49 60.64 -55.14 42.95 58.84 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 30 3 # 30 B 59 ARG C 147 ARG.? 13.23 CH3 ACT C 201 B 130 SER C 32 SER.? 11.23 CH3 ACT C 201 B 159 LYS C 79 LYS^? -3.44 CH3 ACT C 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 61.66 35.17 10.39 61.29 34.14 12.56 -32.31 40.22 56.18 -30.64 40.82 54.50 coo 65.38 28.77 21.17 63.49 28.03 16.12 -43.47 42.54 48.33 -38.69 45.48 48.28 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 31 3 # 31 B 59 ARG D 24 ARG~? 13.98 CH3 ACT D 201 B 130 SER D 18 SER~? 20.00 CH3 ACT D 201 B 159 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 61.66 35.17 10.39 61.29 34.14 12.56 -52.79 52.80 24.41 -53.57 50.53 24.92 coo 65.38 28.77 21.17 63.49 28.03 16.12 -47.37 61.41 34.65 -51.85 60.71 37.83 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 32 3 # 32 B 59 ARG D 24 ARG~? 13.98 CH3 ACT D 201 B 130 SER D 32 SER.? 11.12 CH3 ACT D 201 B 159 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 61.66 35.17 10.39 61.29 34.14 12.56 -58.03 70.18 35.81 -59.79 68.52 36.06 coo 65.38 28.77 21.17 63.49 28.03 16.12 -47.37 61.41 34.65 -51.85 60.71 37.83 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 33 3 # 33 B 59 ARG D 76 ARG^? 14.20 OXT ACT D 201 B 130 SER D 107 SER^? 7.30 OXT ACT D 201 B 159 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 58.72 31.58 20.45 60.80 29.39 20.94 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 61.66 35.17 10.39 61.29 34.14 12.56 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 65.38 28.77 21.17 63.49 28.03 16.12 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 34 3 # 34 B 59 ARG D 92 ARG^? 13.56 CH3 ACT D 201 B 130 SER D 107 SER^? 7.30 OXT ACT D 201 B 159 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 61.66 35.17 10.39 61.29 34.14 12.56 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 65.38 28.77 21.17 63.49 28.03 16.12 -47.37 61.41 34.65 -51.85 60.71 37.83 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 35 3 # 35 B 59 ARG D 106 ARG^? 14.88 OXT ACT D 201 B 130 SER D 155 SER.? 16.53 CH3 ACT D 201 B 159 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 58.72 31.58 20.45 60.80 29.39 20.94 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 61.66 35.17 10.39 61.29 34.14 12.56 -37.80 61.65 32.35 -38.17 59.27 32.14 coo 65.38 28.77 21.17 63.49 28.03 16.12 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 36 3 # 36 B 59 ARG D 138 ARG~? 16.38 OXT ACT D 201 B 130 SER D 107 SER^? 7.30 OXT ACT D 201 B 159 LYS D 134 LYS~? 17.34 O ACT A 201 coo 58.72 31.58 20.45 60.80 29.39 20.94 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 61.66 35.17 10.39 61.29 34.14 12.56 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 65.38 28.77 21.17 63.49 28.03 16.12 -37.62 76.93 46.97 -33.08 76.47 49.79 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 37 3 # 37 B 59 ARG D 138 ARG~? 16.38 OXT ACT D 201 B 130 SER D 107 SER^? 7.30 OXT ACT D 201 B 159 LYS D 139 LYS.? 18.54 OXT ACT D 201 coo 58.72 31.58 20.45 60.80 29.39 20.94 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 61.66 35.17 10.39 61.29 34.14 12.56 -44.25 65.54 45.21 -46.11 66.36 46.55 coo 65.38 28.77 21.17 63.49 28.03 16.12 -39.84 73.21 37.09 -35.07 70.74 37.87 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 38 3 # 38 B 59 ARG D 147 ARG.? 13.02 CH3 ACT D 201 B 130 SER D 32 SER.? 11.12 CH3 ACT D 201 B 159 LYS D 79 LYS^? -3.52 CH3 ACT D 201s coo 58.72 31.58 20.45 60.80 29.39 20.94 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 61.66 35.17 10.39 61.29 34.14 12.56 -58.03 70.18 35.81 -59.79 68.52 36.06 coo 65.38 28.77 21.17 63.49 28.03 16.12 -47.37 61.41 34.65 -51.85 60.71 37.83 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 38 hits 2tps_c01 naa= 3 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 1 3 # 1 18 ARG A 76 ARG^? 8.97 OXT ACT A 203 195 HIS A 98 HIS^? -3.60 C ACT A 203s 199 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 21.96 2.03 15.24 19.33 1.86 13.55 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 2 3 # 2 18 ARG B 51 ARG.? 7.67 O ACT B 201 195 HIS C 98 HIS^? 11.61 O2 EDO A 301 199 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo 21.96 2.03 15.24 19.33 1.86 13.55 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 3 3 # 3 18 ARG B 76 ARG^? 14.33 OXT ACT B 201 195 HIS B 98 HIS^? 14.98 OXT ACT B 201 199 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 21.96 2.03 15.24 19.33 1.86 13.55 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 4 3 # 4 18 ARG B 138 ARG~? 16.35 OXT ACT B 201 195 HIS B 98 HIS^? 14.98 OXT ACT B 201 199 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 21.96 2.03 15.24 19.33 1.86 13.55 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 5 3 # 5 18 ARG C 76 ARG^? 14.32 O ACT C 201 195 HIS C 98 HIS^? 11.61 O2 EDO A 301 199 ASP C 74 ASP^? 14.86 O ACT C 201 coo 21.96 2.03 15.24 19.33 1.86 13.55 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 6 3 # 6 18 ARG D 51 ARG.? 7.60 O ACT D 201 195 HIS A 98 HIS^? -3.60 C ACT A 203s 199 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo 21.96 2.03 15.24 19.33 1.86 13.55 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -44.77 63.42 52.85 -43.43 61.81 52.77 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 7 3 # 7 18 ARG D 76 ARG^? 14.20 OXT ACT D 201 195 HIS D 98 HIS^? 13.13 CH3 ACT A 203 199 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 21.96 2.03 15.24 19.33 1.86 13.55 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -50.30 76.97 42.14 -51.14 78.91 42.11 3cla_c00 source 3cla TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE ( C: 7 hits 3cla_c00 naa= 3 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 A 158 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 161 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 186 HIS A 98 HIS^? -3.60 C ACT A 203s coo 18.62 26.83 58.17 18.48 28.64 57.08 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 23.76 27.69 57.88 24.05 29.81 55.69 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 16.67 31.22 54.64 18.74 31.15 54.14 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 A 158 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 161 ARG D 51 ARG.? 7.60 O ACT D 201 A 186 HIS A 98 HIS^? -3.60 C ACT A 203s coo 18.62 26.83 58.17 18.48 28.64 57.08 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 23.76 27.69 57.88 24.05 29.81 55.69 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 16.67 31.22 54.64 18.74 31.15 54.14 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 3 # 3 A 158 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 161 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 186 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo 18.62 26.83 58.17 18.48 28.64 57.08 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 23.76 27.69 57.88 24.05 29.81 55.69 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 16.67 31.22 54.64 18.74 31.15 54.14 -30.93 39.91 75.36 -31.53 38.49 76.78 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 3 # 4 A 158 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 161 ARG B 51 ARG.? 7.67 O ACT B 201 A 186 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 18.62 26.83 58.17 18.48 28.64 57.08 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 23.76 27.69 57.88 24.05 29.81 55.69 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 16.67 31.22 54.64 18.74 31.15 54.14 -40.81 49.03 67.16 -39.15 48.14 68.10 4mdh_c02 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 4 hits 4mdh_c02 naa= 3 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 B 158 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 161 ARG A 76 ARG^? 8.97 OXT ACT A 203 B 186 HIS A 98 HIS^? -3.60 C ACT A 203s coo 44.53 16.44 28.54 44.89 18.45 28.77 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 39.64 19.27 28.15 40.19 21.74 29.94 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 48.32 20.00 31.44 46.45 20.91 31.50 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 B 158 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 161 ARG A 138 ARG~? 6.49 OXT ACT A 203 B 186 HIS A 98 HIS^? -3.60 C ACT A 203s coo 44.53 16.44 28.54 44.89 18.45 28.77 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 39.64 19.27 28.15 40.19 21.74 29.94 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 48.32 20.00 31.44 46.45 20.91 31.50 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 3 # 3 B 158 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 161 ARG D 51 ARG.? 7.60 O ACT D 201 B 186 HIS A 98 HIS^? -3.60 C ACT A 203s coo 44.53 16.44 28.54 44.89 18.45 28.77 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 39.64 19.27 28.15 40.19 21.74 29.94 -49.81 61.30 50.74 -48.26 63.65 49.51 coo 48.32 20.00 31.44 46.45 20.91 31.50 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 3 # 4 B 158 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 161 ARG B 76 ARG^? 14.33 OXT ACT B 201 B 186 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo 44.53 16.44 28.54 44.89 18.45 28.77 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 39.64 19.27 28.15 40.19 21.74 29.94 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 48.32 20.00 31.44 46.45 20.91 31.50 -30.93 39.91 75.36 -31.53 38.49 76.78 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 5 3 # 5 B 158 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 161 ARG B 138 ARG~? 16.35 OXT ACT B 201 B 186 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo 44.53 16.44 28.54 44.89 18.45 28.77 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 39.64 19.27 28.15 40.19 21.74 29.94 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 48.32 20.00 31.44 46.45 20.91 31.50 -30.93 39.91 75.36 -31.53 38.49 76.78 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 6 3 # 6 B 158 ASP C 74 ASP^? 14.86 O ACT C 201 B 161 ARG C 33 ARG.? 12.41 O ACT C 201 B 186 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 44.53 16.44 28.54 44.89 18.45 28.77 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 39.64 19.27 28.15 40.19 21.74 29.94 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 48.32 20.00 31.44 46.45 20.91 31.50 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 7 3 # 7 B 158 ASP C 74 ASP^? 14.86 O ACT C 201 B 161 ARG C 76 ARG^? 14.32 O ACT C 201 B 186 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 44.53 16.44 28.54 44.89 18.45 28.77 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 39.64 19.27 28.15 40.19 21.74 29.94 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 48.32 20.00 31.44 46.45 20.91 31.50 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 8 3 # 8 B 158 ASP C 74 ASP^? 14.86 O ACT C 201 B 161 ARG C 138 ARG~? 16.31 O ACT C 201 B 186 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 44.53 16.44 28.54 44.89 18.45 28.77 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 39.64 19.27 28.15 40.19 21.74 29.94 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 48.32 20.00 31.44 46.45 20.91 31.50 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 9 3 # 9 B 158 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 161 ARG B 51 ARG.? 7.67 O ACT B 201 B 186 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 44.53 16.44 28.54 44.89 18.45 28.77 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 39.64 19.27 28.15 40.19 21.74 29.94 -37.69 55.58 74.87 -35.47 53.51 74.34 coo 48.32 20.00 31.44 46.45 20.91 31.50 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 10 3 # 10 B 158 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 161 ARG D 33 ARG.? 12.34 OXT ACT D 201 B 186 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo 44.53 16.44 28.54 44.89 18.45 28.77 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 39.64 19.27 28.15 40.19 21.74 29.94 -55.21 72.58 39.53 -56.74 74.11 37.37 coo 48.32 20.00 31.44 46.45 20.91 31.50 -48.48 77.63 46.64 -50.12 78.90 46.30 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 11 3 # 11 B 158 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 161 ARG D 76 ARG^? 14.20 OXT ACT D 201 B 186 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo 44.53 16.44 28.54 44.89 18.45 28.77 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 39.64 19.27 28.15 40.19 21.74 29.94 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 48.32 20.00 31.44 46.45 20.91 31.50 -48.48 77.63 46.64 -50.12 78.90 46.30 4mdh_c03 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 11 hits 4mdh_c03 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 49 ARG^? -3.92 O ACT A 202s 127 ARG B 106 ARG^? 5.91 C1 EDO A 302 270 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo -1.14 25.72 1.64 0.76 28.10 1.50 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 67 ARG~? 13.20 O2 EDO A 302 127 ARG C 67 ARG~? 12.50 O2 EDO A 302 270 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo -1.14 25.72 1.64 0.76 28.10 1.50 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG A 67 ARG~? 13.20 O2 EDO A 302 127 ARG C 67 ARG~? 12.50 O2 EDO A 302 270 GLU A 72 GLU~? 5.31 O ACT A 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG A 67 ARG~? 13.20 O2 EDO A 302 127 ARG C 67 ARG~? 12.50 O2 EDO A 302 270 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo -1.14 25.72 1.64 0.76 28.10 1.50 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 5 3 # 5 71 ARG A 67 ARG~? 13.20 O2 EDO A 302 127 ARG C 67 ARG~? 12.50 O2 EDO A 302 270 GLU C 60 GLU~? 17.22 OXT ACT C 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -23.89 57.63 47.43 -24.47 59.50 46.62 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 6 3 # 6 71 ARG A 67 ARG~? 13.20 O2 EDO A 302 127 ARG C 67 ARG~? 12.50 O2 EDO A 302 270 GLU C 72 GLU~? 5.32 O ACT C 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 7 3 # 7 71 ARG A 76 ARG^? 8.97 OXT ACT A 203 127 ARG A 138 ARG~? 6.49 OXT ACT A 203 270 GLU A 72 GLU~? 5.31 O ACT A 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -50.06 71.52 64.11 -49.59 74.03 62.40 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 8 3 # 8 71 ARG A 76 ARG^? 8.97 OXT ACT A 203 127 ARG A 138 ARG~? 6.49 OXT ACT A 203 270 GLU A 160 GLU.? 13.50 O ACT A 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -50.06 71.52 64.11 -49.59 74.03 62.40 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -45.30 71.21 75.74 -44.17 71.89 74.09 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 9 3 # 9 71 ARG A 92 ARG^? 14.09 CH3 ACT A 201 127 ARG B 88 ARG^? 18.43 CH3 ACT A 201 270 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -31.74 72.75 86.26 -33.87 74.56 85.05 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 10 3 # 10 71 ARG A 138 ARG~? 6.49 OXT ACT A 203 127 ARG A 76 ARG^? 8.97 OXT ACT A 203 270 GLU A 72 GLU~? 5.31 O ACT A 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 11 3 # 11 71 ARG A 138 ARG~? 6.49 OXT ACT A 203 127 ARG A 76 ARG^? 8.97 OXT ACT A 203 270 GLU A 160 GLU.? 13.50 O ACT A 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -45.30 71.21 75.74 -44.17 71.89 74.09 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 12 3 # 12 71 ARG B 76 ARG^? 14.33 OXT ACT B 201 127 ARG B 138 ARG~? 16.35 OXT ACT B 201 270 GLU B 72 GLU~? 5.30 OXT ACT B 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -23.44 41.55 74.26 -23.57 39.98 76.87 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -35.13 47.70 77.85 -34.58 49.69 78.28 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 13 3 # 13 71 ARG B 88 ARG^? 18.43 CH3 ACT A 201 127 ARG A 92 ARG^? 14.09 CH3 ACT A 201 270 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 14 3 # 14 71 ARG B 88 ARG^? 18.43 CH3 ACT A 201 127 ARG B 123 ARG.? 17.76 O ACT B 201 270 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -38.78 69.90 87.63 -38.44 71.99 85.40 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 15 3 # 15 71 ARG B 88 ARG^? 18.43 CH3 ACT A 201 127 ARG B 123 ARG.? 17.76 O ACT B 201 270 GLU B 117 GLU.? 26.48 CH3 ACT B 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -38.78 69.90 87.63 -38.44 71.99 85.40 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -33.80 72.26 99.63 -34.50 73.71 100.99 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 16 3 # 16 71 ARG B 92 ARG^? -3.69 CH3 ACT A 202s 127 ARG A 88 ARG^? 11.13 CH3 ACT A 202 270 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -18.98 69.22 79.04 -17.48 66.59 79.46 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 17 3 # 17 71 ARG B 92 ARG^? -3.69 CH3 ACT A 202s 127 ARG A 88 ARG^? 11.13 CH3 ACT A 202 270 GLU B 156 GLU~? 12.19 CH3 ACT A 202 coo -1.14 25.72 1.64 0.76 28.10 1.50 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -18.98 69.22 79.04 -17.48 66.59 79.46 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -12.52 56.39 79.83 -10.80 57.54 79.39 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 18 3 # 18 71 ARG B 106 ARG^? 5.91 C1 EDO A 302 127 ARG A 49 ARG^? -3.92 O ACT A 202s 270 GLU B 80 GLU^? 7.87 CH3 ACT A 202 coo -1.14 25.72 1.64 0.76 28.10 1.50 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -25.12 58.31 69.83 -26.93 60.25 71.40 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -19.12 60.55 81.96 -17.78 60.17 80.39 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 19 3 # 19 71 ARG B 123 ARG.? 17.76 O ACT B 201 127 ARG B 88 ARG^? 18.43 CH3 ACT A 201 270 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -31.74 72.75 86.26 -33.87 74.56 85.05 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 20 3 # 20 71 ARG B 123 ARG.? 17.76 O ACT B 201 127 ARG B 88 ARG^? 18.43 CH3 ACT A 201 270 GLU B 117 GLU.? 26.48 CH3 ACT B 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -38.78 69.90 87.63 -38.44 71.99 85.40 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -31.74 72.75 86.26 -33.87 74.56 85.05 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -33.80 72.26 99.63 -34.50 73.71 100.99 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 21 3 # 21 71 ARG B 138 ARG~? 16.35 OXT ACT B 201 127 ARG B 76 ARG^? 14.33 OXT ACT B 201 270 GLU B 72 GLU~? 5.30 OXT ACT B 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -23.44 41.55 74.26 -23.57 39.98 76.87 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -35.13 47.70 77.85 -34.58 49.69 78.28 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 22 3 # 22 71 ARG C 67 ARG~? 12.50 O2 EDO A 302 127 ARG A 67 ARG~? 13.20 O2 EDO A 302 270 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo -1.14 25.72 1.64 0.76 28.10 1.50 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 23 3 # 23 71 ARG C 67 ARG~? 12.50 O2 EDO A 302 127 ARG A 67 ARG~? 13.20 O2 EDO A 302 270 GLU A 60 GLU~? 10.63 O2 EDO A 302 coo -1.14 25.72 1.64 0.76 28.10 1.50 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -19.73 62.99 57.19 -19.03 61.21 58.09 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 24 3 # 24 71 ARG C 67 ARG~? 12.50 O2 EDO A 302 127 ARG A 67 ARG~? 13.20 O2 EDO A 302 270 GLU A 72 GLU~? 5.31 O ACT A 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -38.02 65.72 60.64 -36.78 66.00 62.33 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 25 3 # 25 71 ARG C 67 ARG~? 12.50 O2 EDO A 302 127 ARG A 67 ARG~? 13.20 O2 EDO A 302 270 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo -1.14 25.72 1.64 0.76 28.10 1.50 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 26 3 # 26 71 ARG C 67 ARG~? 12.50 O2 EDO A 302 127 ARG A 67 ARG~? 13.20 O2 EDO A 302 270 GLU C 72 GLU~? 5.32 O ACT C 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 27 3 # 27 71 ARG C 76 ARG^? 14.32 O ACT C 201 127 ARG C 138 ARG~? 16.31 O ACT C 201 270 GLU C 72 GLU~? 5.32 O ACT C 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -46.75 44.46 65.88 -44.64 42.30 66.40 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 28 3 # 28 71 ARG C 88 ARG^? 18.42 CH3 ACT D 201 127 ARG C 123 ARG.? 17.68 OXT ACT C 201 270 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -33.35 53.49 35.15 -35.34 55.60 34.14 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 29 3 # 29 71 ARG C 88 ARG^? 18.42 CH3 ACT D 201 127 ARG C 123 ARG.? 17.68 OXT ACT C 201 270 GLU C 117 GLU.? 26.34 CH3 ACT C 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -33.35 53.49 35.15 -35.34 55.60 34.14 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -28.65 43.01 29.05 -27.69 42.85 27.18 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 30 3 # 30 71 ARG C 92 ARG^? 13.71 CH3 ACT C 201 127 ARG D 88 ARG^? 18.35 CH3 ACT C 201 270 GLU C 156 GLU~? 19.44 CH3 ACT C 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -52.23 44.53 37.75 -52.43 42.56 40.08 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -53.30 36.17 49.35 -52.27 34.34 49.18 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 31 3 # 31 71 ARG C 92 ARG^? 13.71 CH3 ACT C 201 127 ARG D 88 ARG^? 18.35 CH3 ACT C 201 270 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -49.94 47.28 44.16 -51.45 46.27 46.66 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -52.23 44.53 37.75 -52.43 42.56 40.08 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 32 3 # 32 71 ARG C 123 ARG.? 17.68 OXT ACT C 201 127 ARG C 88 ARG^? 18.42 CH3 ACT D 201 270 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -39.31 50.22 32.74 -39.14 52.99 31.45 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 33 3 # 33 71 ARG C 123 ARG.? 17.68 OXT ACT C 201 127 ARG C 88 ARG^? 18.42 CH3 ACT D 201 270 GLU C 117 GLU.? 26.34 CH3 ACT C 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -33.35 53.49 35.15 -35.34 55.60 34.14 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -39.31 50.22 32.74 -39.14 52.99 31.45 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -28.65 43.01 29.05 -27.69 42.85 27.18 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 34 3 # 34 71 ARG C 138 ARG~? 16.31 O ACT C 201 127 ARG C 76 ARG^? 14.32 O ACT C 201 270 GLU C 72 GLU~? 5.32 O ACT C 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -42.25 40.39 61.14 -41.06 40.24 63.98 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -37.42 52.13 59.26 -38.02 51.91 57.25 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 35 3 # 35 71 ARG D 92 ARG^? 13.56 CH3 ACT D 201 127 ARG C 88 ARG^? 18.42 CH3 ACT D 201 270 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -39.31 50.22 32.74 -39.14 52.99 31.45 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 36 3 # 36 71 ARG D 147 ARG.? 13.02 CH3 ACT D 201 127 ARG D 24 ARG~? 13.98 CH3 ACT D 201 270 GLU D 156 GLU.? 18.36 CH3 ACT D 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -50.90 63.83 27.93 -49.90 66.74 27.73 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -37.15 64.72 28.61 -38.97 63.94 27.88 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 36 hits 5cpa_c01 naa= 3 ULMN 3 5rsa_c01 RIBONUCLEASE A user 1 3 # 1 12 HIS A 161 HIS.? 19.24 O ACT B 201 41 LYS A 139 LYS.? 17.81 O ACT A 201 119 HIS A 162 HIS.? 14.54 O1 EDO A 301 coo 28.18 18.67 11.43 28.83 17.39 9.89 -48.72 65.75 79.30 -49.45 66.41 81.15 coo 25.33 8.32 6.30 27.86 13.90 7.82 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 33.68 19.99 5.35 34.98 18.36 5.19 -51.28 62.77 74.01 -50.27 62.16 72.28 ULMN 3 5rsa_c01 RIBONUCLEASE A user 2 3 # 2 12 HIS A 162 HIS.? 14.54 O1 EDO A 301 41 LYS A 139 LYS.? 17.81 O ACT A 201 119 HIS A 161 HIS.? 19.24 O ACT B 201 coo 28.18 18.67 11.43 28.83 17.39 9.89 -51.28 62.77 74.01 -50.27 62.16 72.28 coo 25.33 8.32 6.30 27.86 13.90 7.82 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 33.68 19.99 5.35 34.98 18.36 5.19 -48.72 65.75 79.30 -49.45 66.41 81.15 5rsa_c01 source 5rsa RIBONUCLEASE A : 2 hits 5rsa_c01 naa= 3 ULMN 3 1k12_p00 LECTIN user 1 3 # 1 A 52 HIS A 141 HIS.? 11.20 OXT ACT A 203 A 79 ARG A 76 ARG^? 8.97 OXT ACT A 203 A 86 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo -5.53 26.98 5.69 -5.98 25.70 4.09 -49.96 77.41 66.16 -51.01 75.70 66.78 coo -12.15 26.35 6.05 -10.94 27.19 3.35 -44.10 76.39 63.96 -45.67 76.44 61.31 coo -9.59 20.48 4.28 -9.21 22.28 1.82 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 1k12_p00 LECTIN user 2 3 # 2 A 52 HIS A 141 HIS.? 11.20 OXT ACT A 203 A 79 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 86 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo -5.53 26.98 5.69 -5.98 25.70 4.09 -49.96 77.41 66.16 -51.01 75.70 66.78 coo -12.15 26.35 6.05 -10.94 27.19 3.35 -50.06 71.52 64.11 -49.59 74.03 62.40 coo -9.59 20.48 4.28 -9.21 22.28 1.82 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 3 1k12_p00 LECTIN user 3 3 # 3 A 52 HIS A 161 HIS.? 19.24 O ACT B 201 A 79 ARG B 49 ARG^? 10.37 O ACT B 201 A 86 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo -5.53 26.98 5.69 -5.98 25.70 4.09 -48.72 65.75 79.30 -49.45 66.41 81.15 coo -12.15 26.35 6.05 -10.94 27.19 3.35 -40.89 64.28 77.45 -37.86 63.79 77.23 coo -9.59 20.48 4.28 -9.21 22.28 1.82 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1k12_p00 LECTIN user 4 3 # 4 A 52 HIS B 141 HIS.? 15.94 CH3 ACT A 202 A 79 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 86 ARG B 138 ARG~? 16.35 OXT ACT B 201 coo -5.53 26.98 5.69 -5.98 25.70 4.09 -16.42 43.62 79.59 -14.76 44.89 79.44 coo -12.15 26.35 6.05 -10.94 27.19 3.35 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -9.59 20.48 4.28 -9.21 22.28 1.82 -23.44 41.55 74.26 -23.57 39.98 76.87 ULMN 3 1k12_p00 LECTIN user 5 3 # 5 A 52 HIS B 141 HIS.? 15.94 CH3 ACT A 202 A 79 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 86 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo -5.53 26.98 5.69 -5.98 25.70 4.09 -16.42 43.62 79.59 -14.76 44.89 79.44 coo -12.15 26.35 6.05 -10.94 27.19 3.35 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -9.59 20.48 4.28 -9.21 22.28 1.82 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 3 1k12_p00 LECTIN user 6 3 # 6 A 52 HIS C 141 HIS.? 17.85 O ACT C 201 A 79 ARG C 76 ARG^? 14.32 O ACT C 201 A 86 ARG C 138 ARG~? 16.31 O ACT C 201 coo -5.53 26.98 5.69 -5.98 25.70 4.09 -47.33 38.55 64.23 -48.23 40.22 65.13 coo -12.15 26.35 6.05 -10.94 27.19 3.35 -42.25 40.39 61.14 -41.06 40.24 63.98 coo -9.59 20.48 4.28 -9.21 22.28 1.82 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 1k12_p00 LECTIN user 7 3 # 7 A 52 HIS C 141 HIS.? 17.85 O ACT C 201 A 79 ARG C 138 ARG~? 16.31 O ACT C 201 A 86 ARG C 76 ARG^? 14.32 O ACT C 201 coo -5.53 26.98 5.69 -5.98 25.70 4.09 -47.33 38.55 64.23 -48.23 40.22 65.13 coo -12.15 26.35 6.05 -10.94 27.19 3.35 -46.75 44.46 65.88 -44.64 42.30 66.40 coo -9.59 20.48 4.28 -9.21 22.28 1.82 -42.25 40.39 61.14 -41.06 40.24 63.98 ULMN 3 1k12_p00 LECTIN user 8 3 # 8 A 52 HIS D 141 HIS.? 18.95 OXT ACT D 201 A 79 ARG D 76 ARG^? 14.20 OXT ACT D 201 A 86 ARG D 138 ARG~? 16.38 OXT ACT D 201 coo -5.53 26.98 5.69 -5.98 25.70 4.09 -42.77 77.11 33.23 -41.72 76.77 31.45 coo -12.15 26.35 6.05 -10.94 27.19 3.35 -47.81 74.29 36.53 -48.87 77.02 37.43 coo -9.59 20.48 4.28 -9.21 22.28 1.82 -42.61 77.59 41.75 -44.95 78.80 40.20 ULMN 3 1k12_p00 LECTIN user 9 3 # 9 A 52 HIS D 141 HIS.? 18.95 OXT ACT D 201 A 79 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 86 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo -5.53 26.98 5.69 -5.98 25.70 4.09 -42.77 77.11 33.23 -41.72 76.77 31.45 coo -12.15 26.35 6.05 -10.94 27.19 3.35 -42.61 77.59 41.75 -44.95 78.80 40.20 coo -9.59 20.48 4.28 -9.21 22.28 1.82 -47.81 74.29 36.53 -48.87 77.02 37.43 1k12_p00 source 1k12 LECTIN : 9 hits 1k12_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 31 ASN~? 8.53 CH3 ACT A 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -36.15 78.19 63.69 -37.32 77.26 65.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 50 ASN^? 5.02 OXT ACT A 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -28.17 63.14 65.41 -30.17 63.83 65.25 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 57 ASN~? 14.18 O1 EDO A 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.25 65.99 58.99 -17.06 64.89 57.36 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 87 ASN.? 16.46 O ACT A 202 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.21 74.81 76.88 -15.45 72.83 77.10 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 103 ASN.? 7.23 O2 EDO A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -48.04 61.08 60.88 -48.95 59.43 59.91 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 110 ASN^? 10.87 O ACT B 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 112 ASN^? 9.36 O ACT A 202 coo 5.80 63.03 55.85 5.52 65.03 56.45 -24.96 67.02 76.01 -26.38 66.67 77.57 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN A 129 ASN.? 9.65 O ACT B 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -38.33 60.18 72.42 -36.71 58.96 73.06 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 31 ASN~? 8.56 CH3 ACT B 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -26.33 48.60 87.43 -25.42 49.22 85.60 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 50 ASN^? 4.93 O ACT B 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -39.13 57.82 80.42 -37.65 56.39 79.89 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN B 57 ASN~? 18.11 O ACT B 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -46.90 59.98 91.63 -48.14 58.47 90.79 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN B 87 ASN.? 20.06 CH3 ACT B 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -30.91 71.77 92.72 -32.40 72.79 91.60 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN B 103 ASN.? 17.21 C2 EDO A 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 -32.39 41.19 68.51 -33.08 39.66 67.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN B 110 ASN^? 6.46 O ACT A 202 coo 5.80 63.03 55.85 5.52 65.03 56.45 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN B 112 ASN^? 12.13 O ACT B 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -32.04 67.09 81.98 -30.67 67.45 80.39 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN C 31 ASN~? 8.68 CH3 ACT C 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -36.93 39.85 55.08 -38.97 40.48 55.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN C 50 ASN^? 4.97 OXT ACT C 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -35.45 55.77 48.86 -36.44 54.81 50.47 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN C 57 ASN~? 18.23 OXT ACT C 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -22.76 55.02 43.39 -22.13 56.21 45.03 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN C 87 ASN.? 20.02 CH3 ACT C 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -35.14 45.16 31.53 -35.06 47.21 30.96 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN C 103 ASN.? 7.35 O1 EDO A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -44.48 55.23 67.22 -44.54 56.80 68.65 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN C 110 ASN^? 10.92 O ACT D 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN C 112 ASN^? 12.25 OXT ACT C 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -41.01 51.77 39.43 -43.15 51.81 39.53 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN C 129 ASN.? 9.72 O ACT D 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -47.56 56.76 52.53 -47.22 58.18 50.99 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 25 1 # 25 A 461 ASN D 4 ASN.? 30.09 CH3 ACT D 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -75.78 53.94 27.05 -76.38 51.89 27.07 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 26 1 # 26 A 461 ASN D 31 ASN~? 8.51 CH3 ACT D 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -53.58 68.96 34.68 -51.50 68.66 35.10 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 27 1 # 27 A 461 ASN D 50 ASN^? 4.92 O ACT D 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -54.56 58.39 48.20 -53.45 60.06 47.53 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 28 1 # 28 A 461 ASN D 57 ASN~? 18.22 O ACT D 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -67.77 54.18 46.88 -68.13 55.47 48.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 29 1 # 29 A 461 ASN D 87 ASN.? 20.13 CH3 ACT D 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -56.77 45.04 33.02 -56.64 43.87 34.78 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 30 1 # 30 A 461 ASN D 103 ASN.? 11.64 CH3 ACT A 203 coo 5.80 63.03 55.85 5.52 65.03 56.45 -43.97 76.72 52.03 -43.49 78.26 53.43 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 31 1 # 31 A 461 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 32 1 # 32 A 461 ASN D 112 ASN^? 12.21 O ACT D 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -49.94 50.30 41.07 -47.80 50.26 40.97 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 33 1 # 33 A 461 ASN D 129 ASN.? 9.72 OXT ACT C 201 coo 5.80 63.03 55.85 5.52 65.03 56.45 -42.23 60.94 49.15 -42.50 59.01 49.99 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 33 hits 1kbk_p00 naa= 1 ULMN 4 1kqr_p00 VP4 user 1 4 # 1 A 101 ARG A 49 ARG^? -3.92 O ACT A 202s A 187 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 188 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 190 SER B 107 SER^? 7.39 OXT ACT B 201 coo 10.93 40.49 13.39 9.72 39.25 15.90 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 2.71 31.72 11.75 7.91 29.74 9.11 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 1.39 36.04 13.60 -0.23 35.82 15.85 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 4.80 41.21 15.27 3.05 40.92 16.89 -29.25 52.59 73.85 -31.29 51.35 74.31 ULMN 4 1kqr_p00 VP4 user 2 4 # 2 A 101 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 187 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 188 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 190 SER A 107 SER^? 6.74 O1 EDO A 301 coo 10.93 40.49 13.39 9.72 39.25 15.90 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 2.71 31.72 11.75 7.91 29.74 9.11 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 1.39 36.04 13.60 -0.23 35.82 15.85 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 4.80 41.21 15.27 3.05 40.92 16.89 -40.35 65.45 69.21 -39.92 64.63 66.96 ULMN 4 1kqr_p00 VP4 user 3 4 # 3 A 101 ARG B 49 ARG^? 10.37 O ACT B 201 A 187 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 188 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 190 SER A 107 SER^? 6.74 O1 EDO A 301 coo 10.93 40.49 13.39 9.72 39.25 15.90 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 2.71 31.72 11.75 7.91 29.74 9.11 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 1.39 36.04 13.60 -0.23 35.82 15.85 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 4.80 41.21 15.27 3.05 40.92 16.89 -40.35 65.45 69.21 -39.92 64.63 66.96 ULMN 4 1kqr_p00 VP4 user 4 4 # 4 A 101 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 187 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 188 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 190 SER B 107 SER^? 7.39 OXT ACT B 201 coo 10.93 40.49 13.39 9.72 39.25 15.90 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 2.71 31.72 11.75 7.91 29.74 9.11 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 1.39 36.04 13.60 -0.23 35.82 15.85 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 4.80 41.21 15.27 3.05 40.92 16.89 -29.25 52.59 73.85 -31.29 51.35 74.31 ULMN 4 1kqr_p00 VP4 user 5 4 # 5 A 101 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 187 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 188 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 190 SER D 107 SER^? 7.30 OXT ACT D 201 coo 10.93 40.49 13.39 9.72 39.25 15.90 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 2.71 31.72 11.75 7.91 29.74 9.11 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 1.39 36.04 13.60 -0.23 35.82 15.85 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 4.80 41.21 15.27 3.05 40.92 16.89 -44.25 65.54 45.21 -46.11 66.36 46.55 ULMN 4 1kqr_p00 VP4 user 6 4 # 6 A 101 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 187 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 188 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 190 SER C 107 SER^? 6.74 O2 EDO A 301 coo 10.93 40.49 13.39 9.72 39.25 15.90 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 2.71 31.72 11.75 7.91 29.74 9.11 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 1.39 36.04 13.60 -0.23 35.82 15.85 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 4.80 41.21 15.27 3.05 40.92 16.89 -45.59 51.52 55.69 -43.69 52.48 56.86 ULMN 4 1kqr_p00 VP4 user 7 4 # 7 A 101 ARG D 49 ARG^? 10.44 O ACT D 201 A 187 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 188 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 190 SER C 107 SER^? 6.74 O2 EDO A 301 coo 10.93 40.49 13.39 9.72 39.25 15.90 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 2.71 31.72 11.75 7.91 29.74 9.11 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 1.39 36.04 13.60 -0.23 35.82 15.85 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 4.80 41.21 15.27 3.05 40.92 16.89 -45.59 51.52 55.69 -43.69 52.48 56.86 ULMN 4 1kqr_p00 VP4 user 8 4 # 8 A 101 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 187 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 188 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 190 SER D 107 SER^? 7.30 OXT ACT D 201 coo 10.93 40.49 13.39 9.72 39.25 15.90 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 2.71 31.72 11.75 7.91 29.74 9.11 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 1.39 36.04 13.60 -0.23 35.82 15.85 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 4.80 41.21 15.27 3.05 40.92 16.89 -44.25 65.54 45.21 -46.11 66.36 46.55 1kqr_p00 source 1kqr VP4 : 8 hits 1kqr_p00 naa= 4 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 108 TYR^? 12.28 O ACT A 201 A 112 PHE B 125 PHE.? 13.16 O ACT B 201 A 140 ASN A 110 ASN^? 10.87 O ACT B 201 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -40.87 65.49 73.93 -43.61 66.01 74.07 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -37.18 66.81 81.74 -39.05 68.51 82.95 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR B 108 TYR^? -4.79 O ACT A 202s A 112 PHE A 125 PHE.? -4.61 O ACT A 202s A 140 ASN B 110 ASN^? 6.46 O ACT A 202 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -26.20 55.78 72.02 -24.40 54.06 70.73 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -22.79 63.54 72.77 -20.07 62.88 72.67 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 3 3 # 3 A 56 TYR C 108 TYR^? 12.28 O ACT C 201 A 112 PHE D 125 PHE.? 13.16 O ACT D 201 A 140 ASN C 110 ASN^? 10.92 O ACT D 201 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -49.57 50.97 53.11 -51.32 50.02 55.06 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -52.98 49.81 45.21 -54.80 47.77 45.79 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 4 3 # 4 A 56 TYR D 108 TYR^? 12.28 OXT ACT D 201 A 112 PHE C 125 PHE.? 13.13 OXT ACT C 201 A 140 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -40.41 63.05 43.73 -38.60 65.12 43.23 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -37.61 55.67 40.06 -35.81 56.68 38.17 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -44.80 54.88 42.61 -42.77 55.08 41.96 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 4 hits 1o8s_p00 naa= 3 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 108 ASN B 112 ASN^? 12.13 O ACT B 201 A 135 ASN A 110 ASN^? 10.87 O ACT B 201 coo 17.59 4.66 17.88 15.38 5.96 18.97 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 12.36 16.24 15.27 12.06 14.29 16.05 -32.04 67.09 81.98 -30.67 67.45 80.39 coo 18.05 11.56 12.71 17.57 10.75 14.60 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 108 ASN B 112 ASN^? 12.13 O ACT B 201 A 135 ASN B 110 ASN^? 6.46 O ACT A 202 coo 17.59 4.66 17.88 15.38 5.96 18.97 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 12.36 16.24 15.27 12.06 14.29 16.05 -32.04 67.09 81.98 -30.67 67.45 80.39 coo 18.05 11.56 12.71 17.57 10.75 14.60 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 108 ASN B 129 ASN.? 9.80 OXT ACT A 201 A 135 ASN B 110 ASN^? 6.46 O ACT A 202 coo 17.59 4.66 17.88 15.38 5.96 18.97 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 12.36 16.24 15.27 12.06 14.29 16.05 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 18.05 11.56 12.71 17.57 10.75 14.60 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR A 108 TYR^? 12.28 O ACT A 201 A 108 ASN B 112 ASN^? 12.13 O ACT B 201 A 135 ASN A 110 ASN^? 10.87 O ACT B 201 coo 17.59 4.66 17.88 15.38 5.96 18.97 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 12.36 16.24 15.27 12.06 14.29 16.05 -32.04 67.09 81.98 -30.67 67.45 80.39 coo 18.05 11.56 12.71 17.57 10.75 14.60 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 5 3 # 5 A 51 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 108 ASN A 129 ASN.? 9.65 O ACT B 201 A 135 ASN A 110 ASN^? 10.87 O ACT B 201 coo 17.59 4.66 17.88 15.38 5.96 18.97 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 12.36 16.24 15.27 12.06 14.29 16.05 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 18.05 11.56 12.71 17.57 10.75 14.60 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 6 3 # 6 A 51 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 108 ASN A 129 ASN.? 9.65 O ACT B 201 A 135 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 17.59 4.66 17.88 15.38 5.96 18.97 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 12.36 16.24 15.27 12.06 14.29 16.05 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 18.05 11.56 12.71 17.57 10.75 14.60 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 7 3 # 7 A 51 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 108 ASN B 110 ASN^? 6.46 O ACT A 202 A 135 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 17.59 4.66 17.88 15.38 5.96 18.97 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 12.36 16.24 15.27 12.06 14.29 16.05 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 18.05 11.56 12.71 17.57 10.75 14.60 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 8 3 # 8 A 51 TYR B 108 TYR^? -4.79 O ACT A 202s A 108 ASN A 112 ASN^? 9.36 O ACT A 202 A 135 ASN B 110 ASN^? 6.46 O ACT A 202 coo 17.59 4.66 17.88 15.38 5.96 18.97 -26.20 55.78 72.02 -24.40 54.06 70.73 coo 12.36 16.24 15.27 12.06 14.29 16.05 -24.96 67.02 76.01 -26.38 66.67 77.57 coo 18.05 11.56 12.71 17.57 10.75 14.60 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 9 3 # 9 A 51 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 108 ASN D 112 ASN^? 12.21 O ACT D 201 A 135 ASN C 110 ASN^? 10.92 O ACT D 201 coo 17.59 4.66 17.88 15.38 5.96 18.97 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 12.36 16.24 15.27 12.06 14.29 16.05 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 18.05 11.56 12.71 17.57 10.75 14.60 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 10 3 # 10 A 51 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 108 ASN D 112 ASN^? 12.21 O ACT D 201 A 135 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 17.59 4.66 17.88 15.38 5.96 18.97 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 12.36 16.24 15.27 12.06 14.29 16.05 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 18.05 11.56 12.71 17.57 10.75 14.60 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 11 3 # 11 A 51 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 108 ASN D 129 ASN.? 9.72 OXT ACT C 201 A 135 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 17.59 4.66 17.88 15.38 5.96 18.97 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 12.36 16.24 15.27 12.06 14.29 16.05 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 18.05 11.56 12.71 17.57 10.75 14.60 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 12 3 # 12 A 51 TYR C 108 TYR^? 12.28 O ACT C 201 A 108 ASN D 112 ASN^? 12.21 O ACT D 201 A 135 ASN C 110 ASN^? 10.92 O ACT D 201 coo 17.59 4.66 17.88 15.38 5.96 18.97 -49.57 50.97 53.11 -51.32 50.02 55.06 coo 12.36 16.24 15.27 12.06 14.29 16.05 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 18.05 11.56 12.71 17.57 10.75 14.60 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 13 3 # 13 A 51 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 108 ASN C 112 ASN^? 12.25 OXT ACT C 201 A 135 ASN C 110 ASN^? 10.92 O ACT D 201 coo 17.59 4.66 17.88 15.38 5.96 18.97 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 12.36 16.24 15.27 12.06 14.29 16.05 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 18.05 11.56 12.71 17.57 10.75 14.60 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 14 3 # 14 A 51 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 108 ASN C 112 ASN^? 12.25 OXT ACT C 201 A 135 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 17.59 4.66 17.88 15.38 5.96 18.97 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 12.36 16.24 15.27 12.06 14.29 16.05 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 18.05 11.56 12.71 17.57 10.75 14.60 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 15 3 # 15 A 51 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 108 ASN C 129 ASN.? 9.72 O ACT D 201 A 135 ASN C 110 ASN^? 10.92 O ACT D 201 coo 17.59 4.66 17.88 15.38 5.96 18.97 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 12.36 16.24 15.27 12.06 14.29 16.05 -47.56 56.76 52.53 -47.22 58.18 50.99 coo 18.05 11.56 12.71 17.57 10.75 14.60 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 16 3 # 16 A 51 TYR D 108 TYR^? 12.28 OXT ACT D 201 A 108 ASN C 112 ASN^? 12.25 OXT ACT C 201 A 135 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 17.59 4.66 17.88 15.38 5.96 18.97 -40.41 63.05 43.73 -38.60 65.12 43.23 coo 12.36 16.24 15.27 12.06 14.29 16.05 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 18.05 11.56 12.71 17.57 10.75 14.60 -44.80 54.88 42.61 -42.77 55.08 41.96 1uy2_p00 source 1uy2 ENDO-1,4-BETA-XYLANASE A : 16 hits 1uy2_p00 naa= 3 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 108 ASN A 112 ASN^? 9.36 O ACT A 202 A 135 ASN A 110 ASN^? 10.87 O ACT B 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 12.22 15.98 15.24 11.94 14.05 16.09 -24.96 67.02 76.01 -26.38 66.67 77.57 coo 17.94 11.43 12.65 17.42 10.61 14.53 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 108 ASN A 112 ASN^? 9.36 O ACT A 202 A 135 ASN B 110 ASN^? 6.46 O ACT A 202 coo 17.50 4.57 17.85 15.28 5.88 18.97 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 12.22 15.98 15.24 11.94 14.05 16.09 -24.96 67.02 76.01 -26.38 66.67 77.57 coo 17.94 11.43 12.65 17.42 10.61 14.53 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 108 ASN B 112 ASN^? 12.13 O ACT B 201 A 135 ASN A 110 ASN^? 10.87 O ACT B 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 12.22 15.98 15.24 11.94 14.05 16.09 -32.04 67.09 81.98 -30.67 67.45 80.39 coo 17.94 11.43 12.65 17.42 10.61 14.53 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 108 ASN B 112 ASN^? 12.13 O ACT B 201 A 135 ASN B 110 ASN^? 6.46 O ACT A 202 coo 17.50 4.57 17.85 15.28 5.88 18.97 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 12.22 15.98 15.24 11.94 14.05 16.09 -32.04 67.09 81.98 -30.67 67.45 80.39 coo 17.94 11.43 12.65 17.42 10.61 14.53 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 5 3 # 5 A 51 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 108 ASN B 129 ASN.? 9.80 OXT ACT A 201 A 135 ASN B 110 ASN^? 6.46 O ACT A 202 coo 17.50 4.57 17.85 15.28 5.88 18.97 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 12.22 15.98 15.24 11.94 14.05 16.09 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 17.94 11.43 12.65 17.42 10.61 14.53 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 6 3 # 6 A 51 TYR A 108 TYR^? 12.28 O ACT A 201 A 108 ASN B 112 ASN^? 12.13 O ACT B 201 A 135 ASN A 110 ASN^? 10.87 O ACT B 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 12.22 15.98 15.24 11.94 14.05 16.09 -32.04 67.09 81.98 -30.67 67.45 80.39 coo 17.94 11.43 12.65 17.42 10.61 14.53 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 7 3 # 7 A 51 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 108 ASN A 112 ASN^? 9.36 O ACT A 202 A 135 ASN A 110 ASN^? 10.87 O ACT B 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 12.22 15.98 15.24 11.94 14.05 16.09 -24.96 67.02 76.01 -26.38 66.67 77.57 coo 17.94 11.43 12.65 17.42 10.61 14.53 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 8 3 # 8 A 51 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 108 ASN A 112 ASN^? 9.36 O ACT A 202 A 135 ASN B 110 ASN^? 6.46 O ACT A 202 coo 17.50 4.57 17.85 15.28 5.88 18.97 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 12.22 15.98 15.24 11.94 14.05 16.09 -24.96 67.02 76.01 -26.38 66.67 77.57 coo 17.94 11.43 12.65 17.42 10.61 14.53 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 9 3 # 9 A 51 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 108 ASN A 129 ASN.? 9.65 O ACT B 201 A 135 ASN A 110 ASN^? 10.87 O ACT B 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 12.22 15.98 15.24 11.94 14.05 16.09 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 17.94 11.43 12.65 17.42 10.61 14.53 -31.91 65.50 76.29 -33.35 65.88 77.83 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 10 3 # 10 A 51 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 108 ASN A 129 ASN.? 9.65 O ACT B 201 A 135 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 12.22 15.98 15.24 11.94 14.05 16.09 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 17.94 11.43 12.65 17.42 10.61 14.53 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 11 3 # 11 A 51 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 108 ASN B 110 ASN^? 6.46 O ACT A 202 A 135 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 12.22 15.98 15.24 11.94 14.05 16.09 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 17.94 11.43 12.65 17.42 10.61 14.53 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 12 3 # 12 A 51 TYR B 108 TYR^? -4.79 O ACT A 202s A 108 ASN A 112 ASN^? 9.36 O ACT A 202 A 135 ASN B 110 ASN^? 6.46 O ACT A 202 coo 17.50 4.57 17.85 15.28 5.88 18.97 -26.20 55.78 72.02 -24.40 54.06 70.73 coo 12.22 15.98 15.24 11.94 14.05 16.09 -24.96 67.02 76.01 -26.38 66.67 77.57 coo 17.94 11.43 12.65 17.42 10.61 14.53 -29.30 63.23 76.74 -27.50 63.37 75.59 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 13 3 # 13 A 51 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 108 ASN C 112 ASN^? 12.25 OXT ACT C 201 A 135 ASN C 110 ASN^? 10.92 O ACT D 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 12.22 15.98 15.24 11.94 14.05 16.09 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 17.94 11.43 12.65 17.42 10.61 14.53 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 14 3 # 14 A 51 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 108 ASN C 112 ASN^? 12.25 OXT ACT C 201 A 135 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 12.22 15.98 15.24 11.94 14.05 16.09 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 17.94 11.43 12.65 17.42 10.61 14.53 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 15 3 # 15 A 51 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 108 ASN D 112 ASN^? 12.21 O ACT D 201 A 135 ASN C 110 ASN^? 10.92 O ACT D 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 12.22 15.98 15.24 11.94 14.05 16.09 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 17.94 11.43 12.65 17.42 10.61 14.53 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 16 3 # 16 A 51 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 108 ASN D 112 ASN^? 12.21 O ACT D 201 A 135 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 12.22 15.98 15.24 11.94 14.05 16.09 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 17.94 11.43 12.65 17.42 10.61 14.53 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 17 3 # 17 A 51 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 108 ASN D 129 ASN.? 9.72 OXT ACT C 201 A 135 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 12.22 15.98 15.24 11.94 14.05 16.09 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 17.94 11.43 12.65 17.42 10.61 14.53 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 18 3 # 18 A 51 TYR C 108 TYR^? 12.28 O ACT C 201 A 108 ASN D 112 ASN^? 12.21 O ACT D 201 A 135 ASN C 110 ASN^? 10.92 O ACT D 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -49.57 50.97 53.11 -51.32 50.02 55.06 coo 12.22 15.98 15.24 11.94 14.05 16.09 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 17.94 11.43 12.65 17.42 10.61 14.53 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 19 3 # 19 A 51 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 108 ASN C 112 ASN^? 12.25 OXT ACT C 201 A 135 ASN C 110 ASN^? 10.92 O ACT D 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 12.22 15.98 15.24 11.94 14.05 16.09 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 17.94 11.43 12.65 17.42 10.61 14.53 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 20 3 # 20 A 51 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 108 ASN C 112 ASN^? 12.25 OXT ACT C 201 A 135 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 12.22 15.98 15.24 11.94 14.05 16.09 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 17.94 11.43 12.65 17.42 10.61 14.53 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 21 3 # 21 A 51 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 108 ASN C 129 ASN.? 9.72 O ACT D 201 A 135 ASN C 110 ASN^? 10.92 O ACT D 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 12.22 15.98 15.24 11.94 14.05 16.09 -47.56 56.76 52.53 -47.22 58.18 50.99 coo 17.94 11.43 12.65 17.42 10.61 14.53 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 22 3 # 22 A 51 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 108 ASN D 112 ASN^? 12.21 O ACT D 201 A 135 ASN C 110 ASN^? 10.92 O ACT D 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 12.22 15.98 15.24 11.94 14.05 16.09 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 17.94 11.43 12.65 17.42 10.61 14.53 -45.77 52.18 44.66 -47.80 51.56 44.77 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 23 3 # 23 A 51 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 108 ASN D 112 ASN^? 12.21 O ACT D 201 A 135 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 12.22 15.98 15.24 11.94 14.05 16.09 -49.94 50.30 41.07 -47.80 50.26 40.97 coo 17.94 11.43 12.65 17.42 10.61 14.53 -44.80 54.88 42.61 -42.77 55.08 41.96 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 24 3 # 24 A 51 TYR D 108 TYR^? 12.28 OXT ACT D 201 A 108 ASN C 112 ASN^? 12.25 OXT ACT C 201 A 135 ASN D 110 ASN^? 10.92 OXT ACT C 201 coo 17.50 4.57 17.85 15.28 5.88 18.97 -40.41 63.05 43.73 -38.60 65.12 43.23 coo 12.22 15.98 15.24 11.94 14.05 16.09 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 17.94 11.43 12.65 17.42 10.61 14.53 -44.80 54.88 42.61 -42.77 55.08 41.96 1uy4_p00 source 1uy4 ENDO-1,4-BETA-XYLANASE A : 24 hits 1uy4_p00 naa= 3 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 1 3 # 1 A 44 ASN A 87 ASN.? 16.46 O ACT A 202 A 213 PRO A 12 PRO.? 20.24 CH3 ACT A 201 A 219 ASN A 112 ASN^? 9.36 O ACT A 202 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -16.21 74.81 76.88 -15.45 72.83 77.10 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -15.84 78.32 74.82 -16.88 80.04 75.76 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -24.96 67.02 76.01 -26.38 66.67 77.57 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 2 3 # 2 A 44 ASN B 87 ASN.? 20.06 CH3 ACT B 201 A 213 PRO B 12 PRO.? 20.40 CH3 ACT B 201 A 219 ASN B 112 ASN^? 12.13 O ACT B 201 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -30.91 71.77 92.72 -32.40 72.79 91.60 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -30.12 69.94 96.26 -27.96 69.60 96.66 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -32.04 67.09 81.98 -30.67 67.45 80.39 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 3 3 # 3 A 44 ASN C 87 ASN.? 20.02 CH3 ACT C 201 A 213 PRO C 12 PRO.? 20.24 CH3 ACT C 201 A 219 ASN C 112 ASN^? 12.25 OXT ACT C 201 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -35.14 45.16 31.53 -35.06 47.21 30.96 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -32.83 41.85 32.29 -34.03 39.98 32.44 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -41.01 51.77 39.43 -43.15 51.81 39.53 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 4 3 # 4 A 44 ASN C 103 ASN.? 7.35 O1 EDO A 301 A 213 PRO A 132 PRO.? 7.89 O1 EDO A 301 A 219 ASN B 50 ASN^? 4.93 O ACT B 201 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -44.48 55.23 67.22 -44.54 56.80 68.65 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -47.06 58.93 67.49 -47.12 61.07 68.10 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -39.13 57.82 80.42 -37.65 56.39 79.89 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 5 3 # 5 A 44 ASN C 103 ASN.? 7.35 O1 EDO A 301 A 213 PRO A 132 PRO.? 7.89 O1 EDO A 301 A 219 ASN B 129 ASN.? 9.80 OXT ACT A 201 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -44.48 55.23 67.22 -44.54 56.80 68.65 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -47.06 58.93 67.49 -47.12 61.07 68.10 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -31.81 57.09 70.18 -32.97 58.85 69.97 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 6 3 # 6 A 44 ASN D 87 ASN.? 20.13 CH3 ACT D 201 A 213 PRO D 12 PRO.? 20.55 CH3 ACT D 201 A 219 ASN D 112 ASN^? 12.21 O ACT D 201 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -56.77 45.04 33.02 -56.64 43.87 34.78 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -59.18 46.59 30.18 -58.18 47.30 28.33 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -49.94 50.30 41.07 -47.80 50.26 40.97 1wbf_p00 source 1wbf PROTEIN (AGGLUTININ) : 6 hits 1wbf_p00 naa= 3 ULMN 4 2cl8_p00 DECTIN-1 user 1 4 # 1 A 145 ARG A 8 ARG.? 15.23 CH3 ACT A 201 A 148 SER A 39 SER~? 14.37 CH3 ACT A 201 A 152 ALA A 61 ALA~? 11.27 OXT ACT A 201 A 194 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -20.16 79.98 64.14 -22.57 80.76 62.41 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -23.46 73.59 59.60 -22.83 73.90 57.26 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -23.47 66.96 59.63 -22.85 67.97 60.60 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 4 2cl8_p00 DECTIN-1 user 2 4 # 2 A 145 ARG B 37 ARG~? 13.57 CH3 ACT B 201 A 148 SER B 39 SER~? 14.17 CH3 ACT B 201 A 152 ALA B 61 ALA~? 11.33 O ACT B 201 A 194 GLU B 59 GLU~? 20.69 O ACT B 201 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -31.32 49.06 94.80 -28.26 48.93 94.55 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -38.00 54.38 92.68 -39.49 53.00 94.02 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -42.38 55.75 87.87 -41.49 56.65 88.72 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -47.90 53.57 92.50 -49.95 53.72 93.03 ULMN 4 2cl8_p00 DECTIN-1 user 3 4 # 3 A 145 ARG C 8 ARG.? 14.74 CH3 ACT C 201 A 148 SER C 39 SER~? 14.22 CH3 ACT C 201 A 152 ALA C 61 ALA~? 11.19 OXT ACT C 201 A 194 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -27.18 40.10 42.21 -27.55 39.63 45.22 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -26.65 46.46 48.19 -24.39 46.43 49.12 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -27.55 53.08 48.63 -27.85 52.13 47.47 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 4 2cl8_p00 DECTIN-1 user 4 4 # 4 A 145 ARG C 37 ARG~? 13.73 CH3 ACT C 201 A 148 SER C 39 SER~? 14.22 CH3 ACT C 201 A 152 ALA C 61 ALA~? 11.19 OXT ACT C 201 A 194 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -28.52 38.86 52.29 -30.70 36.70 52.27 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -26.65 46.46 48.19 -24.39 46.43 49.12 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -27.55 53.08 48.63 -27.85 52.13 47.47 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 4 2cl8_p00 DECTIN-1 user 5 4 # 5 A 145 ARG D 8 ARG.? 14.56 CH3 ACT D 201 A 148 SER D 39 SER~? 14.16 CH3 ACT D 201 A 152 ALA D 61 ALA~? 11.20 O ACT D 201 A 194 GLU D 59 GLU~? 18.52 O ACT D 201 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -64.40 57.42 32.12 -63.44 60.33 32.35 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -63.83 60.97 39.81 -65.97 62.00 40.33 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -62.57 59.32 46.16 -62.47 58.52 44.86 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -69.73 60.64 47.66 -70.08 62.16 46.23 ULMN 4 2cl8_p00 DECTIN-1 user 6 4 # 6 A 145 ARG D 37 ARG~? 13.59 CH3 ACT D 201 A 148 SER D 39 SER~? 14.16 CH3 ACT D 201 A 152 ALA D 61 ALA~? 11.20 O ACT D 201 A 194 GLU D 59 GLU~? 18.52 O ACT D 201 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -62.21 67.18 33.74 -60.13 67.79 31.56 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -63.83 60.97 39.81 -65.97 62.00 40.33 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -62.57 59.32 46.16 -62.47 58.52 44.86 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -69.73 60.64 47.66 -70.08 62.16 46.23 2cl8_p00 source 2cl8 DECTIN-1 : 6 hits 2cl8_p00 naa= 4 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 1 4 # 1 A 87 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 184 TYR C 95 TYR^? -3.84 O ACT C 201s A 400 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 416 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.32 21.89 76.95 -2.29 21.43 77.55 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -13.84 24.02 81.30 -13.39 23.42 78.61 -41.63 48.44 55.51 -40.56 51.04 55.32 coo -2.45 25.99 82.19 -2.93 24.57 79.52 -39.28 57.54 52.97 -41.40 56.18 54.75 coo -5.39 20.15 83.91 -5.94 21.73 82.59 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 2 4 # 2 A 87 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 184 TYR C 108 TYR^? 12.28 O ACT C 201 A 400 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 416 ASP C 130 ASP.? 4.74 O2 EDO A 301 coo -0.32 21.89 76.95 -2.29 21.43 77.55 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -13.84 24.02 81.30 -13.39 23.42 78.61 -49.57 50.97 53.11 -51.32 50.02 55.06 coo -2.45 25.99 82.19 -2.93 24.57 79.52 -39.28 57.54 52.97 -41.40 56.18 54.75 coo -5.39 20.15 83.91 -5.94 21.73 82.59 -45.39 56.07 57.68 -43.60 56.21 56.54 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 3 4 # 3 A 87 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 184 TYR B 108 TYR^? -4.79 O ACT A 202s A 400 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 416 ASP C 100 ASP.? 9.05 C1 EDO A 301 coo -0.32 21.89 76.95 -2.29 21.43 77.55 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -13.84 24.02 81.30 -13.39 23.42 78.61 -26.20 55.78 72.02 -24.40 54.06 70.73 coo -2.45 25.99 82.19 -2.93 24.57 79.52 -33.46 60.54 65.68 -36.32 61.50 66.33 coo -5.39 20.15 83.91 -5.94 21.73 82.59 -35.91 53.92 69.56 -35.19 55.74 68.76 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 4 4 # 4 A 87 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 184 TYR A 95 TYR^? -3.85 O ACT A 201s A 400 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 416 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.32 21.89 76.95 -2.29 21.43 77.55 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -13.84 24.02 81.30 -13.39 23.42 78.61 -38.20 69.00 66.47 -37.00 66.61 65.61 coo -2.45 25.99 82.19 -2.93 24.57 79.52 -33.46 60.54 65.68 -36.32 61.50 66.33 coo -5.39 20.15 83.91 -5.94 21.73 82.59 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 5 4 # 5 A 87 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 184 TYR A 108 TYR^? 12.28 O ACT A 201 A 400 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 416 ASP A 130 ASP.? 4.80 O1 EDO A 301 coo -0.32 21.89 76.95 -2.29 21.43 77.55 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -13.84 24.02 81.30 -13.39 23.42 78.61 -40.87 65.49 73.93 -43.61 66.01 74.07 coo -2.45 25.99 82.19 -2.93 24.57 79.52 -33.46 60.54 65.68 -36.32 61.50 66.33 coo -5.39 20.15 83.91 -5.94 21.73 82.59 -41.07 60.81 67.56 -39.08 61.04 66.87 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 6 4 # 6 A 87 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 184 TYR D 108 TYR^? 12.28 OXT ACT D 201 A 400 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 416 ASP A 100 ASP.? 9.07 O2 EDO A 301 coo -0.32 21.89 76.95 -2.29 21.43 77.55 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -13.84 24.02 81.30 -13.39 23.42 78.61 -40.41 63.05 43.73 -38.60 65.12 43.23 coo -2.45 25.99 82.19 -2.93 24.57 79.52 -39.28 57.54 52.97 -41.40 56.18 54.75 coo -5.39 20.15 83.91 -5.94 21.73 82.59 -44.77 63.42 52.85 -43.43 61.81 52.77 2g3n_p00 source 2g3n ALPHA-GLUCOSIDASE : 6 hits 2g3n_p00 naa= 4 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 49 ARG^? -3.92 O ACT A 202s A 188 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 190 SER B 107 SER^? 7.39 OXT ACT B 201 coo 37.69 7.64 13.51 38.82 8.84 16.11 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 47.14 12.10 13.73 48.75 12.33 16.01 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 43.77 6.93 15.46 45.49 7.21 17.11 -29.25 52.59 73.85 -31.29 51.35 74.31 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG A 49 ARG^? -3.92 O ACT A 202s A 188 TYR B 95 TYR^? -3.87 OXT ACT B 201s A 190 SER B 107 SER^? 7.39 OXT ACT B 201 coo 37.69 7.64 13.51 38.82 8.84 16.11 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 47.14 12.10 13.73 48.75 12.33 16.01 -29.40 51.18 78.64 -32.01 51.78 77.83 coo 43.77 6.93 15.46 45.49 7.21 17.11 -29.25 52.59 73.85 -31.29 51.35 74.31 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 188 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 190 SER A 107 SER^? 6.74 O1 EDO A 301 coo 37.69 7.64 13.51 38.82 8.84 16.11 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 47.14 12.10 13.73 48.75 12.33 16.01 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 43.77 6.93 15.46 45.49 7.21 17.11 -40.35 65.45 69.21 -39.92 64.63 66.96 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG B 49 ARG^? 10.37 O ACT B 201 A 188 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 190 SER A 107 SER^? 6.74 O1 EDO A 301 coo 37.69 7.64 13.51 38.82 8.84 16.11 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 47.14 12.10 13.73 48.75 12.33 16.01 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 43.77 6.93 15.46 45.49 7.21 17.11 -40.35 65.45 69.21 -39.92 64.63 66.96 ULMN 3 2p3i_p00 VP4 user 5 3 # 5 A 101 ARG B 49 ARG^? 10.37 O ACT B 201 A 188 TYR A 95 TYR^? -3.85 O ACT A 201s A 190 SER A 107 SER^? 6.74 O1 EDO A 301 coo 37.69 7.64 13.51 38.82 8.84 16.11 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 47.14 12.10 13.73 48.75 12.33 16.01 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 43.77 6.93 15.46 45.49 7.21 17.11 -40.35 65.45 69.21 -39.92 64.63 66.96 ULMN 3 2p3i_p00 VP4 user 6 3 # 6 A 101 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 188 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 190 SER B 107 SER^? 7.39 OXT ACT B 201 coo 37.69 7.64 13.51 38.82 8.84 16.11 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 47.14 12.10 13.73 48.75 12.33 16.01 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 43.77 6.93 15.46 45.49 7.21 17.11 -29.25 52.59 73.85 -31.29 51.35 74.31 ULMN 3 2p3i_p00 VP4 user 7 3 # 7 A 101 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 188 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 190 SER D 107 SER^? 7.30 OXT ACT D 201 coo 37.69 7.64 13.51 38.82 8.84 16.11 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 47.14 12.10 13.73 48.75 12.33 16.01 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 43.77 6.93 15.46 45.49 7.21 17.11 -44.25 65.54 45.21 -46.11 66.36 46.55 ULMN 3 2p3i_p00 VP4 user 8 3 # 8 A 101 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 188 TYR D 95 TYR^? -3.79 OXT ACT D 201s A 190 SER D 107 SER^? 7.30 OXT ACT D 201 coo 37.69 7.64 13.51 38.82 8.84 16.11 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 47.14 12.10 13.73 48.75 12.33 16.01 -48.26 66.56 42.41 -49.21 65.61 44.87 coo 43.77 6.93 15.46 45.49 7.21 17.11 -44.25 65.54 45.21 -46.11 66.36 46.55 ULMN 3 2p3i_p00 VP4 user 9 3 # 9 A 101 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 188 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 190 SER C 107 SER^? 6.74 O2 EDO A 301 coo 37.69 7.64 13.51 38.82 8.84 16.11 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 47.14 12.10 13.73 48.75 12.33 16.01 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 43.77 6.93 15.46 45.49 7.21 17.11 -45.59 51.52 55.69 -43.69 52.48 56.86 ULMN 3 2p3i_p00 VP4 user 10 3 # 10 A 101 ARG D 49 ARG^? 10.44 O ACT D 201 A 188 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 190 SER C 107 SER^? 6.74 O2 EDO A 301 coo 37.69 7.64 13.51 38.82 8.84 16.11 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 47.14 12.10 13.73 48.75 12.33 16.01 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 43.77 6.93 15.46 45.49 7.21 17.11 -45.59 51.52 55.69 -43.69 52.48 56.86 ULMN 3 2p3i_p00 VP4 user 11 3 # 11 A 101 ARG D 49 ARG^? 10.44 O ACT D 201 A 188 TYR C 95 TYR^? -3.84 O ACT C 201s A 190 SER C 107 SER^? 6.74 O2 EDO A 301 coo 37.69 7.64 13.51 38.82 8.84 16.11 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 47.14 12.10 13.73 48.75 12.33 16.01 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 43.77 6.93 15.46 45.49 7.21 17.11 -45.59 51.52 55.69 -43.69 52.48 56.86 ULMN 3 2p3i_p00 VP4 user 12 3 # 12 A 101 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 188 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 190 SER D 107 SER^? 7.30 OXT ACT D 201 coo 37.69 7.64 13.51 38.82 8.84 16.11 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 47.14 12.10 13.73 48.75 12.33 16.01 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 43.77 6.93 15.46 45.49 7.21 17.11 -44.25 65.54 45.21 -46.11 66.36 46.55 2p3i_p00 source 2p3i VP4 : 12 hits 2p3i_p00 naa= 3 ULMN 4 2p3k_p00 VP4 user 1 4 # 1 A 101 ARG A 49 ARG^? -3.92 O ACT A 202s A 187 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 188 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 190 SER B 107 SER^? 7.39 OXT ACT B 201 coo 37.00 7.53 13.18 38.22 8.80 15.70 -25.12 58.31 69.83 -26.93 60.25 71.40 coo 45.42 16.25 11.76 45.82 18.39 15.98 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 46.58 11.94 13.55 48.24 12.22 15.76 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 43.09 6.80 15.14 44.84 7.11 16.79 -29.25 52.59 73.85 -31.29 51.35 74.31 ULMN 4 2p3k_p00 VP4 user 2 4 # 2 A 101 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 187 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 188 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 190 SER A 107 SER^? 6.74 O1 EDO A 301 coo 37.00 7.53 13.18 38.22 8.80 15.70 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 45.42 16.25 11.76 45.82 18.39 15.98 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 46.58 11.94 13.55 48.24 12.22 15.76 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 43.09 6.80 15.14 44.84 7.11 16.79 -40.35 65.45 69.21 -39.92 64.63 66.96 ULMN 4 2p3k_p00 VP4 user 3 4 # 3 A 101 ARG B 49 ARG^? 10.37 O ACT B 201 A 187 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 188 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 190 SER A 107 SER^? 6.74 O1 EDO A 301 coo 37.00 7.53 13.18 38.22 8.80 15.70 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 45.42 16.25 11.76 45.82 18.39 15.98 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 46.58 11.94 13.55 48.24 12.22 15.76 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 43.09 6.80 15.14 44.84 7.11 16.79 -40.35 65.45 69.21 -39.92 64.63 66.96 ULMN 4 2p3k_p00 VP4 user 4 4 # 4 A 101 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 187 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 188 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 190 SER B 107 SER^? 7.39 OXT ACT B 201 coo 37.00 7.53 13.18 38.22 8.80 15.70 -23.54 51.33 72.85 -22.07 49.40 71.00 coo 45.42 16.25 11.76 45.82 18.39 15.98 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 46.58 11.94 13.55 48.24 12.22 15.76 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 43.09 6.80 15.14 44.84 7.11 16.79 -29.25 52.59 73.85 -31.29 51.35 74.31 ULMN 4 2p3k_p00 VP4 user 5 4 # 5 A 101 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 187 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 188 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 190 SER D 107 SER^? 7.30 OXT ACT D 201 coo 37.00 7.53 13.18 38.22 8.80 15.70 -37.64 60.68 44.02 -39.72 58.44 44.33 coo 45.42 16.25 11.76 45.82 18.39 15.98 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 46.58 11.94 13.55 48.24 12.22 15.76 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 43.09 6.80 15.14 44.84 7.11 16.79 -44.25 65.54 45.21 -46.11 66.36 46.55 ULMN 4 2p3k_p00 VP4 user 6 4 # 6 A 101 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 187 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 188 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 190 SER C 107 SER^? 6.74 O2 EDO A 301 coo 37.00 7.53 13.18 38.22 8.80 15.70 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 45.42 16.25 11.76 45.82 18.39 15.98 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 46.58 11.94 13.55 48.24 12.22 15.76 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 43.09 6.80 15.14 44.84 7.11 16.79 -45.59 51.52 55.69 -43.69 52.48 56.86 ULMN 4 2p3k_p00 VP4 user 7 4 # 7 A 101 ARG D 49 ARG^? 10.44 O ACT D 201 A 187 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 188 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 190 SER C 107 SER^? 6.74 O2 EDO A 301 coo 37.00 7.53 13.18 38.22 8.80 15.70 -52.37 52.11 51.12 -50.46 52.95 48.87 coo 45.42 16.25 11.76 45.82 18.39 15.98 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 46.58 11.94 13.55 48.24 12.22 15.76 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 43.09 6.80 15.14 44.84 7.11 16.79 -45.59 51.52 55.69 -43.69 52.48 56.86 ULMN 4 2p3k_p00 VP4 user 8 4 # 8 A 101 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 187 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 188 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 190 SER D 107 SER^? 7.30 OXT ACT D 201 coo 37.00 7.53 13.18 38.22 8.80 15.70 -40.22 67.90 41.60 -38.15 70.12 41.98 coo 45.42 16.25 11.76 45.82 18.39 15.98 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 46.58 11.94 13.55 48.24 12.22 15.76 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 43.09 6.80 15.14 44.84 7.11 16.79 -44.25 65.54 45.21 -46.11 66.36 46.55 2p3k_p00 source 2p3k VP4 : 8 hits 2p3k_p00 naa= 4 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 50 ASN^? 5.02 OXT ACT A 201 A 384 ASN C 57 ASN~? 18.23 OXT ACT C 201 A 385 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 -28.17 63.14 65.41 -30.17 63.83 65.25 coo 7.06 50.07 96.17 8.50 48.54 96.31 -22.76 55.02 43.39 -22.13 56.21 45.03 coo 11.59 49.83 99.41 10.92 47.97 100.16 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 50 ASN^? 5.02 OXT ACT A 201 A 384 ASN C 57 ASN~? 18.23 OXT ACT C 201 A 385 GLU C 60 GLU~? 17.22 OXT ACT C 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -28.17 63.14 65.41 -30.17 63.83 65.25 coo 7.06 50.07 96.17 8.50 48.54 96.31 -22.76 55.02 43.39 -22.13 56.21 45.03 coo 11.59 49.83 99.41 10.92 47.97 100.16 -23.89 57.63 47.43 -24.47 59.50 46.62 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 57 ASN~? 14.18 O1 EDO A 302 A 384 ASN A 110 ASN^? 10.87 O ACT B 201 A 385 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -16.25 65.99 58.99 -17.06 64.89 57.36 coo 7.06 50.07 96.17 8.50 48.54 96.31 -31.91 65.50 76.29 -33.35 65.88 77.83 coo 11.59 49.83 99.41 10.92 47.97 100.16 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN A 57 ASN~? 14.18 O1 EDO A 302 A 384 ASN C 50 ASN^? 4.97 OXT ACT C 201 A 385 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -16.25 65.99 58.99 -17.06 64.89 57.36 coo 7.06 50.07 96.17 8.50 48.54 96.31 -35.45 55.77 48.86 -36.44 54.81 50.47 coo 11.59 49.83 99.41 10.92 47.97 100.16 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN A 87 ASN.? 16.46 O ACT A 202 A 384 ASN A 31 ASN~? 8.53 CH3 ACT A 201 A 385 GLU A 27 GLU~? 9.74 CH3 ACT A 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -16.21 74.81 76.88 -15.45 72.83 77.10 coo 7.06 50.07 96.17 8.50 48.54 96.31 -36.15 78.19 63.69 -37.32 77.26 65.21 coo 11.59 49.83 99.41 10.92 47.97 100.16 -34.88 77.89 68.90 -36.12 78.93 70.26 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN A 103 ASN.? 7.23 O2 EDO A 301 A 384 ASN C 112 ASN^? 12.25 OXT ACT C 201 A 385 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -48.04 61.08 60.88 -48.95 59.43 59.91 coo 7.06 50.07 96.17 8.50 48.54 96.31 -41.01 51.77 39.43 -43.15 51.81 39.53 coo 11.59 49.83 99.41 10.92 47.97 100.16 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN A 103 ASN.? 7.23 O2 EDO A 301 A 384 ASN D 57 ASN~? 18.22 O ACT D 201 A 385 GLU D 60 GLU~? 17.31 O ACT D 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -48.04 61.08 60.88 -48.95 59.43 59.91 coo 7.06 50.07 96.17 8.50 48.54 96.31 -67.77 54.18 46.88 -68.13 55.47 48.54 coo 11.59 49.83 99.41 10.92 47.97 100.16 -66.09 57.03 50.37 -65.56 55.61 51.84 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 8 3 # 8 A 270 ASN A 129 ASN.? 9.65 O ACT B 201 A 384 ASN B 87 ASN.? 20.06 CH3 ACT B 201 A 385 GLU B 114 GLU^? 18.04 O ACT B 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -38.33 60.18 72.42 -36.71 58.96 73.06 coo 7.06 50.07 96.17 8.50 48.54 96.31 -30.91 71.77 92.72 -32.40 72.79 91.60 coo 11.59 49.83 99.41 10.92 47.97 100.16 -34.74 70.41 89.54 -36.11 71.74 88.69 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 9 3 # 9 A 270 ASN B 57 ASN~? 18.11 O ACT B 201 A 384 ASN B 110 ASN^? 6.46 O ACT A 202 A 385 GLU B 111 GLU^? 4.46 CH3 ACT B 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -46.90 59.98 91.63 -48.14 58.47 90.79 coo 7.06 50.07 96.17 8.50 48.54 96.31 -29.30 63.23 76.74 -27.50 63.37 75.59 coo 11.59 49.83 99.41 10.92 47.97 100.16 -29.98 61.01 82.70 -30.12 59.10 83.58 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 10 3 # 10 A 270 ASN B 87 ASN.? 20.06 CH3 ACT B 201 A 384 ASN B 31 ASN~? 8.56 CH3 ACT B 201 A 385 GLU B 27 GLU~? 9.83 CH3 ACT B 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -30.91 71.77 92.72 -32.40 72.79 91.60 coo 7.06 50.07 96.17 8.50 48.54 96.31 -26.33 48.60 87.43 -25.42 49.22 85.60 coo 11.59 49.83 99.41 10.92 47.97 100.16 -24.11 53.46 86.45 -22.04 53.54 86.08 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 11 3 # 11 A 270 ASN B 129 ASN.? 9.80 OXT ACT A 201 A 384 ASN A 87 ASN.? 16.46 O ACT A 202 A 385 GLU A 114 GLU^? 11.87 CH3 ACT A 202 coo 22.28 63.17 110.61 22.47 65.06 111.53 -31.81 57.09 70.18 -32.97 58.85 69.97 coo 7.06 50.07 96.17 8.50 48.54 96.31 -16.21 74.81 76.88 -15.45 72.83 77.10 coo 11.59 49.83 99.41 10.92 47.97 100.16 -17.01 70.06 74.63 -16.05 68.26 75.13 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 12 3 # 12 A 270 ASN C 31 ASN~? 8.68 CH3 ACT C 201 A 384 ASN C 57 ASN~? 18.23 OXT ACT C 201 A 385 GLU C 59 GLU~? 13.48 O2 EDO A 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 -36.93 39.85 55.08 -38.97 40.48 55.12 coo 7.06 50.07 96.17 8.50 48.54 96.31 -22.76 55.02 43.39 -22.13 56.21 45.03 coo 11.59 49.83 99.41 10.92 47.97 100.16 -20.25 53.72 49.66 -20.40 52.10 51.04 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 13 3 # 13 A 270 ASN C 50 ASN^? 4.97 OXT ACT C 201 A 384 ASN A 57 ASN~? 14.18 O1 EDO A 302 A 385 GLU A 59 GLU~? 18.41 O2 EDO A 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 -35.45 55.77 48.86 -36.44 54.81 50.47 coo 7.06 50.07 96.17 8.50 48.54 96.31 -16.25 65.99 58.99 -17.06 64.89 57.36 coo 11.59 49.83 99.41 10.92 47.97 100.16 -19.57 66.85 53.38 -18.14 66.20 51.96 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 14 3 # 14 A 270 ASN C 50 ASN^? 4.97 OXT ACT C 201 A 384 ASN A 57 ASN~? 14.18 O1 EDO A 302 A 385 GLU A 60 GLU~? 10.63 O2 EDO A 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 -35.45 55.77 48.86 -36.44 54.81 50.47 coo 7.06 50.07 96.17 8.50 48.54 96.31 -16.25 65.99 58.99 -17.06 64.89 57.36 coo 11.59 49.83 99.41 10.92 47.97 100.16 -19.73 62.99 57.19 -19.03 61.21 58.09 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 15 3 # 15 A 270 ASN C 57 ASN~? 18.23 OXT ACT C 201 A 384 ASN A 50 ASN^? 5.02 OXT ACT A 201 A 385 GLU A 53 GLU^? 10.41 O2 EDO A 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 -22.76 55.02 43.39 -22.13 56.21 45.03 coo 7.06 50.07 96.17 8.50 48.54 96.31 -28.17 63.14 65.41 -30.17 63.83 65.25 coo 11.59 49.83 99.41 10.92 47.97 100.16 -26.96 59.20 61.32 -28.18 60.32 59.98 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 16 3 # 16 A 270 ASN C 57 ASN~? 18.23 OXT ACT C 201 A 384 ASN C 110 ASN^? 10.92 O ACT D 201 A 385 GLU C 111 GLU^? 4.32 CH3 ACT C 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -22.76 55.02 43.39 -22.13 56.21 45.03 coo 7.06 50.07 96.17 8.50 48.54 96.31 -45.77 52.18 44.66 -47.80 51.56 44.77 coo 11.59 49.83 99.41 10.92 47.97 100.16 -40.57 48.44 44.93 -39.46 47.54 46.50 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 17 3 # 17 A 270 ASN C 87 ASN.? 20.02 CH3 ACT C 201 A 384 ASN C 31 ASN~? 8.68 CH3 ACT C 201 A 385 GLU C 27 GLU~? 9.88 CH3 ACT C 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -35.14 45.16 31.53 -35.06 47.21 30.96 coo 7.06 50.07 96.17 8.50 48.54 96.31 -36.93 39.85 55.08 -38.97 40.48 55.12 coo 11.59 49.83 99.41 10.92 47.97 100.16 -40.23 39.97 50.79 -41.89 38.66 50.83 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 18 3 # 18 A 270 ASN C 103 ASN.? 7.35 O1 EDO A 301 A 384 ASN A 112 ASN^? 9.36 O ACT A 202 A 385 GLU A 111 GLU^? 4.34 CH3 ACT A 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -44.48 55.23 67.22 -44.54 56.80 68.65 coo 7.06 50.07 96.17 8.50 48.54 96.31 -24.96 67.02 76.01 -26.38 66.67 77.57 coo 11.59 49.83 99.41 10.92 47.97 100.16 -29.42 69.91 72.34 -30.01 70.85 70.54 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 19 3 # 19 A 270 ASN C 103 ASN.? 7.35 O1 EDO A 301 A 384 ASN B 57 ASN~? 18.11 O ACT B 201 A 385 GLU B 60 GLU~? 17.33 O ACT B 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -44.48 55.23 67.22 -44.54 56.80 68.65 coo 7.06 50.07 96.17 8.50 48.54 96.31 -46.90 59.98 91.63 -48.14 58.47 90.79 coo 11.59 49.83 99.41 10.92 47.97 100.16 -48.17 57.12 87.93 -49.17 58.57 86.76 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 20 3 # 20 A 270 ASN C 129 ASN.? 9.72 O ACT D 201 A 384 ASN D 87 ASN.? 20.13 CH3 ACT D 201 A 385 GLU D 114 GLU^? 18.05 O ACT D 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -47.56 56.76 52.53 -47.22 58.18 50.99 coo 7.06 50.07 96.17 8.50 48.54 96.31 -56.77 45.04 33.02 -56.64 43.87 34.78 coo 11.59 49.83 99.41 10.92 47.97 100.16 -56.92 45.97 38.27 -56.84 44.55 39.82 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 21 3 # 21 A 270 ASN D 31 ASN~? 8.51 CH3 ACT D 201 A 384 ASN D 57 ASN~? 18.22 O ACT D 201 A 385 GLU D 59 GLU~? 18.52 O ACT D 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -53.58 68.96 34.68 -51.50 68.66 35.10 coo 7.06 50.07 96.17 8.50 48.54 96.31 -67.77 54.18 46.88 -68.13 55.47 48.54 coo 11.59 49.83 99.41 10.92 47.97 100.16 -69.73 60.64 47.66 -70.08 62.16 46.23 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 22 3 # 22 A 270 ASN D 57 ASN~? 18.22 O ACT D 201 A 384 ASN D 110 ASN^? 10.92 OXT ACT C 201 A 385 GLU D 111 GLU^? 4.46 CH3 ACT D 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -67.77 54.18 46.88 -68.13 55.47 48.54 coo 7.06 50.07 96.17 8.50 48.54 96.31 -44.80 54.88 42.61 -42.77 55.08 41.96 coo 11.59 49.83 99.41 10.92 47.97 100.16 -50.16 56.56 39.52 -51.23 58.35 39.21 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 23 3 # 23 A 270 ASN D 87 ASN.? 20.13 CH3 ACT D 201 A 384 ASN D 31 ASN~? 8.51 CH3 ACT D 201 A 385 GLU D 27 GLU~? 9.75 CH3 ACT D 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -56.77 45.04 33.02 -56.64 43.87 34.78 coo 7.06 50.07 96.17 8.50 48.54 96.31 -53.58 68.96 34.68 -51.50 68.66 35.10 coo 11.59 49.83 99.41 10.92 47.97 100.16 -50.66 64.65 33.24 -49.08 64.98 31.89 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 24 3 # 24 A 270 ASN D 103 ASN.? 11.64 CH3 ACT A 203 A 384 ASN C 50 ASN^? 4.97 OXT ACT C 201 A 385 GLU C 53 GLU^? 11.18 OXT ACT C 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -43.97 76.72 52.03 -43.49 78.26 53.43 coo 7.06 50.07 96.17 8.50 48.54 96.31 -35.45 55.77 48.86 -36.44 54.81 50.47 coo 11.59 49.83 99.41 10.92 47.97 100.16 -32.08 60.14 50.84 -31.64 58.95 52.54 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 25 3 # 25 A 270 ASN D 129 ASN.? 9.72 OXT ACT C 201 A 384 ASN C 87 ASN.? 20.02 CH3 ACT C 201 A 385 GLU C 114 GLU^? 18.18 OXT ACT C 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 -42.23 60.94 49.15 -42.50 59.01 49.99 coo 7.06 50.07 96.17 8.50 48.54 96.31 -35.14 45.16 31.53 -35.06 47.21 30.96 coo 11.59 49.83 99.41 10.92 47.97 100.16 -34.62 49.81 33.93 -34.65 51.69 32.98 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 25 hits 2v3r_p00 naa= 3 ULMN 4 2v73_p00 PUTATIVE EXO-ALPHA-SIALIDASE user 1 4 # 1 A 79 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 81 ARG A 123 ARG.? 8.27 CH3 ACT A 202 A 151 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 156 ASN A 112 ASN^? 9.36 O ACT A 202 coo 25.74 5.61 48.63 24.52 5.15 50.30 -17.96 60.58 68.89 -19.86 60.60 67.97 coo 27.07 3.11 52.61 25.23 3.35 55.08 -16.75 65.40 71.93 -16.81 64.50 74.86 coo 21.76 -2.20 51.78 21.90 0.24 53.63 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 16.67 0.72 52.58 15.80 1.51 50.78 -24.96 67.02 76.01 -26.38 66.67 77.57 2v73_p00 source 2v73 PUTATIVE EXO-ALPHA-SIALIDASE : 1 hits 2v73_p00 naa= 4 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 88 ARG^? 11.13 CH3 ACT A 202 B 6 THR A 85 THR^? 18.12 O ACT A 202 B 8 THR A 15 THR~? 22.99 CH3 ACT A 201 coo 40.52 16.08 100.90 37.97 16.41 102.60 -18.98 69.22 79.04 -17.48 66.59 79.46 coo 36.11 13.64 95.03 34.54 14.86 95.91 -20.41 74.13 82.96 -20.15 72.63 84.47 coo 32.72 8.05 92.39 31.25 9.11 91.35 -22.30 82.34 82.17 -21.83 84.42 81.76 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG B 88 ARG^? 18.43 CH3 ACT A 201 B 6 THR B 85 THR^? 21.07 CH3 ACT A 201 B 8 THR B 15 THR~? 23.10 CH3 ACT B 201 coo 40.52 16.08 100.90 37.97 16.41 102.60 -31.74 72.75 86.26 -33.87 74.56 85.05 coo 36.11 13.64 95.03 34.54 14.86 95.91 -25.62 73.78 87.96 -25.78 75.31 86.43 coo 32.72 8.05 92.39 31.25 9.11 91.35 -19.99 70.45 93.36 -19.15 70.03 95.31 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG C 88 ARG^? 18.42 CH3 ACT D 201 B 6 THR C 85 THR^? 21.04 CH3 ACT D 201 B 8 THR C 15 THR~? 22.98 CH3 ACT C 201 coo 40.52 16.08 100.90 37.97 16.41 102.60 -39.31 50.22 32.74 -39.14 52.99 31.45 coo 36.11 13.64 95.03 34.54 14.86 95.91 -42.53 44.93 30.94 -43.76 46.38 29.94 coo 32.72 8.05 92.39 31.25 9.11 91.35 -42.08 36.63 32.38 -41.24 34.66 32.12 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG D 88 ARG^? 18.35 CH3 ACT C 201 B 6 THR D 85 THR^? 21.00 CH3 ACT C 201 B 8 THR D 15 THR~? 23.13 CH3 ACT D 201 coo 40.52 16.08 100.90 37.97 16.41 102.60 -52.23 44.53 37.75 -52.43 42.56 40.08 coo 36.11 13.64 95.03 34.54 14.86 95.91 -49.55 44.27 31.82 -48.24 42.86 32.81 coo 32.72 8.05 92.39 31.25 9.11 91.35 -50.62 48.08 24.29 -51.63 48.51 22.43 1b01_d00 source 1b01 GENE REGULATION/DNA : 4 hits 1b01_d00 naa= 3 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN A 47 GLN^? 9.90 O1 EDO A 302 A 11 ASN A 57 ASN~? 14.18 O1 EDO A 302 A 13 ARG A 58 ARG~? 18.13 CH3 ACT A 201 coo 33.45 2.10 7.21 34.51 1.09 5.67 -15.92 64.14 66.68 -15.70 62.99 64.91 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -16.25 65.99 58.99 -17.06 64.89 57.36 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -18.95 73.08 58.27 -17.11 75.32 59.26 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 2 3 # 2 A 9 GLN B 47 GLN^? 17.37 O ACT B 201 A 11 ASN B 57 ASN~? 18.11 O ACT B 201 A 13 ARG B 58 ARG~? 17.86 CH3 ACT B 201 coo 33.45 2.10 7.21 34.51 1.09 5.67 -43.79 66.33 88.09 -45.65 65.30 88.17 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -46.90 59.98 91.63 -48.14 58.47 90.79 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -41.40 56.24 95.43 -40.17 57.59 97.88 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 3 3 # 3 A 9 GLN C 47 GLN^? 17.31 OXT ACT C 201 A 11 ASN C 57 ASN~? 18.23 OXT ACT C 201 A 13 ARG C 58 ARG~? 18.03 CH3 ACT C 201 coo 33.45 2.10 7.21 34.51 1.09 5.67 -28.71 56.50 38.57 -27.41 57.79 39.66 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -22.76 55.02 43.39 -22.13 56.21 45.03 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -22.97 47.67 45.60 -22.11 45.78 43.37 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 4 3 # 4 A 9 GLN D 47 GLN^? 17.53 O ACT D 201 A 11 ASN D 57 ASN~? 18.22 O ACT D 201 A 13 ARG D 58 ARG~? 18.01 CH3 ACT D 201 coo 33.45 2.10 7.21 34.51 1.09 5.67 -62.04 48.65 46.19 -63.34 49.20 47.78 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -67.77 54.18 46.88 -68.13 55.47 48.54 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -67.82 58.42 40.52 -68.76 57.03 37.97 1bdv_d00 source 1bdv GENE REGULATION/DNA : 4 hits 1bdv_d00 naa= 3 ULMN 4 1cf7_d01 TRANSCRIPTION/DNA user 1 4 # 1 B 118 ASN B 112 ASN^? 12.13 O ACT B 201 B 121 ARG B 49 ARG^? 10.37 O ACT B 201 B 122 ARG A 92 ARG^? 14.09 CH3 ACT A 201 B 124 TYR A 108 TYR^? 12.28 O ACT A 201 coo 43.23 33.97 15.91 42.50 32.05 15.39 -32.04 67.09 81.98 -30.67 67.45 80.39 coo 34.72 34.23 15.94 33.05 32.00 17.31 -40.89 64.28 77.45 -37.86 63.79 77.23 coo 39.23 30.42 19.06 37.28 30.09 16.76 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 32.79 36.91 20.45 33.09 39.73 20.13 -40.87 65.49 73.93 -43.61 66.01 74.07 1cf7_d01 source 1cf7 TRANSCRIPTION/DNA : 1 hits 1cf7_d01 naa= 4 ULMN 4 1dsz_d00 TRANSCRIPTION/DNA user 1 4 # 1 A1153 GLU A 160 GLU.? 13.50 O ACT A 201 A1156 LYS A 139 LYS.? 17.81 O ACT A 201 A1160 ARG A 76 ARG^? 8.97 OXT ACT A 203 A1161 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo 24.91 6.66 1.99 23.65 5.59 0.65 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 18.15 8.28 2.24 21.63 3.94 -0.54 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 15.01 1.75 1.61 16.32 0.90 4.30 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 14.98 2.34 8.97 17.45 4.34 8.92 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 4 1dsz_d00 TRANSCRIPTION/DNA user 2 4 # 2 A1153 GLU A 160 GLU.? 13.50 O ACT A 201 A1156 LYS A 139 LYS.? 17.81 O ACT A 201 A1160 ARG A 138 ARG~? 6.49 OXT ACT A 203 A1161 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo 24.91 6.66 1.99 23.65 5.59 0.65 -45.30 71.21 75.74 -44.17 71.89 74.09 coo 18.15 8.28 2.24 21.63 3.94 -0.54 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 15.01 1.75 1.61 16.32 0.90 4.30 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 14.98 2.34 8.97 17.45 4.34 8.92 -44.10 76.39 63.96 -45.67 76.44 61.31 1dsz_d00 source 1dsz TRANSCRIPTION/DNA : 2 hits 1dsz_d00 naa= 4 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 10 PRO.? 17.95 CH3 ACT A 201 A 272 LEU A 25 LEU~? 14.11 CH3 ACT A 201 A 276 ARG A 8 ARG.? 15.23 CH3 ACT A 201 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -23.21 84.05 73.34 -21.34 83.73 72.18 coo 10.97 0.43 16.73 11.31 2.11 18.06 -27.50 82.26 68.63 -26.98 84.36 68.67 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -20.16 79.98 64.14 -22.57 80.76 62.41 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 10 PRO.? 17.95 CH3 ACT A 201 A 272 LEU A 25 LEU~? 14.11 CH3 ACT A 201 A 276 ARG A 24 ARG~? 13.97 CH3 ACT A 201 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -23.21 84.05 73.34 -21.34 83.73 72.18 coo 10.97 0.43 16.73 11.31 2.11 18.06 -27.50 82.26 68.63 -26.98 84.36 68.67 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -33.88 82.79 71.01 -36.66 83.48 69.87 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO A 152 PRO.? 17.76 CH3 ACT A 201 A 272 LEU A 157 LEU~? 16.18 CH3 ACT A 201 A 276 ARG A 106 ARG^? 14.48 O1 EDO A 301 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -45.55 80.80 74.43 -43.59 81.84 74.53 coo 10.97 0.43 16.73 11.31 2.11 18.06 -45.16 75.74 76.44 -45.39 76.60 74.48 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -44.60 68.65 71.93 -47.65 68.54 71.92 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO B 10 PRO.? 18.13 CH3 ACT B 201 A 272 LEU B 25 LEU~? 14.08 CH3 ACT B 201 A 276 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -23.67 63.07 96.78 -25.52 63.38 97.97 coo 10.97 0.43 16.73 11.31 2.11 18.06 -25.39 57.02 94.16 -24.18 57.09 95.95 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -20.35 54.64 90.03 -19.09 51.96 89.19 ULMN 3 1emh_d00 HYDROLASE/DNA user 5 3 # 5 A 271 PRO B 12 PRO.? 20.40 CH3 ACT B 201 A 272 LEU B 11 LEU.? 21.85 CH3 ACT B 201 A 276 ARG B 8 ARG.? 14.49 CH3 ACT B 201 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -30.12 69.94 96.26 -27.96 69.60 96.66 coo 10.97 0.43 16.73 11.31 2.11 18.06 -28.00 67.58 99.91 -29.03 66.43 101.42 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -31.04 58.38 97.06 -32.26 55.57 97.13 ULMN 3 1emh_d00 HYDROLASE/DNA user 6 3 # 6 A 271 PRO B 152 PRO.? 12.80 CH3 ACT A 202 A 272 LEU B 157 LEU~? 8.47 CH3 ACT A 202 A 276 ARG B 106 ARG^? 5.91 C1 EDO A 302 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -13.52 50.58 80.22 -13.74 51.61 82.18 coo 10.97 0.43 16.73 11.31 2.11 18.06 -16.33 52.49 75.80 -16.48 51.26 77.56 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -23.54 51.33 72.85 -22.07 49.40 71.00 ULMN 3 1emh_d00 HYDROLASE/DNA user 7 3 # 7 A 271 PRO C 10 PRO.? 17.95 CH3 ACT C 201 A 272 LEU C 25 LEU~? 14.17 CH3 ACT C 201 A 276 ARG C 8 ARG.? 14.74 CH3 ACT C 201 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -35.65 35.29 38.54 -33.64 35.89 37.85 coo 10.97 0.43 16.73 11.31 2.11 18.06 -34.79 36.68 45.03 -34.22 34.69 44.41 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -27.18 40.10 42.21 -27.55 39.63 45.22 ULMN 3 1emh_d00 HYDROLASE/DNA user 8 3 # 8 A 271 PRO C 10 PRO.? 17.95 CH3 ACT C 201 A 272 LEU C 25 LEU~? 14.17 CH3 ACT C 201 A 276 ARG C 24 ARG~? 14.09 CH3 ACT C 201 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -35.65 35.29 38.54 -33.64 35.89 37.85 coo 10.97 0.43 16.73 11.31 2.11 18.06 -34.79 36.68 45.03 -34.22 34.69 44.41 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -40.53 35.15 48.39 -41.31 34.14 51.19 ULMN 3 1emh_d00 HYDROLASE/DNA user 9 3 # 9 A 271 PRO C 152 PRO.? 18.51 CH3 ACT C 201 A 272 LEU C 157 LEU~? 16.14 CH3 ACT C 201 A 276 ARG C 106 ARG^? 14.47 O2 EDO A 301 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -51.38 34.19 54.95 -49.60 34.51 53.65 coo 10.97 0.43 16.73 11.31 2.11 18.06 -52.51 40.47 54.60 -50.95 39.18 55.35 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -49.78 47.48 57.01 -51.73 47.13 59.31 ULMN 3 1emh_d00 HYDROLASE/DNA user 10 3 # 10 A 271 PRO D 10 PRO.? 18.12 CH3 ACT D 201 A 272 LEU D 25 LEU~? 14.13 CH3 ACT D 201 A 276 ARG D 8 ARG.? 14.56 CH3 ACT D 201 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -56.71 54.56 25.58 -58.72 53.80 26.15 coo 10.97 0.43 16.73 11.31 2.11 18.06 -56.77 60.39 28.97 -57.42 60.38 26.91 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -64.40 57.42 32.12 -63.44 60.33 32.35 ULMN 3 1emh_d00 HYDROLASE/DNA user 11 3 # 11 A 271 PRO D 10 PRO.? 18.12 CH3 ACT D 201 A 272 LEU D 25 LEU~? 14.13 CH3 ACT D 201 A 276 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -56.71 54.56 25.58 -58.72 53.80 26.15 coo 10.97 0.43 16.73 11.31 2.11 18.06 -56.77 60.39 28.97 -57.42 60.38 26.91 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -50.90 63.83 27.93 -49.90 66.74 27.73 1emh_d00 source 1emh HYDROLASE/DNA : 11 hits 1emh_d00 naa= 3 ULMN 4 1hbx_d00 GENE REGULATION user 1 4 # 1 D 140 THR A 66 THR~? 13.87 O ACT A 201 D 143 ARG A 51 ARG.? 6.25 O1 EDO A 301 D 158 TYR C 95 TYR^? -3.84 O ACT C 201s D 163 LYS C 68 LYS~? -2.77 O ACT C 201s coo 59.11 133.43 75.29 57.02 133.64 74.76 -30.35 68.05 54.38 -29.23 68.39 52.56 coo 52.93 123.10 78.03 50.59 121.17 78.38 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 39.29 134.52 82.26 37.39 135.28 80.34 -41.63 48.44 55.51 -40.56 51.04 55.32 coo 42.67 127.66 76.73 46.82 129.80 74.10 -32.77 52.69 57.49 -37.10 50.68 54.61 ULMN 4 1hbx_d00 GENE REGULATION user 2 4 # 2 D 140 THR A 66 THR~? 13.87 O ACT A 201 D 143 ARG C 67 ARG~? 12.50 O2 EDO A 302 D 158 TYR C 42 TYR^? 9.67 CH3 ACT C 201 D 163 LYS C 62 LYS~? 12.50 O2 EDO A 302 coo 59.11 133.43 75.29 57.02 133.64 74.76 -30.35 68.05 54.38 -29.23 68.39 52.56 coo 52.93 123.10 78.03 50.59 121.17 78.38 -28.66 58.05 57.15 -27.52 58.08 54.30 coo 39.29 134.52 82.26 37.39 135.28 80.34 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 42.67 127.66 76.73 46.82 129.80 74.10 -25.76 50.99 51.27 -20.80 47.54 53.29 ULMN 4 1hbx_d00 GENE REGULATION user 3 4 # 3 D 140 THR C 66 THR~? 7.92 O2 EDO A 302 D 143 ARG A 67 ARG~? 13.20 O2 EDO A 302 D 158 TYR A 42 TYR^? 9.79 CH3 ACT A 201 D 163 LYS A 62 LYS~? 17.60 O ACT A 201 coo 59.11 133.43 75.29 57.02 133.64 74.76 -27.55 51.38 57.17 -25.41 51.36 57.47 coo 52.93 123.10 78.03 50.59 121.17 78.38 -30.04 61.33 54.76 -27.14 61.67 55.68 coo 39.29 134.52 82.26 37.39 135.28 80.34 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 42.67 127.66 76.73 46.82 129.80 74.10 -24.69 69.09 56.72 -23.65 73.04 51.86 ULMN 4 1hbx_d00 GENE REGULATION user 4 4 # 4 D 140 THR C 66 THR~? 7.92 O2 EDO A 302 D 143 ARG C 51 ARG.? 6.22 O2 EDO A 301 D 158 TYR A 95 TYR^? -3.85 O ACT A 201s D 163 LYS A 68 LYS~? -2.78 O ACT A 201s coo 59.11 133.43 75.29 57.02 133.64 74.76 -27.55 51.38 57.17 -25.41 51.36 57.47 coo 52.93 123.10 78.03 50.59 121.17 78.38 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 39.29 134.52 82.26 37.39 135.28 80.34 -38.20 69.00 66.47 -37.00 66.61 65.61 coo 42.67 127.66 76.73 46.82 129.80 74.10 -33.65 65.97 58.12 -34.39 67.56 63.36 1hbx_d00 source 1hbx GENE REGULATION : 4 hits 1hbx_d00 naa= 4 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG A 8 ARG.? 15.23 CH3 ACT A 201 E 41 TYR A 42 TYR^? 9.79 CH3 ACT A 201 E 83 ARG D 146 ARG.? 16.60 CH3 ACT D 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -20.16 79.98 64.14 -22.57 80.76 62.41 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -54.51 68.83 27.22 -52.30 68.02 25.26 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG A 58 ARG~? 18.13 CH3 ACT A 201 E 41 TYR A 42 TYR^? 9.79 CH3 ACT A 201 E 83 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 3 3 # 3 E 40 ARG A 58 ARG~? 18.13 CH3 ACT A 201 E 41 TYR A 42 TYR^? 9.79 CH3 ACT A 201 E 83 ARG D 123 ARG.? 17.60 O ACT D 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 4 3 # 4 E 40 ARG A 124 ARG.? -3.54 OXT ACT A 201s E 41 TYR A 42 TYR^? 9.79 CH3 ACT A 201 E 83 ARG D 16 ARG~? 19.88 CH3 ACT D 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -43.87 51.07 24.49 -42.60 51.26 27.28 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 5 3 # 5 E 40 ARG A 124 ARG.? -3.54 OXT ACT A 201s E 41 TYR A 42 TYR^? 9.79 CH3 ACT A 201 E 83 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 6 3 # 6 E 40 ARG B 8 ARG.? 14.49 CH3 ACT B 201 E 41 TYR B 42 TYR^? 9.74 CH3 ACT B 201 E 83 ARG C 58 ARG~? 18.03 CH3 ACT C 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -22.97 47.67 45.60 -22.11 45.78 43.37 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 7 3 # 7 E 40 ARG B 58 ARG~? 17.86 CH3 ACT B 201 E 41 TYR B 42 TYR^? 9.74 CH3 ACT B 201 E 83 ARG C 24 ARG~? 14.09 CH3 ACT C 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -40.53 35.15 48.39 -41.31 34.14 51.19 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 8 3 # 8 E 40 ARG B 58 ARG~? 17.86 CH3 ACT B 201 E 41 TYR B 42 TYR^? 9.74 CH3 ACT B 201 E 83 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 9 3 # 9 E 40 ARG B 76 ARG^? 14.33 OXT ACT B 201 E 41 TYR B 75 TYR^? -4.59 OXT ACT B 201s E 83 ARG C 16 ARG~? 20.89 CH3 ACT C 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -48.56 36.19 35.88 -49.41 34.92 38.55 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 10 3 # 10 E 40 ARG B 76 ARG^? 14.33 OXT ACT B 201 E 41 TYR B 75 TYR^? -4.59 OXT ACT B 201s E 83 ARG C 88 ARG^? 18.42 CH3 ACT D 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -39.31 50.22 32.74 -39.14 52.99 31.45 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 11 3 # 11 E 40 ARG B 76 ARG^? 14.33 OXT ACT B 201 E 41 TYR B 75 TYR^? -4.59 OXT ACT B 201s E 83 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -52.23 44.53 37.75 -52.43 42.56 40.08 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 12 3 # 12 E 40 ARG B 76 ARG^? 14.33 OXT ACT B 201 E 41 TYR B 75 TYR^? -4.59 OXT ACT B 201s E 83 ARG D 124 ARG.? -3.55 O ACT D 201s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -30.51 47.57 81.98 -30.49 50.30 82.57 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -55.86 56.60 42.20 -53.99 58.76 43.32 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 13 3 # 13 E 40 ARG B 92 ARG^? -3.69 CH3 ACT A 202s E 41 TYR B 93 TYR^? -4.16 CH3 ACT B 201s E 83 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -55.21 72.58 39.53 -56.74 74.11 37.37 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 14 3 # 14 E 40 ARG B 92 ARG^? -3.69 CH3 ACT A 202s E 41 TYR B 93 TYR^? -4.16 CH3 ACT B 201s E 83 ARG D 88 ARG^? 18.35 CH3 ACT C 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -52.23 44.53 37.75 -52.43 42.56 40.08 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 15 3 # 15 E 40 ARG B 92 ARG^? -3.69 CH3 ACT A 202s E 41 TYR B 93 TYR^? -4.16 CH3 ACT B 201s E 83 ARG D 123 ARG.? 17.60 O ACT D 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -22.98 63.29 76.72 -21.11 61.06 75.76 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -58.14 46.42 43.58 -55.81 44.43 43.54 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 16 3 # 16 E 40 ARG C 8 ARG.? 14.74 CH3 ACT C 201 E 41 TYR C 42 TYR^? 9.67 CH3 ACT C 201 E 83 ARG B 146 ARG.? 16.58 CH3 ACT B 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -27.18 40.10 42.21 -27.55 39.63 45.22 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -21.21 49.21 92.90 -18.50 50.59 92.50 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 17 3 # 17 E 40 ARG C 58 ARG~? 18.03 CH3 ACT C 201 E 41 TYR C 42 TYR^? 9.67 CH3 ACT C 201 E 83 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 18 3 # 18 E 40 ARG C 58 ARG~? 18.03 CH3 ACT C 201 E 41 TYR C 42 TYR^? 9.67 CH3 ACT C 201 E 83 ARG B 123 ARG.? 17.76 O ACT B 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 19 3 # 19 E 40 ARG C 124 ARG.? -3.50 OXT ACT C 201s E 41 TYR C 42 TYR^? 9.67 CH3 ACT C 201 E 83 ARG B 16 ARG~? 17.22 CH3 ACT A 202 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -15.28 68.46 88.00 -14.07 65.73 87.25 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 20 3 # 20 E 40 ARG C 124 ARG.? -3.50 OXT ACT C 201s E 41 TYR C 42 TYR^? 9.67 CH3 ACT C 201 E 83 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 21 3 # 21 E 40 ARG D 58 ARG~? 18.01 CH3 ACT D 201 E 41 TYR D 42 TYR^? 9.84 CH3 ACT D 201 E 83 ARG A 24 ARG~? 13.97 CH3 ACT A 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -33.88 82.79 71.01 -36.66 83.48 69.87 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 22 3 # 22 E 40 ARG D 58 ARG~? 18.01 CH3 ACT D 201 E 41 TYR D 42 TYR^? 9.84 CH3 ACT D 201 E 83 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 23 3 # 23 E 40 ARG D 76 ARG^? 14.20 OXT ACT D 201 E 41 TYR D 75 TYR^? -4.49 OXT ACT D 201s E 83 ARG A 16 ARG~? 19.68 CH3 ACT A 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -29.16 81.79 84.92 -31.07 79.42 84.55 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 24 3 # 24 E 40 ARG D 76 ARG^? 14.20 OXT ACT D 201 E 41 TYR D 75 TYR^? -4.49 OXT ACT D 201s E 83 ARG A 88 ARG^? 11.13 CH3 ACT A 202 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -18.98 69.22 79.04 -17.48 66.59 79.46 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 25 3 # 25 E 40 ARG D 76 ARG^? 14.20 OXT ACT D 201 E 41 TYR D 75 TYR^? -4.49 OXT ACT D 201s E 83 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 26 3 # 26 E 40 ARG D 76 ARG^? 14.20 OXT ACT D 201 E 41 TYR D 75 TYR^? -4.49 OXT ACT D 201s E 83 ARG B 123 ARG.? 17.76 O ACT B 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -38.78 69.90 87.63 -38.44 71.99 85.40 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 27 3 # 27 E 40 ARG D 76 ARG^? 14.20 OXT ACT D 201 E 41 TYR D 75 TYR^? -4.49 OXT ACT D 201s E 83 ARG B 124 ARG.? -3.52 O ACT B 201s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -52.06 69.71 41.47 -52.08 66.98 40.85 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 28 3 # 28 E 40 ARG D 92 ARG^? 13.56 CH3 ACT D 201 E 41 TYR D 93 TYR^? -4.14 CH3 ACT D 201s E 83 ARG B 88 ARG^? 18.43 CH3 ACT A 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -31.74 72.75 86.26 -33.87 74.56 85.05 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 29 3 # 29 E 40 ARG D 92 ARG^? 13.56 CH3 ACT D 201 E 41 TYR D 93 TYR^? -4.14 CH3 ACT D 201s E 83 ARG B 123 ARG.? 17.76 O ACT B 201 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -40.97 55.58 37.41 -39.40 58.23 37.46 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -38.78 69.90 87.63 -38.44 71.99 85.40 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 29 hits 1id3_d00 naa= 3 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 1 4 # 1 B 242 GLU A 80 GLU^? 14.51 CH3 ACT A 201 B 245 LYS A 79 LYS^? -3.45 CH3 ACT A 201s B 249 ARG A 24 ARG~? 13.97 CH3 ACT A 201 B 250 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo -0.89 32.39 60.42 -0.92 32.12 58.30 -35.46 76.50 78.57 -37.32 76.28 79.54 coo -4.54 26.92 60.10 0.40 29.01 56.76 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 0.78 21.41 59.82 1.77 24.31 59.87 -33.88 82.79 71.01 -36.66 83.48 69.87 coo 0.56 22.39 66.71 0.61 25.40 66.07 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 2 4 # 2 B 242 GLU A 80 GLU^? 14.51 CH3 ACT A 201 B 245 LYS A 79 LYS^? -3.45 CH3 ACT A 201s B 249 ARG A 147 ARG.? 13.06 CH3 ACT A 201 B 250 ARG A 24 ARG~? 13.97 CH3 ACT A 201 coo -0.89 32.39 60.42 -0.92 32.12 58.30 -35.46 76.50 78.57 -37.32 76.28 79.54 coo -4.54 26.92 60.10 0.40 29.01 56.76 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 0.78 21.41 59.82 1.77 24.31 59.87 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 0.56 22.39 66.71 0.61 25.40 66.07 -33.88 82.79 71.01 -36.66 83.48 69.87 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 3 4 # 3 B 242 GLU A 160 GLU.? 13.50 O ACT A 201 B 245 LYS A 139 LYS.? 17.81 O ACT A 201 B 249 ARG A 76 ARG^? 8.97 OXT ACT A 203 B 250 ARG A 147 ARG.? 13.06 CH3 ACT A 201 coo -0.89 32.39 60.42 -0.92 32.12 58.30 -45.30 71.21 75.74 -44.17 71.89 74.09 coo -4.54 26.92 60.10 0.40 29.01 56.76 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 0.78 21.41 59.82 1.77 24.31 59.87 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 0.56 22.39 66.71 0.61 25.40 66.07 -40.14 80.19 70.35 -38.27 80.75 72.73 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 4 4 # 4 B 242 GLU A 160 GLU.? 13.50 O ACT A 201 B 245 LYS A 139 LYS.? 17.81 O ACT A 201 B 249 ARG A 138 ARG~? 6.49 OXT ACT A 203 B 250 ARG A 76 ARG^? 8.97 OXT ACT A 203 coo -0.89 32.39 60.42 -0.92 32.12 58.30 -45.30 71.21 75.74 -44.17 71.89 74.09 coo -4.54 26.92 60.10 0.40 29.01 56.76 -48.50 74.28 70.24 -48.23 71.73 76.05 coo 0.78 21.41 59.82 1.77 24.31 59.87 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 0.56 22.39 66.71 0.61 25.40 66.07 -44.10 76.39 63.96 -45.67 76.44 61.31 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 5 4 # 5 B 242 GLU B 80 GLU^? 7.87 CH3 ACT A 202 B 245 LYS B 79 LYS^? -3.44 CH3 ACT B 201s B 249 ARG B 24 ARG~? 14.02 CH3 ACT B 201 B 250 ARG B 147 ARG.? 12.52 CH3 ACT A 202 coo -0.89 32.39 60.42 -0.92 32.12 58.30 -19.12 60.55 81.96 -17.78 60.17 80.39 coo -4.54 26.92 60.10 0.40 29.01 56.76 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 0.78 21.41 59.82 1.77 24.31 59.87 -20.35 54.64 90.03 -19.09 51.96 89.19 coo 0.56 22.39 66.71 0.61 25.40 66.07 -19.28 50.88 84.48 -18.42 53.72 85.30 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 6 4 # 6 B 242 GLU B 80 GLU^? 7.87 CH3 ACT A 202 B 245 LYS B 79 LYS^? -3.44 CH3 ACT B 201s B 249 ARG B 147 ARG.? 12.52 CH3 ACT A 202 B 250 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo -0.89 32.39 60.42 -0.92 32.12 58.30 -19.12 60.55 81.96 -17.78 60.17 80.39 coo -4.54 26.92 60.10 0.40 29.01 56.76 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 0.78 21.41 59.82 1.77 24.31 59.87 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 0.56 22.39 66.71 0.61 25.40 66.07 -20.35 54.64 90.03 -19.09 51.96 89.19 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 7 4 # 7 B 242 GLU C 80 GLU^? 14.47 CH3 ACT C 201 B 245 LYS C 79 LYS^? -3.44 CH3 ACT C 201s B 249 ARG C 24 ARG~? 14.09 CH3 ACT C 201 B 250 ARG C 147 ARG.? 13.23 CH3 ACT C 201 coo -0.89 32.39 60.42 -0.92 32.12 58.30 -48.24 40.72 45.31 -50.16 40.73 46.15 coo -4.54 26.92 60.10 0.40 29.01 56.76 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 0.78 21.41 59.82 1.77 24.31 59.87 -40.53 35.15 48.39 -41.31 34.14 51.19 coo 0.56 22.39 66.71 0.61 25.40 66.07 -44.23 36.97 53.78 -44.90 36.38 50.84 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 8 4 # 8 B 242 GLU C 80 GLU^? 14.47 CH3 ACT C 201 B 245 LYS C 79 LYS^? -3.44 CH3 ACT C 201s B 249 ARG C 147 ARG.? 13.23 CH3 ACT C 201 B 250 ARG C 24 ARG~? 14.09 CH3 ACT C 201 coo -0.89 32.39 60.42 -0.92 32.12 58.30 -48.24 40.72 45.31 -50.16 40.73 46.15 coo -4.54 26.92 60.10 0.40 29.01 56.76 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 0.78 21.41 59.82 1.77 24.31 59.87 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 0.56 22.39 66.71 0.61 25.40 66.07 -40.53 35.15 48.39 -41.31 34.14 51.19 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 9 4 # 9 B 242 GLU D 80 GLU^? 14.49 CH3 ACT D 201 B 245 LYS D 79 LYS^? -3.52 CH3 ACT D 201s B 249 ARG D 24 ARG~? 13.98 CH3 ACT D 201 B 250 ARG D 147 ARG.? 13.02 CH3 ACT D 201 coo -0.89 32.39 60.42 -0.92 32.12 58.30 -42.96 58.73 31.72 -40.96 59.40 31.80 coo -4.54 26.92 60.10 0.40 29.01 56.76 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 0.78 21.41 59.82 1.77 24.31 59.87 -50.90 63.83 27.93 -49.90 66.74 27.73 coo 0.56 22.39 66.71 0.61 25.40 66.07 -46.62 68.18 31.08 -46.22 65.54 29.55 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 10 4 # 10 B 242 GLU D 80 GLU^? 14.49 CH3 ACT D 201 B 245 LYS D 79 LYS^? -3.52 CH3 ACT D 201s B 249 ARG D 147 ARG.? 13.02 CH3 ACT D 201 B 250 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo -0.89 32.39 60.42 -0.92 32.12 58.30 -42.96 58.73 31.72 -40.96 59.40 31.80 coo -4.54 26.92 60.10 0.40 29.01 56.76 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 0.78 21.41 59.82 1.77 24.31 59.87 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 0.56 22.39 66.71 0.61 25.40 66.07 -50.90 63.83 27.93 -49.90 66.74 27.73 1kb6_d00 source 1kb6 TRANSCRIPTION/DNA : 10 hits 1kb6_d00 naa= 4 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 1 4 # 1 G 5 LYS B 71 LYS~? 10.83 OXT ACT B 201 G 13 LYS C 71 LYS~? 4.19 C1 EDO A 301 G 42 ARG A 92 ARG^? 14.09 CH3 ACT A 201 G 77 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 39.46 58.80 1.48 39.21 55.92 0.43 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 -55.21 72.58 39.53 -56.74 74.11 37.37 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 2 4 # 2 G 5 LYS B 71 LYS~? 10.83 OXT ACT B 201 G 13 LYS C 71 LYS~? 4.19 C1 EDO A 301 G 42 ARG A 92 ARG^? 14.09 CH3 ACT A 201 G 77 ARG D 76 ARG^? 14.20 OXT ACT D 201 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 39.46 58.80 1.48 39.21 55.92 0.43 -35.15 70.11 80.06 -38.17 70.69 80.11 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 -47.81 74.29 36.53 -48.87 77.02 37.43 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 3 4 # 3 G 5 LYS B 71 LYS~? 10.83 OXT ACT B 201 G 13 LYS C 134 LYS~? 17.33 O2 EDO A 301 G 42 ARG C 146 ARG.? 16.63 CH3 ACT C 201 G 77 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 -38.47 44.35 77.96 -37.73 47.88 73.83 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 -51.34 49.79 67.51 -53.85 50.99 71.42 coo 39.46 58.80 1.48 39.21 55.92 0.43 -36.58 32.85 52.68 -38.87 31.31 51.32 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 -55.21 72.58 39.53 -56.74 74.11 37.37 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 4 4 # 4 G 5 LYS B 134 LYS~? 12.79 C2 EDO A 302 G 13 LYS C 62 LYS~? 12.50 O2 EDO A 302 G 42 ARG A 124 ARG.? -3.54 OXT ACT A 201s G 77 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 -24.49 42.38 66.88 -23.94 39.99 62.78 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 39.46 58.80 1.48 39.21 55.92 0.43 -25.78 68.55 67.34 -28.71 67.64 66.97 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 -50.90 63.83 27.93 -49.90 66.74 27.73 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 5 4 # 5 G 5 LYS D 71 LYS~? -3.20 CH3 ACT A 203s G 13 LYS A 134 LYS~? 11.98 O ACT A 203 G 42 ARG A 146 ARG.? 16.48 CH3 ACT A 201 G 77 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 -54.54 71.95 50.35 -50.70 67.51 52.69 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 -53.24 65.33 66.31 -57.37 62.85 65.73 coo 39.46 58.80 1.48 39.21 55.92 0.43 -35.10 85.34 65.39 -35.74 86.54 68.15 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 6 4 # 6 G 5 LYS D 134 LYS~? 17.34 O ACT A 201 G 13 LYS A 62 LYS~? 17.60 O ACT A 201 G 42 ARG C 124 ARG.? -3.50 OXT ACT C 201s G 77 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 -37.62 76.93 46.97 -33.08 76.47 49.79 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 39.46 58.80 1.48 39.21 55.92 0.43 -34.72 50.67 45.47 -36.40 51.18 47.99 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 -20.35 54.64 90.03 -19.09 51.96 89.19 1kx5_d03 source 1kx5 STRUCTURAL PROTEIN/DNA : 6 hits 1kx5_d03 naa= 4 ULMN 4 1lat_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 458 GLU A 59 GLU~? 18.41 O2 EDO A 302 A 461 LYS A 62 LYS~? 17.60 O ACT A 201 A 462 ALA A 63 ALA~? 14.85 OXT ACT A 201 A 466 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 36.22 34.04 93.46 35.20 35.01 95.03 -19.57 66.85 53.38 -18.14 66.20 51.96 coo 29.92 31.01 94.11 31.45 36.50 96.08 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 28.62 33.12 91.21 29.52 33.84 90.21 -25.75 65.96 54.80 -24.85 64.81 54.40 coo 25.27 34.07 87.35 27.76 35.81 87.05 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 4 1lat_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 458 GLU A 60 GLU~? 10.63 O2 EDO A 302 A 461 LYS A 62 LYS~? 17.60 O ACT A 201 A 462 ALA A 63 ALA~? 14.85 OXT ACT A 201 A 466 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 36.22 34.04 93.46 35.20 35.01 95.03 -19.73 62.99 57.19 -19.03 61.21 58.09 coo 29.92 31.01 94.11 31.45 36.50 96.08 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 28.62 33.12 91.21 29.52 33.84 90.21 -25.75 65.96 54.80 -24.85 64.81 54.40 coo 25.27 34.07 87.35 27.76 35.81 87.05 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 4 1lat_d00 TRANSCRIPTION/DNA user 3 4 # 3 A 458 GLU B 59 GLU~? 20.69 O ACT B 201 A 461 LYS B 62 LYS~? 17.44 OXT ACT B 201 A 462 ALA B 63 ALA~? 14.82 O ACT B 201 A 466 ARG B 67 ARG~? 13.55 O ACT B 201 coo 36.22 34.04 93.46 35.20 35.01 95.03 -47.90 53.57 92.50 -49.95 53.72 93.03 coo 29.92 31.01 94.11 31.45 36.50 96.08 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 28.62 33.12 91.21 29.52 33.84 90.21 -44.69 50.92 87.09 -46.09 51.48 86.89 coo 25.27 34.07 87.35 27.76 35.81 87.05 -45.57 49.20 81.23 -45.93 51.82 82.79 ULMN 4 1lat_d00 TRANSCRIPTION/DNA user 4 4 # 4 A 458 GLU B 60 GLU~? 17.33 O ACT B 201 A 461 LYS B 62 LYS~? 17.44 OXT ACT B 201 A 462 ALA B 63 ALA~? 14.82 O ACT B 201 A 466 ARG B 67 ARG~? 13.55 O ACT B 201 coo 36.22 34.04 93.46 35.20 35.01 95.03 -48.17 57.12 87.93 -49.17 58.57 86.76 coo 29.92 31.01 94.11 31.45 36.50 96.08 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 28.62 33.12 91.21 29.52 33.84 90.21 -44.69 50.92 87.09 -46.09 51.48 86.89 coo 25.27 34.07 87.35 27.76 35.81 87.05 -45.57 49.20 81.23 -45.93 51.82 82.79 ULMN 4 1lat_d00 TRANSCRIPTION/DNA user 5 4 # 5 A 458 GLU C 59 GLU~? 13.48 O2 EDO A 302 A 461 LYS C 62 LYS~? 12.50 O2 EDO A 302 A 462 ALA C 63 ALA~? 11.78 O2 EDO A 302 A 466 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 36.22 34.04 93.46 35.20 35.01 95.03 -20.25 53.72 49.66 -20.40 52.10 51.04 coo 29.92 31.01 94.11 31.45 36.50 96.08 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 28.62 33.12 91.21 29.52 33.84 90.21 -25.32 54.06 53.50 -24.62 55.35 53.10 coo 25.27 34.07 87.35 27.76 35.81 87.05 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 4 1lat_d00 TRANSCRIPTION/DNA user 6 4 # 6 A 458 GLU C 60 GLU~? 17.22 OXT ACT C 201 A 461 LYS C 62 LYS~? 12.50 O2 EDO A 302 A 462 ALA C 63 ALA~? 11.78 O2 EDO A 302 A 466 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 36.22 34.04 93.46 35.20 35.01 95.03 -23.89 57.63 47.43 -24.47 59.50 46.62 coo 29.92 31.01 94.11 31.45 36.50 96.08 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 28.62 33.12 91.21 29.52 33.84 90.21 -25.32 54.06 53.50 -24.62 55.35 53.10 coo 25.27 34.07 87.35 27.76 35.81 87.05 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 4 1lat_d00 TRANSCRIPTION/DNA user 7 4 # 7 A 458 GLU D 59 GLU~? 18.52 O ACT D 201 A 461 LYS D 62 LYS~? 17.47 OXT ACT D 201 A 462 ALA D 63 ALA~? 14.77 O ACT D 201 A 466 ARG D 67 ARG~? 13.15 O ACT A 203 coo 36.22 34.04 93.46 35.20 35.01 95.03 -69.73 60.64 47.66 -70.08 62.16 46.23 coo 29.92 31.01 94.11 31.45 36.50 96.08 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 28.62 33.12 91.21 29.52 33.84 90.21 -64.21 63.78 48.75 -64.86 63.06 49.92 coo 25.27 34.07 87.35 27.76 35.81 87.05 -60.60 65.68 53.30 -61.45 62.86 52.44 ULMN 4 1lat_d00 TRANSCRIPTION/DNA user 8 4 # 8 A 458 GLU D 60 GLU~? 17.31 O ACT D 201 A 461 LYS D 62 LYS~? 17.47 OXT ACT D 201 A 462 ALA D 63 ALA~? 14.77 O ACT D 201 A 466 ARG D 67 ARG~? 13.15 O ACT A 203 coo 36.22 34.04 93.46 35.20 35.01 95.03 -66.09 57.03 50.37 -65.56 55.61 51.84 coo 29.92 31.01 94.11 31.45 36.50 96.08 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 28.62 33.12 91.21 29.52 33.84 90.21 -64.21 63.78 48.75 -64.86 63.06 49.92 coo 25.27 34.07 87.35 27.76 35.81 87.05 -60.60 65.68 53.30 -61.45 62.86 52.44 1lat_d00 source 1lat TRANSCRIPTION/DNA : 8 hits 1lat_d00 naa= 4 ULMN 4 1v15_d00 HYDROLASE user 1 4 # 1 D 5 ARG A 33 ARG.? 12.39 O ACT A 201 D 51 ASP A 34 ASP~? 14.63 O ACT A 201 D 54 ARG A 37 ARG~? 13.73 CH3 ACT A 201 D 96 ARG A 24 ARG~? 13.97 CH3 ACT A 201 coo 26.68 123.37 35.42 27.02 123.02 38.47 -37.81 74.92 58.71 -38.09 77.66 57.35 coo 28.85 117.12 30.52 26.97 118.21 30.78 -30.67 77.29 56.10 -29.14 77.80 54.72 coo 27.03 113.91 36.12 26.66 115.85 33.77 -28.83 80.54 58.97 -30.62 82.33 60.70 coo 15.69 117.00 39.50 16.92 119.48 40.82 -33.88 82.79 71.01 -36.66 83.48 69.87 ULMN 4 1v15_d00 HYDROLASE user 2 4 # 2 D 5 ARG A 33 ARG.? 12.39 O ACT A 201 D 51 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 54 ARG A 76 ARG^? 8.97 OXT ACT A 203 D 96 ARG A 146 ARG.? 16.48 CH3 ACT A 201 coo 26.68 123.37 35.42 27.02 123.02 38.47 -37.81 74.92 58.71 -38.09 77.66 57.35 coo 28.85 117.12 30.52 26.97 118.21 30.78 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 27.03 113.91 36.12 26.66 115.85 33.77 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 15.69 117.00 39.50 16.92 119.48 40.82 -35.10 85.34 65.39 -35.74 86.54 68.15 ULMN 4 1v15_d00 HYDROLASE user 3 4 # 3 D 5 ARG A 76 ARG^? 8.97 OXT ACT A 203 D 51 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 54 ARG A 33 ARG.? 12.39 O ACT A 201 D 96 ARG A 146 ARG.? 16.48 CH3 ACT A 201 coo 26.68 123.37 35.42 27.02 123.02 38.47 -44.10 76.39 63.96 -45.67 76.44 61.31 coo 28.85 117.12 30.52 26.97 118.21 30.78 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 27.03 113.91 36.12 26.66 115.85 33.77 -37.81 74.92 58.71 -38.09 77.66 57.35 coo 15.69 117.00 39.50 16.92 119.48 40.82 -35.10 85.34 65.39 -35.74 86.54 68.15 ULMN 4 1v15_d00 HYDROLASE user 4 4 # 4 D 5 ARG B 33 ARG.? 12.67 OXT ACT B 201 D 51 ASP B 34 ASP~? 14.61 OXT ACT B 201 D 54 ARG B 37 ARG~? 13.57 CH3 ACT B 201 D 96 ARG B 24 ARG~? 14.02 CH3 ACT B 201 coo 26.68 123.37 35.42 27.02 123.02 38.47 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 28.85 117.12 30.52 26.97 118.21 30.78 -34.29 46.44 92.12 -35.67 46.00 93.67 coo 27.03 113.91 36.12 26.66 115.85 33.77 -31.32 49.06 94.80 -28.26 48.93 94.55 coo 15.69 117.00 39.50 16.92 119.48 40.82 -20.35 54.64 90.03 -19.09 51.96 89.19 ULMN 4 1v15_d00 HYDROLASE user 5 4 # 5 D 5 ARG B 33 ARG.? 12.67 OXT ACT B 201 D 51 ASP B 74 ASP^? 14.88 OXT ACT B 201 D 54 ARG B 76 ARG^? 14.33 OXT ACT B 201 D 96 ARG B 146 ARG.? 16.58 CH3 ACT B 201 coo 26.68 123.37 35.42 27.02 123.02 38.47 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 28.85 117.12 30.52 26.97 118.21 30.78 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 27.03 113.91 36.12 26.66 115.85 33.77 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 15.69 117.00 39.50 16.92 119.48 40.82 -21.21 49.21 92.90 -18.50 50.59 92.50 ULMN 4 1v15_d00 HYDROLASE user 6 4 # 6 D 5 ARG B 76 ARG^? 14.33 OXT ACT B 201 D 51 ASP B 74 ASP^? 14.88 OXT ACT B 201 D 54 ARG B 33 ARG.? 12.67 OXT ACT B 201 D 96 ARG B 146 ARG.? 16.58 CH3 ACT B 201 coo 26.68 123.37 35.42 27.02 123.02 38.47 -23.34 44.19 81.38 -24.15 41.23 81.47 coo 28.85 117.12 30.52 26.97 118.21 30.78 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 27.03 113.91 36.12 26.66 115.85 33.77 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 15.69 117.00 39.50 16.92 119.48 40.82 -21.21 49.21 92.90 -18.50 50.59 92.50 ULMN 4 1v15_d00 HYDROLASE user 7 4 # 7 D 5 ARG C 33 ARG.? 12.41 O ACT C 201 D 51 ASP C 34 ASP~? 14.66 O ACT C 201 D 54 ARG C 37 ARG~? 13.73 CH3 ACT C 201 D 96 ARG C 24 ARG~? 14.09 CH3 ACT C 201 coo 26.68 123.37 35.42 27.02 123.02 38.47 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 28.85 117.12 30.52 26.97 118.21 30.78 -27.83 42.08 55.68 -25.73 41.87 55.54 coo 27.03 113.91 36.12 26.66 115.85 33.77 -28.52 38.86 52.29 -30.70 36.70 52.27 coo 15.69 117.00 39.50 16.92 119.48 40.82 -40.53 35.15 48.39 -41.31 34.14 51.19 ULMN 4 1v15_d00 HYDROLASE user 8 4 # 8 D 5 ARG C 33 ARG.? 12.41 O ACT C 201 D 51 ASP C 74 ASP^? 14.86 O ACT C 201 D 54 ARG C 76 ARG^? 14.32 O ACT C 201 D 96 ARG C 146 ARG.? 16.63 CH3 ACT C 201 coo 26.68 123.37 35.42 27.02 123.02 38.47 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 28.85 117.12 30.52 26.97 118.21 30.78 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 27.03 113.91 36.12 26.66 115.85 33.77 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 15.69 117.00 39.50 16.92 119.48 40.82 -36.58 32.85 52.68 -38.87 31.31 51.32 ULMN 4 1v15_d00 HYDROLASE user 9 4 # 9 D 5 ARG C 76 ARG^? 14.32 O ACT C 201 D 51 ASP C 74 ASP^? 14.86 O ACT C 201 D 54 ARG C 33 ARG.? 12.41 O ACT C 201 D 96 ARG C 146 ARG.? 16.63 CH3 ACT C 201 coo 26.68 123.37 35.42 27.02 123.02 38.47 -42.25 40.39 61.14 -41.06 40.24 63.98 coo 28.85 117.12 30.52 26.97 118.21 30.78 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 27.03 113.91 36.12 26.66 115.85 33.77 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 15.69 117.00 39.50 16.92 119.48 40.82 -36.58 32.85 52.68 -38.87 31.31 51.32 ULMN 4 1v15_d00 HYDROLASE user 10 4 # 10 D 5 ARG D 33 ARG.? 12.34 OXT ACT D 201 D 51 ASP D 34 ASP~? 14.62 OXT ACT D 201 D 54 ARG D 37 ARG~? 13.59 CH3 ACT D 201 D 96 ARG D 24 ARG~? 13.98 CH3 ACT D 201 coo 26.68 123.37 35.42 27.02 123.02 38.47 -55.21 72.58 39.53 -56.74 74.11 37.37 coo 28.85 117.12 30.52 26.97 118.21 30.78 -62.38 69.46 37.89 -64.50 69.55 37.91 coo 27.03 113.91 36.12 26.66 115.85 33.77 -62.21 67.18 33.74 -60.13 67.79 31.56 coo 15.69 117.00 39.50 16.92 119.48 40.82 -50.90 63.83 27.93 -49.90 66.74 27.73 ULMN 4 1v15_d00 HYDROLASE user 11 4 # 11 D 5 ARG D 33 ARG.? 12.34 OXT ACT D 201 D 51 ASP D 74 ASP^? 14.85 OXT ACT D 201 D 54 ARG D 76 ARG^? 14.20 OXT ACT D 201 D 96 ARG D 146 ARG.? 16.60 CH3 ACT D 201 coo 26.68 123.37 35.42 27.02 123.02 38.47 -55.21 72.58 39.53 -56.74 74.11 37.37 coo 28.85 117.12 30.52 26.97 118.21 30.78 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 27.03 113.91 36.12 26.66 115.85 33.77 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 15.69 117.00 39.50 16.92 119.48 40.82 -54.51 68.83 27.22 -52.30 68.02 25.26 ULMN 4 1v15_d00 HYDROLASE user 12 4 # 12 D 5 ARG D 76 ARG^? 14.20 OXT ACT D 201 D 51 ASP D 74 ASP^? 14.85 OXT ACT D 201 D 54 ARG D 33 ARG.? 12.34 OXT ACT D 201 D 96 ARG D 146 ARG.? 16.60 CH3 ACT D 201 coo 26.68 123.37 35.42 27.02 123.02 38.47 -47.81 74.29 36.53 -48.87 77.02 37.43 coo 28.85 117.12 30.52 26.97 118.21 30.78 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 27.03 113.91 36.12 26.66 115.85 33.77 -55.21 72.58 39.53 -56.74 74.11 37.37 coo 15.69 117.00 39.50 16.92 119.48 40.82 -54.51 68.83 27.22 -52.30 68.02 25.26 1v15_d00 source 1v15 HYDROLASE : 12 hits 1v15_d00 naa= 4 ULMN 4 2bgw_d00 HYDROLASE user 1 4 # 1 A 86 ALA A 52 ALA.? 7.92 O2 EDO A 302 A 87 GLU A 53 GLU^? 10.41 O2 EDO A 302 A 123 TYR B 108 TYR^? -4.79 O ACT A 202s A 182 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo 33.66 63.14 16.62 34.95 63.46 15.91 -28.67 56.33 66.41 -29.48 55.05 66.20 coo 28.97 64.99 12.92 27.92 64.06 11.28 -26.96 59.20 61.32 -28.18 60.32 59.98 coo 38.40 63.73 13.00 38.79 62.53 10.47 -26.20 55.78 72.02 -24.40 54.06 70.73 coo 29.35 67.59 19.60 30.93 68.47 17.09 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 4 2bgw_d00 HYDROLASE user 2 4 # 2 A 86 ALA B 52 ALA.? 10.80 O1 EDO A 301 A 87 GLU B 53 GLU^? 11.09 O ACT B 201 A 123 TYR A 108 TYR^? 12.28 O ACT A 201 A 182 ARG B 51 ARG.? 7.67 O ACT B 201 coo 33.66 63.14 16.62 34.95 63.46 15.91 -42.54 59.91 74.80 -43.03 59.60 73.39 coo 28.97 64.99 12.92 27.92 64.06 11.28 -44.66 56.42 79.28 -43.94 54.52 79.83 coo 38.40 63.73 13.00 38.79 62.53 10.47 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 29.35 67.59 19.60 30.93 68.47 17.09 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 4 2bgw_d00 HYDROLASE user 3 4 # 3 A 86 ALA C 52 ALA.? 12.19 C2 EDO A 301 A 87 GLU C 53 GLU^? 11.18 OXT ACT C 201 A 123 TYR D 108 TYR^? 12.28 OXT ACT D 201 A 182 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo 33.66 63.14 16.62 34.95 63.46 15.91 -37.45 62.38 49.17 -37.97 63.55 50.01 coo 28.97 64.99 12.92 27.92 64.06 11.28 -32.08 60.14 50.84 -31.64 58.95 52.54 coo 38.40 63.73 13.00 38.79 62.53 10.47 -40.41 63.05 43.73 -38.60 65.12 43.23 coo 29.35 67.59 19.60 30.93 68.47 17.09 -39.28 57.54 52.97 -41.40 56.18 54.75 ULMN 4 2bgw_d00 HYDROLASE user 4 4 # 4 A 86 ALA D 52 ALA.? 10.75 O ACT A 203 A 87 GLU D 53 GLU^? 10.32 O ACT A 203 A 123 TYR C 108 TYR^? 12.28 O ACT C 201 A 182 ARG D 51 ARG.? 7.60 O ACT D 201 coo 33.66 63.14 16.62 34.95 63.46 15.91 -52.10 56.30 54.26 -51.39 56.64 55.56 coo 28.97 64.99 12.92 27.92 64.06 11.28 -56.60 59.52 53.75 -57.18 61.28 52.77 coo 38.40 63.73 13.00 38.79 62.53 10.47 -49.57 50.97 53.11 -51.32 50.02 55.06 coo 29.35 67.59 19.60 30.93 68.47 17.09 -49.81 61.30 50.74 -48.26 63.65 49.51 2bgw_d00 source 2bgw HYDROLASE : 4 hits 2bgw_d00 naa= 4 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 1 3 # 1 C 43 GLN A 136 GLN~? 10.47 OXT ACT A 203 C 44 LYS A 134 LYS~? 11.98 O ACT A 203 C 75 ARG A 138 ARG~? 6.49 OXT ACT A 203 coo 34.33 34.01 1.06 32.24 34.35 1.22 -56.96 68.29 67.10 -57.39 67.81 65.07 coo 36.27 30.15 5.40 32.93 24.83 5.96 -53.24 65.33 66.31 -57.37 62.85 65.73 coo 30.88 29.31 6.12 29.39 29.02 3.47 -50.06 71.52 64.11 -49.59 74.03 62.40 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 2 3 # 2 C 43 GLN C 136 GLN~? 18.58 O2 EDO A 301 C 44 LYS C 134 LYS~? 17.33 O2 EDO A 301 C 75 ARG C 138 ARG~? 16.31 O ACT C 201 coo 34.33 34.01 1.06 32.24 34.35 1.22 -54.02 45.96 69.33 -53.29 47.10 70.97 coo 36.27 30.15 5.40 32.93 24.83 5.96 -51.34 49.79 67.51 -53.85 50.99 71.42 coo 30.88 29.31 6.12 29.39 29.02 3.47 -46.75 44.46 65.88 -44.64 42.30 66.40 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 3 3 # 3 C 43 GLN D 136 GLN~? 22.15 CH3 ACT A 203 C 44 LYS D 134 LYS~? 17.34 O ACT A 201 C 75 ARG D 138 ARG~? 16.38 OXT ACT D 201 coo 34.33 34.01 1.06 32.24 34.35 1.22 -34.63 79.41 43.23 -34.21 80.38 45.07 coo 36.27 30.15 5.40 32.93 24.83 5.96 -37.62 76.93 46.97 -33.08 76.47 49.79 coo 30.88 29.31 6.12 29.39 29.02 3.47 -42.61 77.59 41.75 -44.95 78.80 40.20 2er8_d00 source 2er8 TRANSCRIPTION ACTIVATOR/DNA : 3 hits 2er8_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG A 67 ARG~? 13.20 O2 EDO A 302 A 32 LYS A 68 LYS~? -2.78 O ACT A 201s A 46 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -30.04 61.33 54.76 -27.14 61.67 55.68 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -33.65 65.97 58.12 -34.39 67.56 63.36 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 24 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 32 LYS A 139 LYS.? 17.81 O ACT A 201 A 46 ARG A 33 ARG.? 12.39 O ACT A 201 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -50.06 71.52 64.11 -49.59 74.03 62.40 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -48.50 74.28 70.24 -48.23 71.73 76.05 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 24 ARG B 58 ARG~? 17.86 CH3 ACT B 201 A 32 LYS B 62 LYS~? 17.44 OXT ACT B 201 A 46 ARG B 8 ARG.? 14.49 CH3 ACT B 201 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -41.40 56.24 95.43 -40.17 57.59 97.88 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -42.04 52.32 89.45 -42.77 48.33 94.37 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -31.04 58.38 97.06 -32.26 55.57 97.13 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 24 ARG B 138 ARG~? 16.35 OXT ACT B 201 A 32 LYS B 139 LYS.? 6.99 C1 EDO A 302 A 46 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -23.44 41.55 74.26 -23.57 39.98 76.87 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -18.83 46.84 75.05 -16.49 49.79 71.17 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 5 3 # 5 A 24 ARG C 67 ARG~? 12.50 O2 EDO A 302 A 32 LYS C 68 LYS~? -2.77 O ACT C 201s A 46 ARG A 49 ARG^? -3.92 O ACT A 202s coo -8.00 4.27 27.74 -7.09 2.66 30.09 -28.66 58.05 57.15 -27.52 58.08 54.30 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -32.77 52.69 57.49 -37.10 50.68 54.61 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 6 3 # 6 A 24 ARG C 138 ARG~? 16.31 O ACT C 201 A 32 LYS C 139 LYS.? 18.79 O ACT C 201 A 46 ARG C 33 ARG.? 12.41 O ACT C 201 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -46.75 44.46 65.88 -44.64 42.30 66.40 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -50.26 41.49 60.64 -55.14 42.95 58.84 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 7 3 # 7 A 24 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 32 LYS D 139 LYS.? 18.54 OXT ACT D 201 A 46 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -42.61 77.59 41.75 -44.95 78.80 40.20 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -39.84 73.21 37.09 -35.07 70.74 37.87 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -55.21 72.58 39.53 -56.74 74.11 37.37 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 7 hits 2ky8_d00 naa= 3 ULMN 4 2q2t_d00 LIGASE/DNA user 1 4 # 1 A 48 ARG A 16 ARG~? 19.68 CH3 ACT A 201 A 249 THR A 46 THR^? 13.12 OXT ACT A 202 A 285 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 286 PHE A 125 PHE.? -4.61 O ACT A 202s coo -81.95 4.55 64.73 -81.11 4.84 61.78 -29.16 81.79 84.92 -31.07 79.42 84.55 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -17.27 68.11 64.46 -19.35 68.72 64.20 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -22.79 63.54 72.77 -20.07 62.88 72.67 ULMN 4 2q2t_d00 LIGASE/DNA user 2 4 # 2 A 48 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 249 THR C 46 THR^? 13.10 OXT ACT C 201 A 285 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 286 PHE C 54 PHE^? 14.66 OXT ACT C 201 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -33.46 60.54 65.68 -36.32 61.50 66.33 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -27.30 52.39 40.74 -28.28 51.51 42.48 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -37.64 60.68 44.02 -39.72 58.44 44.33 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -32.62 62.02 44.82 -34.97 63.26 43.94 ULMN 4 2q2t_d00 LIGASE/DNA user 3 4 # 3 A 48 ARG A 124 ARG.? -3.54 OXT ACT A 201s A 249 THR B 46 THR^? 13.06 O ACT B 201 A 285 ARG B 49 ARG^? 10.37 O ACT B 201 A 286 PHE B 54 PHE^? 14.58 O ACT B 201 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -25.78 68.55 67.34 -28.71 67.64 66.97 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -41.83 63.03 90.93 -40.53 61.43 90.23 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -40.89 64.28 77.45 -37.86 63.79 77.23 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -45.35 62.65 79.93 -44.68 64.28 77.75 ULMN 4 2q2t_d00 LIGASE/DNA user 4 4 # 4 A 48 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 249 THR B 46 THR^? 13.06 O ACT B 201 A 285 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 286 PHE B 125 PHE.? 13.16 O ACT B 201 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -50.06 71.52 64.11 -49.59 74.03 62.40 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -41.83 63.03 90.93 -40.53 61.43 90.23 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -37.18 66.81 81.74 -39.05 68.51 82.95 ULMN 4 2q2t_d00 LIGASE/DNA user 5 4 # 5 A 48 ARG B 16 ARG~? 17.22 CH3 ACT A 202 A 249 THR B 46 THR^? 13.06 O ACT B 201 A 285 ARG A 92 ARG^? 14.09 CH3 ACT A 201 A 286 PHE B 125 PHE.? 13.16 O ACT B 201 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -15.28 68.46 88.00 -14.07 65.73 87.25 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -41.83 63.03 90.93 -40.53 61.43 90.23 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -35.15 70.11 80.06 -38.17 70.69 80.11 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -37.18 66.81 81.74 -39.05 68.51 82.95 ULMN 4 2q2t_d00 LIGASE/DNA user 6 4 # 6 A 48 ARG B 76 ARG^? 14.33 OXT ACT B 201 A 249 THR A 46 THR^? 13.12 OXT ACT A 202 A 285 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 286 PHE A 125 PHE.? -4.61 O ACT A 202s coo -81.95 4.55 64.73 -81.11 4.84 61.78 -23.34 44.19 81.38 -24.15 41.23 81.47 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -17.27 68.11 64.46 -19.35 68.72 64.20 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -22.79 63.54 72.77 -20.07 62.88 72.67 ULMN 4 2q2t_d00 LIGASE/DNA user 7 4 # 7 A 48 ARG B 124 ARG.? -3.52 O ACT B 201s A 249 THR A 46 THR^? 13.12 OXT ACT A 202 A 285 ARG A 49 ARG^? -3.92 O ACT A 202s A 286 PHE A 54 PHE^? -3.83 O1 EDO A 302s coo -81.95 4.55 64.73 -81.11 4.84 61.78 -35.55 59.87 85.38 -34.97 57.89 83.09 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -17.27 68.11 64.46 -19.35 68.72 64.20 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -25.12 58.31 69.83 -26.93 60.25 71.40 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -22.35 57.66 65.34 -22.90 56.19 67.67 ULMN 4 2q2t_d00 LIGASE/DNA user 8 4 # 8 A 48 ARG B 138 ARG~? 16.35 OXT ACT B 201 A 249 THR A 46 THR^? 13.12 OXT ACT A 202 A 285 ARG B 92 ARG^? -3.69 CH3 ACT A 202s A 286 PHE A 125 PHE.? -4.61 O ACT A 202s coo -81.95 4.55 64.73 -81.11 4.84 61.78 -23.44 41.55 74.26 -23.57 39.98 76.87 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -17.27 68.11 64.46 -19.35 68.72 64.20 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -22.98 63.29 76.72 -21.11 61.06 75.76 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -22.79 63.54 72.77 -20.07 62.88 72.67 ULMN 4 2q2t_d00 LIGASE/DNA user 9 4 # 9 A 48 ARG C 16 ARG~? 20.89 CH3 ACT C 201 A 249 THR C 46 THR^? 13.10 OXT ACT C 201 A 285 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 286 PHE C 125 PHE.? 13.13 OXT ACT C 201 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -48.56 36.19 35.88 -49.41 34.92 38.55 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -27.30 52.39 40.74 -28.28 51.51 42.48 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -37.61 55.67 40.06 -35.81 56.68 38.17 ULMN 4 2q2t_d00 LIGASE/DNA user 10 4 # 10 A 48 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 249 THR A 46 THR^? 13.12 OXT ACT A 202 A 285 ARG A 49 ARG^? -3.92 O ACT A 202s A 286 PHE A 54 PHE^? -3.83 O1 EDO A 302s coo -81.95 4.55 64.73 -81.11 4.84 61.78 -39.28 57.54 52.97 -41.40 56.18 54.75 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -17.27 68.11 64.46 -19.35 68.72 64.20 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -25.12 58.31 69.83 -26.93 60.25 71.40 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -22.35 57.66 65.34 -22.90 56.19 67.67 ULMN 4 2q2t_d00 LIGASE/DNA user 11 4 # 11 A 48 ARG C 138 ARG~? 16.31 O ACT C 201 A 249 THR D 46 THR^? 13.15 O ACT D 201 A 285 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 286 PHE D 125 PHE.? 13.16 O ACT D 201 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -46.75 44.46 65.88 -44.64 42.30 66.40 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -63.51 52.01 43.24 -62.49 53.88 42.85 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -52.98 49.81 45.21 -54.80 47.77 45.79 ULMN 4 2q2t_d00 LIGASE/DNA user 12 4 # 12 A 48 ARG D 16 ARG~? 19.88 CH3 ACT D 201 A 249 THR D 46 THR^? 13.15 O ACT D 201 A 285 ARG C 92 ARG^? 13.71 CH3 ACT C 201 A 286 PHE D 125 PHE.? 13.16 O ACT D 201 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -43.87 51.07 24.49 -42.60 51.26 27.28 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -63.51 52.01 43.24 -62.49 53.88 42.85 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -49.94 47.28 44.16 -51.45 46.27 46.66 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -52.98 49.81 45.21 -54.80 47.77 45.79 ULMN 4 2q2t_d00 LIGASE/DNA user 13 4 # 13 A 48 ARG D 124 ARG.? -3.55 O ACT D 201s A 249 THR C 46 THR^? 13.10 OXT ACT C 201 A 285 ARG C 49 ARG^? 10.47 OXT ACT C 201 A 286 PHE C 54 PHE^? 14.66 OXT ACT C 201 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -55.86 56.60 42.20 -53.99 58.76 43.32 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -27.30 52.39 40.74 -28.28 51.51 42.48 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -37.64 60.68 44.02 -39.72 58.44 44.33 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -32.62 62.02 44.82 -34.97 63.26 43.94 ULMN 4 2q2t_d00 LIGASE/DNA user 14 4 # 14 A 48 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 249 THR C 46 THR^? 13.10 OXT ACT C 201 A 285 ARG D 92 ARG^? 13.56 CH3 ACT D 201 A 286 PHE C 125 PHE.? 13.13 OXT ACT C 201 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -42.61 77.59 41.75 -44.95 78.80 40.20 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -27.30 52.39 40.74 -28.28 51.51 42.48 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -40.97 55.58 37.41 -39.40 58.23 37.46 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -37.61 55.67 40.06 -35.81 56.68 38.17 2q2t_d00 source 2q2t LIGASE/DNA : 14 hits 2q2t_d00 naa= 4 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER B 107 SER^? 7.39 OXT ACT B 201 B 37 ASN B 129 ASN.? 9.80 OXT ACT A 201 B 45 THR C 66 THR~? 7.92 O2 EDO A 302 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -29.25 52.59 73.85 -31.29 51.35 74.31 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -31.81 57.09 70.18 -32.97 58.85 69.97 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -27.55 51.38 57.17 -25.41 51.36 57.47 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER D 107 SER^? 7.30 OXT ACT D 201 B 37 ASN D 129 ASN.? 9.72 OXT ACT C 201 B 45 THR A 66 THR~? 13.87 O ACT A 201 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -44.25 65.54 45.21 -46.11 66.36 46.55 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -42.23 60.94 49.15 -42.50 59.01 49.99 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -30.35 68.05 54.38 -29.23 68.39 52.56 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 2 hits 2z3x_d00 naa= 3 ULMN 4 3exj_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 245 ARG A 88 ARG^? 11.13 CH3 ACT A 202 A 273 ALA A 126 ALA.? 5.06 OXT ACT A 201 A 274 CYH A 127 CYH.? 6.15 O ACT A 202 A 277 ARG A 49 ARG^? -3.92 O ACT A 202s coo -9.51 25.68 9.68 -7.48 27.13 11.50 -18.98 69.22 79.04 -17.48 66.59 79.46 coo -15.76 27.26 20.69 -14.29 27.59 20.95 -28.54 64.52 70.82 -28.98 65.37 69.63 coo -17.65 30.57 20.48 -15.94 31.91 22.28 -31.19 62.06 71.95 -29.40 60.66 73.55 coo -14.96 35.49 18.53 -12.91 33.21 18.62 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 4 3exj_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 245 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 273 ALA B 126 ALA.? 5.01 O ACT B 201 A 274 CYH B 127 CYH.? 10.07 OXT ACT A 201 A 277 ARG B 51 ARG.? 7.67 O ACT B 201 coo -9.51 25.68 9.68 -7.48 27.13 11.50 -44.60 68.65 71.93 -47.65 68.54 71.92 coo -15.76 27.26 20.69 -14.29 27.59 20.95 -34.85 61.51 79.63 -34.73 60.21 80.42 coo -17.65 30.57 20.48 -15.94 31.91 22.28 -34.42 60.97 75.89 -35.29 63.54 75.29 coo -14.96 35.49 18.53 -12.91 33.21 18.62 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 4 3exj_d00 TRANSCRIPTION/DNA user 3 4 # 3 A 245 ARG B 88 ARG^? 18.43 CH3 ACT A 201 A 273 ALA B 126 ALA.? 5.01 O ACT B 201 A 274 CYH B 127 CYH.? 10.07 OXT ACT A 201 A 277 ARG B 49 ARG^? 10.37 O ACT B 201 coo -9.51 25.68 9.68 -7.48 27.13 11.50 -31.74 72.75 86.26 -33.87 74.56 85.05 coo -15.76 27.26 20.69 -14.29 27.59 20.95 -34.85 61.51 79.63 -34.73 60.21 80.42 coo -17.65 30.57 20.48 -15.94 31.91 22.28 -34.42 60.97 75.89 -35.29 63.54 75.29 coo -14.96 35.49 18.53 -12.91 33.21 18.62 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 4 3exj_d00 TRANSCRIPTION/DNA user 4 4 # 4 A 245 ARG B 106 ARG^? 5.91 C1 EDO A 302 A 273 ALA A 126 ALA.? 5.06 OXT ACT A 201 A 274 CYH A 127 CYH.? 6.15 O ACT A 202 A 277 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo -9.51 25.68 9.68 -7.48 27.13 11.50 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -15.76 27.26 20.69 -14.29 27.59 20.95 -28.54 64.52 70.82 -28.98 65.37 69.63 coo -17.65 30.57 20.48 -15.94 31.91 22.28 -31.19 62.06 71.95 -29.40 60.66 73.55 coo -14.96 35.49 18.53 -12.91 33.21 18.62 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 4 3exj_d00 TRANSCRIPTION/DNA user 5 4 # 5 A 245 ARG C 88 ARG^? 18.42 CH3 ACT D 201 A 273 ALA C 126 ALA.? 5.02 OXT ACT C 201 A 274 CYH C 127 CYH.? 10.01 O ACT D 201 A 277 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo -9.51 25.68 9.68 -7.48 27.13 11.50 -39.31 50.22 32.74 -39.14 52.99 31.45 coo -15.76 27.26 20.69 -14.29 27.59 20.95 -39.67 53.99 45.62 -38.91 53.15 46.65 coo -17.65 30.57 20.48 -15.94 31.91 22.28 -42.49 55.99 47.19 -42.84 57.56 44.90 coo -14.96 35.49 18.53 -12.91 33.21 18.62 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 4 3exj_d00 TRANSCRIPTION/DNA user 6 4 # 6 A 245 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 273 ALA D 126 ALA.? 5.05 O ACT D 201 A 274 CYH D 127 CYH.? 10.01 OXT ACT C 201 A 277 ARG D 51 ARG.? 7.60 O ACT D 201 coo -9.51 25.68 9.68 -7.48 27.13 11.50 -49.78 47.48 57.01 -51.73 47.13 59.31 coo -15.76 27.26 20.69 -14.29 27.59 20.95 -50.75 55.53 45.15 -51.51 56.79 44.72 coo -17.65 30.57 20.48 -15.94 31.91 22.28 -47.67 56.31 47.24 -47.42 53.67 48.08 coo -14.96 35.49 18.53 -12.91 33.21 18.62 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 4 3exj_d00 TRANSCRIPTION/DNA user 7 4 # 7 A 245 ARG D 88 ARG^? 18.35 CH3 ACT C 201 A 273 ALA D 126 ALA.? 5.05 O ACT D 201 A 274 CYH D 127 CYH.? 10.01 OXT ACT C 201 A 277 ARG D 49 ARG^? 10.44 O ACT D 201 coo -9.51 25.68 9.68 -7.48 27.13 11.50 -52.23 44.53 37.75 -52.43 42.56 40.08 coo -15.76 27.26 20.69 -14.29 27.59 20.95 -50.75 55.53 45.15 -51.51 56.79 44.72 coo -17.65 30.57 20.48 -15.94 31.91 22.28 -47.67 56.31 47.24 -47.42 53.67 48.08 coo -14.96 35.49 18.53 -12.91 33.21 18.62 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 4 3exj_d00 TRANSCRIPTION/DNA user 8 4 # 8 A 245 ARG D 106 ARG^? 14.88 OXT ACT D 201 A 273 ALA C 126 ALA.? 5.02 OXT ACT C 201 A 274 CYH C 127 CYH.? 10.01 O ACT D 201 A 277 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo -9.51 25.68 9.68 -7.48 27.13 11.50 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -15.76 27.26 20.69 -14.29 27.59 20.95 -39.67 53.99 45.62 -38.91 53.15 46.65 coo -17.65 30.57 20.48 -15.94 31.91 22.28 -42.49 55.99 47.19 -42.84 57.56 44.90 coo -14.96 35.49 18.53 -12.91 33.21 18.62 -39.28 57.54 52.97 -41.40 56.18 54.75 3exj_d00 source 3exj TRANSCRIPTION/DNA : 8 hits 3exj_d00 naa= 4 ULMN 4 3jxy_d00 HYDROLASE/DNA user 1 4 # 1 A 27 TYR A 42 TYR^? 9.79 CH3 ACT A 201 A 109 TRP A 30 TRP~? -4.28 CH3 ACT A 201s A 183 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 215 ARG A 92 ARG^? 14.09 CH3 ACT A 201 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -22.07 72.08 64.22 -24.60 72.36 65.39 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -35.15 70.11 80.06 -38.17 70.69 80.11 ULMN 4 3jxy_d00 HYDROLASE/DNA user 2 4 # 2 A 27 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 109 TRP A 30 TRP~? -4.28 CH3 ACT A 201s A 183 LYS A 62 LYS~? 17.60 O ACT A 201 A 215 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 4 3jxy_d00 HYDROLASE/DNA user 3 4 # 3 A 27 TYR A 93 TYR^? -4.07 CH3 ACT A 201s A 109 TRP A 30 TRP~? -4.28 CH3 ACT A 201s A 183 LYS A 62 LYS~? 17.60 O ACT A 201 A 215 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -34.34 70.13 71.57 -32.99 68.09 70.18 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -29.79 74.32 65.17 -29.61 70.47 64.42 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 4 3jxy_d00 HYDROLASE/DNA user 4 4 # 4 A 27 TYR A 108 TYR^? 12.28 O ACT A 201 A 109 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 183 LYS A 68 LYS~? -2.78 O ACT A 201s A 215 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -33.65 65.97 58.12 -34.39 67.56 63.36 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 4 3jxy_d00 HYDROLASE/DNA user 5 4 # 5 A 27 TYR A 108 TYR^? 12.28 O ACT A 201 A 109 TRP A 97 TRP^? -5.71 O1 EDO A 301s A 183 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 215 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -40.87 65.49 73.93 -43.61 66.01 74.07 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -41.41 66.78 64.19 -41.25 63.55 61.93 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 4 3jxy_d00 HYDROLASE/DNA user 6 4 # 6 A 27 TYR B 42 TYR^? 9.74 CH3 ACT B 201 A 109 TRP B 30 TRP~? -4.15 CH3 ACT B 201s A 183 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 215 ARG B 92 ARG^? -3.69 CH3 ACT A 202s coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -37.05 59.03 91.10 -34.97 58.34 89.38 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -31.05 54.49 87.84 -34.09 54.74 85.35 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -22.98 63.29 76.72 -21.11 61.06 75.76 ULMN 4 3jxy_d00 HYDROLASE/DNA user 7 4 # 7 A 27 TYR B 93 TYR^? -4.16 CH3 ACT B 201s A 109 TRP B 30 TRP~? -4.15 CH3 ACT B 201s A 183 LYS B 62 LYS~? 17.44 OXT ACT B 201 A 215 ARG B 67 ARG~? 13.55 O ACT B 201 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -27.85 57.31 80.17 -30.64 57.51 79.89 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -31.05 54.49 87.84 -34.09 54.74 85.35 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -45.57 49.20 81.23 -45.93 51.82 82.79 ULMN 4 3jxy_d00 HYDROLASE/DNA user 8 4 # 8 A 27 TYR C 42 TYR^? 9.67 CH3 ACT C 201 A 109 TRP C 30 TRP~? -4.24 CH3 ACT C 201s A 183 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 215 ARG C 92 ARG^? 13.71 CH3 ACT C 201 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -29.49 47.84 44.30 -31.93 47.16 45.50 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -49.94 47.28 44.16 -51.45 46.27 46.66 ULMN 4 3jxy_d00 HYDROLASE/DNA user 9 4 # 9 A 27 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 109 TRP C 30 TRP~? -4.24 CH3 ACT C 201s A 183 LYS C 62 LYS~? 12.50 O2 EDO A 302 A 215 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 4 3jxy_d00 HYDROLASE/DNA user 10 4 # 10 A 27 TYR C 93 TYR^? -4.09 CH3 ACT C 201s A 109 TRP C 30 TRP~? -4.24 CH3 ACT C 201s A 183 LYS C 62 LYS~? 12.50 O2 EDO A 302 A 215 ARG C 67 ARG~? 12.50 O2 EDO A 302 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -43.00 47.58 49.22 -41.38 49.87 49.22 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -34.65 44.47 49.46 -34.53 48.36 50.06 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -28.66 58.05 57.15 -27.52 58.08 54.30 ULMN 4 3jxy_d00 HYDROLASE/DNA user 11 4 # 11 A 27 TYR C 108 TYR^? 12.28 O ACT C 201 A 109 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 183 LYS C 68 LYS~? -2.77 O ACT C 201s A 215 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -49.57 50.97 53.11 -51.32 50.02 55.06 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -32.77 52.69 57.49 -37.10 50.68 54.61 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 4 3jxy_d00 HYDROLASE/DNA user 12 4 # 12 A 27 TYR C 108 TYR^? 12.28 O ACT C 201 A 109 TRP C 97 TRP^? -5.77 O2 EDO A 301s A 183 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 215 ARG A 67 ARG~? 13.20 O2 EDO A 302 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -49.57 50.97 53.11 -51.32 50.02 55.06 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -42.17 50.30 59.58 -40.82 53.66 61.13 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -30.04 61.33 54.76 -27.14 61.67 55.68 ULMN 4 3jxy_d00 HYDROLASE/DNA user 13 4 # 13 A 27 TYR D 42 TYR^? 9.84 CH3 ACT D 201 A 109 TRP D 30 TRP~? -4.23 CH3 ACT D 201s A 183 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 215 ARG D 92 ARG^? 13.56 CH3 ACT D 201 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -61.35 56.68 39.82 -58.87 57.88 39.36 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -55.89 62.34 37.62 -55.77 61.79 41.52 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -40.97 55.58 37.41 -39.40 58.23 37.46 ULMN 4 3jxy_d00 HYDROLASE/DNA user 14 4 # 14 A 27 TYR D 93 TYR^? -4.14 CH3 ACT D 201s A 109 TRP D 30 TRP~? -4.23 CH3 ACT D 201s A 183 LYS D 62 LYS~? 17.47 OXT ACT D 201 A 215 ARG D 67 ARG~? 13.15 O ACT A 203 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 -47.46 60.74 39.76 -48.96 60.10 42.05 coo 4.70 1.38 14.78 1.19 -0.08 15.75 -55.89 62.34 37.62 -55.77 61.79 41.52 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -60.60 65.68 53.30 -61.45 62.86 52.44 3jxy_d00 source 3jxy HYDROLASE/DNA : 14 hits 3jxy_d00 naa= 4 ULMN 4 3q05_d00 ANTITUMOR PROTEIN/DNA user 1 4 # 1 D 248 ARG A 88 ARG^? 11.13 CH3 ACT A 202 D 276 ALA A 126 ALA.? 5.06 OXT ACT A 201 D 277 CYH A 127 CYH.? 6.15 O ACT A 202 D 280 ARG A 49 ARG^? -3.92 O ACT A 202s coo -38.95 40.90 -11.07 -41.63 41.20 -9.56 -18.98 69.22 79.04 -17.48 66.59 79.46 coo -39.88 53.74 -8.80 -41.30 53.16 -8.72 -28.54 64.52 70.82 -28.98 65.37 69.63 coo -38.31 54.20 -5.36 -40.94 53.70 -4.50 -31.19 62.06 71.95 -29.40 60.66 73.55 coo -39.47 50.88 -0.65 -41.14 49.97 -3.05 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 4 3q05_d00 ANTITUMOR PROTEIN/DNA user 2 4 # 2 D 248 ARG A 106 ARG^? 14.48 O1 EDO A 301 D 276 ALA B 126 ALA.? 5.01 O ACT B 201 D 277 CYH B 127 CYH.? 10.07 OXT ACT A 201 D 280 ARG B 51 ARG.? 7.67 O ACT B 201 coo -38.95 40.90 -11.07 -41.63 41.20 -9.56 -44.60 68.65 71.93 -47.65 68.54 71.92 coo -39.88 53.74 -8.80 -41.30 53.16 -8.72 -34.85 61.51 79.63 -34.73 60.21 80.42 coo -38.31 54.20 -5.36 -40.94 53.70 -4.50 -34.42 60.97 75.89 -35.29 63.54 75.29 coo -39.47 50.88 -0.65 -41.14 49.97 -3.05 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 4 3q05_d00 ANTITUMOR PROTEIN/DNA user 3 4 # 3 D 248 ARG B 88 ARG^? 18.43 CH3 ACT A 201 D 276 ALA B 126 ALA.? 5.01 O ACT B 201 D 277 CYH B 127 CYH.? 10.07 OXT ACT A 201 D 280 ARG B 49 ARG^? 10.37 O ACT B 201 coo -38.95 40.90 -11.07 -41.63 41.20 -9.56 -31.74 72.75 86.26 -33.87 74.56 85.05 coo -39.88 53.74 -8.80 -41.30 53.16 -8.72 -34.85 61.51 79.63 -34.73 60.21 80.42 coo -38.31 54.20 -5.36 -40.94 53.70 -4.50 -34.42 60.97 75.89 -35.29 63.54 75.29 coo -39.47 50.88 -0.65 -41.14 49.97 -3.05 -40.89 64.28 77.45 -37.86 63.79 77.23 ULMN 4 3q05_d00 ANTITUMOR PROTEIN/DNA user 4 4 # 4 D 248 ARG B 106 ARG^? 5.91 C1 EDO A 302 D 276 ALA A 126 ALA.? 5.06 OXT ACT A 201 D 277 CYH A 127 CYH.? 6.15 O ACT A 202 D 280 ARG A 51 ARG.? 6.25 O1 EDO A 301 coo -38.95 40.90 -11.07 -41.63 41.20 -9.56 -23.54 51.33 72.85 -22.07 49.40 71.00 coo -39.88 53.74 -8.80 -41.30 53.16 -8.72 -28.54 64.52 70.82 -28.98 65.37 69.63 coo -38.31 54.20 -5.36 -40.94 53.70 -4.50 -31.19 62.06 71.95 -29.40 60.66 73.55 coo -39.47 50.88 -0.65 -41.14 49.97 -3.05 -33.46 60.54 65.68 -36.32 61.50 66.33 ULMN 4 3q05_d00 ANTITUMOR PROTEIN/DNA user 5 4 # 5 D 248 ARG C 88 ARG^? 18.42 CH3 ACT D 201 D 276 ALA C 126 ALA.? 5.02 OXT ACT C 201 D 277 CYH C 127 CYH.? 10.01 O ACT D 201 D 280 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo -38.95 40.90 -11.07 -41.63 41.20 -9.56 -39.31 50.22 32.74 -39.14 52.99 31.45 coo -39.88 53.74 -8.80 -41.30 53.16 -8.72 -39.67 53.99 45.62 -38.91 53.15 46.65 coo -38.31 54.20 -5.36 -40.94 53.70 -4.50 -42.49 55.99 47.19 -42.84 57.56 44.90 coo -39.47 50.88 -0.65 -41.14 49.97 -3.05 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 4 3q05_d00 ANTITUMOR PROTEIN/DNA user 6 4 # 6 D 248 ARG C 106 ARG^? 14.47 O2 EDO A 301 D 276 ALA D 126 ALA.? 5.05 O ACT D 201 D 277 CYH D 127 CYH.? 10.01 OXT ACT C 201 D 280 ARG D 51 ARG.? 7.60 O ACT D 201 coo -38.95 40.90 -11.07 -41.63 41.20 -9.56 -49.78 47.48 57.01 -51.73 47.13 59.31 coo -39.88 53.74 -8.80 -41.30 53.16 -8.72 -50.75 55.53 45.15 -51.51 56.79 44.72 coo -38.31 54.20 -5.36 -40.94 53.70 -4.50 -47.67 56.31 47.24 -47.42 53.67 48.08 coo -39.47 50.88 -0.65 -41.14 49.97 -3.05 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 4 3q05_d00 ANTITUMOR PROTEIN/DNA user 7 4 # 7 D 248 ARG D 88 ARG^? 18.35 CH3 ACT C 201 D 276 ALA D 126 ALA.? 5.05 O ACT D 201 D 277 CYH D 127 CYH.? 10.01 OXT ACT C 201 D 280 ARG D 49 ARG^? 10.44 O ACT D 201 coo -38.95 40.90 -11.07 -41.63 41.20 -9.56 -52.23 44.53 37.75 -52.43 42.56 40.08 coo -39.88 53.74 -8.80 -41.30 53.16 -8.72 -50.75 55.53 45.15 -51.51 56.79 44.72 coo -38.31 54.20 -5.36 -40.94 53.70 -4.50 -47.67 56.31 47.24 -47.42 53.67 48.08 coo -39.47 50.88 -0.65 -41.14 49.97 -3.05 -52.37 52.11 51.12 -50.46 52.95 48.87 ULMN 4 3q05_d00 ANTITUMOR PROTEIN/DNA user 8 4 # 8 D 248 ARG D 106 ARG^? 14.88 OXT ACT D 201 D 276 ALA C 126 ALA.? 5.02 OXT ACT C 201 D 277 CYH C 127 CYH.? 10.01 O ACT D 201 D 280 ARG C 51 ARG.? 6.22 O2 EDO A 301 coo -38.95 40.90 -11.07 -41.63 41.20 -9.56 -40.22 67.90 41.60 -38.15 70.12 41.98 coo -39.88 53.74 -8.80 -41.30 53.16 -8.72 -39.67 53.99 45.62 -38.91 53.15 46.65 coo -38.31 54.20 -5.36 -40.94 53.70 -4.50 -42.49 55.99 47.19 -42.84 57.56 44.90 coo -39.47 50.88 -0.65 -41.14 49.97 -3.05 -39.28 57.54 52.97 -41.40 56.18 54.75 3q05_d00 source 3q05 ANTITUMOR PROTEIN/DNA : 8 hits 3q05_d00 naa= 4 ULMN 3 3qsv_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 81 ARG A 138 ARG~? 6.49 OXT ACT A 203 A 83 GLN A 136 GLN~? 10.47 OXT ACT A 203 A 88 LYS A 134 LYS~? 11.98 O ACT A 203 coo 19.97 2.61 -45.02 18.79 3.68 -42.41 -50.06 71.52 64.11 -49.59 74.03 62.40 coo 24.10 10.39 -42.90 23.65 10.53 -40.83 -56.96 68.29 67.10 -57.39 67.81 65.07 coo 20.32 8.01 -45.76 23.08 6.63 -41.24 -53.24 65.33 66.31 -57.37 62.85 65.73 ULMN 3 3qsv_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 81 ARG C 138 ARG~? 16.31 O ACT C 201 A 83 GLN C 136 GLN~? 18.58 O2 EDO A 301 A 88 LYS C 134 LYS~? 17.33 O2 EDO A 301 coo 19.97 2.61 -45.02 18.79 3.68 -42.41 -46.75 44.46 65.88 -44.64 42.30 66.40 coo 24.10 10.39 -42.90 23.65 10.53 -40.83 -54.02 45.96 69.33 -53.29 47.10 70.97 coo 20.32 8.01 -45.76 23.08 6.63 -41.24 -51.34 49.79 67.51 -53.85 50.99 71.42 ULMN 3 3qsv_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 81 ARG D 138 ARG~? 16.38 OXT ACT D 201 A 83 GLN D 136 GLN~? 22.15 CH3 ACT A 203 A 88 LYS D 134 LYS~? 17.34 O ACT A 201 coo 19.97 2.61 -45.02 18.79 3.68 -42.41 -42.61 77.59 41.75 -44.95 78.80 40.20 coo 24.10 10.39 -42.90 23.65 10.53 -40.83 -34.63 79.41 43.23 -34.21 80.38 45.07 coo 20.32 8.01 -45.76 23.08 6.63 -41.24 -37.62 76.93 46.97 -33.08 76.47 49.79 3qsv_d00 source 3qsv TRANSCRIPTION/DNA : 3 hits 3qsv_d00 naa= 3 ULMN 4 4ail_d00 TRANSFERASE user 1 4 # 1 C 495 TYR B 75 TYR^? -4.59 OXT ACT B 201s C 593 LYS C 71 LYS~? 4.19 C1 EDO A 301 C 613 ARG C 33 ARG.? 12.41 O ACT C 201 C 615 ASP C 34 ASP~? 14.66 O ACT C 201 coo 15.47 67.10 68.66 15.00 68.14 71.20 -30.51 47.57 81.98 -30.49 50.30 82.57 coo -0.58 65.96 78.57 4.36 67.40 76.38 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -0.42 56.97 83.23 2.13 57.80 84.74 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 1.55 52.45 87.75 1.51 54.41 86.94 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 4 4ail_d00 TRANSFERASE user 2 4 # 2 C 495 TYR B 93 TYR^? -4.16 CH3 ACT B 201s C 593 LYS C 71 LYS~? 4.19 C1 EDO A 301 C 613 ARG C 33 ARG.? 12.41 O ACT C 201 C 615 ASP C 34 ASP~? 14.66 O ACT C 201 coo 15.47 67.10 68.66 15.00 68.14 71.20 -27.85 57.31 80.17 -30.64 57.51 79.89 coo -0.58 65.96 78.57 4.36 67.40 76.38 -34.21 53.47 62.64 -37.24 57.55 64.61 coo -0.42 56.97 83.23 2.13 57.80 84.74 -34.58 43.27 59.73 -33.36 40.62 60.70 coo 1.55 52.45 87.75 1.51 54.41 86.94 -27.83 42.08 55.68 -25.73 41.87 55.54 ULMN 4 4ail_d00 TRANSFERASE user 3 4 # 3 C 495 TYR D 75 TYR^? -4.49 OXT ACT D 201s C 593 LYS A 71 LYS~? 4.32 C2 EDO A 301 C 613 ARG A 33 ARG.? 12.39 O ACT A 201 C 615 ASP A 34 ASP~? 14.63 O ACT A 201 coo 15.47 67.10 68.66 15.00 68.14 71.20 -52.06 69.71 41.47 -52.08 66.98 40.85 coo -0.58 65.96 78.57 4.36 67.40 76.38 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -0.42 56.97 83.23 2.13 57.80 84.74 -37.81 74.92 58.71 -38.09 77.66 57.35 coo 1.55 52.45 87.75 1.51 54.41 86.94 -30.67 77.29 56.10 -29.14 77.80 54.72 ULMN 4 4ail_d00 TRANSFERASE user 4 4 # 4 C 495 TYR D 93 TYR^? -4.14 CH3 ACT D 201s C 593 LYS A 71 LYS~? 4.32 C2 EDO A 301 C 613 ARG A 33 ARG.? 12.39 O ACT A 201 C 615 ASP A 34 ASP~? 14.63 O ACT A 201 coo 15.47 67.10 68.66 15.00 68.14 71.20 -47.46 60.74 39.76 -48.96 60.10 42.05 coo -0.58 65.96 78.57 4.36 67.40 76.38 -38.35 64.60 55.93 -41.15 60.07 56.77 coo -0.42 56.97 83.23 2.13 57.80 84.74 -37.81 74.92 58.71 -38.09 77.66 57.35 coo 1.55 52.45 87.75 1.51 54.41 86.94 -30.67 77.29 56.10 -29.14 77.80 54.72 4ail_d00 source 4ail TRANSFERASE : 4 hits 4ail_d00 naa= 4 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 78 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 82 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 97 ARG A 49 ARG^? -3.92 O ACT A 202s coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -25.12 58.31 69.83 -26.93 60.25 71.40 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 78 ARG A 51 ARG.? 6.25 O1 EDO A 301 A 82 LYS C 71 LYS~? 4.19 C1 EDO A 301 A 97 ARG B 51 ARG.? 7.67 O ACT B 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -33.46 60.54 65.68 -36.32 61.50 66.33 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -34.21 53.47 62.64 -37.24 57.55 64.61 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -37.69 55.58 74.87 -35.47 53.51 74.34 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 78 ARG A 58 ARG~? 18.13 CH3 ACT A 201 A 82 LYS A 62 LYS~? 17.60 O ACT A 201 A 97 ARG A 8 ARG.? 15.23 CH3 ACT A 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -18.95 73.08 58.27 -17.11 75.32 59.26 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -24.69 69.09 56.72 -23.65 73.04 51.86 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -20.16 79.98 64.14 -22.57 80.76 62.41 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 78 ARG A 147 ARG.? 13.06 CH3 ACT A 201 A 82 LYS A 79 LYS^? -3.45 CH3 ACT A 201s A 97 ARG A 33 ARG.? 12.39 O ACT A 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -40.14 80.19 70.35 -38.27 80.75 72.73 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -34.66 75.11 72.84 -31.25 72.89 69.03 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -37.81 74.92 58.71 -38.09 77.66 57.35 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 78 ARG B 8 ARG.? 14.49 CH3 ACT B 201 A 82 LYS B 22 LYS~? 15.43 CH3 ACT B 201 A 97 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 78 ARG B 8 ARG.? 14.49 CH3 ACT B 201 A 82 LYS B 22 LYS~? 15.43 CH3 ACT B 201 A 97 ARG B 124 ARG.? -3.52 O ACT B 201s coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -31.04 58.38 97.06 -32.26 55.57 97.13 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -24.70 61.49 92.69 -28.99 62.66 95.83 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -35.55 59.87 85.38 -34.97 57.89 83.09 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 A 78 ARG B 58 ARG~? 17.86 CH3 ACT B 201 A 82 LYS B 62 LYS~? 17.44 OXT ACT B 201 A 97 ARG B 8 ARG.? 14.49 CH3 ACT B 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -31.04 58.38 97.06 -32.26 55.57 97.13 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 A 78 ARG B 58 ARG~? 17.86 CH3 ACT B 201 A 82 LYS B 62 LYS~? 17.44 OXT ACT B 201 A 97 ARG B 37 ARG~? 13.57 CH3 ACT B 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -41.40 56.24 95.43 -40.17 57.59 97.88 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -42.04 52.32 89.45 -42.77 48.33 94.37 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -31.32 49.06 94.80 -28.26 48.93 94.55 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 A 78 ARG B 147 ARG.? 12.52 CH3 ACT A 202 A 82 LYS B 79 LYS^? -3.44 CH3 ACT B 201s A 97 ARG B 33 ARG.? 12.67 OXT ACT B 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -19.28 50.88 84.48 -18.42 53.72 85.30 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -23.75 57.07 83.29 -29.11 56.74 84.70 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -30.14 45.04 86.20 -29.28 42.52 87.71 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 10 3 # 10 A 78 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 82 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 97 ARG C 49 ARG^? 10.47 OXT ACT C 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -37.64 60.68 44.02 -39.72 58.44 44.33 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 11 3 # 11 A 78 ARG C 51 ARG.? 6.22 O2 EDO A 301 A 82 LYS A 71 LYS~? 4.32 C2 EDO A 301 A 97 ARG D 51 ARG.? 7.60 O ACT D 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -39.28 57.54 52.97 -41.40 56.18 54.75 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -38.35 64.60 55.93 -41.15 60.07 56.77 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -49.81 61.30 50.74 -48.26 63.65 49.51 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 12 3 # 12 A 78 ARG C 58 ARG~? 18.03 CH3 ACT C 201 A 82 LYS C 62 LYS~? 12.50 O2 EDO A 302 A 97 ARG C 8 ARG.? 14.74 CH3 ACT C 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -27.18 40.10 42.21 -27.55 39.63 45.22 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 13 3 # 13 A 78 ARG C 58 ARG~? 18.03 CH3 ACT C 201 A 82 LYS C 62 LYS~? 12.50 O2 EDO A 302 A 97 ARG C 37 ARG~? 13.73 CH3 ACT C 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -22.97 47.67 45.60 -22.11 45.78 43.37 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -25.76 50.99 51.27 -20.80 47.54 53.29 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -28.52 38.86 52.29 -30.70 36.70 52.27 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 14 3 # 14 A 78 ARG C 147 ARG.? 13.23 CH3 ACT C 201 A 82 LYS C 79 LYS^? -3.44 CH3 ACT C 201s A 97 ARG C 33 ARG.? 12.41 O ACT C 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -44.23 36.97 53.78 -44.90 36.38 50.84 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -43.47 42.54 48.33 -38.69 45.48 48.28 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -34.58 43.27 59.73 -33.36 40.62 60.70 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 15 3 # 15 A 78 ARG D 58 ARG~? 18.01 CH3 ACT D 201 A 82 LYS D 62 LYS~? 17.47 OXT ACT D 201 A 97 ARG D 8 ARG.? 14.56 CH3 ACT D 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -64.40 57.42 32.12 -63.44 60.33 32.35 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 16 3 # 16 A 78 ARG D 58 ARG~? 18.01 CH3 ACT D 201 A 82 LYS D 62 LYS~? 17.47 OXT ACT D 201 A 97 ARG D 37 ARG~? 13.59 CH3 ACT D 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -67.82 58.42 40.52 -68.76 57.03 37.97 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -64.21 62.59 45.12 -69.12 65.87 42.83 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -62.21 67.18 33.74 -60.13 67.79 31.56 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 17 3 # 17 A 78 ARG D 147 ARG.? 13.02 CH3 ACT D 201 A 82 LYS D 79 LYS^? -3.52 CH3 ACT D 201s A 97 ARG D 33 ARG.? 12.34 OXT ACT D 201 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -46.62 68.18 31.08 -46.22 65.54 29.55 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -47.37 61.41 34.65 -51.85 60.71 37.83 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -55.21 72.58 39.53 -56.74 74.11 37.37 4er8_d00 source 4er8 DNA BINDING PROTEIN/DNA : 17 hits 4er8_d00 naa= 3 ULMN 4 4hc9_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 274 LEU B 77 LEU^? 4.66 CH3 ACT B 201 A 276 ARG B 33 ARG.? 12.67 OXT ACT B 201 A 286 ASN B 31 ASN~? 8.56 CH3 ACT B 201 A 290 LEU B 144 LEU.? 13.62 OXT ACT B 201 coo 31.69-116.09 43.91 30.77-114.93 45.50 -26.87 51.40 83.00 -27.59 53.42 83.20 coo 34.46-110.93 43.44 34.34-111.70 46.42 -30.14 45.04 86.20 -29.28 42.52 87.71 coo 35.39-115.43 42.05 36.33-115.36 43.98 -26.33 48.60 87.43 -25.42 49.22 85.60 coo 39.69-111.39 44.20 38.46-112.42 45.66 -26.37 41.09 85.96 -27.47 41.10 84.11 4hc9_d00 source 4hc9 TRANSCRIPTION/DNA : 1 hits 4hc9_d00 naa= 4 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 98 HIS^? -3.60 C ACT A 203s A 208 ASP A 130 ASP.? 4.80 O1 EDO A 301 A 296 SER A 39 SER~? 14.37 CH3 ACT A 201 coo 12.72 17.48 24.71 12.80 19.37 23.81 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 18.47 29.19 29.68 19.30 29.17 27.75 -41.07 60.81 67.56 -39.08 61.04 66.87 coo 6.89 17.22 46.63 5.08 16.21 47.91 -23.46 73.59 59.60 -22.83 73.90 57.26 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 208 ASP B 130 ASP.? 9.25 OXT ACT B 201 A 296 SER B 39 SER~? 14.17 CH3 ACT B 201 coo 12.72 17.48 24.71 12.80 19.37 23.81 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 18.47 29.19 29.68 19.30 29.17 27.75 -33.09 51.46 70.73 -34.18 51.80 72.52 coo 6.89 17.22 46.63 5.08 16.21 47.91 -38.00 54.38 92.68 -39.49 53.00 94.02 ULMN 3 2odj_o00 PORIN D user 3 3 # 3 A 156 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 208 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 296 SER B 39 SER~? 14.17 CH3 ACT B 201 coo 12.72 17.48 24.71 12.80 19.37 23.81 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 18.47 29.19 29.68 19.30 29.17 27.75 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 6.89 17.22 46.63 5.08 16.21 47.91 -38.00 54.38 92.68 -39.49 53.00 94.02 ULMN 3 2odj_o00 PORIN D user 4 3 # 4 A 156 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 208 ASP C 100 ASP.? 9.05 C1 EDO A 301 A 296 SER B 155 SER~? 6.88 CH3 ACT A 202 coo 12.72 17.48 24.71 12.80 19.37 23.81 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 18.47 29.19 29.68 19.30 29.17 27.75 -35.91 53.92 69.56 -35.19 55.74 68.76 coo 6.89 17.22 46.63 5.08 16.21 47.91 -15.94 58.44 77.26 -16.71 60.70 77.77 ULMN 3 2odj_o00 PORIN D user 5 3 # 5 A 156 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 208 ASP C 130 ASP.? 4.74 O2 EDO A 301 A 296 SER C 39 SER~? 14.22 CH3 ACT C 201 coo 12.72 17.48 24.71 12.80 19.37 23.81 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 18.47 29.19 29.68 19.30 29.17 27.75 -45.39 56.07 57.68 -43.60 56.21 56.54 coo 6.89 17.22 46.63 5.08 16.21 47.91 -26.65 46.46 48.19 -24.39 46.43 49.12 ULMN 3 2odj_o00 PORIN D user 6 3 # 6 A 156 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 208 ASP A 100 ASP.? 9.07 O2 EDO A 301 A 296 SER D 39 SER~? 14.16 CH3 ACT D 201 coo 12.72 17.48 24.71 12.80 19.37 23.81 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 18.47 29.19 29.68 19.30 29.17 27.75 -44.77 63.42 52.85 -43.43 61.81 52.77 coo 6.89 17.22 46.63 5.08 16.21 47.91 -63.83 60.97 39.81 -65.97 62.00 40.33 ULMN 3 2odj_o00 PORIN D user 7 3 # 7 A 156 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 208 ASP D 130 ASP.? 7.40 CH3 ACT A 203 A 296 SER D 39 SER~? 14.16 CH3 ACT D 201 coo 12.72 17.48 24.71 12.80 19.37 23.81 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 18.47 29.19 29.68 19.30 29.17 27.75 -44.22 66.27 50.20 -46.22 65.66 49.92 coo 6.89 17.22 46.63 5.08 16.21 47.91 -63.83 60.97 39.81 -65.97 62.00 40.33 2odj_o00 source 2ODJ PORIN D : 7 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 98 HIS^? -3.60 C ACT A 203s B 208 ASP A 130 ASP.? 4.80 O1 EDO A 301 B 296 SER A 39 SER~? 14.37 CH3 ACT A 201 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -41.07 60.81 67.56 -39.08 61.04 66.87 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -23.46 73.59 59.60 -22.83 73.90 57.26 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS A 151 HIS.? 15.97 CH3 ACT A 201 B 208 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 296 SER A 39 SER~? 14.37 CH3 ACT A 201 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -43.83 81.49 70.61 -45.02 79.78 70.42 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -23.46 73.59 59.60 -22.83 73.90 57.26 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 208 ASP B 130 ASP.? 9.25 OXT ACT B 201 B 296 SER B 39 SER~? 14.17 CH3 ACT B 201 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -33.09 51.46 70.73 -34.18 51.80 72.52 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -38.00 54.38 92.68 -39.49 53.00 94.02 ULMN 3 2odj_o01 PORIN D user 4 3 # 4 B 156 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 208 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 296 SER B 39 SER~? 14.17 CH3 ACT B 201 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -38.00 54.38 92.68 -39.49 53.00 94.02 ULMN 3 2odj_o01 PORIN D user 5 3 # 5 B 156 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 208 ASP C 100 ASP.? 9.05 C1 EDO A 301 B 296 SER B 155 SER~? 6.88 CH3 ACT A 202 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -35.91 53.92 69.56 -35.19 55.74 68.76 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -15.94 58.44 77.26 -16.71 60.70 77.77 ULMN 3 2odj_o01 PORIN D user 6 3 # 6 B 156 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 208 ASP C 130 ASP.? 4.74 O2 EDO A 301 B 296 SER C 39 SER~? 14.22 CH3 ACT C 201 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -45.39 56.07 57.68 -43.60 56.21 56.54 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -26.65 46.46 48.19 -24.39 46.43 49.12 ULMN 3 2odj_o01 PORIN D user 7 3 # 7 B 156 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 208 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 296 SER D 39 SER~? 14.16 CH3 ACT D 201 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -63.83 60.97 39.81 -65.97 62.00 40.33 ULMN 3 2odj_o01 PORIN D user 8 3 # 8 B 156 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 208 ASP A 100 ASP.? 9.07 O2 EDO A 301 B 296 SER D 155 SER.? 16.53 CH3 ACT D 201 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -44.77 63.42 52.85 -43.43 61.81 52.77 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -37.80 61.65 32.35 -38.17 59.27 32.14 ULMN 3 2odj_o01 PORIN D user 9 3 # 9 B 156 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 208 ASP D 130 ASP.? 7.40 CH3 ACT A 203 B 296 SER D 39 SER~? 14.16 CH3 ACT D 201 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -44.22 66.27 50.20 -46.22 65.66 49.92 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -63.83 60.97 39.81 -65.97 62.00 40.33 2odj_o01 source 2ODJ PORIN D : 9 hits 2odj_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 107 SER^? 6.74 O1 EDO A 301 A 166 PHE B 54 PHE^? 14.58 O ACT B 201 A 182 PHE B 125 PHE.? 13.16 O ACT B 201 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -40.35 65.45 69.21 -39.92 64.63 66.96 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -45.35 62.65 79.93 -44.68 64.28 77.75 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -37.18 66.81 81.74 -39.05 68.51 82.95 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 155 SER~? 16.89 CH3 ACT A 201 A 166 PHE B 125 PHE.? 13.16 O ACT B 201 A 182 PHE B 54 PHE^? 14.58 O ACT B 201 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -40.89 76.76 80.50 -38.67 76.97 81.48 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -37.18 66.81 81.74 -39.05 68.51 82.95 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -45.35 62.65 79.93 -44.68 64.28 77.75 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER B 107 SER^? 7.39 OXT ACT B 201 A 166 PHE A 54 PHE^? -3.83 O1 EDO A 302s A 182 PHE A 125 PHE.? -4.61 O ACT A 202s coo -46.28 37.24 81.97 -44.96 39.32 82.40 -29.25 52.59 73.85 -31.29 51.35 74.31 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -22.35 57.66 65.34 -22.90 56.19 67.67 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -22.79 63.54 72.77 -20.07 62.88 72.67 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER B 155 SER~? 6.88 CH3 ACT A 202 A 166 PHE A 125 PHE.? -4.61 O ACT A 202s A 182 PHE A 54 PHE^? -3.83 O1 EDO A 302s coo -46.28 37.24 81.97 -44.96 39.32 82.40 -15.94 58.44 77.26 -16.71 60.70 77.77 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -22.79 63.54 72.77 -20.07 62.88 72.67 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -22.35 57.66 65.34 -22.90 56.19 67.67 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER C 107 SER^? 6.74 O2 EDO A 301 A 166 PHE D 54 PHE^? 14.64 O ACT D 201 A 182 PHE D 125 PHE.? 13.16 O ACT D 201 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -45.59 51.52 55.69 -43.69 52.48 56.86 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -57.35 52.85 53.07 -55.03 51.53 53.92 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -52.98 49.81 45.21 -54.80 47.77 45.79 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER C 155 SER~? 16.28 CH3 ACT C 201 A 166 PHE D 125 PHE.? 13.16 O ACT D 201 A 182 PHE D 54 PHE^? 14.64 O ACT D 201 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -53.12 40.76 48.56 -52.79 41.59 46.30 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -52.98 49.81 45.21 -54.80 47.77 45.79 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -57.35 52.85 53.07 -55.03 51.53 53.92 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 7 3 # 7 A 130 SER D 107 SER^? 7.30 OXT ACT D 201 A 166 PHE C 54 PHE^? 14.66 OXT ACT C 201 A 182 PHE C 125 PHE.? 13.13 OXT ACT C 201 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -44.25 65.54 45.21 -46.11 66.36 46.55 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -32.62 62.02 44.82 -34.97 63.26 43.94 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -37.61 55.67 40.06 -35.81 56.68 38.17 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 8 3 # 8 A 130 SER D 155 SER.? 16.53 CH3 ACT D 201 A 166 PHE C 125 PHE.? 13.13 OXT ACT C 201 A 182 PHE C 54 PHE^? 14.66 OXT ACT C 201 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -37.80 61.65 32.35 -38.17 59.27 32.14 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -37.61 55.67 40.06 -35.81 56.68 38.17 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -32.62 62.02 44.82 -34.97 63.26 43.94 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 8 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 107 SER^? 6.74 O1 EDO A 301 B 166 PHE B 54 PHE^? 14.58 O ACT B 201 B 182 PHE B 125 PHE.? 13.16 O ACT B 201 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -40.35 65.45 69.21 -39.92 64.63 66.96 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -45.35 62.65 79.93 -44.68 64.28 77.75 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -37.18 66.81 81.74 -39.05 68.51 82.95 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 155 SER~? 16.89 CH3 ACT A 201 B 166 PHE B 125 PHE.? 13.16 O ACT B 201 B 182 PHE B 54 PHE^? 14.58 O ACT B 201 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -40.89 76.76 80.50 -38.67 76.97 81.48 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -37.18 66.81 81.74 -39.05 68.51 82.95 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -45.35 62.65 79.93 -44.68 64.28 77.75 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER B 107 SER^? 7.39 OXT ACT B 201 B 166 PHE A 54 PHE^? -3.83 O1 EDO A 302s B 182 PHE A 125 PHE.? -4.61 O ACT A 202s coo -19.94 46.29 97.83 -22.38 46.56 97.60 -29.25 52.59 73.85 -31.29 51.35 74.31 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -22.35 57.66 65.34 -22.90 56.19 67.67 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -22.79 63.54 72.77 -20.07 62.88 72.67 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER B 155 SER~? 6.88 CH3 ACT A 202 B 166 PHE A 125 PHE.? -4.61 O ACT A 202s B 182 PHE A 54 PHE^? -3.83 O1 EDO A 302s coo -19.94 46.29 97.83 -22.38 46.56 97.60 -15.94 58.44 77.26 -16.71 60.70 77.77 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -22.79 63.54 72.77 -20.07 62.88 72.67 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -22.35 57.66 65.34 -22.90 56.19 67.67 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER C 107 SER^? 6.74 O2 EDO A 301 B 166 PHE D 54 PHE^? 14.64 O ACT D 201 B 182 PHE D 125 PHE.? 13.16 O ACT D 201 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -45.59 51.52 55.69 -43.69 52.48 56.86 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -57.35 52.85 53.07 -55.03 51.53 53.92 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -52.98 49.81 45.21 -54.80 47.77 45.79 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER C 155 SER~? 16.28 CH3 ACT C 201 B 166 PHE D 125 PHE.? 13.16 O ACT D 201 B 182 PHE D 54 PHE^? 14.64 O ACT D 201 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -53.12 40.76 48.56 -52.79 41.59 46.30 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -52.98 49.81 45.21 -54.80 47.77 45.79 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -57.35 52.85 53.07 -55.03 51.53 53.92 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER D 107 SER^? 7.30 OXT ACT D 201 B 166 PHE C 54 PHE^? 14.66 OXT ACT C 201 B 182 PHE C 125 PHE.? 13.13 OXT ACT C 201 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -44.25 65.54 45.21 -46.11 66.36 46.55 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -32.62 62.02 44.82 -34.97 63.26 43.94 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -37.61 55.67 40.06 -35.81 56.68 38.17 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 8 3 # 8 B 130 SER D 155 SER.? 16.53 CH3 ACT D 201 B 166 PHE C 125 PHE.? 13.13 OXT ACT C 201 B 182 PHE C 54 PHE^? 14.66 OXT ACT C 201 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -37.80 61.65 32.35 -38.17 59.27 32.14 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -37.61 55.67 40.06 -35.81 56.68 38.17 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -32.62 62.02 44.82 -34.97 63.26 43.94 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 8 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 107 SER^? 6.74 O1 EDO A 301 C 166 PHE B 54 PHE^? 14.58 O ACT B 201 C 182 PHE B 125 PHE.? 13.16 O ACT B 201 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -40.35 65.45 69.21 -39.92 64.63 66.96 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -45.35 62.65 79.93 -44.68 64.28 77.75 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -37.18 66.81 81.74 -39.05 68.51 82.95 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 155 SER~? 16.89 CH3 ACT A 201 C 166 PHE B 125 PHE.? 13.16 O ACT B 201 C 182 PHE B 54 PHE^? 14.58 O ACT B 201 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -40.89 76.76 80.50 -38.67 76.97 81.48 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -37.18 66.81 81.74 -39.05 68.51 82.95 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -45.35 62.65 79.93 -44.68 64.28 77.75 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER B 107 SER^? 7.39 OXT ACT B 201 C 166 PHE A 54 PHE^? -3.83 O1 EDO A 302s C 182 PHE A 125 PHE.? -4.61 O ACT A 202s coo -2.19 64.27 51.12 -3.34 62.10 50.60 -29.25 52.59 73.85 -31.29 51.35 74.31 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -22.35 57.66 65.34 -22.90 56.19 67.67 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -22.79 63.54 72.77 -20.07 62.88 72.67 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER B 155 SER~? 6.88 CH3 ACT A 202 C 166 PHE A 125 PHE.? -4.61 O ACT A 202s C 182 PHE A 54 PHE^? -3.83 O1 EDO A 302s coo -2.19 64.27 51.12 -3.34 62.10 50.60 -15.94 58.44 77.26 -16.71 60.70 77.77 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -22.79 63.54 72.77 -20.07 62.88 72.67 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -22.35 57.66 65.34 -22.90 56.19 67.67 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER C 107 SER^? 6.74 O2 EDO A 301 C 166 PHE D 54 PHE^? 14.64 O ACT D 201 C 182 PHE D 125 PHE.? 13.16 O ACT D 201 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -45.59 51.52 55.69 -43.69 52.48 56.86 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -57.35 52.85 53.07 -55.03 51.53 53.92 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -52.98 49.81 45.21 -54.80 47.77 45.79 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER C 155 SER~? 16.28 CH3 ACT C 201 C 166 PHE D 125 PHE.? 13.16 O ACT D 201 C 182 PHE D 54 PHE^? 14.64 O ACT D 201 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -53.12 40.76 48.56 -52.79 41.59 46.30 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -52.98 49.81 45.21 -54.80 47.77 45.79 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -57.35 52.85 53.07 -55.03 51.53 53.92 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER D 107 SER^? 7.30 OXT ACT D 201 C 166 PHE C 54 PHE^? 14.66 OXT ACT C 201 C 182 PHE C 125 PHE.? 13.13 OXT ACT C 201 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -44.25 65.54 45.21 -46.11 66.36 46.55 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -32.62 62.02 44.82 -34.97 63.26 43.94 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -37.61 55.67 40.06 -35.81 56.68 38.17 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 8 3 # 8 C 130 SER D 155 SER.? 16.53 CH3 ACT D 201 C 166 PHE C 125 PHE.? 13.13 OXT ACT C 201 C 182 PHE C 54 PHE^? 14.66 OXT ACT C 201 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -37.80 61.65 32.35 -38.17 59.27 32.14 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -37.61 55.67 40.06 -35.81 56.68 38.17 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -32.62 62.02 44.82 -34.97 63.26 43.94 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 8 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 107 SER^? 6.74 O1 EDO A 301 D 166 PHE B 54 PHE^? 14.58 O ACT B 201 D 182 PHE B 125 PHE.? 13.16 O ACT B 201 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -40.35 65.45 69.21 -39.92 64.63 66.96 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -45.35 62.65 79.93 -44.68 64.28 77.75 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -37.18 66.81 81.74 -39.05 68.51 82.95 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 155 SER~? 16.89 CH3 ACT A 201 D 166 PHE B 125 PHE.? 13.16 O ACT B 201 D 182 PHE B 54 PHE^? 14.58 O ACT B 201 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -40.89 76.76 80.50 -38.67 76.97 81.48 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -37.18 66.81 81.74 -39.05 68.51 82.95 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -45.35 62.65 79.93 -44.68 64.28 77.75 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER B 107 SER^? 7.39 OXT ACT B 201 D 166 PHE A 54 PHE^? -3.83 O1 EDO A 302s D 182 PHE A 125 PHE.? -4.61 O ACT A 202s coo -32.42 55.27 46.18 -30.51 54.94 47.67 -29.25 52.59 73.85 -31.29 51.35 74.31 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -22.35 57.66 65.34 -22.90 56.19 67.67 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -22.79 63.54 72.77 -20.07 62.88 72.67 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER B 155 SER~? 6.88 CH3 ACT A 202 D 166 PHE A 125 PHE.? -4.61 O ACT A 202s D 182 PHE A 54 PHE^? -3.83 O1 EDO A 302s coo -32.42 55.27 46.18 -30.51 54.94 47.67 -15.94 58.44 77.26 -16.71 60.70 77.77 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -22.79 63.54 72.77 -20.07 62.88 72.67 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -22.35 57.66 65.34 -22.90 56.19 67.67 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER C 107 SER^? 6.74 O2 EDO A 301 D 166 PHE D 54 PHE^? 14.64 O ACT D 201 D 182 PHE D 125 PHE.? 13.16 O ACT D 201 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -45.59 51.52 55.69 -43.69 52.48 56.86 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -57.35 52.85 53.07 -55.03 51.53 53.92 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -52.98 49.81 45.21 -54.80 47.77 45.79 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER C 155 SER~? 16.28 CH3 ACT C 201 D 166 PHE D 125 PHE.? 13.16 O ACT D 201 D 182 PHE D 54 PHE^? 14.64 O ACT D 201 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -53.12 40.76 48.56 -52.79 41.59 46.30 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -52.98 49.81 45.21 -54.80 47.77 45.79 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -57.35 52.85 53.07 -55.03 51.53 53.92 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER D 107 SER^? 7.30 OXT ACT D 201 D 166 PHE C 54 PHE^? 14.66 OXT ACT C 201 D 182 PHE C 125 PHE.? 13.13 OXT ACT C 201 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -44.25 65.54 45.21 -46.11 66.36 46.55 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -32.62 62.02 44.82 -34.97 63.26 43.94 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -37.61 55.67 40.06 -35.81 56.68 38.17 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER D 155 SER.? 16.53 CH3 ACT D 201 D 166 PHE C 125 PHE.? 13.13 OXT ACT C 201 D 182 PHE C 54 PHE^? 14.66 OXT ACT C 201 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -37.80 61.65 32.35 -38.17 59.27 32.14 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -37.61 55.67 40.06 -35.81 56.68 38.17 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -32.62 62.02 44.82 -34.97 63.26 43.94 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 8 hits 2r11_o03 naa= 3 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 86 HIS A 98 HIS^? -3.60 C ACT A 203s A 250 ALA A 135 ALA~? 6.35 OXT ACT A 203 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -52.93 68.60 64.38 -53.51 68.88 63.01 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 86 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 250 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP C 74 ASP^? 14.86 O ACT C 201 A 86 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 250 ALA C 135 ALA~? 15.67 O2 EDO A 301 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -49.12 46.81 68.31 -48.42 46.56 69.64 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 86 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 250 ALA D 135 ALA~? 18.41 CH3 ACT A 203 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -39.82 78.98 44.65 -40.33 80.39 44.94 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o00 naa= 3 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 B 49 ASP A 74 ASP^? 5.73 OXT ACT A 203 B 86 HIS A 98 HIS^? -3.60 C ACT A 203s B 250 ALA A 135 ALA~? 6.35 OXT ACT A 203 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -52.93 68.60 64.38 -53.51 68.88 63.01 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 B 49 ASP B 74 ASP^? 14.88 OXT ACT B 201 B 86 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 250 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 B 49 ASP B 99 ASP.? 16.09 OXT ACT B 201 B 86 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 250 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 B 49 ASP C 74 ASP^? 14.86 O ACT C 201 B 86 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 250 ALA C 135 ALA~? 15.67 O2 EDO A 301 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -49.12 46.81 68.31 -48.42 46.56 69.64 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 B 49 ASP D 74 ASP^? 14.85 OXT ACT D 201 B 86 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 250 ALA D 135 ALA~? 18.41 CH3 ACT A 203 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -39.82 78.98 44.65 -40.33 80.39 44.94 2wwt_o01 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 5 hits 2wwt_o01 naa= 3 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 C 49 ASP A 74 ASP^? 5.73 OXT ACT A 203 C 86 HIS A 98 HIS^? -3.60 C ACT A 203s C 250 ALA A 135 ALA~? 6.35 OXT ACT A 203 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -52.93 68.60 64.38 -53.51 68.88 63.01 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 C 49 ASP B 74 ASP^? 14.88 OXT ACT B 201 C 86 HIS B 98 HIS^? 14.98 OXT ACT B 201 C 250 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 C 49 ASP B 99 ASP.? 16.09 OXT ACT B 201 C 86 HIS B 98 HIS^? 14.98 OXT ACT B 201 C 250 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -35.72 42.46 72.53 -35.18 41.59 70.69 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 C 49 ASP C 74 ASP^? 14.86 O ACT C 201 C 86 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 250 ALA C 135 ALA~? 15.67 O2 EDO A 301 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -49.12 46.81 68.31 -48.42 46.56 69.64 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 C 49 ASP D 74 ASP^? 14.85 OXT ACT D 201 C 86 HIS D 98 HIS^? 13.13 CH3 ACT A 203 C 250 ALA D 135 ALA~? 18.41 CH3 ACT A 203 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -39.82 78.98 44.65 -40.33 80.39 44.94 2wwt_o02 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 5 hits 2wwt_o02 naa= 3 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 D 49 ASP A 74 ASP^? 5.73 OXT ACT A 203 D 86 HIS A 98 HIS^? -3.60 C ACT A 203s D 250 ALA A 135 ALA~? 6.35 OXT ACT A 203 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -52.93 68.60 64.38 -53.51 68.88 63.01 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 D 49 ASP B 74 ASP^? 14.88 OXT ACT B 201 D 86 HIS B 98 HIS^? 14.98 OXT ACT B 201 D 250 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 D 49 ASP C 74 ASP^? 14.86 O ACT C 201 D 86 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 250 ALA C 135 ALA~? 15.67 O2 EDO A 301 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -49.12 46.81 68.31 -48.42 46.56 69.64 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 D 49 ASP D 74 ASP^? 14.85 OXT ACT D 201 D 86 HIS D 98 HIS^? 13.13 CH3 ACT A 203 D 250 ALA D 135 ALA~? 18.41 CH3 ACT A 203 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -39.82 78.98 44.65 -40.33 80.39 44.94 2wwt_o03 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o03 naa= 3 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 E 49 ASP A 74 ASP^? 5.73 OXT ACT A 203 E 86 HIS A 98 HIS^? -3.60 C ACT A 203s E 250 ALA A 135 ALA~? 6.35 OXT ACT A 203 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -52.93 68.60 64.38 -53.51 68.88 63.01 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 E 49 ASP A 99 ASP.? 5.71 O2 EDO A 301 E 86 HIS A 98 HIS^? -3.60 C ACT A 203s E 250 ALA A 135 ALA~? 6.35 OXT ACT A 203 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -52.93 68.60 64.38 -53.51 68.88 63.01 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 E 49 ASP B 74 ASP^? 14.88 OXT ACT B 201 E 86 HIS B 98 HIS^? 14.98 OXT ACT B 201 E 250 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 E 49 ASP B 99 ASP.? 16.09 OXT ACT B 201 E 86 HIS B 98 HIS^? 14.98 OXT ACT B 201 E 250 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 E 49 ASP C 74 ASP^? 14.86 O ACT C 201 E 86 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 250 ALA C 135 ALA~? 15.67 O2 EDO A 301 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -49.12 46.81 68.31 -48.42 46.56 69.64 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 E 49 ASP C 99 ASP.? 5.79 O1 EDO A 301 E 86 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 250 ALA C 135 ALA~? 15.67 O2 EDO A 301 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -49.12 46.81 68.31 -48.42 46.56 69.64 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 E 49 ASP D 74 ASP^? 14.85 OXT ACT D 201 E 86 HIS D 98 HIS^? 13.13 CH3 ACT A 203 E 250 ALA D 135 ALA~? 18.41 CH3 ACT A 203 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -39.82 78.98 44.65 -40.33 80.39 44.94 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 E 49 ASP D 99 ASP.? 7.94 CH3 ACT A 203 E 86 HIS D 98 HIS^? 13.13 CH3 ACT A 203 E 250 ALA D 135 ALA~? 18.41 CH3 ACT A 203 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -39.82 78.98 44.65 -40.33 80.39 44.94 2wwt_o04 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o04 naa= 3 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 F 49 ASP A 74 ASP^? 5.73 OXT ACT A 203 F 86 HIS A 98 HIS^? -3.60 C ACT A 203s F 250 ALA A 135 ALA~? 6.35 OXT ACT A 203 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -44.71 72.29 58.72 -45.62 72.95 56.93 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -52.93 68.60 64.38 -53.51 68.88 63.01 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 F 49 ASP A 99 ASP.? 5.71 O2 EDO A 301 F 86 HIS A 98 HIS^? -3.60 C ACT A 203s F 250 ALA A 135 ALA~? 6.35 OXT ACT A 203 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -44.15 62.19 57.97 -45.93 61.14 58.45 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -46.65 67.75 58.52 -46.50 68.86 56.74 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -52.93 68.60 64.38 -53.51 68.88 63.01 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 F 49 ASP B 74 ASP^? 14.88 OXT ACT B 201 F 86 HIS B 98 HIS^? 14.98 OXT ACT B 201 F 250 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -28.72 40.71 79.64 -29.03 38.66 80.05 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 F 49 ASP B 99 ASP.? 16.09 OXT ACT B 201 F 86 HIS B 98 HIS^? 14.98 OXT ACT B 201 F 250 ALA B 135 ALA~? 14.51 C2 EDO A 302 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -35.72 42.46 72.53 -35.18 41.59 70.69 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -30.93 39.91 75.36 -31.53 38.49 76.78 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -23.86 40.30 69.99 -24.20 38.82 70.13 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 F 49 ASP C 74 ASP^? 14.86 O ACT C 201 F 86 HIS C 98 HIS^? 11.61 O2 EDO A 301 F 250 ALA C 135 ALA~? 15.67 O2 EDO A 301 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -39.15 44.77 65.21 -38.14 44.24 67.00 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -49.12 46.81 68.31 -48.42 46.56 69.64 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 F 49 ASP C 99 ASP.? 5.79 O1 EDO A 301 F 86 HIS C 98 HIS^? 11.61 O2 EDO A 301 F 250 ALA C 135 ALA~? 15.67 O2 EDO A 301 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -39.68 54.89 65.92 -41.28 55.63 67.10 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -40.81 49.03 67.16 -39.15 48.14 68.10 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -49.12 46.81 68.31 -48.42 46.56 69.64 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 F 49 ASP D 74 ASP^? 14.85 OXT ACT D 201 F 86 HIS D 98 HIS^? 13.13 CH3 ACT A 203 F 250 ALA D 135 ALA~? 18.41 CH3 ACT A 203 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -50.30 76.97 42.14 -51.14 78.91 42.11 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -39.82 78.98 44.65 -40.33 80.39 44.94 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 F 49 ASP D 99 ASP.? 7.94 CH3 ACT A 203 F 86 HIS D 98 HIS^? 13.13 CH3 ACT A 203 F 250 ALA D 135 ALA~? 18.41 CH3 ACT A 203 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -49.03 74.78 51.99 -47.35 75.78 52.80 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -48.48 77.63 46.64 -50.12 78.90 46.30 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -39.82 78.98 44.65 -40.33 80.39 44.94 2wwt_o05 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o05 naa= 3 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 1 3 # 1 A 89 SER A 101 SER.? 7.80 O2 EDO A 301 A 216 ASP A 74 ASP^? 5.73 OXT ACT A 203 A 243 HIS A 98 HIS^? -3.60 C ACT A 203s coo 11.52 10.39 18.97 12.10 9.11 20.95 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 20.60 4.89 19.19 18.56 4.62 19.55 -44.71 72.29 58.72 -45.62 72.95 56.93 coo 16.75 7.77 21.42 14.85 7.46 20.58 -46.65 67.75 58.52 -46.50 68.86 56.74 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 2 3 # 2 A 89 SER B 101 SER.? 19.25 O ACT C 201 A 216 ASP B 74 ASP^? 14.88 OXT ACT B 201 A 243 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo 11.52 10.39 18.97 12.10 9.11 20.95 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 20.60 4.89 19.19 18.56 4.62 19.55 -28.72 40.71 79.64 -29.03 38.66 80.05 coo 16.75 7.77 21.42 14.85 7.46 20.58 -30.93 39.91 75.36 -31.53 38.49 76.78 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 3 3 # 3 A 89 SER C 101 SER.? 7.85 O1 EDO A 301 A 216 ASP C 74 ASP^? 14.86 O ACT C 201 A 243 HIS C 98 HIS^? 11.61 O2 EDO A 301 coo 11.52 10.39 18.97 12.10 9.11 20.95 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 20.60 4.89 19.19 18.56 4.62 19.55 -39.15 44.77 65.21 -38.14 44.24 67.00 coo 16.75 7.77 21.42 14.85 7.46 20.58 -40.81 49.03 67.16 -39.15 48.14 68.10 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 4 3 # 4 A 89 SER D 101 SER.? 9.16 OXT ACT A 203 A 216 ASP D 74 ASP^? 14.85 OXT ACT D 201 A 243 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo 11.52 10.39 18.97 12.10 9.11 20.95 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 20.60 4.89 19.19 18.56 4.62 19.55 -50.30 76.97 42.14 -51.14 78.91 42.11 coo 16.75 7.77 21.42 14.85 7.46 20.58 -48.48 77.63 46.64 -50.12 78.90 46.30 2xmz_o00 source 2XMZ HYDROLASE, ALPHA/BETA HYDROLASE FOLD FAMILY : 4 hits 2xmz_o00 naa= 3 ULMN 3 2yau_o00 TRYPANOTHIONE REDUCTASE user 1 3 # 1 A 52 CYH B 127 CYH.? 10.07 OXT ACT A 201 A 57 CYH A 127 CYH.? 6.15 O ACT A 202 A 461 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo -30.85 -50.17 -6.40 -28.03 -49.90 -6.67 -34.42 60.97 75.89 -35.29 63.54 75.29 coo -29.10 -46.15 -4.46 -27.11 -46.53 -6.46 -31.19 62.06 71.95 -29.40 60.66 73.55 coo -2.92 -29.38 7.04 -3.45 -29.06 9.05 -48.48 77.63 46.64 -50.12 78.90 46.30 ULMN 3 2yau_o00 TRYPANOTHIONE REDUCTASE user 2 3 # 2 A 52 CYH D 127 CYH.? 10.01 OXT ACT C 201 A 57 CYH C 127 CYH.? 10.01 O ACT D 201 A 461 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo -30.85 -50.17 -6.40 -28.03 -49.90 -6.67 -47.67 56.31 47.24 -47.42 53.67 48.08 coo -29.10 -46.15 -4.46 -27.11 -46.53 -6.46 -42.49 55.99 47.19 -42.84 57.56 44.90 coo -2.92 -29.38 7.04 -3.45 -29.06 9.05 -30.93 39.91 75.36 -31.53 38.49 76.78 2yau_o00 source 2YAU TRYPANOTHIONE REDUCTASE : 2 hits 2yau_o00 naa= 3 ULMN 3 2yau_o01 TRYPANOTHIONE REDUCTASE user 1 3 # 1 B 52 CYH B 127 CYH.? 10.07 OXT ACT A 201 B 57 CYH A 127 CYH.? 6.15 O ACT A 202 B 461 HIS D 98 HIS^? 13.13 CH3 ACT A 203 coo -1.03 -20.83 6.74 -1.88 -23.47 6.56 -34.42 60.97 75.89 -35.29 63.54 75.29 coo -5.28 -22.40 4.62 -5.01 -24.41 6.61 -31.19 62.06 71.95 -29.40 60.66 73.55 coo -22.30 -48.65 -7.07 -22.80 -48.08 -9.04 -48.48 77.63 46.64 -50.12 78.90 46.30 ULMN 3 2yau_o01 TRYPANOTHIONE REDUCTASE user 2 3 # 2 B 52 CYH D 127 CYH.? 10.01 OXT ACT C 201 B 57 CYH C 127 CYH.? 10.01 O ACT D 201 B 461 HIS B 98 HIS^? 14.98 OXT ACT B 201 coo -1.03 -20.83 6.74 -1.88 -23.47 6.56 -47.67 56.31 47.24 -47.42 53.67 48.08 coo -5.28 -22.40 4.62 -5.01 -24.41 6.61 -42.49 55.99 47.19 -42.84 57.56 44.90 coo -22.30 -48.65 -7.07 -22.80 -48.08 -9.04 -30.93 39.91 75.36 -31.53 38.49 76.78 2yau_o01 source 2YAU TRYPANOTHIONE REDUCTASE : 2 hits 2yau_o01 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 59 GLU~? 18.41 O2 EDO A 302 A 44 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 50 THR A 46 THR^? 13.12 OXT ACT A 202 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -19.57 66.85 53.38 -18.14 66.20 51.96 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -17.27 68.11 64.46 -19.35 68.72 64.20 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU A 60 GLU~? 10.63 O2 EDO A 302 A 44 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 50 THR A 46 THR^? 13.12 OXT ACT A 202 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -19.73 62.99 57.19 -19.03 61.21 58.09 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -17.27 68.11 64.46 -19.35 68.72 64.20 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU A 114 GLU^? 11.87 CH3 ACT A 202 A 44 ASP A 86 ASP.? 20.24 CH3 ACT A 202 A 50 THR A 85 THR^? 18.12 O ACT A 202 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -17.01 70.06 74.63 -16.05 68.26 75.13 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -16.25 74.73 81.62 -15.60 74.59 83.62 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -20.41 74.13 82.96 -20.15 72.63 84.47 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU B 59 GLU~? 20.69 O ACT B 201 A 44 ASP B 45 ASP^? 20.35 O ACT B 201 A 50 THR B 46 THR^? 13.06 O ACT B 201 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -47.90 53.57 92.50 -49.95 53.72 93.03 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -41.83 63.03 90.93 -40.53 61.43 90.23 ULMN 3 3hde_o00 LYSOZYME user 5 3 # 5 A 35 GLU B 60 GLU~? 17.33 O ACT B 201 A 44 ASP B 45 ASP^? 20.35 O ACT B 201 A 50 THR B 46 THR^? 13.06 O ACT B 201 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -48.17 57.12 87.93 -49.17 58.57 86.76 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -41.83 63.03 90.93 -40.53 61.43 90.23 ULMN 3 3hde_o00 LYSOZYME user 6 3 # 6 A 35 GLU B 160 GLU.? 4.71 OXT ACT A 202 A 44 ASP A 45 ASP^? 16.09 OXT ACT A 202 A 50 THR A 46 THR^? 13.12 OXT ACT A 202 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -17.96 60.58 68.89 -19.86 60.60 67.97 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -17.27 68.11 64.46 -19.35 68.72 64.20 ULMN 3 3hde_o00 LYSOZYME user 7 3 # 7 A 35 GLU C 59 GLU~? 13.48 O2 EDO A 302 A 44 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 50 THR C 46 THR^? 13.10 OXT ACT C 201 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -20.25 53.72 49.66 -20.40 52.10 51.04 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -27.30 52.39 40.74 -28.28 51.51 42.48 ULMN 3 3hde_o00 LYSOZYME user 8 3 # 8 A 35 GLU C 60 GLU~? 17.22 OXT ACT C 201 A 44 ASP C 45 ASP^? 20.17 OXT ACT C 201 A 50 THR C 46 THR^? 13.10 OXT ACT C 201 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -23.89 57.63 47.43 -24.47 59.50 46.62 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -27.30 52.39 40.74 -28.28 51.51 42.48 ULMN 3 3hde_o00 LYSOZYME user 9 3 # 9 A 35 GLU D 59 GLU~? 18.52 O ACT D 201 A 44 ASP D 45 ASP^? 20.33 O ACT D 201 A 50 THR D 46 THR^? 13.15 O ACT D 201 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -69.73 60.64 47.66 -70.08 62.16 46.23 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -63.51 52.01 43.24 -62.49 53.88 42.85 ULMN 3 3hde_o00 LYSOZYME user 10 3 # 10 A 35 GLU D 60 GLU~? 17.31 O ACT D 201 A 44 ASP D 45 ASP^? 20.33 O ACT D 201 A 50 THR D 46 THR^? 13.15 O ACT D 201 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -66.09 57.03 50.37 -65.56 55.61 51.84 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -63.51 52.01 43.24 -62.49 53.88 42.85 ULMN 3 3hde_o00 LYSOZYME user 11 3 # 11 A 35 GLU D 114 GLU^? 18.05 O ACT D 201 A 44 ASP D 86 ASP.? 24.19 CH3 ACT D 201 A 50 THR D 85 THR^? 21.00 CH3 ACT C 201 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -56.92 45.97 38.27 -56.84 44.55 39.82 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -53.41 42.17 31.38 -52.32 40.44 30.82 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -49.55 44.27 31.82 -48.24 42.86 32.81 3hde_o00 source 3HDE LYSOZYME : 11 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 59 GLU~? 18.41 O2 EDO A 302 B 44 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 50 THR A 43 THR^? 16.05 OXT ACT A 202 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -19.57 66.85 53.38 -18.14 66.20 51.96 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -16.17 72.65 63.81 -15.51 71.79 65.68 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU A 59 GLU~? 18.41 O2 EDO A 302 B 44 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 50 THR A 46 THR^? 13.12 OXT ACT A 202 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -19.57 66.85 53.38 -18.14 66.20 51.96 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -17.27 68.11 64.46 -19.35 68.72 64.20 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU A 60 GLU~? 10.63 O2 EDO A 302 B 44 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 50 THR A 43 THR^? 16.05 OXT ACT A 202 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -19.73 62.99 57.19 -19.03 61.21 58.09 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -16.17 72.65 63.81 -15.51 71.79 65.68 ULMN 3 3hde_o01 LYSOZYME user 4 3 # 4 B 35 GLU A 60 GLU~? 10.63 O2 EDO A 302 B 44 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 50 THR A 46 THR^? 13.12 OXT ACT A 202 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -19.73 62.99 57.19 -19.03 61.21 58.09 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -17.27 68.11 64.46 -19.35 68.72 64.20 ULMN 3 3hde_o01 LYSOZYME user 5 3 # 5 B 35 GLU A 114 GLU^? 11.87 CH3 ACT A 202 B 44 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 50 THR A 43 THR^? 16.05 OXT ACT A 202 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -17.01 70.06 74.63 -16.05 68.26 75.13 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -16.17 72.65 63.81 -15.51 71.79 65.68 ULMN 3 3hde_o01 LYSOZYME user 6 3 # 6 B 35 GLU A 114 GLU^? 11.87 CH3 ACT A 202 B 44 ASP A 45 ASP^? 16.09 OXT ACT A 202 B 50 THR A 46 THR^? 13.12 OXT ACT A 202 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -17.01 70.06 74.63 -16.05 68.26 75.13 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -12.72 67.64 62.66 -11.94 68.82 64.26 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -17.27 68.11 64.46 -19.35 68.72 64.20 ULMN 3 3hde_o01 LYSOZYME user 7 3 # 7 B 35 GLU B 59 GLU~? 20.69 O ACT B 201 B 44 ASP B 45 ASP^? 20.35 O ACT B 201 B 50 THR B 43 THR^? 17.03 O ACT B 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -47.90 53.57 92.50 -49.95 53.72 93.03 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -39.88 62.28 95.16 -39.68 64.27 94.34 ULMN 3 3hde_o01 LYSOZYME user 8 3 # 8 B 35 GLU B 59 GLU~? 20.69 O ACT B 201 B 44 ASP B 45 ASP^? 20.35 O ACT B 201 B 50 THR B 46 THR^? 13.06 O ACT B 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -47.90 53.57 92.50 -49.95 53.72 93.03 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -41.83 63.03 90.93 -40.53 61.43 90.23 ULMN 3 3hde_o01 LYSOZYME user 9 3 # 9 B 35 GLU B 60 GLU~? 17.33 O ACT B 201 B 44 ASP B 45 ASP^? 20.35 O ACT B 201 B 50 THR B 43 THR^? 17.03 O ACT B 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -48.17 57.12 87.93 -49.17 58.57 86.76 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -39.88 62.28 95.16 -39.68 64.27 94.34 ULMN 3 3hde_o01 LYSOZYME user 10 3 # 10 B 35 GLU B 60 GLU~? 17.33 O ACT B 201 B 44 ASP B 45 ASP^? 20.35 O ACT B 201 B 50 THR B 46 THR^? 13.06 O ACT B 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -48.17 57.12 87.93 -49.17 58.57 86.76 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -41.83 63.03 90.93 -40.53 61.43 90.23 ULMN 3 3hde_o01 LYSOZYME user 11 3 # 11 B 35 GLU B 114 GLU^? 18.04 O ACT B 201 B 44 ASP B 45 ASP^? 20.35 O ACT B 201 B 50 THR B 43 THR^? 17.03 O ACT B 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -34.74 70.41 89.54 -36.11 71.74 88.69 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -39.88 62.28 95.16 -39.68 64.27 94.34 ULMN 3 3hde_o01 LYSOZYME user 12 3 # 12 B 35 GLU B 114 GLU^? 18.04 O ACT B 201 B 44 ASP B 45 ASP^? 20.35 O ACT B 201 B 50 THR B 46 THR^? 13.06 O ACT B 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -34.74 70.41 89.54 -36.11 71.74 88.69 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -45.52 64.51 93.81 -44.25 65.94 94.72 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -41.83 63.03 90.93 -40.53 61.43 90.23 ULMN 3 3hde_o01 LYSOZYME user 13 3 # 13 B 35 GLU C 59 GLU~? 13.48 O2 EDO A 302 B 44 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 50 THR C 43 THR^? 17.19 CH3 ACT C 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -20.25 53.72 49.66 -20.40 52.10 51.04 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -25.42 48.08 40.00 -26.53 48.88 38.33 ULMN 3 3hde_o01 LYSOZYME user 14 3 # 14 B 35 GLU C 59 GLU~? 13.48 O2 EDO A 302 B 44 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 50 THR C 46 THR^? 13.10 OXT ACT C 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -20.25 53.72 49.66 -20.40 52.10 51.04 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -27.30 52.39 40.74 -28.28 51.51 42.48 ULMN 3 3hde_o01 LYSOZYME user 15 3 # 15 B 35 GLU C 60 GLU~? 17.22 OXT ACT C 201 B 44 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 50 THR C 43 THR^? 17.19 CH3 ACT C 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -23.89 57.63 47.43 -24.47 59.50 46.62 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -25.42 48.08 40.00 -26.53 48.88 38.33 ULMN 3 3hde_o01 LYSOZYME user 16 3 # 16 B 35 GLU C 60 GLU~? 17.22 OXT ACT C 201 B 44 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 50 THR C 46 THR^? 13.10 OXT ACT C 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -23.89 57.63 47.43 -24.47 59.50 46.62 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -27.30 52.39 40.74 -28.28 51.51 42.48 ULMN 3 3hde_o01 LYSOZYME user 17 3 # 17 B 35 GLU C 114 GLU^? 18.18 OXT ACT C 201 B 44 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 50 THR C 43 THR^? 17.19 CH3 ACT C 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -34.62 49.81 33.93 -34.65 51.69 32.98 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -25.42 48.08 40.00 -26.53 48.88 38.33 ULMN 3 3hde_o01 LYSOZYME user 18 3 # 18 B 35 GLU C 114 GLU^? 18.18 OXT ACT C 201 B 44 ASP C 45 ASP^? 20.17 OXT ACT C 201 B 50 THR C 46 THR^? 13.10 OXT ACT C 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -34.62 49.81 33.93 -34.65 51.69 32.98 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -23.26 53.52 38.24 -24.05 52.31 36.68 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -27.30 52.39 40.74 -28.28 51.51 42.48 ULMN 3 3hde_o01 LYSOZYME user 19 3 # 19 B 35 GLU D 59 GLU~? 18.52 O ACT D 201 B 44 ASP D 45 ASP^? 20.33 O ACT D 201 B 50 THR D 43 THR^? 17.14 O ACT D 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -69.73 60.64 47.66 -70.08 62.16 46.23 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -65.70 52.73 39.05 -64.63 50.86 39.25 ULMN 3 3hde_o01 LYSOZYME user 20 3 # 20 B 35 GLU D 59 GLU~? 18.52 O ACT D 201 B 44 ASP D 45 ASP^? 20.33 O ACT D 201 B 50 THR D 46 THR^? 13.15 O ACT D 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -69.73 60.64 47.66 -70.08 62.16 46.23 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -63.51 52.01 43.24 -62.49 53.88 42.85 ULMN 3 3hde_o01 LYSOZYME user 21 3 # 21 B 35 GLU D 60 GLU~? 17.31 O ACT D 201 B 44 ASP D 45 ASP^? 20.33 O ACT D 201 B 50 THR D 43 THR^? 17.14 O ACT D 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -66.09 57.03 50.37 -65.56 55.61 51.84 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -65.70 52.73 39.05 -64.63 50.86 39.25 ULMN 3 3hde_o01 LYSOZYME user 22 3 # 22 B 35 GLU D 114 GLU^? 18.05 O ACT D 201 B 44 ASP D 45 ASP^? 20.33 O ACT D 201 B 50 THR D 43 THR^? 17.14 O ACT D 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -56.92 45.97 38.27 -56.84 44.55 39.82 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -65.70 52.73 39.05 -64.63 50.86 39.25 ULMN 3 3hde_o01 LYSOZYME user 23 3 # 23 B 35 GLU D 114 GLU^? 18.05 O ACT D 201 B 44 ASP D 45 ASP^? 20.33 O ACT D 201 B 50 THR D 46 THR^? 13.15 O ACT D 201 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -56.92 45.97 38.27 -56.84 44.55 39.82 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -67.68 49.50 43.87 -67.26 48.38 42.12 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -63.51 52.01 43.24 -62.49 53.88 42.85 3hde_o01 source 3HDE LYSOZYME : 23 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 59 GLU~? 18.41 O2 EDO A 302 C 44 ASP A 45 ASP^? 16.09 OXT ACT A 202 C 50 THR A 43 THR^? 16.05 OXT ACT A 202 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -19.57 66.85 53.38 -18.14 66.20 51.96 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 25.48 4.87 1.60 23.90 4.95 0.15 -16.17 72.65 63.81 -15.51 71.79 65.68 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU A 59 GLU~? 18.41 O2 EDO A 302 C 44 ASP A 45 ASP^? 16.09 OXT ACT A 202 C 50 THR A 46 THR^? 13.12 OXT ACT A 202 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -19.57 66.85 53.38 -18.14 66.20 51.96 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 25.48 4.87 1.60 23.90 4.95 0.15 -17.27 68.11 64.46 -19.35 68.72 64.20 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU A 114 GLU^? 11.87 CH3 ACT A 202 C 44 ASP A 45 ASP^? 16.09 OXT ACT A 202 C 50 THR A 43 THR^? 16.05 OXT ACT A 202 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 25.48 4.87 1.60 23.90 4.95 0.15 -16.17 72.65 63.81 -15.51 71.79 65.68 ULMN 3 3hde_o02 LYSOZYME user 4 3 # 4 C 35 GLU A 114 GLU^? 11.87 CH3 ACT A 202 C 44 ASP A 45 ASP^? 16.09 OXT ACT A 202 C 50 THR A 46 THR^? 13.12 OXT ACT A 202 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -17.01 70.06 74.63 -16.05 68.26 75.13 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -12.72 67.64 62.66 -11.94 68.82 64.26 coo 25.48 4.87 1.60 23.90 4.95 0.15 -17.27 68.11 64.46 -19.35 68.72 64.20 ULMN 3 3hde_o02 LYSOZYME user 5 3 # 5 C 35 GLU B 59 GLU~? 20.69 O ACT B 201 C 44 ASP B 45 ASP^? 20.35 O ACT B 201 C 50 THR B 43 THR^? 17.03 O ACT B 201 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -47.90 53.57 92.50 -49.95 53.72 93.03 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 25.48 4.87 1.60 23.90 4.95 0.15 -39.88 62.28 95.16 -39.68 64.27 94.34 ULMN 3 3hde_o02 LYSOZYME user 6 3 # 6 C 35 GLU B 59 GLU~? 20.69 O ACT B 201 C 44 ASP B 45 ASP^? 20.35 O ACT B 201 C 50 THR B 46 THR^? 13.06 O ACT B 201 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -47.90 53.57 92.50 -49.95 53.72 93.03 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 25.48 4.87 1.60 23.90 4.95 0.15 -41.83 63.03 90.93 -40.53 61.43 90.23 ULMN 3 3hde_o02 LYSOZYME user 7 3 # 7 C 35 GLU B 114 GLU^? 18.04 O ACT B 201 C 44 ASP B 45 ASP^? 20.35 O ACT B 201 C 50 THR B 43 THR^? 17.03 O ACT B 201 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 25.48 4.87 1.60 23.90 4.95 0.15 -39.88 62.28 95.16 -39.68 64.27 94.34 ULMN 3 3hde_o02 LYSOZYME user 8 3 # 8 C 35 GLU B 114 GLU^? 18.04 O ACT B 201 C 44 ASP B 45 ASP^? 20.35 O ACT B 201 C 50 THR B 46 THR^? 13.06 O ACT B 201 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -34.74 70.41 89.54 -36.11 71.74 88.69 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -45.52 64.51 93.81 -44.25 65.94 94.72 coo 25.48 4.87 1.60 23.90 4.95 0.15 -41.83 63.03 90.93 -40.53 61.43 90.23 ULMN 3 3hde_o02 LYSOZYME user 9 3 # 9 C 35 GLU C 59 GLU~? 13.48 O2 EDO A 302 C 44 ASP C 45 ASP^? 20.17 OXT ACT C 201 C 50 THR C 43 THR^? 17.19 CH3 ACT C 201 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -20.25 53.72 49.66 -20.40 52.10 51.04 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 25.48 4.87 1.60 23.90 4.95 0.15 -25.42 48.08 40.00 -26.53 48.88 38.33 ULMN 3 3hde_o02 LYSOZYME user 10 3 # 10 C 35 GLU C 59 GLU~? 13.48 O2 EDO A 302 C 44 ASP C 45 ASP^? 20.17 OXT ACT C 201 C 50 THR C 46 THR^? 13.10 OXT ACT C 201 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -20.25 53.72 49.66 -20.40 52.10 51.04 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 25.48 4.87 1.60 23.90 4.95 0.15 -27.30 52.39 40.74 -28.28 51.51 42.48 ULMN 3 3hde_o02 LYSOZYME user 11 3 # 11 C 35 GLU C 114 GLU^? 18.18 OXT ACT C 201 C 44 ASP C 45 ASP^? 20.17 OXT ACT C 201 C 50 THR C 43 THR^? 17.19 CH3 ACT C 201 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 25.48 4.87 1.60 23.90 4.95 0.15 -25.42 48.08 40.00 -26.53 48.88 38.33 ULMN 3 3hde_o02 LYSOZYME user 12 3 # 12 C 35 GLU C 114 GLU^? 18.18 OXT ACT C 201 C 44 ASP C 45 ASP^? 20.17 OXT ACT C 201 C 50 THR C 46 THR^? 13.10 OXT ACT C 201 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -34.62 49.81 33.93 -34.65 51.69 32.98 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -23.26 53.52 38.24 -24.05 52.31 36.68 coo 25.48 4.87 1.60 23.90 4.95 0.15 -27.30 52.39 40.74 -28.28 51.51 42.48 ULMN 3 3hde_o02 LYSOZYME user 13 3 # 13 C 35 GLU D 59 GLU~? 18.52 O ACT D 201 C 44 ASP D 45 ASP^? 20.33 O ACT D 201 C 50 THR D 43 THR^? 17.14 O ACT D 201 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -69.73 60.64 47.66 -70.08 62.16 46.23 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 25.48 4.87 1.60 23.90 4.95 0.15 -65.70 52.73 39.05 -64.63 50.86 39.25 ULMN 3 3hde_o02 LYSOZYME user 14 3 # 14 C 35 GLU D 59 GLU~? 18.52 O ACT D 201 C 44 ASP D 45 ASP^? 20.33 O ACT D 201 C 50 THR D 46 THR^? 13.15 O ACT D 201 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -69.73 60.64 47.66 -70.08 62.16 46.23 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 25.48 4.87 1.60 23.90 4.95 0.15 -63.51 52.01 43.24 -62.49 53.88 42.85 ULMN 3 3hde_o02 LYSOZYME user 15 3 # 15 C 35 GLU D 114 GLU^? 18.05 O ACT D 201 C 44 ASP D 45 ASP^? 20.33 O ACT D 201 C 50 THR D 43 THR^? 17.14 O ACT D 201 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 25.48 4.87 1.60 23.90 4.95 0.15 -65.70 52.73 39.05 -64.63 50.86 39.25 ULMN 3 3hde_o02 LYSOZYME user 16 3 # 16 C 35 GLU D 114 GLU^? 18.05 O ACT D 201 C 44 ASP D 45 ASP^? 20.33 O ACT D 201 C 50 THR D 46 THR^? 13.15 O ACT D 201 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -56.92 45.97 38.27 -56.84 44.55 39.82 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -67.68 49.50 43.87 -67.26 48.38 42.12 coo 25.48 4.87 1.60 23.90 4.95 0.15 -63.51 52.01 43.24 -62.49 53.88 42.85 3hde_o02 source 3HDE LYSOZYME : 16 hits 3hde_o02 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER A 101 SER.? 7.80 O2 EDO A 301 A 123 HIS A 98 HIS^? -3.60 C ACT A 203s A 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 45.74 29.80 42.79 47.58 31.06 41.64 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 44.17 25.61 37.60 45.21 25.56 35.81 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 39.85 24.35 34.94 41.12 25.58 33.83 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 A 98 SER B 101 SER.? 19.25 O ACT C 201 A 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 A 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 45.74 29.80 42.79 47.58 31.06 41.64 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 44.17 25.61 37.60 45.21 25.56 35.81 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 39.85 24.35 34.94 41.12 25.58 33.83 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 A 98 SER C 101 SER.? 7.85 O1 EDO A 301 A 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 A 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 45.74 29.80 42.79 47.58 31.06 41.64 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 44.17 25.61 37.60 45.21 25.56 35.81 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 39.85 24.35 34.94 41.12 25.58 33.83 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 A 98 SER D 101 SER.? 9.16 OXT ACT A 203 A 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 A 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 45.74 29.80 42.79 47.58 31.06 41.64 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 44.17 25.61 37.60 45.21 25.56 35.81 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 39.85 24.35 34.94 41.12 25.58 33.83 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o00 naa= 3 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 B 98 SER A 101 SER.? 7.80 O2 EDO A 301 B 123 HIS A 98 HIS^? -3.60 C ACT A 203s B 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 71.87 39.14 40.71 71.75 41.26 39.36 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 73.25 34.64 35.72 73.65 35.23 33.78 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 70.98 30.38 33.77 70.74 32.03 32.50 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 B 98 SER B 101 SER.? 19.25 O ACT C 201 B 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 B 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 71.87 39.14 40.71 71.75 41.26 39.36 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 73.25 34.64 35.72 73.65 35.23 33.78 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 70.98 30.38 33.77 70.74 32.03 32.50 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 B 98 SER C 101 SER.? 7.85 O1 EDO A 301 B 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 B 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 71.87 39.14 40.71 71.75 41.26 39.36 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 73.25 34.64 35.72 73.65 35.23 33.78 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 70.98 30.38 33.77 70.74 32.03 32.50 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 B 98 SER D 101 SER.? 9.16 OXT ACT A 203 B 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 B 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 71.87 39.14 40.71 71.75 41.26 39.36 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 73.25 34.64 35.72 73.65 35.23 33.78 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 70.98 30.38 33.77 70.74 32.03 32.50 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o01 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o01 naa= 3 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 C 98 SER A 101 SER.? 7.80 O2 EDO A 301 C 123 HIS A 98 HIS^? -3.60 C ACT A 203s C 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 80.36 64.80 34.44 78.44 65.95 33.29 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 83.70 62.42 29.01 83.15 62.88 27.08 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 85.17 57.73 27.21 83.46 58.45 26.25 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 C 98 SER B 101 SER.? 19.25 O ACT C 201 C 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 C 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 80.36 64.80 34.44 78.44 65.95 33.29 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 83.70 62.42 29.01 83.15 62.88 27.08 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 85.17 57.73 27.21 83.46 58.45 26.25 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 C 98 SER C 101 SER.? 7.85 O1 EDO A 301 C 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 C 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 80.36 64.80 34.44 78.44 65.95 33.29 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 83.70 62.42 29.01 83.15 62.88 27.08 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 85.17 57.73 27.21 83.46 58.45 26.25 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 C 98 SER D 101 SER.? 9.16 OXT ACT A 203 C 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 C 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 80.36 64.80 34.44 78.44 65.95 33.29 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 83.70 62.42 29.01 83.15 62.88 27.08 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 85.17 57.73 27.21 83.46 58.45 26.25 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o02 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o02 naa= 3 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 D 98 SER A 101 SER.? 7.80 O2 EDO A 301 D 123 HIS A 98 HIS^? -3.60 C ACT A 203s D 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 65.12 87.33 28.49 62.90 86.32 27.74 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 67.96 87.91 22.28 66.90 87.63 20.52 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 72.12 85.84 19.92 70.35 84.94 19.30 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 D 98 SER B 101 SER.? 19.25 O ACT C 201 D 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 D 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 65.12 87.33 28.49 62.90 86.32 27.74 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 67.96 87.91 22.28 66.90 87.63 20.52 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 72.12 85.84 19.92 70.35 84.94 19.30 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 D 98 SER C 101 SER.? 7.85 O1 EDO A 301 D 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 D 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 65.12 87.33 28.49 62.90 86.32 27.74 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 67.96 87.91 22.28 66.90 87.63 20.52 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 72.12 85.84 19.92 70.35 84.94 19.30 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 D 98 SER D 101 SER.? 9.16 OXT ACT A 203 D 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 D 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 65.12 87.33 28.49 62.90 86.32 27.74 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 67.96 87.91 22.28 66.90 87.63 20.52 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 72.12 85.84 19.92 70.35 84.94 19.30 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o03 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o03 naa= 3 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 E 98 SER A 101 SER.? 7.80 O2 EDO A 301 E 123 HIS A 98 HIS^? -3.60 C ACT A 203s E 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 37.23 89.57 27.33 36.32 87.23 27.07 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 37.64 91.40 20.82 36.88 90.22 19.31 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 41.40 92.80 17.47 40.89 90.79 17.30 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 E 98 SER B 101 SER.? 19.25 O ACT C 201 E 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 E 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 37.23 89.57 27.33 36.32 87.23 27.07 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 37.64 91.40 20.82 36.88 90.22 19.31 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 41.40 92.80 17.47 40.89 90.79 17.30 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 E 98 SER C 101 SER.? 7.85 O1 EDO A 301 E 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 E 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 37.23 89.57 27.33 36.32 87.23 27.07 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 37.64 91.40 20.82 36.88 90.22 19.31 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 41.40 92.80 17.47 40.89 90.79 17.30 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 E 98 SER D 101 SER.? 9.16 OXT ACT A 203 E 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 E 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 37.23 89.57 27.33 36.32 87.23 27.07 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 37.64 91.40 20.82 36.88 90.22 19.31 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 41.40 92.80 17.47 40.89 90.79 17.30 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o04 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o04 naa= 3 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 F 98 SER A 101 SER.? 7.80 O2 EDO A 301 F 123 HIS A 98 HIS^? -3.60 C ACT A 203s F 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 17.74 70.20 32.16 18.92 67.99 31.89 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 15.23 70.97 25.89 15.37 69.49 24.46 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 15.81 74.47 22.06 16.86 72.70 21.69 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 F 98 SER B 101 SER.? 19.25 O ACT C 201 F 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 F 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 17.74 70.20 32.16 18.92 67.99 31.89 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 15.23 70.97 25.89 15.37 69.49 24.46 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 15.81 74.47 22.06 16.86 72.70 21.69 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 F 98 SER C 101 SER.? 7.85 O1 EDO A 301 F 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 F 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 17.74 70.20 32.16 18.92 67.99 31.89 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 15.23 70.97 25.89 15.37 69.49 24.46 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 15.81 74.47 22.06 16.86 72.70 21.69 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 F 98 SER D 101 SER.? 9.16 OXT ACT A 203 F 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 F 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 17.74 70.20 32.16 18.92 67.99 31.89 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 15.23 70.97 25.89 15.37 69.49 24.46 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 15.81 74.47 22.06 16.86 72.70 21.69 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o05 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o05 naa= 3 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 G 98 SER A 101 SER.? 7.80 O2 EDO A 301 G 123 HIS A 98 HIS^? -3.60 C ACT A 203s G 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 21.77 43.27 39.21 24.15 42.72 38.52 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 18.42 41.13 33.64 19.33 40.10 32.10 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 15.38 43.36 30.02 17.34 43.09 29.34 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 G 98 SER B 101 SER.? 19.25 O ACT C 201 G 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 G 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 21.77 43.27 39.21 24.15 42.72 38.52 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 18.42 41.13 33.64 19.33 40.10 32.10 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 15.38 43.36 30.02 17.34 43.09 29.34 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 G 98 SER C 101 SER.? 7.85 O1 EDO A 301 G 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 G 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 21.77 43.27 39.21 24.15 42.72 38.52 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 18.42 41.13 33.64 19.33 40.10 32.10 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 15.38 43.36 30.02 17.34 43.09 29.34 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 G 98 SER D 101 SER.? 9.16 OXT ACT A 203 G 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 G 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 21.77 43.27 39.21 24.15 42.72 38.52 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 18.42 41.13 33.64 19.33 40.10 32.10 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 15.38 43.36 30.02 17.34 43.09 29.34 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o06 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o06 naa= 3 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 H 98 SER A 101 SER.? 7.80 O2 EDO A 301 H 123 HIS A 98 HIS^? -3.60 C ACT A 203s H 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 156.20 56.60 78.78 153.83 56.16 78.10 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 159.24 56.62 72.66 158.17 56.50 70.89 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 162.98 53.88 70.28 161.08 53.28 69.65 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 H 98 SER B 101 SER.? 19.25 O ACT C 201 H 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 H 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 156.20 56.60 78.78 153.83 56.16 78.10 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 159.24 56.62 72.66 158.17 56.50 70.89 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 162.98 53.88 70.28 161.08 53.28 69.65 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 H 98 SER C 101 SER.? 7.85 O1 EDO A 301 H 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 H 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 156.20 56.60 78.78 153.83 56.16 78.10 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 159.24 56.62 72.66 158.17 56.50 70.89 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 162.98 53.88 70.28 161.08 53.28 69.65 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 H 98 SER D 101 SER.? 9.16 OXT ACT A 203 H 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 H 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 156.20 56.60 78.78 153.83 56.16 78.10 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 159.24 56.62 72.66 158.17 56.50 70.89 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 162.98 53.88 70.28 161.08 53.28 69.65 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o07 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o07 naa= 3 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 I 98 SER A 101 SER.? 7.80 O2 EDO A 301 I 123 HIS A 98 HIS^? -3.60 C ACT A 203s I 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 129.29 63.53 77.27 127.98 61.40 77.00 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 129.99 65.24 70.73 129.03 64.19 69.22 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 133.90 66.07 67.39 133.05 64.19 67.15 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 I 98 SER B 101 SER.? 19.25 O ACT C 201 I 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 I 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 129.29 63.53 77.27 127.98 61.40 77.00 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 129.99 65.24 70.73 129.03 64.19 69.22 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 133.90 66.07 67.39 133.05 64.19 67.15 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 I 98 SER C 101 SER.? 7.85 O1 EDO A 301 I 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 I 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 129.29 63.53 77.27 127.98 61.40 77.00 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 129.99 65.24 70.73 129.03 64.19 69.22 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 133.90 66.07 67.39 133.05 64.19 67.15 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 I 98 SER D 101 SER.? 9.16 OXT ACT A 203 I 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 I 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 129.29 63.53 77.27 127.98 61.40 77.00 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 129.99 65.24 70.73 129.03 64.19 69.22 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 133.90 66.07 67.39 133.05 64.19 67.15 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o08 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o08 naa= 3 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 J 98 SER A 101 SER.? 7.80 O2 EDO A 301 J 123 HIS A 98 HIS^? -3.60 C ACT A 203s J 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 106.76 47.89 81.70 107.53 45.50 81.44 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 104.68 49.18 75.33 104.59 47.70 73.89 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 105.94 52.49 71.50 106.71 50.57 71.17 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 J 98 SER B 101 SER.? 19.25 O ACT C 201 J 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 J 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 106.76 47.89 81.70 107.53 45.50 81.44 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 104.68 49.18 75.33 104.59 47.70 73.89 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 105.94 52.49 71.50 106.71 50.57 71.17 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 J 98 SER C 101 SER.? 7.85 O1 EDO A 301 J 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 J 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 106.76 47.89 81.70 107.53 45.50 81.44 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 104.68 49.18 75.33 104.59 47.70 73.89 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 105.94 52.49 71.50 106.71 50.57 71.17 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 J 98 SER D 101 SER.? 9.16 OXT ACT A 203 J 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 J 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 106.76 47.89 81.70 107.53 45.50 81.44 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 104.68 49.18 75.33 104.59 47.70 73.89 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 105.94 52.49 71.50 106.71 50.57 71.17 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o09 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o09 naa= 3 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 K 98 SER A 101 SER.? 7.80 O2 EDO A 301 K 123 HIS A 98 HIS^? -3.60 C ACT A 203s K 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 105.44 20.79 88.82 107.67 19.79 88.18 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 101.74 19.42 83.14 102.50 18.27 81.61 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 99.17 22.17 79.49 101.04 21.51 78.80 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 K 98 SER B 101 SER.? 19.25 O ACT C 201 K 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 K 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 105.44 20.79 88.82 107.67 19.79 88.18 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 101.74 19.42 83.14 102.50 18.27 81.61 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 99.17 22.17 79.49 101.04 21.51 78.80 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 K 98 SER C 101 SER.? 7.85 O1 EDO A 301 K 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 K 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 105.44 20.79 88.82 107.67 19.79 88.18 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 101.74 19.42 83.14 102.50 18.27 81.61 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 99.17 22.17 79.49 101.04 21.51 78.80 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 K 98 SER D 101 SER.? 9.16 OXT ACT A 203 K 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 K 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 105.44 20.79 88.82 107.67 19.79 88.18 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 101.74 19.42 83.14 102.50 18.27 81.61 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 99.17 22.17 79.49 101.04 21.51 78.80 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o10 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o10 naa= 3 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 L 98 SER A 101 SER.? 7.80 O2 EDO A 301 L 123 HIS A 98 HIS^? -3.60 C ACT A 203s L 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 126.72 3.21 92.89 128.70 4.33 91.79 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 L 98 SER B 101 SER.? 19.25 O ACT C 201 L 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 L 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 126.72 3.21 92.89 128.70 4.33 91.79 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 L 98 SER C 101 SER.? 7.85 O1 EDO A 301 L 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 L 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 126.72 3.21 92.89 128.70 4.33 91.79 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 L 98 SER D 101 SER.? 9.16 OXT ACT A 203 L 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 L 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 126.72 3.21 92.89 128.70 4.33 91.79 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o11 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o11 naa= 3 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 M 98 SER A 101 SER.? 7.80 O2 EDO A 301 M 123 HIS A 98 HIS^? -3.60 C ACT A 203s M 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 154.12 8.07 91.14 154.40 10.16 89.78 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 154.65 3.37 86.18 155.13 3.88 84.24 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 151.68 -0.46 84.21 151.70 1.23 82.98 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 M 98 SER B 101 SER.? 19.25 O ACT C 201 M 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 M 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 154.12 8.07 91.14 154.40 10.16 89.78 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 154.65 3.37 86.18 155.13 3.88 84.24 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 151.68 -0.46 84.21 151.70 1.23 82.98 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 M 98 SER C 101 SER.? 7.85 O1 EDO A 301 M 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 M 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 154.12 8.07 91.14 154.40 10.16 89.78 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 154.65 3.37 86.18 155.13 3.88 84.24 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 151.68 -0.46 84.21 151.70 1.23 82.98 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 M 98 SER D 101 SER.? 9.16 OXT ACT A 203 M 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 M 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 154.12 8.07 91.14 154.40 10.16 89.78 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 154.65 3.37 86.18 155.13 3.88 84.24 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 151.68 -0.46 84.21 151.70 1.23 82.98 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o12 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o12 naa= 3 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 N 98 SER A 101 SER.? 7.80 O2 EDO A 301 N 123 HIS A 98 HIS^? -3.60 C ACT A 203s N 172 ASP A 74 ASP^? 5.73 OXT ACT A 203 coo 167.14 31.88 84.83 165.46 33.38 83.69 -48.36 60.96 55.15 -47.04 58.94 54.93 coo 170.00 29.01 79.37 169.53 29.60 77.44 -46.65 67.75 58.52 -46.50 68.86 56.74 coo 170.55 24.16 77.55 169.03 25.18 76.56 -44.71 72.29 58.72 -45.62 72.95 56.93 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 N 98 SER B 101 SER.? 19.25 O ACT C 201 N 123 HIS B 98 HIS^? 14.98 OXT ACT B 201 N 172 ASP B 74 ASP^? 14.88 OXT ACT B 201 coo 167.14 31.88 84.83 165.46 33.38 83.69 -36.32 37.86 70.76 -37.96 39.10 69.46 coo 170.00 29.01 79.37 169.53 29.60 77.44 -30.93 39.91 75.36 -31.53 38.49 76.78 coo 170.55 24.16 77.55 169.03 25.18 76.56 -28.72 40.71 79.64 -29.03 38.66 80.05 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 N 98 SER C 101 SER.? 7.85 O1 EDO A 301 N 123 HIS C 98 HIS^? 11.61 O2 EDO A 301 N 172 ASP C 74 ASP^? 14.86 O ACT C 201 coo 167.14 31.88 84.83 165.46 33.38 83.69 -40.26 55.74 71.04 -39.54 57.94 70.33 coo 170.00 29.01 79.37 169.53 29.60 77.44 -40.81 49.03 67.16 -39.15 48.14 68.10 coo 170.55 24.16 77.55 169.03 25.18 76.56 -39.15 44.77 65.21 -38.14 44.24 67.00 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 N 98 SER D 101 SER.? 9.16 OXT ACT A 203 N 123 HIS D 98 HIS^? 13.13 CH3 ACT A 203 N 172 ASP D 74 ASP^? 14.85 OXT ACT D 201 coo 167.14 31.88 84.83 165.46 33.38 83.69 -48.40 79.65 53.68 -48.43 78.54 55.84 coo 170.00 29.01 79.37 169.53 29.60 77.44 -48.48 77.63 46.64 -50.12 78.90 46.30 coo 170.55 24.16 77.55 169.03 25.18 76.56 -50.30 76.97 42.14 -51.14 78.91 42.11 3qwd_o13 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 4 hits 3qwd_o13 naa= 3 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 1 3 # 1 A 966 SER A 107 SER^? 6.74 O1 EDO A 301 A 967 ARG A 106 ARG^? 14.48 O1 EDO A 301 A 975 TYR A 95 TYR^? -3.85 O ACT A 201s coo 82.02 40.88 31.11 79.88 41.56 30.18 -40.35 65.45 69.21 -39.92 64.63 66.96 coo 78.94 44.79 33.75 77.86 47.56 32.82 -44.60 68.65 71.93 -47.65 68.54 71.92 coo 83.57 40.86 25.45 83.15 43.18 26.91 -38.20 69.00 66.47 -37.00 66.61 65.61 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 2 3 # 2 A 966 SER C 107 SER^? 6.74 O2 EDO A 301 A 967 ARG C 106 ARG^? 14.47 O2 EDO A 301 A 975 TYR C 95 TYR^? -3.84 O ACT C 201s coo 82.02 40.88 31.11 79.88 41.56 30.18 -45.59 51.52 55.69 -43.69 52.48 56.86 coo 78.94 44.79 33.75 77.86 47.56 32.82 -49.78 47.48 57.01 -51.73 47.13 59.31 coo 83.57 40.86 25.45 83.15 43.18 26.91 -41.63 48.44 55.51 -40.56 51.04 55.32 4dqk_o00 source 4DQK BIFUNCTIONAL P-450/NADPH-P450 REDUCTASE : 2 hits 4dqk_o00 naa= 3